3/30/2015
1¥Jmlatobarat forma
Lakatos Peter (Osteo16gia, endokrinol6 ... ) 2015 I. Balla B , Tobias B , Kosa JP , Podani J , Horvath P , Nagy Z , Horany i J , Jaray B , Szekely E , Krenacs L , Arvai K , Dank M , Putz Z , Szabo B , Szili B , Valkusz Z, Vasas B , Gyori G , Lakatos P , Takacs I Vitamin D-neutralizing CYP24A I expression, oncogenic mutation states and histological finding; of human papillary thyroid cancer JOURNAL OF ENDOCRINOLOGICAL/NVESTIGATION38:(3) pp . 313-321. (2015) IF: 1.552** Nyelv : Angol
Foly 6iratcikk /Szakcikk !fudomany os [273 8182] B. Balla, B. Tobias, P. Lakatos and I. Takacs contributed equally to this work. [ Erveny esitett ] 2. Black OM , Reid IR, Cauley JA , Cosman F , Leung PC , Lakatos P , Lippuner K , Cumming; SR, Hue TF , Mukhopadhyay A , Tan M , AftringRP, Eastell R The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis : A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial (PFT). JOURNAL OF BONE AND MINERAL RESEARCH In press: p. Jn press . (2015) IF : 6 .589** Nyelv: Angol
Foly6iratcikk /Szakcikk !fudomanyos [2848667] In press [ Szerzoi rekord ] 3. Horvath P , Balla B, K6sa JP , Tobias B , Szili B , Kirschner G , Gyori G , Kat6 K , Lakatos P , Takacs I Strong effect of SN P rs4988300 of LRP 5 gene on bone phenotype of Caucasian p ostmenop ausal women JOURNAL OF BONE AND MINERAL METABOLISM In press: p. ln press. (2015) IF : 2.114** Nyelv: Angol
Foly6iratcikk /Szakcikk !fudomanyos [2848666] Published online: 12 March 2015 [ Szerz6i rekord ] 4. Khan AA , Bilezikian J, Bone HG, Gurevich A, Lakatos P, Misiorowski W, Rozhinskaya L , Trotman ML, Toth M Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hy perparathyroidism with contraindications to surgery EUROPEAN JOURNAL OF ENDOCRINOLOGY 172:(5) pp . 527-535. (2015) IF : 3.686** Nyelv Angol
Foly6iratcikk /Szakcikk !fudomanyos [2847996] [ Ervenyesitett ]
2014 5. Aliya Aziz Khan, John P Bilezikian, Henry G Bone , Andrey Gurevich, Peter Lakatos, Waldemar M isiorowski, Liudmila Rozhinskaya , Marie-Louise Trotman, Miklos Toth Cinacalcet Normalizes Serum Calcium in a Randomized, Placebo-Controlled Clinical Study in Patients with Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy In : Endocrine Society's 96th Annual Meeting and Expo. Konferencia helye, ideje: Chicago, Amerikai Egyeslilt Allamok, 2014.07.21 -2014.07.24. Endocrine Society Press, Paper M ON-0196. ( Meeting Abstracts ) Nyelv : Angol
Egyeb konferenciakozlemeny /Absztrakt !fudomanyos [2739875] Session: Diseases of Bone and Mineral Metabolism Poster Board DOI: I 0.121O/endo-meeting;.2014.BCHYD.3.M ON0196 [ Admin lattamozott ]
7. Bakos B, Lukats A, Lakatos P , Gyori G, Tremmel A, Takacs I https://1KTI.mtmt.hu/search/d0W1load.php?type=3&lang=O&flag=533211&orderby=3D1a&dtitle=+ Lakatos+P%C3%A9ter+%280steol%C3%B3gia%2C+en. .
1/342
3/30/2015
nyomtatobarat forma
Report on a case of fibrogenesis imperfecta ossium and a possible new treatment option. OSTEOPOROSIS INTERNATIONAL 25:(5) pp. 16431646. (2014) IF: 4.165* Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [2562289] [ Érvényesített ] 8. Bakos B , Takács I , Lakatos P Újdonságok a pajzsmirigy hormonpótló kezelésben MAGYAR ORVOS 22:(10) pp. 1317. (2014) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [2848654] [ Érvényesített ] 9. Balla B , Arvai K , Horvath P , Tobias B , Takacs I , Nagy Z , Dank M , Fekete G , Kosa JP , Lakatos P Fast and Robust NextGeneration Sequencing Technique Using Ion Torrent Personal Genome M achine for the Screening of Neurofibromatosis Type 1 (NF1) Gene JOURNAL OF MOLECULAR NEUROSCIENCE 53:(2) pp. 204210. (2014) IF: 2.757* Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [2566549] Bernadett Balla, Kristóf Árvai, János P. Kósa, and Péter Lakatos contributed equally to this work. [ Érvényesített ] 10. Barna J , Cseuz R , Lakatos P Tények és tévhitek a szamárköhögésről HÁZIORVOS TOVÁBBKÉPZŐ SZEMLE 19:(8) pp. 568570. (2014) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [2848658] [ Érvényesített ] 11. Hollo A , Clemens Z , Lakatos P Epilepsy and Vitamin D. INTERNATIONAL JOURNAL OF NEUROSCIENCE 124:(6) pp. 387393. (2014) IF: 1.528* Nyelv: Angol
Folyóiratcikk /Összefoglaló cikk /Tudományos [2446546] [ Érvényesített ] Független idéző: 1 Összesen: 1 1
Teagarden DL, Meador KJ, Loring DW Low vitamin D levels are common in patients with epilepsy EPILEPSY RESEARCH (ISSN: 09201211) 108: (8) pp. 13521356. ( 2014) Folyóiratcikk [14593855]
12. Lakatos P , Toth E , Szekeres L , Poor G , Hejj G , M arton I , Takacs I Comparative statistical analysis of osteoporosis treatment based on Hungarian claims data and interpretation of the results in respect to costeffectiveness. OSTEOPOROSIS INTERNATIONAL 25:(8) pp. 20772087. (2014) IF: 4.165* Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [2599845] [ Érvényesített ] 13. Lakatos P , Lakatos G Anyagcsere csontbetegségek In: Szekeres L (szerk.) Reumatológia a háziorvosi gyakorlatban . 328 p. Budapest: SpringM ed, 2014. pp. 217245. ( SpringM ed háziorvos könyvtár ) (ISBN:9786155166549) Nyelv: Magyar
Könyvrészlet /Könyvfejezet /Tudományos [2738988] [ Admin láttamozott ] 14. Lakatos P Genetikai vizsgálatok alkalmazása a differenciált pajzsmirigyrákos betegek ellátásában MAGYAR BELORVOSI ARCHIVUM 67:(5) pp. 338342. (2014) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [2848661] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+en…
2/342
3/30/2015
nyomtatobarat forma
[ Érvényesített ] 15. Takács István , Benkő Ilona , Toldy Erzsébet , Wikonkál Norbert , Szekeres László , Bodolay Edit , Kiss Emese , Szabó Boglárka , Valkusz Zsuzsa , Kovács Tibor , Szabó András , Bittner Nóra , Várbíró Szabolcs , Sziller István , Császár Albert , Kiss Róbert Gábor , Lakatos Péter M ásodik magarországi konszenzus a Dvitamin szerepéről a betegségek megelőzésében és kezelésében MAGYAR ORVOS 22:(1. suppl.) pp. 526. (2014) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [2593442] [ Admin láttamozott ] Függő idéző: 2 Összesen: 2 1 * Fata Emőke, Ágota Katalin, Horváth Dóra Eszter, Virágh Éva, Kányási Mária, Kovács László, Balogh Dóra, Schaffer Éva, Oláh András, Lőcsei Zoltán, Salamon Antal, Toldy Erzsébet A Dvitaminellátottság vizsgálata kórházi kezelést igénylő betegek körében LEGE ARTIS MEDICINAE KID 4: (3) pp. 109123. ( 2014) Autopszia alapján ellenőrizve. Folyóiratcikk /Szakcikk /Tudományos [14203194] 2 * Fata Emőke, Ágota Katalin, Horváth Dóra Eszter, Virágh Éva, Kányási Mária, Kovács László, Balogh Dóra, Schaffer Éva, Oláh András, Lőcsei Zoltán, Salamon Antal, Toldy Erzsébet A Dvitaminellátottság vizsgálata kórházi kezelést igénylő betegek körében LEGE ARTIS MEDICINAE (ISSN: 08664811) 24: (1011) pp. 511525. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14422039]
16. Valkusz Zs , Lakatos P , Takács I Dvitaminhiány hatása az endokrin rendszerre és a metabolizmusra MAGYAR ORVOS 22:(suppl. 1) p. 13. (2014) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [2599788] [ Admin láttamozott ] 17. Vaszilkó M ihály , Kovács Evelin , Restar László , Balla Bernadett , Cséplő Krisztina , Kosa János , Lakatos Péter Potential significance of antiestrogen therapy in the development of bisphosphonate related osteonecrosis of the jaw JOURNAL OF CRANIOMAXILLOFACIAL SURGERY 42:(8) pp. 19321936. (2014) IF: 2.597* Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [2739144] [ Érvényesített ]
2013 18. Árvai K , Kósa J , Horváth P , Balla B , Tóbiás B , Takács I , Nagy Zs , Lakatos P Osteogenesis imperfecta rutin genetikai diagnosztikája új generációs szekvenálási (NGS) technológiával MAGYAR BELORVOSI ARCHIVUM 66:(5) pp. 280284. (2013) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [2481720] [ Érvényesített ] 19. Bakos B , Takacs I , Nagy Z , Kosa JP , Balla B , Tobias B , Halaszlaki C , Szili B , Lakatos P Long term efficacy of radioiodine treatment in hyperthyroidism. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES 121:(8) pp. 494497. (2013) IF: 1.760 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [2404530] [ Érvényesített ] 20. Bálint Á , Farkas K , Terhes G , Kunstár É , Urbán E , Bata Zs , Szűcs M , Nagy F , Szepes Z , M iheller P , Lőrinczy K , Lakatos P , Lovász B , Wittmann T , M olnár T Immune response to influenza vaccine and frequency of influenza virus infection in patients with inflammatory bowel disease on maintenance immunosuppressive therapy ZEITSCHRIFT FÜR GASTROENTEROLOGIE 51:(5) p. A5. (2013) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [2445761] [ Admin láttamozott ] 21. Balla B , Kósa J , Tóbiás B , Takács I , Nagy Zs , Horváth P , Horányi J , Székely E , Járay B , Lakatos P Examination of CYP24A1 and ‘threegenes' (SFN, M RC2, HM GA2) expressions in different pathological subgroups of human papillary thyroid cancer ENDOCRINE ABSTRACTS 32: Paper P1098. (2013) Nyelv: Angol https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+en…
3/342
3/30/2015
nyomtatobarat forma
Folyóiratcikk /Absztrakt /Tudományos [2336116] 15th European Congress of Endocrinology, Copenhagen, Denmark 2013.04.27 05.01. [ Érvényesített ] 22. Balla B , Tóth E , Szendrői A , Romics I , Nyirády P , Podani J , Lakatos P , Kósa PJ Biomarkerek a prosztatarák kimutatásában, illetve a PCA3 és a szérum PSAmarkerek prosztatarák diagnosztikai hatékonyságának összehason|ító e|emzése magyar betegeken MAGYAR UROLÓGIA 25:(3) pp. 102110. (2013) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [2460071] [ Érvényesített ] 23. Bolognese M A , Teglbjærg C S , Zanchetta J R , Lippuner K , M cClung M R , Brandi M L , Høiseth A , Lakatos P , M offett A H , Lorenc R S , Wang A , Libanati C Denosumab Significantly Increases DXA BM D at Both Trabecular and Cortical Sites: Results From the FREEDOM Study JOURNAL OF CLINICAL DENSITOMETRY 16:(2) pp. 147153. (2013) IF: 1.603 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1970695] [ Érvényesített ] Független idéző: 4 Összesen: 4 1
Iolascon G, Resmini G, Tarantino U Effects of denosumab on cortical and trabecular microarchitecture: Evidences from clinical studies Aging Clinical and Experimental Research 25: (1 SUP P L.) pp. S19S22. ( 2013) Folyóiratcikk /Konferenciaközlemény /Tudományos [13463264]
2
Scott Lesley J Denosumab: A Review of its Use in P ostmenopausal Women with Osteoporosis DRUGS & AGING (ISSN: 1170229X) 31: (7) pp. 555576. ( 2014) Folyóiratcikk [14593987]
3
Perez Ruixo Juan Jose, Zheng Jenny, Mandema Jaap W Similar Relationship Between the Time Course of Bone Mineral Density Improvement and Vertebral Fracture Risk Reduction With Denosumab Treatment in P ostmenopausal Osteoporosis and P rostate Cancer P atients on Androgen Deprivation Therapy JOURNAL OF CLINICAL PHARMACOLOGY (ISSN: 15524604) 54: (5) pp. 503512. ( 2014) Folyóiratcikk [14593986]
4
Capozzi Anna, Lello Stefano, Pontecorvi Alfredo The inhibition of RANKligand in the management of postmenopausal osteoporosis and related fractures: the role of denosumab GYNECOLOGICAL ENDOCRINOLOGY (ISSN: 09513590) 30: (6) pp. 403408. ( 2014) Folyóiratcikk [14593985]
24. V Csakvary , T Puskas , G Oroszlan , P Lakatos , B Kalman , G L Kovacs , E Toldy Hormonal and biochemical parameters correlated with bone densitometric markers in prepubertal Hungarian children. BONE 54:(1) pp. 106112. (2013) IF: 4.461 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [2218551] [ Admin láttamozott ] Független idéző: 1 Összesen: 1 1
PańczykTomaszewska M, Adamczuk D, Kisiel A, Skrzypczyk P, Przedlacki J, Górska E, StelmaszczykEmmel A, Demkow U, RoszkowskaBlaim M Markers of Bone Metabolism in Children with Nephrotic Syndrome Treated with Corticosteroids Adv. Exp. Med. Biol. (ISSN: 00652598) 840: pp. 2128. ( 2015) Folyóiratcikk /Tudományos [14600073]
25. Fehérvári M , Sarkadi H , Krepuska M , Sótonyi P , Acsády G , Entz L , Lakatos P , Szeberin Z Bone M ineral Density is Associated with SiteSpecific Atherosclerosis in Patients with Severe Peripheral Artery Disease CALCIFIED TISSUE INTERNATIONAL 93:(1) pp. 5561. (2013) IF: 2.748 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [2258447] [ Hitelesített ] 26. Fehervari M atyas , Krepuska M iklos , CsobayNovak Csaba , Lakatos Peter , Olah Zoltan , Acsady Gyoergy , Szeberin Zoltan A csontritkulás előfordulásának vizsgálata perifériás verőérbetegekben [Prevalence of osteoporosis in patients with severe peripheral artery disease] ORVOSI HETILAP 154:(10) pp. 369375. (2013) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [2396483] [ Hitelesített ] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+en…
4/342
3/30/2015
nyomtatobarat forma
Független idéző: 1 Összesen: 1 1
W ang Chunhong, Li Chunlin, Liu Yang, Zhou Jin Correlation between atherosclerosis and osteoporosis in elderly male patients with type 2 diabetes Chinese Journal of Osteoporosis (ISSN: 10067108) 20: (10) pp. 12191221. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14555391]
27. Horváth E , Balla B , Kósa J , Lakatos P , Lazáry Á , Németh D , Jozilan H , Somorácz Á , Korompay A , Gyöngyösi B , Borka K , Kiss A , Kupcsulik P , Schaff Z , Szalay F Study of vitamin D metabolism and signaling in human hepatocellular carcinoma and surrounding liver tissues ZEITSCHRIFT FÜR GASTROENTEROLOGIE 51:(5) Paper A24. (2013) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [2481114] 55th Annual M eeting of the Hungarian Society of Gastroenterology, Tihany, 2013. jún. 14. [ Érvényesített ] 28. Kósa JP , Horváth P , Wölfling J , Kovács D , Balla B , M átyus P , Horváth E , Speer G , Takács I , Nagy Z , Horváth H , Lakatos P CYP24A1 inhibition facilitates the antitumor effect of vitamin D3 on colorectal cancer cells WORLD JOURNAL OF GASTROENTEROLOGY 19:(17) pp. 26212628. (2013) IF: 2.433 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [2302188] [ Érvényesített ] Független idéző: 2 Összesen: 2 1
Brozyna Anna A, Jochymski Cezary, Janjetovic Zorica, Jozwicki W ojciech, Tuckey Robert C, Slominski Andrzej T CYP 24A1 Expression Inversely Correlates with Melanoma P rogression: ClinicP athological Studies INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (ISSN: 14220067) 15: (10) pp. 1900019017. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14473096]
2
Zeng Xiaojun, Tao Hualin Diagnostic and prognostic serum marker of cholangiocarcinoma (Review) ONCOLOGY LETTERS (ISSN: 17921074) 9: (1) pp. 38. ( 2015) Folyóiratcikk /Szakcikk /Tudományos [14473095]
29. Lakatos P Kommentár: Oszteoimmunológia: hogyan befolyásolja a gyulladás a csontok anyagcseréjét? ORVOSTOVÁBBKÉPZŐ SZEMLE 20:(12) pp. 3435. (2013) Nyelv: Magyar
Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [2498448] [ Admin láttamozott ] 30. M annstadt M , Clarke BL , Vokes T , Brandi M L , Ranganath L , Fraser WD , Lakatos P , Bajnok L , Garceau R , M osekilde L , Lagast H , Shoback D , Bilezikian JP Efficacy and safety of recombinant human parathyroid hormone (184) in hypoparathyroidism (REPLACE): a double blind, placebocontrolled, randomised, phase 3 study LANCET DIABETES AND ENDOCRINOLOGY 1:(4) pp. 275283. (2013) Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [2460078] [ Érvényesített ] Független idéző: 2 Függő idéző: 3 Összesen: 5 1
Bislev LS, Sikjaer T, Rejnmark L Effects on Calcium Homeostasis of Changing P TH Replacement Therapy of P ostoperative Hypoparathyroidism from Intact P TH to Teriparatide: A Case Series CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 95: (4) pp. 374381. ( 2014) Folyóiratcikk [14593907]
2 * Mannstadt M, Clarke BL, Vokes T Efficacy and safety of recombinant human parathyroid hormone (184) in hypoparathyroidism (REP LACE): a doubleblind, placebocontrolled, randomised, phase 3 study (vol 1, pg 275, 2013) LANCET DIABETES & ENDOCRINOLOGY (ISSN: 22138587) 2: (1) pp. E3E3. ( 2014) Folyóiratcikk [14593906] 3
Antoniu S Fresh from the designation pipeline: orphan drugs recently designated in the European Union (December 2013February 2014) EXPERT OPINION ON ORPHAN DRUGS (ISSN: 21678707) 2: (6) pp. 635641. ( 2014) Folyóiratcikk [14593905]
4 * Clarke BL, Berg JK, Fox J, Cyran JA, Lagast H P harmacokinetics and P harmacodynamics of Subcutaneous Recombinant P arathyroid Hormone (184) in P atients With Hypoparathyroidism: An OpenLabel, SingleDose, P hase I Study CLINICAL THERAPEUTICS (ISSN: 01492918) 36: (5) pp. 722736. ( 2014) Folyóiratcikk [14593904] 5 * Cusano NE, Rubin MR, McMahon DJ, Irani D, Anderson L, Levy E, Bilezikian JP P TH(184) Is Associated With Improved Quality of Life in Hypoparathyroidism Through 5 Years of Therapy JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 99: (10) pp. 36943699. ( 2014)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+en…
5/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [14593903]
31. K M uller , Hungarian Pediatric IBD , M Papp , P Lakatos , G Veres A nationwide registry of paediatric inflammatory bowel disease: improvement of diagnostic workup and Paris Classification In: M iquel A Gassull (szerk.) 8th Congress of ECCO the European Crohn’s and Colitis Organisation. Abstracts . Konferencia helye, ideje: Bécs , Ausztria , 2013.02.14 2013.02.16. Elsevier, pp. S276S277. Nyelv: Angol
Egyéb konferenciaközlemény /Absztrakt /Tudományos [2212524] [ Admin láttamozott ] 32. Nagy György , Lakatos Péter , Holló Péter Biológiai terápiák és követő molekulák: Elvárások és realitások a reumatológiai, gasztroenterológiai és bőrgyógyászati gyakorlatban ORVOSTOVÁBBKÉPZŐ SZEMLE 20:(3) pp. 7177. (2013) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [2239627] Nagy György: Infliximab a reumatológiai gyakorlatban 7173. Lakatos Péter: A gasztroentrológus elvárásai a biohasonló szerekkel kapcsolatosan 7475. Holló Péter: A bőrgyógyász elvárásai a biohasonló szerekkel kapcsolatosan 7577. [ Hitelesített ] 33. Payer J , Bilezikian JP , Holzer G , Lakatos P , Lesnyak O , Lorenc R , Zendeli A , Resch H Congress Report: 5th Central and Eastern Europe (CEE) Summit on Osteoporosis in Bratislava, 23 December 2011 ARCHIVES OF OSTEOPOROSIS 8:(12) Paper 123. (2013) Nyelv: Angol
Folyóiratcikk /Konferenciaközlemény /Tudományos [2401998] [ Érvényesített ] 34. Speer G , Szamosujvári Jr P , Dombai P , Csóré K , M ikófalvi K , Steindl T , Streicher I , Tarsoly J , Zajzon G , Somogyi P , Szamosújvári P , Lakatos P Dietary calcium intake and calcium supplementation in hungarian patients with osteoporosis INTERNATIONAL JOURNAL OF ENDOCRINOLOGY 2013: Paper 754328. 8 p. (2013) IF: 1.515 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [2401851] [ Hitelesített ] 35. Speer G , Lakatos P A laktózintolerancia hatása a csontanyagcserére LEGE ARTIS MEDICINAE KID 3:(1) p. 19. (2013) Nyelv: Magyar
Folyóiratcikk /Ismertetés /Tudományos [2460053] [ Érvényesített ] 36. Takács István , Benkő Ilona , Toldy Erzsébet , Wikonkál Norbert , Szekeres László , Bodolay Edit , Kiss Emese , Jambrik Zoltán , Szabó Boglárka , M erkely Béla , Valkusz Zsuzsa , Kovács Tibor , Szabó András , Grigoreff Orsolya , Nagy Zsolt , Demeter Judit , Horváth Henrik Csaba , Bitner Nóra , Várbíró Szabolcs , Lakatos Péter Hazai konszenzus a Dvitamin szerepéről a betegségek megelőzésében és kezelésében (másodközlés) VÉDŐNŐ 23:(1) pp. 317. (2013) Nyelv: Magyar
Folyóiratcikk /Nem besorolt /Tudományos [2359550] Eredeti közlemény: Takács I, Benkő I, Toldy E, Wikonkál N, Szekeres L, Bodolay E, Kiss E, Jambrik Z, Szabó B, M erkely B, Valkusz Zs, Kovács T, Szabó A, Grigoreff O, Nagy Z, Demeter J, Horváth HC, Bittner N, Várbíró S, Lakatos P. Hazai konszenzus a Dvitamin szerepéről a betegségek megelőzésében és kezelésében: Állásfoglalás ORVOSI HETILAP 153:(Suppl. 2) pp. 526. (2012) DOI:10.1556/OH.2012.29410 Folyóiratcikk/Jelentés/Tudományos [2028384] Különlenyomat alapján ellenőrizve (BA, 2014.11.27.) [ Érvényesített ] 37. Tobiás B , Balla B , Kósa JP , Horányi J , Takács I , Nagy Zs , Horváth P , Járay B , Székely E , Istók R , Székely T , Lakatos P Detecting somatic oncogene mutations in FNA samples of cold nodules in Hungary https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+en…
6/342
3/30/2015
nyomtatobarat forma
ENDOCRINE ABSTRACTS 32: Paper P1108. (2013) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [2336120] 15th European Congress of Endocrinology, Copenhagen, Denmark 2013.04.27 05.01. [ Érvényesített ]
2012 38. Bakos B , Lakatos P , Takács I A hyperthyreosis radiójód kezelése MAGYAR ORVOS 20:(12) pp. 2225. (2012) Nyelv: Magyar
Folyóiratcikk /Ismertetés /Tudományos [2245391] [ Érvényesített ] 39. Balla B , Vaszilko M , Kosa J , Podani J , Takacs I , Tobias B , Nagy Z , Lazary A , Lakatos P New approach to analyze genetic and clinical data in bisphosphonateinduced osteonecrosis of the jaw. ORAL DISEASES 18:(6) pp. 580585. (2012) IF: 2.377 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1870361] [ Admin láttamozott ] Független idéző: 8 Összesen: 8 1
Troeltzsch M, W oodlock T, Kriegelstein S, Steiner T, Messlinger K, Troeltzsch M P hysiology and P harmacology of Nonbisphosphonate Drugs Implicated in Osteonecrosis of the Jaw J Can Dent Assoc 78: (1) P aper c85. (2012) Folyóiratcikk /Szakcikk /Tudományos [12529966]
2
Zhong DaNi, W u JiZhou, Li GuoJian Association between CYP 2C8 (rs1934951) P olymorphism and BisphosphonateRelated Osteonecrosis of the Jaws in P atients on Bisphosphonate Therapy: A MetaAnalysis ACTA HAEMATOLOGICA (ISSN: 00015792) 129: (2) pp. 9095. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13366705]
3
Yamazaki T, Yamori M, Tanaka S, Yamamoto K, Sumi E, NishimotoSano M, Asai K, Takahashi K, Nakayama T, Bessho K Risk Factors and Indices of Osteomyelitis of the Jaw in Osteoporosis P atients: Results from a HospitalBased Cohort Study in Japan. PLoS ONE (ISSN: 19326203) 8: (11) P aper e79376. (2013) Folyóiratcikk /Szakcikk /Tudományos [13430181]
4
E Dembowska R SamulakZielińska K SporniakTutak Different theories on pathogenesis of bisphosphonaterelated osteonecrosis of the jawA review. HealthMed (ISSN: 18402291) 8: (1) pp. 140147. ( 2014) Folyóiratcikk [13703539]
5
Verron E Bouler J M Is bisphosphonate therapy compromised by the emergence of adverse bone disorders? Drug Discovery Today (ISSN: 13596446) 19: (3) pp. 312319. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [13773859]
6
Yamazaki T Takahashi K Bessho K Recent clinical evidence in bisphosphonaterelated osteomyelitis of the jaw: Focus on risk, prevention and treatment Reviews on Recent Clinical Trials (ISSN: 15748871) 9: (1) pp. 3752. ( 2014) Folyóiratcikk [14084221]
7
Feng Yuchi, Zhao Yan Research progress of the pathogenesis and treatment of bisphosphonaterelated osteonecrosis of the jaws Chinese Journal of Osteoporosis (ISSN: 10067108) 20: (8) pp. 9981002. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14404113]
8
Kim JeeHwan, Ko Yong Jae, Kim JiYoung, Oh Yoonsoo, Hwang Jihye, Han Sangjin, Kim Sanguk, Lee JaeHoon, Han DongHoo Genetic Investigation of BisphosphonateRelated Osteonecrosis of Jaw (BRONJ) via Whole Exome Sequencing and Bioinformatics PLOS ONE (ISSN: 19326203) 10: (2) P aper e0118084. (2015) Folyóiratcikk [14594238]
40. Balla B , Kósa J , Tobiás B , Halászlaki Cs , Takács I , Horváth H , Speer G , Horányi J , Nagy Zs , Járay B , Székely E , Lakatos P Remarkable enhance in CYP24A1 expression in human thyroid cancer tissue ENDOCRINE ABSTRACTS 29: Paper P 1760. (2012) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [2025247] 15th International & 14th European Congress of Endocrinology (ICE/ECE 2012), Firenze, Italy, 2012.05.59. [ Érvényesített ] 41. Balla B , Kósa J , Tóbiás B , Takács I , Nagy Zs , Horányi J , Járay B , Székely E , Halászlaki Cs , Lakatos P A CYP24A1 gén kifejeződésének fokozódása humán papilláris pajzsmirgytumor szövetben In: M agyar Endokrinológiai és Anyagcsere Társaság 24. Kongresszusa: Előadás és poszter absztraktok . Konferencia helye, ideje: Szolnok , M agyarország , 2012.05.17 2012.05.19. pp. 1920. Nyelv: Magyar https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+en…
7/342
3/30/2015
nyomtatobarat forma
Egyéb konferenciaközlemény /Absztrakt /Tudományos [2033381] [ Admin láttamozott ] 42. Balla B , Kosa JP , Podani J , Tobias B , Takacs I , Nagy Z , Lakatos P IM PORTANCE OF ALTERED EXPRESSION OF GENES INVOLVED IN TRANSFORM ING GROWTH FACTOR BETA SIGNALING IN DIFFERENT HUM AN M ETABOLIC BONE DISEASES OSTEOPOROSIS INTERNATIONAL 23:(2) pp. S372S373. (2012) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [2161444] CT IOFECCEO European Congress on Osteoporosis and Osteoarthritis / 2nd IOFESCEO PreClinical Symposium CY M AR 2124, 2012 CL Bordeaux, FRANCE SU 2 [ Admin láttamozott ] 43. Black DM , Reid IR , Boonen S , BucciRechtweg C , Cauley JA , Cosman F , Cummings SR , Hue TF , Lippuner K , Lakatos P , Leung PC , M an Z , M artinez RLM , Tan M , Ruzycky M E , Su G , Eastell R The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZONPivotal Fracture Trial (PFT) JOURNAL OF BONE AND MINERAL RESEARCH 27:(2) pp. 243254. (2012) IF: 6.128 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1877353] [ Érvényesített ] Független idéző: 76 Függő idéző: 14 Összesen: 90 1
Briot K, Cortet B, Thomas T, Audran M, Blain H, Breuil V, Chapuis L, Chapurlat R, Fardellone P, Feron JM, Gauvain JB, Guggenbuhl P, Kolta S, Lespessailles E, Letombe B, Marcelli C, Orcel P, Seret P, Tremollieres F, Rouxa C 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis JOINT BONE SPINE (ISSN: 1297319X) 79: (3) pp. 304313. ( 2012) Folyóiratcikk /Jelentés /Tudományos [12406837]
2
Bauer Douglas C Atypical Femoral Fracture Risk in P atients Treated With Bisphosphonates ARCHIVES OF INTERNAL MEDICINE (ISSN: 00039926) 172: (12) pp. 936937. ( 2012) Folyóiratcikk [14594217]
3
Khosla Sundeep, Bilezikian John P, Dempster David W , Lewiecki E Michael, Miller Paul D, Neer Robert M, Recker Robert R, Shane Elizabeth, Shoback Dolores, Potts John T Benefits and Risks of Bisphosphonate Therapy for Osteoporosis JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 97: (7) pp. 22722282. ( 2012) Folyóiratcikk [14594216]
4
Zarowitz Barbara J Bisphosphonate Duration of Therapy for Management of Osteoporosis GERIATRIC NURSING (ISSN: 01974572) 33: (6) pp. 479481. ( 2012) Folyóiratcikk [14594215]
5
Compston J E, Bilezikian J P Bisphosphonate therapy for osteoporosis: The long and short of it Journal of Bone and Mineral Research (ISSN: 08840431) 27: (2) pp. 240242. ( 2012) Folyóiratcikk /Rövid közlemény /Tudományos [12017630]
6
W hitaker M, Guo J, Kehoe T, Benson G Bisphosphonates for Osteoporosis Where Do We Go from Here? NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 366: (22) pp. 20482051. ( 2012) Folyóiratcikk /Ismertetés /Tudományos [12406836]
7
Diab Dima L, W atts Nelson B Bisphosphonates in the Treatment of Osteoporosis ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (ISSN: 08898529) 41: (3) pp. 487+. ( 2012) Folyóiratcikk [14594214]
8
Anonymous BisphosphonatesDuration of Use Revisited MEDICAL LETTER ON DRUGS AND THERAPEUTICS (ISSN: 0025732X) 54: (1393) pp. 4949. ( 2012) Folyóiratcikk [14594213]
9
* Black DM, Bauer DC, Schwartz AV, Cummings SR, Rosen CJ Continuing Bisphosphonate Treatment for Osteoporosis For Whom and for How Long? NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 366: (22) pp. 20512053. ( 2012) Folyóiratcikk /Ismertetés /Tudományos [12406835]
10 * Bolland Mark J, Grey Andrew, Horne Anne M, Briggs Simon E, Thomas Mark G, EllisPegler Rod B, Gamble Greg D, Reid Ian R Effects of Intravenous Zoledronate on Bone Turnover and Bone Density P ersist for at Least Five Years in HIVInfected Men JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 97: (6) pp. 19221928. ( 2012) Folyóiratcikk [14594212] 11
Zhang Jun, W ang Ran, Zhao YiLei, Sun XiaoHui, Zhao HongXing, Lu Tan, Chen DeCai, Xu HaiBin Efficacy of intravenous zoledronic acid in the prevention and treatment of osteoporosis: A metaanalysis ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (ISSN: 19957645) 5: (9) pp. 743748. ( 2012) Folyóiratcikk [14594211]
12 * Boonen S, Ferrari S, Miller PD, Eriksen EF, Sambrook PN, Compston J, Reid IR, Vanderschueren D, Cosman F P ostmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or longterm continuation on bone turnover and fracture riska perspective JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 27: (5) pp. 963974. ( 2012)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+en…
8/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Ismertetés /Tudományos [12406834] 13
McClung Michael R Revisiting the prevention of bone loss at menopause MENOPAUSETHE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (ISSN: 10723714) 19: (11) pp. 1173 1175. ( 2012) Folyóiratcikk [14594210]
14
Orozco Catalina, Maalouf Naim M Safety of Bisphosphonates RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (ISSN: 0889857X) 38: (4) pp. 681+. ( 2012) Folyóiratcikk [14594209]
15
Shil Asit B, Greer Jonathan R Screening Strategies for Treatment of Osteoporosis in LongTerm Care Residents JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (ISSN: 00028614) 60: (12) pp. 23832384. ( 2012) Folyóiratcikk [14594208]
16 * Black Dennis M, Reid Ian R, Boonen Steven, BucciRechtweg Christina, Cauley Jane A, Cosman Felicia, Cummings Steven R, Hue Trisha F, Lippuner Kurt, Lakatos Peter, Leung Ping Chung, Man Zulema, Martinez Ruvie Lou Maria, Tan Monique, Ruzycky Mary Ellen, Su Guoqin, Eastell Richard The Effect of 3 Versus 6 Years of Zoledronic Acid Treatment of Osteoporosis: A Randomized Extension to the HORIZONP ivotal Fracture Trial (P FT) (vol 27, pg 243, 2012) JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 27: (12) pp. 26122612. ( 2012) Folyóiratcikk [14594207] 17
Tremollieres F What patients need to know about the risk of bone fracture and its prevention JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION (ISSN: 03682315) 41: pp. F20F27. ( 2012) SU 7 Folyóiratcikk [14594206]
18
Mendoza Nicolas, SanchezBorrego Rafael, Villero Jose, Baro Francesc, Calaf Joaquim, Jesus Cancelo Ma, Coronado Pluvio, Estevez Antonio, FernandezMoya Jose M, Gonzalez Silvia, Llaneza Placid, Luis Neyro Jose, del Pino Javier, Rodriguez Esteban, Ruiz Elena, Canon Antonio 2013 Update of the consensus statement of the Spanish Menopause Society on postmenopausal osteoporosis MATURITAS (ISSN: 03785122) 76: (1) pp. 99107. ( 2013) Folyóiratcikk [14594204]
19
Misof Barbara M, Roschger Paul, Gabriel Daniela, Paschalis Eleftherios P, Eriksen Erik F, Recker Robert R, Gasser Juerg A, Klaushofer Klaus Annual intravenous zoledronic acid for three years increased cancellous bone matrix mineralization beyond normal values in the HORIZON biopsy cohort JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 28: (3) pp. 442448. ( 2013) Folyóiratcikk [14594203]
20
Ro Cynthia, Cooper Odelia Bisphosphonate Drug Holiday: Choosing Appropriate Candidates CURRENT OSTEOPOROSIS REPORTS 11: (1) pp. 4551. ( 2013) Folyóiratcikk [14594202]
21
McClung Michael, Harris Steven T, Miller Paul D, Bauer Douglas C, Davison K Shawn, Dian Larry, Hanley David A, Kendler David L, Yuen Chui Kin, Lewiecki E Michael Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday AMERICAN JOURNAL OF MEDICINE (ISSN: 00029343) 126: (1) pp. 1320. ( 2013) Folyóiratcikk [14594201]
22
W ong Peter K, Borromeo Gelsomina L, W ark John D Bisphosphonaterelated osteonecrosis of the jaw in nonmalignant bone disease RHEUMATOLOGY INTERNATIONAL (ISSN: 01728172) 33: (9) pp. 21892198. ( 2013) Folyóiratcikk [14594200]
23
Papapoulos Socrates E Bisphosphonates in osteoporosisbeyond 5 years NATURE REVIEWS RHEUMATOLOGY (ISSN: 17594790) 9: (5) pp. 263264. ( 2013) Folyóiratcikk [14594199]
24 * McNabb Brian Louis, Vittinghoff Eric, Schwartz Ann V, Eastell Richard, Bauer Douglas C, Ensrud Kristine, Rosenberg Elizabeth, Santora Arthur, BarrettConnor Elizabeth, Black Dennis M BMD changes and predictors of increased bone loss in postmenopausal women after a 5year course of alendronate JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 28: (6) pp. 13191327. ( 2013) Folyóiratcikk [14594198] 25
Banu Jameela Causes, consequences, and treatment of osteoporosis in men DRUG DESIGN DEVELOPMENT AND THERAPY (ISSN: 11778881) 7: pp. 849860. ( 2013) Folyóiratcikk [14594197]
26
MessingerRapport Barbara J, Gammack Julie K, Thomas David R, Morley John E Clinical Update on Nursing Home Medicine: 2013 JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (ISSN: 15258610) 14: (12) pp. 860876. ( 2013) Folyóiratcikk [14594172]
27
Mcclung Michael Controversies in Osteoporosis Management: Concerns About Bisphosphonates and When Are "Drug Holidays" Required? CLINICAL OBSTETRICS AND GYNECOLOGY (ISSN: 00099201) 56: (4) pp. 743748. ( 2013) Folyóiratcikk [14594171]
28
Recknor Chris, Czerwinski Edward, Bone Henry G, Bonnick Sydney L, Binkley Neil, Palacios Santiago, Moffett Alfred, Siddhanti Suresh, Ferreira Irene, Ghelani Prayashi, W agman Rachel B, Hall Jesse W , Bolognese Michael A, Benhamou ClaudeLaurent Denosumab Compared With Ibandronate in P ostmenopausal Women P reviously Treated With Bisphosphonate Therapy A Randomized OpenLabel Trial OBSTETRICS AND GYNECOLOGY (ISSN: 00297844) 121: (6) pp. 12911299. ( 2013)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+en…
9/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [14594196] 29
Compston J, Bowring C, Cooper A, Cooper C, Davies C, Francis R, Kanis J A, Marsh D, McCloskey E V, Reid D M, Selby P Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 MATURITAS (ISSN: 03785122) 75: (4) pp. 392396. ( 2013) CA Natl Osteoporosis Guideline Grp Folyóiratcikk [14594195]
30
Brown Jacques P, Roux Christian, Torring Ove, Ho PeiRan, Jensen JensErik Beck, Gilchrist Nigel, Recknor Christopher, Austin Matt, W ang Andrea, Grauer Andreas, W agman Rachel B Discontinuation of denosumab and associated fracture incidence: Analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 28: (4) pp. 746752. ( 2013) Folyóiratcikk [14594194]
31 * Popp Albrecht W , Guler Sabina, Lamy Olivier, Senn Christoph, Buffat Helene, Perrelet Romain, Hans Didier, Lippuner Kurt Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: A threeyear study JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 28: (3) pp. 449454. ( 2013) Folyóiratcikk [14594193] 32
Amadori Dino, Aglietta Massimo, Alessi Barbara, Gianni Lorenzo, Ibrahim Toni, Farina Gabriella, Gaion Fernando, Bertoldo Francesco, Santini Daniele, Rondena Roberta, Bogani Paola, Ripamonti Carla I Efficacy and safety of 12weekly versus 4weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, openlabel, randomised, noninferiority trial LANCET ONCOLOGY (ISSN: 14702045) 14: (7) pp. 663670. ( 2013) Folyóiratcikk [14594192]
33
Schilcher Joerg Epidemiology, radiology and histology of atypical femoral fractures Development of understanding ACTA ORTHOPAEDICA (ISSN: 17453674) 84: pp. 524. ( 2013) SU 352 Folyóiratcikk [14594170]
34
KerschanSchindl K, Haschka J, ObermayerPietsch B, Gasser R W , Dimai H P, FahrleitnerPammer A, Dobnig H, Roschger P, Preisinger E, Klaushofer K, Resch H, Pietschmann P How Long Should Women with P ostmenopausal Osteoporosis be Treated with a Bisphosphonate? HORMONE AND METABOLIC RESEARCH (ISSN: 00185043) 45: (9) pp. 621628. ( 2013) Folyóiratcikk [14594191]
35
Chiha Maguy, Myers Lauren E, Ball Caroline A, Sinacore James M, Camacho Pauline M LONGTERM FOLLOWUP OF P ATIENTS ON DRUG HOLIDAY FROM BISP HOSP HONATES: REALWORLD SETTING ENDOCRINE PRACTICE (ISSN: 1530891X) 19: (6) pp. 989994. ( 2013) Folyóiratcikk [14594169]
36
Yavropoulou M P, Hamdy N A T, Papapoulos S E Longterm treatment of osteoporotic women with bisphosphonates does not impair the response to subsequently administered intravenous pamidronate OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 24: (8) pp. 23532357. ( 2013) Folyóiratcikk [14594190]
37
Anonymous OSHK TASK GROUP FOR THE FORMULATION OF THE 2013 OSHK GUIDELINE FOR CLINICAL MANAGEMENT OF P OSTMENOP AUSAL OSTEOP OROSIS IN HONG KONG HONG KONG MEDICAL JOURNAL (ISSN: 10242708) 19: (2) pp. 640. ( 2013) SU 2 Folyóiratcikk [14594189]
38
Pinkerton Joann V, Thomas Semara, Dalkin Alan C Osteoporosis Treatment and P revention for P ostmenopausal Women: Current and Future Therapeutic Options CLINICAL OBSTETRICS AND GYNECOLOGY (ISSN: 00099201) 56: (4) pp. 711721. ( 2013) Folyóiratcikk [14594167]
39
Adami Silvano, Idolazzi Luca, Fracassi Elena, Gatti Davide, Rossini Maurizio Osteoporosis Treatment: When to Discontinue and When to Restart BONE RESEARCH (ISSN: 20954700) 4: pp. 323335. ( 2013) Folyóiratcikk [14594166]
40
Lewiecki E Michael, Adler Robert A, Bilezikian John P, Bouxsein Mary L, Marcus Robert, McClung Michael R, Miller Paul D, Tanner S Bobo, Randall Susan Osteoporosis Update From the 2012 Santa Fe Bone Symposium JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 16: (4) pp. 584600. ( 2013) Folyóiratcikk [14594165]
41
Goncalves Maria Joao, Rodrigues Ana Maria, Canhao Helena, Fonseca Joao Eurico Osteoporosis: From Bone Biology to Individual Treatment Decision ACTA MEDICA PORTUGUESA (ISSN: 16460758) 26: (4) pp. 445455. ( 2013) Folyóiratcikk [14594188]
42
Diab Dima L, W atts Nelson B P ostmenopausal osteoporosis CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (ISSN: 1752296X) 20: (6) pp. 501509. ( 2013) Folyóiratcikk [14594164]
43 * Reid I R, Black D M, Eastell R, BucciRechtweg C, Su G, Hue T F, Mesenbrink P, Lyles K W , Boonen S Reduction in the Risk of Clinical Fractures After a Single Dose of Zoledronic Acid 5 Milligrams JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 98: (2) pp. 557563. ( 2013) CA HORIZON Pivotal Fracture Trial : HORIZON Recurrent Fracture Trial Folyóiratcikk [14594187] 44
Sharma Abhishek, Chatterjee Saurav, ArbabZadeh Armin, Goyal Sandeep, Lichstein Edgar, Ghosh Joydeep, Aikat Shamik Risk of Serious Atrial Fibrillation and Stroke With Use of Bisphosphonates Evidence From a Metaanalysis CHEST (ISSN: 00123692) 144: (4) pp. 13111322. ( 2013) Folyóiratcikk [14594163]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 10/342
3/30/2015
nyomtatobarat forma 45
Reginster JeanYves, Pelousse Franz, Bruyere Olivier Safety concerns with the longterm management of osteoporosis EXPERT OPINION ON DRUG SAFETY (ISSN: 14740338) 12: (4) pp. 507522. ( 2013) Folyóiratcikk [14594186]
46
W right Nicole C, W arriner Amy H, Saag Kenneth G Study design considerations for a large simple trial of bisphosphonates CURRENT OPINION IN RHEUMATOLOGY (ISSN: 10408711) 25: (4) pp. 517523. ( 2013) Folyóiratcikk [14594185]
47
Ma Chao, Qin Hua, Zhou Yingfeng, W an Guang, Shi Shufeng, Dong Yuzhen, W ang W ei, Tan Haifeng Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis PAKISTAN JOURNAL OF MEDICAL SCIENCES (ISSN: 1682024X) 29: (6) pp. 13811384. ( 2013) Folyóiratcikk [14594162]
48
Herman Anne Pernille, Abrahamsen Bo The bisphosphonates: risks and benefits of long term use CURRENT OPINION IN PHARMACOLOGY (ISSN: 14714892) 13: (3) pp. 435439. ( 2013) Folyóiratcikk [14594184]
49
Adami Silvano, Bertoldo Francesco, Gatti Davide, Minisola Giovanni, Rossini Maurizio, Sinigaglia Luigi, Varenna Massimo Treatment Thresholds for Osteoporosis and Reimbursability Criteria: P erspectives Associated with Fracture RiskAssessment Tools CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 93: (3) pp. 195200. ( 2013) Folyóiratcikk [14594183]
50
闫富宏 唑来膦酸规范化应用骨科专家研讨会纪要 Chinese Journal of Orthopedics (ISSN: 02532352) 33: (7) pp. 782784. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [14594205]
51 * McNabb Brian, Vittinghoff Eric, Eastell Richard, Schwartz Ann V, Bauer Douglas C, Ensrud Kristine, BarrettConnor Elizabeth, Black Dennis M A Model of BMD Changes After Alendronate Discontinuation to Guide P ostalendronate BMD Monitoring JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 99: (11) pp. 40944100. ( 2014) Folyóiratcikk [14594160] 52
Tai TaW ei, Su FongChin, Chen ChingYu, Jou IMing, Lin ChiouFeng Activation of p38 MAP Kregulated BclxL signaling increases survival against zoledronic acidinduced apoptosis in osteoclast precursors BONE (ISSN: 87563282) 67: pp. 166174. ( 2014) Folyóiratcikk [14594159]
53
Ruggiero Salvatore L, Dodson Thomas B, Fantasia John, Goodday Reginald, Aghaloo Tara, Mehrotra Bhoomi, O'Ryan Felice American Association of Oral and Maxillofacial Surgeons P osition P aper on MedicationRelated Osteonecrosis of the Jaw2014 Update JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (ISSN: 02782391) 72: (10) pp. 19381956. ( 2014) Folyóiratcikk [14594158]
54
Maeda Sergio Setsuo, LazarettiCastro Marise An overview on the treatment of postmenopausal osteoporosis ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (ISSN: 00042730) 58: (2) pp. 162171. ( 2014) Folyóiratcikk [14594157]
55
Konsta Maria, Bournia VasilikiKalliopi, Dania Vasiliki, Iliopoulos Alexios Atrial Fibrillation Following Intravenous Zolendronic Acid for Osteoporosis JCRJOURNAL OF CLINICAL RHEUMATOLOGY (ISSN: 10761608) 20: (4) pp. 12. ( 2014) Folyóiratcikk [14594156]
56
IshShalom Sofia Atypical Osteoporotic Fractures: Impact on Therapeutic Decision Making in Osteoporosis ISRAEL MEDICAL ASSOCIATION JOURNAL (ISSN: 15651088) 16: (2) pp. 110112. ( 2014) Folyóiratcikk [14594155]
57
Katz Joseph, Ordoveza Patrisha A Bisphosphonaterelated osteonecrosis of the jaw (BRONJ) associated with a onceyearly IV infusion of zoledronic acid (Reclast) 5 mg: Two cases and review of the literature QUINTESSENCE INTERNATIONAL (ISSN: 00336572) 45: (8) pp. 685690. ( 2014) Folyóiratcikk [14594154]
58
Brown Jacques P, Morin Suzanne, Leslie W illiam, Papaioannou Alexandra, Cheung Angela M, Davison Kenneth S, Goltzman David, Hanley David Arthur, Hodsman Anthony, Josse Robert, Jovaisas Algis, Juby Angela, Kaiser Stephanie, Karaplis Andrew, Kendler David, Khan Aliya, Ngui Daniel, Olszynski W ojciech, SteMarie LouisGeorges, Adachi Jonathan Bisphosphonates for treatment of osteoporosis Expected benefits, potential harms, and drug holidays CANADIAN FAMILY PHYSICIAN (ISSN: 0008350X) 60: (4) pp. 324333. ( 2014) Folyóiratcikk [14594153]
59
Giusti Andrea Bisphosphonates in the management of thalassemiaassociated osteoporosis: a systematic review of randomised controlled trials JOURNAL OF BONE AND MINERAL METABOLISM (ISSN: 09148779) 32: (6) pp. 606615. ( 2014) Folyóiratcikk [14594152]
60 * Cosman F, de Beur S J, LeBoff M S, Lewiecki E M, Tanner B, Randall S, Lindsay R Clinician's Guide to P revention and Treatment of Osteoporosis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (10) pp. 23592381. ( 2014) Folyóiratcikk [14594151] 61
Crandall Carolyn J, Newberry Sydne J, Diamant Allison, Lim YeeW ei, Gellad W alid F, Booth Marika J, Motala Aneesa, Shekelle Paul G Comparative Effectiveness of P harmacologic Treatments to P revent Fractures An Updated Systematic Review ANNALS OF INTERNAL MEDICINE (ISSN: 00034819) 161: (10) pp. 711U163. ( 2014) Folyóiratcikk [14594150]
62 * Popp A W , Buffat H, Cavelti A, W indolf M, Perrelet R, Senn C, Lippuner K Cortical bone loss at the tibia in postmenopausal women with osteoporosis is associated with incident nonvertebral fractures:
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 11/342
3/30/2015
nyomtatobarat forma Results of a randomized controlled ancillary study of HORIZON MATURITAS (ISSN: 03785122) 77: (3) pp. 287293. ( 2014) Folyóiratcikk [14594149] 63
KerschanSchindl K, Mikosch P, ObermayerPietsch B, Gasser R W , Dimai H P, FahrleitnerPammer A, Dobnig H, Roschger P, Preisinger E, Klaushofer K, Resch H, Pietschmann P Current Controversies in Clinical Management of P ostmenopausal Osteoporosis EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (ISSN: 09477349) 122: (8) pp. 437444. ( 2014) Folyóiratcikk [14594148]
64
Gatti Davide, Viapiana Ombretta, Idolazzi Luca, Fracassi Elena, Ionescu Claudio, Dartizio Carmela, Troplini Sonila, Kunnathully Vidya, Adami Silvano, Rossini Maurizio Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis BONE (ISSN: 87563282) 67: pp. 189192. ( 2014) Folyóiratcikk [14594147]
65
Fassbender W J, W illmann B Drug treatment of osteoporosis DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (ISSN: 00120472) 139: (10) pp. 497500. ( 2014) Folyóiratcikk [14594146]
66
Anonymous Drugs for P ostmenopausal Osteoporosis MEDICAL LETTER ON DRUGS AND THERAPEUTICS (ISSN: 0025732X) 56: (1452) pp. 9196. ( 2014) Folyóiratcikk /Jelentés /Tudományos [14594145]
67 * Grey Andrew, Bolland Mark, Mihov Bobby, W ong Sumwai, Horne Anne, Gamble Greg, Reid Ian R Duration of Antiresorptive Effects of LowDose Zoledronate in Osteopenic P ostmenopausal Women: A Randomized, P lacebo Controlled Trial JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 29: (1) pp. 166172. ( 2014) Folyóiratcikk [14594144] 68
Krause M, Soltau M, Zimmermann E A, Hahn M, Kornet J, Hapfelmeier A, Breer S, Morlock M, W ulff B, Pueschel K, Glueer C C, Amling M, Busse B EFFECTS OF LONGTERM ALENDRONATE TREATMENT ON BONE MINERALISATION, RESORP TION P ARAMETERS AND BIOMECHANICS OF SINGLE HUMAN VERTEBRAL TRABECULAE EUROPEAN CELLS & MATERIALS (ISSN: 14732262) 28: pp. 152165. ( 2014) Folyóiratcikk [14594143]
69
Reginster J Y, Neuprez A, Dardenne N, Beaudart C, Emonts P, Bruyere O Efficacy and safety of currently marketed antiosteoporosis medications BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 1521690X) 28: (6) pp. 809834. ( 2014) Folyóiratcikk [14594142]
70 * Bauer Douglas C, Schwartz Ann, Palermo Lisa, Cauley Jane, Hochberg Marc, Santora Art, Cummings Steven R, Black Dennis M Fracture P rediction After Discontinuation of 4 to 5 Years of Alendronate Therapy The FLEX Study JAMA INTERNAL MEDICINE (ISSN: 21686106) 174: (7) pp. 11261134. ( 2014) Folyóiratcikk [14594141] 71
Ferrari Serge Future directions for new medical entities in osteoporosis BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 1521690X) 28: (6) pp. 859870. ( 2014) Folyóiratcikk [14594140]
72
Grados Dolors, MartinezMorillo Melania, Holgado Susana, Erra Alba Intravenous bisphosphonates for bone P aget's disease: Higher risk of adverse events MEDICINA CLINICA (ISSN: 00257753) 142: (10) pp. 469470. ( 2014) Folyóiratcikk [14594139]
73
W illiams Graham R Is prophylactic antiresorptive therapy required in thyroid cancer patients receiving TSHsuppressive treatment with thyroxine? JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (ISSN: 17208386) 37: (8) pp. 775779. ( 2014) Folyóiratcikk [14594138]
74
Miller P D, Recker R R, Harris S, Silverman S, Felsenberg D, Reginster J, Day BM, Barr C, Masanauskaite D Longterm fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE longterm extension studies OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (1) pp. 349357. ( 2014) Folyóiratcikk [14594137]
75
W atts Nelson B Longterm risks of bisphosphonate therapy ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (ISSN: 00042730) 58: (5) pp. 523529. ( 2014) Folyóiratcikk [14594136]
76
Coughlan Tara, Dockery Frances Osteoporosis and fracture risk in older people CLINICAL MEDICINE (ISSN: 14702118) 14: (2) pp. 187191. ( 2014) Folyóiratcikk [14594135]
77
Litwic A, Cooper C, Dennison E Osteoporosis therapies in 2014 PANMINERVA MEDICA (ISSN: 00310808) 56: (4) pp. 273283. ( 2014) Folyóiratcikk [14594134]
78
Bu Shi, Xing Xiaoyan P revention and treatment of osteoporosis in the elderly Chinese Journal of Endocrinology and Metabolism (ISSN: 10006699) 30: (10) pp. 886888. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14594133]
79
Tella Sri Harsha, Gallagher J Christopher P revention and treatment of postmenopausal osteoporosis
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 12/342
3/30/2015
nyomtatobarat forma JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (ISSN: 09600760) 142: pp. 155170. ( 2014) Folyóiratcikk [14594132] 80 * Cosman Felicia, Cauley Jane A, Eastell Richard, Boonen Steven, Palermo Lisa, Reid Ian R, Cummings Steven R, Black Dennis M Reassessment of Fracture Risk in Women After 3 Years of Treatment With Zoledronic Acid: When is it Reasonable to Discontinue Treatment? JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 99: (12) pp. 45464554. ( 2014) Folyóiratcikk [14594131] 81
Sharma Abhishek, Einstein Andrew J, Vallakati Ajay, ArbabZadeh Armin, W alker Marcella Donovan, Mukherjee Debabrata, Homel Peter, Borer Jeffrey S, Lichstein Edgar Risk of Atrial Fibrillation With Use of Oral and Intravenous Bisphosphonates AMERICAN JOURNAL OF CARDIOLOGY (ISSN: 00029149) 113: (11) pp. 18151821. ( 2014) Folyóiratcikk [14594130]
82
Suresh Ernest, Pazianas Michael, Abrahamsen Bo Safety issues with bisphosphonate therapy for osteoporosis RHEUMATOLOGY (ISSN: 14620324) 53: (1) pp. 1931. ( 2014) Folyóiratcikk [14594129]
83
Brown Jacques P, Morin Suzanne, Leslie W illiam, Papaioannou Alexandra, Cheung Angela M, Davison Kenneth S, Goltzman David, Hanley David Arthur, Hodsman Anthony, Josse Robert, Jovaisas Algis, Juby Angela, Kaiser Stephanie, Karaplis Andrew, Kendler David, Khan Aliya, Ngui Daniel, Olszynski W ojciech, SteMarie LouisGeorges, Adachi Jonathan The bisphosphonates in the treatment of osteoporosis Expected Benefits, potential harms and therapeutic time off CANADIAN FAMILY PHYSICIAN (ISSN: 0008350X) 60: (4) pp. E197E207. ( 2014) Folyóiratcikk [14594128]
84
Gosch M, Kammerlander C, Nicholas J A Treatment of osteoporosis in older adults PANMINERVA MEDICA (ISSN: 00310808) 56: (2) pp. 133143. ( 2014) Folyóiratcikk [14594127]
85 * Eriksen Erik F, DiezPerez Adolfo, Boonen Steven Update on longterm treatment with bisphosphonates for postmenopausal osteoporosis: A systematic review BONE (ISSN: 87563282) 58: pp. 126135. ( 2014) Folyóiratcikk [14594126] 86
Diab Dima L, W atts Nelson B Use of drug holidays in women taking bisphosphonates MENOPAUSETHE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (ISSN: 10723714) 21: (2) pp. 195197. ( 2014) Folyóiratcikk [14594125]
87
Huang Shushu, Lin Hua, Zhu Xiufen, Chen Xin, Fan Lu, Liu Changchang Zoledronic acid increases bone mineral density and improves healthrelated quality of life over two years of treatment in Chinese women with postmenopausal osteoporosis ENDOKRYNOLOGIA POLSKA (ISSN: 0423104X) 65: (2) pp. 96104. ( 2014) Folyóiratcikk [14594124]
88
孙阳 经皮穿刺椎体成形术与保守法治疗骨质疏松性椎体压缩性骨折短期疗效对比 Chinese Journal of Gerontology (ISSN: 10059202) 34: (17) pp. 50055006. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14594161]
89
Tsai C H, Lin C L, Hsu H C, Chung W S Increased risk of stroke among hip fracture patients: a nationwide cohort study OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 26: (2) pp. 645652. ( 2015) Folyóiratcikk [14594122]
90
Andreopoulou Panagiota, Bockman Richard S Management of P ostmenopausal Osteoporosis Annual Review of Medicine (ISSN: 00664219) 66: pp. 329342. ( 2015) BE Caskey, CT Folyóiratcikk [14594121]
44. Feldman K , Szappanos Á , Nagy Zs , Lakatos P , Tóth M , Rácz K , Patócs A A HSD11B1 gén polimorfizmusainak csont metabolizmusra gyakorolt hatása oszteoporózisban szenvedő nőkben. (2012) Nyelv: Magyar
Egyéb /Nem besorolt /Tudományos [2002867] [Előadás] [ Admin láttamozott ] 45. Feldman K , Szappanos A , Butz H , Grolmusz V , M ajnik J , Likó I , Kriszt B , Lakatos P , Tóth M , Rácz K , Patócs A The rs4844880 polymorphism in the promoter region of the HSD11B1 gene associates with bone mineral density in healthy and postmenopausal osteoporotic women. STEROIDS 77:(13) pp. 13451351. (2012) IF: 2.803 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [2088979] [ Érvényesített ] Független idéző: 5 Függő idéző: 3 Összesen: 8 1. * FeldmanKovács Karolina
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 13/342
3/30/2015
nyomtatobarat forma A HSD11B1 gén polimorfizmusainak csont metabolizmusra gyakorolt hatása osteoporosisban és mellékvesekéreg adenomás nőbetegekben Beny újtás éve: 2013. Védés éve: 2013. 2013.
Disszertáció /P hD /Tudományos [14250315] 2
Zhou H, Cooper MS, Seibel MJ Endogenous Glucocorticoids and Bone BONE RES (ISSN: 20954700) 1: (2) pp. 107119. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [14416664]
3
Quax RA, Manenschijn L, Koper JW , Hazes JM, Lamberts SW J, van Rossum EFC, Feelders RA Glucocorticoid sensitivity in health and disease NATURE REVIEWS ENDOCRINOLOGY (ISSN: 17595029) 9: (11) pp. 670686. ( 2013) F N: Thomson Reuters W eb of Knowledge Folyóiratcikk /Összefoglaló cikk /Tudományos [13536004]
4 * Feldman K, Likó I, Nagy Z, Szappanos A, Grolmusz VK, Tóth M, Rácz K, Patócs A Importance of the 11βhydroxysteroid dehydrogenase enzyme in clinical disorders Orvosi Hetilap (ISSN: 00306002) 154: (8) pp. 283293. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13047620] 5
Hardy RS, Seibel MJ, Cooper MS Targeting 11 betahydroxysteroid dehydrogenases: a novel approach to manipulating local glucocorticoid levels with implications for rheumatic disease CURRENT OPINION IN PHARMACOLOGY (ISSN: 14714892) 13: (3) pp. 440444. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13288463]
6 * Grolmusz VK, Ács OD, FeldmanKovács K, Szappanos Á, Stenczer B, Fekete T, Szendei G, Reismann P, Rácz K, Patócs A Genetic variants of the HSD11B1 gene promoter may be protective against polycystic ovary syndrome MOLECULAR BIOLOGY REPORTS (ISSN: 03014851) 41: (9) pp. 59615969. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14198869] 7
Xiaoman Liu, Jiali Li, Qian Fu, Shu Liu, Yu Zhang, Xueding W ang, Hongyang W ang, Jun Li, Chen Zhu, Changxi W ang, Min Huang Associations of HSD11B1 P olymorphisms with Tacrolimus Concentrations in Chinese Renal Transplant Recipients with P rednisone Combined Therapy DRUG METABOLISM AND DISPOSITION (ISSN: 00909556) 43: (4) pp. 455458. ( 2015) Folyóiratcikk /Szakcikk /Tudományos [14419134]
8
Quteineh Lina, Vandenberghe Frederik, Saigi Morgui Nuria, Delacrétaz Aurélie, Choong Eva, GholamRezaee Mehdi, Magistretti Pierre, Bondolfi Guido, Von Gunten Armin, Preisig Martin, Castelao Enrique, Vollenweider Peter, W aeber Gerard, Bochud Murielle, Kutalik Zoltán, Conus Philippe, Eap Chin B Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments. PHARMACOGENETICS AND GENOMICS (ISSN: 17446872) In press: p. In press. ( 2015) Folyóiratcikk /Szakcikk /Tudományos [14592907]
46. Halászlaki C , Takács I , Butz H , Patócs A , Lakatos P Novel genetic mutation in the background of Carney complex PATHOLOGY AND ONCOLOGY RESEARCH 18:(2) pp. 149152. (2012) IF: 1.555 Nyelv: Angol
Folyóiratcikk /Összefoglaló cikk /Tudományos [1971123] [ Hitelesített ] Független idéző: 2 Összesen: 2 1
Paolo Ricci A, Álvaro Ibarra V Carney syndrome with breast myxoma: A very rare tumor in interdisciplinary management Revista Chilena de Obstetricia y Ginecologia 78: (1) pp. 5154. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13366734]
2
Bremmer F, Behnes CL, Radzun HJ, Bettstetter M, Schweyer S Sex cord gonadal stromal tumors PATHOLOGE (ISSN: 01728113) 35: (3) pp. 245251. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14457433]
47. Halászlaki C , Lakatos P , Kósa P J , Balla B , Járay B , Takács I A pajzsmirigydaganatok genetikai háttere [Genetic background of thyroid cancers]. LEGE ARTIS MEDICINAE 22:(1) pp. 916. (2012) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [1971147] [ Hitelesített ] 48. Holló A , Clemens Z , Kamondi A , Lakatos P , Szucs A Correction of vitamin D deficiency improves seizure control in epilepsy: A pilot study EPILEPSY & BEHAVIOR 24:(1) pp. 131133. (2012) IF: 1.844 Nyelv: Angol
Folyóiratcikk /Rövid közlemény /Tudományos [1971135] [ Hitelesített ] Független idéző: 12 Függő idéző: 2 Összesen: 14 1
Nowak JK The role of vitamin D in disorders of the central nervous system Neuropsychiatria i Neuropsychologia 7: (2) pp. 8596. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12872413]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 14/342
3/30/2015
nyomtatobarat forma 2
Karczmarewicz E, CzekucKryskiewicz E, Pludowski P Effect of vitamin d status on pharmacological treatment efficiency impact on costeffective management in medicine DermatoEndocrinology (ISSN: 19381972) 5: (2) pp. 299304. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13722061]
3
Karczmarewicz E, CzekućKryśkiewicz E, Płudowski P Effect of vitamin D status on pharmacological treatment efficiency: Impact on costeffective management in medicine DermatoEndocrinology 5: (1) pp. 16. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13355525]
4
W acker M, Holick MF Sunlight and Vitamin D: A global perspective for health DermatoEndocrinology 5: (1) pp. 51108. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13355524]
5
W rzosek M, Lukaszkiewicz J, W rzosek M, Jakubczyk A, Matsumoto H, Piatkiewicz P, RadziwonZaleska M, W ojnar M, Nowicka G Vitamin D and the central nervous system Pharmacological Reports (ISSN: 17341140) 65: (2) pp. 271278. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13355523]
6
Sarajlija A, Djuric M, Tepavcevic DK, Grkovic S, Djordjevic M Vitamin D deficiency in serbian patients with rett syndrome Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 98: (12) pp. E1972E1978. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13722044]
7
Oliveira W elington Saraiva de, Moraes Niele, Santos Fania Cristina Vitamina D e dor crônica em idosos: Vitamin D and chronic pain in the elderly Revista Dor (ISSN: 18060013) 14: (3) pp. 223225. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13722076]
8
Cannell JJ, Grant W B What is the role of vitamin D in autism? DermatoEndocrinology 5: (1) pp. 199204. ( 2013) Folyóiratcikk /Ismertetés /Tudományos [13355522]
9
* Altbacker A, Plozer E, Darnai G, Perlaki G, Orsi G, Nagy SA, Lucza T, Schwarcz A, Koszegi T, Kovacs N, Komoly S, Janszky J, Clemens Z Alexithymia is associated with low level of vitamin D in young healthy adults NUTRITIONAL NEUROSCIENCE (ISSN: 1028415X) 17: (6) pp. 284288. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14273683]
10 * Holló A, Clemens Z, Lakatos P Epilepsy and vitamin D Int. J. Neurosci. (ISSN: 00207454) 124: (6) pp. 387393. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14273658] 11
Jerath NU, Lamichhane D, Jasti M, Yarlagadda V, Zilli E, Nazzal Y, Granner M Treating epilepsy in the setting of medical comorbidities Curr. Treat. Options Neurol. (ISSN: 10928480) 16: (7) P aper 298. (2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14273657]
12
Brandt Alyssa M, Doherty Michael J VEEG models of seizure frequency Do SSRI medications or vitamin D supplements alter seizure collections? EPILEPSY & BEHAVIOR (ISSN: 15255050) 41: pp. 208209. ( 2014) Folyóiratcikk [14594060]
13
Groves NJ, McGrath JJ, Burne THJ Vitamin D as a neurosteroid affecting the developing and adult brain Annu. Rev. Nutr. (ISSN: 01999885) 34: pp. 117141. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14273656]
14
Durk Matthew R, Fan Jianghong, Sun Huadong, Yang Yingbo, Pang Henrianna, Pang K Sandy, de Lannoy Ines A M Vitamin D Receptor Activation Induces P Glycoprotein and Increases Brain Efflux of Quinidine:An Intracerebral Microdialysis Study in Conscious Rats PHARMACEUTICAL RESEARCH (ISSN: 07248741) 32: (3) pp. 11281140. ( 2015) Folyóiratcikk [14594059]
49. Horváth E , Lakatos P , Balla B , Kósa PJ , Tóbiás B , Somorácz Á , Jozilan H , Harsányi L , Kupcsulik P , Schaff Z , Szalay F CYP24A1 and CYP27B1 mRNA expression in human hepatocellular carcinoma In: Szalay Ferenc (szerk.) M agyar Gasztroenterológiai Társaság 54. nagygyűlés program és előadáskivonatok [= 54th Annual M eeting of the Hungarian Society of Gastroenterology. Program/abstracts] . 142 p. Konferencia helye, ideje: Tihany , M agyarország , 2012.06.02 2012.06.05. Budapest: M agyar Gasztroenterológiai Társaság, p. 103. Nyelv: Angol
Egyéb konferenciaközlemény /Absztrakt /Tudományos [1984234] [ Admin láttamozott ] 50. Horvath Evelin , Lakatos Peter , Balla Bernadett , Kosa Janos Pal , Tobias Balint , Jozilan Hasan , Borka Katalin , Horvath Henrik Csaba , Kovalszky Ilona , Szalay Ferenc M arked Increase of CYP24A1 mRNA Level in Hepatocellular Carcinoma Cell Lines Following Vitamin D Administration ANTICANCER RESEARCH 32:(11) pp. 47914796. (2012) IF: 1.713 Nyelv: Angol https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 15/342
3/30/2015
nyomtatobarat forma
Folyóiratcikk /Szakcikk /Tudományos [2162374] [ Érvényesített ] Független idéző: 2 Összesen: 2 1
Salzman J, Chen RE, Olsen MN, W ang PL, Brown PO CellType Specific Features of Circular RNA Expression PLOS GENETICS (ISSN: 15537390) 9: (9) P aper e1003777. (2013) Folyóiratcikk /Szakcikk /Tudományos [13692785]
2
Rubsamen D, Kunze MM, Buderus V, Brauss TF, Bajer MM, Brune B, Schmid T Inflammatory Conditions Induce IRESDependent Translation of cyp24a1 PLOS ONE (ISSN: 19326203) 9: (1) P aper e85314. (2014) Folyóiratcikk /Szakcikk /Tudományos [13692784]
51. Kosa JP , Balla B , Vaszilko M , Zsarko M , Takacs I , Tobias B , Nagy Z , Lazary A , Lakatos P EXAM INATION OF CYP2C8 rs1934951 POLYM ORPHISM IN HUNGARIAN PATIENTS SUFFERING FROM BISPHOSPHONATEINDUCED OSTEONECROSIS OF THE JAW OSTEOPOROSIS INTERNATIONAL 23:(Suppl. 2) p. S373. (2012) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [2240059] IOFECCEO European Congress on Osteoporosis and Osteoarthritis / 2nd : IOFESCEO PreClinical Symposium M AR 2124, 2012. Bordeaux, FRANCE [ Érvényesített ] 52. Lakatos P Laboratóriumi vizsgálatok In: Lakatos Péter , Takács István (szerk.) A csontanyagcsere betegségei . 519 p. Budapest: Semmelweis Kiadó, 2012. pp. 134141. (ISBN:9789633312056) Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1885402] [ Érvényesített ] 53. Lakatos P Juvenilis osteoporosis In: Lakatos Péter , Takács István (szerk.) A csontanyagcsere betegségei . 519 p. Budapest: Semmelweis Kiadó, 2012. pp. 181182. (ISBN:9789633312056) Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1885408] [ Érvényesített ] 54. Lakatos P , Lakatos G Az osteoporosis gyógyszeres kezelése In: Lakatos Péter , Takács István (szerk.) A csontanyagcsere betegségei . 519 p. Budapest: Semmelweis Kiadó, 2012. pp. 194223. (ISBN:9789633312056) Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1885416] [ Érvényesített ] 55. Lakatos P Is systemic supplementation in calcium/vitamin D necessary to treat postmenopausal osteoporosis? MEDICOGRAPHIA 34:(2) p. 194. (2012) Nyelv: Angol
Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [1971100] [ Érvényesített ] 56. Lakatos P A gyógyszeres kezelés kiválasztásának szempontjai és monitorozása In: Lakatos Péter , Takács István (szerk.) A csontanyagcsere betegségei . 519 p. Budapest: Semmelweis Kiadó, 2012. pp. 225228. https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 16/342
3/30/2015
nyomtatobarat forma
(ISBN:9789633312056) Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1974307] [ Érvényesített ] 57. Lakatos P A csontanyagcsere vizsgálatában leggyakrabban használatos laboratóriumi normálértékek In: Lakatos Péter , Takács István (szerk.) A csontanyagcsere betegségei . 519 p. Budapest: Semmelweis Kiadó, 2012. pp. 496498. (ISBN:9789633312056) Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1974310] [ Érvényesített ] 58. Lakatos P , Takács I , Speer G , Nagy Zs A metabolikus csontbetegségek differenciált diagnosztikája In: Lakatos Péter , Takács István (szerk.) A csontanyagcsere betegségei . 519 p. Budapest: Semmelweis Kiadó, 2012. pp. 502503. (ISBN:9789633312056) Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1974311] [ Érvényesített ] 59. Lakatos P A csontanyagcsere betegségeinek kezelésében hazánkban leggyakrabban alkalmazott gyógyszerek In: Lakatos Péter , Takács István (szerk.) A csontanyagcsere betegségei . 519 p. Budapest: Semmelweis Kiadó, 2012. pp. 499501. (ISBN:9789633312056) Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1974314] [ Érvényesített ] 60. Lakatos P , Tóth E , Szekeres L , Poór G , Héjj G , Takács I A csontritkulás kezelésének hatékonysága M agyarországon: Az Országos Egészségbiztosítási Pénztár adatainak elemzése LEGE ARTIS MEDICINAE KID 2:(3) pp. 512. (2012) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [2083762] [ Érvényesített ] 61. LAKATOS P , TÓTH E , LANG Zs , NAGY B , SZEKERES L , TAKÁCS I Adherencia a magyar posztmenopauzális osteoporoticus nôi betegek körében LEGE ARTIS MEDICINAE KID 2:(4) pp. 515. (2012) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [2356812] [ Admin láttamozott ] 62. Lakatos Péter , Takács István (szerk.) A csontanyagcsere betegségei Budapest: Semmelweis Kiadó, 2012. 519 p. (ISBN:9789633312056) Nyelv: Magyar
Könyv /Felsőoktatási tankönyv /Oktatási [1796514] [ Szerzői rekord ] 63. M iller P D , Recker R R , Reginster J Y , Riis B J , Czerwinski E , M asanauskaite D , Kenwright A , Lorenc R , Stakkestad J A , Lakatos P Efficacy of monthly oral ibandronate is sustained over 5 years: the M OBILE longterm extension study OSTEOPOROSIS INTERNATIONAL 23:(6) pp. 17471756. (2012) IF: 4.039 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1809697] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 17/342
3/30/2015
nyomtatobarat forma
[ Érvényesített ] Független idéző: 7 Függő idéző: 1 Összesen: 8 1 * Khosla Sundeep, Bilezikian John P, Dempster David W , Lewiecki E Michael, Miller Paul D, Neer Robert M, Recker Robert R, Shane Elizabeth, Shoback Dolores, Potts John T Benefits and Risks of Bisphosphonate Therapy for Osteoporosis JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 97: (7) pp. 22722282. ( 2012) Folyóiratcikk [14594054] 2
Langdahl Bente, Binkley Neil, Bone Henry, Gilchrist Nigel, Resch Heinrich, Portales Jose Rodriguez, Denker Andrew, Lombardi Antonio, De Tilleghem Celine Le Bailly, DaSilva Carolyn, Rosenberg Elizabeth, Leung Albert Odanacatib in the Treatment of P ostmenopausal Women With Low Bone Mineral Density: Five Years of Continued Therapy in a P hase 2 Study JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 27: (11) pp. 22512258. ( 2012) Folyóiratcikk [14594053]
3
Xu XiaoLong, Gou W enLong, W ang AiYuan, W ang Yu, Guo QuanYi, Lu Qiang, Lu ShiBi, Peng Jiang Basic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years? JOURNAL OF TRANSLATIONAL MEDICINE (ISSN: 14795876) 11: P aper 303. (2013) Folyóiratcikk [14594052]
4
Nakamura Toshitaka, Nakano Tetsuo, Ito Masako, Hagino Hiroshi, Hashimoto Junko, Tobinai Masato, Mizunuma Hideki Clinical Efficacy on Fracture Risk and Safety of 0.5 mg or 1 mg/month Intravenous Ibandronate Versus 2.5 mg/day Oral Risedronate in P atients with P rimary Osteoporosis CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 93: (2) pp. 137146. ( 2013) CA MOVER Study Grp Folyóiratcikk [14594051]
5
W illiams Donald S, McCracken Paul J, Purcell Mona, Pickarski Maureen, Mathers Parker D, Savitz Alan T, Szumiloski John, Jayakar Richa Y, Somayajula Sangeetha, Krause Stephen, Brown Keenan, W inkelmann Christopher T, Scott Boyd B, Cook Lynn, Motzel Sherri L, Hargreaves Richard, Evelhoch Jeffrey L, Cabal Antonio, Dardzinski Bernard J, Hangartner Thomas N, Duong Le T Effect of odanacatib on bone turnover markers, bone density and geometry of the spine and hip of ovariectomized monkeys: A head tohead comparison with alendronate BONE (ISSN: 87563282) 56: (2) pp. 489496. ( 2013) Folyóiratcikk [14594050]
6
Yavropoulou M P, Hamdy N A T, Papapoulos S E Longterm treatment of osteoporotic women with bisphosphonates does not impair the response to subsequently administered intravenous pamidronate OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 24: (8) pp. 23532357. ( 2013) Folyóiratcikk [14594049]
7
Rossini Maurizio, Orsolini Giovanni, Adami Silvano, Kunnathully Vidya, Gatti Davide Osteoporosis treatment: why ibandronic acid? EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 14: (10) pp. 13711381. ( 2013) Folyóiratcikk [14594048]
8
Eriksen Erik F, DiezPerez Adolfo, Boonen Steven Update on longterm treatment with bisphosphonates for postmenopausal osteoporosis: A systematic review BONE (ISSN: 87563282) 58: pp. 126135. ( 2014) Folyóiratcikk [14594047]
64. Németh D , Tamási P , Gasztonyi B , Szabó G , Kósa J , Lakatos P , Szalay F , Szathmári M Klinikai gyógyulás M ARS és kelátképző kezelést követően Wilsonkór által okozott heveny májelégtelenség esetében MAGYAR BELORVOSI ARCHIVUM 65:(6) pp. 378379. (2012) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2158454] [ Admin láttamozott ] 65. Pálfi Eszter , Bakos Bence , Szili Balázs , Kósa János , Lakatos Péter , Takács István A primer hyperparathyreosis klinikai megjelenési formái napjainkban különös tekintettel a cardiovascularis hatásra MAGYAR BELORVOSI ARCHIVUM 65:(5) pp. 312317. (2012) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [2245346] [ Érvényesített ] 66. Péter F , M uzsnai Á , Blatniczky L , Lakatos P Budai iskolás gyermekek szérum 25(OH)Dszintjének és csontásványianyagtartalmának párhuzamos vizsgálata GYERMEKGYÓGYÁSZAT 63:(1) pp. 1623. (2012) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1928683] [ Érvényesített ] 67. Takács I , Benkő I , Toldy E , Wikonkál N , Szekeres L , Bodolay E , Kiss E , Jambrik Z , Szabó B , M erkely B , Valkusz Zs , Kovács T , Szabó A , Grigoreff O , Nagy Z , Demeter J , Horváth HC , Bittner N , Várbíró S , Lakatos P Hazai konszenzus a Dvitamin szerepéről a betegségek megelőzésében és kezelésében: Állásfoglalás ORVOSI HETILAP 153:(Suppl. 2) pp. 526. (2012) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [2028384] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 18/342
3/30/2015
nyomtatobarat forma
[ Hitelesített ] Független idéző: 7 Függő idéző: 7 Összesen: 14 1
2
3
* Virágh É, Horváth D, Lőcsei Z, Kovács L, Jáger R, Varga B, Kovács LG, Toldy E Dvitaminellátottság felmérése Vas megye egészséges véradói körében [Vitamin D supply among healthy blood donors in County Vas, Hungary]. Orvosi Hetilap (ISSN: 00306002) 153: (41) pp. 16291637. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13013715] Hontvári Lívia A Dvitaminról kombináljunk! LAM KID 3: (4) pp. 58. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13543544] * Kovács L, Virágh E, Balogh D, Kálmán B, Locsei Z, Toldy E Clinical evaluation of two parathyroid hormone assays in the context of vitamin D supply in chronic kidney disease Orvosi Hetilap (ISSN: 00306002) 154: (51) pp. 20252036. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13598339]
4
Farkas Erika, RegölyMérei Andrea, Antal Magda Dvitamin és kalciumellátottság gyermek és serdülőkorban GYERMEKGYÓGYÁSZAT (ISSN: 00175900) 64: (4) pp. 192196. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13275648]
5
Speer Gábor Dvitaminterápia: hormonkezelés a rászoruló betegeknek vagy egyszerűen étrendkiegészítés mindenkinek? LAM KID 3: (3) pp. 510. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13514251]
6
Rodé Magdolna, Gaál András KÖVÉRSÉG ÉS ROSSZINDULATÚ DAGANATOK MAGYAR TUDOMÁNY (ISSN: 00250325) 2013: (7) pp. 802810. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13848073]
7
* Płudowski P, Karczmarewicz E, Bayer M, Carter G, ChlebnaSokół D, CzechKowalska J, Dȩbski R, Decsi T, Dobrzańska A, Franek E, Głuszko P, Grant W B, Holick MF, Yankovskaya L, Konstantynowicz J, Ksia̧ zyk JB, KsiȩzopolskaOrłowska K, Lewiński A, Litwin M, Lohner S, Lorenc RS, Łukaszkiewicz J, MarcinowskaSuchowierska E, Milewicz A, Misiorowski W, Nowicki M, Povoroznyuk V, Rozentryt P, Rudenka E, Shoenfeld Y, Socha P, Solnica B, Szalecki M, Tałałaj M, Varbiro S, Zmijewski MA P ractical guidelines for the supplementation of vitamin D and the treatment of defcits in Central Europe Recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency Endokrynologia Polska (ISSN: 0423104X) 64: (4) pp. 319327. ( 2013) Folyóiratcikk /Jelentés /Tudományos [13384948]
8
* Fehérvári M, Krepuska M, CsobayNovák C, Lakatos P, Oláh Z, Acsády G, Szeberin Z P revalence of osteoporosis in patients with severe peripheral artery disease Orvosi Hetilap (ISSN: 00306002) 154: (10) pp. 369375. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13080277]
9
* Salamon A, Biró C, Toldy E The role of vitamin D defi ciency in the pathogenesis of falls and fractures Orvosi Hetilap (ISSN: 00306002) 154: (19) pp. 731736. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13151320]
10
Lorinczy K, Lakatos PL, Tóth M, Salamon A, Nemes A, Csontos AA, Fekete B, Terjék O, Herszényi L, Juhász M, Tulassay Z, Miheller P Vitamin D level in Hungarian patients with inflammatory bowel diseases Orvosi Hetilap (ISSN: 00306002) 154: (46) pp. 18211828. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13481493]
11
Gellén Emese, Emri Gabriella, Szegedi Andrea, Horkay Irén, Remenyik Éva Az UVsugárzás biológiai hatásai és kapcsolata a gyermekkorral GYERMEKORVOS TOVÁBBKÉPZÉS (ISSN: 15890309) 13: (1) pp. 2428. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13734052]
12
Głuszko P, Lorenc RS, Karczmarewicz E, Misiorowski W , Jaworski M P olish guidelines for the diagnosis and management of osteoporosis: A review of 2013 update POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJPOLISH ARCHIVES OF INTERNAL MEDICINE (ISSN: 00323772) 124: (5) pp. 255263. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14225453]
13 * Pludowski P, Grant W B, Bhattoa HP, Bayer M, Povoroznyuk V, Rudenka E, Ramanau H, Varbiro S, Rudenka A, Karczmarewicz E, Lorenc R, CzechKowalska J, Konstantynowicz J Vitamin D status in central Europe International Journal of Endocrinology (ISSN: 16878345) 2014: P aper 589587. (2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [13845358] 14 * Salamon A, Hepp B, Mátrai A, Biró C, Ágota K, Fata E, Locsei Z, Toldy E Vitamin D supply of patients with hip fracture Orvosi Hetilap (ISSN: 17886120) 155: (17) pp. 659668. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13845357]
68. Tobiás B , Balla B , Kósa PJ , Horányi J , Takács I , Bölöny E , Halászlaki C , Nagy Zs , Speer G , Járay B , Székely E , Istók R , Székely T , Lakatos P Comparative examination of somatic oncogene mutation normal and pathologic thyroid tissues of Hungarian patients ENDOCRINE ABSTRACTS 29: Paper P1838. (2012) 15th International & 14th European Congress of Endocrinology. Florence, Olaszország: 2012.05.05 2012.05.09. Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1964347] [ Érvényesített ] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 19/342
3/30/2015
nyomtatobarat forma
69. Tobiás B , Balla B , Kósa PJ , Horányi J , Takács I , Halászlaki C , Nagy Zs , Speer G , Járay B , Székely E , Istók R , Székely T , Lakatos P Comparative examination of somatic oncogene mutation normal and pathologic thyroid tissues of Hungarian patients (2012) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [1964354] [Poszter] [ Admin láttamozott ] 70. Tóbiás B , Balla B , Kósa J , Bölöny E , Takács I , Horváth H , Nagy Zs , Horváth E , Speer G , Horányi J , Járay B , Székely E , Istók R , Székely T , Lakatos P Genetikai eltérések pajzsmirigy daganatos magyar betegekben In: M agyar Endokrinológiai és Anyagcsere Társaság 24. Kongresszusa: Előadás és poszter absztraktok . Konferencia helye, ideje: Szolnok , M agyarország , 2012.05.17 2012.05.19. p. 19. Nyelv: Magyar
Egyéb konferenciaközlemény /Absztrakt /Tudományos [2033374] [ Admin láttamozott ]
2011 71. Ambrus C , Almasi C , Berta K , Deak G , M arton A , M olnar M Z , Nemeth Z , Horvath C , Lakatos P , Szathmari M , M ucsi I Bone mineral density and parathyroid function in patients on maintenance hemodialysis INTERNATIONAL UROLOGY AND NEPHROLOGY 43:(1) pp. 191201. (2011) IF: 1.471 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1532336] [ Érvényesített ] Független idéző: 3 Függő idéző: 2 Összesen: 5 1
W ang Zhiguo, Zhang Jiaming, Zhou Jin The correlation between the marker of bone metabolism and intact parathyroid hormone in patients undergoing maintenance hemodialysis Jiangsu Medical Journal 37: (20) pp. 23912392. ( 2011) Folyóiratcikk /Rövid közlemény /Tudományos [13051225]
2 * Ambrus Cs, Almasi Cs, Berta K, Deak Gy, Marton A, Molnar M Zs, Nemeth Zs, Horvath Cs, Lakatos P, Szathmari M, Mucsi I Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis International Urology and Nephrology (ISSN: 03011623) 43: (2) pp. 475482. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12008686] 3 * Miller Jessica E, Molnar Miklos Z, Kovesdy Csaba P, Zaritsky Joshua J, Streja Elani, Salusky Isidro, Arah Onyebuchi A, KalantarZadeh Kamyar Administered paricalcitol dose and survival in hemodialysis patients: A marginal structural model analysis PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (ISSN: 10538569) 21: (11) pp. 12321239. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13051223] 4
Zywiec Joanna, Pluskiewicz W ojciech, Adamczyk Piotr, Skubala Alina, Gumprecht Janusz P HALANGEAL QUANTITATIVE ULTRASOUND MEASUREMENTS IN CHRONIC HEMODIALYSIS P ATIENTS: A 4 YEAR FOLLOWUP ULTRASOUND IN MEDICINE AND BIOLOGY (ISSN: 03015629) 38: (6) pp. 962971. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13051222]
5
万瑛, 孙桂云, 陈艳 雌激素对进行维持性血液透析的育龄期妇女肾性骨病的影响 Chinese Journal of Clinical Laboratory Science 30: (12) pp. 10061006. ( 2012) Folyóiratcikk /Rövid közlemény /Tudományos [13051224]
72. Ambrus C , Almasi C , Berta K , Deak G , M arton A , M olnar M Z , Nemeth Z , Horvath C , Lakatos P , Szathmari M , M ucsi I Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis INTERNATIONAL UROLOGY AND NEPHROLOGY 43:(2) pp. 475482. (2011) IF: 1.471 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1625612] [ Érvényesített ] Független idéző: 14 Összesen: 14 1
Nickolas T L, Cremers S, Zhang A, Thomas V, Stein E, Cohen A, Chauncey R, Nikkel L, Yin M T, Liu X S, Boutroy S, Staron R B, Leonard M B, McMahon D J, Dworakowski E, Shane E Discriminants of prevalent fractures in chronic kidney disease Journal of the American Society of Nephrology (ISSN: 10466673) 22: (8) pp. 15601572. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12008663]
2
Jean G How to manage mineral metabolism disorders in renal failure: Comment je traite les troubles phosphocalciques en cas d'insuffisance rénale chronique Presse Medicale (ISSN: 07554982) 40: (11) pp. 10431052. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12008662]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 20/342
3/30/2015
nyomtatobarat forma 3
Jamal SA, W est SL, Miller PD Bone and kidney disease: Diagnostic and therapeutic implications Current Rheumatology Reports (ISSN: 15233774) 14: (3) pp. 217223. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13051248]
4
W est Sarah L, Jamal Sophie A Determination of Bone Architecture and Strength in Men and Women with Stage 5 Chronic Kidney Disease SEMINARS IN DIALYSIS (ISSN: 08940959) 25: (4) pp. 397402. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13051240]
5
Nigwekar Sagar U, Bhan Ishir, Thadhani Ravi Ergocalciferol and Cholecalciferol in CKD AMERICAN JOURNAL OF KIDNEY DISEASES (ISSN: 02726386) 60: (1) pp. 139156. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13051239]
6
W est SL, Jamal SA Treatment of osteoporosis in patients with chronic kidney disease International Journal of Clinical Rheumatology (ISSN: 17584272) 7: (4) pp. 453461. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13051247]
7
Chitalia N, RecioMayoral A, Kaski J C, Banerjee D Vitamin D deficiency and endothelial dysfunction in nondialysis chronic kidney disease patients Atherosclerosis (ISSN: 00219150) 220: (1) pp. 265268. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12008661]
8
Hryszko Tomasz, RydzewskaRosolowska Alicja, Gozdzikiewicz Joanna, Brzosko Szymon, KocZorawska Ewa, Zelazowska Rutkowska Beata, Mysliwiec Michal Cholecalciferol supplementation reduces soluble Klotho concentration in hemodialysis patients POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJPOLISH ARCHIVES OF INTERNAL MEDICINE (ISSN: 00323772) 123: (6) pp. 277281. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13477562]
9
Moorthi RN, Moe SM Recent advances in the noninvasive diagnosis of renal osteodystrophy KIDNEY INT (ISSN: 00852538) 84: (5) pp. 886894. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [14096868]
10
Massart Annick, Debelle Frederic Daniel, Racape Judith, Gervy Christine, Husson Cecile, Dhaene Michel, W issing Karl Martin, Nortier Joelle Louise Biochemical P arameters After Cholecalciferol Repletion in Hemodialysis: Results From the VitaDial Randomized Trial AMERICAN JOURNAL OF KIDNEY DISEASES (ISSN: 02726386) 64: (5) pp. 696705. ( 2014) Folyóiratcikk [14594825]
11
Salam SN, Eastell R, Khwaja A Fragility Fractures and Osteoporosis in CKD: P athophysiology and Diagnostic Methods AM J KIDNEY DIS (ISSN: 02726386) 63: (6) pp. 10491059. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14096867]
12
MacW ay F, Azzouz L, Noel C, LafageProust MH Osteomalacia induced by vitamin D deficiency in hemodialysis patients: the crucial role of vitamin D correction J BONE MINER METAB (ISSN: 09148779) 32: (2) pp. 215219. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14096866]
13
W akasugi M, Kazama JJ, W ada A, Taniguchi M, Tsubakihara Y, Iseki K, Narita I Regional Variation in Hip Fracture Incidence Among Japanese Hemodialysis P atients THER APHER DIAL (ISSN: 17449979) 18: (2) pp. 162166. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14096865]
14
Bucur R C, Panjwani D D, Turner L, Rader T, W est S L, Jamal S A Low bone mineral density and fractures in stages 35 CKD: an updated systematic review and metaanalysis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 26: (2) pp. 449458. ( 2015) Folyóiratcikk [14594824]
73. Bacsi K , Kosa JP , Balla B , Lazary A , Takacs I , Nagy Z , Speer G , Lakatos P Lack of Relationship Between CYP3A7(star)1C Polymorphism and Colorectal Carcinogenesis in Hungarian Population EUROPEAN JOURNAL OF CANCER 47:(Suppl. 1) p. S439. (2011) European M ultidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, M edical oncology, Advocacy and Care. Stockholm, Svédország: 2011.09.23 2011.09.27. Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1849415] [ Érvényesített ] 74. Bakos B , Takács I , Ternai Z , Nagy Zs , Kósa PJ , Balla B , Tóbiás Bálint , Halászlaki Cs , Szili B , Lakatos P A hyperthyreosisok radiojódkezelésének hosszú távú hatékonysága MAGYAR BELORVOSI ARCHIVUM 64:(5) pp. 289293. (2011) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1780196] http://lib.semmelweis.hu/sepub/pdf/2011/a102 [ Érvényesített ] 75. Balla B , Kósa JP , Tobiás B , Halászlaki C , Takács I , Horváth H , Speer G , Nagy Z , Horányi J , Járay B , Székely E , Lakatos P M arked increase in CYP24A1 gene expression in human papillary thyroid cancer https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 21/342
3/30/2015
nyomtatobarat forma
THYROID 21:(4) pp. 459460. (2011) IF: 4.792 Nyelv: Angol
Folyóiratcikk /Rövid közlemény /Tudományos [1685716] [ Hitelesített ] Független idéző: 8 Függő idéző: 1 Összesen: 9 1
Zhang L, Shi J, Xu L, Shi B, Hou P, Ji M Aberrant DNA methylation of drug metabolism and transport genes in nodular goiter Thyroid Research 4: (1) P aper 15. (2011) Folyóiratcikk /Rövid közlemény /Tudományos [11883497]
2
PennaMartinez M, RamosLopez E, Stern J, Kahles H, Hinsch N, Hansmann ML, Selkinski I, Grunwald F, Vorlander C, Bechstein W O, Zeuzem S, Holzer K, Badenhoop K Impaired Vitamin D Activation and Association with CYP 24A1 Haplotypes in Differentiated Thyroid Carcinoma Thyroid (ISSN: 10507256) 22: (7) pp. 709716. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12470000]
3 * Horvath E, Lakatos P, Balla B, Kosa JP, Tobias B, Jozilan H, Borka K, Horvath HC, Kovalszky I, Szalay F Marked Increase of CYP 24A1 mRNA level in hepatocellular carcinoma cell lines following vitamin D administration ANTICANCER RES 32: (11) pp. 47914796. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12795166] 4
Zhang L, Shi J, Ji M, Liu W , W ang N, Guan H, Xu L, He N, Shi B, Hou P Methylation analysis of drug metabolism and transport genes in papillary thyroid cancer Advanced Science Letters (ISSN: 19366612) 17: (1) pp. 243250. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13342517]
5
Salzman J, Chen RE, Olsen MN, W ang PL, Brown PO CellType Specific Features of Circular RNA Expression PLOS GENET 9: (9) P aper 10.1371. (2013) Folyóiratcikk /Szakcikk /Tudományos [13413559]
6
Hobaus J, Thiem U, Hummel DM, Kallay E Role of Calcium, Vitamin D, and the Extrarenal Vitamin D Hydroxylases in Carcinogenesis ANTICANCER AGENT ME 13: (1) pp. 2035. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13339130]
7
Streeten EA, Levine MA Vitamin D metabolism or action In: Emery and Rimoin's Principles and Practice of Medical Genetics. Elsevier Ltd, 2013. (ISBN 9780123838346) pp. 128.
Könyvrészlet /Könyvfejezet /Tudományos [13342516] 8
Zou MJ, BinHumaid FS, Alzahrani AS, Baitei EY, AlMohanna FA, Meyer BF, Shi YF Increased CYP 24A1 expression is associated with BRAF(V600E) mutation and advanced stages in papillary thyroid carcinoma CLIN ENDOCRINOL (ISSN: 03000664) 81: (1) pp. 109116. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14087022]
9
Rubsamen D, Kunze MM, Buderus V, Brauss TF, Bajer MM, Brune B Inflammatory Conditions Induce IRESDependent Translation of cyp24a1 PLOS ONE (ISSN: 19326203) 9: (1) P aper e85314. (2014) Folyóiratcikk /Szakcikk /Tudományos [13692502]
76. Balla B , Pintér C , Kósa JP , Podani J , Takács I , Nagy Z , Speer G , Horváth B , Korányi L , Lakatos P Gene expression changes in femoral head necrosis of human bone tissue DISEASE MARKERS 31:(1) pp. 2532. (2011) IF: 1.642 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1724506] [ Szerzői rekord ] Független idéző: 3 Összesen: 3 1
Qin Xueliu, Xin Xiaodong, W ang Dawei, Chen Yueping, Lin Zonghan, Han Jie, Qin Jie Bone marrow transplantation and core decompression for treatment of early necrosis of the femoral head: A nonrandomized controlled study CHINESE JOURNAL OF TISSUE ENGINEERING RESEARCH (ISSN: 20954344) 16: (4) pp. 748751. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [14594822]
2
Carulli C Innocenti M Brandi M L Bone vascularization in normal and disease conditions Frontiers in Endocrinology (ISSN: 16642392) 4: P aper 106. (2013) Folyóiratcikk [13342016]
3
Yanqiong Zhang Rongtian W ang Shangzhu Li Xiangying Kong Zhiyao W ang W eiheng Chen Na Lin Genetic polymorphisms in plasminogen activator inhibitor1 predict susceptibility to steroidinduced osteonecrosis of the femoral head in Chinese population Diagnostic Pathology (ISSN: 17461596) 8: p. 169. ( 2013) doi:10.1186/174615968169 Folyóiratcikk [13401795]
77. Balla B , Kósa PJ , Vaszilkó M , Podani J , Takács I , Tobias B , Nagy Zs , Kiss L , Lakatos P New approach to analyze genetic and clinical data in patients with bisphosphonate induced osteonecrosis of the jaw OSTEOPOROSIS INTERNATIONAL 22:(Supp. 5) pp. S724S725. (2011) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1987474] [ Érvényesített ] 78. Black DM , Reid IR , Cauley J , Boonen S , Cosman F , Leung P , Lakatos P , M an Z , Cummings S , Hue T , Ruzycky https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 22/342
3/30/2015
nyomtatobarat forma
M , M artinz R , Su G , BucciRechtweg CM , Eastell R The effect of 3 versus 6 years of zoledronic acid treatment in osteoporosis: A randomized extension to the HORIZONPivotal Fracture Trial (PFT) BONE 48:(Suppl. 2) p. S91. (2011) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1809741] 3rd Joint M eeting of the : EuropeanCalcifiedTissueSociety/InternationalBoneandM ineralSociety M AY 0711, 2011 Athens, GREECE [ Érvényesített ] 79. Cauley JA , Black D , Boonen S , Cummings SR , M esenbrink P , Palermo L , M an Z , Hadji P , Reid IR , HORIZON Pivotal Fracture Group Egyéb szerzőség: Balogh A , Gomor B , Hidvégi T , Koranyi L , Lakatos P , Poór G , Tulassay Z (kollaborációs közrem.); OnceYearly Zoledronic Acid and Days of Disability, Bed Rest, and Back Pain: Randomized, Controlled HORIZON Pivotal Fracture Trial JOURNAL OF BONE AND MINERAL RESEARCH 26:(5) pp. 984992. (2011) IF: 6.373 Nyelv: Angol
Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [1809721] [ Érvényesített ] Független idéző: 7 Függő idéző: 1 Összesen: 8 1 * Sambrook PN, Silverman SL, Cauley JA, Recknor C, Olson M, Su G, Boonen S, Black D, Adachi JD Healthrelated quality of life and treatment of postmenopausal osteoporosis: Results from the HORIZONP FT BONE (ISSN: 87563282) 48: (6) pp. 12981304. ( 2011) CA: HORIZON Pivotal Fracture Trial Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [11883494] 2
Rossini M, Di Munno O, Gatti D, Giannini S, Minisola S, Varenna M, Adami S Optimising bisphosphonate treatment outcomes in postmenopausal osteoporosis: review and Italian experience CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (ISSN: 0392856X) 29: (4) pp. 728735. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [11883493]
3
Lin Hua, Xu Tianshu, Fan Lu 5 mg zoledronic acid for treatment of postmenopausal women with osteoporosis and osteoporotic fracture Chinese Journal of Orthopaedic Trauma (ISSN: 16717600) 14: (1) pp. 3135. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [14594812]
4
Chung Pui Yan Jenny, Van Hul W im P aget's Disease of Bone: Evidence for Complex P athogenetic Interactions SEMINARS IN ARTHRITIS AND RHEUMATISM (ISSN: 00490172) 41: (5) pp. 619641. ( 2012) Folyóiratcikk [14594811]
5
Desai Pingal A, Vyas Parth A, Lane Joseph M Atypical Femoral fractures: A Review of the Literature CURRENT OSTEOPOROSIS REPORTS 11: (3) pp. 179187. ( 2013) Folyóiratcikk [14594810]
6
Triantafyllopoulos Ioannis K, LambropoulouAdamidou Kalliopi, Nacopoulos Cleopatra C, Papaioannou Nikolaos A, Ceausu Iuliana, Depypere Herman, Erel C Tamer, PerezLopez Faustino R, SchenckGustafsson Karin, van der Schouw Yvonne T, Simoncini Tommaso, Tremollieres Florence, Rees Margaret, Lambrinoudaki Irene EMAS position statement: The management of postmenopausal women with vertebral osteoporotic fracture MATURITAS (ISSN: 03785122) 78: (2) pp. 131137. ( 2014) Folyóiratcikk [14594808]
7
Huang Shushu, Lin Hua, Zhu Xiufen, Chen Xin, Fan Lu, Liu Changchang Zoledronic acid increases bone mineral density and improves healthrelated quality of life over two years of treatment in Chinese women with postmenopausal osteoporosis ENDOKRYNOLOGIA POLSKA (ISSN: 0423104X) 65: (2) pp. 96104. ( 2014) Folyóiratcikk [14594807]
8
王皓 唑来膦酸注射液治疗老年男性骨质疏松的临床疗效 Chinese Journal of Gerontology (ISSN: 10059202) 34: (13) pp. 37763777. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14594809]
80. Halaszlaki C , Takacs I , Patocs A , Lakatos P Új genetikai mutáció a Carneykomplexbetegség magyarországi esetének hátterében. [Novel mutation in a patient with Carney complex.] ORVOSI HETILAP 152:(20) pp. 802804. (2011) Nyelv: Magyar
Folyóiratcikk /Rövid közlemény /Tudományos [1552512] [ Érvényesített ] Független idéző: 2 Összesen: 2 1
Nejkovic L, Pazin V, DragojevicDikic S Carney complex and teratoma maturum ovarii A case report European Journal of Gynaecological Oncology (ISSN: 03922936) 33: (6) pp. 672674. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13366614]
2
Paolo Ricci A, Álvaro Ibarra V
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 23/342
3/30/2015
nyomtatobarat forma Carney syndrome with breast myxoma: A very rare tumor in interdisciplinary management Revista Chilena de Obstetricia y Ginecologia 78: (1) pp. 5154. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13366613]
81. Horányi J , Lakatos P Parathyreoidea In: Kásler M (szerk.) Az onkológia alapjai: Egyetemi tankönyv . 1173 p. Budapest: M edicina Könyvkiadó, 2011. pp. 10831087. (ISBN:9789632263458) Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1711574] [ Érvényesített ] 82. Horváth E , Lakatos P , Balla B , Kósa PJ , Kovalszky I , Pesti V , Németh D , Hasan J , Korompay A , Somorácz Á , Schaff Zs , Kupcsulik P , Szalay F Increased CYP24A1 mRNA expression after 1,25dihydroxyvitamin D3 treatment of hepatocellular carcinoma cell line sin vitro and also in human liver cancer ZEITSCHRIFT FÜR GASTROENTEROLOGIE 49:(644) p. P28. (2011) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1987503] [ Admin láttamozott ] 83. Horváth E , Lakatos P , Balla B , Kósa PJ , Kovalszky I , Szalay F Remarkable increase in CYP24A1 mRNA level after 1,25dihydroxyvitamin D3 treatment of hepatocellular carcinoma cell lines JOURNAL OF HEPATOLOGY 54:(Suppl. 1) p. S94. (2011) 46th Annual M eeting of the EuropeanAssociationfortheStudyoftheLiver (EASL). Berlin, Németország: 2011.03.30 2011.04.03. Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1987507] [ Érvényesített ] Független idéző: 1 Összesen: 1 1
Cholongitas E, Theocharidou E, Goulis J, Tsochatzis E, Akriviadis E, Burroughs A K Review article: the extraskeletal effects of vitamin D in chronic hepatitis C infection ALIMENTARY PHARMACOLOGY & THERAPEUTICS (ISSN: 02692813) 35: (6) pp. 634646. ( 2012) : Emmanuel/0000000150692461 Folyóiratcikk [14594768]
84. Horváth P , Kósa JP , Wölfling J , Balla B , Kovács D , M átyus P , Horváth E , Speer G , Takács I , Nagy Zs , Lakatos P Dhormon és CYP24A1gátlás: Új megközelítés a colorectalis daganatok kezelésében. MAGYAR BELORVOSI ARCHIVUM 64:(5) pp. 266272. (2011) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1828836] [ Érvényesített ] 85. Kiss Z , Ambrus C , Almasi C , Berta K , Deak G , Horonyi P , Kiss I , Lakatos P , M arton A , M olnar M Z , Nemeth Z , Szabo A , M ucsi I Serum 25(OH)Cholecalciferol Concentration Is Associated with Hemoglobin Level and Erythropoietin Resistance in Patients on M aintenance Hemodialysis. NEPHRON CLINICAL PRACTICE 117:(4) pp. c373c378. (2011) IF: 2.038 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1532334] [ Hitelesített ] Független idéző: 22 Összesen: 22 1
W esselingPerry Katherine, Salusky Isidro B 4. Vitamin D in Chronic Kidney Disease: Current and Evolving Concepts Translational Endocrinology & Metabolism 2: (3) pp. 87109. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [14248525]
2
Gutierrez J A, Parikh N, Branch A D Classical and emerging roles of vitamin D in hepatitis C virus infection Seminars in Liver Disease (ISSN: 02728087) 31: (4) pp. 387398. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11883459]
3
Carvalho C, Isakova T, Collerone G, Olbina G, W olf M, W esterman M, Gutierrez OM Hepcidin and disordered mineral metabolism in chronic kidney disease CLINICAL NEPHROLOGY (ISSN: 03010430) 76: (2) pp. 9098. ( 2011)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 24/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [11753013] 4
Meguro S, Tomita M, Katsuki T, Kato K, Oh H, Ainai A, Ito R, Takeda S, Kawai T, Atsumi Y, Itoh H, Hasegawa H P lasma 25Hydroxyvitamin D Is Independently Associated with Hemoglobin Concentration in Male Subjects with Type 2 Diabetes Mellitus INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (ISSN: 16878337) &: P aper 362981. (2011) Folyóiratcikk /Szakcikk /Tudományos [11753012]
5
AbdulRazzak Khalid K, Khoursheed Abeer M, Altawalbeh Shoroq M, Obeidat Bayan A, Ajlony MohammedJafar A Hb level in relation to vitamin D status in healthy infants and toddlers PUBLIC HEALTH NUTRITION (ISSN: 13689800) 15: (9) pp. 16831687. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12641364]
6
ZBROCH Edyta, HRYSZKO Tomasz, MAŁYSZKO Jolanta, MYŚLIW IEC Michał, w Białymstoku Dializ UM, Myśliwiec Michał Stężenia witaminy D u chorych leczonych nerkozastępczo Nefrologia i Dializoterapia Polska 16: (1) pp. 15. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [14248383]
7
Vallianou N, Bountziouka V, Akalestos T, Evangelopoulos A, Vogiatzakis E, Bonou M, Barbetseas J, Avgerinos PC, Panagiotakos DB Vitamin D status and health correlates among apparently healthy participants in an urban, Sunny Region Central European Journal of Public Health (ISSN: 12107778) 20: (4) pp. 262269. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13052890]
8
Rianthavorn Pornpimol, Boonyapapong Pantipa Ergocalciferol decreases erythropoietin resistance in children with chronic kidney disease stage 5 PEDIATRIC NEPHROLOGY (ISSN: 0931041X) 28: (8) pp. 12611266. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13360035]
9
Pantelias Konstantinos, Grapsa Eirini Management of Anemia on Hemodialysis In: Suzuki H (szerk.) : Hemodialy sis. InTech, 2013. (ISBN 9789535109884) pp. 315355.
Könyvrészlet /Könyvfejezet /Tudományos [14248454] 10
Han Seung Seok, Kim Myounghee, Kim Ho, Lee Su Mi, Oh Yun Jung, Lee Jung Pyo, Kim Sejoong, Joo Kwon W ook, Lim Chun Soo, Kim Yon Su, Kim Dong Ki NonLinear Relationship between Serum 25Hydroxyvitamin D and Hemoglobin in Korean Females: The Korean National Health and Nutrition Examination Survey 20102011 PLOS ONE (ISSN: 19326203) 8: (8) P aper e72605. (2013) Folyóiratcikk /Szakcikk /Tudományos [13360034]
11
Schneider Andreas, Schneider Markus P, Scharnagl Hubert, Jardine Alan G, W anner Christoph, Drechsler Christiane P redicting erythropoietin resistance in hemodialysis patients with type 2 diabetes BMC nephrology (ISSN: 14712369) 14: (1) P aper 67. (2013) Folyóiratcikk /Szakcikk /Tudományos [14248355]
12
Icardi Andrea, Paoletti Ernesto, De Nicola Luca, Mazzaferro Sandro, Russo Roberto, Cozzolino Mario Renal anaemia and EP O hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation NEPHROLOGY DIALYSIS TRANSPLANTATION (ISSN: 09310509) 28: (7) pp. 16721679. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13360033]
13
Rasheed H, Mahgoub D, Hegazy R, ElKomy M, Abdel Hay R, Hamid MA, Hamdy E Serum ferritin and vitamin D in female hair loss: Do they play a role? Skin Pharmacology and Physiology 26: (2) pp. 101107. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13151773]
14
Christov M, Thadhani R Vitamin D in Kidney Disease In: Nutritional Management of Renal Disease. Elsevier Inc., 2013. (ISBN 9780123919342) pp. 309322.
Könyvrészlet /Szaktanulmány /Tudományos [13360040] 15
Solá Laura, Leyún Noel, Salvia Juan Carlos Díaz, Rodríguez Susana González, Sehabiague Cristina, Parodi Karina, Olascoaga Alicia, Alallón W alter Asociación de déficit de vitamina D y anemia en pacientes en hemodiálisis crónica Revista Médica del Uruguay (ISSN: 16880390) 30: (3) pp. 157163. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14561456]
16
Hasanato RM Assessment of trace elements in sera of patients undergoing renal dialysis SAUDI MED J (ISSN: 03795284) 35: (4) pp. 365370. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13842727]
17
Chun RF, Liu PT, Modlin RL, Adams JS, Hewison M Impact of vitamin D on immune function: Lessons learned from genomewide analysis FRONTIERS IN PHYSIOLOGY (ISSN: 1664042X) 5: P aper 151. (2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14093713]
18
Locatelli Francesco, Minutolo Roberto Intestinal adsorption of uraemic toxins: a new strategy for anaemia management? Nephrology Dialysis Transplantation (ISSN: 09310509) 29: (9) pp. 16201624. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14248370]
19
Schneider Andreas, GutjahrLengsfeld Lena, Ritz Eberhard, Scharnagl Hubert, Gelbrich Goetz, Pilz Stefan, Macdougall Iain C, W anner Christoph, Drechsler Christiane Longitudinal Assessments of ErythropoietinStimulating Agent Responsiveness and the Association with Specific Clinical Outcomes in Dialysis P atients NEPHRON CLINICAL PRACTICE (ISSN: 16602110) 128: (12) pp. 147152. ( 2014) Folyóiratcikk [14594749]
20
Bacchetta J, Zaritsky JJ, Sea JL, Chun RF, Lisse TS, Zavala K, Nayak A, W esselingPerry K, W esterman M, Hollis BW , Salusky IB, Hewison M Suppression of ironregulatory hepcidin by vitamin D Journal of the American Society of Nephrology (ISSN: 10466673) 25: (3) pp. 564572. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13820448]
21
Atkinson MA, Melamed ML, Kumar J, Roy CN, Miller III ER, Furth SL, Fadrowski JJ
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 25/342
3/30/2015
nyomtatobarat forma Vitamin D, race, and risk for anemia in children Journal of Pediatrics (ISSN: 00223476) 164: (1) pp. 153158.e1. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13820447] 22
Hirani Vasant, Cumming Robert G, Blyth Fiona, Naganathan Vasi, Le Couteur David G, W aite Louise M, Handelsman David J, Seibel Markus J Crosssectional and longitudinal associations between the active vitamin D metabolite (1,25 dihydroxyvitamin D) and haemoglobin levels in older Australian men: the Concord Health and Ageing in Men P roject AGE (ISSN: 01619152) 37: (1) P aper 8. (2015) Folyóiratcikk /Szakcikk /Tudományos [14561459]
86. Kiss Z , M ucsi I , Túri S , Szabó A , Kiss I , Szebeni A , Kecskeméti V , Tóth M , Lakatos P A parathormon extraskeletalis hatásai LEGE ARTIS MEDICINAE KID 1:(3) pp. 2127. (2011) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [1855542] [ Érvényesített ] 87. Kosa JP , Kis A , Bacsi K , Balla B , Nagy Z , Takacs I , Speer G , Lakatos P The protective role of bone morphogenetic protein8 in the glucocorticoidinduced apoptosis on bone cells BONE 48:(5) pp. 10521057. (2011) IF: 4.023 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1729408] [ Hitelesített ] Független idéző: 9 Összesen: 9 1
W u R W , Lin T P, Ko J Y, Yeh D W , Chen M W , Ke H C, W u S L, W ang F S Cannabinoid receptor 1 regulates ERK and GSK3βdependent glucocorticoid inhibition of osteoblast differentiation in murine MC3T3E1 cells Bone (ISSN: 87563282) 49: (6) pp. 12551263. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11883452]
2
Moutsatsou P, Kassi E, Papavassiliou AG Glucocorticoid receptor signaling in bone cells Trends in Molecular Medicine (ISSN: 14714914) 18: (6) pp. 348359. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12622544]
3
Ishikawa S, Ishikawa T, Asano K, Fujiwara H, Okada M, Sunagawa M, Hisamitsu T Suppressive effect of Juzentaihoto on vascularization induced by B16 melanoma cells in vitro and in vivo Evidencebased Complementary and Alternative Medicine (ISSN: 1741427X) 2012: P aper 945714. (2012) Folyóiratcikk /Szakcikk /Tudományos [11883451]
4
Nimal Selvaraj J, W ang Jianqi, Nimal Selvaraj J, Cao W enguang Expressions of Bmp8a and Bmp8b in cultured mouse granulosa cells Journal of China Agricultural University 18: (3) pp. 108114. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13386040]
5
Cao XK, W ang J, Lan XY, Lei CZ, Zhang CL, Qi XL, Chen H Genetic variants in BMP 8B gene are associated with growth traits in Chinese native cattle GENE (ISSN: 03781119) 532: (1) pp. 108113. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13857684]
6
Zhong Xing, Zhang Dezhi, Han Hongbin, Li Kai, Yang Zhiyang, Fu W enju Mechanism of osteoblast apoptosis induced by dexamethasone via the protein kinase C pathway CHINESE JOURNAL OF TISSUE ENGINEERING RESEARCH (ISSN: 20954344) 17: (41) pp. 72057212. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [14594700]
7
Ko JY, Chuang PC, Chen MW , Ke HC, W u SL, Chang YH, Chen YS, W ang FS MicroRNA29a ameliorates glucocorticoidinduced suppression of osteoblast differentiation by regulating betacatenin acetylation BONE (ISSN: 87563282) 57: (2) pp. 468475. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13857683]
8
Zhang LY, Ma P, Collery R, Trowbridge S, Zhang MZ, Zhong W X, Leung YF Expression profiling of the RP E in zebrafish smarca4 mutant revealed altered signals that potentially affect RP E and retinal differentiation MOL VIS (ISSN: 10900535) 20: pp. 5672. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13857682]
9
W ang XF, W ang J Icaritin suppresses the proliferation of human osteosarcoma cells in vitro by increasing apoptosis and decreasing MMP expression ACTA PHARMACOL SIN (ISSN: 16714083) 35: (4) pp. 531539. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13857681]
88. Lakatos G , Tóth M , Szekeres L , Lakatos P M etabolikus oszteopathiák új gyógyszeres terápiái ORVOSTOVÁBBKÉPZŐ SZEMLE November:(klsz.) pp. 2328. (2011) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1980548] [ Hitelesített ] 89. Lakatos P , Kiss Z , Kuluncsics Z , Szekeres L , Horváth Cs , Poór Gy A RANKligandgátlás előnyei a posztmenopauzás osteoporosis kezelésében https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 26/342
3/30/2015
nyomtatobarat forma
MAGYAR REUMATOLÓGIA 52:(1) pp. 3439. (2011) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1532385] [ Érvényesített ] 90. Lakatos P Az osteoporosis gyógyszeres kezelése 2011 [Pharmacologic treatment of osteoporosis 2011]. ORVOSI HETILAP 152:(33) pp. 13201326. (2011) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [1802795] [ Hitelesített ] 91. Lakatos P , Takács I , Szekeres L , Poór Gy. A korral járó és a kortikoszteroidok indukálta osteoporosis diagnosztikus és terápiás protokollja 2011 : a Nemzeti Erőforrás M inisztérium szakmai protokollja MAGYAR REUMATOLÓGIA 52:(1) pp. 2833. (2011) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1806270] [ Szerzői rekord ] 92. Lakatos P , Leprán I A kalcium és csontanyagcserére ható gyógyszerek In: Gyíres K , Fürst Z (szerk.) Farmakológia és farmakoterápia I. . Budapest: M edicina Könyvkiadó, 2011. pp. 805816. Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1923210] [ Admin láttamozott ] 93. Lakatos Péter , Takács István , Szekeres László , Poór Gyula A korral járó és a kortikoszteroidok indukálta osteoporosis diagnosztikus és terápiás protokollja 2011 MEDICAL TRIBUNE 9:(5) pp. 89. (2011) Nyelv: Magyar
Folyóiratcikk /Ismertetés /Tudományos [2267384] [ Érvényesített ] 94. M olnar M Z , Czira M E , Rudas A , Ujszaszi A , Haromszeki B , Kosa JP , Lakatos P , Beko G , Sarvary E , Varga M , Fornadi K , Novak M , Rosivall L , Kiss I , Remport A , Goldsmith DJ , Kovesdy CP , M ucsi I Association between the malnutritioninflammation score and posttransplant anaemia NEPHROLOGY DIALYSIS TRANSPLANTATION 26:(6) pp. 20002006. (2011) IF: 3.396 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1442737] [ Hitelesített ] Független idéző: 10 Függő idéző: 12 Összesen: 22 1
* Czira Maria E, Lindner Anett V, Szeifert Lilla, Molnar Miklos Z, Fornadi Katalin, Kelemen Andrea, Laszlo Gergely, Mucsi Istvan, Keszei Andras P, Kennedy Sidney H Association between the Malnutrition–Inflammation Score and depressive symptoms in kidney transplanted patients General hospital psychiatry (ISSN: 01638343) 33: (2) pp. 157165. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [14249468]
2
* Streja Elani, Molnar Miklos Z, Kovesdy Csaba P, Bunnapradist Suphamai, Jing Jennie, Nissenson Allen R, Mucsi Istvan, Danovitch Gabriel M, KalantarZadeh Kamyar Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients Clinical Journal of the American Society of Nephrology (ISSN: 15559041) 6: (6) pp. 14631473. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [14249467]
3
4
5
Banaga A S, Yousif M E, Elmusharaf K Risk factors of post renal transplant anaemia among Sudanese patients, a study in three renal transplant centres BMC Nephrology (ISSN: 14712369) 12: (1) P aper 37. (2011) Folyóiratcikk /Szakcikk /Tudományos [11959167] * Molnar M Z, Tabak A G, Alam A, Czira M E, Rudas A, Ujszaszi A, Beko G, Novak M, KalantarZadeh K, Kovesdy C P, Mucsi I Serum erythropoietin level and mortality in kidney transplant recipients Clinical Journal of the American Society of Nephrology (ISSN: 15559041) 6: (12) pp. 28792886. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11959166] Lopes A A The malnutritioninflammation score: A valid nutritional tool to assess mortality risk in kidney transplant patients American Journal of Kidney Diseases (ISSN: 02726386) 58: (1) pp. 79. ( 2011) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [11959165]
6. * Czira Mária Eszter A malnutríciógyulladás komplex szindróma felmérése, valamint kapcsolata a depresszív tünetekkel és a halálozással vesetranszplantált betegek körében 133 p. 2012.
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 27/342
3/30/2015
nyomtatobarat forma Disszertáció /P hD /Tudományos [14561446] 7
Jones H, Talwar M, Nogueira JM, Ugarte R, Cangro C, Rasheed H, Klassen DK, W eir MR, Haririan A Anemia After Kidney Transplantation; Its P revalence, Risk Factors, and Independent Association With Graft and P atient Survival: A TimeVarying Analysis TRANSPLANTATION (ISSN: 00411337) 93: (9) pp. 923928. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12408422]
8
Florit EA, Hadad F, Rodriguez Cubillo B, De La Flor JC, Valga F, Perez Flores I, Calvo Romero N, Valero San Cecilio R, Barrientos Guzman A, Sanchez Fructuoso A Anemia in kidney transplants without erythropoietic agents: Levels of erythropoietin and iron parameters Transplantation Proceedings (ISSN: 00411345) 44: (9) pp. 25902592. ( 2012) Folyóiratcikk /Konferenciaközlemény /Tudományos [13052894]
9
Gupta Jayanta, Mitra Nandita, Kanetsky Peter A, Devaney Joe, W ing Maria R, Reilly Muredach, Shah Vallabh O, Balakrishnan Vaidyanathapura S, Guzman Nicolas J, Girndt Matthias, Periera Brian G, Feldman Harold I, Kusek John W , Joffe Marshall M, Raj Dominic S Association between Albuminuria, Kidney Function, and Inflammatory Biomarker P rofile in CKD in CRIC CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (ISSN: 15559041) 7: (12) pp. 19381946. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13052896]
10 * Cortazar F, Molnar MZ, Isakova T, Czira ME, Kovesdy CP, Roth D, Mucsi I, W olf M Clinical Outcomes in Kidney Transplant Recipients Receiving LongTerm Therapy With Inhibitors of the Mammalian Target of Rapamycin AMERICAN JOURNAL OF TRANSPLANTATION (ISSN: 16006135) 12: (2) pp. 379387. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12029316] 11 * Fornadi K, Lindner A, Czira ME, Szentkiralyi A, Lazar AS, Zoller R, Turanyi CZ, Veber O, Novak M, Mucsi I, Molnar MZ Lack of association between objectively assessed sleep disorders and inflammatory markers among kidney transplant recipients INTERNATIONAL UROLOGY AND NEPHROLOGY (ISSN: 03011623) 44: (2) pp. 607617. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12408421] 12 * Ujszaszi Akos, Czira Maria E, Fornadi Katalin, Novak Marta, Mucsi Istvan, Molnar Miklos Z Quality of life and proteinenergy wasting in kidney transplant recipients INTERNATIONAL UROLOGY AND NEPHROLOGY (ISSN: 03011623) 44: (4) pp. 12571268. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12561369] 13. * Molnárné Fornádi Katalin A gyulladás és az alvászavarok összefüggései vesetranszplantált betegek körében 164 p. 2013.
Disszertáció /P hD /Tudományos [14561442] 14
Chan M, Chadban S Nutritional Management of Kidney Transplant Recipients In: Nutritional Management of Renal Disease. Elsevier Inc., 2013. (ISBN 9780123919342) pp. 563580.
Könyvrészlet /Könyvfejezet /Tudományos [13603218] 15
ter W ee PM P rotein Energy Wasting and Transplantation Journal of Renal Nutrition (ISSN: 10512276) 23: (3) pp. 246249. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13603217]
16 * Kovesdy C, KalantarZadeh K P roteinEnergy Wasting as a Risk Factor of Morbidity and Mortality in Chronic Kidney Disease In: Nutritional Management of Renal Disease. Elsevier Inc., 2013. (ISBN 9780123919342) pp. 171195.
Könyvrészlet /Könyvfejezet /Tudományos [13603216] 17 * Ujszaszi A, Molnar MZ, Czira ME, Novak M, Mucsi I Renal function is independently associated with red cell distribution width in kidney transplant recipients: A potential new auxiliary parameter for the clinical evaluation of patients with chronic kidney disease British Journal of Haematology (ISSN: 00071048) 161: (5) pp. 715725. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13603215] 18
Tsuchimoto A, Masutani K, Haruyama N, Nagata M, Noguchi H, Okabe Y, Kitada H, Tanaka M, Tsuruya K, Kitazono T Renal interstitial fibrosis in 0hour biopsy as a predictor of posttransplant anemia American Journal of Nephrology (ISSN: 02508095) 38: (4) pp. 267274. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13603214]
19
Chan W , GW ard D, McClean A, ABosch J, Jones D, Kaur O, Drayson M, W hitelegg A, Iqbal T, McTernan PG, Tselepis C, Borrows R The role of hepcidin25 in kidney transplantation Transplantation (ISSN: 00411337) 95: (11) pp. 13901395. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13603213]
20
Budde Klemens, Rath Thomas, Kliem Volker Anemia Control in Kidney Transplant Recipients Using OnceMonthly Continuous Erythropoietin Receptor Activator: A P rospective, Observational Study Journal of Transplantation (ISSN: 20900007) 2014: P aper 179705. 10 p. (2014) Folyóiratcikk /Szakcikk /Tudományos [14249469]
21 * Molnar MZ, Kümpers P, Kielstein JT, Schiffer M, Czira ME, Ujszaszi A, Kovesdy CP, Mucsi I Circulating Angiopoietin2 levels predict mortality in kidney transplant recipients: A 4year prospective casecohort study TRANSPLANT INTERNATIONAL (ISSN: 14322277) 27: (6) pp. 541552. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14093606] 22 * Mucsi I, Ujszaszi A, Czira ME, Novak M, Molnar MZ Red cell distribution width is associated with mortality in kidney transplant recipients International Urology and Nephrology (ISSN: 15732584) 46: (3) pp. 641651. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13820429]
95. Szendroi A , Speer G , Tabak A , Kosa JP , Nyirady P , M ajoros A , Romics I , Lakatos P The role of vitamin D, estrogen, calcium sensing receptor genotypes and serum calcium in the pathogenesis of prostate cancer. https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 28/342
3/30/2015
nyomtatobarat forma
CANADIAN JOURNAL OF UROLOGY 18:(3) pp. 57105716. (2011) IF: 0.641 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1680992] [ Érvényesített ] Független idéző: 15 Függő idéző: 1 Összesen: 16 1
2
Verma M, Patel P, Verma M Biomarkers in prostate cancer epidemiology Cancers (ISSN: 20726694) 3: (4) pp. 37733798. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [11851275] * Szendrői Attila A prosztatadaganat MAGYAR ORVOS (ISSN: 12176052) 20: (89) pp. 1821. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13492404]
3
Cao J, Li X, Hou Q, Li R, Luo R P olymorphism of vitamin D receptor gene Fokl and susceptibility of prostatic cancer: A Metaanalysis Journal of Central South University. Medical Sciences (ISSN: 16727347) 37: (12) pp. 12151220. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13060531]
4
Garg M, Lubel J S, Sparrow M P, Holt S G, Gibson P R Review article: vitamin D and inflammatory bowel disease established concepts and future directions ALIMENTARY PHARMACOLOGY & THERAPEUTICS (ISSN: 02692813) 36: (4) pp. 324344. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12542372]
5
Ding Xiang, Cui FengMei, Xu SongTao, Pu JinXian, Huang YuHua, Zhang JiangLei, W ei XueDong, Hou JianQuan, Yan ChunYin Variants on ESR1 and their Association with P rostate Cancer Risk: A Metaanalysis ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (ISSN: 15137368) 13: (8) pp. 39313936. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13042047]
6
Van Hemelrijck M, Michaelsson K, Nelson W G, Kanarek N, Dobs A, Platz EA, Rohrmann S Association of serum calcium with serum sex steroid hormones in men in NHANES III Aging Male (ISSN: 13685538) 16: (4) pp. 151158. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13698322]
7
Li J, Mercer E, Gou X, Lu YJ Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgenrelated genes AMERICAN JOURNAL OF CANCER RESEARCH (ISSN: 21566976) 3: (2) pp. 127151. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13758328]
8
Zhang Q, Shan Y Genetic polymorphisms of vitamin D receptor and the risk of prostate cancer: A metaanalysis Journal of B.U.ON. 18: (4) pp. 961969. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13698321]
9
Guo Z, W en J, Kan Q, Huang S, Liu X, Sun N, Li Z Lack of association between vitamin D receptor gene FokI and BsmI polymorphisms and prostate cancer risk: An updated meta analysis involving 21,756 subjects Tumor Biology (ISSN: 10104283) 34: (5) pp. 31893200. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13463087]
10
姜熙, 曹志刚, 戚敏俊, 许旭, 赵树立 南京地区汉族人群VDR基因多态性与前列腺癌易感性的关系研究 National Journal of Andrology (ISSN: 10093591) 19: (10) pp. 953955. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [14594285]
11
Li L, Zhang X, Xia Q, Ma H, Chen L, Hou W Association between estrogen receptor alpha P vuII polymorphism and prostate cancer risk TUMOR BIOLOGY (ISSN: 14230380) 35: (5) pp. 46294635. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14127531]
12
Raimondi S, Pasquali E, Gnagnarella P, Serrano D, Disalvatore D, Johansson HA, Gandini S BsmI polymorphism of vitamin D receptor gene and cancer risk: A comprehensive metaanalysis Mutat. Res. Fundam. Mol. Mech. Mutagen. (ISSN: 09218262) 769: pp. 1734. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14127530]
13
Gu Z, W ang G, Chen W Estrogen receptor alpha gene polymorphisms and risk of prostate cancer: A metaanalysis involving 18 studies TUMOR BIOLOGY (ISSN: 14230380) 35: (6) pp. 59215930. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14127529]
14
Dong Q, Zhang Y, Yang XH, Jing W , Zheng LQ, Liu YP, Qu XJ, Li Z Serum calcium level used as a prognostic predictor in patients with resectable pancreatic ductal adenocarcinoma Clin. Res. Hepatol. Gastroenterol. (ISSN: 22107401) 38: (5) pp. 639648. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14322267]
15
Lee HR, Hwang KA, Choi KC The estrogen receptor signaling pathway activated by phthalates is linked with transforming growth factorβ in the progression of LNCaP prostate cancer models International Journal of Oncology (ISSN: 10196439) 45: (2) pp. 595602. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14079818]
16
Fu CY, Dong W Q, W ang AI, Qiu GZ The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk TUMOR BIOL (ISSN: 10104283) 35: (8) pp. 83198328. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14275496]
96. Tobias B , Balla B , Kosa P J , Horanyi J , Takacs I , Bolony E , Halaszlaki C , Nagy Z , Speer G , Jaray B , Szekely E , Istok R , Lakatos P Szomatikus onkogén mutációk összehasonlító vizsgálata egészséges és tumoros pajzsmirigyszövetmintákban https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 29/342
3/30/2015
nyomtatobarat forma
[Comparative study of somatic oncogene mutations in normal thyroid tissues and thyroid neoplasms]. ORVOSI HETILAP 152:(17) pp. 672677. (2011) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1696318] [ Hitelesített ] 97. Wolf M , M olnar M Z , Amaral AP , Czira M E , Rudas A , Ujszaszi A , Kiss I , Rosivall L , Kosa J , Lakatos P , Kovesdy CP , M ucsi I Elevated Fibroblast Growth Factor 23 is a Risk Factor for Kidney Transplant Loss and M ortality JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 22:(5) pp. 956966. (2011) IF: 9.663 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1532328] [ Hitelesített ] Független idéző: 103 Függő idéző: 13 Összesen: 116 1
* Sampaio M S, Molnar M Z, Kovesdy C P, Mehrotra R, Mucsi I, Sim J J, Krishnan M, Nissenson A R, KalantarZadeh K Association of pretransplant serum phosphorus with posttransplant outcomes Clinical Journal of the American Society of Nephrology (ISSN: 15559041) 6: (11) pp. 27122721. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11959347]
2
Bacchetta J, Ranchin B, Dubourg L, Cochat P FGF23 and paediatric transplantation: a singlecentre French experience NEPHROLOGY DIALYSIS TRANSPLANTATION (ISSN: 09310509) 26: (10) pp. 34213422. ( 2011) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [11959419]
3
W esselingPerry K FGF23 and paediatric transplantation: a singlecentre French experience Reply NEPHROLOGY DIALYSIS TRANSPLANTATION (ISSN: 09310509) 26: (10) pp. 34223422. ( 2011) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [11959418]
4
Larsson T E FGF23 Beyond Mineral Metabolism: A Bridge to Cardiovascular Disease Clinical Journal of the American Society of Nephrology (ISSN: 15559041) 6: (12) pp. 27352737. ( 2011) Folyóiratcikk /Ismertetés /Tudományos [11959346]
5
6
7
* Isakova T, Xie H, Yang W , Xie D, Anderson A H, Scialla J, W ahl P, Gutiérrez O M, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu C Y, Lash J, Leonard M, Kusek J W , Feldman H I, W olf M Fibroblast growth factor 23 and risks of mortality and endstage renal disease in patients with chronic kidney disease JAMA Journal of the American Medical Association 305: (23) pp. 24322439. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11959345] Fukumoto S, Shimizu Y Fibroblast growth factor 23 as a phosphotropic hormone and beyond Journal of Bone and Mineral Metabolism (ISSN: 09148779) 29: (5) pp. 507514. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [11959344] * Isakova T, Xie H, BarchiChung A, Varga G, Sowden N, Houston J, W ahl P, Lundquist A, Epstein M, Smith K, Contreras G, Ortega L, Lenz O, Briones P, Egbert P, Ikizler T A, Jueppner H, W olf M Fibroblast growth factor 23 in patients undergoing peritoneal dialysis Clinical Journal of the American Society of Nephrology (ISSN: 15559041) 6: (11) pp. 26882695. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11959343]
8
Schmitt C P, Mehls O Mineral and bone disorders in children with chronic kidney disease Nature Reviews Nephrology (ISSN: 17595061) 7: (11) pp. 624634. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [11959342]
9
Ix J H New insights to fibroblast growth factor 23 in kidney transplant Journal of the American Society of Nephrology (ISSN: 10466673) 22: (5) pp. 799801. ( 2011) Folyóiratcikk /Ismertetés /Tudományos [11959341]
10
Barros X, Torregrosa JV Role of FGF23 in Kidney Transplantation J Transplant Technol Res 2011: (S') pp. 14. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [14239845]
11
Dai Bing, David Valentin, Martin Aline, Huang Jinsong, Li Hua, Jiao Yan, Gu W eikuan, Quarles L Darryl A Comparative Transcriptome Analysis Identifying FGF23 Regulated Genes in the Kidney of a Mouse CKD Model PLOS ONE (ISSN: 19326203) 7: (9) P aper e44161. (2012) Folyóiratcikk /Szakcikk /Tudományos [13056487]
12
Filler G, Liu D, Sharma AP, Grimmer J Are fibroblast growth factor 23 concentrations in renal transplant patients different from nontransplanted chronic kidney disease patients? PEDIATRIC TRANSPLANTATION (ISSN: 13973142) 16: (1) pp. 7377. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [11959417]
13
De Serres Sacha A, Varghese Jay C, Levin Adeera Biomarkers in native and transplant kidneys: opportunities to improve prediction of outcomes in chronic kidney disease CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (ISSN: 10624821) 21: (6) pp. 619627. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13056486]
14
Karohl C, Raggi P Cinacalcet: Will it play a role in reducing cardiovascular events? Future Cardiology 8: (3) pp. 357370. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12406880]
15
Angelin Bo, Larsson Tobias E, Rudling Mats Circulating Fibroblast Growth Factors as Metabolic RegulatorsA Critical Appraisal
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 30/342
3/30/2015
nyomtatobarat forma CELL METABOLISM (ISSN: 15504131) 16: (6) pp. 693705. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13056485] 16
Barros Xoana, Vicente Torregrosa Jose, Martinez de Osaba Maria J, Casals Gregori, Paschoalin Raphael, Duran Carlos E, Campistol Josep M Earlier Decrease of FGF23 and Less Hypophosphatemia in P reemptive Kidney Transplant Recipients TRANSPLANTATION (ISSN: 00411337) 94: (8) pp. 830836. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13056484]
17.
Lundberg Sigrid Factors predicting progression of chronic kidney disease in IgA nephropathy 70 p. 2012.
Disszertáció /P hD /Tudományos [14239406] 18
Siomou Ekaterini, Stefanidis Constantinos J FGF23 in children with CKD: a new player in the development of CKDmineral and bone disorder NEPHROLOGY DIALYSIS TRANSPLANTATION (ISSN: 09310509) 27: (12) pp. 42594262. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13056483]
19
Rodriguez M, Lopez I, Munoz J, AguileraTejero E, Almaden Y FGF23 and mineral metabolism, implications in CKDMBD NEFROLOGIA (ISSN: 02116995) 32: (3) pp. 275278. ( 2012) Folyóiratcikk /Ismertetés /Tudományos [12408489]
20
Lundberg S, Qureshi A R, Olivecrona S, Gunnarsson I, Jacobson S H, Larsson T E FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy Clinical Journal of the American Society of Nephrology (ISSN: 15559041) 7: (5) pp. 727734. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12406879]
21
Isakova T Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (ISSN: 10624821) 21: (3) pp. 334340. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12307867]
22
Van Husen M, Lehnhardt A, Fischer AK, Brinkert F, Loos S, Oh J, Kemper MJ Fibroblast growth factor 23 and calcium phosphate homeostasis after pediatric renal transplantation Pediatric Transplantation (ISSN: 13973142) 16: (5) pp. 443450. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12562123]
23
Tangri N, Levey AS Fibroblast Growth Factor 23 and CKD P rognosis AMERICAN JOURNAL OF KIDNEY DISEASES (ISSN: 02726386) 59: (5) pp. 607610. ( 2012) Folyóiratcikk /Ismertetés /Tudományos [12323863]
24
Rao M, Jain P, Ojo T, Surya G, Balakrishnan V Fibroblast growth factor and mineral metabolism parameters among prevalent kidney transplant patients International Journal of Nephrology 2012: P aper 490623. (2012) Folyóiratcikk /Szakcikk /Tudományos [13056492]
25
Ix Joachim H, Katz Ronit, Kestenbaum Bryan R, de Boer Ian H, Chonchol Michel, Mukamal Kenneth J, Rifkin Dena, Siscovick David S, Sarnak Mark J, Shlipak Michael G Fibroblast Growth Factor23 and Death, Heart Failure, and Cardiovascular Events in CommunityLiving Individuals CHS (Cardiovascular Health Study) JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (ISSN: 07351097) 60: (3) pp. 200207. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12561366]
26
Sinha Manish D, Turner Charles, Dalton R N, Rasmussen Pernille, W aller Simon, Booth Caroline J, Goldsmith David J Investigating FGF23 concentrations and its relationship with declining renal function in paediatric patients with predialysis CKD Stages 35 NEPHROLOGY DIALYSIS TRANSPLANTATION (ISSN: 09310509) 27: (12) pp. 43614368. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13056482]
27
* KalantarZadeh K, Molnar M Z, Kovesdy C P, Mucsi I, Bunnapradist S Management of mineral and bone disorder after kidney transplantation Current Opinion in Nephrology and Hypertension (ISSN: 10624821) 21: (4) pp. 389403. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12406878]
28
Souberbielle JC Measurements of calciotropic hormones: P arathyroid hormone, vitamin D metabolites, Fibroblast Growth Factor 23 Revue du Rhumatisme Monographies 79: (4) pp. 221226. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13056491]
29.
Karras GeorgesAlexandre Modifications des propriétés structurelles et fonctionnelles des gros troncs artériels dans l'insuffisance rénale: valeur pronostique et évolution après transplantation 168 p. 2012.
Disszertáció /Egyetemi doktor /Tudományos [14240082] 30
Schiavi Susan C, Tang W en, Bracken Christina, O'Brien Stephen P, Song W enping, Boulanger Joseph, Ryan Susan, Phillips Lucy, Liu Shiguang, Arbeeny Cynthia, Ledbetter Steven, Sabbagh Yves Npt2b Deletion Attenuates Hyperphosphatemia Associated with CKD JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (ISSN: 10466673) 23: (10) pp. 16911700. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13056481]
31
Sirilak S, Chatsrisak K, Ingsathit A, Kantachuvesiri S, Sumethkul V, Stitchantrakul W , Radinahamed P, Disthabanchong S Renal P hosphate Loss in LongTerm Kidney Transplantation CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (ISSN: 15559041) 7: (2) pp. 323331. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12307866]
32
Semba RD, Fink JC, Sun K, Cappola AR, Dalal M, Crasto C, Ferrucci L, Fried LP Serum Fibroblast Growth Factor23 and Risk of Incident Chronic Kidney Disease in Older CommunityDwelling Women CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (ISSN: 15559041) 7: (1) pp. 8591. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12307865]
33
Sanchez Fructuoso Ana I, Maestro Maria L, PerezFlores Isabel, Valero Rosala, Rafael Sara, Veganzones Silvia, Calvo Natividad, De la Orden Virginia, De la Flor Jose C, Valga Francisco, Vidaurreta Marta, FernandezPerez Cristina, Barrientos Alberto
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 31/342
3/30/2015
nyomtatobarat forma Serum level of fibroblast growth factor 23 in maintenance renal transplant patients NEPHROLOGY DIALYSIS TRANSPLANTATION (ISSN: 09310509) 27: (11) pp. 42274235. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13056480] 34
35
Christov M, Sprague SM The transplant recipient and issues in bone metabolism Clinical Reviews in Bone and Mineral Metabolism 10: (3) pp. 209218. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12562122] * W olf Myles Update on fibroblast growth factor 23 in chronic kidney disease KIDNEY INTERNATIONAL (ISSN: 00852538) 82: (7) pp. 737747. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13056479]
36
Hastings MC, Moldoveanu Z, Suzuki H, Berthoux F, Julian BA, Sanders JT, Renfrow MB, Novak J, W yatt RJ Biomarkers in IgA nephropathy: Relationship to pathogenetic hits Expert Opinion on Medical Diagnostics (ISSN: 17530059) 7: (6) pp. 615627. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474922]
37
W esselingPerry K Bone disease in pediatric chronic kidney disease Pediatric Nephrology (ISSN: 0931041X) 28: (4) pp. 569576. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474921]
38
de Sousa Tavares Marcelo, Penido Maria Goretti Moreira Guimarães Bone Mineral Disease and Kidney Transplantation in Children and Adolescents Journal of Clinical Pediatric Nephrology (ISSN: 23202297) 2: (2) pp. 3846. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [14239059]
39
McQuarrie EP, Jardine AG Cardiovascular Disease in Renal Transplantation In: Kidney TransplantationPrinciples and Practice: Seventh Edition. Elsevier Inc., 2013. (ISBN 9781455740963) pp. 472490.
Könyvrészlet /Könyvfejezet /Tudományos [14108821] 40
W esselingPerry K, Salusky IB Chronic Kidney Disease: Mineral and Bone Disorder in Children Seminars in Nephrology (ISSN: 02709295) 33: (2) pp. 169179. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13064071]
41
Xiao Y, Peng C, Huang W , Zhang J, Xia M, Zhang Y, Ling W Circulating Fibroblast Growth Factor 23 Is Associated with Angiographic Severity and Extent of Coronary Artery Disease PLoS ONE (ISSN: 19326203) 8: (8) P aper e72545. (2013) N1 Funding Details: 81130052, NSFC, National Natural Science Foundation of China Folyóiratcikk /Szakcikk /Tudományos [13474920]
42
Fukumoto S Clinical Aspects of Fibroblast Growth Factor 23 In: Translational Endocrinology of Bone. Elsevier Inc., 2013. (ISBN 9780124157842) pp. 151166.
Könyvrészlet /Könyvfejezet /Tudományos [13474919] 43
Fukagawa M, Yokoyama K, Koiwa F, Taniguchi M, Shoji T, Kazama JJ, Komaba H, Ando R, Kakuta T, Fujii H, Nakayama M, Shibagaki Y, Fukumoto S, Fujii N, Hattori M, Ashida A, Iseki K, Shigematsu T, Tsukamoto Y, Tsubakihara Y, Tomo T, Hirakata H, Akizawa T Clinical practice guideline for the management of chronic kidney diseasemineral and bone disorder Therapeutic Apheresis and Dialysis (ISSN: 17449979) 17: (3) pp. 247288. ( 2013) Folyóiratcikk /Jelentés /Tudományos [13474918]
44
Isakova T Comparison of Mineral Metabolites as Risk Factors for Adverse Clinical Outcomes in CKD Seminars in Nephrology (ISSN: 02709295) 33: (2) pp. 106117. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13064070]
45
Anonymous Current World Literature CURRENT OPINION IN ORGAN TRANSPLANTATION (ISSN: 10872418) 18: (5) pp. 601629. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13822288]
46
Jia T, Qureshi AR, Brandenburg V, Ketteler M, Barany P, Heimburger O, Uhlin F, Magnusson P, Fernström A, Lindholm B, Stenvinkel P, Larsson TE Determinants of fibroblast growth factor23 and parathyroid hormone variability in dialysis patients American Journal of Nephrology (ISSN: 02508095) 37: (5) pp. 462471. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13474917]
47
De Oliveira RB, Graciolli FG, Dos Reis LM, Cancela ALE, Cuppari L, Canziani ME, Carvalho AB, Jorgetti V, Moysés RMA Disturbances of Wnt/βcatenin pathway and energy metabolism in early CKD: Effect of phosphate binders Nephrology Dialysis Transplantation (ISSN: 09310509) 28: (10) pp. 25102517. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13474916]
48
Spatz C, Roe K, Lehman E, Verma N Effect of a noncalciumbased phosphate binder on fibroblast growth factor 23 in chronic kidney disease Nephron Clinical Practice 123: (12) pp. 6166. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13474915]
49
Seifert ME, De Las Fuentes L, Rothstein M, Dietzen DJ, Bierhals AJ, Cheng SC, Ross W , W indus D, DávilaRomán VG, Hruska KA Effects of phosphate binder therapy on vascular stiffness in earlystage chronic kidney disease American Journal of Nephrology (ISSN: 02508095) 38: (2) pp. 158167. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13474914]
50
PérezSáez M José, Crespo Marta, Cofan Frederic, AlonsoMelgar Ángel, Díaz Joan M, Errasti Pedro, Fijo Julia, Fraile Pilar, GutiérrezDalmau Álex, Hernández Ana Enfermedad mineral ósea del trasplante renal: clínica y diagnóstico Nefrologia Sup Ext 4: (1) pp. 2742. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [14239391]
51
Gravesen E, HofmanBang J, Lewin E, Olgaard K Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 45
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 32/342
3/30/2015
nyomtatobarat forma SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (ISSN: 00365513) 73: (2) pp. 107116. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13822285] 52
Olauson H, Larsson TE FGF23 and Klotho in chronic kidney disease Current Opinion in Nephrology and Hypertension (ISSN: 10624821) 22: (4) pp. 397404. ( 2013) N1 Funding Details: 20066555, Swedish Foundation for Strategic Research Folyóiratcikk /Összefoglaló cikk /Tudományos [13474913]
53
W esselingPerry K, Pereira RC, Tsai E, Ettenger R, Jüppner H, Salusky IB FGF23 and mineral metabolism in the early postrenal transplantation period Pediatric Nephrology (ISSN: 0931041X) 28: (11) pp. 22072215. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13474912]
54
Ketteler M, Biggar PH, Liangos O FGF23 antagonism: The thin line between adaptation and maladaptation in chronic kidney disease Nephrology Dialysis Transplantation (ISSN: 09310509) 28: (4) pp. 821825. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13474910]
55
Zoccali C, Yilmaz MI, Mallamaci F FGF23: A mature renal and cardiovascular risk factor? Blood Purification (ISSN: 02535068) 36: (1) pp. 5257. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13474908]
56
Baia LC, Humalda JK, Vervloet MG, Navis G, Bakker SJL, de Borst MH Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation Clinical Journal of the American Society of Nephrology (ISSN: 15559041) 8: (11) pp. 19681978. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13474907]
57
* Kovesdy CP, Quarles LD Fibroblast growth factor23: What we know, what we don't know, and what we need to know Nephrology Dialysis Transplantation (ISSN: 09310509) 28: (9) pp. 22282236. ( 2013) N1 Funding Details: RO1 AR 045955, NIH, National Institutes of Health N1 Funding Details: Amgen Folyóiratcikk /Összefoglaló cikk /Tudományos [13474906]
58
Arnlov Johan, Carlsson Axel C, Sundstrom Johan, Ingelsson Erik, Larsson Anders, Lind Lars, Larsson Tobias E Higher fibroblast growth factor23 increases the risk of allcause and cardiovascular mortality in the community KIDNEY INTERNATIONAL (ISSN: 00852538) 83: (1) pp. 160166. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13056478]
59
Ho Julie, W iebe Chris, Rush David N, Rigatto Claudio, Storsley Leroy, Karpinski Martin, Gao Ang, Gibson Ian W , Nickerson Peter W Increased Urinary CCL2: Cr Ratio at 6 Months is Associated With Late Renal Allograft Loss TRANSPLANTATION (ISSN: 00411337) 95: (4) pp. 595602. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13056477]
60
Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Turker T, Unal HU, Gok M, Cetinkaya H, Eyileten T, Oguz Y, Caglar K, Vural A, Mallamaci F, Zoccali C Longitudinal analysis of vascular function and biomarkers of metabolic bone disorders before and after renal transplantation American Journal of Nephrology (ISSN: 02508095) 37: (2) pp. 126134. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13056490]
61
Bacchetta J, LafageProust MH, Chapurlat R Mineral and bone disorders in renal transplantation NEPHROLOGIE & THERAPEUTIQUE (ISSN: 17697255) 9: (7) pp. 461470. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13820444]
62
Poesen R, Evenepoel P Novel insights in phosphate homeostasis: The role of fibroblast growth factor 23 Tijdschrift voor Geneeskunde (ISSN: 0371683X) 69: (7) pp. 359364. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13474905]
63
Ott SM, Elder G Osteoporosis Associated with Chronic Kidney Disease In: Osteoporosis: Fourth Edition. Elsevier Inc., 2013. (ISBN 9780124158535) pp. 13871424.
Könyvrészlet /Könyvfejezet /Tudományos [14108820] 64
Di Iorio BR, Bellizzi V, Bellasi A, Torraca S, D'Arrigo G, Tripepi G, Zoccali C P hosphate attenuates the antiproteinuric effect of very lowprotein diet in CKD patients Nephrology Dialysis Transplantation (ISSN: 09310509) 28: (3) pp. 632640. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13056489]
65
W esselingPerry K, Salusky IB P hosphate binders, vitamin D and calcimimetics in the management of chronic kidney diseasemineral bone disorders (CKD MBD) in children Pediatric Nephrology (ISSN: 0931041X) 28: (4) pp. 617625. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474904]
66
* Houston J, Isakova T, W olf M P hosphate Metabolism and Fibroblast Growth Factor 23 in Chronic Kidney Disease In: Nutritional Management of Renal Disease. Elsevier Inc., 2013. (ISBN 9780123919342) pp. 285308.
Könyvrészlet /Könyvfejezet /Tudományos [13474903] 67
* Christov M, W aikar SS, Pereira RC, Havasi A, Leaf DE, Goltzman D, Pajevic PD, W olf M, Jüppner H P lasma FGF23 levels increase rapidly after acute kidney injury Kidney International (ISSN: 00852538) 84: (4) pp. 776785. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13474902]
68
Prié D, Forand A, Francoz C, Elie C, Cohen I, Courbebaisse M, Eladari D, Lebrec D, Durand F, Friedlander G P lasma Fibroblast Growth Factor 23 Concentration Is Increased and P redicts Mortality in P atients on the LiverTransplant Waiting List PLoS ONE (ISSN: 19326203) 8: (6) P aper e66182. (2013) Folyóiratcikk /Szakcikk /Tudományos [13474901]
69
Evenepoel P Recovery Versus P ersistence of Disordered Mineral Metabolism in Kidney Transplant Recipients Seminars in Nephrology (ISSN: 02709295) 33: (2) pp. 191203. ( 2013)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 33/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Összefoglaló cikk /Tudományos [13064069] 70
Ärnlöv J, Carlsson AC, Sundstrom J, Ingelsson E, Larsson A, Lind L, Larsson TE Serum FGF23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology Clinical Journal of the American Society of Nephrology (ISSN: 15559041) 8: (5) pp. 781786. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13474899]
71
Bacchetta J, Ranchin B, Demède D, Allard L The consequences of pediatric renal transplantation on bone metabolism and growth Current Opinion in Organ Transplantation (ISSN: 10872418) 18: (5) pp. 555562. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13820443]
72
W esselingPerry K, Jüppner H The osteocyte in CKD: New concepts regarding the role of FGF23 in mineral metabolism and systemic complications Bone (ISSN: 87563282) 54: (2) pp. 222229. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474898]
73
74.
* Kovesdy CP, Quarles LD The role of fibroblast growth factor23 in cardiorenal syndrome NEPHRON CLINICAL PRACTICE (ISSN: 16602110) 123: (34) pp. 194201. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13820442] Kinsella Sinéad Vascular calcification and mineral bone disorder in chronic kidney disease 252 p. 2013.
Disszertáció /P hD /Tudományos [14239031] 75
李苏芳, 解汝娟 血清成纤维细胞生长因子 23 水平在慢性肾脏病中的作用 Chin J Clinicians 7: (9) pp. 40174019. ( 2013) Folyóiratcikk /Rövid közlemény /Tudományos [14239668]
76
Evenepoel P, Cooper K, Holdaas H, Messa P, Mourad G, Olgaard K, Rutkowski B, Schaefer H, Deng H, Torregrosa JV A Randomized Study Evaluating Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients With P ersistent Hyperparathyroidism American Journal of Transplantation (ISSN: 16006143) 14: (11) pp. 25452555. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14238979]
77
McCarty MF, DiNicolantonio JJ Bioavailable dietary phosphate, a mediator of cardiovascular disease, may be decreased with plantbased diets, phosphate binders, niacin, and avoidance of phosphate additives Nutrition (ISSN: 18731244) 30: (78) pp. 739747. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14093628]
78
Levin A, Rigatto C, Barrett B, Madore F, Muirhead N, Holmes D, Clase CM, Tang M, Djurdjev O Biomarkers of inflammation, fibrosis, cardiac stretch and injury predict death but not renal replacement therapy at 1 year in a Canadian chronic kidney disease cohort Nephrology Dialysis Transplantation (ISSN: 14602385) 29: (5) pp. 10371047. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13842665]
79
* Molnar MZ, Naser MS, Rhee CM, KalantarZadeh K, Bunnapradist S Bone and mineral disorders after kidney transplantation: Therapeutic strategies Transplantation Reviews (ISSN: 15579816) 28: (2) pp. 5662. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [13820441]
80
Kulak CAM, Borba VZC, Kulak Júnior J, Custódio MR Bone disease after transplantation: Osteoporosis and fractures risk ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (ISSN: 00042730) 58: (5) pp. 484492. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14200597]
81
Liabeuf S, Neirynck N, Drüeke TB, Vanholder R, Massy ZA Clinical Studies and Chronic Kidney Disease: What Did we Learn Recently? Seminars in Nephrology (ISSN: 15584488) 34: (2) pp. 164179. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [13820440]
82
Stompór Tomasz Coronary artery calcification in chronic kidney disease: An update World Journal of Cardiology (ISSN: 19498462) 6: (4) pp. 115129. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14573902]
83
* W olf M, W hite KE Coupling fibroblast growth factor 23 production and cleavage: Iron deficiency, rickets, and kidney disease Curr. Opin. Nephrol. Hypertens. (ISSN: 14736543) 23: (4) pp. 411419. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14093627]
84
* Kovesdy CP Do FGF23 levels change over time and if yes, what do such changes mean? Nephrology Dialysis Transplantation (ISSN: 09310509) 29: (1) pp. 1214. ( 2014) Folyóiratcikk /Rövid közlemény /Tudományos [13820439]
85
Rao M, Steffes M, Bostom A, Ix JH Effect of niacin on FGF23 concentration in chronic kidney disease Am. J. Nephrol. (ISSN: 14219670) 39: (6) pp. 484490. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14108819]
86
Japanese Society of Nephrology Evidencebased Clinical P ractice Guideline for CKD 2013 CLINICAL AND EXPERIMENTAL NEPHROLOGY (ISSN: 13421751) 18: (3) pp. 346423. ( 2014) Folyóiratcikk /Jelentés /Tudományos [14124271]
87
Xiao YJ, Luo XR, Huang W , Zhang JZ, Peng CQ FGF 23 and risk of allcause mortality and cardiovascular events: A metaanalysis of prospective cohort studies INTERNATIONAL JOURNAL OF CARDIOLOGY (ISSN: 01675273) 177: (2) pp. 575577. ( 2014) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [14502543]
88
Malyszko J, KocZorawska E, MatuszkiewiczRowinska J, Malyszko J FGF23 and Klotho in Relation to Markers of Endothelial Dysfunction in Kidney Transplant Recipients
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 34/342
3/30/2015
nyomtatobarat forma TRANSPLANTATION PROCEEDINGS (ISSN: 00411345) 46: (8) pp. 26472650. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14502542] 89
Van Venrooij NA, Pereira RC, Tintut Y, Fishbein MC, Tumber N, Demer LL, Salusky IB, W esselingPerry K FGF23 protein expression in coronary arteries is associated with impaired kidney function NEPHROLOGY DIALYSIS TRANSPLANTATION (ISSN: 14602385) 29: (8) pp. 15251532. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14124267]
90
Smith ER, McMahon LP, Holt SG Fibroblast growth factor 23 Annals of Clinical Biochemistry (ISSN: 17581001) 51: (2) pp. 203227. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [13820438]
91
Xiao Y, Luo X, Huang W , Zhang J, Peng C Fibroblast growth factor 23 and risk of allcause mortality and cardiovascular events: A metaanalysis of prospective cohort studies Int. J. Cardiol. (ISSN: 18741754) 174: (3) pp. 824828. ( 2014) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [14093626]
92
Negri AL Fibroblast growth factor 23: Associations with cardiovascular disease and mortality in chronic kidney disease International Urology and Nephrology (ISSN: 03011623) 46: (1) pp. 917. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [13820437]
93
Asicioglu E, Kahveci A, Arikan H, Koc M, Tuglular S, Ozener C Fibroblast growth factor23 levels are associated with uric acid but not carotid intima media thickness in renal transplant recipients Transplantation Proceedings (ISSN: 00411345) 46: (1) pp. 180183. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13820436]
94
Baia LC, Van den Berg E, Vervloet MG, Heilberg IP, Navis G, Bakker SJL, Geleijnse JM, Kromhout D, SoedamahMuthu SS, De Borst MH, on behalf of the NIGRAM consortium Fish and omega3 fatty acid intake in relation to circulating fibroblast growth factor 23 levels in renal transplant recipients NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (ISSN: 09394753) 24: (12) pp. 13101316. ( 2014) Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [14238986]
95
Ingulli EG, Mak RH Growth in children with chronic kidney disease: Role of nutrition, growth hormone, dialysis, and steroids Current Opinion in Pediatrics (ISSN: 1531698X) 26: (2) pp. 187192. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [13820435]
96
Chitalia N, Ismail T, Tooth L, Boa F, Hampson G, Goldsmith D, Kaski JC, Banerjee D Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients PLoS ONE (ISSN: 19326203) 9: (3) P aper e91363. (2014) Folyóiratcikk /Szakcikk /Tudományos [13820434]
97
Cianciolo G, Capelli I, Angelini ML, Valentini C, Baraldi O, Scolari MP, Stefoni S Importance of vascular calcification in kidney transplant recipients Am. J. Nephrol. (ISSN: 14219670) 39: (5) pp. 418426. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14093625]
98
Evenepoel P, Rodriguez M, Ketteler M Laboratory Abnormalities in CKDMBD: Markers, P redictors, or Mediators of Disease? Seminars in Nephrology (ISSN: 15584488) 34: (2) pp. 151163. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [13820433]
99
Olauson H, Vervloet MG, Cozzolino M, Massy ZA, Torres PU, Larsson TE New Insights Into the FGF23Klotho Axis SEMINARS IN NEPHROLOGY (ISSN: 02709295) 34: (6) pp. 586597. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14502541]
100
Bleskestad IH, Bergrem H, Leivestad T, Hartmann A, Gøransson LG P arathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function Clinical Transplantation (ISSN: 13990012) 28: (4) pp. 479486. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13820432]
101
Yilmaz Mahmut Ilker, Sonmez Alper, Saglam M, Kurt YG, Unal HU, Karaman M, Gok M, Cetinkaya H, Eyileten T, Oguz Y Ramipril Lowers P lasma FGF23 in P atients with Diabetic Nephropathy American Journal of Nephrology (ISSN: 14219670) 40: (3) pp. 208214. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14238955]
102
Zaritsky J, Rastogi A, Fischmann G, Yan J, Kleinman K, Chow G, Gales B, Salusky IB, W esselingPerry K Short daily hemodialysis is associated with lower plasma FGF23 levels when compared with conventional hemodialysis Nephrology Dialysis Transplantation (ISSN: 09310509) 29: (2) pp. 437441. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13820431]
103
Taal MW , Thurston V, McIntyre NJ, Fluck RJ, McIntyre CW The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease KIDNEY INT (ISSN: 00852538) 86: (2) pp. 407413. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14147783]
104
Hansen D, Rasmussen K, Rasmussen LM, Bruunsgaard H, Brandi L The influence of vitamin D analogs on calcification modulators, Nterminal proBtype natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study BMC NEPHROL (ISSN: 14712369) 15: P aper 130. 11 p. (2014) Folyóiratcikk /Szakcikk /Tudományos [14212337]
105
Srivali N, Ungprasert P, Kittanamongkolchai W The role of fibroblast growth factor 23 in sepsis Crit. Care Med. (ISSN: 15300293) 42: (7) p. e539. ( 2014) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [14093624]
106
Smith ER The Use of Fibroblast Growth Factor 23 Testing in P atients with Kidney Disease
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 35/342
3/30/2015
nyomtatobarat forma CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (ISSN: 15559041) 9: (7) pp. 12831303. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14124270] 107
Ponticelli C, Sala G Vitamin D: A new player in kidney transplantation? EXPERT REVIEW OF CLINICAL IMMUNOLOGY (ISSN: 1744666X) 10: (10) pp. 13751383. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14228338]
108
Larsson TobiasE, Olauson Hannes FGF23 and P hosphate: Two Cardiovascular Toxins with Distinct Toxicity P rofiles? In: Goldsmith David, Covic Adrian, Spaak Jonas (szerk.) : CardioRenal Clinical Challenges. Springer International Publishing, 2015. (ISBN 9783 319091617) p. 7380
Könyvrészlet /Könyvfejezet /Tudományos [14573938] 109
Neyra JavierA, Moe OrsonW , Hu MingChang Fibroblast growth factor 23 and acute kidney injury Pediatr Nephrol (ISSN: 0931041X) In press: p. In press. ( 2015) Folyóiratcikk /Szakcikk /Tudományos [14573985]
110
Guo YuChen, Yuan Quan Fibroblast growth factor 23 and bone mineralisation INTERNATIONAL JOURNAL OF ORAL SCIENCE (ISSN: 16742818) 7: (1) pp. 813. ( 2015) Folyóiratcikk /Összefoglaló cikk /Tudományos [14557651]
111 * Isakova T, Craven TE, Lee J, Scialla JJ, Xie HL, W ahl P, Marcovina SM, Byington RP, W olf M Fibroblast Growth Factor 23 and Incident CKD in Type 2 Diabetes CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (ISSN: 15559041) 10: (1) pp. 2938. ( 2015) Folyóiratcikk /Szakcikk /Tudományos [14573952] 112
Humalda Jelmer K, Heerspink Hiddo J Lambers, Kwakernaak Arjan J, Slagman Maartje CJ, W aanders Femke, Vervloet Marc G, Ter W ee Pieter M, Navis Gerjan, de Borst Martin H, NIGRAM Consortium Fibroblast Growth Factor 23 and the Antiproteinuric Response to Dietary Sodium Restriction During ReninAngiotensin Aldosterone System Blockade American Journal of Kidney Diseases (ISSN: 02726386) 65: (2) pp. 259266. ( 2015) Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [14238968]
113
Pihlstrøm H, Dahle DO, Mjøen G, Pilz S, März W , Abedini S, Holme I, Fellström B, Jardine AG, Holdaas H Increased risk of allcause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism Transplantation (ISSN: 00411337) 99: (2) pp. 351359. ( 2015) Folyóiratcikk /Szakcikk /Tudományos [14573918]
114
Negri Armando Luis, Ureña Torres Pablo Antonio Ironbased phosphate binders: do they offer advantages over currently available phosphate binders? CLINICAL KIDNEY JOURNAL (CKJ) (ISSN: 20488505) 8: (2) pp. 161167. ( 2015) Folyóiratcikk /Összefoglaló cikk /Tudományos [14573933]
115
Evenepoel Pieter, Daenen Kristien, Bammens Bert, Claes Kathleen, Meijers Björn, Naesens Maarten, Sprangers Ben, Kuypers Dirk, Lerut Eveline Microscopic nephrocalcinosis in chronic kidney disease patients Nephrology Dialysis Transplantation (ISSN: 09310509) In press: p. In press. ( 2015) Folyóiratcikk /Szakcikk /Tudományos [14573960]
116
Bleskestad Inger Hjørdis, Thorsen Inga Strand, Jonsson Grete, Skadberg Øyvind, Bergrem Harald, Gøransson Lasse Gunnar Soluble Klotho and intact Fibroblast Growth Factor 23 in longterm kidney transplant patients European Journal of Endocrinology (ISSN: 08044643) In press: p. In press. ( 2015) Folyóiratcikk /Szakcikk /Tudományos [14573974]
2010 98. Balla B , Kósa P J , Kiss J , Podaní J , Takács I , Lazary Á , Bácsi K , Nagy Z , Speer G , Lakatos P A menopausa hatása az immunrendszer működését szabályozó gének transzkriptomikai változásaira humán csontszövetben LEGE ARTIS MEDICINAE 20:(10) pp. 667673. (2010) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1802766] [ Érvényesített ] 99. Halászlaki C , Horváth H , Kiss L , Takács I , Speer G , Nagy Z , Winternitz T , Dabasi G , Zalatnai A , Patócs A , Lakatos P VernerM orrison szindróma egy esete [VernerM orrison syndrome: a case study] ORVOSI HETILAP 151:(27) pp. 11111114. (2010) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1363287] [ Hitelesített ] Független idéző: 2 Összesen: 2 1
Rushikesh Raviraj Maheshwari, Madhav Desai, Vara Prasada G Rao, Radha Rani Palanki, Rajendra Prasad Namburi, Karthik T S Reddy, Amaresh P Reddy Ischemic stroke as a presenting feature of VIP oma due to MEN 1 syndrome INDIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (ISSN: 22308210) 17: (Suppl. 1) pp. S215S218. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [14479894]
2
Boronsuzov Iv, Starbanov Iv, Hristozova I, Konstantinov D Case report of neuroblastoma, associated with werner Morrison syndrome Pediatriya 54: (1) pp. 4548. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14068653]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 36/342
3/30/2015
nyomtatobarat forma
100. Horvath HC , Lakatos P , Kosa JP , Bacsi K , Borka K , Bises G , Nittke T , Hershberger PA , Speer G , Kallay E The candidate oncogene CYP24A1: A potential biomarker for colorectal tumorigenesis. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY 58:(3) pp. 277285. (2010) IF: 2.381 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1335535] [ Érvényesített ] Független idéző: 24 Függő idéző: 13 Összesen: 37 1
* Speer G A Dnap. A Dvitamin helye a daganatprevencióban és a kiegészítő kezelésben [The Dday. The role of vitamin D in the prevention and the additional therapy of cancers]. Magyar Onkologia (ISSN: 00250244) 54: (4) pp. 303314. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11910902]
2
Fang Z, Xiong Y, Zhang C, Li J, Liu L, Li M, Zhang W , W an J Coexistence of copy number increases of ZNF217 and CYP 24A1 in colorectal cancers in a chinese population Oncology Letters (ISSN: 17921074) 1: (5) pp. 925930. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11910903]
3
Plum L A, Deluca H F Vitamin D, disease and therapeutic opportunities Nature Reviews Drug Discovery (ISSN: 14741776) 9: (12) pp. 941955. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11910901]
4
5
* Cross H S, Nittke T, Kallay E Colonic vitamin D metabolism: Implications for the pathogenesis of inflammatory bowel disease and colorectal cancer Molecular and Cellular Endocrinology (ISSN: 03037207) 347: (12) pp. 7079. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [11910900] Schuster I Cytochromes P 450 are essential players in the vitamin D signaling system Biochimica et Biophysica Acta Proteins and Proteomics 1814: (1) pp. 186199. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [11910899]
6
* Balla B, Kósa J P, Tobiás B, Halászlaki C, Takács I, Horváth H, Speer G, Nagy Z, Horányi J, Járay B, Székely E, Lakatos P Marked increase in CYP 24A1 gene expression in human papillary thyroid cancer Thyroid (ISSN: 10507256) 21: (4) pp. 459460. ( 2011) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [11910898]
7
W lcek K, Svoboda M, Riha J, Zakaria S, Olszewski U, Dvorak Z, Sellner F, Ellinger I, Jäger W , Thalhammer T The analysis of organic anion transporting polypeptide (OATP ) mRNA and protein patterns in primary and metastatic liver cancer Cancer Biology and Therapy 11: (9) pp. 801811. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11910897]
8
Davis C D, Milner J A Vitamin D and colon cancer Expert Review of Gastroenterology and Hepatology 5: (1) pp. 6781. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [11910896]
9
Jones G, Prosser DE, Kaufmann M 25Hydroxyvitamin D24hydroxylase (CYP 24A1): Its important role in the degradation of vitamin D ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (ISSN: 00039861) 523: (1) pp. 918. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12432111]
10
Clinckspoor I, Hauben E, Verlinden L, Van den Bruel A, Vanwalleghem L, Poorten VV, Delaere P, Mathieu C, Verstuyf A, Decallonne B Altered Expression of Key P layers in Vitamin D Metabolism and Signaling in Malignant and Benign Thyroid Tumors JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (ISSN: 00221554) 60: (7) pp. 502511. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13043204]
11
W elsh J Cellular and molecular effects of vitamin D on carcinogenesis ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (ISSN: 00039861) 523: (1) pp. 107114. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12432110]
12
Koszewski NJ, Horst RL, Goff JP Importance of apical membrane delivery of 1,25dihydroxyvitamin D3 to vitamin Dresponsive gene expression in the colon AMERICAN JOURNAL OF PHYSIOLOGYGASTROINTESTINAL AND LIVER PHYSIOLOGY (ISSN: 01931857) 303: (7) pp. G870G878. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13043203]
13 * Horvath E, Lakatos P, Balla B, Kosa JP, Tobias B, Jozilan H, Borka K, Horvath HC, Kovalszky I, Szalay F Marked Increase of CYP 24A1 mRNA Level in Hepatocellular Carcinoma Cell Lines Following Vitamin D Administration ANTICANCER RESEARCH (ISSN: 02507005) 32: (11) pp. 47914796. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13043202] 14
Peng XJ, Tiwari N, Roy S, Yuan L, Murillo G, Mehta RR, Benya RV, Mehta RG Regulation of CYP 24 splicing by 1,25dihydroxyvitamin D3 in human colon cancer cells JOURNAL OF ENDOCRINOLOGY (ISSN: 00220795) 212: (2) pp. 207215. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12432109]
15
W elsh J Vitamin D and cancer: Integration of cellular biology, molecular mechanisms and animal models SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (ISSN: 00365513) 72: (Suppl. 243) pp. 103 111. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12432108]
16
Giardina C, Madigan JP, Tierney CAG, Brenner BM, Rosenberg DW Vitamin D resistance and colon cancer prevention CARCINOGENESIS (ISSN: 01433334) 33: (3) pp. 475482. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12432107]
17
Gueli N, Verrusio W , Linguanti A, Di Maio F, Martinez A, Marigliano B, Cacciafesta M
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 37/342
3/30/2015
nyomtatobarat forma Vitamin D: Drug of the future. A new therapeutic approach Archives of Gerontology and Geriatrics (ISSN: 01674943) 54: (1) pp. 222227. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [11910895] 18 * Luo W , Hershberger PA, Trump DL, Johnson CS 24Hydroxylase in cancer: Impact on vitamin Dbased anticancer therapeutics JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (ISSN: 09600760) 136: (Spec. Iss.) pp. 252257. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13792749] 19
Salvador JAR, Carvalho JFS, Neves MAC, Silvestre SM, Leitao AJ, Silva MMC, Melo MLSE Anticancer steroids: linking natural and semisynthetic compounds NATURAL PRODUCT REPORTS (ISSN: 02650568) 30: (2) pp. 324374. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13043201]
20 * Brennan SC, Thiem U, Roth S, Aggarwal A, Fetahu IS, Tennakoon S, Gomes AR, Brandi ML, Bruggeman F, Mentaverri R, Riccardi D, Kallay E Calcium sensing receptor signalling in physiology and cancer BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR CELL RESEARCH (ISSN: 01674889) 1833: (7) pp. 17321744. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13792748] 21
Salzman J, Chen RE, Olsen MN, W ang PL, Brown PO CellType Specific Features of Circular RNA Expression PLOS GENETICS (ISSN: 15537404) 9: (9) P aper e1003777. (2013) Folyóiratcikk /Szakcikk /Tudományos [13792747]
22 * Kosa JP, Horvath P, W olfling J, Kovacs D, Balla B, Matyus P, Horvath E, Speer G, Takacs I, Nagy Z, Horvath H, Lakatos P CYP 24A1 inhibition facilitates the antitumor effect of vitamin D3 on colorectal cancer cells WORLD JOURNAL OF GASTROENTEROLOGY (ISSN: 10079327) 19: (17) pp. 26212628. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13792746] 23 * Hobaus J, Fetahu IS, Khorchide M, Manhardt T, Kallay E Epigenetic regulation of the 1,25dihydroxyvitamin D3 24hydroxylase (CYP 24A1) in colon cancer cells JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (ISSN: 09600760) 136: pp. 296299. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13792745] 24 * Hobaus J, Hummel DM, Thiem U, Fetahu IS, Aggarwal A, Mullauer L, Heller G, Egger G, Mesteri I, BaumgartnerParzer S, Kallay E Increased copynumber and not DNA hypomethylation causes overexpression of the candidate protooncogene CYP 24A1 in colorectal cancer INTERNATIONAL JOURNAL OF CANCER (ISSN: 00207136) 133: (6) pp. 13801388. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13792743] 25
Luo W , Yu W D, Ma YY, Chernov M, Trump DL, Johnson CS Inhibition of P rotein Kinase CK2 Reduces Cyp24a1 Expression and Enhances 1,25Dihydroxyvitamin D3 Antitumor Activity in Human P rostate Cancer Cells CANCER RESEARCH (ISSN: 00085472) 73: (7) pp. 22892297. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13792742]
26 * Hobaus J, Thiem U, Hummel DM, Kallay E Role of Calcium, Vitamin D, and the Extrarenal Vitamin D Hydroxylases in Carcinogenesis ANTICANCER AGENTS IN MEDICINAL CHEMISTRY (ISSN: 18715206) 13: (1) pp. 2035. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13792741] 27
Urbschat A, Paulus P, von Quernheim QF, Bruck P, Badenhoop K, Zeuzem S, RamosLopez E Vitamin D hydroxylases CYP 2R1, CYP 27B1 and CYP 24A1 in renal cell carcinoma EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ISSN: 00142972) 43: (12) pp. 12821290. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13792740]
28
Clinckspoor I, Verlinden L, Mathieu C, Bouillon R, Verstuyf A, Decallonne B Vitamin D in thyroid tumorigenesis and development PROGRESS IN HISTOCHEMISTRY AND CYTOCHEMISTRY (ISSN: 00796336) 48: (2) pp. 6598. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13792739]
29 * Fetahu Irfete S, Hoebaus Julia, Aggarwal Abhishek, Hummel Doris M, Tennakoon Samawansha, Mesteri Ildiko, BaumgartnerParzer Sabina, Kallay Eniko Calciumsensing receptor silencing in colorectal cancer is associated with promoter hypermethylation and loss of acetylation on histone 3 INTERNATIONAL JOURNAL OF CANCER (ISSN: 00207136) 135: (9) pp. 20142023. ( 2014) Folyóiratcikk [14595173] 30
Sakaki T, Yasuda K, Kittaka A, Yamamoto K, Chen TC CYP 24A1 as a P otential Target for Cancer Therapy ANTICANCER AGENTS IN MEDICINAL CHEMISTRY (ISSN: 18715206) 14: (1) pp. 97108. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13792738]
31
Brozyna Anna A, Jochymski Cezary, Janjetovic Zorica, Jozwicki W ojciech, Tuckey Robert C, Slominski Andrzej T CYP 24A1 Expression Inversely Correlates with Melanoma P rogression: ClinicP athological Studies INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (ISSN: 14220067) 15: (10) pp. 1900019017. ( 2014) Folyóiratcikk [14595172]
32
Zou Minjing, BinHumaid Faisal S, Alzahrani Ali S, Baitei Essa Y, AlMohanna Futwan A, Meyer Brian F, Shi Yufei Increased CYP 24A1 expression is associated with BRAF(V600E) mutation and advanced stages in papillary thyroid carcinoma CLINICAL ENDOCRINOLOGY (ISSN: 03000664) 81: (1) pp. 109116. ( 2014) Folyóiratcikk [14595171]
33
Rubsamen D, Kunze MM, Buderus V, Brauss TF, Bajer MM, Brune B, Schmid T Inflammatory Conditions Induce IRESDependent Translation of cyp24a1 PLOS ONE (ISSN: 19326203) 9: (1) P aper e85314. (2014) Folyóiratcikk /Szakcikk /Tudományos [13792737]
34 * Hummel Doris M, Fetahu Irfete S, Groeschel Charlotte, Manhardt Teresa, Kallay Eniko Role of proinflammatory cytokines on expression of vitamin D metabolism and target genes in colon cancer cells JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (ISSN: 09600760) 144: pp. 9195. ( 2014) PN A
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 38/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [14595170] 35
Thomas Emmanuel, Brion JeanDaniel, Peyrat JeanFrancois Synthesis and preliminary biological evaluation of new antiproliferative aromatic analogues of 1 alpha,25dihydroxyvitamin D3 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (ISSN: 02235234) 86: pp. 381393. ( 2014) Folyóiratcikk [14595169]
36 * Hummel Doris, Aggarwal Abhishek, Borka Katalin, Bajna Erika, Kallay Enikoe, Horvath Henrik Csaba The vitamin D system is deregulated in pancreatic diseases JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (ISSN: 09600760) 144: pp. 402409. ( 2014) PN B Folyóiratcikk [14595168] 37
Jones G, Prosser DE, Kaufmann M Thematic Review Series: FatSoluble Vitamins: Vitamin D Cytochrome P 450mediated metabolism of vitamin D JOURNAL OF LIPID RESEARCH (ISSN: 00222275) 55: (1) pp. 1331. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [13792736]
101. Kiss J , Balla B , Kósa JP , Borsy A , Podani J , Takács I , Lazáry Á , Nagy Z , Bácsi K , Kis A , Szlávy E , Szendrői M , Speer G , Orosz L , Lakatos P Gene expression patterns in the bone tissue of women with fibrous dysplasia AMERICAN JOURNAL OF MEDICAL GENETICS PART A 152A:(9) pp. 22112220. (2010) IF: 2.505 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1371299] [ Admin láttamozott ] Független idéző: 2 Összesen: 2 1
Koutlas Ioannis G Forsman Cynthia L Kyrkanides Stephanos Oetting W illiam S Petryk Anna Autosomal dominant mesomandibular fibroosseous dysplasia: a selfresolving inherited fibroosseous lesion of the jaws Frontiers in Physiology (ISSN: 1664042X) 3: p. 458. ( 2012) Folyóiratcikk [12971890]
2
Louis Mugambe Muwazi Adriane Kamulegeya The fiveyear prevalence of maxillofacial fibroosseous lesions in Uganda Oral Diseases (ISSN: 1354523X) 21: (1) pp. 7985. ( 2014) Folyóiratcikk [14365568]
102. Kiss J , Balla B , Kosa PJ , Borsy A , Podani J , Takacs I , Lazary A , Nagy Z , Bacsi K , Szlavy E , Szendroi M , Speer G , Orosz L , Lakatos P A génexpresszió változásai és patogenetikai jelentőségük fibrosus dysplasiás és nem fibrosus dysplasiás nők csontszövetében [Changes of gene expression and its role in pathogenesis in fibrous and nonfibrous dysplastic bone tissues in women] ORVOSI HETILAP 151:(40) pp. 16561665. (2010) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1385679] [ Admin láttamozott ] 103. Kovesdy CP , M olnar M Z , Czira M E , Rudas A , Ujszaszi A , Rosivall L , Szathmari M , Covic A , Keszei A , Beko G , Lakatos P , Kosa J , M ucsi I Associations between Serum Leptin Level and Bone Turnover in Kidney Transplant Recipients CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 5:(12) pp. 22972304. (2010) IF: 4.763 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1405970] [ Érvényesített ] Független idéző: 2 Függő idéző: 9 Összesen: 11 1
* Kovesdy CP, Mucsi I, Czira ME, Rudas A, Ujszaszi A, Rosivall L, Kim SJ, W olf M, Molnar MZ Association of Serum P hosphorus Level With Anemia in Kidney Transplant Recipients TRANSPLANTATION (ISSN: 00411337) 91: (8) pp. 875882. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11384294]
2
* Kovesdy CP, KalantarZadeh K Diuretics and secondary hyperparathyroidism in chronic kidney disease NEPHROLOGY DIALYSIS TRANSPLANTATION (ISSN: 09310509) 26: (4) pp. 11221125. ( 2011) Folyóiratcikk /Ismertetés /Tudományos [11384293]
3
* Molnar MZ, Tabak AG, Alam A, Czira ME, Rudas A, Ujszaszi A, Beko G, Novak M, KalantarZadeh K, Kovesdy CP, Mucsi I Serum Erythropoietin Level and Mortality in Kidney Transplant Recipients CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (ISSN: 15559041) 6: (12) pp. 28792886. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11958486]
4
Torres PU Biological parameters for the diagnosis of bone turnover in dialysis patient In: Nephrology and Clinical Chemistry : The Essential Link. Bentham Science Publishers Ltd., 2012. (ISBN 9781608056392) pp. 106121.
Könyvrészlet /Könyvfejezet /Tudományos [13476886] 5
* Cortazar F, Molnar MZ, Isakova T, Czira ME, Kovesdy CP, Roth D, Mucsi I, W olf M Clinical Outcomes in Kidney Transplant Recipients Receiving LongTerm Therapy With Inhibitors of the Mammalian Target of Rapamycin AMERICAN JOURNAL OF TRANSPLANTATION (ISSN: 16006135) 12: (2) pp. 379387. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12324157] Kawarazaki H, Shibagaki Y, Kido R, Nakajima I, Fuchinoue S, Ando K, Fujita T, Fukagawa M, Teraoka S, Fukumoto S
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 39/342
3/30/2015
nyomtatobarat forma 6
Kidney transplantation restored uncoupled bone turnover in endstage renal disease Clinical Nephrology (ISSN: 03010430) 78: (1) pp. 1016. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13051035]
7
* Fornadi K, Lindner A, Czira ME, Szentkiralyi A, Lazar AS, Zoller R, Turanyi CZ, Veber O, Novak M, Mucsi I, Molnar MZ Lack of association between objectively assessed sleep disorders and inflammatory markers among kidney transplant recipients INTERNATIONAL UROLOGY AND NEPHROLOGY (ISSN: 03011623) 44: (2) pp. 607617. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12408361]
8
* Turkmen K, Tonbul H Z, Erdur F M, Guney I, Kayikcioglu H, Altintepe L, Ozbek O, Yilmaz M I, Gaipov A, Turk S, Covic A, Kanbay M P eriaortic fat tissue and malnutritioninflammationatherosclerosis/calcification syndrome in endstage renal disease patients INTERNATIONAL UROLOGY AND NEPHROLOGY (ISSN: 03011623) 45: (3) pp. 857867. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13476884]
9
* Ujszaszi Akos, Molnar Miklos Z, Czira Maria E, Novak Marta, Mucsi Istvan Renal function is independently associated with red cell distribution width in kidney transplant recipients: a potential new auxiliary parameter for the clinical evaluation of patients with chronic kidney disease BRITISH JOURNAL OF HAEMATOLOGY (ISSN: 00071048) 161: (5) pp. 715725. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13476883]
10 * Molnar MZ, Kumpers P, Kielstein JT, Schiffer M, Czira ME, Ujszaszi A, Kovesdy CP, Mucsi I Circulating Angiopoietin2 levels predict mortality in kidney transplant recipients: a 4year prospective casecohort study TRANSPL INT (ISSN: 09340874) 27: (6) pp. 541552. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14094326] 11 * Mucsi I, Ujszaszi A, Czira M, Novak M, Molnar M Red cell distribution width is associated with mortality in kidney transplant recipients INT UROL NEPHROL (ISSN: 03011623) 46: (3) pp. 641651. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14094325]
104. Lakatos G , Lakatos P A férfiak osteoporosisa MAGYAR ANDROLÓGIA 15:(1) pp. 912. (2010) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1806290] http://lib.semmelweis.hu/sepub/pdf/2010/a74 [ Érvényesített ] 105. Lakatos P A korral járó osteoporosis korszerű terápiája ORVOSTOVÁBBKÉPZŐ SZEMLE 17:(9) pp. 1118. (2010) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1806292] [ Érvényesített ] 106. Lakatos P Az endokrin rendszer In: Petrányi Gyula (szerk.) Belgyógyászati diagnosztika: Az orvosi vizsgálat módszertana . 582 p. Budapest: M edicina Könyvkiadó, 2010. pp. 300317. (ISBN:978 963 226 240 6) Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1923170] [ Hitelesített ] [9. kiad.] 107. Lakatos P Bevezető HÁZIORVOS TOVÁBBKÉPZŐ SZEMLE 15:(7) p. 394. (2010) Nyelv: Magyar
Folyóiratcikk /Nem besorolt /Tudományos [1980535] [ Érvényesített ] 108. Lakatos Péter A csontritkulás kezelése. Gyógyszerek sokasága közül lehet választani MEDICAL TRIBUNE 8:(22) pp. 1415. (2010) Nyelv: Magyar
Folyóiratcikk /Rövid közlemény /Közérdekű [1806300] [ Érvényesített ] 109. M olnar M Z , Keszei A , Czira M E , Rudas A , Ujszaszi A , Haromszeki B , Kosa JP , Lakatos P , Sarvary E , Beko G , Fornadi K , Kiss I , Remport A , Novak M , KalantarZadeh K , Kovesdy CP , M ucsi I https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 40/342
3/30/2015
nyomtatobarat forma
Evaluation of the M alnutritionInflammation Score in Kidney Transplant Recipients AMERICAN JOURNAL OF KIDNEY DISEASES 56:(1) pp. 102111. (2010) IF: 5.242 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1350774] [ Érvényesített ] Független idéző: 11 Függő idéző: 21 Összesen: 32 1
* Kovesdy CP, Czira ME, Rudas A, Ujszaszi A, Rosivall L, Novak M, KalantarZadeh K, Molnar MZ, Mucsi I Body mass index, waist circumference and mortality in kidney transplant recipients American Journal of Transplantation (ISSN: 16006135) 10: (12) pp. 26442651. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12702635]
2
* Molnar MZ, Mucsi I In Reply to 'MalnutritionInflammation Complex Syndrome in Kidney Transplant Recipients' AMERICAN JOURNAL OF KIDNEY DISEASES (ISSN: 02726386) 56: (5) pp. 10121013. ( 2010) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [11122720]
3
Elsurer R, Afsar B MalnutritionInflammation Complex Syndrome in Kidney Transplant Recipients AMERICAN JOURNAL OF KIDNEY DISEASES (ISSN: 02726386) 56: (5) pp. 10121012. ( 2010) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [11122719]
4
* Czira ME, Lindner AV, Szeifert L, Molnar MZ, Fornadi K, Kelemen A, Laszlo G, Mucsi I, Keszei AP, Kennedy SH, Novak M Association between the MalnutritionInflammation Score and depressive symptoms in kidney transplanted patients GENERAL HOSPITAL PSYCHIATRY (ISSN: 01638343) 33: (2) pp. 157165. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11384281]
5
* Molnar MZ, Czira ME, Rudas A, Ujszaszi A, Haromszeki B, Kosa JP, Lakatos P, Beko G, Sarvary E, Varga M, Fornadi K, Novak M, Rosivall L, Kiss I, Remport A, Goldsmith DJ, Kovesdy CP, Mucsi I Association between the malnutritioninflammation score and posttransplant anaemia NEPHROLOGY DIALYSIS TRANSPLANTATION (ISSN: 09310509) 26: (6) pp. 20002006. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12324111]
6
* Kovesdy CP, Mucsi I, Czira ME, Rudas A, Ujszaszi A, Rosivall L, Kim SJ, W olf M, Molnar MZ Association of Serum P hosphorus Level With Anemia in Kidney Transplant Recipients TRANSPLANTATION (ISSN: 00411337) 91: (8) pp. 875882. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11384280]
7
* Molnar MZ, Czira ME, Rudas A, Ujszaszi A, Lindner A, Fornadi K, Kiss I, Remport A, Novak M, Kennedy SH, Rosivall L, Kovesdy CP, Mucsi I Association of the MalnutritionInflammation Score With Clinical Outcomes in Kidney Transplant Recipients AMERICAN JOURNAL OF KIDNEY DISEASES (ISSN: 02726386) 58: (1) pp. 101108. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12324110]
8
* Streja E, Molnar MZ, Kovesdy CP, Bunnapradist S, Jing J, Nissenson AR, Mucsi I, Danovitch GM, KalantarZadeh K Associations of P retransplant Weight and Muscle Mass with Mortality in Renal Transplant Recipients CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (ISSN: 15559041) 6: (6) pp. 14631473. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12324109]
9
* KalantarZadeh K, Cano NJ, Budde K, Chazot C, Kovesdy CP, Mak RH, Mehrotra R, Raj DS, Sehgal AR, Stenvinkel P, Ikizler TA Diets and enteral supplements for improving outcomes in chronic kidney disease NATURE REVIEWS NEPHROLOGY (ISSN: 17595061) 7: (7) pp. 369384. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12324108]
10 * Molnar MZ, Streja E, Kovesdy CP, Budoff MJ, Nissenson AR, Krishnan M, Anker SD, Norris KC, Fonarow GC, Kalantar Zadeh K High platelet count as a link between renal cachexia and cardiovascular mortality in endstage renal disease patients AMERICAN JOURNAL OF CLINICAL NUTRITION (ISSN: 00029165) 94: (3) pp. 945954. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12324107] 11 * Feroze U, Molnar MZ, Dukkipati R, Kovesdy CP, KalantarZadeh K Insights Into Nutritional and Inflammatory Aspects of Low P arathyroid Hormone in Dialysis P atients JOURNAL OF RENAL NUTRITION (ISSN: 10512276) 21: (1) pp. 100104. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [11262817] 12 * Molnar MZ, Tabak AG, Alam A, Czira ME, Rudas A, Ujszaszi A, Beko G, Novak M, KalantarZadeh K, Kovesdy CP, Mucsi I Serum Erythropoietin Level and Mortality in Kidney Transplant Recipients CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (ISSN: 15559041) 6: (12) pp. 28792886. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12324106] 13
Grothe Ann 9 Nutrition for Chronic Kidney Disease, Stage 4 In: Thomas LK, Othersen JB (szerk.) : Nutrition Therapy for Chronic Kidney Disease. Tay lor & Francis, 2012. pp. 123134.
Könyvrészlet /Könyvfejezet /Tudományos [14247210] 14 * Molnar MZ, Bunnapradist S, Huang E, Krishnan M, Nissenson AR, Kovesdy CP, KalantarZadeh K Association of pretransplant erythropoiesisstimulating agent responsiveness with posttransplant outcomes NEPHROLOGY DIALYSIS TRANSPLANTATION (ISSN: 09310509) 27: (8) pp. 33453351. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12675547] 15 * Cortazar F, Molnar MZ, Isakova T, Czira ME, Kovesdy CP, Roth D, Mucsi I, W olf M Clinical Outcomes in Kidney Transplant Recipients Receiving LongTerm Therapy With Inhibitors of the Mammalian Target of Rapamycin AMERICAN JOURNAL OF TRANSPLANTATION (ISSN: 16006135) 12: (2) pp. 379387. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12324105] 16
Mao W ei, Lv Congkui, Bao Kun Comparative study on malnutritioninflammation score and subjective global assessment in patients with maintenance hemodialysis Journal of Jinan University 33: (6) pp. 583586. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13051178]
17 * Fornadi Katalin, Lindner Anett, Czira Maria E, Szentkiralyi Andras, Lazar Alpar S, Zoller Rezso, Turanyi Csilla Z, Veber
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 41/342
3/30/2015
nyomtatobarat forma Orsolya, Novak Marta, Mucsi Istvan, Molnar Miklos Z Lack of association between objectively assessed sleep disorders and inflammatory markers among kidney transplant recipients INTERNATIONAL UROLOGY AND NEPHROLOGY (ISSN: 03011623) 44: (2) pp. 607617. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12561371] 18 * Ujszaszi Akos, Czira Maria E, Fornadi Katalin, Novak Marta, Mucsi Istvan, Molnar Miklos Z Quality of life and proteinenergy wasting in kidney transplant recipients INTERNATIONAL UROLOGY AND NEPHROLOGY (ISSN: 03011623) 44: (4) pp. 12571268. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12561370] 19
Graziani MS, Caldini A, Basile U, Dolci A, Ferraro S, Ferrarotti I, Infusino I, Muratore MT, Mussap M, Obici L, Pezzati P, Previtali G, Szoke D, Terreni A, Zaninotto M, Merlini G Recommendations for the measurement of the most important plasma proteins: Indicazioni per la misura delle principali proteine sieriche Biochimica Clinica (ISSN: 03930564) 36: (4) pp. 244267. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12702633]
20. * Molnárné Fornádi Katalin A gyulladás és az alvászavarok összefüggései vesetranszplantált betegek körében 164 p. 2013.
Disszertáció /P hD /Tudományos [14561462] 21
Leeming DJ, Karsdal MA, Rasmussen LM, Scholze A, Tepel M Association of Systemic Collagen Type IV Formation with Survival among P atients Undergoing Hemodialysis PLoS ONE (ISSN: 19326203) 8: (8) P aper e71050. (2013) Folyóiratcikk /Szakcikk /Tudományos [13603696]
22
Amparo FC, Cordeiro AC, Carrero JJ, Cuppari L, Lindholm B, Amodeo C, Kamimura MA Malnutritioninflammation score is associated with handgrip strength in nondialysisdependent chronic kidney disease patients Journal of Renal Nutrition (ISSN: 10512276) 23: (4) pp. 283287. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13820454]
23
Veroux M, Corona D, Sinagra N, Tallarita T, Ekser B, Giaquinta A, Zerbo D, Veroux P Nutrition in kidney transplantation International Journal of Artificial Organs (ISSN: 03913988) 36: (10) pp. 677686. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13603695]
24
Chan M, Chadban S Nutritional Management of Kidney Transplant Recipients In: Nutritional Management of Renal Disease. Elsevier Inc., 2013. (ISBN 9780123919342) pp. 563580.
Könyvrészlet /Könyvfejezet /Tudományos [13603694] 25
ter W ee PM P rotein Energy Wasting and Transplantation Journal of Renal Nutrition (ISSN: 10512276) 23: (3) pp. 246249. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13603693]
26 * Kovesdy C, KalantarZadeh K P roteinEnergy Wasting as a Risk Factor of Morbidity and Mortality in Chronic Kidney Disease In: Nutritional Management of Renal Disease. Elsevier Inc., 2013. (ISBN 9780123919342) pp. 171195.
Könyvrészlet /Könyvfejezet /Tudományos [13603692] 27 * Ujszaszi A, Molnar MZ, Czira ME, Novak M, Mucsi I Renal function is independently associated with red cell distribution width in kidney transplant recipients: A potential new auxiliary parameter for the clinical evaluation of patients with chronic kidney disease British Journal of Haematology (ISSN: 00071048) 161: (5) pp. 715725. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13603691] 28 * Alam A, Molnar MZ, Czira ME, Rudas A, Ujszaszi A, KalantarZadeh K, Rosivall L, Mucsi I Serum Adiponectin levels and mortality after kidney transplantation Clinical Journal of the American Society of Nephrology (ISSN: 15559041) 8: (3) pp. 460467. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13603690] 29
Chan W , GW ard D, McClean A, ABosch J, Jones D, Kaur O, Drayson M, W hitelegg A, Iqbal T, McTernan PG, Tselepis C, Borrows R The role of hepcidin25 in kidney transplantation Transplantation (ISSN: 00411337) 95: (11) pp. 13901395. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13603689]
30 * Molnar MZ, Kümpers P, Kielstein JT, Schiffer M, Czira ME, Ujszaszi A, Kovesdy CP, Mucsi I Circulating Angiopoietin2 levels predict mortality in kidney transplant recipients: A 4year prospective casecohort study TRANSPLANT INTERNATIONAL (ISSN: 14322277) 27: (6) pp. 541552. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14093810] 31
Gursu M, Celik K, Ozturk S, Turkmen A, Gorcin S, Kocak B, Sari S, Koldas M, Feyizoglu H, Kazancioglu R P entraxin 3 and Creactive protein as inflammatory markers after a kidney transplant EXPERIMENTAL AND CLINICAL TRANSPLANTATION (ISSN: 13040855) 12: (4) pp. 295299. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14200651]
32 * Mucsi I, Ujszaszi A, Czira ME, Novak M, Molnar MZ Red cell distribution width is associated with mortality in kidney transplant recipients International Urology and Nephrology (ISSN: 15732584) 46: (3) pp. 641651. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13820453]
110. Reid IR , Gamble GD , M esenbrink P , Lakatos P , Black DM Characterization of and risk factors for the acutephase response after zoledronic acid JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 95:(9) pp. 43804387. (2010) IF: 6.495 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802767] [ Hitelesített ] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 42/342
3/30/2015
nyomtatobarat forma
Független idéző: 48 Függő idéző: 10 Összesen: 58 1
2
Rizzoli R Bisphosphonates for postmenopausal osteoporosis: Are they all the same? QJM 104: (4) pp. 281300. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12008705] * Reid IR Bisphosphonates in the treatment of osteoporosis: A review of their contribution and controversies Skeletal Radiology (ISSN: 03642348) 40: (9) pp. 11911196. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12008704]
3
Eisner A, Luoh S W Breast cancer medications and vision: Effects of treatments for earlystage disease Current Eye Research (ISSN: 02713683) 36: (10) pp. 867885. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12008703]
4
Hadji P Clinical considerations for the use of antiresorptive agents in the treatment of metastatic bone disease Critical Reviews in Oncology/Hematology 80: (2) pp. 301313. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12008702]
5
Lin Hua, Xu Tiansu, Fan Lu, Yang Haiming, Chen Xin, Qian Cheng Effect of 5 mg zoledronic acid on bone mineral density in women with postmenopausal osteoporosis Chinese Journal of Orthopedics (ISSN: 02532352) 31: (12) pp. 13311336. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [14594839]
6
Lin H, Xu T, Fan L, Yang H, Chen X EFFECT OFA ONCEYEARLY ZOLEDRONIC ACID ON BMD AND THE RISK OF FALLING IN P OSTMENOP AUSAL WOMEN WITH OSTEOP OROSIS OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: pp. S649S650. ( 2011) SU 4 Folyóiratcikk [14594898]
7
Morgan GJ, Child JA, Gregory W M, Szubert AJ, Cocks K, Bell SE, NavarroCoy N, Drayson MT, Owen RG, Feyler S, Ashcroft AJ, Ross FM, Byrne J, Roddie H, Rudin C, Cook G, Jackson GH, W u P, Davies FE Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial The Lancet Oncology 12: (8) pp. 743752. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12008701]
8
Zhao Fang, Cong Baohua, Song Fei Efficacy analysis of zoledronic acid treatment for postmenopausal and senile osteoporosis Chinese Journal of Osteoporosis (ISSN: 10067108) 17: (10) pp. 915916,902. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [14594838]
9
Deng Haiou, Li Dongfeng, Zhang W eijie, Zhi Ximei, Xu Ling, W u W en Factors associated with acute febrile reaction in elderly patients receiving intravenous zoledronic acid for osteoporosis Journal of Southern Medical University (ISSN: 16734254) 31: (12) pp. 20762078. ( 2011) Folyóiratcikk [14594837]
10
Makras P, Anastasilakis A D, Polyzos S A, Bisbinas I, Sakellariou G T, Papapoulos S E No effect of rosuvastatin in the zoledronateinduced acutephase response Calcified Tissue International (ISSN: 0171967X) 88: (5) pp. 402408. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12008700]
11
Pazianas M, Abrahamsen B Safety of bisphosphonates Bone (ISSN: 87563282) 49: (1) pp. 103110. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12008699]
12
Lewiecki EM Safety of longterm bisphosphonate therapy for the management of osteoporosis Drugs (ISSN: 00126667) 71: (6) pp. 791814. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12008698]
13
Karga H, Giagourta I, Papaioannou G, Katsichti P, Pardalakis A, Kassi G, Zagoreou A, Triantaphyllopoulou M, Zerva C Transient changes in thyroid functions tests after zoledronic acid infusion Endocrine Journal (ISSN: 09188959) 58: (11) pp. 969977. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12008697]
14
Nie H, Peng C, Hao J, Hu Z M, An H Zoledronic acid in preventing fractures in women with postmenopausal osteoporosis: A meta analysis Academic Journal of Second Military Medical University 32: (9) pp. 985990. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12008696]
15
Lipton A Zoledronic acid: Multiplicity of use across the cancer continuum Expert Review of Anticancer Therapy (ISSN: 14737140) 11: (7) pp. 9991012. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12008695]
16
Moser B, Eberl M γ δ TAP Cs: A novel tool for immunotherapy? Cellular and Molecular Life Sciences (ISSN: 1420682X) 68: (14) pp. 24432452. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12008694]
17
Lin Hua, Xu Tianshu, Fan Lu 5 mg zoledronic acid for treatment of postmenopausal women with osteoporosis and osteoporotic fracture Chinese Journal of Orthopaedic Trauma (ISSN: 16717600) 14: (1) pp. 3135. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [14594897]
18
Schwab Pascale, Harmon David, Bruno Richard, Fraunfelder Frederick W , Kim Donna Hyunchung A 55yearold woman with orbital inflammation ARTHRITIS CARE & RESEARCH (ISSN: 2151464X) 64: (11) pp. 17761782. ( 2012) Folyóiratcikk [14594896]
19
Belliveau Michel J, Almeida David R P, Urton Todd E
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 43/342
3/30/2015
nyomtatobarat forma Acute anterior uveitis following zoledronic acid infusion for osteoporosis CANADIAN JOURNAL OF OPHTHALMOLOGYJOURNAL CANADIEN D OPHTALMOLOGIE (ISSN: 00084182) 47: (5) pp. E22E23. ( 2012) Folyóiratcikk [14594895] 20
Anastasilakis AD, Polyzos SA, Makras P, Sakellariou GT, Bisbinas I, Gkiomisi A, Delaroudis S, Gerou S, Ballaouri I, Oikonomou D, Papapoulos SE Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass BONE (ISSN: 87563282) 50: (5) pp. 11301134. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12431889]
21
Rossini M, Adami S, Viapiana O, Ortolani R, Vella A, Fracassi E, Gatti D Circulating γ δ T cells and the risk of acutephase response after zoledronic acid administration Journal of Bone and Mineral Research (ISSN: 08840431) 27: (1) pp. 227230. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12008693]
22
Rossini Maurizio, Adami Silvano, Viapiana Ombretta, Fracassi Elena, Ortolani Riccardo, Vella Antonio, Zanotti Roberta, Tripi Gaia, Idolazzi Luca, Gatti Davide LongTerm Effects of AminoBisphosphonates on Circulating gamma delta T Cells CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 91: (6) pp. 395399. ( 2012) Folyóiratcikk [14594894]
23 * Grey A, Bolland M, W ong S, Horne A, Gamble G, Reid I R Lowdose zoledronate in osteopenic postmenopausal women: A randomized controlled trial Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 97: (1) pp. 286292. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12008692] 24
Orozco Catalina, Maalouf Naim M Safety of Bisphosphonates RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (ISSN: 0889857X) 38: (4) pp. 681+. ( 2012) Folyóiratcikk [14594893]
25
Hadji P, Ziller V, Gamerdinger D, Spieler W , Moericke R, Kann P H Summary of the results of the ROSEStudy: direct comparison of the two bisphosphonates alendronate and zoledronic acid OSTEOLOGIE (ISSN: 10191291) 21: (2) pp. 94100. ( 2012) Folyóiratcikk [14594892]
26 * Black DM, Reid IR, Boonen S, BucciRechtweg C, Cauley JA, Cosman F, Cummings SR, Hue TF, Lippuner K, Lakatos P, Leung PC, Man Z, Martinez RLM, Tan M, Ruzycky ME, Su G, Eastell R The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZONP ivotal Fracture Trial (P FT) Journal of Bone and Mineral Research (ISSN: 08840431) 27: (2) pp. 243254. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12008691] 27
Anastasilakis Athanasios D, Polyzos Stergios A, Delaroudis Sideris, Bisbinas Ilias, Sakellariou Grigorios T, Gkiomisi Athina, Papadopoulou Evridiki, Gerou Spyridon, Makras Polyzois The role of cytokines and adipocytokines in zoledronateinduced acute phase reaction in postmenopausal women with low bone mass CLINICAL ENDOCRINOLOGY (ISSN: 03000664) 77: (6) pp. 816822. ( 2012) Folyóiratcikk [14594891]
28 * W ark JD, Bensen W , Recknor C, Ryabitseva O, Chiodo J, Mesenbrink P, de Villiers TJ Treatment with acetaminophen/paracetamol or ibuprofen alleviates postdose symptoms related to intravenous infusion with zoledronic acid 5 mg OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (2) pp. 503512. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12431888] 29
Catalano A, Morabito N, Atteritano M, Basile G, Cucinotta D, Lasco A Vitamin D Reduces Musculoskeletal P ain After Infusion of Zoledronic Acid for P ostmenopausal Osteoporosis CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 90: (4) pp. 279285. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12431887]
30
Lou Zhenkai, Li Chunhai, Ye W ei, Ding Yue, Zhu W eirong, Ren Jinke Zoledronic acid injection in treating 36 patients with postmenopausal osteoporosis Chinese Journal of New Drugs and Clinical Remedies (ISSN: 10077669) 31: (5) pp. 247250. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [14594889]
31
Laslett Laura Louise, Dore Dawn A, Quinn Stephen J, Boon Philippa, Ryan Emma, W inzenberg Tania Maree, Jones Graeme Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial ANNALS OF THE RHEUMATIC DISEASES (ISSN: 00034967) 71: (8) pp. 13221328. ( 2012) Folyóiratcikk [14594888]
32
McClung Michael R, Benhamou ClaudeLaurent, Man Zulema, Tlustochowicz W itold, Zanchetta Jose R, Eusebio Rachelle, Balske Ana M, Matzkin Ellen, Olszynski W ojciech P, Recker Robert, Delmas Pierre D A Novel Monthly Dosing Regimen of Risedronate for the Treatment of P ostmenopausal Osteoporosis: 2Year Data CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 92: (1) pp. 5967. ( 2013) Folyóiratcikk [14594887]
33
Yang Yi, Li Pengqiu, Xian Yang Analysis of acute fever reaction in postmenopausal women with zoledronic acid treatment for osteoporosis Chinese Journal of Osteoporosis (ISSN: 10067108) 19: (1) pp. 5860. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [14594886]
34
McClung Michael, Harris Steven T, Miller Paul D, Bauer Douglas C, Davison K Shawn, Dian Larry, Hanley David A, Kendler David L, Yuen Chui Kin, Lewiecki E Michael Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday AMERICAN JOURNAL OF MEDICINE (ISSN: 00029343) 126: (1) pp. 1320. ( 2013) Folyóiratcikk [14594885]
35
Boeni C, Kordic H, Chaloupka K BisphosphonateAssociated Orbital Inflammatory Disease and Uveitis Anterior a Case Report and Review KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE (ISSN: 00232165) 230: (4) pp. 367369. ( 2013) Folyóiratcikk [14594884]
36
Sun Jinghua, Xu Xiaofeng, Chi Xiaofei, Yi Dongsheng Efficacy of 2year continuous injection of zoledronic acid on postmenopausal osteoporosis
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 44/342
3/30/2015
nyomtatobarat forma Chinese Journal of Osteoporosis (ISSN: 10067108) 19: (6) pp. 619621,640. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [14594883] 37
W elton Joanne L, Morgan Matt P, Marti Salvador, Stone Michael D, Moser Bernhard, Sewell Andrew K, Turton Jane, Eberl Matthias Monocytes and gamma delta cells control the acutephase response to intravenous zoledronate: Insights from a phase IV safety trial JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 28: (3) pp. 464471. ( 2013) Folyóiratcikk [14594882]
38
Pang Xue, Liu Ying, Cao Jihong, W ang Li, Guo Yan, W ang Liheng Observation and nursing of the transient adverse effect of zoledronic acid in the treatment of postmenopausal osteoporosis Chinese Journal of Osteoporosis (ISSN: 10067108) 19: (11) pp. 11871189. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [14594880]
39 * Reid Ian R Osteoporosis treatment: Focus on safety EUROPEAN JOURNAL OF INTERNAL MEDICINE (ISSN: 09536205) 24: (8) pp. 691697. ( 2013) Folyóiratcikk [14594879] 40
Ralston Stuart H P aget's Disease of Bone NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 368: (7) pp. 644650. ( 2013) Folyóiratcikk [14594878]
41
Chen Yan, Lu Chunyan, Liu Ting, Guo Yanhong, W ang Qin, Chen Decai Risk Factors of Acutephase Response Following the Firstdose Administration of Zoledronic Acid in the Treatment of Osteoporosis Journal of Sichuan University. Medical Science Edition (ISSN: 1672173X) 44: (4) pp. 681684. ( 2013) Folyóiratcikk [14594877]
42 * Bourke S, Bolland M J, Grey A, Horne A M, W attie D J, W ong S, Gamble G D, Reid I R The impact of dietary calcium intake and vitamin D status on the effects of zoledronate OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 24: (1) pp. 349354. ( 2013) Folyóiratcikk [14594876] 43 * Patel Dipika V, Horne Anne, House Meaghan, Reid Ian R, McGhee Charles N J The Incidence of Acute Anterior Uveitis after Intravenous Zoledronate OPHTHALMOLOGY (ISSN: 01616420) 120: (4) pp. 773776. ( 2013) Folyóiratcikk [14594875] 44
Guangdong Medical Journal (ISSN: 10019448) 35: (6) pp. 928930. ( 2014) Folyóiratcikk [14594873]
45
Pappagallo Marco, Breuer Brenda, Lin HungMo, Moberly James B, Tai Julia, Noto Christopher, Sanchez Angela, Manfredi Paolo L A pilot trial of intravenous pamidronate for chronic low back pain PAIN (ISSN: 03043959) 155: (1) pp. 108117. ( 2014) Folyóiratcikk [14594872]
46
Zhang Jianan, Zhang Lixia, Li Chong, W ang Zhifang, Zhang Shujun, Shi Shuangwei, Liu Zhenzhen Correlation analysis of the influential factors of acute phase response after intravenous zoledronic acid treatment for postmenopausal osteoporosis Chinese Journal of Osteoporosis (ISSN: 10067108) 20: (5) pp. 538541. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14594871]
47
Popp A W , Buffat H, Cavelti A, W indolf M, Perrelet R, Senn C, Lippuner K Cortical bone loss at the tibia in postmenopausal women with osteoporosis is associated with incident nonvertebral fractures: Results of a randomized controlled ancillary study of HORIZON MATURITAS (ISSN: 03785122) 77: (3) pp. 287293. ( 2014) Folyóiratcikk [14594870]
48
Koivisto Katri, Kyllonen Eero, Haapea Marianne, Niinimaki Jaakko, Sundqvist Kaj, Pehkonen Timo, Seitsalo Seppo, Tervonen Osmo, Karppinen Jaro Efficacy of zoledronic acid for chronic low back pain associated with Modic changes in magnetic resonance imaging BMC MUSCULOSKELETAL DISORDERS (ISSN: 14712474) 15: P aper 64. (2014) Folyóiratcikk [14594868]
49
Sykiotis Antonis, Papaioannou Garyphallia, Mavropoulos Jordan, Triantaphyllopoulou Maria, Papandroulaki Fotini, Ktena Vassiliki, Thanou Stavroula, Pardalakis Argyris, Kaltsa Aikaterini, Karga Helen Markers of inflammation after zoledronic acid redosing JOURNAL OF BONE AND MINERAL METABOLISM (ISSN: 09148779) 32: (1) pp. 7277. ( 2014) Folyóiratcikk [14594867]
50
Kheir W ajiha J, Sniegowski Matthew C, ElSawy Tarek, Li Alexa, Esmaeli Bita Ophthalmic complications of targeted cancer therapy and recently recognized ophthalmic complications of traditional chemotherapy SURVEY OF OPHTHALMOLOGY (ISSN: 00396257) 59: (5) pp. 493502. ( 2014) Folyóiratcikk [14594866]
51 * Singer Frederick R, Bone Henry G III, Hosking David J, Lyles Kenneth W , Murad Mohammad Hassan, Reid Ian R, Siris Ethel S P aget's Disease of Bone: An Endocrine Society Clinical P ractice Guideline JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 99: (12) pp. 44084422. ( 2014) Folyóiratcikk [14594864] 52
Gennari Luigi, Merlotti Daniela, Rendina Domenico, Gianfrancesco Fernando, Esposito Teresa, Nuti Ranuccio P aget's disease of bone: epidemiology, pathogenesis and pharmacotherapy EXPERT OPINION ON ORPHAN DRUGS (ISSN: 21678707) 2: (6) pp. 591603. ( 2014) Folyóiratcikk [14594863]
53
Ripamonti C I, Bossi P, Santini D, Fallon M P ain related to cancer treatments and diagnostic procedures: a no man's land? ANNALS OF ONCOLOGY (ISSN: 09237534) 25: (6) pp. 10971106. ( 2014) Folyóiratcikk [14594862]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 45/342
3/30/2015
nyomtatobarat forma 54
Suresh Ernest, Pazianas Michael, Abrahamsen Bo Safety issues with bisphosphonate therapy for osteoporosis RHEUMATOLOGY (ISSN: 14620324) 53: (1) pp. 1931. ( 2014) Folyóiratcikk [14594861]
55 * Dalbeth Nicola, Aati Opetaia, Gamble Gregory D, Horne Anne, House Meaghan E, Roger Mark, Doyle Anthony J, Chhana Ashika, McQueen Fiona M, Reid Ian R Zoledronate for prevention of bone erosion in tophaceous gout: a randomised, doubleblind, placebocontrolled trial ANNALS OF THE RHEUMATIC DISEASES (ISSN: 00034967) 73: (6) pp. 10441051. ( 2014) Folyóiratcikk [14594860] 56
Huang Shushu, Lin Hua, Zhu Xiufen, Chen Xin, Fan Lu, Liu Changchang Zoledronic acid increases bone mineral density and improves healthrelated quality of life over two years of treatment in Chinese women with postmenopausal osteoporosis ENDOKRYNOLOGIA POLSKA (ISSN: 0423104X) 65: (2) pp. 96104. ( 2014) Folyóiratcikk [14594859]
57
史丽璞, 郇稳 唑来膦酸联合甲氨蝶呤治疗绝经后早期类风湿关节炎的疗效 Chinese Journal of Gerontology (ISSN: 10059202) 34: (3) pp. 813814. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14594874]
58 * Patel D V, Bolland M, Nisa Z, AlAbuwsi F, Singh M, Horne A, Reid I R, McGhee C N J Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 26: (2) pp. 499503. ( 2015) Folyóiratcikk [14594858]
111. Stéger V , M olnár A , Borsy A , Gyurján I , Szabolcsi Z , Dancs G , M olnár J , Papp P , Nagy J , Puskás L , Barta E , Zomborszky Z , Horn P , Podani J , Semsey S , Lakatos P , Orosz L Antler development and coupled osteoporosis in the skeleton of red deer Cervus elaphus: expression dynamics for regulatory and effector genes MOLECULAR GENETICS AND GENOMICS 284:(4) pp. 273287. (2010) IF: 2.453 Nyelv: Angol
Folyóiratcikk /Összefoglaló cikk /Tudományos [1376344] [ Hitelesített ] Független idéző: 6 Függő idéző: 1 Összesen: 7 1
Tomas LandeteCastillejos, Inmaculada MolinaQuilez, Jose Antonio Estevez, Francisco Ceacero, Andres Jose Garcia, Laureano Gallego Alternative hypothesis for the origin of osteoporosis: the role of Mn. FRONT BIOSCI (ELITE EDITION) 4: pp. 13851390. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12548286]
2
Liao L, Hu YB, Xiao XH, Li HP Full Length cDNA Cloning and Expression Analysis of Calmodulin Gene from Deer Antler Tissue PAK J ZOOL 44: (5) pp. 12251230. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12649798]
3.
Cha En Hui P reparation of the Recombinant Sika Velvet Antler P olypeptide and Study on Its Bioactivity Témavezető(k): Yue Xi Qing. 2012.
Shenyang Agricultural University Disszertáció /P hD /Tudományos [14293557] 4
Villanyi Z, Mai A, Szabad J Repeated template switching: Obstacles in cDNA libraries and ways to avoid them Open Genomics Journal (ISSN: 1875693X) 5: (1) pp. 16. ( 2012) Folyóiratcikk [12129481]
5 * J BOKOR, Á BOKOR, J NAGY, P HORN, I NAGY A magyar gímszarvas trófea paramétereinek összefoglaló elemzése főkomponens analízissel két megyében J CENT EUR AGRIC 14: (1) pp. 452466. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13057356] 6
Sui Z, Yuan H, Liang Z, Zhao Q, W u Q, Xia S, Zhang L, Huo Y, Zhang Y An activitymaintaining sequential protein extraction method for bioactive assay and proteome analysis of velvet antlers TALANTA (ISSN: 00399140) 107: pp. 189194. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13760877]
7
Zoltan Villanyi Antal Mai, Janos Szabad Drosophila Orthologs, Expressed Specifically in Courting Zebra Finch Males, are Engaged in Courtship The Open Genomics Journal 6: pp. 815. ( 2013) Folyóiratcikk [13612305]
112. Takacs I , Lazary A , Kosa JP , Kiss J , Balla B , Nagy Z , Bacsi K , Speer G , Lakatos P Allelic variations of RANKL/OPG signaling system are related to bone mineral density and in vivo gene expression EUROPEAN JOURNAL OF ENDOCRINOLOGY 162:(2) pp. 423431. (2010) IF: 3.482 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1464645] I Takács and Á Lazáry contributed equally to this work [ Érvényesített ] Független idéző: 5 Összesen: 5 1
Piedra M, GarcíaUnzueta MT, Berja A, Paule B, Lavín BA, Valero C, Riancho JA, Amado JA Single nucleotide polymorphisms of the OP G/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 46/342
3/30/2015
nyomtatobarat forma BMC Medical Genetics (ISSN: 14712350) 12: P aper 168. (2011) Folyóiratcikk /Szakcikk /Tudományos [12008689] 2
Žofková I Význam genetiky v predikci rizika osteoporózy [Role of genetics in prediction of osteoporosis risk]. Vnitrni Lekarstvi (ISSN: 0042773X) 57: (1) pp. 7884. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12008690]
3
HulinCurtis SL, Bidwell JL, Perry MJ Tumour necrosis factor receptor superfamily member 11B polymorphisms and association with knee osteoarthritis in women INTERNATIONAL JOURNAL OF IMMUNOGENETICS (ISSN: 17443121) 39: (3) pp. 207209. ( 2012) Folyóiratcikk /Rövid közlemény /Tudományos [13041621]
4
Navratilova Z, Gallo J, Smizansky M, Mrazek F, Petrek M Osteoprotegerin gene polymorphism is not associated with prosthetic joint infection after total joint arthroplasty in the Czech population BIOMEDICAL PAPERS (ISSN: 12138118) 158: (2) pp. 273276. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14188690]
5
Pereira S, Lavado N, Nogueira L, Lopez M, Abreu J, Silva H P olymorphisms of genes encoding P 2X7R, IL1B, OP G and RANK in orthodonticinduced apical root resorption ORAL DISEASES (ISSN: 1354523X) 20: (7) pp. 659667. ( 2014) Folyóiratcikk [14594827]
2009 113. Bácsi K , Kósa J , Balla B , Lazáry Á , Takács I , Nagy Z , Speer G , Lakatos P A kalcium metabolizmus jelentősége a csontritkulás és a colorectalis daganat patogenezisében ORVOSKÉPZÉS 84:(2. ksz.) pp. 101110. (2009) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1335701] [ Érvényesített ] 114. Bacsi K , Kosa JP , Lazary A , Balla B , Horvath H , Kis A , Nagy Z , Takacs I , Lakatos P , Speer G LCT 13910 C/T polymorphism, serum calcium, and bone mineral density in postmenopausal women OSTEOPOROSIS INTERNATIONAL 20:(4) pp. 639645. (2009) IF: 4.997 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1464652] [ Hitelesített ] Független idéző: 6 Összesen: 6 1
Agueda L, Urreizti R, Bustamante M, Jurado S, GarciaGiralt N, DiezPerez A, Nogues X, Mellibovsky L, Grinberg D, Balcells S Analysis of Three Functional P olymorphisms in Relation to Osteoporosis P henotypes: Replication in a Spanish Cohort CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 87: (1) pp. 1424. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11278279]
2
Marques EA, W anderley F, Machado L, Sousa F, Viana JL, MoreiraGoncalves D, Moreira P, Mota J, Carvalho J Effects of resistance and aerobic exercise on physical function, bone mineral density, OP G and RANKL in older women EXPERIMENTAL GERONTOLOGY (ISSN: 05315565) 46: (7) pp. 524532. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12432547]
3
Tolonen S, Laaksonen M, Mikkila V, Sievanen H, Mononen N, Rasanen L, Viikari J, Raitakari OT, Kahonen M, Lehtimaki TJ Lactase Gene C/T13910 P olymorphism, Calcium Intake, and pQCT Bone Traits in Finnish Adults CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 88: (2) pp. 153161. ( 2011) CA: Cardiovasc Risk Young Finns Study Folyóiratcikk /Szakcikk /Tudományos [11278278]
4
Marques EA, Mota J, Machado L, Sousa F, Coelho M, Moreira P, Carvalho J Multicomponent Training P rogram with WeightBearing Exercises Elicits Favorable Bone Density, Muscle Strength, and Balance Adaptations in Older Women CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 88: (2) pp. 117129. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11278277]
5
Marques EA, Moreira P, W anderley F, Pizarro AN, LeaoRosas JP, Mota J, Carvalho J Appendicular fat mass is positively associated with femoral neck bone mineral density in older women MENOPAUSETHE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (ISSN: 10723714) 19: (3) pp. 311318. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12432546]
6
Mattar R, Mazo DFC, Carrilho FJ Lactose intolerance: Diagnosis, genetic, and clinical factors Clinical and Experimental Gastroenterology (ISSN: 11787023) 5: (1) pp. 113121. ( 2012) N1 Molecular Sequence Numbers: GENBANK: NG_008104 Folyóiratcikk /Összefoglaló cikk /Tudományos [12622560]
115. Balla B , Kosa JP , Kiss J , Podani J , Takacs I , Lazary A , Nagy Z , Bacsi K , Speer G , Lakatos P Transcriptional profiling of immune systemrelated genes in postmenopausal osteoporotic versus nonosteoporotic human bone tissue. CLINICAL IMMUNOLOGY 131:(2) pp. 354359. (2009) IF: 3.863 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1335539] [ Admin láttamozott ] Független idéző: 6 Függő idéző: 1 Összesen: 7 1
Reppe S, Refvem H, Gautvik VT, Olstad OK, Hovring PI, Reinholt FP, Holden M, Frigessi A, Jemtland R, Gautvik KM
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 47/342
3/30/2015
nyomtatobarat forma Eight genes are highly associated with BMD variation in postmenopausal Caucasian women BONE (ISSN: 87563282) 46: (3) pp. 604612. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11709747] 2
Li W F, Hou SX, Yu B, Li MM, Ferec C, Chen JM Genetics of osteoporosis: accelerating pace in gene identification and validation HUMAN GENETICS (ISSN: 03406717) 127: (3) pp. 249285. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11709746]
3
Jia Qian, Ivanov Ivan, Zlatev Zlatomir Z Dietary fish oil and curcumin combine to modulate colonic cytokinetics and gene expression in dextran sodium sulphatetreated mice BRITISH JOURNAL OF NUTRITION (ISSN: 00071145) 10: (4) pp. 519529. ( 2011) Folyóiratcikk [11709742]
4 * Balla Bernadett, Pinter Csaba, Kosa Janos P, Podani Janos, Takacs Istvan, Nagy Zsolt, Speer Gabor, Horvath Balazs, Koranyi Laszlo, Lakatos Peter Gene expression changes in femoral head necrosis of human bone tissue DISEASE MARKERS (ISSN: 02780240) 31: (1) pp. 2532. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13064098] 5.
Póliska Sz Genomic and genetic analysis of chronic obstructive pulmonary disease... 2011.
Debreceni Egyetem Disszertáció /P hD /Tudományos [11709743] 6
Philipp Stockmann Emeka Nkenke Matthias Englbrecht Tilo Schlittenbauer Falk W ehrhan Claudia Rauh Matthias W Beckmann Peter A Fasching Thomas Kreusch Andreas Mackensen Bernd W ullich Georg Schett Bernd M Spriewald Major histocompatibility complex class II polymorphisms are associated with the development of antiresorptive agentinduced osteonecrosis of the jaw Journal of CranioMaxillofacial Surgery (ISSN: 10105182) 41: (1) pp. 7175. ( 2012) Available online 6 December 2012 Folyóiratcikk [12765314]
7
Toti Paolo / Sbordone Carolina / Martuscelli Ranieri / Califano Luigi / Ramaglia Luca / Sbordone Ludovico Gene clustering analysis in human osteoporosis disease and modifications of the jawbone Archives of Oral Biology (ISSN: 00039969) 58: (8) pp. 912929. ( 2013) Folyóiratcikk [13057398]
116. Balla B , Kósa J , Takács I , Kiss J , Podani J , Lazáry Á , Bácsi K , Nagy Z , Speer G , Lakatos P Rendszerbiológiai szemlélet a primer csontvesztés molekuláris biológiai kutatásában és az osteoporosis immunológiai vonatkozásai ORVOSKÉPZÉS 84:(5. ksz.) pp. 397407. (2009) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1335704] [ Érvényesített ] 117. Balla B , Kósa PJ , Kiss J , Podani J , Takács I , Lazáry Á , Bácsi K , Nagy Zs , Speer G , Lakatos P Az immunrendszerben szerepet játszó gének expressziós változásainak vizsgálata osteoporoticus humán csontszövetben. IMMUNOLÓGIAI SZEMLE 1:(12) pp. 1320. (2009) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1803719] [ Hitelesített ] 118. Borsy A , Podani J , Stéger V , Balla B , Horváth A , Kósa JP , Gyurján I Jr , M olnár A , Szabolcsi Z , Szabó L , Jakó E , Zomborszky Z , Nagy J , Semsey S , Vellai T , Lakatos P , Orosz L Identifying novel genes involved in both deer physiological and human pathological osteoporosis. MOLECULAR GENETICS AND GENOMICS 281: pp. 301313. (2009) IF: 2.579 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1186250] [ Admin láttamozott ] Független idéző: 6 Függő idéző: 2 Összesen: 8 1
Lovell SC, Li XT, W eerasinghe NR, Hentges KE Correlation of microsynteny conservation and disease gene distribution in mammalian genomes BMC GENOMICS (ISSN: 14712164) 10: p. 521. ( 2009) Folyóiratcikk [11101969]
2 * Steger V, Molnar A, Borsy A, Gyurjan I, Szabolcsi Z, Dancs G, Molnar J, Papp P, Nagy J, Puskas L, Barta E, Zomborszky Z, Horn P, Podani J, Semsey S, Lakatos P, Orosz L Antler development and coupled osteoporosis in the skeleton of red deer Cervus elaphus: expression dynamics for regulatory and effector genes MOLECULAR GENETICS AND GENOMICS (ISSN: 16174615) 284: (4) pp. 273287. ( 2010) Folyóiratcikk [11101968] 3
Xu XH, Dong SS, Guo Y, Yang TL, Lei SF, Papasian CJ, Zhao M, Deng HW Molecular Genetic Studies of Gene Identification for Osteoporosis: The 2009 Update ENDOCRINE REVIEWS (ISSN: 0163769X) 31: (4) pp. 447505. ( 2010) Folyóiratcikk [11101967]
4 * Balla B, Pintér C, Kósa JP, Podani J, Takács I, Nagy Z, Speer G, Horváth B, Korányi L, Lakatos P Gene expression changes in femoral head necrosis of human bone tissue
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 48/342
3/30/2015
nyomtatobarat forma DISEASE MARKERS (ISSN: 02780240) 31: (1) pp. 2532. ( 2011) Folyóiratcikk [12010674] 5
Mesko B, Poliska S, Nagy L Gene expression profiles in peripheral blood for the diagnosis of autoimmune diseases TRENDS IN MOLECULAR MEDICINE (ISSN: 14714914) 17: (4) pp. 223233. ( 2011) Folyóiratcikk [11425395]
6
Geert Groot Bruinderink Dennis Lammertsma Bas W orm DE MINERALENSTATUS VAN EDELHERTEN IN NEDERLAND Het Edelhert 24: (3) pp. 2429. ( 2012) Folyóiratcikk [12405368]
7
Ingrid Garzón, Antonio Roa, Gerardo Moreu, Ana Celeste, Oliveira Olga, Roda Camilo, Andrés AlfonsoRodríguez, Maximino GonzálezJaranay, María del Carmen, SánchezQuevedo Miguel Alaminos Development of a diagnostic algorithm in periodontal disease and identification of genetic expression patterns: A preliminary report Journal of Dental Sciences (ISSN: 19917902) 7: (1) pp. 4856. ( 2012) Folyóiratcikk [12245256]
8
Zoltan Villanyi Antal Mai, Janos Szabad Drosophila Orthologs, Expressed Specifically in Courting Zebra Finch Males, are Engaged in Courtship The Open Genomics Journal 6: pp. 815. ( 2013) Folyóiratcikk [13612301]
119. Cummings SR , San M artin J , M cClung M R , Siris ES , Eastell R , Reid IR , Delmas P , Zoog HB , Austin M , Wang A , Kutilek S , Adami S , Zanchetta J , Libanati C , Siddhanti S , Christiansen C , FREEDOM Trial Egyéb szerzőség: Spengler B , Insperger A , Balázs T , Lakatos P , Takács K , Szombati I , Tarján K , Valkusz Z , Torma O , Seregely K (kollaborációs közrem.); Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis NEW ENGLAND JOURNAL OF MEDICINE 361:(8) pp. 756765. (2009) IF: 47.050 Nyelv: Angol
Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [1980905] FREEDOM Trial Cummings S, Christiansen C, Delmas P, Eastell R, M cClung M , Reid I, Siris E, Aqua K, Lee E, Boling E, Bolognese M , Burch F, Cohen S, Fiske D, Petit C, Pierson M , Garrison K, Gallup E, Geisberg H, Hassman D, Helfrich D, Krohn K, Cuevas E, Larson W, Seiler J, Lederman S, Lewiecki M , M acCarter D, M cClung M , M iller P, M offett A Jr, Recknor C, Simon J, Trapp R, Woodson G 3rd, Bone H, M urtaugh T, Ruckle J, Wasnich R, Gallagher C, Dhillon G, Feldman R, Pennington G, Saxe P, Goldberg C, Rogers K, Keller M , Swor M , Rosen A, Stjernholm M , Adachi J, Brown J, Faraawi R, Kendler D, Kremer R, Olszynski W, Yuen CK, M cKendry R, Boudreau J, M an Z, Zanchetta J, M autalen C, de Gregorio L, Eis S, Radominski S, da Silva N, Griz L, Provenza J, Zerbini C, GarcíaHernández P, AraujoArias M , Bueno E, FuentesCantu A, Perez M , BalderasAcata J, Avila Armengol H, de la PeñaRodríguez M , Nicholson G, Ebeling P, Sambrook P, Hooper M , Prins J, Russell A, Reid I, Gilchrist N, Preisinger E, Resch H, FahrleitnerPammer A, Huber J, Kudlacek S, Reginster JY, Kaufman JM , Boonen S, Body JJ, Devogelaer JP, Tegibjearg C, Juel R, Alexandersen P, Hoeck HC, Jensen JE, Välimäki M , Salmi J, Delmas P, Fardellone P, Weryha G, Benhamou CL, M augars Y, Roux C, Stahl HD, BlomeHenning U, Lochman B, Kopsch U, Roitenberg A, Adami S, Brandi M , M inisola S, Bianchi G, Sinigaglia L, Frediani B, M arcolongo R, Fiore C, Nuti R, Realdi G, Dijkmans B, Laan R, Bruyn G, Deijl A, M eesters E, Lems W, Verhage A, van de Walle V, Halse J, Hoiseth A, Syversen U, Stakkestad J, M inguella J, M ola E, Torres M , Gómez J, Hawkins F, Román J, Alvaro Gracia J, Del Pino J, Palacios S, Ljunggren O, Toss G, Samsioe G, M ellström D, Löfgren J, Törring O, Lippuner K, Krieg M A, Uebelhart D, Eastell R, Thomas H, Shaw H, Donnachie H, PavelKnox I, Robinson J, Kola N, Sarmiento R, Pawa R, Savani N, Kucerova I, Kuba V, Vyskocil V, Kutilek S, Novosad P, Slesinger J, Dokoupilova E, Doubravsky J, Gorgol J, Pavelka K, Valter I, M aasalu K, Kull I, Phenekos C, Lyritis G, Dimitriadis A, Spengler B, Insperger A, Balázs T, Lakatos P, Takács K, Szombati I, Tarján K, Valkusz Z, Torma O, Seregely K, Kaze I, Lejnieks A, M edne A, Tamulaitiene M , Velickiene D, Stonkus S, Brincat M , Walecki J, Bykowska M , SidorowiczBialynicka A, Szechinski J, Korkosz M , Supronik J, Koziara M , Czerwinski E, M ilewicz A, Jeka S, Kania G, Gidzinski P, Sawicki A, Tlustochowicz W, Franek E, Hoszowski K, Pluskiewicz W, Porawska W, Zgliczynski W, Killinger Z, M asaryk P, Kmecova Z, Tomkova S, Spustova V, Steno B, Zbranca E, Codreanu C, Hristov V, Russev T, Ivanova AM , Velev R, M itkov M , Troev D, Brankovic S, Dimic A, Pilipovic N, Hlatky M , Goldschlager N, Herrington D, Ryan C, M igliorati C, Ruggiero S, Schubert M . [ Érvényesített ] Független idéző: 631 Függő idéző: 83 Összesen: 714 1
2
* Davison KS, Kendler DL, Ammann P, Bauer DC, Dempster DW , Dian L, Hanley DA, Harris ST, McClung MR, Olszynski W P, Yuen CK Assessing Fracture Risk and Effects of Osteoporosis Drugs: Bone Mineral Density and Beyond AMERICAN JOURNAL OF MEDICINE (ISSN: 00029343) 122: (11) pp. 992997. ( 2009) Z9: 6 W C: Medicine, General & Internal Folyóiratcikk [12352040] Hanada R, Leibbrandt A, Hanada T, Kitaoka S, Furuyashiki T, Fujihara H, Trichereau J, Paolino M, Qadri F, Plehm R, Klaere S, Komnenovic V, Mimata H, Yoshimatsu H, Takahashi N, von Haeseler A, Bader M, Kilic SS, Ueta Y, Pifl C, Narumiya S, Penninger JM Central control of fever and female body temperature by RANKL/RANK NATURE (ISSN: 00280836) 462: (7272) pp. 505509. ( 2009) Z9: 28 W C: Multidisciplinary Sciences
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 49/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [12352039] 3
Kiechl S, W illeit J, Schett G Denosumab, Osteoporosis, and P revention of Fractures NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 361: (22) pp. 21882189. ( 2009) W C: Medicine, General & Internal Folyóiratcikk [12352038]
4
Santini D, Fratto ME, Vincenzi B, Napoli N, Galluzzo S, Tantardini M, Abbruzzese A, Caraglia M, Tonini G Denosumab: The Era of Targeted Therapies in Bone Metastatic Diseases CURRENT CANCER DRUG TARGETS (ISSN: 15680096) 9: (7) pp. 834842. ( 2009) Z9: 2 W C: Oncology Folyóiratcikk [12352037]
5
Doggrell SA Good clinical endpoints with denosumab in osteoporosis and cancer EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 10: (17) pp. 29392943. ( 2009) W C: Pharmacology & Pharmacy Folyóiratcikk [12352036]
6
Khosla S Increasing Options for the Treatment of Osteoporosis NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 361: (8) pp. 818820. ( 2009) Z9: 15 W C: Medicine, General & Internal Folyóiratcikk [12352035]
7
Ebeling PR METABOLIC BONE DISEASES Translational researchpreventing fractures with denosumab NATURE REVIEWS RHEUMATOLOGY (ISSN: 17594790) 5: (12) pp. 660661. ( 2009) Z9: 2 W C: Rheumatology Folyóiratcikk [12352034]
8
AlShamahi A, Kirkham K, Hookes L Odanacatib, a cathepsin K inhibitor for the treatment of osteoporosis and other skeletal disorders associated with excessive bone remodeling IDRUGS (ISSN: 13697056) 12: (12) pp. 799809. ( 2009) W C: Pharmacology & Pharmacy Folyóiratcikk [12352033]
9
Cesareo R, Napoletano C, Iozzino M, De Rosa B, Iarussi G, Scona M, Romitelli F Osteoporosis: recent physiopatologic acquisitions and new therapeutic perspectives MINERVA ENDOCRINOLOGICA (ISSN: 03911977) 34: (3) pp. 255262. ( 2009) W C: Endocrinology & Metabolism Folyóiratcikk [12352032]
10
Gennari L, Merlotti D, Nuti R P ERSP ECTIVES IN THE TREATMENT AND P REVENTION OF OSTEOP OROSIS DRUGS OF TODAY (ISSN: 16993993) 45: (8) pp. 629647. ( 2009) Z9: 5 W C: Pharmacology & Pharmacy Folyóiratcikk [12352031]
11
Saag KG, Geusens P P rogress in osteoporosis and fracture prevention: focus on postmenopausal women ARTHRITIS RESEARCH & THERAPY (ISSN: 14786354) 11: (5) P aper 251. (2009) Z9: 11 W C: Rheumatology Folyóiratcikk [12352030]
12
Geusens P Strategies for treatment to prevent fragility fractures in postmenopausal women BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (ISSN: 15216942) 23: (6) pp. 727740. ( 2009) Z9: 2 W C: Rheumatology Folyóiratcikk [12352029]
13
Lewiecki EM, Bilezikian JP, Laster AJ, Miller PD, Recker RR, Russell RGG, W hyte MP 2009 Santa Fe Bone Symposium JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 13: (Santa Fe, NM) pp. 19. ( 2010) Z9: 6 W C: Endocrinology & Metabolism Folyóiratcikk [12352028]
14
Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie W D 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary CANADIAN MEDICAL ASSOCIATION JOURNAL (ISSN: 08203946) 182: (17) pp. 18641873. ( 2010) CA: Sci Advisory Council Osteoporosis Z9: 52 W C: Medicine, General & Internal Folyóiratcikk [12352027]
15
Le Goff B, Guillot P, Glemarec J, Berthelot JM, Maugars Y A Comparison Between Bisphosphonates and Other Treatments for Osteoporosis CURRENT PHARMACEUTICAL DESIGN (ISSN: 13816128) 16: (27) pp. 30373044. ( 2010) Z9: 2 W C: Pharmacology & Pharmacy Folyóiratcikk [12352026]
16
Rove KO, Flaig TW A Renaissance in the Medical Treatment of Advanced P rostate Cancer ONCOLOGYNEW YORK (ISSN: 08909091) 24: (14) pp. 13081318. ( 2010) Z9: 2 W C: Oncology Folyóiratcikk [12352025]
17
W eiss AJ, Lipshtat A, Mechanick JI A systems approach to bone pathophysiology In: MOLECULAR AND INTEGRATIVE PHYSIOLOGY OF THE MUSCULOSKELETAL SYSTEM. Malden: Whiley Blackwell, 2010. pp. 9 24. (Annals of the New York Academy of Sciences)
BE: Mechanick, JI : Sun, L : Zaidi, M W C: Multidisciplinary Sciences Könyvrészlet /Könyvfejezet [12352024] 18
Orcel P Advances treatment of osteoporosis: new molecules, new strategies
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 50/342
3/30/2015
nyomtatobarat forma BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE (ISSN: 00014079) 194: (8) pp. 15051516. ( 2010) W C: Medicine, General & Internal Folyóiratcikk [12352023] 19
Hamdy RC, Baim S, Broy SB, Lewiecki EM, Morgan SL, Tanner SB, W illiamson HF Algorithm for the Management of Osteoporosis SOUTHERN MEDICAL JOURNAL (ISSN: 00384348) 103: (10) pp. 10091015. ( 2010) Z9: 1 W C: Medicine, General & Internal Folyóiratcikk [12352022]
20
Szekanecz Z, Szanto S, Szabo Z, Vancsa A, Szamosi S, Bodnar N, Szucs G Biologics beyond the joints AUTOIMMUNITY REVIEWS (ISSN: 15689972) 9: (12) pp. 820824. ( 2010) Z9: 6 W C: Immunology Folyóiratcikk [12352021]
21
Lieb W , Gona P, Larson MG, Massaro JM, Lipinska I, Keaney JF, Rong JA, Corey D, Hoffmann U, Fox CS, Vasan RS, Benjamin EJ, O'Donnell CJ, Kathiresan S Biomarkers of the Osteoprotegerin P athway Clinical Correlates, Subclinical Disease, Incident Cardiovascular Disease, and Mortality ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (ISSN: 10795642) 30: (9) pp. 1849U386. ( 2010) Z9: 18 W C: Hematology; Peripheral Vascular Disease Folyóiratcikk [12352020]
22
Roelofs AJ, Thompson K, Ebetino FH, Rogers MJ, Coxon FP Bisphosphonates: Molecular Mechanisms of Action and Effects on Bone Cells, Monocytes and Macrophages CURRENT PHARMACEUTICAL DESIGN (ISSN: 13816128) 16: (27) pp. 29502960. ( 2010) Z9: 16 W C: Pharmacology & Pharmacy Folyóiratcikk [12352019]
23
Lattouf JB, Saad F Bone complications of androgen deprivation therapy: screening, prevention, and treatment CURRENT OPINION IN UROLOGY (ISSN: 09630643) 20: (3) pp. 247252. ( 2010) Z9: 6 W C: Urology & Nephrology Folyóiratcikk [12352018]
24
Balducci L Bone Complications of Cancer Treatment in the Elderly ONCOLOGYNEW YORK (ISSN: 08909091) 24: (8) pp. 741747. ( 2010) Z9: 1 W C: Oncology Folyóiratcikk [12352017]
25
Karmakar S, Kay J, Gravallese EM Bone Damage in Rheumatoid Arthritis: Mechanistic Insights and Approaches to P revention RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (ISSN: 0889857X) 36: (2) pp. 385+. ( 2010) Z9: 8 W C: Rheumatology Folyóiratcikk [12352016]
26
Barlow DH, Bouchard P, Brandi ML, Evers JLH, Glasier A, Negri E, Papapoulos SE, Ralston SH, Rizzoli R, Baird DT, Collins J, Benagiano G, Crosignani PG, La Vecchia C, Volpe A Bone fractures after menopause HUMAN REPRODUCTION UPDATE (ISSN: 13554786) 16: (6) pp. 761773. ( 2010) CA: ESHRE Capri W orkshop Grp Z9: 2 W C: Obstetrics & Gynecology; Reproductive Biology Folyóiratcikk [12352015]
27
Lattouf JB, Saad F Bone health in nonmetastatic prostate cancer: what's the big deal? CURRENT ONCOLOGY (TORONTO) (ISSN: 11980052) 17: pp. S49S54. ( 2010) SU: 2 W C: Oncology Folyóiratcikk [12352014]
28
Egerdie B, Saad F Bone health in the prostate cancer patient receiving androgen deprivation therapy: a review of present and future management options CANADIAN UROLOGICAL ASSOCIATION JOURNAL (ISSN: 19116470) 4: (2) pp. 129135. ( 2010) Z9: 2 W C: Urology & Nephrology Folyóiratcikk [12352013]
29
* Eastell R, Newman C, Crossman DC Cardiovascular disease and bone ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (ISSN: 00039861) 503: (1) pp. 7883. ( 2010) Z9: 2 W C: Biochemistry & Molecular Biology; Biophysics Folyóiratcikk [12352012]
30
Eriksen EF Cellular mechanisms of bone remodeling REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (ISSN: 13899155) 11: (4) pp. 219227. ( 2010) Z9: 9 W C: Endocrinology & Metabolism Folyóiratcikk [12352011]
31
Lewiecki EM Clinical use of denosumab for the treatment for postmenopausal osteoporosis CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 26: (12) pp. 28072812. ( 2010) W C: Medicine, General & Internal; Medicine, Research & Experimental Folyóiratcikk [12352010]
32
Anonymous Denosumab AUSTRALIAN PRESCRIBER (ISSN: 03128008) 33: (6) pp. 194194. ( 2010) W C: Medicine, General & Internal; Pharmacology & Pharmacy Folyóiratcikk [12352008]
33
Rizzoli R, Yasothan U, Kirkpatrick P Denosumab NATURE REVIEWS DRUG DISCOVERY (ISSN: 14741776) 9: (8) pp. 591592. ( 2010) Z9: 7 W C: Biotechnology & Applied Microbiology; Pharmacology & Pharmacy Folyóiratcikk [12352009]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 51/342
3/30/2015
nyomtatobarat forma 34
Lewiecki EM Denosumab an emerging treatment for postmenopausal osteoporosis EXPERT OPINION ON BIOLOGICAL THERAPY (ISSN: 14712598) 10: (3) pp. 467476. ( 2010) Z9: 4 W C: Biotechnology & Applied Microbiology; Medicine, Research & Experimental Folyóiratcikk [12352007]
35
Anonymous Denosumab (P rolia) for P ostmenopausal Osteoporosis MEDICAL LETTER ON DRUGS AND THERAPEUTICS (ISSN: 0025732X) 52: (1349) pp. 8182. ( 2010) W C: Pharmacology & Pharmacy Folyóiratcikk [12352006]
36
Stopeck AT, Lipton A, Body JJ, Steger GG, Tonkin K, de Boer RH, Lichinitser M, Fujiwara Y, Yardley DA, Viniegra M, Fan M, Jiang Q, Dansey R, Jun S, Braun A Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in P atients With Advanced Breast Cancer: A Randomized, DoubleBlind Study JOURNAL OF CLINICAL ONCOLOGY (ISSN: 0732183X) 28: (35) pp. 51325139. ( 2010) Z9: 112 W C: Oncology Folyóiratcikk [12352005]
37
Singer A, Grauer A Denosumab for the Management of P ostmenopausal Osteoporosis POSTGRADUATE MEDICINE (ISSN: 00325481) 122: (6) pp. 176187. ( 2010) W C: Medicine, General & Internal Folyóiratcikk [12352004]
38
39
40
* Genant HK, Engelke K, Hanley DA, Brown JP, Omizo M, Bone HG, Kivitz AJ, Fuerst T, W ang H, Austin M, Libanati C Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density BONE (ISSN: 87563282) 47: (1) pp. 131139. ( 2010) Z9: 12 W C: Endocrinology & Metabolism Folyóiratcikk [12352003] Muir VJ, Scott LJ Denosumab In Cancer TreatmentInduced Bone Loss BIODRUGS (ISSN: 11738804) 24: (6) pp. 379386. ( 2010) Z9: 3 W C: Oncology; Immunology; Pharmacology & Pharmacy Folyóiratcikk [12352002] * Boonen S, Lippuner K, Adachi JD, Cummings S, Man Z, Farrerons J, Torring O, Gallagher JC, Franchimont N, Martin JS, W ang A, McClung M DENOSUMAB REDUCED THE INCIDENCE OF HIP AND NEW VERTEBRAL FRACTURES IN P OSTMENOP AUSAL WOMEN WITH HIGHER FRACTURE RISK: A SUBANALYSIS OF THE FREEDOM STUDY OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (Singapore, SINGAP ORE) pp. S746S747. ( 2010) SU: 5 W C: Endocrinology & Metabolism Folyóiratcikk [12352001]
41
Fornier MN Denosumab: Second Chapter in Controlling Bone Metastases or a New Book? JOURNAL OF CLINICAL ONCOLOGY (ISSN: 0732183X) 28: (35) pp. 51275131. ( 2010) Z9: 4 W C: Oncology Folyóiratcikk [12352000]
42
Karaguzel G, Holick MF Diagnosis and treatment of osteopenia REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (ISSN: 13899155) 11: (4) pp. 237251. ( 2010) Z9: 1 W C: Endocrinology & Metabolism Folyóiratcikk [12351999]
43
Halloran BP, W ronski TJ, VonHerzen DC, Chu VV, Xia XC, Pingel JE, W illiams AA, Smith BJ Dietary Dried P lum Increases Bone Mass in Adult and Aged Male Mice JOURNAL OF NUTRITION (ISSN: 00223166) 140: (10) pp. 17811787. ( 2010) Z9: 1 W C: Nutrition & Dietetics Folyóiratcikk [12351998]
44
* Bolland MJ, Grey AB, Gamble GD, Reid IR Effect of Osteoporosis Treatment on Mortality: A MetaAnalysis JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 95: (3) pp. 11741181. ( 2010) Z9: 34 W C: Endocrinology & Metabolism Folyóiratcikk [12351997]
45
* Brown JP, Dempster DW , Ding B, Dent R, San Martin J, W agman RB EFFECTS OF DENOSUMAB DISCONTINUATION ON BONE HISTOLOGY AND HISTOMORP HOMETRY OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (Florence, ITALY) pp. 134135. ( 2010) SU: 1 W C: Endocrinology & Metabolism Folyóiratcikk [12351996]
46
* Reid IR, Miller PD, Brown JP, Kendler DL, FahrleitnerPammer A, Valter I, Maasalu K, Bolognese MA, W oodson G, Bone H, Ding BY, W agman RB, Martin JS, Ominsky MS, Dempster DW Effects of Denosumab on Bone Histomorphometry: The FREEDOM and STAND Studies JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 25: (10) pp. 22562265. ( 2010) CA: Denosumab Phase 3 Bone Histology Z9: 26 W C: Endocrinology & Metabolism Folyóiratcikk [12351995]
47
Freemantle N, DiezPerez A, Cooper C, Man H, Shepherd S, Badamgarav E, Gitlin M, Roux C EFFICACY OF DENOSUMAB RELATIVE TO OTHER OSTEOP OROSIS THERAP IES FOR P REVENTION OF FRACTURES IN P OSTMENOP AUSAL OSTEOP OROSIS: RESULTS OF AN ADJUSTED INDIRECT AND MIXED TREATMENT COMP ARISON OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (Florence, ITALY) pp. 1718. ( 2010) SU: 1 W C: Endocrinology & Metabolism Folyóiratcikk [12351994]
48
Olivieri I, D'Angelo S, Palazzi C, Lubrano E, Leccese P Emerging drugs for psoriatic arthritis EXPERT OPINION ON EMERGING DRUGS (ISSN: 14728214) 15: (3) pp. 399414. ( 2010)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 52/342
3/30/2015
nyomtatobarat forma Z9: 1 W C: Pharmacology & Pharmacy Folyóiratcikk [12351993] 49
Allen JG, Fotsch C, Babij P Emerging Targets in Osteoporosis Disease Modification JOURNAL OF MEDICINAL CHEMISTRY (ISSN: 00222623) 53: (11) pp. 43324353. ( 2010) Z9: 4 W C: Chemistry, Medicinal Folyóiratcikk [12351992]
50
Rose AAN, Siegel PM Emerging therapeutic targets in breast cancer bone metastasis FUTURE ONCOLOGY (ISSN: 14796694) 6: (1) pp. 5574. ( 2010) Z9: 18 W C: Oncology Folyóiratcikk [12351991]
51
Hubold C, Monig H, Lehnert H Endocrinology 2010 What's new? DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (ISSN: 00120472) 135: (2526) pp. 12951298. ( 2010) W C: Medicine, General & Internal Folyóiratcikk [12351990]
52
Body JJ, Bergmann P, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, Kaufman JM, Rozenberg S, Reginster JY Evidencebased guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (10) pp. 16571680. ( 2010) Z9: 16 W C: Endocrinology & Metabolism Folyóiratcikk [12351989]
53
* Bone HG, Papapoulos S, Brandi ML, Brown JP, Chapurlat R, Czerwinski E, Daizadeh N, Grauer A, Haller C, Krieg MA, Libanati C, Man Z, Mellstrom D, Radominski S, Reginster JY, Resch H, Roman JA, Roux C, Cummings S FREEDOM TRIAL FIRSTYEAR EXTENSION: RESULTS FROM 4 YEARS OF DENOSUMAB EXP OSURE IN WOMEN WITH P OSTMENOP AUSAL OSTEOP OROSIS OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (Singapore, SINGAP ORE) pp. S668S669. ( 2010) SU: 5 W C: Endocrinology & Metabolism Folyóiratcikk [12351988]
54
Onishi T, Hayashi N, Theriault RL, Hortobagyi GN, Ueno NT Future directions of bonetargeted therapy for metastatic breast cancer NATURE REVIEWS CLINICAL ONCOLOGY (ISSN: 17594774) 7: (11) pp. 641651. ( 2010) Z9: 13 W C: Oncology Folyóiratcikk [12351987]
55
Douni E Genetically modified animal models and Osteoimmunology JOURNAL OF THE HELLENIC VETERINARY MEDICAL SOCIETY (ISSN: 17922720) 61: (3) pp. 236240. ( 2010) W C: Veterinary Sciences Folyóiratcikk [12351986]
56
Li W F, Hou SX, Yu B, Li MM, Ferec C, Chen JM Genetics of osteoporosis: accelerating pace in gene identification and validation HUMAN GENETICS (ISSN: 03406717) 127: (3) pp. 249285. ( 2010) Z9: 17 W C: Genetics & Heredity Folyóiratcikk [12351985]
57
Li W F, Hou SX, Yu B, Jin D, Ferec C, Chen JM Genetics of osteoporosis: perspectives for personalized medicine PERSONALIZED MEDICINE (ISSN: 17410541) 7: (6) pp. 655668. ( 2010) W C: Pharmacology & Pharmacy Folyóiratcikk [12351984]
58
Paternoster L, Lorentzon M, Vandenput L, Karlsson MK, Ljunggren O, Kindmark A, Mellstrom D, Kemp JP, Jarett CE, Holly JMP, Sayers A, St Pourcain B, Timpson NJ, Deloukas P, Smith GD, Ring SM, Evans DM, Tobias JH, Ohlsson C GenomeWide Association MetaAnalysis of Cortical Bone Mineral Density Unravels Allelic Heterogeneity at the RANKL Locus and P otential P leiotropic Effects on Bone PLOS GENETICS (ISSN: 15537390) 6: (11) P aper e1001217. (2010) Z9: 6 W C: Genetics & Heredity Folyóiratcikk [12351983]
59
Morley JE Hip Fractures JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (ISSN: 15258610) 11: (2) pp. 8183. ( 2010) Z9: 13 W C: Geriatrics & Gerontology Folyóiratcikk [12351982]
60
Gallacher SJ, Dixon T Impact of Treatments for P ostmenopausal Osteoporosis (Bisphosphonates, P arathyroid Hormone, Strontium Ranelate, and Denosumab) on Bone Quality: A Systematic Review CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 87: (6) pp. 469484. ( 2010) Z9: 4 W C: Endocrinology & Metabolism Folyóiratcikk [12351981]
61
Toulis KA, Anastasilakis AD Increased risk of serious infections in women with osteopenia or osteoporosis treated with denosumab OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (11) pp. 19631964. ( 2010) Z9: 8 W C: Endocrinology & Metabolism Folyóiratcikk [12351980]
62
Shao JS, Cheng SL, Sadhu J, Towler DA Inflammation and the Osteogenic Regulation of Vascular Calcification A Review and P erspective HYPERTENSION (ISSN: 0194911X) 55: (3) pp. 579592. ( 2010) Z9: 31 W C: Peripheral Vascular Disease Folyóiratcikk [12351979]
63
KalantarZadeh K, Shah A, Duong U, Hechter RC, Dukkipati R, Kovesdy CP Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals KIDNEY INTERNATIONAL (ISSN: 00852538) 78: (Brooklyn, NY) pp. S10S21. ( 2010)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 53/342
3/30/2015
nyomtatobarat forma Z9: 4 SU: 117 W C: Urology & Nephrology Folyóiratcikk [12351978] 64
Plenge RM, Raychaudhuri S Leveraging Human Genetics to Develop Future Therapeutic Strategies in Rheumatoid Arthritis RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (ISSN: 0889857X) 36: (2) pp. 259+. ( 2010) Z9: 2 W C: Rheumatology Folyóiratcikk [12351977]
65
Hall MP, Gegg C, W alker K, Spahr C, Ortiz R, Patel V, Yu S, Zhang LA, Lu H, DeSilva B, Lee JW LigandBinding Mass Spectrometry to Study Biotransformation of Fusion P rotein Drugs and Guide Immunoassay Development: Strategic Approach and Application to P eptibodies Targeting the Thrombopoietin Receptor AAPS JOURNAL (ISSN: 15507416) 12: (4) pp. 576585. ( 2010) Z9: 4 W C: Pharmacology & Pharmacy Folyóiratcikk [12351976]
66
Pazianas Michael, Cooper Cyrus, Ebetino F Hal, Russell R Graham G Longterm treatment with bisphosphonates and their safety in postmenopausal osteoporosis THERAPEUTICS AND CLINICAL RISK MANAGEMENT (ISSN: 1178203X) 6: pp. 325343. ( 2010) Folyóiratcikk [14595248]
67
Oyen J, Gjesdal CG, Brudvik C, Hove LM, Apalset EM, Gulseth HC, Haugeberg G Lowenergy distal radius fractures in middleaged and elderly men and womenthe burden of osteoporosis and fracture risk OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (7) pp. 12571267. ( 2010) Z9: 10 W C: Endocrinology & Metabolism Folyóiratcikk [12351975]
68
Ip TP, Leung J, Kung AW C Management of osteoporosis in patients hospitalized for hip fractures OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: pp. S605S614. ( 2010) Z9: 1 SU: 4 W C: Endocrinology & Metabolism Folyóiratcikk [12351974]
69
* Bonnick SL, Harris ST, Kendler DL, McClung MR, Silverman SL Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society MENOPAUSETHE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (ISSN: 10723714) 17: (1) pp. 2554. ( 2010) CA: N Amer Menopause Soc Z9: 29 W C: Obstetrics & Gynecology Folyóiratcikk [12351973]
70
Rizzoli R Management of the oldest old with osteoporosis EUROPEAN GERIATRIC MEDICINE (ISSN: 18787649) 1: (1) pp. 1521. ( 2010) W C: Geriatrics & Gerontology Folyóiratcikk [12351972]
71
Vondracek SF Managing osteoporosis in postmenopausal women AMERICAN JOURNAL OF HEALTHSYSTEM PHARMACY (ISSN: 10792082) 67: (7) pp. S9S19. ( 2010) Z9: 4 SU: 3 W C: Pharmacology & Pharmacy Folyóiratcikk [12351971]
72
Kyrgidis A, Triaridis S Methods and Biostatistics: a concise guide for peer reviewers HIPPOKRATIA (ISSN: 11084189) 14: (1) pp. 1322. ( 2010) Z9: 2 SU: 1 W C: Medicine, General & Internal Folyóiratcikk [12351970]
73
* Seeman E, Delmas PD, Hanley DA, Sellmeyer D, Cheung AM, Shane E, Kearns A, Thomas T, Boyd SK, Boutroy S, Bogado C, Majumdar S, Fan M, Libanati C, Zanchetta J Microarchitectural Deterioration of Cortical and Trabecular Bone: Differing Effects of Denosumab and Alendronate JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 25: (8) pp. 18861894. ( 2010) Z9: 31 W C: Endocrinology & Metabolism Folyóiratcikk [12351969]
74
Gallagher JC, Sai AJ Molecular biology of bone remodeling: Implications for new therapeutic targets for osteoporosis MATURITAS (ISSN: 03785122) 65: (4) pp. 301307. ( 2010) Z9: 11 W C: Geriatrics & Gerontology; Obstetrics & Gynecology Folyóiratcikk [12351968]
75
Rozenberg S New therapeutic targets and agents for osteoporosis MATURITAS (ISSN: 03785122) 65: (4) pp. 299300. ( 2010) W C: Geriatrics & Gerontology; Obstetrics & Gynecology Folyóiratcikk [12351967]
76
Canalis E NEW TREATMENT MODALITIES IN OSTEOP OROSIS ENDOCRINE PRACTICE (ISSN: 1530891X) 16: (Boston, MA) pp. 855863. ( 2010) Z9: 3 W C: Endocrinology & Metabolism Folyóiratcikk [12351966]
77
Roux S New treatment targets in osteoporosis JOINT BONE SPINE (ISSN: 1297319X) 77: (3) pp. 222228. ( 2010) Z9: 6 W C: Rheumatology Folyóiratcikk [12351965]
78
Paternoster L, Ohlsson C, Sayers A, Vandenput L, Lorentzon M, Evans DM, Tobias JH OP G and RANK P olymorphisms Are Both Associated with Cortical Bone Mineral Density: Findings from a Metaanalysis of the Avon Longitudinal Study of P arents and Children and Gothenburg Osteoporosis and Obesity Determinants Cohorts JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 95: (8) pp. 39403948. ( 2010) Z9: 8 W C: Endocrinology & Metabolism Folyóiratcikk [12351964]
79
Dotan E, Goldstein LJ
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 54/342
3/30/2015
nyomtatobarat forma Optimizing Chemotherapy Regimens for P atients With EarlyStage Breast Cancer CLINICAL BREAST CANCER (ISSN: 15268209) 10: pp. E8E15. ( 2010) Z9: 1 SU: 1 W C: Oncology Folyóiratcikk [12351963] 80
* Henriksen K, BayJensen AC, Christiansen C, Karsdal MA Oral salmon calcitonin pharmacology in osteoporosis EXPERT OPINION ON BIOLOGICAL THERAPY (ISSN: 14712598) 10: (11) pp. 16171629. ( 2010) Z9: 6 W C: Biotechnology & Applied Microbiology; Medicine, Research & Experimental Folyóiratcikk [12351962]
81
Schramek D, Leibbrandt A, Sigl V, Kenner L, Pospisilik JA, Lee HJ, Hanada R, Joshi PA, Aliprantis A, Glimcher L, Pasparakis M, Khokha R, Ormandy CJ, W idschwendter M, Schett G, Penninger JM Osteoclast differentiation factor RANKL controls development of progestindriven mammary cancer NATURE (ISSN: 00280836) 468: (7320) pp. 98+. ( 2010) Z9: 49 W C: Multidisciplinary Sciences Folyóiratcikk [12351961]
82
Koide M, Kinugawa S, Takahashi N, Udagawa N Osteoclastic bone resorption induced by innate immune responses PERIODONTOLOGY 2000 (ISSN: 09066713) 54: pp. 235246. ( 2010) Z9: 4 W C: Dentistry, Oral Surgery & Medicine Folyóiratcikk [12351960]
83
Bolster MB Osteoporosis and Bone Health in P atients with Lung Disease CLINICS IN CHEST MEDICINE (ISSN: 02725231) 31: (3) pp. 555+. ( 2010) W C: Respiratory System Folyóiratcikk [12351959]
84
Braun J, Pfeilschifter J Osteoporosis diagnosis and therapy according to the 2010 guidelines ZEITSCHRIFT FÜR RHEUMATOLOGIE (ISSN: 03401855) 69: (4) pp. 327338. ( 2010) Z9: 4 W C: Rheumatology Folyóiratcikk [12351958]
85
Resch H Osteoporosis: NewGeneration Drugs BREAST CARE (ISSN: 16613791) 5: (5) pp. 313319. ( 2010) Z9: 1 W C: Oncology; Obstetrics & Gynecology Folyóiratcikk [12351957]
86
Caidahl K, Ueland T, Aukrust P Osteoprotegerin: A Biomarker With Many Faces ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (ISSN: 10795642) 30: (9) pp. 16841686. ( 2010) Z9: 2 W C: Hematology; Peripheral Vascular Disease Folyóiratcikk [12351956]
87
Hanada R, Hanada T, Penninger JM P hysiology and pathophysiology of the RANKL/RANK system BIOLOGICAL CHEMISTRY (ISSN: 14316730) 391: (12) pp. 13651370. ( 2010) Z9: 6 W C: Biochemistry & Molecular Biology Folyóiratcikk [12351955]
88
Rosen CJ, Khosla S P laceboControlled Fracture Trials in Osteoporosis P roceeding with Caution NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 363: (14) pp. 13651367. ( 2010) Z9: 8 W C: Medicine, General & Internal Folyóiratcikk [12351954]
89
Hiligsmann M, Reginster JY P otential costeffectiveness of denosumab for the treatment of postmenopausal osteoporotic women BONE (ISSN: 87563282) 47: (1) pp. 3440. ( 2010) Z9: 7 W C: Endocrinology & Metabolism Folyóiratcikk [12351953]
90
Almehed K, Hetenyi S, Ohlsson C, Carlsten H, Forsbladd'Elia H P revalence and risk factors of vertebral compression fractures in female SLE patients ARTHRITIS RESEARCH & THERAPY (ISSN: 14786354) 12: (4) P aper R153. (2010) W C: Rheumatology Folyóiratcikk [12351952]
91
Nanes MS P reventing Metastases to Bone: Denosumab or Bisphosphonates? JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 25: (3) pp. 437439. ( 2010) Z9: 1 W C: Endocrinology & Metabolism Folyóiratcikk [12351951]
92
Habib Z, Camacho P P rimary hyperparathyroidism: an update CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (ISSN: 1752296X) 17: (6) pp. 554560. ( 2010) Z9: 1 W C: Endocrinology & Metabolism Folyóiratcikk [12351950]
93
Dai Zhehao, Dai Ruchun, Xiao Yi P rogress in antiosteoporosis drug treatment Chinese Journal of Osteoporosis (ISSN: 10067108) 16: (11) pp. 894906. ( 2010) Folyóiratcikk [14595247]
94
George S, Brenner A, Sarantopoulos J, Bukowski RM RANK Ligand: Effects of Inhibition CURRENT ONCOLOGY REPORTS (ISSN: 15233790) 12: (2) pp. 8086. ( 2010) Z9: 6 W C: Oncology Folyóiratcikk [12351949]
95
Trouvin AP, Goeb V
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 55/342
3/30/2015
nyomtatobarat forma Receptor activator of nuclear factorkappa B ligand and osteoprotegerin: maintaining the balance to prevent bone loss CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 5: pp. 345354. ( 2010) Z9: 4 W C: Geriatrics & Gerontology Folyóiratcikk [12351948] 96
Shifren JL, Schiff I Role of Hormone Therapy in the Management of Menopause OBSTETRICS AND GYNECOLOGY (ISSN: 00297844) 115: (4) pp. 839855. ( 2010) Z9: 15 W C: Obstetrics & Gynecology Folyóiratcikk [12351947]
97
Mortimer JE, Pal SK Safety Considerations for Use of BoneTargeted Agents in P atients With Cancer SEMINARS IN ONCOLOGY (ISSN: 00937754) 37: (3) pp. S66S72. ( 2010) Z9: 1 SU: 1 W C: Oncology Folyóiratcikk [12351946]
98
Jules J, Ashley JW , Feng X Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis EXPERT OPINION ON THERAPEUTIC TARGETS (ISSN: 14728222) 14: (9) pp. 923934. ( 2010) Z9: 4 W C: Pharmacology & Pharmacy Folyóiratcikk [12351945]
99
Kaltsas G, Makras P Skeletal Diseases in Cushing's Syndrome: Osteoporosis versus Arthropathy NEUROENDOCRINOLOGY (ISSN: 00283835) 92: (Naples, ITALY) pp. 6064. ( 2010) Z9: 2 SU: 1 W C: Endocrinology & Metabolism; Neurosciences Folyóiratcikk [12351944]
100
Resnick J, Gupta N, W agner J, Costa G, Cruz RJ, Martin L, Koritsky DA, Perera S, Matarese L, Eid K, Schuster B, Roberts M, Greenspan S, AbuElmagd K Skeletal Integrity and Visceral Transplantation AMERICAN JOURNAL OF TRANSPLANTATION (ISSN: 16006135) 10: (10) pp. 23312340. ( 2010) Z9: 2 W C: Surgery; Transplantation Folyóiratcikk [12351943]
101
Liu CZ, W alter TS, Huang P, Zhang SQ, Zhu XK, W u Y, W edderburn LR, Tang PF, Owens RJ, Stuart DI, Ren JS, Gao B Structural and Functional Insights of RANKLRANK Interaction and Signaling JOURNAL OF IMMUNOLOGY (ISSN: 00221767) 184: (12) pp. 69106919. ( 2010) Z9: 10 W C: Immunology Folyóiratcikk [12351942]
102
Ta HM, Nguyen GTT, Jin HM, Choi J, Park H, Kim N, Hwang HY, Kim KK Structurebased development of a receptor activator of nuclear factorkappa B ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (ISSN: 0027 8424) 107: (47) pp. 2028120286. ( 2010) Z9: 4 W C: Multidisciplinary Sciences Folyóiratcikk [12351941]
103 * Rizzoli R, Boonen S, Bone HG, Minisola S, W ang A, Benhamou CL, Halse J, Hoeck H, Siddhanti S, McClung M, Franchimont N THE EFFECT OF DENOSUMAB ON VERTEBRAL FRACTURE RISK BY TYP E AND SUBGROUP : RESULTS FROM THE FREEDOM TRIAL OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (Florence, ITALY) pp. 357358. ( 2010) SU: 1 W C: Endocrinology & Metabolism Folyóiratcikk [12351940] 104 * Miller PD, Lewiecki EM, Bolognese MA, W einstein R, Ding B, W agman RB, Martin JS, McClung M The Effects of Short and LongTerm Denosumab Treatment on CTX P rofile: Results from 6 Years of Continuous Denosumab Administration. ENDOCRINE REVIEWS (ISSN: 0163769X) 31: (Suppl 1) p. 1. ( 2010) 92nd Meeting and Expo of the Endocrine Society ( ENDO 2010) Location: San Diego, CA Date: JUN 1922, 2010 Folyóiratcikk /Absztrakt /Tudományos [12351939] 105
Stein CM, Ray W A The Ethics of P lacebo in Studies with Fracture End P oints in Osteoporosis. NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 363: (14) pp. 13671370. ( 2010) Z9: 4 W C: Medicine, General & Internal Folyóiratcikk [12351938]
106
Maraldo MV, Vestergaard P, McMurdo MET, Schwarz P The evidence for antiresorptive osteoporosis treatment in the elderly and old EUROPEAN GERIATRIC MEDICINE (ISSN: 18787649) 1: (5) pp. 279292. ( 2010) Z9: 2 W C: Geriatrics & Gerontology Folyóiratcikk [12351937]
107
Tremollieres Florence The future of menopausal treatment opposition: current and new SERMs are facing better alternatives In: BenRafael Z (szerk.) : 13th World Congress on Controversies in Obstetrics, Gy necology andInfertility (COGI) Held Jointly with the German Society ofObstetricsandGy necology . Monduzzi, 2010. (ISBN 9788865210390) pp. 6366.
Könyvrészlet /Konferenciaközlemény /Tudományos [14595246] 108
Edwards CJ, W illiams E The role of interleukin6 in rheumatoid arthritisassociated osteoporosis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (8) pp. 12871293. ( 2010) Z9: 7 W C: Endocrinology & Metabolism Folyóiratcikk [12351936]
109
Hashemi J, Mansouri H, Slauterbeck JR, Beynnon BD Tibial P lateau Geometry Is Related to the Risk of Suffering an Anterior Cruciate Ligament Injury JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (ISSN: 1067151X) 18: (10) pp. 639641. ( 2010) W C: Orthopedics; Surgery Folyóiratcikk [12351935] Hadji P, Lippuner K, Concin H, Scharla S, Birkhaeuser M, FahrleitnerPammer A, Finkenstedt G, Jakob F J, Schwarz H,
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 56/342
3/30/2015
nyomtatobarat forma 110
Stute P, Ziller V Treatment of Osteoporosis Selective Estrogen Receptor Modulators (SERMs) and new Options OSTEOLOGIE (ISSN: 10191291) 19: (4) pp. 384391. ( 2010) Folyóiratcikk [14595245]
111
Lewiecki EM Treatment of osteoporosis with denosumab MATURITAS (ISSN: 03785122) 66: (2) pp. 182186. ( 2010) Z9: 10 W C: Geriatrics & Gerontology; Obstetrics & Gynecology Folyóiratcikk [12351934]
112
Guise TA, Brufsky A, Coleman RE Understanding and optimizing bone health in breast cancer CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 26: pp. 620. ( 2010) SU: 3 W C: Medicine, General & Internal; Medicine, Research & Experimental Folyóiratcikk [12351933]
113
Khosla S Update on Estrogens and the Skeleton JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 95: (8) pp. 35693577. ( 2010) Z9: 25 W C: Endocrinology & Metabolism Folyóiratcikk [12351932]
114
Lau Arthur N, Ioannidis George, Potts Yelena, Giangregorio Lora M, Van der Horst MaryLou, Adachi Jonathan D, Papaioannou Alexandra What are the beliefs, attitudes and practices of frontline staff in longterm care (LTC) facilities related to osteoporosis awareness, management and fracture prevention? BMC GERIATRICS (ISSN: 14712318) 10: P aper 73. (2010) Folyóiratcikk [14595244]
115
Miller PD, Derman RJ What is the best balance of benefits and risks among antiresorptive therapies for postmenopausal osteoporosis? OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (11) pp. 17931802. ( 2010) Z9: 8 W C: Endocrinology & Metabolism Folyóiratcikk [12351931]
116
MessingerRapport B What's new in treating older adults? CLEVELAND CLINIC JOURNAL OF MEDICINE (ISSN: 08911150) 77: (11) pp. 770+. ( 2010) W C: Medicine, General & Internal Folyóiratcikk [12351930]
117
Lee C E, Leslie W D, Czaykowski P, Gingerich J, Geirnaert M, Lau Y K J A comprehensive bonehealth management approach for men with prostate cancer receiving androgen deprivation therapy CURRENT ONCOLOGY (ISSN: 11980052) 18: (4) pp. E163E172. ( 2011) Folyóiratcikk [14595266]
118
Rizzoli R A new drug: denosumab EJHP PRACTICE (ISSN: 17819989) 17: (4) pp. 2325. ( 2011) W C: Pharmacology & Pharmacy Folyóiratcikk [12351929]
119
Kumagai Y, Hasunuma T, Padhi D A randomized, doubleblind, placebocontrolled, singledose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of denosumab administered subcutaneously to postmenopausal Japanese women BONE (ISSN: 87563282) 49: (5) pp. 11011107. ( 2011) W C: Endocrinology & Metabolism Folyóiratcikk [12351928]
120
Rizzoli R, Reginster JY, Boonen S, Breart G, DiezPerez A, Felsenberg D, Kaufman JM, Kanis JA, Cooper C Adverse Reactions and DrugDrug Interactions in the Management of Women with P ostmenopausal Osteoporosis CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 89: (2) pp. 91104. ( 2011) Z9: 4 W C: Endocrinology & Metabolism Folyóiratcikk [12351927]
121
Reginster JY Antifracture Efficacy of Currently Available Therapies for P ostmenopausal Osteoporosis DRUGS (ISSN: 00126667) 71: (1) pp. 6578. ( 2011) Z9: 3 W C: Pharmacology & Pharmacy; Toxicology Folyóiratcikk [12351926]
122
Dalerba P Bloodcell banking for workers at the Fukushima Daiichi nuclear power plant LANCET (ISSN: 01406736) 378: (9790) pp. 485485. ( 2011) W C: Medicine, General & Internal Folyóiratcikk [12351925]
123
Coluzzi F, Di Bussolo E, Mandatori I, Mattia C Bone Metastatic Disease: Taking Aim at New Therapeutic Targets CURRENT MEDICINAL CHEMISTRY (ISSN: 09298673) 18: (20) pp. 30933115. ( 2011) Z9: 1 W C: Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology & : Pharmacy Folyóiratcikk [12351924]
124
Maimoun L, Fattal C, Sultan C Bone remodeling and calcium homeostasis in patients with spinal cord injury: a review METABOLISMCLINICAL AND EXPERIMENTAL (ISSN: 00260495) 60: (12) pp. 16551663. ( 2011) W C: Endocrinology & Metabolism Folyóiratcikk [12351923]
125 * Brown JP, Dempster DW , Ding BY, DentAcosta R, San Martin J, Grauer A, W agman RB, Zanchetta J Bone Remodeling in P ostmenopausal Women Who Discontinued Denosumab Treatment: OffTreatment Biopsy Study JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 26: (11) pp. 27372744. ( 2011) Z9: 2 W C: Endocrinology & Metabolism Folyóiratcikk [12351922]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 57/342
3/30/2015
nyomtatobarat forma 126
Lumachi F, Motta R, Cecchin D, Ave S, Camozzi V, Basso SMM, Luisetto G Calcium Metabolism & Hypercalcemia in Adults CURRENT MEDICINAL CHEMISTRY (ISSN: 09298673) 18: (23) pp. 35293536. ( 2011) W C: Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology & : Pharmacy Folyóiratcikk [12351921]
127 * Reid IR, Bolland MJ, Avenell A, Grey A Cardiovascular effects of calcium supplementation OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (6) pp. 16491658. ( 2011) Z9: 9 W C: Endocrinology & Metabolism Folyóiratcikk [12351920] 128
Meier C, Kraenzlin M E Cathepsin K inhibitors in the treatment of osteoporosis OSTEOLOGIE (ISSN: 10191291) 20: (3) pp. 211216. ( 2011) Folyóiratcikk [14595265]
129
Hadji P Clinical considerations for the use of antiresorptive agents in the treatment of metastatic bone disease CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (ISSN: 10408428) 80: (2) pp. 301313. ( 2011) Z9: 3 W C: Oncology; Hematology Folyóiratcikk [12351919]
130
von Keyserlingk C, Hopkins R, Anastasilakis A, Toulis K, Goeree R, Tarride JE, Xie F Clinical Efficacy and Safety of Denosumab in P ostmenopausal Women with Low Bone Mineral Density and Osteoporosis: A MetaAnalysis SEMINARS IN ARTHRITIS AND RHEUMATISM (ISSN: 00490172) 41: (2) pp. 178186. ( 2011) Z9: 1 W C: Rheumatology Folyóiratcikk [12351918]
131
Cole RE Clinical Strategies to Address P atients' Concerns in Osteoporosis Management with Bisphosphonates POSTGRADUATE MEDICINE (ISSN: 00325481) 123: (2) pp. 131144. ( 2011) W C: Medicine, General & Internal Folyóiratcikk [12351917]
132
MessingerRapport BJ, Morley JE, Thomas DR, Gammack JK Clinical Update on Nursing Home Medicine: 2011 JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (ISSN: 15258610) 12: (9) pp. 615626. ( 2011) W C: Geriatrics & Gerontology Folyóiratcikk [12351916]
133
Adler RA, Gill RS Clinical utility of denosumab for treatment of bone loss in men and women CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 6: pp. 119124. ( 2011) Z9: 1 W C: Geriatrics & Gerontology Folyóiratcikk [12351915]
134
FunckBrentano T, Biver E, Chopin F, Bouvard B, Coiffier G, Souberbielle JC, Garnero P, Roux C Clinical Utility of Serum Bone Turnover Markers in P ostmenopausal Osteoporosis Therapy Monitoring: A Systematic Review SEMINARS IN ARTHRITIS AND RHEUMATISM (ISSN: 00490172) 41: (2) pp. 157169. ( 2011) W C: Rheumatology Folyóiratcikk [12351914]
135
Albers J, Schulze J, Beil FT, Gebauer M, Baranowsky A, Keller J, Marshall RP, W intges K, Friedrich FW , Priemel M, Schilling AF, Rueger JM, Cornils K, Fehse B, Streichert T, Sauter G, Jakob F, Insogna KL, Pober B, Knobeloch KP, Francke U, Amling M, Schinke T Control of bone formation by the serpentine receptor Frizzled9 JOURNAL OF CELL BIOLOGY (ISSN: 00219525) 192: (6) pp. 10571072. ( 2011) Z9: 6 W C: Cell Biology Folyóiratcikk [12351913]
136
Szulc P, Hawa G, Boutroy S, Vilayphiou N, Schoppet M, Chapurlat R, Hofbauer LC Cortical Bone Status Is Associated with Serum Osteoprotegerin Concentration in Men: The STRAMBO Study JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 96: (7) pp. 22162226. ( 2011) Z9: 3 W C: Endocrinology & Metabolism Folyóiratcikk [12351912]
137
Hiligsmann M, Reginster JY Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of P ostMenopausal Osteoporotic Women in Belgium PHARMACOECONOMICS (ISSN: 11707690) 29: (10) pp. 895911. ( 2011) Z9: 1 W C: Economics; Health Policy & Services; Pharmacology & Pharmacy Folyóiratcikk [12351911]
138
Borgstrom F, Strom O, Kleman M, McCloskey E, Johansson H, Oden A, Kanis JA Costeffectiveness of bazedoxifene incorporating the FRAXA (R) algorithm in a European perspective OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (3) pp. 955965. ( 2011) Z9: 2 W C: Endocrinology & Metabolism Folyóiratcikk [12351910]
139 * Jonsson B, Strom O, Eisman JA, Papaioannou A, Siris ES, Tosteson A, Kanis JA Costeffectiveness of Denosumab for the treatment of postmenopausal osteoporosis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (3) pp. 967982. ( 2011) Z9: 5 W C: Endocrinology & Metabolism Folyóiratcikk [12351909] 140
Brewer L, W illiams D, Moore A Current and future treatment options in osteoporosis EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (ISSN: 00316970) 67: (4) pp. 321331. ( 2011) W C: Pharmacology & Pharmacy Folyóiratcikk [12351908]
141
Boonen S Current developments and treatments in osteoporosis
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 58/342
3/30/2015
nyomtatobarat forma EJHP PRACTICE (ISSN: 17819989) 17: (4) pp. 1618. ( 2011) W C: Pharmacology & Pharmacy Folyóiratcikk [12351907] 142
Lecart MP, Reginster JY Current options for the management of postmenopausal osteoporosis EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 12: (16) pp. 25332552. ( 2011) W C: Pharmacology & Pharmacy Folyóiratcikk [12351906]
143
Sharif PS, Abdollahi M, Larijani B Current, new and future treatments of osteoporosis RHEUMATOLOGY INTERNATIONAL (ISSN: 01728172) 31: (3) pp. 289300. ( 2011) Z9: 4 W C: Rheumatology Folyóiratcikk [12351905]
144
Kostenuik PJ, Smith SY, Jolette J, Schroeder J, Pyrah I, Ominsky MS Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody BONE (ISSN: 87563282) 49: (2) pp. 151161. ( 2011) Z9: 6 W C: Endocrinology & Metabolism Folyóiratcikk [12351904]
145
Tolman C Denosumab AUSTRALIAN PRESCRIBER (ISSN: 03128008) 34: (3) pp. 6364. ( 2011) W C: Medicine, General & Internal; Pharmacology & Pharmacy Folyóiratcikk [12351902]
146
Dubois EA, Rissmann R, Cohen AF Denosumab BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ISSN: 03065251) 71: (6) pp. 804806. ( 2011) W C: Pharmacology & Pharmacy Folyóiratcikk [12351903]
147
Franek E Denosumab a new option in the treatment of osteoporosis ENDOKRYNOLOGIA POLSKA (ISSN: 0423104X) 62: (1) pp. 7983. ( 2011) Z9: 1 W C: Endocrinology & Metabolism Folyóiratcikk [12351901]
148
Resch H, Trubrich A, Kocijan R, Muschitz Ch Denosumab the RANKLantibody as an example of the biotechnological development OSTEOLOGIE (ISSN: 10191291) 20: (3) pp. 203210. ( 2011) Folyóiratcikk [14595264]
149
Moen MD, Keam SJ Denosumab A Review of its Use in the Treatment of P ostmenopausal Osteoporosis DRUGS & AGING (ISSN: 1170229X) 28: (1) pp. 6382. ( 2011) Z9: 6 W C: Geriatrics & Gerontology; Pharmacology & Pharmacy Folyóiratcikk [12351900]
150
Baron R, Ferrari S, Russell RGG Denosumab and bisphosphonates: Different mechanisms of action and effects BONE (ISSN: 87563282) 48: (4) pp. 677692. ( 2011) Z9: 15 W C: Endocrinology & Metabolism Folyóiratcikk [12351899]
151
Anastasilakis AD, Polyzos SA, Anastasilakis CD, Toulis KA, Makras P Denosumab and bisphosphonates: Rivals or potential "partners"? A "hybrid" molecule hypothesis MEDICAL HYPOTHESES (ISSN: 03069877) 77: (1) pp. 109111. ( 2011) W C: Medicine, Research & Experimental Folyóiratcikk [12351898]
152
Smith MR, Saad F, Egerdie B, Sieber P, Tammela TLJ, Leder BZ, Ke CL, Goessl C Denosumab and Changes in Bone Turnover Markers During Androgen Deprivation Therapy for P rostate Cancer JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 26: (12) pp. 28272833. ( 2011) W C: Endocrinology & Metabolism Folyóiratcikk [12351897]
153
Tsourdi E, Rachner TD, Rauner M, Hamann C, Hofbauer LC Denosumab for bone diseases: translating bone biology into targeted therapy EUROPEAN JOURNAL OF ENDOCRINOLOGY (ISSN: 08044643) 165: (6) pp. 833840. ( 2011) Z9: 3 W C: Endocrinology & Metabolism Folyóiratcikk [12351895]
154
Scotland G, W augh N, Royle P, McNamee P, Henderson R, Hollick R Denosumab for the P revention of Osteoporotic Fractures in P ostMenopausal Women A NICE Single Technology Appraisal PHARMACOECONOMICS (ISSN: 11707690) 29: (11) pp. 951961. ( 2011) Z9: 3 W C: Economics; Health Policy & Services; Pharmacology & Pharmacy Folyóiratcikk [12351894]
155
Bridgeman MB, Pathak R Denosumab for the Reduction of Bone Loss in P ostmenopausal Osteoporosis: A Review CLINICAL THERAPEUTICS (ISSN: 01492918) 33: (11) pp. 15471559. ( 2011) W C: Pharmacology & Pharmacy Folyóiratcikk [12351893]
156
Chitre M, Shechter D, Grauer A Denosumab for treatment of postmenopausal osteoporosis AMERICAN JOURNAL OF HEALTHSYSTEM PHARMACY (ISSN: 10792082) 68: (15) pp. 14091418. ( 2011) Z9: 1 W C: Pharmacology & Pharmacy Folyóiratcikk [12351892]
157
Ominsky MS, Stouch B, Schroeder J, Pyrah I, Stolina M, Smith SY, Kostenuik PJ Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 59/342
3/30/2015
nyomtatobarat forma BONE (ISSN: 87563282) 49: (2) pp. 162173. ( 2011) Z9: 3 W C: Endocrinology & Metabolism Folyóiratcikk [12351891] 158 * Bogado CE, Boailchuk JA, Zanchetta MB, Massari FE, Zanchetta JR DENOSUMAB: AN UP DATE DRUGS OF TODAY (ISSN: 16993993) 47: (8) pp. 605613. ( 2011) W C: Pharmacology & Pharmacy Folyóiratcikk [12351890] 159
Ashley JW , McCoy EM, Clements DA, Shi ZQ, Chen TS, Feng X Development of CellBased HighThroughput Assays for the Identification of Inhibitors of Receptor Activator of Nuclear FactorKappa B Signaling ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (ISSN: 1540658X) 9: (1) pp. 4049. ( 2011) W C: Biochemical Research Methods; Pharmacology & Pharmacy Folyóiratcikk [12351889]
160
Gold DT, Horne R, Coon CD, Price MA, Borenstein J, Varon SF, SatramHoang S, Macarios D Development, Reliability, and Validity of a New P reference and Satisfaction Questionnaire VALUE IN HEALTH (ISSN: 10983015) 14: (8) pp. 11091116. ( 2011) W C: Economics; Health Care Sciences & Services; Health Policy & Services Folyóiratcikk [12351888]
161 * Frost ML, Siddique M, Blake GM, Moore AEB, Schleyer PJ, Dunn JT, Somer EJ, Marsden PK, Eastell R, Fogelman I Differential Effects of Teriparatide on Regional Bone Formation Using F18Fluoride P ositron Emission Tomography JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 26: (5) pp. 10021011. ( 2011) Z9: 3 W C: Endocrinology & Metabolism Folyóiratcikk [12351887] 162
FerrariLacraz S, Ferrari S Do RANKL inhibitors (denosumab) affect inflammation and immunity? OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (2) pp. 435446. ( 2011) Z9: 9 W C: Endocrinology & Metabolism Folyóiratcikk [12351886]
163
Khajuria Deepak Kumar, Razdan Rema, Mahapatra D Roy Drugs for the management of osteoporosis: a review REVISTA BRASILEIRA DE REUMATOLOGIA (ISSN: 04825004) 51: (4) pp. 365382. ( 2011) Folyóiratcikk [14595274]
164
Laster AJ, Tanner SB Duration of Treatment in P ostmenopausal Osteoporosis: How Long to Treat and What are the Consequences of Cessation of Treatment? RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (ISSN: 0889857X) 37: (3) pp. 323+. ( 2011) W C: Rheumatology Folyóiratcikk [12351885]
165
Recker Robert R Early postmenopausal bone loss and what to do about it Annals of the New York Academy of Sciences (ISSN: 00778923) 1240: pp. E26E30. ( 2011) BE Zaidi, M Folyóiratcikk [14595263]
166 * Miller PD, W agman RB, Peacock M, Lewiecki EM, Bolognese MA, W einstein RL, Ding BY, Martin JS, McClung MR Effect of Denosumab on Bone Mineral Density and Biochemical Markers of Bone Turnover: SixYear Results of a P hase 2 Clinical Trial JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 96: (2) pp. 394402. ( 2011) Z9: 17 W C: Endocrinology & Metabolism Folyóiratcikk [12351884] 167 * Jamal SA, Hamilton CJ, Eastell R, Cummings SR Effect of Nitroglycerin Ointment on Bone Density and Strength in P ostmenopausal Women A Randomized Trial JAMAJOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (ISSN: 00987484) 305: (8) pp. 800807. ( 2011) Z9: 10 W C: Medicine, General & Internal Folyóiratcikk [12351883] 168 * Mackey DC, Black DM, Bauer DC, McCloskey EV, Eastell R, Mesenbrink P, Thompson JR, Cummings SR Effects of Antiresorptive Treatment on Nonvertebral Fracture Outcomes JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 26: (10) pp. 24112418. ( 2011) W C: Endocrinology & Metabolism Folyóiratcikk [12351882] 169
W ensel TM, Iranikhah MM, W ilborn TW Effects of Denosumab on Bone Mineral Density and Bone Turnover in P ostmenopausal Women PHARMACOTHERAPY (ISSN: 02770008) 31: (5) pp. 510523. ( 2011) W C: Pharmacology & Pharmacy Folyóiratcikk [12351881]
170 * Eastell R, Christiansen C, Grauer A, Kutilek S, Libanati C, McClung MR, Reid IR, Resch H, Siris E, Uebelhart D, W ang A, W eryha G, Cummings SR Effects of Denosumab on Bone Turnover Markers in P ostmenopausal Osteoporosis JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 26: (3) pp. 530537. ( 2011) Z9: 4 W C: Endocrinology & Metabolism Folyóiratcikk [12351880] 171 * Jamal SA, Ljunggren O, StehmanBreen C, Cummings SR, McClung MR, Goemaere S, Ebeling PR, Franek E, Yang YC, Egbuna OI, Boonen S, Miller PD Effects of Denosumab on Fracture and Bone Mineral Density by Level of Kidney Function JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 26: (8) pp. 18291835. ( 2011) Z9: 8 W C: Endocrinology & Metabolism Folyóiratcikk [12351879] 172 * Bone HG, Bolognese MA, Yuen CK, Kendler DL, Miller PD, Yang YC, Grazette L, San Martin J, Gallagher JC Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in P ostmenopausal Women with Low Bone Mass JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 96: (4) pp. 972980. ( 2011)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 60/342
3/30/2015
nyomtatobarat forma Z9: 14 W C: Endocrinology & Metabolism Folyóiratcikk [12351878] 173
Kawai M, Modder UI, Khosla S, Rosen CJ Emerging therapeutic opportunities for skeletal restoration NATURE REVIEWS DRUG DISCOVERY (ISSN: 14741776) 10: (2) pp. 141156. ( 2011) Z9: 6 W C: Biotechnology & Applied Microbiology; Pharmacology & Pharmacy Folyóiratcikk [12351877]
174
Coluzzi F, Mandatori I, Mattia C Emerging therapies in metastatic bone pain EXPERT OPINION ON EMERGING DRUGS (ISSN: 14728214) 16: (3) pp. 441458. ( 2011) W C: Pharmacology & Pharmacy Folyóiratcikk [12351876]
175
Rove KO, Crawford ED Evolution of Treatment Options for P atients With CRP C and Bone Metastases: BoneTargeted Agents That Go Beyond P alliation of Symptoms to Improve Overall Survival ONCOLOGYNEW YORK (ISSN: 08909091) 25: (14) pp. 13621387. ( 2011) W C: Oncology Folyóiratcikk [12351875]
176
Santini D, Perrone G, Roato I, Godio L, Pantano F, Grasso D, Russo A, Vincenzi B, Fratto ME, Sabbatini R, Della Pepa C, Porta C, Del Conte A, Schiavon G, Berruti A, Tomasino RM, Papotti M, Papapietro N, Muda AO, Denaro V, Tonini G Expression P attern of Receptor Activator of NF kappa B (RANK) in a Series of P rimary Solid Tumors and Related Bone Metastases JOURNAL OF CELLULAR PHYSIOLOGY (ISSN: 00219541) 226: (3) pp. 780784. ( 2011) Z9: 12 W C: Cell Biology; Physiology Folyóiratcikk [12351874]
177
Hofbauer LC, Rachner TD, Hamann C From bone to breast and back the bone cytokine RANKL and breast cancer BREAST CANCER RESEARCH (ISSN: 1465542X) 13: (3) P aper 107. (2011) W C: Oncology Folyóiratcikk [12351873]
178
Mitsiades CS, Davies FE, Laubach JP, Joshua D, Miguel JS, Anderson KC, Richardson PG Future Directions of NextGeneration Novel Therapies, Combination Approaches, and the Development of P ersonalized Medicine in Myeloma JOURNAL OF CLINICAL ONCOLOGY (ISSN: 0732183X) 29: (14) pp. 19161923. ( 2011) Z9: 4 W C: Oncology Folyóiratcikk [12351872]
179
Cawthon PM Gender Differences in Osteoporosis and Fractures CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (ISSN: 0009921X) 469: (7) pp. 19001905. ( 2011) Z9: 1 W C: Orthopedics; Surgery Folyóiratcikk [12351871]
180
W einstein RS GlucocorticoidInduced Bone Disease NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 365: (1) pp. 6270. ( 2011) Z9: 10 W C: Medicine, General & Internal Folyóiratcikk [12351870]
181
Narod SA Hormone replacement therapy and the risk of breast cancer NATURE REVIEWS CLINICAL ONCOLOGY (ISSN: 17594774) 8: (11) pp. 669676. ( 2011) Z9: 6 W C: Oncology Folyóiratcikk [12351869]
182
Body JJ HOW TO MANAGE P OSTMENOP AUSAL OSTEOP OROSIS? ACTA CLINICA BELGICA (ISSN: 00015512) 66: (6) pp. 443447. ( 2011) W C: Medicine, General & Internal Folyóiratcikk [12351868]
183
Adachi JD, Josse RG, Russell RGG If you don't take it it can't work: the consequences of not being treated or nonadherence to osteoporosis therapy THERAPEUTICS AND CLINICAL RISK MANAGEMENT (ISSN: 11766336) 7: pp. 181198. ( 2011) W C: Health Care Sciences & Services Folyóiratcikk [12351867]
184
Rizzoli R, Kraenzlin M, Krieg MA, Mellinghoff HU, Lamy O, Lippuner K Indications to teriparatide treatment in patients with osteoporosis SWISS MEDICAL WEEKLY (ISSN: 14247860) 141: P aper w13297. (2011) W C: Medicine, General & Internal Folyóiratcikk [12351866]
185
Korn EL, Freidlin B Inefficacy Interim Monitoring P rocedures in Randomized Clinical Trials: The Need to Report AMERICAN JOURNAL OF BIOETHICS (ISSN: 15265161) 11: (3) pp. 210. ( 2011) Z9: 5 W C: Ethics; History & Philosophy Of Science; Medical Ethics; Social Issues; : Social Sciences, Biomedical Folyóiratcikk [12351865]
186
Iolascon G, Resmini G, Tarantino U Inhibition of RANK ligand: a new option for preventing fragility fractures AGING CLINICAL AND EXPERIMENTAL RESEARCH (ISSN: 15940667) 23: pp. 2829. ( 2011) SU: S W C: Geriatrics & Gerontology Folyóiratcikk [12351864]
187
Tsourdi E, Hofbauer LC Innovations in the treatment of osteoporosis DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (ISSN: 00120472) 136: (48) pp. 24582460. ( 2011) W C: Medicine, General & Internal Folyóiratcikk [12351863]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 61/342
3/30/2015
nyomtatobarat forma 188
Zheng HF, Spector TD, Richards JB Insights into the genetics of osteoporosis from recent genomewide association studies EXPERT REVIEWS IN MOLECULAR MEDICINE (ISSN: 14623994) 13: P aper e28. (2011) W C: Biochemistry & Molecular Biology; Medicine, Research & Experimental Folyóiratcikk [12351862]
189
Terpos E, Dimopoulos MA Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications CANCER IMMUNOLOGY IMMUNOTHERAPY (ISSN: 03407004) 60: (3) pp. 305317. ( 2011) Z9: 3 W C: Oncology; Immunology Folyóiratcikk [12351861]
190
Pulkkinen P, Gluer CC, Jamsa T Investigation of differences between hip fracture types: A worthy strategy for improved risk assessment and fracture prevention BONE (ISSN: 87563282) 49: (4) pp. 600604. ( 2011) W C: Endocrinology & Metabolism Folyóiratcikk [12351860]
191
Devogelaer JP, Boutsen Y, Gruson D, Manicourt D Is There a P lace for Bone Turnover Markers in the Assessment of Osteoporosis and its Treatment? RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (ISSN: 0889857X) 37: (3) pp. 365+. ( 2011) W C: Rheumatology Folyóiratcikk [12351859]
192
Adler RA Management of osteoporosis in men on androgen deprivation therapy MATURITAS (ISSN: 03785122) 68: (2) pp. 143147. ( 2011) Z9: 4 W C: Geriatrics & Gerontology; Obstetrics & Gynecology Folyóiratcikk [12351858]
193 * Vasikaran S, Eastell R, Bruyere O, Foldes AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T, W ahl DA, Cooper C, Kanis JA Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (2) pp. 391420. ( 2011) CA: IOFIFCC Bone Marker Stand W orking Z9: 16 W C: Endocrinology & Metabolism Folyóiratcikk [12351857] 194
Clines GA Mechanisms and treatment of hypercalcemia of malignancy CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (ISSN: 1752296X) 18: (6) pp. 339346. ( 2011) W C: Endocrinology & Metabolism Folyóiratcikk [12351856]
195
Khajuria Deepak Kumar, Razdan Rema, Mahapatra DRoy Medicamentos para o tratamento da osteoporose: revisão: Drugs for the management of osteoporosis: a review Revista Brasileira de Reumatologia (ISSN: 04825004) 51: (4) pp. 372382. ( 2011) Folyóiratcikk [14595273]
196
Hautmann AH, Elad S, Lawitschka A, Greinix H, Bertz H, Halter J, Faraci M, Hofbauer LC, Lee S, W olff D, Holler E Metabolic bone diseases in patients after allogeneic hematopoietic stem cell transplantation: Report from the Consensus Conference on Clinical P ractice in chronic graftversushost disease TRANSPLANT INTERNATIONAL (ISSN: 09340874) 24: (9) pp. 867879. ( 2011) Z9: 3 W C: Surgery; Transplantation Folyóiratcikk [12351855]
197
Guven Z, Celiker R, Atalay A, Bagis S New Agents for the Treatment of Osteoporosis TURKIYE FIZIKSEL TIP VE REHABILITASYON DERGISI / TURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION (ISSN: 13020234) 57: (3) pp. 165171. ( 2011) W C: Rehabilitation Folyóiratcikk [12351854]
198
Silva BC, Bilezikian JP New Approaches to the Treatment of Osteoporosis In: Caskey CT (szerk.) : ANNUAL REVIEW OF MEDICINE, VOL 62, 2011. Palo Alto: Annual Reviews, 2011. pp. 307322. (Annual Review of Medicine)
Könyvrészlet /Szaktanulmány [12351853] 199
Ebeling PR New drugs for osteoporosis AUSTRALIAN PRESCRIBER (ISSN: 03128008) 34: (6) pp. 176181. ( 2011) W C: Medicine, General & Internal; Pharmacology & Pharmacy Folyóiratcikk [12351852]
200
Sobczuk A, Sobczuk K, Pertynski T New strategies of treatment of postmenopausal osteoporosis PRZEGLAD MENOPAUZALNY (ISSN: 16438876) 10: (6) pp. 480486. ( 2011) W C: Obstetrics & Gynecology Folyóiratcikk [12351851]
201
Lewiecki EM New targets for intervention in the treatment of postmenopausal osteoporosis NATURE REVIEWS RHEUMATOLOGY (ISSN: 17594790) 7: (11) pp. 631638. ( 2011) Z9: 1 W C: Rheumatology Folyóiratcikk [12351850]
202
Masud T, Binkley N, Boonen S, Hannan MT Official P ositions for FRAX (R) Clinical Regarding Falls and Frailty: Can Falls and Frailty be Used in FRAX (R)? JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 14: (3) pp. 194204. ( 2011) CA: FRAX Position Dev Conf Members Z9: 2 W C: Endocrinology & Metabolism Folyóiratcikk [12351849]
203
Sipos W , Zysset P, Kostenuik P, Mayrhofer E, Bogdan C, Rauner M, Stolina M, Dwyer D, SommerfeldStur I, Pendl G, Resch H, Dall'Ara E, Varga P, Pietschmann P OP GFc Treatment in Growing P igs Leads to Rapid Reductions in Bone Resorption Markers, Serum Calcium, and Bone
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 62/342
3/30/2015
nyomtatobarat forma Formation Markers HORMONE AND METABOLIC RESEARCH (ISSN: 00185043) 43: (13) pp. 944949. ( 2011) W C: Endocrinology & Metabolism Folyóiratcikk [12351848] 204
McGrath EE OP G/RANKL/RANK P athway as a Therapeutic Target in Cancer JOURNAL OF THORACIC ONCOLOGY (ISSN: 15560864) 6: (9) pp. 14681473. ( 2011) W C: Oncology; Respiratory System Folyóiratcikk [12351847]
205
Berglund J ORTHOP AEDICS Structural support NATURE (ISSN: 00280836) 480: (7377) pp. S56S57. ( 2011) W C: Multidisciplinary Sciences Folyóiratcikk [12351846]
206
Henriksen K, Bollerslev J, Everts V, Karsdal MA Osteoclast Activity and Subtypes as a Function of P hysiology and P athologyImplications for Future Treatments of Osteoporosis ENDOCRINE REVIEWS (ISSN: 0163769X) 32: (1) pp. 3163. ( 2011) Z9: 4 W C: Endocrinology & Metabolism Folyóiratcikk [12351845]
207
Drozdzowska B Osteonecrosis of the jaw ENDOKRYNOLOGIA POLSKA (ISSN: 0423104X) 62: (1) pp. 8892. ( 2011) W C: Endocrinology & Metabolism Folyóiratcikk [12351844]
208
Cortet B Osteoporosis medications and renal failure JOINT BONE SPINE (ISSN: 1297319X) 78: (3) pp. 228229. ( 2011) W C: Rheumatology Folyóiratcikk [12351843]
209
ColonEmeric C, O'Connell MB, Haney E Osteoporosis P iece of MultiMorbidity P uzzle in Geriatric Care MOUNT SINAI JOURNAL OF MEDICINE (ISSN: 00272507) 78: (4) pp. 515526. ( 2011) W C: Medicine, General & Internal Folyóiratcikk [12351842]
210
Grossman JM Osteoporosis prevention CURRENT OPINION IN RHEUMATOLOGY (ISSN: 10408711) 23: (2) pp. 203210. ( 2011) W C: Rheumatology Folyóiratcikk [12351841]
211
Lange U, MullerLadner U, Pfeilschifter J Osteoporosis P rophylaxis, diagnostics and therapy according to the guidelines INTERNIST (ISSN: 00209554) 52: (7) pp. 843852. ( 2011) W C: Medicine, General & Internal Folyóiratcikk [12351840]
212
Ragucci KR, Shrader SP Osteoporosis Treatment An EvidenceBased Approach JOURNAL OF GERONTOLOGICAL NURSING (ISSN: 00989134) 37: (7) pp. 1722. ( 2011) Z9: 1 W C: Geriatrics & Gerontology; Gerontology; Nursing Folyóiratcikk [12351839]
213
Schuiling KD, Robinia K, Nye R Osteoporosis Update JOURNAL OF MIDWIFERY & WOMENS HEALTH (ISSN: 15269523) 56: (6) pp. 615627. ( 2011) Z9: 1 W C: Nursing Folyóiratcikk [12351838]
214 * Lewiecki EM, Bilezikian JP, Khosla S, Marcus R, McClung MR, Miller PD, W atts NB, Maricic M Osteoporosis Update From the 2010 Santa Fe Bone Symposium JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 14: (1) pp. 121. ( 2011) Z9: 2 W C: Endocrinology & Metabolism Folyóiratcikk [12351837] 215
McBane S Osteoporosis: A review of current recommendations and emerging treatment options FORMULARY (ISSN: 1082801X) 46: (10) pp. 432+. ( 2011) W C: Pharmacology & Pharmacy Folyóiratcikk [12351836]
216
Rachner TD, Khosla S, Hofbauer LC Osteoporosis: now and the future LANCET (ISSN: 01406736) 377: (9773) pp. 12761287. ( 2011) Z9: 39 W C: Medicine, General & Internal Folyóiratcikk [12351835]
217
Lane NE Osteoporosis: yesterday, today and tomorrow Rapid progress, but do not forget the simple things RHEUMATOLOGY (ISSN: 14620324) 50: (7) pp. 11811183. ( 2011) W C: Rheumatology Folyóiratcikk [12351834]
218
Labropoulou VT, Theocharis AD, Symeonidis A, Skandalis SS, Karamanos NK, Kalofonos HP P athophysiology and P harmacological Targeting of TumorInduced Bone Disease: Current Status and Emerging Therapeutic Interventions CURRENT MEDICINAL CHEMISTRY (ISSN: 09298673) 18: (11) pp. 15841598. ( 2011) W C: Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology & : Pharmacy Folyóiratcikk [12351833]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 63/342
3/30/2015
nyomtatobarat forma 219
Compston J P athophysiology of atypical femoral fractures and osteonecrosis of the jaw OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (12) pp. 29512961. ( 2011) Z9: 2 W C: Endocrinology & Metabolism Folyóiratcikk [12351832]
220
Sutjandra L, Rodriguez RD, Doshi S, Ma M, Peterson MC, Jang GR, Chow AT, PerezRuixo JJ P opulation P harmacokinetic MetaAnalysis of Denosumab in Healthy Subjects and P ostmenopausal Women with Osteopenia or Osteoporosis CLINICAL PHARMACOKINETICS (ISSN: 03125963) 50: (12) pp. 793807. ( 2011) Z9: 3 W C: Pharmacology & Pharmacy Folyóiratcikk [12351831]
221
W alkerBone K P reventing fractures in the elderly BRITISH JOURNAL OF HOSPITAL MEDICINE (ISSN: 17508460) 72: (10) pp. 576581. ( 2011) W C: Medicine, General & Internal Folyóiratcikk [12351830]
222
Gallagher JC, Levine JP P reventing osteoporosis in symptomatic postmenopausal women MENOPAUSETHE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (ISSN: 10723714) 18: (1) pp. 109 118. ( 2011) Z9: 2 W C: Obstetrics & Gynecology Folyóiratcikk [12351829]
223
Zhong Xuli, Feng Yufei, Zhang Junli P rogress in pharmacological and clinical studies of denesumab,a new bone resorption inhibitorp Chinese Journal New Drugs (ISSN: 10033734) 20: (5) pp. 389392. ( 2011) Folyóiratcikk [14595262]
224
Kong Xianghe, Niu Yinbo, Li Yuhua, Mei Qibing P rogress of Research on the Relationship Between OP G/RANK/RANKL System and Osteoporosis Life Science Research (ISSN: 10077847) 15: (1) pp. 8085. ( 2011) Folyóiratcikk [14595261]
225
Blake GM, Siddique M, Frost ML, Moore AEB, Fogelman I Radionuclide studies of bone metabolism: Do bone uptake and bone plasma clearance provide equivalent measurements of bone turnover? BONE (ISSN: 87563282) 49: (3) pp. 537542. ( 2011) Z9: 2 W C: Endocrinology & Metabolism Folyóiratcikk [12351828]
226
Silva I, Branco JC RANK/RANKL/OP G: LITERATURE REVIEW ACTA REUMATOLOGICA PORTUGUESA (ISSN: 0303464X) 36: (3) pp. 209218. ( 2011) Z9: 1 W C: Rheumatology Folyóiratcikk [12351827]
227
Schramek D, Sigl V, Penninger JM RANKL and RANK in sex hormoneinduced breast cancer and breast cancer metastasis TRENDS IN ENDOCRINOLOGY AND METABOLISM (ISSN: 10432760) 22: (5) pp. 188194. ( 2011) Z9: 5 W C: Endocrinology & Metabolism Folyóiratcikk [12351826]
228
Hanada R, Hanada T, Sigl V, Schramek D, Penninger JM RANKL/RANKbeyond bones JOURNAL OF MOLECULAR MEDICINEJMM (ISSN: 09462716) 89: (7) pp. 647656. ( 2011) Z9: 6 W C: Genetics & Heredity; Medicine, Research & Experimental Folyóiratcikk [12351825]
229
Yuan HP, Gupte R, Zelkha S, Amar S Receptor activator of nuclear factorkappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitis JOURNAL OF CLINICAL PERIODONTOLOGY (ISSN: 03036979) 38: (11) pp. 10291036. ( 2011) Z9: 1 W C: Dentistry, Oral Surgery & Medicine Folyóiratcikk [12351824]
230
Nybo M, Preil SR, Juhl HF, Olesen M, Yderstraede K, Gram J, Henriksen JE, Rasmussen LM Rosiglitazone Decreases P lasma Levels of Osteoprotegerin in a Randomized Clinical Trial with Type 2 Diabetes P atients BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (ISSN: 17427835) 109: (6) pp. 481485. ( 2011) W C: Pharmacology & Pharmacy; Toxicology Folyóiratcikk [12351823]
231
Lewiecki EM Safety of LongTerm Bisphosphonate Therapy for the Management of Osteoporosis DRUGS (ISSN: 00126667) 71: (6) pp. 791814. ( 2011) Z9: 5 W C: Pharmacology & Pharmacy; Toxicology Folyóiratcikk [12351822]
232
Lewiecki EM Sclerostin monoclonal antibody therapy with AMG 785: a potential treatment for osteoporosis EXPERT OPINION ON BIOLOGICAL THERAPY (ISSN: 14712598) 11: (1) pp. 117127. ( 2011) Z9: 3 W C: Biotechnology & Applied Microbiology; Medicine, Research & Experimental Folyóiratcikk [12351821]
233
Lewiecki E Michael Sclerostin: A Novel Target for Intervention in the Treatment of Osteoporosis DISCOVERY MEDICINE (ISSN: 15396509) 65: pp. 263273. ( 2011) Folyóiratcikk [14595283]
234
Sayegh RA Screening for postmenopausal osteoporosis after 70 years of age: dualenergy xray absorptiometry, radiography, both, or none? MENOPAUSETHE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (ISSN: 10723714) 18: (1) pp. 1516.
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 64/342
3/30/2015
nyomtatobarat forma ( 2011) W C: Obstetrics & Gynecology Folyóiratcikk [12351820] 235
W ANG Ou, XING Xiaoping Senile osteoporosis:updates in pathogenesis and medication treatment Chinese Journal of Practical Internal Medicine (ISSN: 10052194) 31: (8) pp. 584586. ( 2011) Folyóiratcikk [14595259]
236
Jorgensen L, Hansen JB, Brox J, Mathiesen E, Vik A, Jacobsen BK Serum osteoprotegerin levels are related to height loss: The Tromso Study EUROPEAN JOURNAL OF EPIDEMIOLOGY (ISSN: 03932990) 26: (4) pp. 305312. ( 2011) Z9: 2 W C: Public, Environmental & Occupational Health Folyóiratcikk [12351819]
237
Belaya ZE Should we really compare absolute risk reduction in different trials on osteoporosis: comment on the article by Ringe JD and Doherty JG RHEUMATOLOGY INTERNATIONAL (ISSN: 01728172) 31: (12) pp. 16691671. ( 2011) W C: Rheumatology Folyóiratcikk [12351818]
238
Moen MD, Keam SJ Spotlight on Denosumab in P ostmenopausal Osteoporosis BIODRUGS (ISSN: 11738804) 25: (4) pp. 261264. ( 2011) Z9: 1 W C: Oncology; Immunology; Pharmacology & Pharmacy Folyóiratcikk [12351817]
239
Imai Y, Kouzmenko A, Kato S Targeting Fas/FasL signaling, a new strategy for maintaining bone health EXPERT OPINION ON THERAPEUTIC TARGETS (ISSN: 14728222) 15: (10) pp. 11431145. ( 2011) W C: Pharmacology & Pharmacy Folyóiratcikk [12351816]
240
Aspenberg P, Agholme F, Magnusson P, Fahlgren A Targeting RANKL for reduction of bone loss around unstable implants: OP GFc compared to alendronate in a model for mechanically induced loosening BONE (ISSN: 87563282) 48: (2) pp. 225230. ( 2011) Z9: 2 W C: Endocrinology & Metabolism Folyóiratcikk [12351815]
241
Papapoulos SE Targeting sclerostin as potential treatment of osteoporosis ANNALS OF THE RHEUMATIC DISEASES (ISSN: 00034967) 70: pp. I119I122. ( 2011) Z9: 1 SU: 1 W C: Rheumatology Folyóiratcikk [12351814]
242
Blake GM, Frost ML, Moore AEB, Siddique M, Fogelman I The Assessment of Regional Skeletal Metabolism: Studies of Osteoporosis Treatments Using Quantitative Radionuclide Imaging JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 14: (3) pp. 263271. ( 2011) W C: Endocrinology & Metabolism Folyóiratcikk [12351813]
243
Lories R The balance of tissue repair and remodeling in chronic arthritis NATURE REVIEWS RHEUMATOLOGY (ISSN: 17594790) 7: (12) pp. 700707. ( 2011) W C: Rheumatology Folyóiratcikk [12351812]
244
Recker RR, Armas L The Effect of Antiresorptives on Bone Quality CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (ISSN: 0009921X) 469: (8) pp. 22072214. ( 2011) W C: Orthopedics; Surgery Folyóiratcikk [12351811]
245
Harslof T, Husted LB, Carstens M, Stenkjaer L, Sorensen L, Pedersen SB, Langdahl BL The Expression and Regulation of Boneacting Cytokines in Human P eripheral Adipose Tissue in Organ Culture HORMONE AND METABOLIC RESEARCH (ISSN: 00185043) 43: (7) pp. 477482. ( 2011) W C: Endocrinology & Metabolism Folyóiratcikk [12351810]
246
Rousiere M The importance of taking care of osteoporosis PRESSE MEDICALE (ISSN: 07554982) 40: (10) pp. 900909. ( 2011) W C: Medicine, General & Internal Folyóiratcikk [12351809]
247
Miller PD The kidney and bisphosphonates BONE (ISSN: 87563282) 49: (1) pp. 7781. ( 2011) Z9: 4 W C: Endocrinology & Metabolism Folyóiratcikk [12351808]
248
Paice JA, Ferrell B The Management of Cancer P ain CAA CANCER JOURNAL FOR CLINICIANS (ISSN: 00079235) 61: (3) pp. 157182. ( 2011) Z9: 4 W C: Oncology Folyóiratcikk [12351807]
249
Sandhu SK, Hampson G The pathogenesis, diagnosis, investigation and management of osteoporosis JOURNAL OF CLINICAL PATHOLOGY (ISSN: 00219746) 64: (12) pp. 10421050. ( 2011) Z9: 1 W C: Pathology Folyóiratcikk [12351806]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 65/342
3/30/2015
nyomtatobarat forma 250
Siddique M, Frost ML, Blake GM, Moore AEB, AlBeyatti Y, Marsden PK, Schleyer PJ, Fogelman I The P recision and Sensitivity of F18Fluoride P ET for Measuring Regional Bone Metabolism: A Comparison of Quantification Methods JOURNAL OF NUCLEAR MEDICINE (ISSN: 01615505) 52: (11) pp. 17481755. ( 2011) Z9: 1 W C: Radiology, Nuclear Medicine & Medical Imaging Folyóiratcikk [12351805]
251
Dore RK The RANKL P athway and Denosumab RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (ISSN: 0889857X) 37: (3) pp. 433+. ( 2011) Z9: 1 W C: Rheumatology Folyóiratcikk [12351804]
252
Hopkins RB, Goeree R, Pullenayegum E, Adachi JD, Papaioannou A, Xie F, Thabane L The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in postmenopausal women BMC MUSCULOSKELETAL DISORDERS (ISSN: 14712474) 12: P aper 209. (2011) W C: Orthopedics; Rheumatology Folyóiratcikk [12351803]
253
Charopoulos I, Orme S, Giannoudis PV The role and efficacy of denosumab in the treatment of osteoporosis: an update EXPERT OPINION ON DRUG SAFETY (ISSN: 14740338) 10: (2) pp. 205217. ( 2011) Z9: 1 W C: Pharmacology & Pharmacy Folyóiratcikk [12351802]
254
Pozzi S, Raje N The Role of Bisphosphonates in Multiple Myeloma: Mechanisms, Side Effects, and the Future ONCOLOGIST (ISSN: 10837159) 16: (5) pp. 651662. ( 2011) W C: Oncology Folyóiratcikk [12351801]
255
QuemeraisDurieu MA, Kerlan V, Chabre O Therapeutic innovation in osteoporosis (antisclerostin antibody and denosumab) ANNALES D ENDOCRINOLOGIE (ISSN: 00034266) 72: pp. S15S22. ( 2011) SU: 1 W C: Endocrinology & Metabolism Folyóiratcikk [12351800]
256
Bronson Joanne, Dhar Murali, Ewing W illiam, Lonberg Nils To Market, To Market2010 Annual Reports in Medicinal Chemistry (ISSN: 00657743) 46: pp. 433502. ( 2011) BE Macor, JE Folyóiratcikk [14595258]
257
Epstein S, Stuss M Transplantation osteoporosis ENDOKRYNOLOGIA POLSKA (ISSN: 0423104X) 62: (5) pp. 472485. ( 2011) W C: Endocrinology & Metabolism Folyóiratcikk [12351799]
258
Todenhoefer T, Schwentner C, Schilling D, Gakis G, Stenzl A Treatment of metastatic bone disease and treatmentinduced osteoporosis in prostate cancer. Evolution of osteoprotective strategies UROLOGEAUSGABE A (ISSN: 03402592) 50: (9) pp. 1055+. ( 2011) Z9: 2 W C: Urology & Nephrology Folyóiratcikk [12351798]
259
Gosch M, Roth T, Kammerlander C, JoostenGstrein B, BenvenutiFalger U, Blauth M, Lechleitner M Treatment of osteoporosis in postmenopausal hip fracture patients after geriatric rehabilitation Changes over the last decade ZEITSCHRIFT FÜR GERONTOLOGIE UND GERIATRIE (ISSN: 09486704) 44: (6) pp. 381386. ( 2011) W C: Geriatrics & Gerontology; Gerontology Folyóiratcikk [12351797]
260
Schieker M, Jakob F, Amling M, Mutschler W , Boecker W Treatment of osteoporotic fractures: a trauma perspective OSTEOLOGIE (ISSN: 10191291) 20: (1) pp. 510. ( 2011) Folyóiratcikk [14595257]
261 * Boonen S, Adachi JD, Man Z, Cummings SR, Lippuner K, Torring O, Gallagher JC, Farrerons J, W ang A, Franchimont N, San Martin J, Grauer A, McClung M Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in P ostmenopausal Women at High Risk JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 96: (6) pp. 17271736. ( 2011) Z9: 7 W C: Endocrinology & Metabolism Folyóiratcikk [12351796] 262
Vucic D, Dixit VM, W ertz IE Ubiquitylation in apoptosis: a posttranslational modification at the edge of life and death NATURE REVIEWS MOLECULAR CELL BIOLOGY (ISSN: 14710072) 12: (7) pp. 439452. ( 2011) Z9: 13 W C: Cell Biology Folyóiratcikk [12351795]
263
Suva LJ, Brander BE, Makhoul I Update on bonemodifying agents in metastatic breast cancer NATURE REVIEWS ENDOCRINOLOGY (ISSN: 17595029) 7: (7) pp. 380381. ( 2011) Z9: 1 W C: Endocrinology & Metabolism Folyóiratcikk [12351794]
264
Sturdee DW , Pines A Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health CLIMACTERIC (ISSN: 13697137) 14: (3) pp. 302320. ( 2011) CA: Int Menopause Society W riting Grp Z9: 11 W C: Obstetrics & Gynecology Folyóiratcikk [12351793]
265
Curtis JR, Singh JA Use of Biologics in Rheumatoid Arthritis: Current and Emerging P aradigms of Care CLINICAL THERAPEUTICS (ISSN: 01492918) 33: (6) pp. 679707. ( 2011)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 66/342
3/30/2015
nyomtatobarat forma Z9: 1 W C: Pharmacology & Pharmacy Folyóiratcikk [12351792] 266
Ensrud KE, Schousboe JT Vertebral Fractures NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 364: (17) pp. 16341642. ( 2011) Z9: 6 W C: Medicine, General & Internal Folyóiratcikk [12351791]
267
W arriner AH, Patkar NM, Curtis JR, Delzell E, Gary L, Kilgore M, Saag K Which fractures are most attributable to osteoporosis? JOURNAL OF CLINICAL EPIDEMIOLOGY (ISSN: 08954356) 64: (1) pp. 4653. ( 2011) Z9: 5 W C: Public, Environmental & Occupational Health Folyóiratcikk [12351790]
268
Chinese Journal of Geriatrics (ISSN: 02549026) 31: (8) pp. 641645. ( 2012) Folyóiratcikk [14595303]
269
Briot Karine, Cortet Bernard, Thomas Thierry, Audran Maurice, Blain Hubert, Breuil Veronique, Chapuis Laure, Chapurlat Roland, Fardellone Patrice, Feron JeanMarc, Gauvain JeanBernard, Guggenbuhl Pascal, Kolta Sami, Lespessailles Eric, Letombe Brigitte, Marcelli Christian, Orcel Philippe, Seret Patrick, Tremollieres Florence, Rouxa Christian 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis JOINT BONE SPINE (ISSN: 1297319X) 79: (3) pp. 304313. ( 2012) Folyóiratcikk [14595341]
270
Gianfrancesco F, Rendina D, Di Stefano M, Mingione A, Esposito T, Merlotti D, Gallone S, Magliocca S, Goode A, Formicola D, Morello G, Layfield R, Frattini A, De Filippo G, Nuti R, Searle M, Strazzullo P, Isaia G, Mossetti G, Gennari L A nonsynonymous TNFRSF11A variation increases NF? B activity and the severity of P aget's disease JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 27: (2) pp. 443452. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12351789]
271
Darcy Ariana, Meltzer Micah, Miller Joseph, Lee Steven, Chappell Scott, Donck Kris Ver, Montano Monty A novel library screen identifies immunosuppressors that promote osteoblast differentiation BONE (ISSN: 87563282) 50: (6) pp. 12941303. ( 2012) Folyóiratcikk [14595340]
272 * Orwoll Eric, Teglbjrg Christence S, Langdahl Bente L, Chapurlat Roland, Czerwinski Edward, Kendler David L, Reginster JeanYves, Kivitz Alan, Lewiecki E Michael, Miller Paul D, Bolognese Michael A, McClung Michael R, Bone Henry G, Ljunggren Oesten, Abrahamsen Bo, Gruntmanis Ugis, Yang YuChing, W agman Rachel B, Siddhanti Suresh, Grauer Andreas, Hall Jesse W , Boonen Steven A Randomized, P laceboControlled Study of the Effects of Denosumab for the Treatment of Men with Low Bone Mineral Density JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 97: (9) pp. 31613169. ( 2012) Folyóiratcikk [14595339] 273
Douni E, Rinotas V, Makrinou E, Zwerina J, Penninger JM, Eliopoulos E, Schett G, Kollias G A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNF HUMAN MOLECULAR GENETICS (ISSN: 09646906) 21: (4) pp. 784798. ( 2012) W C: Biochemistry & Molecular Biology; Genetics & Heredity Folyóiratcikk [12351788]
274
Kanis JA, Reginster JY, Kaufman JM, Ringe JD, Adachi JD, Hiligsmann M, Rizzoli R, Cooper C A reappraisal of generic bisphosphonates in osteoporosis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (1) pp. 213221. ( 2012) Z9: 1 W C: Endocrinology & Metabolism Folyóiratcikk [12351787]
275
Block Geoffrey A, Bone Henry G, Fang Liang, Lee Edward, Padhi Desmond A singledose study of denosumab in patients with various degrees of renal impairment JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 27: (7) pp. 14711479. ( 2012) Folyóiratcikk [14595338]
276
Banu J, Varela E, Fernandes G Alternative therapies for the prevention and treatment of osteoporosis NUTRITION REVIEWS (ISSN: 00296643) 70: (1) pp. 2240. ( 2012) W C: Nutrition & Dietetics Folyóiratcikk [12351786]
277
Nosál'ová G, Rozborilová E, Jureček L Analysis of relationships between COP D Glucocorticoids Osteoporosis and vitamin D Studia Pneumologica et Phthiseologica 72: (5) pp. 247254. ( 2012) Folyóiratcikk [13474752]
278
Teixeira MZ Antiresorptive drugs (bisphosphonates), atypical fractures and rebound effect: New evidence of similitude Homeopathy (ISSN: 14754916) 101: (4) pp. 231242. ( 2012) Folyóiratcikk [13474751]
279
Chen JS, Sambrook PN Antiresorptive therapies for osteoporosis: a clinical overview NATURE REVIEWS ENDOCRINOLOGY (ISSN: 17595029) 8: (2) pp. 8191. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12351785]
280 * Kendler DL, Palacios S, Cox DA, Stock J, Alam J, Dowsett SA, Zanchetta J Arzoxifene versus raloxifene: effect on bone and safety parameters in postmenopausal women with osteoporosis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (3) pp. 10911101. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12351784] 281 * Lacey DL, Boyle W J, Simonet W S, Kostenuik PJ, Dougall W C, Sullivan JK, San Martin J, Dansey R Bench to bedside: elucidation of the OP GRANKRANKL pathway and the development of denosumab
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 67/342
3/30/2015
nyomtatobarat forma NATURE REVIEWS DRUG DISCOVERY (ISSN: 14741776) 11: (5) pp. 401U150. ( 2012) W C: Biotechnology & Applied Microbiology; Pharmacology & Pharmacy Folyóiratcikk [12351783] 282
Bieglmayer C, Dimai HP, Gasser RW , Kudlacek S, ObermayerPietsch B, W oloszczuk W , Zwettler E, Griesmacher A Biomarkers of bone turnover in diagnosis and therapy of osteoporosis: A consensus advice from an Austrian working group Wiener Medizinische Wochenschrift (ISSN: 00435341) 162: (2122) pp. 464477. ( 2012) Folyóiratcikk [13474750]
283
Lustberg MB, Reinbolt RE, Shapiro CL Bone health in adult cancer survivorship Journal of Clinical Oncology (ISSN: 0732183X) 30: (30) pp. 36653674. ( 2012) Folyóiratcikk [13474749]
284
Garnero P Bone remodeling assessment in osteoporosis: Which markers to be used? Revue Francophone des Laboratoires 2012: (446) pp. 4351. ( 2012) Folyóiratcikk [13474748]
285
Luhmann Tessa, Germershaus Oliver, Groll Juergen, Meinel Lorenz Bone targeting for the treatment of osteoporosis JOURNAL OF CONTROLLED RELEASE (ISSN: 01683659) 161: (2) pp. 198213. ( 2012) Folyóiratcikk [14595337]
286 * Naylor Kim, Eastell Richard Bone turnover markers: use in osteoporosis NATURE REVIEWS RHEUMATOLOGY (ISSN: 17594790) 8: (7) pp. 379389. ( 2012) Folyóiratcikk [14595335] 287
FigueroaMagalhães MC, Miller RS Bonemodifying agents as adjuvant therapy for earlystage breast cancer ONCOLOGY (United States) 26: (10) p. §. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474747]
288
Morgans AK, Smith MR BoneTargeted Agents. P reventing Skeletal Complications in P rostate Cancer Urologic Clinics of North America (ISSN: 00940143) 39: (4) pp. 533546. ( 2012) Folyóiratcikk [13474746]
289
Hamann C, Kirschner S, Gunther KP, Hofbauer LC Bone, sweet boneosteoporotic fractures in diabetes mellitus NATURE REVIEWS ENDOCRINOLOGY (ISSN: 17595029) 8: (5) pp. 297305. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12351782]
290
Dweck MR, Boon NA, Newby DE Calcific aortic stenosis: A disease of the valve and the myocardium Journal of the American College of Cardiology (ISSN: 07351097) 60: (19) pp. 18541863. ( 2012) Folyóiratcikk [13474745]
291
Jamal SA, Moe SM Calcium builds strong bones, and more is bettercorrect? Well, maybe not Clinical Journal of the American Society of Nephrology (ISSN: 15559041) 7: (11) pp. 18771883. ( 2012) Folyóiratcikk [13474744]
292
Bac Martin Can the reengineering of P HC and/or the introduction of community paediatricians be the solution? SAMJ SOUTH AFRICAN MEDICAL JOURNAL (ISSN: 02569574) 102: (11) pp. 815+. ( 2012) Folyóiratcikk [14595352]
293
Chau D, Becker DL, Coombes ME, Ioannidis G, Adachi JD, Goeree R Costeffectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada Journal of Medical Economics 15: (SUP P L. 1) pp. 314. ( 2012) Folyóiratcikk [13474743]
294
Dore Robin K Data from Extension Trials: Denosumab and Zoledronic Acid CURRENT OSTEOPOROSIS REPORTS 10: (1) pp. 1621. ( 2012) Folyóiratcikk [14595302]
295
Farahmand P, Ringe JD Denosumab Trade name: P rolia Tagliche Praxis 53: (4) pp. 899903. ( 2012) Folyóiratcikk [13474738]
296
Farahmand P, Ringe JD Denosumab Trade name: P rolia Internistische Praxis 52: (4) pp. 899903. ( 2012) Folyóiratcikk [13474739]
297
Farahmand P, Ringe JD Denosumab Trade name: P rolia Gynakologische Praxis 36: (4) pp. 771775. ( 2012) Folyóiratcikk [13474740]
298
Farahmand P, Ringe JD Denosumab Trade name: P rolia Chirurgische Praxis (ISSN: 00094846) 75: (3) pp. 541545. ( 2012) Folyóiratcikk [13474741]
299
Farahmand P, Ringe JD Denosumab Trade name: P rolia Padiatrische Praxis (ISSN: 00309346) 79: (3) pp. 507511. ( 2012) Folyóiratcikk [13474742]
300
Johnson Gretchen L Denosumab (P rolia) for Treatment of P ostmenopausal Osteoporosis
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 68/342
3/30/2015
nyomtatobarat forma AMERICAN FAMILY PHYSICIAN (ISSN: 0002838X) 85: (4) pp. 334+. ( 2012) Folyóiratcikk [14595301] 301
Shroff R, Beringer O, Rao K, Hofbauer LC, Schulz A Denosumab for posttransplantation hypercalcemia in osteopetrosis New England Journal of Medicine (ISSN: 00284793) 367: (18) pp. 17661767. ( 2012) Folyóiratcikk [13474737]
302
Body JJ Denosumab for the management of bone disease in patients with solid tumors EXPERT REVIEW OF ANTICANCER THERAPY (ISSN: 14737140) 12: (3) pp. 307322. ( 2012) W C: Oncology Folyóiratcikk [12351781]
303
Lewiecki EM, Bilezikian JP Denosumab for the Treatment of Osteoporosis and CancerRelated Conditions CLINICAL PHARMACOLOGY & THERAPEUTICS (ISSN: 00099236) 91: (1) pp. 123133. ( 2012) Z9: 1 W C: Pharmacology & Pharmacy Folyóiratcikk [12351780]
304
Simonelli C Denosumab is an option for treatment of osteoporosis American Family Physician (ISSN: 0002838X) 86: (11) pp. 992994. ( 2012) Folyóiratcikk [13474736]
305
Scotland G, W augh N, Royle P, Mcnamee P, Henderson R, Hollick R Denosumab per la prevenzione delle fratture osteoporotiche in donne in postmenopausa valutazione di tecnologia singola presso il nice PharmacoEconomics Italian Research Articles 14: (2) pp. 131142. ( 2012) Folyóiratcikk [13474734]
306 * McCloskey Eugene V, Johansson Helena, Oden Anders, Austin Matt, Siris Ethel, W ang Andrea, Lewiecki E Michael, Lorenc Roman, Libanati Cesar, Kanis John A Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 27: (7) pp. 14801486. ( 2012) Folyóiratcikk [14595334] 307 * Adami S, Libanati C, Boonen S, Cummings SR, Ho PR, W ang A, Siris E, Lane J, Adachi JD, Bhandari M, De Gregorio L, Gilchrist N, Lyritis G, Möller G, Palacios S, Pavelka K, Resch H, Roux C, Uebelhart D Denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracturehealing: Results from the FREEDOM trial Journal of Bone and Joint Surgery Series A 94: (23) pp. 21132119. ( 2012) Folyóiratcikk [13474733] 308
Barrasa Rodriguez Maria Consuelo, Ulla Anes Mariano, Perez Rojas Florencia, Garcia Melcon Gerardo Denosumabinduced severe hypocalcemia MEDICINA CLINICA (ISSN: 00257753) 139: (5) pp. 227228. ( 2012) Folyóiratcikk [14595333]
309
Diz P, LópezCedrún JL, Arenaz J, Scully C Denosumabrelated osteonecrosis of the jaw Journal of the American Dental Association (ISSN: 00028177) 143: (9) pp. 981984. ( 2012) Folyóiratcikk [13474732]
310
Sutton Emily E, Riche Daniel M Denosumab, a RANK Ligand Inhibitor, for P ostmenopausal Women with Osteoporosis ANNALS OF PHARMACOTHERAPY (ISSN: 10600280) 46: (78) pp. 10001009. ( 2012) Folyóiratcikk [14595332]
311
Yee Andrew J, Raje Noopur S Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 7: pp. 331338. ( 2012) Folyóiratcikk [14595300]
312
Hanley DA, Adachi JD, Bell A, Brown V Denosumab: Mechanism of action and clinical outcomes International Journal of Clinical Practice (ISSN: 13685031) 66: (12) pp. 11391146. ( 2012) Folyóiratcikk [13474730]
313
Gomes da Silva IMC, Branco JC Denosumab: Recent update in postmenopausal osteoporosis Acta Reumatologica Portuguesa (ISSN: 0303464X) 37: (4) pp. 302313. ( 2012) Folyóiratcikk [13474729]
314
Perlot T, Penninger JM Development and Function of Murine B Cells Lacking RANK JOURNAL OF IMMUNOLOGY (ISSN: 00221767) 188: (3) pp. 12011205. ( 2012) Z9: 1 W C: Immunology Folyóiratcikk [12351779]
315
Del Mar Arriero M, Ramis JM, Perelló J, Monjo M Differential response of MC3T3E1 and human mesenchymal stem cells to inositol hexakisphosphate Cellular Physiology and Biochemistry (ISSN: 10158987) 30: (4) pp. 974986. ( 2012) N1 Molecular Sequence Numbers: GENBANK: NM_000088, NM_000478, NM_001101, NM_002046, NM_007431, NM_007541, NM_008084, NM_008318, NM_008764, NM_011613, NM_130458; Folyóiratcikk [13474728]
316
Richards J Brent, Zheng HouFeng, Spector Tim D DISEASE MECHANISMS Genetics of osteoporosis from genomewide association studies: advances and challenges NATURE REVIEWS GENETICS (ISSN: 14710056) 13: (8) pp. 576588. ( 2012) Folyóiratcikk [14595331]
317
Thudium CS, Jensen VK, Karsdal MA, Henriksen K Disruption of the VATP ase Functionality as a Way to Uncouple Bone Formation and Resorption A Novel Target for Treatment of Osteoporosis
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 69/342
3/30/2015
nyomtatobarat forma CURRENT PROTEIN & PEPTIDE SCIENCE (ISSN: 13892037) 13: (2) pp. 141151. ( 2012) W C: Biochemistry & Molecular Biology Folyóiratcikk [12351778] 318
Nakamura T, Matsumoto T, Sugimoto T, Shiraki M Doseresponse study of denosumab on bone mineral density and bone turnover markers in Japanese postmenopausal women with osteoporosis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (3) pp. 11311140. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12351777]
319 * McClung MR, Boonen S, Torring O, Roux C, Rizzoli R, Bone HG, Benhamou CL, Lems W F, Minisola S, Halse J, Hoeck HC, Eastell R, W ang A, Siddhanti S, Cummings SR Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 27: (1) pp. 211218. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12351776] 320
Schwarz P, Jorgensen NR, Mosekilde L, Vestergaard P Effects of Increasing Age, Dosage, and Duration of P TH Treatment on BMD IncreaseA Metaanalysis CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 90: (3) pp. 165173. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12351775]
321
Vanlint SJ, Ried K Efficacy and tolerability of calcium, vitamin D and a plantbased omega3 oil for osteopenia: A pilot RCT MATURITAS (ISSN: 03785122) 71: (1) pp. 4448. ( 2012) W C: Geriatrics & Gerontology; Obstetrics & Gynecology Folyóiratcikk [12351774]
322
Leistner DM, Seeger FH, Fischer A, Röxe T, Klotsche J, Iekushi K, Seeger T, Assmus B, Honold J, Karakas M, Badenhoop K, Frantz S, Dimmeler S, Zeiher AM Elevated levels of the mediator of catabolic bone remodeling rankl in the bone marrow environment link chronic heart failure with osteoporosis Circulation: Heart Failure 5: (6) pp. 769777. ( 2012) Folyóiratcikk [13474727]
323 * Reid IR, Cornish J Epidemiology and pathogenesis of osteonecrosis of the jaw NATURE REVIEWS RHEUMATOLOGY (ISSN: 17594790) 8: (2) pp. 9096. ( 2012) W C: Rheumatology Folyóiratcikk [12351773] 324
Khosla S, Oursler MJ, Monroe DG Estrogen and the skeleton Trends in Endocrinology and Metabolism (ISSN: 10432760) 23: (11) pp. 576581. ( 2012) Folyóiratcikk [13474725]
325
Rubin CD Evaluation and Management of Hip Fracture Risk in the Aged AMERICAN JOURNAL OF THE MEDICAL SCIENCES (ISSN: 00029629) 343: (3) pp. 233242. ( 2012) W C: Medicine, General & Internal Folyóiratcikk [12351772]
326
Gurban Camelia V, Balas Melania, Zosin Ioana, Vlad Daliborca C, Dumitrascu Victor Evaluation of Osteoblastic/Osteoclastic Activity in P ostmenopausal Osteoporosis REVISTA ROMANA DE MEDICINA DE LABORATOR (ISSN: 18416624) 20: (2) pp. 143150. ( 2012) Folyóiratcikk [14595330]
327
Body J J, Bergmann P, Boonen S, Devogelaer J P, Gielen E, Goemaere S, Kaufman J M, Rozenberg S, Reginster J Y Extraskeletal benefits and risks of calcium, vitamin D and antiosteoporosis medications OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: pp. S1S23. ( 2012) SU 1 Folyóiratcikk [14595299]
328 * Freemantle N, SatramHoang S, Tang ET, Kaur P, Macarios D, Siddhanti S, Borenstein J, Kendler DL Final results of the DAP S (Denosumab Adherence P reference Satisfaction) study: a 24month, randomized, crossover comparison with alendronate in postmenopausal women OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (1) pp. 317326. ( 2012) CA: DAPS Investigators W C: Endocrinology & Metabolism Folyóiratcikk [12351771] 329
Semler O, Netzer C, HoyerKuhn H, Becker J, Eysel P, Schoenau E First use of the RANKL antibody denosumab in osteogenesis imperfecta Type VI Journal of Musculoskeletal Neuronal Interactions 12: (3) pp. 183188. ( 2012) Folyóiratcikk [13474724]
330 * Grey Andrew, Bolland Mark J, Horne Anne, W attie Diana, House Meaghan, Gamble Greg, Reid Ian R Five years of antiresorptive activity after a single dose of zoledronate Results from a randomized doubleblind placebo controlled trial BONE (ISSN: 87563282) 50: (6) pp. 13891393. ( 2012) Folyóiratcikk [14595329] 331 * Papapoulos S, Chapurlat R, Libanati C, Brandi ML, Brown JP, Czerwinski E, Krieg MA, Man Z, Mellstrom D, Radominski SC, Reginster JY, Resch H, Ivorra JAR, Roux C, Vittinghoff E, Austin M, Daizadeh N, Bradley MN, Grauer A, Cummings SR, Bone HG Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 27: (3) pp. 694701. ( 2012) Z9: 3 W C: Endocrinology & Metabolism Folyóiratcikk [12351770] 332 * Boonen S, Reginster JY, Kaufman JM, Lippuner K, Zanchetta J, Langdahl B, Rizzoli R, Lipschitz S, Dimai HP, W itvrouw R, Eriksen E, Brixen K, Russo L, Claessens F, Papanastasiou P, Antunez O, Su G, BucciRechtweg C, Hruska J, Incera E, Vanderschueren D, Orwoll E Fracture risk and zoledronic acid therapy in men with osteoporosis
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 70/342
3/30/2015
nyomtatobarat forma New England Journal of Medicine (ISSN: 00284793) 367: (18) pp. 17141723. ( 2012) Folyóiratcikk [13474723] 333
Bone Henry Future Directions in Osteoporosis Therapeutics ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (ISSN: 08898529) 41: (3) pp. 655+. ( 2012) Folyóiratcikk [14595328]
334
MessingerRapport BJ Geriatrics update 2012: What parts of our practice to change, what to 'think about' CLEVELAND CLINIC JOURNAL OF MEDICINE (ISSN: 08911150) 79: (5) pp. 347353. ( 2012) W C: Medicine, General & Internal Folyóiratcikk [12351769]
335
W einstein Robert S GlucocorticoidInduced Osteoporosis and Osteonecrosis ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (ISSN: 08898529) 41: (3) pp. 595+. ( 2012) Folyóiratcikk [14595327]
336
Depypere H, Depauw M, Goemaere S, Villeirs G, Cocquyt V, Comhaire F Hormones and medication in recently menopaused women: Responsible use Tijdschrift voor Geneeskunde (ISSN: 0371683X) 68: (20) pp. 979985. ( 2012) Folyóiratcikk [13474722]
337 * Silverman S, Viswanathan HN, Yang YC, W ang A, Boonen S, RagiEis S, Fardellone P, Gilchrist N, Lips P, Nevitt M, Gil Antunano SP, Pavelka K, Revicki D, Simon J, Macarios D, Siris ES Impact of clinical fractures on healthrelated quality of life is dependent on time of assessment since fracture: results from the FREEDOM trial OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (4) pp. 13611369. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12351768] 338
Hough S, Brown S, Cassim B, Davey M, de Villiers T, Ellis G, Lipschitz S, Lukhele M, Pettifor J Improved management of patients with osteoporosis South African Medical Journal 102: (11) p. 815. ( 2012) Folyóiratcikk [13474721]
339
Outman RC, Curtis JR, Locher JL, Allison JJ, Saag KG, Kilgore ML Improving osteoporosis care in highrisk home health patients through a highintensity intervention CONTEMPORARY CLINICAL TRIALS (ISSN: 15517144) 33: (1) pp. 206212. ( 2012) W C: Medicine, Research & Experimental; Pharmacology & Pharmacy Folyóiratcikk [12351767]
340
Johnson GL In reply American Family Physician (ISSN: 0002838X) 86: (11) pp. 994994. ( 2012) Folyóiratcikk [13474720]
341
W ang Y, Lin B In Silico Investigations of the AntiCatabolic Effects of P amidronate and Denosumab on Multiple MyelomaInduced Bone Disease PLoS ONE (ISSN: 19326203) 7: (9) P aper e44868. (2012) Folyóiratcikk [13474719]
342
Fichna M, Zurawek M, Fichna P, Gryczynska M, Nowak J, Ruchala M Increased serum osteoprotegerin in patients with primary adrenal insufficiency receiving conventional hydrocortisone substitution Journal of Physiology and Pharmacology (ISSN: 08675910) 63: (6) pp. 677682. ( 2012) Folyóiratcikk [13474718]
343 * Silverman S, Christiansen C Individualizing osteoporosis therapy OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (3) pp. 797809. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12351766] 344
W atts NB, Roux C, Modlin JF, Brown JP, Daniels A, Jackson S, Smith S, Zack DJ, Zhou L, Grauer A, Ferrari S Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association? OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (1) pp. 327337. ( 2012) Z9: 1 W C: Endocrinology & Metabolism Folyóiratcikk [12351765]
345
Klingenberg R, Lüscher TF Inflammation in coronary artery disease and acute myocardial infarction is the stage set for novel therapies? Current Pharmaceutical Design (ISSN: 13816128) 18: (28) pp. 43584369. ( 2012) Folyóiratcikk [13474717]
346
Redlich K, Smolen JS Inflammatory bone loss: pathogenesis and therapeutic intervention NATURE REVIEWS DRUG DISCOVERY (ISSN: 14741776) 11: (3) pp. 234250. ( 2012) W C: Biotechnology & Applied Microbiology; Pharmacology & Pharmacy Folyóiratcikk [12351764]
347
Hein G E Inflammatory Diseases and Osteoporosis P otential of RANKL Inhibition in Rheumatoid Arthritis AKTUELLE RHEUMATOLOGIE (ISSN: 0341051X) 37: (4) pp. 243247. ( 2012) Folyóiratcikk [14595326]
348
Labranche TP, Jesson MI, Radi ZA, Storer CE, Guzova JA, Bonar SL, Thompson JM, Happa FA, Stewart ZS, Zhan Y, Bollinger CS, Bansal PN, W ellen JW , W ilkie DP, Bailey SA, Symanowicz PT, Hegen M, Head RD, Kishore N, Mbalaviele G, Meyer DM JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production Arthritis and Rheumatism (ISSN: 00043591) 64: (11) pp. 35313542. ( 2012) Folyóiratcikk [13474716]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 71/342
3/30/2015
nyomtatobarat forma 349
Cooper C, Reginster JY, Cortet B, DiazCuriel M, Lorenc RS, Kanis JA, Rizzoli R Longterm treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 28: (3) pp. 475491. ( 2012) W C: Medicine, General & Internal; Medicine, Research & Experimental Folyóiratcikk [12351763]
350
Anastasilakis AD, Toulis KA, Polyzos SA, Anastasilakis CD, Makras P Longterm treatment of osteoporosis: Safety and efficacy appraisal of denosumab Therapeutics and Clinical Risk Management (ISSN: 11766336) 8: pp. 295306. ( 2012) Folyóiratcikk [13474715]
351 * Grey A, Bolland M, W ong S, Horne A, Gamble G, Reid IR LowDose Zoledronate in Osteopenic P ostmenopausal Women: A Randomized Controlled Trial JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 97: (1) pp. 286292. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12351762] 352 * Eisman JA, Bogoch ER, Dell R, Harrington JT, McKinney Jr RE, McLellan A, Mitchell PJ, Silverman S, Singleton R, Siris E Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention Journal of Bone and Mineral Research (ISSN: 08840431) 27: (10) pp. 20392046. ( 2012) Folyóiratcikk [13474714] 353
Paller CJ, Carducci MA, Philips GK Management of bone metastases in refractory prostate cancer role of denosumab Clinical Interventions in Aging (ISSN: 11769092) 7: pp. 363372. ( 2012) Folyóiratcikk [13474713]
354
Rizzoli R, Adachi JD, Cooper C, Dere W , Devogelaer JP, DiezPerez A, Kanis JA, Laslop A, Mitlak B, Papapoulos S, Ralston S, Reiter S, W erhya G, Reginster JY Management of glucocorticoidinduced osteoporosis Calcified Tissue International (ISSN: 0171967X) 91: (4) pp. 225243. ( 2012) Folyóiratcikk [13474712]
355
Curtis Jeffrey R, Safford Monika M Management of Osteoporosis among the Elderly with Other Chronic Medical Conditions DRUGS & AGING (ISSN: 1170229X) 29: (7) pp. 549564. ( 2012) Folyóiratcikk [14595298]
356
Lobersztajn A, Trémollières F Menopause and bone Journal de Gynecologie Obstetrique et Biologie de la Reproduction (ISSN: 03682315) 41: (7 SUP P L.) pp. F28F32. ( 2012) Folyóiratcikk [13474711]
357
Hommel E, Ghazi A, W hite H Minimal Trauma Fractures: Lifting the Specter of Misconduct by Identifying Risk Factors and P lanning for P revention JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (ISSN: 15258610) 13: (2) pp. 180186. ( 2012) W C: Geriatrics & Gerontology Folyóiratcikk [12351761]
358
Bocker W , Radic T, Schonitzer V, Haasters F, Mutschler W , Schieker M Molecular cloning and functional characterization of the porcine extracellular domain of Receptor Activator of NFkappa B Ligand (sRANKL) GENE (ISSN: 03781119) 492: (1) pp. 296304. ( 2012) W C: Genetics & Heredity Folyóiratcikk [12351760]
359
Powroźnik B, Kubowicz P, Pȩkala E Monoclonal antibodies in targeted therapy Postepy Higieny i Medycyny Doswiadczalnej (ISSN: 00325449) 66: pp. 663673. ( 2012) Folyóiratcikk [13474710]
360
Zankl A, Duncan EL, Leo PJ, Clark GR, Glazov EA, Addor MC, Herlin T, Kim CA, Leheup BP, McGill J, McTaggart S, Mittas S, Mitchell AL, Mortier GR, Robertson SP, Schroeder M, Terhal P, Brown MA Multicentric Carpotarsal Osteolysis Is Caused by Mutations Clustering in the AminoTerminal Transcriptional Activation Domain of MAFB AMERICAN JOURNAL OF HUMAN GENETICS (ISSN: 00029297) 90: (3) pp. 494501. ( 2012) W C: Genetics & Heredity Folyóiratcikk [12351759]
361
Michalská D New perspectives of the treatment of osteoporosis Interni Medicina pro Praxi (ISSN: 12127299) 14: (89) pp. 309311. ( 2012) Folyóiratcikk [13474709]
362
Zhang Haiwei, Liu Fang New progress in drug therapy for osteoporosis Chinese Journal of Osteoporosis (ISSN: 10067108) 18: (6) pp. 583588. ( 2012) Folyóiratcikk [14595297]
363
Mazziotti G, Bilezikian J, Canalis E, Cocchi D, Giustina A New understanding and treatments for osteoporosis ENDOCRINE (ISSN: 1355008X) 41: (1) pp. 5869. ( 2012) Z9: 3 W C: Endocrinology & Metabolism Folyóiratcikk [12351758]
364
Jamal Sophie A, Hamilton Celeste J Nitric Oxide Donors for the Treatment of Osteoporosis CURRENT OSTEOPOROSIS REPORTS 10: (1) pp. 8692. ( 2012) Folyóiratcikk [14595296]
365
Grey A Nonsurgical management of mild primary hyperparathyroidism A reasonable option Clinical Endocrinology (ISSN: 03000664) 77: (5) pp. 639644. ( 2012) Folyóiratcikk [13474708]
366
Rachner TD, Hadji P, Hofbauer LC
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 72/342
3/30/2015
nyomtatobarat forma Novel therapies in benign and malignant bone diseases PHARMACOLOGY AND THERAPEUTICS (ISSN: 01637258) 134: (3) pp. 338344. ( 2012) W C: Pharmacology & Pharmacy Folyóiratcikk [12351757] 367
Langdahl B, Binkley N, Bone H, Gilchrist N, Resch H, Rodriguez Portales J, Denker A, Lombardi A, Le Bailly De Tilleghem C, Dasilva C, Rosenberg E, Leung A Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study Journal of Bone and Mineral Research (ISSN: 08840431) 27: (11) pp. 22512258. ( 2012) Folyóiratcikk [13474707]
368
HaVinh P, Guimond C, Bourdel H, Ricard JL, RocheApaire B Off label prescriptions of dualbiphotonic Xrays absorptiometry and osteoporosis treatments in community patients Journal d'Economie Medicale 30: (4) pp. 266278. ( 2012) Folyóiratcikk [13474706]
369
Jacobsen Christine, Metzler Philipp, Obwegeser Joachim Anton, Zemann W olfgang, Graetz Klaus W ilhelm Osteopathology of the jaw associated with bone resorption inhibitors: what have we learned in the last 8 years? A single centre experience with 110 patients SWISS MEDICAL WEEKLY (ISSN: 14247860) 142: P aper w13605. (2012) Folyóiratcikk [14595325]
370
Kolarov Zl, Nestorova R Osteoporosis and bone quality Achievements, modern technologies, newly emerged questions and unresolved problems Revmatologiia (Bulgaria) 20: (2) pp. 2430. ( 2012) Folyóiratcikk [13474705]
371
OtomoCorgel J Osteoporosis and osteopenia: implications for periodontal and implant therapy PERIODONTOLOGY 2000 (ISSN: 09066713) 59: pp. 111139. ( 2012) Z9: 1 W C: Dentistry, Oral Surgery & Medicine Folyóiratcikk [12351756]
372
Baron R OSTEOP OROSIS IN 2011 Osteoporosis therapydawn of the postbisphosphonate era NATURE REVIEWS ENDOCRINOLOGY (ISSN: 17595029) 8: (2) pp. 7678. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12351755]
373
Bell JS, Blacker N, Edwards S, Frank O, Alderman CP, Karan L, Husband A, Rowett D Osteoporosis P harmacological prevention and management in older people AUSTRALIAN FAMILY PHYSICIAN (ISSN: 03008495) 41: (3) pp. 110+. ( 2012) Z9: 1 W C: Primary Health Care; Medicine, General & Internal Folyóiratcikk [12351754]
374
van den Bergh JP, van Geel TA, Geusens PP Osteoporosis, frailty and fracture: implications for case finding and therapy NATURE REVIEWS RHEUMATOLOGY (ISSN: 17594790) 8: (3) pp. 163172. ( 2012) W C: Rheumatology Folyóiratcikk [12351753]
375
Pollycove Ricki, Simon James A Osteoporosis: Screening and Treatment in Women CLINICAL OBSTETRICS AND GYNECOLOGY (ISSN: 00099201) 55: (3) pp. 681691. ( 2012) Folyóiratcikk [14595324]
376
Gosch M, Kammerlander C, Pils K, Lechleitner M, BenvenutiFalger U, Roth T, JoostenGstrein B, Pietschmann P Osteoporotic treatment options in geriatric patients ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE (ISSN: 09486704) 45: (5) pp. 417428. ( 2012) Folyóiratcikk [14595323]
377
Roysland R, Bonaca MP, Omland T, Sabatine M, Murphy SA, Scirica BM, Bjerre M, Flyvbjerg A, Braunwald E, Morrow DA Osteoprotegerin and cardiovascular mortality in patients with nonST elevation acute coronary syndromes HEART (ISSN: 13556037) 98: (10) pp. 786791. ( 2012) Z9: 1 W C: Cardiac & Cardiovascular Systems Folyóiratcikk [12351752]
378
Jorgensen Lone, Hansen JohnBjarne, Ahmed Luai, Bjornerem Ashild, Emaus Nina, Joakimsen Ragnar, Mathiesen Ellisiv, Stormer Jan, Vik Anders, Jacobsen Bjarne K Osteoprotegerin is associated with hip fracture incidence: the Tromso Study INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (ISSN: 03005771) 41: (4) pp. 10331039. ( 2012) Folyóiratcikk [14595320]
379
Schwarz P, Rasmussen AQ, Kvist TM, Andersen UB, Jorgensen NR P aget's disease of the bone after treatment with Denosumab: A case report BONE (ISSN: 87563282) 50: (5) pp. 10231025. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12351751]
380
Kim HKW P athophysiology and New Strategies for the Treatment of LeggCalveP erthes Disease JOURNAL OF BONE AND JOINT SURGERYAMERICAN VOLUME (ISSN: 00219355) 94A: (7) pp. 659669. ( 2012) W C: Orthopedics; Surgery Folyóiratcikk [12351750]
381
Riancho JA, Hernandez JL P harmacogenomics of osteoporosis: a pathway approach PHARMACOGENOMICS (ISSN: 14622416) 13: (7) pp. 815829. ( 2012) W C: Pharmacology & Pharmacy Folyóiratcikk [12351749]
382 * Boonen S, Ferrari S, Miller PD, Eriksen EF, Sambrook PN, Compston J, Reid IR, Vanderschueren D, Cosman F P ostmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or longterm continuation on bone turnover and fracture riska perspective JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 27: (5) pp. 963974. ( 2012)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 73/342
3/30/2015
nyomtatobarat forma W C: Endocrinology & Metabolism Folyóiratcikk [12351748] 383
Ng Kong W ah P otential role of odanacatib in the treatment of osteoporosis CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 7: pp. 235247. ( 2012) Folyóiratcikk [14595295]
384
W ustrack R, Seeman E, BucciRechtweg C, Burch S, Palermo L, Black DM P redictors of new and severe vertebral fractures: results from the HORIZON P ivotal Fracture Trial OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (1) pp. 5358. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12351747]
385
Atkinson Jr AJ, Huang SM, Lertora JJL, Markey SP P rinciples of Clinical P harmacology Elsevier Inc., 2012. (ISBN 9780123854711)
Könyv [13474704] 386
Panuccio V, Enia G, Tripepi R, Aliotta R, Mallamaci F, Tripepi G, Zoccali C P roinflammatory cytokines and bone fractures in CKD patients. An exploratory single centre study BMC Nephrology (ISSN: 14712369) 13: (1) P aper 134. (2012) Folyóiratcikk [13474703]
387
Lewiecki EM, Bilezikian JP, Jankowski LG, McCloskey EV, Miller PD, Morgan SL, Orwoll ES, Potts JT P roceedings of the 2011 Santa Fe Bone Symposium JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 15: (Santa Fe, NM) pp. 120. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12351746]
388
Aft R P rotection of bone in premenopausal women with breast cancer: Focus on zoledronic acid International Journal of Women's Health 4: (1) pp. 569576. ( 2012) Folyóiratcikk [13474702]
389
Hausmann Ralph RANK Ligand Inhibitor protects the Bone ZEITSCHRIFT FUR ORTHOPADIE UND UNFALLCHIRURGIE (ISSN: 18646697) 150: (3) pp. 246246. ( 2012) Folyóiratcikk [14595319]
390
Thomas David M RANKL, denosumab, and giant cell tumor of bone CURRENT OPINION IN ONCOLOGY (ISSN: 10408746) 24: (4) pp. 397403. ( 2012) Folyóiratcikk [14595318]
391
Lippuner K, Buchard PA, De Geyter C, Imthurn B, Lamy O, Litschgi M, Luzuy F, Schiessl K, Stute P, Birkhäuser M Recommendations for raloxifene use in daily clinical practice in the Swiss setting European Spine Journal (ISSN: 09406719) 21: (12) pp. 24072417. ( 2012) Folyóiratcikk [13474701]
392 * Palacios S, Christiansen C, Sánchez Borrego R, Gambacciani M, Hadji P, Karsdal M, Lambrinoudaki I, Lello S, O'beirne B, Romao F, Rozenberg S, Stevenson JC, BenRafael Z Recommendations on the management of fragility fracture risk in women younger than 70 years Gynecological Endocrinology (ISSN: 09513590) 28: (10) pp. 770786. ( 2012) Folyóiratcikk [13474700] 393
Zhao E, W ang L, Dai J, Kryczek I, W ei S, Vatan L, Altuwaijri S, Sparwasser T, W ang G, Keller ET, Zou W Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer OncoImmunology (ISSN: 21624011) 1: (2) pp. 152161. ( 2012) Folyóiratcikk [13474699]
394 * Austin M, Yang YC, Vittinghoff E, Adami S, Boonen S, Bauer DC, Bianchi G, Bolognese MA, Christiansen C, Eastell R, Grauer A, Hawkins F, Kendler DL, Oliveri B, McClung MR, Reid IR, Siris ES, Zanchetta J, Zerbini CAF, Libanati C, Cummings SR Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 27: (3) pp. 687693. ( 2012) CA: FREEDOM Trial Z9: 1 W C: Endocrinology & Metabolism Folyóiratcikk [12351745] 395
W ang Ying, Yang Yunmei Research and application of target therapy for osteoporosis Journal of Shanghai Jiaotong University .Medical Science (ISSN: 16748115) 32: (8) pp. 11011105. ( 2012) Folyóiratcikk [14595294]
396
Greenspan SL, Resnick NM Response to Shil and Greer Journal of the American Geriatrics Society (ISSN: 00028614) 60: (12) p. 2384. ( 2012) Folyóiratcikk [13474698]
397
DiezPerez A, Olmos JM, Nogues X, Sosa M, DiazCuriel M, PerezCastrillon JL, PerezCano R, MunozTorres M, Torrijos A, Jodar E, Del Rio L, CaeiroRey JR, Farrerons J, Vila J, Arnaud C, GonzalezMacias J Risk Factors for P rediction of Inadequate Response to Antiresorptives JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 27: (4) pp. 817824. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12351744]
398
BrownGlaberman U, Stopeck AT Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors Biologics: Targets and Therapy 6: pp. 8999. ( 2012) Folyóiratcikk [13474697]
399
Dempster DW , Lambing CL, Kostenuik PJ, Grauer A Role of RANK Ligand and Denosumab, a Targeted RANK Ligand Inhibitor, in Bone Health and Osteoporosis: A Review of P reclinical and Clinical Data CLINICAL THERAPEUTICS (ISSN: 01492918) 34: (3) pp. 521536. ( 2012)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 74/342
3/30/2015
nyomtatobarat forma W C: Pharmacology & Pharmacy Folyóiratcikk [12351743] 400 * Gatti D, Viapiana O, Fracassi E, Idolazzi L, Dartizio C, Povino MR, Adami S, Rossini M Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab Journal of Bone and Mineral Research (ISSN: 08840431) 27: (11) pp. 22592263. ( 2012) Folyóiratcikk [13474696] 401
Li Tao, Liu Zhi, Sun Tiansheng, Zhang Jianzheng, Dai Heling, Zhu Heyu Secondary contralateral hip fractures following hip fractures in the elderly Chinese Journal of Tissue Engineering Research (ISSN: 16738225) 16: (4) pp. 752756. ( 2012) Folyóiratcikk [14595293]
402
Makras P, Polyzos SA, Anastasilakis AD, Terpos E, Kanakis G, Schini M, Papatheodorou A, Kaltsas GA Serum Osteoprotegerin, RANKL, and Dkk1 Levels in Adults with Langerhans Cell Histiocytosis JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 97: (4) pp. E618E621. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12351742]
403
Mccormick BB, Davis J, Burns KD Severe hypocalcemia following denosumab injection in a hemodialysis patient American Journal of Kidney Diseases (ISSN: 02726386) 60: (4) pp. 626628. ( 2012) Folyóiratcikk [13474695]
404
Sinningen Kathrin, Tsourdi Elena, Rauner Martina, Rachner Tilman D, Hamann Christine, Hofbauer Lorenz C Skeletal and extraskeletal actions of denosumab ENDOCRINE (ISSN: 1355008X) 42: (1) pp. 5262. ( 2012) Folyóiratcikk [14595315]
405
Buckle Clive Henry, De Leenheer Evy, Lawson Michelle Anne, Yong Kwee, Rabin Neil, Perry Mark, Vanderkerken Karen, Croucher Peter Ian Soluble Rank Ligand P roduced by Myeloma Cells Causes Generalised Bone Loss in Multiple Myeloma PLOS ONE (ISSN: 19326203) 7: (8) P aper e41127. (2012) Folyóiratcikk [14595314]
406
Saidak Z, Marie PJ Strontium signaling: Molecular mechanisms and therapeutic implications in osteoporosis Pharmacology and Therapeutics (ISSN: 01637258) 136: (2) pp. 216226. ( 2012) Folyóiratcikk [13474694]
407
Cavalli L, Brandi ML Targeted approaches in the treatment of osteoporosis: Differential mechanism of action of denosumab and clinical utility Therapeutics and Clinical Risk Management (ISSN: 11766336) 8: pp. 253266. ( 2012) Folyóiratcikk [13474693]
408
Landfeldt E, Ström O The comparative gastrointestinal tolerability of proprietary versus generic alendronate in patients treated for primary osteoporosis Bone (ISSN: 87563282) 51: (4) pp. 637642. ( 2012) Folyóiratcikk [13474692]
409 * Goessl Carsten, Katz Leonid, Dougall W illiam C, Kostenuik Paul J, Zoog Holly Brenza, Braun Ada, Dansey Roger, W agman Rachel B The development of denosumab for the treatment of diseases of bone loss and cancerinduced bone destruction Annals of the New York Academy of Sciences (ISSN: 00778923) 1263: pp. 2940. ( 2012) Folyóiratcikk [14595292] 410
Lippuner Kurt The future of osteoporosis treatment a research update SWISS MEDICAL WEEKLY (ISSN: 14247860) 142: P aper w13624. (2012) Folyóiratcikk [14595313]
411
Boyce BF, Rosenberg E, de Papp AE, Duong LT The osteoclast, bone remodelling and treatment of metabolic bone disease European Journal of Clinical Investigation (ISSN: 00142972) 42: (12) pp. 13321341. ( 2012) Folyóiratcikk [13474691]
412
Cotter Aoife G, Mallon Patrick W G Therapeutic Options for Low Bone Mineral Density in HIVInfected Subjects CURRENT HIV/AIDS REPORTS (ISSN: 15483568) 9: (2) pp. 148159. ( 2012) Folyóiratcikk [14595312]
413
Malberti F Treatment of immobilizationrelated hypercalcaemia with denosumab Clinical Kidney Journal 5: (6) pp. 491495. ( 2012) Folyóiratcikk [13474690]
414
Eriksen Erik Fink Treatment of osteopenia REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (ISSN: 13899155) 13: (3) pp. 209223. ( 2012) Folyóiratcikk [14595311]
415
Bedrač SM, Zupan J, Kocjan T, Mlakar V, Preželj J, Marc J, Ostanek B Treatment of osteoporosis now and in the future Farmacevtski Vestnik (ISSN: 00148229) 63: (56) pp. 279289. ( 2012) Folyóiratcikk [13474689]
416
Galluzzi L, Vacchelli E, Fridman W H, Galon J, SautèsFridman C, Tartour E, ZucmanRossi J, Zitvogel L, Kroemer G Trial watch: Monoclonal antibodies in cancer therapy OncoImmunology (ISSN: 21624011) 1: (1) pp. 2837. ( 2012) Folyóiratcikk [13474688]
417
Eiken PA, BraskLindemann D, Vestbo J, Langdahl BL, Abrahamsen B Udredning og behandling af osteoporose hos patienter med kronisk obstruktiv lungesygdom Ugeskrift for Laeger (ISSN: 00415782) 174: (47) pp. 29222926. ( 2012) Folyóiratcikk [13474687]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 75/342
3/30/2015
nyomtatobarat forma 418
Muschitz C, FahrleitnerPammer A, Huber J, Preisinger E, Kudlacek S, Resch H Update on denosumab in postmenopausal osteoporosisrecent clinical data Wiener Medizinische Wochenschrift (ISSN: 00435341) 162: (1718) pp. 374379. ( 2012) Folyóiratcikk [13474686]
419
Paccou J, Brazier M, Mentaverri R, Kamel S, Fardellone P, Massy ZA Vascular calcification in rheumatoid arthritis: P revalence, pathophysiological aspects and potential targets Atherosclerosis (ISSN: 00219150) 224: (2) pp. 283290. ( 2012) Folyóiratcikk [13474685]
420
Trémollières F What patients need to know about the risk of bone fracture and its prevention Journal de Gynecologie Obstetrique et Biologie de la Reproduction (ISSN: 03682315) 41: (7 SUP P L.) pp. F20F27. ( 2012) Folyóiratcikk [13474684]
421
Fiore CE, Gaudio A When the FRAX® test is applied to controlled clinical trials Clinical Cases in Mineral and Bone Metabolism 9: (3) pp. 135137. ( 2012) Folyóiratcikk [13474683]
422
Chinese Journal of Thoracic and Cardiovascular Surgery (ISSN: 10014497) 29: (4) pp. 233236. ( 2013) Folyóiratcikk [14595350]
423
Paparodis R, Buehring B, Pelley EM, Binkley N A case of an unusual subtrochanteric fracture in a patient receiving denosumab Endocrine Practice (ISSN: 1530891X) 19: (3) pp. e64e68. ( 2013) Folyóiratcikk [13474682]
424
Förster AN, Hermann R, Derendorf H A female patient with heart arrhythmia Deutsche Apotheker Zeitung 153: (33) pp. 4855. ( 2013) Folyóiratcikk [13474681]
425
Tarantino U, Celi M, Feola M, Liuni FM, Resmini G, Iolascon G A new antiresorptive approach to the treatment of fragility fractures: Longterm efficacy and safety of denosumab Aging Clinical and Experimental Research 25: (1 SUP P L.) pp. S65S69. ( 2013) Folyóiratcikk [13474680]
426
Liu D, Ahmet A, W ard L, Krishnamoorthy P, Mandelcorn ED, Leigh R, Brown JP, Cohen A, Kim H A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy Allergy, Asthma and Clinical Immunology (ISSN: 17101484) 9: (1) P aper 30. (2013) Folyóiratcikk [13474679]
427
Kandel L, Schler D, Brezis M, Liebergall M, Mattan Y, DresnerPollak R A simple intervention for improving the implementation rate of a recommended osteoporosis treatment after hip fracture Endocrine Practice (ISSN: 1530891X) 19: (1) pp. 4650. ( 2013) Folyóiratcikk [13474678]
428
Papaneophytou CP, Rinotas V, Douni E, Kontopidis G A statistical approach for optimization of RANKL overexpression in Escherichia coli: P urification and characterization of the protein Protein Expression and Purification (ISSN: 10465928) 90: (1) pp. 919. ( 2013) Folyóiratcikk [13474677]
429
Stavraka C, Maclaran K, Gabra H, Agarwal R, GhaemMaghami S, Taylor A, Dhillo W S, Panay N, Blagden SP A study to evaluate the cause of bone demineralization in gynecological cancer survivors Oncologist (ISSN: 10837159) 18: (4) pp. 423429. ( 2013) Folyóiratcikk [13474676]
430
W ang Juan, Yu Yu, W ang Qunbo A systematic meta review of denosumab injection in treatment of postmeno pausal osteoporosis Chinese Journal of New Drugs and Clinical Remedies (ISSN: 10077669) 32: (11) pp. 885891. ( 2013) Folyóiratcikk [14595370]
431
Sutcliffe P, Connock M, Shyangdan D, Court R, Kandala NB, Clarke A A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression HEALTH TECHNOLOGY ASSESSMENT (ISSN: 13665278) 17: (42) pp. 1+. ( 2013) Folyóiratcikk [14595391]
432
W an X, Zhao Y, Burge R, Jiang Y Actions of osteoporosis treatments on bone histomorphometric remodeling: a twofold principal component analysis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 24: (12) pp. 30113019. ( 2013) Folyóiratcikk [14595445]
433
Rauner M, Sipos W , Thiele S, Pietschmann P Advances in osteoimmunology: P athophysiologic concepts and treatment opportunities International Archives of Allergy and Immunology (ISSN: 10182438) 160: (2) pp. 114125. ( 2013) Folyóiratcikk [13474675]
434
O'Malley G, Ryan J, O'Sullivan F, Shanahan E, Sheehy C, Carew S, Ryan C, Costello A, O'Connor C, O'Connor M, Peters C, Lyons D An Assessment of the Effect of Donusemab on Orthostatic Hypotension IRISH JOURNAL OF MEDICAL SCIENCE (ISSN: 00211265) 182: pp. S235S235. ( 2013) SU 6 Folyóiratcikk [14595390]
435
Kaufman JM, Palacios S, Silverman S, Sutradhar S, Chines A An evaluation of the Fracture Risk Assessment Tool (FRAX®) as an indicator of treatment efficacy: The effects of bazedoxifene and raloxifene on vertebral, nonvertebral, and all clinical fractures as a function of baseline fracture risk assessed by FRAX® Osteoporosis International (ISSN: 0937941X) 24: (10) pp. 25612569. ( 2013) N1 Funding Details: Pfizer Folyóiratcikk [13474674]
436
Ruggiero SL An officebased approach to the diagnosis and management of osteonecrosis
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 76/342
3/30/2015
nyomtatobarat forma Atlas of the Oral and Maxillofacial Surgery Clinics of North America 21: (2) pp. 167173. ( 2013) Folyóiratcikk [13474673] 437
Olsen KR, Hansen C, Abrahamsen B Association between refill compliance to oral bisphosphonate treatment, incident fractures, and health care costs An analysis using national health databases Osteoporosis International (ISSN: 0937941X) 24: (10) pp. 26392647. ( 2013) Folyóiratcikk [13474672]
438
Forstein DA, Bernardini C, Cole RE, Harris ST, Singer A Before the breaking point: Reducing the risk of osteoporotic fractuze Journal of the American Osteopathic Association 113: (2 SUP P L1) pp. S5S24. ( 2013) Folyóiratcikk [13474671]
439
Dimitroulas T, Nikas SN, Trontzas P, Kitas GD Biologic therapies and systemic bone loss in rheumatoid arthritis Autoimmunity Reviews (ISSN: 15689972) 12: (10) pp. 958966. ( 2013) Folyóiratcikk [13474670]
440
Barrio Pablo, Hidalgo Diego, Udina Marc Bipolar Depressive Recurrence Following Treatment with the Human Monoclonal Antibody Denosumab: A Case Report BIOLOGICAL PSYCHIATRY (ISSN: 00063223) 74: (12) pp. E37E38. ( 2013) Folyóiratcikk [14595444]
441
W ong PK, Borromeo GL, W ark JD Bisphosphonaterelated osteonecrosis of the jaw in nonmalignant bone disease Rheumatology International (ISSN: 01728172) 33: (9) pp. 21892198. ( 2013) Folyóiratcikk [13474669]
442
Bock O, Felsenberg D Bisphosphonates are no contraindication for dental implants Internistische Praxis 53: (3) pp. 593598. ( 2013) Folyóiratcikk [13474668]
443
Brixen K, Chapurlat R, Cheung AM, Keaveny TM, Fuerst T, Engelke K, Recker R, Dardzinski B, Verbruggen N, Ather S, Rosenberg E, De Papp AE Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: A randomized trial Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 98: (2) pp. 571580. ( 2013) Folyóiratcikk [13474667]
444
Edwards W B, Schnitzer TJ, Troy KL Bone mineral loss at the proximal femur in acute spinal cord injury Osteoporosis International (ISSN: 0937941X) 24: (9) pp. 24612469. ( 2013) Folyóiratcikk [13474666]
445
Roza T, Hakim L, Van Poppel H, Joniau S Bonetargeted therapies for elderly patients with renal cell carcinoma: Current and future directions Drugs and Aging 30: (11) pp. 877886. ( 2013) Folyóiratcikk [13474665]
446
Cheung Angela M, Heisey Ruth, Srighanthan Jeevitha Breast cancer and osteoporosis CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (ISSN: 1752296X) 20: (6) pp. 532538. ( 2013) Folyóiratcikk [14595443]
447
Parthan A, Emptage NP, Taylor DCA, Viswanathan HN, Yurgin N, Stolshek B, Clements KM, Tao CY, W einstein MC Budgetary impact analysis of denosumab in a US health plan American Journal of Pharmacy Benefits 5: (5) pp. e129e138. ( 2013) Folyóiratcikk [13474664]
448
Åkesson K, Marsh D, Mitchell PJ, McLellan AR, Stenmark J, Pierroz DD, Kyer C, Cooper C Capture the Fracture: A Best P ractice Framework and global campaign to break the fragility fracture cycle Osteoporosis International (ISSN: 0937941X) 24: (8) pp. 21352152. ( 2013) Folyóiratcikk [13474663]
449
Hilbe W , Abacioglu U, Aebersold DM, Bachouchi M, Brodowicz T, Gaafar R, Holzer G, MohnStaudner A, Kalev D, KalinkaW arzocha E, Kovac V, Siano M, Yumuk F, Tamasi L CECOG experts' recommendations on the use of denosumab in the prevention of skeletalrelated events in bone metastases of lung cancer Memo Magazine of European Medical Oncology 6: (2) pp. 7582. ( 2013) Folyóiratcikk [13474662]
450
Krieckaert CLM, Nurmohamed MT, W olbink G, Lems W F Changes in bone mineral density during longterm treatment with adalimumab in patients with rheumatoid arthritis: A cohort study Rheumatology (United Kingdom) 52: (3) pp. 547553. ( 2013) Folyóiratcikk [13474661]
451
Rianon N, Anand D, Rasu R Changing trends in osteoporosis care from specialty to primary care physicians Current Medical Research and Opinion (ISSN: 03007995) 29: (8) pp. 881888. ( 2013) Folyóiratcikk [13474660]
452
Larina VN, Bart BYa, Raspopova TN Chronic heart failure and osteoporosis Kardiologiya (ISSN: 00229040) 53: (6) pp. 7684. ( 2013) Folyóiratcikk [13474659]
453
Croft M, Benedict CA, W are CF Clinical targeting of the TNF and TNFR superfamilies Nature Reviews Drug Discovery (ISSN: 14741776) 12: (2) pp. 147168. ( 2013) Folyóiratcikk [13474658]
454
Anastasilakis AD, Polyzos SA, Gkiomisi A, Bisbinas I, Gerou S, Makras P Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf1 levels of naive postmenopausal women with low bone mass: A randomized, headtohead clinical trial
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 77/342
3/30/2015
nyomtatobarat forma Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 98: (8) pp. 32063212. ( 2013) Folyóiratcikk [13474657] 455
Leitner H Congress report: Osteoporosis We can still do better Journal fur Mineralstoffwechsel 20: (2) pp. 7576. ( 2013) Folyóiratcikk [13474656]
456
Dimai HP Congress report: Osteoporosis treatment undergoing change: The cortical bone structure in focus Journal fur Mineralstoffwechsel 20: (2) pp. 7273. ( 2013) Folyóiratcikk [13474655]
457
Parthan A, Kruse M, Yurgin N, Huang J, Viswanathan HN, Taylor D Cost effectiveness of denosumab versus oral bisphosphonates for postmenopausal osteoporosis in the US Applied Health Economics and Health Policy (ISSN: 11755652) 11: (5) pp. 485497. ( 2013) N1 Funding Details: Amgen Folyóiratcikk [13474654]
458
Hiligsmann M, Boonen A, Dirksen CD, Sedrine W B, Reginster JY Costeffectiveness of denosumab in the treatment of postmenopausal osteoporotic women Expert Review of Pharmacoeconomics and Outcomes Research 13: (1) pp. 1928. ( 2013) Folyóiratcikk [13474653]
459
Osako MK, Nakagami H, Shimamura M, Koriyama H, Nakagami F, Shimizu H, Miyake T, Yoshizumi M, Rakugi H, Morishita R Crosstalk of receptor activator of nuclear factorkB ligand signaling with reninAngiotensin system in vascular calcification Arteriosclerosis, Thrombosis, and Vascular Biology 33: (6) pp. 12871296. ( 2013) Folyóiratcikk [13474652]
460
Singh H, Goyal M, Singh J, Arora E, Natt NK Current and emerging trends in pharmacological management of osteoporosis International Journal of Pharmaceutical Sciences Review and Research 21: (2) pp. 143147. ( 2013) Folyóiratcikk [13474651]
461
Honig S, Rajapakse CS, Chang G Current treatment approaches to osteoporosis2013 Bulletin of the NYU Hospital for Joint Diseases (ISSN: 08839344) 71: (3) pp. 184188. ( 2013) Folyóiratcikk [13474650]
462
Skácelová M, Horák P, Žurek M Current treatment options for osteoporosis Interni Medicina pro Praxi (ISSN: 12127299) 15: (89) pp. 249253. ( 2013) Folyóiratcikk [13474649]
463
Reddy MS, Morgan SL Decreased bone mineral density and periodontal management Periodontology 2000 (ISSN: 09066713) 61: (1) pp. 195218. ( 2013) Folyóiratcikk [13474648]
464
CatingCabral MT, Clarke BL Denosumab and atypical femur fractures Maturitas (ISSN: 03785122) 76: (1) pp. 12. ( 2013) Folyóiratcikk [13474647]
465 * Recknor C, Czerwinski E, Bone HG, Bonnick SL, Binkley N, Palacios S, Moffett A, Siddhanti S, Ferreira I, Ghelani P, W agman RB, Hall JW , Bolognese MA, Benhamou CL Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: A Randomized OpenLabel Trial Obstetrics and Gynecology (ISSN: 00297844) 121: (6) pp. 12911299. ( 2013) Folyóiratcikk [13474646] 466 * McClung MR, Zanchetta JR, Høiseth A, Kendler DL, Yuen CK, Brown JP, Stonkus S, Goemaere S, Recknor C, W oodson GC, Bolognese MA, Franek E, Brandi ML, W ang A, Libanati C Denosumab densitometric changes assessed by quantitative computed tomography at the spine and hip in postmenopausal women with osteoporosis Journal of Clinical Densitometry (ISSN: 10946950) 16: (2) pp. 250256. ( 2013) Folyóiratcikk [13474644] 467
SilvaFernández L, Rosario MP, MartínezLópez JA, Carmona L, Loza E Denosumab for the treatment of osteoporosis: A systematic literature review Reumatologia Clinica (ISSN: 1699258X) 9: (1) pp. 4252. ( 2013) Folyóiratcikk [13474643]
468
Drooger JC, Van Der Padt A, Sleijfer S, Jager A Denosumab in breast cancer treatment European Journal of Pharmacology (ISSN: 00142999) 717: (13) pp. 1219. ( 2013) Folyóiratcikk [13474642]
469
Pichardo SEC, Kuypers SCC, Van Merkesteyn JPR Denosumab osteonecrosis of the mandible: A new entity? A case report Journal of CranioMaxillofacial Surgery (ISSN: 10105182) 41: (4) pp. e65e69. ( 2013) Folyóiratcikk [13474641]
470 * Bolognese MA, Teglbjærg CS, Zanchetta JR, Lippuner K, McClung MR, Brandi ML, Høiseth A, Lakatos P, Moffett AH, Lorenc RS, W ang A, Libanati C Denosumab significantly increases DXA BMD at both trabecular and cortical sites: Results from the FREEDOM study Journal of Clinical Densitometry (ISSN: 10946950) 16: (2) pp. 147153. ( 2013) Folyóiratcikk [13474640] 471
Farinola N, Kanjanapan Y Denosumabinduced hypocalcaemia in high bone turnover states of malignancy and secondary hyperparathyroidism from renal failure INTERNAL MEDICINE JOURNAL (ISSN: 14440903) 43: (11) pp. 12431246. ( 2013) Folyóiratcikk [14595389]
472
Josse R, Khan A, Ngui D, Shapiro M
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 78/342
3/30/2015
nyomtatobarat forma Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis Current Medical Research and Opinion (ISSN: 03007995) 29: (3) pp. 205216. ( 2013) Folyóiratcikk [13474639] 473
Lewin J, Thomas D DENOSUMAB: A NEW TREATMENT OP TION FOR GIANT CELL TUMOR OF BONE DRUGS OF TODAY (ISSN: 16993993) 49: (11) pp. 693700. ( 2013) Folyóiratcikk [14595388]
474
Jiang X, Schnatz PF Denosumab: An antifracture therapy for postmenopausal women with osteoporosis Menopause 20: (2) pp. 117119. ( 2013) Folyóiratcikk [13474638]
475
Zhang C, Ibrahim PN, Zhang J, Burton EA, Habets G, Zhang Y, Powell B, W est BL, Matusow B, Tsang G, Shellooe R, Carias H, Nguyen H, Marimuthu A, Zhang KYJ, Oh A, Bremer R, Hurt CR, Artis DR, W u G, Nespi M, Spevak W , Lin P, Nolop K, Hirth P, Tesch GH, Bollag G Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor Proceedings of the National Academy of Sciences of the United States of America (ISSN: 00278424) 110: (14) pp. 5689 5694. ( 2013) Folyóiratcikk [13474637]
476
Takami M Development and pharmacological effects of antiRANKL monoclonal antibody drug denosumab Japanese Journal of Clinical Immunology 36: (3) pp. 162169. ( 2013) Folyóiratcikk [13474636]
477
Diab DL, W atts NB Diagnosis and Treatment of Osteoporosis in Older Adults Endocrinology and Metabolism Clinics of North America (ISSN: 08898529) 42: (2) pp. 305317. ( 2013) Folyóiratcikk [13474635]
478
W ilczek ML, Kälvesten J, Algulin J, Beiki O, Brismar TB Digital Xray radiogrammetry of hand or wrist radiographs can predict hip fracture risk A study in 5,420 women and 2,837 men European Radiology (ISSN: 09387994) 23: (5) pp. 13831391. ( 2013) Folyóiratcikk [13474634]
479 * Brown JP, Roux C, Törring O, Ho PR, Beck Jensen JE, Gilchrist N, Recknor C, Austin M, W ang A, Grauer A, W agman RB Discontinuation of denosumab and associated fracture incidence: Analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial Journal of Bone and Mineral Research (ISSN: 08840431) 28: (4) pp. 746752. ( 2013) Folyóiratcikk [13474633] 480
Bolland MJ, Jackson R, Gamble GD, Grey A Discrepancies in predicted fracture risk in elderly people BMJ (Online) 346: (7892) P aper e8669. (2013) Folyóiratcikk [13474632]
481
Decani S, Baruzzi E, Martini V, Ficarra G, Lodi G Drugrelated oral conditions Dental Cadmos 81: (2) pp. 7691. ( 2013) Folyóiratcikk [13474631]
482 * McClung MR, Lewiecki EM, Geller ML, Bolognese MA, Peacock M, W einstein RL, Ding B, Rockabrand E, W agman RB, Miller PD Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8year results of a phase 2 clinical trial Osteoporosis International (ISSN: 0937941X) 24: (1) pp. 227235. ( 2013) Folyóiratcikk [13474630] 483 * Lindsay R, W atts NB, Lange JL, Delmas PD, Silverman SL Effectiveness of risedronate and alendronate on nonvertebral fractures: An observational study through 2 years of therapy Osteoporosis International (ISSN: 0937941X) 24: (8) pp. 23452352. ( 2013) Folyóiratcikk [13474629] 484 * Schwartz AV, Schafer AL, Grey A, Vittinghoff E, Palermo L, Lui LYL, W allace RB, Cummings SR, Black DM, Bauer DC, Reid IR Effects of antiresorptive therapies on glucose metabolism: Results from the FIT, HORIZONP FT, and FREEDOM trials Journal of Bone and Mineral Research (ISSN: 08840431) 28: (6) pp. 13481354. ( 2013) Folyóiratcikk [13474628] 485
Iolascon G, Resmini G, Tarantino U Effects of denosumab on cortical and trabecular microarchitecture: Evidences from clinical studies Aging Clinical and Experimental Research 25: (1 SUP P L.) pp. S19S22. ( 2013) Folyóiratcikk [13474627]
486
Omodei U, Mazziotti G, Donarini G, Gola M, Guella V, Pagani F, Bugari G, Porcelli T, Giustina A Effects of recombinant folliclestimulating hormone on bone turnover markers in infertile women undergoing in vitro fertilization procedure Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 98: (1) pp. 330336. ( 2013) Folyóiratcikk [13474626]
487
Rauner M, Thiele S, Sinningen K, W inzer M, SalbachHirsch J, Gloe I, Peschke K, Haegeman G, Tuckermann JP, Hofbauer LC Effects of the selective glucocorticoid receptor modulator compound a on bone metabolism and inflammation in male mice with collageninduced arthritis Endocrinology (ISSN: 00137227) 154: (10) pp. 37193728. ( 2013) N1 Funding Details: RA1923/41, DFG, Deutsche Forschungsgemeinschaft Folyóiratcikk [13474624]
488
Pathan E, Abraham S, Van Rossen E, W ithrington R, Keat A, Charles PJ, Paterson E, Chowdhury M, McClinton C, Taylor PC Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis Annals of the Rheumatic Diseases (ISSN: 00034967) 72: (9) pp. 14751480. ( 2013) Folyóiratcikk [13474623]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 79/342
3/30/2015
nyomtatobarat forma 489
Petranova T, Sheytanov I, Monov S, Rashkov R, Kinov P Efficacy of denosumab for control of bone mineral density and microarchitecture in postmenopausal women with osteoporosis: A oneyear experience Biotechnology and Biotechnological Equipment 27: (4) pp. 39773981. ( 2013) Folyóiratcikk [13474622]
490
CataláLópez F, SanfélixGimeno G, Tobías A, Hurtado I, SanfélixGenovés J, Peiró S Efficacy of osteoporosis therapies in a network metaanalysis with indirect comparisons: Many concerns for new tools of evidence synthesis? Osteoporosis International (ISSN: 0937941X) 24: (6) pp. 19271928. ( 2013) Folyóiratcikk [13474621]
491
Lems W F, den Heijer M Established and forthcoming drugs for the treatment of osteoporosis Netherlands Journal of Medicine (ISSN: 03002977) 71: (4) pp. 188193. ( 2013) Folyóiratcikk [13474620]
492
Lin TH, Yang RS, W ang KC, Lu DH, Liou HC, Ma Y, Chang SH, Fu W M Ethanol extracts of fresh Davallia formosana (WL1101) inhibit osteoclast differentiation by suppressing RANKLinduced nuclear factorκB activation Evidencebased Complementary and Alternative Medicine (ISSN: 1741427X) 2013: P aper 647189. (2013) Folyóiratcikk [13474619]
493
Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporosis International (ISSN: 0937941X) 24: (1) pp. 2357. ( 2013) Folyóiratcikk [13474618]
494
Chen Andy B, Zhang Ping, Yokota Hiroki Evaluating treatment of osteoporosis using particle swarm on a bone remodelling mathematical model IET SYSTEMS BIOLOGY (ISSN: 17518849) 7: (6) pp. 231242. ( 2013) Folyóiratcikk [14595442]
495
Paternoster L, Lorentzon M, Lehtimäki T, Eriksson J, Kähönen M, Raitakari O, Laaksonen M, Sievänen H, Viikari J, Lyytikäinen LP, Mellström D, Karlsson M, Ljunggren Ö, Grundberg E, Kemp JP, Sayers A, Nethander M, Evans DM, Vandenput L, Tobias JH, Ohlsson C Genetic Determinants of Trabecular and Cortical Volumetric Bone Mineral Densities and Bone Microstructure PLoS Genetics (ISSN: 15537390) 9: (2) P aper e1003247. (2013) Folyóiratcikk [13474617]
496
Kocjan T, Preželj J, Pfeifer M, Jensterle Sever M, Čokolič M, Zavratnik A Guidelines for the detection and treatment of osteoporosis Zdravniski Vestnik 82: (4) pp. 207217. ( 2013) Hiányzó nyelv: 'English; Slovenian' Folyóiratcikk [13474616]
497
Schurman L, Bagur A, ClausHermberg H, Messina OD, Negri AL, Sánchez A, González C, Diehl M, Rey P, Gamba J, Chiarpenello J, Moggia MS, Mastaglia S Guidelines for the diagnosis, prevention and treatment of osteoporosis, 2012 Medicina (Argentina) 73: (1) pp. 5574. ( 2013) Hiányzó nyelv: 'English; Spanish' Folyóiratcikk [13474615]
498
Schurman L, Bagur A, ClausHermberg H, Messina OD, Negri AL, Sánchez A, González C, Diehl M, Rey P, Gamba J, Chiarpenello J, Moggia MS, Mastaglia S Guidelines for the diagnosis, prevention, and treatment of osteoporosis 2012 Actualizaciones en Osteologia 9: (2) pp. 4474. ( 2013) Hiányzó nyelv: 'English; Spanish' Folyóiratcikk [13474614]
499
Brandi ML Healing of the bone with antifracture drugs Expert Opinion on Pharmacotherapy (ISSN: 14656566) 14: (11) pp. 14411447. ( 2013) Folyóiratcikk [13474613]
500
Hiligsmann M, Kanis JA, Compston J, Cooper C, Flamion B, Bergmann P, Body JJ, Boonen S, Bruyere O, Devogelaer JP, Goemaere S, Kaufman JM, Rozenberg S, Reginster JY Health technology assessment in osteoporosis Calcified Tissue International (ISSN: 0171967X) 93: (1) pp. 114. ( 2013) Folyóiratcikk [13474612]
501
MartínBaez IM, BlancoGarcía R, AlonsoSuárez M, CossioAranibar C, BeatoCoo LV, FernándezFleming F Hipocalcemia severa posdenosumab Nefrologia (ISSN: 02116995) 33: (4) pp. 614615. ( 2013) Folyóiratcikk [13474611]
502
McGowan B, Casey MC, Silke C, W helan B, Bennett K Hospitalisations for fracture and associated costs between 2000 and 2009 in Ireland: A trend analysis Osteoporosis International (ISSN: 0937941X) 24: (3) pp. 849857. ( 2013) Folyóiratcikk [13474610]
503
BrownGlaberman U, Stopeck AT Impact of denosumab on bone mass in cancer patients Clinical Pharmacology: Advances and Applications 5: pp. 117129. ( 2013) Folyóiratcikk [13474609]
504 * Simon JA, Recknor C, Moffett AH, Adachi JD, Franek E, Lewiecki EM, McClung MR, Mautalen CA, RagiEis S, Nicholson GC, Muschitz C, Nuti R, Törring O, W ang A, Libanati C Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: Bone density, mass, and strength of the radius, and wrist fracture Menopause 20: (2) pp. 130137. ( 2013) Folyóiratcikk [13474608] 505 * Genant HK, Libanati C, Engelke K, Zanchetta JR, Høiseth A, Yuen CK, Stonkus S, Bolognese MA, Franek E, Fuerst T, Radcliffe HS, McClung MR
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 80/342
3/30/2015
nyomtatobarat forma Improvements in hip trabecular, subcortical, and cortical density and mass in postmenopausal women with osteoporosis treated with denosumab Bone (ISSN: 87563282) 56: (2) pp. 482488. ( 2013) Folyóiratcikk [13474607] 506
Neyro JL, Cancelo MJ, Palacios S Inhibition of RANKL in the pathophysiology of osteoporosis. Evidence clinical use Ginecologia y Obstetricia de Mexico 81: (3) pp. 146157. ( 2013) Hiányzó nyelv: 'English; Spanish' Folyóiratcikk [13474606]
507
Ström O, Jönsson B, Kanis JA Intervention thresholds for denosumab in the UK using a FRAX®based costeffectiveness analysis Osteoporosis International (ISSN: 0937941X) 24: (4) pp. 14911502. ( 2013) Folyóiratcikk [13474605]
508
Shen PC, Lu CS, Shiau AL, Lee CH, Jou IM, Hsieh JL Lentiviral small hairpin RNA knockdown of macrophage inflammatory protein1γ ameliorates experimentally induced osteoarthritis in mice Human Gene Therapy (ISSN: 10430342) 24: (10) pp. 871882. ( 2013) Folyóiratcikk [13474604]
509
Ungprasert Patompong, Cheungpasitporn W isit, Srivali Narat, Kittanamongkolchai W onngarm, Bischof Edward F Lifethreatening hypocalcemia associated with denosumab in a patient with moderate renal insufficiency AMERICAN JOURNAL OF EMERGENCY MEDICINE (ISSN: 07356757) 31: (4) P aper 756.e1. (2013) Folyóiratcikk [14595369]
510
Anonymus Medicines safety update Australian Prescriber (ISSN: 03128008) 36: (2) p. §. ( 2013) Folyóiratcikk /Rövid közlemény /Tudományos [13474603]
511
Lewiecki EM Monoclonal antibodies for the treatment of osteoporosis Expert Opinion on Biological Therapy (ISSN: 14712598) 13: (2) pp. 183196. ( 2013) Folyóiratcikk [13474602]
512
Kukita A, Kukita T Multifunctional properties of RANKL/RANK in cell differentiation, proliferation and metastasis Future Oncology (ISSN: 14796694) 9: (11) pp. 16091622. ( 2013) Folyóiratcikk [13474601]
513
Silbermann R, Roodman GD Myeloma bone disease: P athophysiology and management Journal of Bone Oncology 2: (2) pp. 5969. ( 2013) Folyóiratcikk [13474600]
514
Gralow JR, Biermann JS, Farooki A, Fornier MN, Gagel RF, Kumar R, Litsas G, McKay R, Podoloff DA, Srinivas S, Van Poznak CH NCCN task force report: Bone health in cancer care JNCCN Journal of the National Comprehensive Cancer Network 11: (SUP P L.3) pp. S1S50. ( 2013) Folyóiratcikk [13474599]
515
Saylor PJ, Armstrong AJ, Fizazi K, Freedland S, Saad F, Smith MR, Tombal B, Pienta K New and emerging therapies for bone metastases in genitourinary cancers European Urology (ISSN: 03022838) 63: (2) pp. 309320. ( 2013) Folyóiratcikk [13474598]
516
Eriksen EF, Halse J, Moen MH New developments in the treatment of osteoporosis Acta Obstetricia et Gynecologica Scandinavica (ISSN: 00016349) 92: (6) pp. 620636. ( 2013) Folyóiratcikk [13474597]
517 * Bucur RC, Reid LS, Hamilton CJ, Cummings SR, Jamal SA Nitrates and bone turnover (NABT) trial to select the best nitrate preparation: Study protocol for a randomized controlled trial Trials (ISSN: 17456215) 14: (1) P aper 284. (2013) Folyóiratcikk [13474596] 518
Imai Y, Youn MY, Inoue K, Takada I, Kouzmenko A, Kato S Nuclear receptors in bone physiology and diseases Physiological Reviews (ISSN: 00319333) 93: (2) pp. 481523. ( 2013) Folyóiratcikk [13474595]
519 * Reid IR, Bolland MJ Observational studies Just telling us what we want to hear or telling us where we need to look? Journal of Bone and Mineral Research (ISSN: 08840431) 28: (5) pp. 980983. ( 2013) Folyóiratcikk [13474594] 520
Anonymous OSHK TASK GROUP FOR THE FORMULATION OF THE 2013 OSHK GUIDELINE FOR CLINICAL MANAGEMENT OF P OSTMENOP AUSAL OSTEOP OROSIS IN HONG KONG HONG KONG MEDICAL JOURNAL (ISSN: 10242708) 19: (2) pp. 640. ( 2013) SU 2 Folyóiratcikk [14595368]
521
Das Subhajit, Crockett Julie C Osteoporosis a current view of pharmacological prevention and treatment DRUG DESIGN DEVELOPMENT AND THERAPY (ISSN: 11778881) 7: pp. 435447. ( 2013) Folyóiratcikk [14595349]
522
W arriner AH, Saag KG Osteoporosis Diagnosis and Medical Treatment Orthopedic Clinics of North America (ISSN: 00305898) 44: (2) pp. 125135. ( 2013) Folyóiratcikk [13474593]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 81/342
3/30/2015
nyomtatobarat forma 523
Ricciardi BF, Paul J, Kim A, Russell LA, Lane JM Osteoporosis drug therapy strategies in the setting of diseasemodifying agents for autoimmune disease Osteoporosis International (ISSN: 0937941X) 24: (2) pp. 423432. ( 2013) Folyóiratcikk [13474592]
524
Marcus R Osteoporosis in Adults In: Nutrition in the Prevention and Treatment of Disease. Elsevier Inc., 2013. (ISBN 9780123918840) pp. 859877.
Könyvrészlet [13474591] 525
Romme Elisabeth A P M, Smeenk Frank W J M, Rutten Erica P A, W outers Emiel F M Osteoporosis in chronic obstructive pulmonary disease EXPERT REVIEW OF RESPIRATORY MEDICINE (ISSN: 17476348) 7: (4) pp. 397410. ( 2013) Folyóiratcikk [14595387]
526
Romme EAMP, Smeenk FW JM, W outers EFM, Rutten EPA Osteoporosis in COP D European Respiratory Monograph (ISSN: 1025448X) 59: pp. 93104. ( 2013) Folyóiratcikk [13474590]
527
Ebeling PR Osteoporosis in men Current Opinion in Rheumatology (ISSN: 10408711) 25: (4) pp. 542552. ( 2013) Folyóiratcikk [13474589]
528
Stompór T, Zablocki M, Lesiów M Osteoporosis in mineral and bone disorders of chronic kidney disease Polskie Archiwum Medycyny Wewnetrznej 123: (6) pp. 314320. ( 2013) Folyóiratcikk [13474588]
529
Sanders Suzanne, Geraci Stephen A Osteoporosis in P ostmenopausal Women: Considerations in P revention and Treatment (Women's Health Series) SOUTHERN MEDICAL JOURNAL (ISSN: 00384348) 106: (12) pp. 698706. ( 2013) Folyóiratcikk [14595441]
530
Sindel Dilsad Osteoporosis Treatment at P resent and in the Future TURKIYE FIZIKSEL TIP VE REHABILITASYON DERGISITURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION (ISSN: 13020234) 59: (4) pp. 330337. ( 2013) Folyóiratcikk [14595440]
531 * Reid Ian R Osteoporosis treatment: Focus on safety EUROPEAN JOURNAL OF INTERNAL MEDICINE (ISSN: 09536205) 24: (8) pp. 691697. ( 2013) Folyóiratcikk [14595439] 532 * Adami Silvano, Idolazzi Luca, Fracassi Elena, Gatti Davide, Rossini Maurizio Osteoporosis Treatment: When to Discontinue and When to Restart BONE RESEARCH (ISSN: 20954700) 4: pp. 323335. ( 2013) Folyóiratcikk [14595438] 533
Gonçalves MJ, Rodrigues AM, Canhão H, Fonseca JE Osteoporosis: From bone biology to individual treatment decision Acta Medica Portuguesa (ISSN: 16460758) 26: (4) pp. 445455. ( 2013) Hiányzó nyelv: 'English; Portuguese' Folyóiratcikk [13474587]
534
Ziller V Osteoporosis: Guidelinecompliant diagnosis and treatment Gynakologe (ISSN: 00175994) 46: (4) pp. 225231. ( 2013) Folyóiratcikk [13474586]
535
Silva Barbara C, Costa Aline G, Cusano Natalie E, Bilezikian John P Osteoporosis: What's New and on the Horizon CLINICAL OBSTETRICS AND GYNECOLOGY (ISSN: 00099201) 56: (4) pp. 730738. ( 2013) Folyóiratcikk [14595386]
536
Freye R Osteoporosis. Loss of bone substance: Localization is agedependent Medizinische Monatsschrift fur Pharmazeuten 36: (9) pp. 349350. ( 2013) Folyóiratcikk [13474585]
537
Augoulea A, Vrachnis N, Lambrinoudaki I, Dafopoulos K, Iliodromiti Z, Daniilidis A, Varras M, Alexandrou A, Deligeoroglou E, Creatsas G Osteoprotegerin as a marker of atherosclerosis in diabetic patients International Journal of Endocrinology (ISSN: 16878337) 2013: P aper 182060. (2013) Folyóiratcikk [13474584]
538
W eiss RM, Lund DD, Chu Y, Brooks RM, Zimmerman KA, Accaoui RE, Davis MK, Hajj GP, Zimmerman MB, Heistad DD Osteoprotegerin Inhibits Aortic Valve Calcification and P reserves Valve Function in Hypercholesterolemic Mice PLoS ONE (ISSN: 19326203) 8: (6) P aper e65201. (2013) Folyóiratcikk [13474583]
539
Makras P, Polyzos SA, Papatheodorou A, Kokkoris P, Chatzifotiadis D, Anastasilakis AD P arathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis Clinical Endocrinology (ISSN: 03000664) 79: (4) pp. 499503. ( 2013) Folyóiratcikk [13474582]
540
Shiels II W E, Mayerson JL P ercutaneous doxycycline treatment of aneurysmal bone cysts with low recurrence rate: A preliminary report tumor Clinical Orthopaedics and Related Research (ISSN: 0009921X) 471: (8) pp. 26752683. ( 2013) Folyóiratcikk [13474581]
541
Aynardi M, Ilyas AM P harmacologic management of osteoporosis Journal of Hand Surgery 38: (3) pp. 588592. ( 2013)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 82/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [13474580] 542
Soen S P harmacotherapy of osteoporosis: A review of treatment and adherence rates Therapeutic Research 34: (3) pp. 391397. ( 2013) Folyóiratcikk [13474579]
543
AppelmanDijkstra Natasha M, Papapoulos Socrates E P revention of incident fractures in patients with prevalent fragility fractures: Current and future approaches BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (ISSN: 15216942) 27: (6) pp. 805820. ( 2013) Folyóiratcikk [14595437]
544
LópezGonzález AA, Grases F, Monroy N, Marí B, VicenteHerrero MT, Tur F, Perelló J P rotective effect of myoinositol hexaphosphate (phytate) on bone mass loss in postmenopausal women European Journal of Nutrition (ISSN: 14366207) 52: (2) pp. 717726. ( 2013) Folyóiratcikk [13474578]
545
Migliore A, Broccoli S, Massafra U, Cassol M, Frediani B Ranking antireabsorptive agents to prevent vertebral fractures in postmenopausal osteoporosis by mixed treatment comparison metaanalysis European Review for Medical and Pharmacological Sciences (ISSN: 11283602) 17: (5) pp. 658667. ( 2013) Folyóiratcikk [13474577]
546
Schmiedel BJ, Scheible CA, Nuebling T, Kopp HG, W irths S, Azuma M, Schneider P, Jung G, GrosseHovest L, Salih HR RANKL expression, function, and therapeutic targeting in multiple myeloma and chronic lymphocytic leukemia Cancer Research (ISSN: 00085472) 73: (2) pp. 683694. ( 2013) N1 Molecular Sequence Numbers: GENBANK: NM_003701, NM_033012; Folyóiratcikk [13474576]
547
Sato K, Lee JW , Sakamoto K, Iimura T, Kayamori K, Yasuda H, Shindoh M, Ito M, Omura K, Yamaguchi A RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer American Journal of Pathology (ISSN: 00029440) 182: (5) pp. 18901899. ( 2013) Folyóiratcikk [13474575]
548
Sam AH, Meeran K Recent advancements in the drug treatment of endocrine diseases Clinical Medicine, Journal of the Royal College of Physicians of London 13: (2) pp. 170175. ( 2013) Folyóiratcikk [13474574]
549
Schmiedel BJ, Nuebling T, Steinbacher J, Malinovska A, W ende CM, Azuma M, Schneider P, GrosseHovest L, Salih HR Receptor activator for NFκB ligand in acute myeloid leukemia: Expression, function, and modulation of NK cell immunosurveillance Journal of Immunology (ISSN: 00221767) 190: (2) pp. 821831. ( 2013) Folyóiratcikk [13474573]
550
Rejnmark Lars Recombinant hormones in osteoporosis EXPERT OPINION ON BIOLOGICAL THERAPY (ISSN: 14712598) 13: (8) pp. 11351147. ( 2013) Folyóiratcikk [14595384]
551
Evenepoel P Recovery Versus P ersistence of Disordered Mineral Metabolism in Kidney Transplant Recipients Seminars in Nephrology (ISSN: 02709295) 33: (2) pp. 191203. ( 2013) Folyóiratcikk [13474572]
552 * Reid IR, Black DM, Eastell R, BucciRechtweg C, Su G, Hue TF, Mesenbrink P, Lyles KW , Boonen S Reduction in the risk of clinical fractures after a single dose of zoledronic acid 5 milligrams Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 98: (2) pp. 557563. ( 2013) Folyóiratcikk [13474571] 553 * Hadji P, Bock O, Resch H, Kraenzlin M, W ang A, Steinle T, Eisen C Reduction of fracture risk with denosumab among women with osteoporosis with or without need for treatment according to DVO 2009 guideline: A subgroup analysis of the FREEDOM trial Osteologie (ISSN: 10191291) 22: (1) pp. 3945. ( 2013) Folyóiratcikk [13474570] 554
Venuturupalli Swamy R, Sacks W endy Review of New Guidelines for the Management of Glucocorticoid Induced Osteoporosis CURRENT OSTEOPOROSIS REPORTS 11: (4) pp. 357364. ( 2013) Folyóiratcikk [14595436]
555
Bischoff SC, Arends J, Dörje F, Engeser P, Hanke G, Köchling K, Leischker AH, Mühlebach S, Schneider A, Seipt C, Volkert D, Zech U, Stanga Z S3guideline of the German society for nutritional medicine (DGEM) in cooperation with the GESKES and the AKE: Nutritional support in the homecare and outpatient sector Aktuelle Ernahrungsmedizin (ISSN: 03410501) 38: (5) pp. e101e154. ( 2013) Folyóiratcikk [13474569]
556
Reginster JY, Pelousse F, Bruyère O Safety concerns with the longterm management of osteoporosis Expert Opinion on Drug Safety (ISSN: 14740338) 12: (4) pp. 507522. ( 2013) Folyóiratcikk [13474568]
557
Varenna M, Bertoldo F, Di Monaco M, Giusti A, Martini G, Rossini M Safety profile of drugs used in the treatment of osteoporosis: A systematical review of the literature Reumatismo 65: (4) pp. 143166. ( 2013) Folyóiratcikk [13474567]
558
Overman Robert A, Borse Mrudula, Gourlay Margaret L Salmon Calcitonin Use and Associated Cancer Risk ANNALS OF PHARMACOTHERAPY (ISSN: 10600280) 47: (12) pp. 16751684. ( 2013) Folyóiratcikk [14595435]
559 * Mitchell Paul James, Chem C Secondary prevention and estimation of fracture risk
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 83/342
3/30/2015
nyomtatobarat forma BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (ISSN: 15216942) 27: (6) pp. 789803. ( 2013) Folyóiratcikk [14595433] 560
Choksi Palak, W illiams Margaret, Clark Patricia M, Van Poznak Catherine Skeletal Manifestations of Treatment of Breast Cancer CURRENT OSTEOPOROSIS REPORTS 11: (4) pp. 319328. ( 2013) Folyóiratcikk [14595432]
561
Vosse D, Lems W F, Geusens PP Spinal fractures in ankylosing spondylitis: P revalence, prevention and management International Journal of Clinical Rheumatology (ISSN: 17584272) 8: (5) pp. 597608. ( 2013) Folyóiratcikk [13474566]
562
Furuya Y, Inagaki A, Khan M, Mori K, Penninger JM, Nakamura M, Udagawa N, Aoki K, Ohya K, Uchida K, Yasuda H Stimulation of bone formation in cortical bone of mice treated with a receptor activator of nuclear FactorB Ligand (RANKL) binding peptide that possesses osteoclastogenesis inhibitory activity Journal of Biological Chemistry (ISSN: 00219258) 288: (8) pp. 55625571. ( 2013) N1 Molecular Sequence Numbers: GENBANK: AW 319615, BB345784, BF227507, BG075165, BG873440, NM_007541, NM_007554, NM_010217, NM_010514, NM_021355, U08020; Folyóiratcikk [13474565]
563
Otto S, Baumann S, Ehrenfeld M, Pautke C Successful surgical management of osteonecrosis of the jaw due to RANKligand inhibitor treatment using fluorescence guided bone resection Journal of CranioMaxillofacial Surgery (ISSN: 10105182) 41: (7) pp. 694698. ( 2013) Folyóiratcikk [13474564]
564
Lopes VB, Robbrecht D, Van Thiel S, Van Guldener C Symptomatic hypocalcaemia on denosumab use Nederlands Tijdschrift voor Geneeskunde (ISSN: 00282162) 157: (32) P aper A6159. (2013) Folyóiratcikk [13474563]
565
Azim H, Azim Jr HA Targeting RANKL in breast cancer: Bone metastasis and beyond Expert Review of Anticancer Therapy (ISSN: 14737140) 13: (2) pp. 195201. ( 2013) Folyóiratcikk [13474562]
566
Tsai JN, Uihlein AV, Lee H, Kumbhani R, SiwilaSackman E, McKay EA, BurnettBowie SAM, Neer RM, Leder BZ Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: The DATA study randomised trial The Lancet 382: (9886) pp. 5056. ( 2013) N1 Funding Details: 1 UL1 RR02575804, NCRR, National Center for Research Resources Folyóiratcikk [13474560]
567
Sprague SM, Moe SM The case for routine parathyroid hormone monitoring Clinical Journal of the American Society of Nephrology (ISSN: 15559041) 8: (2) pp. 313318. ( 2013) Folyóiratcikk [13474559]
568 * Bone HG, Chapurlat R, Brandi ML, Brown JP, Czerwiński E, Krieg MA, Mellström D, Radominski SC, Reginster JY, Resch H, Román Ivorra JA, Roux C, Vittinghoff E, Daizadeh NS, W ang A, Bradley MN, Franchimont N, Geller ML, W agman RB, Cummings SR, Papapoulos S The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: Results from the FREEDOM extension Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 98: (11) pp. 44834492. ( 2013) Folyóiratcikk [13474558] 569
Grey A, Bolland MJ The effect of treatments for osteoporosis on mortality Osteoporosis International (ISSN: 0937941X) 24: (1) pp. 16. ( 2013) Folyóiratcikk [13474557]
570
Jamal SA, Reid LS, Hamilton CJ The effects of organic nitrates on osteoporosis: A systematic review Osteoporosis International (ISSN: 0937941X) 24: (3) pp. 763770. ( 2013) Folyóiratcikk [13474556]
571
Zhu Xiaowen, Chen Jianting The influence and safety of denosumab on bone mineral density of lumbar spine in women with low bone mass: a metaanalysis Journal of Southern Medical University (ISSN: 16734254) 33: (6) pp. 913917. ( 2013) Folyóiratcikk [14595367]
572
Yeap SS, Hew FL, Lee JK, Goh EML, Chee W , Mumtaz M, Damodaran P, Lim HH, Chan SP The Malaysian Clinical Guidance on the Management of P ostmenopausal Osteoporosis, 2012: A Summary International Journal of Rheumatic Diseases (ISSN: 17561841) 16: (1) pp. 3040. ( 2013) Folyóiratcikk [13474555]
573
Huntjens KMB, Van Geel TACM, Van Helden S, Van Den Bergh J, W illems P, W inkens B, Geusens PP, Brink PRG The role of the combination of bone and fall related risk factors on shortterm subsequent fracture risk and mortality BMC Musculoskeletal Disorders (ISSN: 14712474) 14: P aper 121. (2013) Folyóiratcikk [13474554]
574
Ringe J D, Farahmand P Therapeutic options in male osteoporosis OSTEOLOGIE (ISSN: 10191291) 22: (4) pp. 271276. ( 2013) Folyóiratcikk [14595366]
575
Kaufman JM, Reginster JY, Boonen S, Brandi ML, Cooper C, Dere W , Devogelaer JP, DiezPerez A, Kanis JA, McCloskey E, Mitlak B, Orwoll E, Ringe JD, W eryha G, Rizzoli R Treatment of osteoporosis in men Bone (ISSN: 87563282) 53: (1) pp. 134144. ( 2013) Folyóiratcikk [13474553]
576 * Adami S, Bertoldo F, Gatti D, Minisola G, Rossini M, Sinigaglia L, Varenna M Treatment thresholds for osteoporosis and reimbursability criteria: P erspectives associated with fracture riskassessment tools Calcified Tissue International (ISSN: 0171967X) 93: (3) pp. 195200. ( 2013)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 84/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [13474552] 577
De Villiers TJ, Pines A, Panay N, Gambacciani M, Archer DF, Baber RJ, Davis SR, Gompel AA, Henderson VW , Langer R, Lobo RA, PluBureau G, Sturdee DW Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health Climacteric (ISSN: 13697137) 16: (3) pp. 316337. ( 2013) Folyóiratcikk [13474551]
578
Mudano AS, Gary LC, Oliveira AL, Melton M, W right NC, Curtis JR, Delzell E, Harrington TM, Kilgore ML, Lewis CE, Singh JA, W arriner AH, Pace W D, Saag KG Using tablet computers compared to interactive voice response to improve subject recruitment in osteoporosis pragmatic clinical trials: Feasibility, satisfaction, and sample size Patient Preference and Adherence (ISSN: 1177889X) 7: pp. 517523. ( 2013) N1 Funding Details: AR053351, NIH, National Institutes of Health Folyóiratcikk [13474550]
579
Kuet KP, Charlesworth D, Peel NFA Vertebral fracture assessment scans enhance targeting of investigations and treatment within a fracture risk assessment pathway Osteoporosis International (ISSN: 0937941X) 24: (3) pp. 10071014. ( 2013) Folyóiratcikk [13474549]
580
National Medical Journal of China (ISSN: 03762491) 94: (37) pp. 29562959. ( 2014) Folyóiratcikk [14595431]
581
Lim HyunJu, Bang ManSeok, Jung HyeMin, Shin JangIn, Chun GaeSig, Oh ChungHun A 635nm lightemitting diode (LED) therapy inhibits bone resorptive osteoclast formation by regulating the actin cytoskeleton LASERS IN MEDICAL SCIENCE (ISSN: 02688921) 29: (2) pp. 659670. ( 2014) Folyóiratcikk [14595501]
582
Bialek P, Parkington J, Li X, Gavin D, W allace C, Zhang J, Root A, Yan G, W arner L, Seeherman H J, Yaworsky P J A myostatin and activin decoy receptor enhances bone formation in mice BONE (ISSN: 87563282) 60: pp. 162171. ( 2014) Folyóiratcikk [14595500]
583
Miyazaki Tsuyoshi, Tokimura Fumiaki, Tanaka Sakae A review of denosumab for the treatment of osteoporosis PATIENT PREFERENCE AND ADHERENCE (ISSN: 1177889X) 8: pp. 463471. ( 2014) Folyóiratcikk [14595430]
584
Grigorie D, Sucaliuc A A SINGLEDOSE, OP ENLABEL, P ROSP ECTIVE CLINICAL STUDY OF DENOSUMAB IN P ATIENTS WITH P RIMARY HYP ERP ARATHYROIDISM ACTA ENDOCRINOLOGICABUCHAREST (ISSN: 18410987) 10: (3) pp. 396403. ( 2014) Folyóiratcikk [14595499]
585
Shen Jieliang, Hao Jie Advances in the treatment of osteoporosisnew targets and new drugs Chinese Journal of Osteoporosis (ISSN: 10067108) 20: (7) pp. 844848. ( 2014) Folyóiratcikk [14595429]
586
Li Linghui, Zhan Hongsheng, Ding Daofang, Chen Bo, Du Guoqing, Song Yi Advances of molecular targeted therapy based on Wnt signaling pathway in osteoporosis Chinese Journal of Endocrinology and Metabolism (ISSN: 10006699) 30: (8) pp. 712715. ( 2014) Folyóiratcikk [14595428]
587
Ruggiero Salvatore L, Dodson Thomas B, Fantasia John, Goodday Reginald, Aghaloo Tara, Mehrotra Bhoomi, O'Ryan Felice American Association of Oral and Maxillofacial Surgeons P osition P aper on MedicationRelated Osteonecrosis of the Jaw 2014 Update JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (ISSN: 02782391) 72: (10) pp. 19381956. ( 2014) Folyóiratcikk [14595555]
588
Collie A, Maung K P, Ahukannah J, Shahim M, Gallacher S, Gallagher A, MacLean F, Hinnie J AN AUDIT OF THE CLINICAL INDICATIONS FOR INITIATING DENOSUMAB AS A TREATMENT FOR OSTEOP OROSIS IN A SECONDARY CARE CLINIC OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: pp. S720S720. ( 2014) SU 6 Folyóiratcikk [14595554]
589 * Del Fattore A, Cappariello A, Capulli M, Rucci N, Muraca M, De Benedetti F, Teti A An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL6 OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (2) pp. 681692. ( 2014) Folyóiratcikk [14595427] 590
Chen ChienLiang, Chen NaiChing, Hsu ChihYang, Chou KangJu, Lee PoTsang, Fang HuaChang, Renn JennHuei An OpenLabel, P rospective P ilot Clinical Study of Denosumab for Severe Hyperparathyroidism in P atients With Low Bone Mass Undergoing Dialysis JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 99: (7) pp. 24262432. ( 2014) Folyóiratcikk [14595553]
591
Yoshida Shinji, Ikari Katsunori, Furuya Takefumi, Toyama Yoshiaki, Taniguchi Atsuo, Yamanaka Hisashi, Momohara Shigeki An Osteoprotegerin Gene P olymorphism Is Associated with an Increased Risk of Hip Fracture in Japanese P atients with Rheumatoid Arthritis: Results from the IORRA Observational Cohort Study PLOS ONE (ISSN: 19326203) 9: (8) P aper e104587. (2014) Folyóiratcikk [14595552]
592
Maeda Sergio Setsuo, LazarettiCastro Marise An overview on the treatment of postmenopausal osteoporosis ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (ISSN: 00042730) 58: (2) pp. 162171. ( 2014) Folyóiratcikk [14595498]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 85/342
3/30/2015
nyomtatobarat forma 593
Yavropoulou Maria P, Pikilidou Maria, Yovos John G AntiOsteoporotic Drugs and Vascular Calcification: The Bidirectional Calcium Traffic JOURNAL OF VASCULAR RESEARCH (ISSN: 10181172) 51: (1) pp. 3749. ( 2014) Folyóiratcikk [14595426]
594
Drampalos Efstathios, Skarpas George, Barbounakis Nikos, Michos Ioannis Atypical femoral fractures bilaterally in a patient receiving denosumab a case report ACTA ORTHOPAEDICA (ISSN: 17453674) 85: (1) pp. 35. ( 2014) Folyóiratcikk [14595425]
595
Thompson Robin N, Armstrong Ciara L, Heyburn Gary Bilateral atypical femoral fractures in a patient prescribed denosumab A case report BONE (ISSN: 87563282) 61: pp. 4447. ( 2014) Folyóiratcikk [14595497]
596
Hlaing Thinn Thinn, Compston Juliet E Biochemical markers of bone turnover uses and limitations ANNALS OF CLINICAL BIOCHEMISTRY (ISSN: 00045632) 51: (2) pp. 189202. ( 2014) Folyóiratcikk [14595496]
597
Tella Sri Harsha, Gallagher J Christopher Biological agents in management of osteoporosis EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (ISSN: 00316970) 17: (11) pp. 12911301. ( 2014) Folyóiratcikk [14595551]
598
Miller Paul D Bone Disease in CKD: A Focus on Osteoporosis Diagnosis and Management AMERICAN JOURNAL OF KIDNEY DISEASES (ISSN: 02726386) 64: (2) pp. 290304. ( 2014) Folyóiratcikk [14595550]
599
Bandeira Francisco, Costa Aline G, Soares Filho Manoel Aderson, Pimentel Larissa, Lima Lourena, Bilezikian John P Bone markers and osteoporosis therapy ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (ISSN: 00042730) 58: (5) pp. 504513. ( 2014) Folyóiratcikk [14595495]
600
Saylor Philip J Bone targeted therapies for the prevention of skeletal morbidity in men with prostate cancer ASIAN JOURNAL OF ANDROLOGY (ISSN: 1008682X) 16: (3) pp. 341347. ( 2014) Folyóiratcikk [14595494]
601
Zangeneh Farhad, Clarke Bart L, Hurley Daniel L, W atts Nelson B, Miller Paul D CHRONIC KIDNEY DISEASEMINERAL AND BONE DISORDERS (CKDMBDs): WHAT THE ENDOCRINOLOGIST NEEDS TO KNOW ENDOCRINE PRACTICE (ISSN: 1530891X) 20: (5) pp. 500516. ( 2014) Folyóiratcikk [14595492]
602
Nakamura Toshitaka, Matsumoto Toshio, Sugimoto Toshitsugu, Hosoi Takayuki, Miki Takami, Gorai Itsuo, Yoshikawa Hideki, Tanaka Yoshiya, Tanaka Sakae, Sone Teruki, Nakano Tetsuo, Ito Masako, Matsui Shigeyuki, Yoneda Toshiyuki, Takami Hideo, W atanabe Ko, Osakabe Taisuke, Shiraki Masataka, Fukunaga Masao Clinical Trials Express: Fracture Risk Reduction With Denosumab in Japanese P ostmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized P lacebo Controlled Trial (DIRECT) JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 99: (7) pp. 25992607. ( 2014) Folyóiratcikk [14595491]
603
Cosman F, de Beur S J, LeBoff M S, Lewiecki E M, Tanner B, Randall S, Lindsay R Clinician's Guide to P revention and Treatment of Osteoporosis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (10) pp. 23592381. ( 2014) Folyóiratcikk [14595549]
604
Kudo Takeru, Ishizawa Michiyasu, Maekawa Kazuki, Nakabayashi Makoto, W atarai Yusuke, Uchida Hikaru, Tokiwa Hiroaki, Ikura Teikichi, Ito Nobutoshi, Makishima Makoto, Yamada Sachiko Combination of Triple Bond and Adamantane Ring on the Vitamin D Side Chain P roduced P artial Agonists for Vitamin D Receptor JOURNAL OF MEDICINAL CHEMISTRY (ISSN: 00222623) 57: (10) pp. 40734087. ( 2014) Folyóiratcikk [14595490]
605
Kim K, Svedbom A, Luo X, Sutradhar S, Kanis J A Comparative costeffectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (1) pp. 325337. ( 2014) Folyóiratcikk [14595423]
606
Crandall Carolyn J, Newberry Sydne J, Diamant Allison, Lim YeeW ei, Gellad W alid F, Booth Marika J, Motala Aneesa, Shekelle Paul G Comparative Effectiveness of P harmacologic Treatments to P revent Fractures An Updated Systematic Review ANNALS OF INTERNAL MEDICINE (ISSN: 00034819) 161: (10) pp. 711U163. ( 2014) Folyóiratcikk [14595548]
607
BischoffFerrari Heike A, Meyer Otto Comparative Effectiveness of P harmacologic Treatments to P revent Fractures: Is This All We Need to Know? ANNALS OF INTERNAL MEDICINE (ISSN: 00034819) 161: (10) pp. 755U212. ( 2014) Folyóiratcikk [14595547]
608 * Lakatos P, Toth E, Szekeres L, Poor G, Hejj G, Marton I, Takacs I Comparative statistical analysis of osteoporosis treatment based on Hungarian claims data and interpretation of the results in respect to costeffectiveness OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (8) pp. 20772087. ( 2014) Folyóiratcikk [14595545] 609
Crilly R G, Kloseck M, Chesworth B, Mequanint S, Sadowski E, Gilliland J Comparison of hip fracture and osteoporosis medication prescription rates across Canadian provinces OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (1) pp. 205210. ( 2014) Folyóiratcikk [14595422]
610
Reginster JeanYves, Ferrari Serge, Hadji Peyman Current challenges in the treatment of osteoporosis: an opportunity for bazedoxifene
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 86/342
3/30/2015
nyomtatobarat forma CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 30: (6) pp. 11651176. ( 2014) Folyóiratcikk [14595489] 611
KerschanSchindl K, Mikosch P, ObermayerPietsch B, Gasser R W , Dimai H P, FahrleitnerPammer A, Dobnig H, Roschger P, Preisinger E, Klaushofer K, Resch H, Pietschmann P Current Controversies in Clinical Management of P ostmenopausal Osteoporosis EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (ISSN: 09477349) 122: (8) pp. 437444. ( 2014) Folyóiratcikk [14595544]
612
MacKinlay Kenneth, Falls Thomas, Lau Edmund, Day Judd, Kurtz Steven, Ong Kevin, Malkani Arthur Decreasing Incidence of Femoral Neck Fractures in the Medicare P opulation ORTHOPEDICS (ISSN: 01477447) 37: (10) pp. E917E924. ( 2014) Folyóiratcikk [14595543]
613 * Roux C, Hofbauer LC, Ho PR, W ark JD, Zillikens MC, FahrleitnerPammer A, Hawkins F, Micaelo M, Minisola S, Papaioannou N, Stone M, Ferreira I, Siddhanti S, W agman RB, Brown JP Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized openlabel study Bone (ISSN: 87563282) 58: pp. 4854. ( 2014) Folyóiratcikk [13474548] 614
Vellanki Priyathama, Lange Karoline, Elaraj Dina, Kopp Peter A, El Muayed Malek Denosumab for Management of P arathyroid CarcinomaMediated Hypercalcemia JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 99: (2) pp. 387390. ( 2014) Folyóiratcikk [14595421]
615
Diab Dima L, W atts Nelson B Denosumab in osteoporosis EXPERT OPINION ON DRUG SAFETY (ISSN: 14740338) 13: (2) pp. 247253. ( 2014) Folyóiratcikk [14595420]
616
Brown J P, Roux C, Ho P R, Bolognese M A, Hall J, Bone H G, Bonnick S, van den Bergh J P, Ferreira I, Dakin P, W agman R B, Recknor C Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (7) pp. 19531961. ( 2014) Folyóiratcikk [14595488]
617
Parthan A, Kruse M, Agodoa I, Silverman S, Orwoll E Denosumab: A costeffective alternative for older men with osteoporosis from a Swedish payer perspective BONE (ISSN: 87563282) 59: pp. 105113. ( 2014) Folyóiratcikk [14595419]
618
Scott Lesley J Denosumab: A Review of its Use in P ostmenopausal Women with Osteoporosis DRUGS & AGING (ISSN: 1170229X) 31: (7) pp. 555576. ( 2014) Folyóiratcikk [14595542]
619
Hoffman Veena, Xue Fei, Gardstein Betsey, Skerry Kathleen, Critchlow Cathy W , Enger Cheryl Development and evaluation of an algorithm to identify users of P rolia (R) during the early postmarketing period using health insurance claims data PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (ISSN: 10538569) 23: (9) pp. 993998. ( 2014) Folyóiratcikk [14595541]
620
Kemp John P, Sayers Adrian, Paternoster Lavinia, Evans David M, Deere Kevin, St Pourcain Beate, Timpson Nicholas J, Ring Susan M, Lorentzon Mattias, Lehtimaki Terho, Eriksson Joel, Kahonen Mika, Raitakari Olli, Laaksonen Marika, Sievanen Harri, Viikari Jorma, Lyytikainen LeoPekka, Smith George Davey, Fraser W illiam D, Vandenput Liesbeth, Ohlsson Claes, Tobias Jon H Does Bone Resorption Stimulate P eriosteal Expansion? A CrossSectional Analysis of bCtelopeptides of Type I Collagen ( CTX),Genetic Markers of the RANKL P athway, and P eriosteal Circumference as Measured by JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 29: (4) pp. 10151024. ( 2014) Folyóiratcikk [14595487]
621
Anonymous Drugs for P ostmenopausal Osteoporosis MEDICAL LETTER ON DRUGS AND THERAPEUTICS (ISSN: 0025732X) 56: (1452) pp. 9196. ( 2014) Folyóiratcikk [14595540]
622 * Grey Andrew, Bolland Mark, Mihov Bobby, W ong Sumwai, Horne Anne, Gamble Greg, Reid Ian R Duration of Antiresorptive Effects of LowDose Zoledronate in Osteopenic P ostmenopausal Women: A Randomized, P lacebo Controlled Trial JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 29: (1) pp. 166172. ( 2014) Folyóiratcikk [14595418] 623
Ristow Oliver, Gerngross Carlos, Schwaiger Markus, HohlwegMajert Bettina, Kehl Victoria, Jansen Heike, Hahnefeld Lilian, Koerdt Steffen, Otto Sven, Pautke Christoph Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY (ISSN: 02664356) 52: (4) pp. 308313. ( 2014) Folyóiratcikk [14595486]
624 * Eastell Richard, Nagase Shinichi, Small Maria, Boonen Steven, Spector Tim, Ohyama Michiyo, Kuwayama Tomohiro, Deacon Steve Effect of ONO5334 on Bone Mineral Density and Biochemical Markers of Bone Turnover in P ostmenopausal Osteoporosis: 2 Year Results From the OCEAN Study JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 29: (2) pp. 458466. ( 2014) Folyóiratcikk [14595417] 625
Amugongo Sarah K, Yao W ei, Jia Junjing, Dai W eiwei, Lay YuAn E, Jiang Li, Harvey Danielle, Zimmermann Elizabeth A, Schaible Eric, Dave Neil, Ritchie Robert O, Kimmel Donald B, Lane Nancy E Effect of sequential treatments with alendronate, parathyroid hormone (134) and raloxifene on cortical bone mass and strength in ovariectomized rats BONE (ISSN: 87563282) 67: pp. 257268. ( 2014) Folyóiratcikk [14595539]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 87/342
3/30/2015
nyomtatobarat forma 626
W ang Howard D, Boyce Alison M, Tsai Jeffrey Y, Gafni Rachel I, Farley Frances A, KasaVubu Josephine Z, Molinolo Alfredo A, Collins Michael T Effects of Denosumab Treatment and Discontinuation on Human Growth P lates JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 99: (3) pp. 891897. ( 2014) Folyóiratcikk [14595485]
627 * Brown Jacques P, Reid Ian R, W agman Rachel B, Kendler David, Miller Paul D, Jensen JensErik Beck, Bolognese Michael A, Daizadeh Nadia, Valter Ivo, Zerbini Cristiano A F, Dempster David W Effects of Up to 5 Years of Denosumab Treatment on Bone Histology and Histomorphometry: The FREEDOM Study Extension JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 29: (9) pp. 20512056. ( 2014) Folyóiratcikk [14595538] 628
Triantafyllopoulos Ioannis K, LambropoulouAdamidou Kalliopi, Nacopoulos Cleopatra C, Papaioannou Nikolaos A, Ceausu Iuliana, Depypere Herman, Erel C Tamer, PerezLopez Faustino R, SchenckGustafsson Karin, van der Schouw Yvonne T, Simoncini Tommaso, Tremollieres Florence, Rees Margaret, Lambrinoudaki Irene EMAS position statement: The management of postmenopausal women with vertebral osteoporotic fracture MATURITAS (ISSN: 03785122) 78: (2) pp. 131137. ( 2014) Folyóiratcikk [14595484]
629
Feurer Elodie, Chapurlat Roland Emerging drugs for osteoporosis EXPERT OPINION ON EMERGING DRUGS (ISSN: 14728214) 19: (3) pp. 385395. ( 2014) Folyóiratcikk [14595537]
630
Khan Imran S, Mouchess Maria L, Zhu MengLei, Conley Bridget, Fasano Kayla J, Hou Yafei, Fong Lawrence, Su Maureen A, Anderson Mark S Enhancement of an antitumor immune response by transient blockade of central T cell tolerance JOURNAL OF EXPERIMENTAL MEDICINE (ISSN: 00221007) 211: (5) pp. 761768. ( 2014) Folyóiratcikk [14595483]
631
de Villiers T J Estrogen and bone: have we completed a full circle? CLIMACTERIC (ISSN: 13697137) 17: pp. 47. ( 2014) SU 2 Folyóiratcikk [14595536]
632
Newa Madhuri, Lam Michael, Bhandari Krishna Hari, Xu Biwen, Doschak Michael R Expression, Characterization, and Evaluation of a RANKBinding Single Chain Fraction Variable: An Osteoclast Targeting Drug Delivery Strategy MOLECULAR PHARMACEUTICS (ISSN: 15438384) 11: (1) pp. 8189. ( 2014) Folyóiratcikk [14595416]
633
Dinca O, Bucur M B, Bodnar D, Vladan C, Bucur A EXTENSIVE OSTEONECROSIS OF THE MANDIBLE AFTER THERAP Y WITH DENOSUMAB FOLLOWING BISP HOSP HONATES THERAP Y ACTA ENDOCRINOLOGICABUCHAREST (ISSN: 18410987) 10: (3) pp. 457462. ( 2014) Folyóiratcikk [14595482]
634
Elvey M H, Pugh H, Schaller G, Dhotar G, Patel B, Oddy M J Failure in the application of fragility fracture prevention guidelines ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND (ISSN: 00358843) 96: (5) pp. 381385. ( 2014) Folyóiratcikk [14595481]
635 * Keaveny Tony M, McClung Michael R, Genant Harry K, Zanchetta Jose R, Kendler David, Brown Jacques P, Goemaere Stefan, Recknor Chris, Brandi Maria L, Eastell Richard, Kopperdahl David L, Engelke Klaus, Fuerst Thomas, Radcliffe HoiShen, Libanati Cesar Femoral and Vertebral Strength Improvements in P ostmenopausal Women With Osteoporosis Treated With Denosumab JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 29: (1) pp. 158165. ( 2014) Folyóiratcikk [14595415] 636
Garfield Lauren D, Mueller Daniel J, Kennedy James L, Mulsant Benoit H, Reynolds Charles F III, Teitelbaum Steven L, Civitelli Roberto, Dixon David, Todorov Alexandre A, Lenze Eric J Genetic variation in the serotonin transporter and HTR1B receptor predicts reduced bone formation during serotonin reuptake inhibitor treatment in older adults WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (ISSN: 15622975) 15: (5) pp. 404410. ( 2014) Folyóiratcikk [14595480]
637
Nakamura Haruhiko, Nakashima Tomoki, Hayashi Mikihito, Izawa Naohiro, Yasui Tetsuro, Aburatani Hiroyuki, Tanaka Sakae, Takayanagi Hiroshi Global epigenomic analysis indicates protocadherin7 activates osteoclastogenesis by promoting cellcell fusion BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (ISSN: 0006291X) 455: (34) pp. 305311. ( 2014) Folyóiratcikk [14595535]
638
Juozaityte Elona, Aleknavicius Eduardas, Janciauskiene Rasa, Cesas Alvydas, PipirieneZelviene Terese, Liutkauskiene Sigita, Krasauskiene Aurelija, Venceviciene Lina Guidelines for diagnostics and treatment of aromatase inhibitorinduced bone loss in women with breast cancer A consensus of Lithuanian medical oncologists, radiation oncologists, endocrinologists, and family medicine physicians MEDICINALITHUANIA (ISSN: 1010660X) 50: (4) pp. 197203. ( 2014) Folyóiratcikk [14595414]
639
Roux C, Briot K How long should we treat? OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (6) pp. 16591666. ( 2014) Folyóiratcikk [14595479]
640
Blake Glen M, Siddique Musib, Frost Michelle L, Moore Amelia E B, Fogelman Ignac Imaging of Site Specific Bone Turnover in Osteoporosis Using P ositron Emission Tomography CURRENT OSTEOPOROSIS REPORTS 12: (4) pp. 475485. ( 2014) Folyóiratcikk [14595534]
641
Sims Natalie A, Ng Kong W ah Implications of OsteoblastOsteoclast Interactions in the Management of Osteoporosis by Antiresorptive Agents Denosumab and Odanacatib CURRENT OSTEOPOROSIS REPORTS 12: (1) pp. 98106. ( 2014) Folyóiratcikk [14595478]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 88/342
3/30/2015
nyomtatobarat forma 642
Ringe J D, Farahmand P Improved reallife adherence of 6monthly denosumab injections due to positive feedback based on rapid 6month BMD increase and good safety profile RHEUMATOLOGY INTERNATIONAL (ISSN: 01728172) 34: (5) pp. 727732. ( 2014) Folyóiratcikk [14595477]
643
Schmuhl Ellen, Ramer Robert, Salamon Achim, Peters Kirsten, Hinz Burkhard Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAP K BIOCHEMICAL PHARMACOLOGY (ISSN: 00062952) 87: (3) pp. 489501. ( 2014) Folyóiratcikk [14595413]
644
Ferrucci L, Baroni M, Ranchelli A, Lauretani F, Maggio M, Mecocci P, Ruggiero C Interaction Between Bone and Muscle in Older P ersons with Mobility Limitations CURRENT PHARMACEUTICAL DESIGN (ISSN: 13816128) 20: (19) pp. 31783197. ( 2014) Folyóiratcikk [14595412]
645
Torstrick F Brennan, Guldberg Robert E Local Strategies to P revent and Treat Osteoporosis CURRENT OSTEOPOROSIS REPORTS 12: (1) pp. 3340. ( 2014) Folyóiratcikk [14595476]
646
Tamas Nagykalnai, Laszlo Landherr Management of bone metastases ORVOSI HETILAP (ISSN: 00306002) 155: (6) pp. 217225. ( 2014) Folyóiratcikk [14595411]
647
Rizzoli R, Branco J, Brandi ML, Boonen S, Bruyere O, Cacoub P, Cooper C, DiezPerez A, Duder J, Fielding R A, Harvey N C, Hiligsmann M, Kanis J A, Petermans J, Ringe J D, Tsouderos Y, W einman J, Reginster JY Management of osteoporosis of the oldest old OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (11) pp. 25072529. ( 2014) Folyóiratcikk [14595533]
648
Gambacciani M, Levancini M Management of postmenopausal osteoporosis and the prevention of fractures PANMINERVA MEDICA (ISSN: 00310808) 56: (2) pp. 115131. ( 2014) Folyóiratcikk [14595475]
649
Maria Sifat, W ittEnderby Paula A Melatonin effects on bone: potential use for the prevention and treatment for osteopenia, osteoporosis, and periodontal disease and for use in bonegrafting procedures JOURNAL OF PINEAL RESEARCH (ISSN: 07423098) 56: (2) pp. 115125. ( 2014) Folyóiratcikk [14595474]
650
Jiang Yan, Zhang ZhenLin, Zhang ZhongLan, Zhu HanMin, W u YiYong, Cheng Qun, W u FengLi, Xing XiaoPing, Liu JianLi, Yu W ei, Meng XunW u Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, doubleblinded, doubledummy, positive drugcontrolled clinical trial CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 9: pp. 121127. ( 2014) Folyóiratcikk [14595410]
651
Murphy Andrew J, Macdonald Lynn E, Stevens Sean, Karow Margaret, Dore Anthony T, Pobursky Kevin, Huang Tammy T, Poueymirou W illiam T, Esau Lakeisha, Meola Melissa, Mikulka W arren, Krueger Pamela, Fairhurst Jeanette, Valenzuela David M, Papadopoulos Nicholas, Yancopoulos George D Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (ISSN: 0027 8424) 111: (14) pp. 51535158. ( 2014) Folyóiratcikk [14595473]
652
Rinotas Vagelis, Niti Alexandra, Dacquin Romain, Bonnet Nicolas, Stolina Marina, Han ChunYa, Kostenuik Paul, Jurdic Pierre, Ferrari Serge, Douni Eleni Novel Genetic Models of Osteoporosis by Overexpression of Human RANKL in Transgenic Mice JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 29: (5) pp. 11581169. ( 2014) Folyóiratcikk [14595472]
653 * Karsdal M A, Christiansen C, Ladel C, Henriksen K, Kraus V B, BayJensen A C Osteoarthritis a case for personalized health care? OSTEOARTHRITIS AND CARTILAGE (ISSN: 10634584) 22: (1) pp. 716. ( 2014) Folyóiratcikk [14595409] 654
Hallmer Fredrik, Bjornland Tore, Nicklasson Anders, Becktor Jonas P, Andersson Gunilla Osteonecrosis of the jaw in patients treated with oral and intravenous bisphosphonates: experience in Sweden ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (ISSN: 22124403) 118: (2) pp. 202208. ( 2014) Folyóiratcikk [14595532]
655
Nanes Mark S, Kellen Caleb B Osteoporosis SEMINARS IN NUCLEAR MEDICINE (ISSN: 00012998) 44: (6) pp. 439450. ( 2014) Folyóiratcikk [14595531]
656
Sidlauskas Kristel M, Sutton Emily E, Biddle Michael A Osteoporosis in men: epidemiology and treatment with denosumab CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 9: pp. 593601. ( 2014) Folyóiratcikk [14595408]
657
Peeters Geeske, Tett Susan E, Duncan Emma L, Mishra Gita D, Dobson Annette J Osteoporosis medication dispensing for older Australian women from 2002 to 2010: influences of publications, guidelines, marketing activities and policy PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (ISSN: 10538569) 23: (12) pp. 13031311. ( 2014) Folyóiratcikk [14595530]
658
Kling Juliana M, Clarke Bart L, Sandhu Nicole P Osteoporosis P revention, Screening, and Treatment: A Review JOURNAL OF WOMENS HEALTH (ISSN: 15409996) 23: (7) pp. 563572. ( 2014) Folyóiratcikk [14595471]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 89/342
3/30/2015
nyomtatobarat forma 659
Litwic A, Cooper C, Dennison E Osteoporosis therapies in 2014 PANMINERVA MEDICA (ISSN: 00310808) 56: (4) pp. 273283. ( 2014) Folyóiratcikk [14595529]
660
Hiligsmann Mickael, Dellaert Benedict G, Dirksen Carmen D, van der W eijden Trudy, Goemaere Stefan, Reginster Jean Yves, W atson Verity, Boonen Annelies P atients' preferences for osteoporosis drug treatment: a discretechoice experiment ARTHRITIS RESEARCH & THERAPY (ISSN: 14786354) 16: (1) P aper R36. (2014) Folyóiratcikk [14595407]
661
Lehmann G, W olf G P harmaceutical therapy of bone metabolism disorders in chronic kidney disease mineral bone disorder (CKDMBD) with special respect to antiresorptive substances ZEITSCHRIFT FUR RHEUMATOLOGIE (ISSN: 03401855) 73: (4) pp. 329+. ( 2014) Folyóiratcikk [14595470]
662
Fontenot Holly B, Harris Allyssa L P harmacologic Management of Osteoporosis JOGNNJOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING (ISSN: 08842175) 43: (2) pp. 236245. ( 2014) Folyóiratcikk [14595469]
663
Nardone Valeria, D'Asta Federica, Brandi Maria Luisa P harmacological management of osteogenesis CLINICS (ISSN: 18075932) 69: (6) pp. 438446. ( 2014) Folyóiratcikk [14595406]
664
Ershova O B, Lesnyak O M, Belova K Yu, Nazarova A V, Manovitskaya A V, Musaeva T M, Mustaev R M, Nurlygayanov R Z, Rozhinskaya L Ya, Skripnikova I A, Toroptsova N V P reliminary results of an openlabel observational study evaluating the efficacy and safety of P rolia used in women with postmenopausal osteoporosis TERAPEVTICHESKII ARKHIV (ISSN: 00403660) 86: (10) pp. 6064. ( 2014) Folyóiratcikk [14595405]
665 * Lubwama R, Nguyen A, Modi A, Diana C, Miller P D P revalence of renal impairment among osteoporotic women in the USA, NHANES 20052008: Is treatment with bisphosphonates an option? OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (5) pp. 16071615. ( 2014) Folyóiratcikk [14595468] 666
Tella Sri Harsha, Gallagher J Christopher P revention and treatment of postmenopausal osteoporosis JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (ISSN: 09600760) 142: pp. 155170. ( 2014) Folyóiratcikk [14595467]
667 * Samelson Elizabeth J, Miller Paul D, Christiansen Claus, Daizadeh Nadia S, Grazette Luanda, Anthony Mary S, Egbuna Ogo, W ang Andrea, Siddhanti Suresh R, Cheung Angela M, Franchimont Nathalie, Kiel Douglas P RANKL Inhibition With Denosumab Does Not Influence 3Year P rogression of Aortic Calcification or Incidence of Adverse Cardiovascular Events in P ostmenopausal Women With Osteoporosis and High Cardiovascular Risk JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 29: (2) pp. 450457. ( 2014) Folyóiratcikk [14595404] 668
Aghaloo Tara L, Cheong Simon, Bezouglaia Olga, Kostenuik Paul, Atti Elisa, Dry Sarah M, Pirih Flavia Q, Tetradis Sotirios RANKL Inhibitors Induce Osteonecrosis of the Jaw in Mice With P eriapical Disease JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 29: (4) pp. 843854. ( 2014) Folyóiratcikk [14595466]
669
Sigl Verena, Penninger Josef M RANKL/RANK From bone physiology to breast cancer CYTOKINE & GROWTH FACTOR REVIEWS (ISSN: 13596101) 25: (2) pp. 205214. ( 2014) Folyóiratcikk [14595465]
670
Ganda K, Seibel M J Rapid biochemical response to denosumab in fibrous dysplasia of bone: report of two cases OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (2) pp. 777782. ( 2014) Folyóiratcikk [14595403]
671
Manolagas Stavros C, Kronenberg Henry M Reproducibility of Results in P reclinical Studies: A P erspective From the Bone Field JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 29: (10) pp. 21312140. ( 2014) Folyóiratcikk [14595528]
672
Zeng Yi, Shen Bin Research progress of the molecular signal pathway in the prevention and treatment of osteoporosis Chinese Journal of Osteoporosis (ISSN: 10067108) 20: (3) pp. 305309. ( 2014) Folyóiratcikk [14595402]
673 * Karsdal Morten A, BayJensen AnneChristine, Henriksen Kim, Christiansen Claus, Genant Harry K, Chamberlain Chris, Platt Adam Rheumatoid Arthritis: A Case for P ersonalized Health Care? ARTHRITIS CARE & RESEARCH (ISSN: 2151464X) 66: (9) pp. 12731280. ( 2014) Folyóiratcikk [14595527] 674 * DiezPerez Adolfo, Adachi Jonathan D, Adami Silvano, Anderson Frederick A Jr, Boonen Steven, Chapurlat Roland, Compston Juliet E, Cooper Cyrus, Gehlbach Stephen H, Greenspan Susan L, Hooven Frederick H, LaCroix Andrea Z, Nieves Jeri W , Netelenbos J Coen, Pfeilschifter Johannes, Rossini Maurizio, Roux Christian, Saag Kenneth G, Silverman Stuart, Siris Ethel S, W yman Allison, RushtonSmith Sophie K, W atts Nelson B Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW) JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 29: (1) pp. 260267. ( 2014) CA Global Longitudinal Study Folyóiratcikk [14595401]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 90/342
3/30/2015
nyomtatobarat forma 675
Zhou Zhenyu, Chen Chen, Zhang Jun, Ji Xinran, Liu Lifeng, Zhang Guichun, Cao Xuecheng, W ang Pingshan Safety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a metaanalysis INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY (ISSN: 19362625) 7: (5) pp. 21132122. ( 2014) Folyóiratcikk [14595400]
676
DehamchiaRehailia N, Ursu D, HenryDesailly I, Fardellone P, Paccou J Secondary prevention of osteoporotic fractures: evaluation of the Amiens University Hospital's fracture liaison service between January 2010 and December 2011 OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (10) pp. 24092416. ( 2014) Folyóiratcikk [14595526]
677
Shafqat H, Alquadan K F, Olszewski A J Severe hypocalcemia after denosumab in a patient with acquired Fanconi syndrome OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (3) pp. 11871190. ( 2014) Folyóiratcikk [14595399]
678
Perez Ruixo Juan Jose, Zheng Jenny, Mandema Jaap W Similar Relationship Between the Time Course of Bone Mineral Density Improvement and Vertebral Fracture Risk Reduction With Denosumab Treatment in P ostmenopausal Osteoporosis and P rostate Cancer P atients on Androgen Deprivation Therapy JOURNAL OF CLINICAL PHARMACOLOGY (ISSN: 15524604) 54: (5) pp. 503512. ( 2014) Folyóiratcikk [14595464]
679
Piemonte Sara, Romagnoli Elisabetta, Cipriani Cristiana, De Lucia Federica, Pilotto Roberta, Diacinti Daniele, Pepe Jessica, Minisola Salvatore Sixyear followup of a characteristic osteolytic lesion in a patient with tumorinduced osteomalacia EUROPEAN JOURNAL OF ENDOCRINOLOGY (ISSN: 08044643) 170: (1) pp. K1K4. ( 2014) Folyóiratcikk [14595398]
680
Canoa Antonio, Manuel Silvan Jose, Estevez Antonio, Baro Francesc, Villero Jose, Quereda Francisco, Ferrer Javier, Mendoza Nicolas, SanchezBorrego Rafael Spanish Menopause Society position statement: Use of denosumab in postmenopausal women MATURITAS (ISSN: 03785122) 79: (1) pp. 117121. ( 2014) Folyóiratcikk [14595525]
681
Antebi Ben, Pelled Gadi, Gazit Dan Stem Cell Therapy for Osteoporosis CURRENT OSTEOPOROSIS REPORTS 12: (1) pp. 4147. ( 2014) Folyóiratcikk [14595463]
682
Pelle Dominic W , Ringler Jonathan W , Peacock Jacqueline D, Kampfschulte Kevin, Scholten Donald J II, Davis Mary M, Mitchell Deanna S, Steensma Matthew R Targeting receptoractivator of nuclear kappaB ligand in aneurysmal bone cysts: verification of target and therapeutic response TRANSLATIONAL RESEARCH (ISSN: 19315244) 164: (2) pp. 139148. ( 2014) Folyóiratcikk [14595524]
683
Muruganandan Shanmugam, Sinal Christopher J The impact of bone marrow adipocytes on osteoblast and osteoclast differentiation IUBMB LIFE (ISSN: 15216543) 66: (3) pp. 147155. ( 2014) Folyóiratcikk [14595462]
684
Capozzi Anna, Lello Stefano, Pontecorvi Alfredo The inhibition of RANKligand in the management of postmenopausal osteoporosis and related fractures: the role of denosumab GYNECOLOGICAL ENDOCRINOLOGY (ISSN: 09513590) 30: (6) pp. 403408. ( 2014) Folyóiratcikk [14595461]
685
Edwards W Brent, Schnitzer Thomas J, Troy Karen L The mechanical consequence of actual bone loss and simulated bone recovery in acute spinal cord injury BONE (ISSN: 87563282) 60: pp. 141147. ( 2014) Folyóiratcikk [14595460]
686
de W aure Chiara, Specchia Maria Lucia, Cadeddu Chiara, Capizzi Silvio, Capri Stefano, Di Pietro Maria Luisa, Veneziano Maria Assunta, Gualano Maria Rosaria, Kheiraoui Flavia, La Torre Giuseppe, Nicolotti Nicola, Sferrazza Antonella, Ricciardi W alter The P revention of P ostmenopausal Osteoporotic Fractures: Results of the Health Technology Assessment of a New Antiosteoporotic Drug BIOMED RESEARCH INTERNATIONAL (ISSN: 23146133) 2014: P aper 975927. 16 p. (2014) Folyóiratcikk [14595397]
687 * Mandema Jaap W , Zheng Jenny, Libanati Cesar, Perez Ruixo Juan Jose Time Course of Bone Mineral Density Changes With Denosumab Compared With Other Drugs in P ostmenopausal Osteoporosis: A DoseResponseBased MetaAnalysis JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 99: (10) pp. 37463755. ( 2014) Folyóiratcikk [14595523] 688
Knutson Todd P, Lange Carol A Tracking progesterone receptormediated actions in breast cancer PHARMACOLOGY & THERAPEUTICS (ISSN: 01637258) 142: (1) pp. 114125. ( 2014) Folyóiratcikk [14595459]
689
Gosch M, Kammerlander C, Nicholas J A Treatment of osteoporosis in older adults PANMINERVA MEDICA (ISSN: 00310808) 56: (2) pp. 133143. ( 2014) Folyóiratcikk [14595458]
690
Chapurlat Roland D Treatment of postmenopausal osteoporosis with odanacatib EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 15: (4) pp. 559564. ( 2014) Folyóiratcikk [14595457]
691
Park Byoungduck Triptolide, a diterpene, inhibits osteoclastogenesis, induced by RANKL signaling and human cancer cells BIOCHIMIE (ISSN: 03009084) 105C: pp. 129136. ( 2014) Folyóiratcikk [14595522]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 91/342
3/30/2015
nyomtatobarat forma 692
Leder Benjamin Z, Tsai Joy N, Uihlein Alexander V, BurnettBowie SherriAnn M, Zhu Yuli, Foley Katelyn, Lee Hang, Neer Robert M Two Years of Denosumab and Teriparatide Administration in P ostmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 99: (5) pp. 16941700. ( 2014) Folyóiratcikk [14595456]
693
HoyerKuhn Heike, Netzer Christian, Koerber Friederike, Schoenau Eckhard, Semler Oliver Two years' experience with denosumab for children with Osteogenesis imperfecta type VI ORPHANET JOURNAL OF RARE DISEASES (ISSN: 17501172) 9: P aper 145. (2014) Folyóiratcikk [14595521]
694 * Lewiecki E Michael, Miller Paul D, Harris Steve T, Bauer Douglas C, Davison K Shawn, Dian Larry, Hanley David A, McClung Michael R, Yuen Chui K, Kendler David L Understanding and Communicating the Benefits and Risks of Denosumab, Raloxifene, and Teriparatide for the Treatment of Osteoporosis JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 17: (4) pp. 490495. ( 2014) Folyóiratcikk [14595520] 695
Eriksen EF, DíezPérez A, Boonen S Update on longterm treatment with bisphosphonates for postmenopausal osteoporosis: A systematic review Bone (ISSN: 87563282) 58: pp. 126135. ( 2014) Folyóiratcikk [13474547]
696
Macdonald H M, Garland A, Burr J, Strachan A, W ood A D, Jamil N A, McLernon D, Black A J Validation of a short questionnaire for estimating dietary calcium intakes OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (6) pp. 17651773. ( 2014) Folyóiratcikk [14595454]
697
Mattei Tobias A, Mendel Ehud, Bourekas Eric C Vertebral compression fractures in patients under treatment with denosumab: a contraindication for percutaneous vertebroplasty? SPINE JOURNAL (ISSN: 15299430) 14: (6) pp. E29E35. ( 2014) Folyóiratcikk [14595453]
698 * Mosali P, Bernard L, W ajed J, Mohamed Z, Ewang M, Moore A, Fogelman I, Hampson G Vitamin D Status and P arathyroid Hormone Concentrations Influence the Skeletal Response to Zoledronate and Denosumab CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 94: (5) pp. 553559. ( 2014) Folyóiratcikk [14595452] 699
Manolagas Stavros C Wnt signaling and osteoporosis MATURITAS (ISSN: 03785122) 78: (3) pp. 233237. ( 2014) Folyóiratcikk [14595451]
700
Chen W eiqiang, Foo SuanSin, Sims Natalie A, Herrero Lara J, W alsh Nicole C, Mahalingam Suresh Arthritogenic alphaviruses: new insights into arthritis and bone pathology TRENDS IN MICROBIOLOGY (ISSN: 0966842X) 23: (1) pp. 3543. ( 2015) Folyóiratcikk [14595519]
701
Lyell Veronica, Henderson Emily, Devine Mark, Gregson Celia Assessment and management of fracture risk in patients with P arkinson's disease AGE AND AGEING (ISSN: 00020729) 44: (1) pp. 3441. ( 2015) Folyóiratcikk [14595518]
702
Solomon Daniel H, Diem Susan J, Ruppert Kristine, Lian Yin Juan, Liu ChihChin, W ohlfart Alyssa, Greendale Gail A, Finkelstein Joel S Bone Mineral Density Changes Among Women Initiating P roton P ump Inhibitors or H2 Receptor Antagonists: A SWAN Cohort Study JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 30: (2) pp. 232239. ( 2015) Folyóiratcikk [14595517]
703 * Poole Kenneth E S, Treece Graham M, Gee Andrew H, Brown Jacques P, McClung Michael R, W ang Andrea, Libanati Cesar Denosumab Rapidly Increases Cortical Bone in Key Locations of the Femur: A 3D Bone Mapping Study in Women With Osteoporosis JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 30: (1) pp. 4654. ( 2015) Folyóiratcikk [14595516] 704
Khan Aliya A, Morrison Archie, Hanley David A, Felsenberg Dieter, McCauley Laurie K, O'Ryan Felice, Reid Ian R, Ruggiero Salvatore L, Taguchi Akira, Tetradis Sotirios, W atts Nelson B, Brandi Maria Luisa, Peters Edmund, Guise Teresa, Eastell Richard, Cheung Angela M, Morin Suzanne N, Masri Basel, Cooper Cyrus, Morgan Sarah L, Obermayer Pietsch Barbara, Langdahl Bente L, Al Dabagh Rana, Davison K Shawn, Kendler David L, Sandor George K, Josse Robert G, Bhandari Mohit, El Rabbany Mohamed, Pierroz Dominique D, Sulimani Riad, Saunders Deborah P, Brown Jacques P, Compston Juliet Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 30: (1) pp. 323. ( 2015) CA Int Task Force Osteonecrosis Jaw Folyóiratcikk [14595515]
705
Mukhtar Omar, Jackson Stephen H D Drug therapies in older adults (part 1) CLINICAL MEDICINE (ISSN: 14702118) 15: (1) pp. 4753. ( 2015) Folyóiratcikk [14595514]
706
Ciccarelli Fedra, De Martinis Massimo, Ginaldi Lia Glucocorticoids in P atients with Rheumatic Diseases: Friends or Enemies of Bone? CURRENT MEDICINAL CHEMISTRY (ISSN: 09298673) 22: (5) pp. 596603. ( 2015) Folyóiratcikk [14595513]
707
Kylloenen Laura, D'Este Matteo, Alini Mauro, Eglin David Local drug delivery for enhancing fracture healing in osteoporotic bone ACTA BIOMATERIALIA (ISSN: 17427061) 11: pp. 412434. ( 2015) Folyóiratcikk [14595512]
708
Andreopoulou Panagiota, Bockman Richard S Management of P ostmenopausal Osteoporosis
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 92/342
3/30/2015
nyomtatobarat forma Annual Review of Medicine (ISSN: 00664219) 66: pp. 329342. ( 2015) BE Caskey, CT Folyóiratcikk [14595511] 709 * Bone H G, Dempster D W , Eisman J A, Greenspan S L, Mcclung M R, Nakamura T, Papapoulos S, Shih W J, RybakFeiglin A, Santora A C, Verbruggen N, Leung A T, Lombardi A Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the LongTerm Odanacatib Fracture Trial OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 26: (2) pp. 699712. ( 2015) Folyóiratcikk [14595510] 710
W atson J Tracy, Nicolaou Daemeon A Orthobiologics in the Augmentation of Osteoporotic Fractures CURRENT OSTEOPOROSIS REPORTS 13: (1) pp. 2229. ( 2015) Folyóiratcikk [14595509]
711
Ganda K, Schaffer A, Seibel M J P redictors of refracture amongst patients managed within a secondary fracture prevention program: a 7year prospective study OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 26: (2) pp. 543551. ( 2015) Folyóiratcikk [14595508]
712
Rubin Katrine Hass, Holmberg Teresa, Rothmann Mette Juel, Hoiberg Mikkel, Barkmann Reinhard, Gram Jeppe, Hermann Anne Pernille, Bech Mickael, Rasmussen Ole, Glueer Claus C, Brixen Kim The RiskStratified Osteoporosis Strategy Evaluation study (ROSE): A Randomized P rospective P opulationBased Study. Design and Baseline Characteristics CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 96: (2) pp. 167179. ( 2015) Folyóiratcikk [14595507]
713
Sugimoto T, Matsumoto T, Hosoi T, Miki T, Gorai I, Yoshikawa H, Tanaka Y, Tanaka S, Fukunaga M, Sone T, Nakano T, Ito M, Matsui S, Yoneda T, Takami H, W atanabe K, Osakabe T, Okubo N, Shiraki M, Nakamura T Threeyear denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1year open label extension of the Denosumab Fracture Intervention Randomized P lacebo Controlled Trial (DIRECT) OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 26: (2) pp. 765774. ( 2015) Folyóiratcikk [14595506]
714
Giusti Andrea, Bianchi Gerolamo Treatment of primary osteoporosis in men CLINICAL INTERVENTIONS IN AGING (ISSN: 11781998) 10: pp. 105115. ( 2015) Folyóiratcikk [14595505]
120. Eastell R , Black DM , Boonen S , Adami S , Felsenberg D , Lippuner K , Cummings SR , Delmas PD , Palermo L , M esenbrink P , Cauley JA , HORIZON Pivotal Fracture Trial Egyéb szerzőség: Balogh A , Gomor B , Hidvégi T , Koranyi L , Lakatos P , Poór G , Tulassay Z (kollaborációs közrem.); Effect of OnceYearly Zoledronic Acid Five M illigrams on Fracture Risk and Change in Femoral Neck Bone M ineral Density JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 94:(9) pp. 32153225. (2009) IF: 6.202 Nyelv: Angol
Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [1981009] HORIZON Pivotal Fracture Trial Kerzberg E, M an Z, M autalen C, Ridruejo M , Tate G, Velasco J, Hooper M , Kotowicz M , Nash P, Prince R, Roberts A, Sambrook P, Dobnig H, Finkenstedt G, Hoefle G, Klaushofer K, Pecherstorfer M , Peichl P, Body J, Boonen S, Devogelaer JP, Geusens P, Kaufman J, Brenol J, Kochen J, Lederman R, Radominski S, Szejnfeld V, Zerbini C, Adachi J, Brown J, Choquette D, Hanley D, Josse R, Kendler D, Kremer R, M orin F, Olszynski W, Papaioannou A, Yuen CK, Chen B, Lin S, Casas N, Chalem M , Jaller J, M olina J, Aro H, Heikkinen J, Kröger H, M äkinen L, Saltevo J, Salmi J, Välimäki M , Benhamou CL, Delmas P, Fardellone P, Werhya G, Allolio B, Felsenberg D, Happ J, Hartard M , Hensen J, Kaps P, Kekow J, M oericke R, Ortloff B, Schneider P, Wassenberg S, Leung PC, Balogh A, Gomor B, Hidvégi T, Koranyi L, Lakatos P, Poór G, Tulassay Z, Pollak RD, Eshed V, Foldes AJ, IshShalom S, Vered I, Weiss M , Adami S, Barone A, Bianchi G, Giannini S, Isaia GC, Luisetto G, M inisola S, M olea N, Nuti R, Ortolani S, Passeri M , Rubinacci A, Seriolo B, Sinigaglia L, Choi WH, Kang M I, Kim GS, Kim HS, Kim YK, Lim SK, Son HY, Yoon HK, Abud C, Garcia P, Jasqui S, Ochoa L, Orozco J, Santos J, Reid I, Elle S, Halse J, Høiseth A, Olav H, Røed HI, Skag A, Stakkestad J, Syversen U, Badurski J, Czerwinski E, Lorenc R, M arcinowskaSuchowierska E, Sawicki A, Supronik J, Ailamazyan E, Benevolenskaya L, Dreval A, Dvoretsky L, Dyomina R, M azurov V, M elnichenko G, M krtoumyan A, OrlovM orozov A, Ostroumova O, Pikhlak E, Shemerovskaya T, Shostak N, Skripnikova I, Smetnik V, Tsyrlina E, Usova G, Zalevskaya A, Zazerskaya I, Zotkin E, Ljunggren O, Lofgren J, Palmér M , Saaf M , Stenström M , Hasler P, Lamy O, Lippuner K, M erlin C, Rizzoli R, Theiler R, Tyndall A, Uebelhart D, Chen JF, Chen PQ, Chin LS, Hwang JS, Yang TS, Jirapinyo M , Sattaya R, Sriussadaporn S, Supasin S, Taechakraichana N, Wilawan K, Donnachie H, Eastell R, Fraser W, M cLellan A, Reid D, Abruzzo J, Ackerman R, Adler R, Aloia J, Birbara C, Bode B, Bone H, Brandon D, Cauley J, Cosman F, Dionne D, Downs R Jr, Dreyfus J, Elinoff V, Emkey R, Fanciullo J, Fiske D, Genaro P, Gollapudi M , Gordon R, Hennessey J, Howard P, Johnson K, Johnston C, Kagan R, Kafka S, Kaine J, Klein T, Koltun W, Leboff M , Levine B, Lewiecki EM , Lewis CE, Licata A, Lillestol M , Lubin B, M alamet R, M angione A, M atkovic V, M ehta D, M iller P, M iller S, M urphy FT, Nattrass S, Podlecki D, Recknor C, Rosen C, Rowe D, Rude R, Schnitzer T, Sherrer Y, Silverman S, Stephenson K, Troupin B, Tucci J, Villareal R, Watts N, Weinstein R, Weinstein R, Weitz M , White R [ Érvényesített ] Független idéző: 26 Függő idéző: 9 Összesen: 35 https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 93/342
3/30/2015
nyomtatobarat forma 1
Barlow DH, Bouchard P, Brandi ML, Evers JLH, Glasier A, Negri E, Papapoulos SE, Ralston SH, Rizzoli R, Baird DT, Collins J, Benagiano G, Crosignani PG, La Vecchia C, Volpe A Bone fractures after menopause HUMAN REPRODUCTION UPDATE (ISSN: 13554786) 16: (6) pp. 761773. ( 2010) CA: ESHRE Capri W orkshop Grp Z9: 2 W C: Obstetrics & Gynecology; Reproductive Biology Folyóiratcikk [12352342]
2
Polyzos SA, Anastasilakis AD, Litsas I, Sapranidis M, Efstathiadou Z, Kita M, Arsos G, Moralidis E, Zafeiriadou E, Papatheodorou A, Terpos E DualEnergy XRay Absorptiometry and Quantitative Ultrasound in P atients With P aget's Disease of Bone Before and After Treatment With Zoledronic Acid: Association With Serum Bone Markers and Dickkopf1 JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 13: (2) pp. 190196. ( 2010) W C: Endocrinology & Metabolism Folyóiratcikk [12352341]
3
Anonymous Raloxifene more P rotection against vertebral fractures in younger Women than older Women OSTEOLOGIE (ISSN: 10191291) 19: (3) pp. 274274. ( 2010) Folyóiratcikk [14595205]
4
* Eastell R, W alsh JS, W atts NB, Siris E Bisphosphonates for postmenopausal osteoporosis BONE (ISSN: 87563282) 49: (1) pp. 8288. ( 2011) Z9: 1 W C: Endocrinology & Metabolism Folyóiratcikk [12352340]
5
* Marsh D, Akesson K, Beaton DE, Bogoch ER, Boonen S, Brandi ML, McLellan AR, Mitchell PJ, Sale JEM, W ahl DA Coordinatorbased systems for secondary prevention in fragility fracture patients OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (7) pp. 20512065. ( 2011) CA: IOF CSA Fracture W orking Grp Z9: 7 W C: Endocrinology & Metabolism Folyóiratcikk [12352339]
6
* Cauley JA, Cummings S, Palermo L, Cosman F, Eastell R, Boonen S, Hue T, BucciRechtweg C, Black DM Fracture risk reduction with zoledronic acid by predicted fracture risk score BONE (ISSN: 87563282) 48: (Athens, GREECE) pp. S93S93. ( 2011) SU: 2 W C: Endocrinology & Metabolism Folyóiratcikk [12352338]
7
Yoon RS, Hwang JS, Beebe KS Longterm bisphosphonate usage and subtrochanteric insufficiency fractures A CAUSE FOR CONCERN? JOURNAL OF BONE AND JOINT SURGERYBRITISH VOLUME (ISSN: 0301620X) 93B: (10) pp. 12891295. ( 2011) W C: Orthopedics; Surgery Folyóiratcikk [12352337]
8
Rakel A, Boucher A, SteMarie LG Role of zoledronic acid in the prevention and treatment of osteoporosis CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 6: pp. 8999. ( 2011) Z9: 2 W C: Geriatrics & Gerontology Folyóiratcikk [12352336]
9
Hwang JS, Chin LS, Chen JF, Yang TS, Chen PQ, Tsai KS, Leung PC The effects of intravenous zoledronic acid in Chinese women with postmenopausal osteoporosis JOURNAL OF BONE AND MINERAL METABOLISM (ISSN: 09148779) 29: (3) pp. 328333. ( 2011) Z9: 4 W C: Endocrinology & Metabolism; Medicine, Research & Experimental Folyóiratcikk [12352335]
10
NIE Hai, PENG Chao, HAO Jie, HU Zhenming, AN Hong Zoledronic acid in preventing fractures in women with postmenopausal osteoporosis:a meta analysis Academic Journal of Second Military Medical University 32: (9) pp. 985990. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [14595204]
11
McCloskey Eugene V, Johansson Helena, Oden Anders, Austin Matt, Siris Ethel, W ang Andrea, Lewiecki E Michael, Lorenc Roman, Libanati Cesar, Kanis John A Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 27: (7) pp. 14801486. ( 2012) Folyóiratcikk [14595203]
12 * McClung MR, Boonen S, Torring O, Roux C, Rizzoli R, Bone HG, Benhamou CL, Lems W F, Minisola S, Halse J, Hoeck HC, Eastell R, W ang A, Siddhanti S, Cummings SR Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 27: (1) pp. 211218. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12352334] 13
Kanis JA, McCloskey E, Johansson H, Oden A, Leslie W D FRAX(A (R)) with and without Bone Mineral Density CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 90: (1) pp. 113. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12352333]
14
Nielson CM, Srikanth P, Orwoll ES Obesity and fracture in men and women: An epidemiologic perspective JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 27: (1) pp. 110. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12352332]
15
van den Bergh JP, van Geel TA, Geusens PP Osteoporosis, frailty and fracture: implications for case finding and therapy NATURE REVIEWS RHEUMATOLOGY (ISSN: 17594790) 8: (3) pp. 163172. ( 2012) W C: Rheumatology Folyóiratcikk [12352331]
16
Misof Barbara M, Roschger Paul, Gabriel Daniela, Paschalis Eleftherios P, Eriksen Erik F, Recker Robert R, Gasser Juerg A, Klaushofer Klaus Annual intravenous zoledronic acid for three years increased cancellous bone matrix mineralization beyond normal values in the
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 94/342
3/30/2015
nyomtatobarat forma HORIZON biopsy cohort JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 28: (3) pp. 442448. ( 2013) Folyóiratcikk [14595202] 17 * Abrahamsen B, Rubin K H, Eiken P A, Eastell R Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National P rescription registry study OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 24: (1) pp. 321328. ( 2013) Folyóiratcikk [14595201] 18
Devogelaer JeanPierre, Sambrook Philip, Reid David M, Goemaere Stefan, IshShalom Sophia, Collette Julien, Su Guoqin, BucciRechtweg Christina, Papanastasiou Philemon, Reginster JeanYves Effect on bone turnover markers of onceyearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids RHEUMATOLOGY (ISSN: 14620324) 52: (6) pp. 10581069. ( 2013) Folyóiratcikk [14595200]
19 * Popp Albrecht W , Guler Sabina, Lamy Olivier, Senn Christoph, Buffat Helene, Perrelet Romain, Hans Didier, Lippuner Kurt Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: A threeyear study JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 28: (3) pp. 449454. ( 2013) Folyóiratcikk [14595199] 20
Compston Juliet Obesity and Bone CURRENT OSTEOPOROSIS REPORTS 11: (1) pp. 3035. ( 2013) Folyóiratcikk [14595198]
21
Compston Juliet Obesity and fractures JOINT BONE SPINE (ISSN: 1297319X) 80: (1) pp. 810. ( 2013) Folyóiratcikk [14595197]
22
Leung PingChung Osteoporosis and the orthopaedic surgeon CHINESE MEDICAL JOURNAL (ISSN: 03666999) 126: (20) pp. 38033805. ( 2013) Folyóiratcikk [14595196]
23
AppelmanDijkstra Natasha M, Papapoulos Socrates E P revention of incident fractures in patients with prevalent fragility fractures: Current and future approaches BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (ISSN: 15216942) 27: (6) pp. 805820. ( 2013) Folyóiratcikk [14595195]
24
Bai Hua, Jing Danqing, Guo Aitao, Yin Shinan Randomized controlled trial of zoledronic acid for treatment of osteoporosis in women JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (ISSN: 03000605) 41: (3) pp. 697704. ( 2013) Folyóiratcikk [14595194]
25
Doo Loomee, Shapiro Charles L Skeletal Manifestations of Treatment of Breast Cancer on P remenopausal Women CURRENT OSTEOPOROSIS REPORTS 11: (4) pp. 311318. ( 2013) Folyóiratcikk [14595193]
26
Ma Chao, Qin Hua, Zhou Yingfeng, W an Guang, Shi Shufeng, Dong Yuzhen, W ang W ei, Tan Haifeng Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis PAKISTAN JOURNAL OF MEDICAL SCIENCES (ISSN: 1682024X) 29: (6) pp. 13811384. ( 2013) Folyóiratcikk [14595192]
27
Chen B, Li Y, Yang X, Xu H, Xie D Zoledronic acid enhances boneimplant osseointegration more than alendronate and strontium ranelate in ovariectomized rats OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 24: (7) pp. 21152121. ( 2013) Folyóiratcikk [14595191]
28
Yu Elaine W Bone Metabolism After Bariatric Surgery JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 29: (7) pp. 15071518. ( 2014) Folyóiratcikk [14595190]
29 * Paggiosi M A, Peel N, McCloskey E, W alsh J S, Eastell R Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (12) pp. 27292741. ( 2014) Folyóiratcikk [14595189] 30 * Popp A W , Buffat H, Cavelti A, W indolf M, Perrelet R, Senn C, Lippuner K Cortical bone loss at the tibia in postmenopausal women with osteoporosis is associated with incident nonvertebral fractures: Results of a randomized controlled ancillary study of HORIZON MATURITAS (ISSN: 03785122) 77: (3) pp. 287293. ( 2014) Folyóiratcikk [14595188] 31
Caffarelli Carla, Alessi Chiara, Nuti Ranuccio, Gonnelli Stefano Divergent effects of obesity on fragility fractures CLINICAL INTERVENTIONS IN AGING (ISSN: 11781998) 9: pp. 16291636. ( 2014) Folyóiratcikk [14595187]
32
Premaor Melissa Orlandin, Comim Fabio Vasconcellos, Compston Juliet E Obesity and fractures ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (ISSN: 00042730) 58: (5) pp. 470477. ( 2014) Folyóiratcikk [14595186]
33
Cao PengChong, Xiao W enXing, Yan YaBo, Zhao Xiong, Liu Shuai, Feng Jing, Zhang W ei, W ang Jun, Feng YaFei, Lei W ei P reventive Effect of Crocin on Osteoporosis in an Ovariectomized Rat Model EVIDENCEBASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (ISSN: 1741427X) 2014: P aper 825181. 11 p. (2014)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 95/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [14595185] 34 * Magaziner Jay S, Orwig Denise L, Lyles Kenneth W , Nordsletten Lars, Boonen Steven, Adachi Jonathan D, Recknor Chris, ColonEmeric Cathleen S, Mesenbrink Peter, BucciRechtweg Christina, Su Guoqin, Johnson Rasheeda, Pieper Carl F Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 29: (12) pp. 25452551. ( 2014) Folyóiratcikk [14595184] 35
Huang Shushu, Lin Hua, Zhu Xiufen, Chen Xin, Fan Lu, Liu Changchang Zoledronic acid increases bone mineral density and improves healthrelated quality of life over two years of treatment in Chinese women with postmenopausal osteoporosis ENDOKRYNOLOGIA POLSKA (ISSN: 0423104X) 65: (2) pp. 96104. ( 2014) Folyóiratcikk [14595183]
121. Kósa J , Balla B , Speer G , Kiss J , Borsy A , Podani J , Takács I , Lazáry Á , Nagy Zs , Bácsi K , Orosz L , Lakatos P Effect of menopause on gene expression pattern in bone tissue of nonosteoporotic women MENOPAUSETHE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY 16:(2) pp. 367377. (2009) IF: 3.082 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1209414] [ Admin láttamozott ] Független idéző: 6 Függő idéző: 1 Összesen: 7 1
Jiang SY, Shu R, Xie YF, Zhang SY Agerelated changes in biological characteristics of human alveolar osteoblasts CELL PROLIFERATION (ISSN: 09607722) 43: (5) pp. 464470. ( 2010) Folyóiratcikk [11101971]
2.
CATHERINE ROYBELLA VANCE IMP LICATION DE LA VOIE DE L'AMP K DANS LA MODULATION DE L'ADIP OGENESE P AR LE CALCIUM 2010.
FACULTE DE PHARMACIE UNIVERSITÉ LAVAL QUÉBEC Disszertáció /Külföldi fokozat (nem P hD) /Tudományos [12835815] 3
Zaman G, Saxon LK, Sunters A, Hilton H, Underhill P, W illiams D, Price JS, Lanyon LE Loadingrelated regulation of gene expression in bone in the contexts of estrogen deficiency, lack of estrogen receptor alpha and disuse BONE (ISSN: 87563282) 46: (3) pp. 628642. ( 2010) Folyóiratcikk [11101970]
4 * Balla B, Pintér C, Kósa J P, Podani J, Takács I, Nagy Z, Speer G, Horváth B, Korányi L, Lakatos P Gene expression changes in femoral head necrosis of human bone tissue Disease Markers (ISSN: 02780240) 31: (1) pp. 2532. ( 2011) Chemicals/CAS: collagen, 9007345; metalloproteinase, 81669707 Folyóiratcikk [11917096] 5
Sowers MR, Harlow SAD, Karvonen C, Bromberger J, Cauley J, Gold E, Matthews K Menopause: Its Epidemiology In: Women and Health. Elsevier Inc., 2013. (ISBN 9780123849786) pp. 371387.
Könyvrészlet /Könyvfejezet /Tudományos [13338926] 6
RR Kanherkar N BhatiaDey AB Csoka Epigenetics Across the Human Lifespan Frontiers in Cell and Developmental Biology 2: P aper 49. (2014) Folyóiratcikk [14175506]
7
R Jansen S Batista AI Brooks JA Tischfield Sex differences in the human peripheral blood transcriptome BMC Genomics (ISSN: 14712164) 15: P aper 33. (2014) Folyóiratcikk [13647541]
122. Kósa J , Kis A , Bácsi K , Balla B , Nagy Zs , Speer G , Takács I , Lakatos P The role of bone morphogenetic protein8 in the mediation of glucocorticoidinduced effects on osteoblasts ASBM R Kongresszus , Denver (2009) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434227] [Poszter] [ Admin láttamozott ] 123. Kósa JP , Balla B , Kiss J , Podani J , Takács I , Lazáry Á , Nagy Z , Bácsi K , Karsai A , Speer G , Lakatos P Postmenopausal expression changes of immune systemrelated genes in human bone tissue JOURNAL OF CLINICAL IMMUNOLOGY 29:(6) pp. 761768. (2009) IF: 3.583 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1242039] [ Admin láttamozott ] Független idéző: 4 Függő idéző: 1 Összesen: 5 1
Mesko B, Poliska S, Szegedi A, Szekanecz Z, Palatka K, Papp M, Nagy L P eripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets BMC Medical Genomics (ISSN: 17558794) 3: P aper 15. (2010)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 96/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [12008733] 2 * Balla B, Pintér C, Kósa J P, Podani J, Takács I, Nagy Z, Speer G, Horváth B, Korányi L, Lakatos P Gene expression changes in femoral head necrosis of human bone tissue Disease Markers (ISSN: 02780240) 31: (1) pp. 2532. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12008732] 3
Zhao R Immune regulation of osteoclast function in postmenopausal osteoporosis: A critical interdisciplinary perspective International Journal of Medical Sciences (ISSN: 14491907) 9: (9) pp. 825832. ( 2012) Folyóiratcikk [12710742]
4
Shabat Y Lichtenstein Y Zolotarov L Ben Yaacov A Ilan Y Hepatoprotective effect of DT56a is associated with changes in natural killer T cells and regulatory T cells Journal of Digestive Diseases (ISSN: 17512972) 14: (2) pp. 8492. ( 2013) Folyóiratcikk [12992353]
5
Samar R El Khoudary Kelly J Shields HsiangYu Chen Karen A Matthews Menopause, Complement, and Hemostatic Markers in Women at Midlife: The Study of Women’ s Health Across the Nation Original Research Article Atherosclerosis (ISSN: 00219150) 231: (1) pp. 5458. ( 2013) Folyóiratcikk [13412574]
124. Lakatos P , Gimes G , Speer G A PCOS klinikai képe felnőttben In: Lakatos Péter , Speer Gábor (szerk.) Policisztás ovarium szindróma: gyakorlati útmutató . 175 p. Budapest: Semmelweis Kiadó, 2009. pp. 4766. (ISBN:9789639879553) Nyelv: Magyar
Könyvrészlet /Szaktanulmány /Tudományos [1335623] [ Hitelesített ] 125. Lakatos P Egyszerűen, vizeletmintából. PCA3 az első prosztatarákspecifikus genetikai teszt STUDIUM AND PRACTICUM 3: pp. 1819. (2009) Nyelv: Magyar
Folyóiratcikk /Rövid közlemény /Tudományos [1806450] [ Admin láttamozott ] 126. Lakatos P A PCOS differenciáldiagnosztikája In: Lakatos Péter , Speer Gábor (szerk.) Policisztás ovarium szindróma: gyakorlati útmutató . 175 p. Budapest: Semmelweis Kiadó, 2009. pp. 7375. (ISBN:9789639879553) Nyelv: Magyar
Könyvrészlet /Könyvfejezet /Tudományos [1923152] [ Hitelesített ] 127. Lakatos P D vitamin In: Lakatos Péter , Speer Gábor (szerk.) Policisztás ovarium szindróma: gyakorlati útmutató . 175 p. Budapest: Semmelweis Kiadó, 2009. pp. 8283. (ISBN:9789639879553) Nyelv: Magyar
Könyvrészlet /Könyvfejezet /Tudományos [1923158] A PCOS kezelése: A meddőség kezelése: Gyógyszeres kezelés c. fejezetben. [ Hitelesített ] 128. Lakatos P Klinikum In: Palkó András , Szarvas Ferenc (szerk.) Tünetorientált klinikoradiológia . 463 p. Budapest: M edicina Könyvkiadó, 2009. pp. 358360. (ISBN:978 963 226 259 8) Nyelv: Magyar
Könyvrészlet /Szaktanulmány /Tudományos [1923163] Osteoporosis c. fejezetben. [ Érvényesített ] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 97/342
3/30/2015
nyomtatobarat forma
129. Lakatos Péter , Speer Gábor (szerk.) Policisztás ovarium szindróma: gyakorlati útmutató Budapest: Semmelweis Kiadó, 2009. 175 p. (ISBN:9789639879553) Nyelv: Magyar
Könyv /Kézikönyv /Tudományos [1335595] [ Hitelesített ] 130. Lakatos Péter A természet csodája: középpontban a kalcium MAGYAR TUDOMÁNY 170:(6) pp. 710713. (2009) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1806433] [ Hitelesített ] 131. M adarasz E , Tabak AG , Speer G , Lakatos P , Kerenyi Z , Tamas G Abnormal glucose tolerance is associated with diminished postload change in leptin levels in women DIABETES METABOLISM RESEARCH AND REVIEWS 25:(7) pp. 632638. (2009) IF: 2.762 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1335536] Dr M adarász and Dr Tabák have contributed equally to the present paper. [ Érvényesített ] Független idéző: 1 Összesen: 1 1
Shi Yeu Ching, Liao Jiunn W ang, Pan Tzu Ming Antihypertriglyceridemia and AntiInflammatory Activities of MonascusFermented Dioscorea in StreptozotocinInduced Diabetic Rats Experimental Diabetes Research (ISSN: 16875214) 2011: P aper 710635. (2011) Folyóiratcikk /Szakcikk /Tudományos [11842692]
132. M adarasz E , Tamas G , Tabak AG , Speer G , Lakatos P , Kerenyi Z Osteoprotegerin levels in women with prior gestational diabetes mellitus DIABETES CARE 32:(1) p. e5. (2009) Nyelv: Angol
Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [1335540] [ Érvényesített ] Független idéző: 1 Összesen: 1 1
Akinci Baris, Celtik Aygul, Yuksel Faize, Genc Sinan, Yener Serkan, Secil Mustafa, Ozcan Mehmet Ali, Yesil Sena Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome Diabetes Research and Clinical Practice (ISSN: 01688227) 91: (1) pp. 2631. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12273128]
133. M ező T , Tabák Á , Bhattoa HP , Lakatos P Az osteoporosis és az osteoporoticus törések kockázati tényezői magyar nők csoportjában: a Nemzeti Osteoporosis Kozckázati Kérdőív vizsgálat eredményei CA ÉS CSONT 12:(3) pp. 118124. (2009) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1806412] [ Érvényesített ] 134. Speer G , Lakatos P A PCOS diagnózisa In: Lakatos Péter , Speer Gábor (szerk.) Policisztás ovarium szindróma: gyakorlati útmutató . 175 p. Budapest: Semmelweis Kiadó, 2009. pp. 6772. (ISBN:9789639879553) Nyelv: Magyar
Könyvrészlet /Könyvfejezet /Tudományos [1335624] [ Hitelesített ] 135. Szendrői A , Speer G , Tabák Á , Kósa JP , Horváth H , Szűcs M , Riesz P , Romics I , Lakatos P A D vitamin, ösztrogén és calcium sensing receptor genotípusainak valamint a szérum kalciumnak a prosztatarák kialakulásában betöltött szerepe. UROONKOLÓGIA 6:(2) pp. 4047. (2009) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1335705] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 98/342
3/30/2015
nyomtatobarat forma
[ Érvényesített ] 136. Takács I , Lazáry Á , Kósa J , Kiss J , Balla B , Nagy Z , Bácsi K , Speer G , Lakatos P A RANKL/OPG jelátviteli rendszer allélikus variációinak összefüggése a csonttömeggel és az in vivo génexpresszióval. MAGYAR BELORVOSI ARCHIVUM 62:(5) pp. 363370. (2009) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1335703] [ Érvényesített ] 137. Takacs I , Lazary A , Kosa JP , Kiss J , Balla B , Nagy Z , Bacsi K , Speer G , Lakatos P Allelic variations of RANK/RANKL/OPG signaling system is related to bone mineral density and in vivo gene expression BONE 44:(Suppl. 1) p. S116. (2009) 2nd Joint M eeting of the International Bone & M ineral Society and the Australian & New Zealand Bone & M ineral Society. Sydney, Ausztrália: 2009.03.21 2009.03.25. Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1464649] [ Érvényesített ]
2008 138. Bacsi K , Hitre E , Kosa JP , Horvath H , Lazary A , Lakatos PL , Balla B , Budai B , Lakatos P , Speer G Effects of the lactase 13910 C/T and calciumsensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population BMC CANCER 8: Paper 317. (2008) IF: 3.087 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1464651] [ Érvényesített ] Független idéző: 16 Függő idéző: 1 Összesen: 17 1
2
Tímár J, Kásler M, Heringh A, Soós M, Mathiász D, Romány A, Józsa A, Szilák L, Forrai T, Patthy L, Kovács G A daganatos betegellátás innovatív fejlesztése genomikai módszerekkel. Beszámoló a nemzeti onkológiai konzorcium 2008. évi tevékenységéről MAGYAR ONKOLÓGIA (ISSN: 00250244) 53: (4) pp. 321334. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11910437] * Lakatos PL Gastrointestinal genetic novelties in the diseases of colon In: GASTRO UPDATE, 2009. Gastro update Alapítvány , 2009. pp. 456468. Paper http://www.gastroupdate.hu/pdf/2009/Lakatos_Peter_Laszlo_Gasztrointeszt.pdf.
Könyvrészlet /Könyvfejezet /Tudományos [13241641] 3
Riccardi D, Finney BA, W ilkinson W J, Kemp PJ Novel regulatory aspects of the extracellular Ca2+sensing receptor; CaR PFLUGERS ARCH 458: (6) pp. 10071022. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [11910436]
4
Ádány R The use of genomics in public health In: STRATÉGIAI KUTATÁSOK 20082009. Tinta Köny vkiadó, 2009. pp. 209231. Paper http://www.sulinet.hu/oroksegtar/data/tudomany _es_ismeretterjesztes/strategiai_kutatasok_2008_2009/pages/09_Genomika.pdf.
Könyvrészlet /Könyvfejezet /Tudományos [13241643] 5
Agueda L, Urreizti R, Bustamante M, Jurado S, GarciaGiralt N, DíezPérez A, Nogués X, Mellibovsky L, Grinberg D, Balcells S Analysis of Three Functional P olymorphisms in Relation to Osteoporosis P henotypes: Replication in a Spanish Cohort CALCIFIED TISSUE INT 87: (1) pp. 1424. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11910438]
6
Jacobs ET, Martinez ME, Campbell PT, Conti DV, Duggan D, Figueiredo JC, Haile RW , LeRoy EC, Poynter JN, Thompson PA, Baron JA Genetic variation in the retinoid X receptor and calciumsensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry CARCINOGENESIS (ISSN: 01433334) 31: (8) pp. 14121426. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11910439]
7
Tarabra E, Pazienza P, Borghesio E, Actis GC, Tappero G, Framarin L, Ayoubi M, Castellino F, Leone N, Sansoè G, De Paolis P, Comandone A, Rosina F LCT13910C>T polymorphismassociated lactose malabsorption and risk for colorectal cancer in Italy. DIGEST LIVER DIS 42: (10) pp. 741743. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11910440]
8
Ghevariya V, Anand S A short primer on the calcium sensing receptor: An important cog in the colon cancer wheel? DIGEST DIS SCI 56: (2) pp. 279284. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [11910441]
9
Brown EM Vitamin D and the calciumsensing receptor In: Feldman D, Pike JW, Glorieux FH (szerk.) : VITAMIN D. Elsevier, 2011. pp. 425456.
Könyvrészlet /Könyvfejezet /Tudományos [13810112] 10
Zeisel SH
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+e… 99/342
3/30/2015
nyomtatobarat forma How Nutrients are Affected by Genetics In: Kohlmeier M (szerk.) : Nutrigenetics: Apply ing the Science of Personal Nutrition. Kannapolis: Academic Press, 2012. (ISBN 9780123859006) pp. 103221. Paper 4.
Könyvrészlet /Könyvfejezet /Tudományos [13358491] 11
Hibler EA, Hu CC, Jurutka PW , Martinez ME, Jacobs ET P olymorphic Variation in the GC and CASR Genes and Associations with Vitamin D Metabolite Concentration and Metachronous Colorectal Neoplasia CANCER EPIDEM BIOMAR 21: (2) pp. 368375. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12021373]
12
Lu F, Zhang S Role of calciumsensing receptor in urolithiasis research JOURNAL OF MODERN UROLOGY 17: (5) pp. 523526. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13250311]
13
DiezFraile A, Lammens T, Benoit Y, D'Herde KGMA The calciumsensing receptor as a regulator of cellular fate in normal and pathological conditions CURR MOL MED 13: (2) pp. 282295. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13062078]
14.
Casalà Albacete C Analysis of the expression and function of the calcium sensing receptor in tumor development 2013.
Disszertáció /P hD /Tudományos [13810093] 15
Kim KZ, Shin A, Kim J, Park JW , Park SC, Choi HS, Chang HJ, Kim DY, Oh JH Association between CASR P olymorphisms; Calcium Intake; and Colorectal Cancer Risk PLOS ONE (ISSN: 19326203) 8: (3) p. e59628. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13064826]
16
Masvidal L, Iniesta R, Casalà C, Galván P, Rodríguez E, Lavarino C, Mora J, de Torres C P olymorphisms in the calciumsensing receptor gene are associated with clinical outcome of neuroblastoma. PLOS ONE (ISSN: 19326203) 8: (3) p. e59762. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13060926]
17
Mahmoudi T, Karimi K, Arkani M, Farahani H, Nobakht H, Dabiri R, Asadi A, Zali MR P arathyroid Hormone Gene rs6256 and Calcium Sensing Receptor Gene rs1801725 Variants are not Associated with Susceptibility to Colorectal Cancer in Iran ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (ISSN: 15137368) 15: pp. 60356039. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14143970]
139. Bacsi K , Kosa JP , Balla B , Lazary A , Nagy Z , Takacs I , Speer G , Lakatos P Decreased activity of lactase phlorizin hydrolase and bone mineral density CALCIFIED TISSUE INTERNATIONAL 82:(Suppl. 1) p. S184. (2008) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1464660] [ Érvényesített ] 140. Bácsi K , Kósa J , Balla B , Lazáry Á , Nagy Zs , Takács I , Speer G , Lakatos P Decreased activity of lactase phlorizin hydrolase and bone mineral density ASBM R Kongresszus, M ontreal (2008) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434166] [Poszter] [ Admin láttamozott ] 141. Balla B , Kósa J , Takács I , Kiss J , Podani J , Borsy A , Lazáry Á , Bácsi K , Nagy Zs , Speer G , Orosz L , Lakatos P A menopauza hatása a csontszöveti génkifejeződésre posztmenopauzás és premenopauzás korú nem oszteoporotikus nőkben MAGYAR BELORVOSI ARCHIVUM 61: pp. 208219. (2008) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1134655] [ Admin láttamozott ] 142. Balla B , Kósa JP Kiss J , Borsy A , Podani J , Lazáry Á , Bácsi K , Nagy Zs , Takács I , Speer G , Orosz L , Lakatos P Different gene expression patterns in bone tissue of aging postmenopausal osteoporotic and nonosteoporotic women. CALCIFIED TISSUE INTERNATIONAL 82:(1) pp. 1226. (2008) IF: 2.737 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1153330] [ Admin láttamozott ] Független idéző: 17 Függő idéző: 10 Összesen: 27 1
* Lazáry A, Kósa JP, Tóbiás B, Lazáry J, Balla B, Bácsi K, Takács I, Nagy Z, Mezo T, Speer G, Lakatos P
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
100/342
3/30/2015
nyomtatobarat forma Single nucleotide polymorphisms in new candidate genes are associated with bone mineral density and fracture risk EUR J ENDOCRINOL 159: (2) pp. 187196. ( 2008) Folyóiratcikk [10632785] 2
Tan SL, W ood AM Chronic obstructive pulmonary disease and comorbidity: a review and consideration of pathophysiology PANMINERVA MEDICA (ISSN: 00310808) 51: (2) pp. 8193. ( 2009) Folyóiratcikk [10907445]
3
* Kósa J, Balla B, Speer G, Kiss J, Borsy A, Podani J, Takács I, Lazáry Á, Nagy Zs, Bácsi K, Orosz L, Lakatos P Effect of menopause on gene expression pattern in bone tissue of nonosteoporotic women MENOPAUSE 16: (2) pp. 367377. ( 2009) Folyóiratcikk [10632782]
4
Hopwood B, Tsykin A, Findlay DM, Fazzalari NL Gene expression profile of the bone microenvironment in human fragility fracture bone BONE (ISSN: 87563282) 44: (1) pp. 87101. ( 2009) Folyóiratcikk [10607073]
5
* Borsy A, Podani J, Stéger V, Balla B, Horváth A, Kósa JP, Gyurján I Jr, Molnár A, Szabolcsi Z, Szabó L, Jakó E, Zomborszky Z, Nagy J, Semsey S, Vellai T, Lakatos P, Orosz L Identifying novel genes involved in both deer physiological and human pathological osteoporosis MOL GENET GENOMICS 281: (3) pp. 301313. ( 2009) Folyóiratcikk [10632784]
6
* Kósa J P, Balla B, Kiss J, Podani J, Takács I, Lazáry Á, Nagy Z, Bácsi K, Karsai A, Speer G, Lakatos P P ostmenopausal expression changes of immune systemrelated genes in human bone tissue Journal of Clinical Immunology (ISSN: 02719142) 29: (6) pp. 761768. ( 2009) Chemicals/CAS: osteoclast differentiation factor, 200145933; Gonadal Steroid Hormones; RNA, Messenger Folyóiratcikk [11916997]
7
* Balla B, Kósa JP, Kiss J, Podani J, Takács I, Lazáry A, Nagy Z, Bácsi K, Speer G, Lakatos P Transcriptional profiling of immune systemrelated genes in postmenopausal osteoporotic versus nonosteoporotic human bone tissue CLIN IMMUNOL 131: (2) pp. 354359. ( 2009) Folyóiratcikk [10632783]
8
* Takacs I, Lazary A, Kosa JP, Kiss J, Balla B, Nagy Z, Bacsi K, Speer G, Lakatos P Allelic variations of RANKL/OP G signaling system are related to bone mineral density and in vivo gene expression EUROPEAN JOURNAL OF ENDOCRINOLOGY (ISSN: 08044643) 162: (2) pp. 423431. ( 2010) Folyóiratcikk [11101966]
9
* Steger V, Molnar A, Borsy A, Gyurjan I, Szabolcsi Z, Dancs G, Molnar J, Papp P, Nagy J, Puskas L, Barta E, Zomborszky Z, Horn P, Podani J, Semsey S, Lakatos P, Orosz L Antler development and coupled osteoporosis in the skeleton of red deer Cervus elaphus: expression dynamics for regulatory and effector genes MOLECULAR GENETICS AND GENOMICS (ISSN: 16174615) 284: (4) pp. 273287. ( 2010) Folyóiratcikk [11101965]
10 * Kiss J, Balla B, Kósa J P, Borsy A, Podani J, Takács I, Lazáry Á, Nagy Z, Bácsi K, Szlávy E, Szendroi M, Speer G, Orosz L, Lakatos P Changes of gene expression and its role in pathogenesis in fibrous and nonfibrous dysplastic bone tissues in women: A génexpresszió változásai és patogenetikai jelentoségük fibrosus dysplasiás és nem fibrosus dysplasiás nok csontszövetében Orvosi Hetilap (ISSN: 00306002) 151: (40) pp. 16561665. ( 2010) Chemicals/CAS: Bone Morphogenetic Proteins; RNA, Messenger Folyóiratcikk [11916995] 11
Jurado S, GarciaGiralt N, DiezPerez A, Esbrit P, Yoskovitz G, Agueda L, Urreizti R, PerezEdo L, Salo G, Mellibovsky L, Balcells S, Grinberg D, Nogues X Effect of IL1 beta, P GE(2), and TGFbeta 1 on the Expression of OP G and RANKL in Normal and Osteoporotic P rimary Human Osteoblasts JOURNAL OF CELLULAR BIOCHEMISTRY (ISSN: 07302312) 110: (2) pp. 304310. ( 2010) Folyóiratcikk [11101964]
12
Reppe S, Refvem H, Gautvik VT, Olstad OK, Hovring PI, Reinholt FP, Holden M, Frigessi A, Jemtland R, Gautvik KM Eight genes are highly associated with BMD variation in postmenopausal Caucasian women BONE (ISSN: 87563282) 46: (3) pp. 604612. ( 2010) Folyóiratcikk [11101963]
13 * Kiss J, Balla B, Kosa JP, Borsy A, Podani J, Takács I, Lazary A, Nagy Z, Bacsi K, Kis A, Szlavy E, Szendrői M, Speer G, Orosz L, Lakatos P Gene Expression P atterns in the Bone Tissue of Women With Fibrous Dysplasia AMERICAN JOURNAL OF MEDICAL GENETICS PART A (ISSN: 15524825) 152A: (9) pp. 22112220. ( 2010) Folyóiratcikk [11101962] 14
Li W F, Hou SX, Yu B, Li MM, Ferec C, Chen JM Genetics of osteoporosis: accelerating pace in gene identification and validation HUMAN GENETICS (ISSN: 03406717) 127: (3) pp. 249285. ( 2010) Folyóiratcikk [11101961]
15
Hie M, Tsukamoto I Increased expression of the receptor for activation of NFκB and decreased runtrelated transcription factor 2 expression in bone of rats with streptozotocininduced diabetes International Journal of Molecular Medicine (ISSN: 11073756) 26: (4) pp. 611618. ( 2010) Folyóiratcikk /Tudományos [13765735]
16.
Gunhild Melhus Molecular studies on bone with focus on fracture healing in experimental osteoporosis 2010.
INSTITUTE OF PATHOLOGY, OSLO UNIVERSITY HOSPITAL RIKSHOSPITALET Disszertáció /P hD /Tudományos [12820856] 17
Eriksen CG, Olsen H, Husted LB, Sorensen L, Carstens M, Soballe K, Langdahl BL The Expression of IL6 by Osteoblasts Is Increased in Healthy Elderly Individuals: Stimulated P roliferation and Differentiation Are Unaffected by Age
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
101/342
3/30/2015
nyomtatobarat forma CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 87: (5) pp. 414423. ( 2010) Folyóiratcikk [11101959] 18 * Balla B, Pintér C, Kósa J P, Podani J, Takács I, Nagy Z, Speer G, Horváth B, Korányi L, Lakatos P Gene expression changes in femoral head necrosis of human bone tissue Disease Markers (ISSN: 02780240) 31: (1) pp. 2532. ( 2011) Chemicals/CAS: collagen, 9007345; metalloproteinase, 81669707 Folyóiratcikk [11916994] 19.
Peggy Benisch Molekulare Analysen zur Knochenregeneration im Alter und bei Osteoporose 2011.
Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der JuliusMaximiliansUniversität W ürzburg Disszertáció /P hD /Tudományos [11751041] 20
Patsch JM, Kohler T, Berzlanovich A Trabecular Bone Microstructure and Local Gene Expression in Iliac Crest Biopsies of Men With Idiopathic Osteoporosis JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 26: (7) pp. 15841592. ( 2011) Folyóiratcikk [11460869]
21
Zupan Janja, Pristovsek Nusa, MencejBedrac Simona Interleukin1 alpha gene variants influence bone mineral density and the risk of osteoporotic hip fractures in elderly Slovenian people CLINICAL CHEMISTRY AND LABORATORY MEDICINE (ISSN: 14346621) 50: (8) pp. 13791385. ( 2012) Folyóiratcikk [12680976]
22
Bernardini G, Braconi D, Spreafico A, Santucci A P ostgenomics of bone metabolic dysfunctions and neoplasias Proteomics (ISSN: 16159853) 12: (45) pp. 708721. ( 2012) Folyóiratcikk [12262406]
23
Chung E, Rylander M N Response of a preosteoblastic cell line to cyclic tensile stress conditioning and growth factors for bone tissue engineering Tissue Engineering Part A 18: (34) pp. 397410. ( 2012) Folyóiratcikk [12019023]
24
Toti Paolo / Sbordone Carolina / Martuscelli Ranieri / Califano Luigi / Ramaglia Luca / Sbordone Ludovico Gene clustering analysis in human osteoporosis disease and modifications of the jawbone Archives of Oral Biology (ISSN: 00039969) 58: (7) pp. 912929. ( 2013) Folyóiratcikk [13057396]
25
FögerSamwald U Pietschmann P Gene expression analyses for osteoporosis research Osteologie (ISSN: 10191291) 22: (1) pp. 2530. ( 2013) Folyóiratcikk /Szakcikk [13084805]
26
W u X M Ma X Tang C Xie K N Liu J Guo W Yan Y L Shen G H Luo E P P roteinprotein interaction network and significant gene analysis of osteoporosis Genetics and Molecular Research (ISSN: 16765680) 12: (4) pp. 47514759. ( 2013) Folyóiratcikk [13462293]
27
Volk Susan W , Shah Shalin R, Cohen Arthur J Type III Collagen Regulates Osteoblastogenesis and the Quantity of Trabecular Bone CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 94: (6) pp. 621631. ( 2014) Folyóiratcikk [13876011]
143. Balla B , Kosa JP , Kiss J , Podani J , Lazary A , Bacsi K , Nagy Z , Speer G , Takacs F , Lakatos P Transcriptional profile of immun systemrelated genes in postmenopausal osteoporotic versus nonosteoporotic human bone tissue CALCIFIED TISSUE INTERNATIONAL 82:(Suppl. 1) p. S137. (2008) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1464658] [ Érvényesített ] 144. Balla B , Kósa JP , Kiss J , Podani J , Lazáry Á , Bácsi K , Nagy Zs , Speer G , Takács I , Lakatos P Translational profile of immune systemrelated genes in postmenopausal osteoporotic versus nonosteoporotic human bone tissue. JOURNAL OF BONE AND MINERAL RESEARCH 82:(S1) p. 137. (2008) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1822838] [ Admin láttamozott ] 145. Balla B , Kósa J , Kiss J , Podani J , Lazáry Á , Bácsi K , Nagy Zs , Speer G , Takács I , Lakatos P Translational profile of immune systemrelated genes in postmenopausal osteoporotic versus nonosteoporotic human bone tissue ASBM R Kongresszus, M ontreal (2008) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434177] [Poszter] [ Admin láttamozott ]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
102/342
3/30/2015
nyomtatobarat forma
146. Balla B , Kósa J , Kiss J , Podani J , Takács I , Lazáry Á , Nagy Zs , Bácsi K , Speer G , Lakatos P Transcriptional profile of immune systemrelated genes in postmenopausal osteoporotic versus nonosteoporotic human bone tissue ECTS 35th European Symposium on Calcified Tissues Barcelona, spain (2008) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434218] [Poszter] [ Admin láttamozott ] 147. Cummings SR , Ettinger B , Delmas PD , Kenemans P , Stathopoulos V , Verweij P , M olArts M , Kloosterboer L , M osca L , Christiansen C , Bilezikian J , Kerzberg EM , Johnson S , Zanchetta J , Grobbee DE , Seifert W , Eastell R , LIFT Trial Investigators Egyéb szerzőség: Lakatos P , Szombati I , Korányi L , Spengler B , Szabo Z , Nafradi L , Takacs K (kollaborációs közrem.); The effects of tibolone in older postmenopausal women NEW ENGLAND JOURNAL OF MEDICINE 359:(7) pp. 697708. (2008) IF: 50.017 Nyelv: Angol
Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [1980874] LIFT Trial Investigators Zanchetta J, Kerzberg E, Eden J, Eisman J, Howarda J, M acLennan A, Norman R, Devogelaer J, Reginster Y, Ragi Eis S, Griz L, Zerbini C, Jiménez L, Stepan J, Christiansen C, Valter I, M aasalu K, Vahula K, Orcel P, Delmas P, Benhamou L, Ribot C, Felsenberg D, Spieler W, Dammann H, Lakatos P, Szombati I, Korányi L, Spengler B, Szabo Z, Nafradi L, Takacs K, Alekna V, Krasauskiene A, Jurgutis R, Jasqui S, de la Pena P, Garcia P, Baka A, Jonker J, Øfjord E, Lunde T, Skag A, Sawicki A, Bochenek A, Badurski J, Czerwinski E, Lipinski K, Payer J, Díez A, Gabriel R, Erenus M , Saracoglu F, Sendag F, Reid D, Albertazzia P, Eastell R, Pavela I, Pawaa R, Robinson J, BarrettConnor E, Boling E, Caldwell J, Bowen P, Wasnich R, Johnson S, Simon J, Lewiecki E, M cCluskey D, Sultany G, Kivitz A, Henry W, Downs R, Riera G, Pérez M onteverde A, Grady D, M cClung M , Pols H, Davis K, Herrington D, Hendrix S, Neven P, van Diest P, Harbeck N, Senn H, Svane G, Longo M , Davidson B, Kappelle J, Peters R, Prins M . [ Érvényesített ] Független idéző: 180 Függő idéző: 8 Összesen: 188 1
Martin KA, Manson JE Approach to the P atient with Menopausal Symptoms JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 93: (12) pp. 45674575. ( 2008) Z9: 19 W C: Endocrinology & Metabolism Folyóiratcikk [12351686]
2
Villa R Hormonal therapy in menopause: What information for women? Tempo Medico Cuore 4: (4) pp. 3032. ( 2008) Folyóiratcikk [13474522]
3
Cuzick J Hormone replacement therapy and the risk of breast cancer EUROPEAN JOURNAL OF CANCER (ISSN: 09598049) 44: (16) pp. 23442349. ( 2008) Z9: 17 W C: Oncology Folyóiratcikk [12351685]
4
Renoux C, Dell'Aniello S, Garbe E, Suissa S Hormone replacement therapy use and the risk of stroke MATURITAS (ISSN: 03785122) 61: (4) pp. 305309. ( 2008) Z9: 9 W C: Geriatrics & Gerontology; Obstetrics & Gynecology Folyóiratcikk [12351684]
5
Gompel A HRT and breast cancer: A decreased incidence? Medecine Therapeutique Medecine de la Reproduction, Gynecologie et Endocrinologie 10: (6) pp. 412416. ( 2008) Folyóiratcikk [13474521]
6
Legro RS Impact of Metformin, Oral Contraceptives, and Lifestyle Modification on P olycystic Ovary Syndrome in Obese Adolescent Women: Do We Need a New Drug? JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 93: (11) pp. 42184220. ( 2008) W C: Endocrinology & Metabolism Folyóiratcikk [12351683]
7
Liedtke C, Kiesel L P ostmenopausal hormone therapy and the risk of breast cancer. An update Gynakologe (ISSN: 00175994) 41: (11) pp. 865873. ( 2008) Folyóiratcikk [13474520]
8
Gompel A, Rozenberg S, Barlow DH The EMAS 2008 update on clinical recommendations on postmenopausal hormone replacement therapy MATURITAS (ISSN: 03785122) 61: (3) pp. 227232. ( 2008) CA: EMAS Board Members Z9: 15 W C: Geriatrics & Gerontology; Obstetrics & Gynecology Folyóiratcikk [12351682]
9
Fuleihan GEH Tibolone and the promise of ideal hormonereplacement therapy NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 359: (7) pp. 753755. ( 2008)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
103/342
3/30/2015
nyomtatobarat forma Z9: 1 W C: Medicine, General & Internal Folyóiratcikk [12351681] 10
RaccahTebeka B Tibolone for elderly women: Benefits and risks Revue du Praticien Gynecologie et Obstetrique §: (128) p. 9. ( 2008) Folyóiratcikk /Rövid közlemény /Tudományos [13474519]
11
Chlebowski RT, Prentice R Tibolone in Older P ostmenopausal Women NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 359: (20) pp. 21722173. ( 2008) W C: Medicine, General & Internal Folyóiratcikk [12351680]
12
De Souza MAM, Geber S Tibolone's effect on retinal and ophthalmic arteries flowmetry Revista Brasileira de Ginecologia e Obstetricia 30: (11) pp. 537543. ( 2008) Folyóiratcikk [13474518]
13
Francès C What's new in internal medicine? Annales de Dermatologie et de Venereologie (ISSN: 01519638) 135: (SUP P L. 7) pp. S335S342. ( 2008) Folyóiratcikk [13474517]
14
Visvanathan K, Chlebowski RT, Hurley P, Col NF, Ropka M, Collyar D, Morrow M, Runowicz C, Pritchard KI, Hagerty K, Arun B, Garber J, Vogel VG, W ade JL, Brown P, Cuzick J, Kramer BS, Lippman SM American Society of Clinical Oncology Clinical P ractice Guideline Update on the Use of P harmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction JOURNAL OF CLINICAL ONCOLOGY (ISSN: 0732183X) 27: (19) pp. 32353258. ( 2009) Z9: 59 W C: Oncology Folyóiratcikk [12351679]
15
Alés Martínez JE Chemoprevention of breast cancer Revisiones en Cancer (ISSN: 02138573) 23: (3) pp. 93101. ( 2009) Folyóiratcikk [13474516]
16
Qu F, Cai XF, Gu Y, Zhou J, Zhang RJ, Burrows E, Huang HF Chinese Medicinal Herbs in Relieving P erimenopausal Depression: A Randomized, Controlled Trial JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (ISSN: 10755535) 15: (1) pp. 93100. ( 2009) W C: Integrative & Complementary Medicine Folyóiratcikk [12351678]
17
Kane SC, Quinn MA Complex endometrial hyperplasia in the context of tibolone administration AUSTRALIAN AND NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (ISSN: 00048666) 49: (3) pp. 338 339. ( 2009) W C: Obstetrics & Gynecology Folyóiratcikk [12351677]
18
De Paepe P, Van Bortel L Current pharmacotherapy Tijdschrift voor Geneeskunde (ISSN: 0371683X) 65: (1415) pp. 652654. ( 2009) Folyóiratcikk [13474515]
19
Gallagher JC Does tibolone reduce the risk of fracture in older postmenopausal women with osteoporosis? NATURE CLINICAL PRACTICE ENDOCRINOLOGY (ISSN: 17458366) 5: (3) pp. 128129. ( 2009) W C: Endocrinology & Metabolism Folyóiratcikk [12351676]
20
* Mosca L, Grady D, BarrettConnor E, Collins P, W enger N, Abramson BL, PaganiniHill A, Geiger MJ, Dowsett SA, AmewouAtisso M, Kornitzer M Effect of Raloxifene on Stroke and Venous Thromboembolism According to Subgroups in P ostmenopausal Women at Increased Risk of Coronary Heart Disease STROKE (ISSN: 00392499) 40: (1) pp. 147155. ( 2009) Z9: 23 W C: Clinical Neurology; Peripheral Vascular Disease Folyóiratcikk [12351675]
21
Perrone G, Capri O, Galoppi P, Brunelli R, Bevilacqua E, Ceci F, Ciarla MV, Strom R Effects of either Tibolone or Continuous Combined Transdermal Estradiol with Medroxyprogesterone Acetate on Coagulatory Factors and Lipoprotein(a) in Menopause GYNECOLOGIC AND OBSTETRIC INVESTIGATION (ISSN: 03787346) 68: (1) pp. 3339. ( 2009) Z9: 6 W C: Obstetrics & Gynecology Folyóiratcikk [12351674]
22
Middeldorp S Epidemiology of hormonerelated venous thromboembolism THROMBOSIS RESEARCH (ISSN: 00493848) 123: (P rague, CZECH REP UBLIC) pp. S65S69. ( 2009) Z9: 5 W C: Hematology; Peripheral Vascular Disease Folyóiratcikk [12351673]
23
Sherman LW Evidence and liberty: The promise of experimental criminology CRIMINOLOGY AND CRIMINAL JUSTICE (ISSN: 17488958) 9: (1) pp. 528. ( 2009) Z9: 13 W C: Criminology & Penology Folyóiratcikk [12351672]
24
Jamin CG Hormone replacement therapy: 7 years of controversy Medecine et Longevite 1: (1) pp. 3137. ( 2009) Folyóiratcikk [13474514]
25
Bushnell C Hormone therapy and stroke: Is it all about timing?
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
104/342
3/30/2015
nyomtatobarat forma Current Treatment Options in Cardiovascular Medicine 11: (3) pp. 241250. ( 2009) Folyóiratcikk [13474513] 26
Bijl D Increased risk of breast cancer relapse in using tibolone Geneesmiddelenbulletin 43: (9) pp. 9091. ( 2009) Folyóiratcikk [13474512]
27
Andrikoula M, Prelevic G Menopausal hot flushes revisited CLIMACTERIC (ISSN: 13697137) 12: (1) pp. 315. ( 2009) Z9: 16 W C: Obstetrics & Gynecology Folyóiratcikk [12351671]
28
Doggrell SA New findings with old drugs for osteoporosis EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 10: (3) pp. 513516. ( 2009) Z9: 1 W C: Pharmacology & Pharmacy Folyóiratcikk [12351670]
29
Hoffmeister M, Raum E, Krtschil A, ChangClaude J, Brenner H No Evidence for Variation in Colorectal Cancer Risk Associated With Different Types of P ostmenopausal Hormone Therapy CLINICAL PHARMACOLOGY & THERAPEUTICS (ISSN: 00099236) 86: (4) pp. 416424. ( 2009) Z9: 14 W C: Pharmacology & Pharmacy Folyóiratcikk [12351669]
30
StrambaBadiale M P ostmenopausal hormone therapy and the risk of cardiovascular disease JOURNAL OF CARDIOVASCULAR MEDICINE (ISSN: 15582027) 10: (4) pp. 303309. ( 2009) Z9: 6 W C: Cardiac & Cardiovascular Systems Folyóiratcikk [12351668]
31
* Kenemans P, Bundred NJ, Foidart JM, Kubista E, von Schoultz B, Sismondi P, VassilopoulouSellin R, Yip CH, Egberts J, MolArts M, Mulder R, van Os S, Beckmann MW Safety and efficacy of tibolone in breastcancer patients with vasomotor symptoms: a doubleblind, randomised, noninferiority trial LANCET ONCOLOGY (ISSN: 14702045) 10: (2) pp. 135146. ( 2009) CA: LIBERATE Study Grp Z9: 58 W C: Oncology Folyóiratcikk [12351667]
32
Nelson HD, Fu RW , Griffin JC, Nygren P, Smith B, Humphrey L Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for P rimary Breast Cancer ANNALS OF INTERNAL MEDICINE (ISSN: 00034819) 151: (10) pp. 703W 235. ( 2009) Z9: 23 W C: Medicine, General & Internal Folyóiratcikk [12351666]
33
Prevrhal S, Krege JH, Chen P, Genant H, Black DM Teriparatide vertebral fracture risk reduction determined by quantitative and qualitative radiographic assessment CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 25: (4) pp. 921928. ( 2009) Z9: 5 W C: Medicine, General & Internal; Medicine, Research & Experimental Folyóiratcikk [12351665]
34
Davis SR, Hirschberg AL, W agner LK, Lodhi I, von Schoultz B The Effect of Transdermal Testosterone on Mammographic Density in P ostmenopausal Women Not Receiving Systemic Estrogen Therapy JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 94: (12) pp. 49074913. ( 2009) Z9: 5 W C: Endocrinology & Metabolism Folyóiratcikk [12351664]
35
Stachowiak G, Pertynski T The impact of tibolone on cardiovascular system and haemostasis of menopausal women PRZEGLAD MENOPAUZALNY (ISSN: 16438876) 8: (4) pp. 179183. ( 2009) W C: Obstetrics & Gynecology Folyóiratcikk [12351663]
36
Untch M, Beckmann MW , Emons G, Thomssen C, Kimmig R The LIBERATE Study: Hormone Replacement Therapy with Tibolone Increases the Risk of Recurrence and Metastases in Breast Cancer P atients GEBURTSHILFE UND FRAUENHEILKUNDE (ISSN: 00165751) 69: (3) pp. 199201. ( 2009) Z9: 1 W C: Obstetrics & Gynecology Folyóiratcikk [12351662]
37
Speroff L The LIBERATE tibolone trial in breast cancer survivors MATURITAS (ISSN: 03785122) 63: (1) pp. 13. ( 2009) W C: Geriatrics & Gerontology; Obstetrics & Gynecology Folyóiratcikk [12351661]
38
Stachowiak G, Pertynski T The role of tibolone in the treatment of ailments and diseases of the menopausal period PRZEGLAD MENOPAUZALNY (ISSN: 16438876) 8: (3) pp. 132136. ( 2009) W C: Obstetrics & Gynecology Folyóiratcikk [12351660]
39
Nappi RE, Polatti F The Use of Estrogen Therapy in Women's Sexual Functioning (CME) THE JOURNAL OF SEXUAL MEDICINE (ISSN: 17436095) 6: (3) pp. 603616. ( 2009) Z9: 22 W C: Urology & Nephrology Folyóiratcikk [12351659]
40
Vieira CS, Pereira FV, de Sa MFS, Louzada P, Martins W P, Ferriani RA Tibolone in postmenopausal women with systemic lupus erythematosus: A pilot study MATURITAS (ISSN: 03785122) 62: (3) pp. 311316. ( 2009) Z9: 3 W C: Geriatrics & Gerontology; Obstetrics & Gynecology Folyóiratcikk [12351658]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
105/342
3/30/2015
nyomtatobarat forma 41
Tibolone link with stroke Australian Journal of Pharmacy (ISSN: 03118002) 90: (1067) p. 78. ( 2009) Folyóiratcikk [13474511]
42
Naessen T, Lindmark B, Larsen HC, van Os S, Larsson M Tibolone low dose (1.25 mg/d) therapy and postural balance in elderly women MATURITAS (ISSN: 03785122) 62: (1) pp. 7275. ( 2009) Z9: 1 W C: Geriatrics & Gerontology; Obstetrics & Gynecology Folyóiratcikk [12351657]
43
Goodwin PJ Tibolone: the risk is too high LANCET ONCOLOGY (ISSN: 14702045) 10: (2) pp. 103104. ( 2009) Z9: 1 W C: Oncology Folyóiratcikk [12351656]
44
Donaldson JF Untitled MENOPAUSETHE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (ISSN: 10723714) 16: (2) pp. 423 424. ( 2009) W C: Obstetrics & Gynecology Folyóiratcikk [12351655]
45
Tanaka Y, W ake N, Kato K Untitled Reply MENOPAUSETHE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (ISSN: 10723714) 16: (2) pp. 424 424. ( 2009) W C: Obstetrics & Gynecology Folyóiratcikk [12351654]
46
Silverman BG, Kokia ES Use of Hormone Replacement Therapy, 19982007: Sustained Impact of the Women's Health Initiative Findings ANNALS OF PHARMACOTHERAPY (ISSN: 10600280) 43: (2) pp. 251258. ( 2009) Z9: 7 W C: Pharmacology & Pharmacy Folyóiratcikk [12351653]
47
Lyytinen HK, Dyba T, Ylikorkala O, Pukkala EI A casecontrol study on hormone therapy as a risk factor for breast cancer in Finland: intrauterine system carries a risk as well INTERNATIONAL JOURNAL OF CANCER (ISSN: 00207136) 126: (2) pp. 483489. ( 2010) Z9: 9 W C: Oncology Folyóiratcikk [12351652]
48
Toussaint ND, Elder GJ, Kerr PG A Rational Guide to Reducing Fracture Risk in Dialysis P atients SEMINARS IN DIALYSIS (ISSN: 08940959) 23: (1) pp. 4354. ( 2010) Z9: 3 W C: Urology & Nephrology Folyóiratcikk [12351651]
49
Melisko ME, Goldman M, Rugo HS Amelioration of sexual adverse effects in the early breast cancer patient JOURNAL OF CANCER SURVIVORSHIPRESEARCH AND PRACTICE (ISSN: 19322259) 4: (3) pp. 247255. ( 2010) Z9: 3 W C: Oncology Folyóiratcikk [12351650]
50
Barlow DH, Bouchard P, Brandi ML, Evers JLH, Glasier A, Negri E, Papapoulos SE, Ralston SH, Rizzoli R, Baird DT, Collins J, Benagiano G, Crosignani PG, La Vecchia C, Volpe A Bone fractures after menopause HUMAN REPRODUCTION UPDATE (ISSN: 13554786) 16: (6) pp. 761773. ( 2010) CA: ESHRE Capri W orkshop Grp Z9: 2 W C: Obstetrics & Gynecology; Reproductive Biology Folyóiratcikk [12351649]
51
Post TM, Cremers SCLM, Kerbusch T, Danhof M Bone P hysiology, Disease and Treatment Towards Disease System Analysis in Osteoporosis CLINICAL PHARMACOKINETICS (ISSN: 03125963) 49: (2) pp. 89118. ( 2010) Z9: 7 W C: Pharmacology & Pharmacy Folyóiratcikk [12351648]
52
De Carvalho ACB, Henriques HN, Pantaleão JAS, Pollastri CE, De Oliveira Fernandes GV, Granjeiro JM, GuzmánSilva MA Bone tissue histomorphometry in castrated rats treated with tibolone Jornal Brasileiro de Patologia e Medicina Laboratorial 46: (3) pp. 235243. ( 2010) Folyóiratcikk [13474510]
53
Arun B, Dunn BK, Ford LG, Ryan A Breast Cancer P revention Trials: Large and Small Trials SEMINARS IN ONCOLOGY (ISSN: 00937754) 37: (4) pp. 367383. ( 2010) Z9: 3 W C: Oncology Folyóiratcikk [12351647]
54
* Eastell R, Newman C, Crossman DC Cardiovascular disease and bone ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (ISSN: 00039861) 503: (1) pp. 7883. ( 2010) Z9: 2 W C: Biochemistry & Molecular Biology; Biophysics Folyóiratcikk [12351646]
55
Guan Yutao, Cai Lianlian, Ding Hongxiang, Chen Guodan, Hu Yue Clinical study on combination of multiple regimens in treatment of osteoporosis in perimenopause and postmenopausal women Chinese Journal of Obstetrics and Gynecology (ISSN: 0529567X) 45: (8) pp. 571574. ( 2010) Folyóiratcikk [14595673]
56
Ziaei S, Moaya M, Faghihzadeh S Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women CLIMACTERIC (ISSN: 13697137) 13: (3) pp. 249253. ( 2010) Z9: 1 W C: Obstetrics & Gynecology Folyóiratcikk [12351645] Farage MA, Miller KW , Ledger W
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
106/342
3/30/2015
nyomtatobarat forma 57
Confronting the challenges of postmenopausal urogenital health Aging Health 6: (5) pp. 611626. ( 2010) Folyóiratcikk [13474509]
58
Davis SR, Jane F Drugs for the treatment of menopausal symptoms EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 11: (8) pp. 13291341. ( 2010) Z9: 1 W C: Pharmacology & Pharmacy Folyóiratcikk [12351644]
59
* Kenemans P Editorial: Tibolone revisited: Still a good treatment option for healthy, early postmenopausal women Gynecological Endocrinology (ISSN: 09513590) 26: (4) pp. 237239. ( 2010) Folyóiratcikk [13474508]
60
Lambrinoudaki I, Brincat M, Erel CT, Gambacciani M, Moen MH, SchenckGustafsson K, Tremollieres F, Vujovic S, Rees M, Rozenberg S EMAS position statement: Managing obese postmenopausal women MATURITAS (ISSN: 03785122) 66: (3) pp. 323326. ( 2010) Z9: 5 W C: Geriatrics & Gerontology; Obstetrics & Gynecology Folyóiratcikk [12351643]
61
Moen MH, Rees M, Brincat M, Erel T, Gambacciani M, Lambrinoudaki I, SchenckGustafsson K, Tremollieres F, Vujovic S, Rozenberg S EMAS position statement: Managing the menopause in women with a past history of endometriosis MATURITAS (ISSN: 03785122) 67: (1) pp. 9497. ( 2010) Z9: 3 W C: Geriatrics & Gerontology; Obstetrics & Gynecology Folyóiratcikk [12351642]
62
W ierman ME, Nappi RE, Avis N, Davis SR, Labrie F, Rosner W , Shifren JL Endocrine Aspects of Women's Sexual Function THE JOURNAL OF SEXUAL MEDICINE (ISSN: 17436095) 7: (1) pp. 561585. ( 2010) Z9: 18 PN: Part 2 W C: Urology & Nephrology Folyóiratcikk [12351641]
63
Garattini S Evaluation of BenefitRisk PHARMACOECONOMICS (ISSN: 11707690) 28: (11) pp. 981986. ( 2010) Z9: 3 W C: Economics; Health Policy & Services; Pharmacology & Pharmacy Folyóiratcikk [12351640]
64
Body JJ, Bergmann P, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, Kaufman JM, Rozenberg S, Reginster JY Evidencebased guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (10) pp. 16571680. ( 2010) Z9: 16 W C: Endocrinology & Metabolism Folyóiratcikk [12351639]
65
Renoux C, Dell'Aniello S, Suissa S Hormone replacement therapy and the risk of venous thromboembolism: a populationbased study JOURNAL OF THROMBOSIS AND HAEMOSTASIS (ISSN: 15387933) 8: (5) pp. 979986. ( 2010) Z9: 24 W C: Hematology; Peripheral Vascular Disease Folyóiratcikk [12351638]
66
* Cummings SR, Ensrud K, Delmas PD, LaCroix AZ, Vukicevic S, Reid DM, Goldstein S, Sriram U, Lee A, Thompson J, Armstrong RA, Thompson DD, Powles T, Zanchetta J, Kendler D, Neven P, Eastell R Lasofoxifene in P ostmenopausal Women with Osteoporosis NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 362: (8) pp. 686696. ( 2010) CA: PEARL Study Investigators Z9: 62 W C: Medicine, General & Internal Folyóiratcikk [12351637]
67
Pachman DR, Jones JM, Loprinzi CL Management of menopauseassociated vasomotor symptoms: Current treatment options, challenges and future directions International Journal of Women's Health 2: (1) pp. 123135. ( 2010) Folyóiratcikk [13474507]
68
The North American Menopause Society Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society MENOPAUSETHE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (ISSN: 10723714) 17: (1) pp. 2554. ( 2010) Z9: 29 W C: Obstetrics & Gynecology Folyóiratcikk [12351636]
69
Joshi D, Center JR, Eisman JA Managing the patient with osteoporosis Medicine Today 11: (10) pp. 4755+5659. ( 2010) Folyóiratcikk [13474505]
70
Huang KE Menopause P erspectives and Treatment of Asian Women SEMINARS IN REPRODUCTIVE MEDICINE (ISSN: 15268004) 28: (5) pp. 396403. ( 2010) W C: Obstetrics & Gynecology; Reproductive Biology Folyóiratcikk [12351635]
71
Liu AJ, Guo JM, Xia W L, Su DF New strategies for the prevention of stroke CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ISSN: 03051870) 37: (2) pp. 265271. ( 2010) Z9: 4 W C: Pharmacology & Pharmacy; Physiology Folyóiratcikk [12351634]
72
Canalis E NEW TREATMENT MODALITIES IN OSTEOP OROSIS ENDOCRINE PRACTICE (ISSN: 1530891X) 16: (Boston, MA) pp. 855863. ( 2010) Z9: 3 W C: Endocrinology & Metabolism
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
107/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [12351633] 73
Hochberg MC Osteoporosis In: Targeted Treatment of the Rheumatic Diseases. Elsevier Inc., 2010. (ISBN 9781416099932) pp. 317329.
Könyvrészlet [13474504] 74
Bhanwra S P ostmenopausal hormone replacement therapy A review International Journal of Pharma and Bio Sciences 1: (2) P aper 81. (2010) Folyóiratcikk [13474503]
75
Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, Burger HG, Colditz GA, Davis SR, Gambacciani M, Gower BA, Henderson VW , Jarjour W N, Karas RH, Kleerekoper M, Lobo RA, Manson JE, Marsden J, Martin KA, Martin L, Pinkerton JV, Rubinow DR, Teede H, Thiboutot DM, Utian W H P ostmenopausal Hormone Therapy: An Endocrine Society Scientific Statement JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 95: (7) pp. S7+. ( 2010) Z9: 61 SU: 1 W C: Endocrinology & Metabolism Folyóiratcikk [12351632]
76
Birkhäuser M, Braendle W , Kuhl H, Mück AO, Neulen J, Thaler CJ Recommendations on hormone therapy with estrogens and gestagens in climacteric and in postmenopause: A statement from the 43rd "Zürcher Roundtable" Workshop (43rd workshop of September 2009) Journal fur Gynakologische Endokrinologie 20: (1) pp. 1219. ( 2010) Folyóiratcikk [13474502]
77
Martín JHM Study and treatment of women in the climacteric and postmenopause. P oint of view of the Mexican Association for the Study of Climacteric 2010 Ginecologia y Obstetricia de Mexico 78: (8) pp. 423440. ( 2010) Folyóiratcikk [13474501]
78
Stuckey BGA, Barrett PHR, W agner JM, Hampton RA, Chan DC, Brown SJ, W atts GF The effect of fenofibrate on HDL cholesterol and HDL particle concentration in postmenopausal women on tibolone therapy CLINICAL ENDOCRINOLOGY (ISSN: 03000664) 73: (4) pp. 497501. ( 2010) W C: Endocrinology & Metabolism Folyóiratcikk [12351631]
79
Stein CM, Ray W A The Ethics of P lacebo in Studies with Fracture End P oints in Osteoporosis. NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 363: (14) pp. 13671370. ( 2010) Z9: 4 W C: Medicine, General & Internal Folyóiratcikk [12351630]
80
Davey MR The role of hormone therapy in the treatment of osteoporosis Journal of Endocrinology, Metabolism and Diabetes of South Africa (ISSN: 16089677) 15: (1) pp. 4951. ( 2010) Folyóiratcikk [13474500]
81
Tibolone and breast cancer Prescrire International (ISSN: 11677422) 19: (111) p. 281. ( 2010) Folyóiratcikk [13474499]
82
Biglia N, Maffei S, Lello S, Nappi RE Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials GYNECOLOGICAL ENDOCRINOLOGY (ISSN: 09513590) 26: (11) pp. 804814. ( 2010) Z9: 2 W C: Endocrinology & Metabolism; Obstetrics & Gynecology Folyóiratcikk [12351629]
83
de Melo NR, Pompei LM Tibolone reduces osteoporotic fracture risk and breast cancer risk, but increases the risk of stroke GYNECOLOGICAL ENDOCRINOLOGY (ISSN: 09513590) 26: (2) pp. 7375. ( 2010) W C: Endocrinology & Metabolism; Obstetrics & Gynecology Folyóiratcikk [12351628]
84
Huang KE, Baber R Updated clinical recommendations for the use of tibolone in Asian women CLIMACTERIC (ISSN: 13697137) 13: (4) pp. 317327. ( 2010) CA: Asia Pacific Tibolone Consensus Gr W C: Obstetrics & Gynecology Folyóiratcikk [12351627]
85
Kluft C Various HRT regimens and risk of venous thromboembolism Climacteric (ISSN: 13697137) 13: (4) pp. 401402. ( 2010) Folyóiratcikk [13474498]
86
Oger E Vascular risks and HRT Revue du Praticien (ISSN: 00352640) 60: (8) p. 1124. ( 2010) Folyóiratcikk [13474497]
87
Kontos M, Agbaje OF, Rymer J, Fentiman IS What can be done about hot flushes after treatment for breast cancer? CLIMACTERIC (ISSN: 13697137) 13: (1) pp. 421. ( 2010) Z9: 6 W C: Obstetrics & Gynecology Folyóiratcikk [12351626]
88
Dimitrakakis C, Tsigginou A, Keramopoulos D, Antsaklis A What have we really learned from 'LIBERATE' trial? MATURITAS (ISSN: 03785122) 66: (1) pp. 99100. ( 2010) W C: Geriatrics & Gerontology; Obstetrics & Gynecology Folyóiratcikk [12351625]
89
Journal of Practical Obstetrics and Gynecology (ISSN: 10036946) 27: (8) pp. 580583. ( 2011) Folyóiratcikk [14595670]
90
Chineses Journal of Practical Gynecology and Obstetrics (ISSN: 10052216) 27: (5) pp. 346348. ( 2011)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
108/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [14595671] 91
* Cummings SR, McClung M, Reginster JY, Cox D, Mitlak B, Stock J, AmewouAtisso M, Powles T, Miller P, Zanchetta J, Christiansen C Arzoxifene for P revention of Fractures and Invasive Breast Cancer in P ostmenopausal Women JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 26: (2) pp. 397404. ( 2011) Z9: 4 W C: Endocrinology & Metabolism Folyóiratcikk [12351624]
92
Lambrechts S, Decloedt J, Neven P BREAST CANCER P REVENTION: LIFESTYLE CHANGES AND CHEMOP REVENTION ACTA CLINICA BELGICA (ISSN: 00015512) 66: (4) pp. 283292. ( 2011) W C: Medicine, General & Internal Folyóiratcikk [12351623]
93
von Schoultz B Breast cancer risk and the interval between menopause and starting HT CLIMACTERIC (ISSN: 13697137) 14: (5) pp. 598599. ( 2011) W C: Obstetrics & Gynecology Folyóiratcikk [12351622]
94
LiYu J, Perez EC, Canete A, Bonifacio L, Llamado LQ, Martinez R, Lanzon A, Sison M Consensus statements on osteoporosis diagnosis, prevention, and management in the P hilippines INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ISSN: 17561841) 14: (3) pp. 223238. ( 2011) CA: OSPFI : Philippine Orthopedic Assoc POA W C: Rheumatology Folyóiratcikk [12351621]
95
Burich R, Degregorio M Current treatment options for vulvovaginal atrophy Expert Review of Obstetrics and Gynecology 6: (2) pp. 141151. ( 2011) Folyóiratcikk [13474496]
96
Lundstrom E, Hirschberg AL, Soderqvist G Digitized assessment of mammographic breast density Effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo MATURITAS (ISSN: 03785122) 70: (4) pp. 361364. ( 2011) W C: Geriatrics & Gerontology; Obstetrics & Gynecology Folyóiratcikk [12351620]
97
Zhang H, von Schoultz B, Cline JM, Sahlin L Distribution of cyclooxygenases 1 and 2 in the uterus and breast of cynomolgus monkeyseffects of hormone treatment MENOPAUSETHE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (ISSN: 10723714) 18: (9) pp. 1001 1009. ( 2011) W C: Obstetrics & Gynecology Folyóiratcikk [12351619]
98
Vassalle C, Cicinelli E, Lello S, Mercuri A, Battaglia D, Maffei S Effects of menopause and tibolone on different cardiovascular biomarkers in healthy women GYNECOLOGICAL ENDOCRINOLOGY (ISSN: 09513590) 27: (3) pp. 163169. ( 2011) Z9: 1 W C: Endocrinology & Metabolism; Obstetrics & Gynecology Folyóiratcikk [12351618]
99
Tremollieres F, Brincat M, Erel CT, Gambacciani M, Lambrinoudaki I, Moen MH, SchenckGustafsson K, Vujovic S, Rozenberg S, Rees M EMAS position statement: Managing menopausal women with a personal or family history of VTE MATURITAS (ISSN: 03785122) 69: (2) pp. 190193. ( 2011) Z9: 2 W C: Geriatrics & Gerontology; Obstetrics & Gynecology Folyóiratcikk [12351617]
100
SchenckGustafsson K, Brincat M, Erel CT, Gambacciani M, Lambrinoudaki I, Moen MH, Tremollieres F, Rozenberg SVS, Rees M EMAS position statement: Managing the menopause in the context of coronary heart disease MATURITAS (ISSN: 03785122) 68: (1) pp. 9497. ( 2011) CA: EMAS Board Cardiologist Z9: 4 W C: Geriatrics & Gerontology; Obstetrics & Gynecology Folyóiratcikk [12351616]
101
Guidozzi F, Alperstein A, Koller AB, de Villiers T, Coetzee J, Davey M, W hite R, Koll P, Kopenhager T, Dalmeyer P, Hayward F Guideline for the use of tibolone in South Africa SAJOGSOUTH AFRICAN JOURNAL OF OBSTETRICS AND GYNAECOLOGY (ISSN: 00382329) 17: (2) pp. 31+. ( 2011) CA: Tibolone Advisory Board W C: Obstetrics & Gynecology Folyóiratcikk [12351615]
102
Goldstein LB, Bushnell CCD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, Creager MA, Culebras A, Eckel RH, Hart RG, Hinchey JA, Howard VJ, Jauch EC, Levine SR, Meschia JF, Moore W S, Nixon JV, Pearson TA Guidelines for the P rimary P revention of Stroke A Guideline for Healthcare P rofessionals From the American Heart Association/American Stroke Association STROKE (ISSN: 00392499) 42: (2) pp. 517584. ( 2011) CA: Amer Heart Assoc Stroke Council : Council Cardiovasc Nursing : Council On Epidemiology Prevention : Council High Blood Pressure Res : Council Peripheral Vasc Dis : Council Quality Care Outcomes Res Z9: 86 W C: Clinical Neurology; Peripheral Vascular Disease Folyóiratcikk [12351614]
103
Nock NL, PatrickMelin A, Cook M, Thompson C, Kirwan JP, Li L Higher bone mineral density is associated with a decreased risk of colorectal adenomas INTERNATIONAL JOURNAL OF CANCER (ISSN: 00207136) 129: (4) pp. 956964. ( 2011) Z9: 1 W C: Oncology Folyóiratcikk [12351613]
104
Kloosterboer HJ Historical milestones in the development of tibolone (Livial (R)) CLIMACTERIC (ISSN: 13697137) 14: (6) pp. 609621. ( 2011) W C: Obstetrics & Gynecology Folyóiratcikk [12351612]
105
Howell A, Evans GD
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
109/342
3/30/2015
nyomtatobarat forma Hormone Replacement Therapy and Breast Cancer In: Senn HJ, Otto F (szerk.) : CLINICAL CANCER PREVENTION. Berlin: Berlin, Springer, 2011. (ISBN 9783642108563) pp. 115124. (Recent Results in Cancer Research)
Könyvrészlet /Könyvfejezet /Tudományos [12351611] 106
Sieuwerts AM, De Napoli G, van Galen A, Kloosterboer HJ, de W eerd V, Zhang H, Martens JW M, Foekens JA, De Geyter C Hormone replacement therapy dependent changes in breast cancerrelated gene expression in breast tissue of healthy postmenopausal women MOLECULAR ONCOLOGY (ISSN: 15747891) 5: (6) pp. 504516. ( 2011) W C: Oncology Folyóiratcikk [12351610]
107
Vlieg AV, Middeldorp S Hormone therapies and venous thromboembolism: where are we now? JOURNAL OF THROMBOSIS AND HAEMOSTASIS (ISSN: 15387933) 9: (2) pp. 257266. ( 2011) W C: Hematology; Peripheral Vascular Disease Folyóiratcikk [12351609]
108
Renoux C, Suissa S Hormone therapy administration in postmenopausal women and risk of stroke Women's Health (ISSN: 17455057) 7: (3) pp. 355361. ( 2011) Folyóiratcikk [13474495]
109
MacLennan AH HRT in difficult circumstances: are there any absolute contraindications? CLIMACTERIC (ISSN: 13697137) 14: (4) pp. 409417. ( 2011) Z9: 3 W C: Obstetrics & Gynecology Folyóiratcikk [12351608]
110
Mikkola TM, Heinonen A, Kovanen V, Cheng SL, Kujala UM, Suominen H, Alen M, Puolakka J, AnkarbergLindgren C, Ronkainen PHA, Koskenvuo M, Kaprio J, Rantanen T, Sipila S Influence of LongTerm P ostmenopausal HormoneReplacement Therapy on Estimated Structural Bone Strength: A Study in Discordant Monozygotic Twins JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 26: (3) pp. 546552. ( 2011) W C: Endocrinology & Metabolism Folyóiratcikk [12351607]
111
Ribom EL, Svensson P, van Os S, Larsson M, Naessen T Lowdose tibolone (1.25 mg/d) does not affect muscle strength in older women MENOPAUSETHE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (ISSN: 10723714) 18: (2) pp. 194 197. ( 2011) Z9: 1 W C: Obstetrics & Gynecology Folyóiratcikk [12351606]
112
Loibl S, Lintermans A, Dieudonne AS, Neven P Management of menopausal symptoms in breast cancer patients MATURITAS (ISSN: 03785122) 68: (2) pp. 148154. ( 2011) Z9: 3 W C: Geriatrics & Gerontology; Obstetrics & Gynecology Folyóiratcikk [12351605]
113
Maclaran K, Panay N Managing low sexual desire in women Women's Health (ISSN: 17455057) 7: (5) pp. 571583. ( 2011) Folyóiratcikk [13474494]
114
Luchavová M, Raška I Novelties and possibility of prevention and treatment in the outpatient clinic of general practicioner Interni Medicina pro Praxi (ISSN: 12127299) 13: (2) pp. 7074. ( 2011) Folyóiratcikk [13474493]
115
De Villiers TJ Options in the prevention and treatment of osteoporosis Obstetrics and Gynaecology Forum (ISSN: 10291962) 21: (1) pp. 914. ( 2011) Folyóiratcikk [13474492]
116
Osteoporosis in primary care FMC Formacion Medica Continuada en Atencion Primaria 18: (SUP P L.4) pp. 729. ( 2011) Folyóiratcikk [13474491]
117
Rozenberg S, Eyckerman M P revention and treatment of osteoporosis with Selective EstrogenReceptor Modulators (SERMS) A revival? Journal fur Mineralstoffwechsel 18: (SONDERHEFT 2) pp. 45. ( 2011) Folyóiratcikk [13474490]
118
Stevenson JC P revention of osteoporosis: One step forward, two steps back Menopause International 17: (4) pp. 137141. ( 2011) Folyóiratcikk [13474489]
119
Cuzick J, DeCensi A, Arun B, Brown PH, Castiglione M, Dunn B, Forbes JF, Glaus A, Howell A, von Minckwitz G, Vogel V, Zwierzina H P reventive therapy for breast cancer: a consensus statement LANCET ONCOLOGY (ISSN: 14702045) 12: (5) pp. 496503. ( 2011) Z9: 17 W C: Oncology Folyóiratcikk [12351604]
120
Canonico M, PluBureau G, Scarabin PY P rogestogens and venous thromboembolism among postmenopausal women using hormone therapy MATURITAS (ISSN: 03785122) 70: (4) pp. 354360. ( 2011) Z9: 2 W C: Geriatrics & Gerontology; Obstetrics & Gynecology Folyóiratcikk [12351603]
121
Engel P, Fabre A, Fournier A, Mesrine S, BoutronRuault MC, ClavelChapelon F Risk of Osteoporotic Fractures After Discontinuation of Menopausal Hormone Therapy: Results From the E3N Cohort AMERICAN JOURNAL OF EPIDEMIOLOGY (ISSN: 00029262) 174: (1) pp. 1221. ( 2011) W C: Public, Environmental & Occupational Health
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
110/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [12351602] 122
Caruso S, Falduzzi C, Ventura B, Rubino C, Ferrara L, Polizzi S, Grasso S, Di Leo S, Cianci A Role of tibolone in the prevention and treatment of postmenopausal osteoporosis Giornale Italiano di Ostetricia e Ginecologia (ISSN: 03919013) 33: (6) pp. 335337. ( 2011) Folyóiratcikk [13474488]
123
Dukes MNG Sex hormones and related compounds, including hormonal contraceptives Side Effects of Drugs Annual 33: (1) pp. 851880. ( 2011) Folyóiratcikk [13474487]
124
Lains J, Campos I, Morais F, Casalta P Stroke prevention In: Micheo W (szerk.) : 6TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY OF PHYSICAL AND REHABILITATION MEDICINE. Edizioni Minerva Medica, 2011. (ISBN 9788877116161) pp. 185186.
Könyvrészlet /Konferenciaközlemény /Tudományos [14595669] 125
Rajamanohara R, Robinson J, Rymer J, Patel R, Fogelman I, Blake GM The effect of weight and weight change on the longterm precision of spine and hip DXA measurements OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (5) pp. 15031512. ( 2011) Z9: 1 W C: Endocrinology & Metabolism Folyóiratcikk [12351601]
126
Sandhu SK, Hampson G The pathogenesis, diagnosis, investigation and management of osteoporosis JOURNAL OF CLINICAL PATHOLOGY (ISSN: 00219746) 64: (12) pp. 10421050. ( 2011) Z9: 1 W C: Pathology Folyóiratcikk [12351600]
127
Vukicevic S, Grgurevi L The P EARL trial: Lasofoxifene and incidence of fractures, breast cancer and cardiovascular events in postmenopausal osteoporotic women International Journal of Clinical Rheumatology (ISSN: 17584272) 6: (4) pp. 387391. ( 2011) Folyóiratcikk [13474486]
128
Ko SS, Jordan VC Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene (Retracted article. See vol. 13, pg. 1081, 2012) EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 12: (4) pp. 657674. ( 2011) Z9: 2 W C: Pharmacology & Pharmacy Folyóiratcikk [12351599]
129
Sturdee DW , Pines A Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health CLIMACTERIC (ISSN: 13697137) 14: (3) pp. 302320. ( 2011) CA: Int Menopause Society W riting Grp Z9: 11 W C: Obstetrics & Gynecology Folyóiratcikk [12351598]
130
Eden JA Why does oestrogenonly hormone therapy have such a small impact on breast cancer risk? A hypothesis GYNECOLOGICAL ENDOCRINOLOGY (ISSN: 09513590) 27: (3) pp. 170175. ( 2011) Z9: 1 W C: Endocrinology & Metabolism; Obstetrics & Gynecology Folyóiratcikk [12351597]
131
Chinese Journal of Geriatrics (ISSN: 02549026) 31: (1) pp. 7678. ( 2012) Folyóiratcikk [14595663]
132
Fooladi E, Davis SR An update on the pharmacological management of female sexual dysfunction Expert Opinion on Pharmacotherapy (ISSN: 14656566) 13: (15) pp. 21312142. ( 2012) Folyóiratcikk [13474485]
133
Rahman RL, Pruthi S Chemoprevention of breast cancer: The P aradox of evidence versus advocacy inaction Cancers (ISSN: 20726694) 4: (4) pp. 11461160. ( 2012) Folyóiratcikk [13474484]
134
Yesil Y, Ulger Z, Halil M, Halacli B, Yavuz BB, Yesil NK, Kuyumcu ME, Cankurtaran M, Ariogul S Coexistence of osteoporosis (OP ) and coronary artery disease (CAD) in the elderly: It is not just a by chance event ARCHIVES OF GERONTOLOGY AND GERIATRICS (ISSN: 01674943) 54: (3) pp. 473476. ( 2012) W C: Geriatrics & Gerontology Folyóiratcikk [12351596]
135
Sioulas VD, Politi E, Rizos D, Augoulea A, Kyroudi A, Sergentanis TN, Panoulis C, Aravantinos L, Creatsa M, Lambrinoudaki I Does hormone therapy, tibolone or raloxifene modify VEGF expression in cervical epithelial cells? CLIMACTERIC (ISSN: 13697137) 15: (2) pp. 181185. ( 2012) W C: Obstetrics & Gynecology Folyóiratcikk [12351595]
136
Badruddoja M Ductal carcinoma in situ of the breast: A surgical perspective International Journal of Surgical Oncology 2012: P aper 761364. (2012) Folyóiratcikk [13474483]
137
Close H, Mason JM, W ilson D, Hungin APS Hormone replacement therapy is associated with gastrooesophageal reflux disease: A retrospective cohort study BMC Gastroenterology (ISSN: 1471230X) 12: P aper 56. (2012) Folyóiratcikk [13474482]
138
Eriksen EF Hormone replacement therapy or SERMS in the long term treatment of osteoporosis Minerva Ginecologica (ISSN: 00264784) 64: (3) pp. 207221. ( 2012) Folyóiratcikk [13474481]
139
Henderson VW , Lobo RA
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
111/342
3/30/2015
nyomtatobarat forma Hormone therapy and the risk of stroke: P erspectives 10 years after the Women's Health Initiative trials Climacteric (ISSN: 13697137) 15: (3) pp. 229234. ( 2012) Folyóiratcikk [13474480] 140
László A Is postmenopausal hormone therapy suitable for cardiovascular prevention? Lege Artis Medicinae (ISSN: 08664811) 22: (1011) pp. 582589. ( 2012) Folyóiratcikk [13474479]
141
Moraska AR, Moraska JM, Sideras K, Loprinzi CL Management of hot flashes in breast cancer patients European journal of Clinical and Medical Oncology 4: (1) pp. 19. ( 2012) Folyóiratcikk [13474478]
142
Boutet G Management of hot flushes for breast cancer survivors GYNECOLOGIE OBSTETRIQUE & FERTILITE (ISSN: 12979589) 40: (4) pp. 241254. ( 2012) W C: Obstetrics & Gynecology Folyóiratcikk [12351594]
143
Maclaran K, Stevenson JC P rimary prevention of cardiovascular disease with HRT Women's Health (ISSN: 17455057) 8: (1) pp. 6374. ( 2012) Folyóiratcikk [13474477]
144
Jacobsen DE, Melis RJF, Verhaar HJJ, Rikkert MGMO Raloxifene and Tibolone in Elderly Women: A Randomized, DoubleBlind, DoubleDummy, P laceboControlled Trial JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (ISSN: 15258610) 13: (2) P aper 189.e1. (2012) W C: Geriatrics & Gerontology Folyóiratcikk [12351593]
145 * Palacios S, Christiansen C, Sánchez Borrego R, Gambacciani M, Hadji P, Karsdal M, Lambrinoudaki I, Lello S, O'beirne B, Romao F, Rozenberg S, Stevenson JC, BenRafael Z Recommendations on the management of fragility fracture risk in women younger than 70 years Gynecological Endocrinology (ISSN: 09513590) 28: (10) pp. 770786. ( 2012) Folyóiratcikk [13474476] 146
Formoso G, Perrone E, Maltoni S, Balduzzi S, D'Amico R, Bassi C, Basevi V, Marata AM, Magrini N, Maestri E Short and long term effects of tibolone in postmenopausal women COCHRANE DATABASE OF SYSTEMATIC REVIEWS (ISSN: 1469493X) §: (2) p. §. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12351592]
147
Artero A, Tarín JJ, Cano A The adverse effects of estrogen and selective estrogen receptor modulators on hemostasis and thrombosis Seminars in Thrombosis and Hemostasis (ISSN: 00946176) 38: (8) pp. 797807. ( 2012) Folyóiratcikk [13474475]
148
Lin KJ, Cheung W Y, Lai JYC, Giovannucci EL The effect of estrogen vs. combined estrogenprogestogen therapy on the risk of colorectal cancer INTERNATIONAL JOURNAL OF CANCER (ISSN: 00207136) 130: (2) pp. 419430. ( 2012) Z9: 1 W C: Oncology Folyóiratcikk [12351591]
149
Zhu HM, Qin L, Garnero P, Genant HK, Zhang G, Dai K, Yao X, Gu G, Hao Y, Li Z, Zhao Y, Li W , Yang J, Zhao X, Shi D, Fuerst T, Lu Y, Li H, Zhang X, Li C, Zhao J, W u Q, Zhao SJ The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (4) pp. 13171327. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk [12351590]
150
Hickey M, Elliott J, Davison SL THERAP EUTICS Hormone replacement therapy BRITISH MEDICAL JOURNAL (BMJ) (ISSN: 0959535X) 344: P aper e763. (2012) Z9: 2 W C: Medicine, General & Internal Folyóiratcikk [12351589]
151 * Bundred NJ, Kenemans P, Yip CH, Beckmann MW , Foidart JM, Sismondi P, Schoultz BV, VassilopoulouSellin R, Galta RE, Lieshout EV, MolArts M, Planellas J, Kubista E Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy Breast Cancer Research (ISSN: 14655411) 14: (1) P aper R13. (2012) Folyóiratcikk [13474474] 152
Antoine C, Ameye L, Paesmans M, Rozenberg S Update of the evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium Maturitas (ISSN: 03785122) 72: (4) pp. 317323. ( 2012) Folyóiratcikk [13474473]
153
de Souza MAM, de Souza BM, Geber S Vascular resistance of central retinal and ophthalmic arteries in postmenopausal women after use of tibolone MENOPAUSETHE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (ISSN: 10723714) 19: (3) pp. 328 331. ( 2012) W C: Obstetrics & Gynecology Folyóiratcikk [12351588]
154
Chineses Journal of Practical Gynecology and Obstetrics (ISSN: 10052216) 29: (11) pp. 911913. ( 2013) Folyóiratcikk [14595662]
155
Green VL Breast cancer risk assessment, prevention, and the future Obstetrics and Gynecology Clinics of North America (ISSN: 08898545) 40: (3) pp. 525549. ( 2013) Folyóiratcikk [13474472]
156
Min YK, Lee DY, Choi SJ, Kim JH, Choi DS, Yoon BK Effects of adding alendronate to ongoing hormone therapy on bone mineral density in postmenopausal Korean women: A randomized, doubleblind, placebocontrolled clinical trial Menopause 20: (7) pp. 761766. ( 2013)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
112/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [13474471] 157
Chen Siyu, Ma Cailing, Zhang Yuanyuan, Li Jing Effects of different add back therapies on endometriosis patients treated with a gonadotropin releasing hormone agonist Chinese Journal of New Drugs and Clinical Remedies (ISSN: 10077669) 32: (6) pp. 464468. ( 2013) Folyóiratcikk [14595661]
158
Xuan Miao, Yang Jun, Li Ying, Zhou Yun, W ang Bo, Song Lige, W ang Yonglan, Zhang Xiuzhen Effects of zoledronic acid and tibolone on bone mineral density, indexes of bone metabolism, and the risk of fracture in patients with postmenopausal osteoporosis Chinese Journal of Endocrinology and Metabolism (ISSN: 10006699) 29: (6) pp. 504508. ( 2013) Folyóiratcikk [14595660]
159
Donati Sarti C, Lello S, Gallo M, Mincigrucci M, Maffei S, Stomati M, Agostinelli D, Becorpi AM, Nappi R, Nocera F, Fiorillo F, Baldi S, Cancellieri F, Leli P, Mapelli C, Cordopatri A, Repetti F, Volpe A, Dessole S, Lanzone A, Cagnacci A, Cicinelli E, Grimaldi E, Guaschino S, Maffei S, Massobrio M, Melis GB, Omodei U, Paoletti AM, Sciacchitano S, Venturoli S, Villa P Joint document of the SIGiTESIM 2013 Management of hormone replacement therapy in menopausal women Giornale Italiano di Ostetricia e Ginecologia (ISSN: 03919013) 35: (2) pp. 389396. ( 2013) Folyóiratcikk [13474470]
160
Stuenkel CA Management of Menopausal Symptoms in the P ostWomen's Health Initiative Era In: Women and Health. Elsevier Inc., 2013. (ISBN 9780123849786) pp. 899913.
Könyvrészlet [13474469] 161
StrambaBadiale M Menopause and the risk of cardiovascular diseases In: Current Topics in Menopause. Bentham Science Publishers Ltd., 2013. (ISBN 9781608055159) pp. 126142.
Könyvrészlet [13474468] 162
Anonymous OSHK TASK GROUP FOR THE FORMULATION OF THE 2013 OSHK GUIDELINE FOR CLINICAL MANAGEMENT OF P OSTMENOP AUSAL OSTEOP OROSIS IN HONG KONG HONG KONG MEDICAL JOURNAL (ISSN: 10242708) 19: (2) pp. 640. ( 2013) SU 2 Folyóiratcikk [14595659]
163
Rozenberg S, Vandromme J, Antoine C P ostmenopausal hormone therapy: Risks and benefits Nature Reviews Endocrinology (ISSN: 17595029) 9: (4) pp. 216227. ( 2013) Folyóiratcikk [13474467]
164
W ood CE, Branstetter D, Jacob AP, Cline JM, Register TC, Rohrbach K, Huang LY, Borgerink H, Dougall W C P rogestin effects on cell proliferation pathways in the postmenopausal mammary gland Breast Cancer Research (ISSN: 14655411) 15: (4) P aper R62. (2013) N1 Molecular Sequence Numbers: GENBANK: GSE27228; N1 Funding Details: Pfizer Folyóiratcikk [13474466]
165
ZayasJaime FJ, OrnelasAguirre JM, PérezNápoles DE Reasons for discontinuation of therapy with tibolone hormone replacement in menopausal women Ginecologia y Obstetricia de Mexico 81: (10) pp. 593601. ( 2013) Hiányzó nyelv: 'English; Spanish' Folyóiratcikk [13474465]
166
Fisher W I, Johnson AK, Elkins GR, Otte JL, Burns DS, Yu M, Carpenter JS Risk factors, pathophysiology, and treatment of hot flashes in cancer CA Cancer Journal for Clinicians 63: (3) pp. 167192. ( 2013) Folyóiratcikk [13474464]
167
Mendoza N, Abad P, Baró F, Cancelo MJ, Llaneza P, Manubens M, Quereda F, SánchezBorrego R Spanish Menopause Society position statement: Use of tibolone in postmenopausal women Menopause 20: (7) pp. 754760. ( 2013) Folyóiratcikk [13474463]
168
Morozkina SN, Abusalimov ShN, Selivanov SI, Shavva AG Synthesis and biological activity of some 8αanalogs of steroidal estrogens Russian Journal of Organic Chemistry (ISSN: 10704280) 49: (4) pp. 603609. ( 2013) Folyóiratcikk [13474462]
169
Maximov PY, Lee TM, Craig Jordan V The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice Current Clinical Pharmacology (ISSN: 15748847) 8: (2) pp. 135155. ( 2013) Folyóiratcikk [13474461]
170
Yeap SS, Hew FL, Lee JK, Goh EML, Chee W , Mumtaz M, Damodaran P, Lim HH, Chan SP The Malaysian Clinical Guidance on the Management of P ostmenopausal Osteoporosis, 2012: A Summary International Journal of Rheumatic Diseases (ISSN: 17561841) 16: (1) pp. 3040. ( 2013) Folyóiratcikk [13474460]
171
Kulkarni J, Gavrilidis E, W orsley R, Rheenen TV, Hayes E The role of estrogen in the treatment of men with schizophrenia International Journal of Endocrinology and Metabolism (ISSN: 1726913X) 11: (3) pp. 129136. ( 2013) Folyóiratcikk [13474459]
172
W ren BG Treatment regimens for the menopause In: Current Topics in Menopause. Bentham Science Publishers Ltd., 2013. (ISBN 9781608055159) pp. 326384.
Könyvrészlet [13474458] 173
De Villiers TJ, Pines A, Panay N, Gambacciani M, Archer DF, Baber RJ, Davis SR, Gompel AA, Henderson VW , Langer R, Lobo RA, PluBureau G, Sturdee DW Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health Climacteric (ISSN: 13697137) 16: (3) pp. 316337. ( 2013)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
113/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [13474457] 174
Nelson HD, Smith MEB, Griffin JC, Fu R Use of medications to reduce risk for primary breast cancer: A systematic review for the U.S. preventive services task force Annals of Internal Medicine (ISSN: 00034819) 158: (8) pp. 604614. ( 2013) Folyóiratcikk [13474456]
175
Jane F M, Davis S R A P ractitioner's Toolkit for Managing the Menopause CLIMACTERIC (ISSN: 13697137) 17: (5) pp. 564579. ( 2014) Folyóiratcikk [14595658]
176
Santen Richard J, Stuenkel Cynthia A, Burger Henry G, Manson JoAnn E Competency in Menopause Management: Whither Goest the Internist? JOURNAL OF WOMENS HEALTH (ISSN: 15409996) 23: (4) pp. 281285. ( 2014) Folyóiratcikk [14595657]
177
Triantafyllopoulos Ioannis K, LambropoulouAdamidou Kalliopi, Nacopoulos Cleopatra C, Papaioannou Nikolaos A, Ceausu Iuliana, Depypere Herman, Erel C Tamer, PerezLopez Faustino R, SchenckGustafsson Karin, van der Schouw Yvonne T, Simoncini Tommaso, Tremollieres Florence, Rees Margaret, Lambrinoudaki Irene EMAS position statement: The management of postmenopausal women with vertebral osteoporotic fracture MATURITAS (ISSN: 03785122) 78: (2) pp. 131137. ( 2014) Folyóiratcikk [14595656]
178
de Villiers T J Estrogen and bone: have we completed a full circle? CLIMACTERIC (ISSN: 13697137) 17: pp. 47. ( 2014) SU 2 Folyóiratcikk [14595655]
179
Reviriego C FLIBANSERIN FOR FEMALE SEXUAL DYSFUNCTION DRUGS OF TODAY (ISSN: 16993993) 50: (8) pp. 549556. ( 2014) Folyóiratcikk [14595654]
180
Gambacciani M, Levancini M Management of postmenopausal osteoporosis and the prevention of fractures PANMINERVA MEDICA (ISSN: 00310808) 56: (2) pp. 115131. ( 2014) Folyóiratcikk [14595653]
181
Xu Ling Menopausal hormone therapy and osteoporosis in midlife and postmenopausal women Chineses Journal of Practical Gynecology and Obstetrics (ISSN: 10052216) 30: (5) pp. 333336. ( 2014) Folyóiratcikk [14595652]
182
Ameye Lieveke, Antoine Caroline, Paesmans Marianne, de Azambuja Evandro, Rozenberg Serge Menopausal hormone therapy use in 17 European countries during the last decade MATURITAS (ISSN: 03785122) 79: (3) pp. 287291. ( 2014) Folyóiratcikk [14595651]
183
BiancoMiotto Tina, Trotta Andrew P, Need Eleanor F, Lee Alice M C, Ochnik Aleksandra M, Giorgio Lauren, Leach Damien A, Swinstead Erin E, O'Loughlin Melissa A, Newman Michelle R, Birrell Stephen N, Butler Lisa M, Harris Jonathan M, Buchanan Grant Molecular and structural basis of androgen receptor responses to dihydrotestosterone, medroxyprogesterone acetate and Delta(4)tibolone MOLECULAR AND CELLULAR ENDOCRINOLOGY (ISSN: 03037207) 382: (2) pp. 899908. ( 2014) Folyóiratcikk [14595650]
184
Lambrinoudaki Irene P rogestogens in postmenopausal hormone therapy and the risk of breast cancer MATURITAS (ISSN: 03785122) 77: (4) pp. 311317. ( 2014) Folyóiratcikk [14595649]
185
Bleker Suzanne M, Coppens Michiel, Middeldorp Saskia Sex, thrombosis and inherited thrombophilia BLOOD REVIEWS (ISSN: 0268960X) 28: (3) pp. 123133. ( 2014) Folyóiratcikk [14595648]
186
Antoine C, Ameye L, Paesmans M, Rozenberg S Systematic review about breast cancer incidence in relation to hormone replacement therapy use CLIMACTERIC (ISSN: 13697137) 17: (2) pp. 116132. ( 2014) Folyóiratcikk [14595647]
187
Choi Jaesung, Psarommatis Basil, Gao Yan Ru, Zheng Yu, Handelsman David J, Simanainen Ulla The role of androgens in experimental rodent mammary carcinogenesis BREAST CANCER RESEARCH (ISSN: 1465542X) 16: (6) P aper 483. (2014) Folyóiratcikk [14595646]
188
Vaid Isam, Ahmed Kaha, May Dianne, Manheim Diane The WISEWOMAN P rogram: Smoking P revalence and Key Approaches to Smoking Cessation Among P articipants, July 2008June 2013 JOURNAL OF WOMENS HEALTH (ISSN: 15409996) 23: (4) pp. 288295. ( 2014) Folyóiratcikk [14595645]
148. Horányi J , Duffek L , Darvas K , Lakatos P , Tóth M , Györke T , Tarjányi M , Szlávik R 50 év – 1000 mellékpajzsmirigyműtét MAGYAR SEBÉSZET 61:(3) p. 159. (2008) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2026576] M agyar Sebész Társaság 59. Kongresszusa, Debrecen, 2008.jún. 1820. https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
114/342
3/30/2015
nyomtatobarat forma
[ Admin láttamozott ] 149. Horváth C , Lakatos P , Speer G , Szűcs J A D vitaminhiány felismerése és kezelése CA ÉS CSONT 11:(1) pp. 3435. (2008) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1335698] In: Horváth Csaba (szerk.): Az osteoporosis felismerése, megelőzése és kezelése 2008ban: szakmai ajánlás. Ca&Csont 2008;11(1):4–56 [ Szerzői rekord ] 150. Horváth C , Balogh Á , Forgács S , Lakatos P , M ester Á , M észáros S Az osteoporosis felismerése: A főbb ajánlások összefoglalása (a bizonyítékok szintje) CA ÉS CSONT 11:(1) pp. 1020. (2008) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1806462] In: Horváth Csaba (szerk.): Az osteoporosis felismerése, megelőzése és kezelése 2008ban: szakmai ajánlás. Ca&Csont 2008;11(1):4–56 [ Szerzői rekord ] 151. Lakatos P , Horváth C , Balogh Á , Bors K , M arton I , Poór Gy , Szekeres L Az életkorral járó osteoporosisok kezelése: A főbb ajánlások összefoglalása (a bizonyítékok szintje) CA ÉS CSONT 11:(1) pp. 2029. (2008) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1806463] In: Horváth Csaba (szerk.): Az osteoporosis felismerése, megelőzése és kezelése 2008ban: szakmai ajánlás. Ca&Csont 2008;11(1):4–56 [ Szerzői rekord ] 152. Lakatos P Új terápiás lehetőségek a csontritkulás kezelésében MEDICUS ANONYMUS 16:(56) pp. 2526. (2008) Nyelv: Magyar
Folyóiratcikk /Rövid közlemény /Tudományos [1806466] [ Hitelesített ] 153. Lakatos P Osteoporosis In: Kerpel Frónius S , Gyires K , Fürst Zs (szerk.) Farmakológia és Farmakoterápia: Egyetemi tankönyv . 454 p. Budapest: M edicina Könyvkiadó, 2008. pp. 243251. 2. kötet., Farmakoterápia : válogatott betegségek bizonyítékon alapuló kezelésének klinikai farmakológiai elvei (ISBN:9789632261386) Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1923072] [ Érvényesített ] 154. Lakatos P Csontizületkötőszövet időskori eltérései In: Semsei Imre (szerk.) Gerontológia . 577 p. Nyíregyháza: Debreceni Egyetem OEC Egészségügyi Kar, 2008. pp. 201210. ( Egészségügyi Kari Jegyzetek; 15. ) Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1923148] [ Érvényesített ] 155. Lakatos Péter Pajzsmirigybetegségek korszerű diagnosztikája és terápiája MAGYAR BELORVOSI ARCHIVUM 61:(Klnsz 2) pp. 2123. (2008) III. Belgyógyászati kötelező szinten tartó tanfolyam. Program és előadásösszefoglalók Európa Kongresszusi Központ. Budapest, M agyarország: 2008.10.01 2008.10.04. Nyelv: Magyar https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
115/342
3/30/2015
nyomtatobarat forma
Folyóiratcikk /Konferenciaközlemény /Tudományos [1806487] [ Érvényesített ] 156. Lakatos Péter Az ibandronát helye a postmenopausális osteoporosis kezelésében LEGE ARTIS MEDICINAE 18:(10) pp. 657661. (2008) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1806505] [ Érvényesített ] 157. Lazary A , Speer G , Varga PP , Balla B , Bacsi K , Kosa JP , Nagy Z , Takacs I , Lakatos P Effect of vertebroplasty filler materials on viability and gene expression of human nucleus pulposus cells. JOURNAL OF ORTHOPAEDIC RESEARCH 26:(5) pp. 601607. (2008) IF: 2.963 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1435439] [ Szerzői rekord ] Független idéző: 9 Összesen: 9 1
CHEN Liang, YANG Huilin, TANG Tiansi Followup of intradiscal cement leakage during kyphoplasty Chinese Journal of Orthopedics (ISSN: 02532352) 28: (12) pp. 10151018. ( 2008) Folyóiratcikk [13148182]
2
Kondo KL Osteoporotic vertebral compression fractures and vertebral augmentation Seminars in Interventional Radiology (ISSN: 07399529) 25: (4) pp. 413424. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [13342157]
3
TANG Hui, XU Yongqing, ZHENG Tiane Research progress in treatment of osseous defects with calcium sulfate Chinese Journal of Trauma (ISSN: 10018050) 25: (1) pp. 8285. ( 2009) Folyóiratcikk [13148181]
4
Sonmez E, Yilmaz C, Caner H Development of Lumbar Disc Herniation Following P ercutaneous Vertebroplasty SPINE (ISSN: 03622436) 35: (3) pp. E93E95. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11709727]
5
Daniel W endlinga Michel Rungeb Éric Toussirota Ewa Bertolinia, Clément Pratia Ostéite vertébrale adjacente à une cyphoplastie Revue du Rhumatisme (ISSN: 11698330) 77: (1) pp. 8890. ( 2010) Folyóiratcikk [11237721]
6
W endling D, Runge M, Toussirot E, Bertolini E, Prati C Vertebral osteitis adjacent to kyphoplasty JOINT BONE SPINE (ISSN: 1297319X) 77: (1) pp. 6769. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11709726]
7
Krebs Joerg, Ferguson Stephen J, Goss Ben G, Stauffer Edouard, Ettinger Ladina, Aebli Nikolaus Effect of vertebral cement augmentation with polymethylmethacrylate on intervertebral disc and bone tissue JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART BAPPLIED BIOMATERIALS (ISSN: 15524973) 100B: (3) pp. 660667. ( 2012) Folyóiratcikk [13148180]
8
Mao Haiqing, Geng Dechun, Zhu Xuesong, Ji Shundong, Zhu Mo, Gao Maofeng, Zou Jun, Yang Huilin Intervertebral disc degeneration induced by intradiscal poly(methyl methacrylate) leakage after spine augmentation in an in vivo rabbit model ACTA BIOMATERIALIA (ISSN: 17427061) 10: (7) pp. 30593067. ( 2014) Folyóiratcikk [14595574]
9
Gan Minfeng, Zou Jun, Song Dawei, Zhu Xuesong, W ang Genlin, Yang Huilin Is balloon kyphoplasty better than percutaneous vertebroplasty for osteoporotic vertebral biconcaveshaped fractures? ACTA RADIOLOGICA (ISSN: 02841851) 55: (8) pp. 985991. ( 2014) Folyóiratcikk [14595573]
158. Lazary A , Kosa JP , Tobias B , Lazary J , Balla B , Bacsi K , Takacs I , Nagy Z , M ezo T , Speer G , Lakatos P Single nucleotide polymorphisms in new candidate genes are associated with bone mineral density and fracture risk. EUROPEAN JOURNAL OF ENDOCRINOLOGY 159:(2) pp. 187196. (2008) IF: 3.791 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1459327] [ Hitelesített ] Független idéző: 6 Összesen: 6 1
Han X, Zhan Z W , Zhang H H, Pei Y, Hu Y Z, W ang X R, Han Z T Association between vitamin D receptor genetypes of Fok I polymorphism and bone mineral density in male of the Han nationality in Beijing area Journal of Clinical Rehabilitative Tissue Engineering Research 13: (24) pp. 47634766. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11915854]
2
Guan YF, AckertBicknell CL, Kell B, Troyanskaya OG, Hibbs MA Functional Genomics Complements Quantitative Genetics in Identifying DiseaseGene Associations PLOS COMPUTATIONAL BIOLOGY (ISSN: 1553734X) 6: (11) P aper e1000991. (2010) Folyóiratcikk /Szakcikk /Tudományos [11258349]
3
Cheung CL, Livshits G, Zhou YH, Meigs JB, McAteer JB, Florez JC, Cupples LA, Demissie S, Kiel DP, Karasik D
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
116/342
3/30/2015
nyomtatobarat forma Hip Geometry Variation Is Associated With Bone Mineralization P athway Gene Variants: The Framingham Study JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 25: (7) pp. 15641571. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11258348] 4
Xu XH, Dong SS, Guo Y, Yang TL, Lei SF, Papasian CJ, Zhao M, Deng HW Molecular Genetic Studies of Gene Identification for Osteoporosis: The 2009 Update ENDOCRINE REVIEWS (ISSN: 0163769X) 31: (4) pp. 447505. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11258347]
5
Smathers RL, Petersen DR The human fatty acidbinding protein family: Evolutionary divergences and functions Human Genomics (ISSN: 14797364) 5: (3) pp. 170191. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13865999]
6
Nie SW , W ang XF, Tang ZC Correlations between MMP 2/MMP 9 promoter polymorphisms and ischemic stroke INT J CLIN EXP MED (ISSN: 19405901) 7: (2) pp. 400404. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13865998]
159. Lazary A , Kosa JP , Tobias B , Lazary J , Balla B , Bacsi K , Takacs I , Nagy Z , M ezo T , Speer G , Lakatos P Single nucleotide polymorphisms in new candidate genes are associated with bone mineral density and fracture risk CALCIFIED TISSUE INTERNATIONAL 82:(Suppl. 1) p. S142. (2008) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1461337] [ Érvényesített ] 160. Lazáry Á , Kósa J , Tóbiás B , Lazáry J , Balla B , Bácsi K , Takács I , Nagy Zs , M ezo T , Speer G , Lakatos P Single nucleotide polymorphisms in new candidate genes are associated with bone mineral density and fracture risk ASBM R Kongresszus, M ontreal (2008) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434271] [Poszter] [ Admin láttamozott ] 161. I M ucsi , M E Czira , A Lindner , G Beko , J Kosa , P Lakatos , A Remport , L Rosivall , E Sarvary , M Z M olnar Serum Adiponectin Level Is Associated with Hemoglobin Concentration in Kidney Transplanted Patients JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 19: p. FPO1501. (2008) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1150471] Supplementum [ Admin láttamozott ] 162. Somogyi Péter , Drescher Edit , Lakatos Péter A nemzeti törésmegelőző és kockázatjavító program első éves eredményei Veszprémben HÁZIORVOS TOVÁBBKÉPZŐ SZEMLE 13:(5) pp. 324328. (2008) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1806507] [ Érvényesített ] 163. Speer G , Lakatos P Szöveti hormonsokk: az intrakrinológia: A lokálisan képződő hormonok szerepe különböző betegségek patogenezisében. LEGE ARTIS MEDICINAE 18:(1) pp. 2330. (2008) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [1335695] [ Hitelesített ] 164. Speer G , Horányi J , Kerényi Zs , Nagy Zs , Takács I , Tamás Gy , Lakatos P A spontán hypoglycaemia differenciáldiagnózisa az elmúlt tíz évben insulinomában szenvedő eseteink kapcsán MAGYAR BELORVOSI ARCHIVUM 61:(3) p. 261. (2008) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2026588] M agyar Endokrinológiai és Anyagcsere Társaság 22. Kongresszusa, Eger, 2008.jún. 57. [ Admin láttamozott ] 165. Stakkestad J A , Lakatos P , Lorenc R , Sedarati F , Neate C , Reginster J Y M onthly oral ibandronate is effective and well tolerated after 3 years: The M OBILE longterm extension CLINICAL RHEUMATOLOGY 27:(8) pp. 955960. (2008) IF: 1.559 Nyelv: Angol https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
117/342
3/30/2015
nyomtatobarat forma
Folyóiratcikk /Szakcikk /Tudományos [1802721] [ Érvényesített ] Független idéző: 13 Függő idéző: 6 Összesen: 19 1
Frampton JE, Perry CM Ibandronate A Review of its Use in the Management of P ostmenopausal Osteoporosis DRUGS (ISSN: 00126667) 68: (18) pp. 26832707. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12432099]
2
Kastelan D, Korsic M, Vlak T Ibandronate: is there an effect on nonvertebral fractures? CLINICAL RHEUMATOLOGY (ISSN: 07703198) 27: (10) pp. 13131315. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12432098]
3
Baim S, Miller PD Assessing the Clinical Utility of Serum CTX in P ostmenopausal Osteoporosis and Its Use in P redicting Risk of Osteonecrosis of the Jaw JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 24: (4) pp. 561574. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12432097]
4
* Felsenberg D, Czerwinski E, Stakkestad J, Neate C, Masanauskaite D, Reginster JY EFFICACY OF MONTHLY ORAL IBANDRONATE IS MAINTAINED OVER 5 YEARS: THE MOBILE LTE STUDY OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (Suppl. 1) pp. 1515. ( 2009) Folyóiratcikk /Absztrakt /Tudományos [12432096]
5
Clarke BL New and emerging treatments for osteoporosis CLINICAL ENDOCRINOLOGY (ISSN: 03000664) 71: (3) pp. 309321. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12432095]
6
Kastelan D, Lozo P, Stamenkovic D, Miskic B, Vlak T, Kolak Z, Ahic JM, Altabas V, Orlic ZC, Korsic M P reference for weekly and monthly bisphosphonates among patients with postmenopausal osteoporosis: results from the Croatian P ROMO Study CLINICAL RHEUMATOLOGY (ISSN: 07703198) 28: (3) pp. 321326. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12432094]
7
Epstein S, Jeglitsch M, McCloskey E Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 25: (12) pp. 29512960. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12432093]
8
* Body JJ, Bergmann P, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, Kaufman JM, Rozenberg S, Reginster JY Evidencebased guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (10) pp. 16571680. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12432092]
9
Bertoldo F, Pancheri S, Zenari S, Boldini S, Giovanazzi B, Zanatta M, Valenti MT, Carbonare LD, Lo Cascio V Serum 25Hydroxyvitamin D Levels Modulate the AcuteP hase Response Associated With the First NitrogenContaining Bisphosphonate Infusion JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 25: (3) pp. 447454. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12432091]
10
ZHU Hanmin Bisphosphonates and osteoporosis ZHONGGUO SHIYONG NEIKE ZAZHI / CHINESE JOURNAL OF PRACTICAL INTERNAL MEDICINE (ISSN: 10052194) 31: (7) pp. 517520. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [14595570]
11 * Lecart MP, Reginster JY Current options for the management of postmenopausal osteoporosis EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 12: (16) pp. 25332552. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12432090] 12
Bumbasirevic M, Lesic A, DenicMarkovic L, Zivkovic K, ORPHEUM Study Group P rospective Clinical Study of Once Monthly Ibandronate in the Treatment of Osteoporosis and P revention of Fractures in P ostmenopausal Women: ORP HEUM Study SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO (ISSN: 03708179) 139: (1112) pp. 790794. ( 2011) Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [12432089]
13 * Rizzoli R, Akesson K, Bouxsein M, Kanis JA, Napoli N, Papapoulos S, Reginster JY, Cooper C Subtrochanteric fractures after longterm treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (2) pp. 373390. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12432088] 14
Bock O, Borst H, Beller G, Armbrecht G, Degner C, Martus P, Roth HJ, Felsenberg D Impact of oral ibandronate 150 mg once monthly on bone structure and density in postmenopausal osteoporosis or osteopenia derived from in vivo mu CT BONE (ISSN: 87563282) 50: (1) pp. 317324. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12432087]
15
Boonen Steven, Rosenberg Elizabeth, Claessens Frank, Vanderschueren Dirk, Papapoulos Socrates Inhibition of Cathepsin K for Treatment of Osteoporosis CURRENT OSTEOPOROSIS REPORTS 10: (1) pp. 7379. ( 2012) Folyóiratcikk [14595569]
16
Langdahl Bente, Binkley Neil, Bone Henry, Gilchrist Nigel, Resch Heinrich, Portales Jose Rodriguez, Denker Andrew, Lombardi Antonio, De Tilleghem Celine Le Bailly, DaSilva Carolyn, Rosenberg Elizabeth, Leung Albert Odanacatib in the Treatment of P ostmenopausal Women With Low Bone Mineral Density: Five Years of Continued Therapy in a P hase 2 Study JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 27: (11) pp. 22512258. ( 2012) Folyóiratcikk [14595568]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
118/342
3/30/2015
nyomtatobarat forma 17
Nakamura Toshitaka, Nakano Tetsuo, Ito Masako, Hagino Hiroshi, Hashimoto Junko, Tobinai Masato, Mizunuma Hideki Clinical Efficacy on Fracture Risk and Safety of 0.5 mg or 1 mg/month Intravenous Ibandronate Versus 2.5 mg/day Oral Risedronate in P atients with P rimary Osteoporosis CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 93: (2) pp. 137146. ( 2013) CA MOVER Study Grp Folyóiratcikk [14595567]
18 * Reginster J Y, Neuprez A, Dardenne N, Beaudart C, Emonts P, Bruyere O Efficacy and safety of currently marketed antiosteoporosis medications BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 1521690X) 28: (6) pp. 809834. ( 2014) Folyóiratcikk [14595566] 19 * Miller P D, Recker R R, Harris S, Silverman S, Felsenberg D, Reginster J, Day BM, Barr C, Masanauskaite D Longterm fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE longterm extension studies OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (1) pp. 349357. ( 2014) Folyóiratcikk [14595565]
2007 166. Almási C , Ambrus C , M arton A , Németh Z , Berta K , Deák Gy , Horváth C , Lakatos P , Szabó A , Pálfi P , M olnár M Z , M ucsi I A csontminõségre jellemzõ "Broadband Ultrasound Attenuation" (BUA) meghatározó tényezõi hemodializált vesebetegekben HYPERTONIA ÉS NEPHROLOGIA 11:(S2) p. 53. (2007) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1128579] [ Admin láttamozott ] 167. Bacsi K , Kosa J , Lazary A , Balla B , Horvath H , Takacs I , Nagy Z , Speer G , Lakatos P A CYP3A7*1Cpolimorfizmus hatása a csont ásványanyagtartalmára posztmenopauzás nőkben [Impact of CYP3A7*1C polymorphism on bone mineral content in postmenopausal women] ORVOSI HETILAP 148:(27) pp. 12731280. (2007) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1335549] [ Érvényesített ] Független idéző: 2 Összesen: 2 1
Lee SS, Jung H J, Park JS, Cha I J, Cho D Y, Shin J G Identification of a null allele of cytochrome P 450 3A7: CYP 3A7 polymorphism in a Korean population Molecular Biology Reports (ISSN: 03014851) 37: (1) pp. 213217. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11910966]
2
Neunzig I, Drǎgan C A, W idjaja M, Schwaninger AE, Peters FT, Maurer HH, Bureik M Wholecell biotransformation assay for investigation of the human drug metabolizing enzyme CYP 3A7 Biochimica et Biophysica Acta Proteins and Proteomics 1814: (1) pp. 161167. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11910965]
168. Bacsi K , Kosa J , Lazary A , Horvath H , Balla B , Lakatos P , Speer G A dehidroepiandroszteron és dehidroepiandroszteronszulfát jelentôsége különböző kórállapotokban [Significance of dehydroepiandrosterone and dehydroepiandrosterone sulfate in different diseases] ORVOSI HETILAP 148:(14) pp. 651657. (2007) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [1335550] [ Érvényesített ] Független idéző: 4 Összesen: 4 1
Lee W K, Kwak JO, Hwang J S, Suh CK, Cha SH Identification and characterization of single nucleotide polymorphisms of SLC22A11 (hOAT4) in Korean women osteoporosis patients Molecules and Cells (ISSN: 10168478) 25: (2) pp. 265271. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [11910990]
2
Jacob MHVM, da Rocha Janner D, Jahn MP, Kucharski LCR, BellóKlein A, Ribeiro MFM DHEA effects on myocardial Akt signaling modulation and oxidative stress changes in aged rats Steroids (ISSN: 0039128X) 74: (1314) pp. 10451050. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11910989]
3
Jacob MHVM, Janner DDR, Jahn MP, Kucharski LC, BellóKlein A, Ribeiro MFM Agerelated effects of DHEA on peripheral markers of oxidative stress Cell Biochemistry and Function (ISSN: 02636484) 28: (1) pp. 5257. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11910988]
4
Jacob MHVM, Janner DDR, Araújo ASDR, Jahn MP, Kucharski LCR, Moraes TB, Dutra Filho CS, Ribeiro MFM, BellóKlein A Dehydroepiandrosterone improves hepatic antioxidant reserve and stimulates Akt signaling in young and old rats Journal of Steroid Biochemistry and Molecular Biology (ISSN: 09600760) 127: (35) pp. 331336. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11910987]
169. Bacsi K , Kosa JP , Balla B , Lazary A , Nagy Z , Takacs I , Speer G , Lakatos P The decreased activity of lactase phlorizin hydrolase and bone mineral density in postmenopausal women https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
119/342
3/30/2015
nyomtatobarat forma
JOURNAL OF BONE AND MINERAL RESEARCH 22:(Suppl. 1) p. S186. (2007) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1464664] 29th Annual M eeting of the : AmericanSocietyforBoneandM ineralResearch SEP 1619, 2007, Honolulu, HI [ Érvényesített ] 170. Bacsi K , Kosa JP , Borgulya G , Balla B , Lazary A , Nagy Z , Horvath C , Speer G , Lakatos P CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulfate level, and bone mineral density in postmenopausal women CALCIFIED TISSUE INTERNATIONAL 80:(3) pp. 154159. (2007) IF: 2.435 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1464667] [ Érvényesített ] Független idéző: 11 Összesen: 11 1
IngelmanSundberg M, Sim SC, Gomez A, RodriguezAntona C Influence of cytochrome P 450 polymorphisms on drug therapies: P harmacogenetic, pharmacoepigenetic and clinical aspects PHARMACOLOGY & THERAPEUTICS 116: (3) pp. 496526. ( 2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [11278222]
2
Bergemann N, Parzer P, Mundt C, Auler B High bone turnover but normal bone mineral density in women suffering from schizophrenia Psychological Medicine (ISSN: 00332917) 38: (8) pp. 11951201. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12017788]
3
Guo Y, Yang T L, Pan F, Xu X H, Dong S S, Deng H W Molecular genetic studies of gene identification for osteoporosis Expert Review of Endocrinology and Metabolism 3: (2) pp. 223267. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12017787]
4
Hines RN, Koukouritaki SB, Poch MT, Stephens MC Regulatory polymorphisms and their contribution to interindividual differences in the expression of enzymes influencing drug and toxicant disposition DRUG METABOLISM REVIEWS (ISSN: 03602532) 40: (2) pp. 263301. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [11278221]
5
ZHANG Ruifang, BI Lifu, SU Xiulan The relationship between CYP 3A7 polymorphisms and density in menopausal Mongolian women Chinese Journal of Osteoporosis 15: (2) pp. 9295. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [13041614]
6
Lee SS, Jung HJ, Park JS, Cha IJ, Cho DY, Shin JG Identification of a null allele of cytochrome P 450 3A7: CYP 3A7 polymorphism in a Korean population MOLECULAR BIOLOGY REPORTS (ISSN: 03014851) 37: (1) pp. 213217. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11278220]
7
Crettol S, Petrovic N, Murray M P harmacogenetics of P hase I and P hase II Drug Metabolism CURRENT PHARMACEUTICAL DESIGN (ISSN: 13816128) 16: (2) pp. 204219. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11278219]
8
Perera M The missing linkage: what pharmacogenetic associations are left to find in CYP 3A? EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY 6: (1) pp. 1728. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11278218]
9
Ghebre MA, Hart DJ, Hakim AJ, Kato BS, Thompson V, Arden NK, Spector TD, Zhai G Association between DHEAS and bone loss in postmenopausal women: A 15year longitudinal populationbased study Calcified Tissue International (ISSN: 0171967X) 89: (4) pp. 295302. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12017786]
10
Neunzig I, Dragan CA, W idjaja M, Schwaninger AE, Peters FT, Maurer HH, Bureik M Wholecell biotransformation assay for investigation of the human drug metabolizing enzyme CYP 3A7 BIOCHIMICA ET BIOPHYSICA ACTAPROTEINS AND PROTEOMICS (ISSN: 15709639) 1814: (1) pp. 161167. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11278217]
11
W u Haishan, Deng Lu, Zhao Lipin, Zhao Jingping, Li Lehua, Chen Jindong Osteoporosis Associated with Antipsychotic Treatment in Schizophrenia INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (ISSN: 16878337) 2013: P aper 167138. (2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13382544]
171. Bácsi K , Kósa JP , Balla B , Lazáry Á , Nagy Zs , Takács I , Speer G , Lakatos P A laktázflorizinhidroláz és a csontdenzitás kapcsolatának vizsgálata posztmenopauzás nőkben CA ÉS CSONT 10:(2) p. 50. (2007) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1820151] [ Admin láttamozott ] 172. Bácsi K , Kósa J , Balla B , Lazáry Á , Nagy Zs , Takács I , Speer G , Lakatos P The decreased activity of lactase phlorizin hydrolase and bone mineral density in postmenopausal women ASBM R Kongresszus, Honolulu (2007) Nyelv: Angol https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
120/342
3/30/2015
nyomtatobarat forma
Egyéb /Nem besorolt /Tudományos [2434147] [Poszter] [ Admin láttamozott ] 173. Balla B , Kosa J , Kiss J , Borsy A , Podani J , Takacs I , Lazary A , Nagy Z , Bacsi K , Speer G , Orosz L , Lakatos P Effect of estrogen deficiency on gene expression pattern in the bone tissue of postmenopausal versus premenopausal healthy women JOURNAL OF BONE AND MINERAL RESEARCH 22: p. S261. (2007) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1464665] 29th Annual M eeting of the : AmericanSocietyforBoneandM ineralResearch SEP 1619, 2007,Honolulu, HI SU: Suppl. 1 [ Érvényesített ] 174. Balla B , Kósa JP , Takács I , Kiss J , Podani J , Borsy A , Lazáry Á , Bácsi K , Speer G , Nagy Zs , Orosz L , Lakatos P Ösztrogén hiányában fellépő génexpressziós változás vizsgálata posztmenopauzás és premenopauzás nem osteoporosisos nők csontszövetében CA ÉS CSONT 10:(2) p. 51. (2007) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1820190] [ Admin láttamozott ] 175. Balla B , Kósa J , Kiss J , Borsy A , Podani J , Takács I , Lazáry Á , Nagy Zs , Bácsi K , Speer G , Orosz L , Lakatos P Effect of estrogen deficiency on gene expression pattern in the bone tissue of postpenopausal versus premenopausal healthy women ASBM R Kongresszus, Honolulu (2007) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434125] [Poszter] [ Admin láttamozott ] 176. Black DM , Delmas PD , Eastell R , Reid IR , Boonen S , Cauley JA , Cosman F , Lakatos P , Leung PC , M an Z , M autalen C , M esenbrink P , Hu H , Caminis J , Tong K , RosarioJansen T , Krasnow J , Hue TF , Sellmeyer D , Eriksen EF , Cummings SR Onceyearly zoledronic acid for treatment of postmenopausal osteoporosis NEW ENGLAND JOURNAL OF MEDICINE 356:(18) pp. 18091822. (2007) IF: 52.589 Nyelv: Angol
Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [1802689] *Investigators for the Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly (HORIZON) Pivotal Fracture Trial are listed in the Appendix. [ Hitelesített ] Független idéző: 1036 Függő idéző: 141 Összesen: 1177 1
* Cummings SR, Schwartz AV, Black DM Alendronate and atrial fibrillation NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 356: (18) pp. 18951896. ( 2007) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12347083]
2
Owens G, Jackson R, Lewiecki EM An integrated approach: Bisphosphonate management for the treatment of osteoporosis AMERICAN JOURNAL OF MANAGED CARE (ISSN: 10880224) 13: (11) pp. S290S308. ( 2007) SU: S Folyóiratcikk /Szakcikk /Tudományos [12347082]
3
* Black DM Annual treatment for postmenopausal osteoporosis SAMJ SOUTH AFRICAN MEDICAL JOURNAL (ISSN: 02569574) 97: (6) pp. 430431. ( 2007) Folyóiratcikk /Ismertetés /Tudományos [12347081]
4
Russell RGG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, Kavanagh KL, Triffitt JT, Lundy MW , Phipps RJ, Barnett BL, Coxon FP, Rogers MJ, W atts NB, Ebetino FH Bisphosphonates An update on mechanisms of action and how these relate to clinical efficacy SKELETAL BIOLOGY AND MEDICINE, PT B: DISEASE MECHANISMS AND THERAPEUTIC CHALLENGES 1117: pp. 209257. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [12347080]
5
Bertoldo F, Santini D, Lo Cascio V Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle NATURE CLINICAL PRACTICE ONCOLOGY (ISSN: 17434254) 4: (12) pp. 711721. ( 2007)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
121/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Összefoglaló cikk /Tudományos [12347079] 6
Levine JP Effective strategies to identify postmenopausal women at risk of osteoporosis GERIATRICS (ISSN: 0016867X) 62: (11) pp. 2230. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [12347078]
7
Grey A Emerging pharmacologic therapies for osteoporosis EXPERT OPINION ON EMERGING DRUGS (ISSN: 14728214) 12: (3) pp. 493508. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [12347077]
8
Vaile J, Sullivan L, Bennett C, Bleasel J First Fracture P roject: addressing the osteoporosis care gap INTERNAL MEDICINE JOURNAL (ISSN: 14440903) 37: (10) pp. 717720. ( 2007) Folyóiratcikk /Rövid közlemény /Tudományos [12347076]
9
Anonymous HORIZON: Yearly infusion of zoledronic acid reduces risk of fracture in postmenopausal women with osteoporosis FORMULARY (ISSN: 1082801X) 42: (8) pp. 488489. ( 2007) Folyóiratcikk /Ismertetés /Tudományos [12347075]
10
Milgrom L Jabbing away at osteoporosis CHEMISTRY WORLD (ISSN: 14737604) 4: (6) pp. 2222. ( 2007) Folyóiratcikk /Ismertetés /Tudományos [12347074]
11
Lewiecki EM Long dosing intervals in the treatment of postmenopausal osteoporosis CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 23: (11) pp. 26172625. ( 2007) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12347073]
12
13
14
* Cauley JA, Hochberg MC, Lui LY, Palermo L, Ensrud KE, Hillier TA, Nevitt MC, Cummings SR Longterm risk of incident vertebral fractures JAMAJOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (ISSN: 00987484) 298: (23) pp. 27612767. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [12347072] Rizzoli R Longterm strategy in the management of postmenopausal osteoporosis JOINT BONE SPINE (ISSN: 1297319X) 74: (6) pp. 540543. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [12347071] * Body JJ, Bergmann P, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, Reginster JY, Rozenberg S, Kaufman JM Management of cancer treatmentinduced bone loss in early breast and prostate cancer a consensus paper of the Belgian Bone Club OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 18: (11) pp. 14391450. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [12347070]
15
Kimmel DB Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogencontaining bisphosphonates JOURNAL OF DENTAL RESEARCH (ISSN: 00220345) 86: (11) pp. 10221033. ( 2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347069]
16
Anonymous P ostmenopausal osteoporosis: one annual injection of zoledronic acid reduces the fractures PRESSE MEDICALE (ISSN: 07554982) 36: (10) pp. 14081408. ( 2007) PN: Part 1 Folyóiratcikk /Ismertetés /Tudományos [12347068]
17
Lewiecki EM, Miller PD Renal safety of intravenous bisphosphonates in the treatment of osteoporosis EXPERT OPINION ON DRUG SAFETY (ISSN: 14740338) 6: (6) pp. 663672. ( 2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347067]
18
Hashimoto T, Shigetomi M, Ohno T, Matsunaga T, Muramatsu K, Tanaka H, Sugiyama T, Taguchi T Sequential treatment with intermittent lowdose human parathyroid hormone (134) and bisphosphonate enhances largesize skeletal reconstruction by vascularized bone transplantation CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 81: (3) pp. 232239. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [12347066]
19
Vega D, Maalouf NM, Sakhaee K The role of receptor activator of nuclear factorkappa B (RANK)/RANK ligand/osteoprotegerin: Clinical implications JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 92: (12) pp. 45144521. ( 2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347065]
20
Perez AD Therapeutics issues in osteoporosis MEDICINA CLINICA (ISSN: 00257753) 129: (20) pp. 773774. ( 2007) Folyóiratcikk /Ismertetés /Tudományos [12347064]
21
Compston J Treatments for osteoporosis Looking beyond the HORIZON NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 356: (18) pp. 18781880. ( 2007) Folyóiratcikk /Ismertetés /Tudományos [12347061]
22
de Nijs RNJ, W estgeest AAA Yearly zoledronic acid in postmenopausal osteoporosis NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 357: (7) pp. 711711. ( 2007) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12347060]
23
* Lyles KW , ColonEmeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S Zoledronic acid and clinical fractures and mortality after hip fracture NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 357: (18) pp. 17991809. ( 2007) CA: HORIZON Recurrent Fracture
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
122/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [12347059] 24
Maricic M Zoledronic acid for P aget's disease of bone DRUGS OF TODAY (ISSN: 16993993) 43: (12) pp. 879885. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [12347058]
25
Devogelaer JP, Manicourt DH Zoledronic acid for treatment of P aget"s disease of bone EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 8: (16) pp. 28632869. ( 2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347057]
26
Lewiecki EM A Clinician's P erspective on the Use of Zoledronic Acid in the Treatment of P ostmenopausal Osteoporosis JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 11: (4) pp. 478484. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347056]
27
Sander B, ElliotGibson V, Beaton DE, Bogoch ER, Maetzel A A coordinator program in postfracture osteoporosis management improves outcomes and saves costs JOURNAL OF BONE AND JOINT SURGERYAMERICAN VOLUME (ISSN: 00219355) 90A: (6) pp. 11971205. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347055]
28
O'Malley P A onceayear intravenous treatment of osteoporosis postmenopausal women CLINICAL NURSE SPECIALIST (ISSN: 08876274) 22: (4) pp. 169171. ( 2008) Folyóiratcikk /Ismertetés /Tudományos [12347054]
29
Bartl R A query from medical practice: the biological halflife of biophosphonates DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (ISSN: 00120472) 133: (5152) pp. 27002701. ( 2008) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12347053]
30
Abelson A A review of P aget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 24: (3) pp. 695705. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347052]
31
Bjarnason NH, Hitz M, Jorgensen NR, Vestergaard P Adverse bone effects during pharmacological breast cancer therapy ACTA ONCOLOGICA (ISSN: 0284186X) 47: (4) pp. 747754. ( 2008) CA: Danish Bone Soc Folyóiratcikk /Összefoglaló cikk /Tudományos [12347051]
32
LiYu JT Agony of a retired pediatrician INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ISSN: 17561841) 11: (3) pp. 296302. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347050]
33
34
35
* Heckbert SR, Li G, Cummings SR, Smith NL, Psaty BM Alendronate, Osteoporosis, and Atherosclerosis Reply ARCHIVES OF INTERNAL MEDICINE (ISSN: 00039926) 168: (21) pp. 23872387. ( 2008) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12347049] Higano CS Androgrendeprivationtherapyinduced fractures in men with nonmetastatic prostate cancer: what do we really know? NATURE CLINICAL PRACTICE UROLOGY (ISSN: 17434270) 5: (1) pp. 2434. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347048] * Reid IR Antiresorptive therapies for osteoporosis SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (ISSN: 10849521) 19: (5) pp. 473478. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347047]
36
Miller PD Antiresorptives in the management of osteoporosis BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 1521690X) 22: (5) pp. 849868. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347046]
37
Tuck SP Antifracture efficacy of osteoporosis treatments CURRENT ORTHOPAEDICS (ISSN: 02680890) 22: (5) pp. 328335. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347045]
38
Pant S, Shapiro CL Aromatase InhibitorAssociated Bone Loss Clinical Considerations DRUGS (ISSN: 00126667) 68: (18) pp. 25912600. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347044]
39
Lewiecki EM, W atts NB Assessing response to osteoporosis therapy OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 19: (10) pp. 13631368. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347043]
40
W eiss HM, Pfaar U, Schweitzer A, W iegand H, Skerjanec A, Schran H Biodistribution and plasma protein binding of zoledronic acid DRUG METABOLISM AND DISPOSITION (ISSN: 00909556) 36: (10) pp. 20432049. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347042]
41
Perazella MA, Markowitz GS Bisphosphonate nephrotoxicity KIDNEY INTERNATIONAL (ISSN: 00852538) 74: (11) pp. 13851393. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347040]
42
Kristensen B, Ejlertsen B, Mouridsen HT, Jensen MB, Andersen J, Bjerregaard B, Cold S, Edlund P, Ewertz M, Kamby C, Lindman H, Nordenskjold B, Bergh J Bisphosphonate treatment in primary breast cancer: Results from a randomised comparison of oral pamidronate versus no
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
123/342
3/30/2015
nyomtatobarat forma pamidronate in patients with primary breast cancer ACTA ONCOLOGICA (ISSN: 0284186X) 47: (4) pp. 740746. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347039] 43
Krauth MT, Fugl A, Gruber R Bisphosphonateassociated osteonecrosis of the jaw WIENER KLINISCHE WOCHENSCHRIFT 120: (1516) pp. 467476. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347038]
44
Brown JJ, Ramalingam L, Zacharin MR Bisphosphonateassociated osteonecrosis of the jaw: does it occur in children? CLINICAL ENDOCRINOLOGY (ISSN: 03000664) 68: (6) pp. 863867. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347037]
45
Carey JJ, Palomo L Bisphosphonates and osteonecrosis of the jaw: Innocent association or significant risk? CLEVELAND CLINIC JOURNAL OF MEDICINE (ISSN: 08911150) 75: (12) pp. 871879. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347036]
46
Polascik TJ Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases DRUG DESIGN DEVELOPMENT AND THERAPY (ISSN: 11778881) 3: pp. 2740. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347035]
47
Bock Oliver, Felsenberg Dieter Bisphosphonates in the management of postmenopausal osteoporosis optimizing efficacy in clinical practice CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 3: (2) pp. 279297. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [14598236]
48
Papapoulos SE Bisphosphonates: how do they work? BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 1521690X) 22: (5) pp. 831847. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347034]
49
Drake MT, Clarke BL, Khosla S Bisphosphonates: Mechanism of action and role in clinical practice MAYO CLINIC PROCEEDINGS (ISSN: 00256196) 83: (9) pp. 10321045. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347033]
50
McDonald MM, Dulai S, Godfrey C, Amanat N, Sztynda T, Little DG Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling BONE (ISSN: 87563282) 43: (4) pp. 653662. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347032]
51
Coleman RE, Body JJ, Gralow JR, Lipton A Bone boss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategies CANCER TREATMENT REVIEWS (ISSN: 03057372) 34: (Suppl. 1) pp. S31S42. ( 2008) Folyóiratcikk /Konferenciaközlemény /Tudományos [12347031]
52
Sun SG Bone disease drug discovery: examining the interactions between osteoblast and osteoclast EXPERT OPINION ON THERAPEUTIC TARGETS (ISSN: 14728222) 12: (2) pp. 239251. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347030]
53
Neuprez A, Reginster JY Boneforming agents in the management of osteoporosis BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 1521690X) 22: (5) pp. 869883. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347029]
54
Brufsky AM Cancer treatmentinduced bone loss: P athophysiology and clinical perspectives ONCOLOGIST (ISSN: 10837159) 13: (2) pp. 187195. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347028]
55
Khan MN, Khan AA Cancer treatmentrelated bone loss: a review and synthesis of the literature CURRENT ONCOLOGY 15: (Suppl. 1) pp. S30S40. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347027]
56
Vondracek Sheryl F, Minne Paul, McDermott Michael T Clinical challenges in the management of osteoporosis CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 3: (2) pp. 315329. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [14598235]
57
58
* Delmas PD Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 11: (2) pp. 325338. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347026] MessingerRapport BJ, Thomas DR, Gammack JK, Morley JE Clinical update on nursing home medicine: 2008 JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (ISSN: 15258610) 9: (7) pp. 460475. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347025]
59
* Bouxsein ML, Delmas PD Considerations for development of surrogate endpoints for antifracture efficacy of new treatments in osteoporosis: A perspective JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 23: (8) pp. 11551167. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347024]
60
* Cauley JA, Ensrud KE Considering competing risks ... not all black and white
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
124/342
3/30/2015
nyomtatobarat forma ARCHIVES OF INTERNAL MEDICINE (ISSN: 00039926) 168: (8) pp. 793795. ( 2008) Folyóiratcikk /Ismertetés /Tudományos [12347023] 61
Lloyd SAJ, Travis ND, Lu T, Bateman TA Development of a lowdose antiresorptive drug regimen reveals synergistic suppression of bone formation when coupled with disuse JOURNAL OF APPLIED PHYSIOLOGY (ISSN: 87507587) 104: (3) pp. 729738. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347022]
62
Junquera LM, MartínGranizo R Diagnóstico, prevención y tratamiento de la osteonecrosis de los maxilares por bisfosfonatos: Recomendaciones de la Sociedad Española de Cirugía Oral y Maxilofacial (SECOM): Diagnosis, prevention, and treatment of bisphosphonate associated osteonecrosis of the jaw: Recommendations of the Spanish Society of Oral and Maxillofacial Surgery (SECOM) Revista Española de Cirugía Oral y Maxilofacial (ISSN: 11300558) 30: (3) pp. 145156. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [14598227]
63
* Granger CB, Vogel V, Cummings SR, Held P, Fiedorek F, Lawrence M, Neal B, Reidies H, Santarelli L, Schroyer R, Stockbridge NL, Zhao F Do we need to adjudicate major clinical events? CLINICAL TRIALS (ISSN: 17407745) 5: (1) pp. 5660. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347021]
64
Geusens PP, Roux CH, Reid DM, Lems W F, Adami S, Adachi JD, Sambrook PN, Saag KG, Lane NE, Hochberg MC Drug Insight: choosing a drug treatment strategy for women with osteoporosis an evidencebased clinical perspective NATURE CLINICAL PRACTICE RHEUMATOLOGY (ISSN: 17458382) 4: (5) pp. 240248. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347020]
65
Marx RE Editorial opinion versus real data and knowledge of the literature INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS (ISSN: 08822786) 23: (4) pp. 587588. ( 2008) Folyóiratcikk /Ismertetés /Tudományos [12347019]
66
Bundred NJ, Campbell ID, Davidson N, DeBoer RH, Eidtmann H, Monnier A, Neven P, von Minckwitz G, Miller JC, Schenk NL, Coleman RE Effective inhibition of aromatase inhibitorassociated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole CANCER (ISSN: 0008543X) 112: (5) pp. 10011010. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347017]
67
* Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, EllisPegler RB, Callon KE, Gamble GD, Reid IR Effects of intravenous zoledronate on bone turnover and BMD persist for at least 24 months JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 23: (8) pp. 13041308. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347016]
68
* Recker RR, Delmas PD, Halse J, Reid IR, Boonen S, GarciaHernandez PA, Supronik J, Lewiecki EM, Ochoa L, Miller P, Hu H, Mesenbrink P, Hartl F, Gasser J, Eriksen EF Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 23: (1) pp. 616. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347015]
69
* Delmas PD, McClung MR, Zanchetta JR, Racewicz A, Roux C, Benhamou CL, Mang Z, Eusebio RA, Beary JF, Burgio DE, Matzkin E, Boonen S Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis BONE (ISSN: 87563282) 42: (1) pp. 3642. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347014]
70
* Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R European guidance for the diagnosis and management of osteoporosis in postmenopausal women OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 19: (4) pp. 399428. ( 2008) CA: European Soc Clinical Economic Folyóiratcikk /Összefoglaló cikk /Tudományos [12347013]
71
Denger S, Reid G, Gannon F Expression of the estrogen receptor during differentiation of human osteoclasts STEROIDS (ISSN: 0039128X) 73: (7) pp. 765774. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347012]
72
Hess LM, Jeter JM, BenhamHutchins M, Alberts DS Factors associated with osteonecrosis of the jaw among bisphosphonate users AMERICAN JOURNAL OF MEDICINE (ISSN: 00029343) 121: (6) pp. 475483.e3. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347011]
73
Sack F Fighting the Fracture Cascade: Evaluation and Management of Osteoporotic Fractures POSTGRADUATE MEDICINE (ISSN: 00325481) 120: (4) pp. 5157. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347010]
74
Gallagher AM, Rietbrock S, Olson M, van Staa TP Fracture outcomes related to persistence and compliance with oral bisphosphonates JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 23: (10) pp. 15691575. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347009]
75
Mehler PS, Sabel AL, W atson T, Andersen AE High Risk of Osteoporosis in Male P atients with Eating Disorders INTERNATIONAL JOURNAL OF EATING DISORDERS (ISSN: 02763478) 41: (7) pp. 666672. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347008]
76
Iwamoto J, Sato Y, Takeda T, Matsumoto H Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 3: (3) pp. 483489. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347007]
77
Amezyane T, Lecoules S, Bordier L, Blade JS, Desrame J, Bechade D, Coutant G, Algayres JP Humoral hypercalcemia revealing a malignant non hodgkin lymphoma ANNALES D ENDOCRINOLOGIE (ISSN: 00034266) 69: (1) pp. 5862. ( 2008)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
125/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Összefoglaló cikk /Tudományos [12347006] 78
Frampton JE, Perry CM Ibandronate A Review of its Use in the Management of P ostmenopausal Osteoporosis DRUGS (ISSN: 00126667) 68: (18) pp. 26832707. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12347005]
79
Harris ST, Blumentals W A, Miller PD Ibandronate and the risk of nonvertebral and clinical fractures in women with postmenopausal osteoporosis: results of a metaanalysis of phase III studies CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 24: (1) pp. 237245. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347004]
80
Blouin J, Dragomir A, Moride Y, SteMarie LG, Fernandes JC, Perreault S Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ISSN: 03065251) 66: (1) pp. 117127. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347003]
81
Rozental TD, Makhni EC, Day CS, Bouxsein ML Improving evaluation and treatment for osteoporosis following distal radial fractures JOURNAL OF BONE AND JOINT SURGERYAMERICAN VOLUME (ISSN: 00219355) 90A: (5) pp. 953961. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347002]
82
* Grbic JT, Landesberg R, Lin SQ, Mesenbrink P, Reid IR, Leung PC, Casas N, Recknor CP, Hua Y, Delmas PD, Eriksen EF Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly P ivotal Fracture Trial JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (ISSN: 00028177) 139: (1) pp. 3240. ( 2008) CA: Hlth Outcomes Reduced Incidence Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [12347001]
83
Kasperk C, Noldge G, Grafe I, Meeder P, Huber F, Nawroth P Indications and results of kypho and vertebroplasty INTERNIST (ISSN: 00209554) 49: (10) pp. 12061218. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12347000]
84
Brouwers JEM, van Rietbergen B, Bouxsein ML Influence of Early and Late Zoledronic Acid Administration on Vertebral Structure and Strength in Ovariectomized Rats CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 83: (3) pp. 186191. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346999]
85
W imalawansa SJ Insight into bisphosphonateassociated osteomyelitis of the jaw: pathophysiology, mechanisms and clinical management EXPERT OPINION ON DRUG SAFETY (ISSN: 14740338) 7: (4) pp. 491512. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346998]
86
Brufsky A, Bundred N, Coleman R, LambertFalls R, Mena R, Hadji P, Jin L, Schenk N, Ericson S, Perez EA Integrated analysis of zoledronic acid for prevention of aromatase inhibitorassociated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole ONCOLOGIST (ISSN: 10837159) 13: (5) pp. 503514. ( 2008) CA: Grp, ZF& ZFS Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [12346997]
87
Adami S, Gatti D, Bertoldo F, Sartori L, Di Munno O, Filipponi P, Marcocci C, Frediani B, Palummeri E, Fiore CE, Costi D, Rossini M Intramuscular Neridronate in P ostmenopausal Women with Low Bone Mineral Density CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 83: (5) pp. 301307. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346996]
88
Aschenbrenner DS Is there a link between bisphosphonates and atrial fibrillation? AMERICAN JOURNAL OF NURSING (ISSN: 0002936X) 108: (3) pp. 3737. ( 2008) Folyóiratcikk /Ismertetés /Tudományos [12346995]
89
Kasperk C, Noldge G, Meeder P, Nawroth P, Huber FX Kyphoplasty Method for minimally invasive treatment of painful vertebral fractures CHIRURG (ISSN: 00094722) 79: (10) pp. 944955. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346994]
90
Pazianas M, Blumentals W A, Miller PD Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 19: (6) pp. 773779. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346993]
91
Greiner SH, W ildemann B, Back DA, Alidoust M, Schwabe P, Haas NP, Schmidmaier G Local application of zoledronic acid incorporated in a poly(D, Llactide)coated implant accelerates fracture healing in rats ACTA ORTHOPAEDICA (ISSN: 17453674) 79: (5) pp. 717725. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346992]
92
Tanaka M, Mori H, Kayasuga R, Ochi Y, Kawada N, Yamada H, Kishikawa K Longterm minodronic acid (ONO5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia BONE (ISSN: 87563282) 43: (5) pp. 894900. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346991]
93
Gasser JA, Ingold P, Venturiere A, Shen V, Green JR Longterm protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 23: (4) pp. 544551. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346990]
94
Nguyen TV Mapping translational research into individualized prognosis of fracture risk INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ISSN: 17561841) 11: (4) pp. 347358. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346989]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
126/342
3/30/2015
nyomtatobarat forma 95
Martens MG, Shaw H Maximizing effectiveness of bisphosphonate therapy for osteoporosis SOUTHERN MEDICAL JOURNAL (ISSN: 00384348) 101: (8) pp. 824830. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346988]
96
Russell RGG, W atts NB, Ebetino FH, Rogers MJ Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 19: (6) pp. 733759. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346987]
97
Mori H, Tanaka M, Kayasuga R, Masuda T, Ochi Y, Yamada H, Kishikawa K, Ito M, Nakamura T Minodronic acid (ONO5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys BONE (ISSN: 87563282) 43: (5) pp. 840848. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346986]
98
Arum SM New developments surrounding the safety of bisphosphonates CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (ISSN: 1752296X) 15: (6) pp. 508513. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346985]
99
Doggrell SA New horizons for zoledronic acid: results of the HORIZON trials in postmenopausal women with osteoporosis and after hip fracture EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 9: (4) pp. 663668. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346984]
100
Malaise O, Neuprez A, Reginster JY Nonhormonal treatments of postmenopausal osteoporosis GYNECOLOGIE OBSTETRIQUE & FERTILITE (ISSN: 12979589) 36: (78) pp. 815822. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346983]
101
Miller PD Nonvertebral fracture risk reduction with oral bisphosphonates: challenges with interpreting clinical trial data CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 24: (1) pp. 107119. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346982]
102
Anderson P, Kopp L, Anderson N, Cornelius K, Herzog C, Hughes D, Htth W Novel bone cancer drugs: investigational agents and control paradigms for primary bone sarcomas (Ewing's sarcoma and osteosareoma) EXPERT OPINION ON INVESTIGATIONAL DRUGS (ISSN: 13543784) 17: (11) pp. 17031715. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346981]
103
Volpon José B, Cecim Paulo Eugênio Santos, Miyase Cátia Isumi, Gava Nelson Fabrício O alendronato de sódio na prevenção da osteopenia secundária à imobilização gessada, em ratas: avaliação histomorfométrica: Alendronate sodium to prevent osteopenia caused by cast immobilization in female rats: histomorphometric evaluation Revista Brasileira de Ortopedia (ISSN: 01023616) 43: (10) pp. 442451. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [14598216]
104
W oodis CB Onceyearly administered intravenous zoledronic acid for postmenopausal osteoporosis ANNALS OF PHARMACOTHERAPY (ISSN: 10600280) 42: (78) pp. 10851089. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346980]
105
LafageProust MH Onceyearly intravenous zoledronate does not impair renal function in postmenopausal women KIDNEY INTERNATIONAL (ISSN: 00852538) 74: (5) pp. 557559. ( 2008) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12346979]
106
* Reid IR Onceyearly zoledronate An effective preventative therapy for new fractures after hip fracture? NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM 4: (6) pp. 308309. ( 2008) Folyóiratcikk /Ismertetés /Tudományos [12346978]
107
Lambrinoudaki I, Vlachou S, Galapi F, Papadimitriou D, Papadias K Onceyearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 3: (3) pp. 445451. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346977]
108
Sunyecz J Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 3: (4) pp. 611627. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346976]
109
Majumdar SR Oral bisphosphonates and atrial fibrillation BRITISH MEDICAL JOURNAL 336: (7648) pp. 784785. ( 2008) Folyóiratcikk /Ismertetés /Tudományos [12346975]
110
Miki RA, Oetgen ME, Kirk J, Insogna KL, Lindskog DM Orthopaedic Management Improves the Rate of Early Osteoporosis Treatment After Hip Fracture A Randomized Clinical Trial JOURNAL OF BONE AND JOINT SURGERYAMERICAN VOLUME (ISSN: 00219355) 90: (11) pp. 23462353. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346974]
111
Bensadoun RJ, Blanc JL, Confavreux C, Gourmet R, Maes JM, Penel G, Vieillard MH, W oeller A Osteonecrosis of the jaw and bisphophonates in oncology BULLETIN DU CANCER (ISSN: 00074551) 95: (4) pp. 413418. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346973]
112
King AE, Umland EM Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates PHARMACOTHERAPY (ISSN: 02770008) 28: (5) pp. 667677. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346972]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
127/342
3/30/2015
nyomtatobarat forma 113
Khan A Osteonecrosis of the jaw: New developments in an old disease JOURNAL OF RHEUMATOLOGY (ISSN: 0315162X) 35: (4) pp. 547549. ( 2008) Folyóiratcikk /Ismertetés /Tudományos [12346971]
114
Carvalho A, Mendes RA, Carvalho D, Carvalho JFC OSTEONECROSIS OF THE MANDIBLE INDUCED BY INTRAVENOUS BIP HOSP HONATES IN ONCOLOGICAL P ATIENTS ACTA MEDICA PORTUGUESA (ISSN: 16460758) 21: (5) pp. 505510. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346970]
115
Kitchin M Osteoporosis Handy tools for detection, helpful tips for treatment JOURNAL OF FAMILY PRACTICE (ISSN: 00943509) 57: (5) pp. 311320. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346969]
116.
Dimai HP, Kastner P, Nitzlnader M, Schauer A, ModreOsprian R, Rauchegger G, Schreier G OSTEOP OROSIS A REMINDER ACTIVE P ATIENT REMINDER SYSTEM ECARD WITH GIN AND CONNECTIVITY In: Schreier G Hay n D Ammenwerth E (szerk.) Conference on eHealth 2008 and eHealth Benchmarking 2008. Wien, Ausztria: 2008.05.29 2008.05.30. Wien: OSTERREICHISCHE COMPUTER GESELLSCHAFTOCG, (2008.) , pp. 151156 . ISBN: 9783854032359
Egyéb konferenciaközlemény /Konferenciaközlemény /Tudományos [12346968] 117
Kocjan T, Franic D OSTEOP OROSIS AND HORMONE REP LACEMENT THERAP Y ZDRAVNISKI VESTNIKSLOVENIAN MEDICAL JOURNAL 77: pp. 4348. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346967]
118
Edwards BJ, Migliorati CA Osteoporosis and its implications for dental patients JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (ISSN: 00028177) 139: (5) pp. 545552. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346966]
119
Feron JM, Thomas T, Roux C, Puget J Osteoporosis and the orthopaedic surgeon in 2007 REVUE DE CHIRURGIE ORTHOPEDIQUE ET REPARATRICE DE L APPAREIL MOTEUR (ISSN: 00351040) 94: (6) pp. S99S107. ( 2008) SU: S Folyóiratcikk /Konferenciaközlemény /Tudományos [12346965]
120
Kuehn BM Osteoporosis Drugs JAMAJOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (ISSN: 00987484) 300: (24) pp. 28462846. ( 2008) Folyóiratcikk /Ismertetés /Tudományos [12346964]
121
* Singer AJ, Boonen S Osteoporosis management: translating research into optimal fracture protection II CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 24: (6) pp. 17891796. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346963]
122
Kearns AE, Kallmes DF Osteoporosis P rimer for the Vertebroplasty P ractitioner: Expanding the Focus Beyond Needles and Cement AMERICAN JOURNAL OF NEURORADIOLOGY (ISSN: 01956108) 29: (10) pp. 18161822. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346962]
123
Sebba A Osteoporosis: how long should we treat? CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (ISSN: 1752296X) 15: (6) pp. 502507. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346961]
124
Gehrig L, Lane J, O'Connor MI Osteoporosis: Management and treatment strategies for orthopaedic surgeons JOURNAL OF BONE AND JOINT SURGERYAMERICAN VOLUME (ISSN: 00219355) 90A: (6) pp. 13621374. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346960]
125
Pongchaiyakul Chatlert, Songpattanasilp Thawee, Taechakraichana Nimit Osteoporosis: Overview in disease, epidemiology, treatment and health economy Journal of the Medical Association of Thailand 91: (4) pp. 581594. ( 2008) BIOSIS Citation Index alapján. Folyóiratcikk /Szakcikk /Tudományos [12426281]
126
Hoffmann F, Jung TI, Felsenberg D, Glaeske G P attern of intravenous bisphosphonate use in outpatient care in Germany PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (ISSN: 10538569) 17: (9) pp. 896903. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346959]
127
Qaseem A, Snow V, Shekelle P, Hopkins R, Forciea MA, Owens DK P harmacologic treatment of low bone density or osteoporosis to prevent fractures: A clinical practice guideline from the American College of P hysicians ANNALS OF INTERNAL MEDICINE (ISSN: 00034819) 149: (6) pp. 404415. ( 2008) CA: Clinical Efficacy Assessment Subco Folyóiratcikk /Összefoglaló cikk /Tudományos [12346958]
128
Ebeling PR, Burr DB P ositive effects of intravenous zoledronic acid on bone remodeling and structure: Are different effects on osteoblast activity to other oral Bisphosphonates responsible? JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 23: (1) pp. 25. ( 2008) Folyóiratcikk /Ismertetés /Tudományos [12346957]
129
* Bruyere O, Brandi ML, Burlet N, Harvey N, Lyritis G, Minne H, Boonen S, Reginster JY, Rizzoli R, Akesson K P ostfracture management of patients with hip fracture: a perspective CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 24: (10) pp. 28412851. ( 2008) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12346956]
130
* Cauley JA, Palermo L, Voot M, Ensrud KE, Ewing S, Hochberg M, Nevitt MC, Black DM P revalent vertebral fractures in black women and white women JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 23: (9) pp. 14581467. ( 2008)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
128/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [12346955] 131
Lewiecki EM P revention and treatment of postmenopausal osteoporosis OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (ISSN: 08898545) 35: (2) pp. 301315. ( 2008) W oSban a szerző hibásan Lewlecki Folyóiratcikk /Szakcikk /Tudományos [12346954]
132
Lester JE, Dodwell D, Purohit OP, Gutcher SA, Ellis SP, Thorpe R, Horsman JM, Brown JE, Hannon RA, Coleman RE P revention of AnastrozoleInduced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer CLINICAL CANCER RESEARCH (ISSN: 10780432) 14: (19) pp. 63366342. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346953]
133
Javid KS, Karim MA, Keenan J, Ferky H, Garlick N, Maruthainar N P revention of osteoporotic fractures in postmenopausal women MINERVA ORTOPEDICA E TRAUMATOLOGICA (ISSN: 00264911) 59: (6) pp. 343354. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346952]
134
Goodship AE, Blunn GW , Green J, Coathup MJ P revention of strainrelated osteopenia in aseptic loosening of hip prostheses using perioperative bisphosphonate JOURNAL OF ORTHOPAEDIC RESEARCH (ISSN: 07360266) 26: (5) pp. 693703. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346951]
135
Moore AEB, Blake GM, Fogelman I Quantitative measurements of bone remodeling using Tc99mmethylene diphosphonate bone scans and blood sampling JOURNAL OF NUCLEAR MEDICINE (ISSN: 01615505) 49: (3) pp. 375382. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346950]
136
Suzuki A, Sekiguchi S, Asano S, Itoh M Recent advances in pharmacological management of osteoporosis JOURNAL OF PHARMACOLOGICAL SCIENCES (ISSN: 13478613) 106: (4) pp. 530535. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346949]
137
* Boonen S, Vanderschueren D, Venken K, Milisen K, Delforge M, Haentjens P Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance JOURNAL OF INTERNAL MEDICINE (ISSN: 09546820) 264: (4) pp. 315332. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346948]
138
Massironi S, Ulivieri FM, Marchelli D, Basilisco G Reduced bone mineral density in chronic intestinal idiopathic pseudoobstruction AMERICAN JOURNAL OF GASTROENTEROLOGY (ISSN: 00029270) 103: (6) pp. 15791581. ( 2008) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12346947]
139
* Boonen S, Sellmeyer DE, Lippuner K, OrlovMorozov A, Abrams K, Mesenbrink P, Eriksen EF, Miller PD Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women KIDNEY INTERNATIONAL (ISSN: 00852538) 74: (5) pp. 641648. ( 2008) CA: HORIZON Pivotal Fracture Trial Folyóiratcikk /Szakcikk /Tudományos [12346946]
140
141
Miller PD, W ard P, Pfister T, Leigh C, Body JJ Renal tolerability of intermittent intravenous ibandronate treatment for patients with postmenopausal osteoporosis: a review CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (ISSN: 0392856X) 26: (6) pp. 11251133. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346945] * Black DM, Boonen S, Delmas P, Lyles KW Review of comparative effectiveness of treatments to prevent fractures ANNALS OF INTERNAL MEDICINE (ISSN: 00034819) 148: (11) pp. 885886. ( 2008) Folyóiratcikk /Rövid közlemény /Tudományos [12346944]
142
Greenspan SL, Brufsky A, Lembersky BC, Bhattacharya R, Vujevich KT, Perera S, Sereika SM, Vogel VG Risedronate prevents bone loss in breast cancer survivors: A 2year, randomized, doubleblind, placebocontrolled clinical trial JOURNAL OF CLINICAL ONCOLOGY (ISSN: 0732183X) 26: (16) pp. 26442652. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346943]
143
Coleman RE Risks and benefits of bisphosphonates BRITISH JOURNAL OF CANCER (ISSN: 00070920) 98: (11) pp. 17361740. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346942]
144
Maestri E Say Dr No to shifting from falls to osteoporosis BRITISH MEDICAL JOURNAL 337: P aper a2684. (2008) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12346941]
145
Papapoulos S, Makras P Selection of antiresorptive or anabolic treatments for postmenopausal osteoporosis NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM 4: (9) pp. 514523. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346940]
146
Misof BM, Bodinghauer M, Roschger P, W ekerle T, Pakrah B, Haas M, Kainz A, Oberbauer R, Muhlbacher F, Klaushofer K ShortTerm Effects of HighDose Zoledronic Acid Treatment on Bone Mineralization Density Distribution After Orthotopic Liver Transplantation CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 83: (3) pp. 167175. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346939]
147
Blain H Should we screen osteoporosis in the elderly? REVUE DE MEDECINE INTERNE (ISSN: 02488663) 29: (4) pp. 269270. ( 2008) Folyóiratcikk /Ismertetés /Tudományos [12346938]
148
Chapurlat RD
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
129/342
3/30/2015
nyomtatobarat forma Single annual injectable a treatment for postmenopausal osteoporosis EXPERT OPINION ON DRUG DELIVERY (ISSN: 17425247) 5: (5) pp. 583591. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346937] 149
Fan TM, de Lorimier LP, Garrett LD, Lacoste HI The bone biologic effects of zoledronate in healthy dogs and dogs with malignant osteolysis JOURNAL OF VETERINARY INTERNAL MEDICINE (ISSN: 08916640) 22: (2) pp. 380387. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346936]
150
Gozzetti A, Gennari L, Merlotti D, Salvadori S, De Paola V, Avanzati A, Franci B, Marchini E, Tozzi M, Campagna MS, Nuti R, Lauria F, Martini G The effects of zoledronic acid on serum lipids in multiple myeloma patients CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 82: (4) pp. 258262. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346935]
151
Bogoch ER, ElliotGibson V, Escott BG, Beaton DE The osteoporosis needs of patients with wrist fracture JOURNAL OF ORTHOPAEDIC TRAUMA (ISSN: 08905339) 22: (8) pp. S73S78. ( 2008) Suppl. Folyóiratcikk /Szakcikk /Tudományos [12346934]
152
Bartl R Treatment of osteoporosis according to the "European guidance 2008". Fractureoriented economical costeffective INTERNIST (ISSN: 00209554) 49: (9) pp. 11261135. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346933]
153
Laroche M Treatment of osteoporosis: All the questions we still cannot answer AMERICAN JOURNAL OF MEDICINE (ISSN: 00029343) 121: (9) pp. 744747. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346932]
154
Chu EYW , Tsang SW Y, Kung AW C Treatment options for postmenopausal osteoporosis in Asia INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ISSN: 17561841) 11: (4) pp. 386392. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346931]
155
Johnson NK, Clifford T, Smith KM Understanding risk factors, screening, and treatment of postmenopausal osteoporosis ORTHOPEDICS (ISSN: 01477447) 31: (7) pp. 676680. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346930]
156
Duque G, Troen BR Understanding the mechanisms of senile osteoporosis: New facts for a major geriatric syndrome JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (ISSN: 00028614) 56: (5) pp. 935941. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346929]
157
Banal F, Briot K, Ayoub G, Dougados M, Roux C Unilateral Anterior Uveitis Complicating Zoledronic Acid Therapy in P rostate Cancer JOURNAL OF RHEUMATOLOGY (ISSN: 0315162X) 35: (12) pp. 24582459. ( 2008) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12346928]
158
Cole Z, Dennison E, Cooper C Update on the treatment of postmenopausal osteoporosis BRITISH MEDICAL BULLETIN (ISSN: 00071420) 86: (1) pp. 129143. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346927]
159
Edwards BJ, Hellstein JW , Jacobsen PL, Kaltman S, Mariotti A, Migliorati CA Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy An advisory statement from the American Dental Association Council on Scientific Affairs JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (ISSN: 00028177) 139: (12) pp. 16741677. ( 2008) CA: Amer Dent Assoc Council Sci Folyóiratcikk /Szakcikk /Tudományos [12346926]
160
* Heckbert SR, Li G, Cummings SR, Smith NL, Psaty BM Use of alendronate and risk of incident atrial fibrillation in women ARCHIVES OF INTERNAL MEDICINE (ISSN: 00039926) 168: (8) pp. 826831. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346925]
161
* Sorensen HT, Christensen S, Mehnert F, Pedersen L, Chapurlat RD, Cummings SR, Baron JA Use of bisphosphonates among women and risk of atrialfibrillation and flutter: population based casecontrol study BRITISH MEDICAL JOURNAL 336: (7648) pp. 813816. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346924]
162
Bartl R, Bartl C, Gradinger R Use of bisphosphonates in orthopedic surgery ORTHOPADE (ISSN: 00854530) 37: (6) pp. 595613. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346923]
163
Singer FR, Eyre DR Using biochemical markers of bone turnover in clinical practice CLEVELAND CLINIC JOURNAL OF MEDICINE (ISSN: 08911150) 75: (10) pp. 739750. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346922]
164
Vasikaran SD Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (ISSN: 10408363) 45: (2) pp. 221258. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346921]
165
Lopez CA, Tasneem Z Zoledronate, fractures, and mortality after hip fracture NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 358: (9) pp. 967968. ( 2008) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12346919]
166
Karam R, AlKhalidi H, Steinbuch M Zoledronate, fractures, and mortality after hip fracture NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 358: (9) pp. 968968. ( 2008)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
130/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12346920] 167
* ColonEmeric CS, Lyles KW , Mesenbrink P Zoledronate, fractures, and mortality after hip fracture Reply NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 358: (9) pp. 968969. ( 2008) CA: HORIZON Recurrent Fracture Trial Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12346918]
168
W essel JH, Dodson TB, Zavras AI Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: A casecontrol study JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (ISSN: 02782391) 66: (4) pp. 625631. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346917]
169
GoldmanLevine J Zoledronic acid (reclast) for osteoporosis AMERICAN FAMILY PHYSICIAN (ISSN: 0002838X) 78: (4) pp. 508509. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346916]
170
Deeks ED, Perry CM Zoledronic Acid A Review of its Use in the Treatment of Osteoporosis DRUGS & AGING (ISSN: 1170229X) 25: (11) pp. 963986. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346915]
171
Brufsky AM Zoledronic acid for cancer therapyinduced and postmenopausal bone loss EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 9: (6) pp. 10131028. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346914]
172
Ringe JD, Nitschmann S Zoledronic acid for preventing fractures. HORIZON trial (Health Outcomes and Reduced Incidence with Zoledronic acid ONce yearly) INTERNIST (ISSN: 00209554) 49: (4) pp. 502504. ( 2008) Folyóiratcikk /Ismertetés /Tudományos [12346913]
173
Berenson JR, Yellin O, Boccia RV, Flam M, W ong SF, Batuman O, Moezi MM, W oytowitz D, Duvivier H, Nassir Y, Swift RA Zoledronic Acid Markedly Improves Bone Mineral Density for P atients with Monoclonal Gammopathy of Undetermined Significance and Bone Loss CLINICAL CANCER RESEARCH (ISSN: 10780432) 14: (19) pp. 62896295. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346912]
174
Hershman DL, McMahon DJ, Crew KD, Cremers S, Irani D, Cucchiara G, Brafman L, Shane E Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for earlystage breast cancer JOURNAL OF CLINICAL ONCOLOGY (ISSN: 0732183X) 26: (29) pp. 47394745. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [12346911]
175
Nuti R Zoledronic acid: A comprehensive approach to osteoporotic fractures OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 19: (11) pp. 16761676. ( 2008) Folyóiratcikk /Absztrakt /Tudományos [12346910]
176
Anonymus Chinese Journal of Orthopedics (ISSN: 02532352) 29: (7) pp. 690693. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [14598203]
177
* Black DM, Eastell R, Cosman F, McLellan A, Man Z, BucciRechtweg C, Mesenbrink P (P REMIER P OSTER AWARD CANDIDATE) EFFECT OF ONCEYEARLY ZOLEDRONIC ACID 5 MG ON 'SUP ER SIX' NONVERTEBRAL FRACTURES OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (Suppl. 4) pp. S281S281. ( 2009) Folyóiratcikk /Absztrakt /Tudományos [12346909]
178
* Lewiecki EM, Baim S, Bilezikian JP, Eastell R, LeBoff MS, Miller PD 2008 Santa Fe Bone Symposium: Update on Osteoporosis JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 12: (2) pp. 135157. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346908]
179
180
181
182
Huang J, Meixner L, Fernandez S, McCutchan JA A doubleblinded, randomized controlled trial of zoledronate therapy for HIVassociated osteopenia and osteoporosis AIDS (ISSN: 02699370) 23: (1) pp. 5157. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346907] * Eriksen EF ACHIEVING RAP Id AND SUSTAINED EFFICACY IN OSTEOP OROSIS CARE OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (Suppl. 1) pp. 180180. ( 2009) Folyóiratcikk /Absztrakt /Tudományos [12346906] Fauser BCJM, Mannaerts BMJL, Devroey P, Leader A, Boime I, Baird DT Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained folliclestimulating activity and reduced injection frequency HUMAN REPRODUCTION UPDATE (ISSN: 13554786) 15: (3) pp. 309321. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346905] * Boonen S ADVANCING STANDARDS IN OSTEOP OROSIS OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (Suppl. 1) pp. 179179. ( 2009) Folyóiratcikk /Absztrakt /Tudományos [12346904]
183
Kennel KA, Drake MT Adverse Effects of Bisphosphonates: Implications for Osteoporosis Management MAYO CLINIC PROCEEDINGS (ISSN: 00256196) 84: (7) pp. 632638. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346801]
184
KemenySuss N, Kasneci A, Rivas D, Afilalo J, Komarova SV, Chalifour LE, Duque G Alendronate affects calcium dynamics in cardiomyocytes in vitro VASCULAR PHARMACOLOGY (ISSN: 15371891) 51: (56) pp. 350358. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346800]
185
Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
131/342
3/30/2015
nyomtatobarat forma American Association of Oral and Maxillofacial Surgeons P osition P aper on BisphosphonateRelated Osteonecrosis of the Jaw2009 Update AUSTRALIAN ENDODONTIC JOURNAL (ISSN: 13291947) 35: (3) pp. 119130. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346799] 186
Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B American Association of Oral and Maxillofacial Surgeons P osition P aper on BisphosphonateRelated Osteonecrosis of the Jaws2009 Update JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (ISSN: 02782391) 67: (5) pp. 212. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346903]
187
Dunbar MJ, Howard A, Bogoch ER, Parvizi J, Kreder HJ An AOACOA Symposium Orthopaedics in 2020: P redictors of Musculoskeletal Need JOURNAL OF BONE AND JOINT SURGERYAMERICAN VOLUME (ISSN: 00219355) 91: (9) pp. 22762286. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346798]
188
Nochowitz B, Siegert S, W asik M An Update on Osteoporosis AMERICAN JOURNAL OF THERAPEUTICS (ISSN: 10752765) 16: (5) pp. 437445. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346797]
189
* Eriksen EF, Lyles KW , ColonEmeric CS, Pieper CF, Magaziner JS, Adachi JD, Hyldstrup L, Recknor C, Nordsletten L, Lavecchia C, Hu HL, Boonen S, Mesenbrink P Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 24: (7) pp. 13081313. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346796]
190
Hadji P Aromatase inhibitorassociated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (ISSN: 10408428) 69: (1) pp. 7382. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346902]
191
Baim S, Miller PD Assessing the Clinical Utility of Serum CTX in P ostmenopausal Osteoporosis and Its Use in P redicting Risk of Osteonecrosis of the Jaw JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 24: (4) pp. 561574. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346901]
192
Abrahamsen B, Eiken P, Brixen K Atrial fibrillation in fracture patients treated with oral bisphosphonates JOURNAL OF INTERNAL MEDICINE (ISSN: 09546820) 265: (5) pp. 581592. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346900]
193
Karsdal MA, Henriksen K, Leeming DJ, Mitchell P, Duffin K, Barascuk N, Klickstein L, Aggarwal P, Nemirovskiy O, Byrjalsen I, Qvist P, BayJensen AC, Dam EB, Madsen SH, Christiansen C Biochemical markers and the FDA Critical P ath: How biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development BIOMARKERS (ISSN: 1354750X) 14: (3) pp. 181202. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346899]
194
Migliorati Cesar Augusto BIP HOSP HONATES IN THE TREATMENT OF BONE METASTASES OSTEONECROSIS OF THE JAW In: Bone Metastases: A Translational and Clinical Approach. Springer, 2009. pp. 251262.
Könyvrészlet /Szaktanulmány /Tudományos [12426280] 195
Khan AA, Sandor GKB, Dore E, Morrison AD, Alsahli M, Amin F, Peters E, Hanley DA, Chaudry SR, Lentle B, Dempster DW , Glorieux FH, Neville AJ, Talwar RM, Clokie CM, Al Mardini M, Paul T, Khosla S, Josse RG, Sutherland S, Lam DK, Carmichael RP, Blanas N, Kendler D, Petak S, SteMarie LG, Brown J, Evans AW , Rios L, Compston JE Bisphosphonate Associated Osteonecrosis of the Jaw JOURNAL OF RHEUMATOLOGY (ISSN: 0315162X) 36: (3) pp. 478490. ( 2009) Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [12346898]
196
Makras P, Hamdy NAT, Zwinderman AH, Ballieux BEPB, Papapoulos SE Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis BONE (ISSN: 87563282) 44: (5) pp. 766771. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346897]
197
Papapetrou PD Bisphosphonateassociated adverse events HORMONESINTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM 8: (2) pp. 96110. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346896]
198
Lehrer S, Montazem A, Ramanathan L, PessinMinsley M, Pfail J, Stock RG, Kogan R BisphosphonateInduced Osteonecrosis of the Jaws, Bone Markers, and a Hypothesized Candidate Gene JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (ISSN: 02782391) 67: (1) pp. 159161. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346895]
199
Cardona F, Bagan JV, Sainz E, Figuerido J, Giner F, Vidan FJ Bisphosphonaterelated osteonecrosis of the jaws. An update ANALES DEL SISTEMA SANITARIO DE NAVARRA (ISSN: 11376627) 32: (3) pp. 423437. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346795]
200
Loke YK, Jeevanantham V, Singh S Bisphosphonates and Atrial Fibrillation Systematic Review and MetaAnalysis DRUG SAFETY (ISSN: 01145916) 32: (3) pp. 219228. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346894]
201
Mak A, Cheung MW L, Ho RCM, Cheak AAC, Lau CS Bisphosphonates and atrial fibrillation: Bayesian metaanalyses of randomized controlled trials and observational studies BMC MUSCULOSKELETAL DISORDERS (ISSN: 14712474) 10: P aper 113. (2009) Folyóiratcikk /Szakcikk /Tudományos [12346794]
202
Hollander JM, Mechanick JL Bisphosphonates and metabolic bone disease in the ICU CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (ISSN: 13631950) 12: (2) pp. 190195. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346893]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
132/342
3/30/2015
nyomtatobarat forma 203
Ashjazadeh N, Zamani A, Pourjafar M, Omrani GR Bone Density of Ambulatory Adult P atients Receiving Longterm Anticonvulsant Drug Therapy ARCHIVES OF IRANIAN MEDICINE (ISSN: 10292977) 12: (6) pp. 550554. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346793]
204
de Villiers TJ Bone health and osteoporosis in postmenopausal women BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY (ISSN: 15216934) 23: (1) pp. 7385. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346892]
205
Civitelli R, ArmamentoVillareal R, Napoli N Bone turnover markers: understanding their value in clinical trials and clinical practice OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (6) pp. 843851. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346891]
206
Burgess J, Raven E CALCIUM IN BIOLOGICAL SYSTEMS In: ADVANCES IN INORGANIC CHEMISTRY, VOL 61: METAL ION CONTROLLED REACTIVITY. (61) San Diego: Elsevier Academic Press, 2009. (ISBN 9780123750334) pp. 251366. (Advances in Inorganic Chemistry )
Könyvrészlet /Szaktanulmány /Tudományos [12346890] 207
Kayan K, Johansson H, Oden A, Vasireddy S, Pande K, Orgee J, Kanis JA, McCloskey EV Can fall risk be incorporated into fracture risk assessment algorithms: a pilot study of responsiveness to clodronate OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (12) pp. 20552061. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346792]
208
Brown SA, Guise TA Cancer TreatmentRelated Bone Disease CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (ISSN: 10454403) 19: (1) pp. 4760. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346889]
209
Raj SR, Stein CM, Saavedra PJ, Roden DM Cardiovascular Effects of Noncardiovascular Drugs CIRCULATION (ISSN: 00097322) 120: (12) pp. 11231132. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346791]
210
Arabmotlagh M, Pilz M, W arzecha J, Rauschmann M Changes of Femoral P eriprosthetic Bone Mineral Density 6 Years after Treatment with Alendronate following Total Hip Arthroplasty JOURNAL OF ORTHOPAEDIC RESEARCH (ISSN: 07360266) 27: (2) pp. 183188. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346888]
211
W ukich DK, Sung W J Charcot arthropathy of the foot and ankle: modern concepts and management review JOURNAL OF DIABETES AND ITS COMPLICATIONS (ISSN: 10568727) 23: (6) pp. 409426. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346790]
212
Compston J Clinical and therapeutic aspects of osteoporosis EUROPEAN JOURNAL OF RADIOLOGY (ISSN: 0720048X) 71: (3) pp. 388391. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346789]
213
Nanes MS, Kallen CB Clinical assessment of fracture risk and novel therapeutic strategies to combat osteoporosis FERTILITY AND STERILITY (ISSN: 00150282) 92: (2) pp. 403412. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346788]
214
Doggrell SA Clinical efficacy and safety of zoledronic acid in prostate and breast cancer EXPERT REVIEW OF ANTICANCER THERAPY (ISSN: 14737140) 9: (9) pp. 12111218. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346787]
215
Frediani B, Cavalieri L, Cremonesi G Clodronic Acid Formulations Available in Europe and their Use in Osteoporosis A Review CLINICAL DRUG INVESTIGATION (ISSN: 11732563) 29: (6) pp. 359379. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346887]
216
Greiner S, KadowRomacker A, Schmidmaier G, W ildemann B Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L lactide) implant coating JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (ISSN: 15493296) 91A: (1) pp. 288295. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346786]
217
Poole K Comment on: Hypovitaminosis D among rheumatology outpatients in clinical practice: reply RHEUMATOLOGY (ISSN: 14620324) 48: (2) pp. 204204. ( 2009) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12346886]
218
Sebba A Comparing nonvertebral fracture risk reduction with osteoporosis therapies: looking beneath the surface OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (5) pp. 675686. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346885]
219
Rozental TD, Vazquez MA, Chacko AT, Ayogu N, Bouxsein ML Comparison of Radiographic Fracture Healing in the Distal Radius for P atients on and off Bisphosphonate Therapy JOURNAL OF HAND SURGERYAMERICAN VOLUME (ISSN: 03635023) 34A: (4) pp. 595602. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346884]
220
Brown JP, Prince RL, Deal C, Recker RR, Kiel DP, de Gregorio LH, Hadji P, Hofbauer LC, AlvaroGracia JM, W ang H, Austin M, W agman RB, Newmark R, Libanati C, Martin JS, Bone HG Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in P ostmenopausal Women With Low Bone Mass: A Randomized, Blinded, P hase 3 Trial JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 24: (1) pp. 153161. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346883]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
133/342
3/30/2015
nyomtatobarat forma 221
Ferrari S Continuous broad protection against osteoporotic fractures with strontium ranelate RHEUMATOLOGY (ISSN: 14620324) 48: (Suppl. 4) pp. IV20IV24. ( 2009) Folyóiratcikk /Konferenciaközlemény /Tudományos [12346785]
222
Restrepo Valencia César Augusto, Manjarrés Iglesias Gilberto Controversia en relación con el uso de bifosfonatos en pacientes con enfermedad renal: Controversy about the use of bisphosphonates in patients with kidney disease Acta Medica Colombiana (ISSN: 01202448) 34: (4) pp. 176184. ( 2009) Folyóiratcikk [14598166]
223
Kwon YD, Kim DY, Ohe JY, Yoo JY, W alter C Correlation Between Serum CTerminal CrossLinking Telopeptide of Type I Collagen and Staging of Oral Bisphosphonate Related Osteonecrosis of the Jaws JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (ISSN: 02782391) 67: (12) pp. 26442648. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346784]
224
Blake GM, Compston JE, Fogelman I Could Strontium Ranelate Have a Synergistic Role in the Treatment of Osteoporosis? JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 24: (8) pp. 13541357. ( 2009) Folyóiratcikk /Ismertetés /Tudományos [12346783]
225
Lorenc RS, Misiorowski W , Karczmarewicz E Critical points in strategies for the diagnosis and treatment of osteoporosis ENDOKRYNOLOGIA POLSKA (ISSN: 0423104X) 60: (2) pp. 124133. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346882]
226
Kamath AF Current Controversies in Bisphosphonate Therapy ORTHOPEDICS (ISSN: 01477447) 32: (7) pp. 473475. ( 2009) Folyóiratcikk /Ismertetés /Tudományos [12346782]
227
Sebba A CURRENT CONTROVERSIES IN OSTEOP OROSIS MANAGEMENT OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (Suppl. 1) pp. 183183. ( 2009) Folyóiratcikk /Absztrakt /Tudományos [12346881]
228
O'Sullivan S, Horne A, W attie D, Porteous F, Callon K, Gamble G, Ebeling P, Browett P, Grey A Decreased Bone Turnover Despite P ersistent Secondary Hyperparathyroidism during P rolonged Treatment with Imatinib JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 94: (4) pp. 11311136. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346879]
229
* Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, W ang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C Denosumab for P revention of Fractures in P ostmenopausal Women with Osteoporosis NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 361: (8) pp. 756765. ( 2009) CA: FREEDOM Trial Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [12346781]
230
Horning Kristin K, Hegge Karly A, Bottenerg Michelle M Denosumab: A Novel Agent For Osteoporosis Journal of Pharmacy Technology 25: (2) pp. 9499. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12426269]
231
Brouwers JEM, Ruchelsman M, van Rietbergen B, Bouxsein ML Determination of rat vertebral bone compressive fatigue properties in untreated intact rats and zoledronicacidtreated, ovariectomized rats OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (8) pp. 13771384. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346780]
232
Lash RW , Nicholson JM, Velez L, Van Harrison R, McCort J Diagnosis and Management of Osteoporosis PRIMARY CARE (ISSN: 00954543) 36: (1) pp. 181198. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346878]
233
Vondracek SF, Linnebur SA Diagnosis and management of osteoporosis in the older senior CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 4: pp. 121136. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346877]
234
Sweet MG, Sweet JM, Jeremiah MP, Galazka SS Diagnosis and Treatment of Osteoporosis AMERICAN FAMILY PHYSICIAN (ISSN: 0002838X) 79: (3) pp. 193200. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346876]
235
Miller PD Diagnosis and Treatment of Osteoporosis in Chronic Renal Disease SEMINARS IN NEPHROLOGY (ISSN: 02709295) 29: (2) pp. 144155. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346875]
236
Ringe JD, Moller G Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1year results of a retrospective patient chart review analysis RHEUMATOLOGY INTERNATIONAL (ISSN: 01728172) 30: (2) pp. 213221. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346779]
237
Lespessailles E, Jaffre C, Beaupied H, Nanyan P, Dolleans E, Benhamou C, Courteix D Does Exercise Modify the Effects of Zoledronic Acid on Bone Mass, Microarchitecture, Biomechanics, and Turnover in Ovariectomized Rats? CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 85: (2) pp. 146157. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346778]
238
Bart R, Bartl C, Gradinger R Druginduced osteopathies. Drugs, pathogenesis, forms, diagnosis, prevention and therapy ORTHOPADE (ISSN: 00854530) 38: (12) pp. 12451260. ( 2009)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
134/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [12346777] 239
Chlebowski RT, Tagawa T Early Breast and P rostate Cancer and Clinical Outcomes (Fracture) ONCOLOGYNEW YORK (ISSN: 08909091) 23: (14) pp. 1620. ( 2009) Suppl. 5 Folyóiratcikk /Szakcikk /Tudományos [12346776]
240
Matsumoto T, Hagino H, Shiraki M, Fukunaga M, Nakano T, Takaoka K, Morii H, Ohashi Y, Nakamura T Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebocontrolled doubleblind study OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (8) pp. 14291437. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346775]
241
* Black DM, Eastell R, Cosman F, Man Z, BucciRechtweg C, Mesenbrink P Effect of onceyearly zoledronic acid 5 mg on 'Super Six' nonvertebral fractures BONE (ISSN: 87563282) 44: (Suppl. 2) pp. S429S429. ( 2009) Folyóiratcikk /Absztrakt /Tudományos [12346874]
242
* Eastell R, Black DM, Boonen S, Adami S, Felsenberg D, Lippuner K, Cummings SR, Delmas PD, Palermo L, Mesenbrink P, Cauley JA Effect of OnceYearly Zoledronic Acid Five Milligrams on Fracture Risk and Change in Femoral Neck Bone Mineral Density JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 94: (9) pp. 32153225. ( 2009) CA: HORIZON Pivotal Fracture Trial Folyóiratcikk /Szakcikk /Tudományos [12346774]
243
Feldstein AC, W eycker D, Nichols GA, Oster G, Rosales G, Boardman DL, Perrin N Effectiveness of bisphosphonate therapy in a community setting BONE (ISSN: 87563282) 44: (1) pp. 153159. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346873]
244
Noa M, Mas R, Mendoza S, Valle M, Mendoza N, Goicochea E Effects Of D003, a Mixture of HighMolecular Weight Aliphatic Acids from Sugarcane Wax, and Omega3 Fatty Acids on Bones of Ovariectomized Rats LATIN AMERICAN JOURNAL OF PHARMACY (ISSN: 03262383) 28: (5) pp. 728733. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346773]
245
* Delmas PD, Munoz F, Black DM, Cosman F, Boonen S, W atts NB, Kendler D, Eriksen EF, Mesenbrink PG, Eastell R Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of P INP With Fracture Reduction in P ostmenopausal Women With Osteoporosis JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 24: (9) pp. 15441551. ( 2009) CA: HORIZONPFT Res Grp Folyóiratcikk /Szakcikk /Tudományos [12346772]
246
Inderjeeth CA, Foo ACH, Lai MMY, Glendenning P Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: Review of the evidence BONE (ISSN: 87563282) 44: (5) pp. 744751. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346872]
247
Rackoff P Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 4: pp. 207214. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346871]
248
Bilezikian JP Efficacy of Bisphosphonates in Reducing Fracture Risk in P ostmenopausal Osteoporosis AMERICAN JOURNAL OF MEDICINE (ISSN: 00029343) 122: (2) pp. S14S21. ( 2009) Suppl. Folyóiratcikk /Szakcikk /Tudományos [12346870]
249
Lewiecki EM Emerging drugs for postmenopausal osteoporosis EXPERT OPINION ON EMERGING DRUGS (ISSN: 14728214) 14: (1) pp. 129144. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346869]
250
* Glover SJ, Gall MT, SchoenbornKellenberger O, W agener M, Garnero P, Boonen S, Cauley JA, Black DM, Delmas PD, Eastell R Establishing a Reference Interval for Bone Turnover Markers in 637 Healthy, Young, P remenopausal Women From the United Kingdom, France, Belgium, and the United States JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 24: (3) pp. 389397. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346868]
251
Lewiecki EM, Binkley N EVIDENCEBASED MEDICINE, CLINICAL P RACTICE GUIDELINES, AND COMMON SENSE IN THE MANAGEMENT OF OSTEOP OROSIS ENDOCRINE PRACTICE (ISSN: 1530891X) 15: (6) pp. 573579. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346771]
252
Henriquez MS, Romero MJGD Evidenced based medicine and drugs approved for the treatment of osteoporosis. Role of calcium and vitamin D REVISTA CLINICA ESPANOLA (ISSN: 00142565) 209: (1) pp. 2536. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346867]
253
MessingerRapport B, Dumas LG Falls in the Nursing Home: A Collaborative Approach NURSING CLINICS OF NORTH AMERICA (ISSN: 00296465) 44: (2) pp. 187195. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346866]
254
Ayazpoor U First ortho trauma update Comprehensive advanced education over 2 days ORTHOPADE (ISSN: 00854530) 38: (8) pp. 771773. ( 2009) Folyóiratcikk /Ismertetés /Tudományos [12346770]
255
Ayazpoor U First OrthoTraumaUpdateSeminar Comprehensive training about 2 days UNFALLCHIRURG (ISSN: 01775537) 112: (8) pp. 749752. ( 2009)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
135/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [12346769] 256
Sundaram M Founders lecture 2007 Metabolic bone disease: what has changed in 30 years? SKELETAL RADIOLOGY (ISSN: 03642348) 38: (9) pp. 841853. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346768]
257
Miller PD Fragility fractures in chronic kidney disease: An opinionbased approach CLEVELAND CLINIC JOURNAL OF MEDICINE (ISSN: 08911150) 76: (12) pp. 715723. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346767]
258
Ng K W Future Developments in Osteoporosis Therapy Endocrine Metabolic & Immune DisordersDrug Targets 9: (4) pp. 371384. ( 2009) BIOSIS Citation Index alapján. Folyóiratcikk /Ismertetés /Tudományos [12426268]
259
Gennari L, Bilezikian JP Glucocorticoidinduced osteoporosis: hope on the HORIZON LANCET (ISSN: 01406736) 373: (9671) pp. 12251226. ( 2009) Folyóiratcikk /Ismertetés /Tudományos [12346865]
260
Doggrell SA Good clinical endpoints with denosumab in osteoporosis and cancer EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 10: (17) pp. 29392943. ( 2009) Folyóiratcikk /Ismertetés /Tudományos [12346766]
261
Ryg P, Rejnmark L, Overgaard S, Brixen K, Vestergaard P Hip Fracture P atients at Risk of Second Hip Fracture: A Nationwide P opulationBased Cohort Study of 169,145 Cases During 19772001 JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 24: (7) pp. 12991307. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346764]
262
Roux C HOW IS SAFETY OF THERAP Y A DETERMINANT IN LONGTERM MANAGEMENT OF OSTEOP OROSIS? OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (Suppl. 1) pp. 185185. ( 2009) Folyóiratcikk /Absztrakt /Tudományos [12346864]
263
Tremollieres F, Pouilles JM, Ribot C How to prevent early postmenopausal fracture risk? P roposition of a strategy GYNECOLOGIE OBSTETRIQUE & FERTILITE (ISSN: 12979589) 37: (1) pp. 5056. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346863]
264
Sebba AI, Emkey RD, Kohles JD, Sambrook PN Ibandronate dose response is associated with increases in bone mineral density and reductions in clinical fractures: Results of a metaanalysis BONE (ISSN: 87563282) 44: (3) pp. 423427. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346862]
265
Li W J, Kornak J, Harris T, Keyak J, Li CX, Lu Y, Cheng XG, Lang T Identify fracturecritical regions inside the proximal femur using statistical parametric mapping BONE (ISSN: 87563282) 44: (4) pp. 596602. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346861]
266
Hines SL, Mincey B, Dentchev T, Sloan JA, Perez EA, Johnson DB, Schaefer PL, Alberts S, Liu HS, Kahanic S, Mazurczak MA, Nikcevich DA, Loprinzi CL Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifenN03CC BREAST CANCER RESEARCH AND TREATMENT (ISSN: 01676806) 117: (3) pp. 603609. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346762]
267
Kase NG Impact of Hormone Therapy for Women Aged 35 to 65 Years, From Contraception to Hormone Replacement GENDER MEDICINE (ISSN: 15508579) 6: (P art 1) pp. 3759. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346860]
268
Siris ES, Selby PL, Saag KG, Borgstrom F, Herings RMC, Silverman SL Impact of Osteoporosis Treatment Adherence on Fracture Rates in North America and Europe AMERICAN JOURNAL OF MEDICINE (ISSN: 00029343) 122: (2) pp. 313. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346859]
269
* Boonen S Impact of treatment efficacy and dosing frequency on costeffectiveness of bisphosphonate treatment for osteoporosis: a perspective CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 25: (10) pp. 23352341. ( 2009) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12346761]
270
Strom O, Borgstrom F, Kanis J, Jonsson B Incorporating adherence into health economic modelling of osteoporosis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (1) pp. 2334. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346858]
271
Khosla S Increasing Options for the Treatment of Osteoporosis NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 361: (8) pp. 818820. ( 2009) Folyóiratcikk /Ismertetés /Tudományos [12346760]
272
Dodson TB Intravenous Bisphosphonate Therapy and BisphosphonateRelated Osteonecrosis of the Jaws JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (ISSN: 02782391) 67: (5) pp. 4452. ( 2009) Suppl. Folyóiratcikk /Szakcikk /Tudományos [12346857]
273
Chapman I, Greville H, Ebeling PR, King SJ, Kotsimbos T, Nugent P, Player R, Topliss DJ, W arner J, W ilson JW Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
136/342
3/30/2015
nyomtatobarat forma CLINICAL ENDOCRINOLOGY (ISSN: 03000664) 70: (6) pp. 838846. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346759] 274
Bhoopalam N, Campbell SC, Moritz T, Broderick W R, Iyer P, Arcenas AG, Van Veldhuizen PJ, Friedman N, Reda D, W arren S, Garewal H Intravenous Zoledronic Acid to P revent Osteoporosis in a Veteran P opulation With Multiple Risk Factors for Bone Loss on Androgen Deprivation Therapy JOURNAL OF UROLOGY (ISSN: 00225347) 182: (5) pp. 22572264. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346758]
275
Leeming DJ, Henriksen K, Byrjalsen I, Qvist P, Madsen SH, Garnero P, Karsdal MA Is bone quality associated with collagen age? OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (9) pp. 14611470. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346757]
276
Zamani A, Omrani GR, Nasab MM Lithium's effect on bone mineral density BONE (ISSN: 87563282) 44: (2) pp. 331334. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346856]
277
Bobyn JD, McKenzie K, Karabasz D, Krygier JJ, Tanzer M Locally Delivered Bisphosphonate for Enhancement of Bone Formation and Implant Fixation JOURNAL OF BONE AND JOINT SURGERYAMERICAN VOLUME (ISSN: 00219355) 91: (Suppl. 6) pp. 2331. ( 2009) Folyóiratcikk /Konferenciaközlemény /Tudományos [12346756]
278
Kuehn BM Longterm Risks of Bisphosphonates P robed JAMAJOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (ISSN: 00987484) 301: (7) pp. 710711. ( 2009) Folyóiratcikk /Ismertetés /Tudományos [12346855]
279
IngLorenzini K, Desmeules J, Plachta O, Suva D, Dayer P, Peter R LowEnergy Femoral Fractures Associated with the LongTerm Use of Bisphosphonates A Case Series from a Swiss University Hospital DRUG SAFETY (ISSN: 01145916) 32: (9) pp. 775785. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346854]
280
Gnant M, Dubsky P, Fitzal F, Blaha P, Schoppmann S, Steger G, Marth C, Samonigg H, Huttner K, Fohler H, Ruecklinger E, Jakesz R, Greil R Maintaining Bone Density in P atients Undergoing Treatment for Breast Cancer: Is There an Adjuvant Benefit? CLINICAL BREAST CANCER (ISSN: 15268209) 9: (Suppl. 1) pp. S18S27. ( 2009) CA: Austrian Breast Colorectal Canc St Folyóiratcikk /Szakcikk /Tudományos [12346853]
281
Mohile SG, Mustian K, Bylow K, Hall W , Dale W Management of complications of androgen deprivation therapy in the older man CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (ISSN: 10408428) 70: (3) pp. 235255. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346852]
282
W arriner AH, Outman RC, Saag KG, Berry SD, ColonEmeric C, Flood KL, Lyles KW , Tanner SB, W atts NB, Curtis JR Management of Osteoporosis Among Home Health and LongTerm Care P atients with a P rior Fracture SOUTHERN MEDICAL JOURNAL (ISSN: 00384348) 102: (4) pp. 397404. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346851]
283
Piper PK, Gruntmanis U Management of osteoporosis in the aging male: Focus on zoledronic acid CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 4: pp. 289303. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346850]
284
Rizzoli R, Bruyere O, CannataAndia JB, Devogelaer JP, Lyritis G, Ringe JD, Vellas B, Reginster JY Management of osteoporosis in the elderly CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 25: (10) pp. 23732387. ( 2009) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12346755]
285
Kirazli Y Medical Treatment in P atients with Osteoporotic Hip Fracture TURKIYE FIZIKSEL TIP VE REHABILITASYON DERGISITURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION 55: pp. 4650. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346849]
286
Verhaar HJJ Medical treatment of osteoporosis in the elderly AGING CLINICAL AND EXPERIMENTAL RESEARCH (ISSN: 15940667) 21: (6) pp. 407413. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346754]
287
Ebeling PR METABOLIC BONE DISEASES Translational researchpreventing fractures with denosumab NATURE REVIEWS RHEUMATOLOGY (ISSN: 17594790) 5: (12) pp. 660661. ( 2009) Folyóiratcikk /Ismertetés /Tudományos [12346753]
288
Compston J Monitoring osteoporosis treatment BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (ISSN: 15216942) 23: (6) pp. 781788. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346752]
289
Clarke BL New and emerging treatments for osteoporosis CLINICAL ENDOCRINOLOGY (ISSN: 03000664) 71: (3) pp. 309321. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346751]
290
Doggrell SA New findings with old drugs for osteoporosis EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 10: (3) pp. 513516. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346848]
291
Demontiero O, Duque G Onceyearly zoledronic acid in hip fracture prevention
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
137/342
3/30/2015
nyomtatobarat forma CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 4: pp. 153164. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346847] 292
* Yang L, Sycheva AV, Palermo L, Black DM, Eastell R Onceyearly zoledronic acid increases the proximal femur strength as assessed by finite element analysis of QCT scans BONE (ISSN: 87563282) 44: (Suppl. 2) pp. S225S225. ( 2009) Folyóiratcikk /Absztrakt /Tudományos [12346846]
293
Zahrowski JJ Optimizing orthodontic treatment in patients taking bisphosphonates for osteoporosis AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS (ISSN: 08895406) 135: (3) pp. 361 374. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346845]
294
Grosso A, Douglas I, Hingorani A, MacAllister R, Smeeth L Oral Bisphosphonates and Risk of Atrial Fibrillation and Flutter in Women: A SelfControlled CaseSeries Safety Analysis PLOS ONE (ISSN: 19326203) 4: (3) P aper e4720. (2009) Folyóiratcikk /Szakcikk /Tudományos [12346844]
295
Assael LA Oral Bisphosphonates as a Cause of BisphosphonateRelated Osteonecrosis of the Jaws: Clinical Findings, Assessment of Risks, and P reventive Strategies JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (ISSN: 02782391) 67: (5) pp. 3543. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346843]
296
Sedghizadeh PP ORAL BISP HOSP HONATES Response JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (ISSN: 00028177) 140: (5) pp. 518519. ( 2009) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12346842]
297
Junquera L, Gallego L, Pelaz A, Olay S Oral bisphosphonatesassociated osteonecrosis in rheumatoid arthritis MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL (ISSN: 16984447) 14: (6) pp. E292E294. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346841]
298
* Reid IR Osteonecrosis of the jaw Who gets it, and why? BONE (ISSN: 87563282) 44: (1) pp. 410. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346840]
299
Silverman SL, Landesberg R Osteonecrosis of the Jaw and the Role of Bisphosphonates: A Critical Review AMERICAN JOURNAL OF MEDICINE (ISSN: 00029343) 122: (2) pp. 3345. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346839]
300
Dell RM, Greene D, Anderson D, W illiams K Osteoporosis Disease Management: What Every Orthopedic Surgeon Should Know JOURNAL OF BONE AND JOINT SURGERYAMERICAN VOLUME (ISSN: 00219355) 91: (Suppl. 6) pp. 7986. ( 2009) Folyóiratcikk /Konferenciaközlemény /Tudományos [12346750]
301
* Boonen S, Kay R, Cooper C, Haentjens P, Vanderschueren D, Callewaert F, Milisen K, Ferrari S Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ISSN: 13685031) 63: (12) pp. 17921804. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346749]
302
Solomon DH, Rekedal L, Cadarette SM Osteoporosis treatments and adverse events CURRENT OPINION IN RHEUMATOLOGY (ISSN: 10408711) 21: (4) pp. 363368. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346748]
303
Switzer JA, Jaglal S, Bogoch ER Overcoming Barriers to Osteoporosis Care in Vulnerable Elderly P atients With Hip Fractures JOURNAL OF ORTHOPAEDIC TRAUMA (ISSN: 08905339) 23: (6) pp. 454459. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346747]
304
Gennari L, Merlotti D, Nuti R P ERSP ECTIVES IN THE TREATMENT AND P REVENTION OF OSTEOP OROSIS DRUGS OF TODAY (ISSN: 16993993) 45: (8) pp. 629647. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346746]
305
Rabenda V, Hiligsmann M, Reginster JY P oor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 10: (14) pp. 23032315. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346745]
306
NurmiLuthje I, Luthje P, Kaukonen JP, Kataja M, Kuurne S, Naboulsi H, Karjalainen K P ostFracture P rescribed Calcium and Vitamin D Supplements Alone or, in Females, with Concomitant AntiOsteoporotic Drugs is Associated with Lower Mortality in Elderly Hip Fracture P atients A P rospective Analysis DRUGS & AGING (ISSN: 1170229X) 26: (5) pp. 409421. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346838]
307
Thomas T P ostmenopausal osteoporosis: Current management of the disease MEDECINE NUCLEAIREIMAGERIE FONCTIONNELLE ET METABOLIQUE 33: (1) pp. 26. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346837]
308
Duque G, Demontiero O, Troen BR P revention and treatment of senile osteoporosis and hip fractures MINERVA MEDICA (ISSN: 00264806) 100: (1) pp. 7994. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346836]
309
Rahmani P, Morin S P revention of osteoporosisrelated fractures among postmenopausal women and older men CANADIAN MEDICAL ASSOCIATION JOURNAL (ISSN: 08203946) 181: (11) pp. 815820. ( 2009)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
138/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Összefoglaló cikk /Tudományos [12346744] 310
Jansen JP, Bergman GJD, Huels J, Olson M P revention of vertebral fractures in osteoporosis: mixed treatment comparison of bisphosphonate therapies CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 25: (8) pp. 18611868. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346743]
311
Bonura F P revention, Screening, and Management of Osteoporosis: An Overview of the Current Strategies POSTGRADUATE MEDICINE (ISSN: 00325481) 121: (4) pp. 517. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346742]
312
Saag KG, Geusens P P rogress in osteoporosis and fracture prevention: focus on postmenopausal women ARTHRITIS RESEARCH & THERAPY (ISSN: 14786354) 11: (5) P aper 251. (2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346835]
313
Ebert R, Zeck S, Krug R, MeissnerW eigl J, Schneider D, Seefried L, Eulert J, Jakob F P ulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiation BONE (ISSN: 87563282) 44: (5) pp. 858864. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346834]
314
Blake GM, Frost ML, Fogelman I Quantitative Radionuclide Studies of Bone JOURNAL OF NUCLEAR MEDICINE (ISSN: 01615505) 50: (11) pp. 17471750. ( 2009) Folyóiratcikk /Ismertetés /Tudományos [12346741]
315
Blake GM, Moore AEB, Fogelman I Quantitative Studies of Bone Using Tc99mMethylene Diphosphonate Skeletal P lasma Clearance SEMINARS IN NUCLEAR MEDICINE (ISSN: 00012998) 39: (6) pp. 369379. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346740]
316
Grados F, Fechtenbaum J, Flipon E, Kolta S, Roux C, Fardellone P Radiographic methods for evaluating osteoporotic vertebral fractures JOINT BONE SPINE (ISSN: 1297319X) 76: (3) pp. 241247. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346833]
317
Compston J Recent advances in the management of osteoporosis CLINICAL MEDICINE (ISSN: 14702118) 9: (6) pp. 565569. ( 2009) Folyóiratcikk /Ismertetés /Tudományos [12346739]
318
Ferran P, MassaAuvray L, Mathivas N, Tessaire J, Gligorov J, Krakowski I, Luporsi E, Namer M Recommendations for clinical practice in healthcare support, Nice, SaintP auldeVence 2009 "breast cancers" and "support care" ONCOLOGIE (ISSN: 12923818) 11: (12) pp. 612793. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346738]
319
Masud T, McClung M, Geusens P Reducing hip fracture risk with risedronate in elderly women with established osteoporosis CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 4: pp. 445449. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346832]
320
Bunch TJ, Anderson JL, May HT, Muhlestein JB, Home BD, Crandall BG, W eiss JP, Lappe DL, Osborn JS, Day JD Relation of Bisphosphonate Therapies and Risk of Developing Atrial Fibrillation AMERICAN JOURNAL OF CARDIOLOGY (ISSN: 00029149) 103: (6) pp. 824828. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346831]
321
Gates BJ, Sonnett TE, DuVall CAK, Dobbins EK Review of Osteoporosis P harmacotherapy for Geriatric P atients AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (ISSN: 15435946) 7: (6) pp. 293323. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346737]
322
Iwamoto J, Sato Y, Takeda T, Matsumoto H Role of sport and exercise in the maintenance of female bone health JOURNAL OF BONE AND MINERAL METABOLISM (ISSN: 09148779) 27: (5) pp. 530537. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346736]
323
Recker RR, Lewiecki EM, Miller PD, Reiffel J Safety of Bisphosphonates in the Treatment of Osteoporosis AMERICAN JOURNAL OF MEDICINE (ISSN: 00029343) 122: (2) pp. 2232. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346830]
324
Stubbs B, ZapataBravo E, Haw C Screening for osteoporosis: a survey of older psychiatric inpatients at a tertiary referral centre INTERNATIONAL PSYCHOGERIATRICS (ISSN: 10416102) 21: (1) pp. 180186. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346829]
325
Napiorkowska L, Franek E Senile osteoporosis ENDOKRYNOLOGIA POLSKA (ISSN: 0423104X) 60: (2) pp. 110114. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346828]
326
Matzno S, Nishiguchi T, Akiyoshi T, Anami S, Nakabayashi T, Matsuyama K Synergistic action of statins and nitrogencontaining bisphosphonates in the development of rhabdomyolysis in L6 rat skeletal myoblasts JOURNAL OF PHARMACY AND PHARMACOLOGY (ISSN: 00223573) 61: (6) pp. 781788. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346827]
327
* Prevrhal S, Krege JH, Chen P, Genant H, Black DM Teriparatide vertebral fracture risk reduction determined by quantitative and qualitative radiographic assessment CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 25: (4) pp. 921928. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346826]
328
* Grey A, Bolland MJ, W attie D, Horne A, Gamble G, Reid IR The Antiresorptive Effects of a Single Dose of Zoledronate P ersist for Two Years: A Randomized, P laceboControlled Trial in
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
139/342
3/30/2015
nyomtatobarat forma Osteopenic P ostmenopausal Women JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 94: (2) pp. 538544. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346825] 329
McClung M The clinical and epidemiologic consequences of redefining treatment criteria: Who should be treated? SALUD PUBLICA DE MEXICO (ISSN: 00363634) 51: (Suppl. 1) pp. S46S51. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346824]
330
Blake GM, Fogelman I The clinical role of dual energy Xray absorptiometry EUROPEAN JOURNAL OF RADIOLOGY (ISSN: 0720048X) 71: (3) pp. 406414. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346735]
331
Gnant M The evolving role of zoledronic acid in early breast cancer ONCOTARGETS AND THERAPY (ISSN: 11786930) 2: pp. 95104. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346823]
332
Curtis JR, Laster A, Becker DJ, Carbone L, Gary LC, Kilgore ML, Matthews RS, Morrisey MA, Saag KG, Tanner SB, Delzell E The geographic availability and associated utilization of dualenergy Xray absorptiometry (DXA) testing among older persons in the United States OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (9) pp. 15531561. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346734]
333
Rietbrock S, Olson M, van Staa TP The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates QJMAN INTERNATIONAL JOURNAL OF MEDICINE (ISSN: 14602725) 102: (1) pp. 3542. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346822]
334
Gennari L, Merlotti D, Mossetti G, Rendina D, De Paola V, Martini G, Nuti R The Use of Intravenous Aminobisphosphonates for the Treatment of P aget's Disease of Bone MINIREVIEWS IN MEDICINAL CHEMISTRY (ISSN: 13895575) 9: (9) pp. 10521063. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346821]
335
* Cosman F TREATMENT OF OSTEOP OROSIS AND P REVENTION OF NEW FRACTURES: ROLE OF INTRAVENOUSLY ADMINISTERED BISP HOSP HONATES ENDOCRINE PRACTICE (ISSN: 1530891X) 15: (5) pp. 483493. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346733]
336
Carmona R, Adachi R Treatment of postmenopausal osteoporosis, patient perspectives focus on once yearly zoledronic acid PATIENT PREFERENCE AND ADHERENCE (ISSN: 1177889X) 3: pp. 189193. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346820]
337
Eekman DA, Vis M, Bultink IEM, Derikx HJGM, Dijkmans BAC, Lems W F Treatment with intravenous pamidronate is a good alternative in case of gastrointestinal side effects or contraindications for oral bisphosphonates BMC MUSCULOSKELETAL DISORDERS (ISSN: 14712474) 10: P aper 86. (2009) Folyóiratcikk /Szakcikk /Tudományos [12346732]
338
Farley JF, Blalock SJ Trends and determinants of prescription medication use for treatment of osteoporosis AMERICAN JOURNAL OF HEALTHSYSTEM PHARMACY (ISSN: 10792082) 66: (13) pp. 11911201. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346731]
339
Luthje P, NurmiLuthje I, Kaukonen JP, Kuurne S, Naboulsi H, Kataja M Undertreatment of osteoporosis following hip fracture in the elderly ARCHIVES OF GERONTOLOGY AND GERIATRICS (ISSN: 01674943) 49: (1) pp. 153157. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346730]
340
Epstein S, Jeglitsch M, McCloskey E Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 25: (12) pp. 29512960. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346729]
341
Shima Y, Engebretsen L, Iwasa J, Kitaoka K, Tomita K Use of bisphosphonates for the treatment of stress fractures in athletes KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY (ISSN: 09422056) 17: (5) pp. 542550. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346819]
342
Ringe JD, Fardellone P, Kruse HP, Amling M, van der Geest SAP, Moller G Value of a New FixedCombination P ack of Bisphosphonate, Calcium and Vitamin D in the Therapy of Osteoporosis Results of Two Quantitative P atient Research Studies DRUGS & AGING (ISSN: 1170229X) 26: (3) pp. 241253. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346818]
343
Franek E, W ichrowska H, Gozdowski D, PuzianowskaKuznicka M WHO fracture risk calculator (FRAX (TM)) in the assessment of obese patients with osteoporosis ENDOKRYNOLOGIA POLSKA (ISSN: 0423104X) 60: (2) pp. 8287. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346817]
344
Cruz M Why do we close our eyes while the world is falling? A study on proximal femur osteoporotic fractures in a P ortuguese population ACTA REUMATOLOGICA PORTUGUESA (ISSN: 0303464X) 34: (2B) pp. 370377. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346816]
345
HANG Xiaomei, LIU Zhonghou Zoledronate and osteoporosis Chinese Journal of Osteoporosis (ISSN: 10067108) 15: (11) pp. 857863,867. ( 2009)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
140/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Összefoglaló cikk /Tudományos [14598201] 346
Coleman RE Zoledronic acid ameliorates the effects of endocrine therapy on bone health in women with earlystage breast cancer NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM 5: (2) pp. 7273. ( 2009) Folyóiratcikk /Ismertetés /Tudományos [12346815]
347
* Reid DM, Devogelaer JP, Saag K, Roux C, Lau CS, Reginster JY, Papanastasiou P, Ferreira A, Hartl F, Fashola T, Mesenbrink P, Sambrook PN Zoledronic acid and risedronate in the prevention and treatment of glucocorticoidinduced osteoporosis (HORIZON): a multicentre, doubleblind, doubledummy, randomised controlled trial LANCET (ISSN: 01406736) 373: (9671) pp. 12531263. ( 2009) CA: HORIZON Investigators Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [12346814]
348
* McClung M, Miller P, Recknor C, Mesenbrink P, BucciRechtweg C, Benhamou CL Zoledronic Acid for the P revention of Bone Loss in P ostmenopausal Women With Low Bone Mass A Randomized Controlled Trial OBSTETRICS AND GYNECOLOGY (ISSN: 00297844) 114: (5) pp. 9991007. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12346728]
349
Le Goff B, Guillot P, Glemarec J, Berthelot JM, Maugars Y A Comparison Between Bisphosphonates and Other Treatments for Osteoporosis CURRENT PHARMACEUTICAL DESIGN (ISSN: 13816128) 16: (27) pp. 30373044. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346727]
350
Amir E, Simmons CE, Freedman OC, Dranitsaris G, Cole DEC, Vieth R, Ooi W S, Clemons M A P hase 2 Trial Exploring the Effects of HighDose (10,000 IU/Day) Vitamin D(3) in Breast Cancer P atients With Bone Metastases CANCER (ISSN: 0008543X) 116: (2) pp. 284291. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346726]
351
Austin PC, Manca A, Zwarenstein M, Juurlink DN, Stanbrook MB A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals JOURNAL OF CLINICAL EPIDEMIOLOGY (ISSN: 08954356) 63: (2) pp. 142153. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346725]
352
Ringe JD, Doherty JG Absolute risk reduction in osteoporosis: assessing treatment efficacy by number needed to treat RHEUMATOLOGY INTERNATIONAL (ISSN: 01728172) 30: (7) pp. 863869. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346724]
353
Thompson K, Roelofs AJ, Jauhiainen M, Monkkonen H, Monkkonen J, Rogers MJ Activation of gamma delta T Cells by Bisphosphonates OSTEOIMMUNOLOGY: INTERACTIONS OF THE IMMUNE AND SKELETAL SYSTEMS II 658: pp. 1120. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346723]
354
Abrahamsen B Adverse Effects of Bisphosphonates CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 86: (6) pp. 421435. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346722]
355
Hamdy RC, Baim S, Broy SB, Lewiecki EM, Morgan SL, Tanner SB, W illiamson HF Algorithm for the Management of Osteoporosis SOUTHERN MEDICAL JOURNAL (ISSN: 00384348) 103: (10) pp. 10091015. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346721]
356
Miller PD All Bisphosphonates Are (or May Not Be) the Same: P otential Reasons for Clinical Differences JOURNAL OF WOMENS HEALTH (ISSN: 15409996) 19: (4) pp. 665669. ( 2010) Folyóiratcikk /Ismertetés /Tudományos [12346720]
357
Cheng Qun, Zhu Hanmin All the bisphosphonate are same Chinese Journal of Osteoporosis (ISSN: 10067108) 16: (5) pp. 369376. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [14598143]
358
Caplan L, Pittman CB, Zeringue AL, Scherrer JF, W ehmeier KR, Cunningham FE, Eisen SA, McDonald JR An Observational Study of Musculoskeletal P ain Among P atients Receiving Bisphosphonate Therapy MAYO CLINIC PROCEEDINGS (ISSN: 00256196) 85: (4) pp. 341348. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346719]
359
Blake GM, Fogelman I An Update on DualEnergy XRay Absorptiometry SEMINARS IN NUCLEAR MEDICINE (ISSN: 00012998) 40: (1) pp. 6273. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346718]
360
Taylor HS Approaching the ideal selective estrogen receptor modulator for prevention and treatment of postmenopausal osteoporosis FORMULARY (ISSN: 1082801X) 45: (2) pp. 52+. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346717]
361
Simon JA Are All Bisphosphonates the Same? P otential Reasons for Clinical Differences: A P erspective JOURNAL OF WOMENS HEALTH (ISSN: 15409996) 19: (4) pp. 719727. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346716]
362
Pazianas M, Compston J, Huang CLH Atrial Fibrillation and Bisphosphonate Therapy JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 25: (1) pp. 210. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346715]
363
W ilkinson GS, Baillargeon J, Kuo YF, Freeman JL, Goodwin JS Atrial Fibrillation and Stroke Associated With Intravenous Bisphosphonate Therapy in Older P atients With Cancer JOURNAL OF CLINICAL ONCOLOGY (ISSN: 0732183X) 28: (33) pp. 48984905. ( 2010)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
141/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [12346714] 364
* Sellmeyer DE Atypical Fractures as a P otential Complication of Longterm Bisphosphonate Therapy JAMAJOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (ISSN: 00987484) 304: (13) pp. 14801484. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346713]
365
Bula P, Lein T, Strassberger C, Bonnaire F Balloon Kyphoplasty in the Treatment of Osteoporotic Vertebral Fractures: Indications Treatment Strategy Complications ZEITSCHRIFT FUR ORTHOPADIE UND UNFALLCHIRURGIE 148: (6) pp. 646656. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346712]
366
Zhao XM, Xu XF, Guo L, Ragaz J, Guo HY, W u JO, Shao ZM, Zhu J, Guo XM, Chen JY, Zhu BL, W ang ZH, Hu XC Biomarker alterations with metronomic use of lowdose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance BREAST CANCER RESEARCH AND TREATMENT (ISSN: 01676806) 124: (3) pp. 733743. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346711]
367
Abrahamsen B Bisphosphonate adverse effects, lessons from large databases CURRENT OPINION IN RHEUMATOLOGY (ISSN: 10408711) 22: (4) pp. 404409. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346710]
368
Gralow JR Bisphosphonate Risks and Benefits: Finding a Balance JOURNAL OF CLINICAL ONCOLOGY (ISSN: 0732183X) 28: (33) pp. 48734876. ( 2010) Folyóiratcikk /Ismertetés /Tudományos [12346709]
369
Drake MT, Cremers SCLM BISP HOSP HONATE THERAP EUTICS IN BONE DISEASE: The Hard and Soft Data on Osteoclast Inhibition MOLECULAR INTERVENTIONS (ISSN: 15340384) 10: (3) pp. 141152. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346708]
370
Bauer DC Bisphosphonate Use and Atypical Femoral Fractures: Getting Down to Brass Tacks JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 95: (12) pp. 52075209. ( 2010) Folyóiratcikk /Ismertetés /Tudományos [12346707]
371
Elmariah S, Delaney JAC, O'Brien KD, Budoff MJ, VogelClaussen J, Fuster V, Kronmal RA, Halperin JL Bisphosphonate Use and P revalence of Valvular and Vascular Calcification in Women MESA (The MultiEthnic Study of Atherosclerosis) JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (ISSN: 07351097) 56: (21) pp. 17521759. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346706]
372
Gallagher JC, Sai AJ Bisphosphonate use in osteoporosis: cardiovascular effects MENOPAUSETHE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (ISSN: 10723714) 17: (1) pp. 57. ( 2010) Folyóiratcikk /Ismertetés /Tudományos [12346705]
373
Bhuriya R, Singh M, Molnar J, Arora R, Khosla S Bisphosphonate use in women and the risk of atrial fibrillation: A systematic review and metaanalysis INTERNATIONAL JOURNAL OF CARDIOLOGY (ISSN: 01675273) 142: (3) pp. 213217. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346704]
374
Knight RJW , Reddy C, Rtshiladze MA, Lvoff G, Sherring D, Marucci D BisphosphonateRelated Osteonecrosis of the Jaw: Tip of the Iceberg JOURNAL OF CRANIOFACIAL SURGERY (ISSN: 10492275) 21: (1) pp. 2532. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346703]
375
* Black DM, Kelly MP, Genant HK, Palermo L, Eastell R, BucciRechtweg C, Cauley J, Leung PC, Boonen S, Santora A, de Papp A, Bauer DC Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 362: (19) pp. 17611771. ( 2010) CA: Fracture Intervention Trial and HORIZON Pivotal Fracture Trial Steering Committees Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [12346702]
376
Migliario M, Melle A, Bonda PLF Bisphosphonates and jaw osteonecrosis: Clinical protocols for dental hygienists Prevenzione e Assistenza Dentale 36: (2) pp. 4248. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [13474412]
377
W ilkes MM, Navickis RJ, Chan W W , Lewiecki EM Bisphosphonates and osteoporotic fractures: a crossdesign synthesis of results among compliant/persistent postmenopausal women in clinical practice versus randomized controlled trials OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (4) pp. 679688. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346701]
378
Kim SY, Kim MJ, Cadarette SM, Solomon DH Bisphosphonates and risk of atrial fibrillation: a metaanalysis ARTHRITIS RESEARCH & THERAPY (ISSN: 14786354) 12: (1) P aper R30. (2010) Folyóiratcikk /Szakcikk /Tudományos [12346700]
379
Favus MJ Bisphosphonates for Osteoporosis NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 363: (21) pp. 20272035. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346699]
380
Arantes HP, da Silva AG, LazarettiCastro M Bisphosphonates in the treatment of metabolic bone diseases ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (ISSN: 00042730) 54: (2) pp. 206212. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346698]
381
Lyritis GP, Georgoulas T, Zafeiris CP Bone anabolic versus bone anticatabolic treatment of postmenopausal osteoporosis
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
142/342
3/30/2015
nyomtatobarat forma WOMEN'S HEALTH AND DISEASE 1205: pp. 277283. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346697] 382
McComsey GA, Tebas P, Shane E, Yin MT, Overton ET, Huang JS, Aldrovandi GM, Cardoso SW , Santana JL, Brown TT Bone Disease in HIV Infection: A P ractical Review and Recommendations for HIV Care P roviders CLINICAL INFECTIOUS DISEASES (ISSN: 10584838) 51: (8) pp. 937946. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346696]
383
Barlow DH, Bouchard P, Brandi ML, Evers JLH, Glasier A, Negri E, Papapoulos SE, Ralston SH, Rizzoli R, Baird DT, Collins J, Benagiano G, Crosignani PG, La Vecchia C, Volpe A Bone fractures after menopause HUMAN REPRODUCTION UPDATE (ISSN: 13554786) 16: (6) pp. 761773. ( 2010) CA: ESHRE Capri W orkshop Grp Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [12346695]
384
* Black DM, Eastell R, BucciRechtweg CM, Su G, Reid I BONE MINERAL DENSITY IN P ATIENTS AFTER DISCONTINUATION OF ZOLEDRONIC ACID TREATMENT: P OST HOC ANALYSIS OF HORIZON P IVOTAL FRACTURE TRIAL OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (Suppl. 1) pp. 162162. ( 2010) Folyóiratcikk /Absztrakt /Tudományos [12346694]
385
Cameron DA, Douglas S, Brown JE, Anderson RA Bone mineral density loss during adjuvant chemotherapy in premenopausal women with early breast cancer: is it dependent on oestrogen deficiency? BREAST CANCER RESEARCH AND TREATMENT (ISSN: 01676806) 123: (3) pp. 805814. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346693]
386
Post TM, Cremers SCLM, Kerbusch T, Danhof M Bone P hysiology, Disease and Treatment Towards Disease System Analysis in Osteoporosis CLINICAL PHARMACOKINETICS (ISSN: 03125963) 49: (2) pp. 89118. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346692]
387
Mamtani M, Kulkarni H Bone recovery after zoledronate therapy in thalassemiainduced osteoporosis: a metaanalysis and systematic review OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (1) pp. 183187. ( 2010) Folyóiratcikk /Rövid közlemény /Tudományos [12346691]
388
Allen MR, Kubek DI, Burr DB Cancer Treatment Dosing Regimens of Zoledronic Acid Result in NearComplete Suppression of Mandible Intracortical Bone Remodeling in Beagle Dogs JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 25: (1) pp. 98105. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346690]
389
* Reid IR, Gamble GD, Mesenbrink P, Lakatos P, Black DM Characterization of and Risk Factors for the AcuteP hase Response after Zoledronic Acid JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 95: (9) pp. 43804387. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346689]
390
Xu Liang, HAO Xiaomeng, ZHANG Min, ZHANG Jin Clinical Trial on the Efficacy of Zoledronic Acid in P reventing Bone Loss Induced by Aromatase Inhibitor in Breast Cancer Chinese Journal of Clinical Oncology (ISSN: 10008179) 37: (7) pp. 392394. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [14598140]
391
Lewiecki EM Clinical use of denosumab for the treatment for postmenopausal osteoporosis CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 26: (12) pp. 28072812. ( 2010) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12346688]
392
Fardellone P, Cortet B, Legrand E, Bresse X, BisotLocard S, Vigneron AM, Beresniak A Costeffectiveness model of using zoledronic acid once a year versus current treatment strategies in postmenopausal osteoporosis JOINT BONE SPINE (ISSN: 1297319X) 77: (1) pp. 5357. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346687]
393
Delea TE, Taneja C, Sofrygin O, Kaura S, Gnant M CostEffectiveness of Zoledronic Acid P lus Endocrine Therapy in P remenopausal Women With HormoneResponsive Early Breast Cancer CLINICAL BREAST CANCER (ISSN: 15268209) 10: (4) pp. 267274. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346686]
394
* Abrahamsen B, Eiken P, Eastell R Cumulative Alendronate Dose and the LongTerm Absolute Risk of Subtrochanteric and Diaphyseal Femur Fractures: A RegisterBased National Cohort Analysis JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 95: (12) pp. 52585265. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346685]
395
Abrahamsen B, Vestergaard P Declining incidence of hip fractures and the extent of use of antiosteoporotic therapy in Denmark 19972006 OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (3) pp. 373380. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346684]
396
Confavreux CB, Paccou J, David C, Mehsen N, Leboime A, Thomas T Defining treatment failure in severe osteoporosis JOINT BONE SPINE (ISSN: 1297319X) 77: (Suppl. 2) pp. S128S132. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346683]
397
Delank KS, Rollinghoff M, EyselGosepath K, Sobottke R, Eysel P Degeneration and Osteoporosis of the Spine. Is There a Modified P rocedure? ORTHOPADE (ISSN: 00854530) 39: (4) pp. 425431. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346682]
398
Lewiecki EM Denosumab an emerging treatment for postmenopausal osteoporosis EXPERT OPINION ON BIOLOGICAL THERAPY (ISSN: 14712598) 10: (3) pp. 467476. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346681]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
143/342
3/30/2015
nyomtatobarat forma 399
Ringe JD Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis PATIENT PREFERENCE AND ADHERENCE (ISSN: 1177889X) 4: pp. 231245. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346680]
400
Lawson MA, Xia Z, Barnett BL, Triffitt JT, Phipps RJ, Dunford JE, Locklin RM, Ebetino FH, Russell RGG Differences Between Bisphosphonates in Binding Affinities for Hydroxyapatite JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART BAPPLIED BIOMATERIALS (ISSN: 15524973) 92B: (1) pp. 149155. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346679]
401
FahrleitnerPammer A Do that one and do not leave the other: What all selective estrogen receptor modulators can do? Journal fur Mineralstoffwechsel 17: (2) pp. 8789. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474410]
402
Kramer I, Keller H, Leupin O, Kneissel M Does osteocytic SOST suppression mediate P TH bone anabolism? TRENDS IN ENDOCRINOLOGY AND METABOLISM (ISSN: 10432760) 21: (4) pp. 237244. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346678]
403
* Genant HK, BucciRechtweg C, Bauer DC, Mesenbrink PG, Palermo L, Nusgarten L, Eastell R, Black DM DOES ZOLEDRONIC ACID INCREASE RISK OF ATYP ICAL FEMORAL SHAFT FRACTURES? RESULTS FROM THE HORIZONP FT OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (Suppl. 1) pp. 161162. ( 2010) Folyóiratcikk /Absztrakt /Tudományos [12346677]
404
Corrado A, Neve A, Maruotti N, Gaudio A, Marucci A, Cantatore FP Dosedependent metabolic effect of zoledronate on primary human osteoblastic cell cultures CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (ISSN: 0392856X) 28: (6) pp. 873879. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346676]
405
Bartl R, Bartl C, Gradinger R Druginduced osteopathies. Drugs, pathogenesis, forms, diagnosis, prevention and therapy ZEITSCHRIFT FUR RHEUMATOLOGIE 69: (2) pp. 135150. ( 2010) W C: Rheumatology Folyóiratcikk /Szakcikk /Tudományos [12346675]
406
* Eastell R, Lang T, Boonen S, Cummings S, Delmas PD, Cauley JA, Horowitz Z, Kerzberg E, Bianchi G, Kendler D, Leung P, Man Z, Mesenbrink P, Eriksen EF, Black DM Effect of onceyearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON P ivotal Fracture Trial OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (7) pp. 12771285. ( 2010) CA: HORIZON Pivotal Fracture Trial Folyóiratcikk /Szakcikk /Tudományos [12346674]
407
* Bolland MJ, Grey AB, Gamble GD, Reid IR Effect of Osteoporosis Treatment on Mortality: A MetaAnalysis JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 95: (3) pp. 11741181. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346673]
408
Yildiz A, Esen E, Kurkcu M, Damlar I, Daglioglu K, Akova T Effect of Zoledronic Acid on Osseointegration of Titanium Implants: An Experimental Study in an Ovariectomized Rabbit Model JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (ISSN: 02782391) 68: (3) pp. 515523. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346672]
409
* Reid IR, Miller PD, Brown JP, Kendler DL, FahrleitnerPammer A, Valter I, Maasalu K, Bolognese MA, W oodson G, Bone H, Ding BY, W agman RB, Martin JS, Ominsky MS, Dempster DW Effects of Denosumab on Bone Histomorphometry: The FREEDOM and STAND Studies JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 25: (10) pp. 22562265. ( 2010) CA: Denosumab Phase 3 Bone Histology Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [12346671]
410
Vieillard MH, Paccou J, Cortet B, Biver E, Salleron J, Falgayrac G, Penel G Effects of high dose of zoledronic acid on superficial vascular network of membranous bone sites: an intravital study on rat calvarium OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (11) pp. 19191925. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346670]
411
Hwang H, Hale SL, Leeka J, Kloner RA Effects of Zoledronate in the Repair of Chronically Infarcted Rat Myocardium JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (ISSN: 01602446) 56: (6) pp. 604609. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346669]
412
De Paz SP, Bolaños PI, Martínez MD, Roldán JO, De Armas GG, García JIP Effects of zoledronic acid in adults with osteogenesis imperfecta Endocrinologia y Nutricion (ISSN: 15750922) 57: (6) pp. 245250. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [13474409]
413
* Orwoll ES, Miller PD, Adachi JD, Brown J, Adler RA, Kendler D, BucciRechtweg C, Readie A, Mesenbrink P, W einstein RS Efficacy and Safety of a OnceYearly i.v. Infusion of Zoledronic Acid 5 mg Versus a OnceWeekly 70mg Oral Alendronate in the Treatment of Male Osteoporosis: A Randomized, Multicenter, DoubleBlind, ActiveControlled Study JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 25: (10) pp. 22392250. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346668]
414
* Boonen S, Black DM, ColonEmeric CS, Eastell R, Magaziner JS, Eriksen EF, Mesenbrink P, Haentjens P, Lyles KW Efficacy and Safety of a OnceYearly Intravenous Zoledronic Acid 5 mg for Fracture P revention in Elderly P ostmenopausal Women with Osteoporosis Aged 75 and Older JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (ISSN: 00028614) 58: (2) pp. 292299. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346667]
415
Marchenkova L A, Dreval A V, Kryukova I V, Vishnyakova M V, Polyakova E Yu, Tishenina R S, Rubin M P Efficacy and safety of Bivalos therapy in patients with postmenopausal osteoporosis without calcium and vitamin D supplement
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
144/342
3/30/2015
nyomtatobarat forma Problemy Endokrinologii (ISSN: 03759660) 56: (1) pp. 3541. ( 2010) Folyóiratcikk /Ismertetés /Tudományos [12426267] 416
Orwoll ES, Binkley NC, Lewiecki EM, Gruntmanis U, Fries MA, Dasic G Efficacy and safety of monthly ibandronate in men with low bone density BONE (ISSN: 87563282) 46: (4) pp. 970976. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346666]
417
Serefoglu Ege Can, Tandogdu Zafer Efficacy and safety of zoledronic acid in the treatment of glucocorticoidinduced osteoporosis THERAPEUTICS AND CLINICAL RISK MANAGEMENT (ISSN: 11766336) 6: pp. 219223. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [14598164]
418
Bertoldo F, Pancheri S, Zenari S, Boldini S Emerging drugs for the management of cancer treatment induced bone loss EXPERT OPINION ON EMERGING DRUGS (ISSN: 14728214) 15: (2) pp. 323342. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346665]
419
420
421
* Body JJ, Bergmann P, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, Kaufman JM, Rozenberg S, Reginster JY Evidencebased guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (10) pp. 16571680. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346664] Lumb A, W ass J Expanding boundaries of endocrinology CLINICAL MEDICINE (ISSN: 14702118) 10: (3) pp. 238241. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346663] * Seeman E, Boonen S, Borgstrom F, Vellas B, Aquino JP, Semler J, Benhamou CL, Kaufman JM, Reginster JY Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining lifeyears in women over 80 years of age BONE (ISSN: 87563282) 46: (4) pp. 10381042. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346662]
422
de Castro GRW , Neves FS, Fialho SCDS, Pereira IA, Ribeiro G, Zimmermann AF Flareup of hand osteoarthritis caused by zoledronic acid infusion OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (9) pp. 16171619. ( 2010) Folyóiratcikk /Rövid közlemény /Tudományos [12346661]
423
Banerjee A, Bassil BS, Roschenthaler GV, Kortz U Fluorine Tagging of P olyoxometalates: The Cyclic [{(Mo2O4)OV(H2O)}(4){O3P C(CF3)(O)P O3}(4)](12) EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (ISSN: 14341948) 2010: (25) pp. 39153919. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346660]
424
Lippuner K, Johansson H, Kanis JA, Rizzoli R FRAXA (R) assessment of osteoporotic fracture probability in Switzerland OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (3) pp. 381389. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346659]
425
Riancho JA Genetics of osteoporosis: Halffull or halfempty? Clinical Reviews in Bone and Mineral Metabolism 8: (2) pp. 4950. ( 2010) Folyóiratcikk /Ismertetés /Tudományos [13474408]
426
Shahnazari M, Yao W , Dai W W , W ang B, IonovaMartin SS, Ritchie RO, Heeren D, Burghardt AJ, Nicolella DP, Kimiecik MG, Lane NE Higher doses of bisphosphonates further improve bone mass, architecture, and strength but not the tissue material properties in aged rats BONE (ISSN: 87563282) 46: (5) pp. 12671274. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346658]
427
Cameron ID, Chen JS, March LM, Simpson JM, Cumming RG, Seibel MJ, Sambrook PN Hip Fracture Causes Excess Mortality Owing to Cardiovascular and Infectious Disease in Institutionalized Older P eople: A P rospective 5Year Study JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 25: (4) pp. 866872. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346657]
428
Seton M How soon after hip fracture surgery should a patient start bisphosphonates? CLEVELAND CLINIC JOURNAL OF MEDICINE (ISSN: 08911150) 77: (11) pp. 751755. ( 2010) Folyóiratcikk /Ismertetés /Tudományos [12346656]
429
Dore RK How to prevent glucocorticoidinduced osteoporosis CLEVELAND CLINIC JOURNAL OF MEDICINE (ISSN: 08911150) 77: (8) pp. 529536. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346655]
430
Kometani M, Nonomura K, Tomoo T, Niwa S Hurdles in the Drug Discovery of Cathepsin K Inhibitors CURRENT TOPICS IN MEDICINAL CHEMISTRY (ISSN: 15680266) 10: (7) pp. 733744. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346654]
431
Lewiecki EM, Cooper C, Thompson E, Hartl F, Mehta D, Papapoulos SE Ibandronate does not increase risk of atrial fibrillation in analysis of pivotal clinical trials INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ISSN: 13685031) 64: (6) pp. 821826. ( 2010) Folyóiratcikk /Rövid közlemény /Tudományos [12346653]
432
Sambrook PN, Chen JS, Simpson JM, March LM Impact of adverse news media on prescriptions for osteoporosis: effect on fractures and mortality MEDICAL JOURNAL OF AUSTRALIA (ISSN: 0025729X) 193: (3) pp. 154156. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346652]
433
Howard PA, Barnes BJ, Vacek JL, Chen W R, Lai SM Impact of Bisphosphonates on the Risk of Atrial Fibrillation AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (ISSN: 11753277) 10: (6) pp. 359367. ( 2010)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
145/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Összefoglaló cikk /Tudományos [12346651] 434
Gallacher SJ, Dixon T Impact of Treatments for P ostmenopausal Osteoporosis (Bisphosphonates, P arathyroid Hormone, Strontium Ranelate, and Denosumab) on Bone Quality: A Systematic Review CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 87: (6) pp. 469484. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346650]
435
BAO Nirong, ZHU Liangliang, ZHOU Liwu Inhibitory effect of zoledronic acid on osteolysls induced by human periprosthetic tissue:an animal study Orthopedic Journal of China (ISSN: 10058478) 18: (10) pp. 853858. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [14598125]
436
Morris PG, Van Poznak C, Modi S, Mak AF, Patil S, Larson S, Hudis CA, Divgi C, Grewal RK Intravenous Bisphosphonate Therapy Does Not Acutely Alter Nuclear Bone Scan Results CLINICAL BREAST CANCER (ISSN: 15268209) 10: (1) pp. 3339. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346649]
437
Mottaghi P Intravenous bisphosphonates for postmenopausal osteoporosis JOURNAL OF RESEARCH IN MEDICAL SCIENCES (ISSN: 17351995) 15: (3) pp. 175184. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346648]
438
* Bolland MJ, Grey A, Gamble GD, Reid IR Investigating harms in clinical trials no easy task INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ISSN: 13685031) 64: (13) pp. 17191722. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346647]
439
Habib HA, GilHernandez B, AbuShandi K, Sanchiz J, Janiak C Iron, copper and zinc ammonium1hydroxyalkylidenediphosphonates with zero, one and twodimensional covalent metal ligand structures extended into threedimensional supramolecular networks by chargeassisted hydrogenbonding POLYHEDRON (ISSN: 02775387) 29: (12) pp. 25372545. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346646]
440
Curtis JR, Arora T, Matthews RS, Taylor A, Becker DJ, ColonEmeric C, Kilgore ML, Morrisey MA, Saag KG, Safford MM, W arriner A, Delzell E Is Withholding Osteoporosis Medication After Fracture Sometimes Rational? A Comparison of the Risk for Second Fracture Versus Death JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (ISSN: 15258610) 11: (8) pp. 584591. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346645]
441
Agis H, Blei J, W atzek G, Gruber R Is Zoledronate Toxic to Human P eriodontal Fibroblasts? JOURNAL OF DENTAL RESEARCH (ISSN: 00220345) 89: (1) pp. 4045. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346644]
442
* Cummings SR, Ensrud K, Delmas PD, LaCroix AZ, Vukicevic S, Reid DM, Goldstein S, Sriram U, Lee A, Thompson J, Armstrong RA, Thompson DD, Powles T, Zanchetta J, Kendler D, Neven P, Eastell R Lasofoxifene in P ostmenopausal Women with Osteoporosis NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 362: (8) pp. 686696. ( 2010) CA: PEARL Study Investigators Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [12346643]
443
Pazianas Michael, Cooper Cyrus, Ebetino F Hal, Russell R Graham G Longterm treatment with bisphosphonates and their safety in postmenopausal osteoporosis THERAPEUTICS AND CLINICAL RISK MANAGEMENT (ISSN: 1178203X) 6: pp. 325343. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [14598163]
444
W atts NB, Diab DL LongTerm Use of Bisphosphonates in Osteoporosis JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 95: (4) pp. 15551565. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346642]
445
Oyen J, Gjesdal CG, Brudvik C, Hove LM, Apalset EM, Gulseth HC, Haugeberg G Lowenergy distal radius fractures in middleaged and elderly men and womenthe burden of osteoporosis and fracture risk OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (7) pp. 12571267. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346641]
446
Bauman W A, Schnitzer TJ, Chen D Management of Osteoporosis After Spinal Cord Injury: What Can Be Done? PM and R 2: (6) pp. 566572. ( 2010) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [13474405]
447
Inderjeeth Charles A, Poland Kate E Management of Osteoporosis in Older P eople Journal of Pharmacy Practice and Research 40: (3) pp. 229234. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12426266]
448
Ip TP, Leung J, Kung AW C Management of osteoporosis in patients hospitalized for hip fractures OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (4) pp. S605S614. ( 2010) Suppl. Folyóiratcikk /Összefoglaló cikk /Tudományos [12346640]
449
Bonnick SL, Harris ST, Kendler DL, McClung MR, Silverman SL Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society MENOPAUSETHE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (ISSN: 10723714) 17: (1) pp. 2554. ( 2010) CA: N Amer Menopause Soc Folyóiratcikk /Összefoglaló cikk /Tudományos [12346639]
450
Rizzoli R Management of the oldest old with osteoporosis EUROPEAN GERIATRIC MEDICINE (ISSN: 18787649) 1: (1) pp. 1521. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346638]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
146/342
3/30/2015
nyomtatobarat forma 451
Vondracek SF Managing osteoporosis in postmenopausal women AMERICAN JOURNAL OF HEALTHSYSTEM PHARMACY (ISSN: 10792082) 67: (7) pp. S9S19. ( 2010) SU: 3 Folyóiratcikk /Szakcikk /Tudományos [12346637]
452
Juillard A, Falgayrac G, Cortet B, Vieillard MH, Azaroual N, Hornez JC, Penel G Molecular interactions between zoledronic acid and bone: An in vitro Raman microspectroscopic study BONE (ISSN: 87563282) 47: (5) pp. 895904. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346636]
453
Canalis E NEW TREATMENT MODALITIES IN OSTEOP OROSIS ENDOCRINE PRACTICE (ISSN: 1530891X) 16: (5) pp. 855863. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346635]
454
Biver E, Vieillard MH, Cortet B, Salleron J, Falgayrac G, Penel G No antiangiogenic effect of clinical dosing regimens of a single zoledronic acid injection in an experimental bone healing site BONE (ISSN: 87563282) 46: (3) pp. 643648. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346634]
455
Faßbender W J, Stracke HG Osteoporosis Diagnosis, therapy and prevention Medizinische Welt (ISSN: 00258512) 61: (1) pp. 4449. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [13474404]
456
Bolster MB Osteoporosis and Bone Health in P atients with Lung Disease CLINICS IN CHEST MEDICINE (ISSN: 02725231) 31: (3) pp. 555563. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346633]
457
Navarro M, Torres B, Masanés F, Sacanella E, LópezSoto A Osteoporosis in the elderly Revista Multidisciplinar de Gerontologia 20: (3) pp. 104113. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [13474403]
458
Silverman SL Osteoporosis Therapies: Evidence from HealthCare Databases and Observational P opulation Studies CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 87: (5) pp. 375384. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346632]
459
Huang W F, Tsai YW , W en YW , Hsiao FY, Kuo KN, Tsai CR Osteoporosis treatment and atrial fibrillation: alendronate versus raloxifene MENOPAUSETHE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (ISSN: 10723714) 17: (1) pp. 5763. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346631]
460
Davie M, Jeffreson P, Jones T, Roberts T, Adekunle F, Mitchell P P eripatetic intravenous service for metabolic bone disease: case study in patient centredcare for new NHS CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 26: (8) pp. 20332039. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346630]
461
Pietschmann P, AziziSemrad U, Pils K, FahrleitnerPammer A, Resch H, Dobnig H P harmacologic undertreatment of osteoporosis in Austrian nursing homes and senior's residences WIENER KLINISCHE WOCHENSCHRIFT 122: (1718) pp. 532537. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346629]
462
Cole R P ostmenopausal osteoporosis: Another approach to management JOURNAL OF FAMILY PRACTICE (ISSN: 00943509) 59: (6) pp. E1E7. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346628]
463
Hiligsmann M, Rabenda V, Gathon HJ, Ethgen O, Reginster JY P otential Clinical and Economic Impact of Nonadherence with Osteoporosis Medications CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 86: (3) pp. 202210. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346627]
464
* ColonEmeric CS, Mesenbrink P, Lyles KW , Pieper CF, Boonen S, Delmas P, Eriksen EF, Magaziner J P otential Mediators of the Mortality Reduction With Zoledronic Acid After Hip Fracture JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 25: (1) pp. 9197. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346626]
465
Rozental TD, Shah J, Chacko AT, Zurakowski D P revalence and P redictors of Osteoporosis Risk in Orthopaedic P atients CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (ISSN: 0009921X) 468: (7) pp. 17651772. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346625]
466
Brar LCKS P revalent and emerging therapies for osteoporosis Medical Journal Armed Forces India 66: (3) pp. 249254. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [13474401]
467
* Van Poznak C, Hannon RA, Mackey JR, Campone M, Apffelstaedt JP, Clack G, Barlow D, Makris A, Eastell R P revention of Aromatase InhibitorInduced Bone Loss Using Risedronate: The SABRE Trial JOURNAL OF CLINICAL ONCOLOGY (ISSN: 0732183X) 28: (6) pp. 967975. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346624]
468
Hershman DL, McMahon DJ, Crew KD, Shao T, Cremers S, Brafman L, Awad D, Shane E P revention of Bone Loss by Zoledronic Acid in P remenopausal Women Undergoing Adjuvant Chemotherapy P ersist up to One Year following Discontinuing Treatment JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 95: (2) pp. 559566. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346623]
469
Crilly RG, Hillier LM, Mason M, Gutmanis I, Cox L P revention of Hip Fractures in LongTerm Care: Relevance of CommunityDerived Data
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
147/342
3/30/2015
nyomtatobarat forma JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (ISSN: 00028614) 58: (4) pp. 738745. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346622] 470
471
Dai Zhehao, Dai Ruchun, Xiao Yi P rogress in antiosteoporosis drug treatment Chinese Journal of Osteoporosis (ISSN: 10067108) 16: (11) pp. 894906. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [14598111] * Grey A, Bolland M, W attie D, Horne A, Gamble G, Reid IR P rolonged Antiresorptive Activity of Zoledronate: A Randomized, Controlled Trial JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 25: (10) pp. 22512255. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346621]
472
Leal T, Tevaarwerk A, Love R, Stewart J, Binkley N, Eickhoff J, Parrot B, Mulkerin D Randomized Trial of Adjuvant Zoledronic Acid in P ostmenopausal Women With HighRisk Breast Cancer CLINICAL BREAST CANCER (ISSN: 15268209) 10: (6) pp. 471476. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346620]
473
Langston AL, Campbell MK, Fraser W D, MacLennan GS, Selby PL, Ralston SH Randomized Trial of Intensive Bisphosphonate Treatment Versus Symptomatic Management in P aget's Disease of Bone JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 25: (1) pp. 2031. ( 2010) CA: PRISM Trial Grp Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [12346619]
474
Hossain M Repeated falls and broken bones BRITISH MEDICAL JOURNAL 341: P aper c5755. (2010) Folyóiratcikk /Rövid közlemény /Tudományos [12346618]
475
Taggart H, Cheng J, Archbold P Respiratory complications associated with IV zoledronic acid infusion in the treatment of postmenopausal osteoporosis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (9) pp. 16211622. ( 2010) Folyóiratcikk /Rövid közlemény /Tudományos [12346617]
476
Camm AJ Review of the Cardiovascular Safety of Zoledronic Acid and Other Bisphosphonates for the Treatment of Osteoporosis CLINICAL THERAPEUTICS (ISSN: 01492918) 32: (3) pp. 426436. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346616]
477
Vestergaard P, Schwartz K, Pinholt EM, Rejnmark L, Mosekilde L Risk of Atrial Fibrillation Associated with Use of Bisphosphonates and Other Drugs Against Osteoporosis: A Cohort Study CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 86: (5) pp. 335342. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346615]
478
Schmidt GA, Horner KE, McDanel DL, Ross MB, Moores KG Risks and benefits of longterm bisphosphonate therapy AMERICAN JOURNAL OF HEALTHSYSTEM PHARMACY (ISSN: 10792082) 67: (12) pp. 9941001. ( 2010) Folyóiratcikk /Ismertetés /Tudományos [12346614]
479
Shifren JL, Schiff I Role of Hormone Therapy in the Management of Menopause OBSTETRICS AND GYNECOLOGY (ISSN: 00297844) 115: (4) pp. 839855. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346613]
480
Zapolski T, W ysokinski A Safety of pharmacotherapy of osteoporosis in cardiology patients CARDIOLOGY JOURNAL (ISSN: 18975593) 17: (4) pp. 335343. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346612]
481
Nelson HD, Haney EM, Dana T, Bougatsos C, Chou R Screening for Osteoporosis: An Update for the US P reventive Services Task Force ANNALS OF INTERNAL MEDICINE (ISSN: 00034819) 153: (2) pp. 99111. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346611]
482
Bertoldo F, Pancheri S, Zenari S, Boldini S, Giovanazzi B, Zanatta M, Valenti MT, Carbonare LD, Lo Cascio V Serum 25Hydroxyvitamin D Levels Modulate the AcuteP hase Response Associated With the First NitrogenContaining Bisphosphonate Infusion JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 25: (3) pp. 447454. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346610]
483
Iwamoto Jun, Sato Yoshihiro, Uzawa Mitsuyoshi, Takeda Tsuyoshi, Matsumoto Hideo Seven years' experience with alendronate in postmenopausal Japanese women with osteoporosis THERAPEUTICS AND CLINICAL RISK MANAGEMENT (ISSN: 11766336) 6: pp. 201206. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [14598162]
484
Henriksen K, Bohren KM, BayJensen AC, Karsdal MA Should biochemical markers of bone turnover be considered standard practice for safety pharmacology? BIOMARKERS (ISSN: 1354750X) 15: (3) pp. 195204. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346609]
485
* Noon E, Singh S, Cuzick J, Spector TD, W illiams FMK, Frost ML, Howell A, Harvie M, Eastell R, Coleman RE, Fogelman I, Blake GM Significant differences in UK and US female bone density reference ranges OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (11) pp. 18711880. ( 2010) CA: IBISII Bone Substudy Folyóiratcikk /Szakcikk /Tudományos [12346608]
486
* Sankaran S, Gamble G, Bolland M, Reid IR, Grey A Skeletal Effects of Interventions in Mild P rimary Hyperparathyroidism: A MetaAnalysis JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 95: (4) pp. 16531662. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346607]
487
Ruscica R, Bianchi M, Quintero M, Martinez A, Vega DR SolidState Forms of Zoledronic Acid: P olymorphism in Hydrates JOURNAL OF PHARMACEUTICAL SCIENCES (ISSN: 00223549) 99: (12) pp. 49624972. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346606]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
148/342
3/30/2015
nyomtatobarat forma 488
Middleton ET, Steel SA, Aye M, Doherty SM The Effect of P rior Bisphosphonate Therapy on the Subsequent BMD and Bone Turnover Response to Strontium Ranelate JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 25: (3) pp. 455462. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346605]
489
Stein CM, Ray W A The Ethics of P lacebo in Studies with Fracture End P oints in Osteoporosis. NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 363: (14) pp. 13671370. ( 2010) Folyóiratcikk /Ismertetés /Tudományos [12346604]
490
Maraldo MV, Vestergaard P, McMurdo MET, Schwarz P The evidence for antiresorptive osteoporosis treatment in the elderly and old EUROPEAN GERIATRIC MEDICINE (ISSN: 18787649) 1: (5) pp. 279292. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346603]
491
Thompson M, Pasquale M, Grima D, Moehrke W , Kruse HP The Impact of Fewer Hip Fractures with Risedronate Versus Alendronate in the First Year of Treatment: Modeled German CostEffectiveness Analysis VALUE IN HEALTH (ISSN: 10983015) 13: (1) pp. 4654. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346602]
492
* Grbic JT, Black DM, Lyles KW , Reid DM, Orwoll E, McClung M, BucciRechtweg C, Su GQ The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid Data from the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly clinical trials program JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (ISSN: 00028177) 141: (11) pp. 13651370. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346601]
493
W eaver MJ, Miller MA, Vrahas MS The Orthopaedic Implications of Diphosphonate Therapy JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (ISSN: 1067151X) 18: (6) pp. 367374. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346600]
494
Ekman EF The Role of the Orthopaedic Surgeon in Minimizing Mortality and Morbidity Associated With Fragility Fractures JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (ISSN: 1067151X) 18: (5) pp. 278285. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346599]
495
Maricic M The role of zoledronic acid in the management of osteoporosis CLINICAL RHEUMATOLOGY (ISSN: 07703198) 29: (10) pp. 10791084. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346597]
496
Rodrigues P, Meler A, Hering F Titration of Dosage for the P rotective Effect of Zoledronic Acid on Bone Loss in P atients Submitted to Androgen Deprivation Therapy due to P rostate Cancer: A P rospective OpenLabel Study UROLOGIA INTERNATIONALIS (ISSN: 00421138) 85: (2) pp. 180185. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346596]
497
Fernández ávila Daniel G, Mora Claudia, Reyes Sanmiguel Elsa, Londoño John Darío, Santos Moreno Pedro, Valle Oñate Rafael Tratamiento farmacológico de la osteoporosis postmenopáusica: P harmacological treatment of postmenopausal osteoporosis Revista Colombiana de Reumatología (ISSN: 01218123) 17: (2) pp. 96110. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [14598109]
498
MoroÁlvarez MJ, DíazCuriel M Treatment of osteoporosis with bisphosphonates. Differences by mechanism of action. Data on longterm efficacy and safety Medicine (ISSN: 00257974) 10: (60) pp. 41354143. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474400]
499
Mouridsen HT, Lonning P, Beckmann MW , Blackwell K, Doughty J, Gligorov J, LlombartCussac A, Robidoux A, Thurlimann B, Gnant M Use of aromatase inhibitors and bisphosphonates as an anticancer therapy in postmenopausal breast cancer EXPERT REVIEW OF ANTICANCER THERAPY (ISSN: 14737140) 10: (11) pp. 18251836. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346595]
500
Lamberg AL, HorvathPuho E, Christensen S, Sorensen HT Use of oral bisphosphonates and risk of venous thromboembolism: a populationbased casecontrol study OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (11) pp. 19111917. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346594]
501
Hundrup YA, Jacobsen RK, Andreasen AH, Davidsen M, Obel EB, Abrahamsen B Validation of a 5year risk score of hip fracture in postmenopausal women: the Danish Nurse Cohort Study OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (12) pp. 21352142. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346593]
502
Diacinti D, Guglielmi G Vertebral Morphometry RADIOLOGIC CLINICS OF NORTH AMERICA (ISSN: 00338389) 48: (3) pp. 561575. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346592]
503
Miller PD, Derman RJ What is the best balance of benefits and risks among antiresorptive therapies for postmenopausal osteoporosis? OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (11) pp. 17931802. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346591]
504
Sbrocchi AM, Forget S, Laforte D, Azouz EM, Rodd C Zoledronic acid for the treatment of osteopenia in pediatric Crohn's disease PEDIATRICS INTERNATIONAL (ISSN: 13288067) 52: (5) pp. 754761. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346590]
505
* Seeman E, Black DM, BucciRechtweg C, Eastell R, Boonen S, Mesenbrink P ZOLEDRONIC ACID REDUCES THE INCREASED RISK CONFERRED BY FURTHER FRACTURES OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (Suppl. 1) pp. 363364. ( 2010)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
149/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Absztrakt /Tudományos [12346589] 506
Johnson DA, W illiams MI, Petkov VI, Adler RA ZOLEDRONIC ACID TREATMENT OF OSTEOP OROSIS: EFFECTS IN MEN ENDOCRINE PRACTICE (ISSN: 1530891X) 16: (6) pp. 960967. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12346588]
507
Hamdy RC Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass DRUG DESIGN DEVELOPMENT AND THERAPY (ISSN: 11778881) 4: pp. 321335. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346587]
508
Acosta Martínez J, Atienza Amores MR, Terán Redondo R, Varela Aguilar JM Zoledronicassociated paroxysmal atrial flutter: A new adverse effect? Cardiocore 45: (3) pp. 127128. ( 2010) Folyóiratcikk /Rövid közlemény /Tudományos [13474399]
509
Pérez Edo L, Alonso Ruiz A, Roig Vilaseca D, García Vadillo A, Guañabens Gay N, Peris P, Torrijos Eslava A, Beltrán Audera C, Fiter Aresté J, Arboleya Rodríguez L, Graña Gil J, Carbonell Abelló J, Nolla JM, Holgado Pérez S, Salas Heredia E, Zubieta Tabernero J, Del Pino Montes J, Blanch i Rubió J, Caamaño Freire M, Rodríguez Pérez M, Castañeda S, Cerdá D, Gómez Vaquero C, Calvo Catalá J, Ciria M, Loza E 2011 Update of the consensus statement of the Spanish Society of Rheumatology on osteoporosis Reumatologia Clinica (ISSN: 1699258X) 7: (6) pp. 357379. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474332]
510
Brown JP, Adachi JD, Kendler DL, Rigal R, Deutsch G, Leclerc JM A communitybased clinical trial of IntraVenous zOledRonic acid once Yearly in comparison to oral bisphosphonates in postmenopausal women with osteoporosis: The IVORY trial Methodological considerations CONTEMPORARY CLINICAL TRIALS (ISSN: 15517144) 32: (5) pp. 741746. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346586]
511
Rebolledo BJ, Unnanuntana A, Lane JM A Comprehensive Approach to Fragility Fractures JOURNAL OF ORTHOPAEDIC TRAUMA (ISSN: 08905339) 25: (9) pp. 566573. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346585]
512
Ross S, Samuels E, Gairy K, Iqbal S, Badamgarav E, Siris E A MetaAnalysis of Osteoporotic Fracture Risk with Medication Nonadherence VALUE IN HEALTH (ISSN: 10983015) 14: (4) pp. 571581. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346584]
513
Khan A, Lascaratos G, RaneMalcolm T, Sanders R A rare case of zolendronate infusion complication leading to glaucoma filtration surgery Clinical Ophthalmology 5: (1) pp. 11471149. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474331]
514
Borromeo GL, Tsao CE, Darby IB, Ebeling PR A review of the clinical implications of bisphosphonates in dentistry AUSTRALIAN DENTAL JOURNAL (ISSN: 00450421) 56: (1) pp. 29. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346583]
515
Lippuner K, Pollock RF, SmithPalmer J, Meury T, Valentine W J A review of the cost effectiveness of bisphosphonates in the treatment of postmenopausal osteoporosis in Switzerland Applied Health Economics and Health Policy (ISSN: 11755652) 9: (6) pp. 403417. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474330]
516
Klaus J, Haenle MM, Schroter C, Adler G, von Boyen G, Reinshagen M, von Tirpitz C A Single Dose of Intravenous Zoledronate P revents Glucocorticoid TherapyAssociated Bone Loss in Acute Flare of Crohn's Disease, a Randomized Controlled Trial AMERICAN JOURNAL OF GASTROENTEROLOGY (ISSN: 00029270) 106: (4) pp. 786793. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346582]
517
Felsenberg D, Bock O, Borst H, Armbrecht G, Beller G, Degner C, StephanOelkers M, Schacht E, Mazor Z, Hashimoto J, Roth HJ, Martus P, Runge M Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS 11: (1) pp. 3445. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346581]
518
Rizzoli R, Reginster JY Adverse drug reactions to osteoporosis treatments Expert Review of Clinical Pharmacology (ISSN: 17512433) 4: (5) pp. 593604. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474329]
519
Arboleya L, Alperi M, Alonso S Adverse effects of bisphosphonates Reumatologia Clinica (ISSN: 1699258X) 7: (3) pp. 189197. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474398]
520
* Rizzoli R, Reginster JY, Boonen S, Breart G, DiezPerez A, Felsenberg D, Kaufman JM, Kanis JA, Cooper C Adverse Reactions and DrugDrug Interactions in the Management of Women with P ostmenopausal Osteoporosis CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 89: (2) pp. 91104. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346580]
521
Lin TC, Yang CY, Yang YHK, Lin SJ Alendronate Adherence and Its Impact on HipFracture Risk in P atients With Established Osteoporosis in Taiwan CLINICAL PHARMACOLOGY & THERAPEUTICS (ISSN: 00099236) 90: (1) pp. 109116. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346579]
522
Lu PY, Hsieh CF, Tsai YW , Huang W F Alendronate and Raloxifene Use Related to Cardiovascular Diseases: Differentiation by Different Dosing Regimens of Alendronate CLINICAL THERAPEUTICS (ISSN: 01492918) 33: (9) pp. 11731179. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346578]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
150/342
3/30/2015
nyomtatobarat forma 523
Reginster JY Antifracture Efficacy of Currently Available Therapies for P ostmenopausal Osteoporosis DRUGS (ISSN: 00126667) 71: (1) pp. 6578. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346577]
524
Pazianas M, Cooper C, W ang YT, Lange JL, Russell RGG Atrial fibrillation and the use of oral bisphosphonates THERAPEUTICS AND CLINICAL RISK MANAGEMENT (ISSN: 11766336) 7: pp. 131144. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346576]
525
Puhaindran ME, Farooki A, Steensma MR, Hameed M, Healey JH, Boland PJ Atypical Subtrochanteric Femoral Fractures in P atients with Skeletal Malignant Involvement Treated with Intravenous Bisphosphonates JOURNAL OF BONE AND JOINT SURGERYAMERICAN VOLUME (ISSN: 00219355) 93A: (13) pp. 12351242. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346575]
526
Czerwinski E Atypical subtrochanteric fractures after longterm bisphosphonate therapy ENDOKRYNOLOGIA POLSKA (ISSN: 0423104X) 62: (1) pp. 8487. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346574]
527
528
* Lakatos Peter Az osteoporosis gyógyszeres kezelése 2011 [P harmacologic treatment of osteoporosis2011]. Orvosi Hetilap (ISSN: 00306002) 152: (33) pp. 13201326. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12426264] Cremers S, Farooki A Biochemical markers of bone turnover in osteonecrosis of the jaw in patients with osteoporosis and advanced cancer involving the bone In: Bilezikian JP, Grbic JT (szerk.) : BISPHOSPHONATES AND OSTEONECROSIS OF THE JAW. (1218) Malden: Wiley Blackwell, 2011. (ISBN 9781573317108) pp. 8087. (Annals of the New York Academy of Sciences)
Könyvrészlet /Konferenciaközlemény /Tudományos [12346573] 529
No author name available Biphosphonates: From osteoporosis treatment to cancer prevention Informe Medico 13: (2) pp. 8991. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474327]
530
Syversen U, Halse JI Bisfosfonatbehandling av osteoporose og andre skjelettsykdommer Tidsskrift for den Norske Laegeforening (ISSN: 00292001) 131: (3) pp. 244247. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474397]
531
McKenzie K, Bobyn JD, Roberts J, Karabasz D, Tanzer M Bisphosphonate Remains Highly Localized After Elution From P orous Implants CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (ISSN: 0009921X) 469: (2) pp. 514522. ( 2011) Folyóiratcikk /Konferenciaközlemény /Tudományos [12346572]
532
* Reid IR Bisphosphonate Therapy for Secondary Osteoporosis: Adult P erspective HORMONE RESEARCH IN PAEDIATRICS (ISSN: 16632818) 76: (Suppl. 1) pp. 2832. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346571]
533
No author name available Bisphosphonates and atrial fibrillation: Clinical trial data suggest possible link Prescrire International (ISSN: 11677422) 20: (115) pp. 9697. ( 2011) Folyóiratcikk /Rövid közlemény /Tudományos [13474396]
534
Assael LA Bisphosphonates and Oral Health: P rimer and an Update for the P racticing Surgeon ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA (ISSN: 10423699) 23: (3) pp. 443453. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346570]
535
ZHU Hanmin Bisphosphonates and osteoporosis Chinese Journal of Practical Internal Medicine (ISSN: 10052194) 31: (7) pp. 517520. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [14598079]
536
Sewerynek E, Stuss M Bisphosphonates and the risk of atrial fibrillation ENDOKRYNOLOGIA POLSKA (ISSN: 0423104X) 62: (1) pp. 9396. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346569]
537
Sewerynek E Bisphosphonates and the risk of atrial fibrillation in elderly women with osteoporosis Aging Health 7: (4) pp. 585589. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474326]
538
Zakraoui L, Souabni L BISP HOSP HONATES DILEMMA: WHEN TO START AND WHEN TO STOP OR SWITCH OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: pp. S681S682. ( 2011) SU 5 Folyóiratcikk /Absztrakt /Tudományos [14597998]
539
Rizzoli R Bisphosphonates for postmenopausal osteoporosis: are they all the same? QJMAN INTERNATIONAL JOURNAL OF MEDICINE (ISSN: 14602725) 104: (4) pp. 281300. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346568]
540
541
* Eastell R, W alsh JS, W atts NB, Siris E Bisphosphonates for postmenopausal osteoporosis BONE (ISSN: 87563282) 49: (1) pp. 8288. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346567] Makitie O Bisphosphonates in P ediatrics More Questions than Answers HORMONE RESEARCH IN PAEDIATRICS (ISSN: 16632818) 76: (4) pp. 292292. ( 2011)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
151/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Ismertetés /Tudományos [12346566] 542
* Reid IR Bisphosphonates in the treatment of osteoporosis: a review of their contribution and controversies SKELETAL RADIOLOGY (ISSN: 03642348) 40: (9) pp. 11911196. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346565]
543
Gong L, Altman RB, Klein TE Bisphosphonates pathway PHARMACOGENETICS AND GENOMICS (ISSN: 17446872) 21: (1) pp. 5053. ( 2011) Folyóiratcikk /Ismertetés /Tudományos [12346564]
544
Li BJ, Chau JFL, W ang XY, Leong W F Bisphosphonates, Specific Inhibitors of Osteoclast Function and a Class of Drugs for Osteoporosis Therapy JOURNAL OF CELLULAR BIOCHEMISTRY (ISSN: 07302312) 112: (5) pp. 12291242. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346563]
545
Russell RGG Bisphosphonates: The first 40 years BONE (ISSN: 87563282) 49: (1) pp. 219. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346562]
546
Halse J Blåreseptordningen disfavoriserer osteoporosepasienter Tidsskrift for den Norske Laegeforening (ISSN: 00292001) 131: (9) p. 933. ( 2011) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [13474325]
547
Goldstein SR Bone health medications: research questions versus clinical choices MENOPAUSETHE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (ISSN: 10723714) 18: (8) pp. 835 836. ( 2011) Folyóiratcikk /Ismertetés /Tudományos [12346561]
548
* Gamsjaeger S, Buchinger B, Zwettler E, Recker R, Black D, Gasser JA, Eriksen EF, Klaushofer K, Paschalis EP Bone Material P roperties in Actively BoneForming Trabeculae in P ostmenopausal Women With Osteoporosis After Three Years of Treatment With OnceYearly Zoledronic Acid JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 26: (1) pp. 1218. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346560]
549
Gomez JMQ, Rubio JB, Curiel MD, Perez AD Calcium Citrate and Vitamin D in the Treatment of Osteoporosis CLINICAL DRUG INVESTIGATION (ISSN: 11732563) 31: (5) pp. 285298. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346559]
550
* Reid IR, Bolland MJ, Avenell A, Grey A Cardiovascular effects of calcium supplementation OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (6) pp. 16491658. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346558]
551
Kraenzlin ME, Meier C Cathepsin K inhibitors in the treatment of osteoporosis Osteologie (ISSN: 10191291) 20: (3) pp. 211216. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474324]
552
Isaia GC, Braga V, Minisola S, Bianchi G, Del Puente A, Di Matteo L, Mariano GP, Latte VM, D'Amico F, Bonali C, D'Amelio P Clinical characteristics and incidence of first fracture in a consecutive sample of postmenopausal women attending osteoporosis centers: The P ROTEO1 study JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (ISSN: 03914097) 34: (7) pp. 534540. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346557]
553
Hadji P Clinical considerations for the use of antiresorptive agents in the treatment of metastatic bone disease CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (ISSN: 10408428) 80: (2) pp. 301313. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346556]
554
Tsang SW Y, Bow CH, Chu EYW , Yeung SC, Soong CC, Kung AW C Clinical risk factor assessment had better discriminative ability than bone mineral density in identifying subjects with vertebral fracture OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (2) pp. 667674. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346555]
555
Cole RE Clinical Strategies to Address P atients' Concerns in Osteoporosis Management with Bisphosphonates POSTGRADUATE MEDICINE (ISSN: 00325481) 123: (2) pp. 131144. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346554]
556
ZHENG Jiaoyang, ZHANG Lanyu, ZOU Junjie Clinical study of zoledronic acid treatment for postmenopausal osteoporosis Chinese Journal of Osteoporosis (ISSN: 10067108) 17: (4) pp. 344346. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [14598078]
557
W ANG Zeng, LU Hongyang, W ENG Lin Clinical trials progression of anticancer effects exerted by zoledronic acid Chinese Journal of Clinical Pharmacology and Therapeutics (ISSN: 10092501) 16: (8) pp. 945950. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [14598077]
558
Muratore M, Quarta E, Grimaldi A, Calcagnile F, Quarta L Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates DRUG DESIGN DEVELOPMENT AND THERAPY (ISSN: 11778881) 5: pp. 445454. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346553]
559
LiYu J, Perez EC, Canete A, Bonifacio L, Llamado LQ, Martinez R, Lanzon A, Sison M Consensus statements on osteoporosis diagnosis, prevention, and management in the P hilippines INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ISSN: 17561841) 14: (3) pp. 223238. ( 2011) CA: OSPFI
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
152/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [12346552] 560
561
Brewer L, W illiams D, Moore A Current and future treatment options in osteoporosis EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (ISSN: 00316970) 67: (4) pp. 321331. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346551] * Boonen S Current developments and treatments in osteoporosis EJHP PRACTICE (ISSN: 17819989) 17: (4) pp. 1618. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346550]
562
Lecart MP, Reginster JY Current options for the management of postmenopausal osteoporosis EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 12: (16) pp. 25332552. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346549]
563
Sharif PS, Abdollahi M, Larijani B Current, new and future treatments of osteoporosis RHEUMATOLOGY INTERNATIONAL (ISSN: 01728172) 31: (3) pp. 289300. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346548]
564
Silverman SL Defining zoledronate's duration of action and optimal dosing interval for an effective therapy Current Osteoporosis Reports 9: (1) pp. 45. ( 2011) Folyóiratcikk /Rövid közlemény /Tudományos [13474395]
565
Baron R, Ferrari S, Russell RGG Denosumab and bisphosphonates: Different mechanisms of action and effects BONE (ISSN: 87563282) 48: (4) pp. 677692. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346547]
566
* Syversen U, Halse JI, Geisler J, Eriksen EF Denosumab for behandling av postmenopausal osteoporose Tidsskrift for den Norske Laegeforening (ISSN: 00292001) 131: (19) pp. 18931896. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474323]
567
Ominsky MS, Stouch B, Schroeder J, Pyrah I, Stolina M, Smith SY, Kostenuik PJ Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys BONE (ISSN: 87563282) 49: (2) pp. 162173. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346546]
568
Hamdy RC, Price DM, Mottl MM Diagnostic thresholds in osteoporosis: How are they used in clinical trials? Current Osteoporosis Reports 9: (3) pp. 160166. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474322]
569
* Frost ML, Siddique M, Blake GM, Moore AEB, Schleyer PJ, Dunn JT, Somer EJ, Marsden PK, Eastell R, Fogelman I Differential Effects of Teriparatide on Regional Bone Formation Using F18Fluoride P ositron Emission Tomography JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 26: (5) pp. 10021011. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346545]
570
Fairman KA, Curtiss FR Does Medicalization of Life Imperil Health? Expanding Indications for Diagnosis and Treatment of Chronic "Disease" JOURNAL OF MANAGED CARE PHARMACY (ISSN: 10834087) 17: (6) pp. 469480. ( 2011) Folyóiratcikk /Ismertetés /Tudományos [12346544]
571
Hadji P, Gnant M, Aapro M, Lipton A, Coleman R Dosing of zoledronic acid throughout the treatment continuum in breast cancer CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (ISSN: 10408428) 79: (2) pp. 175188. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346543]
572
Khajuria DK, Razdan R, Mahapatra DR Drugs for the management of osteoporosis: A review Revista Brasileira de Reumatologia (ISSN: 04825004) 51: (4) pp. 365382. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474321]
573
Laster AJ, Tanner SB Duration of Treatment in P ostmenopausal Osteoporosis: How Long to Treat and What are the Consequences of Cessation of Treatment? RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (ISSN: 0889857X) 37: (3) pp. 323336. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346542]
574
Zhang QW , W ang YM, Xue QY, Zhang HC Early side effects of zoledronic acid in treating postmenopausal osteoporosis Chinese Journal of New Drugs 20: (8) pp. 757760. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474320]
575
Bubbear JS, Gall A, Middleton FRI, FergusonPell M, Swaminathan R, Keen RW Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (1) pp. 271279. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346541]
576
Lin Hua, Xu Tiansu, Fan Lu, Yang Haiming, Chen Xin, Qian Cheng Effect of 5 mg zoledronic acid on bone mineral density in women with postmenopausal osteoporosis Chinese Journal of Orthopedics (ISSN: 02532352) 31: (12) pp. 13311336. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [14598076]
577
Silverman SL, Kriegman A, Goncalves J, Kianifard F, Carlson T, Leary E Effect of acetaminophen and fluvastatin on postdose symptoms following infusion of zoledronic acid OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (8) pp. 23372345. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346540]
578
* Jamal SA, Hamilton CJ, Eastell R, Cummings SR Effect of Nitroglycerin Ointment on Bone Density and Strength in P ostmenopausal Women A Randomized Trial
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
153/342
3/30/2015
nyomtatobarat forma JAMAJOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (ISSN: 00987484) 305: (8) pp. 800807. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346539] 579
Yamashita J, Koi K, Yang DY, McCauley LK Effect of Zoledronate on Oral Wound Healing in Rats CLINICAL CANCER RESEARCH (ISSN: 10780432) 17: (6) pp. 14051414. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346538]
580
Bachmann G, Kriegman A, Goncalves J, Kianifard F, W arren M, Simon JA Effect of zoledronic acid compared with raloxifene on bone turnover markers in postmenopausal women with low bone density MENOPAUSETHE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (ISSN: 10723714) 18: (8) pp. 851 856. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346537]
581
Lin H, Xu T, Fan L, Yang H, Chen X EFFECT OFA ONCEYEARLY ZOLEDRONIC ACID ON BMD AND THE RISK OF FALLING IN P OSTMENOP AUSAL WOMEN WITH OSTEOP OROSIS OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: pp. S649S650. ( 2011) SU 4 Folyóiratcikk /Absztrakt /Tudományos [14597997]
582
583
* Mackey DC, Black DM, Bauer DC, McCloskey EV, Eastell R, Mesenbrink P, Thompson JR, Cummings SR Effects of Antiresorptive Treatment on Nonvertebral Fracture Outcomes JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 26: (10) pp. 24112418. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346536] Songpatanasilp T, Chanprasertyothin S Effects of differences in polymorphism of gene encoding enzyme faenesyl diphosphate synthase (FDP S), rs2297480, on bone mineral density and biochemical markers of bone turnover in thai postmenopausal women Journal of the Medical Association of Thailand 94: (10 SUP P L.) pp. S38S46. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474319]
584
* Cosman F, Eriksen EF, Recknor C, Miller PD, Guanabens N, Kasperk C, Papanastasiou P, Readie A, Rao H, Gasser JA, BucciRechtweg C, Boonen S Effects of Intravenous Zoledronic Acid P lus Subcutaneous Teriparatide [rhP TH(134)] in P ostmenopausal Osteoporosis JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 26: (3) pp. 503511. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346535]
585
Ochi Y, Yamada H, Mori H, Nakanishi Y, Nishikawa S, Kayasuga R, Kawada N, Kunishige A, Hashimoto Y, Tanaka M, Sugitani M, Kawabata K Effects of ONO5334, a novel orallyactive inhibitor of cathepsin K, on bone metabolism BONE (ISSN: 87563282) 49: (6) pp. 13511356. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346534]
586
Geoffroy V, Paschalis EP, Libouban H, Blouin S, Ostertag A, Chappard D, Cros M, Phipps R, de Vernejoul MC Effects of Risedronate in Runx2 Overexpressing Mice, an Animal Model for Evaluation of Treatment Effects on Bone Quality and Fractures CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 88: (6) pp. 464475. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346533]
587
Pfeifer M, Kohlwey L, Begerow B, Minne HW Effects of Two Newly Developed Spinal Orthoses on Trunk Muscle Strength, P osture, and QualityofLife in Women with P ostmenopausal Osteoporosis A Randomized Trial AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (ISSN: 08949115) 90: (10) pp. 805815. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346532]
588
Tatli U, Ustun Y, Kurkcu M, Erdogan O, Gurbuz CC, Ozgur H, Polat S Effects of Zoledronic Acid on Healing of Mandibular Fractures: An Experimental Study in Rabbits JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (ISSN: 02782391) 69: (6) pp. 17261735. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346530]
589
Zhao Fang, Cong Baohua, Song Fei Efficacy analysis of zoledronic acid treatment for postmenopausal and senile osteoporosis Chinese Journal of Osteoporosis (ISSN: 10067108) 17: (10) pp. 915916,902. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [14598075]
590
Lee S, Glendenning P, Inderjeeth CA Efficacy, side effects and route of administration are more important than frequency of dosing of antiosteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009 OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (3) pp. 741753. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346529]
591
Rossini M, Idolazzi L, Adami S Evidence of sustained vertebral and nonvertebral antifracture efficacy with ibandronate therapy: A systematic review Therapeutic Advances in Musculoskeletal Disease 3: (2) pp. 6779. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474318]
592
Lippuner K, Popp A, Schwab P, Gitlin M, Schaufler T, Senn C, Perrelet R Fracture hospitalizations between years 2000 and 2007 in Switzerland: a trend analysis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (9) pp. 24872497. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346528]
593
Premaor MO, Das TK, Debiram I, Parker RA, Ninkovic M, Alexander GT, Compston JE Fracture incidence after liver transplantation: results of a 10year audit QJMAN INTERNATIONAL JOURNAL OF MEDICINE (ISSN: 14602725) 104: (7) pp. 599606. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346527]
594
Charopoulos I, Orme S, Giannoudis PV Fracture risk associated with chronic use of bisphosphonates: evidence today EXPERT OPINION ON DRUG SAFETY (ISSN: 14740338) 10: (1) pp. 6776. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346526]
595
Fraser LA, Ioannidis G, Adachi JD, Pickard L, Kaiser SM, Prior J, Brown JP, Hanley DA, Olszynski W P, Anastassiades T, Jamal S, Josse R, Goltzman D, Papaioannou A
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
154/342
3/30/2015
nyomtatobarat forma Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (3) pp. 789796. ( 2011) CA: CaMos Res Group Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [12346525] 596
Grob GN From Aging to P athology: The Case of Osteoporosis JOURNAL OF THE HISTORY OF MEDICINE AND ALLIED SCIENCES (ISSN: 00225045) 66: (1) pp. 139. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346524]
597
Cawthon PM Gender Differences in Osteoporosis and Fractures CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (ISSN: 0009921X) 469: (7) pp. 19001905. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346523]
598
Bonnick SL Going on a Drug Holiday? JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 14: (4) pp. 377383. ( 2011) Folyóiratcikk /Ismertetés /Tudományos [12346522]
599
Girgis CM, Seibel MJ Guilt by association? Examining the role of bisphosphonate therapy in the development of atypical femur fractures BONE (ISSN: 87563282) 48: (5) pp. 963965. ( 2011) Folyóiratcikk /Ismertetés /Tudományos [12346521]
600
* Sambrook PN, Silverman SL, Cauley JA, Recknor C, Olson M, Su G, Boonen S, Black D, Adachi JD Healthrelated quality of life and treatment of postmenopausal osteoporosis: Results from the HORIZONP FT BONE (ISSN: 87563282) 48: (6) pp. 12981304. ( 2011) CA: HORIZON Pivotal Fracture Trial Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [12346520]
601
Cotter AG, Mallon PW G HIV infection and bone disease: implications for an aging population SEXUAL HEALTH (ISSN: 14485028) 8: (4) pp. 493501. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346519]
602
Body JJ HOW TO MANAGE P OSTMENOP AUSAL OSTEOP OROSIS? ACTA CLINICA BELGICA (ISSN: 00015512) 66: (6) pp. 443447. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346518]
603
Park SJ, Kim JH, Ha TS, Shin JI Hypophosphatemia in patients with autosomal dominant polycystic kidney disease: The role of fibroblast growth factor 23 or loss of sodium/phosphate cotransporter Kidney International (ISSN: 00852538) 80: (5) pp. 554555. ( 2011) Teljes dokumentumban: Ott MS; Drueke BT; Moe MS: To authors reply. Kidney International ( 2011) 80, 554. Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [13474314]
604
Adachi JD, Josse RG, Russell RGG If you don't take it it can't work: the consequences of not being treated or nonadherence to osteoporosis therapy THERAPEUTICS AND CLINICAL RISK MANAGEMENT (ISSN: 11766336) 7: pp. 181198. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346517]
605
Cotton D, Taichman D, W illiams S, W riter P, Lewiecki EM In the clinic: Osteoporosis Annals of Internal Medicine (ISSN: 00034819) 155: (1) p. 71. ( 2011) Folyóiratcikk /Rövid közlemény /Tudományos [13474313]
606
Rizzoli R, Kraenzlin M, Krieg MA, Mellinghoff HU, Lamy O, Lippuner K Indications to teriparatide treatment in patients with osteoporosis SWISS MEDICAL WEEKLY (ISSN: 14247860) 141: P aper w13297. (2011) Folyóiratcikk /Szakcikk /Tudományos [12346516]
607
Erichsen R, Christiansen CF, Froslev T, Jacobsen J, Sorensen HT Intravenous bisphosphonate therapy and atrial fibrillation/flutter risk in cancer patients: a nationwide cohort study BRITISH JOURNAL OF CANCER (ISSN: 00070920) 105: (7) pp. 881883. ( 2011) Folyóiratcikk /Rövid közlemény /Tudományos [12346515]
608
Yeh Y, Slovik D, Carter D, Clapp M, Churchill W , Reddy P Intravenous bisphosphonates for postmenopausal osteoporosis: adherence to a network guideline JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (ISSN: 02694727) 36: (3) pp. 342347. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346514]
609
Craig SJ, Youssef PP, Vaile JH, Sullivan L, Bleasel JF Intravenous zoledronic acid and oral alendronate in patients with a low trauma fracture: experience from an osteoporosis clinic INTERNAL MEDICINE JOURNAL (ISSN: 14440903) 41: (2) pp. 186190. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346513]
610
Pulkkinen P, Gluer CC, Jamsa T Investigation of differences between hip fracture types: A worthy strategy for improved risk assessment and fracture prevention BONE (ISSN: 87563282) 49: (4) pp. 600604. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346512]
611
Borromeo GL, Brand C, Clement JG, McCullough M, Thomson W , Flitzanis E, W ark JD Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A casecontrolled study BMC MUSCULOSKELETAL DISORDERS (ISSN: 14712474) 12: P aper 71. (2011) Folyóiratcikk /Szakcikk /Tudományos [12346511]
612
Squarzoni I, Cocco C, Caruso B, Righetti G, Viapiana O, Abaterusso C, Lupo A, Graziani MS Is it possible to use the identification of neutrophil gelatinase associated lipocalin (NGAL) in the evaluation of bisphosphonates nephrotoxicity? Biochimica Clinica (ISSN: 03930564) 35: (4) pp. 331333. ( 2011) Folyóiratcikk /Rövid közlemény /Tudományos [13474312]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
155/342
3/30/2015
nyomtatobarat forma 613
Devogelaer JP, Boutsen Y, Gruson D, Manicourt D Is There a P lace for Bone Turnover Markers in the Assessment of Osteoporosis and its Treatment? RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (ISSN: 0889857X) 37: (3) pp. 365386. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346510]
614
Ott SM, Drueke TB, Moe SM KDIGO clinical practice guidelines for biphosphonate treatment in chronic kidney disease Reply KIDNEY INTERNATIONAL (ISSN: 00852538) 80: (5) pp. 554554. ( 2011) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12346509]
615
Panteliou E, Young N, Naysmith M Lifethreatening hyperkalemia following zoledronic acid infusion for P aget's disease: A case report Journal of Medical Case Reports (ISSN: 17521947) 5: P aper 367. (2011) Folyóiratcikk /Rövid közlemény /Tudományos [13474311]
616
Yoon RS, Hwang JS, Beebe KS Longterm bisphosphonate usage and subtrochanteric insufficiency fractures A CAUSE FOR CONCERN? JOURNAL OF BONE AND JOINT SURGERYBRITISH VOLUME (ISSN: 0301620X) 93B: (10) pp. 12891295. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346508]
617
Edgington A, Morgan MA Looking beyond recurrence: Comorbidities in cancer survivors Clinical Journal of Oncology Nursing (ISSN: 10921095) 15: (1) pp. E3E12. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474394]
618
Hadji P Managing bone health with zoledronic acid: a review of randomized clinical study results CLIMACTERIC (ISSN: 13697137) 14: (3) pp. 321332. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346507]
619
Doi Y, Miyazaki M, Yoshiiwa T, Hara K, Kataoka M, Tsumura H Manipulation of the anabolic and catabolic responses with BMP 2 and zoledronic acid in a rat femoral fracture model BONE (ISSN: 87563282) 49: (4) pp. 777782. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346506]
620
* Vasikaran S, Eastell R, Bruyere O, Foldes AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T, W ahl DA, Cooper C, Kanis JA Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (2) pp. 391420. ( 2011) CA: IOFIFCC Bone Marker Stand W orking Folyóiratcikk /Szakcikk /Tudományos [12346505]
621
Langdahl BL, Harsløf T Medical treatment of osteoporotic vertebral fractures Therapeutic Advances in Musculoskeletal Disease 3: (1) pp. 1729. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474393]
622
Leung S, LeFrancois D, Eisen LA Metforminassociated lactic acidosis precipitated by zoledronic acidinduced acute kidney injury: A case of polypharmacy in an elderly patient Clinical Geriatrics (ISSN: 10951598) 19: (2) pp. 5052. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474392]
623
Senn C, Lippuner K Monoclonal antibodies for the treatment of osteoporosis New clinical data Journal fur Mineralstoffwechsel 18: (SONDERHEFT 2) pp. 1220. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474391]
624
Haworth CS, Sharples L, Hughes V, Elkin SL, Hodson ME, Conway SP, Etherington C, Elborn JS, Rendall J, W heaton E, Kadri E, Elliott J, Barker HC, Bearcroft PW P, Hlaing T, Compston JE Multicentre trial of weekly risedronate on bone density in adults with cystic fibrosis JOURNAL OF CYSTIC FIBROSIS (ISSN: 15691993) 10: (6) pp. 470476. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346504]
625
Sridhar B, Ravikumar K Multiple hydrogen bonds in cytosinium zoledronate trihydrate ACTA CRYSTALLOGRAPHICA SECTION CCRYSTAL STRUCTURE COMMUNICATIONS (ISSN: 01082701) 67: pp. O115 O119. ( 2011) PN: Part 3 Folyóiratcikk /Szakcikk /Tudományos [12346503]
626
Guven Z, Celiker R, Atalay A, Bagis S New Agents for the Treatment of Osteoporosis TURKIYE FIZIKSEL TIP VE REHABILITASYON DERGISITURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION 57: (3) pp. 165171. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346502]
627
Silva BC, Bilezikian JP New Approaches to the Treatment of Osteoporosis ANNUAL REVIEW OF MEDICINE (ISSN: 00664219) 62: pp. 307322. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346501]
628
Ebeling PR New drugs for osteoporosis AUSTRALIAN PRESCRIBER (ISSN: 03128008) 34: (6) pp. 176181. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346500]
629
Lewiecki EM New targets for intervention in the treatment of postmenopausal osteoporosis NATURE REVIEWS RHEUMATOLOGY (ISSN: 17594790) 7: (11) pp. 631638. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346499]
630
Makras P, Anastasilakis AD, Polyzos SA, Bisbinas I, Sakellariou GT, Papapoulos SE No Effect of Rosuvastatin in the ZoledronateInduced AcuteP hase Response
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
156/342
3/30/2015
nyomtatobarat forma CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 88: (5) pp. 402408. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346498] 631
Luchavová M, Raška I Novelties and possibility of prevention and treatment in the outpatient clinic of general practicioner Interni Medicina pro Praxi (ISSN: 12127299) 13: (2) pp. 7074. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474390]
632
* Masud T, Binkley N, Boonen S, Hannan MT Official P ositions for FRAX (R) Clinical Regarding Falls and Frailty: Can Falls and Frailty be Used in FRAX (R)? JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 14: (3) pp. 194204. ( 2011) CA: FRAX Position Dev Conf Members Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [12346497]
633
* Cauley JA, Black D, Boonen S, Cummings SR, Mesenbrink P, Palermo L, Man Z, Hadji P, Reid IR OnceYearly Zoledronic Acid and Days of Disability, Bed Rest, and Back P ain: Randomized, Controlled HORIZON P ivotal Fracture Trial JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 26: (5) pp. 984992. ( 2011) CA: HORIZON Pivotal Fracture Grp Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [12346496]
634
* Boonen S, Orwoll E, Magaziner J, ColonEmeric CS, Adachi JD, BucciRechtweg C, Haentjens P, Kaufman JM, Rizzoli R, Vanderschueren D, Claessens F, Sermon A, W itvrouw R, Milisen K, Su G, Lyles KW OnceYearly Zoledronic Acid in Older Men Compared with Women with Recent Hip Fracture JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (ISSN: 00028614) 59: (11) pp. 20842090. ( 2011) CA: HORIZON Recurrent Fracture Trial Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [12346495]
635
Aljumaily R, Mathew P Optimal Management of Bone Metastases in P rostate Cancer CURRENT ONCOLOGY REPORTS (ISSN: 15233790) 13: (3) pp. 222230. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346494]
636
Rossini M, Di Munno O, Gatti D, Giannini S, Minisola S, Varenna M, Adami S Optimising bisphosphonate treatment outcomes in postmenopausal osteoporosis: review and Italian experience CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (ISSN: 0392856X) 29: (4) pp. 728735. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346493]
637
Christensen S, Mehnert F, Chapurlat RD, Baron JA, Sorensen HT Oral bisphosphonates and risk of ischemic stroke: a casecontrol study OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (6) pp. 17731779. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346492]
638
Sambrook PN, Cameron ID, Chen JS, March LM, Simpson JM, Cumming RG, Seibel MJ Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective fiveyear study OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (9) pp. 25512556. ( 2011) Folyóiratcikk /Rövid közlemény /Tudományos [12346491]
639
Gruber R Osteonecrosis of the jaw Austrian Journal of Clinical Endocrinology and Metabolism 4: (1) pp. 812. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474389]
640
Pazianas M Osteonecrosis of the Jaw and the Role of Macrophages JOURNAL OF THE NATIONAL CANCER INSTITUTE (ISSN: 00278874) 103: (3) pp. 232240. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346490]
641
Otto S, Sotlar K, Ehrenfeld M, Pautke C Osteonecrosis of the jaw as a possible rare side effect of annual bisphosphonate administration for osteoporosis: A case report Journal of Medical Case Reports (ISSN: 17521947) 5: P aper 477. (2011) Folyóiratcikk /Rövid közlemény /Tudományos [13474310]
642
Baillargeon J, Kuo YF, Lin YL, W ilkinson GS, Goodwin JS Osteonecrosis of the Jaw in Older Osteoporosis P atients Treated with Intravenous Bisphosphonates ANNALS OF PHARMACOTHERAPY (ISSN: 10600280) 45: (10) pp. 11991206. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346489]
643
Zini M Osteoporosis Rivista Italiana della Medicina di Laboratorio 7: (2) pp. 100105. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474309]
644
Hamilton CJ, Jamal SA, Bogoch ER Osteoporosis and Metabolic Disorders In: EvidenceBased Orthopedics. Wiley Blackwell, 2011. (ISBN 1405184760) pp. 3555.
Könyvrészlet /Könyvfejezet /Tudományos [13474308] 645
Oyen J, Brudvik C, Gjesdal CG, Tell GS, Lie SA, Hove LM Osteoporosis as a Risk Factor for Distal Radial Fractures A CaseControl Study JOURNAL OF BONE AND JOINT SURGERYAMERICAN VOLUME (ISSN: 00219355) 93A: (4) pp. 348356. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346488]
646
Cortet B Osteoporosis medications and renal failure JOINT BONE SPINE (ISSN: 1297319X) 78: (3) pp. 228229. ( 2011) Folyóiratcikk /Ismertetés /Tudományos [12346487]
647
Grossman JM Osteoporosis prevention CURRENT OPINION IN RHEUMATOLOGY (ISSN: 10408711) 23: (2) pp. 203210. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346486]
648
Ragucci KR, Shrader SP Osteoporosis Treatment An EvidenceBased Approach JOURNAL OF GERONTOLOGICAL NURSING (ISSN: 00989134) 37: (7) pp. 1722. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346485]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
157/342
3/30/2015
nyomtatobarat forma 649
Jay RH, Marrinan SL Osteoporosis treatment and the older patient Reviews in Clinical Gerontology 21: (3) pp. 233245. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474307]
650
Schuiling KD, Robinia K, Nye R Osteoporosis Update JOURNAL OF MIDWIFERY & WOMENS HEALTH (ISSN: 15269523) 56: (6) pp. 615627. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346484]
651
Lewiecki EM, Bilezikian JP, Khosla S, Marcus R, McClung MR, Miller PD, W atts NB, Maricic M Osteoporosis Update From the 2010 Santa Fe Bone Symposium JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 14: (1) pp. 121. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346483]
652
Dedov I I, Melnichenko G A, Belaya Zh E, Rozhinskaya L Ya Osteoporosis: from a rare symptom of endocrine diseases to the tacit epidemic of XXXXI centuries Problemy Endokrinologii (ISSN: 03759660) 57: (1) pp. 3545. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12426265]
653
Rachner TD, Khosla S, Hofbauer LC Osteoporosis: now and the future LANCET (ISSN: 01406736) 377: (9773) pp. 12761287. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346482]
654
Vyskočil V Overview of current treatment options in antiresorptive Klinicka Farmakologie a Farmacie 25: (2) pp. 6470. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474306]
655
Baun L, Russell TM Overview of the management of osteoporosis in women U.S. Pharmacist 36: (9) pp. 3036. ( 2011) Folyóiratcikk /Rövid közlemény /Tudományos [13474305]
656
Cipriani C, Romagnoli E, Minisola S P harmacological treatment of Osteoporosis Old and new drugs European Musculoskeletal Review 6: (2) pp. 8387. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474387]
657
Chua W M, Nandi N, Masud T P harmacological treatments for osteoporosis in very elderly people Therapeutic Advances in Chronic Disease 2: (4) pp. 279286. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474304]
658
Čerbák R P harmacotherapy and the aortic stenosis progression Intervencni a Akutni Kardiologie 10: (56) pp. 240244. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474303]
659
Hodgkinson JA, Taylor CJ, Hobbs FDR P redictors of incident atrial fibrillation and influence of medications: A retrospective casecontrol study British Journal of General Practice (ISSN: 09601643) 61: (587) pp. e353e361. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474302]
660
Stevenson JC P revention of osteoporosis: One step forward, two steps back Menopause International 17: (4) pp. 137141. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474301]
661
Zhao XM, Xu XF, Zhang QL, Jia Z, Sun S, Zhang J, W ang BY, W ang ZH, Hu XC P rognostic and predictive value of clinical and biochemical factors in breast cancer patients with bone metastases receiving "metronomic" zoledronic acid BMC CANCER (ISSN: 14712407) 11: P aper 403. (2011) Folyóiratcikk /Szakcikk /Tudományos [12346481]
662
Huang Peng, Zhang Shenqi, Guo Yanmei P rogress in osteoporosis treatment Chinese Journal of Osteoporosis (ISSN: 10067108) 17: (11) pp. 10191024. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [14598074]
663
Polyzos SA P rolonged antiresorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with P aget's disease of bone CLINICAL RHEUMATOLOGY (ISSN: 07703198) 30: (1) pp. 149150. ( 2011) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12346480]
664
Sosa M, GonzálezPadilla E P romising developments in osteoporosis treatment International Journal of Clinical Rheumatology (ISSN: 17584272) 6: (3) pp. 325332. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474300]
665
Stewart DL P ROSTHODONTIC TREATMENT OF A P ATIENT TAKING NITROGENCONTAINING BISP HOSP HONATES TO P RESERVE THE INTEGRITY OF THE EP ITHELIAL ATTACHMENT: A CLINICAL REP ORT JOURNAL OF PROSTHETIC DENTISTRY (ISSN: 00223913) 106: (6) pp. 350354. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346479]
666
Yuksel N P utting longterm adverse events of bisphosphonates into perspective Canadian Pharmacists Journal 144: (SP EC. ISSUE) pp. S13S14. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474386]
667
Blake GM, Siddique M, Frost ML, Moore AEB, Fogelman I Radionuclide studies of bone metabolism: Do bone uptake and bone plasma clearance provide equivalent measurements of bone turnover?
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
158/342
3/30/2015
nyomtatobarat forma BONE (ISSN: 87563282) 49: (3) pp. 537542. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346478] 668
Hudson B, Toop L, Mangin D, Pearson J Risk communication methods in hip fracture prevention: A randomised trial in primary care British Journal of General Practice (ISSN: 09601643) 61: (589) pp. e469e476. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474291]
669
Hollick RJ, Reid DM Role of bisphosphonates in the management of postmenopausal osteoporosis: An update on recent safety anxieties Menopause International 17: (2) pp. 6672. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474290]
670
Rakel A, Boucher A, SteMarie LG Role of zoledronic acid in the prevention and treatment of osteoporosis CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 6: pp. 8999. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346477]
671
* Eastell R, Nagase S, Ohyama M, Small M, Sawyer J, Boonen S, Spector T, Kuwayama T, Deacon S Safety and Efficacy of the Cathepsin K Inhibitor ONO5334 in P ostmenopausal Osteoporosis: The OCEAN Study JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 26: (6) pp. 13031312. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346476]
672
Lewiecki EM Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis Drug, Healthcare and Patient Safety 3: (1) pp. 7991. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474289]
673
Pazianas M, Abrahamsen B Safety of bisphosphonates BONE (ISSN: 87563282) 49: (1) pp. 103110. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346475]
674
Lewiecki EM Safety of LongTerm Bisphosphonate Therapy for the Management of Osteoporosis DRUGS (ISSN: 00126667) 71: (6) pp. 791814. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346474]
675
Coleman R, W oodward E, Brown J, Cameron D, Bell R, Dodwell D, Keane M, Gil M, Davies C, Burkinshaw R, Houston SJ, Grieve RJ, BarrettLee PJ, Thorpe H Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 0104) for women with stage II/III breast cancer BREAST CANCER RESEARCH AND TREATMENT (ISSN: 01676806) 127: (2) pp. 429438. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346473]
676
Lewiecki EM Sclerostin monoclonal antibody therapy with AMG 785: a potential treatment for osteoporosis EXPERT OPINION ON BIOLOGICAL THERAPY (ISSN: 14712598) 11: (1) pp. 117127. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346472]
677
Lewiecki E Michael Sclerostin: A Novel Target for Intervention in the Treatment of Osteoporosis DISCOVERY MEDICINE (ISSN: 15396509) 65: pp. 263273. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [14597993]
678
Tang Songtao, Liu Anyin, Zhang Qiu Screening of high risk population of osteoporosis using FRAX method Chinese Journal of Osteoporosis (ISSN: 10067108) 17: (11) pp. 984988. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [14598069]
679
Vidal M A, Medina C, Torres L M Seguridad de los bifosfonatos: Safety of bisphosphonates Revista de la Sociedad Española del Dolor (ISSN: 11348046) 18: (1) pp. 4355. ( 2011) Folyóiratcikk [14598066]
680
* Boonen S, Milisen K, Gielen E, Vanderschueren D Sequential therapy in the treatment of osteoporosis CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 27: (6) pp. 11491155. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346471]
681
Belaya ZE Should we really compare absolute risk reduction in different trials on osteoporosis: comment on the article by Ringe JD and Doherty JG RHEUMATOLOGY INTERNATIONAL (ISSN: 01728172) 31: (12) pp. 16691671. ( 2011) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12346470]
682
Rizzoli R, Akesson K, Bouxsein M, Kanis JA, Napoli N, Papapoulos S, Reginster JY, Cooper C Subtrochanteric fractures after longterm treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (2) pp. 373390. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346469]
683
Yu Bolong, Li Yikai The adverse effects of bisphosphonates application Chinese Journal of Osteoporosis (ISSN: 10067108) 17: (1) pp. 8085. ( 2011) Folyóiratcikk [14598065]
684
Blake GM, Frost ML, Moore AEB, Siddique M, Fogelman I The Assessment of Regional Skeletal Metabolism: Studies of Osteoporosis Treatments Using Quantitative Radionuclide Imaging JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 14: (3) pp. 263271. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346468]
685
* Hwang JS, Chin LS, Chen JF, Yang TS, Chen PQ, Tsai KS, Leung PC The effects of intravenous zoledronic acid in Chinese women with postmenopausal osteoporosis JOURNAL OF BONE AND MINERAL METABOLISM (ISSN: 09148779) 29: (3) pp. 328333. ( 2011)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
159/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [12346467] 686
Jansen JP, Bergman GJD, Huels J, Olson M The Efficacy of Bisphosphonates in the P revention of Vertebral, Hip, and NonvertebralNonhip Fractures in Osteoporosis: A Network MetaAnalysis SEMINARS IN ARTHRITIS AND RHEUMATISM (ISSN: 00490172) 40: (4) pp. 275284.e2. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346466]
687
Bell AD, Bell BR The FREEDOM trial Is family medicine ready for biologic therapies? CANADIAN FAMILY PHYSICIAN (ISSN: 0008350X) 57: (4) pp. 438441. ( 2011) Folyóiratcikk /Ismertetés /Tudományos [12346465]
688
Rousiere M The importance of taking care of osteoporosis PRESSE MEDICALE (ISSN: 07554982) 40: (10) pp. 900909. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346464]
689
Miller PD The kidney and bisphosphonates BONE (ISSN: 87563282) 49: (1) pp. 7781. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346463]
690
W ang Li, Yang Yi, Zhang Xuejun The pain relief and safety observation of zoledronic acid for the treatment of 50 cases or primary osteoporosis Chinese Journal of Osteoporosis (ISSN: 10067108) 17: (12) pp. 10921094. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [14598063]
691
Sandhu SK, Hampson G The pathogenesis, diagnosis, investigation and management of osteoporosis JOURNAL OF CLINICAL PATHOLOGY (ISSN: 00219746) 64: (12) pp. 10421050. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346462]
692
Vukicevic S, Grgurevi L The P EARL trial: Lasofoxifene and incidence of fractures, breast cancer and cardiovascular events in postmenopausal osteoporotic women International Journal of Clinical Rheumatology (ISSN: 17584272) 6: (4) pp. 387391. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474288]
693
Siddique M, Frost ML, Blake GM, Moore AEB, AlBeyatti Y, Marsden PK, Schleyer PJ, Fogelman I The P recision and Sensitivity of F18Fluoride P ET for Measuring Regional Bone Metabolism: A Comparison of Quantification Methods JOURNAL OF NUCLEAR MEDICINE (ISSN: 01615505) 52: (11) pp. 17481755. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346461]
694
Ebetino FH, Hogan AML, Sun S, Tsoumpra MK, Duan X, Triffitt JT, Kwaasi AA, Dunford JE, Barnett BL, Oppermann U, Lundy MW , Boyde A, Kashemirov BA, McKenna CE, Russell RGG The relationship between the chemistry and biological activity of the bisphosphonates Bone (ISSN: 87563282) 49: (1) pp. 2033. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474287]
695
Hopkins RB, Goeree R, Pullenayegum E, Adachi JD, Papaioannou A, Xie F, Thabane L The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in postmenopausal women BMC MUSCULOSKELETAL DISORDERS (ISSN: 14712474) 12: P aper 209. (2011) Folyóiratcikk /Szakcikk /Tudományos [12346460]
696
Cvikl B, Agis H, Stogerer K, Moritz A, W atzek G, Gruber R The response of dental pulpderived cells to zoledronate depends on the experimental model INTERNATIONAL ENDODONTIC JOURNAL (ISSN: 01432885) 44: (1) pp. 3340. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346459]
697
Lewiecki EM The role of risk communication in the care of osteoporosis Current Osteoporosis Reports 9: (3) pp. 141148. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474286]
698
Kamienski M, Tate D, Vega CPTM The Silent Thief Diagnosis and Management of Osteoporosis ORTHOPAEDIC NURSING 30: (3) pp. 162171. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346458]
699
Lyons KJ, Majumdar SR, Ezekowitz JA The Unrecognized Burden of OsteoporosisRelated Vertebral Fractures in P atients With Heart Failure CIRCULATIONHEART FAILURE 4: (4) pp. 419424. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346457]
700
Majanović SK, Orlić ZC, Eržen DJ, Palčevski VV, Štmac D Therapeutic approach to osteoporosis Medicina Fluminensis 47: (3) pp. 233245. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474285]
701
Spazzapan S, Crivellari D, Bedard P, Lombardi D, Miolo G, Scalone S, Veronesi A Therapeutic management of breast cancer in the elderly EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 12: (6) pp. 945960. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346456]
702
Karga H, Giagourta I, Papaioannou G, Katsichti P, Pardalakis A, Kassi G, Zagoreou A, Triantaphyllopoulou M, Zerva C Transient changes in thyroid functions tests after zoledronic acid infusion ENDOCRINE JOURNAL (ISSN: 09188959) 58: (11) pp. 969977. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346455]
703
Su K, Shi XT, Varshney RR, W ang DA Transplantable delivery systems for in situ controlled release of bisphosphonate in orthopedic therapy EXPERT OPINION ON DRUG DELIVERY (ISSN: 17425247) 8: (1) pp. 113126. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346454]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
160/342
3/30/2015
nyomtatobarat forma 704
Ko SS, Jordan VC Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene (Retracted article. See vol. 13, pg. 1081, 2012) EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 12: (4) pp. 657674. ( 2011) Folyóiratcikk /Ismertetés /Tudományos [12346453]
705
Gosch M, Roth T, Kammerlander C, JoostenGstrein B, BenvenutiFalger U, Blauth M, Lechleitner M Treatment of osteoporosis in postmenopausal hip fracture patients after geriatric rehabilitation Changes over the last decade ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE 44: (6) pp. 381386. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346452]
706
* Boonen S, Adachi JD, Man Z, Cummings SR, Lippuner K, Torring O, Gallagher JC, Farrerons J, W ang A, Franchimont N, San Martin J, Grauer A, McClung M Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in P ostmenopausal Women at High Risk JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 96: (6) pp. 17271736. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346451]
707
Cortet B Treatments of osteoporosis and kidney failure Revue du Rhumatisme (Edition Francaise) 78: (2) pp. 107108. ( 2011) Folyóiratcikk /Ismertetés /Tudományos [13474385]
708
Gold DT Understanding P atient Compliance and P ersistence with Osteoporosis Therapy DRUGS & AGING (ISSN: 1170229X) 28: (4) pp. 249255. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346450]
709
de Santis A Update in endocrinology: Evidence published in 2010 Annals of Internal Medicine (ISSN: 00034819) 154: (10) pp. 684689. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474284]
710
Schwarz H, Thierolf R Update: Treatment of osteoporosis to prevent fractures in traumatology Journal fur Mineralstoffwechsel 18: (SUP P L.1) pp. 1822. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474384]
711
Raef H, AlBugami M, Balharith S, Moawad M, ElShaker M, Hussain A, AlShaikh A, AlBadawi I Updated Recommendations for the Diagnosis and Management of Osteoporosis: A Local P erspective ANNALS OF SAUDI MEDICINE (ISSN: 02564947) 31: (2) pp. 111+. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346449]
712
Papapoulos SE Use of bisphosphonates in the management of postmenopausal osteoporosis BISPHOSPHONATES AND OSTEONECROSIS OF THE JAW 1218: pp. 1532. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346448]
713
Henriksen K, Leeming DJ, Christiansen C, Karsdal MA Use of bone turnover markers in clinical osteoporosis assessment in women: Current issues and future options Women's Health (ISSN: 17455057) 7: (6) pp. 689698. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474283]
714
Pedrazzoni M, Giusti A, Pioli G Uses and misuses of statistics: The case of strontium ranelate and the number needed to treat JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (ISSN: 03914097) 34: (8) pp. 572575. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346447]
715
Diacinti D, Pisani D, Del Fiacco R, Francucci CM, Fiore CE, Frediani B, Barone A, Bartalena T, Cattaruzza MS, Guglielmi G, Diacinti D, Romagnoli E, Minisola S Vertebral morphometry by Xray absorptiometry: Which reference data for vertebral heights? BONE (ISSN: 87563282) 49: (3) pp. 526536. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346446]
716
Ebeling PR, Eisman JA Vitamin D and osteoporosis In: Vitamin D. Elsevier Inc., 2011. (ISBN 9780123819789) pp. 11291144.
Könyvrészlet /Könyvfejezet /Tudományos [13474282] 717
Audran M, Cortet B, Thomas T What do we know about atypical femoral fractures? Insights and enigmas JOINT BONE SPINE (ISSN: 1297319X) 78: (6) pp. 568571. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346445]
718
Audran M, Cortet B, Thomas T What is known of atypical femoral fractures? Between progress and the unknown Revue du Rhumatisme (Edition Francaise) 78: (5) pp. 423426. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474281]
719
W inzenberg T, Jones G When do bisphosphonates make the most sense? A Cochrane Musculoskeletal Group review JOURNAL OF FAMILY PRACTICE (ISSN: 00943509) 60: (1) pp. 1828. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346444]
720
Coleman R, Burkinshaw R, W inter M, NevilleW ebbe H, Lester J, W oodward E, Brown J Zoledronic acid EXPERT OPINION ON DRUG SAFETY (ISSN: 14740338) 10: (1) pp. 133145. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346443]
721
Arslan C, Aksoy S, Dizdar O, Dede DS, Harputluoglu H, Altundag K Zoledronic acid and atrial fibrillation in cancer patients SUPPORTIVE CARE IN CANCER (ISSN: 09414355) 19: (3) pp. 425430. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346442]
722
W ynn RL Zoledronic acid and osteonecrosis of the jaw: Incidence varies with use
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
161/342
3/30/2015
nyomtatobarat forma General Dentistry 59: (5) pp. 330332. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474280] 723
Ressler S, Mlineritsch B, Greil R Zoledronic acid for adjuvant use in patients with breast cancer EXPERT REVIEW OF ANTICANCER THERAPY (ISSN: 14737140) 11: (3) pp. 333349. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346441]
724
Recknor C Zoledronic acid for prevention and treatment of osteoporosis EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 12: (5) pp. 807815. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346440]
725
Nie H, Peng C, Hao J, Hu ZM, An H Zoledronic acid in preventing fractures in women with postmenopausal osteoporosis: A meta analysis Academic Journal of Second Military Medical University 32: (9) pp. 985990. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474279]
726
Shapiro CL, Halabi S, Hars V, Archer L, W eckstein D, Kirshner J, Sikov W , W iner E, Burstein HJ, Hudis C, Isaacs C, Schilsky R, Paskett E Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809 EUROPEAN JOURNAL OF CANCER (ISSN: 09598049) 47: (5) pp. 683689. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346439]
727
Kim JE, Ahn JH, Jung KH, Kim SB, Kim HJ, Lee KS, Ro JS, Park YH, Ahn JS, Im YH, Im SA, Lee MH, Kim SY Zoledronic acid prevents bone loss in premenopausal women with early breast cancer undergoing adjuvant chemotherapy: a phase III trial of the Korean Cancer Study Group (KCSGBR0601) BREAST CANCER RESEARCH AND TREATMENT (ISSN: 01676806) 125: (1) pp. 99106. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346438]
728
* Boonen S, Luyten F, Borghs H, Vanderschueren D Zoledronic acid to reduce osteoporotic fracture risk Tijdschrift voor Geneeskunde (ISSN: 0371683X) 67: (5) pp. 215222. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13474383]
729
Vuorimies I, ToiviainenSalo S, Hero M, Makitie O Zoledronic Acid Treatment in Children with Osteogenesis Imperfecta HORMONE RESEARCH IN PAEDIATRICS (ISSN: 16632818) 75: (5) pp. 346353. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12346437]
730
李莹, 宁永明, 张春霖, 娄朝晖, 严旭 唑来膦酸治疗椎体成形术后残余疼痛早期疗效观察 Chinese Journal of Trauma (ISSN: 10018050) 27: (5) pp. 461462. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [14598081]
731
Sheng Hui Li W enjun, Shengchun Jun W ang, W uguo Ting, Qinling Chinese Journal of Geriatrics (ISSN: 02549026) 31: (8) pp. 641645. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [14597975]
732
Daichen Lin, Zhu Mei Chinese Journal of Geriatrics (ISSN: 02549026) 31: (10) pp. 923926. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [14597976]
733
Yuanyuan Xing, Li Qing, Mei Liangdao Chen Zhang, Hai, Fanzhi Dan Chinese Journal of Gerontology (ISSN: 10059202) 32: (11) pp. 23952396. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [14597977]
734
Anonymus Chinese Journal of Cardiology (ISSN: 02533758) 40: (1) pp. 8285. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [14597978]
735
Briot K, Cortet B, Thomas T, Audran M, Blain H, Breuil V, Chapuis L, Chapurlat R, Fardellone P, Feron JM, Gauvain JB, Guggenbuhl P, Kolta S, Lespessailles E, Letombe B, Marcelli C, Orcel P, Seret P, Trémollières F, Roux C 2012 update of French guidelines for medical treatment of postmenopausal osteoporosis Revue de Geriatrie 37: (7) pp. 469479. ( 2012) Folyóiratcikk /Jelentés /Tudományos [13473949]
736
Briot K, Cortet B, Thomas T, Audran M, Blain H, Breuil V, Chapuis L, Chapurlat R, Fardellone P, Feron JM, Gauvain JB, Guggenbuhl P, Kolta S, Lespessailles E, Letombe B, Marcelli C, Orcel P, Seret P, Tremollieres F, Rouxa C 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis JOINT BONE SPINE (ISSN: 1297319X) 79: (3) pp. 304313. ( 2012) Folyóiratcikk /Jelentés /Tudományos [12426263]
737
Lin Hua, Xu Tianshu, Fan Lu 5 mg zoledronic acid for treatment of postmenopausal women with osteoporosis and osteoporotic fracture Chinese Journal of Orthopaedic Trauma (ISSN: 16717600) 14: (1) pp. 3135. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [14597974]
738
Kanis JA, Reginster JY, Kaufman JM, Ringe JD, Adachi JD, Hiligsmann M, Rizzoli R, Cooper C A reappraisal of generic bisphosphonates in osteoporosis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (1) pp. 213221. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346436]
739
Richards JS, Cannon GW , Hayden CL, Amdur RL, Lazaro D, Mikuls TR, Reimold AM, Caplan L, Johnson DS, Schwab P, Cherascu BN, Kerr GS Adherence with bisphosphonate therapy in US veterans with rheumatoid arthritis Arthritis Care and Research (ISSN: 08937524) 64: (12) pp. 18641870. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473948]
740
Demontiero O, Vidal C, Duque G Aging and bone loss: New insights for the clinician Therapeutic Advances in Musculoskeletal Disease 4: (2) pp. 6176. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474278]
741
BarrettConnor E, Swern AS, Hustad CM, Bone HG, Liberman UA, Papapoulos S, W ang H, de Papp A, Santora AC Alendronate and atrial fibrillation: a metaanalysis of randomized placebocontrolled clinical trials OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (1) pp. 233245. ( 2012)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
162/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [12346435] 742
Chen JS, Sambrook PN Antiresorptive therapies for osteoporosis: a clinical overview NATURE REVIEWS ENDOCRINOLOGY (ISSN: 17595029) 8: (2) pp. 8191. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346434]
743
Hadji P, Aapro M, Costa L, Gnant M Antiresorptive treatment options and bone health in cancer patientssafety profiles and clinical considerations Cancer Treatment Reviews (ISSN: 03057372) 38: (6) pp. 815824. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473947]
744
Olenginski TP, Antohe JL, Sunderlin E, Harrington TM Appraising osteoporosis care gaps Rheumatology International (ISSN: 01728172) 32: (11) pp. 36193624. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473946]
745
Kendler DL, Palacios S, Cox DA, Stock J, Alam J, Dowsett SA, Zanchetta J Arzoxifene versus raloxifene: effect on bone and safety parameters in postmenopausal women with osteoporosis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (3) pp. 10911101. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346433]
746
* Boonen S, Lioen P, Sermon A, Gielen E, Laurent M, Borghs H, Vanderschueren D, Grootaert V, De Keulenaer J, Spriet I, Rademakers F, Luyten F Atypical femoral fractures and longterm use of bisphosphonates Tijdschrift voor Geneeskunde (ISSN: 0371683X) 68: (11) pp. 531538. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474277]
747
Komm BS, Chines AA Bazedoxifene: The evolving role of thirdgeneration selective estrogenreceptor modulators in the management of postmenopausal osteoporosis Therapeutic Advances in Musculoskeletal Disease 4: (1) pp. 2134. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13474276]
748
Khosla S, Bilezikian JP, Dempster DW , Lewiecki EM, Miller PD, Neer RM, Recker RR, Shane E, Shoback D, Potts JT Benefits and risks of bisphosphonate therapy for osteoporosis Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 97: (7) pp. 22722282. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474275]
749
ObermayerPietsch B Biomarkers of bone metabolism Update 2012 Journal fur Mineralstoffwechsel 19: (3) pp. 102107. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473945]
750
Zarowitz BJ Bisphosphonate Duration of Therapy for Management of Osteoporosis Geriatric Nursing (ISSN: 01974572) 33: (6) pp. 479481. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473944]
751
Beard MK Bisphosphonate therapy for osteoporosis: combining optimal fracture risk reduction with patient preference CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 28: (1) pp. 141147. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346431]
752
Peterson JD, Bedrossian Jr EH Bisphosphonateassociated orbital inflammationa case report and review Orbit (ISSN: 01676830) 31: (2) pp. 119123. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474274]
753
Cattalini JP, Boccaccini AR, Lucangioli S, Mouriño V Bisphosphonatebased strategies for bone tissue engineering and orthopedic implants Tissue Engineering Part B: Reviews 18: (5) pp. 323340. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474273]
754
Fitzpatrick SG, Stavropoulos MF, Bowers LM, Neuman AN, Hinkson DW , Green JG, Bhattacharyya I, Cohen DM BisphosphonateRelated Osteonecrosis of Jaws in 3 Osteoporotic P atients With History of Oral Bisphosphonate Use Treated With Single Yearly Zoledronic Acid Infusion JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (ISSN: 02782391) 70: (2) pp. 325330. ( 2012) Folyóiratcikk /Ismertetés /Tudományos [12346430]
755
Górski B, Bryłka M Bisphosphonates Risk assessment of osteonecrosis of the jaw and potential benefits for periodontal therapy Dental and Medical Problems 49: (4) pp. 576582. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473943]
756
Marx RE Bisphosphonates and BisphosphonateInduced Osteonecrosis of the Jaws In: Current Therapy in Oral and Maxillofacial Surgery . Elsevier Inc., 2012. (ISBN 9781416025276) pp. 533545.
Könyvrészlet /Könyvfejezet /Tudományos [13473942] 757
Poole Kenneth E, Compston Juliet E Bisphosphonates in the treatment of osteoporosis BRITISH MEDICAL JOURNAL 344: P aper e3211. (2012) Folyóiratcikk /Ismertetés /Tudományos [12426262]
758
Diab DL, W atts NB Bisphosphonates in the Treatment of Osteoporosis Endocrinology and Metabolism Clinics of North America (ISSN: 08898529) 41: (3) pp. 487506. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473941]
759
Rizzoli R Bisphosphonates treatment in patients with osteoporosis Therapeutische Umschau (ISSN: 00405930) 69: (3) pp. 173181. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13474272]
760
Iannitti T, Rosini S, Lodi D, Frediani B, Rottigni V, Palmieri B Bisphosphonates: Focus on Inflammation and Bone Loss
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
163/342
3/30/2015
nyomtatobarat forma AMERICAN JOURNAL OF THERAPEUTICS (ISSN: 10752765) 19: (3) pp. 228246. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346429] 761
Blokhuis TJ, Buma P, Verdonschot N, Gotthardt M, Hendriks T BMP 7 stimulates early diaphyseal fracture healing in estrogen deficient rats JOURNAL OF ORTHOPAEDIC RESEARCH (ISSN: 07360266) 30: (5) pp. 720725. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346428]
762
Grey A, Cundy T Bone density testing in older women [1] JAMA Journal of the American Medical Association 308: (14) pp. 14281429. ( 2012) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [13473940]
763
Lustberg MB, Reinbolt RE, Shapiro CL Bone health in adult cancer survivorship Journal of Clinical Oncology (ISSN: 0732183X) 30: (30) pp. 36653674. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473939]
764
Harris VW , Brown TT Bone Loss in the HIVInfected P atient: Evidence, Clinical Implications, and Treatment Strategies JOURNAL OF INFECTIOUS DISEASES (ISSN: 00221899) 205: (Suppl. 3) pp. S391S398. ( 2012) Folyóiratcikk /Konferenciaközlemény /Tudományos [12346427]
765
Miller PD Bone strength and surrogate markers: The first, second, and third fiddle Journal of Bone and Mineral Research (ISSN: 08840431) 27: (8) pp. 16231626. ( 2012) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [13473938]
766
* Naylor K, Eastell R Bone turnover markers: Use in osteoporosis Nature Reviews Rheumatology (ISSN: 17594790) 8: (7) pp. 379389. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474264]
767
Jamal SA, Moe SM Calcium builds strong bones, and more is bettercorrect? Well, maybe not Clinical Journal of the American Society of Nephrology (ISSN: 15559041) 7: (11) pp. 18771883. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473937]
768
W u CC, W ang CC, Lu DH, Hsu LH, Yang KC, Lin FH Calcium phosphate cement delivering zoledronate decreases bone turnover rate and restores bone architecture in ovariectomized rats BIOMEDICAL MATERIALS (ISSN: 17486041) 7: (3) P aper 035009. (2012) Folyóiratcikk /Szakcikk /Tudományos [12346426]
769
Hampson G, Fogelman I Clinical role of bisphosphonate therapy International Journal of Women's Health 4: (1) pp. 455469. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473936]
770
Cusano NE, Bilezikian JP Combination Anabolic and Antiresorptive Therapy for Osteoporosis Endocrinology and Metabolism Clinics of North America (ISSN: 08898529) 41: (3) pp. 643654. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473935]
771
Cooper MS, Palmer AJ, Seibel MJ Costeffectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (1) pp. 97107. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346425]
772
Dore RK Data from extension trials: Denosumab and zoledronic acid Current Osteoporosis Reports 10: (1) pp. 1621. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13474263]
773
Yee AJ, Raje NS Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients Clinical Interventions in Aging (ISSN: 11769092) 7: pp. 331338. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473934]
774
Hanley DA, Adachi JD, Bell A, Brown V Denosumab: Mechanism of action and clinical outcomes International Journal of Clinical Practice (ISSN: 13685031) 66: (12) pp. 11391146. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473933]
775
Park YeSoo Diagnosis and treatment of osteoporosis JOURNAL OF THE KOREAN MEDICAL ASSOCIATION (ISSN: 19758456) 55: (11) pp. 10831094. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [14597925]
776
Quattrocchi CC, Dell'Aia P, Errante Y, Occhicone F, Longo D, Virzi V, Tonini G, Napoli N, Santini D, Zobel BB Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases Journal of Bone Oncology 1: (1) pp. 2429. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13474262]
777
Seraphim A, AlHadithy N, Mordecai SC, AlNammari S Do bisphosphonates cause femoral insufficiency fractures? Journal of Orthopaedics and Traumatology 13: (4) pp. 171177. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473932]
778
Kaakeh Y, Overholser BR, Lopshire JC, Tisdale JE Druginduced atrial fibrillation Drugs (ISSN: 00126667) 72: (12) pp. 16171630. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473931]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
164/342
3/30/2015
nyomtatobarat forma 779
Tamargo J, Caballero R, Delpón E Druginduced atrial fibrillation Expert Opinion on Drug Safety (ISSN: 14740338) 11: (4) pp. 615634. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474261]
780
Brandi ML Drugs for bone healing Expert Opinion on Investigational Drugs (ISSN: 13543784) 21: (8) pp. 11691176. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473930]
781
* Bolland MJ, Grey A, Horne AM, Briggs SE, Thomas MG, EllisPegler RB, Gamble GD, Reid IR Effects of intravenous zoledronate on bone turnover and bone density persist for at least five years in HIVinfected men Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 97: (6) pp. 19221928. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13474260]
782
Iwamoto J, Sato Y, Takeda T, Matsumoto H Efficacy of Antiresorptive Agents for P reventing Fractures in Japanese P atients with an Increased Fracture Risk: Review of the Literature DRUGS & AGING (ISSN: 1170229X) 29: (3) pp. 191203. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346424]
783
Zhang J, W ang R, Zhao YL, Sun XH, Zhao HX, Tan L, Chen DC, HaiBin X Efficacy of intravenous zoledronic acid in the prevention and treatment of osteoporosis: A metaanalysis Asian Pacific Journal of Tropical Medicine (ISSN: 19957645) 5: (9) pp. 743748. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473929]
784
Takahashi Shunji, Iwase Takuji, Kohno Norio, Ishikawa Takashi, Taguchi Tetsuya, Takahashi Masato, Horiguchi Jun, Nakamura Seigo, Hozumi Yasuo, Fukunaga Masao, Noguchi Shinzaburo Efficacy of zoledronic acid in postmenopausal Japanese women with early breast cancer receiving adjuvant letrozole: 12 month results BREAST CANCER RESEARCH AND TREATMENT (ISSN: 01676806) 133: (2) pp. 685693. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12426261]
785
Rubin CD Evaluation and Management of Hip Fracture Risk in the Aged AMERICAN JOURNAL OF THE MEDICAL SCIENCES (ISSN: 00029629) 343: (3) pp. 233242. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346423]
786
Rastogi A, Bowman PD, Stavchansky S Evaluation of a perforated drug delivery system in mice for prolonged and constant release of a hydrophilic drug Drug Delivery and Translational Research 2: (2) pp. 106111. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473928]
787
Kijowski R, Tuite M, Kruger D, Munoz Del Rio A, Kleerekoper M, Binkley N Evaluation of trabecular microarchitecture in nonosteoporotic postmenopausal women with and without fracture Journal of Bone and Mineral Research (ISSN: 08840431) 27: (7) pp. 14941500. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473927]
788
* Body JJ, Bergmann P, Boonen S, Devogelaer JP, Gielen E, Goemaere S, Kaufman JM, Rozenberg S, Reginster JY Extraskeletal benefits and risks of calcium, vitamin D and antiosteoporosis medications Osteoporosis International (ISSN: 0937941X) 23: (SUP P L. 1) pp. S1S23. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13474259]
789
* Grey Andrew, Bolland Mark J, Horne Anne, W attie Diana, House Meaghan, Gamble Greg, Reid Ian R Five years of antiresorptive activity after a single dose of zoledronate Results from a randomized doubleblind placebo controlled trial BONE (ISSN: 87563282) 50: (6) pp. 13891393. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12426260]
790
Smidt A, LipovetskyAdler M, Sharon E Forced eruption as an alternative to tooth extraction in longterm use of oral bisphosphonates: Review, risks and technique Journal of the American Dental Association (ISSN: 00028177) 143: (12) pp. 13031312. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473926]
791
* Boonen S, Reginster JY, Kaufman JM, Lippuner K, Zanchetta J, Langdahl B, Rizzoli R, Lipschitz S, Dimai HP, W itvrouw R, Eriksen E, Brixen K, Russo L, Claessens F, Papanastasiou P, Antunez O, Su G, BucciRechtweg C, Hruska J, Incera E, Vanderschueren D, Orwoll E Fracture risk and zoledronic acid therapy in men with osteoporosis New England Journal of Medicine (ISSN: 00284793) 367: (18) pp. 17141723. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473925]
792
Hagino H Fragility fracture prevention: Review from a Japanese P erspective Yonago Acta Medica (ISSN: 05135710) 55: (2) pp. 2128. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474258]
793
Pereira RMR, de Carvalho JF, Paula AP, Zerbini C, Domiciano DS, Gonçalves H, Danowski JS, Marques Neto JF, Mendonça LMC, Bezerra MC, Terreri MT, Imamura M, W eingrill P, Plapler PG, Radominski S, Tourinho T, Szejnfeld VL, Andrada NC Guidelines for the prevention and treatment of glucocorticoidinduced osteoporosis Revista Brasileira de Reumatologia (ISSN: 04825004) 52: (4) pp. 580593. ( 2012) Folyóiratcikk /Jelentés /Tudományos [13474257]
794
Rodrigues Pereira Rosa Maria, de Carvalho Jozelio Freire, Paula Ana Patricia, Zerbini Cristiano, Domiciano Diogo S, Goncalves Helenice, Danowski Jaime S, Marques Neto Joao F, Mendonca Laura M C, Bezerra Mailze C, Terreri Maria Teresa, Imamura Marta, W eingrill Pedro, Plapler Perola G, Radominski Sebastiao, Tourinho Tatiana, Szejnfeld Vera L, Andrada Nathalia C Guidelines for the prevention and treatment of glucocorticoidinduced osteoporosis REVISTA BRASILEIRA DE REUMATOLOGIA (ISSN: 04825004) 52: (4) pp. 569593. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [14597937]
795
Ferko NC, Borisova N, Airia P, Grima DT, Thompson MF How rebates, copayments, and administration costs affect the costeffectiveness of osteoporosis therapies Managed Care 21: (11) pp. 4452. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473924]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
165/342
3/30/2015
nyomtatobarat forma 796
Outman RC, Curtis JR, Locher JL, Allison JJ, Saag KG, Kilgore ML Improving osteoporosis care in highrisk home health patients through a highintensity intervention CONTEMPORARY CLINICAL TRIALS (ISSN: 15517144) 33: (1) pp. 206212. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346422]
797
Dimitriou R, Calori GM, Giannoudis PV Improving patients' outcomes after osteoporotic fractures International Journal of Clinical Rheumatology (ISSN: 17584272) 7: (1) pp. 109124. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474256]
798
Dell RM, Adams AL, Greene DF, Funahashi TT, Silverman SL, Eisemon EO, Zhou H, Burchette RJ, Ott SM Incidence of atypical nontraumatic diaphyseal fractures of the femur Journal of Bone and Mineral Research (ISSN: 08840431) 27: (12) pp. 25442550. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473923]
799
Yamazaki T, Yamori M, Ishizaki T, Asai K, Goto K, Takahashi K, Nakayama T, Bessho K Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: A cohort study International Journal of Oral and Maxillofacial Surgery (ISSN: 09015027) 41: (11) pp. 13971403. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473921]
800
Silverman S, Christiansen C Individualizing osteoporosis therapy OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (3) pp. 797809. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346421]
801
Metz LN, W ustrack R, Lovell AF, Sawyer AJ Infectious, Inflammatory, and Metabolic Diseases Affecting the Athlete's Spine Clinics in Sports Medicine (ISSN: 02785919) 31: (3) pp. 535567. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474255]
802
Ibrahim T, Mercatali L, Sacanna E, Tesei A, Carloni S, Ulivi P, Liverani C, Fabbri F, Zanoni M, Zoli W , Amadori D Inhibition of breast cancer cell proliferation in repeated and nonrepeated treatment with zoledronic acid Cancer Cell International (ISSN: 14752867) 12: P aper 48. (2012) Folyóiratcikk /Szakcikk /Tudományos [13473920]
803
Salari P, Abdollahi M Long term bisphosphonate use in osteoporotic patients; a step forward, two steps back Journal of Pharmacy and Pharmaceutical Sciences (ISSN: 14821826) 15: (2) pp. 305317. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474254]
804
Cooper C, Reginster JY, Cortet B, DiazCuriel M, Lorenc RS, Kanis JA, Rizzoli R Longterm treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 28: (3) pp. 475491. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346420]
805
* Grey A, Bolland M, W ong S, Horne A, Gamble G, Reid IR LowDose Zoledronate in Osteopenic P ostmenopausal Women: A Randomized Controlled Trial JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 97: (1) pp. 286292. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346419]
806
Eisman JA, Bogoch ER, Dell R, Harrington JT, McKinney Jr RE, McLellan A, Mitchell PJ, Silverman S, Singleton R, Siris E Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention Journal of Bone and Mineral Research (ISSN: 08840431) 27: (10) pp. 20392046. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473919]
807
Curtis JR, Safford MM Management of osteoporosis among the elderly with other chronic medical conditions Drugs and Aging 29: (7) pp. 549564. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473918]
808
Lobersztajn A, Trémollières F Menopause and bone Journal de Gynecologie Obstetrique et Biologie de la Reproduction (ISSN: 03682315) 41: (7 SUP P L.) pp. F28F32. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473917]
809
* Eriksen EF, Halse J Når seponere bisfosfonater? Tidsskrift for den Norske Laegeforening (ISSN: 00292001) 132: (14) pp. 16301632. ( 2012) Folyóiratcikk /Rövid közlemény /Tudományos [13473916]
810
AubryRozier B, Krieg MA, Lamy O, Tonetti J, Duff J, Schizas C, Theumann N New management of vertebral osteoporic fracture: P roposition of a vertebroplasty or a kyphoplasty Revue Medicale Suisse (ISSN: 16609379) 8: (347) pp. 14171421. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474252]
811
Jamal SA, Hamilton CJ Nitric oxide donors for the treatment of osteoporosis Current Osteoporosis Reports 10: (1) pp. 8692. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474251]
812
Grey A Nonsurgical management of mild primary hyperparathyroidism A reasonable option Clinical Endocrinology (ISSN: 03000664) 77: (5) pp. 639644. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473914]
813
Kharazmi M, Sjoqvist K, W arfvinge G Oral Ulcers, a Little Known Adverse Effect of Alendronate: Review of the Literature JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (ISSN: 02782391) 70: (4) pp. 830836. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346418]
814
Sirisoontorn I, Hotokezaka H, Hashimoto M, Gonzales C, Luppanapornlarp S, Darendeliler MA, Yoshida N Orthodontic tooth movement and root resorption in ovariectomized rats treated by systemic administration of zoledronic acid
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
166/342
3/30/2015
nyomtatobarat forma AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS (ISSN: 08895406) 141: (5) pp. 563 573. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346417] 815
Heerva E, Peltonen S, Svedstrom E, Aro HT, Vaananen K, Peltonen J Osteoclasts derived from patients with neurofibromatosis 1 (NF1) display insensitivity to bisphosphonates in vitro BONE (ISSN: 87563282) 50: (3) pp. 798803. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346416]
816
Casal C, Someso E, Álvarez AM, Fariña J, Álvarez T Osteonecrosis of the jaws related with the use of biphosphonates Farmaceuticos de Atencion Primaria 10: (1) pp. 914. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473913]
817
* W atts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES, Finkelstein JS Osteoporosis in men: An Endocrine Society clinical practice guideline Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 97: (6) pp. 18021822. ( 2012) Folyóiratcikk /Jelentés /Tudományos [13474250]
818
* Boonen S Osteoporosis treatment with denosumab Tijdschrift voor Geneeskunde (ISSN: 0371683X) 68: (3) pp. 128137. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474249]
819
Gasser JA Osteoporosis: Limitations of current antiresorptive treatments European Cells and Materials 24: (SUP P L. 1) p. 1. ( 2012) Folyóiratcikk /Rövid közlemény /Tudományos [13473912]
820
Pereira FA, Mattar R, Facincani I, Defno HLA, Ramalho LNZ, Jorgetti V, Volpon JB, de Paula FJA P amidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in wistar rats Brazilian Journal of Medical and Biological Research (ISSN: 0100879X) 45: (12) pp. 12551261. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473911]
821
Nagase S, Ohyama M, Hashimoto Y, Small M, Kuwayama T, Deacon S P harmacodynamic Effects on Biochemical Markers of Bone Turnover and P harmacokinetics of the Cathepsin K Inhibitor, ONO5334, in an Ascending MultipleDose, P hase 1 Study JOURNAL OF CLINICAL PHARMACOLOGY (ISSN: 00912700) 52: (3) pp. 306318. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346415]
822
Kharazmi M, Persson U, W arfvinge G P harmacovigilance of oral bisphosphonates: Adverse effects manifesting in the soft tissue of the oral cavity Journal of Oral and Maxillofacial Surgery (ISSN: 02782391) 70: (12) pp. 27932797. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473910]
823
Roux C, Reid DM, Devogelaer JP, Saag K, Lau CS, Reginster JY, Papanastasiou P, BucciRechtweg C, Su G, Sambrook PN P ost hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoidinduced osteoporosis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (3) pp. 10831090. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346414]
824
Ng KW P otential role of odanacatib in the treatment of osteoporosis Clinical Interventions in Aging (ISSN: 11769092) 7: pp. 235247. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473909]
825
Committee on Practice BulletinsGynecology The American College of Obstetricians, Gynecologists P ractice bulletin No. 129: Osteoporosis Obstetrics and Gynecology (ISSN: 00297844) 120: (3) pp. 718734. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473908]
826
* W ustrack R, Seeman E, BucciRechtweg C, Burch S, Palermo L, Black DM P redictors of new and severe vertebral fractures: results from the HORIZON P ivotal Fracture Trial OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (1) pp. 5358. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346413]
827
Lester JE, Dodwell D, BrownJE, Purohit OP, Gutcher SA, Ellis SP, Thorpe R, Horsman JM, Coleman RE P revention of anastrozole induced bone loss with monthly oral ibandronate: Final 5 year results from the ARIBON trial Journal of Bone Oncology 1: (2) pp. 5762. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473907]
828
Lewiecki EM, Bilezikian JP, Jankowski LG, McCloskey EV, Miller PD, Morgan SL, Orwoll ES, Potts JT P roceedings of the 2011 Santa Fe Bone Symposium JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 15: (1) pp. 120. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346412]
829
Aft R P rotection of bone in premenopausal women with breast cancer: Focus on zoledronic acid International Journal of Women's Health 4: (1) pp. 569576. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473906]
830
Hadji P, Ziller V, Gamerdinger D, Spieler W , Articus K, Baier M, Moericke R, Kann P H Quality of life and health status with zoledronic acid and generic alendronatea secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone mass OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (7) pp. 20432051. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12426259]
831
Blake GM, Siddique M, Frost ML, Moore AEB, Fogelman I Quantitative P ET imaging using 18F sodium fluoride in the assessment of metabolic bone diseases and the monitoring of their response to therapy PET Clinics (ISSN: 15568598) 7: (3) pp. 275291. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473905]
832
Koivu H, MacKiewicz Z, Takakubo Y, Trokovic N, Pajarinen J, Konttinen YT RANKL in the osteolysis of AES total ankle replacement implants Bone (ISSN: 87563282) 51: (3) pp. 546552. ( 2012)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
167/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [13473904] 833
Hadji P, Gamerdinger D, Spieler W , Kann PH, Loeffler H, Articus K, Moricke R, Ziller V Rapid Onset and Sustained Efficacy (ROSE) study: results of a randomised, multicentre trial comparing the effect of zoledronic acid or alendronate on bone metabolism in postmenopausal women with low bone mass OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (2) pp. 625633. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346411]
834
Lippuner K, Buchard PA, De Geyter C, Imthurn B, Lamy O, Litschgi M, Luzuy F, Schiessl K, Stute P, Birkhäuser M Recommendations for raloxifene use in daily clinical practice in the Swiss setting European Spine Journal (ISSN: 09406719) 21: (12) pp. 24072417. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473903]
835
Donnelly E, Meredith DS, Nguyen JT, Gladnick BP, Rebolledo BJ, Shaffer AD, Lorich DG, Lane JM, Boskey AL Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 27: (3) pp. 672678. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346410]
836
* Jacques RM, Boonen S, Cosman F, Reid IR, Bauer DC, Black DM, Eastell R Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with onceyearly zoledronic acid 5 mg: The HORIZONP ivotal Fracture Trial (P FT) Journal of Bone and Mineral Research (ISSN: 08840431) 27: (8) pp. 16271634. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473902]
837
W ang Y, Yang YM Research and application of target therapy for osteoporosis Journal of Shanghai Jiaotong University (Medical Science) 32: (8) pp. 11011105. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473901]
838
Greenspan SL, Resnick NM Response to Shil and Greer Journal of the American Geriatrics Society (ISSN: 00028614) 60: (12) p. 2384. ( 2012) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [13473898]
839
Yamazaki T, Yamori M, Yamamoto K, Saito K, Asai K, Sumi E, Goto K, Takahashi K, Nakayama T, Bessho K Risk of osteomyelitis of the jaw induced by oral bisphosphonates in patients taking medications for osteoporosis: A hospitalbased cohort study in Japan Bone (ISSN: 87563282) 51: (5) pp. 882887. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473897]
840
Barros ER, Saraiva GL, De Oliveira TP, LazarettiCastro M Safety and efficacy of a 1year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta Journal of Pediatric Endocrinology and Metabolism (ISSN: 0334018X) 25: (56) pp. 485491. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13474248]
841
Orozco C, Maalouf NM Safety of Bisphosphonates Rheumatic Disease Clinics of North America (ISSN: 0889857X) 38: (4) pp. 681705. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473896]
842
Zhu Xiaofeng, Cao Yanming Sclerostin monoclonal antibody: A future new drug for the treatment of osteoporosis Chinese Journal of Osteoporosis (ISSN: 10067108) 18: (6) pp. 568572,541. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [14597972]
843
Bogoch ER, ElliotGibson V, W ang RYC, Josse RG Secondary causes of osteoporosis in fracture patients Journal of Orthopaedic Trauma (ISSN: 08905339) 26: (9) pp. e145e152. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473895]
844
Li Tao, Liu Zhi, Sun Tiansheng, Zhang Jianzheng, Dai Heling, Zhu Heyu Secondary contralateral hip fractures following hip fractures in the elderly Chinese Journal of Tissue Engineering Research (ISSN: 16738225) 16: (4) pp. 752756. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [14597971]
845
Adler RA Secondary fracture prevention Current Osteoporosis Reports 10: (1) pp. 2227. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13474247]
846
Zhao M, Tominaga Y, Ohuchida K, Mizumoto K, Cui L, Kozono S, Fujita H, Maeyama R, Toma H, Tanaka M Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer CANCER SCIENCE (ISSN: 13479032) 103: (1) pp. 5866. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346409]
847
Teede H J, Renouf D A, Jayasuriya I A, Barrie D STOP Fracture study: Southern Health Osteoporotic Fracture Screening P roject INTERNAL MEDICINE JOURNAL (ISSN: 14440903) 42: (5) pp. e74e79. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12426258]
848
Hadji P, Ziller V, Gamerdinger D, Spieler W , Möricke R, Kann PH Summary of the results of the ROSEStudy: Direct comparison of the two bisphosphonates alendronate and zoledronic acid Osteologie (ISSN: 10191291) 21: (2) pp. 94100. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473894]
849
Cavalli Loredana, Brandi Maria Luisa Targeted approaches in the treatment of osteoporosis: differential mechanism of action of denosumab and clinical utility THERAPEUTICS AND CLINICAL RISK MANAGEMENT (ISSN: 11766336) 8: pp. 253266. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12426257]
850
Krege JH, W an X Teriparatide and the risk of nonvertebral fractures in women with postmenopausal osteoporosis BONE (ISSN: 87563282) 50: (1) pp. 161164. ( 2012)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
168/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [12346408] 851
Carmel AS, Shieh A, Bang H, Bockman RS The 25(OH)D level needed to maintain a favorable bisphosphonate response is ≥33 ng/ml Osteoporosis International (ISSN: 0937941X) 23: (10) pp. 24792487. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473893]
852
* Black DM, Reid IR, Boonen S, BucciRechtweg C, Cauley JA, Cosman F, Cummings SR, Hue TF, Lippuner K, Lakatos P, Leung PC, Man Z, Martinez RLM, Tan M, Ruzycky ME, Su GQ, Eastell R The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZONP ivotal Fracture Trial (P FT) JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 27: (2) pp. 243254. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346407]
853
Li YF, Zhou CC, Li JH, Luo E, Zhu SS, Feng G, Hu J The effects of combined human parathyroid hormone (134) and zoledronic acid treatment on fracture healing in osteoporotic rats OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (4) pp. 14631474. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346406]
854
Yan TT, Yin W J, Zhou Q, Zhou LH, Jiang YW , Du YY, Shao ZM, Lu JS The efficacy of zoledronic acid in breast cancer adjuvant therapy: A metaanalysis of randomised controlled trials EUROPEAN JOURNAL OF CANCER (ISSN: 09598049) 48: (2) pp. 187195. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346405]
855
Hadji P The evolution of selective estrogen receptor modulators in osteoporosis therapy Climacteric (ISSN: 13697137) 15: (6) pp. 513523. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473892]
856
Lippuner K The future of osteoporosis treatment A research update Swiss Medical Weekly (ISSN: 14247860) 142: P aper w13624. (2012) Folyóiratcikk /Rövid közlemény /Tudományos [13473891]
857
Hadji P, Coleman R, Gnant M, Green JR The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis Annals of Oncology (ISSN: 09237534) 23: (11) pp. 27822790. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473890]
858
Yuan Yuanxing, Li Qing, Zhang Fei The observation of shortterm safety of zoledronic sodium application Chinese Journal of Osteoporosis (ISSN: 10067108) 18: (10) pp. 921924. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [14597970]
859
Li C, W ang HR, Li XL, Zhou XG, Dong J The relation between zoledronic acid infusion and interbody fusion in patients undergoing transforaminal lumbar interbody fusion surgery ACTA NEUROCHIRURGICA (ISSN: 00016268) 154: (4) pp. 731738. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346404]
860
Pan Yuancheng, Li Yizhong The research progress in osteoporotic hip fractures Chinese Journal of Osteoporosis (ISSN: 10067108) 18: (12) pp. 11401144. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [14597969]
861
CandelariaQuintana D, Dayao ZR, Royce ME The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer BREAST CANCER RESEARCH AND TREATMENT (ISSN: 01676806) 132: (2) pp. 355363. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346403]
862
Hodis H N, Collins P, Mack W J, Schierbeck L Lind The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective CLIMACTERIC (ISSN: 13697137) 15: (3) pp. 217228. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12426256]
863
Compston J The use of combination therapy in the treatment of postmenopausal osteoporosis ENDOCRINE (ISSN: 1355008X) 41: (1) pp. 1118. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346402]
864
Xu Ling, Deng Haiou, Zhi Ximei, Zhang W eijie, W ang Xiaona, W u W en Therapeutic effect of zoledronic acid on primary ostsoporosis in elderly patients JOURNAL OF SOUTHERN MEDICAL UNIVERSITY (CHINA) (ISSN: 16734254) 32: (9) pp. 12871289. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [14597967]
865
Cotter AG, Mallon PW G Therapeutic options for low bone mineral density in HIVinfected subjects Current HIV/AIDS Reports 9: (2) pp. 148159. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13474246]
866
* Boonen S, Eastell R, Su G, Mesenbrink P, Cosman F, Cauley JA, Reid IR, Claessens F, Vanderschueren D, Lyles KW , Black DM Time to onset of antifracture efficacy and yearbyyear persistence of effect of zoledronic acid in women with osteoporosis Journal of Bone and Mineral Research (ISSN: 08840431) 27: (7) pp. 14871493. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473889]
867
Inderjeeth CA, Chan K, Kwan K, Lai M Time to onset of efficacy in fracture reduction with current antiosteoporosis treatments Journal of Bone and Mineral Metabolism (ISSN: 09148779) 30: (5) pp. 493503. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473888]
868
Aspray TJ, Francis RM Treatment of osteoporosis in women intolerant of oral bisphosphonates MATURITAS (ISSN: 03785122) 71: (1) pp. 7678. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346401]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
169/342
3/30/2015
nyomtatobarat forma 869
* W ark JD, Bensen W , Recknor C, Ryabitseva O, Chiodo J, Mesenbrink P, de Villiers TJ Treatment with acetaminophen/paracetamol or ibuprofen alleviates postdose symptoms related to intravenous infusion with zoledronic acid 5 mg OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (2) pp. 503512. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346400]
870
Eiken PA, BraskLindemann D, Vestbo J, Langdahl BL, Abrahamsen B Udredning og behandling af osteoporose hos patienter med kronisk obstruktiv lungesygdom Ugeskrift for Laeger (ISSN: 00415782) 174: (47) pp. 29222926. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473887]
871
Briot K, Cortet B, Thomas T, Audran M, Blain H, Breuil V, Chapuis L, Chapurlat R, Fardellone P, Feron JM, Gauvain JB, Guggenbuhl P, Kolta S, Lespessailles E, Letombe B, Marcelli C, Orcel P, Seret P, Trémollières F, Roux C Update of the 2012 French recommendations of drug treatment for postmenopausal osteoporosis Revue du Rhumatisme (Edition Francaise) 79: (3) pp. 264274. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474245]
872
Rhee CW , Lee J, Oh S, Choi NK, Park BJ Use of bisphosphonate and risk of atrial fibrillation in older women with osteoporosis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (1) pp. 247254. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346399]
873
Katzman Scott A, Nieto Jorge E, Arens Amanda M, MacDonald Melinda H, Puchalski Sarah M, Galuppo Larry D, Snyder Jack R, Maher Omar, Bell Robin J W Use of zoledronate for treatment of a bone fragility disorder in horses JAVMAJOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION 240: (11) pp. 13231328. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12426255]
874
Yiǧitoǧlu PH, Güzel R, Evran M, Gürkan E Use of zoledronic acid in thalassemiainduced osteoporosis: Two case reports and review of the literature Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi 58: (2) pp. 154158. ( 2012) Folyóiratcikk /Rövid közlemény /Tudományos [13473886]
875
ObermayerPietsch Barbara, Schwetz Verena Utility of the Determination of Biomarkers of Bone Metabolism In: Pietschmann P (szerk.) : Principles of Osteoimmunology : Molecular Mechanisms and Clinical Applications. Vienna: Springer, 2012. pp. 113 135.
Könyvrészlet /Szaktanulmány /Tudományos [12426254] 876
AlbaniCampanario M, BuendíaDíaz G, FloresIslas ML, MaquitaNakano C, OchoaCervantes J Uveitis zoledronic acid: A case report and review of the bibliography Ginecologia y Obstetricia de Mexico 80: (5) pp. 355359. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474244]
877
Narongroeknawin P, Patkar NM, Shakoory B, Jain A, Curtis JR, Delzell E, Lander PH, LopezBen RR, Pitt MJ, Safford MM, Volgas DA, Saag KG Validation of Diagnostic Codes for Subtrochanteric, Diaphyseal, and Atypical Femoral Fractures Using Administrative Claims Data JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 15: (1) pp. 92102. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346398]
878
No author name available Vigilance, rather than alarm, is needed to manage adverse events associated with bisphosphonate use for osteoporosis Drugs and Therapy Perspectives 28: (2) pp. 2023. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13474243]
879
Catalano A, Morabito N, Atteritano M, Basile G, Cucinotta D, Lasco A Vitamin D Reduces Musculoskeletal P ain After Infusion of Zoledronic Acid for P ostmenopausal Osteoporosis CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 90: (4) pp. 279285. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12346397]
880
Albergaria BenHur WHAT HAVE IV BISP HOSP HONATES ADDED TO THE FIELD? OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: pp. S466S467. ( 2012) SU 4 Folyóiratcikk /Absztrakt /Tudományos [14597934]
881
Trémollières F What patients need to know about the risk of bone fracture and its prevention Journal de Gynecologie Obstetrique et Biologie de la Reproduction (ISSN: 03682315) 41: (7 SUP P L.) pp. F20F27. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473885]
882
Abela S, Chotai M, Bister D What you need to know about bisphosphonates: An overview and general recommendations for orthodontic treatment Journal of Orthodontics 39: (3) pp. 186192. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473884]
883
* Siris ES, Boonen S, Mitchell PJ, Bilezikian J, Silverman S What's in a name? What constitutes the clinical diagnosis of osteoporosis? Osteoporosis International (ISSN: 0937941X) 23: (8) pp. 20932097. ( 2012) Folyóiratcikk /Ismertetés /Tudományos [13473882]
884
Lewis VO, Scherl SA, O'Connor MI Women in orthopaedics Way behind the number curve Journal of Bone and Joint Surgery Series A 94: (5) P aper e30. (2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13474242]
885
Lou Zhenkai, Li Chunhai, Ye W ei, Ding Yue, Zhu W eirong, Ren Jinke Zoledronic acid injection in treating 36 patients with postmenopausal osteoporosis Chinese Journal of New Drugs and Clinical Remedies (ISSN: 10077669) 31: (5) pp. 247250. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [14597966]
886
Laslett LL, Doré DA, Quinn SJ, Boon P, Ryan E, W inzenberg TM, Jones G Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: A randomised controlled trial
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
170/342
3/30/2015
nyomtatobarat forma Annals of the Rheumatic Diseases (ISSN: 00034967) 71: (8) pp. 13221328. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473879] 887
Shane E, Cohen A, Stein EM, McMahon DJ, Zhang C, Young P, Pandit K, Staron RB, Verna EC, Brown R, Restaino S, Mancini D Zoledronic acid versus alendronate for the prevention of bone loss after heart or liver transplantation Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 97: (12) pp. 44814490. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13473878]
888
Crilly RG, Cox L A comparison of bone density and bone morphology between patients presenting with hip fractures, spinal fractures or a combination of the two BMC Musculoskeletal Disorders (ISSN: 14712474) 14: P aper 68. (2013) Folyóiratcikk /Szakcikk /Tudományos [13473877]
889
Brown JP, Davison KS, Olszynski W P, Beattie KA, Adachi JD A critical review of brand and generic alendronate for the treatment of osteoporosis SpringerPlus (ISSN: 21931801) 2: (1) P aper 550. (2013) Folyóiratcikk /Szakcikk /Tudományos [13473875]
890
Liu J, Zheng L, Zhang W , Chang K, Pang Y A Modified method for reducing renal injury in zoledronic acid treatment of hypercalcemia and adverse skeletal events Indian Journal of Palliative Care 19: (1) pp. 5863. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473874]
891
Lang Joshua M, W allace Marianne, Becker Jordan T, Eickhoff Jens C, Buehring Bjoern, Binkley Neil, Staab Mary Jane, W ilding George, Liu Glenn, Malkovsky Miroslav, McNeel Douglas G A Randomized P hase II Trial Evaluating Different Schedules of Zoledronic Acid on Bone Mineral Density in P atients With P rostate Cancer Beginning Androgen Deprivation Therapy CLINICAL GENITOURINARY CANCER (ISSN: 15587673) 11: (4) pp. 407415. ( 2013) Folyóiratcikk [14596052]
892
Kandel L, Schler D, Brezis M, Liebergall M, Mattan Y, DresnerPollak R A simple intervention for improving the implementation rate of a recommended osteoporosis treatment after hip fracture Endocrine Practice (ISSN: 1530891X) 19: (1) pp. 4650. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473873]
893
Kaufman JM, Palacios S, Silverman S, Sutradhar S, Chines A An evaluation of the Fracture Risk Assessment Tool (FRAX®) as an indicator of treatment efficacy: The effects of bazedoxifene and raloxifene on vertebral, nonvertebral, and all clinical fractures as a function of baseline fracture risk assessed by FRAX® Osteoporosis International (ISSN: 0937941X) 24: (10) pp. 25612569. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473872]
894
Ruggiero SL An officebased approach to the diagnosis and management of osteonecrosis Atlas of the Oral and Maxillofacial Surgery Clinics of North America 21: (2) pp. 167173. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473871]
895
Yang Yi, Li Pengqiu, Xian Yang Analysis of acute fever reaction in postmenopausal women with zoledronic acid treatment for osteoporosis Chinese Journal of Osteoporosis (ISSN: 10067108) 19: (1) pp. 5860. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [14597904]
896
* Misof BM, Roschger P, Gabriel D, Paschalis EP, Eriksen EF, Recker RR, Gasser JA, Klaushofer K Annual intravenous zoledronic acid for three years increased cancellous bone matrix mineralization beyond normal values in the HORIZON biopsy cohort Journal of Bone and Mineral Research (ISSN: 08840431) 28: (3) pp. 442448. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473870]
897
Zwolak P, Dudek AZ Antineoplastic activity of zoledronic acid and denosumab Anticancer Research (ISSN: 02507005) 33: (8) pp. 29812988. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473869]
898
Yazici Ozan, Aksoy Sercan, Ucar Ozgul, Ozdemir Nuriye, Demir Mevlut, Sendur Mehmet Ali Nahit, Arik Zafer, Yaman Sebnem, Eren Tulay, Uncu Dogan, Zengin Nurullah Arrhythmias during and after zoledronic acid infusion patients with bone metastasis MEDICAL ONCOLOGY (ISSN: 13570560) 30: (3) P aper UNSP 609. (2013) Folyóiratcikk [14597875]
899
Chiu W Y, Lee JJ, Tsai KS Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 98: (4) pp. E723E726. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473868]
900
Unnanuntana A, Saleh A, Mensah KA, Kleimeyer JP, Lane JM Atypical femoral fractures: What do we know about them? AAOS exhibit selection Journal of Bone and Joint Surgery Series A 95: (2) p. e8. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473867]
901
ClausHermberg H, Pozzo MJ Atypical fractures associated with prolonged use of bisphosphonates: A minor problem? Actualizaciones en Osteologia 9: (1) pp. 8695. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473866]
902
Xu XiaoLong, Gou W enLong, W ang AiYuan, W ang Yu, Guo QuanYi, Lu Qiang, Lu ShiBi, Peng Jiang Basic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years? JOURNAL OF TRANSLATIONAL MEDICINE (ISSN: 14795876) 11: P aper 303. (2013) Folyóiratcikk [14596050]
903
Forstein DA, Bernardini C, Cole RE, Harris ST, Singer A Before the breaking point: Reducing the risk of osteoporotic fractuze Journal of the American Osteopathic Association 113: (2 SUP P L1) pp. S5S24. ( 2013) Folyóiratcikk /Konferenciaközlemény /Tudományos [13473865]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
171/342
3/30/2015
nyomtatobarat forma 904
Giger EV, Castagner B, Leroux JC Biomedical applications of bisphosphonates Journal of Controlled Release (ISSN: 01683659) 167: (2) pp. 175188. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473864]
905
Liu W enChih, Yen JenFen, Lang ChengLin, Yan MingTso, Lu KuoCheng Bisphophonates in CKD P atients with Low Bone Mineral Density THE SCIENTIFIC WORLD JOURNAL (ISSN: 1537744X) 2013: P aper 837573. 11 p. (2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [14597903]
906
Ro C, Cooper O Bisphosphonate drug holiday: Choosing appropriate candidates Current Osteoporosis Reports 11: (1) pp. 4551. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473863]
907
Saleh A, Hegde VV, Potty AG, Lane JM Bisphosphonate Therapy and Atypical Fractures Orthopedic Clinics of North America (ISSN: 00305898) 44: (2) pp. 137151. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473862]
908
McClung M, Harris ST, Miller PD, Bauer DC, Davison KS, Dian L, Hanley DA, Kendler DL, Yuen CK, Lewiecki EM Bisphosphonate therapy for osteoporosis: Benefits, risks, and drug holiday American Journal of Medicine (ISSN: 00029343) 126: (1) pp. 1320. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473861]
909
W ong PK, Borromeo GL, W ark JD Bisphosphonaterelated osteonecrosis of the jaw in nonmalignant bone disease Rheumatology International (ISSN: 01728172) 33: (9) pp. 21892198. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473860]
910
Lespessailles E Bisphosphonates and glucocorticoidinduced osteoporosis: Efficacy and tolerability Joint Bone Spine (ISSN: 1297319X) 80: (3) pp. 258264. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473859]
911
Lespessailles E Bisphosphonates in glucocorticoidinduced osteoporosis: Efficacy and tolerability Revue du Rhumatisme (Edition Francaise) 80: (2) pp. 123129. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473858]
912
Kang JH, Keller JJ, Lin HC Bisphosphonates reduced the risk of acute myocardial infarction: A 2year followup study Osteoporosis International (ISSN: 0937941X) 24: (1) pp. 271277. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473857]
913
* McNabb BL, Vittinghoff E, Schwartz AV, Eastell R, Bauer DC, Ensrud K, Rosenberg E, Santora A, BarrettConnor E, Black DM BMD changes and predictors of increased bone loss in postmenopausal women after a 5year course of alendronate Journal of Bone and Mineral Research (ISSN: 08840431) 28: (6) pp. 13191327. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473856]
914
Panayiotopoulos A, Bhat N, Bhangoo A Bone and vitamin D metabolism in HIV Reviews in Endocrine and Metabolic Disorders 14: (2) pp. 119125. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473855]
915
Edwards W B, Schnitzer TJ, Troy KL Bone mineral loss at the proximal femur in acute spinal cord injury Osteoporosis International (ISSN: 0937941X) 24: (9) pp. 24612469. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473854]
916
Alghamdi HS, Jansen JA Bone regeneration associated with nontherapeutic and therapeutic surface coatings for dental implants in osteoporosis Tissue Engineering Part B: Reviews 19: (3) pp. 233253. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473853]
917
Roza T, Hakim L, Van Poppel H, Joniau S Bonetargeted therapies for elderly patients with renal cell carcinoma: Current and future directions Drugs and Aging 30: (11) pp. 877886. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473852]
918
* Bolland M, Grey A, Reid I Calcium and cardiovascular risks Australian Prescriber (ISSN: 03128008) 36: (1) pp. 58. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473851]
919
Åkesson K, Marsh D, Mitchell PJ, McLellan AR, Stenmark J, Pierroz DD, Kyer C, Cooper C Capture the Fracture: A Best P ractice Framework and global campaign to break the fragility fracture cycle Osteoporosis International (ISSN: 0937941X) 24: (8) pp. 21352152. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473850]
920
Torger B, Vehlow D, Urban B, Salem S, Appelhans D, Müller M Cast adhesive polyelectrolyte complex particle films of unmodified or maltosemodified poly (ethyleneimine) and cellulose sulphate: Fabrication, film stability and retarded release of zoledronate Biointerphases (ISSN: 19348630) 8: (1) P aper 25. (2013) Scopusban: pp. 111 Folyóiratcikk /Szakcikk /Tudományos [13473849]
921
Banu J Causes, consequences, and treatment of osteoporosis in men Drug Design, Development and Therapy 7: pp. 849860. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473848]
922
Donegan R, Sumpio B, Blume PA Charcot foot and ankle with osteomyelitis Diabetic Foot and Ankle 4: P aper 21361. (2013)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
172/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Összefoglaló cikk /Tudományos [13473847] 923
Ruza I, Mirfakhraee S, Orwoll E, Gruntmanis U Clinical experience with intravenous zoledronic acid in the treatment of male osteoporosis: Evidence and opinions Therapeutic Advances in Musculoskeletal Disease 5: (4) pp. 182198. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473846]
924
Mitchell BD, Streeten EA Clinical impact of recent genetic discoveries in osteoporosis Application of Clinical Genetics 6: pp. 7585. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473845]
925
Zhang W eitao, Shang Guowei, Liu Hongjian, Xia Yuechong, Kou Hongwei, Tie W eibin, Pi Guofu Clinical study of integrated therapy in treating osteoporotic vertebral compression fractures Chinese Journal of Experimental Surgery (ISSN: 10019030) 30: (3) pp. 633635. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [14597902]
926
Li Guoxin, Yuan Zhongzhi, W en Jian, W u Hailong, Tang Chenjian Clinical study of oral administration or intravenous injection of bisphosphonate for the treatment of postmenopausal osteoporosis Chinese Journal of Osteoporosis (ISSN: 10067108) 19: (9) pp. 988990. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [14597901]
927
Anastasilakis AD, Polyzos SA, Gkiomisi A, Bisbinas I, Gerou S, Makras P Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf1 levels of naive postmenopausal women with low bone mass: A randomized, headtohead clinical trial Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 98: (8) pp. 32063212. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473842]
928
Leitner H Congress report: Osteoporosis We can still do better Journal fur Mineralstoffwechsel 20: (2) pp. 7576. ( 2013) Folyóiratcikk /Konferenciaközlemény /Tudományos [13473841]
929
Mcclung Michael Controversies in Osteoporosis Management: Concerns About Bisphosphonates and When Are "Drug Holidays" Required? CLINICAL OBSTETRICS AND GYNECOLOGY (ISSN: 00099201) 56: (4) pp. 743748. ( 2013) Folyóiratcikk [14596044]
930
Aeberli D, Schett G Cortical remodeling during menopause, rheumatoid arthritis, glucocorticoid and bisphosphonate therapy Arthritis Research and Therapy 15: (2) P aper 208. (2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473840]
931
* Schousboe JT, Gourlay M, Fink HA, Taylor BC, Orwoll ES, BarrettConnor E, Melton III LJ, Cummings SR, Ensrud KE Costeffectiveness of bone densitometry among Caucasian women and men without a prior fracture according to age and body weight Osteoporosis International (ISSN: 0937941X) 24: (1) pp. 163177. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473838]
932
Honig S, Rajapakse CS, Chang G Current treatment approaches to osteoporosis2013 Bulletin of the NYU Hospital for Joint Diseases (ISSN: 08839344) 71: (3) pp. 184188. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473837]
933
Skácelová M, Horák P, Žurek M Current treatment options for osteoporosis Interni Medicina pro Praxi (ISSN: 12127299) 15: (89) pp. 249253. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473836]
934
Josse R, Khan A, Ngui D, Shapiro M Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis Current Medical Research and Opinion (ISSN: 03007995) 29: (3) pp. 205216. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473835]
935
Mattheos Nikos, Caldwell Patrick, Petcu Eugen B, Ivanovski Saso, Reher Peter Dental Implant P lacement with Bone Augmentation in a P atient Who Received Intravenous Bisphosphonate Treatment for Osteoporosis JOURNAL OF THE CANADIAN DENTAL ASSOCIATION (ISSN: 14882159) 79: P aper UNSP d2. (2013) Folyóiratcikk [14597899]
936
W ilczek ML, Kälvesten J, Algulin J, Beiki O, Brismar TB Digital Xray radiogrammetry of hand or wrist radiographs can predict hip fracture risk A study in 5,420 women and 2,837 men European Radiology (ISSN: 09387994) 23: (5) pp. 13831391. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473834]
937
Bolland MJ, Jackson R, Gamble GD, Grey A Discrepancies in predicted fracture risk in elderly people BMJ (Online) 346: (7892) P aper e8669. (2013) Folyóiratcikk /Szakcikk /Tudományos [13473832]
938
Moorthy RS, London NJS, Garg SJ, Cunningham ET Druginduced uveitis Current Opinion in Ophthalmology (ISSN: 10408738) 24: (6) pp. 589597. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473831]
939
Idolazzi L, Fassio A, Gatti D, Tamanini S, Viapiana O, Rossini M, Adami S Duration of treatment for osteoporosis Reumatismo 65: (1) pp. 2235. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473830]
940
Gifre L, Peris P, Monegal A, MartinezFerrer A, Hernandez M V, Guanabens N Effect of bisphosphonates on renal function in patients with osteoporosis EUROPEAN GERIATRIC MEDICINE (ISSN: 18787649) 4: (6) pp. 380383. ( 2013)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
173/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [14596042] 941
Kong Xijian, W u Dan, Ye Jin Effect of zoledronic acid and calcitonin on bone metabolic biochemical markers, BAP , NMID, and betaCTX Chinese Journal of Osteoporosis (ISSN: 10067108) 19: (1) pp. 4650. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [14597898]
942
Lim R, Zailskas S, Goldsby TU, Lukens C, Muravev R, Dulipsingh L Effect of zoledronic acid on bone density and markers of bone turnover in a community clinic Connecticut Medicine 77: (6) pp. 357359. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473829]
943
Scott DF, W oltz JN, Smith RR Effect of Zoledronic Acid on Reducing Femoral Bone Mineral Density Loss following Total Hip Arthroplasty. P reliminary Results of a P rospective Randomized Trial. Journal of Arthroplasty (ISSN: 08835403) 28: (4) pp. 671675. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473828]
944
Devogelaer JP, Sambrook P, Reid DM, Goemaere S, IshShalom S, Collette J, Su G, BucciRechtweg C, Papanastasiou P, Reginster JY Effect on bone turnover markers of onceyearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids Rheumatology (United Kingdom) 52: (6) pp. 10581069. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473827]
945
* Lindsay R, W atts NB, Lange JL, Delmas PD, Silverman SL Effectiveness of risedronate and alendronate on nonvertebral fractures: An observational study through 2 years of therapy Osteoporosis International (ISSN: 0937941X) 24: (8) pp. 23452352. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473826]
946
* Gamsjaeger S, Hofstetter B, Zwettler E, Recker R, Gasser JA, Eriksen EF, Klaushofer K, Paschalis EP Effects of 3 years treatment with onceyearly zoledronic acid on the kinetics of bone matrix maturation in osteoporotic patients Osteoporosis International (ISSN: 0937941X) 24: (1) pp. 339347. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473825]
947
* Schwartz AV, Schafer AL, Grey A, Vittinghoff E, Palermo L, Lui LYL, W allace RB, Cummings SR, Black DM, Bauer DC, Reid IR Effects of antiresorptive therapies on glucose metabolism: Results from the FIT, HORIZONP FT, and FREEDOM trials Journal of Bone and Mineral Research (ISSN: 08840431) 28: (6) pp. 13481354. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473824]
948
Polidoro S, Broccoletti R, Campanella G, Di Gaetano C, Menegatti E, Scoletta M, Lerda E, Matullo G, Vineis P, Berardi D, Scully C, Arduino PG Effects of bisphosphonate treatment on DNA methylation in osteonecrosis of the jaw Mutation Research Genetic Toxicology and Environmental Mutagenesis 757: (2) pp. 104113. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473823]
949
Nagira K, Hagino H, Kameyama Y, Teshima R Effects of minodronate on cortical bone response to mechanical loading in rats Bone (ISSN: 87563282) 53: (1) pp. 277283. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473822]
950
Omodei U, Mazziotti G, Donarini G, Gola M, Guella V, Pagani F, Bugari G, Porcelli T, Giustina A Effects of recombinant folliclestimulating hormone on bone turnover markers in infertile women undergoing in vitro fertilization procedure Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 98: (1) pp. 330336. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473821]
951
Popp AW , Guler S, Lamy O, Senn C, Buffat H, Perrelet R, Hans D, Lippuner K Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: A threeyear study Journal of Bone and Mineral Research (ISSN: 08840431) 28: (3) pp. 449454. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473820]
952
Xuan Miao, Yang Jun, Li Ying, Zhou Yun, W ang Bo, Song Lige, W ang Yonglan, Zhang Xiuzhen Effects of zoledronic acid and tibolone on bone mineral density, indexes of bone metabolism, and the risk of fracture in patients with postmenopausal osteoporosis Chinese Journal of Endocrinology and Metabolism (ISSN: 10006699) 29: (6) pp. 504508. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [14597897]
953
Schilcher Joerg Epidemiology, radiology and histology of atypical femoral fractures Development of understanding ACTA ORTHOPAEDICA (ISSN: 17453674) 84: pp. 524. ( 2013) SU 352 Folyóiratcikk [14596040]
954
Lems W F, den Heijer M Established and forthcoming drugs for the treatment of osteoporosis Netherlands Journal of Medicine (ISSN: 03002977) 71: (4) pp. 188193. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473819]
955
Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporosis International (ISSN: 0937941X) 24: (1) pp. 2357. ( 2013) Folyóiratcikk /Jelentés /Tudományos [13473818]
956
Goltz L, Degenhardt G, Maywald U, Kirch W , Schindler C Evaluation of a program of integrated care to reduce recurrent osteoporotic fractures Pharmacoepidemiology and Drug Safety (ISSN: 10538569) 22: (3) pp. 263270. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473817]
957
Liu Yuan, Lin Yicong, Zhang W ei, Pang Chunyan, W ang Yongfu Experimental study of 99TcMDP on the treatment of glucocorticoidinduced osteoporosis in rats Chinese Journal of Osteoporosis (ISSN: 10067108) 19: (8) pp. 829833. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [14597896]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
174/342
3/30/2015
nyomtatobarat forma 958
Kocjan T, Preželj J, Pfeifer M, Jensterle Sever M, Čokolič M, Zavratnik A Guidelines for the detection and treatment of osteoporosis Zdravniski Vestnik 82: (4) pp. 207217. ( 2013) Folyóiratcikk /Jelentés /Tudományos [13473816]
959
Schurman L, Bagur A, ClausHermberg H, Messina OD, Negri AL, Sánchez A, González C, Diehl M, Rey P, Gamba J, Chiarpenello J, Moggia MS, Mastaglia S Guidelines for the diagnosis, prevention and treatment of osteoporosis, 2012 Medicina (Argentina) 73: (1) pp. 5574. ( 2013) Folyóiratcikk /Jelentés /Tudományos [13473813]
960
Schurman L, Bagur A, ClausHermberg H, Messina OD, Negri AL, Sánchez A, González C, Diehl M, Rey P, Gamba J, Chiarpenello J, Moggia MS, Mastaglia S Guidelines for the diagnosis, prevention, and treatment of osteoporosis 2012 Actualizaciones en Osteologia 9: (2) pp. 4474. ( 2013) Folyóiratcikk /Jelentés /Tudományos [13473812]
961
* Hiligsmann M, Kanis JA, Compston J, Cooper C, Flamion B, Bergmann P, Body JJ, Boonen S, Bruyere O, Devogelaer JP, Goemaere S, Kaufman JM, Rozenberg S, Reginster JY Health technology assessment in osteoporosis Calcified Tissue International (ISSN: 0171967X) 93: (1) pp. 114. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473810]
962
Grove EL, Abrahamsen B, Vestergaard P Heart failure in patients treated with bisphosphonates Journal of Internal Medicine (ISSN: 09546820) 274: (4) pp. 342350. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473809]
963
Tan S, Yao J, Yao L, W ard MM High precision semiautomated computed tomography measurement of lumbar disk and vertebral heights Medical Physics (ISSN: 00942405) 40: (1) P aper 011905. (2013) Folyóiratcikk /Szakcikk /Tudományos [13473808]
964
Chang W W , Friedman S Hip Fracture Management Hospital Medicine Clinics 2: (3) pp. e399e421. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473806]
965
Arias LHM, Treceño C, GarcíaOrtega P, RodríguezParedes J, Escudero A, Sáinz M, Salado I, Velasco V, Carvajal A Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study European Journal of Clinical Pharmacology (ISSN: 00316970) 69: (3) pp. 559564. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473805]
966
KerschanSchindl K, Haschka J, ObermayerPietsch B, Gasser RW , Dimai HP, FahrleitnerPammer A, Dobnig H, Roschger P, Preisinger E, Klaushofer K, Resch H, Pietschmann P How long should women with postmenopausal osteoporosis be treated with a bisphosphonate? Hormone and Metabolic Research (ISSN: 00185043) 45: (9) pp. 621628. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473804]
967
Liem IS, Kammerlander C, Suhm N, Blauth M, Roth T, Gosch M, HoangKim A, Mendelson D, Zuckerman J, Leung F, Burton J, Moran C, Parker M, Giusti A, Pioli G, Goldhahn J, Kates SL Identifying a standard set of outcome parameters for the evaluation of orthogeriatric comanagement for hip fractures Injury 44: (11) pp. 14031412. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473803]
968
Frediani B, Bertoldi I, Pierguidi S, Nicosia A, Picerno V, Filippou G, Cantarini L, Galeazzi M Improved efficacy of intramuscular weekly administration of clodronate 200 mg (100 mg twice weekly) compared with 100 mg (Once Weekly) for increasing bone mineral density in postmenopausal osteoporosis Clinical Drug Investigation (ISSN: 11732563) 33: (3) pp. 193198. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473802]
969
Dore Naomi, Kennedy Courtney, Fisher Pauline, Dolovich Lisa, Farrauto Leonardo, Papaioannou Alexandra Improving care after hip fracture: the fracture? Think osteoporosis (FTOP ) program BMC GERIATRICS (ISSN: 14712318) 13: P aper 130. (2013) Folyóiratcikk [14596038]
970
Fisher JE, Rosenberg E, Santora AC, Reszka AA In vitro and in vivo responses to high and low doses of nitrogencontaining bisphosphonates suggest engagement of different mechanisms for inhibition of osteoclastic bone resorption Calcified Tissue International (ISSN: 0171967X) 92: (6) pp. 531538. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473800]
971
Tamminen IS, YliKyyny T, Isaksson H, Turunen MJ, Tong X, Jurvelin JS, Kröger H Incidence and bone biopsy findings of atypical femoral fractures Journal of Bone and Mineral Metabolism (ISSN: 09148779) 31: (5) pp. 585594. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473799]
972
Assaf AT, Smeets R, Riecke B, W eise E, Gröbe A, Blessmann M, Steiner T, W ikner J, Friedrich RE, Heiland M, Hoelzle F, Gerhards F Incidence of bisphosphonaterelated osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies Anticancer Research (ISSN: 02507005) 33: (9) pp. 39173924. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473798]
973
Pazianas M, Clark EM, Eiken PA, Brixen K, Abrahamsen B Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: Cohort analysis using a national prescription database Journal of Bone and Mineral Research (ISSN: 08840431) 28: (3) pp. 455463. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473796]
974
Hari P, DeFor TE, Vesole DH, Bredeson CN, Burns LJ Intermittent zoledronic acid prevents bone loss in adults after allogeneic hematopoietic cell transplantation Biology of Blood and Marrow Transplantation (ISSN: 10838791) 19: (9) pp. 13611367. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473794]
975
Seeherman HJ, Li XJ, Smith E, Parkington J, Li R, W ozney JM Intraosseous injection of rhBMP 2/calcium phosphate matrix improves bone structure and strength in the proximal aspect of
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
175/342
3/30/2015
nyomtatobarat forma the femur in chronic ovariectomized nonhuman primates Journal of Bone and Joint Surgery Series A 95: (1) pp. 3647. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473792] 976
Sieber P, Lardelli P, Kraenzlin CA, Kraenzlin ME, Meier C Intravenous bisphosphonates for postmenopausal osteoporosis: Safety profiles of zoledronic acid and ibandronate in clinical practice Clinical Drug Investigation (ISSN: 11732563) 33: (2) pp. 117122. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473790]
977
Mathavan N, Bosemark P, Isaksson H, Tägil M Investigating the synergistic efficacy of BMP 7 and zoledronate on bone allografts using an open rat osteotomy model Bone (ISSN: 87563282) 56: (2) pp. 440448. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473789]
978
AshcroftHands R Management of osteoporosis update Journal of Community Nursing 27: (2) p. §. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473788]
979
Lewiecki EM Monoclonal antibodies for the treatment of osteoporosis Expert Opinion on Biological Therapy (ISSN: 14712598) 13: (2) pp. 183196. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473787]
980
W elton JL, Morgan MP, Martí S, Stone MD, Moser B, Sewell AK, Turton J, Eberl M Monocytes and γ δ T cells control the acutephase response to intravenous zoledronate: Insights from a phase IV safety trial Journal of Bone and Mineral Research (ISSN: 08840431) 28: (3) pp. 464471. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473786]
981
Gralow JR, Biermann JS, Farooki A, Fornier MN, Gagel RF, Kumar R, Litsas G, McKay R, Podoloff DA, Srinivas S, Van Poznak CH NCCN task force report: Bone health in cancer care JNCCN Journal of the National Comprehensive Cancer Network 11: (SUP P L.3) pp. S1S50. ( 2013) Folyóiratcikk /Konferenciaközlemény /Tudományos [13473785]
982
* Eriksen EF, Halse J, Moen MH New developments in the treatment of osteoporosis Acta Obstetricia et Gynecologica Scandinavica (ISSN: 00016349) 92: (6) pp. 620636. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473784]
983
* Bucur RC, Reid LS, Hamilton CJ, Cummings SR, Jamal SA Nitrates and bone turnover (NABT) trial to select the best nitrate preparation: Study protocol for a randomized controlled trial Trials (ISSN: 17456215) 14: (1) P aper 284. (2013) Folyóiratcikk /Szakcikk /Tudományos [13473783]
984
Hagino H, Shiraki M, Fukunaga M, Nakano T, Takaoka K, Ohashi Y, Nakamura T, Matsumoto T Number and severity of prevalent vertebral fractures and the risk of subsequent vertebral fractures in Japanese women with osteoporosis: Results from the minodronate trial Journal of Bone and Mineral Metabolism (ISSN: 09148779) 31: (5) pp. 544550. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473782]
985
Pang Xue, Liu Ying, Cao Jihong, W ang Li, Guo Yan, W ang Liheng Observation and nursing of the transient adverse effect of zoledronic acid in the treatment of postmenopausal osteoporosis Chinese Journal of Osteoporosis (ISSN: 10067108) 19: (11) pp. 11871189. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [14597895]
986
* Reid IR, Bolland MJ Observational studies Just telling us what we want to hear or telling us where we need to look? Journal of Bone and Mineral Research (ISSN: 08840431) 28: (5) pp. 980983. ( 2013) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [13473781]
987
Anonymous OSHK TASK GROUP FOR THE FORMULATION OF THE 2013 OSHK GUIDELINE FOR CLINICAL MANAGEMENT OF P OSTMENOP AUSAL OSTEOP OROSIS IN HONG KONG HONG KONG MEDICAL JOURNAL (ISSN: 10242708) 19: (2) pp. 640. ( 2013) SU 2 Folyóiratcikk [14597893]
988
Gutiérrez Restrepo Johnayro OSTEONECROSIS DE MANDÍBULA ASOCIADA AL TRATAMIENTO CON BIFOSFONATOS EN P ACIENTES CON OSTEOP OROSIS: UNA REVISIÓN: OSTEONECROSIS OF THE JAW ASSOCIATED TO BISP HOSP HONATES TREATMENT IN OSTEOP OROSIS P ATIENTS: A REVIEW Revista Facultad de Odontología Universidad de Antioquia (ISSN: 0121246X) 24: (2) pp. 307320. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [14597871]
989
OuteiriñoFernández A Osteonecrosis of the jaw associated with Bisphosphonate therapy in primary osteoporosis. Review of the literature Anales del Sistema Sanitario de Navarra (ISSN: 11376627) 36: (1) pp. 8797. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473780]
990
Lee JJ, Cheng SJ, W ang YP, Jeng JH, Chiang CP, Kok SH Osteonecrosis of the jaws associated with the use of yearly zoledronic acid: Report of 2 cases Head and Neck 35: (1) pp. E6E10. ( 2013) Folyóiratcikk /Rövid közlemény /Tudományos [13473779]
991
Das Subhajit, Crockett Julie C Osteoporosis a current view of pharmacological prevention and treatment DRUG DESIGN DEVELOPMENT AND THERAPY (ISSN: 11778881) 7: pp. 435447. ( 2013) Folyóiratcikk [14597892]
992
* Leung PC Osteoporosis and the Orthopaedic surgeon Chinese Medical Journal (ISSN: 03666999) 126: (20) pp. 38033805. ( 2013)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
176/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Ismertetés /Tudományos [13473778] 993
W arriner AH, Saag KG Osteoporosis Diagnosis and Medical Treatment Orthopedic Clinics of North America (ISSN: 00305898) 44: (2) pp. 125135. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473777]
994
Sanders Suzanne, Geraci Stephen A Osteoporosis in P ostmenopausal Women: Considerations in P revention and Treatment (Women's Health Series) SOUTHERN MEDICAL JOURNAL (ISSN: 00384348) 106: (12) pp. 698706. ( 2013) Folyóiratcikk [14596035]
995
Shepherd AJ, Howrey BT, Cass AR, W ilkinson GS Osteoporosis therapy after fracture in elderly men Journal of Clinical Outcomes Management 20: (7) pp. 303312. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473776]
996
* Reid Ian R Osteoporosis treatment: Focus on safety EUROPEAN JOURNAL OF INTERNAL MEDICINE (ISSN: 09536205) 24: (8) pp. 691697. ( 2013) Folyóiratcikk [14596033]
997
Adami Silvano, Idolazzi Luca, Fracassi Elena, Gatti Davide, Rossini Maurizio Osteoporosis Treatment: When to Discontinue and When to Restart BONE RESEARCH (ISSN: 20954700) 4: pp. 323335. ( 2013) Folyóiratcikk [14596031]
998
Rossini M, Orsolini G, Adami S, Kunnathully V, Gatti D Osteoporosis treatment: Why ibandronic acid? Expert Opinion on Pharmacotherapy (ISSN: 14656566) 14: (10) pp. 13711381. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473775]
999
Gonçalves MJ, Rodrigues AM, Canhão H, Fonseca JE Osteoporosis: From bone biology to individual treatment decision Acta Medica Portuguesa (ISSN: 16460758) 26: (4) pp. 445455. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473774]
1000
Kelly KN, Kelly C P attern and cause of fractures in patients who abuse alcohol: What should we do about it? Postgraduate Medical Journal (ISSN: 00325473) 89: (1056) pp. 578583. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473773]
1001
Zhuang Qingshan, Xu Zhaowan, W u Qinmin, Shi Feng, Ji Xubin, Sui Guoxia P ercutaneous kyphoplasty for treatment of osteoporotic vertebral fractures and collapse with intravertebral vacuum sign Chinese Journal of Trauma (ISSN: 10018050) 29: (7) pp. 608613. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [14597891]
1002
Gatti D, Rossini M, Sblendorio I, Lello S P harmacokinetic evaluation of bazedoxifene for the treatment of osteoporosis Expert Opinion on Drug Metabolism and Toxicology (ISSN: 17425255) 9: (7) pp. 883892. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473772]
1003
Nieto JE, Maher O, Stanley SD, Knych HK, Snyder JR P harmacokinetics, pharmacodynamics, and safety of zoledronic acid in horses American Journal of Veterinary Research (ISSN: 00029645) 74: (4) pp. 550556. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473770]
1004
Jia Xiujuan, Jia Li, Zhong Lina, Zhang Zheng P reliminary analysis of the safety and efficacy of zoledronic acid injection on osteoporosis in advanced aged patients Chinese Journal of Osteoporosis (ISSN: 10067108) 19: (10) pp. 10841086,1098. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [14597890]
1005
AppelmanDijkstra Natasha M, Papapoulos Socrates E P revention of incident fractures in patients with prevalent fragility fractures: Current and future approaches BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (ISSN: 15216942) 27: (6) pp. 805820. ( 2013) Folyóiratcikk [14596029]
1006
Raccor BS, Sun J, Lawrence RF, Li L, Zhang H, Somerman MJ, Totah RA Quantitation of zoledronic acid in murine bone by liquid chromatography coupled with tandem mass spectrometry Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 935: pp. 5460. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473769]
1007
Bai H, Jing D, Guo A, Yin S Randomized controlled trial of zoledronic acid for treatment of osteoporosis in women Journal of International Medical Research (ISSN: 03000605) 41: (3) pp. 697704. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473768]
1008
Migliore A, Broccoli S, Massafra U, Cassol M, Frediani B Ranking antireabsorptive agents to prevent vertebral fractures in postmenopausal osteoporosis by mixed treatment comparison metaanalysis European Review for Medical and Pharmacological Sciences (ISSN: 11283602) 17: (5) pp. 658667. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473767]
1009
Rejnmark Lars Recombinant hormones in osteoporosis EXPERT OPINION ON BIOLOGICAL THERAPY (ISSN: 14712598) 13: (8) pp. 11351147. ( 2013) Folyóiratcikk [14597870]
1010 * Reid IR, Black DM, Eastell R, BucciRechtweg C, Su G, Hue TF, Mesenbrink P, Lyles KW , Boonen S Reduction in the risk of clinical fractures after a single dose of zoledronic acid 5 milligrams Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 98: (2) pp. 557563. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473766] 1011 * Miller PD, Jamal SA, Evenepoel P, Eastell R, Boonen S Renal safety in patients treated with bisphosphonates for osteoporosis: A review Journal of Bone and Mineral Research (ISSN: 08840431) 28: (10) pp. 20492059. ( 2013)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
177/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Összefoglaló cikk /Tudományos [13473765] 1012 * Napoli N, Schwartz AV, Palermo L, Jin JJ, W ustrack R, Cauley JA, Ensrud KE, Kelly M, Black DM Risk factors for subtrochanteric and diaphyseal fractures: The study of osteoporotic fractures Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 98: (2) pp. 659667. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473764] 1013
Sharma A, Chatterjee S, ArbabZadeh A, Goyal S, Lichstein E, Ghosh J, Aikat S Risk of serious atrial fibrillation and stroke with use of bisphosphonates: Evidence from a metaanalysis Chest (ISSN: 00123692) 144: (4) pp. 13111322. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473763]
1014
Reginster JY, Pelousse F, Bruyère O Safety concerns with the longterm management of osteoporosis Expert Opinion on Drug Safety (ISSN: 14740338) 12: (4) pp. 507522. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473762]
1015
Varenna M, Bertoldo F, Di Monaco M, Giusti A, Martini G, Rossini M Safety profile of drugs used in the treatment of osteoporosis: A systematical review of the literature Reumatismo 65: (4) pp. 143166. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473760]
1016
Chandran Manju, Akesson Kristina Secondary Fracture P revention: P lucking The Low Hanging Fruit ANNALS ACADEMY OF MEDICINE SINGAPORE (ISSN: 03044602) 42: (10) pp. 541544. ( 2013) Folyóiratcikk [14596026]
1017
Mitchell Paul James, Chem C Secondary prevention and estimation of fracture risk BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (ISSN: 15216942) 27: (6) pp. 789803. ( 2013) Folyóiratcikk [14596024]
1018 * Chandran M, Tan M Z W , Cheen M, Tan S B, Leong M, Lau T C Secondary prevention of osteoporotic fracturesan "OP TIMAL" model of care from Singapore OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 24: (11) pp. 28092817. ( 2013) Folyóiratcikk [14596022] 1019 * Yang L, Sycheva AV, Black DM, Eastell R Sitespecific differential effects of onceyearly zoledronic acid on the hip assessed with quantitative computed tomography: Results from the HORIZON P ivotal Fracture Trial Osteoporosis International (ISSN: 0937941X) 24: (1) pp. 329338. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473759] 1020
W right NC, W arriner AH, Saag KG Study design considerations for a large simple trial of bisphosphonates Current Opinion in Rheumatology (ISSN: 10408711) 25: (4) pp. 517523. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473758]
1021
Chamizo Carmona E, Gallego Flores A, Loza Santamaría E, Herrero Olea A, Rosario Lozano MP Systematic literature review of bisphosphonates and osteonecrosis of the jaw in patients with osteoporosis Reumatologia Clinica (ISSN: 1699258X) 9: (3) pp. 172177. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473757]
1022
Serrano AJ, Begoña L, Anitua E, Cobos R, Orive G Systematic review and metaanalysis of the efficacy and safety of alendronate and zoledronate for the treatment of postmenopausal osteoporosis Gynecological Endocrinology (ISSN: 09513590) 29: (12) pp. 10051014. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473756]
1023
Luengratsameerung S, Panyakhamlerd K, Treratanachat S, Taechakraichana N Systemic effects of conjugated equine estrogen vaginal cream on bone turnover markers in postmenopausal women Climacteric (ISSN: 13697137) 16: (1) pp. 133140. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473755]
1024
Sprague SM, Moe SM The case for routine parathyroid hormone monitoring Clinical Journal of the American Society of Nephrology (ISSN: 15559041) 8: (2) pp. 313318. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473754]
1025
Maximov PY, Lee TM, Craig Jordan V The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice Current Clinical Pharmacology (ISSN: 15748847) 8: (2) pp. 135155. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473753]
1026
Grey A, Bolland MJ The effect of treatments for osteoporosis on mortality Osteoporosis International (ISSN: 0937941X) 24: (1) pp. 16. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473752]
1027
Cardemil C, Omar OM, Norlindh B, W exell CL, Thomsen P The effects of a systemic single dose of zoledronic acid on postimplantation bone remodelling and inflammation in an ovariectomised rat model Biomaterials (ISSN: 01429612) 34: (5) pp. 15461561. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473751]
1028
Jamal SA, Reid LS, Hamilton CJ The effects of organic nitrates on osteoporosis: A systematic review Osteoporosis International (ISSN: 0937941X) 24: (3) pp. 763770. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473750]
1029 * Bourke S, Bolland MJ, Grey A, Horne AM, W attie DJ, W ong S, Gamble GD, Reid IR The impact of dietary calcium intake and vitamin D status on the effects of zoledronate Osteoporosis International (ISSN: 0937941X) 24: (1) pp. 349354. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473749] 1030
ObermayerPietsch B The importance of biological markers of bone metabolism in osteology 2012
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
178/342
3/30/2015
nyomtatobarat forma Journal fur Mineralstoffwechsel 20: (SONDERHEFT 1) pp. 49. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473748] 1031 * Patel DV, Horne A, House M, Reid IR, McGhee CNJ The incidence of acute anterior uveitis after intravenous zoledronate Ophthalmology (ISSN: 01616420) 120: (4) pp. 773776. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473747] 1032
Yeap SS, Hew FL, Lee JK, Goh EML, Chee W , Mumtaz M, Damodaran P, Lim HH, Chan SP The Malaysian Clinical Guidance on the Management of P ostmenopausal Osteoporosis, 2012: A Summary International Journal of Rheumatic Diseases (ISSN: 17561841) 16: (1) pp. 3040. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473746]
1033
Huntjens KMB, Van Geel TACM, Van Helden S, Van Den Bergh J, W illems P, W inkens B, Geusens PP, Brink PRG The role of the combination of bone and fall related risk factors on shortterm subsequent fracture risk and mortality BMC Musculoskeletal Disorders (ISSN: 14712474) 14: P aper 121. (2013) Folyóiratcikk /Szakcikk /Tudományos [13473745]
1034
Ott Susan M Therapy for patients with CKD and low bone mineral density NATURE REVIEWS NEPHROLOGY (ISSN: 17595061) 9: (11) pp. 681692. ( 2013) Folyóiratcikk [14596020]
1035
Kaptan Figen, Kazandag Meric Karapinar, Iseri Ufuk Treatment of bisphosphonate related osteonecrosis following root canal therapy at the 1year followup: report of two cases THERAPEUTICS AND CLINICAL RISK MANAGEMENT (ISSN: 11766336) 9: pp. 477482. ( 2013) Folyóiratcikk [14597884]
1036 * Kaufman JM, Reginster JY, Boonen S, Brandi ML, Cooper C, Dere W , Devogelaer JP, DiezPerez A, Kanis JA, McCloskey E, Mitlak B, Orwoll E, Ringe JD, W eryha G, Rizzoli R Treatment of osteoporosis in men Bone (ISSN: 87563282) 53: (1) pp. 134144. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473744] 1037
Adami S, Bertoldo F, Gatti D, Minisola G, Rossini M, Sinigaglia L, Varenna M Treatment thresholds for osteoporosis and reimbursability criteria: P erspectives associated with fracture riskassessment tools Calcified Tissue International (ISSN: 0171967X) 93: (3) pp. 195200. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473743]
1038
W ysowski DK, Greene P Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 20022012 Bone (ISSN: 87563282) 57: (2) pp. 423428. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473742]
1039
Dunn RL, Bird ML, Conway SE, Stratton MA Use of bisphosphonates in older adults: How long is long enough? Consultant Pharmacist 28: (1) pp. 3957. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473741]
1040
Mudano AS, Gary LC, Oliveira AL, Melton M, W right NC, Curtis JR, Delzell E, Harrington TM, Kilgore L, Lewis CE, Singh JA, W arriner AH, Pace W D, Saag KG Using tablet computers compared to interactive voice response to improve subject recruitment in osteoporosis pragmatic clinical trials: Feasibility, satisfaction, and sample size Patient Preference and Adherence (ISSN: 1177889X) 7: pp. 517523. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473740]
1041
Kuet KP, Charlesworth D, Peel NFA Vertebral fracture assessment scans enhance targeting of investigations and treatment within a fracture risk assessment pathway Osteoporosis International (ISSN: 0937941X) 24: (3) pp. 10071014. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473738]
1042
Coleman R, De Boer R, Eidtmann H, Llombart A, Davidson N, Neven P, Von Minckwitz G, Sleeboom HP, Forbes J, Barrios C, Frassoldati A, Campbell I, Paija O, Martin N, Modi A, Bundred N Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZOFAST study): Final 60month results Annals of Oncology (ISSN: 09237534) 24: (2) pp. 398405. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473737]
1043
Catalano A, Morabito N, Basile G, Brancatelli S, Cucinotta D, Lasco A Zoledronic acid acutely increases sclerostin serum levels in women with postmenopausal osteoporosis Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 98: (5) pp. 19111915. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473736]
1044
Chen B, Li Y, Yang X, Xu H, Xie D Zoledronic acid enhances boneimplant osseointegration more than alendronate and strontium ranelate in ovariectomized rats Osteoporosis International (ISSN: 0937941X) 24: (7) pp. 21152121. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473735]
1045
W estin JR, Thompson MA, Cataldo VD, Fayad LE, Fowler N, Fanale MA, Neelapu S, Samaniego F, Romaguera J, Shah J, McLaughlin P, Pro B, Kwak LW , Sanjorjo P, Murphy W A, Jimenez C, Toth B, Dong W , Hagemeister FB Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: A prospective, randomized controlled phase III trial Clinical Lymphoma, Myeloma and Leukemia 13: (2) pp. 99105. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473734]
1046
Young RJ, Coleman RE Zoledronic acid to prevent and treat cancer metastasis: New prospects for an old drug Future Oncology (ISSN: 14796694) 9: (5) pp. 633643. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13473733]
1047
闫富宏 唑来膦酸规范化应用骨科专家研讨会纪要 Chinese Journal of Orthopedics (ISSN: 02532352) 33: (7) pp. 782784. ( 2013)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
179/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [14597906] 1048
中华医学会风湿病学分会 糖皮质激素诱导的骨质疏松诊治的专家共识 Chinese Journal of Rheumatology (ISSN: 10077480) 17: (6) pp. 363368. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [14597907]
1049
Chinese Journal of Gerontology (ISSN: 10059202) 34: (15) pp. 42264227. ( 2014) Folyóiratcikk [14596017]
1050
Moe Sharon M, Chen Neal X, Newman Christopher L, Gattone Vincent H II, Organ Jason M, Chen Xianming, Allen Matthew R A Comparison of Calcium to Zoledronic Acid for Improvement of Cortical Bone in an Animal Model of CKD JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 29: (4) pp. 902910. ( 2014) Folyóiratcikk [14595943]
1051
Van der Kallen John, Giles Michelle, Cooper Kerry, Gill Kerry, Parker Vicki, Tembo Agness, Major Gabor, Ross Linda, Carter Jan A fracture prevention service reduces further fractures two years after incident minimal trauma fracture INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ISSN: 17561841) 17: (2) pp. 195203. ( 2014) Folyóiratcikk [14595942]
1052 * McNabb Brian, Vittinghoff Eric, Eastell Richard, Schwartz Ann V, Bauer Douglas C, Ensrud Kristine, BarrettConnor Elizabeth, Black Dennis M A Model of BMD Changes After Alendronate Discontinuation to Guide P ostalendronate BMD Monitoring JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 99: (11) pp. 40944100. ( 2014) Folyóiratcikk [14595865] 1053
Qiu Ling, Lin Jianguo, W ang Liqing, Cheng W en, Cao Yang, Liu Xuewen, Luo Shineng A Series of ImidazolylContaining Bisphosphonates with Abundant HydrogenBonding Interactions: Syntheses, Structures, and BoneBinding Affinity AUSTRALIAN JOURNAL OF CHEMISTRY (ISSN: 00049425) 67: (2) pp. 192205. ( 2014) Folyóiratcikk [14596014]
1054
Tai TaW ei, Su FongChin, Chen ChingYu, Jou IMing, Lin ChiouFeng Activation of p38 MAP Kregulated BclxL signaling increases survival against zoledronic acidinduced apoptosis in osteoclast precursors BONE (ISSN: 87563282) 67: pp. 166174. ( 2014) Folyóiratcikk [14595864]
1055
Vegger Jens Bay, Nielsen Esben Sommer, Bruel Annemarie, Thomsen Jesper Skovhus Additive effect of P TH (134) and zoledronate in the prevention of disuse osteopenia in rats BONE (ISSN: 87563282) 66: pp. 287295. ( 2014) Folyóiratcikk [14595863]
1056
Raje Noopur S, Yee Andrew J, Roodman G David Advances in Supportive Care for Multiple Myeloma JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (ISSN: 15401405) 12: (4) pp. 502511. ( 2014) Folyóiratcikk [14595940]
1057
Keller David L Adverse Cardiac Effects of Bisphosphonates MAYO CLINIC PROCEEDINGS (ISSN: 00256196) 89: (7) pp. 10251026. ( 2014) Folyóiratcikk [14595939]
1058
Maeda Sergio Setsuo, LazarettiCastro Marise An overview on the treatment of postmenopausal osteoporosis ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (ISSN: 00042730) 58: (2) pp. 162171. ( 2014) Folyóiratcikk [14595931]
1059
Qian Shanshan, Qin Lirong, Dai Huizhen Analysis of the Utilization of Bisphosphonates Drugs in 34 Hospitals from Nanjing Area during 20102012 China Pharmacy (ISSN: 10010408) 25: (22) pp. 20292031. ( 2014) Folyóiratcikk [14596012]
1060
Marcano Alejandro, Taormina David, Egol Kenneth A, Peck Valerie, Tejwani Nirmal C Are Race and Sex Associated With the Occurrence of Atypical Femoral Fractures? CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (ISSN: 0009921X) 472: (3) pp. 10201027. ( 2014) Folyóiratcikk [14595930]
1061
Konsta Maria, Bournia VasilikiKalliopi, Dania Vasiliki, Iliopoulos Alexios Atrial Fibrillation Following Intravenous Zolendronic Acid for Osteoporosis JCRJOURNAL OF CLINICAL RHEUMATOLOGY (ISSN: 10761608) 20: (4) pp. 12. ( 2014) Folyóiratcikk [14595928]
1062
Bronson W esley H, Kaye I David, Egol Kenneth A Atypical Femur Fractures: A Review CURRENT OSTEOPOROSIS REPORTS 12: (4) pp. 446453. ( 2014) Folyóiratcikk [14595862]
1063
Hlaing Thinn Thinn, Compston Juliet E Biochemical markers of bone turnover uses and limitations ANNALS OF CLINICAL BIOCHEMISTRY (ISSN: 00045632) 51: (2) pp. 189202. ( 2014) Folyóiratcikk [14595927]
1064
Boyce Alison M, Tosi Laura L, Paul Scott M Bisphosphonate Treatment for Children With Disabling Conditions PM&R (ISSN: 19341482) 6: (5) pp. 427436. ( 2014) Folyóiratcikk [14595925]
1065
Katz Joseph, Ordoveza Patrisha A Bisphosphonaterelated osteonecrosis of the jaw (BRONJ) associated with a onceyearly IV infusion of zoledronic acid (Reclast) 5 mg: Two cases and review of the literature QUINTESSENCE INTERNATIONAL (ISSN: 00336572) 45: (8) pp. 685690. ( 2014) Folyóiratcikk [14595861]
1066
Safford Monika M, Barasch Andrei, Curtis Jeffrey R, Outman Ryan, Saag Kenneth
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
180/342
3/30/2015
nyomtatobarat forma Bisphosphonates and Hip and Nontraumatic Subtrochanteric Femoral Fractures in the Veterans Health Administration JCRJOURNAL OF CLINICAL RHEUMATOLOGY (ISSN: 10761608) 20: (7) pp. 357362. ( 2014) Folyóiratcikk [14595860] 1067
Perkins Robert M, Kirchner H Lester, Matsushita Kunihiro, Bucaloiu Ion D, Norfolk Evan, Hartle James E Bisphosphonates and Mortality in Women with CKD and the P resence or Absence of Cardiovascular Disease CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (ISSN: 15559041) 9: (5) pp. 874880. ( 2014) Folyóiratcikk [14595924]
1068
Brown Jacques P, Morin Suzanne, Leslie W illiam, Papaioannou Alexandra, Cheung Angela M, Davison Kenneth S, Goltzman David, Hanley David Arthur, Hodsman Anthony, Josse Robert, Jovaisas Algis, Juby Angela, Kaiser Stephanie, Karaplis Andrew, Kendler David, Khan Aliya, Ngui Daniel, Olszynski W ojciech, SteMarie LouisGeorges, Adachi Jonathan Bisphosphonates for treatment of osteoporosis Expected benefits, potential harms, and drug holidays CANADIAN FAMILY PHYSICIAN (ISSN: 0008350X) 60: (4) pp. 324333. ( 2014) Folyóiratcikk [14595922]
1069
Giusti Andrea Bisphosphonates in the management of thalassemiaassociated osteoporosis: a systematic review of randomised controlled trials JOURNAL OF BONE AND MINERAL METABOLISM (ISSN: 09148779) 32: (6) pp. 606615. ( 2014) Folyóiratcikk [14595859]
1070
Coleman R, Body J J, Aapro M, Hadji P, Herrstedt J Bone health in cancer patients: ESMO Clinical P ractice Guidelines ANNALS OF ONCOLOGY (ISSN: 09237534) 25: pp. 124137. ( 2014) CA ESMO Guidelines W orking Grp SU 3 Folyóiratcikk [14595858]
1071
Bandeira Francisco, Costa Aline G, Soares Filho Manoel Aderson, Pimentel Larissa, Lima Lourena, Bilezikian John P Bone markers and osteoporosis therapy ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (ISSN: 00042730) 58: (5) pp. 504513. ( 2014) Folyóiratcikk [14595921]
1072
Sosa Henríquez M, Gómez de Tejada Romero MJ, Malouf Sierra J Caso clínico a debate: vacaciones terapéuticas: ¿ sí o no? : Clinical case discussion: therapeutic holiday: yes or not? Revista de Osteoporosis y Metabolismo Mineral (ISSN: 1889836X) 6: (2) pp. 6369. ( 2014) Folyóiratcikk [14595913]
1073 * Sestak Ivana, Singh Shalini, Cuzick Jack, Blake Glen M, Patel Rajesh, Gossiel Fatma, Coleman Rob, Dowsett Mitch, Forbes John F, Howell Anthony, Eastell Richard Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBISII bone substudy: an international, doubleblind, randomised, placebocontrolled trial LANCET ONCOLOGY (ISSN: 14702045) 15: (13) pp. 14601468. ( 2014) Folyóiratcikk [14595857] 1074 * Cosman F, de Beur S J, LeBoff M S, Lewiecki E M, Tanner B, Randall S, Lindsay R Clinician's Guide to P revention and Treatment of Osteoporosis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (10) pp. 23592381. ( 2014) Folyóiratcikk [14595856] 1075
Crandall Carolyn J, Newberry Sydne J, Diamant Allison, Lim YeeW ei, Gellad W alid F, Booth Marika J, Motala Aneesa, Shekelle Paul G Comparative Effectiveness of P harmacologic Treatments to P revent Fractures An Updated Systematic Review ANNALS OF INTERNAL MEDICINE (ISSN: 00034819) 161: (10) pp. 711U163. ( 2014) Folyóiratcikk [14595855]
1076
Senn C, Guenther B, Popp A W , Perrelet R, Hans D, Lippuner K Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2year openlabel study OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (7) pp. 19451951. ( 2014) Folyóiratcikk [14595912]
1077
Tadrous M, W ong L, Mamdani M M, Juurlink D N, Krahn M D, Levesque L E, Cadarette S M Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network metaanalysis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (4) pp. 12251235. ( 2014) Folyóiratcikk [14595911]
1078 * Lakatos P, Toth E, Szekeres L, Poor G, Hejj G, Marton I, Takacs I Comparative statistical analysis of osteoporosis treatment based on Hungarian claims data and interpretation of the results in respect to costeffectiveness OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (8) pp. 20772087. ( 2014) Folyóiratcikk [14595854] 1079
Zhang Jianan, Zhang Lixia, Li Chong, W ang Zhifang, Zhang Shujun, Shi Shuangwei, Liu Zhenzhen Correlation analysis of the influential factors of acute phase response after intravenous zoledronic acid treatment for postmenopausal osteoporosis Chinese Journal of Osteoporosis (ISSN: 10067108) 20: (5) pp. 538541. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14596009]
1080
Popp A W , Buffat H, Cavelti A, W indolf M, Perrelet R, Senn C, Lippuner K Cortical bone loss at the tibia in postmenopausal women with osteoporosis is associated with incident nonvertebral fractures: Results of a randomized controlled ancillary study of HORIZON MATURITAS (ISSN: 03785122) 77: (3) pp. 287293. ( 2014) Folyóiratcikk [14595910]
1081
ChavezValencia Venice, Alejandro ArceSalinas Cesar, EspinosaOrtega Fabricio CostMinimization Study Comparing Annual Infusion of Zoledronic Acid or Weekly Oral Alendronate in Women With Low Bone Mineral Density JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 17: (4) pp. 484489. ( 2014) Folyóiratcikk [14595853]
1082
Kaufman JeanMarc, Lapauw Bruno, Goemaere Stefan Current and future treatments of osteoporosis in men BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 1521690X) 28: (6) pp. 871884.
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
181/342
3/30/2015
nyomtatobarat forma ( 2014) Folyóiratcikk [14595852] 1083
Reginster JeanYves, Ferrari Serge, Hadji Peyman Current challenges in the treatment of osteoporosis: an opportunity for bazedoxifene CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 30: (6) pp. 11651176. ( 2014) Folyóiratcikk [14595909]
1084
KerschanSchindl K, Mikosch P, ObermayerPietsch B, Gasser R W , Dimai H P, FahrleitnerPammer A, Dobnig H, Roschger P, Preisinger E, Klaushofer K, Resch H, Pietschmann P Current Controversies in Clinical Management of P ostmenopausal Osteoporosis EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (ISSN: 09477349) 122: (8) pp. 437444. ( 2014) Folyóiratcikk [14595851]
1085
Tajeu Gabriel S, Delzell Elizabeth, Smith W ilson, Arora Tarun, Curtis Jeffrey R, Saag Kenneth G, Morrisey Michael A, Yun Huifeng, Kilgore Meredith L Death, Debility, and Destitution Following Hip Fracture JOURNALS OF GERONTOLOGY SERIES ABIOLOGICAL SCIENCES AND MEDICAL SCIENCES (ISSN: 10795006) 69: (3) pp. 346353. ( 2014) Folyóiratcikk [14595908]
1086
Parthan A, Kruse M, Agodoa I, Silverman S, Orwoll E Denosumab: A costeffective alternative for older men with osteoporosis from a Swedish payer perspective BONE (ISSN: 87563282) 59: pp. 105113. ( 2014) Folyóiratcikk [14596006]
1087
Bae Susan, Sun Shuting, Aghaloo Tara, Oh JuEun, McKenna Charles E, Kang Mo K, Shin KiHyuk, Tetradis Sotirios, Park NoHee, Kim Reuben H Development of oral osteomucosal tissue constructs in vitro and localization of fluorescentlylabeled bisphosphonates to hard and soft tissue INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (ISSN: 11073756) 34: (2) pp. 559563. ( 2014) Folyóiratcikk [14595850]
1088
Anonymous Drugs for P ostmenopausal Osteoporosis MEDICAL LETTER ON DRUGS AND THERAPEUTICS (ISSN: 0025732X) 56: (1452) pp. 9196. ( 2014) Folyóiratcikk /Jelentés /Tudományos [14595849]
1089 * Grey Andrew, Bolland Mark, Mihov Bobby, W ong Sumwai, Horne Anne, Gamble Greg, Reid Ian R Duration of Antiresorptive Effects of LowDose Zoledronate in Osteopenic P ostmenopausal Women: A Randomized, P laceboControlled Trial JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 29: (1) pp. 166172. ( 2014) Folyóiratcikk [14596004] 1090 * Hue Trisha F, Cummings Steven R, Cauley Jane A, Bauer Douglas C, Ensrud Kristine E, BarrettConnor Elizabeth, Black Dennis M Effect of Bisphosphonate Use on Risk of P ostmenopausal Breast Cancer Results From the Randomized Clinical Trials of Alendronate and Zoledronic Acid JAMA INTERNAL MEDICINE (ISSN: 21686106) 174: (10) pp. 15501557. ( 2014) Folyóiratcikk [14595848] 1091
Zhu Eric D, Louis Leeann, Brooks Daniel J, Bouxsein Mary L, Demay Marie B Effect of Bisphosphonates on the Rapidly Growing Male Murine Skeleton ENDOCRINOLOGY (ISSN: 00137227) 155: (4) pp. 11881196. ( 2014) Folyóiratcikk [14595907]
1092
GajicVeljanoski Olga, Tomlinson George, Srighanthan Jeevitha, Adachi Jonathan D, Josse Robert, Brown Jacques P, Cheung Angela M Effect of Odanacatib on BMD and Fractures: Estimates from Bayesian Univariate and Bivariate Metaanalyses JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 99: (9) pp. 30703079. ( 2014) Folyóiratcikk [14595847]
1093 * Eastell Richard, Nagase Shinichi, Small Maria, Boonen Steven, Spector Tim, Ohyama Michiyo, Kuwayama Tomohiro, Deacon Steve Effect of ONO5334 on Bone Mineral Density and Biochemical Markers of Bone Turnover in P ostmenopausal Osteoporosis: 2Year Results From the OCEAN Study JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 29: (2) pp. 458466. ( 2014) Folyóiratcikk [14596001] 1094
Amugongo Sarah K, Yao W ei, Jia Junjing, Dai W eiwei, Lay YuAn E, Jiang Li, Harvey Danielle, Zimmermann Elizabeth A, Schaible Eric, Dave Neil, Ritchie Robert O, Kimmel Donald B, Lane Nancy E Effect of sequential treatments with alendronate, parathyroid hormone (134) and raloxifene on cortical bone mass and strength in ovariectomized rats BONE (ISSN: 87563282) 67: pp. 257268. ( 2014) Folyóiratcikk [14595845]
1095
Brennan MA, Gleeson JP, O'Brien FJ, McNamara LM Effects of ageing, prolonged estrogen deficiency and zoledronate on bone tissue mineral distribution Journal of the Mechanical Behavior of Biomedical Materials (ISSN: 17516161) 29: pp. 161170. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13473732]
1096
Ochi Yasuo, Yamada Hiroyuki, Mori Hiroshi, Nakanishi Yasutomo, Nishikawa Satoshi, Kayasuga Ryoji, Kawada Naoki, Kunishige Akiko, Hashimoto Yasuaki, Tanaka Makoto, Sugitani Masafumi, Kawabata Kazuhito Effects of eightmonth treatment with ONO5334, a cathepsin K inhibitor, on bone metabolism, strength and microstructure in ovariectomized, cynomolgus monkeys BONE (ISSN: 87563282) 65: pp. 18. ( 2014) Folyóiratcikk [14595843]
1097
Duan Peng, Tu Ping, W u Heping, Ding Xun, Xiao W eihua, Deng Bo Efficacy and application of zoledronic acid in the treatment of osteoporosis Chinese Journal of Osteoporosis (ISSN: 10067108) 20: (4) pp. 420422,435. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14595999]
1098
Reginster J Y, Neuprez A, Dardenne N, Beaudart C, Emonts P, Bruyere O Efficacy and safety of currently marketed antiosteoporosis medications
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
182/342
3/30/2015
nyomtatobarat forma BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 1521690X) 28: (6) pp. 809834. ( 2014) Folyóiratcikk [14595842] 1099
Vohra Fahim, AlRifaiy Mohammad Qasim, Almas Khalid, Javed Fawad Efficacy of systemic bisphosphonate delivery on osseointegration of implants under osteoporotic conditions: Lessons from animal studies ARCHIVES OF ORAL BIOLOGY (ISSN: 00039969) 59: (9) pp. 912920. ( 2014) Folyóiratcikk [14595841]
1100
Koivisto Katri, Kyllonen Eero, Haapea Marianne, Niinimaki Jaakko, Sundqvist Kaj, Pehkonen Timo, Seitsalo Seppo, Tervonen Osmo, Karppinen Jaro Efficacy of zoledronic acid for chronic low back pain associated with Modic changes in magnetic resonance imaging BMC MUSCULOSKELETAL DISORDERS (ISSN: 14712474) 15: P aper 64. (2014) Folyóiratcikk [14595905]
1101
Feurer Elodie, Chapurlat Roland Emerging drugs for osteoporosis EXPERT OPINION ON EMERGING DRUGS (ISSN: 14728214) 19: (3) pp. 385395. ( 2014) Folyóiratcikk [14595840]
1102
de Villiers T J Estrogen and bone: have we completed a full circle? CLIMACTERIC (ISSN: 13697137) 17: pp. 47. ( 2014) SU 2 Folyóiratcikk [14595839]
1103
Gutowski Christina J, Ilyas Asif M Evaluation and Medical Management of Fragility Fractures of the Upper Extremity ORTHOPEDIC CLINICS OF NORTH AMERICA (ISSN: 00305898) 45: (2) pp. 233243. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14595904]
1104
Bouvard B, Soulie P, Hoppe E, GeorginMege M, Royer M, MesgouezNebout N, Lassalle C, Cellier P, Jadaud E, Abadie Lacourtoisie S, Tuchais C, VinchonPetit S, Audran M, Chappard D, Legrand E Fracture incidence after 3 years of aromatase inhibitor therapy ANNALS OF ONCOLOGY (ISSN: 09237534) 25: (4) pp. 843847. ( 2014) Folyóiratcikk [14595903]
1105
Sattui Sebastian E, Saag Kenneth G Fracture mortality: associations with epidemiology and osteoporosis treatment NATURE REVIEWS ENDOCRINOLOGY (ISSN: 17595029) 10: (10) pp. 592602. ( 2014) Folyóiratcikk [14595838]
1106
PrietoAlhambra D, Judge A, Arden N K, Cooper C, Lyles K W , Javaid M K Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (1) pp. 7783. ( 2014) Folyóiratcikk [14595997]
1107
Garfield Lauren D, Mueller Daniel J, Kennedy James L, Mulsant Benoit H, Reynolds Charles F III, Teitelbaum Steven L, Civitelli Roberto, Dixon David, Todorov Alexandre A, Lenze Eric J Genetic variation in the serotonin transporter and HTR1B receptor predicts reduced bone formation during serotonin reuptake inhibitor treatment in older adults WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (ISSN: 15622975) 15: (5) pp. 404410. ( 2014) Folyóiratcikk [14595902]
1108
Roux C, Briot K How long should we treat? OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (6) pp. 16591666. ( 2014) Folyóiratcikk [14595901]
1109
Blake Glen M, Siddique Musib, Frost Michelle L, Moore Amelia E B, Fogelman Ignac Imaging of Site Specific Bone Turnover in Osteoporosis Using P ositron Emission Tomography CURRENT OSTEOPOROSIS REPORTS 12: (4) pp. 475485. ( 2014) Folyóiratcikk [14595837]
1110
Sims Natalie A, Ng Kong W ah Implications of OsteoblastOsteoclast Interactions in the Management of Osteoporosis by Antiresorptive Agents Denosumab and Odanacatib CURRENT OSTEOPOROSIS REPORTS 12: (1) pp. 98106. ( 2014) Folyóiratcikk [14595900]
1111
Lin T C, Yang C Y, Yang Y H Kao, Lin S J Incidence and risk of osteonecrosis of the jaw among the Taiwan osteoporosis population OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (5) pp. 15031511. ( 2014) Folyóiratcikk [14595898]
1112
Lin TzuChieh, Lee ChengHan, Yang ChyunYu, Yang YeaHuei Kao, Lin SwuJane Incidence and Risk of Venous Thromboembolism Among Taiwan Osteoporotic Fracture P opulation under Osteoporosis P harmacological Treatments JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 99: (5) pp. 15991607. ( 2014) Folyóiratcikk [14595896]
1113
Misof Barbara M, Patsch Janina M, Roschger Paul, Muschitz Christian, Gamsjaeger Sonja, Paschalis Eleftherios P, Prokop Eva, Klaushofer Klaus, Pietschmann Peter, Resch Heinrich Intravenous Treatment With Ibandronate Normalizes Bone Matrix Mineralization and Reduces Cortical P orosity After Two Years in Male Osteoporosis: A P aired Biopsy Study JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 29: (2) pp. 440449. ( 2014) Folyóiratcikk [14595994]
1114
W illiams Graham R Is prophylactic antiresorptive therapy required in thyroid cancer patients receiving TSHsuppressive treatment with thyroxine? JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (ISSN: 17208386) 37: (8) pp. 775779. ( 2014)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
183/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [14595836] 1115
Torstrick F Brennan, Guldberg Robert E Local Strategies to P revent and Treat Osteoporosis CURRENT OSTEOPOROSIS REPORTS 12: (1) pp. 3340. ( 2014) Folyóiratcikk [14595895]
1116
Zhao Jindong, Tang Hai, W ang Jiayang, Li Gang Local treatment of osteoporosis with alendronateloaded calcium phosphate cement CHINESE MEDICAL JOURNAL (ISSN: 03666999) 127: (22) pp. 39063914. ( 2014) Folyóiratcikk [14595835]
1117
Miller P D, Recker R R, Harris S, Silverman S, Felsenberg D, Reginster J, Day BM, Barr C, Masanauskaite D Longterm fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE longterm extension studies OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (1) pp. 349357. ( 2014) Folyóiratcikk [14595991]
1118
W atts Nelson B Longterm risks of bisphosphonate therapy ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (ISSN: 00042730) 58: (5) pp. 523529. ( 2014) Folyóiratcikk [14595894]
1119
Sabatino Raffaella, Antonelli Antonella, Battistelli Serafina, Schwendener Reto, Magnani Mauro, Rossi Luigia Macrophage Depletion by Free Bisphosphonates and ZoledronateLoaded Red Blood Cells PLOS ONE (ISSN: 19326203) 9: (6) P aper e101260. (2014) Folyóiratcikk [14595893]
1120 * Rizzoli R, Branco J, Brandi ML, Boonen S, Bruyere O, Cacoub P, Cooper C, DiezPerez A, Duder J, Fielding R A, Harvey N C, Hiligsmann M, Kanis J A, Petermans J, Ringe J D, Tsouderos Y, W einman J, Reginster JY Management of osteoporosis of the oldest old OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (11) pp. 25072529. ( 2014) Folyóiratcikk [14595834] 1121
Gambacciani M, Levancini M Management of postmenopausal osteoporosis and the prevention of fractures PANMINERVA MEDICA (ISSN: 00310808) 56: (2) pp. 115131. ( 2014) Folyóiratcikk [14595892]
1122
Kodera R, Miyazaki M, Yoshiiwa T, Kawano M, Kaku N, Tsumura H Manipulation of anabolic and catabolic responses with bone morphogenetic protein and zoledronic acid in a rat spinal fusion model Bone (ISSN: 87563282) 58: pp. 2632. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13473731]
1123
Sykiotis Antonis, Papaioannou Garyphallia, Mavropoulos Jordan, Triantaphyllopoulou Maria, Papandroulaki Fotini, Ktena Vassiliki, Thanou Stavroula, Pardalakis Argyris, Kaltsa Aikaterini, Karga Helen Markers of inflammation after zoledronic acid redosing JOURNAL OF BONE AND MINERAL METABOLISM (ISSN: 09148779) 32: (1) pp. 7277. ( 2014) Folyóiratcikk [14595986]
1124
Lehmann G, W olf G Medikamentöse Therapie von Knochenstoffwechselstörungen bei CKDMBD („ chronic kidney disease – mineral bone disorder“ ) unter besonderer Berücksichtigung antiresorptiver Wirkstoffe: P harmaceutical therapy of bone metabolism disorders in chronic kidney disease mineral bone disorder (CKDMBD) with special respect to antiresorptive substances ZEITSCHRIFT FÜR RHEUMATOLOGIE (ISSN: 03401855) 73: (4) pp. 329334. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14595889]
1125
Nanes Mark S, Kellen Caleb B Osteoporosis SEMINARS IN NUCLEAR MEDICINE (ISSN: 00012998) 44: (6) pp. 439450. ( 2014) Folyóiratcikk [14595833]
1126
Varacallo Matthew A, Fox Ed J Osteoporosis and Its Complications MEDICAL CLINICS OF NORTH AMERICA (ISSN: 00257125) 98: (4) pp. 817+. ( 2014) Folyóiratcikk [14595891]
1127
Peeters Geeske, Tett Susan E, Duncan Emma L, Mishra Gita D, Dobson Annette J Osteoporosis medication dispensing for older Australian women from 2002 to 2010: influences of publications, guidelines, marketing activities and policy PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (ISSN: 10538569) 23: (12) pp. 13031311. ( 2014) Folyóiratcikk [14595831]
1128
Litwic A, Cooper C, Dennison E Osteoporosis therapies in 2014 PANMINERVA MEDICA (ISSN: 00310808) 56: (4) pp. 273283. ( 2014) Folyóiratcikk [14595830]
1129
W ei Xinwei, Chen Zhixin Osteoporotic chronic pain: how to understand and prevent it? CHINESE JOURNAL OF TISSUE ENGINEERING RESEARCH (ISSN: 20954344) 18: (38) pp. 61946199. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14595984]
1130
Neuner Joan M, Schapira Marilyn M P atient P erceptions of Osteoporosis Treatment Thresholds JOURNAL OF RHEUMATOLOGY (ISSN: 0315162X) 41: (3) pp. 516522. ( 2014) Folyóiratcikk [14595890]
1131
Nardone Valeria, D'Asta Federica, Brandi Maria Luisa P harmacological management of osteogenesis CLINICS (ISSN: 18075932) 69: (6) pp. 438446. ( 2014) Folyóiratcikk [14595981]
1132
PrietoAlhambra Daniel, PagesCastella Aina, W allace Gemma, Javaid M Kassim, Judge Andrew, Nogues Xavier, Arden
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
184/342
3/30/2015
nyomtatobarat forma Nigel K, Cooper Cyrus, DiezPerez Adolfo P redictors of Fracture While on Treatment With Oral Bisphosphonates: A P opulationBased Cohort Study JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 29: (1) pp. 268274. ( 2014) Folyóiratcikk [14595979] 1133
Lubwama R, Nguyen A, Modi A, Diana C, Miller P D P revalence of renal impairment among osteoporotic women in the USA, NHANES 20052008: Is treatment with bisphosphonates an option? OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (5) pp. 16071615. ( 2014) Folyóiratcikk [14595888]
1134
Tella Sri Harsha, Gallagher J Christopher P revention and treatment of postmenopausal osteoporosis JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (ISSN: 09600760) 142: pp. 155170. ( 2014) Folyóiratcikk [14595886]
1135
Lobo R A, Davis S R, De Villiers T J, Gompel A, Henderson V W , Hodis H N, Lumsden M A, Mack W J, Shapiro S, Baber R J P revention of diseases after menopause CLIMACTERIC (ISSN: 13697137) 17: (5) pp. 540556. ( 2014) Folyóiratcikk [14595829]
1136
Ganda K, Seibel M J Rapid biochemical response to denosumab in fibrous dysplasia of bone: report of two cases OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (2) pp. 777782. ( 2014) Folyóiratcikk [14595974]
1137
Ge XiYuan, Yang LinQian, Jiang Yang, Yang W enW en, Fu Jia, Li ShengLin Reactive Oxygen Species and Autophagy Associated Apoptosis and Limitation of Clonogenic Survival Induced by Zoledronic Acid in Salivary Adenoid Cystic Carcinoma Cell Line SACC83 PLOS ONE (ISSN: 19326203) 9: (6) P aper e101207. (2014) Folyóiratcikk [14595884]
1138 * Cosman Felicia, Cauley Jane A, Eastell Richard, Boonen Steven, Palermo Lisa, Reid Ian R, Cummings Steven R, Black Dennis M Reassessment of Fracture Risk in Women After 3 Years of Treatment With Zoledronic Acid: When is it Reasonable to Discontinue Treatment? JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 99: (12) pp. 45464554. ( 2014) Folyóiratcikk [14595828] 1139
Sejling AnneSophie, Thorsteinsson AnneLuise, PedersenBjergaard Ulrik, Eiken Pia Recovery From SIADHAssociated Osteoporosis: A Case Report JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 99: (10) pp. 35273530. ( 2014) Folyóiratcikk [14595827]
1140 * DiezPerez Adolfo, Adachi Jonathan D, Adami Silvano, Anderson Frederick A Jr, Boonen Steven, Chapurlat Roland, Compston Juliet E, Cooper Cyrus, Gehlbach Stephen H, Greenspan Susan L, Hooven Frederick H, LaCroix Andrea Z, Nieves Jeri W , Netelenbos J Coen, Pfeilschifter Johannes, Rossini Maurizio, Roux Christian, Saag Kenneth G, Silverman Stuart, Siris Ethel S, W yman Allison, RushtonSmith Sophie K, W atts Nelson B Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW) JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 29: (1) pp. 260267. ( 2014) CA Global Longitudinal Study Folyóiratcikk [14595964] 1141
Sharma Abhishek, Einstein Andrew J, Vallakati Ajay, ArbabZadeh Armin, W alker Marcella Donovan, Mukherjee Debabrata, Homel Peter, Borer Jeffrey S, Lichstein Edgar Risk of Atrial Fibrillation With Use of Oral and Intravenous Bisphosphonates AMERICAN JOURNAL OF CARDIOLOGY (ISSN: 00029149) 113: (11) pp. 18151821. ( 2014) Folyóiratcikk [14595883]
1142
Suresh Ernest, Pazianas Michael, Abrahamsen Bo Safety issues with bisphosphonate therapy for osteoporosis RHEUMATOLOGY (ISSN: 14620324) 53: (1) pp. 1931. ( 2014) Folyóiratcikk [14595963]
1143
Brance M L, Brun L R, Di Loreto V E, Lupo M, Rigalli A Sequential treatment with monofluorophosphate and zoledronic acid in osteoporotic rats CLIMACTERIC (ISSN: 13697137) 17: (4) pp. 478485. ( 2014) Folyóiratcikk [14595826]
1144
Pochintesta Lara, Mangiacavalli Silvia, Cocito Federica, Pompa Alessandra, Albertini Riccardo, Pascutto Cristiana, Ferretti Virginia Valeria, Cazzola Mario, Corso Alessandro Serum C terminal telopeptide maintains its correlation with bone disease in patients with myeloma even under treatment with bisphosphonates LEUKEMIA & LYMPHOMA (ISSN: 10428194) 55: (6) pp. 13971398. ( 2014) Folyóiratcikk [14595882]
1145
Oswald Ailsa J, Berg Jackie, Milne Garry, Ralston Stuart H Teriparatide Treatment of Severe Osteoporosis Reduces the Risk of Vertebral Fractures Compared with Standard Care in Routine Clinical P ractice CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 94: (2) pp. 176182. ( 2014) Folyóiratcikk [14595960]
1146
Brown Jacques P, Morin Suzanne, Leslie W illiam, Papaioannou Alexandra, Cheung Angela M, Davison Kenneth S, Goltzman David, Hanley David Arthur, Hodsman Anthony, Josse Robert, Jovaisas Algis, Juby Angela, Kaiser Stephanie, Karaplis Andrew, Kendler David, Khan Aliya, Ngui Daniel, Olszynski W ojciech, SteMarie LouisGeorges, Adachi Jonathan The bisphosphonates in the treatment of osteoporosis Expected Benefits, potential harms and therapeutic time off CANADIAN FAMILY PHYSICIAN (ISSN: 0008350X) 60: (4) pp. E197E207. ( 2014) Folyóiratcikk [14595881]
1147
Siris E S, Adler R, Bilezikian J, Bolognese M, DawsonHughes B, Favus M J, Harris S T, Jan de Beur S M, Khosla S, Lane N E, Lindsay R, Nana A D, Orwoll E S, Saag K, Silverman S, W atts N B The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (5) pp. 14391443. ( 2014)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
185/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [14595880] 1148
Chen LeiPo, Chang TingKuo, Huang TeYang, Kwok TiewGuan, Lu YungChang The Correlation Between Lateral Bowing Angle of the Femur and the Location of Atypical Femur Fractures CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 95: (3) pp. 240247. ( 2014) Folyóiratcikk [14595825]
1149
Spiegel R, Nawroth P P, Kasperk C The effect of zoledronic acid on the fracture risk in men with osteoporosis JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (ISSN: 03914097) 37: (3) pp. 229232. ( 2014) Folyóiratcikk [14595878]
1150
Edwards W Brent, Schnitzer Thomas J, Troy Karen L The mechanical consequence of actual bone loss and simulated bone recovery in acute spinal cord injury BONE (ISSN: 87563282) 60: pp. 141147. ( 2014) Folyóiratcikk [14595877]
1151
Matuszewski Lukasz, Matuszewska Anna, Jaszek Magdalena, Stefaniuk Dawid, Grzywnowicz Krzysztof, Mazurkiewicz Tomasz, Polkowska Izabela The presence of pamidronate in bone cement affects serum biochemical markers in the rat BULLETIN OF THE VETERINARY INSTITUTE IN PULAWY (ISSN: 00424870) 58: (2) pp. 295299. ( 2014) Folyóiratcikk [14595959]
1152
de W aure Chiara, Specchia Maria Lucia, Cadeddu Chiara, Capizzi Silvio, Capri Stefano, Di Pietro Maria Luisa, Veneziano Maria Assunta, Gualano Maria Rosaria, Kheiraoui Flavia, La Torre Giuseppe, Nicolotti Nicola, Sferrazza Antonella, Ricciardi W alter The P revention of P ostmenopausal Osteoporotic Fractures: Results of the Health Technology Assessment of a New Antiosteoporotic Drug BIOMED RESEARCH INTERNATIONAL (ISSN: 23146133) 2014: P aper 975927. 16 p. (2014) Folyóiratcikk /Szakcikk /Tudományos [14595958]
1153
Guo Bingling, Li Faqi The safety observation of zoledronic acid in the treatment of senile osteoporosis Chinese Journal of Osteoporosis (ISSN: 10067108) 20: (7) pp. 820823. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14595957]
1154
Maurice S B, Bell T, Daniels T, Fetterly C R, Nelson D R, W inwood P J, Bourque W T, Harris R L Tibial bone versican content decreases with zoledronate treatment in adult mice OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 25: (7) pp. 19751981. ( 2014) Folyóiratcikk [14595876]
1155
Chapurlat Roland D Treatment of postmenopausal osteoporosis with odanacatib EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 15: (4) pp. 559564. ( 2014) Folyóiratcikk [14595875]
1156
Leder Benjamin Z, Tsai Joy N, Uihlein Alexander V, BurnettBowie SherriAnn M, Zhu Yuli, Foley Katelyn, Lee Hang, Neer Robert M Two Years of Denosumab and Teriparatide Administration in P ostmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 0021972X) 99: (5) pp. 16941700. ( 2014) Folyóiratcikk [14595874]
1157 * Eriksen EF, DíezPérez A, Boonen S Update on longterm treatment with bisphosphonates for postmenopausal osteoporosis: A systematic review Bone (ISSN: 87563282) 58: pp. 126135. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [13473729] 1158
LozanoCalderon Santiago A, Colman Matthew W , Raskin Kevin A, Hornicek Francis J, Gebhardt Mark Use of Bisphosphonates in Orthopedic Surgery: P earls and P itfalls ORTHOPEDIC CLINICS OF NORTH AMERICA (ISSN: 00305898) 45: (3) pp. 403+. ( 2014) Folyóiratcikk [14595872]
1159
Reynolds Kristi, Viswanathan Hema N, Muntner Paul, Harrison Teresa N, Cheetham T Craig, Hsu JinW en Y, Gold Deborah T, Silverman Stuart, Grauer Andreas, Morisky Donald E, O'Malley Cynthia D Validation of the OsteoporosisSpecific Morisky Medication Adherence Scale in longterm users of bisphosphonates QUALITY OF LIFE RESEARCH (ISSN: 09629343) 23: (7) pp. 21092120. ( 2014) Folyóiratcikk [14595824]
1160
Mosali P, Bernard L, W ajed J, Mohamed Z, Ewang M, Moore A, Fogelman I, Hampson G Vitamin D Status and P arathyroid Hormone Concentrations Influence the Skeletal Response to Zoledronate and Denosumab CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 94: (5) pp. 553559. ( 2014) Folyóiratcikk [14595871]
1161 * Dalbeth Nicola, Aati Opetaia, Gamble Gregory D, Horne Anne, House Meaghan E, Roger Mark, Doyle Anthony J, Chhana Ashika, McQueen Fiona M, Reid Ian R Zoledronate for prevention of bone erosion in tophaceous gout: a randomised, doubleblind, placebocontrolled trial ANNALS OF THE RHEUMATIC DISEASES (ISSN: 00034967) 73: (6) pp. 10441051. ( 2014) Folyóiratcikk [14595870] 1162
Liu ShouSheng, W ang XiaoPai, Li XiuBo, Liang JiaYi, Liu LingLing, Lu Ying, Zhong XueYun, Chen YunXian Zoledronic acid exerts antitumor effects in NB4 acute promyelocytic leukemia cells by inducing apoptosis and S phase arrest BIOMEDICINE & PHARMACOTHERAPY (ISSN: 07533322) 68: (8) pp. 10311036. ( 2014) Folyóiratcikk [14595823]
1163
Khajuria Deepak Kumar, Razdan Rema, Mahapatra Debiprosad Roy Zoledronic acid in combination with alfacalcidol has additive effects on trabecular microarchitecture and mechanical properties in osteopenic ovariectomized rats JOURNAL OF ORTHOPAEDIC SCIENCE (ISSN: 09492658) 19: (4) pp. 646656. ( 2014) Folyóiratcikk [14595869]
1164
Rossini Maurizio, Zanotti Roberta, Viapiana Ombretta, Tripi Gaia, Idolazzi Luca, Biondan Marta, Orsolini Giovanni, Bonadonna Patrizia, Adami Silvano, Gatti Davide Zoledronic Acid in Osteoporosis Secondary to Mastocytosis AMERICAN JOURNAL OF MEDICINE (ISSN: 00029343) 127: (11) P aper 1127.e1. (2014) Folyóiratcikk [14595822]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
186/342
3/30/2015
nyomtatobarat forma 1165
Huang Shushu, Lin Hua, Zhu Xiufen, Chen Xin, Fan Lu, Liu Changchang Zoledronic acid increases bone mineral density and improves healthrelated quality of life over two years of treatment in Chinese women with postmenopausal osteoporosis ENDOKRYNOLOGIA POLSKA (ISSN: 0423104X) 65: (2) pp. 96104. ( 2014) Folyóiratcikk [14595956]
1166 * Tu ChaoW ei, Huang KuoFeng, Hsu HsienTa, Li HungYu, Yang Stephen SheiDei, Chen YiChu Zoledronic acid infusion for lumbar interbody fusion in osteoporosis JOURNAL OF SURGICAL RESEARCH (ISSN: 00224804) 192: (1) pp. 112116. ( 2014) Folyóiratcikk [14595821] 1167
张钢( 综述), 蒋电明( 审校) 双磷酸盐药物与心房颤动的相关性研究进展 Chongqing Medicine (ISSN: 16718348) 43: (16) pp. 20742076. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14596018]
1168
李莹, 王经宇, 张春霖, 宁永明, 严旭 唑来膦酸对椎体成形术后邻近椎体骨密度的影响 Chinese Journal of Trauma (ISSN: 10018050) 30: (11) pp. 11221123. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14596015]
1169
孙阳 经皮穿刺椎体成形术与保守法治疗骨质疏松性椎体压缩性骨折短期疗效对比 Chinese Journal of Gerontology (ISSN: 10059202) 34: (17) pp. 50055006. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14596016]
1170
Lyell Veronica, Henderson Emily, Devine Mark, Gregson Celia Assessment and management of fracture risk in patients with P arkinson's disease AGE AND AGEING (ISSN: 00020729) 44: (1) pp. 3441. ( 2015) Folyóiratcikk [14595820]
1171
Khajuria Deepak Kumar, Razdan Rema, Mahapatra Debiprosad Roy Development, in vitro and in vivo characterization of zoledronic acid functionalized hydroxyapatite nanoparticle based formulation for treatment of osteoporosis in animal model EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (ISSN: 09280987) 66: pp. 173183. ( 2015) Folyóiratcikk [14595819]
1172 * Patel D V, Bolland M, Nisa Z, AlAbuwsi F, Singh M, Horne A, Reid I R, McGhee C N J Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 26: (2) pp. 499503. ( 2015) Folyóiratcikk [14595818] 1173
Andreopoulou Panagiota, Bockman Richard S Management of P ostmenopausal Osteoporosis Annual Review of Medicine (ISSN: 00664219) 66: pp. 329342. ( 2015) BE Caskey, CT Folyóiratcikk [14595817]
1174
Ganda K, Schaffer A, Seibel M J P redictors of refracture amongst patients managed within a secondary fracture prevention program: a 7year prospective study OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 26: (2) pp. 543551. ( 2015) Folyóiratcikk [14595816]
1175
Singh Anshuman, Adams Annette L, Burchette Raoul, Dell Richard M, Funahashi Tadashi T, Navarro Ronald A The effect of osteoporosis management on proximal humeral fracture JOURNAL OF SHOULDER AND ELBOW SURGERY (ISSN: 10582746) 24: (2) pp. 191198. ( 2015) Folyóiratcikk [14595814]
1176
Rubin Katrine Hass, Holmberg Teresa, Rothmann Mette Juel, Hoiberg Mikkel, Barkmann Reinhard, Gram Jeppe, Hermann Anne Pernille, Bech Mickael, Rasmussen Ole, Glueer Claus C, Brixen Kim The RiskStratified Osteoporosis Strategy Evaluation study (ROSE): A Randomized P rospective P opulationBased Study. Design and Baseline Characteristics CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 96: (2) pp. 167179. ( 2015) Folyóiratcikk [14595813]
1177
Giusti Andrea, Bianchi Gerolamo Treatment of primary osteoporosis in men CLINICAL INTERVENTIONS IN AGING (ISSN: 11781998) 10: pp. 105115. ( 2015) Folyóiratcikk [14595811]
177. Csupor E , Szűcs J , M észáros Sz , Tóth E , Lakatos P , Ferencz V , Ács T B , Horváth Cs A fokozott parathormontermelés csonthatásai a csontultrahang paraméterek tükrében CA ÉS CSONT 10:(2) p. 52. (2007) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2095792] [ Admin láttamozott ] 178. Gyurján I , M olnár A , Borsy A , Stéger V , Hackler L , Zomborszky Z , Papp P , Duda E , Deák F , Lakatos P , Puskás L , Orosz L Gene expression dynamics in deer antler: mesenchymal differentiation toward chondrogenesis MOLECULAR GENETICS AND GENOMICS 277:(3) pp. 221235. (2007) IF: 2.978 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1078050] [ Admin láttamozott ] Független idéző: 10 Függő idéző: 3 Összesen: 13 https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
187/342
3/30/2015
nyomtatobarat forma 1
Feng HH, Bi XM, Zhao LH, Song Y, Yue ZP, Zhang XM, Li CY, Deng XM Effects of insulinlike growth factor 1 on the in vitro proliferation of antler organic center cells at different growing periods Journal of Clinical Rehabilitative Tissue Engineering Research 11: (37) pp. 73737376. ( 2007) Folyóiratcikk [13332405]
2
Gu LJ, Mo EK, Zhu XM, Jia XD, Fang ZM, Sun BS, Sung CK Analysis of gene expression in four parts of the reddeer antler using DNA chip microarray technology ANIM BIOL 58: pp. 6790. ( 2008) Folyóiratcikk [10627480]
3
Feng HH, Zhao LH, Song SW , Li GF, Yue ZP, Zhang XM, Deng XM Differentiation of antler mesenchymal stem cells into chondrocytes in vitro Journal of Clinical Rehabilitative Tissue Engineering Research 12: (8) pp. 14851488. ( 2008) Folyóiratcikk /Szakcikk [13332404]
4
5
6
* Villányi Z, Gyurján I, Stéger V, Orosz L P laqueBased Competitive Hybridization J BIOMOL SCREEN 13: (1) pp. 8084. ( 2008) Folyóiratcikk [10627482] Bao JR, Li CY, Xing XM, Yang FH Research progress in deer antler regeneration and stem cells Journal of Clinical Rehabilitative Tissue Engineering Research 12: (51) pp. 1016310166. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [13332403] * Borsy A, Podani J, Stéger V, Balla B, Horváth A, Kósa JP, Gyurján I Jr, Molnár A, Szabolcsi Z, Szabó L, Jakó E, Zomborszky Z, Nagy J, Semsey S, Vellai T, Lakatos P, Orosz L Identifying novel genes involved in both deer physiological and human pathological osteoporosis MOL GENET GENOMICS 281: (3) pp. 301313. ( 2009) Folyóiratcikk [10627481]
7
Kierdorf U, Li CY, Price JS Improbable appendages: Deer antler renewal as a unique case of mammalian regeneration SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (ISSN: 10849521) 20: (5) pp. 535542. ( 2009) Folyóiratcikk [10823187]
8
Djouad F, Bony C, Canovas F, Fromigue O, Reme T, Jorgensen C, Noel D Transcriptomic Analysis Identifies Foxo3A as a Novel Transcription Factor Regulating Mesenchymal Stem Cell Chrondrogenic Differentiation CLONING AND STEM CELLS (ISSN: 15362302) 11: (3) pp. 407416. ( 2009) Folyóiratcikk [10823186]
9
* Steger V, Molnar A, Borsy A, Gyurjan I, Szabolcsi Z, Dancs G, Molnar J, Papp P, Nagy J, Puskas L, Barta E, Zomborszky Z, Horn P, Podani J, Semsey S, Lakatos P, Orosz L Antler development and coupled osteoporosis in the skeleton of red deer Cervus elaphus: expression dynamics for regulatory and effector genes MOLECULAR GENETICS AND GENOMICS (ISSN: 16174615) 284: (4) pp. 273287. ( 2010) Folyóiratcikk [11101946]
10
Kierdorf U, Kierdorf H Deer Antlers A Model of Mammalian Appendage Regeneration: An Extensive Review GERONTOLOGY (ISSN: 0304324X) 57: (1) pp. 5365. ( 2011) Z9: 2 W C: Geriatrics & Gerontology Folyóiratcikk [12269694]
11
Kierdorf U, Kierdorf H Antler regrowth as a form of epimorphic regeneration in vertebrates A comparative view FRONT BIOSCI (ELITE EDITION) 4 E: (5) pp. 16061624. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13332402]
12
Li CY, Harper A, Puddick J, W ang W Y, McMahon C P roteomes and Signalling P athways of Antler Stem Cells PLOS ONE (ISSN: 19326203) 7: (1) P aper e30026. (2012) W C: Biology Folyóiratcikk [12269693]
13
Sui ZG, Yuan H, Liang ZM, Zhao Q, W u Q, Xia SM, Zhang LH, Huo YS, Zhang YK An activitymaintaining sequential protein extraction method for bioactive assay and proteome analysis of velvet antlers TALANTA (ISSN: 00399140) 107: pp. 189194. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13332394]
179. Horányi J , Lakatos P Sebészeti kezelés In: Lakatos P , Takács I Pajzsmirigybetegségek a gyakorlat oldaláról . 288 p. Budapest: Semmelweis Kiadó, 2007. pp. 114116. (ISBN:9789639656888) Nyelv: Magyar
Könyvrészlet /Szaktanulmány /Tudományos [1733429] [ Hitelesített ] Autopszia alapján hitelesítve. 180. Kerényi Z , Tamás G , Tabák GÁ , Speizer S , Speer G , M észáros S , Lakatos P , Horváth C Csontanyagcserezavarok 1es típusú diabetesben. CA ÉS CSONT 10:(1) pp. 1421. (2007) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1335688] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
188/342
3/30/2015
nyomtatobarat forma
[ Érvényesített ] 181. Kósa JP , Kis A , Bácsi K , Nagy Z , Balla B , Lazáry Á , Takács I , Speer G , Lakatos P Új, a glükokortikoidok csontsejtekre gyakorolt hatásának közvetítésében szerepet játszó gének azonosítása izolált és immortalizált egér osteoblast sejteken. MAGYAR BELORVOSI ARCHIVUM 60:(5) pp. 443450. (2007) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1335693] [ Érvényesített ] 182. Lakatos P , Leprán I A kálcium és csontanyagcserére ható gyógyszerek. In: Gyires K , Fürst Zs (szerk.) Farmakológia és Farmakoterápia: 1., Farmakológia . 1211 p. Budapest: M edicina Könyvkiadó, 2007. pp. 787798. 1. kötet., Farmakológia (ISBN:9789632261379 ; 9789632261393) Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1183393] [ Admin láttamozott ] 183. Lakatos P , Takács I Pajzsmirigybetegségek a gyakorlat oldaláról Budapest: Semmelweis Kiadó, 2007. 288 p. (ISBN:9789639656888) Nyelv: Magyar
Könyv /Kézikönyv /Tudományos [1817317] Autopszia alapján hitelesítve. [ Hitelesített ] 184. Lakatos P A csont, a porc és az ízületek betegségei In: M andl J , M achovich R (szerk.) Orvosi patobiokémia . 693 p. Budapest: M edicina Könyvkiadó, 2007. pp. 600606. (ISBN:9789632260631) Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1923043] [ Érvényesített ] 185. Lakatos Péter Csontritkulás korszerű irányelvek szerinti kezelése : kommentár ORVOSTOVÁBBKÉPZŐ SZEMLE 14:(9) pp. 7778. (2007) Nyelv: Magyar
Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [1806506] [ Érvényesített ] 186. Lakatos PL , Bajnok E , WillheimPolli C , Ferenci P , Takacs I , Lakatos P , Szalay F Gene polymorphisms in primary biliary cirrhosis: association with the disease and hepatic osteopathy In: Burns JL (szerk.) Liver Cirrhosis Research . 232 p. New York: Nova Science Publishers, 2007. pp. 5978. (ISBN:1594541558) Nyelv: Angol
Könyvrészlet /Szaktanulmány /Tudományos [1074740] [ Érvényesített ] 187. Lazary A , Balla B , Kosa J , Bacsi K , Nagy Z , Takacs I , Varga PP , Speer G , Lakatos P A szintetikus csontpotló graftok alkalmazásának összefoglalása. A gipsz szerepe a csontpotlásban: molekularis biologiai megközelitéssel, saját eredményeink ORVOSI HETILAP 148:(51) pp. 24272433. (2007) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [1435440] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
189/342
3/30/2015
nyomtatobarat forma
[ Szerzői rekord ] Független idéző: 1 Összesen: 1 1
Park AG, Paglia DN, AlZube L, Hreha J, Vaidya S, Breitbart E, Benevenia J, O'Connor JP, Lin SS Local insulin therapy affects fracture healing in a rat model Journal of Orthopaedic Research (ISSN: 07360266) 31: (5) pp. 776782. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13353239]
188. Lazary A , Balla B , Kosa JP , Bacsi K , Nagy Z , Takacs I , Varga PP , Speer G , Lakatos P Effect of gypsum on proliferation and differentiation of M C3T3E1 mouse osteoblastic cells. BIOMATERIALS 28:(3) pp. 393399. (2007) IF: 6.262 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1435441] [ Szerzői rekord ] Független idéző: 57 Függő idéző: 2 Összesen: 59 1
Slater N, Dasmah A, Sennerby L, Hallman M, Piattelli A, Sammons R Backscattered electron imaging and elemental microanalysis of retrieved bone tissue following maxillary sinus floor augmentation with calcium sulphate CLINICAL ORAL IMPLANTS RESEARCH (ISSN: 09057161) 19: (8) pp. 814822. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [11709672]
2
Ricci J L, W einer M J, Mamidwar S, Alexander H Calcium sulfate In: Kokubo T (szerk.) : BIOCERAMICS AND THEIR CLINICAL APPLICATIONS. Japán: Chubu University , 2008. pp. 302325. (Woodhead Publishing in Materials)
Könyvrészlet /Könyvfejezet /Tudományos [13342182] 3
W ang P, Lee EJ, Park CS, Yoon BH, Shin DS, Kim HE, Koh YH, Park SH Calcium sulfate hemihydrate powders with a controlled morphology for use as bone cement JOURNAL OF THE AMERICAN CERAMIC SOCIETY (ISSN: 00027820) 91: (6) pp. 20392042. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [11709671]
4
Takernura T, Ikoma T, Hanagata N Effect of acid treated hydroxyapatite on osteoblast maturation In: Daculsi G Lay rolle P (szerk.) : BIOCERAMICS, VOL 20, PTS 1 AND 2. (Part 12) Switzerland: TRANS TECH PUBLICATIONS LTD, 2008. pp. 10291032. (KEY ENGINEERING MATERIALS (Volume: 361363))
Könyvrészlet /Konferenciaközlemény /Tudományos [11709670] 5
6
Chang YC, W ang DJ, Lee SY, Chang W C, Yang W CV Effect of calcium sulfate on osteopontin expression in U2 osteosarcoma cells JOURNAL OF DENTAL SCIENCES (ISSN: 19917902) 3: (1) pp. 3037. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [11709669] * Lazary Aron, Speer Gabor, Varga Peter Pal, Balla Bernadett, Bacsi Krisztian, Kosa Janos P, Nagy Zsolt, Takacs Istvan, Lakatos Peter Effect of vertebroplasty filler materials on viability and gene expression of human nucleus pulposus cells JOURNAL OF ORTHOPAEDIC RESEARCH (ISSN: 07360266) 26: (5) pp. 601607. ( 2008) Folyóiratcikk [13148178]
7
Park JW , Jang JH, Bae SR, An CH, Suh JY Bone formation with various bone graft substitutes in criticalsized rat calvarial defect CLINICAL ORAL IMPLANTS RESEARCH (ISSN: 09057161) 20: (4) pp. 372378. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11709668]
8
Thomas MV, Puleo DA Calcium Sulfate: P roperties and Clinical Applications JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART BAPPLIED BIOMATERIALS (ISSN: 15524973) 88B: (2) pp. 597610. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [11709667]
9
Farina R, Scabbia A, Bozzi L, Barbè G, Meotti E, Trombelli L Calcium sulphate in the reconstruction of periodontal intraosseus defects Dental Cadmos 77: (2) pp. 2129. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [13342291]
10
W oo KM, Yu B, Jung HM, Lee YK Comparative Evaluation of Different CrystalStructured Calcium Sulfates as BoneFilling Materials JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART BAPPLIED BIOMATERIALS (ISSN: 15524973) 91B: (2) pp. 545554. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11709666]
11
Hesaraki S, Nemati R, Nazarian H P hysicoChemical and In Vitro Biological Study of ZincDoped Calcium Sulfate Bone Substitute JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART BAPPLIED BIOMATERIALS (ISSN: 15524973) 91B: (1) pp. 3745. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11709665]
12
W ei Junqiang, Tian Xuezhong, Zhang Boxun, Chen Hua, Tang Peifu, W ang Yan Effect of calcium sulfate on gene expression in differentiation of human BMSCs into osteoblasts Chinese Journal of Experimental Surgery (ISSN: 10019030) 27: (11) pp. 15891591. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [14595722]
13
Borhan S, Hesaraki S, AhmadzadehAsl S Evaluation of colloidal silica suspension as efficient additive for improving physicochemical and in vitro biological properties of calcium sulfatebased nanocomposite bone cement JOURNAL OF MATERIALS SCIENCEMATERIALS IN MEDICINE (ISSN: 09574530) 21: (12) pp. 31713181. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11709664]
14
Suchenski M, McCarthy MB, Chowaniec D, Hansen D, McKinnon W , Apostolakos J, Arciero R, Mazzocca AD Material P roperties and Composition of SoftTissue Fixation ARTHROSCOPYTHE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY (ISSN: 07498063) 26: (6) pp. 821831.
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
190/342
3/30/2015
nyomtatobarat forma ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11709663] 15
Jung HM, Song GA, Lee YK, Baek JH, Ryoo HM, Kim GS, Choung PH, W oo KM Modulation of the resorption and osteoconductivity of alphacalcium sulfate by histone deacetylase inhibitors BIOMATERIALS (ISSN: 01429612) 31: (1) pp. 2937. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11709662]
16
Zhou HJ, W ei J, W u XH, Shi JL, Liu CS, Jia JF, Dai CL, Gan Q The biofunctional role of calcium in mesoporous silica xerogels on the responses of osteoblasts in vitro JOURNAL OF MATERIALS SCIENCEMATERIALS IN MEDICINE (ISSN: 09574530) 21: (7) pp. 21752185. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11709661]
17
Liu DD, Zhang JC, Yi CQ, Yang MS The effects of gold nanoparticles on the proliferation, differentiation, and mineralization function of MC3T3E1 cells in vitro CHINESE SCIENCE BULLETIN (ISSN: 10016538) 55: (11) pp. 10131019. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11709660]
18
张金超, 刘丹丹, 易长青, 杨梦甦 金纳米粒子对成骨细胞MC3T3E1增殖,分化和矿化功能的影响 CHINESE SCIENCE BULLETIN (ISSN: 10016538) 55: (6) pp. 435441. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [14595723]
19
Li Zhiliang, Kong W eina, Li Xiulan, Xu Chen, He Yongqiang, Gao Jianping, Ma Zhiqing, W ang Xiaodong, Zhang Yang, Xing Fubao, Li Min, Liu Yu AntibioticContaining Biodegradable Bead Clusters with P orous P LGA Coating as Controllable DrugReleasing Bone Fillers JOURNAL OF BIOMATERIALS SCIENCEPOLYMER EDITION (ISSN: 09205063) 22: (13) pp. 17131731. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13041640]
20
W ashington Jelani T, Schneiderman Emet, Spears Robert, Fernandez Claudia R, He Jianing, Opperman Lynne A Biocompatibility and Osteogenic P otential of New Generation Endodontic Materials Established by Using P rimary Osteoblasts JOURNAL OF ENDODONTICS (ISSN: 00992399) 37: (8) pp. 11661170. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13041639]
21 * Lazary A, Varga PP Clinical use of gypsum: P erspectives of spinal applications In: Gy psum: Properties, Production and Applications. Nova Science Publishers, Inc., 2011. (ISBN 9781617283086) pp. 205216.
Könyvrészlet /Könyvfejezet /Tudományos [13857340] 22
W u HongDa, Yang JenChang, Tsai Tsuimin, Ji DainYu, Chang W eiJen, Chen ChienChung, Lee ShengYang Development of a chitosanpolyglutamate based injectable polyelectrolyte complex scaffold CARBOHYDRATE POLYMERS (ISSN: 01448617) 85: (2) pp. 318324. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13041638]
23
Khorami Mina, Hesaraki Saeed, Behnamghader Aliasghar, Nazarian Hamid, Shahrabi Sara In vitro bioactivity and biocompatibility of lithium substituted 45S5 bioglass MATERIALS SCIENCE & ENGINEERING CMATERIALS FOR BIOLOGICAL APPLICATIONS 31: (7) pp. 15841592. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13041637]
24
Chen Zonggang, Liu Huanye, Liu Xi, Cui FuZhai Injectable calcium sulfate/mineralized collagenbased bone repair materials with regulable selfsetting properties JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (ISSN: 15493296) 99A: (4) pp. 554563. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13041636]
25
López J, Alarcón M Sulfato de calcio: propiedades y aplicaciones clínicas: Calcium sulfate: properties and clinical applications Revista clínica de periodoncia, implantología y rehabilitación oral (ISSN: 07190107) 4: (3) pp. 138143. ( 2011) Folyóiratcikk [14595721]
26
W ang YL, Pan ZJ, Yang ZH Calcium sulfate: A new application as a mixture with other bone graft materials JOURNAL OF CLINICAL REHABILITATIVE TISSUE ENGINEERING RESEARCH / ZHONG GUO ZU ZHI GONG CHENG YAN JIU YU LIN CHUANG KANG FU (ISSN: 16738225) 16: (51) pp. 96249628. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13857339]
27
CalvoGuirado J L, DelgadoRuiz R A, RamirezFernandez M P, MateSanchez J E, OrtizRuiz A, Marcus Abboud Histomorphometric and mineral degradation study of Ossceram (R): a novel biphasic Btricalcium phosphate, in critical size defects in rabbits CLINICAL ORAL IMPLANTS RESEARCH (ISSN: 09057161) 23: (6) pp. 667675. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13041635]
28
Hesaraki Saeed, Barounian Mohammad Hasan, Farhangdoust Sajad, Khorami Mina, Zamanian Ali, Borhan Shokoufeh Mechanical and In Vitro Biological P roperties of Hydroxyapatite Bioceramics Reinforced with StrontiumContaining Nano Bioactive Glass CURRENT NANOSCIENCE (ISSN: 15734137) 8: (4) pp. 612622. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13041634]
29
Hu NingMin, Chen Zonggang, Liu Xi, Liu Huanye, Lian Xiaojie, W ang Xiumei, Cui FuZhai Mechanical properties and in vitro bioactivity of injectable and selfsetting calcium sulfate/nanoHA/collagen bone graft substitute JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS (ISSN: 17516161) 12: pp. 119128. ( 2012) Folyóiratcikk /Rövid közlemény /Tudományos [13041633]
30
MateSanchez de Val Jose E, CalvoGuirado Jose L, DelgadoRuiz Rafael A, RamirezFernandez Ma P, Negri Bruno, Abboud Marcus, Martinez Isabel M, de Aza Piedad N P hysical properties, mechanical behavior, and electron microscopy study of a new alphaTCP block graft with silicon in an animal model JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (ISSN: 15493296) 100A: (12) pp. 34463454. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13041632]
31
Pouria Amir, Bandegani Hadis, PourbaghiMasouleh Milad, Hesaraki Saeed, Alizadeh Masoud P hysicochemical P roperties and Cellular Responses of StrontiumDoped Gypsum Biomaterials BIOINORGANIC CHEMISTRY AND APPLICATIONS (ISSN: 15653633) 2012: (2012) P aper 976495. (2012) Folyóiratcikk /Szakcikk /Tudományos [13041631]
32
Kuo ShuTing, W u HaoW ei, Tuan W eiHsing, Tsai YuYu, W ang SeaFue, Sakka Yoshio
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
191/342
3/30/2015
nyomtatobarat forma P orous calcium sulfate ceramics with tunable degradation rate JOURNAL OF MATERIALS SCIENCEMATERIALS IN MEDICINE (ISSN: 09574530) 23: (10) pp. 24372443. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13041630] 33
Mao Kezheng, Mao Keya, Cheng Zishen, Li Peng, Chen Zonggang, W ang Xumei, Cui Fuzhai P roperties of injectable composite cements and its application in burst fracture of the spine ADVANCED MATERIALS AND ENGINEERING APPLICATIONS 161: pp. 105112. ( 2012) Folyóiratcikk /Konferenciaközlemény /Tudományos [13041629]
34
Alfotawi R, Naudi K, Dalby MJ, Tanner KE, Mcmahon JD, Ayoub A Assessment of cellular viability on calcium sulphate/hydroxyapatite injectable scaffolds Journal of Tissue Engineering (ISSN: 20417314) 4: (1) pp. 112. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13857338]
35
Thitiyanaporn C, Thengchaisri N, Udomkusonsri P Comparison of polymethylmethacrylate (P MMA), native calcium sulfate, and high porous calcium sulfate beads as gentamicin carriers and osteoblast attachment Songklanakarin Journal of Science and Technology (ISSN: 01253395) 35: (3) pp. 293301. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13342290]
36
Li Fan, Liu Jianli, Yang Guangyong, Pan Zongyou, Ni Xiao, Xu Huazi, Huang Qing Effect of pH and succinic acid on the morphology of alphacalcium sulfate hemihydrate synthesized by a salt solution method JOURNAL OF CRYSTAL GROWTH (ISSN: 00220248) 374: pp. 3136. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13342181]
37
Chen Zonggang, Liu Huanye, Liu Xi, Lian Xiaojie, Guo Zhongwu, Jiang HongJiang, Cui FuZhai Improved workability of injectable calcium sulfate bone cement by regulation of selfsetting properties MATERIALS SCIENCE & ENGINEERING CMATERIALS FOR BIOLOGICAL APPLICATIONS 33: (3) pp. 10481053. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13142478]
38
Tsai YuYu, W ang SeaFue, Kuo ShuTing, Tuan W eiHsing Improving biodegradation behavior of calcium sulfate bone graft tablet by using water vapor treatment MATERIALS SCIENCE & ENGINEERING CMATERIALS FOR BIOLOGICAL APPLICATIONS 33: (1) pp. 121126. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13041628]
39
Liu J, Mao K, Liu Z, W ang X, Cui F, Guo W , Mao K, Yang S Injectable Biocomposites for Bone Healing in Rabbit Femoral Condyle Defects PLoS ONE (ISSN: 19326203) 8: (10) P aper e75668. (2013) Folyóiratcikk /Szakcikk /Tudományos [13857337]
40
Nelson Clarke, Magge Anil, St Bernard Tiffany, Khan Yusuf, Laurencin Cato T Nanostructured Composites for Bone Repair JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING (ISSN: 21579083) 3: (4) pp. 426439. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13342180]
41
Mao K, Mao K, Cheng Z, Li P, Chen Z, W ang X, Cui F P erformance of composite cements in the repair of porcine thoracolumbar burst fracture in vitro Materials Science Forum (ISSN: 02555476) 745746: pp. 1320. ( 2013) Folyóiratcikk /Konferenciaközlemény /Tudományos [13342289]
42
Nilsson M, Zheng MH, Tägil M The composite of hydroxyapatite and calcium sulphate: A review of preclinical evaluation and clinical applications Expert Review of Medical Devices (ISSN: 17434440) 10: (5) pp. 675684. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13857336]
43
W u LC, Liu HW , Chen CK, Kuo JT, Chou HK, Chung YC The effect on a new sintered calcium sulfate ceramic to osteoprogenitor MC 3T3E1 Advanced Materials Research (ISSN: 10226680) 677: pp. 201206. ( 2013) Folyóiratcikk /Konferenciaközlemény /Tudományos [13342288]
44
Piedad RamirezFernandez Maria, Luis CalvoGuirado Jose, Arcesio DelgadoRuiz Rafael, Eduardo MateSanchez del Val Jose, Negri Bruno, Penarrocha Diago Maria Ultrastructural study by backscattered electron imaging and elemental microanalysis of biomaterialtobone interface and mineral degradation of bovine xenografts in maxillary sinus floor elevation CLINICAL ORAL IMPLANTS RESEARCH (ISSN: 09057161) 24: (6) pp. 645651. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13142477]
45
Piedad RamirezFernandez Maria, Luis CalvoGuirado Jose, Eduardo MateSanchez del Val Jose, Arcesio DelgadoRuiz Rafael, Negri Bruno, BaronaDorado Cristina Ultrastructural study by backscattered electron imaging and elemental microanalysis of bonetobiomaterial interface and mineral degradation of porcine xenografts used in maxillary sinus floor elevation CLINICAL ORAL IMPLANTS RESEARCH (ISSN: 09057161) 24: (5) pp. 523530. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13142476]
46
Li Xue, Xu Changpeng, Hou Yilong, Song Jinqi, Cui Zhuang, W ang Shengnan, Huang Lei, Zhou Changren, Yu Bin A novel resorbable strontiumcontaining alphacalcium sulfate hemihydrate bone substitute: a preparation and preliminary study BIOMEDICAL MATERIALS (ISSN: 17486041) 9: (4) P aper 045010. (2014) Folyóiratcikk [14595720]
47
De Aza PN, Peña JI, Luklinska ZB, MeseguerOlmo L Bioeutectic® ceramics for biomedical application obtained by laser floating zone method. In vivo evaluation Materials (ISSN: 19961944) 7: (4) pp. 23952410. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13857335]
48
W iens Matthias, Elkhooly Tarek A, Schroeder HeinzChristoph, Mohamed Tawheed H A, Mueller W erner E G Characterization and osteogenic activity of a silicatein/biosilicacoated chitosangraftpolycaprolactone ACTA BIOMATERIALIA (ISSN: 17427061) 10: (10) pp. 44564464. ( 2014) Folyóiratcikk [14595719]
49
Hesaraki S, Nazarian H, PourbaghiMasouleh M, Borhan S Comparative study of mesenchymal stem cells osteogenic differentiation on lowtemperature biomineralized nanocrystalline carbonated hydroxyapatite and sintered hydroxyapatite JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART BAPPLIED BIOMATERIALS (ISSN: 15524973) 102: (1) pp. 108118. ( 2014)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
192/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [13857334] 50
MatéSánchez De Val JE, Mazõn P, Guirado JLC, Ruiz RAD, Ramírez Fernández MP, Negri B, Abboud M, De Aza PN Comparison of three hydroxyapatite/βtricalcium phosphate/collagen ceramic scaffolds: An in vivo study JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (ISSN: 15493296) 102: (4) pp. 10371046. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13857333]
51
Chen Zonggang, Kang Lingzhi, Meng QingYuan, Liu Huanye, W ang Zhaoliang, Guo Zhongwu, Cui FuZhai Degradability of injectable calcium sulfate/mineralized collagenbased bone repair material and its effect on bone tissue regeneration MATERIALS SCIENCE & ENGINEERING CMATERIALS FOR BIOLOGICAL APPLICATIONS (ISSN: 09284931) 45: pp. 94 102. ( 2014) Folyóiratcikk [14595718]
52
Bi Xin, Li Duoyu, Yang Yi, Gong Yuekun, Li Biao Different artificial bones combined with bone marrow mesenchymal stem cell therapy for early osteonecrosis of the femoral head:controversy and progress CHINESE JOURNAL OF TISSUE ENGINEERING RESEARCH (ISSN: 20954344) 18: (12) pp. 19571962. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14595717]
53
Tao Zhoushan, Lv Yangxun, Cui W ei, He Xingwen, Liu W ei, Huang Zhengliang, Tu Kaikai, Zhou Xianting, Yang Lei Experimental study on the repairing of osteoporotic bone defect using betaTCP Chinese Journal of Osteoporosis (ISSN: 10067108) 20: (10) pp. 11781183. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14595715]
54
Lin M, Zhang L, W ang JC, Chen XY, Yang XY, Cui W G, Zhang W , Yang GJ, Liu M, Zhao Y, Gao CY, Gou ZR Novel highly bioactive and biodegradable gypsum/calcium silicate composite bone cements: from physicochemical characteristics to in vivo aspects J MATER CHEM B (ISSN: 2050750X) 2: (14) pp. 20302038. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13857343]
55
W ang Peng, Pi Bin, W ang Jinning, Zhu Xuesong, Yang Huilin P hysicochemical properties of chitosan microspheres/silk fibroin/calcium sulfate bone cement CHINESE JOURNAL OF TISSUE ENGINEERING RESEARCH (ISSN: 20954344) 18: (12) pp. 18311838. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14595714]
56
W ang Juncheng, Zhang Lei, Sun Xiaoliang, Chen Xiaoyi, Xie Kailuo, Lin Mian, Yang Guojing, Xu Sanzhong, Xia W ei, Gou Zhongru P reparation and in vitro evaluation of strontiumdoped calcium silicate/gypsum bioactive bone cement BIOMEDICAL MATERIALS (ISSN: 17486041) 9: (4) P aper 045002. (2014) Folyóiratcikk [14595713]
57
Sohrabi M, Hesaraki S, Kazemzadeh A The influence of polymeric component of bioactive glassbased nanocomposite paste on its rheological behaviors and in vitro responses: Hyaluronic acid versus sodium alginate J BIOMED MATER RES B (ISSN: 15524973) 102: (3) pp. 561573. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13857342]
58
W u X H, W u Z Y, Su J C, Yan Y G, Yu B Q, W ei J, Zhao L M Nanohydroxyapatite promotes selfassembly of honeycomb pores in poly(Llactide) films through breathfigure method and MC3T3E1 cell functions RSC ADVANCES (ISSN: 20462069) 5: (9) pp. 66076616. ( 2015) Folyóiratcikk [14595712]
59
W oo Kyung Mi, Jung HongMoon, Oh JoungHwan, Rahman Saeed Ur, Kim Soung Min, Baek JeongHwa, Ryoo HyunMo Synergistic effects of dimethyloxalylglycine and butyrate incorporated into alphacalcium sulfate on bone regeneration BIOMATERIALS (ISSN: 01429612) 39: pp. 114. ( 2015) Folyóiratcikk [14595711]
189. Lazary A , Varga P , Speer G , Bacsi K , Balla B , Kosa J , Nagy Z , Takacs I , Lakatos P Effect of vertebroplasty filler materials on viability and gene expression of mouse and human nucleus pulposus cells JOURNAL OF BONE AND MINERAL RESEARCH 22:(Suppl. 1) p. S160. (2007) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1464663] 29th Annual M eeting of the : AmericanSocietyforBoneandM ineralResearch SEP 1619, 2007, Honolulu, HI [ Érvényesített ] 190. Lazáry Á , Speer G , Kósa JP , Tóbiás B , Balla B , Bácsi K , Nagy Zs , Takács I , Lakatos P M ultiplex SNPgenotipizálás és adatfeldolgozás 360 posztmenopauzás nő vérmintájából CA ÉS CSONT 10:(2) p. 59. (2007) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1820204] [ Admin láttamozott ] 191. Lazáry Á , Varga PP , Speer G , Bácsi K , Balla B , Kósa J , Nagy Zs , Takács I , Lakatos P Effect of vertebroplasty filler material on viability and gene expression of mouse and human nucleus pulposus cells ASBM R Kongresszus, Honolulu (2007) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434154] [Poszter] [ Admin láttamozott ] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
193/342
3/30/2015
nyomtatobarat forma
192. M iheller P , M uzes G , Rácz K , Blázovits A , Lakatos P , Herszényi L , Tulassay Z Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy INFLAMMATORY BOWEL DISEASES 13:(11) pp. 13791384. (2007) IF: 4.705 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [155006] [ Hitelesített ] Független idéző: 24 Függő idéző: 4 Összesen: 28 1
Cashman KD Altered bone metabolism in inflammatory disease: role for nutrition PROCEEDINGS OF THE NUTRITION SOCIETY (ISSN: 00296651) 67: (2) pp. 196205. ( 2008) Z9: 8 W C: Nutrition & Dietetics Conference: Symposium on Diet and Cancer/Diet and Bone Health/Diet and CVD Location: Univ Ulster, Coleraine, IRELAND Date: JUL 1619, 2008 Folyóiratcikk /Konferenciaközlemény /Tudományos [12365023]
2
Thayu M, Leonard MB, Hyams JS, Crandall W V, Kugathasan S, Otley AR, Olson A, Johanns J, Marano CW , Heuschkel RB, VeeremanW auters G, Griffiths AM, Baldassano RN Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: Results of the REACH Study CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (ISSN: 15423565) 6: (12) pp. 13781384. ( 2008) Folyóiratcikk /Szakcikk [262997]
3
* Miheller P, Muzes G, Hritz I, Lakatos G, Pregun I, Lakatos PL, Herszenyi L, Tulassay Z Comparison of the Effects of 1,25 Dihydroxyvitamin D and 25 Hydroxyvitamin D on Bone P athology and Disease Activity in Crohn's Disease P atients INFLAMMATORY BOWEL DISEASES (ISSN: 10780998) 15: (11) pp. 16561662. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11047264]
4
Ali T, Lam D, Bronze MS, Humphrey MB Osteoporosis in Inflammatory Bowel Disease AMERICAN JOURNAL OF MEDICINE (ISSN: 00029343) 122: (7) pp. 599604. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [11047263]
5
Malik S, Ahmed S F Biologic therapy and its effect on skeletal development in children with chronic inflammation Expert Review of Endocrinology and Metabolism 5: (5) pp. 733740. ( 2010) Chemicals/CAS: adalimumab, 331731181; etanercept, 185243690, 200013861; follitropin, 9002680; growth hormone, 36992731, 37267053, 66419509, 9002726; growth hormone releasing factor, 83930136, 9034393; infliximab, 170277313; luteinizing hormone, 39341838, 9002679 Tradenames: enbrel; humira; remicade Folyóiratcikk /Összefoglaló cikk /Tudományos [12361160]
6
* Miheller P, Lorinczy K, Lakatos PL Clinical relevance of changes in bone metabolism in inflammatory bowel disease WORLD JOURNAL OF GASTROENTEROLOGY (ISSN: 10079327) 16: (44) pp. 55365542. ( 2010) Z9: 1 W C: Gastroenterology & Hepatology Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [11550840]
7
W agner D, FahrleitnerPammer A Levels of osteoprotegerin (OP G) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: Are they of any help? Wiener Medizinische Wochenschrift (ISSN: 00435341) 160: (1718) pp. 452457. ( 2010) Chemicals/CAS: alendronic acid, 66376361; infliximab, 170277313; osteoclast differentiation factor, 200145933; osteoprotegerin, 205944509; parathyroid hormone[134], 12583685, 52232674; raloxifene, 82640048, 84449901; risedronic acid, 105462246, 122458826; Osteoprotegerin; RANK Ligand; TNFSF11 protein, human Folyóiratcikk /Összefoglaló cikk /Tudományos [12361159]
8
Ghishan FK, Kiela PR Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases AMERICAN JOURNAL OF PHYSIOLOGYGASTROINTESTINAL AND LIVER PHYSIOLOGY (ISSN: 01931857) 300: (2) pp. G191G201. ( 2011) W C: Gastroenterology & Hepatology; Physiology Folyóiratcikk /Összefoglaló cikk /Tudományos [11550839]
9
Agrawal M, Arora S, Li J, Rahmani R, Sun L, Steinlauf A F, Mechanick J I, Zaidi M Bone, inflammation, and inflammatory bowel disease Current Osteoporosis Reports 9: (4) pp. 251257. ( 2011) Chemicals/CAS: C reactive protein, 9007414; infliximab, 170277313; osteoclast differentiation factor, 200145933; osteoprotegerin, 205944509; prednisone, 53032; somatomedin C, 67763966 Folyóiratcikk /Szakcikk /Tudományos [12361158]
10
Galliera E, de Girolamo L, Dogliotti G, De Salvo C, Tosetti G, Pastorelli L Circulating OP G Levels Are Reduced Following Infliximab Treatment and Correlate with CRP Levels: Is Serum OP G a P otential Marker of IBD Disease Activity? INFLAMMATORY BOWEL DISEASES (ISSN: 10780998) 17: (6) pp. E59E60. ( 2011) W C: Gastroenterology & Hepatology Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [11550838]
11 * Lorinczy K, Lakatos G, Mullner K, Hritz I, Lakatos PL, Tulassay Z, Miheller P Low bone mass in microscopic colitis BMC GASTROENTEROLOGY (ISSN: 1471230X) 11: P aper 58. (2011) W C: Gastroenterology & Hepatology Folyóiratcikk /Szakcikk /Tudományos [11550837] 12
Lorenzo J, Choi Y, Horowitz M, Takayanagi H Osteoimmunology Elsevier Inc., 2011. (ISBN 9780123756701)
Könyv /Szakkönyv /Tudományos [13718541] 13
Veerappan SG, O Morain CA, Daly JS, Ryan BM Review article: the effects of antitumour necrosis factoralpha on bone metabolism in inflammatory bowel disease ALIMENTARY PHARMACOLOGY & THERAPEUTICS (ISSN: 02692813) 33: (12) pp. 12611272. ( 2011) W C: Gastroenterology & Hepatology; Pharmacology & Pharmacy
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
194/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Összefoglaló cikk /Tudományos [11550836] 14
Hyams J, W alters TD, Crandall W , Kugathasan S, Griffiths A, Blank M, Johanns J, Lang YH, Markowitz J, Cohen S, W inter HS, VeeremanW auters G, Ferry G, Baldassano R Safety and efficacy of maintenance infliximab therapy for moderatetosevere Crohn's disease in children: REACH openlabel extension CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 27: (3) pp. 651662. ( 2011) W C: Medicine, General & Internal; Medicine, Research & Experimental Folyóiratcikk /Szakcikk /Tudományos [11550835]
15
Pappa H, Thayu M, Sylvester F, Leonard M, Zemel B, Gordon C Skeletal Health of Children and Adolescents With Inflammatory Bowel Disease JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (ISSN: 02772116) 53: (1) pp. 1125. ( 2011) : F N Thomson Reuters W eb of Knowledge W C: Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics Folyóiratcikk /Szakcikk /Tudományos [11550834]
16
Nielsen OH, Bjerrum JT, Seidelin JB, Nyberg C, Ainsworth M Biological treatment of crohn's disease Digestive Diseases (ISSN: 02572753) 30: (SUP P L. 3) pp. 121133. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13041303]
17
Pacios S, Kang J, Galicia J, Gluck K, Patel H, OvaydiMandel A, Petrov S, Alawi F, Graves D T Diabetes aggravates periodontitis by limiting repair through enhanced inflammation FASEB Journal (ISSN: 08926638) 26: (4) pp. 14231430. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12361157]
18
Katz S, W einerman S The elderly inflammatory bowel disease patient and osteoporosis Aging Health 8: (1) pp. 3142. ( 2012) Chemicals/CAS: alendronic acid, 66376361; calcitonin, 12321447, 21215623, 9007129; calcium, 14092945, 7440 702; denosumab, 615258407; ibandronic acid, 114084785, 138844812, 138926199; infliximab, 170277313; osteoclast differentiation factor, 200145933; osteoprotegerin, 205944509; parathyroid hormone[134], 12583685, 52232674; prednisone, 53032; raloxifene, 82640048, 84449901; risedronic acid, 105462246, 122458826; strontium ranelate, 135459879; vitamin K group, 12001795 Folyóiratcikk /Összefoglaló cikk /Tudományos [12361156]
19
Lakatos PL, Lakatos L, Kiss LS, PeyrinBiroulet L, Schoepfer A, Vavricka S Treatment of extraintestinal manifestations in inflammatory bowel disease Digestion (ISSN: 00122823) 86: (SUP P L. 1) pp. 2835. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12739288]
20
Corte C, Saxena P, Tattersall S, Selinger C, Leong R W When to use biological agents in inflammatory bowel disease Journal of Gastroenterology and Hepatology (ISSN: 08159319) 27: (7) pp. 11411149. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12412315]
21
Lucendo AJ, GarciaManzanares A Bone mineral density in adult coeliac disease: An updated review REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (ISSN: 11300108) 105: (3) pp. 154162. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13288714]
22
Huh SY, Gordon CM Fractures in hospitalized children Metabolism: Clinical and Experimental 62: (3) pp. 315325. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13041302]
23 * Miheller P, Gesztes W , Lakatos PL Manipulating bone disease in inflammatory bowel disease patients Annals of Gastroenterology (ISSN: 11087471) 26: (4) pp. 296303. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13493449] 24
Salem M, Seidelin JB, Rogler G, Nielsen OH Muramyl dipeptide responsive pathways in Crohn's disease: From NOD2 and beyond Cellular and Molecular Life Sciences (ISSN: 1420682X) 70: (18) pp. 33913404. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13493448]
25
Nahidi L, Leach ST, Lemberg DA, Day AS Osteoprotegerin Exerts Its P roinflammatory Effects Through Nuclear Factorkappa B Activation DIGESTIVE DISEASES AND SCIENCES (ISSN: 01632116) 58: (11) pp. 31443155. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13718540]
26
Azzopardi N, Ellul P Risk factors for osteoporosis in Crohn's Disease: Infliximab, corticosteroids, body mass index, and age of onset Inflammatory Bowel Diseases (ISSN: 10780998) 19: (6) pp. 11731178. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13288718]
27
Zeitz J, Vavricka SR Therapy of extraintestinal manifestion in CIBD: A difficult challenge Gastroenterologe 8: (3) pp. 217225. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13288717]
28
Zeitz J, Vavricka SR Therapy of extraintestinal manifestion in CIBD: A difficult challenge Coloproctology (ISSN: 01742442) 36: (6) pp. 439446. ( 2014) Hiányzó Besorolás: 'Therapie der extraintestinalen CEDManifestationen: Eine schwierige Herausforderung',24 Folyóiratcikk /Tudományos [14368657]
193. M iheller P , M uzes G , Racz K , Blazovits A , Lakatos P , Herszenyi L , Tulassay Z Infliximab treatment decreases serum osteoprotegerin concentration inpatients with Crohn's disease GASTROENTEROLOGY 132:(4) p. A364. (2007) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1260681] SU: Suppl. 2 Blázovics A neve elírva szerepel Blázovits Aként. https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
195/342
3/30/2015
nyomtatobarat forma
[ Érvényesített ] 194. M iheller P , M űzes G , Rácz K , Blázovits A , Lakatos P , Herszényi L , Tulassay Z Infliximab treatment decreases serum osteoprotegerin concentration in patients with Crohn’s disease. JOURNAL OF CROHN'S & COLITIS 1:(Suppl. 1) p. 46. (2007) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1982550] [Előadás] 2nd Congress of the European Crohn's Colitis Organization, Insbruck, 2007. III.13. Blázovics A neve elírva, Blázovits Aként szerepel. [ Érvényesített ] 195. Nemcsik J , Speer G , Othmane T E H , Tabak A G , Fekete B , Egresits J , Lakatos P , Fodor E , Kiss I , Tisler A Correlations of arterial stiffness, ACE gene I/D and collagen1A1 gene1245G/T polymorphism in patients with end stage renal disease NEPHROLOGY DIALYSIS TRANSPLANTATION 22:(Suppl 6) p. 317. (2007) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1821076] XLIV Congress of the European Renal Association European Dialysis and Transplant Association (ERAEDTA), June 2124, 2007, Barcelona, Spain [ Érvényesített ] 196. Sallai László , Lakatos Péter , Tímár Csaba , Putz Zsuzsanna , Istenes Ildikó , Speer Gábor , Demeter Judit , Kempler Péter Típusos diabeteses talpi fekély egy cukorbetegségben nem szenvedő betegben: a kardiovaszkuláris rizikótényezők és az esszenciális thrombocythaemia szerepe MAGYAR BELORVOSI ARCHIVUM 60:(2) pp. 165170. (2007) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1809837] [ Érvényesített ] 197. Speer G , Lazary A , Kosa J , Tobias B , M ez T , Bacsi K , Balla B , Takacs I , Nagy Z , Lakatos P M ultiplex SNP genotyping and data analysis on 360 Hungarian postmenopausal women JOURNAL OF BONE AND MINERAL RESEARCH 22:(Suppl. 1) p. S286. (2007) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1464666] 29th Annual M eeting of the : AmericanSocietyforBoneandM ineralResearch SEP 1619, 2007, Honolulu, HI [ Érvényesített ] 198. Speer G , Lazáry Á , Kósa J , Tóbiás B , M ezo T , Bácsi K , Balla B , Takács I , Nagy Zs , Lakatos P M ultiplex SNP genotyping and data analysis on 360 Hungarian postmenopausal women ASBM R Kongresszus, Honolulu (2007) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434258] [Poszter] [ Admin láttamozott ] 199. Szekeres L , Lakatos P , Nagy Z Labordiagnosztika In: Szendrői M iklós , Vízkelety Tibor (szerk.) Csontízületi daganatok és daganatszerű elváltozások . 367 p. Budapest: M edicina Könyvkiadó, 2007. pp. 303307. (ISBN:978 963 226 112 6) Nyelv: Magyar
Könyvrészlet /Könyvfejezet /Tudományos [1923034] [ Hitelesített ] Lektorok: Rahóty Pál, Sápi Zoltán 200. Tőke J , Tóth M , Patócs A , Bertalan R , Gergics P , Stenczer B , Speer G , Lakatos P , Rácz K , Tulassay Zs A kalciumszenzor gén mutációvizsgálatának hazai tapasztalatai MAGYAR BELORVOSI ARCHIVUM 60:(5) pp. 451454. (2007) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1253669] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
196/342
3/30/2015
nyomtatobarat forma
[ Érvényesített ] 201. Vajda E , Lakatos P A tuberkulózis endokrinológiai és anyagcserebetegséget okozó formái In: M agyar P , Somoskövi Á (szerk.) Pulmonális és extrapulmonális tuberkulózis . 256 p. Budapest: M edicina Könyvkiadó, 2007. pp. 227230. (ISBN:9789632261102) Nyelv: Magyar
Könyvrészlet /Szaktanulmány /Tudományos [1923030] [ Érvényesített ]
2006 202. Bajnok Éva , Takács István , Tabák Ádám , Speer Gábor , Nagy Zsolt , Horváth Csaba , M észáros Szilvia , Kósa János , Nyiri Péter , Lakatos Péter Génpolimorfizmusok lehetséges szerepe a toxikus adenoma és az ezt kísérő osteopathia kialakulásában MAGYAR BELORVOSI ARCHIVUM 59:(2) pp. 97102. (2006) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1681055] [ Érvényesített ] 203. Balla B , Kósa JP , Takács I , Lazáry Á , Bácsi K , Lakatos P Génexpressziós mintázat vizsgálata prae és postmenopausás egészséges nők csontszövetében. MAGYAR BELORVOSI ARCHIVUM 60:(S1) p. 24. (2006) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1819826] [ Admin láttamozott ] 204. Balla B , Borsy A , Kósa JP , Kiss J , Lazáry Á , Takács I , Nagy Zs , Speer G , Bajnok É , Bácsi K , Orosz L , Lakatos P Génexpressziós mintázat vizsgálata posztmenopauzában lévő egészséges és osteoporosisos nők csontszövetében. CA ÉS CSONT 9: p. 11. (2006) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1819838] [ Admin láttamozott ] 205. Borsy A , Balla B , Gyurján I , Stéger V , M olnár A , Szabolcsi Z , Kósa J , Zomborszky Z , Papp P , Vellai T , Lakatos P , Orosz L Red deer biology for biomedical research on human osteoporosis CALCIFIED TISSUE INTERNATIONAL 78:(Suppl. 1) p. S74. (2006) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1078054] [ Admin láttamozott ] 206. Horányi J , Szlávik R , Duffek L , Darvas K , Györke T , Lakatos P , Tóth M A primer hyperparathyreosis sebészi kezelése [Surgery of primary hyperparathyroidism] ORVOSI HETILAP 147:(49) pp. 23472351. (2006) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1384744] [ Érvényesített ] Független idéző: 4 Függő idéző: 3 Összesen: 7 1 * Tőke J, Tóth M, Patócs A, Bertalan R, Gergics P, Stenczer B, Speer G, Lakatos P, Rácz K, Tulassay Zs A kalciumszenzor gén mutációvizsgálatának hazai tapasztalatai MAGYAR BELORVOSI ARCHIVUM (ISSN: 01335464) 60: (5) pp. 451454. ( 2007) Folyóiratcikk [12547917] 2 * Igaz P, Tóth M, Rácz K, Tulassay Zs A primer hyperparathyreosis kezelésének új szemlélete – a gyógyszeres kezelés lehetőségei MAGYAR BELORVOSI ARCHIVUM (ISSN: 01335464) 61: (1) pp. 3641. ( 2008) Folyóiratcikk [12547919] 3 * Toke J, Patócs A, Balogh K, Gergics P, Stenczer B, Rácz K, Tóth M P arathyroid hormonedependent hypercalcemia: P arathormonabhängige hyperkalzämie Wiener Klinische Wochenschrift 121: (78) pp. 236245. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [11688706] 4
Salehian MT, Namdari O, Mohammadi SS, Fazaeli Yousofabad H P rimary Hyperparathyroidism Due to a Giant P arathyroid Adenoma: A Case Report INT J ENDOC METABOL 9: (2) pp. 101105. ( 2009) Folyóiratcikk /Rövid közlemény /Tudományos [12644637]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
197/342
3/30/2015
nyomtatobarat forma 5
Afzal A, Gauhar T M, Butt W T, Khawaja A A, Azim K M Management of hyperparathyroidism: A five year surgical experience Journal of the Pakistan Medical Association (ISSN: 00309982) 61: (12) pp. 11941198. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12005220]
6
Bilge U, Yaşar N F, Ihtiyar E A retrospective evaluation of 75 patients operated for hyperparathyroidism between 20002010: 20002010 yillari arasinda hiperparatiroidi nedeniyle ameliyat edilen 75 hastanin geriyedönük olarak deǧerlendirilmesi Turkish Journal of Surgery 28: (2) pp. 8183. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12423862]
7
Péter Ferenc, Szeleczky Márton, Petheő István, Szécsényi Nagy Iistván, Fábián Mária, Lellei Ilona, Muzsnai Ágota, Patócs Attila, Vörös Attila P rimer hyperparathyreosis serdülőkorban „ éhes csont” szindrómával GYERMEKGYÓGYÁSZATI TOVÁBBKÉPZŐ SZEMLE (ISSN: 15854396) 19: (5) pp. 231237. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14450175]
207. Kerényi Zs , Horváth Cs , Tabák Á , Speizer Sz , M észáros Sz , Lakatos P , Tamás Gy Csontanyagcserezavarok 1es tipusú cukorbetegségben szenvedők körében CA ÉS CSONT 9:(1) p. 18. (2006) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2095713] [ Érvényesített ] 208. Kis A , Kósa JP , Balla B , Lazáry Á , Takács I , Nagy Zs , Speer G , M ező T , Bácsi K , Lakatos P A tartós glükokortikoid terápia okozta osteoporosis létrejöttében részt vevő gének kimutatása osteoblastsejteken CA ÉS CSONT 9: p. 19. (2006) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1819941] [ Admin láttamozott ] 209. Kósa JP , Kis A , Nagy Zs , Speer G , Lakatos P , Takács I Glükokortikoid indukálta csontvesztés Kialakulásában szerepet játszó gének azonosítása egér M C3T3 sejtvonalon és calvaria osteoblast sejteken. MAGYAR BELORVOSI ARCHIVUM 60:(S1) p. 49. (2006) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1819833] [ Admin láttamozott ] 210. Lakatos P Az osteoporosis diagnosztikája, a törési kockázat megítélése ORVOSI HETILAP 147:(25) pp. 11631166. (2006) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [1802690] [ Érvényesített ] 211. Lakatos P Osteoporosis, osteomalacia, hyperparathyreosis MAGYAR BELORVOSI ARCHIVUM 59:(3. Suppl.) pp. 6164. (2006) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1806850] [ Érvényesített ] 212. Lakatos P M ikor, melyiket? REUMAINFÓ 2006:(2) p. 45. (2006) Nyelv: Magyar
Folyóiratcikk /Ismertetés /Tudományos [1806867] Terápiás ajánlás [ Admin láttamozott ] 213. Lakatos P M ilyen szerepe van a háziorvosnak az osteoporosisos beteg gyógyszeres kezelésében? CSALÁDORVOSI FÓRUM 7:(4) pp. 416. (2006) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Közérdekű [1806873] [ Érvényesített ] 214. Lakatos P https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
198/342
3/30/2015
nyomtatobarat forma
Az öregedéshez társuló csontritkulás kezelése In: Igazvölgyi K (szerk.) A reumatológiai betegségek kezelése : Terápiás ajánlások . Budapest: Documed Kft., 2006. pp. 6775. Nyelv: Magyar
Könyvrészlet /Könyvfejezet /Tudományos [1908962] [ Admin láttamozott ] 215. Lakatos P Az osteoporosisok felismerése és elkülönítése In: Szarvas Ferenc (szerk.) Differenciáldiagnosztikai kalauz . 686 p. Budapest: M edicina Könyvkiadó, 2006. pp. 419434. 3. átdolg. kiad. (ISBN:9632428978) Nyelv: Magyar
Könyvrészlet /Szaktanulmány /Tudományos [1909040] [ Admin láttamozott ] 2013: 5. bővített, átdolgozott kiadás,ISBN: 9789632264356 216. Lakatos P , Takács I , Speer G , Nagy Zs A metabolikus csontbetegségek differenciáldiagnosztikája In: Lakatos Péter , Takács István (szerk.) M etabolikus csontbetegségek . 505 p. Budapest: M edintel Kiadó, 2006. pp. 494496. (ISBN:9789638433299) Nyelv: Magyar
Könyvrészlet /Szaktanulmány /Tudományos [1958867] [ Admin láttamozott ] 217. Lakatos Péter , Takács István (szerk.) M etabolikus csontbetegségek Budapest: M edintel Kiadó, 2006. 505 p. (ISBN:9789638433299) Nyelv: Magyar
Könyv /Szakkönyv /Tudományos [1335609] [ Érvényesített ] 218. Lakatos Péter , Takács István A változókor után lévő nők kezeléséről LEGE ARTIS MEDICINAE 16:(89) p. 816. (2006) Nyelv: Magyar
Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [1802438] Autopszia alapján ellenőrizve (20150320, BA) [ Érvényesített ] 219. Lazáry Á , Balla B , Kósa JP , Takács I , Nagy Zs , Speer G , Bácsi K , Koppány V , Lakatos P A gipsz in vitro hatása az osteoblastok osztódására és differenciálódására. CA ÉS CSONT 9: p. 22. (2006) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1819954] [ Admin láttamozott ] 220. Rass P , Pakozdi A , Lakatos P , Zilahi E , Sipka S , Szegedi G , Szekanecz Z Vitamin D Receptor Gene Polymorphism in Rheumatoid Arthritis And Associated Osteoporosis. RHEUMATOLOGY INTERNATIONAL 26:(11) pp. 964971. (2006) IF: 1.070 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1091728] [ Admin láttamozott ] Független idéző: 13 Függő idéző: 1 Összesen: 14 1
Petkova R, Chakarov S, Ganev V Genetic bases for predisposition to common multifactorial disease in man. P art II BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT (ISSN: 13102818) 21: (4) pp. 385392. ( 2007) Folyóiratcikk [12222935]
2
GomezVaquero C, Fiter J, Enjuanes A, Nogues X, DiezPerez A, Nolla JM Influence of the BsmI polymorphism of the vitamin D receptor gene on rheumatoid arthritis clinical activity
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
199/342
3/30/2015
nyomtatobarat forma JOURNAL OF RHEUMATOLOGY (ISSN: 0315162X) 34: (9) pp. 18231826. ( 2007) Folyóiratcikk [12222934] 3
Canhao H Vitamin D Applications and perspectives ACTA REUMATOLOGICA PORTUGUESA (ISSN: 0303464X) 32: (3) pp. 201203. ( 2007) Folyóiratcikk [12222933]
4
Arnson Y, Amital H, Shoenfeld Y Vitamin D and autoimmunity: New aetiological and therapeutic considerations ANNALS OF THE RHEUMATIC DISEASES (ISSN: 00034967) 66: (9) pp. 11371142. ( 2007) Folyóiratcikk [12222932]
5
Leventis P, Patel S Clinical aspects of vitamin D in the management of rheumatoid arthritis RHEUMATOLOGY (ISSN: 14620324) 47: (11) pp. 16171621. ( 2008) Folyóiratcikk [12222931]
6
Xiong Q, Zhu JW , Hasty KA, Canale ST, Stuart J, Gu W K The complexity in hunting for candidate genes within QTL that determine susceptibility to arthritis in rats CRITICAL REVIEWS IN IMMUNOLOGY (ISSN: 10408401) 28: (2) pp. 127157. ( 2008) Folyóiratcikk [12222930]
7
Kiran G, Debashish D Vitamin D and rheumatoid arthritis: is there a link? INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ISSN: 17561841) 11: (3) pp. 206211. ( 2008) Folyóiratcikk [12222929]
8
Ranganathan P Genetics of bone loss in rheumatoid arthritisrole of vitamin D receptor polymorphisms RHEUMATOLOGY (ISSN: 14620324) 48: (4) pp. 342346. ( 2009) Folyóiratcikk [12222928]
9
* Szekanecz Z, Szanto S, Szabo Z, Vancsa A, Szamosi S, Bodnar N, Szucs G Biologics beyond the joints AUTOIMMUNITY REVIEWS (ISSN: 15689972) 9: (12) pp. 820824. ( 2010) Folyóiratcikk [12222927]
10
Ghelani AM, Samanta A, Jones AC, Mastana SS Association analysis of TNFR2, VDR, A2M, GSTT1, GSTM1, and ACE genes with rheumatoid arthritis in South Asians and Caucasians of East Midlands in the United Kingdom RHEUMATOLOGY INTERNATIONAL (ISSN: 01728172) 31: (10) pp. 13551361. ( 2011) Folyóiratcikk [12222926]
11
Lee YH, Bae SC, Choi SJ, Ji JD, Song GG Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a metaanalysis MOLECULAR BIOLOGY REPORTS (ISSN: 03014851) 38: (6) pp. 36433651. ( 2011) Folyóiratcikk [12222925]
12
Zold E, Barta Z, Bodolay E VITAMIN D DEFICIENCY AND CONNECTIVE TISSUE DISEASE In: VITAMINS AND THE IMMUNE SYSTEM. Amsterdam: Elsevier, 2011. pp. 261286. (Vitamins and Hormones)
Könyvrészlet [12222924] 13
Ates O, Dolek B, Dalyan L, TopalSarikaya A Vitamin D Receptor Gene P olymorphisms in Rheumatoid Arthritis TURKISH JOURNAL OF RHEUMATOLOGY (ISSN: 13090291) 26: (2) pp. 145149. ( 2011) Folyóiratcikk [12222923]
14
Karray EF, Ben Dhifallah I, Ben Abdelghani K, Ben Ghorbel I, Khanfir M, Houman H, Hamzaoui K, Zakraoui L Associations of vitamin D receptor gene polymorphisms FokI and BsmI with susceptibility to rheumatoid arthritis and Behcet's disease in Tunisians JOINT BONE SPINE (ISSN: 1297319X) 79: (2) pp. 144148. ( 2012) Folyóiratcikk [12432103]
221. Reginster J Y , Adami S , Lakatos P , Greenwald M , Stepan J J , Silverman S L , Christiansen C , Rowell L , M airon N , Bonvoisin B , Drezner M K , Emkey R , Felsenberg D , Cooper C , Delmas P D , M iller P D Efficacy and tolerability of oncemonthly oral ibandronate in postmenopausal osteoporosis: 2 Year results from the M OBILE study ANNALS OF THE RHEUMATIC DISEASES 65:(5) pp. 654661. (2006) IF: 5.767 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1806937] Correction: Ann Rheum Dis. 2008;67:280 doi:10.1136/ard.2005.044958.corr1 Tradenames: boniva [ Érvényesített ] Független idéző: 143 Függő idéző: 57 Összesen: 200 1
* Silverman S, Emkey R, Reginster JY, Lorenc R, Hughes C, Kendler D Adverse event profile with oncemonthly oral ibandronate: The MOBILE study longterm extension. JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 21: (P hiladelphia, P A) pp. S418S418. ( 2006) SU: 1 W C: Endocrinology & Metabolism Folyóiratcikk /Absztrakt /Tudományos [12346373]
2
* W eiss TW , Gold DT, Silverman SL, McHorney CA An evaluation of patient preferences for osteoporosis medication attributes: Results from the P REFERUS study Current Medical Research and Opinion (ISSN: 03007995) 22: (5) pp. 949960. ( 2006) Folyóiratcikk /Konferenciaközlemény /Tudományos [13475156]
3
Jordan N, Barry M, Murphy E Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 1: (4) pp. 377387. ( 2006)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
200/342
3/30/2015
nyomtatobarat forma Z9: 2 Folyóiratcikk /Összefoglaló cikk /Tudományos [12346372] 4
* Close P, Neuprez A, Reginster JY Developments in the pharmacotherapeutic management of osteoporosis EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 7: (12) pp. 16031615. ( 2006) Z9: 23 W C: Pharmacology & Pharmacy Folyóiratcikk /Összefoglaló cikk /Tudományos [12346371]
5
* Reginster JY Ibandronate (Bonviva®) in the treatment of postmenopausal osteoporosis Revue Medicale de Liege 61: (11) pp. 783786. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [13475155]
6
7
Sewerynek E Ibandronate: A new option in osteoporosis treatment Przeglad Menopauzalny (ISSN: 16438876) 5: (4) pp. 231238. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [13475154] * Emkey R Ibandronate: Oncemonthly and intravenous dosing options for osteoporosis treatment Women's Health (ISSN: 17455057) 2: (3) pp. 341349. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [13475153]
8
Simonelli C, Burke MS Less frequent dosing of bisphosphonates in osteoporosis: focus on ibandronate CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 22: (6) pp. 11011108. ( 2006) Z9: 5 W C: Medicine, General & Internal; Medicine, Research & Experimental Folyóiratcikk /Összefoglaló cikk /Tudományos [12346370]
9
Zaidi M, Epstein S, Friend K Modeling of serum Ctelopeptide levels with daily and monthly oral ibandronate in humans In: Zaidi M (szerk.) : SKELETAL DEVELOPMENT AND REMODELING IN HEALTH, DISEASE, AND AGING. Oxon: Blackwell, 2006. (ISBN 1573315834) pp. 560563. (ANNALS OF THE NEW YORK ACADEMY OF SCIENCES)
Könyvrészlet /Szaktanulmány /Tudományos [12346369] 10
Sotoca Momblona JM, Alberdi Leniz A, Ribas Sala J Monthly ibandronate for the treatment of postmenopausal osteoporosis Atencion Farmaceutica (ISSN: 11397357) 8: (6) pp. 380383. ( 2006) Folyóiratcikk [13475152]
11
Pyon EY Oncemonthly Ibandronate for postmenopausal Osteoporosis: Review of a new dosing regimen Clinical Therapeutics (ISSN: 01492918) 28: (4) pp. 475490. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [13475151]
12
Thomas T, Breuil V, Briot K Oral bisphosphosphonates in the treatment of postmenopausal osteoporosis Revue du Rhumatisme (Edition Francaise) 73: (8) pp. 817827. ( 2006) Folyóiratcikk /Rövid közlemény /Tudományos [13475150]
13
* Reginster JY, Rabenda V P atient preference in the management of postmenopausal osteoporosis with bisphosphonates CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 1: (4) pp. 415423. ( 2006) Z9: 13 Folyóiratcikk /Összefoglaló cikk /Tudományos [12346368]
14
Pillai G, Gieschke R, Goggin T, Barrett J, W orth E, Steimer JL P opulation pharmacokinetics of ibandronate in Caucasian and Japanese healthy males and postmenopausal females International Journal of Clinical Pharmacology and Therapeutics (ISSN: 09461965) 44: (12) pp. 655667. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [13475149]
15
Chaiamnuay S, Saag KG P ostmenopausal osteoporosis. What have we learned since the introduction of bisphosphonates? Reviews in Endocrine and Metabolic Disorders 7: (12) pp. 101112. ( 2006) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475148]
16
* Lewiecki EM, Reginster JY, ElizondoAlanis LJ, Neate C, Adami S P rogressive bone density gains with oncemonthly oral Ibandronate: The MOBILE study longterm extension. ARTHRITIS AND RHEUMATISM (ISSN: 00043591) 54: (Washington, DC) pp. S584S584. ( 2006) SU: S W C: Rheumatology Folyóiratcikk /Absztrakt /Tudományos [12346367]
17
Borges JLC, Bilezikian JP Update on osteoporosis therapy Arquivos Brasileiros de Endocrinologia e Metabologia (ISSN: 00042730) 50: (4) pp. 755763. ( 2006) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475147]
18
NietoAndueza E A new dose of bisphosphonate for the prevention and the treatment of the postmenopausal osteoporosis Revista Espanola de Enfermedades Metabolicas Oseas 16: (3) pp. 5861. ( 2007) Folyóiratcikk [13475146]
19
20
21
* Reginster JY Advances in the treatment of postmenopausal osteoporosis Revue Medicale de Liege 62: (56) pp. 352359. ( 2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475145] Duarte JW , Bolge SC, Sen SS An evaluation of patients' preferences for osteoporosis medications and their attributes: The P REFERInternational study CLINICAL THERAPEUTICS (ISSN: 01492918) 29: (3) pp. 488503. ( 2007) Z9: 7 W C: Pharmacology & Pharmacy Folyóiratcikk /Szakcikk /Tudományos [12346366] * Adami S Bisphosphonate antifracture efficacy BONE (ISSN: 87563282) 41: (Valencia, SP AIN) pp. S8S15. ( 2007)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
201/342
3/30/2015
nyomtatobarat forma Z9: 9 SU: 1 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12346365] 22
Cranney A, Adachi JD Bisphosphonates for the treatment of postmenopausal osteoporosis: An update Clinical Reviews in Bone and Mineral Metabolism 5: (3) pp. 145152. ( 2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475143]
23
Reinsdorf S, Habermann B, Hochmuth K, Kurth AA Bisphosphonates in osteopovosis therapy. Standards and perspectives ORTHOPADE (ISSN: 00854530) 36: (2) pp. 110117. ( 2007) Z9: 1 W C: Orthopedics Folyóiratcikk /Összefoglaló cikk /Tudományos [12346364]
24
Inoue Daisuke Current and future prospects for antiosteoporotic drugs Folia Pharmacologica Japonica (ISSN: 00155691) 130: (3) pp. 206209. ( 2007) Folyóiratcikk [12426316]
25
Iwamoto J, Takeda T, Sato Y Effects of antifracture drugs in postmenopausal, male and glucocorticoidinduced osteoporosis usefulness of alendronate and risedronate EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 8: (16) pp. 27432756. ( 2007) Z9: 13 W C: Pharmacology & Pharmacy Folyóiratcikk /Összefoglaló cikk /Tudományos [12346362]
26
* Reginster JY, Burlet N, Close P, Bruyere O Injectable bisphosphonates for the treatment of osteoporosis Women's Health (ISSN: 17455057) 3: (6) pp. 719723. ( 2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475142]
27
* Reginster JY, Malaise O, Neuprez A, Jouret VE, Close P Intermittent bisphosphonate therapy in postmenopausal osteoporosis P rogress to date DRUGS & AGING (ISSN: 1170229X) 24: (5) pp. 351359. ( 2007) Z9: 7 W C: Geriatrics & Gerontology; Pharmacology & Pharmacy Folyóiratcikk /Szakcikk /Tudományos [12346361]
28
Lewiecki EM Long dosing intervals in the treatment of postmenopausal osteoporosis CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 23: (11) pp. 26172625. ( 2007) Z9: 2 W C: Medicine, General & Internal; Medicine, Research & Experimental Folyóiratcikk /Szakcikk /Tudományos [12346360]
29
Hawkins Carranza F, Guerra GMD New strategies in the treatment of osteoporosis Endocrinologia y Nutricion (ISSN: 15750922) 54: (8) pp. 420431. ( 2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475141]
30
Cranney A, W ells G, Adachi R Nonvertebral fracture reduction with highversus lowdose ibandronate: A metaanalysis of individual patient data ANNALS OF THE RHEUMATIC DISEASES (ISSN: 00034967) 66: (Barcelona, SP AIN) pp. 681681. ( 2007) CA: SCI Meta Anal Grp Z9: 6 SU: 2 W C: Rheumatology Folyóiratcikk /Absztrakt /Tudományos [12346359]
31
* Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu HL, Caminis J, Tong K, RosarioJansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR Onceyearly zoledronic acid for treatment of postmenopausal osteoporosis NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 356: (18) pp. 18091822. ( 2007) CA: HORIZON Pivotal Fracture Trial Z9: 700 W C: Medicine, General & Internal Folyóiratcikk /Szakcikk /Tudományos [12346358]
32
* Stakkestad JA, Lorenc R, Czerwinski E, Sedarati F, Neate C, Reginster JY Oral ibandronate (150 mg) continues to be effective and well tolerated when administered monthly: the mobile study loneterm extension OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 18: (Washington, DC) pp. S135S136. ( 2007) SU: 1 W C: Endocrinology & Metabolism Folyóiratcikk /Absztrakt /Tudományos [12346357]
33
Rizzoli R Osteoporosis: nonhormonal treatment CLIMACTERIC (ISSN: 13697137) 10: (Budapest, HUNGARY) pp. 7478. ( 2007) Z9: 1 SU: 2 W C: Obstetrics & Gynecology Folyóiratcikk /Szakcikk /Tudományos [12346356]
34
Papaioannou A, Kennedy CC, Dolovich L, Lau E, Adachi JD P atient adherence to osteoporosis medications P roblems, consequences and management strategies DRUGS & AGING (ISSN: 1170229X) 24: (1) pp. 3755. ( 2007) Z9: 48 W C: Geriatrics & Gerontology; Pharmacology & Pharmacy Folyóiratcikk /Összefoglaló cikk /Tudományos [12346355]
35
Camacho PM, ArmamentoVillareal R, Kleerekoper M P ostmenopausal osteoporosis: An update on current and future therapeutic options Expert Review of Endocrinology and Metabolism 2: (1) pp. 7990. ( 2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475140]
36
McAdamMarx C, LaFleur J, Kirkness C, Asche C P ostmenopausal osteoporosis: Current and future treatment options P and T 32: (7) pp. 392402. ( 2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475139]
37
Zaidi M, Epstein S, Harris ST, Kohles JD, Chesnut CH P rogression of efficacy with ibandronate A paradigm for the development of new bisphosphonates In: Zaidi M (szerk.) : SKELETAL BIOLOGY AND MEDICINE, PT B: DISEASE MECHANISMS AND THERAPEUTIC CHALLENGES. Oxon: Blackwell, 2007. (ISBN 9781573317283) pp. 273282. (ANNALS OF THE NEW YORK ACADEMY OF SCIENCES)
BE: Zaidi, M Z9: 5 W C: Multidisciplinary Sciences Könyvrészlet /Szaktanulmány /Tudományos [12346354]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
202/342
3/30/2015
nyomtatobarat forma 38
Brown JE, Ellis SP, Lester JE, Gutcher S, Khanna T, Purohit OP, McCloskey E, Coleman RE P rolonged efficacy of a single dose of the bisphosphonate zoledronic acid CLINICAL CANCER RESEARCH (ISSN: 10780432) 13: (18) pp. 54065410. ( 2007) Z9: 20 PN: Part 1 W C: Oncology Folyóiratcikk /Szakcikk /Tudományos [12346353]
39
Tavares V, Canhao H, Gomes JAM, Simoes E, Romeu JC, Coelho P, Santos RA, Malcata A, Araujo D, Vaz C Recommendations for the diagnosis and management of osteoporosis ACTA REUMATOLOGICA PORTUGUESA (ISSN: 0303464X) 32: (1) pp. 51+. ( 2007) W C: Rheumatology Folyóiratcikk /Szakcikk /Tudományos [12346352]
40
41
42
* Strampel W , Emkey R, Civitelli R Safety considerations with bisphosphonates for the treatment of osteoporosis DRUG SAFETY (ISSN: 01145916) 30: (9) pp. 755763. ( 2007) Z9: 47 W C: Public, Environmental & Occupational Health; Pharmacology & Pharmacy; : Toxicology Folyóiratcikk /Összefoglaló cikk /Tudományos [12346351] Rowe CA, Nantz MP, Bukowski JF, Percival SS Specific formulation of Camellia sinensis prevents cold and flu symptoms and enhances gamma delta T cell function: A randomized, doubleblind, placebocontrolled study JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (ISSN: 07315724) 26: (5) pp. 445452. ( 2007) Z9: 15 W C: Nutrition & Dietetics Folyóiratcikk /Szakcikk /Tudományos [12346350] * Stepan J, Riis BJ, Sedarati F, Neate C, Felsenberg D The efficacy of monthly oral ibandronate (150mg) 15 maintained: Mobile study longterm extension ANNALS OF THE RHEUMATIC DISEASES (ISSN: 00034967) 66: (Barcelona, SP AIN) pp. 533533. ( 2007) SU: 2 W C: Rheumatology Folyóiratcikk /Absztrakt /Tudományos [12346349]
43
Jastrzěbski Z, Napiórkowska L, Pykalo R The histopathological evaluation of the local tolerance of alendronate containing medicines Endokrynologia Polska (ISSN: 0423104X) 58: (1) pp. 1117. ( 2007) Folyóiratcikk [13475138]
44
Lewiecki EM, Sedarati F, Neate C, Lorenc R The MOBILE study longterm extension: Continuing improvements in efficacy with monthly oral ibandronate (150 mg) BONE (ISSN: 87563282) 40: (Montreal, CANADA) pp. S302S302. ( 2007) SU: 2 W C: Endocrinology & Metabolism Folyóiratcikk /Absztrakt /Tudományos [12346348]
45
* Reginster JY, Cooper C, Sedarati F, Nea C, Stakkestad JA The mobile study longterm extension: P rogressive improvements in efficacy with oral ibandronate (150mg) when administered monthly CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 80: pp. S144S144. ( 2007) SU: 1 W C: Endocrinology & Metabolism Folyóiratcikk /Absztrakt /Tudományos [12346347]
46
CannataAndia J Tolerability of less frequent dosing with ibandronate BONE (ISSN: 87563282) 41: (Valencia, SP AIN) pp. S34S35. ( 2007) SU: 1 W C: Endocrinology & Metabolism Folyóiratcikk /Absztrakt /Tudományos [12346346]
47
Shoback D Update in osteoporosis and metabolic bone disorders JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 92: (3) pp. 747753. ( 2007) Z9: 38 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12346345]
48
Kamel HK Update on osteoporosis management in longterm care: Focus on bisphosphonates JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (ISSN: 15258610) 8: (7) pp. 434440. ( 2007) Z9: 31 W C: Geriatrics & Gerontology Folyóiratcikk /Összefoglaló cikk /Tudományos [12346344]
49
Sunyecz JA, Derman R Update on the use of bisphosphonates in the management of postmenopausal osteoporosis by obstetriciansgynecologists OBSTETRICAL & GYNECOLOGICAL SURVEY (ISSN: 00297828) 62: (6) pp. 407416. ( 2007) Z9: 3 W C: Obstetrics & Gynecology Folyóiratcikk /Szakcikk /Tudományos [12346343]
50
Sosa Henríquez M, Gómez De Tejada Romero MJ Adherence level in the treatment of osteoporosis: Contribution of bisphosphonates Medicina Clinica Monografias 9: (6) pp. 1115. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [13475137]
51
Lewiecki EM, Babbitt AM, Piziak VK, Ozturk ZE, Bone HG Adherence to and gastrointestinal tolerability of monthly oral or quarterly intravenous ibandronate therapy in women with previous intolerance to oral bisphosphonates: A 12month, openlabel, prospective evaluation CLINICAL THERAPEUTICS (ISSN: 01492918) 30: (San Diego, CA) pp. 605621. ( 2008) Z9: 20 W C: Pharmacology & Pharmacy Folyóiratcikk /Szakcikk /Tudományos [12346342]
52
Camacho PM Advances in the evaluation and treatment of osteoporosis is there an optimal regimen? US Endocrinology 4: (1) pp. 104107. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [13475136]
53
Bjarnason NH, Hitz M, Jorgensen NR, Vestergaard P Adverse bone effects during pharmacological breast cancer therapy ACTA ONCOLOGICA (ISSN: 0284186X) 47: (4) pp. 747754. ( 2008) CA: Danish Bone Soc Z9: 9 W C: Oncology Folyóiratcikk /Összefoglaló cikk /Tudományos [12346341]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
203/342
3/30/2015
nyomtatobarat forma 54
55
56
Adverseeffect profiles of bisphosphonates are largely determined by their route of administration Drugs and Therapy Perspectives 24: (7) pp. 2326. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [13475135] * Szulc P, Delmas PD Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 19: (12) pp. 16831704. ( 2008) Z9: 41 W C: Endocrinology & Metabolism Folyóiratcikk /Összefoglaló cikk /Tudományos [12346340] Malouf Sierra J, Farrerons Minguella J Bisphosphonates in osteoporosis Medicina Clinica Monografias (ISSN: 15771512) 9: (7) pp. 2832. ( 2008) Folyóiratcikk [13475134]
57
* Bock O, Felsenberg D Bisphosphonates in the management of postmenopausal osteoporosis Optimizing efficacy in clinical practice Clinical Interventions in Aging (ISSN: 11769092) 3: (2) pp. 279297. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475133]
58
* Miller PD Bisphosphonates: P harmacology and Use in the Treatment of Osteoporosis In: Osteoporosis, TwoVolume Set. Elsevier Inc., 2008. (ISBN 9780123705440) pp. 17251742.
Könyvrészlet /Könyvfejezet /Tudományos [13475132] 59
Gass ML, Kagan R, Kohles JD, Martens MG Bone turnover marker profile in relation to the menstrual cycle of premenopausal healthy women MENOPAUSETHE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (ISSN: 10723714) 15: (4) pp. 667 675. ( 2008) Z9: 5 PN: Part 1 W C: Obstetrics & Gynecology Folyóiratcikk /Szakcikk /Tudományos [12346339]
60
* Neuprez A, Reginster JY Boneforming agents in the management of osteoporosis BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (ISSN: 1521690X) 22: (5) pp. 869883. ( 2008) Z9: 5 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12346338]
61
Papapoulos SE, Schimmer RC Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronate POSTGRADUATE MEDICAL JOURNAL (ISSN: 00325473) 84: (992) pp. 307312. ( 2008) W C: Medicine, General & Internal Folyóiratcikk /Összefoglaló cikk /Tudományos [12346337]
62
Guo C, Guo Q, Qi J, Liu Q, W u N Comparison of the effects of Ibandronate and Bonefos on nonsmall cell lung cancer with bone metastases Chinese Journal of Clinical Oncology (ISSN: 16727118) 35: (6) pp. 310312. ( 2008) Folyóiratcikk [13475131]
63
Maxwell AE, Maclayton D, Nguyen H Current and emerging treatment options for postmenopausal osteoporosis FORMULARY (ISSN: 1082801X) 43: (5) pp. 166+. ( 2008) W C: Pharmacology & Pharmacy Folyóiratcikk /Szakcikk /Tudományos [12346336]
64
* Reginster JY, Adami S, Lakatos P, Greenwald M, Stepan JJ, Silverman SL Efficacy and tolerability of oncemonthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study (vol 65, pg 654, 2006) ANNALS OF THE RHEUMATIC DISEASES (ISSN: 00034967) 67: (2) pp. 280280. ( 2008) Z9: 3 W C: Rheumatology Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [12346335]
65
* Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R European guidance for the diagnosis and management of osteoporosis in postmenopausal women OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 19: (4) pp. 399428. ( 2008) CA: European Soc Clinical Economic Z9: 283 W C: Endocrinology & Metabolism Folyóiratcikk /Összefoglaló cikk /Tudományos [12346334]
66
Adkins J, Kassianos G Ibandronate A convenient and effective treatment option for the management of postmenopausal osteoporosis Drugs in Context 4: (2) pp. 121134. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [13475130]
67
Frampton JE, Perry CM Ibandronate A Review of its Use in the Management of P ostmenopausal Osteoporosis DRUGS (ISSN: 00126667) 68: (18) pp. 26832707. ( 2008) Z9: 4 W C: Pharmacology & Pharmacy; Toxicology Folyóiratcikk /Összefoglaló cikk /Tudományos [12346333]
68
69
70
* Harris ST, Blumentals W A, Miller PD Ibandronate and the risk of nonvertebral and clinical fractures in women with postmenopausal osteoporosis: results of a meta analysis of phase III studies CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 24: (Boston, MA) pp. 237245. ( 2008) Z9: 43 W C: Medicine, General & Internal; Medicine, Research & Experimental Folyóiratcikk /Szakcikk /Tudományos [12346332] W inzenberg T, Jones G Ibandronate in benign bone disease Reviews on Recent Clinical Trials (ISSN: 15748871) 3: (2) pp. 139149. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475129] * Reginster JY, Neuprez A, Bruyère O Ibandronate in profile: Drug characteristics and clinical efficacy
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
204/342
3/30/2015
nyomtatobarat forma Expert Opinion on Drug Metabolism and Toxicology (ISSN: 17425255) 4: (7) pp. 941951. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475128] 71
* Péter L Ibandronate in the treatment of postmenopausal osteoporosis Lege Artis Medicinae (ISSN: 08664811) 18: (10) pp. 657661. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475127]
72
Kastelan D, Korsic M, Vlak T Ibandronate: is there an effect on nonvertebral fractures? CLINICAL RHEUMATOLOGY (ISSN: 07703198) 27: (10) pp. 13131315. ( 2008) Z9: 1 W C: Rheumatology Folyóiratcikk /Szakcikk /Tudományos [12346330]
73
Blouin J, Dragomir A, Moride Y, SteMarie LG, Fernandes JC, Perreault S Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ISSN: 03065251) 66: (1) pp. 117127. ( 2008) Z9: 25 W C: Pharmacology & Pharmacy Folyóiratcikk /Szakcikk /Tudományos [12346329]
74
75
76
77
* Adami S, Gatti D, Bertoldo F, Sartori L, Di Munno O, Filipponi P, Marcocci C, Frediani B, Palummeri E, Fiore CE, Costi D, Rossini M Intramuscular Neridronate in P ostmenopausal Women with Low Bone Mineral Density CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 83: (5) pp. 301307. ( 2008) Z9: 7 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12346328] Martens MG, Shaw H Maximizing effectiveness of bisphosphonate therapy for osteoporosis SOUTHERN MEDICAL JOURNAL (ISSN: 00384348) 101: (8) pp. 824830. ( 2008) Z9: 1 W C: Medicine, General & Internal Folyóiratcikk /Összefoglaló cikk /Tudományos [12346327] * Stakkestad JA, Lakatos P, Lorenc R, Sedarati F, Neate C, Reginster JY Monthly oral ibandronate is effective and well tolerated after 3 years: the MOBILE longterm extension CLINICAL RHEUMATOLOGY (ISSN: 07703198) 27: (8) pp. 955960. ( 2008) Z9: 16 W C: Rheumatology Folyóiratcikk /Szakcikk /Tudományos [12346326] Menkes CJ, Allanore Y Musculoskeletal disorders In: PREVENTION OF FUNCTIONAL DEPENDENCY. Wolters Kluwer, 2008. (ISBN 9782952874786) pp. 173185. (LES COLLOQUES DE L INSTITUT SERVIER)
Könyvrészlet /Szaktanulmány /Tudományos [12346325] 78
79
Kanakamani J, Tandon N Newer therapies in osteoporosis Indian Journal of Rheumatology (ISSN: 09733698) 3: (4) pp. 148157. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475126] * Malaise O, Neuprez A, Reginster JY Nonhormonal treatments of postmenopausal osteoporosis GYNECOLOGIE OBSTETRIQUE & FERTILITE (ISSN: 12979589) 36: (78) pp. 815822. ( 2008) W C: Obstetrics & Gynecology Folyóiratcikk /Szakcikk /Tudományos [12346324]
80
Hochberg MC Nonvertebral fracture risk reduction with nitrogencontaining bisphosphonates Current Osteoporosis Reports 6: (3) pp. 8994. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475125]
81
Sunyecz J Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 3: (4) pp. 611627. ( 2008) Z9: 4 Folyóiratcikk /Szakcikk /Tudományos [12346323]
82
Gehrig L, Lane J, O'Connor MI Osteoporosis: Management and treatment strategies for orthopaedic surgeons JOURNAL OF BONE AND JOINT SURGERYAMERICAN VOLUME (ISSN: 00219355) 90A: (6) pp. 13621374. ( 2008) Z9: 11 W C: Orthopedics; Surgery Folyóiratcikk /Szakcikk /Tudományos [12346322]
83
Pongchaiyakul Chatlert, Songpattanasilp Thawee, Taechakraichana Nimit Osteoporosis: Overview in disease, epidemiology, treatment and health economy Journal of the Medical Association of Thailand 91: (4) pp. 581594. ( 2008) Folyóiratcikk [12426315]
84
Bröll HJA, Dobnig H, Resch H, Erlacher L, FahrleitnerPammer A, Finkenstedt G, Holzer G, Pietschmann P, Pirich C, W icker A P arenteral ibandronate in the treatment of postmenopausal osteoporosis Journal fur Mineralstoffwechsel 15: (SUP P L. 2) pp. 28. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475124]
85
Lester JE, Dodwell D, Purohit OP, Gutcher SA, Ellis SP, Thorpe R, Horsman JM, Brown JE, Hannon RA, Coleman RE P revention of AnastrozoleInduced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer CLINICAL CANCER RESEARCH (ISSN: 10780432) 14: (19) pp. 63366342. ( 2008) Z9: 63 W C: Oncology Folyóiratcikk /Szakcikk /Tudományos [12346321]
86
* Emkey RD Quarterly intravenous ibandronate for postmenopausal osteoporosis Women's Health (ISSN: 17455057) 4: (3) pp. 219228. ( 2008)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
205/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Összefoglaló cikk /Tudományos [13475122] 87
88
Sebba AI, Broy S, Kohles JD, W eissman P Rapid suppression of bone resorption marker levels with ibandronate therapy in a bisphosphonatenaive population JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 11: (3) pp. 417423. ( 2008) Z9: 3 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12346320] * Adami S, Boisdron J, Silverman S Rapid suppression of serum CTX with oncemonthly oral ibandronate CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 82: pp. S211S211. ( 2008) SU: 1 W C: Endocrinology & Metabolism Folyóiratcikk /Absztrakt /Tudományos [12346319]
89
Boonen S, Vanderschueren D, Venken K, Milisen K, Delforge M, Haentjens P Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance JOURNAL OF INTERNAL MEDICINE (ISSN: 09546820) 264: (4) pp. 315332. ( 2008) Z9: 20 W C: Medicine, General & Internal Folyóiratcikk /Összefoglaló cikk /Tudományos [12346318]
90
Sebba A, Barr C, Harris S Relationship between annual cumulative exposure to ibandronate, bone mineral density and clinical fracture reduction CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 82: pp. S247S247. ( 2008) SU: 1 W C: Endocrinology & Metabolism Folyóiratcikk /Absztrakt /Tudományos [12346317]
91
* Reginster JY, Collette J, Neuprez A, Zegels B, Deroisy R, Bruyere O Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy BONE (ISSN: 87563282) 42: (5) pp. 832836. ( 2008) Z9: 21 W C: Endocrinology & Metabolism Folyóiratcikk /Ismertetés /Tudományos [12346316]
92
Sebba AI Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment CLINICAL THERAPEUTICS (ISSN: 01492918) 30: (3) pp. 443452. ( 2008) Z9: 7 W C: Pharmacology & Pharmacy Folyóiratcikk /Összefoglaló cikk /Tudományos [12346315]
93
Chapurlat RD Single annual injectable a treatment for postmenopausal osteoporosis EXPERT OPINION ON DRUG DELIVERY (ISSN: 17425247) 5: (5) pp. 583591. ( 2008) Z9: 1 W C: Pharmacology & Pharmacy Folyóiratcikk /Összefoglaló cikk /Tudományos [12346314]
94
Brandão CMR, Lima MG, Da Silva AL, Silva GD, Guerra Jr AA, De Assis Acúrcio F Treatment of postmenopausal osteoporosis in women: A systematic review Cadernos de Saude Publica (ISSN: 0102311X) 24: (SUP P L.4) pp. S592S606. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475120]
95
Camacho PM, Lopez NA Use of biochemical markers of bone turnover in the management of postmenopausal osteoporosis CLINICAL CHEMISTRY AND LABORATORY MEDICINE (ISSN: 14346621) 46: (10) pp. 13451357. ( 2008) Z9: 12 W C: Medical Laboratory Technology Folyóiratcikk /Összefoglaló cikk /Tudományos [12346313]
96
Cotte FE, Fautrel B, De Pouvourville G A Markov Model Simulation of the Impact of Treatment P ersistence in P ostmenopausal Osteoporosis MEDICAL DECISION MAKING (ISSN: 0272989X) 29: (1) pp. 125139. ( 2009) Z9: 7 W C: Health Care Sciences & Services; Medical Informatics Folyóiratcikk /Szakcikk /Tudományos [12346312]
97
* Neuprez A, Hiligsmann M, Bruyère O, Reginster JY Antifraacture efficaacy of intraavenous ibaandronaate: How to traanslaate epidemmiologicaal studies into Daily clinicaal praactice Revue Medicale de Liege 64: (10) pp. 525529. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475116]
98
Dimai HP, Pietschmann P, Resch H, Preisinger E, FahrleitnerPammer A, Dobnig H, Klaushofer K Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women Update 2009 Wiener Medizinische Wochenschrift (ISSN: 00435341) 159: (SUP P L. 122) pp. 134. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475115]
99
De Marinis F, Eberhardt W , Harper PG, Sureda BM, Nackaerts K, Soerensen JB, Syrigos K, Tredaniel J Bisphosphonate Use in P atients with Lung Cancer and Bone Metastases Recommendations of a European Expert P anel JOURNAL OF THORACIC ONCOLOGY (ISSN: 15560864) 4: (10) pp. 12801288. ( 2009) Z9: 6 W C: Oncology; Respiratory System Folyóiratcikk /Összefoglaló cikk /Tudományos [12346311]
100
Mak A, Cheung MW L, Ho RCM, Cheak AAC, Lau CS Bisphosphonates and atrial fibrillation: Bayesian metaanalyses of randomized controlled trials and observational studies BMC MUSCULOSKELETAL DISORDERS (ISSN: 14712474) 10: P aper 113. (2009) Z9: 14 W C: Orthopedics; Rheumatology Folyóiratcikk /Szakcikk /Tudományos [12346310]
101
Civitelli R, ArmamentoVillareal R, Napoli N Bone turnover markers: understanding their value in clinical trials and clinical practice OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (6) pp. 843851. ( 2009) Z9: 24 W C: Endocrinology & Metabolism Folyóiratcikk /Összefoglaló cikk /Tudományos [12346309]
102
Lorenc RS, Misiorowski W , Karczmarewicz E Critical points in strategies for the diagnosis and treatment of osteoporosis ENDOKRYNOLOGIA POLSKA (ISSN: 0423104X) 60: (2) pp. 124133. ( 2009) Z9: 2 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12346308]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
206/342
3/30/2015
nyomtatobarat forma 103
Lewiecki EM Current and Emerging P harmacologic Therapies for the Management of P ostmenopausal Osteoporosis JOURNAL OF WOMENS HEALTH (ISSN: 15409996) 18: (10) pp. 16151626. ( 2009) Z9: 16 W C: Public, Environmental & Occupational Health; Medicine, General & : Internal; Obstetrics & Gynecology; W omen's Studies Folyóiratcikk /Összefoglaló cikk /Tudományos [12346307]
104
Sebba A CURRENT CONTROVERSIES IN OSTEOP OROSIS MANAGEMENT OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (Athens, GREECE) pp. 183183. ( 2009) SU: 1 W C: Endocrinology & Metabolism Folyóiratcikk /Absztrakt /Tudományos [12346306]
105
Lenchik L Dual XRay Absorptiometry In: Imaging of Arthritis and Metabolic Bone Disease. Elsevier Inc., 2009. (ISBN 9780323041775) pp. 8188.
Könyvrészlet /Könyvfejezet /Tudományos [13475114] 106 * Delmas PD, Munoz F, Black DM, Cosman F, Boonen S, W atts NB, Kendler D, Eriksen EF, Mesenbrink PG, Eastell R Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of P INP With Fracture Reduction in P ostmenopausal Women With Osteoporosis JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 24: (9) pp. 15441551. ( 2009) CA: HORIZONPFT Res Grp Z9: 20 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12346305] 107 * McClung MR, Bolognese MA, Sedarati F, Recker RR, Miller PD Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone loss BONE (ISSN: 87563282) 44: (3) pp. 418422. ( 2009) Z9: 7 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12346304] 108
Bilezikian JP Efficacy of Bisphosphonates in Reducing Fracture Risk in P ostmenopausal Osteoporosis AMERICAN JOURNAL OF MEDICINE (ISSN: 00029343) 122: (2) pp. 1421. ( 2009) Z9: 35 W C: Medicine, General & Internal Folyóiratcikk /Szakcikk /Tudományos [12346303]
109 * Felsenberg D, Czerwinski E, Stakkestad J, Neate C, Masanauskaite D, Reginster JY EFFICACY OF MONTHLY ORAL IBANDRONATE IS MAINTAINED OVER 5 YEARS: THE MOBILE LTE STUDY OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (Athens, GREECE) pp. 1515. ( 2009) Z9: 1 SU: 1 W C: Endocrinology & Metabolism Folyóiratcikk /Absztrakt /Tudományos [12346302] 110
Epstein S, McCloskey E EFFICACY OF ONCEMONTHLY ORAL BISP HOSP HONATES (IBANDRONATE AND RISEDRONATE) IN WOMEN WITH P OSTMENOP AUSAL OSTEOP OROSIS OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (Athens, GREECE) pp. 146146. ( 2009) SU: 1 W C: Endocrinology & Metabolism Folyóiratcikk /Absztrakt /Tudományos [12346301]
111
Pazianas M, Epstein S, Zaidi M Evaluating the antifracture efficacy of bisphosphonates Reviews on Recent Clinical Trials (ISSN: 15748871) 4: (2) pp. 122130. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475113]
112 * Bergmann P, Body JJ, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, Kaufman JM, Reginster JY, Gangji V Evidencebased guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ISSN: 13685031) 63: (1) pp. 1926. ( 2009) CA: Advisory Board Bone Markers Z9: 30 W C: Medicine, General & Internal; Pharmacology & Pharmacy Folyóiratcikk /Szakcikk /Tudományos [12346300] 113
Derman R, Kohles JD, Babbitt A Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment CLINICAL INTERVENTIONS IN AGING (ISSN: 11769092) 4: pp. 357365. ( 2009) Z9: 2 Folyóiratcikk /Szakcikk /Tudományos [12346299]
114
Miller E HighDose Versus LowDose Ibandronate Decreases Risk of Clinical Fractures POSTGRADUATE MEDICINE (ISSN: 00325481) 121: (4) pp. 4547. ( 2009) W C: Medicine, General & Internal Folyóiratcikk /Ismertetés /Tudományos [12346298]
115 * Sebba AI, Emkey RD, Kohles JD, Sambrook PN Ibandronate dose response is associated with increases in bone mineral density and reductions in clinical fractures: Results of a metaanalysis BONE (ISSN: 87563282) 44: (3) pp. 423427. ( 2009) Z9: 14 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12346297] 116 * Cranney A, W ells GA, Yetisir E, Adami S, Cooper C, Delmas PD, Miller PD, Papapoulos S, Reginster JY, Sambrook PN, Silverman S, Siris E, Adachi JD Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (2) pp. 291297. ( 2009) Z9: 28 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12346296] 117
Amling M, Kurth A Ibandronate: A review of its vertebral and nonvertebral antifracture efficacy Women's Health (ISSN: 17455057) 5: (5) pp. 467473. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475112]
118 * Binkley N, Silverman SL, Simonelli C, Santiago N, Kohles JD, Dasic G, Sunyecz JA Monthly ibandronate suppresses serum CTXI within 3 days and maintains a monthly fluctuating pattern of suppression OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 20: (9) pp. 15951601. ( 2009)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
207/342
3/30/2015
nyomtatobarat forma Z9: 3 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12346295] 119
Clarke BL New and emerging treatments for osteoporosis CLINICAL ENDOCRINOLOGY (ISSN: 03000664) 71: (3) pp. 309321. ( 2009) Z9: 2 W C: Endocrinology & Metabolism Folyóiratcikk /Összefoglaló cikk /Tudományos [12346294]
120 * Rossini M, Viapiana O, Gatti D, Adami S OnceMonthly Oral Ibandronate in P ostmenopausal Osteoporosis: Translation and Updated Review CLINICAL THERAPEUTICS (ISSN: 01492918) 31: (7) pp. 14971510. ( 2009) Z9: 6 W C: Pharmacology & Pharmacy Folyóiratcikk /Szakcikk /Tudományos [12346293] 121 * Rabenda V, Hiligsmann M, Reginster JY P oor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 10: (14) pp. 23032315. ( 2009) Z9: 20 W C: Pharmacology & Pharmacy Folyóiratcikk /Összefoglaló cikk /Tudományos [12346292] 122
Cole RE, Harris ST P reventing nonvertebral osteoporotic fractures with extendedinterval bisphosphonates: Regimen selection and clinical application MedGenMed Medscape General Medicine 11: (1) P aper 12. (2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475111]
123
Duque G, Demontiero O, Troen BR P revention and treatment of senile osteoporosis and hip fractures MINERVA MEDICA (ISSN: 00264806) 100: (1) pp. 7994. ( 2009) Z9: 6 W C: Medicine, General & Internal Folyóiratcikk /Összefoglaló cikk /Tudományos [12346291]
124 * Harris ST, Reginster JY, Harley C, Blumentals W A, Poston SA, Barr CE, Silverman SL Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: The eValuation of IBandronate Efficacy (VIBE) database fracture study BONE (ISSN: 87563282) 44: (5) pp. 758765. ( 2009) Z9: 22 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12346290] 125 * Blumentals W A, Harris ST, Cole RE, Huang LP, Silverman SL Risk of Severe Gastrointestinal Events in Women Treated with Monthly Ibandronate or Weekly Alendronate and Risedronate ANNALS OF PHARMACOTHERAPY (ISSN: 10600280) 43: (4) pp. 577585. ( 2009) Z9: 6 W C: Pharmacology & Pharmacy Folyóiratcikk /Szakcikk /Tudományos [12346289] 126
Cosman F TREATMENT OF OSTEOP OROSIS AND P REVENTION OF NEW FRACTURES: ROLE OF INTRAVENOUSLY ADMINISTERED BISP HOSP HONATES ENDOCRINE PRACTICE (ISSN: 1530891X) 15: (5) pp. 483493. ( 2009) Z9: 8 W C: Endocrinology & Metabolism Folyóiratcikk /Összefoglaló cikk /Tudományos [12346288]
127
OrtizLuna G, GarciaHernandez P, TamayoOrozco JA Treatment options for osteoporosis and decision making criteria: 2009 SALUD PUBLICA DE MEXICO (ISSN: 00363634) 51: pp. S114S125. ( 2009) Z9: 1 W C: Public, Environmental & Occupational Health Folyóiratcikk /Szakcikk /Tudományos [12346287]
128
Epstein S, Jeglitsch M, McCloskey E Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 25: (12) pp. 29512960. ( 2009) Z9: 2 W C: Medicine, General & Internal; Medicine, Research & Experimental Folyóiratcikk /Összefoglaló cikk /Tudományos [12346286]
129
Cruz M Why do we close our eyes while the world is falling? A study on proximal femur osteoporotic fractures in a P ortuguese population ACTA REUMATOLOGICA PORTUGUESA (ISSN: 0303464X) 34: (2B) pp. 370377. ( 2009) Z9: 4 W C: Rheumatology Folyóiratcikk /Szakcikk /Tudományos [12346285]
130
Arantes HP, da Silva AG, LazarettiCastro M Bisphosphonates in the treatment of metabolic bone diseases ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (ISSN: 00042730) 54: (2) pp. 206212. ( 2010) Z9: 3 W C: Endocrinology & Metabolism Folyóiratcikk /Összefoglaló cikk /Tudományos [12346284]
131
Post TM, Cremers SCLM, Kerbusch T, Danhof M Bone P hysiology, Disease and Treatment Towards Disease System Analysis in Osteoporosis CLINICAL PHARMACOKINETICS (ISSN: 03125963) 49: (2) pp. 89118. ( 2010) Z9: 7 W C: Pharmacology & Pharmacy Folyóiratcikk /Összefoglaló cikk /Tudományos [12346283]
132
Vyskočil V Current options for the treatment of osteoporosis Vnitrni Lekarstvi (ISSN: 0042773X) 56: (7) pp. 749758. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475110]
133
Ringe JD Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis PATIENT PREFERENCE AND ADHERENCE (ISSN: 1177889X) 4: pp. 231245. ( 2010) Z9: 1 Folyóiratcikk /Összefoglaló cikk /Tudományos [12346282]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
208/342
3/30/2015
nyomtatobarat forma 134 * Recker RR, SteMarie LG, Langdahl B, Czerwinski E, Bonvoisin B, Masanauskaite D, Rowell L, Felsenberg D Effects of intermittent intravenous ibandronate injections on bone quality and microarchitecture in women with postmenopausal osteoporosis: The DIVA study BONE (ISSN: 87563282) 46: (3) pp. 660665. ( 2010) Z9: 5 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12346281] 135
Orwoll ES, Binkley NC, Lewiecki EM, Gruntmanis U, Fries MA, Dasic G Efficacy and safety of monthly ibandronate in men with low bone density BONE (ISSN: 87563282) 46: (4) pp. 970976. ( 2010) Z9: 6 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12346280]
136
VujasinovicStupar N, Milic N, PetrovicRackov L, Prodanovic N, MijailovicIvkovic M, Grujic Z, Bukovic S, Novkovic S, PasalicSimic K, Petrovic V, Vukasinovic D, Perunicic G Efficacy and Safety of Once Monthly Ibandronate Treatment in P atients with Reduced Bone Mineral Density ESTHER Study SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO (ISSN: 03708179) 138: (12) pp. 5661. ( 2010) CA: ESTHER Study Grp Z9: 1 W C: Medicine, General & Internal Folyóiratcikk /Szakcikk /Tudományos [12346279]
137
Di Munno O, Delle Sedie A Efficacy of ibandronate: A long term confirmation Clinical Cases in Mineral and Bone Metabolism 7: (1) pp. 2326. ( 2010) Folyóiratcikk /Rövid közlemény /Tudományos [13475109]
138 * Body JJ, Bergmann P, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, Kaufman JM, Rozenberg S, Reginster JY Evidencebased guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 21: (10) pp. 16571680. ( 2010) Z9: 16 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12346278] 139 * Lewiecki EM, Cooper C, Thompson E, Hartl F, Mehta D, Papapoulos SE Ibandronate does not increase risk of atrial fibrillation in analysis of pivotal clinical trials INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ISSN: 13685031) 64: (6) pp. 821826. ( 2010) Z9: 8 W C: Medicine, General & Internal; Pharmacology & Pharmacy Folyóiratcikk /Szakcikk /Tudományos [12346277] 140
Li EK, Zhu TY, Hung VY, Kwok AW , Lee VW , Lee KK, Griffith JF, Li M, W ong KC, Leung PC, Qin L, Tam LS Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on longterm glucocorticoid ARTHRITIS RESEARCH & THERAPY (ISSN: 14786354) 12: (5) P aper R198. (2010) Z9: 3 W C: Rheumatology Folyóiratcikk /Szakcikk /Tudományos [12346276]
141
GarcíaHernández P, CarranzaLira S, MottaMartínez E Monthly ibandronate attachment to Mexican and Chilean women with osteoporosis, with or without a biofeedback strategy Ginecologia y Obstetricia de Mexico 78: (6) pp. 322328. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [13475108]
142
Hochberg MC Osteoporosis In: Targeted Treatment of the Rheumatic Diseases. Elsevier Inc., 2010. (ISBN 9781416099932) pp. 317329.
Könyvrészlet /Könyvfejezet /Tudományos [13475107] 143
Faßbender W J, Stracke HG Osteoporosis Diagnosis, therapy and prevention Medizinische Welt (ISSN: 00258512) 61: (1) pp. 4449. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [13475106]
144
F Moseley K, Jan de Beur SM Osteoporosis in Men and Women In: Principles of GenderSpecific Medicine. Elsevier Inc., 2010. (ISBN 9780123742711) pp. 716736.
Könyvrészlet /Könyvfejezet /Tudományos [13475105] 145
Engelke K, Fuerst T, Dasic G, Davies RY, Genant HK Regional distribution of spine and hip QCT BMD responses after one year of oncemonthly ibandronate in postmenopausal osteoporosis BONE (ISSN: 87563282) 46: (6) pp. 16261632. ( 2010) Z9: 1 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12346275]
146
Yemisci OU, Yalbuzdag SA, Karatas M RisedronateInduced Arthritis JCRJOURNAL OF CLINICAL RHEUMATOLOGY (ISSN: 10761608) 16: (4) pp. 168169. ( 2010) Z9: 1 W C: Rheumatology Folyóiratcikk /Szakcikk /Tudományos [12346274]
147
Sambrook P, Cranney A, Adachi JD Risk reduction of nonvertebral fractures with intravenous ibandronate: posthoc analysis from DIVA CURRENT MEDICAL RESEARCH AND OPINION (ISSN: 03007995) 26: (3) pp. 599604. ( 2010) Z9: 2 W C: Medicine, General & Internal; Medicine, Research & Experimental Folyóiratcikk /Szakcikk /Tudományos [12346273]
148
Carbonare LD, Zanatta M, Gasparetto A, Valenti MT Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management Drug, Healthcare and Patient Safety 2: (1) pp. 121137. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475104]
149 * Hochberg MC, Silverman SL, Barr CE, Miller PD The Utility of Changes in Serum Levels of CTerminal Telopeptide of Type I Collagen in P redicting P atient Response to Oral Monthly Ibandronate Therapy JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 13: (2) pp. 181189. ( 2010) Z9: 2 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12346272] 150
Pérez Edo L, Alonso Ruiz A, Roig Vilaseca D, García Vadillo A, Guañabens Gay N, Peris P, Torrijos Eslava A, Beltrán Audera C, Fiter Aresté J, Arboleya Rodríguez L, Graña Gil J, Carbonell Abelló J, Nolla JM, Holgado Pérez S, Salas Heredia
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
209/342
3/30/2015
nyomtatobarat forma E, Zubieta Tabernero J, Del Pino Montes J, Blanch i Rubió J, Caamaño Freire M, Rodríguez Pérez M, Castañeda S, Cerdá D, Gómez Vaquero C, Calvo Catalá J, Ciria M, Loza E 2011 Update of the consensus statement of the Spanish Society of Rheumatology on osteoporosis Reumatologia Clinica (ISSN: 1699258X) 7: (6) pp. 357379. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13475103] 151
Ross S, Samuels E, Gairy K, Iqbal S, Badamgarav E, Siris E A MetaAnalysis of Osteoporotic Fracture Risk with Medication Nonadherence VALUE IN HEALTH (ISSN: 10983015) 14: (4) pp. 571581. ( 2011) Z9: 3 W C: Economics; Health Care Sciences & Services; Health Policy & Services Folyóiratcikk /Szakcikk /Tudományos [12346271]
152 * Rizzoli R, Reginster JY, Boonen S, Breart G, DiezPerez A, Felsenberg D, Kaufman JM, Kanis JA, Cooper C Adverse Reactions and DrugDrug Interactions in the Management of Women with P ostmenopausal Osteoporosis CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 89: (2) pp. 91104. ( 2011) Z9: 4 W C: Endocrinology & Metabolism Folyóiratcikk /Összefoglaló cikk /Tudományos [12346270] 153
Rizzoli R Bisphosphonates for postmenopausal osteoporosis: are they all the same? QJMAN INTERNATIONAL JOURNAL OF MEDICINE (ISSN: 14602725) 104: (4) pp. 281300. ( 2011) Z9: 4 W C: Medicine, General & Internal Folyóiratcikk /Összefoglaló cikk /Tudományos [12346269]
154
Khanna S, Pillai KK, Vohora D Bisphosphonates in phenytoininduced bone disorder BONE (ISSN: 87563282) 48: (3) pp. 597606. ( 2011) Z9: 1 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12346268]
155
Cole RE Clinical Strategies to Address P atients' Concerns in Osteoporosis Management with Bisphosphonates POSTGRADUATE MEDICINE (ISSN: 00325481) 123: (2) pp. 131144. ( 2011) W C: Medicine, General & Internal Folyóiratcikk /Szakcikk /Tudományos [12346267]
156
Muratore M, Quarta E, Grimaldi A, Calcagnile F, Quarta L Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates DRUG DESIGN DEVELOPMENT AND THERAPY (ISSN: 11778881) 5: pp. 445454. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [12346266]
157
Boonen S Current developments and treatments in osteoporosis EJHP PRACTICE (ISSN: 17819989) 17: (4) pp. 1618. ( 2011) W C: Pharmacology & Pharmacy Folyóiratcikk /Szakcikk /Tudományos [12346265]
158 * Lecart MP, Reginster JY Current options for the management of postmenopausal osteoporosis EXPERT OPINION ON PHARMACOTHERAPY (ISSN: 14656566) 12: (16) pp. 25332552. ( 2011) W C: Pharmacology & Pharmacy Folyóiratcikk /Összefoglaló cikk /Tudományos [12346264] 159
De La Piedra C, Quiroga I, Montero M, Dapia S, Caeiro JR, Rubert M, DiazCuriel M, Bauss F Daily or monthly ibandronate prevents or restores deteriorations of bone mass, architecture, biomechanical properties and markers of bone turnover in androgendeficient aged rats AGING MALE (ISSN: 13685538) 14: (4) pp. 220230. ( 2011) W C: Endocrinology & Metabolism; Urology & Nephrology Folyóiratcikk /Szakcikk /Tudományos [12346263]
160
Bittner B, McIntyre C, Jordan P, Schmidt J Drugdrug interaction study between a novel oral ibandronate formulation and metformin ARZNEIMITTELFORSCHUNGDRUG RESEARCH 61: (12) pp. 707713. ( 2011) W C: Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & : Pharmacy Folyóiratcikk /Szakcikk /Tudományos [12346262]
161
Mackey DC, Black DM, Bauer DC, McCloskey EV, Eastell R, Mesenbrink P, Thompson JR, Cummings SR Effects of Antiresorptive Treatment on Nonvertebral Fracture Outcomes JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 26: (10) pp. 24112418. ( 2011) W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12346261]
162
Frediani B Effects of Two Administration Schemes of Intramuscular Clodronic Acid on Bone Mineral Density A Randomized, OpenLabel, P arallelGroup Study CLINICAL DRUG INVESTIGATION (ISSN: 11732563) 31: (1) pp. 4350. ( 2011) Z9: 1 W C: Pharmacology & Pharmacy Folyóiratcikk /Szakcikk /Tudományos [12346260]
163
Lee Young Ho, Song Gwan Gyu Efficacy and Safety of Monthly 150 mg Oral Ibandronate in Women with P ostmenopausal Osteoporosis: A Systematic Review and MetaAnalysis of Randomized Controlled Trials Korean Journal of Internal Medicine 26: (3) pp. 340347. ( 2011) Folyóiratcikk [12426314]
164 * Rossini M, Idolazzi L, Adami S Evidence of sustained vertebral and nonvertebral antifracture efficacy with ibandronate therapy: A systematic review Therapeutic Advances in Musculoskeletal Disease 3: (2) pp. 6779. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475102] 165
Langdahl BL, Harsløf T Medical treatment of osteoporotic vertebral fractures Therapeutic Advances in Musculoskeletal Disease 3: (1) pp. 1729. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13475101]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
210/342
3/30/2015
nyomtatobarat forma 166 * Rossini M, Di Munno O, Gatti D, Giannini S, Minisola S, Varenna M, Adami S Optimising bisphosphonate treatment outcomes in postmenopausal osteoporosis: review and Italian experience CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (ISSN: 0392856X) 29: (4) pp. 728735. ( 2011) W C: Rheumatology Folyóiratcikk /Összefoglaló cikk /Tudományos [12346259] 167
Jay RH, Marrinan SL Osteoporosis treatment and the older patient Reviews in Clinical Gerontology 21: (3) pp. 233245. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475100]
168
Dedov I I, Melnichenko G A, Belaya Zh E, Rozhinskaya L Ya Osteoporosis: from a rare symptom of endocrine diseases to the tacit epidemic of XXXXI centuries Problemy Endokrinologii (ISSN: 03759660) 57: (1) pp. 3545. ( 2011) Folyóiratcikk [12426313]
169
Vyskočil V Overview of current treatment options in antiresorptive Klinicka Farmakologie a Farmacie 25: (2) pp. 6470. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13475099]
170
Cipriani C, Romagnoli E, Minisola S P harmacological treatment of Osteoporosis Old and new drugs European Musculoskeletal Review 6: (2) pp. 8387. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13475098]
171
Pazianas M, Abrahamsen B Safety of bisphosphonates BONE (ISSN: 87563282) 49: (1) pp. 103110. ( 2011) Z9: 2 W C: Endocrinology & Metabolism Folyóiratcikk /Összefoglaló cikk /Tudományos [12346258]
172
McIntyre C, Schmidt J, Castelli MC, Bittner B Study on the impact of SNAC (sodium N[8(2hydroxybenzoyl) amino] caprylate) on the bioavailability of ibandronate (IBN) in postmenopausal women JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (ISSN: 17732247) 21: (6) pp. 521525. ( 2011) W C: Pharmacology & Pharmacy Folyóiratcikk /Szakcikk /Tudományos [12346257]
173
Hwang JS, Chin LS, Chen JF, Yang TS, Chen PQ, Tsai KS, Leung PC The effects of intravenous zoledronic acid in Chinese women with postmenopausal osteoporosis JOURNAL OF BONE AND MINERAL METABOLISM (ISSN: 09148779) 29: (3) pp. 328333. ( 2011) Z9: 4 W C: Endocrinology & Metabolism; Medicine, Research & Experimental Folyóiratcikk /Szakcikk /Tudományos [12346256]
174
Jansen JP, Bergman GJD, Huels J, Olson M The Efficacy of Bisphosphonates in the P revention of Vertebral, Hip, and NonvertebralNonhip Fractures in Osteoporosis: A Network MetaAnalysis SEMINARS IN ARTHRITIS AND RHEUMATISM (ISSN: 00490172) 40: (4) pp. 275284. ( 2011) Z9: 4 W C: Rheumatology Folyóiratcikk /Összefoglaló cikk /Tudományos [12346255]
175
Sewerynek E, Stuss M The role of i.v. ibandronate administration in osteoporosis therapy ENDOKRYNOLOGIA POLSKA (ISSN: 0423104X) 62: (1) pp. 5160. ( 2011) W C: Endocrinology & Metabolism Folyóiratcikk /Összefoglaló cikk /Tudományos [12346254]
176
Kamienski M, Tate D, Vega CPTM The Silent Thief Diagnosis and Management of Osteoporosis ORTHOPAEDIC NURSING 30: (3) pp. 162171. ( 2011) W C: Nursing; Orthopedics Folyóiratcikk /Szakcikk /Tudományos [12346253]
177
Raef H, AlBugami M, Balharith S, Moawad M, ElShaker M, Hussain A, AlShaikh A, AlBadawi I Updated Recommendations for the Diagnosis and Management of Osteoporosis: A Local P erspective ANNALS OF SAUDI MEDICINE (ISSN: 02564947) 31: (2) pp. 111+. ( 2011) W C: Medicine, General & Internal Folyóiratcikk /Szakcikk /Tudományos [12346252]
178
Papapoulos SE Use of bisphosphonates in the management of postmenopausal osteoporosis In: Bilezikian JP Grbic JT (szerk.) : BISPHOSPHONATES AND OSTEONECROSIS OF THE JAW. Malden: Wiley Blackwell, 2011. pp. 1532. (Annals of the New York Academy of Sciences)
Könyvrészlet /Szaktanulmány /Tudományos [12346251] 179
Bieglmayer C, Dimai HP, Gasser RW , Kudlacek S, ObermayerPietsch B, W oloszczuk W , Zwettler E, Griesmacher A Biomarkers of bone turnover in diagnosis and therapy of osteoporosis: A consensus advice from an Austrian working group Wiener Medizinische Wochenschrift (ISSN: 00435341) 162: (2122) pp. 464477. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13475097]
180
Hurley B, Armstrong TJ Bisphosphonates vs Exercise for the P revention and Treatment of Osteoporosis Journal for Nurse Practitioners 8: (3) pp. 217224. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13475096]
181
Okazaki R, Hagino H, Ito M, Sone T, Nakamura T, Mizunuma H, Fukunaga M, Shiraki M, Nishizawa Y, Ohashi Y, Matsumoto T Efficacy and safety of monthly oral minodronate in patients with involutional osteoporosis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (6) pp. 17371745. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12426312]
182 * Miller P D, Recker R R, Reginster J Y, Riis B J, Czerwinski E, Masanauskaite D, Kenwright A, Lorenc R, Stakkestad J A, Lakatos P Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE longterm extension study OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (6) pp. 17471756. ( 2012)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
211/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [12426311] 183
Kutilek S, Plasilová I, Nemec V Oncemonthly oral ibandronate treatment in an adolescent with recurrent fractures and inadequately low bone mass Journal of Paediatrics and Child Health (ISSN: 10344810) 48: (7) pp. 622623. ( 2012) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [13475095]
184
Eskiyurt N, Irdesel J, Sepici V, Uǧurlu H, Kirazli Y, Ardiç F, Bütün B, Akyüz G, Cerrahoǧlu L, Şendur ÖF, Yalçin P, Öncel S, Saridoǧan M, Sarpel T, Tosun M, Kutsal YG, Şenel K, Gürsoy S, Cantürk F, Demir H, Özdener F, Öncel H Open, prospective, multicenter, twopart study of patient preference with monthly ibandronate therapy in women with postmenopausal osteoporosis switched from daily or weekly alendronate or risendronateBONCURE: Results of Turkish sub study Turk Osteoporoz Dergisi 18: (1) pp. 17. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13475094]
185
Bittner B, McIntyre C, Tian H, Tang K, Shah N, Phuapradit W , Ahmed H, Chokshi H, Infeld M, Fotaki N, Ma H, Portron A, Jordan P, Schmidt J P hase I clinical study to select a novel oral formulation for ibandronate containing the excipient sodium N[8(2 hydroxybenzoyl) amino] caprylate (SNAC) PHARMAZIE (ISSN: 00317144) 67: (3) pp. 233241. ( 2012) W C: Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & : Pharmacy Folyóiratcikk /Szakcikk /Tudományos [12346250]
186
Lester JE, Dodwell D, BrownJE, Purohit OP, Gutcher SA, Ellis SP, Thorpe R, Horsman JM, Coleman RE P revention of anastrozole induced bone loss with monthly oral ibandronate: Final 5 year results from the ARIBON trial Journal of Bone Oncology 1: (2) pp. 5762. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13475093]
187
Grazyna B, Marek C, Andrzej K The relationship between selected biochemical parameters, clinical factors and bone mineral density in postmenopausal women with osteoporosis GINEKOLOGIA POLSKA (ISSN: 00170011) 83: (3) pp. 194201. ( 2012) W C: Obstetrics & Gynecology Folyóiratcikk /Szakcikk /Tudományos [12346249]
188
Szulc P The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis Clinical Biochemistry (ISSN: 00099120) 45: (12) pp. 907919. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475092]
189 * Åkesson K, Marsh D, Mitchell PJ, McLellan AR, Stenmark J, Pierroz DD, Kyer C, Cooper C Capture the Fracture: A Best P ractice Framework and global campaign to break the fragility fracture cycle Osteoporosis International (ISSN: 0937941X) 24: (8) pp. 21352152. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13475091] 190
Nakamura T, Nakano T, Ito M, Hagino H, Hashimoto J, Tobinai M, Mizunuma H Clinical efficacy on fracture risk and safety of 0.5 mg or 1 mg/month intravenous ibandronate versus 2.5 mg/day oral risedronate in patients with primary osteoporosis Calcified Tissue International (ISSN: 0171967X) 93: (2) pp. 137146. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13475090]
191
Skácelová M, Horák P, Žurek M Current treatment options for osteoporosis Interni Medicina pro Praxi (ISSN: 12127299) 15: (89) pp. 249253. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13475089]
192
Reddy MS, Morgan SL Decreased bone mineral density and periodontal management Periodontology 2000 (ISSN: 09066713) 61: (1) pp. 195218. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13475088]
193 * Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporosis International (ISSN: 0937941X) 24: (1) pp. 2357. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13475087] 194 * Hiligsmann M, Kanis JA, Compston J, Cooper C, Flamion B, Bergmann P, Body JJ, Boonen S, Bruyere O, Devogelaer JP, Goemaere S, Kaufman JM, Rozenberg S, Reginster JY Health technology assessment in osteoporosis Calcified Tissue International (ISSN: 0171967X) 93: (1) pp. 114. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475086] 195
McGowan B, Casey MC, Silke C, W helan B, Bennett K Hospitalisations for fracture and associated costs between 2000 and 2009 in Ireland: A trend analysis Osteoporosis International (ISSN: 0937941X) 24: (3) pp. 849857. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13475085]
196
Frediani B, Bertoldi I, Pierguidi S, Nicosia A, Picerno V, Filippou G, Cantarini L, Galeazzi M Improved efficacy of intramuscular weekly administration of clodronate 200 mg (100 mg twice weekly) compared with 100 mg (Once Weekly) for increasing bone mineral density in postmenopausal osteoporosis Clinical Drug Investigation (ISSN: 11732563) 33: (3) pp. 193198. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13475084]
197
Bala Y, Kohles J, Recker RR, Boivin G Oral ibandronate in postmenopausal osteoporotic women alters micromechanical properties independently of changes in mineralization Calcified Tissue International (ISSN: 0171967X) 92: (1) pp. 614. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13475083]
198 * Rossini M, Orsolini G, Adami S, Kunnathully V, Gatti D Osteoporosis treatment: Why ibandronic acid? Expert Opinion on Pharmacotherapy (ISSN: 14656566) 14: (10) pp. 13711381. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475082] 199 * Miller PD, Jamal SA, Evenepoel P, Eastell R, Boonen S
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
212/342
3/30/2015
nyomtatobarat forma Renal safety in patients treated with bisphosphonates for osteoporosis: A review Journal of Bone and Mineral Research (ISSN: 08840431) 28: (10) pp. 20492059. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475081] 200
Eriksen EF, DíezPérez A, Boonen S Update on longterm treatment with bisphosphonates for postmenopausal osteoporosis: A systematic review Bone (ISSN: 87563282) 58: pp. 126135. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [13475080]
222. Speer G , Szenthe P , Kosa JP , Tabak AG , Folhoffer A , Fuszek P , Cseh K , Lakatos P M yocardial infarction is associated with Spl binding site polymorphism of collagen type 1A1 gene ACTA CARDIOLOGICA 61:(3) pp. 321325. (2006) IF: 0.519 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1335553] [ Érvényesített ] Független idéző: 9 Összesen: 9 1
Posthumus M, September AV, Keegan M, O Cuinneagain D, Van der Merwe W , Schwellnus MP, Collins M Genetic risk factors for anterior cruciate ligament ruptures: COL1A1 gene variant BRITISH JOURNAL OF SPORTS MEDICINE (ISSN: 03063674) 43: (5) pp. 352356. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11584594]
2
Collins M, Raleigh S M Genetic risk factors for musculoskeletal soft tissue injuries Medicine and Sport Science 54: pp. 136149. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11599668]
3
Posthumus M, September AV, Schwellnus MP, Collins M Investigation of the Sp1binding site polymorphism within the COL1A1 gene in participants with Achilles tendon injuries and controls JOURNAL OF SCIENCE AND MEDICINE IN SPORT (ISSN: 14402440) 12: (1) pp. 184189. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11584593]
4
Tang W J, Pan QH, Sun FY, Ma J, Tang S, Le K, W an Y, Chen QY, Liu PQ Involvement of Sp1 binding sequences in basal transcription of the rat fibroblast growth factor2 gene in neonatal cardiomyocytes LIFE SCIENCES (ISSN: 00243205) 84: (1314) pp. 421427. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11584592]
5
Gaetz MB, Iverson GL Sex differences in selfreported symptoms after aerobic exercise in noninjured athletes: implications for concussion management programmes BRITISH JOURNAL OF SPORTS MEDICINE (ISSN: 03063674) 43: (7) pp. 508513. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11584591]
6
September AV, Posthumus M, Collins M Application of genomics in the prevention, treatment and management of Achilles tendinopathy and anterior cruciate ligament ruptures Recent Patents on DNA and Gene Sequences (ISSN: 18722156) 6: (3) pp. 216223. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12787178]
7
Tural Sengul, Kara Nurten, Alayli Gamze, Tomak Leman Association between osteoporosis and polymorphisms of the bone Gla protein, estrogen receptor 1, collagen 1A1 and calcitonin receptor genes in Turkish postmenopausal women GENE (ISSN: 03781119) 515: (1) pp. 167172. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13060504]
8
Maffulli N, Margiotti K, Longo UG, Loppini M, Fazio VM, Denaro V The genetics of sports injuries and athletic performance Muscles, Ligaments and Tendons Journal (ISSN: 22404554) 3: (3) pp. 173189. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13758053]
9
Erduran M, Altinisik J, Meric G, Ates O, Ulusal AE, Akseki D Is Sp1 binding site polymorphism within COL1A1 gene associated with tennis elbowα Gene (ISSN: 03781119) 537: (2) pp. 308311. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13758052]
223. Speer G , Kerényi Zs , Kempler P , Lakatos P , Tamás Gy A diabeteszes neuroarthropathia kezelése bisphosphonattal. Esettanulmány: első eredményeink DIABETOLOGIA HUNGARICA 14:(2) pp. 145147. (2006) A M agyar Diabetes Társaság XVIII. Kongresszusa. Tihany, M agyarország: 2006.04.21 2006.04.23. Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1843571] [ Admin láttamozott ] 224. Tabak A G , Tamas G , Speizer S , Speer G , Lakatos P , Kerenyi Z Association between plasma osteoprotegerin levels and metabolic parameters in type 1 diabetic patients DIABETES 55:(Suppl 1) p. A497. (2006) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1821046] [ Érvényesített ] 225. Tabák Á G , Tamás G , Speizer S , Speer G , Horváth C , Lakatos P , Kerényi Z A plazma oszteoprotegerin és egyéb metabolikus paraméterek kapcsolata 1es típusú cukorbetegekben https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
213/342
3/30/2015
nyomtatobarat forma
DIABETOLOGIA HUNGARICA 14:(Suppl. 2) p. 156. (2006) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1821047] [ Admin láttamozott ] 226. Takács István , Lakatos Péter A változókor utáni nők ösztrogénreceptorra ható kezelésének komplex hatása LEGE ARTIS MEDICINAE 16:(5) pp. 427432. (2006) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [1802439] [ Érvényesített ] 227. Tamás G , Speizer S , Tabák Á G , Horváth C , Lakatos P , Kerényi Z Csontanyagcserezavarok gyakorisága és összefüggése egyéb jellemzőkkel 1es típusú cukorbetegekben DIABETOLOGIA HUNGARICA 14:(Suppl. 2) pp. 159160. (2006) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1821048] [ Admin láttamozott ]
2005 228. Almási Cs , Ambrus Cs , Deak Gy , M arton A , Berta K , Lakatos P , Szabó A , Horváth Cs , M ucsi I A szérum25(OH)D3vitaminszint és a csontanyagcsere kapcsolatának vizsgálata hemodializált betegeken CA ÉS CSONT 8:(3) pp. 8590. (2005) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1092057] [ Érvényesített ] 229. Csupor Emőke , Tóth Edit , M észáros Szilvia , Ferencz Viktória , Szűcs János , Lakatos Péter , Horányi János , Perner Ferenc , Horváth Csaba Is there any connection between the presence of kidney stones in primary hyperparathyroidism and the location of an underlying adenoma? EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES 113:(5) pp. 257261. (2005) IF: 1.367 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1690099] [ Érvényesített ] Független idéző: 4 Függő idéző: 1 Összesen: 5 1. * Csupor Emőke A parathormon hatása a csontanyagcserére primaer hyperparathyreosisban és más mellékpajzsmirigybetetgségekben 38 p. 2005.
Disszertáció /P hD /Tudományos [12652977] 2
Cooperberg M R, Duh Q Y, Stackhouse G B, Stoller M L Oral calcium supplementation associated with decreased likelihood of nephrolithiasis prior to surgery for hyperparathyroidism International Journal of Urology (ISSN: 09198172) 14: (12) pp. 11131115. ( 2007) Chemicals/CAS: calcium, 7440702; Calcium, 7440702 Folyóiratcikk /Szakcikk /Tudományos [11719998]
3
Kiraç M, Küpeli B, Çamtosun A, Karaoǧlan Ü, Bozkirli I Importance of paratyroid adenoma that was detected in the patients with recurrent calcium oxalat stone disease: Tekrarlayan kalsiyum oksalat taş hastalarιnda saptanan paratiroid adenomunun önemi Turk Uroloji Dergisi 34: (2) pp. 215220. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [11719997]
4
Parks J H, Coe F L, Evan A P, W orcester E M Clinical and laboratory characteristics of calcium stoneformers with and without primary hyperparathyroidism BJU International 103: (5) pp. 670678. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11719996]
5
Diaz De La Guardia F V, Martin M A, Arrabal Polo M A, Flores S Q, Ortiz J L M, Gomez A Z Renal lithiasis in patients with primary hyperparathyroidism. Evolution and treatment: Litiasis renal en pacientes con hiperparatiroidismo primario. Evolución y tratamiento Archivos Espanoles de Urologia 63: (1) pp. 3240. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11719995]
230. Folhoffer A , Lakatos PL , Horvath C , Csak T , Osztovics J , Bajnok E , Speer G , Nagy Z , Habior A , Tornai I , Lakatos P , Szalay F Calciumsensing receptor (CASR) A986S polymorphism and bone disease in primary biliary cirrhosis and Wilson disease ZEITSCHRIFT FÜR GASTROENTEROLOGIE 43: p. 485. (2005) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391305] [ Admin láttamozott ] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
214/342
3/30/2015
nyomtatobarat forma
231. Horányi J , Duffek L , Kemenes M , Szlávik R , Darvas K , Dabasi G , Lakatos P , Tóth M Új, intraoperatív diagnosztikus módszerek a mellékpajzsmirigysebészetben: Gammaszondás adenomalokalizáció [New intraoperative diagnostic methods in parathyroid surgery. Adenoma localization by gamma probem] ORVOSI HETILAP 146:(27) pp. 14431445. (2005) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1374603] [ Érvényesített ] Függő idéző: 3 Összesen: 3 1 * Horányi J, Szlávik R, Duffek L, Darvas K, Györke T, Lakatos P, Tóth M A primer hyperparathyreosis sebészi kezelése [Surgery of primary hyperparathyroidism] Orvosi Hetilap (ISSN: 00306002) 147: (49) pp. 23472351. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [11056541] 2 * Igaz P, Tóth M, Rácz K, Tulassay Zs A primer hyperparathyreosis kezelésének új szemlélete – a gyógyszeres kezelés lehetőségei MAGYAR BELORVOSI ARCHIVUM (ISSN: 01335464) 61: (1) pp. 3641. ( 2008) Folyóiratcikk [12498716] 3 * Horanyi J, Duffek L, Szlávik R, Takács I, Tóth M, Romics Jr L Intraoperative determination of pth concentrations in fine needle tissue aspirates to identify parathyroid tissue during parathyroidectomy World Journal of Surgery (ISSN: 03642313) 34: (3) pp. 538543. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11056540]
232. Horváth Cs , Lakatos P , M arton I , Bors K , Poór Gy , Holló I Ajánlás az osteoporosis és más metabolikus csontbetegségek diagnosztikájára 2005ben HÁZIORVOS TOVÁBBKÉPZŐ SZEMLE 10:(5) pp. 437446. (2005) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1015874] [ Érvényesített ] 233. Lakatos P , Horváth Cs , Takács I , M arton I , Poór Gy , Holló I Ajánlás a korral járó osteoporosisok gyógyszeres kezelésére 2005ben HÁZIORVOS TOVÁBBKÉPZŐ SZEMLE 10:(5) pp. 447454. (2005) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1015875] [ Érvényesített ] 234. Lakatos P A csontritkulás megelőzése és korszerű kezelése POLI KLINIKA: JÁRÓBETEGSZAKORVOSI FOLYÓIRAT 1: pp. 1821. (2005) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1806947] [ Admin láttamozott ] 235. Lakatos P Az osteoporosis gyógyszeres kezelésének korszerű szemlélete HIPPOCRATES (BP) 7:(2) pp. 120124. (2005) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1807184] [ Érvényesített ] 236. Lakatos P A férfi osteoporosis és kezelése PRAXIS: A MINŐSÉGI GYÓGYÍTÁS ELMÉLETE ÉS GYAKORLATA 14:(1) pp. 2529. (2005) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1807192] [ Érvényesített ] 237. Lakatos P Rossz csontok: avagy mit tegyünk, hogy csontjaink egészségesek maradjanak Budapest: Semmelweis Kiadó, 2005. 229 p. (ISBN:9639214507) Nyelv: Magyar
Könyv /Szakkönyv /Tudományos [1908750] [ Érvényesített ] 238. Lakatos P (szerk.) https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
215/342
3/30/2015
nyomtatobarat forma
Endokrin segédlet: néhány fontosabb kórképhez a Semmelweis Egyetem I. Sz. Belgyógyászati Klinika Endokrin M unkacsoportjának összeállításában Budapest: Semmelweis Kiadó, 2005. 92 p. (ISBN:9639214558) Nyelv: Magyar
Könyv /Nem besorolt /Tudományos [1908795] Autopszia alapján ellenőrizve (20150318, BA) [ Érvényesített ] 239. Lakatos P Az involúciós (primer) csontritkulás korszerű kezelése In: Rózsa R (szerk.) Docindex (Reumatológia) . Budapest: Documed Kft., 2005. pp. 5762. Nyelv: Magyar
Könyvrészlet /Könyvfejezet /Tudományos [1908841] [ Admin láttamozott ] 240. Lakatos P Anyagcsere csontbetegségek In: Gömör Béla (szerk.) Klinikai reumatológia . 895 p. Budapest: M edicina Könyvkiadó, 2005. pp. 706712. (ISBN:963242896X) Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1908847] [ Admin láttamozott ] 241. Lakatos P A csontszövet szerkezete és élettana In: Gömör Béla (szerk.) Klinikai reumatológia . 895 p. Budapest: M edicina Könyvkiadó, 2005. pp. 671679. (ISBN:963242896X) Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1908908] [ Admin láttamozott ] 242. Lakatos P Hypoparathyreosis szindrómák In: Gömör Béla (szerk.) Klinikai reumatológia . 895 p. Budapest: M edicina Könyvkiadó, 2005. pp. 698700. (ISBN:963242896X) Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1908958] [ Admin láttamozott ] 243. M adarász E , Kerényi Z , Tabák Á G , Speer G , Lakatos P , Tamás G Az adiponektin szerepe korábban gestatiós diabeteszes asszonyokban DIABETOLOGIA HUNGARICA 13:(Suppl. 1) p. 22. (2005) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1821014] [ Admin láttamozott ] 244. M ucsi I , Almasi C , Deak G , M arton A , Ambrus C , Berta K , Lakatos P , Szabo A , Horvath C Serum 25(OH)vitamin D levels and bone metabolism in patients on maintenance hemodialysis CLINICAL NEPHROLOGY 64:(4) pp. 288294. (2005) IF: 1.543 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1021141] 37th Congress of ERAEDTA NICE, FRANCE SEP 1720, 2000 [ Érvényesített ] Független idéző: 26 Függő idéző: 4 Összesen: 30 1
Elder GJ, Mackun K 25hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
216/342
3/30/2015
nyomtatobarat forma JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 21: (11) pp. 17781784. ( 2006) Folyóiratcikk [10293030] 2
Monge M, Shahapuni I, Oprisiu R, El Esper N, Moriniere P, Massy Z, Choukroun G, Fournier A Reappraisal of 2003 NKFK/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients NAT CLIN PRACT NEPHROL 2: pp. 326336. ( 2006) Folyóiratcikk [10053393]
3
ElAbbadi M, Giachelli CM Mechanisms of vascular calcification ADVANCES IN CHRONIC KIDNEY DISEASE (ISSN: 15485595) 14: (1) pp. 5466. ( 2007) Folyóiratcikk [10293031]
4
* Deák György Renal and cardiovascular risk reduction in chronic kidney disease Orvoskepzes (ISSN: 00306037) 82: (3) pp. 137152. ( 2007) Folyóiratcikk [13158675]
5
Covic A, GusbethTatomir P, Goldsmith DJA Vascular calcification A new window on the cardiovascular system: Role of agents used to manipulate skeletal integrity SEMINARS IN DIALYSIS (ISSN: 08940959) 20: (2) pp. 158169. ( 2007) Folyóiratcikk [10293033]
6
W olf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA, Tonelli M, Thadhani R Vitamin D levels and early mortality among incident hemodialysis patients KIDNEY INTERNATIONAL (ISSN: 00852538) 72: (8) pp. 10041013. ( 2007) Folyóiratcikk [10293034]
7
Elder GJ Vitamin D levels, bone turnover and bone mineral density show seasonal variation in patients with chronic kidney disease stage 5 NEPHROLOGY (ISSN: 13205358) 12: (1) pp. 9094. ( 2007) Folyóiratcikk [10293032]
8
Diez GJR, Fassi J, Crucelequi S, Nunez HR, Trillini M, Furci A, Algranati S, Plantalech L 25Hydroxy Vitamin D Levels in HemodialysisRequiring EndStage Renal Disease P atients DIALYSIS & TRANSPLANTATION (ISSN: 00902934) 37: (10) pp. 388+. ( 2008) Folyóiratcikk [10497949]
9
Stavroulopoulos A, Porter CJ, Roe SD, Hosking DJ, Cassidy MJD Relationship between vitamin D status, parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4 Nephrology (ISSN: 13205358) 13: (1) pp. 6367. ( 2008) N1 : Chemicals/CAS25 hydroxyvitamin D, 64719499; parathyroid hormone, 12584962, 68893823, 9002646; Parathyroid Hormone; Vitamin D, 1406162 Folyóiratcikk [13158674]
10
Jean G, Charra B, Chazot C Vitamin D deficiency and associated factors in hemodialysis patients JOURNAL OF RENAL NUTRITION (ISSN: 10512276) 18: (5) pp. 395399. ( 2008) Folyóiratcikk [10497948]
11
Bacchetta J, Boutroy S, Delmas P, Fouque D Bone imaging in patient with chronic kidney disease: A new tool for managing renal osteodystrophy? NEPHROLOGIE & THERAPEUTIQUE (ISSN: 17697255) 5: (1) pp. 2533. ( 2009) Folyóiratcikk [11014865]
12
W esselingPerry K, Salusky IB Is replacement therapy with nutritional and active forms of vitamin D required in chronic kidney disease mineral and bone disorder? CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (ISSN: 10624821) 18: (4) pp. 308314. ( 2009) Folyóiratcikk [11014864]
13
Sahin G, Kirli I, Sirmagul B, Colak E, Yalcin AU Loss via peritoneal fluid as a factor for low 25(OH)D3 level in peritoneal dialysis patients INTERNATIONAL UROLOGY AND NEPHROLOGY (ISSN: 03011623) 41: (4) pp. 989996. ( 2009) Folyóiratcikk [11014863]
14
Milinkovic NLJ, MajkicSingh NT, Mirkovic DD, Beletic AD, Pejanovic SD, Vujanic ST Relation Between 25(OH)Vitamin D Deficiency and Markers of Bone Formation and Resorption in Haemodialysis P atients CLINICAL LABORATORY (ISSN: 14336510) 55: (910) pp. 333339. ( 2009) Folyóiratcikk [11014862]
15
Hage FG, Venkataraman R, Zoghbi GJ, Perry GJ, DeMattos AM, Iskandrian AE The Scope of Coronary Heart Disease in P atients With Chronic Kidney Disease JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (ISSN: 07351097) 53: (23) pp. 21292140. ( 2009) Folyóiratcikk [11014861]
16
GarciaCanton C, Bosch E, Auyanet I, Ramirez A, Rossique P, Culebras C, Sanchez A, Toledo A, Lago M, Esparza N, Checa MD 25 hydroxyvitamin D levels and cardiovascular risk in a cohort of patients with chronic kidney disease NEFROLOGIA (ISSN: 02116995) 30: (4) pp. 435442. ( 2010) Folyóiratcikk [11122635]
17 * Ambrus C, Marton A, Nemeth ZK, Mucsi I Bone mineral density in patients on maintenance dialysis INTERNATIONAL UROLOGY AND NEPHROLOGY (ISSN: 03011623) 42: (3) pp. 723739. ( 2010) Folyóiratcikk [11382988] 18
Mehra S, Movahed A Update on cardiac risk stratification of renal transplant candidates Reviews in Cardiovascular Medicine (ISSN: 15306550) 11: (3) pp. e130e140. ( 2010) N1 : Chemicals/CASazathioprine, 446866; calcium, 14092945, 7440702; cyclosporin A, 59865133, 63798732; mycophenolic acid 2 morpholinoethyl ester, 116680014, 128794945; phosphorus, 7723140; rapamycin, 53123889; tacrolimus, 104987113 Folyóiratcikk [13158673]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
217/342
3/30/2015
nyomtatobarat forma 19
Fusaro M, D Angelo A, Scalzo G, Gallieni M, Giannini S, Guglielmi G Vertebral fractures in dialysis: Endocrinological disruption of the bonekidney axis JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (ISSN: 03914097) 33: (5) pp. 347352. ( 2010) Folyóiratcikk [11014860]
20
Schulz W What is the signification of native vitamin D (cholecalciferol) in the treatment of the chronic renal insufficient patient and the chronic dialysis patient? Nieren und Hochdruckkrankheiten 39: (7) pp. 284294. ( 2010) N1 : Chemicals/CAScalcitriol, 32222063, 32511630, 66772143; colecalciferol, 1406162, 67970 Folyóiratcikk [13158672]
21
W ANG Jialin, YUAN W eijie Active versus nutritional Vitamin D compounds in clinical outcomes of chronic kidney disease Chinese Journal of Nephrology, Dialysis & Transplantation 20: (2) pp. 173175,200. ( 2011) Folyóiratcikk [13158670]
22
Bucharles S, Barberato SH, Stinghen AE, Gruber B, Meister H, Mehl A, Piekala L, Dambiski AC, Souza A, Olandoski M, Pecoits R Hypovitaminosis D Is Associated with Systemic Inflammation and Concentric Myocardial Geometric P attern in Hemodialysis P atients with Low iP TH Levels NEPHRON CLINICAL PRACTICE (ISSN: 16602110) 118: (4) pp. C384C391. ( 2011) Folyóiratcikk [12324585]
23
D'Amour P, Rousseau L, Hornyak S, Yang Z, Cantor T Influence of Secondary Hyperparathyroidism Induced by Low Dietary Calcium, Vitamin D Deficiency, and Renal Failure on Circulating Rat P TH Molecular Forms INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (ISSN: 16878337) 2011: P aper 469783. (2011) Folyóiratcikk [12324584]
24 * Kiss Z, Ambrus C, Almasi C, Berta K, Deak G, Horonyi P, Kiss I, Lakatos P, Marton A, Molnar MZ, Nemeth Z, Szabo A, Mucsi I Serum 25(OH)Cholecalciferol Concentration Is Associated with Hemoglobin Level and Erythropoietin Resistance in P atients on Maintenance Hemodialysis NEPHRON CLINICAL PRACTICE (ISSN: 16602110) 117: (4) pp. C373C378. ( 2011) Folyóiratcikk [11122634] 25 * Ambrus C, Almasi C, Berta K, Deak G, Marton A, Molnar MZ, Nemeth Z, Horvath C, Lakatos P, Szathmari M, Mucsi I Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis INTERNATIONAL UROLOGY AND NEPHROLOGY (ISSN: 03011623) 43: (2) pp. 475482. ( 2011) Folyóiratcikk [12324583] 26
Elewa Usama, Dolores SanchezNino Maria, MartinCleary Catalina, FernandezFernandez Beatriz, Egido Jesus, Ortiz Alberto Cardiovascular risk biomarkers in CKD: the inflammation link and the road less traveled INTERNATIONAL UROLOGY AND NEPHROLOGY (ISSN: 03011623) 44: (6) pp. 17311744. ( 2012) Folyóiratcikk [13158669]
27
Bucharles S, Barberato SH, Stinghen AEM, Gruber B, Piekala L, Dambiski C, Custodio MR, Pecoits R Impact of Cholecalciferol Treatment on Biomarkers of Inflammation and Myocardial Structure in Hemodialysis P atients Without Hyperparathyroidism JOURNAL OF RENAL NUTRITION (ISSN: 10512276) 22: (2) pp. 284291. ( 2012) Folyóiratcikk [12324582]
28
Mirfakhraee S, Sakhaee K, Zerwekh J, AdamsHuet B, Gruntmanis U Risk factors for diminished bone mineral density among male hemodialysis patientsa crosssectional study Archives of Osteoporosis (ISSN: 18623522) 7: (12) pp. 283290. ( 2012) N1 : Chemicals/CASalkaline phosphatase, 9001789; estradiol, 50282 Folyóiratcikk [13158671]
29
Bosworth C, de Boer IH, Targher G, Kendrick J, Smits G, Chonchol M The effect of combined calcium and cholecalciferol supplementation on bone mineral density in elderly women with moderate chronic kidney disease CLINICAL NEPHROLOGY (ISSN: 03010430) 77: (5) pp. 358365. ( 2012) Folyóiratcikk [12429060]
30
Singer Richard Francis Vitamin D in Dialysis: Defining Deficiency and Rationale for Supplementation SEMINARS IN DIALYSIS (ISSN: 08940959) 26: (1) pp. 4046. ( 2013) Folyóiratcikk [13158668]
245. Speer G , Szenthe P , Kósa JP , Tabák ÁG , Nagy Z , Folhoffer A , Cseh K , Lakatos P Az 1es típusú kollagén A1 génjének 1245G/T polimorfizmusa összefügg a miokardiális infarktussal: az új patogenetikai faktor? CARDIOLOGIA HUNGARICA 35:(2) pp. 6469. (2005) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1335678] A M OBban hibás a szerzők sorrendje! [ Érvényesített ] 246. Speer G , Lakatos P Csont az érben zsír a csontban? A vascularis kalcifikáció elmélete és klinikuma LEGE ARTIS MEDICINAE 15:(89) pp. 624631. (2005) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [1335679] [ Érvényesített ] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
218/342
3/30/2015
nyomtatobarat forma
247. Szalay F , Folhoffer A , Horvath A , Csak T , Speer G , Nagy Z , Lakatos P , Horvath C , Habior A , Tornai I , Lakatos PL Serum leptin, soluble leptin receptor, free leptin index and bone mineral density in patients with primary biliary cirrhosis EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 17:(9) pp. 923928. (2005) IF: 1.690 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1074520] [ Érvényesített ] Független idéző: 10 Összesen: 10 1
Zografos TA, Rigopoulou EI, Liaskos C, Togousidis E, Zachou K, Gatselis N, Germenis A, Dalekos GN Alterations of leptin during IFNalpha therapy in patients with chronic viral hepatitis JOURNAL OF HEPATOLOGY (ISSN: 01688278) 44: pp. 848855. ( 2006) Folyóiratcikk /Konferenciaközlemény /Tudományos [10226731]
2
Reshetnyak VI Concept on the pathogenesis and treatment of primary biliary cirrhosis WORLD JOURNAL OF GASTROENTEROLOGY (ISSN: 10079327) 12: pp. 72507262. ( 2006) Folyóiratcikk /Ismertetés /Tudományos [10226732]
3
Fu L, Zhou L, Chen XQ Changes in bone mineral density in patients with liver cirrhosis WORLD CHINESE JOURNAL OF DIGESTOLOGY 17: (27) pp. 28502853. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [10932254]
4
Nakchbandi IA, van der Merwe SW Current understanding of osteoporosis associated with liver disease NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (ISSN: 17595045) 6: (11) pp. 660670. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [10825923]
5
Petelenz M, Musialik J, Kokocińska D, KlimackaNawrot E Relationship between bone mineral density and estrogen precursors in primary biliary cirrhosis Experimental and Clinical Hepatology 6: (1) pp. 3033. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11087304]
6
Motoi O Risk factors for osteoporosis in chronic liver diseases Annals of Fundeni Hospital 16: (12) pp. 4247. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [11736562]
7
Yadav A, Carey EJ Osteoporosis in Chronic Liver Disease NUTR CLIN PRACT 28: (1) pp. 5264. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13061848]
8
Nakchbandi IA Osteoporosis and fractures in liver disease: Relevance; pathogenesis and therapeutic implications WORLD J GASTROENTERO (ISSN: 10079327) 20: pp. 94279438. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14098520]
9
RaszejaW yszomirska J, Miazgowski T Osteoporosis in primary biliary cirrhosis of the liver PRZ GASTROENTEROL (ISSN: 18955770) 9: pp. 8287. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [13823576]
10
LópezLarramona G, Tenías Burillo JM, Lucendo Villarín AJ The Association between Nutritional Screening Via The Conut Index And Bone Mineral Density In Chronic Liver Disease of Various Etiologies. HEPATOL RES (ISSN: 13866346) 44: p. 2014 Jul 25. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14110154]
248. Szalay F , Csak T , Folhoffer A , Horvath A , Speer G , Nagy Z , Lakatos P , Habior A , Tornai I , Lakatos PL Serum leptin; soluble leptin receptor levels and free leptin index in patients with primary biliary cirrhosis. ZEITSCHRIFT FÜR GASTROENTEROLOGIE 43: p. 513. (2005) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391307] [ Admin láttamozott ]
2004 249. Agostoni A , AygörenPürsün E , Binkley K E , Blanch A , Bork K , Bouillet L , Bucher C , Castaldo A J , Cicardi M , Davis III A E , De Carolis C , Drouet C , Duponchel C , Farkas H , Fáy K , Fekete B , Fischer B , Fontana L , Füst G , Giacomelli R , Gröner A , Erik Hack C , Harmat G , Jakenfelds J , Juers M , Kalmár L , Kaposi P N , Karádi I , Kitzinger A , Kollár T , Kreuz W , Lakatos P , Longhurst H J , LopezTrascasa M , M artinezSaguer I , M onnier N , Nagy I , Németh E , Nielsen E W , Nuijens J H , O Grady C , Pappalardo E , Penna V , Perricone C , Perricone R , Rauch U , Roche O , Rusicke E , Späth P J , Szendei G , Takács E , Tordai A , Truedsson L , Varga L , Visy B , Williams K , Zanichelli A , Zingale L Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 114:(3 SUPPL.) pp. S51S131. (2004) IF: 7.205 Nyelv: Angol
Folyóiratcikk /Sokszerzős vagy csoportos szerzőségű közlemény /Tudományos [1359680] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
219/342
3/30/2015
nyomtatobarat forma
[ Érvényesített ] Független idéző: 226 Függő idéző: 122 Összesen: 348 1
Frank M M Hereditary angioedema: A half century of progress Journal of Allergy and Clinical Immunology (ISSN: 00916749) 114: (3) pp. 626628. ( 2004) Folyóiratcikk [11025899]
2
Copeland B, Aljitawi O, Fitzgerald S M, Chi D S, Krishnaswamy G A patient with facial and neck swelling, dyspnea, and dysphagia Annals of Allergy, Asthma and Immunology 95: (6) pp. 510517. ( 2005) Folyóiratcikk [11025893]
3
* Van Doorn M B A, Burggraaf J, Van Dam T, Eerenberg A, Levi M, Hack C E, Schoemaker R C, Cohen A F, Nuijens J A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema Journal of Allergy and Clinical Immunology (ISSN: 00916749) 116: (4) pp. 876883. ( 2005) Folyóiratcikk [11025892]
4
* Duan Q L, Nikpoor B, Dubé M P, Molinaro G, Meijer I A, Dion P, Rochefort D, SaintOnge J, Flury L, Brown N J, Gainer J V, Rouleau J L, Agostoni A, Cugno M, Simon P, Clavel P, Potier J, W ehbe B, Benarbia S, MarcAurèle J, Chanard J, Foroud T, Adam A, Rouleau G A A variant in XP NP EP 2 is associated with angioedema induced by angiotensin Iconverting enzyme inhibitors American Journal of Human Genetics (ISSN: 00029297) 77: (4) pp. 617626. ( 2005) Folyóiratcikk [11025891]
5
* Széplaki G, Varga L, Valentin S, Kleiber M, Karádi I, Romics L, Füst G, Farkas H Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema Journal of Allergy and Clinical Immunology (ISSN: 00916749) 115: (4) pp. 864869. ( 2005) Folyóiratcikk [11025898]
6
* Gompels M M, Lock R J, Abinun M, Bethune C A, Davies G, Grattan C, Fay A C, Longhurst H J, Morrison L, Price A, Price M, W atters D C1 inhibitor deficiency: Consensus document Clinical and Experimental Immunology (ISSN: 00099104) 139: (3) pp. 379394. ( 2005) Folyóiratcikk [11025897]
7
* Cicardi M, Zingale L, Zanichelli A, Pappalardo E, Cicardi B C1 inhibitor: Molecular and clinical aspects Springer Seminars in Immunopathology (ISSN: 03444325) 27: (3) pp. 286298. ( 2005) Folyóiratcikk [11025890]
8
Cimbollek S H, GonzalezQuevedo T, Fernandez M D CA 125: Marker of serosal inflammation in hereditary angioedema? Allergy: European Journal of Allergy and Clinical Immunology 60: (6) pp. 835836. ( 2005) Folyóiratcikk [11025889]
9
Kaplan A P, Ghebrehiwet B Does C2 kinin exist? Journal of Allergy and Clinical Immunology (ISSN: 00916749) 115: (4) pp. 876876. ( 2005) Folyóiratcikk [11025896]
10
Boyle R J, Nikpour M, Tang M L K Hereditary angiooedema in children: A management guideline Pediatric Allergy and Immunology (ISSN: 09056157) 16: (4) pp. 288294. ( 2005) Folyóiratcikk [11025888]
11
Frank M M Hereditary angioedema Current Opinion in Pediatrics (ISSN: 10408703) 17: (6) pp. 686689. ( 2005) Folyóiratcikk [11025886]
12
Bracho F A Hereditary angioedema Current Opinion in Hematology (ISSN: 10656251) 12: (6) pp. 493498. ( 2005) Folyóiratcikk [11025887]
13
Obtułowicz K, Obtułowicz P, Kapusta M Hereditary angioedema (HAE) in patients with C1 inhibitor deficiency Cracow register: Wrodzony obrzek naczynioruchowy u osób z niedoborem C1 inhibitora Rejestr krakowski Postepy Dermatologii I Alergologii (ISSN: 1642395X) 22: (1) pp. 2328. ( 2005) Folyóiratcikk [11025895]
14
* Roche O, Blanch A, Caballero T, Sastre N, Callejo D, LópezTrascasa M Hereditary angioedema due to C1 inhibitor deficiency: P atient registry and approach to the prevalence in Spain Annals of Allergy, Asthma and Immunology 94: (4) pp. 498503. ( 2005) Folyóiratcikk [11025894]
15
* Felvinci Réka, Németh Éva, Visy Beáta, Varga Lilian, Jakab László, Farkas Henriette The effect of sexual hormon alterations on the frequency of oedematous attacks in patients with hereditary angioneurotic edema: A nemi hormonok változásának hatása a hereditaer angioneuroticus oedemában szenvedö betegek rohaniainak gyakoriságára Lege Artis Medicinae (ISSN: 08664811) 15: (3) pp. 191196. ( 2005) Folyóiratcikk [11025885]
16
Moreau M E, Garbacki N, Molinaro G, Brown N J, Marceau F, Adam A The kallikreinkinin system: Current and future pharmacological targets Journal of Pharmacological Sciences (ISSN: 13478613) 99: (1) pp. 638. ( 2005) Folyóiratcikk [11025884]
17
Baxi S, Dinakar C Urticaria and angioedema Immunology and Allergy Clinics of North America (ISSN: 08898561) 25: (2) pp. 353367. ( 2005) Folyóiratcikk [11025883]
18
Lazzeri E, Netti G S, Mazzinghi B, Cirami C, Salvadori M, Romagnani P A young woman with oedema Internal and Emergency Medicine (ISSN: 18280447) 1: (3) pp. 209215. ( 2006)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
220/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [11025882] 19
* Zingale L C, Castelli R, Zanichelli A, Cicardi M Acquired Deficiency of the Inhibitor of the First Complement Component: P resentation, Diagnosis, Course, and Conventional Management Immunology and Allergy Clinics of North America (ISSN: 08898561) 26: (4) pp. 669690. ( 2006) Folyóiratcikk [11025881]
20
Matesic D, Pérez E R F, Vlahakis N E, Hagan J B Acute pancreatitis due to hereditary angioedema Annals of Allergy, Asthma and Immunology 97: (5) pp. 611614. ( 2006) Folyóiratcikk [11025880]
21
Nowicki R Angioedema: Obrzȩk naczynioruchowy Alergia Astma Immunologia 11: (3) pp. 115121. ( 2006) Folyóiratcikk [11025878]
22
Cassano N, Ieva R, Vena G A Angioedema: L'angioedema Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale 60: (1) pp. 18. ( 2006) Folyóiratcikk [11025879]
23
Bowen T Angioedema and the Canadian Network of Rare Blood Disorder Organizations: Extending the Canadian hemophilia care model Canadian Medical Association Journal (ISSN: 08203946) 175: (9) pp. 10831084. ( 2006) Folyóiratcikk [11025877]
24
* Nielsen E W , Gramstad S Angioedema from angiotensinconverting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate Acta Anaesthesiologica Scandinavica (ISSN: 00015172) 50: (1) pp. 120122. ( 2006) Folyóiratcikk [11025876]
25
* Zingale L C, Beltrami L, Zanichelli A, Maggioni L, Pappalardo E, Cicardi B, Cicardi M Angioedema without urticaria: A large clinical survey Canadian Medical Association Journal (ISSN: 08203946) 175: (9) pp. 10651070. ( 2006) Folyóiratcikk [11025875]
26
Yucelten D, Kus S Chickenwire erythema, but not urticaria, as the presenting sign of hereditary angioedema [2] European Journal of Dermatology (ISSN: 11671122) 16: (2) pp. 197198. ( 2006) Folyóiratcikk [11025874]
27
Schatz M, Leung DYM, Goldstein S Consultation and referral guidelines citing the evidence: How the allergistimmunologist can help JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (ISSN: 00916749) 117: (2) pp. S495S521. ( 2006) Folyóiratcikk [12538013]
28
29
* Széplaki G, Varga L, Osváth L, Karádi I, Füst G, Farkas H Deep venous thrombosis associated with acquired angioedema type II in a patient heterozygous for the mutation of factor V Leiden: Effective treatment and followup for four years Thrombosis and Haemostasis (ISSN: 03406245) 95: (5) pp. 898899. ( 2006) Folyóiratcikk [11025873] W eldon D Differential Diagnosis of Angioedema Immunology and Allergy Clinics of North America (ISSN: 08898561) 26: (4) pp. 603613. ( 2006) Folyóiratcikk [11025872]
30
* Skogøy K, Nielsen E W En 24 år gammel kvinne med utslett og hevelser under ppillebruk og graviditet Tidsskrift for den Norske Laegeforening (ISSN: 00292001) 126: (21) pp. 28062807. ( 2006) Folyóiratcikk [11025871]
31
* Blanch A, Roche O, Urrutia I, Gamboa P, Fontán G, LópezTrascasa M First case of homozygous C1 inhibitor deficiency Journal of Allergy and Clinical Immunology (ISSN: 00916749) 118: (6) pp. 13301335. ( 2006) Folyóiratcikk [11025870]
32
Prohászka Z GeneGene Interactions in Immunology as Exemplified by Studies on Autoantibodies against 60 kDa Heatshock P rotein In: Immunogenomics and Human Disease. John Wiley & Sons, Ltd, 2006. (ISBN 9780470015308) pp. 351370.
Könyvrészlet /Könyvfejezet /Tudományos [14420478] 33
W eiler C R, Van Dellen R G Genetic test indications and interpretations in patients with hereditary angioedema Mayo Clinic Proceedings (ISSN: 00256196) 81: (7) pp. 958972. ( 2006) Folyóiratcikk [11025869]
34
* Guarino S, Perricone C, Guarino M D, Giardina E, Gambardella S, D apice M R, Bulli C, Perricone R, Novelli G Gonadal mosaicism in hereditary angioedema [6] Clinical Genetics (ISSN: 00099163) 70: (1) pp. 8385. ( 2006) Folyóiratcikk [11025868]
35
* Longhurst Hilary J, Bork Konrad Hereditary angioedema: causes, manifestations and treatment BRITISH JOURNAL OF HOSPITAL MEDICINE (ISSN: 17508460) 67: (12) pp. 654657. ( 2006) Folyóiratcikk [12538012]
36
Frigas E, Park M Idiopathic Recurrent Angioedema Immunology and Allergy Clinics of North America (ISSN: 08898561) 26: (4) pp. 739751. ( 2006) Folyóiratcikk [11025867]
37
Piirilä H, Väliaho J, Vihinen M Immunodeficiency mutation databases (IDbases) Human Mutation (ISSN: 10597794) 27: (12) pp. 12001208. ( 2006)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
221/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [11025866] 38
* Cichon S, Martin L, Hennies H C, Müller F, Van Driessche K, Karpushova A, Stevens W , Colombo R, Renné T, Drouet C, Bork K, Nöthen M M Increased activity of coagulation factor XII (Hageman Factor) causes hereditary angioedema type III American Journal of Human Genetics (ISSN: 00029297) 79: (6) pp. 10981104. ( 2006) Folyóiratcikk [11025865]
39
Bjørge L Kommentar: Østrogenavhengig angioødem Tidsskrift for den Norske Laegeforening (ISSN: 00292001) 126: (21) p. 2808. ( 2006) Folyóiratcikk [11025864]
40
Nathani F, Sullivan H, Churchill D P regnancy and C1 esterase inhibitor deficiency: A successful outcome Archives of Gynecology and Obstetrics (ISSN: 09320067) 274: (6) pp. 381384. ( 2006) Folyóiratcikk [11025863]
41
* Levi M, Hack C E, van Oers M H Rituximabinduced Elimination of Acquired Angioedema Due to C1Inhibitor Deficiency American Journal of Medicine (ISSN: 00029343) 119: (8) pp. e3e5. ( 2006) Folyóiratcikk [11025862]
42
43
Storini C, Bergamaschini L, Gesuete R, Rossi E, Maiocchi D, De Simoni M G Selective inhibition of plasma kallikrein protects brain from reperfusion injury Journal of Pharmacology and Experimental Therapeutics (ISSN: 00223565) 318: (2) pp. 849854. ( 2006) Folyóiratcikk [11025861] * Levi M, Choi G, Picavet C, Hack C E Selfadministration of C1inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1inhibitor deficiency Journal of Allergy and Clinical Immunology (ISSN: 00916749) 117: (4) pp. 904908. ( 2006) Folyóiratcikk [11025860]
44
Levy J H, O Donnell P S The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema Expert Opinion on Investigational Drugs (ISSN: 13543784) 15: (9) pp. 10771090. ( 2006) Folyóiratcikk [11025859]
45
Yano C, Ota A, Nakagawa H A case of angioedema associated with decreased C1 inhibitor activity Allergology International 56: (3) pp. 309311. ( 2007) Folyóiratcikk [11025858]
46
Healy C, Abuzakouk M, Feighery C, Flint S Acquired angioedema in nonHodgkin's lymphoma Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology 103: (5) pp. e29e32. ( 2007) Folyóiratcikk [11025857]
47
Habibi S, Drexler C Angioedema and urticaria In: Complications in Anesthesia. Elsevier Inc., 2007. (ISBN 9781416022152) pp. 426428.
Könyvrészlet /Könyvfejezet /Tudományos [14420477] 48
* Varga L, Bíró A, Széplaki G, Tóth L, Horváth A, Füst G, Farkas H Anticholesterol antibody levels in hereditary angioedema Journal of Cellular and Molecular Medicine (ISSN: 15821838) 11: (6) pp. 13771383. ( 2007) Folyóiratcikk [11025843]
49
* Cicardi M, Zingale LC C1 Inhibitor autoantibodies In: Autoantibodies. Elsevier Inc., 2007. (ISBN 9780444527639) pp. 695701.
Könyvrészlet /Könyvfejezet /Tudományos [14420476] 50
Lin Joann H, Casillas Adrian M, Sattar Sabah C1esterase inhibitor autoantibodies in a patient with acute tongue swelling ALLERGY AND ASTHMA PROCEEDINGS (ISSN: 10885412) 28: (1) pp. 9396. ( 2007) Folyóiratcikk [12538011]
51
* Varga L, Széplaki G, Visy B, Füst G, Harmat G, Miklós K, Németh J, Cervenak L, Karádi I, Farkas H C1inhibitor (C1INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1INH concentrate naïve patients Molecular Immunology (ISSN: 01615890) 44: (6) pp. 14541460. ( 2007) Folyóiratcikk [11025856]
52
* Guarino M D, Perricone C, Guarino S, Gambardella S, D Apice M R, Fontana L, Novelli G, Perricone R Denaturing HP LC in laboratory diagnosis of hereditary angioedema Journal of Allergy and Clinical Immunology (ISSN: 00916749) 120: (4) pp. 962965. ( 2007) Folyóiratcikk [11025855]
53
Jauhar S, Staines K, McQueen M, W atson I B, W ray D, Felix D H Dermographism and delayed pressure urticaria Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology 103: (6) pp. 774779. ( 2007) Folyóiratcikk [11025854]
54
Pekdemir M, Ersel M, Aksay E, Yanturali S, Akturk A, Kiyan S Effective Treatment of Hereditary Angioedema with Fresh Frozen P lasma in an Emergency Department Journal of Emergency Medicine (ISSN: 07364679) 33: (2) pp. 137139. ( 2007) Folyóiratcikk [11025853]
55
* Cicardi M, Zingale L, Zanichelli A, Deliliers D L Established and new treatments for hereditary angioedema: An update Molecular Immunology (ISSN: 01615890) 44: (16) pp. 38583861. ( 2007) Folyóiratcikk [11025852]
56
* Martin L, RaisonPeyron N, Nöthen M M, Cichon S, Drouet C Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
222/342
3/30/2015
nyomtatobarat forma p.Thr328Lys mutation in the F12 gene Journal of Allergy and Clinical Immunology (ISSN: 00916749) 120: (4) pp. 975977. ( 2007) Folyóiratcikk [11025851] 57
* Farkas H, Jakab L, Temesszentandrási G, Visy B, Harmat G, Füst G, Széplaki G, Fekete B, Karádi I, Varga L Hereditary angioedema: A decade of human C1inhibitor concentrate therapy Journal of Allergy and Clinical Immunology (ISSN: 00916749) 120: (4) pp. 941947. ( 2007) Folyóiratcikk [11025850]
58
Roskiewicz F, Andriamanana I, GrasChampel V, Andrejak M, Massy Z A Iatrogenic angioedema: the role of angiotensin converting enzyme inhibitor and angiotensin II receptor blockers: Angio œdèmes iatrogènes : rôle des inhibiteurs de l'enzyme de conversion et des antagonistes des récepteurs à l'angiotensine II (sartans) Nephrologie et Therapeutique 3: (3) pp. 8995. ( 2007) Folyóiratcikk [11025849]
59
Thon V, Härle P, Schölmerich J, Kuklinek P, Lokaj J, Straub R H Lack of dehydroepiandrosterone in type I and II hereditary angioedema and role of danazol in steroid hormone conversion Allergy: European Journal of Allergy and Clinical Immunology 62: (11) pp. 13201325. ( 2007) Folyóiratcikk [11025848]
60
61
* Farkas Henriette, Varga Lilian, Szeplaki Gabor, Visy Beata, Harmat George, Bowen Tom Management of hereditary angioedema in pediatric patients PEDIATRICS (ISSN: 00314005) 120: (3) pp. E713E722. ( 2007) Folyóiratcikk [12538010] Bas M, Adams V, Suvorava T, Niehues T, Hoffmann T K, Kojda G Nonallergic angioedema: Role of bradykinin Allergy: European Journal of Allergy and Clinical Immunology 62: (8) pp. 842856. ( 2007) Folyóiratcikk [11025847]
62
* Blaskó B, Széplaki G, Varga L, Ronai Z, Prohászka Z, SasvariSzekely M, Visy B, Farkas H, Füst G Relationship between copy number of genes (C4A, C4B) encoding the fourth component of complement and the clinical course of hereditary angioedema (HAE) Molecular Immunology (ISSN: 01615890) 44: (10) pp. 26672674. ( 2007) Folyóiratcikk [11025846]
63
Hermans C Successful management with C1inhibitor concentrate of hereditary angioedema attacks during two successive pregnancies: A case report Archives of Gynecology and Obstetrics (ISSN: 09320067) 276: (3) pp. 271276. ( 2007) Folyóiratcikk [11025845]
64
65
66
* Cicardi M, Zingale L C The deficiency of C1 inhibitor and its treatment Immunobiology (ISSN: 01712985) 212: (45) pp. 325331. ( 2007) Folyóiratcikk [11025844] Mallbris L, Nordenfelt P, Björkander J, Lindfors A, W erner S, W ahlgren C F The establishment and utility of SwehaReg: A Swedish populationbased registry to understand hereditary angioedema BMC Dermatology (ISSN: 14715945) 7: P aper 6. (2007) PubMed ID: 18053127 Folyóiratcikk [11025842] * Cicardi M, Zingale L C, Zanichelli A, Deliliers D L, Caccia S The use of plasmaderived C1 inhibitor in the treatment of hereditary angioedema Expert Opinion on Pharmacotherapy (ISSN: 14656566) 8: (18) pp. 31733181. ( 2007) Folyóiratcikk [11577049]
67
Lin Joann H Untitle ALLERGY AND ASTHMA PROCEEDINGS (ISSN: 10885412) 28: (5) pp. 607608. ( 2007) Folyóiratcikk [12538009]
68
Frank M M 8. Hereditary angioedema Journal of Allergy and Clinical Immunology (ISSN: 00916749) 121: (2, Suppl. 2) pp. S398S401. ( 2008) Folyóiratcikk [11025841]
69
Guilarte M, Luengo O, Nogueiras C, LabradorHorrillo M, Munoz E, Lopez A, Cardona V Acquired Angioedema associated with hereditary Angioedema due to C1 inhibitor deficiency JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY 18: (2) pp. 126130. ( 2008) Folyóiratcikk [12538008]
70
* Szeplaki Gabor, Varga Lilian, Szepvolgyi Aniko, Simon Kornel, Blasko Bernadett, Nagy Eszter, Karadi Istvan, Fust George, Farkas Henriette Acquired angioedema associated with primary antiphospholipid syndrome in a patient with antithrombin III deficiency INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (ISSN: 10182438) 146: (2) pp. 164168. ( 2008) Folyóiratcikk [12538007]
71
Désormeaux A, Byrd J B, Brown N J, Adam A Acute sideeffects of angiotensin converting enzyme inhibitors; among which angioedema different in their clinical etiology, share the same pathophysiology: Les effets secondaires aigus des inhibiteurs de l'enzyme de conversion de l'angiotensine dont l'angioœdème, différents dans leur étiologie clinique, partagent une physiopathologie semblable Revue Francaise d'Allergologie et d'Immunologie Clinique 48: (6) pp. 434440. ( 2008) Folyóiratcikk [11025840]
72
Gelée B, Michel P, Haas R, Boishardy F Angiotensinconverting enzyme inhibitorrelated angioedema: Treatment in an emergency room with complement C1 inhibitor concentrate: Angioœdème acquis induit par les IEC : traitement aux urgences par concentré de C1 inhibiteur Revue de Medecine Interne (ISSN: 02488663) 29: (6) pp. 516519. ( 2008) Folyóiratcikk [11025839]
73
Craig Timothy J Appraisal of danazol prophylaxis for hereditary angioederna
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
223/342
3/30/2015
nyomtatobarat forma ALLERGY AND ASTHMA PROCEEDINGS (ISSN: 10885412) 29: (3) pp. 225231. ( 2008) Folyóiratcikk [12538006] 74
Collet E, Jeudy G Clinical aspects of severe cutaneous allergies (excluding cutaneous drug eruptions): Aspects cliniques des allergies cutanées graves (toxidermies exclues) Revue Francaise d'Allergologie et d'Immunologie Clinique 48: (3) pp. 115119. ( 2008) Folyóiratcikk [11025838]
75
Epstein Tolly G, Bernstein Jonathan A Current and Emerging Management Options for Hereditary Angioedema in the US DRUGS (ISSN: 00126667) 68: (18) pp. 25612573. ( 2008) Folyóiratcikk [12538005]
76
* W agenaarBos I G A, Drouet C, AygörenPursun E, Bork K, Bucher C, Bygum A, Farkas H, Fust G, Gregorek H, Hack C E, Hickey A, JollerJemelka H I, Kapusta M, Kreuz W , Longhurst H, LopezTrascasa M, Madalinski K, Naskalski J, Nieuwenhuys E, Ponard D, Truedsson L, Varga L, Nielsen E W , W agner E, Zingale L, Cicardi M, van Ham S M Functional C1Inhibitor diagnostics in hereditary angioedema: Assay evaluation and recommendations Journal of Immunological Methods (ISSN: 00221759) 338: (12) pp. 1420. ( 2008) Folyóiratcikk [11025837]
77
* Bowen Tom, Cicardi Marco, Bork Konrad, Zuraw Bruce, Frank Mike, Ritchie Bruce, Farkas Henriette, Varga Lilian, Zingale Lorenza C, Binkley Karen, W agner Eric, Adomaitis Peggy, Brosz Kristylea, Burnham Jeanne, W arrington Richard, Kalicinsky Chrystyna, Mace Sean, McCusker Christine, Schellenberg Robert, Celeste Lucia, Hebert Jacques, Valentine Karen, Poon ManChiu, Serushaco Bazir, Neurath Doris, Yang W illiam, Lacuesta Gina, Issekutz Andrew, Harried Azza, Kamra Palinder, Dean John, Kanani Amin, Stark Donald, Rivard GeorgesEtienne, Leith Eric, Tsai Ellie, W aserman Susan, Keith Paul K, Page David, Marchesm Silvia, Longhurst Hilary J, Kreuz W olfhart, Rusicke Eva, MartinezSaguer Inmaculada, AygorenPursun Emel, Harmat George, Fust George, Li Henry, Bouillet Laurence, Caballero Teresa, Moldovan Dumitru, Spath Peter J, SmithFoltz Sara, Nagy Istvan, Nielsen Erik W , Bucher Christoph, Nordenfelt Patrik, Xiang Zhi Yu Hereditary angiodema: a current stateoftheart review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (ISSN: 10811206) 100: (1) pp. S30S40. ( 2008) SU 2 Folyóiratcikk [12538004]
78
Zuraw Bruce L Hereditary angioedema NEW ENGLAND JOURNAL OF MEDICINE (ISSN: 00284793) 359: (10) pp. 10271036. ( 2008) Folyóiratcikk [12538003]
79
Bemstein Jonathan A Hereditary angioedema: a current stateoftheart review, VIII: current status of emerging therapies ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (ISSN: 10811206) 100: (1) pp. S41S46. ( 2008) SU 2 Folyóiratcikk [12538002]
80
* Perricone R, De Carolis C, Kroeegler B, Greco E, Giacomelli R, Cipriani P, Fontana L, Perricone C Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion RHEUMATOLOGY (ISSN: 14620324) 47: (5) pp. 646651. ( 2008) Folyóiratcikk [12538001]
81
* Szegedi Robert, Szeplaki Gabor, Varga Lilian, Prohaszka Zoltan, Szeplaki Zoltan, Karadi Istvan, Fuest George, Farkas Henriette Longterm danazol prophylaxis does not intimamedia thickness in hereditary lead to increased carotid angioedema patients ATHEROSCLEROSIS (ISSN: 00219150) 198: (1) pp. 184191. ( 2008) Folyóiratcikk [12538000]
82
* Pappalardo E, Caccia S, Suffritti C, Tordai A, Zingale L C, Cicardi M Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: Functional and structural correlates Molecular Immunology (ISSN: 01615890) 45: (13) pp. 35363544. ( 2008) Folyóiratcikk [11025836]
83
84
85
86
Zuraw Bruce L, Christiansen Sandra C New promise and hope for treating hereditary angioedema EXPERT OPINION ON INVESTIGATIONAL DRUGS (ISSN: 13543784) 17: (5) pp. 697706. ( 2008) Folyóiratcikk [12537999] * Davis III A E New treatments addressing the pathophysiology of hereditary angioedema Clinical and Molecular Allergy 6: P aper 2. (2008) Folyóiratcikk [11025835] Serrano C, Guilarte M, Tella R, Dalmau G, Bartra J, Gaig P, Cerdà M, Cardona V, Valero A Oestrogendependent hereditary angiooedema with normal C1 inhibitor: Description of six new cases and review of pathogenic mechanisms and treatment Allergy: European Journal of Allergy and Clinical Immunology 63: (6) pp. 735741. ( 2008) Folyóiratcikk [11025834] * Altorjai P, Visy B, Kormos Z, Harmat G, Fekete F, Farkas H P ericardiac effusion complicating an acute abdominal attack of hereditary angioneurotic edema American Journal of Case Reports (ISSN: 19415923) 2008: (9) pp. 233236. ( 2008) Folyóiratcikk [11182244]
87
Cedzynski Maciej, Madalinski Kazimierz, Gregorek Hanna, Swierzko Anna S, Nowicka Ewa, Obtulowicz Krystyna, DzierzanowskaFangrat Katarzyna, W ojda Urszula, Rabczenko Daniel, Kawakami Masaya P ossible diseasemodifying factors: the mannanbinding lectin pathway and infections in hereditary angioedema of children and adults ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (ISSN: 0004069X) 56: (1) pp. 6975. ( 2008) Folyóiratcikk [12537998]
88
Bas M, Kirchhartz N, Hochfeld J, Tüllmann C, Kumpf S, Suvorava T, Oppermann M, Hafner D, Bier H, Hoffmann T K, Balz V, Kojda G P otential role of vasomotor effects of fibrinogen in bradykinininduced angioedema
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
224/342
3/30/2015
nyomtatobarat forma Journal of Allergy and Clinical Immunology (ISSN: 00916749) 121: (4) pp. 969975. ( 2008) Folyóiratcikk [11025833] 89
Foerster T, Mueller C R, Oldenburg J Recombinant expression and 3Dmodelling of C1inhibitor mutants In: Scharrer I, Schramm W (szerk.) : 37TH HEMOPHILIA SYMPOSIUM. Berlin: SpringerVerlag, 2008. (ISBN 9783540735342) pp. 271 272.
Könyvrészlet [12537997] 90
KasperskaZajac A, Brzoza Z, Rogala B Sex hormones and urticaria Journal of Dermatological Science (ISSN: 09231811) 52: (2) pp. 7986. ( 2008) Folyóiratcikk [11025832]
91
Yarmohammadi H, CunninghamRundles C Treatment of primary immunodeficiency diseases In: Primary Immunodeficiency Diseases: Definition, Diagnosis, and Management. Springer Berlin Heidelberg, 2008. (ISBN 9783540785378) pp. 315334.
Könyvrészlet /Könyvfejezet /Tudományos [14420471] 92
* Varga L, Farkas H Treatment of type i and II hereditary angioedema with Rhucin <sup>®, a recombinant human C1 inhibitor Expert Review of Clinical Immunology (ISSN: 1744666X) 4: (6) pp. 653661. ( 2008) Folyóiratcikk [11025831]
93
Anon 8: Inhibitors Transfusion Medicine and Hemotherapy (ISSN: 16603796) 36: (6) pp. 437448. ( 2009) Folyóiratcikk [11025819]
94
De Knop K J, Hagendorens M M, Stevens W J, De Clerck L S, Ebo D G ANGIOEDEMA BEYOND HISTAMINE: AN EDUCATIONAL CASE SERIES ACTA CLINICA BELGICA (ISSN: 00015512) 64: (6) pp. 520528. ( 2009) Folyóiratcikk [12537993]
95
Bluestein Hazel M, Hoover Todd A, Banerji Aleena Suryadevara, Camargo Carlos A Jr, Reshef Avner, Herscu Paul Angiotensinconverting enzyme inhibitorinduced angioedema in a community hospital emergency department ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (ISSN: 10811206) 103: (6) pp. 502507. ( 2009) Folyóiratcikk [12537992]
96
* Cugno M, Zanichelli A, Foieni F, Caccia S, Cicardi M C1inhibitor deficiency and angioedema: molecular mechanisms and clinical progress Trends in Molecular Medicine (ISSN: 14714914) 15: (2) pp. 6978. ( 2009) Folyóiratcikk [11025830]
97
Cocchio C, Marzella N Cinryze, a human plasmaderived C1 esterase inhibitor for prophylaxis of hereditary angioedema P and T 34: (6) pp. 293328. ( 2009) Folyóiratcikk [11025829]
98
W eis Mark Clinical Review of Hereditary Angioedema: Diagnosis and Management POSTGRADUATE MEDICINE (ISSN: 00325481) 121: (6) pp. 113120. ( 2009) Folyóiratcikk [12537991]
99
Pettigrew H D, Teuber S S, Gershwin M E, Shoenfeld Y, Gershwin M Clinical significance of complement deficiencies In: Annals of the New York Academy of Sciences: Contemporary Challenges in Autoimmunity . (1173) New York: Wiley , 2009. (ISBN 9781573317627) pp. 108123.
Könyvrészlet [11025828] 100
Anonymous CrossSectional Guidelines: Cutting Edge in Scientific Evidence and P ractical Guidance TRANSFUSION MEDICINE AND HEMOTHERAPY (ISSN: 16603796) 36: (6) pp. 356482. ( 2009) Folyóiratcikk [12537996]
101 * Duan Q L, Binkley K, Rouleau G A Genetic analysis of Factor XII and bradykinin catabolic enzymes in a family with estrogendependent inherited angioedema Journal of Allergy and Clinical Immunology (ISSN: 00916749) 123: (4) pp. 906910. ( 2009) Folyóiratcikk [11025827] 102
Bygum A Hereditary angiooedema in Denmark: A nationwide survey British Journal of Dermatology (ISSN: 00070963) 161: (5) pp. 11531158. ( 2009) PubMed ID: 19709101 Folyóiratcikk [11025826]
103
Smith Jorge A, Duarte Dortas Jr S, Oliveira Rodrigues Valle S, Tavares França A Hereditary angioedema and chronic urticaria: Is there a possible association? Journal of Investigational Allergology and Clinical Immunology 19: (4) pp. 327328. ( 2009) Folyóiratcikk [11025825]
104
Chinniah N, Katelaris H Hereditary angioedema and pregnancy Australian and New Zealand Journal of Obstetrics and Gynaecology 49: (1) pp. 25. ( 2009) Folyóiratcikk [11025824]
105
Speletas M, Boukas K, PapadopoulouAlataki E, Tsitsami E, Germenis A E Hereditary angioedema in Greek families caused by novel and recurrent mutations Human Immunology (ISSN: 01988859) 70: (11) pp. 925929. ( 2009) Folyóiratcikk [11025823]
106
Kuş S, Yücelten D Hereditary angioedema: Report of three cases and approach to diagnosis and management: Herediter anjiyoödem: Üç olgu sunumu ve tani ve tedavide yaklaşim Turk Dermatoloji Dergisi 3: (2) pp. 4346. ( 2009) Folyóiratcikk [11025822]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
225/342
3/30/2015
nyomtatobarat forma 107
Lara Becerra A, Vega Morales D Hereditary angioedema: Series of cases and bibliography update: Angioedema hereditario: Serie de casos y actualización de la bibliografía Revista Alergia Mexico 56: (2) pp. 4855. ( 2009) Folyóiratcikk [11025821]
108
Moldovan D, Mihaly E, Popescu F D, Szöllösi G A, Dobreanu M Hereditary C1inhibitor esterase deficiency: A rather well defined entity Revista Romana de Medicina de Laborator 15: (2) pp. 4148. ( 2009) Folyóiratcikk [11025820]
109
Vanderschueren S, Mylle M, Dierickx D, Delforge M, Verhamme P, Peerlinck K, Meersseman W , Knockaert D C Monoclonal gammopathy of undetermined significance: Significant beyond hematology Mayo Clinic Proceedings (ISSN: 00256196) 84: (9) pp. 842845. ( 2009) Folyóiratcikk [11025818]
110 * Bossi F, Fischetti F, Regoli D, Durigutto P, Frossi B, Gobeil Jr F, Ghebrehiwet B, Peerschke E I, Cicardi M, Tedesco F Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency Journal of Allergy and Clinical Immunology (ISSN: 00916749) 124: (6) pp. 13031310. ( 2009) Folyóiratcikk [11025817] 111
Mishriki Y Y, Radermacher A, Maldonado E P uzzles in practice Postgraduate Medicine (ISSN: 00325481) 121: (4) pp. 173175. ( 2009) Folyóiratcikk [11025816]
112
Gesuete R, Storini C, Fantin A, Stravalaci M, Zanier E R, Orsini F, Vietsch H, Mannesse M L M, Ziere B, Gobbi M, De Simoni M G Recombinant C1 inhibitor in brain ischemic injury Annals of Neurology (ISSN: 03645134) 66: (3) pp. 332342. ( 2009) Folyóiratcikk [11025815]
113
Bygum A, Andersen K E, Mikkelson C S Selfadministration of intravenous C1inhibitor therapy for hereditary angioedema and associated quality of life benefits European Journal of Dermatology (ISSN: 11671122) 19: (2) pp. 147151. ( 2009) Folyóiratcikk [11025814]
114
RoussetJablonski C, Thalabard J C, Gompel A Tamoxifen contraindicated in women with hereditary angioedema? ANNALS OF ONCOLOGY (ISSN: 09237534) 20: (7) pp. 12811282. ( 2009) Folyóiratcikk [12537990]
115
Banerji Aleena, Sheffer Albert L The spectrum of chronic angioedema ALLERGY AND ASTHMA PROCEEDINGS (ISSN: 10885412) 30: (1) pp. 1116. ( 2009) Folyóiratcikk [12537994]
116
Pedrosa M, Caballero T, GómezTraseira C, Olveira A, LópezSerrano C Usefulness of abdominal ultrasonography in the followup of patients with hereditary C1inhibitor deficiency Annals of Allergy, Asthma and Immunology 102: (6) pp. 483486. ( 2009) Folyóiratcikk [11025813]
117
Craig Timothy, Riedl Marc, Dykewicz Mark S, Gower Richard G, Baker James, Edelman Frank J, Hurewitz David, Jacobs Joshua, Kalfus Ira When is prophylaxis for hereditary angioedema necessary? ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (ISSN: 10811206) 102: (5) pp. 366372. ( 2009) Folyóiratcikk [12537989]
118 * Kelemen Z, Visy B, Csuka D, Czaller I, Füst G, Farkas H Abdominal symptoms of hereditary angioedema and early weaning European Journal of Clinical Nutrition (ISSN: 09543007) 64: (9) pp. 10251027. ( 2010) Folyóiratcikk [11182239] 119
Breitbart S I, Bielory L Acquired angioedema: Autoantibody associations and C1q utility as a diagnostic tool Allergy and Asthma Proceedings (ISSN: 10885412) 31: (5) pp. 428434. ( 2010) Folyóiratcikk [11182238]
120
Yazawa T, O Higashi T, Daijo H, Shinomura T Anesthesia management for emergency laparotomy in a pediatric patient with suspected hereditary angioedema Journal of Anesthesia (ISSN: 09138668) 24: (1) pp. 121123. ( 2010) Folyóiratcikk [11025812]
121 * Cicardi Marco, Zanichelli Andrea Angioedema due to acquired C1 inhibitor deficiency IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (ISSN: 08898561) 30: (Suppl. 1) pp. 2934. ( 2010) Folyóiratcikk [12537988] 122
Halloy J L Angioedema food allergy or digestive pathology: L'angioedème allergie alimentaire ou pathologie digestive Revue Francaise d'Allergologie 50: (2) pp. 6265. ( 2010) Folyóiratcikk [11025811]
123
Hoover T, Lippmann M, Grouzmann E, Marceau F, Herscu P Angiotensin converting enzyme inhibitor induced angiooedema: A review of the pathophysiology and risk factors Clinical and Experimental Allergy (ISSN: 09547894) 40: (1) pp. 5061. ( 2010) Folyóiratcikk [11025810]
124 * Kelemen Z, Moldovan D, Mihály E, Visy B, Széplaki G, Csuka D, Füst G, Farkas H, Varga L Baseline level of functional C1inhibitor correlates with disease severity scores in hereditary angioedema Clinical Immunology (ISSN: 15216616) 134: (3) pp. 354358. ( 2010) Folyóiratcikk [11025809] 125
Lipsker D, Hauptmann G Cutaneous manifestations of complement deficiencies Lupus (ISSN: 09612033) 19: (9) pp. 10961106. ( 2010)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
226/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [11182237] 126
Maskatia Z K, Orson F M Delayed diagnosis of hereditary angioedema American Journal of the Medical Sciences (ISSN: 00029629) 340: (1) pp. 8283. ( 2010) Folyóiratcikk [11182236]
127
Nzeako U C Diagnosis and management of angioedema with abdominal involvement: A gastroenterology perspective World Journal of Gastroenterology (ISSN: 10079327) 16: (39) pp. 49134921. ( 2010) Folyóiratcikk [11182235]
128
Khan D A, Solensky R Drug allergy Journal of Allergy and Clinical Immunology (ISSN: 00916749) 125: (2 SUP P L. 2) pp. S126S137. ( 2010) Folyóiratcikk [11025808]
129
Stolz L E, Horn P T Ecallantide: A plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema Drugs of Today (ISSN: 16993993) 46: (8) pp. 547555. ( 2010) Folyóiratcikk [11577047]
130 * W ilson D A, Bork K, Shea E P, Rentz A M, Blaustein M B, Pullman W E Economic costs associated with acute attacks and longterm management of hereditary angioedema Annals of Allergy, Asthma and Immunology 104: (4) pp. 314320. ( 2010) PubMed ID: 20408341 Folyóiratcikk [11025807] 131
Bas M, Greve J, Bier H, Knopf A, Stark T, Schuler P, Hoffmann T K, Kojda G Emergency management of acute angioedema: Notfallsituation akutes angioödem Deutsche Medizinische Wochenschrift (ISSN: 00120472) 135: (20) pp. 10271031. ( 2010) Folyóiratcikk [11025806]
132
Bas M, Greve J, Bier H, Knopf A, Stark T, Schuler P, Hoffmann T K Emergency management of acute angioedema: Notfallsituation akutes Angioödem<sup>1 Notarzt (ISSN: 01772309) 26: (6) pp. 251255. ( 2010) Folyóiratcikk [11182232]
133
Kaplan A P Enzymatic pathways in the pathogenesis of hereditary angioedema: The role of C1 inhibitor therapy Journal of Allergy and Clinical Immunology (ISSN: 00916749) 126: (5) pp. 918925. ( 2010) Folyóiratcikk [11182231]
134
Csép K, Moldovan D Genetics of hereditary angioedema: Elemente de geneticǎ în angioedemul ereditar Revista Romana de Medicina de Laborator 18: (14) pp. 714. ( 2010) Folyóiratcikk [11025805]
135
DeShazo R D, Frank M M Genius at work: Osler's 1888 article on hereditary angioedema American Journal of the Medical Sciences (ISSN: 00029629) 339: (2) pp. 179181. ( 2010) Folyóiratcikk [11025804]
136 * Bouillet L Hereditary angioedema Revue de Medecine Interne (ISSN: 02488663) 31: (SUP P L.1) pp. S29S31. ( 2010) Folyóiratcikk [13475010] 137
Paiva M, Gaspar A, Loureiro V, LeiriaPinto P Hereditary angioedema characterization of a paediatric population: Angioedema hereditário Caracterização de uma população pediátrica Revista Portuguesa de Imunoalergologia 18: (2) pp. 157174. ( 2010) Folyóiratcikk [11577046]
138
Ebo D G, Verweij M M, De Knop K J, Hagendorens M M, Bridts C H, De Clerck L S, Stevens W J Hereditary angioedema in childhood: An approach to management Pediatric Drugs (ISSN: 11745878) 12: (4) pp. 257268. ( 2010) Folyóiratcikk [11182230]
139
Maurer M, Magerl M Hereditary angioedema: An update on available therapeutic options: Hereditäres Angioödem: Update zu verfügbaren Therapieoptionen JDDG Journal of the German Society of Dermatology 8: (9) pp. 663673. ( 2010) Folyóiratcikk [11182229]
140
Levy J H, Freiberger D J, Roback J Hereditary angioedema: Current and emerging treatment options Anesthesia and Analgesia (ISSN: 00032999) 110: (5) pp. 12711280. ( 2010) Folyóiratcikk [11025803]
141
Eidelman F J Hereditary angioedema: New therapeutic options for a potentially deadly disorder BMC Blood Disorders (ISSN: 14712326) 10: P aper 3. (2010) Folyóiratcikk [11025802]
142
Van Sickels N J, Hunsaker R B, Van Sickels J E Hereditary angioedema: treatment, management, and precautions in patients presenting for dental care Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology 109: (2) pp. 168172. ( 2010) Folyóiratcikk [11025801]
143
RamosRomey CJ, Craig TJ Idiopathic angioedema In: Challenging Cases in Allergic and Immunologic Diseases of the Skin. Springer New York, 2010. (ISBN 9781607612957) pp. 5972.
Könyvrészlet /Könyvfejezet /Tudományos [14420396] 144
Micali G, W est DP, Paller AS Immunodeficiency disorders
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
227/342
3/30/2015
nyomtatobarat forma In: Therapy of Skin Diseases: A Worldwide Perspective on Therapeutic Approaches and Their Molecular Basis. Springer Berlin Heidelberg, 2010. (ISBN 9783540788133) pp. 575588.
Könyvrészlet /Könyvfejezet /Tudományos [14420395] 145
Furlanetto Junior Vilson, Giassi Karina de Souza, Neves Fabricio de Souza, Zimmermann Adriana Fontes, W erner Castro Glaucio Ricardo, Pereira Ivanio Alves Intractable acquired autoimmune angioedema in a patient with systemic lupus erythematosus REVISTA BRASILEIRA DE REUMATOLOGIA (ISSN: 04825004) 50: (1) pp. 104106. ( 2010) Folyóiratcikk [12537987]
146
Lunn M L, Santos C B, Craig T J Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients? Annals of Allergy, Asthma and Immunology 104: (3) pp. 211214. ( 2010) Folyóiratcikk [11025800]
147 * Longhurst H J Management of acute attacks of hereditary angioedema: P otential role of icatibant Vascular Health and Risk Management (ISSN: 11766344) 6: (1) pp. 795802. ( 2010) Folyóiratcikk [11585786] 148
FaiyazUlHaque M, AlGazlan S, Abalkhail H A, AlAbdulatif A, Toulimat M, Peltekova I, Khaliq A M R, AlDayel F, Zaidi S H E Novel and recurrent mutations in the C1NH gene of arab patients affected with hereditary angioedema International Archives of Allergy and Immunology (ISSN: 10182438) 151: (2) pp. 149154. ( 2010) Folyóiratcikk [11025799]
149
Banta E, Craig T J Overview of ecallantide in the treatment of hereditary angioedema types i and II Therapy (ISSN: 14750708) 7: (5) pp. 565571. ( 2010) Folyóiratcikk [11182227]
150 * Farkas Henriette P ediatric aspects of hereditary angioedema: diagnosis, treatment, and followup IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (ISSN: 08898561) 30: (Suppl. 1) pp. 3542. ( 2010) Folyóiratcikk [12537986] 151
Spyridonidou A, Iatrou C, Alexoudis A, Vogiatzaki T, Polychronidis A, Simopoulos C P erioperative management of a patient with hereditary angioedema undergoing laparoscopic cholecystectomy Anaesthesia (ISSN: 00032409) 65: (1) pp. 7477. ( 2010) Folyóiratcikk [11025798]
152
Bernstein J A, Ritchie B, Levy R J, W asserman R L, Bewtra A K, Hurewitz D S, Obtulowicz K, Reshef A, Moldovan D, Shirov T, GrivchevaPanovska V, Kiessling P C, Schindel F, Craig T J P opulation pharmacokinetics of plasmaderived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks Annals of Allergy, Asthma and Immunology 105: (2) pp. 149154. ( 2010) Folyóiratcikk [11182226]
153
Craig T J, W asserman R L, Levy R J, Bewtra A K, Schneider L, Packer F, Yang W H, Keinecke H O, Kiessling P C P rospective study of rapid relief provided by C1 esterase inhibitor in emergency treatment of acute laryngeal attacks in hereditary angioedema Journal of Clinical Immunology (ISSN: 02719142) 30: (6) pp. 823829. ( 2010) Folyóiratcikk [11182225]
154 * Zuraw B, Cicardi M, Levy R J, Nuijens J H, Relan A, Visscher S, Haase G, Kaufman L, Hack C E Recombinant human C1inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema Journal of Allergy and Clinical Immunology (ISSN: 00916749) 126: (4) pp. 821827.e14. ( 2010) Folyóiratcikk [11182224] 155
Bernstein J A, Coleman S, Bonnin A J Successful C1 inhibitor shortterm prophylaxis during redo mitral valve replacement in a patient with hereditary angioedema Journal of Cardiothoracic Surgery (ISSN: 17498090) 5: (1) P aper 86. (2010) Folyóiratcikk [11182223]
156
Kaplan A P, Joseph K The bradykininforming cascade and its role in hereditary angioedema Annals of Allergy, Asthma and Immunology 104: (3) pp. 193204. ( 2010) Folyóiratcikk [11025797]
157 * Farkas H, Czaller I, Csuka D, Vas A, Valentin S, Varga L, Széplaki G, Jakab L, Füst G, Prohászka Z, Harmat G, Visy B, Karádi I The effect of longterm danazol prophylaxis on liver function in hereditary angioedemaa longitudinal study European Journal of Clinical Pharmacology (ISSN: 00316970) 66: (4) pp. 419426. ( 2010) Folyóiratcikk [11182222] 158 * Lumry W R, Castaldo A J, Vernon M K, Blaustein M B, W ilson D A, Horn P T The humanistic burden of hereditary angioedema: Impact on healthrelated quality of life, productivity, and depression Allergy and Asthma Proceedings (ISSN: 10885412) 31: (5) pp. 407414. ( 2010) Folyóiratcikk [11182221] 159 * Czaller I, Visy B, Csuka D, Füst G, Tóth F, Farkas H The natural history of hereditary angioedema and the impact of treatment with human C1inhibitor concentrate during pregnancy: A longterm survey European Journal of Obstetrics Gynecology and Reproductive Biology (ISSN: 03012115) 152: (1) pp. 4449. ( 2010) Folyóiratcikk [11182220] 160
W agner E, Frank M M Therapeutic potential of complement modulation Nature Reviews Drug Discovery (ISSN: 14741776) 9: (1) pp. 4356. ( 2010) Folyóiratcikk [11025796]
161
Magerl M, Keßler B, Maurer M Treatment of acute attacks of hereditary angioedema (HAE) with the bradykinin B2 receptor antagonist icatibant Revista Portuguesa de Imunoalergologia 18: (3) pp. 207214. ( 2010) Folyóiratcikk [11577045]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
228/342
3/30/2015
nyomtatobarat forma 162
Litzman J, Kuklínek P Treatment possibilities in hereditary angioedema: Léčebné možnosti u hereditárního angioedému (HAE) Alergie 12: (2) pp. 121125. ( 2010) Folyóiratcikk [11182219]
163
Al Marri MRHA, Al Nisf M, Al Marri ND Two cases of recurrent episodes of angio edema without urticaria or pruritus Qatar Medical Journal 19: (2) pp. 7273. ( 2010) Folyóiratcikk [12537979]
164 * VitratHincky V, Gompel A, DumestrePerard C, BocconGibod I, Drouet C, Cesbron J Y, Lunardi J, Massot C, Bouillet L Type III hereditary angiooedema: Clinical and biological features in a French cohort Allergy: European Journal of Allergy and Clinical Immunology 65: (10) pp. 13311336. ( 2010) Folyóiratcikk [11182218] 165
PapadopoulouAlataki E Upper airway considerations in hereditary angioedema Current Opinion in Allergy and Clinical Immunology (ISSN: 15284050) 10: (1) pp. 2025. ( 2010) Folyóiratcikk [11025795]
166
Raap U, Kapp A, W edi B Urticaria In: Pruritus. Springer London, 2010. (ISBN 9781848823211) pp. 103109.
Könyvrészlet /Könyvfejezet /Tudományos [14420394] 167
Ebo D G, De Knop K J, Maes J W , De Clerck L S, Stevens W J Vanishing tumour of the colon ascendens due to acquired type II C1inhibitor deficiency Acta Clinica Belgica (ISSN: 00015512) 65: (2) pp. 122126. ( 2010) Folyóiratcikk [11025794]
168 * Ferraro MF, Moreno AS, Castelli EC, Donadi EA, Palma MS, Arcuri HA, Lange AP, Bork K, Sarti W , Arruda LK A single nucleotide deletion at the C1 inhibitor gene as the cause of hereditary angioedema: Insights from a Brazilian family Allergy: European Journal of Allergy and Clinical Immunology 66: (10) pp. 13841390. ( 2011) Folyóiratcikk [12537970] 169
Vogetseder W , Tilg H Abdominal pain beyond IBS Gastroenterology (ISSN: 00165085) 140: (1) p. 34. ( 2011) Folyóiratcikk [11182217]
170
Klarin I, Kozić M, Nakić D, SantiniDušević D Acquired angioedema as the cause for acute abdomena case view: Stečeni angioedem kao uzrok akutnog abdomena prikaz slučaja Medica Jadertina 41: (12) pp. 5961. ( 2011) Folyóiratcikk [11577044]
171
Malik SS, Uppal H, Sinha A, Malik SS, Katam K, Srinivasan K Acute paediatric compartment syndrome of the hand caused by hereditary angiooedema Annals of the Royal College of Surgeons of England (ISSN: 00358843) 93: (7) pp. 138E140E. ( 2011) Folyóiratcikk [12537969]
172
Leimgruber A Allergyimmunology. New therapies for acute attacks in hereditary angioedema: Allergoimmunologie. Nouveautés dans le traitement des crises aiguës d'angiœdème héréditaire Revue Medicale Suisse (ISSN: 16609379) 7: (278) pp. 103105. ( 2011) Folyóiratcikk [11577043]
173
Verdi M, Shaker M An update on hereditary angioedema Advanced Emergency Nursing Journal 33: (2) pp. 163178. ( 2011) Folyóiratcikk [11577042]
174
Baliga M, Ramanathan A, Bhambar RS Angioedema triggered by pulp extirpationa case report Oral and Maxillofacial Surgery (ISSN: 18651550) 15: (4) pp. 253255. ( 2011) Folyóiratcikk [12537968]
175
Busse PJ Angioedema: Differential diagnosis and treatment Allergy and Asthma Proceedings (ISSN: 10885412) 32: (SUP P L. 1) pp. S3S11. ( 2011) Folyóiratcikk [12537967]
176
Scheirey C D, Scholz F J, Shortsleeve M J, Katz D S Angiotensinconverting enzyme inhibitorinduced smallbowel angioedema: Clinical and imaging findings in 20 patients American Journal of Roentgenology (ISSN: 0361803X) 197: (2) pp. 393398. ( 2011) Folyóiratcikk [11577041]
177 * Csuka D, Kelemen Z, Czaller I, Molnár K, Füst G, Varga L, Rajczy K, Szabó Z, Miklós K, Bors A, Farkas H Association of celiac disease and hereditary angioedema due to C1inhibitor deficiency. Screening patients with hereditary angioedema for celiac disease: Is it worth the effort? European Journal of Gastroenterology and Hepatology (ISSN: 0954691X) 23: (3) pp. 238244. ( 2011) Folyóiratcikk [11577040] 178
DuThanh A, RaisonPeyron N, Guillot B Bradykinin angioedemas: Les angioedmes à bradykinine Annales de Dermatologie et de Venereologie (ISSN: 01519638) 138: (4) pp. 328335. ( 2011) Folyóiratcikk [11577039]
179 * Bouillet L, BocconGibod I, Massot C Bradykinin mediated angioedema: Les angiœdèmes bradykiniques héréditaires ou acquis Revue de Medecine Interne (ISSN: 02488663) 32: (4) pp. 225231. ( 2011) Folyóiratcikk [11577038] 180
GiavinaBianchi P, França AT, Grumach AS, Motta AA, Fernandes FR, Campos RA, Valle SO, Rosário NA, Solé D Brazilian guidelines for the diagnosis and treatment of hereditary angioedema Clinics (ISSN: 18075932) 66: (9) pp. 16271636. ( 2011)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
229/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [12537966] 181
Valle SOR, França AT, Campos RA, Grumach AS C1 esterase inhibitor (human) for the treatment of acute Hereditary angioedema Clinical Medicine Insights: Blood Disorders 4: pp. 421430. ( 2011) Folyóiratcikk [12537965]
182 * Balanti E, Dimuzio G, Chimenti MS, Conigliaro P, Gracefa D, Guarino MD, Greco E, Kroegler B, Noveli L, Perricone C, Perricone R Complement factor C3 as marker of efficacy in patients with rheumatoid arthritis treated with antiTNFα agents: C3 come indicatore di efficacia terapeutica in pazienti con artrite reumatoide in terapia con inibitori del TNFα Italian Journal of Allergy and Clinical Immunology 21: (1) pp. 1117. ( 2011) Folyóiratcikk [12537978] 183 * Di Muzio G, Ballanti E, Chimenti MS, Conigliaro P, Graceffa D, Guarino MD, Greco E, Kroegler B, Novelli L, Perricone C, Perricone R Complement system and Rheumatoid Arthritis: Relationships with autoantibodies, serological, clinical features and antiTNF α treatment: Sistema complementare e artrite reumatoide: Correlazioni con autoanticorpi, caratteristiche cliniche e di laboratorio e farmaci antiTNF α Italian Journal of Allergy and Clinical Immunology 21: (3) pp. 7380. ( 2011) Folyóiratcikk [12537964] 184 * Di Muzio G, Perricone C, Ballanti E, Kroegler B, Greco E, Novelli L, Conigliaro P, Cipriani P, Giacomelli R, Perricone R Complement system and rheumatoid arthritis: Relationships with autoantibodies, serological, clinical features, and antiTNF treatment International Journal of Immunopathology and Pharmacology (ISSN: 03946320) 24: (2) pp. 357366. ( 2011) Folyóiratcikk [12537977] 185 * Caballero T, Baeza M, Cabañas R, Campos A, Cimbollek S, GómezTraseira C, GonzálezQuevedo T, Guilarte M, Jurado Palomo J, Larco J I, LópezSerrano M C, LópezTrascasa M, Marcos C, MuñozCaro J M, Pedrosa M, Prior N, Rubio M, SalaCunill A Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. P art I. classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis Journal of Investigational Allergology and Clinical Immunology 21: (5) pp. 333347. ( 2011) Folyóiratcikk [11585785] 186 * Caballero T, Baeza ML, Cabañas R, Campos A, Cimbollek S, GómezTraseira C, GonzálezQuevedo T, Guilarte M, Jurado Palomo J, Larco JI, LópezSerrano MC, LópezTrascasa M, Marcos C, MuñozCaro JM, Pedrosa M, Prior N, Rubio M, Sala Cunill A Consensus statement on the diagnosis, management, and treatment of angioedema mediated by Bradykinin. P art II. treatment, followup, and special situations Journal of Investigational Allergology and Clinical Immunology 21: (6) pp. 422441. ( 2011) Folyóiratcikk [12537963] 187
Collongues N, De Seze J Current and future treatment approaches for neuromyelitis optica Therapeutic Advances in Neurological Disorders (ISSN: 17562856) 4: (2) pp. 111121. ( 2011) Folyóiratcikk [11577037]
188
Riedl M, Gower R G, Chrvala C A Current medical management of hereditary angioedema: Results from a large survey of US physicians Annals of Allergy, Asthma and Immunology 106: (4) pp. 316322. ( 2011) Folyóiratcikk [11577036]
189
Zilberberg MD, Nathanson BH, Jacobsen T, Tillotson G Descriptive epidemiology of hereditary angioedema emergency department visits in the United States, 20062007 Allergy and Asthma Proceedings (ISSN: 10885412) 32: (5) pp. 390394. ( 2011) Folyóiratcikk [12537962]
190
Zilberberg M D, Nathanson B H, Jacobsen T, Tillotson G Descriptive epidemiology of hereditary angioedema hospitalizations in the United States, 20042007 Allergy and Asthma Proceedings (ISSN: 10885412) 32: (3) pp. 248254. ( 2011) Folyóiratcikk [11577035]
191
Johnston D T Diagnosis and management of Hereditary Angioedema Journal of the American Osteopathic Association 111: (1) pp. 2836. ( 2011) Folyóiratcikk [11577034]
192
El Koraichi A, Tadili J, Benjelloun MY, Benafitou R, El Kharraz H, Lahlou J, Chkoura M, El Haddoury M, EchChérif El Kettani SS Enapranilinduced angioedema in a 2yearold infant: Case report Cardiovascular Toxicology (ISSN: 15307905) 11: (4) pp. 382384. ( 2011) Folyóiratcikk [12537961]
193 * Perricone C, AgmonLevin N, Shoenfeld N, De Carolis C, Guarino M D, Gigliucci G, Milana I, Novelli L, Valesini G, Perricone R, Shoenfeld Y Evidence of impaired sense of smell in hereditary angioedema Allergy: European Journal of Allergy and Clinical Immunology 66: (1) pp. 149154. ( 2011) Folyóiratcikk [11182216] 194
Zamborský T, Desatová B, Bátovský M Gastrointestinal manifestation of hereditary angioedema in 24 year old patient Lekarsky Obzor (ISSN: 04574214) 60: (9) pp. 394396. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [13475009]
195 * Gower RG, Busse PJ, AygörenPürsün E, Barakat AJ, Caballero T, DavisLorton M, Farkas H, Hurewitz DS, Jacobs JS, Johnston DT, Lumry W , Maurer M Hereditary angioedema caused by C1esterase inhibitor deficiency: A literaturebased analysis and clinical commentary on prophylaxis treatment strategies World Allergy Organization Journal 4: (SUP P L. 2) pp. S9S21. ( 2011) Folyóiratcikk [12537976] 196
Bowen T Hereditary angioedema: Beyond international consensus circa December 2010 The Canadian Society of Allergy and Clinical Immunology Dr. David McCourtie Lecture
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
230/342
3/30/2015
nyomtatobarat forma Allergy, Asthma and Clinical Immunology (ISSN: 17101484) 7: (1) P aper 1. (2011) Folyóiratcikk [12537975] 197
Banerji A Hereditary angioedema: Classification, pathogenesis, and diagnosis Allergy and Asthma Proceedings (ISSN: 10885412) 32: (6) pp. 403407. ( 2011) Folyóiratcikk [12537960]
198
Khan D A Hereditary angioedema: Historical aspects, classification, pathophysiology, clinical presentation, and laboratory diagnosis Allergy and Asthma Proceedings (ISSN: 10885412) 32: (1) pp. 110. ( 2011) Folyóiratcikk [11577033]
199 * Perricone C, De Carolis C, Giacomelli R, Greco E, Cipriani P, Ballanti E, Novelli L, Perricone R Inhibition of the complement system by glutathione: Molecular mechanisms and potential therapeutic implications International Journal of Immunopathology and Pharmacology (ISSN: 03946320) 24: (1) pp. 6368. ( 2011) Folyóiratcikk [12537974] 200 * Cicardi M, Cugno M Kallikreinkinin system in angioedema In: Kinins. Walter de Gruy ter GmbH and Co. KG, 2011. (ISBN 9783110252347) pp. 289306.
Könyvrészlet [13475008] 201
MajlufCruz A, NietoMartínez S Longterm follow up analysis of nadroparin for hereditary angioedema. A preliminary report International Immunopharmacology (ISSN: 15675769) 11: (8) pp. 11271132. ( 2011) Folyóiratcikk [12537973]
202
Maurer M, Magerl M Longterm prophylaxis of hereditary angioedema with androgen derivates: A critical appraisal and potential alternatives: Langzeitprophylaxe des heredit? ren Angioödems mit ndrogenderivaten: kritische Bewertung und mögliche Alternativen JDDG Journal of the German Society of Dermatology 9: (2) pp. 99108. ( 2011) Folyóiratcikk [11577032]
203 * Floccard B, Crozon J, Rimmelé T, Vulliez A, Coppere B, Chamouard V, BocconGibod I, Bouillet L, Allaouchiche B Management of bradykininmediated angioedema: P rise en charge en urgence de l'angiœdème à bradykinine Annales Francaises d'Anesthesie et de Reanimation 30: (78) pp. 578588. ( 2011) Folyóiratcikk [11577031] 204 * Bygum A, Fagerberg C R, Ponard D, Monnier N, Lunardi J, Drouet C Mutational spectrum and phenotypes in Danish families with hereditary angioedema because of C1 inhibitor deficiency Allergy: European Journal of Allergy and Clinical Immunology 66: (1) pp. 7684. ( 2011) Folyóiratcikk [11182215] 205
Parikh N, Riedl M A New therapeutics in C1INH deficiency: A review of recent studies and advances Current Allergy and Asthma Reports (ISSN: 15297322) 11: (4) pp. 300308. ( 2011) Folyóiratcikk [11585784]
206 * Maurer M, Bader M, Bas M, Bossi F, Cicardi M, Cugno M, Howarth P, Kaplan A, Kojda G, LeebLundberg F, Lötvall J, Magerl M New topics in bradykinin research Allergy: European Journal of Allergy and Clinical Immunology 66: (11) pp. 13971406. ( 2011) Folyóiratcikk [12537959] 207
Thomas MC, Shah S New treatment options for acute edema attacks caused by hereditary angioedema American Journal of HealthSystem Pharmacy (ISSN: 10792082) 68: (22) pp. 21292138. ( 2011) Folyóiratcikk [12537958]
208 * Csuka D, Füst G, Farkas H, Varga L P arameters of the classical complement pathway predict disease severity in hereditary angioedema Clinical Immunology (ISSN: 15216616) 139: (1) pp. 8593. ( 2011) Folyóiratcikk [11577030] 209
Luz S, da Silva JA, Barbosa F, Santos AS, Ferreira MB, Barbosa MP Quality of life evaluation in patients with hereditary angioedema: Avaliação da qualidade de vida em doentes com angioedema hereditário Revista Portuguesa de Imunoalergologia 19: (3) pp. 143149. ( 2011) Folyóiratcikk [12537972]
210
Banta E, Horn P, Craig T J Response to ecallantide treatment of acute attacks of hereditary angioedema based on time to intervention: Results from the EDEMA clinical trials Allergy and Asthma Proceedings (ISSN: 10885412) 32: (4) pp. 319324. ( 2011) Folyóiratcikk [11577029]
211 * Varga L, Farkas H rhC1INH: A new drug for the treatment of attacks in hereditary angioedema caused by C1inhibitor deficiency Expert Review of Clinical Immunology (ISSN: 1744666X) 7: (2) pp. 143153. ( 2011) Folyóiratcikk [11577028] 212
Park SW , Bae IY, Eun HW , Park HW , Choe JW Smallbowel angioedema during screening computed tomography due to intravenous contrast material Journal of Computer Assisted Tomography (ISSN: 03638715) 35: (5) pp. 549552. ( 2011) Folyóiratcikk [12537957]
213 * Zanichelli A, Vacchini R, Badini M, Penna V, Cicardi M Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: A 21month prospective study in a cohort of 103 patients Allergy: European Journal of Allergy and Clinical Immunology 66: (2) pp. 192196. ( 2011) Folyóiratcikk [11182214] 214 * Czaller I, Molnár K, Csuka D, Varga L, Farkas H Successful outcome using C1inhibitor concentrate in acute pancreatitis caused by hereditary angioedema Gastroenterology Nursing (ISSN: 1042895X) 34: (1) pp. 6063. ( 2011) Folyóiratcikk [11577027]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
231/342
3/30/2015
nyomtatobarat forma 215
Tourangeau LM, Zuraw BL The new era of C1esterase inhibitor deficiency therapy Current Allergy and Asthma Reports (ISSN: 15297322) 11: (5) pp. 345351. ( 2011) Folyóiratcikk [12537956]
216
Kesim B, Uyguner ZO, Gelincik A, Gökmen NM, Sin AZ, Karakaya G, Erdenen F, Ardeniz O, Özşeker F, Gülbahar O, Çolakoǧlu B, Dal M, Büyüköztürk S The turkish hereditary angioedema pilot study (TURHAP S): The first turkish series of hereditary angioedema International Archives of Allergy and Immunology (ISSN: 10182438) 156: (4) pp. 443450. ( 2011) Folyóiratcikk [12537955]
217
Antoniu Sabina Antonela Therapeutic Approaches in Hereditary Angioedema CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (ISSN: 10800549) 41: (1) pp. 114122. ( 2011) Folyóiratcikk [12537985]
218 * Varga L, Füst G, Csuka D, Farkas H Treatment with C1inhibitor concentrate does not induce IgM type antiC1 inhibitor antibodies in patients with hereditary angioedema Molecular Immunology (ISSN: 01615890) 48: (4) pp. 572576. ( 2011) Folyóiratcikk [11182213] 219
Riedl M A Update on the acute treatment of hereditary angioedema Allergy and Asthma Proceedings (ISSN: 10885412) 32: (1) pp. 1116. ( 2011) Folyóiratcikk [11577026]
220
Galdi E, Cremonte LG Acquired C1inhibitor deficiency: A case report European Annals of Allergy and Clinical Immunology 44: (4) pp. 178180. ( 2012) Folyóiratcikk [13475007]
221 * Floccard B, Hautin E, Bouillet L, Coppere B, Allaouchiche B An evidencebased review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type i and II Core Evidence 7: pp. 105114. ( 2012) Folyóiratcikk [13475006] 222 * Mena de la Cruz Rocio, LopezLera Alberto, LopezTrascasa Margarita Analysis of SERP ING1 expression on hereditary angioedema patients: Quantitative analysis of fulllength and exon 3 splicing variants IMMUNOLOGY LETTERS (ISSN: 01652478) 141: (2) pp. 158164. ( 2012) Folyóiratcikk [12424720] 223
Rye Rasmussen EH, BindslevJensen C, Bygum A Angioødem udredning og behandling Tidsskrift for den Norske Laegeforening (ISSN: 00292001) 132: (21) pp. 23912395. ( 2012) Folyóiratcikk [13371025]
224
Baş M Clinical efficacy of icatibant in the treatment of acute hereditary angioedema during the FAST3 trial Expert Review of Clinical Immunology (ISSN: 1744666X) 8: (8) pp. 707717. ( 2012) Folyóiratcikk [13371024]
225 * Kusuma A, Relan A, Knulst AC, Moldovan D, Zuraw B, Cicardi M, Levy RJ, Nuijens JH, Hack CE Clinical impact of peripheral attacks in hereditary angioedema patients American Journal of Medicine (ISSN: 00029343) 125: (9) pp. 937.e17937.e24. ( 2012) Folyóiratcikk [12537954] 226
Zhou ZH, Chen TN, Arora K, Hyams K, Kozlowski S Complement C1 Esterase Inhibitor Levels Linked to Infections and Contaminated HeparinAssociated Adverse Events PLOS ONE (ISSN: 19326203) 7: (4) P aper e34978. (2012) Folyóiratcikk [12529741]
227 * Chimenti M S, Perricone C, Graceffa D, Di Muzio G, Ballanti E, Guarino M D, Conigliaro P, Greco E, Kroegler B, Perricone R Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of antiTNF treatment CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (ISSN: 0392856X) 30: (1) pp. 2330. ( 2012) Folyóiratcikk [12424719] 228 * McMillan Carolyn Vivienne, Speight Jane, Relan Anurag, Bellizzi Luca, Haase Gerald, Cicardi Marco Content Validity of Visual Analog Scales to Assess Symptom Severity of Acute Angioedema Attacks in Adults with Hereditary Angioedema An Interview Study PATIENTPATIENT CENTERED OUTCOMES RESEARCH (ISSN: 11781653) 5: (2) pp. 113126. ( 2012) Folyóiratcikk [12424718] 229 * Defendi F, Charignon D, Csopaki F, Ponard D, Drouet C Current biological investigations of kininmediated angioedema: Actualités biologiques sur les angioedèmes à kinines Revue Francophone des Laboratoires 2012: (444) pp. 3952. ( 2012) Folyóiratcikk [12537953] 230
Prior Nieves, Remor Eduardo, GomezTraseira Carmen, LopezSerrano Concepcion, Cabanas Rosario, Contreras Javier, Campos Angel, Cardona Victoria, Cimbollek Stefan, GonzalezQuevedo Teresa, Guilarte Mar, Fernandez de Rojas Dolores Hernandez, Marcos Carmen, Rubio Maria, Angel TejedorAlonso Miguel, Caballero Teresa Development of a diseasespecific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAEQoL): Spanish multicentre research project HEALTH AND QUALITY OF LIFE OUTCOMES (ISSN: 14777525) 10: P aper 82. (2012) Folyóiratcikk [12862464]
231
Moellman JJ, Bernstein JA Diagnosis and management of hereditary angioedema: An emergency medicine perspective Journal of Emergency Medicine (ISSN: 07364679) 43: (2) pp. 391400. ( 2012) Folyóiratcikk [12537952]
232
Canonica G W , Rossi O
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
232/342
3/30/2015
nyomtatobarat forma Diagnosis and treatment of hereditary angioedema PANMINERVA MEDICA (ISSN: 00310808) 54: (3) pp. 241253. ( 2012) Folyóiratcikk [12862364] 233
Magerl M, Brasch J, Forster U, Hauswald B, Mohr B, Prassler J, Treudler R, Vetter R, W ahn V, Zampelli V, Ziemer M, Maurer M Diagnostics and exclusion of hereditary angioedema. A standarized approach for the practice HAUTARZT (ISSN: 00178470) 63: (7) pp. 567572. ( 2012) Folyóiratcikk [12529740]
234
Dalle Lucca JJ, Li Y, Simovic M, Pusateri AE, Falabella M, Dubick MA, Tsokos GC Effects of C1 inhibitor on tissue damage in a porcine model of controlled hemorrhage Shock 38: (1) pp. 8291. ( 2012) Folyóiratcikk [12537951]
235
Caballero Teresa Efficacy Assessments in Randomized Controlled Studies of Acute Therapy for Hereditary Angioedema JOURNAL OF CLINICAL IMMUNOLOGY (ISSN: 02719142) 32: (6) pp. 12041212. ( 2012) Folyóiratcikk [12862363]
236 * Czucz Judit, Schaffer Gyula, Csuka Dorottya, W alentin Szilvia, Kunde Jan, Prohaszka Zoltan, Farkas Henriette, Cervenak Laszlo Endothelial Cell Function in P atients with Hereditary Angioedema: Elevated Soluble Eselectin Level During Interattack P eriods JOURNAL OF CLINICAL IMMUNOLOGY (ISSN: 02719142) 32: (1) pp. 6169. ( 2012) Folyóiratcikk [12424717] 237 * Cicardi M, Bork K, Caballero T, Craig T, Li H H, Longhurst H, Reshef A, Zuraw B Evidencebased recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group ALLERGY (ISSN: 01054538) 67: (2) pp. 147157. ( 2012) CA Hawk Hereditary Angioedema Int W o Folyóiratcikk [12424716] 238 * Cicardi Marco, Johnston Douglas T Hereditary and Acquired Complement Component 1 Esterase Inhibitor Deficiency: A Review for the Hematologist ACTA HAEMATOLOGICA (ISSN: 00015792) 127: (4) pp. 208220. ( 2012) Folyóiratcikk [12424715] 239 * Longhurst H, Cicardi M Hereditary angiooedema The Lancet 379: (9814) pp. 474481. ( 2012) Folyóiratcikk [12537950] 240
Yamamoto Tetsuro, Horiuchi Takahiko, Miyahara Hisaaki, Yoshizawa Shigeru, Maehara Junichi, Shono Eisuke, Takamura Kazuto, Machida Haruhisa, Tsujioka Kaoru, Kaneko Takehiko, Uemura Naoki, Suzawa Kenichi, Inagaki Norihiko, Umegaki Noriko, Kasamatsu Yoshihiro, Hara Akihito, Arinobu Yojiro, Inoue Yasushi, Niiro Hiroaki, Kashiwagai Yoichiro, Harashima ShinIchi, Tahira Tomoko, Tsukamoto Hiroshi, Akashi Koichi Hereditary Angioedema in Japan: Genetic Analysis of 13 Unrelated Cases AMERICAN JOURNAL OF THE MEDICAL SCIENCES (ISSN: 00029629) 343: (3) pp. 210214. ( 2012) Folyóiratcikk [12424714]
241
W all M Hereditary angioedema presenting as refractory urticaria: A case report Osteopathic Family Physician 4: (1) pp. 2428. ( 2012) Folyóiratcikk [12537949]
242
Riedl Marc Hereditary Angioedema Therapies in the United States: Movement Toward an International Treatment Consensus CLINICAL THERAPEUTICS (ISSN: 01492918) 34: (3) pp. 623630. ( 2012) Folyóiratcikk [12424713]
243
Aberer W Hereditary angioedema treatment options: The availability of new therapies Annals of Medicine (ISSN: 07853890) 44: (6) pp. 523529. ( 2012) Folyóiratcikk [12537948]
244
Jaiganesh T, Hughan C, W ebster A, Bethune C Hereditary angioedema: a survey of UK emergency departments and recommendations for management EUROPEAN JOURNAL OF EMERGENCY MEDICINE (ISSN: 09699546) 19: (4) pp. 271274. ( 2012) Folyóiratcikk [12529739]
245 * Bouillet L Hereditary angioedema: A therapeutic revolution REVUE DE MEDECINE INTERNE (ISSN: 02488663) 33: (3) pp. 150154. ( 2012) Folyóiratcikk [12424712] 246
Viegas LP, Ferreira MB, Santos AS, Barbosa MP Hereditary angioedema: Experience with icatibant in severe attacks: Angioedema hereditário: Experiência com icatibant em crises graves Revista Portuguesa de Imunoalergologia 20: (2) pp. 129137. ( 2012) Folyóiratcikk [12537947]
247 * Zanichelli A, Bova M, Coerezza A, Petraroli A, Triggiani M, Cicardi M Icatibant treatment for acquired C1inhibitor deficiency: a realworld observational study ALLERGY (ISSN: 01054538) 67: (8) pp. 10741077. ( 2012) Folyóiratcikk [12529738] 248 * Hack CE, Mannesse M, Baboeram A, Oortwijn B, Relan A Immunogenicity assessment of recombinant human C1inhibitor: An integrated analysis of clinical studies BioDrugs (ISSN: 11738804) 26: (5) pp. 303313. ( 2012) Folyóiratcikk [13475005] 249 * Caballero Teresa, Farkas Henriette, Bouillet Laurence, Bowen Tom, Gompel Anne, Fagerberg Christina, Bjokander Janne, Bork Konrad, Bygum Anette, Cicardi Marco, de Carolis Caterina, Frank Michael, Gooi Jimmy H C, Longhurst Hilary, MartinezSaguer Inmaculada, Nielsen Erik W aage, Obtulowitz Krystina, Perricone Roberto, Prior Nieves
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
233/342
3/30/2015
nyomtatobarat forma International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (ISSN: 00916749) 129: (2) pp. 308320. ( 2012) Folyóiratcikk [12424711] 250
Lang David M, Aberer W erner, Bernstein Jonathan A, Chng Hiok Hee, Grumach Anete Sevciovic, Hide Michihiro, Maurer Marcus, W eber Richard, Zuraw Bruce International consensus on hereditary and acquired angioedema ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (ISSN: 10811206) 109: (6) pp. 395402. ( 2012) Folyóiratcikk [12862362]
251
Lane Charles Joseph, Grant J Andrew, Dougherty Dane III Life with Hereditary Angioedema: Then and Now POSTGRADUATE MEDICINE (ISSN: 00325481) 124: (1) pp. 144151. ( 2012) Folyóiratcikk [12424710]
252 * Nzeako Ugochukwu C, Longhurst Hilary J Many faces of angioedema: focus on the diagnosis and management of abdominal manifestations of hereditary angioedema EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (ISSN: 0954691X) 24: (4) pp. 353361. ( 2012) Folyóiratcikk [12424709] 253 * Groener Albrecht, Nowak Thomas, Schaefer W olfram P athogen safety of human C1 esterase inhibitor concentrate TRANSFUSION (ISSN: 00411132) 52: (10) pp. 21042112. ( 2012) Folyóiratcikk [12862361] 254
Bernstein JA, Moellman JJ P rogress in the Emergency Management of Hereditary Angioedema: Focus on New Treatment Options in the United States POSTGRADUATE MEDICINE (ISSN: 00325481) 124: (3) pp. 91100. ( 2012) Folyóiratcikk [12529737]
255
Stolz LE, Sheffer AL P rospective, doubleblind, placebocontrolled trials of ecallantide for acute attacks of hereditary angioedema Expert Review of Clinical Immunology (ISSN: 1744666X) 8: (1) pp. 2532. ( 2012) Folyóiratcikk [12537946]
256 * Tourangeau Louanne M, Castaldo Anthony J, Davis Donna K, Koziol James, Christiansen Sandra C, Zuraw Bruce L Safety and Efficacy of P hysicianSupervised SelfManaged C1 Inhibitor Replacement Therapy INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (ISSN: 10182438) 157: (4) pp. 417424. ( 2012) Folyóiratcikk [12424708] 257
Zuraw BL, Kalfus I Safety and efficacy of prophylactic nanofiltered C1inhibitor in hereditary angioedema American Journal of Medicine (ISSN: 00029343) 125: (9) pp. 938.e1938.e7. ( 2012) Folyóiratcikk [12537945]
258 * Farkas H, Zotter Z, Csuka D, Szabo E, Nebenfuhrer Z, Temesszentandrasi G, Jakab L, Varga L, Harmat G, Karadi I Shortterm prophylaxis in hereditary angioedema due to deficiency of the C1inhibitor a longterm survey ALLERGY (ISSN: 01054538) 67: (12) pp. 15861593. ( 2012) Folyóiratcikk [12862360] 259 * Csuka D, Varga L, Farkas H, Füst G Strong correlation of high EBNA1IgG levels with edematous attacks involving upper airway mucosa in hereditary angioedema due to C1inhibitor deficiency Molecular Immunology (ISSN: 01615890) 49: (4) pp. 649654. ( 2012) Folyóiratcikk [12537944] 260
Klausegger A, W iednig M, Urban C, Lackner H, Reiter H, Bauer J W , Aberer W Successful allogeneic cord blood transplantation in a patient with Evans syndrome leads to correction of hereditary angioedema type I as secondary effect BONE MARROW TRANSPLANTATION (ISSN: 02683369) 47: (9) pp. 12591261. ( 2012) Folyóiratcikk [12862463]
261
Shum Mili, Jariwala Sunit P, Rosenstreich David Successful C1 inhibitor prophylaxis during zenker diverticulum repair in a patient with hereditary angioedema ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (ISSN: 10811206) 108: (2) pp. 126128. ( 2012) Folyóiratcikk [12424707]
262
Christensen Edward, Hurewitz David, Sullivan Steven Successful Hereditary Angioedema P rophylaxis With C1 Inhibitor in Orthognathic Surgery JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (ISSN: 02782391) 70: (6) pp. 14561458. ( 2012) Folyóiratcikk [12424706]
263
Hermans Cedric, Vorst Sebastien VanDer, Lambert Catherine Successful management of hereditary angioedema during tonsillectomy: a case report BLOOD COAGULATION AND FIBRINOLYSIS (ISSN: 09575235) 23: (2) pp. 155157. ( 2012) Folyóiratcikk [12424705]
264 * Farkas H, Csuka D, Tóth F, Koszegi L, Varga L Successful pregnancy outcome after treatment with C1inhibitor concentrate in a patient with hereditary angioedema and a history of four miscarriages European Journal of Obstetrics Gynecology and Reproductive Biology (ISSN: 03012115) 165: (2) pp. 366367. ( 2012) Folyóiratcikk [13371023] 265 * Bygum A, AygörenPürsün E, Caballero T, Beusterien K, Gholizadeh S, Musingarimi P, W ait S, Boysen H The hereditary angioedema burden of illness study in Europe (HAEBOISEurope): Background and methodology BMC Dermatology (ISSN: 14715945) 12: P aper 4. (2012) Folyóiratcikk [13475003] 266
Demirturk Mustafa, Polat Nihat, Guz Goksel, Gurdal Ahmet, Altun Ibrahim, Gelincik Asli, Toz Bahtiyar, Oflaz Huseyin, Colakoglu Bahattin, Dal Murat, Buyukozturk Suna There is an increased risk of atherosclerosis in hereditary angioedema INTERNATIONAL IMMUNOPHARMACOLOGY (ISSN: 15675769) 12: (1) pp. 212216. ( 2012) Folyóiratcikk [12424704]
267
Richman MJ, Talan DA, Lumry W R
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
234/342
3/30/2015
nyomtatobarat forma Treatment of laryngeal hereditary angioedema Journal of Emergency Medicine (ISSN: 07364679) 42: (1) pp. 4447. ( 2012) Folyóiratcikk [12537943] 268
Guilarte Mar Update in hereditary angioedema due to C1 inhibitor deficiency MEDICINA CLINICA (ISSN: 00257753) 139: (10) pp. 452457. ( 2012) Folyóiratcikk [12862359]
269
Boccongibod I Urticaria/angioedema histaminergic or bradykininmediated? : Urticaire/angioedème histaminique ou bradykinique ? Revue Francaise d'Allergologie 52: (4) pp. 327332. ( 2012) Folyóiratcikk [12537942]
270
Zuraw BL, Bernstein JA, Lang DM, Craig T, Dreyfus D, Hsieh F, Khan D, Sheikh J, W eldon D, Bernstein DI, BlessingMoore J, Cox L, Nicklas RA, Oppenheimer J, Portnoy JM, Randolph CR, Schuller DE, Spector SL, Tilles SA, W allace D A focused parameter update: Hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensinconverting enzyme inhibitorassociated angioedema Journal of Allergy and Clinical Immunology (ISSN: 00916749) 131: (6) pp. 14911493.e25. ( 2013) Folyóiratcikk [13371022]
271
Baram M, Kommuri A, Sellers SA, Cohn JR ACE InhibitorInduced Angioedema Journal of Allergy and Clinical Immunology: In Practice 1: (5) pp. 442445. ( 2013) Folyóiratcikk [13371021]
272
Bygum A, Vestergaard H Acquired angioedema Occurrence, clinical features and associated disorders in a danish nationwide patient cohort International Archives of Allergy and Immunology (ISSN: 10182438) 162: (2) pp. 149155. ( 2013) Folyóiratcikk [13371020]
273 * Castelli R, Zanichelli A, Cicardi M, Cugno M Acquired C1inhibitor deficiency and lymphoproliferative disorders: A tight relationship Critical Reviews in Oncology/Hematology 87: (3) pp. 323332. ( 2013) Folyóiratcikk [13371019] 274
Jaiganesh T, W iese M, Hollingsworth J, Hughan C, Kamara M, W ood P, Bethune C Acute angioedema: Recognition and management in the emergency department European Journal of Emergency Medicine (ISSN: 09699546) 20: (1) pp. 1017. ( 2013) Folyóiratcikk [13371018]
275
Navarro Ruiz A, Crespo Diz C, Poveda Andrés JL, Cebollero De Torre A Algorithm for diagnosis and treatment of hereditary angioedema as a tool for management Farmacia Hospitalaria (ISSN: 11306343) 37: (6) pp. 521529. ( 2013) Folyóiratcikk /Tudományos [13834976]
276
Campo P, Fernandez TD, Canto G, Mayorga C Angioedema induced by angiotensinconverting enzyme inhibitors Current Opinion in Allergy and Clinical Immunology (ISSN: 15284050) 13: (4) pp. 337344. ( 2013) Folyóiratcikk [13371017]
277
Sher J, DavisLorton M Angioedema with normal laboratory values: The next step Current Allergy and Asthma Reports (ISSN: 15297322) 13: (5) pp. 563570. ( 2013) Folyóiratcikk [13475002]
278
Lewis LM Angioedema: Etiology, pathophysiology, current and emerging therapies Journal of Emergency Medicine (ISSN: 07364679) 45: (5) pp. 789796. ( 2013) Folyóiratcikk [13475001]
279 * Saule C, BocconGibod I, Fain O, Kanny G, PluBureau G, Martin L, Launay D, Bouillet L, Gompel A Benefits of progestin contraception in nonallergic angioedema Clinical and Experimental Allergy (ISSN: 09547894) 43: (4) pp. 475482. ( 2013) Folyóiratcikk [13371016] 280 * BocconGibod I, Bouillet L Bradykininmediated angioedemas: Therapeutic approach in 2013 Revue Francaise d'Allergologie 53: (3) pp. 195200. ( 2013) Folyóiratcikk [13371015] 281
Xu YY, Jiang Y, Zhi YX, Yin J, W ang LL, W en LP, Gu JQ, Guan K, Zhang HY Clinical features of hereditary angioedema in chinese patients: New findings and differences from other populations European Journal of Dermatology (ISSN: 11671122) 23: (4) pp. 500504. ( 2013) Folyóiratcikk [13371014]
282
Katz DS, Scheirey CD, Bordia R, Hines JJ, Javors BR, Scholz FJ Computed Tomography of Miscellaneous Regional and Diffuse Small Bowel Disorders Radiologic Clinics of North America (ISSN: 00338389) 51: (1) pp. 4568. ( 2013) Folyóiratcikk [13371013]
283
Kawalec P, Holko P, Paszulewicz A Costutility analysis of Ruconest® (conestat alfa) compared to Berinert® P (human C1 esterase inhibitor) in the treatment of acute, lifethreatening angioedema attacks in patients with hereditary angioedema Postepy Dermatologii i Alergologii (ISSN: 1642395X) 30: (3) pp. 152158. ( 2013) Folyóiratcikk [13371012]
284
Riedl MA Creating a Comprehensive Treatment P lan for Hereditary Angioedema Immunology and Allergy Clinics of North America (ISSN: 08898561) 33: (4) pp. 471485. ( 2013) Folyóiratcikk [13475000]
285 * Farkas H Current pharmacotherapy of bradykininmediated angioedema Expert Opinion on Pharmacotherapy (ISSN: 14656566) 14: (5) pp. 571586. ( 2013) Folyóiratcikk [13371011]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
235/342
3/30/2015
nyomtatobarat forma 286 * LópezLera A, Cabo FS, Garrido S, Dopazo A, LópezTrascasa M Diseasemodifying factors in hereditary angioedema: An RNA expressionbased screening Orphanet Journal of Rare Diseases (ISSN: 17501172) 8: (1) P aper 77. (2013) Folyóiratcikk [13371010] 287
Hassen GW , Tu TJ, W ei DH, Hwang A, Lamothe R, Costea A, Liyun Liu L, Smith T, Mualim F, Johnston P, Ming W ai Ng J, Usmani S, Kalantari H Does angiotensinconverting enzyme inhibitor use exacerbate hereditary angioedema? Journal of Emergency Medicine (ISSN: 07364679) 45: (4) pp. 602608. ( 2013) Folyóiratcikk [13371009]
288
Hassen GW , Kalantari H, Parraga M, Chirurgi R, Meletiche C, Chan C, Ciarlo J, Gazi F, Lobaito C, Tadayon S, Yemane S, Velez C Fresh frozen plasma for progressive and refractory angiotensinconverting enzyme inhibitorinduced angioedema Journal of Emergency Medicine (ISSN: 07364679) 44: (4) pp. 764772. ( 2013) Folyóiratcikk [13371008]
289
Kjær L, Bygum A Hereditary angioedema in childhood: A challenging diagnosis you cannot afford to miss Pediatric Dermatology (ISSN: 07368046) 30: (1) pp. 9496. ( 2013) Folyóiratcikk [13371007]
290
Rijavec M, Korošec P, Šilar M, Zidarn M, Miljković J, Košnik M Hereditary Angioedema Nationwide Study in Slovenia Reveals Four Novel Mutations in SERP ING1 Gene PLoS ONE (ISSN: 19326203) 8: (2) P aper e56712. (2013) Folyóiratcikk [13371006]
291 * Bouillet L, Launay D, Fain O, BocconGibod I, Laurent J, Martin L, Montauban V, Finck K, Bouée S, Gompel A, Kanny G Hereditary angioedema with C1 inhibitor deficiency: Clinical presentation and quality of life of 193 French patients Annals of Allergy, Asthma and Immunology 111: (4) pp. 290294. ( 2013) Folyóiratcikk [13371003] 292 * Zanichelli A, Magerl M, Longhurst H, Fabien V, Maurer M Hereditary angioedema with C1 inhibitor deficiency: Delay in diagnosis in Europe Allergy, Asthma and Clinical Immunology (ISSN: 17101484) 9: (1) pp. 14. ( 2013) Folyóiratcikk [13371002] 293
Ghazi A, Andrew Grant J Hereditary angioedema: Epidemiology, management, and role of icatibant Biologics: Targets and Therapy 7: (1) pp. 103113. ( 2013) Folyóiratcikk [13371001]
294
Gomide MACMS, Toledo E, Valle SOR, Campos RA, França AT, Gomez NP, Andrade Jr HF, Caballero T, Grumach AS Hereditary angioedema: Quality of life in Brazilian patients Clinics (ISSN: 18075932) 68: (1) pp. 8183. ( 2013) Folyóiratcikk [13371000]
295 * Hack CE, Relan A, Baboeram A, Oortwijn B, Versteeg S, Van Ree R, Pijpstra R Immunosafety of recombinant human C1inhibitor in hereditary angioedema: Evaluation of IgE antibodies Clinical Drug Investigation (ISSN: 11732563) 33: (4) pp. 275281. ( 2013) Folyóiratcikk [13370999] 296
Sullivan KE Inherited Complement Deficiencies In: Emery and Rimoin's Principles and Practice of Medical Genetics. Elsevier Ltd, 2013. (ISBN 9780123838346) pp. 113.
Könyvrészlet [13370998] 297
Bhattacharjee G, Revenko AS, Crosby JR, May C, Gao D, Zhao C, Monia BP, MacLeod AR Inhibition of vascular permeability by antisensemediated inhibition of plasma kallikrein and coagulation factor 12 Nucleic Acid Therapeutics (ISSN: 21593337) 23: (3) pp. 175187. ( 2013) Folyóiratcikk [13370997]
298 * Bors A, Csuka D, Varga L, Farkas H, Tordai A, Füst G, Szilagyi A Less severe clinical manifestations in patients with hereditary angioedema with missense C1INH gene mutations Journal of Allergy and Clinical Immunology (ISSN: 00916749) 131: (6) pp. 17081711. ( 2013) Folyóiratcikk [13370996] 299
Ohsawa Isao, Nagamachi Seiji, Suzuki Hiyori, Honda Daisuke, Sato Nobuyuki, Ohi Hiroyuki, Horikoshi Satoshi, Tomino Yasuhiko Leukocytosis and high hematocrit levels during abdominal attacks of hereditary angioedema BMC GASTROENTEROLOGY (ISSN: 1471230X) 13: P aper 123. (2013) Folyóiratcikk [14434027]
300
Lumry W R Management and prevention of hereditary angioedema attacks Am. J. Managed Care (ISSN: 10880224) 19: (7 SUP P L) pp. S111S118. ( 2013) Folyóiratcikk /Tudományos [14420356]
301
JuradoPalomo J, MuñozCaro J, LópezSerrano MC, Prior N, Cabañas R, Pedrosa M, Burgueño M, Caballero T Management of dentaloral procedures in patients with hereditary angioedema due to C1 inhibitor deficiency Journal of Investigational Allergology and Clinical Immunology 23: (1) pp. 16. ( 2013) Folyóiratcikk [13370994]
302
Lumry W , Manning ME, Hurewitz DS, DavisLorton M, Fitts D, Kalfus IN, Uknis ME Nanofiltered C1esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to c1 inhibitor deficiency in children Journal of Pediatrics (ISSN: 00223476) 162: (5) pp. 10171022.e2. ( 2013) Folyóiratcikk [13370993]
303
Busse PJ, Buckland MS Nonhistaminergic angioedema: Focus on bradykininmediated angioedema Clinical and Experimental Allergy (ISSN: 09547894) 43: (4) pp. 385394. ( 2013) Folyóiratcikk [13370991]
304 * Farkas H Orphan drugs for the treatment of hereditary angioedema Expert Opinion on Orphan Drugs (ISSN: 21678707) 1: (2) pp. 141156. ( 2013)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
236/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Tudományos [13834975] 305
Sheffer AL, Macginnitie AJ, Campion M, Stolz LE, Pullman W E Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks Annals of Allergy, Asthma and Immunology 110: (3) pp. 184188e2. ( 2013) Folyóiratcikk [13370988]
306
Lumry W R Overview of epidemiology, pathophysiology, and disease progression in hereditary angioedema Am. J. Managed Care (ISSN: 10880224) 19: (7 SUP P L) pp. S103S110. ( 2013) Folyóiratcikk /Tudományos [14420355]
307 * Bork K, DavisLorton M Overview of hereditary angioedema caused by C1inhibitor deficiency: Assessment and clinical management European Annals of Allergy and Clinical Immunology 45: (1) pp. 716. ( 2013) Folyóiratcikk [13370987] 308 * Farkas H, Csuka D, Zotter Z, Varga L, Füst G P rophylactic therapy in children with hereditary angioedema Journal of Allergy and Clinical Immunology (ISSN: 00916749) 131: (2) pp. 579582.e2. ( 2013) Folyóiratcikk [13370986] 309
Reshef A, Moldovan D, Obtulowicz K, Leibovich I, Mihaly E, Visscher S, Relan A Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study ALLERGY (ISSN: 01054538) 68: (1) pp. 118124. ( 2013) Folyóiratcikk [12862358]
310 * Cicardi M, Craig TJ, MartinezSaguer I, Hébert J, Longhurst HJ Review of recent guidelines and consensus statements on hereditary angioedema therapy with focus on selfadministration International Archives of Allergy and Immunology (ISSN: 10182438) 161: (SUP P L.1) pp. 39. ( 2013) Folyóiratcikk [13370985] 311 * AygörenPürsün E, Martinez Saguer I, Kreuz W , Klingebiel T, Schwabe D Risk of angioedema following invasive or surgical procedures in HAE type i and II The natural history Allergy: European Journal of Allergy and Clinical Immunology 68: (8) pp. 10341039. ( 2013) Folyóiratcikk [13370984] 312
Bossi F, Tedesco F Role of the B1 Bradykinin Receptor and gC1qR/p33 in Angioedema Immunology and Allergy Clinics of North America (ISSN: 08898561) 33: (4) pp. 535544. ( 2013) Folyóiratcikk [13474999]
313
ÁlvarezPerea A, Rodríguez Mazariego E, Núñez Cabezas T, Pelta Fernández R Skin and mucosal allergy. Urticaria, angioedema, anaphylaxis Medicine (Spain) 11: (29) pp. 17781787. ( 2013) Folyóiratcikk [13370982]
314
Oostergo T, Prins G, Schrama YC, Leeuwenburgh I Small bowel angioedema due to acquired C1 inhibitor deficiency: A case report and overview European Journal of Gastroenterology and Hepatology (ISSN: 0954691X) 25: (4) pp. 507513. ( 2013) Folyóiratcikk [13370981]
315 * Perricone C, Shoenfeld N, AgmonLevin N, De Carolis C, Perricone R, Shoenfeld Y Smell and autoimmunity: A comprehensive review Clinical Reviews in Allergy and Immunology 45: (1) pp. 8796. ( 2013) Folyóiratcikk [13370979] 316
Berry A, Firszt R Successful treatment of idiopathic angioedema with ecallantide Journal of Allergy and Clinical Immunology: In Practice 1: (3) pp. 297298. ( 2013) Folyóiratcikk [13370978]
317
Banerji A The burden of illness in patients with hereditary angioedema Annals of Allergy, Asthma and Immunology 111: (5) pp. 329336. ( 2013) Folyóiratcikk [13474998]
318
Maurer M, Parish LC The dermatology view of hereditary angiooedema: P ractical diagnostic and management considerations Journal of the European Academy of Dermatology and Venereology (ISSN: 09269959) 27: (2) pp. 133141. ( 2013) Folyóiratcikk [13370977]
319
Porebski G The prophylaxis of hereditary angioedema attacks with recombinant human C1 inhibitor: Who will take advantage of the individualized treatment approach? Allergy: European Journal of Allergy and Clinical Immunology 68: (9) pp. 12071208. ( 2013) Folyóiratcikk [13474997]
320 * Csuka D, MuntheFog L, Skjoedt MO, Kocsis A, Zotter Z, Gál P, Varga L, Farkas H, Füst G, Garred P The role of ficolins and MASP s in hereditary angioedema due to C1inhibitor deficiency Molecular Immunology (ISSN: 01615890) 54: (34) pp. 271277. ( 2013) Folyóiratcikk [13370975] 321 * Zanichelli A, Mansi M, Periti G, Cicardi M Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency Expert Review of Clinical Immunology (ISSN: 1744666X) 9: (5) pp. 477488. ( 2013) Folyóiratcikk [13370974] 322 * Castelli Roberto, Zanichelli Andrea, Cugno Massimo Therapeutic options for patients with angioedema due to C1inhibitor deficiencies: from pathophysiology to the clinic IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (ISSN: 08923973) 35: (1) pp. 181190. ( 2013) Folyóiratcikk [12862357] 323 * Farkas H, Csuka D, Zotter Z, Szabó E, Czaller I, Varga L, Fejes J, Füst G, Harmat G Treatment of attacks with plasmaderived C1inhibitor concentrate in pediatric hereditary angioedema patients Journal of Allergy and Clinical Immunology (ISSN: 00916749) 131: (3) pp. 909911.e5. ( 2013)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
237/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [13370973] 324
董旭南, 王惠妩, 支玉香, 陈璇, 向阳冰 新疆首次诊断遗传性血管性水肿3个家系报道 Chinese Journal of Practical Internal Medicine (ISSN: 10052194) 33: (1) pp. 7779. ( 2013) Folyóiratcikk /Rövid közlemény /Tudományos [14434038]
325 * Csuka D, MuntheFog L, Hein E, Zotter Z, Prohászka Z, Farkas H, Varga L, Garred P Activation of the ficolinlectin pathway during attacks of hereditary angioedema J. Allergy Clin. Immunol. (ISSN: 00916749) 134: (6) pp. 13881393.e1. ( 2014) Folyóiratcikk /Tudományos [14420350] 326
Vela Vizcaino C, Sola Enrique L, Chugo Gordillo S, Lizaso Bacaicoa MT, Caballero Molina T, García Figueroa BE Bradykininmediated hereditary angioedema (non estrogendependent) without C1 inhibitor deficiency J. Invest. Allergol. Clin. Immunol. (ISSN: 10189068) 24: (4) pp. 280281. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14258621]
327 * Varga L, Dobó J C1 inhibitor: Quantification and purification Methods in Molecular Biology (ISSN: 10643745) 1100: pp. 189205. ( 2014) Folyóiratcikk /Tudományos [13834973] 328 * Betschel Stephen, Badiou Jacquie, Binkley Karen, Hebert Jacques, Kanani Amin, Keith Paul, Lacuesta Gina, Yang Bill, AygoerenPuersuen Emel, Bernstein Jonathan, Bork Konrad, Caballero Teresa, Cicardi Marco, Craig Timothy, Farkas Henriette, Longhurst Hilary, Zuraw Bruce, Boysen Henrik, BoriciMazi Rozita, Bowen Tom, Dallas Karen, Dean John, LangRobertson Kelly, Laramee Benoit, Leith Eric, Mace Sean, McCusker Christine, Moote Bill, Poon ManChiu, Ritchie Bruce, Stark Donald, Sussman Gordon, W aserman Susan Canadian hereditary angioedema guideline ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (ISSN: 17101484) 10: P aper 50. (2014) Folyóiratcikk [14434023] 329 * Cicardi M, Aberer W , Banerji A, Bas M, Bernstein JA, Bork K, Caballero T, Farkas H, Grumach A, Kaplan AP, Riedl MA, Triggiani M, Zanichelli A, Zuraw B Classification, diagnosis, and approach to treatment for angioedema: Consensus report from the Hereditary Angioedema International Working Group Allergy: European Journal of Allergy and Clinical Immunology (ISSN: 13989995) 69: (5) pp. 602616. ( 2014) Folyóiratcikk /Tudományos [13834972] 330
Ohsawa Isao, Honda Daisuke, Nagamachi Seiji, Hisada Atsuko, Shimamoto Mamiko, Inoshita Hiroyuki, Mano Satoshi, Tomino Yasuhiko Clinical and Laboratory Characteristics That Differentiate Hereditary Angioedema in 72 P atients with Angioedema ALLERGOLOGY INTERNATIONAL (ISSN: 13238930) 63: (4) pp. 595602. ( 2014) Folyóiratcikk [14591523]
331
Bygum A Hereditary angioedema Consequences of a new treatment paradigm in Denmark Acta Derm.Venereol. (ISSN: 00015555) 94: (4) pp. 436441. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14258620]
332
Chen X, Yang YX, Liu YL, Gan HT, W en ZH Hereditary angioedema a rare cause of recurrent abdominal pain Pak. J. Med. Sci. (ISSN: 1682024X) 30: (5) p. 1147. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14258619]
333
Prkačin I, Ban A, Cavrić G, Hamp DB Hereditary angioedema type I in a female patient: A case report Signa Vitae (ISSN: 13345605) 9: (SUP P L. 1) pp. 9798. ( 2014) Folyóiratcikk /Tudományos [14258618]
334
Altman KA, Naimi DR Hereditary angioedema: A brief review of new developments Current Medical Research and Opinion (ISSN: 14734877) 30: (5) pp. 923930. ( 2014) Folyóiratcikk /Tudományos [13834971]
335 * Suffritti C, Zanichelli A, Maggioni L, Bonanni E, Cugno M, Cicardi M Highmolecularweight kininogen cleavage correlates with disease states in the bradykininmediated angioedema due to hereditary C1inhibitor deficiency Clin. Exp. Allergy (ISSN: 09547894) 44: (12) pp. 15031514. ( 2014) Folyóiratcikk /Tudományos [14420348] 336 * Farkas H, Csuka D, Veszeli N, Zotter Z, Szabó E, Varga L Home treatment of attacks with conestat alfa in hereditary angioedema due to C1inhibitor deficiency Allergy Asthma Proc. (ISSN: 10885412) 35: (3) pp. 255259. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14258617] 337
Demirtürk M, Gelincik A, Çinar S, Kilercik M, OnayUcar E, Çolakoǧlu B, Arda N, Büyüköztürk S, Deniz G Increased eNOS levels in hereditary angioedema International Immunopharmacology (ISSN: 18781705) 20: (1) pp. 264268. ( 2014) Folyóiratcikk /Tudományos [13834970]
338
Ceccarini A, Nori A, Fuscà F, Zavaglia V, Marinangeli L, Zoli A Management of a patient with hereditary angioedema in dentistry: A case report Dental Cadmos (ISSN: 00118524) 82: (4) pp. 293299. ( 2014) Folyóiratcikk /Tudományos [13834969]
339
Pedrosa M, PrietoGarcía A, SalaCunill A, Caballero T, Baeza ML, Cabañas R, Campos A, Cimbollek S, GómezTraseira C, González Quevedo T, Guilarte M, JuradoPalomo J, Lobera T, LópezSerrano MC, Marcos C, PiñeroSaavedra M, Prior N, Sáenz De San Pedro B, Ferrer M, Barceló JM, Daschner A, Echechipía M, Garcés M, Iriarte P, Jáuregui I, Lázaro M, Quiñones M, Veleiro B, Villareal O Management of angioedema without urticaria in the emergency department Ann. Med. (ISSN: 07853890) 46: (8) pp. 607618. ( 2014) Folyóiratcikk /Tudományos [14420346]
340
Caballero T, Canabal J, RiveroPaparoni D, Cabañas R Management of hereditary angioedema in pregnant women: A review Int. J. Womens Health (ISSN: 11791411) 6: pp. 839848. ( 2014)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
238/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [14258616] 341
Bafunno V, Bova M, Loffredo S, Divella C, Petraroli A, Marone G, Montinaro V, Margaglione M, Triggiani M Mutational spectrum of the C1 inhibitor gene in a cohort of italian patients with hereditary angioedema: Description of nine novel mutations Annals of Human Genetics (ISSN: 00034800) 78: (2) pp. 7382. ( 2014) Folyóiratcikk /Tudományos [13834968]
342
Read N, Lim E, Tarzi MD, HildickSmith P, Burns S, Fidler KJ P aediatric hereditary angioedema: A survey of UK service provision and patient experience Clin. Exp. Immunol. (ISSN: 00099104) 178: (3) pp. 483488. ( 2014) Folyóiratcikk /Tudományos [14420345]
343 * Bork K P asteurized and nanofiltered, plasmaderived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema Immunother. (ISSN: 1750743X) 6: (5) pp. 533551. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14258615] 344
Iturri Clavero F, González Uriarte A, Tamayo Medel G, Gamboa Setién PM P rophylactic use of icatibant before tracheal intubation of a patient with hereditary angioedema type iii. (A literature review of perioperative management of patients with hereditary angioedema type iii) Rev. Esp. Anestesiol. Reanim. (ISSN: 00349356) 61: (7) pp. 375381. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14258614]
345
Dreyfus David H, Na Chang Rim, Randolph Christopher C, Kearney Denise, Price Christina, Podell David Successful Rituximab B Lymphocyte Depletion Therapy for Angioedema due to Acquired C1 inhibitor P rotein Deficiency: Association with Reduced C1 inhibitor P rotein Autoantibody Titers ISRAEL MEDICAL ASSOCIATION JOURNAL (ISSN: 15651088) 16: (5) pp. 315316. ( 2014) Folyóiratcikk [14434014]
346 * Caballero T, AygörenPürsün E, Bygum A, Beusterien K, Hautamaki E, Sisic Z, W ait S, Boysen HB The humanistic burden of hereditary angioedema: Results from the Burden of Illness Study in Europe Allergy and Asthma Proceedings (ISSN: 10885412) 35: (1) pp. 4753. ( 2014) Folyóiratcikk /Tudományos [13834967] 347 * Zotter Z, Csuka D, Szabó E, Czaller I, Nébenführer Z, Temesszentandrási G, Fust G, Varga L, Farkas H The influence of trigger factors on hereditary angioedema due to C1inhibitor deficiency Orphanet Journal of Rare Diseases (ISSN: 17501172) 9: (1) P aper 44. (2014) Folyóiratcikk /Tudományos [13834966] 348
Shapiro RS, Zacek L Training hereditary angioedema patients to selfadminister intravenous C1 Esterase inhibitor concentrate J. Infus. Nurs. (ISSN: 15331458) 37: (4) pp. 284290. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14258613]
250. Bajnok E , Tabak A , Takacs I , Lakatos PL , Horvath C , Nagy Z , Speer G , Lakatos P Insulinlike growth factor I (IGFI) gene microsatellite repeat polymorphism and its relation to hyperthyroidism and thyroid hormonestimulated bone loss JOURNAL OF BONE AND MINERAL RESEARCH 19:(Suppl 1) p. s384. (2004) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1074814] [ Érvényesített ] 251. Bajnok É , Lakatos G , Tabák Á , Takács I , Horváth Cs , Kósa JP , Speer G , M adarász E , Nagy Zs , Lakatos P Association between collagen type I alphaI (COL1A1) gene Sp1, calciumsensing receptor (CaSR) gene A986S, interleukin1 receptor antagonist (IL1RN) gene VNTR polymorphisms and osteoporosis: Their impact in prediction of osteoporotic bone fracture JOURNAL OF BONE AND MINERAL RESEARCH 19:(Suppl. 1) p. s384. (2004) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1822739] [ Érvényesített ] Független idéző: 1 Összesen: 1 1
Liu YJ, Shen H, Xiao P, Xiong DH, Li LH, Recker RR, Deng HW Molecular genetic studies of gene identification for osteoporosis: A 2004 update JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 21: (10) pp. 15111535. ( 2006) Folyóiratcikk /Összefoglaló cikk /Tudományos [13800353]
252. Bajnok E , Tabák Á , Takács I , Lakatos PL , Horváth Cs , Nagy Zs , Speer G , Lakatos P Insulinlike growth factor I (IGFI) gene microsatellite repeat polymorphism and its relation to hyperthyroidism and thyroid hormonerelated bone loss ASBM R Kongresszus, Seattle (2004) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434105] poszter [ Admin láttamozott ] 253. Bajnok É , Lakatos G , Tabák Á , Takács I , Horváth Cs , Kósa J , Speer G , M adarász E , Nagy Zs , Lakatos P Association between collagen type I alpha 1 (COL1A1) gene Sp1, calcium sensing receptor (CaSR) gene A986S, https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
239/342
3/30/2015
nyomtatobarat forma
interleukin1 receptor antagonist (IL1RN9 gene VNTR polymorphisms and osteoporosis: Their impact in prediction of osteoporotic bone fracture ASBM R Kongresszus, Seattle (2004) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434114] poszter [ Admin láttamozott ] 254. Csupor E , Tóth E , M észáros Sz , Ferencz V , Lakatos P , Szűcs J , Horváth Cs Kalcium oxalát veseköves betegek csontanyagcseréjének vizsgálata a mellékpajzsmirigy működés függvényében MAGYAR BELORVOSI ARCHIVUM 57:(S2) p. 49. (2004) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2089540] [ Admin láttamozott ] 255. Donath J , Speer G , Poor G , Gergely P Jr , Tabak A , Lakatos P Vitamin D receptor, oestrogen receptoralpha and calciumsensing receptor genotypes, bone mineral density and biochemical markers in Paget's disease of bone RHEUMATOLOGY 43:(6) pp. 692695. (2004) IF: 4.102 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1335559] [ Érvényesített ] Független idéző: 19 Függő idéző: 1 Összesen: 20 1
Thompson M D, Burnham W M, Cole D E C The G proteincoupled receptors: P harmacogenetics and disease Critical Reviews in Clinical Laboratory Sciences (ISSN: 10408363) 42: (4) pp. 311392. ( 2005) Folyóiratcikk /Összefoglaló cikk /Tudományos [11842562]
2
Reddy S V Etiologic factors in P aget's disease of bone Cellular and Molecular Life Sciences (ISSN: 1420682X) 63: (4) pp. 391398. ( 2006) Folyóiratcikk /Összefoglaló cikk /Tudományos [11842561]
3
Roberts W E, Epker B N, Burr D B, Hartsfield Jr, Roberts J A Remodeling of Mineralized Tissues, P art II: Control and P athophysiology Seminars in Orthodontics 12: (4) pp. 238253. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [11851145]
4
W ang Yan, Guo Jing, Liu Yong, Deng Fei, Jiang De, Deng Hong The human calciumsensing receptor and interleukin6 genes are associated with bone mineral density in Chinese Acta Genetica Sinica 33: (10) pp. 870880. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [11842560]
5
Hsieh Y, W ang Y, Chang C, Lin C Estrogen receptor alpha351 XbaI*G and 397 P vuII*Crelated genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma Molecular Human Reproduction (ISSN: 13609947) 13: (2) pp. 117122. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [11842559]
6
Beyens Greet, Daroszewska Anna, de Freitas Fenna, Fransen Erik, Vanhoenacker Filip, Verbruggen Leon, Zmierczak Hans Georg, W esthovens Ren, Van Offel Jan, Ralston Stuart H, Devogelaer Jean Pierre, Van Hul W im Identification of sexspecific associations between. polymorphisms of the Osteoprotegerin gene, TNFRSF11B, and P aget's disease of bone Journal of Bone and Mineral Research (ISSN: 08840431) 22: (7) pp. 10621071. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [11842558]
7
Beyens Greet, Van Hul W im P athophysiology and genetics of metabolic bone disorders characterized by increased bone turnover Critical Reviews in Eukaryotic Gene Expression (ISSN: 10454403) 17: (3) pp. 215240. ( 2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [11842557]
8
Thompson Miles D, Siminoivitch Katherine A, Cole David E G proteincoupled receptor pharmacogenetics Methods in Molecular Biology (ISSN: 10643745) 448: pp. 139185. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [11842556]
9
Helfrich Miep H, Hocking Lynne J Genetics and aetiology of P agetic disorders of bone Archives of Biochemistry and Biophysics (ISSN: 00039861) 473: (2) pp. 172182. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [11842555]
10
Rice AM, Rivkees SA Receptor Transduction of Hormone Action In: Pediatric Endocrinology . Elsevier Inc., 2008. (ISBN 9781416040903) pp. 2673.
Könyvrészlet /Könyvfejezet /Tudományos [13300464] 11
Mossetti Giuseppe, Gennari Luigi, Rendina Domenico, De Filippo Gianpaolo, Merlotti Daniela, De Paola Vincenzo, Fusco Pina, Esposito Teresa, Gianfrancesco Fernando, Martini Giuseppe, Nuti Ranuccio, Strazzullo Pasquale Vitamin D Receptor Gene P olymorphisms P redict Acquired Resistance to Clodronate Treatment in P atients with P aget's Disease of Bone Calcified Tissue International (ISSN: 0171967X) 83: (6) pp. 414424. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [11842554]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
240/342
3/30/2015
nyomtatobarat forma 12
Falchetti Alberto, Di Stefano Marco, Marini Francesca, Ortolani Sergio, Ulivieri Massimo Fabio, Bergui Simona, Masi Laura, Cepollaro Chiara, Benucci Maurizio, Di Munno Ombretta, Rossini Maurizio, Adami Silvano, Del Puente Antonio, Isaia Giancarlo, Torricelli Francesca, Brandi Maria Luisa Genetic Epidemiology of P aget's Disease of Bone in Italy: sequestosome1/p62 Gene Mutational Test and Haplotype Analysis at 5q35 in a Large Representative Series of Sporadic and Familial Italian Cases of P aget's Disease of Bone Calcified Tissue International (ISSN: 0171967X) 84: (1) pp. 2037. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11842553]
13
LI Shengqiang, GE Jirong, XIE Bingying The relationship between polymorphisms of vitamin D receptor gene and bone mineral density in Fuzhou elderly male Chinese Journal of Osteoporosis (ISSN: 10067108) 15: (8) pp. 598601. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [12787116]
14
Alberto Falchetti, Francesca Marini, Laura Masi, Antonietta Amedei, Luisa Brandi Maria Genetic aspects of the P aget's disease of bone: concerns on the introduction of DNAbased tests in the clinical practice. Advantages and disadvantages of its application European Journal of Clinical Investigation (ISSN: 00142972) 40: (7) pp. 655667. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11842552]
15
Ralston S H, Albagha O M E Genetic determinants of P aget's disease of bone ANN NY ACAD SCI 1240: (1) pp. 5360. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11851144]
16 * Donath Judit, Poor Gyula P aget's disease: clinical update Orvosi Hetilap (ISSN: 00306002) 152: (33) pp. 13371346. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11842551] 17
Chung PYJ, Van Hul W P aget's Disease of Bone: Evidence for Complex P athogenetic Interactions SEMINARS IN ARTHRITIS AND RHEUMATISM (ISSN: 00490172) 41: (5) pp. 619641. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12364471]
18
Sundaram G, Pramod, Sudhakar U, Kumar J P eriodontal management in P aget's disease: Case presentation and a brief review of literature Journal of Indian Society of Periodontology 16: (1) pp. 129133. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12541297]
19
Hudson B, Loots GG Genomic P rofiling in Bone In: Genetics of Bone Biology and Skeletal Disease. Elsevier Inc., 2013. (ISBN 9780123878298) pp. 101121.
Könyvrészlet /Könyvfejezet /Tudományos [14278803] 20
Kublaoui B, Levine MA Receptor transduction pathways mediating hormone action In: Pediatric Endocrinology : Fourth Edition. Elsevier Inc., 2014. (ISBN 9781455748587) pp. 3489.e2.
Könyvrészlet /Könyvfejezet /Tudományos [14278802]
256. F Szalay , A Folhoffer , A Horvath , T Csak , A Habior , I Tornai , G Speer , Z Nagy , P Lakatos , PL Lakatos Low serum lepitn level in patients with primary biliary cirrhosis. GUT 53:(SUPPL VI) p. A64. (2004) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391514] [ Admin láttamozott ] 257. Ferencz V , Bors K , M észáros Sz , Csupor E , Tóth E , Lakatos P , Horváth Cs Calcium supplementation fails to reduce bone turnover in elderly women with osteoporosis or osteopenia with vitamin D insufficiency OSTEOPOROSIS INTERNATIONAL 15:(S1) p. S96. (2004) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [2089497] [ Érvényesített ] 258. Fuszek P , Lakatos P , Tabak A , Papp J , Nagy Z , Takacs I , Horvath HC , Lakatos PL , Speer G Relationship between serum calcium and Ca199 levels in colorectal cancer. WORLD JOURNAL OF GASTROENTEROLOGY 10:(13) pp. 18901892. (2004) Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1074545] [ Érvényesített ] Független idéző: 11 Függő idéző: 3 Összesen: 14 1
Liu Y, Tian SL Clinical significance of carcinoembryonic antigen detection in rectal cancer patients with total mesorectal excision World Chinese Journal of Digestology 12: (12) pp. 28262828. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [10226550]
2
* Lakatos Peter Laszlo, Lakatos Laszlo Current concepts on the genetics of hereditary and sporadic colorectal cancer and the role of genetics in the patient management Orvosi Hetilap (ISSN: 00306002) 147: (10) pp. 449455. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [11842606]
3
* Fuszek P, Horvath HC, Speer G, Papp J, Haller P, Fischer S, Halasz J, Jaray B, Szekely E, Schaff Z, Papp A, Bursics A, Harsanyi L, Lukovich P, Kupcsulik P, Hitre E, Lakatos PL Location and age at onset of colorectal cancer in Hungarian patients between 1993 and 2004. The high number of advanced cases supports the need for a colorectal cancer screening program in Hungary
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
241/342
3/30/2015
nyomtatobarat forma ANTICANCER RESEARCH (ISSN: 02507005) 26: (1B) pp. 527531. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [10226546] 4
5
Fernandes LC, Kim SB, Saad SS, Matos D Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer WORLD JOURNAL OF GASTROENTEROLOGY (ISSN: 10079327) 12: (24) pp. 38913894. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [10226548] * Lakatos PL, Hitre E, Szalay F, Zinober K, Fuszek P, Lakatos L, Fischer S, Osztovits J, Gemela O, Veres G, Papp J, Ferenci P Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients. BMC CANCER (ISSN: 14712407) 7: P aper 54. (2007) Folyóiratcikk /Szakcikk /Tudományos [10235186]
6
Dong LM, Ulrich CM, Hsu L, Duggan DJ, Benitez DS, W hite E, Slattery ML, Caan BJ, Potter JD, Peters U Genetic variation in calciumsensing receptor and risk for colon cancer CANCER EPIDEM BIOMAR 17: (10) pp. 27552765. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [10448310]
7
Freire P, Portela F, Donato MM, Figueiredo P, Ferreira M, Amaro P, Sá A, Andrade P, Gouveia H, Sofia C CARD15 mutations and colorectal cancer in a South European country INT J COLORECTAL DIS 25: (10) pp. 12111219. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11052765]
8
Jacobs ET, Martinez ME, Campbell PT, Conti DV, Duggan D, Figueiredo JC, Haile RW , LeRoy EC, Poynter JN, Thompson PA, Baron JA Genetic variation in the retinoid X receptor and calciumsensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry CARCINOGENESIS (ISSN: 01433334) 31: (8) pp. 14121416. ( 2010) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [11047244]
9
Dasgupta S, Bhattacharya S, Biswas A, Majumdar SS, Mukhopadhyay S, Ray S, Bhattacharya S NFkappa B mediates lipidinduced fetuinA expression in hepatocytes that impairs adipocyte function effecting insulin resistance BIOCHEM J 429: (3) pp. 451462. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11042779]
10
Decker GA, Batheja MJ, Collins JM, Silva AC, Mekeel KL, Moss AA, Nguyen CC, Lake DF, Miller LJ Risk factors for pancreatic adenocarcinoma and prospects for screening GASTROENTEROL HEPATOL 6: (4) pp. 246254. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11391220]
11
Takano S, Kaji H, Hayashi F, Higashiguchi K, Joukei S, Kido Y, Takahashi J, Osawa K A calculation model for serum ionized calcium based on an equilibrium equation for complexation ANAL CHEM INSIGHTS 7: (1) pp. 2330. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12488134]
12
Zhang D, Yu M, Xu T, Hu F, Li X, Xiong B P redictive value of serum CEA; CA199 and CA125 in diagnosis of liver metastases from colorectal cancer in the Chinese population HEPATOGASTROENTEROL 60: (126) pp. 12971301. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13420268]
13
Salem S, Hosseini M, Allameh F, Babakoohi S, Mehrsai A, Pourmand G Serum Calcium Concentration and P rostate Cancer Risk: A Multicenter Study. NUTR CANCER 65: (7) pp. 961968. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13340578]
14
Mahmoudi T, Karimi K, Arkani M, Farahani H, Nobakht H, Dabiri R, Asadi A, Zali MR P arathyroid Hormone Gene rs6256 and Calcium Sensing Receptor Gene rs1801725 Variants are not Associated with Susceptibility to Colorectal Cancer in Iran ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (ISSN: 15137368) 15: pp. 60356039. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14163966]
259. Fuszek P , Lakatos P , Tabák Á , Papp J , Nagy Z , Lakatos PL , Speer G A szérumkalciumszint jelentősége colorectalis daganatos betegekben ORVOSI HETILAP 145:(30) pp. 15611565. (2004) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1074548] [ Érvényesített ] 260. Horányi J , Duffek L , Szlávik R , Tarjányi M , Rácz K , Tóth M , Lakatos P Tévedési lehetőség a parathormonszint intraoperatív értékelésénél MAGYAR SEBÉSZET 57:(3) p. 159. (2004) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2026640] A M agyar Sebész Társaság 57. Kongresszusa, Pécs, 2004. jún. 1618. [ Admin láttamozott ] 261. Horváth C , Lakatos P , Balogh A Ajánlás a férfiak osteoporosisának diagnosztikájára és kezelésére 2005ben CA ÉS CSONT 7:(3) pp. 102104. (2004) Nyelv: Magyar https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
242/342
3/30/2015
nyomtatobarat forma
Folyóiratcikk /Jelentés /Tudományos [1807015] [ Érvényesített ] 262. Horváth C , Lakatos P , M arton I , Bors K , Poór G , Holló I Ajánlás az osteoporosis és más metabolikus csontbetegségek diagnosztikájára 2005ben CA ÉS CSONT 7:(3) pp. 7484. (2004) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1807054] [ Érvényesített ] 263. Hubina E , Lakatos P , Kovacs L , Szabolcs I , Racz K , Toth M , Szucs N , Goth M I Effects of 24 months of growth hormone (GH) treatment on serum carboxylated and undercarboxylated osteocalcin levels in GHdeficient adults CALCIFIED TISSUE INTERNATIONAL 74:(1) pp. 5559. (2004) IF: 2.258 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1318745] [ Admin láttamozott ] Független idéző: 6 Összesen: 6 1
Giustina A, Mazziotti G, Canalis E Growth hormone, insulinlike growth factors, and the skeleton ENDOCRINE REVIEWS (ISSN: 0163769X) 29: (5) pp. 535559. ( 2008) Folyóiratcikk [10920780]
2
Tritos N A, Biller B M K Growth hormone and bone Current Opinion in Endocrinology, Diabetes and Obesity 16: (6) pp. 415422. ( 2009) Chemicals/CAS: anastrozole, 120511731; growth hormone, 36992731, 37267053, 66419509, 9002726; parathyroid hormone, 12584962, 68893823, 9002646; somatomedin C, 67763966 UR: http://www.scopus.com/inward/record.url? eid=2s2.070350752357& partnerID=40& md5=69e7c908c6f10d78a84979326807ed04 Folyóiratcikk [10920781]
3
Huang Y, Eapen E, Steele S, Grey V Establishment of reference intervals for bone markers in children and adolescents Clinical Biochemistry (ISSN: 00099120) 44: (1011) pp. 771778. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11522667]
4
HermanBonert VS, Melmed S Growth Hormone In: Melmed S (szerk.) : The Pituitary . Elsevier Inc., 2011. (ISBN 9780123809261) pp. 83117.
Könyvrészlet /Könyvfejezet /Tudományos [13463173] 5
Khokhlova OI, Kalayeva GY, Ustiantseva IM Characteristics of bone tissue metabolism in adolescents with undifferentiated connective tissue dysplasia HUMAN PHYSIOLOGY (ISSN: 03621197) 40: (3) pp. 323329. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14198847]
6
Bredella MA, Gerweck AV, Barber LA, Breggia A, Rosen CJ, Torriani M, Miller KK Effects of growth hormone administration for 6months on bone turnover and bone marrow fat in obese premenopausal women Bone (ISSN: 87563282) 62: pp. 2935. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14198846]
264. Koppány V , Takács I , Bajnok É , Tabák Á , Speer G , Nagy Zs , Kósa JP , Lakatos P Ösztrogén receptoralfa gén Xbal polimorfizmusa toxikus adenomában és thyreogén csontvesztésben ORVOSI HETILAP 145:(Suppl. 3) p. 1093. (2004) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1819778] [ Admin láttamozott ] 265. Kósa JP , Nagy Zs , Puskás L , Zvara Á , Speer g , Takács I , Bajnok É , Kökény G , Hamar P , Lakatos P Az ösztrogén aktívitás átfogó transzkripcionális vizsgálata: ösztrogén regulálta gének egér csontban. ORVOSI HETILAP 145:(S3) pp. 10931094. (2004) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1819793] [ Admin láttamozott ] 266. Lakatos P , Horváth C , M arton I , Poór G , Holló I Ajánlás az életkorral járó osteoporosis gyógyszeres kezelésére 2005ben CA ÉS CSONT 7:(3) pp. 8591. (2004) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1807039] [ Admin láttamozott ] 267. Lakatos P Kommentár Gambacciani M : Újdonságok a csontok vizsgálatában című cikkéhez NŐGYÓGYÁSZATI ÉS SZÜLÉSZETI TOVÁBBKÉPZŐ SZEMLE 6:(6) p. 360. (2004) https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
243/342
3/30/2015
nyomtatobarat forma
Nyelv: Magyar
Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [1807217] [ Admin láttamozott ] 268. Lakatos P Az öregedéshez társuló csontritkulás kezelése In: Gömör B (szerk.) Reumatológia, 2004 . 249 p. Budapest: Documed Kft., 2004. pp. 8592. Nyelv: Magyar
Könyvrészlet /Könyvfejezet /Tudományos [1889656] [ Admin láttamozott ] 269. Lakatos P , M OOT vezetősége Diagnosztikus és terápiás ajánlás az anyagcsere csontbetegségek vizsgálatára In: Hatfaludy Zsófia (szerk.) AnyagcsereEndokrinológia útmutató 2004: Klinikai irányelvek kézikönyve . Budapest: M edition Kiadó, 2004. pp. 6 65. Nyelv: Magyar
Könyvrészlet /Könyvfejezet /Tudományos [1892946] [ Admin láttamozott ] 270. Lakatos P Az öregedéshez társuló csontritkulás kezelése In: Kasza M , Németh K , Ambrus M , Stelich K , Hajnal F , Amberger G , Kulcsár B (szerk.) Családorvostan II . 612 p. Budapest: Documed Kft., 2004. pp. 107112. Nyelv: Magyar
Könyvrészlet /Könyvfejezet /Tudományos [1892988] [ Admin láttamozott ] 271. Lakatos P Nemzetközi konszenzus: Osteoporosis A csont mennyiségi és minőségi rendellenessége CA ÉS CSONT 7: pp. S1S24. (2004) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1974437] [ Szerzői rekord ] 272. Lakatos PL , Bajnok E , Tornai I , Folhoffer A , Horvath A , Lakatos P , Habior A , Szalay F Insulinlike growth factor I (IGFI) gene microsatellite repeat and collagen type I alpha 1 Sp1 polymorphism (COLIA1) and bone disease in primary biliary cirrhosis (PBC). EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 16:(8) pp. 753759. (2004) IF: 1.843 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1074542] [ Érvényesített ] Független idéző: 16 Függő idéző: 1 Összesen: 17 1
Pares A, Guanabens N, Rodes J Gene polymorphisms as predictors of decreased bone mineral density and osteoporosis in primary biliary cirrhosis EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 17: pp. 311315. ( 2005) Folyóiratcikk [10226626]
2
Selmi C, Invernizzi P, Zuin M, Podda M, Seldin MF, Gershwin ME Genes and (auto) immunity in primary biliary cirrhosis GENES AND IMMUNITY (ISSN: 14664879) 6: pp. 543556. ( 2005) Folyóiratcikk [10226630]
3
Selmi C, Invernizzi P, Zuin M, Podda M, Gershwin ME Genetics and geoepidemiology of primary biliary cirrhosis: Following the footprints to disease etiology SEMINARS IN LIVER DISEASE (ISSN: 02728087) 25: pp. 265280. ( 2005) Folyóiratcikk [10226629]
4
* Szalay F, Folhoffer A, Horvath A, Csak T, Speer G, Nagy Z, Lakatos P, Horvath C, Habior A, Tornai I, Lakatos PL Serum leptin; soluble leptin receptor; free leptin index and bone mineral density in patients with primary biliary cirrhosis EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 17: pp. 923928. ( 2005) Folyóiratcikk [10226628]
5
Niu TH, Rosen CJ The insulinlike growth factorI gene and osteoporosis: A critical appraisal GENE (ISSN: 03781119) 361: pp. 3856. ( 2005) Folyóiratcikk [10226631]
6
Thijssen JHH Gene polymorphisms involved in the regulation of bone quality
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
244/342
3/30/2015
nyomtatobarat forma GYNECOLOGICAL ENDOCRINOLOGY (ISSN: 09513590) 22: pp. 131139. ( 2006) Folyóiratcikk [10226633] 7
Parés A, Guañabens N Osteoporosis in P rimary Biliary Cirrhosis: P athogenesis and Treatment Clinics in Liver Disease (ISSN: 10893261) 12: (2) pp. 407424. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [10346626]
8
Nakchbandi IA, van der Merwe SW Current understanding of osteoporosis associated with liver disease NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (ISSN: 17595045) 6: (11) pp. 660670. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [10825924]
9
Guañabens N, Parés A Liver and bone ARCH BIOCHEM BIOPHYS 503: (1) pp. 8494. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11074845]
10
W ariaghli G, Allali F, El Maghraoui A, HajjajHassouni N Osteoporosis in patients with primary biliary cirrhosis EUR J GASTROEN HEPAT 22: (12) pp. 13971401. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11106509]
11
Gaugg M, Erlacher L Liver diseases and osteoporosis Austrian Journal of Clinical Endocrinology and Metabolism 4: (1) pp. 1419. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [11330727]
12
Motoi O Risk factors for osteoporosis in chronic liver diseases Annals of Fundeni Hospital 16: (12) pp. 4247. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [11726796]
13
Zhang F, Guo X, W u S, Han J, Liu Y, Shen H, Deng HW GenomeWide P athway Association Studies of Multiple Correlated Quantitative P henotypes Using P rinciple Component Analyses PLOS ONE (ISSN: 19326203) 7: (12) p. e53320. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13061877]
14
Kostik MM, Smirnov AM, Demin GS, Nuskina M, Scheplyagina LA, Larionova VI Genetic polymorphisms of collagen type I alpha1 chain (COL1A1) gene increase the frequency of low bone mineral density in the subgroup of children with juvenile idiopathic arthritis EPMA J. 4: P aper 15. (2013) Folyóiratcikk /Szakcikk /Tudományos [13165486]
15
Yadav A, Carey EJ Osteoporosis in Chronic Liver Disease NUTR CLIN PRACT 28: (1) pp. 5264. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13061875]
16
Ahmed A, Mayo MJ Complications of Cholestasis In: Elizabeth J Carey , Keith D Lindor (szerk.) : Cholestatic Liver Disease. Springer Science+Business Media B.V, 2014. (ISBN 9781493910120) pp. 163188.
Könyvrészlet /Könyvfejezet /Tudományos [14110155] 17
Nakchbandi IA Osteoporosis and fractures in liver disease: Relevance; pathogenesis and therapeutic implications WORLD J GASTROENTERO (ISSN: 10079327) 20: pp. 94279438. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14098521]
273. Lakatos PL , Bajnok E , Tornai I , Folhoffer A , Horvath A , Lakatos P , Szalay F Csökkent csontásványanyagtartalom és génpolimorfizmus primer biliaris cirrhosisban ORVOSI HETILAP 145:(7) pp. 331336. (2004) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1074543] [ Érvényesített ] Független idéző: 7 Összesen: 7 1
Hagymasi K, Tulassay Z A primer biliaris cirrhosis genetikája ORV HETIL 146: pp. 21512156. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226614]
2
Lengyel G, Tulassay Z A P rimer biliaris cirrhosis kezelésének lehetőségei ORV HETIL 146: pp. 12451249. ( 2005) Folyóiratcikk /Összefoglaló cikk /Tudományos [10226612]
3
Battochio AP, Sartori MS, Coelho CA Watersoluble extract of Coleus barbatus modulates weight gain; energy utilization and lipid metabolism in secondary biliary cirrhosis: an experimental study in young rats. Acta Cir Bras 20: pp. 229236. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226611]
4
Reshetnyak VI Concept on the pathogenesis and treatment of primary biliary cirrhosis WORLD JOURNAL OF GASTROENTEROLOGY (ISSN: 10079327) 12: pp. 72507262. ( 2006) Folyóiratcikk /Ismertetés /Tudományos [10226610]
5
Hagymási K, Tulassay Z Multifaktoriális máj és epebetegségek genetikai háttere [Genetic background of the multifactorial liver and bile duct diseases]. ORVOSI HETILAP (ISSN: 00306002) 148: (4) pp. 147153. ( 2007)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
245/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [10346627] 6
Buzas GM Az Orvosi Hetilap szerepe a kortárs magyar gasztroenterológia kialakulásában. 4. rész: 19892008] ORVOSI HETILAP (ISSN: 00306002) 150: (15) pp. 703709. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [11940736]
7
Khorashad A K, Nohesara N, Razavi M S, Saadatnia H, Vossooghinia H, Saghafi M, Esmaili H, Lari S M Evaluation of osteoporosis in patients with nonalcoholic liver cirrhosis Govaresh 17: (4) pp. 254260. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13062311]
274. M ezo T , Tabak A G , Bhattoa H P , Lakatos P Environmental determinants of bone mineral density: Results from the Hungarian osteoporosis risk assessment (HORA) study OSTEOPOROSIS INTERNATIONAL 15:(Suppl 1) p. S50. (2004) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1821006] [ Érvényesített ] 275. Nagy Z , Puskás GL , Zvara A , Nagy BZS , Speer G , Takács I , Bajnok É , Kósa J , Hamar P , Kökény G , Lakatos P Global transcription profiling of estrogen activity: Estrogen regulates gene expression in the mouse bone IOF, Rio de Janeiro (2004) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434096] poszter [ Admin láttamozott ] 276. Nagy ZS , Puskas GL , Zvara A , Nagy BZS , Speer G , Takacs I , Bajnok E , Kosa J , Lakatos P , Hamar P , Kokeny G Global transcription profiling of estrogen activity: Estrogen regulatesgene expression in the mouse bone OSTEOPOROSIS INTERNATIONAL 15:(Suppl. 1) p. S17. (2004) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1270343] [ Érvényesített ] 277. Somogyi P , Poór Gy , Bucsi L , Sárváry A , Fröhlich P , Szendrői M , Lakatos P Közös szakmai állásfoglalás az osteoporosissal összefüggésbe hozható csonttörések másodlagos megelőzése, a törést szenvedett betegek kivizsgálása és hatékony védelme érdekében CA ÉS CSONT 7:(4) pp. 153157. (2004) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1015772] [ Érvényesített ] 278. Speer G , Toth M , Takacs I , Nagy ZS , Lakatos P Calcium metabolism and endocrine functions in a family with familial hypocalciuric hypercalcemia OSTEOPOROSIS INTERNATIONAL 15:(Suppl. 1) p. S140. (2004) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1403234] [ Érvényesített ] Független idéző: 2 Összesen: 2 1
Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Brixen K, Mosekilde L Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a followup study on methods CLINICAL ENDOCRINOLOGY (ISSN: 03000664) 69: (5) pp. 713720. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [11115111]
2
Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Rejnmark L, Brixen K, Mosekilde L Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism CLINICAL ENDOCRINOLOGY (ISSN: 03000664) 71: (6) pp. 798807. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11115110]
279. Speer G , Tóth M , Takács I , Nagy Zs , Lakatos P Calcium metabolism and endocrine functions in a family with familiar hypocalciuric hypercalcemia IOF, Rio de Janeiro (2004) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434103] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
246/342
3/30/2015
nyomtatobarat forma
poszter [ Admin láttamozott ] 280. Szalay F , Folhoffer A , Horvath A , Csak T , Tornai I , Habior A , Speer G , Nagy Z , Lakatos P , Lakatos PL Szérum leptin szint és osteoporosis primer biliaris cirrhosisban MAGYAR BELORVOSI ARCHIVUM 57:(SUPPL 2) p. 122. (2004) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1391500] [ Admin láttamozott ] 281. Szalay F , Folhoffer A , Horvath A , Csak T , Tornai I , Habior A , Speer G , Nagy Z , Lakatos P , Lakatos PL Serum leptin levels in patients with primary biliary cirrhosis. ZEITSCHRIFT FÜR GASTROENTEROLOGIE 42: p. 423. (2004) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391525] [ Admin láttamozott ] 282. Szombati I , Speer G , Tabák Á , Poór Gy , Gergely P Jr , Nékám K , Lakatos P Az ösztogén receptor alpha és a kálcium szenzor receptor gének vizsgálata rheumatoid arthritises betegekben MAGYAR REUMATOLÓGIA 45:(4) pp. 209215. (2004) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1015768] [ Érvényesített ] 283. Takács I , Kósa JP , Speer G , Nagy Zs , Tabák Á , Kiss J , Lakatos P A génexpresszió különbségei postmenopausás osteoporosisban szenvedő és egészséges nőkben MAGYAR BELORVOSI ARCHIVUM 57:(Suppl. 2) pp. 129130. (2004) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1819806] [ Admin láttamozott ] 284. Takács I , Bajnok É , Tabák Á , Speer G , Nagy Zs , Horváth Cs , M észáros Sz , Lakatos P Estrogen receptor alpha Xbal polymorphism, toxic adenoma and thyroid hormonestimulated bone loss OSTEOPOROSIS INTERNATIONAL 15:(Suppl. 1) p. 140. (2004) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1822672] [ Érvényesített ] 285. Takács I , Kósa JP , Speer G , Tabák Á , Nagy Zs , Kiss J , Lakatos P Differential gene expression in bone tissue of postmenopausal osteoporotic and healthy women JOURNAL OF BONE AND MINERAL RESEARCH 19:(Suppl. 1) p. 442. (2004) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1822756] [ Érvényesített ] 286. Takács I , Bajnok É , Tabák Á , Speer G , Nagy Z , Horváth Cs , M észáros Sz , Lakatos P Estrogen receptor alpha Xbal polymorphism, toxic adenoma, and thyroid hormonestimulated bone loss IOF, Rio de Janeiro (2004) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434099] poszter [ Admin láttamozott ] 287. Takács I , Kósa J , Speer G , Tabák Á , Nagy Zs , Kiss J , Lakatos P Differential gene expression in bone tissue of postmenopausal osteoporotic and healthy women ASBM R Kongresszus, Seattle (2004) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434118] poszter [ Admin láttamozott ]
2003 https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
247/342
3/30/2015
nyomtatobarat forma
288. Ambrus C , M arton A , Almasi C , Berta K , Deak G , Horvath C , Lakatos P , Szabo A , M ucsi I Native vitamin D supplementation may slow down bone loss in patients on maintenance hemodialysis JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 14:(Suppl.) p. 48A. (2003) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1120065] [ Érvényesített ] 289. Ambrus C , Almasi C , Berta M , Deak G , Horvath C , Lakatos P , Szabo A , M arton A , M ucsi I Predictors of bone mineral density and bone loss in patients on maintenance hemodialysis JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 14:(Suppl.) pp. 470A471A. (2003) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1120066] [ Érvényesített ] 290. Bajnok É , Lakatos P A pajzsmirigyhormonok csonthatásai CA ÉS CSONT 6:(4) pp. 134146. (2003) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [1807063] [ Érvényesített ] 291. Bors K , Bálint G. , Szekeres L. , Balogh Á , Forgács S , Genti G , Holló I , Horváth C , Lakatos P , Kiss L , M arton I , Poór G , Somogyi P , Szekanecz Z , Szűcs J , Takács I , Tamási L Ajánlás az osteoporosis prevenciójára, az osteoporosisos beteg rehabilitációjára CA ÉS CSONT 6: pp. 116120. (2003) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1803501] [ Szerzői rekord ] 292. Csupor E , Toth E , Ferencz V , Szucs J , Lakatos P , Horanyi J , Perner F , M cCloskey EV , Horvath C Does the location of the parathyroid adenoma influence kidney stone formation in primary hyperparathyroidism? JOURNAL OF BONE AND MINERAL RESEARCH 18:(Suppl 2) p. S391. (2003) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1683604] 25th Annual M eeting of the American Society for Bone and M ineral Research, M inneapolis, (USA), Sept. 1923, 2003 [ Érvényesített ] 293. Csupor E , Szucs J , M észáros S , Lakatos P , Tóth E , Horváth C A csont ásványianyagtartalmának vizsgálata primer hyperparathyreosis renal is formájában LEGE ARTIS MEDICINAE 13:(2) pp. 134138. (2003) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1802602] [ Érvényesített ] 294. Csupor E , Tóth E , M észáros S , Ferencz V , Szűcs J , Lakatos P , Horányi J , Perner F , Horváth C Befolyásoljae a mellékpajzsmirigyadenoma elhelyezkedése a primer hyperparathyreosis veseköves vagy nem veseköves klinikai formáinak megjelenését? CA ÉS CSONT 6:(1) pp. 1317. (2003) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1807149] [ Érvényesített ] Függő idéző: 1 Összesen: 1 1. * Csupor Emőke A parathormon hatása a csontanyagcserére primaer hyperparathyreosisban és más mellékpajzsmirigybetetgségekben 38 p. 2005.
Disszertáció /P hD /Tudományos [12652974]
295. Csupor E , Szűcs J , M észáros Sz , Tóth E , Lakatos P , Ferencz V , Horváth Cs A primer hyperparathyreosis veseköves és nem veseköves formájának összehasonlítása posztmenopauzában ill. ferilis korban lévő nőbetegnél CA ÉS CSONT 6:(S1) pp. 2728. (2003) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2083690] [ Admin láttamozott ] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
248/342
3/30/2015
nyomtatobarat forma
296. Csupor E , Tóth E , Ferencz V , Szűcs J , Lakatos P , Horváth Cs Primaer hyperparthyreosisban szenvedő fertilis ill. postmenopausás nők, valamint férfiak csontanyagcsere paramétereinek és a törések előfordulásának összehasonlítása CA ÉS CSONT 6:(S1) pp. 2526. (2003) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2083695] [ Admin láttamozott ] 297. Ferencz V , Bojszkó Á , Pállinger É , Falus A , M észáros Sz , Lakatos P , Horváth Cs Allergiás gyermekek csontanyagcseréjének vizsgálata CA ÉS CSONT 6:(S1) p. 25. (2003) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2082591] [ Admin láttamozott ] 298. Ferencz V , Bors K , Hosszú É , Lakatos P , Horváth Cs A komplex összetételű kalciumsók hatása a csontturnoverre posztmenopauzában lévő osteoporosisos és osteopeniás nőknél CA ÉS CSONT 6:(S1) pp. 2122. (2003) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2082592] [ Admin láttamozott ] 299. Ferencz Viktória , Bors Katalin , M észáros Szilvia , Bereczki János , Csupor Emőke , Gujás M árta , Horváth Katalin , Korányi András , Lakatos Péter , M agdics M ária , Rápolthy Ildikó , Szekeres László , Torma Olga , Tóth Edit , Valkai Teréz , Horváth Csaba A rövid távú kalcium és Dvitaminpótlás hatása a posztmenopauzában lévő osteopeniás vagy osteoporosisos nőkre, a Dvitaminellátottság függvényében CA ÉS CSONT 6:(4) pp. 148156. (2003) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1955844] [ Érvényesített ] 300. P Fuszek , G Speer , Z Nagy , J Papp , PL Lakatos , P Lakatos Lack of association between the calciumsensing receptor (CaSR) A986S polymorphism and colorectal cancer GASTROENTEROLOGY 124:(4. Suppl. 1) pp. A551A552. (2003) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391600] [ Érvényesített ] 301. Hollo G , Visontai Z , Lakatos P , Vargha P Unoprostone isopropyl pretreatment decreases endothelin1 release and the intraocular pressure spike induced by laser trabeculoplasty in the rabbit. OPHTHALMOLOGICA 217:(3) pp. 231236. (2003) IF: 0.663 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1723940] CI: Copyright 2003 S. Karger AG, Basel : ophthalmology. Zeitschrift fur Augenheilkunde [ Érvényesített ] Független idéző: 1 Összesen: 1 1
Kimura I, Shinoda K, Tanino T, Ohtake Y, Mashima Y Effect of topical unoprostone isopropyl on optic nerve head circulation in controls and in normaltension glaucoma patients Japanese Journal of Ophthalmology (ISSN: 00215155) 49: (4) pp. 287293. ( 2005) Folyóiratcikk [13479873]
302. Horanyi J , Duffek L , Szlavik R , Darvas K , Lakatos P , Toth M , Racz K Parathyroid surgical failures with misleading falls of intraoperative parathyroid hormone levels JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 26:(11) pp. 10951099. (2003) IF: 1.621 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1367669] [ Érvényesített ] Független idéző: 16 Függő idéző: 3 Összesen: 19 1
Grzela T, Chudzinski W , Lazarczyk M, Niderla J, Dziunycz P, Milewski L, Samaha R, Kobylecka M, Miskiewicz J, Bogacka Zatorska E, Gornicka B, Swiercz P, Jelenska M, Krolick L P ersisted/recurrent hyperparathyroidism associated with development of multidrug resistance phenotype and proliferation of parathyroid transplants INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (ISSN: 11073756) 14: (4) pp. 595599. ( 2004)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
249/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [11047387] 2
Bilezikian J P, Rubin M, Silverberg S J P rimary hyperparathyroidism: Diagnosis, evaluation, and treatment Current Opinion in Endocrinology and Diabetes 11: (6) pp. 345352. ( 2004) Folyóiratcikk [12005262]
3
Hunt JL, Carty SE, Yim JH, Murphy J, Barnes L Allelic loss in parathyroid neoplasia can help characterize malignancy AMERICAN JOURNAL OF SURGICAL PATHOLOGY (ISSN: 01475185) 29: (8) pp. 10491055. ( 2005) Folyóiratcikk [11047386]
4
Johnson SJ, Sheffield EA, McNicol AM Examination of parathyroid gland specimens JOURNAL OF CLINICAL PATHOLOGY (ISSN: 00219746) 58: (4) pp. 338342. ( 2005) Folyóiratcikk [11047385]
5
Simonella G, Massaccesi E, De Marzi C, Staffolani P, Falco A, Morosini P Minimally invasive surgery versus bilateral neck exploration for primary hyperparathyroidism: Controlled prospective study. Role of intraoperative rapid parathyroid hormone assay and radiological preoperative detection of adenomas: Terapia chirurgica dell'iperparatiroidismo primitivo. Studio prospettico di confronto fra chirurgia tradizionale e chirurgia mininvasiva. Ruolo della localizzazione radiologica preoperatoria e del dosaggio intraoperatorio del paratormone Recenti Progressi in Medicina (ISSN: 00341193) 96: (10) pp. 483487. ( 2005) PubMed ID: 16491770 Chemicals/CAS: calcium, 7440702; parathyroid hormone, 12584962, 68893823, 9002646; Parathyroid Hormone Folyóiratcikk [11047846]
6
Phillips IJ, Kurzawinski TR, Honour JW P otential pitfalls in intraoperative parathyroid hormone measurements during parathyroid surgery ANNALS OF CLINICAL BIOCHEMISTRY (ISSN: 00045632) 42: pp. 453458. ( 2005) PN: Part 6 Folyóiratcikk [11047384]
7
Bilezikian J P, Silverberg S J, Rubin M, Potts Jr J T Asymptomatic primary hyperparathyroidism: P resent management and future options Clinical Cases in Mineral and Bone Metabolism 3: (2) pp. 132140. ( 2006) Folyóiratcikk [12005261]
8.
Fregoli L Confronto fra: esplorazione cervicale bilaterale e dosaggio intraoperatorio del paratormone nella paratiroidectomia videoassistita miniinvasiva (MIVAP ) 42 p. 2006.
Medicina e Chirurgia, Università di Pisa Disszertáció /Külföldi fokozat (nem P hD) /Tudományos [12645691] 9
W esterdahl J, Bergenfelz A P arathyroid surgical failures with sufficient decline of intraoperative parathyroid hormone levels Unobserved multiple endocrine neoplasia as an explanation ARCHIVES OF SURGERY (ISSN: 00040010) 141: (6) pp. 589594. ( 2006) Folyóiratcikk [11047383]
10 * Horányi J, Szlávik R, Duffek L, Darvas K, Györke T, Lakatos P, Tóth M Surgery of primary hyperparathyroidism: A primer hyperparathyreosis sebészi kezelése Orvosi Hetilap (ISSN: 00306002) 147: (49) pp. 23472351. ( 2006) PubMed ID: 17228513 Chemicals/CAS: calcium, 7440702; parathyroid hormone, 12584962, 68893823, 9002646; Calcium, 7440702; Parathyroid Hormone Folyóiratcikk [11047845] 11
Solorzano CC, CarneiroPla DM, Lew JI, Rodgers SE, Montano R, Irvin GL Intraoperative parathyroid hormone monitoring in patients with parathyroid cancer ANNALS OF SURGICAL ONCOLOGY (ISSN: 10689265) 14: (11) pp. 32163222. ( 2007) Folyóiratcikk [11047382]
12
SitgesSerra A Selective parathyroidectomy in sporadic primary hyperparathyroidism: P aratiroidectomía selectiva en el hiperparatiroidismo primario esporádico Cirugia Espanola (ISSN: 0009739X) 81: (3) pp. 111114. ( 2007) Folyóiratcikk [12005260]
13
SitgesSerra A, Rosa P, Valero M, Membrilla E, Sancho JJ Surgery for sporadic primary hyperparathyroidism: controversies and evidencebased approach LANGENBECKS ARCHIVES OF SURGERY (ISSN: 14352443) 393: (3) pp. 239244. ( 2008) Folyóiratcikk [11047381]
14 * Horanyi J, Duffek L, Szlavik R, Takacs I, Toth M, Romics L Intraoperative Determination of P TH Concentrations in Fine Needle Tissue Aspirates to Identify P arathyroid Tissue During P arathyroidectomy WORLD JOURNAL OF SURGERY (ISSN: 03642313) 34: (3) pp. 538543. ( 2010) Folyóiratcikk [11047380] 15
Moalem J, Ruan DT, Farkas RL, Shen W T, Miller S, Duh QY, Clark OH, Kebebew E P rospective Evaluation of the Rate and Impact of Hemolysis on Intraoperative P arathyroid Hormone (IOP TH) Assay Results ANNALS OF SURGICAL ONCOLOGY (ISSN: 10689265) 17: (11) pp. 29632969. ( 2010) Folyóiratcikk [11128502]
16
Sidell D, W ang J, Sercarz J Spurious decline in intraoperative parathyroid hormone: false positives in parathyroid surgery AMERICAN JOURNAL OF OTOLARYNGOLOGY (ISSN: 01960709) 31: (6) pp. 479481. ( 2010) Folyóiratcikk [11128501]
17. * Tóth Miklós A glükokortikoidtermelés és a glükokortikoidhatás vizsgálata a hypothalamushypophysismellékvese tengely megbetegedéseiben 143 p. 2012.
Disszertáció /MTA Doktora /Tudományos [12652756]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
250/342
3/30/2015
nyomtatobarat forma 18
Riss P, Krall C, Scheuba C, Bieglmayer C, Niederle B Risk factors for "pTH spikes" during surgery for primary hyperparathyroidism Langenbeck's Archives of Surgery 398: (6) pp. 881886. ( 2013) Folyóiratcikk [13256287]
19.
Черноусов АФ КОМПЛЕКСНОЕ УЛЬТР АЗВУКОВОЕ ИССЛЕДОВАНИЕ В ДИАГНОСТИКЕ И ХИР УР ГИЧЕСКОМ ЛЕЧЕНИИ ПЕР ВИЧНОГО ГИПЕР ПАР АТИР ЕОЗА Témavezető(k): Лабораторная диагностика. 143 p. 2014.
Disszertáció /Nem besorolt /Tudományos [14257356]
303. Horváth C , Lakatos P. , M arton I , Bors K , Poór Gy , Holló I , Takács I Ajánlás az osteoporosis és más metabolikus csontbetegségek diagnosztikájára 2004ben CA ÉS CSONT 6:(3) pp. 7887. (2003) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1803455] [ Szerzői rekord ] 304. Horváth Cs , Lakatos P. , Balogh Á. , M OOT vezetősége Egyéb szerzőség: Takács I (kollaborációs közrem.); Ajánlás a férfiak osteoporosisának diagnosztikájára és kezelésére 2004ben. CA ÉS CSONT 6: pp. 104106. (2003) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1803486] [ Szerzői rekord ] 305. Lakatos P Thyroid hormones: Beneficial or deleterious for bone? CALCIFIED TISSUE INTERNATIONAL 73:(3) pp. 205209. (2003) IF: 2.198 Nyelv: Angol
Folyóiratcikk /Összefoglaló cikk /Tudományos [1802599] [ Érvényesített ] Független idéző: 24 Összesen: 24 1
Retornaz F, Seux V, Soubeyrand J Secondary osteoporosis in internal medicine REVUE DE MEDECINE INTERNE (ISSN: 02488663) 25: pp. S543S551. ( 2004) Z9: 1 SU: 5 W C: Medicine, General & Internal Folyóiratcikk [12350532]
2
Talaeipour AR, Shirazi M, Kheirandish Y, Delrobaie A, Jafari F, Dehpour AR Densitometric evaluation of skull and jaw bones after administration of thyroid hormones in rats DENTOMAXILLOFACIAL RADIOLOGY (ISSN: 0250832X) 34: (6) pp. 332336. ( 2005) Z9: 5 W C: Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & : Medical Imaging Folyóiratcikk [12350531]
3
JacobsKosmin D, DeHoratius RJ Musculoskeletal manifestations of endocrine disorders CURRENT OPINION IN RHEUMATOLOGY (ISSN: 10408711) 17: (1) pp. 6469. ( 2005) Z9: 7 W C: Rheumatology Folyóiratcikk [12350530]
4
Kaste SC, Rai SN, Fleming K, McCammon EA, Tylavsky FA, Danish RK, Rose SR, Sitter CD, Pui CH, Hudson MM Changes in bone mineral density in survivors of childhood acute lymphoblastic leukemia PEDIATRIC BLOOD & CANCER (ISSN: 15455009) 46: (1) pp. 7787. ( 2006) Z9: 29 W C: Oncology; Hematology; Pediatrics Folyóiratcikk [12350529]
5
Majima T, Komatsu Y, Doi K, Takagi C, Shigemoto M, Fukao A, Morimoto T, Corners J, Nakao K Clinical significance of risedronate for osteoporosis in the initial treatment of male patients with Graves' disease JOURNAL OF BONE AND MINERAL METABOLISM (ISSN: 09148779) 24: (2) pp. 105113. ( 2006) Z9: 12 W C: Endocrinology & Metabolism; Medicine, Research & Experimental Folyóiratcikk [12350528]
6
Zaidi M, Sun L, Davies TF, Abe E Low TSH triggers bone loss: Fact or fiction? THYROID (ISSN: 10507256) 16: (11) pp. 10751076. ( 2006) Z9: 10 W C: Endocrinology & Metabolism Folyóiratcikk [12350527]
7
Sun L, Davies TE, Blair HC, Abe E, Zaidi M TSH and bone loss In: Zaidi M (szerk.) : SKELETAL DEVELOPMENT AND REMODELING IN HEALTH, DISEASE, AND AGING. Oxon: Blackwell, 2006. pp. 309 318. (ANNALS OF THE NEW YORK ACADEMY OF SCIENCES)
Könyvrészlet [12350526] 8
Demartini ADAC, Kulak CAM, Borba VC, Cat MNL, Dondoni RS, Sandrini R, NesiFranca S, De Lacerda Filho L Bone mineral density of children and adolescents with congenital hypothyroidism ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (ISSN: 00042730) 51: (7) pp. 10841092. ( 2007) Z9: 2 W C: Endocrinology & Metabolism Folyóiratcikk [12350525]
9
Sharma CGD, Pradeep AR Localized attachment loss in pendred syndrome: Incidental?
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
251/342
3/30/2015
nyomtatobarat forma JOURNAL OF PERIODONTOLOGY (ISSN: 00223492) 78: (5) pp. 948954. ( 2007) Z9: 1 W C: Dentistry, Oral Surgery & Medicine Folyóiratcikk [12350524] 10
Papadimitriou A, Papadimitriou DT, Papadopoulou A, Nicolaidou P, Fretzayas A Low TSH levels are not associated with osteoporosis in childhood EUROPEAN JOURNAL OF ENDOCRINOLOGY (ISSN: 08044643) 157: (2) pp. 221223. ( 2007) Z9: 3 W C: Endocrinology & Metabolism Folyóiratcikk [12350523]
11
McCormick RK Osteoporosis: Integrating biomakers and other diagnostic correlate into the management of bone fragility ALTERNATIVE MEDICINE REVIEW (ISSN: 10895159) 12: (2) pp. 113145. ( 2007) Z9: 27 W C: Integrative & Complementary Medicine; Pharmacology & Pharmacy Folyóiratcikk [12350522]
12
Morris MS The association between serum thyroidstimulating hormone in its reference range and bone status in postmenopausal American women BONE (ISSN: 87563282) 40: (4) pp. 11281134. ( 2007) Z9: 28 W C: Endocrinology & Metabolism Folyóiratcikk [12350521]
13
Sbaihi M, Kacem A, Aroua S, Baloche S, Rousseau K, Lopez E, Meunier F, Dufour S Thyroid hormoneinduced demineralisation of the vertebral skeleton of the eel, Anguilla anguilla GENERAL AND COMPARATIVE ENDOCRINOLOGY (ISSN: 00166480) 151: (1) pp. 98107. ( 2007) Z9: 11 W C: Endocrinology & Metabolism Folyóiratcikk [12350520]
14
Routti H, Nyman M, Jenssen BM, Backman C, Koistinen J, Gabrielsen GW Bonerelated effects of contaminants in seals may be associated with vitamin D and thyroid hormones ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY (ISSN: 07307268) 27: (4) pp. 873880. ( 2008) Z9: 16 W C: Environmental Sciences; Toxicology Folyóiratcikk [12350519]
15
Oelzner P Rheumatic and Osteological Aspects of Thyroid Diseases AKTUELLE RHEUMATOLOGIE (ISSN: 0341051X) 33: (5) pp. 250256. ( 2008) W C: Rheumatology Folyóiratcikk [12350518]
16
Saraiva PR, Teixeira SS, Nogueira CR, Padovani CR Triiodothyronine (T3) does not induce RANKL expression in rat ROS 17/2.8 cells ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (ISSN: 00042730) 52: (1) pp. 109113. ( 2008) Z9: 2 W C: Endocrinology & Metabolism Folyóiratcikk [12350517]
17
Lachowicz K, KoszelaPiotrowska I, RosolowskaHuszcz D Dietary fat type and level affect thyroid hormone plasma concentrations in rats JOURNAL OF ANIMAL AND FEED SCIENCES (ISSN: 12301388) 18: (3) pp. 541550. ( 2009) W C: Agriculture, Dairy & Animal Science Folyóiratcikk [12350516]
18
Tuchendler D, Bolanowski M The role of osteoprotegerin and witamin D in thyroid pathology ENDOKRYNOLOGIA POLSKA (ISSN: 0423104X) 60: (6) pp. 470475. ( 2009) Z9: 1 W C: Endocrinology & Metabolism Folyóiratcikk [12350515]
19
Elbakry AM, ElGareib AW , Ahmed RG Comparative study of the effects of experimentally induced hypothyroidism and hyperthyroidism in some brain regions in albino rats INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (ISSN: 07365748) 28: (5) pp. 371389. ( 2010) Z9: 2 W C: Developmental Biology; Neurosciences Folyóiratcikk [12350514]
20
Mazziotti G, Canalis E, Giustina A Druginduced Osteoporosis: Mechanisms and Clinical Implications AMERICAN JOURNAL OF MEDICINE (ISSN: 00029343) 123: (10) pp. 877884. ( 2010) Z9: 20 W C: Medicine, General & Internal Folyóiratcikk [12350513]
21
Lee JS, Buzkova P, Fink HA, Vu J, Carbone L, Chen Z, Cauley J, Bauer DC, Cappola AR, Robbins J Subclinical Thyroid Dysfunction and Incident Hip Fracture in Older Adults ARCHIVES OF INTERNAL MEDICINE (ISSN: 00039926) 170: (21) pp. 18761883. ( 2010) Z9: 6 W C: Medicine, General & Internal Folyóiratcikk [12350512]
22
Sjoberg C, Bladh L, Klintberg L, Mellstrom D, Ohlsson C, W allerstedt SM Treatment with FallRiskIncreasing and FractureP reventing Drugs Before and After a Hip Fracture An Observational Study DRUGS & AGING (ISSN: 1170229X) 27: (8) pp. 653661. ( 2010) W C: Geriatrics & Gerontology; Pharmacology & Pharmacy Folyóiratcikk [12350511]
23
IgnaszakSzczepaniak M, HorstSikorska W , Dytfeld J, Gowin E, Slomski R, Stajgis M Association between estrogen receptor alpha gene polymorphisms and bone mineral density in P olish female patients with Graves' disease ACTA BIOCHIMICA POLONICA (ISSN: 0001527X) 58: (1) pp. 101109. ( 2011) W C: Biochemistry & Molecular Biology Folyóiratcikk [12350510]
24
Roef G, Lapauw B, Goemaere S, Zmierczak H, Fiers T, Kaufman JM, Taes Y Thyroid hormone status within the physiological range affects bone mass and density in healthy men at the age of peak bone mass EUROPEAN JOURNAL OF ENDOCRINOLOGY (ISSN: 08044643) 164: (6) pp. 10271034. ( 2011) Z9: 1 W C: Endocrinology & Metabolism
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
252/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [12350509]
306. Lakatos P Az osteoporosis kezelése ORVOSI HETILAP 144:(31) pp. 15511552. (2003) Nyelv: Magyar
Folyóiratcikk /Rövid közlemény /Tudományos [1802600] [ Érvényesített ] 307. Lakatos P Az osteoporosis diagnosztikája és gyógyszeres kezelése ORVOSI HETILAP 144:(28) pp. 13731379. (2003) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [1802601] [ Érvényesített ] 308. Lakatos P , Horváth C , M arton I , Poór Gy , Holló I. , M OOT vezetősége (Takács I.) Ajánlás az életkorral járó osteoporosis gyógyszeres kezelésére. CA ÉS CSONT 6: pp. 8893. (2003) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1803459] [ Szerzői rekord ] 309. Lakatos P Pajzsmirigyhormonok és a csont : hasznos vagy káros? ORVOSKÉPZÉS 78:(1) pp. 1116. (2003) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1807246] [ Érvényesített ] 310. Lakatos P , Christiansen C , M arton I (szerk.) New Europe: Consensus on Osteoporosis 2003: Developed by the 2nd Central and Eastern European Regional Osteoporosis M eeting Konferencia helye, ideje: Balatonfüred, M agyarország, 2003.05.21. Budapest: Lacrima, 2003. 52 p. Nyelv: Angol
Egyéb konferenciakötet / /Tudományos [1889595] [ Érvényesített ] 311. Lakatos P (szerk.) AnyagcsereEndokrinológia útmutató 2003: Klinikai irányelvek kézikönyve Budapest: M edition Kiadó, 2003. Nyelv: Magyar
Könyv /Kézikönyv /Tudományos [1889633] [ Admin láttamozott ] 312. Lakatos P A korral járó oszteoporózis gyógyszeres kezelése In: Nemeskéri G (szerk.) Pharmindex zsebkönyv, 2003: Reumatológia . 366 p. Budapest: M ediM edia Információs Kft., 2003. pp. 5968. Nyelv: Magyar
Könyvrészlet /Könyvfejezet /Tudományos [1889637] Autopszia alapján ellenőrizve (20150326, BA) [ Érvényesített ] 313. Lakatos PL , Bajnok E , Tornai I , Folhoffer A , Horvath A , Lakatos P , Szalay F Insulinlike growth factor I (IGFI) gene microsatellite repeat and collagen type 1A1 Sp1 polymorphism (COLIA1) and bone disease in primary biliary cirrhosis (PBC) GUT 52:(SUPPL VI) p. A164. (2003) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391556] [ Admin láttamozott ] 314. Lakatos PL , Bajnok E , Tornai I , Folhoffer A , Horvath A , Lakatos P , Szalay F https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
253/342
3/30/2015
nyomtatobarat forma
Insulinlike growth factor I (IGFI) gene microsatellite repeat and collagen type 1A1 Sp1 polymorphism (COLIA1) and bone disease in Hungarian patients with primary biliary cirrhosis (PBC) ZEITSCHRIFT FÜR GASTROENTEROLOGIE 41: p. 444. (2003) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391575] [ Admin láttamozott ] 315. Lakatos PL , Bajnok E , Folhoffer A , Horváth A , Tornai I , Lakatos P , Szalay F Collagen type 1A1 gene Sp1 polymorphism and bone disease in primary biliary cirrhosis JOURNAL OF HEPATOLOGY 38:(Suppl. 2) pp. 212213. (2003) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391610] [ Érvényesített ] 316. M adarász E , Kerényi Z , Tabák Á G , Speer G , Lakatos P , Szalay J , Tamás G Osteoprotegerin vérszintek korábban gesztációs diabéteszes és egészséges kontroll asszonyokban DIABETOLOGIA HUNGARICA 11:(Suppl. 1) p. 33. (2003) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1820991] [ Admin láttamozott ] 317. M ezo T , Tabak A G , Bhattoa H P , Lakatos P The Hungarian osteoporosis risk assessment (HORA) study BONE 32:(Suppl S) p. S185. (2003) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1820992] [ Érvényesített ] 318. P Fuszek , G Speer , Z Nagy , J Papp , PL Lakatos , P Lakatos Calciumsensing receptor (CaSR) A986S polymorphism in Hungarian patients with colorectal cancer. GUT 52:(SUPPL VI) p. A74. (2003) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391564] [ Admin láttamozott ] 319. P Fuszek , G Speer , Z Nagy , J Papp , PL Lakatos , P Lakatos Lack of association between the calciumsensing receptor (CaSR) A986S polymorphism and colorectal cancer. ZEITSCHRIFT FÜR GASTROENTEROLOGIE 41: p. 437. (2003) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391583] [ Admin láttamozott ] 320. Somogyi P , Lakatos P , Poór Gy , Horváth Cs , M OOT vezetősége Nemzeti törésmegelőző és kockázatjavító program: szakmai összefogás az osteoporosis talaján kialakult ismételt csonttörések megelőzéséért, a törést szenvedett betegek kivizsgálásáért és hatékony védelméért CA ÉS CSONT 6:(1) pp. 2229. (2003) Nyelv: Magyar
Folyóiratcikk /Nem besorolt /Tudományos [1015471] [ Érvényesített ] 321. Speer G , Tóth M , Niller HH , Salamon D , Takács I , M iheller P , Patócs A , Nagy Z , Bajnok E , Nyiri P , Lakatos P Calcium metabolism and endocrine functions in a family with familial hypocalciuric hypercalcemia EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES 111:(8) pp. 486490. (2003) IF: 1.956 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1102217] [ Érvényesített ] Független idéző: 7 Összesen: 7 1
Bass J K, Chan G M Calcium nutrition and metabolism during infancy Nutrition (ISSN: 08999007) 22: (10) pp. 10571066. ( 2006) Folyóiratcikk /Összefoglaló cikk /Tudományos [11035116]
2
Bevilacqua M, Dominguez L J, Righini V, Valdes V, Vago T, Leopaldi E, Baldi G, Barrella M, Barbagallo M Dissimilar P TH, gastrin, and calcitonin responses to oral calcium and peptones in hypocalciuric hypercalcemia, primary hyperparathyroidism, and normal subjects: A useful tool for differential diagnosis Journal of Bone and Mineral Research (ISSN: 08840431) 21: (3) pp. 406412. ( 2006)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
254/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [11035118] 3
SMARZW IDELSKA Iwona, SYROKAGŁÓW KA Małgorzata, KSIĄŻEK Piotr, ZAŁUSKA W ojciech Hiperkalcemia w wybranych przypadkach klinicznych: Hypercalcemia in selected clinical cases Nefrologia i Dializoterapia Polska (ISSN: 14291029) 10: (1) pp. 3437. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [14198793]
4
Tebben PJ, Kumar R The Hormonal Regulation of Calcium Metabolism In: Seldin and Giebisch's The Kidney . Elsevier Inc., 2008. (ISBN 9780120884889) pp. 18911909.
Könyvrészlet /Könyvfejezet /Tudományos [13359546] 5
Hendy G N, Guarnieri V, Canaff L Chapter 3 CalciumSensing Receptor and Associated Diseases In: Tao YX (szerk.) : Progress in Molecular Biology and Translational Science. (89) Academic Press, 2009. (ISBN 9780123747563) pp. 3195.
Könyvrészlet /Könyvfejezet /Tudományos [12367074] 6
Bevilacqua M, Invernizzi M, Righini V, Carda S, Cisari C Different vitamin D substrateproduct relationship after oral vitamin D supplementation in familial benign hypercalcemia, primary hyperparathyroidism, and healthy controls EUROPEAN JOURNAL OF ENDOCRINOLOGY (ISSN: 08044643) 164: (5) pp. 833838. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12365105]
7
Tebben PJ, Kumar R The Hormonal Regulation of Calcium Metabolism In: Seldin and Geibisch's The Kidney . Elsevier Inc., 2013. (ISBN 9780123814623) pp. 22492272.
Könyvrészlet /Könyvfejezet /Tudományos [13359545]
322. Stepan J J , Alenfeld F , Boivin G , Feyen J H M , Lakatos P M echanisms of action of antiresorptive therapies of postmenopausal osteoporosis ENDOCRINE REGULATIONS 37:(4) pp. 225238. (2003) Nyelv: Angol
Folyóiratcikk /Összefoglaló cikk /Tudományos [1802598] [ Érvényesített ] 323. Szalay F , Hegedus D , Lakatos PL , Tornai I , Bajnok E , Dunkel K , Lakatos P High serum osteoprotegerin and low RANKL levels in patients with primary biliary cirrhosis. JOURNAL OF HEPATOLOGY 38:(4) pp. 395400. (2003) IF: 5.283 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1074565] [ Érvényesített ] Független idéző: 60 Függő idéző: 5 Összesen: 65 1
2
* Hegedus D, Ferencz V, Lakatos PL, Meszaros S, Lakatos P, Horvath C, Szalay F Decreased bone density; elevated serum osteoprotegerin; and betacrosslaps in Wilson disease J BONE MINER RES 17: pp. 19611967. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [10226516] Trauner M, Boyer JL Cholestatic syndromes CURR OPIN GASTROENT 20: pp. 220230. ( 2004) Folyóiratcikk /Összefoglaló cikk /Tudományos [10226519]
3
* Lakatos PL, Bajnok É, Tornai I, Folhoffer A, Horváth A, Lakatos P, Szalay F Decreased bone mineral density, insulinlike growth factor I (IGFI) gene microsatellite repeat and collagen type /α1 Sp1 polymorphism in primary biliary cirrhosis Orvosi Hetilap (ISSN: 00306002) 145: (7) pp. 331336. ( 2004) N1 : Chemicals/CASsomatomedin C, 67763966; Collagen Type I; InsulinLike Growth Factor I, 67763966 Folyóiratcikk /Szakcikk /Tudományos [13121493]
4
* Lakatos PL, Bajnok E, Tornai I, Folhoffer A, Horvath A, Lakatos P, Habior A, Szalay F Insulinlike growth factor I gene microsatellite repeat; collagen type I alpha 1 gene Sp1 polymorphism; and bone disease in primary biliary cirrhosis EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 16: pp. 753759. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [10226522]
5
Dovio A, Data V, Angeli A P athophysiological significance and clinical utility of circulating osteoprotegerin Annali Italiani di Medicina Interna 19: (1) pp. 819. ( 2004) N1 : Chemicals/CAScarrier protein, 80700396; osteoclast differentiation factor, 200145933; osteoprotegerin, 205944 509; tumor necrosis factor receptor, 129203936, 184595015; Biological Markers; Carrier Proteins; Glycoproteins; Membrane Glycoproteins; NFkappa B; Osteoprotegerin; RANK Ligand; Receptor Activator of Nuclear Factorkappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; TNFRSF11A protein, human; TNFRSF11B protein, human; TNFSF11 protein, human Folyóiratcikk /Szakcikk /Tudományos [13121491]
6
Emanuele E, Peros E, Scioli GA, DAngelo A, Olivieri C, Montagna L, Geroldi D P lasma osteoprotegerin as a biochemical marker for vascular dementia and Alzheimer's disease INT J MOL MED 13: pp. 849853. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [10226521]
7
* Horvath A, Folhoffer A, Lakatos PL, Halosz J, Illyes G, Schaff Z, Hantos MB, Tekes K, Szalay F Rising plasma nociceptin level during development of HCC: A case report WORLD J GASTROENTEROL 10: pp. 152154. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [10226518]
8
Pusl T, Beuers U Extrahepatic manifestations of cholestatic liver diseases: P athogenesis and therapy Clinical Reviews in Allergy and Immunology 28: (2) pp. 147157. ( 2005)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
255/342
3/30/2015
nyomtatobarat forma N1 : Chemicals/CASalendronic acid, 66376361; calcitonin, 12321447, 21215623, 9007129; calcium, 7440702; clonidine, 4205907, 4205918, 57066258; colestipol, 25085170, 37296803, 50925796; colestyramine, 11041126, 58391370; etidronic acid, 2809214, 3794830, 58449824, 7414837; fluoride sodium, 51668543, 7681494, 79933 270; nalmefene, 55096269; naloxone, 357084, 465656; naltrexone, 16590413, 16676292; ondansetron, 10363904 9, 116002701, 99614014; opiate, 53663619, 8002764, 8008604; prednisone, 53032; rifampicin, 13292461; sertraline, 79617962; ursodeoxycholic acid, 128132, 2898955 Folyóiratcikk /Összefoglaló cikk /Tudományos [13121490] 9
Pares A, Guanabens N, Rodes J Gene polymorphisms as predictors of decreased bone mineral density and osteoporosis in primary biliary cirrhosis EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 17: pp. 311315. ( 2005) Folyóiratcikk /Összefoglaló cikk /Tudományos [10226526]
10
Gaudio A, Lasco A, Morabito N, Atteritano M, Vergara C, Catalano A, Fries W , Trifiletti A, Frisina N Hepatic osteodystrophy: Does the osteoprotegerin/receptor activator of nuclear factorkB ligand system play a role? JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (ISSN: 03914097) 28: pp. 677682. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226535]
11
Fiore CE, Riccobene S, Mangiafico R, Santoro F, Pennisi P Hepatitis Cassociated osteosclerosis (HCAO): report of a new case with involvement of the OP G/RANKL system OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 16: pp. 21802184. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226538]
12
Fabrega E, Orive A, GarciaSuarez C, GarciaUnzueta M, Antonio Amado J, PonsRomero F Osteoprotegerin and RANKL in alcoholic liver cirrhosis LIVER INTERNATIONAL (ISSN: 14783223) 25: pp. 305310. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226524]
13
Rogers A, Eastell R REVIEW: Circulating osteoprotegerin and receptor activator for nuclear factor kappa B ligand: Clinical utility in metabolic bone disease assessment JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 90: pp. 63236331. ( 2005) Folyóiratcikk /Összefoglaló cikk /Tudományos [10226537]
14 * Szalay F, Folhoffer A, Horvath A, Csak T, Speer G, Nagy Z, Lakatos P, Horvath C, Habior A Tornai I Lakatos PL Serum leptin; soluble leptin receptor; free leptin index and bone mineral density in patients with primary biliary cirrhosis EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 17: pp. 923928. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226532] 15
Bernstein CN, Sargent M, Leslie W D Serum osteoprotegerin is increased in Crohn's disease: A populationbased case control study INFLAMMATORY BOWEL DISEASES (ISSN: 10780998) 11: pp. 325330. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226527]
16
Mosheimer BA, Kaneider NC, Feistritzer C, Djanani AM, Sturn DH, Patsch JR, W iedermann CJ Syndecan1 is involved in osteoprotegerininduced chemotaxis in human peripheral blood monocytes JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 90: pp. 29642971. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226528]
17
MezquitaRaya P, de la Higuera M, Garcia DF, Alonso G, RuizRequena ME, de Dios Luna J, EscobarJimenez F, Munoz Torres M The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 13: pp. 13681374. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226536]
18
Moschen AR, Kaser A, Stadlmann S, Millonig G, Kaser S, Muhllechner P, Habior A, Graziadei I, Vogel W , Tilg H The RANKL/OP G system and bone mineral density in patients with chronic liver disease JOURNAL OF HEPATOLOGY (ISSN: 01688278) 43: pp. 973983. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226534]
19
Moschen AR, Kaser A, Enrich B, Ludwiczek O, Gabriel M, Obrist P, W olf AM, Tilg H The RANKL/OP G system is activated in inflammatory bowel disease and relates to the state of bone loss GUT (ISSN: 00175749) 54: pp. 479487. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226523]
20
Fiore CE, Pennisi P, Ferro G, Ximenes B, Privitelli L, Mangiafico RA, Santoro F, Parisi N, Lombardo T Altered osteoprotegerin/RANKL ratio and low bone mineral density in celiac patients on longterm treatment with glutenfree diet HORMONE AND METABOLIC RESEARCH (ISSN: 00185043) 38: pp. 417422. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [10226542]
21
Bernstein CN Inflammatory bowel disease as a secondary cause of osteoporosis Current Osteoporosis Reports 4: pp. 116123. ( 2006) Folyóiratcikk /Összefoglaló cikk /Tudományos [10226545]
22
Nishida N, Komatsu Y, Komeda T, Fukuda Y Interferonalpha improves bone resorption and osteopenia in patients with chronic hepatitis C HEPATOLOGY RESEARCH (ISSN: 13866346) 34: pp. 222227. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [10226540]
23
GarciaValdecasasCampelo E, GonzalezReimers E, SantolariaFernandez F, De la VegaPrieto MJ, MilenaAbril A, SanchezPerez MJ, MartinezRiera A, GomezRodriguez Mde Serum osteoprotegerin and rankl levels in chronic alcoholic liver disease ALCOHOL AND ALCOHOLISM (ISSN: 07350414) 41: pp. 261266. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [10226541]
24
RodriguezBores L, BarahonaGarrido J, YamamotoFurusho JK Basic and clinical aspects of asteoporosis in inflammatory bowed disease WORLD J GASTROENTERO 13: (46) pp. 61566165. ( 2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [10287378]
25
Kurban S, Mehmetoglu I Osteoprotegerin; rank and rank ligand TURKISH JOURNAL OF BIOCHEMISTRY 32: (4) pp. 178184. ( 2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [10335279]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
256/342
3/30/2015
nyomtatobarat forma 26
Sasaki A, Ishikawa K, Haraguchi N, Inoue H, Ishio T, Shibata K, Ohta M, Kitano S, Mori M Receptor activator of nuclear Factorkappa B ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis ANN SURG ONCOL 14: (3) pp. 11911199. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [10233635]
27
Monegal A, Navasa M, Peris P, Alvarez L, Pons F, Rodés J, Guañabens N Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: Relationship with metabolic bone disease LIVER INT 27: (4) pp. 492497. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [10244473]
28
Ertorer ME, Bakiner O, Anaforoglu I, Sezgin N, Dernirag NG, Tutuncu NB Serum osteoprotegerin concentration with strontium ranelate treatment for postmenopausal osteoporosis: An open prospective study CURR THER RES CLIN E 68: (4) pp. 217225. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [10259585]
29
Gasser RW Cholestasis and metabolic bone disease A clinical review WIEN MED WOCHENSCHR 158: (1920) pp. 553557. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [10466836]
30
W iwanitkit V Effect of interleukin2 and tumor necrosis factoralpha on osteopontin: molecular function and biological process PEDIATR INT 50: (2) pp. 213215. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [10323966]
31
Olivier BJ, Schoenmaker T, Mebius RE, Everts V, Mulder CJ, van Nieuwkerk KM, de Vries TJ, van der Merwe SW Increased osteoclast formation and activity by peripheral blood mononuclear cells in chronic liver disease patients with osteopenia HEPATOLOGY (ISSN: 02709139) 47: (1) pp. 259267. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [10287379]
32
Parés A, Guañabens N Osteoporosis in P rimary Biliary Cirrhosis: P athogenesis and Treatment Clinics in Liver Disease (ISSN: 10893261) 12: (2) pp. 407424. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [10346638]
33
Lee JS, Ryu CH, Moon NH, Kim SJ, Park SY, Suh KT Changes in serum levels of receptor activator of nuclear factorkappaB ligand; osteoprotegerin; IL6 and TNFalpha in patients with a concomitant head injury and fracture. ARCH ORTHOP TRAUM SU 129: (5) pp. 711718. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [10623291]
34
Nakchbandi IA, van der Merwe SW Current understanding of osteoporosis associated with liver disease Nature Reviews Gastroenterology and Hepatology 6: (11) pp. 660670. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [13121489]
35
Pereira FA, Facincani I, Jorgetti V, Ramalho LN, Volpon JB, Dos Reis LM, de Paula FJ Etiopathogenesis of hepatic osteodystrophy in wistar rats with cholestatic liver disease CALCIFIED TISSUE INT 85: (1) pp. 7583. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [10694318]
36
Guañabens N, Enjuanes A, Alvarez L, Peris P, Caballería L, Jesús Martínez de Osaba M, Cerdá D, Monegal A, Pons F, Parés A High osteoprotegerin serum levels in primary biliary cirrhosis are associated with disease severity but not with the mRNA gene expression in liver tissue J BONE MINER RES 27: (3) pp. 347354. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [10626417]
37
Yongchaitrakul T, Manokawinchoke J, Pavasant P Osteoprotegerin induces osteopontin via syndecan1 and phosphoinositol 3kinase/Akt in human periodontal ligament cells J PERIODONTAL RES 44: (6) pp. 776783. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [10822186]
38
Anastasilakis AD, Toulis KA, Polyzos SA, Terpos E RANKL inhibition for the management of patients with benign metabolic bone disorders EXPERT OPIN INV DRUG 18: (8) pp. 10851102. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [10708944]
39
Honsawek S, Chaiwatanarat T, Vejchapipat P, Chongsrisawat V, Thawornsuk N, Poovorawan Y Relationships between OP G; RANKL; bone metabolism; and bone mineral density in biliary atresia. PEDIATR SURG INT 25: (3) pp. 261267. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [10581521]
40
W agner D, FahrleitnerPammer A Levels of osteoprotegerin (OP G) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: Are they of any help? WIEN MED WOCHENSCHR 160: (1718) pp. 452457. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11112808]
41
Guañabens N, Parés A Liver and bone ARCH BIOCHEM BIOPHYS 503: (1) pp. 8494. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11074846]
42
W ariaghli G, Mounach A, Achemlal L, Benbaghdadi I, Aouragh A, Bezza A, El Maghraoui A Osteoporosis in chronic liver disease: a casecontrol study RHEUMATOL INT 30: (7) pp. 893899. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [10992814]
43
W ariaghli G, Allali F, El Maghraoui A, HajjajHassouni N Osteoporosis in patients with primary biliary cirrhosis EUR J GASTROEN HEPAT 22: (12) pp. 13971401. ( 2010)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
257/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Összefoglaló cikk /Tudományos [11106596] 44
Kochetkova EA, Nevzorova VA, Maistrovskaya YV, Massard G Osteoprotegerin and bone mineral density in patients with chronic obstructive pulmonary disease TERAPEVT ARKH 82: (8) pp. 1014. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11079386]
45
Yilmaz Y, Yonal O, Kurt R, Oral AY, Eren F, Ozdogan O, Ari F, Celikel CA, Korkmaz S, Ulukaya E, Imeryuz N, Kalayci C, Avsar E Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease SCAND J CLIN LAB INV 70: (8) pp. 541546. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11267843]
46
GonzálezReimers E, AlvisaNegrín J, SantolariaFernández F, RosVilamajó R, MartínGonzález MC, HernándezBetancor I, GarcíaValdecasasCampelo E, GonzálezDíaz A P rognosis of osteopenia in chronic alcoholics ALCOHOL (ISSN: 07418329) 45: (3) pp. 227238. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11364575]
47
Motoi O Risk factors for osteoporosis in chronic liver diseases Annals of Fundeni Hospital 16: (12) pp. 4247. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [11771316]
48
Iannitti T, Rosini S, Lodi D, Frediani B, Rottigni V, Palmieri B Bisphosphonates: Focus on inflammation and bone loss AM J THER 19: (3) pp. 228246. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12341794]
49
Owen HC, Vanhees I, Solie L, Roberts SJ, W auters A, Luyten FP, Van Cromphaut S, Van den Berghe G Critical illnessrelated bone loss is associated with osteoclastic and angiogenic abnormalities J BONE MINER RES 27: (7) pp. 15411552. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12412763]
50
Guañabens N, Parés A Osteoporosis in liver cirrhosis Gastroenterologia y Hepatologia (ISSN: 02105705) 35: (6) pp. 411420. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12433023]
51
Sakai N, Van Sweringen H L, Schuster R, Blanchard J, Burns J M, Tevar A D, Edwards M J, Lentsch A B Receptor activator of nuclear factorκB ligand (RANKL) protects against hepatic ischemia/reperfusion injury in mice HEPATOLOGY (ISSN: 02709139) 55: (3) pp. 888897. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12129740]
52
Kim SH, Tae Un Yang, Byeong Kwang Choi, Hye Jin Yoo, Ji A Seo, Kyung Mook Choi, Nan Hee Kim, Sin Gon Kim, Sei Hyun Baik, Dong Seop Choi, Hae Yoon Choi A Case of Multiple Osteoporotic Compression Fractures in Young Man with BuddChiari Syndrome ENDOCRINOL METAB 27: (4) pp. 334339. ( 2013) Folyóiratcikk /Rövid közlemény /Tudományos [13062301]
53
PelazasGonzález R, GonzálezReimers E, AlemánValls MR, SantolariaFernández F, LópezPrieto J, GonzálezDíaz A, GómezSirvent JL, de la VegaPrieto MJ Bone alterations in hepatitis C virus infected patients. EUR J INTEGR MED 24: (1) pp. 9296. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [12617825]
54
Lucendo AJ, GarcíaManzanares A Bone mineral density in adult coeliac disease: An updated review. REV ESP ENFERM DIG 105: (3) pp. 154162. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13194241]
55
Huang W H, Yu MC, Huang JY, Lai C Impact of Hepatitis C Virus Infection on Bone Mineral Density in Renal Transplant Recipients PLOS ONE (ISSN: 19326203) 8: (5) p. e63263. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13127748]
56
Kim J, Yang J, Park OJ, Kang SS, Kim W S, Kurokawa K, Yun CH, Kim HH, Lee BL, Han SH Lipoproteins are an important bacterial component responsible for bone destruction through the induction of osteoclast differentiation and activation. J BONE MINER RES 28: (11) pp. 23812391. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13113858]
57
GarcíaManzanares A, Lucendo AJ Metabolismo óseo y osteoporosis en la enfermedad celíaca. In: En Rodrigo L, Peña AS (szerk.) : En fermedad celíaca y sensibilidad al gluten no celíaca. Barcelona: OmniaScience, 2013. pp. 325344. Paper google scholar.
Könyvrészlet /Könyvfejezet /Tudományos [13245527] 58
Yadav A, Carey EJ Osteoporosis in Chronic Liver Disease. NUTR CLIN PRACT 28: (1) pp. 5264. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13062300]
59
GarcíaManzanares A, Lucendo AJ Bone Metabolism and Osteoporosis in Adult Celiac Disease. In: Rodrigo L, Peña AS (szerk.) : Celiac Disease and NonCeliac Gluten Sensitvity . OmniaScience, 2014. (ISBN 9788494211829) pp. 327346.
Könyvrészlet /Könyvfejezet /Tudományos [14288742] 60
Ahmed A, Mayo MJ Complications of Cholestasis In: Elizabeth J Carey , Keith D Lindor (szerk.) : Cholestatic Liver Disease. Springer Science+Business Media, 2014. (ISBN 9781493910120) pp. 163188.
Könyvrészlet /Könyvfejezet /Tudományos [14110156] 61
Gatta A, Verardo A, Di Pascoli M, Giannini S, Bolognesi M Hepatic osteodystrophy Clinical Cases in Mineral and Bone Metabolism 11: pp. 185191. ( 2014)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
258/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Összefoglaló cikk /Tudományos [14364123] 62
Stanisławowski M, W iśniewski P, Guzek M, W ierzbicki PM, Adrych K, Smoczyński M, Sworczak K, Celiński K, Kmieć Z Influence of receptor activator of nuclear factor kappa B ligand; osteoprotegerin and interleukin33 on bone metabolism in patients with longstanding ulcerative colitis. J CROHNS COLITIS 8: pp. 802810. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13600815]
63
Detert J, Klaus P, Loddenkemper K Metabolic diseases in osteology Aktuelle Rheumatologie (ISSN: 0341051X) 39: pp. 2736. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [13725161]
64
RaszejaW yszomirska J, Miazgowski T Osteoporosis in primary biliary cirrhosis of the liver PRZ GASTROENTEROL (ISSN: 18955770) 9: pp. 8287. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [13823588]
65
Eshraghian A, Taghavi SA Systematic Review: Endocrine Abnormalities in P atients with Liver Cirrhosis. ARCHIVES OF IRANIAN MEDICINE (ISSN: 10292977) 17: pp. 713721. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14260492]
324. Takács István , Lakatos Péter A csontanyagcserére ható genetikai tényezők ORVOSI HETILAP 144:(30) pp. 14671472. (2003) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1802440] [ Érvényesített ] 325. Tamas G , M adarasz E , Tabak A , Speer G , Szalay J , Lakatos P , Kerenyl Z Serum osteoprotegerin levels in prior gestational diabetic women DIABETES 52:(Suppl 1) p. A168. (2003) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1820996] [ Érvényesített ] 326. Tóth M , Speer G , Patócs A , Salamon D , Lakatos P , Rácz K , Tulassay ZS Familiáris hypocalciuriás hypocalcaemia ORVOSI HETILAP 144:(41) pp. 20292031. (2003) Nyelv: Magyar
Folyóiratcikk /Rövid közlemény /Tudományos [155078] Autopszia alapján érvényesítve. [ Érvényesített ]
2002 327. Bajnok É , Takács I , Tabák Á , Nagy Zs , Horváth Cs , M észáros Sz , Speer G , Lakatos P Az ösztrogén receptor alpha gén XbaI polimorfizmusa és annak hatása a hyperthyreosis kialakulására, valamint a pajzsmirigyhormonok stimulálta csontvesztésre ORVOSI HETILAP 143:(Suppl. 1) p. 972. (2002) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1819693] [ Admin láttamozott ] 328. Bajnok É , Takács I , Tabák Á , Nagy Zs , Horváth Cs , M észáros Sz , Speer G , Lakatos P Az ösztrogénreceptoralfagén Pvull és Xbalpolimorfizmusa és annak hatása a hyperthyreosis kialakulására, valamint a pajzsmirigyhormonok által stimulált csontvesztésre CA ÉS CSONT 5:(Suppl. 1) p. 13. (2002) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1819744] [ Érvényesített ] 329. Bajnok E , Takacs I , Tabak A , Horvath C , Speer G , Nagy Z , Lakatos P Effect of ER alpha gene PvuIIXbaI polymorpisms on the development of hyperthyroidism and thyroid hormone stimulated bone loss JOURNAL OF BONE AND MINERAL RESEARCH 17:(Suppl 1) p. S238. (2002) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1820959] [ Érvényesített ] 330. Bajnok É , Takács I , Tabák Á , Horváth Cs , Speer G , Nagy Zs , Lakatos P https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
259/342
3/30/2015
nyomtatobarat forma
Effect of ER Alpha Gene PvuIIXbal Polymorphisms on the Development of Hyperthyroidism and Thyroid Hormonestimulated Bone Loss ASBM R Kongresszus, San Antonio (2002) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434085] poszter [ Admin láttamozott ] 331. Bors K , Bálint G , Szekeres L , Lakatos P , M OOT vezetősége Ajánlás az osteoporosis prevenciójára, az orsteoporosisos beteg rehabilitációjára CA ÉS CSONT 5:(3) pp. 9397. (2002) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1974392] [ Szerzői rekord ] 332. Csupor E , Szücs J , M észáros Sz , Lakatos P , Ferencz V , Tóth E , Horányi J , Perner F , Horváth Cs Összefügge a primer hyperparathyreosis veseköves és nem veseköves formáinak klinikai manifesztációja az adenoma lokalizációjával? CA ÉS CSONT 5:(Suppl 1) pp. S14S15. (2002) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2027900] 3. M agyar Oszteológiai Kongresszus. A M agyar Osteoporosis és Osteoarthrológiai Társaság 11. Kongresszusa, Balatonfüred, 2002. máj. 2225. [ Admin láttamozott ] 333. Csupor E , Szűcs J , M észáros Sz , Lakatos P , Ferencz V , Tóth E , Horváth Cs A csont ásványianyag tartalmának és szerkezetének vizsgálata primear hyperparathyreosisban CA ÉS CSONT 5:(S1) p. 33. (2002) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2081161] [ Admin láttamozott ] 334. Csupor E , Szűcs J , Tóth E , M észáros Sz , Ferencz V , Lakatos P , M cCloskey E V , Horváth Cs Bone mass or bone quality is the major determinanant of fractures in primary hyperparathyroidism? CALCIFIED TISSUE INTERNATIONAL S4: p. 272. (2002) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [2081312] [ Admin láttamozott ] 335. Donáth J , Poór Gy , Paksy A , Lakatos P Relationship between plasma endothelinl and biochemical markers of bone turnover in the assessment of Paget’s disease ANNALS OF THE RHEUMATIC DISEASES 61:(Suppl 1) p. 465. (2002) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1221458] Annual European EULAR Congress of Rheumatology. Stockholm, June 1216, 2002 [ Admin láttamozott ] 336. Földes J , Lakatos P , M edgyesi K A pajzsmirigy In: Horváth Cs (szerk.) Tabularium Endocrinologiae . 142 p. Budapest: M elania Kiadó, 2002. pp. 6069. (ISBN:9639106631) Nyelv: Magyar
Könyvrészlet /Szaktanulmány /Tudományos [1889484] [ Admin láttamozott ] 337. Hegedus D , Ferencz V , Lakatos PL , M eszaros S , Lakatos P , Horvath C , Szalay F Decreased bone density, elevated serum osteoprotegerin, and betacrosslaps in Wilson disease JOURNAL OF BONE AND MINERAL RESEARCH 17:(11) pp. 19611967. (2002) IF: 6.329 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1074567] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
260/342
3/30/2015
nyomtatobarat forma
[ Hitelesített ] Független idéző: 43 Összesen: 43 1
Nielsen KL, Allen MR, Bloomfield SA, Andersen TL, Chen XD, Poulsen HS, Young MF, Heegaard AM Biglycan deficiency interferes with ovariectomyinduced bone loss J BONE MINER RES 18: pp. 21522158. ( 2003) Folyóiratcikk /Konferenciaközlemény /Tudományos [10226438]
2
Korenblat KM, Schilsky ML Inherited metabolic liver disease CURR OPIN GASTROEN 19: pp. 194202. ( 2003) Folyóiratcikk /Összefoglaló cikk /Tudományos [10226437]
3
Nagy J, Vincze Z, Folhoffer A, Horváth A, Csák T, Zelkó R P athogenesis and treatment of Wilson's disease | [A Wilsonkór patomechanizmusa és gyógyszeres kezelése] Acta Pharmaceutica Hungarica (ISSN: 00016659) 73: p. 237. ( 2003) Folyóiratcikk /Összefoglaló cikk /Tudományos [10226839]
4
Morabito N, Gaudio A, Lasco A, Atteritano M, Pizzoleo MA, Cincotta M, La Rosa M, Guarino R, Meo A, Frisina N Osteoprotegerin and RANKL in the pathogenesis of thalassemiainduced osteoporosis: new pieces of the puzzle J BONE MINER RES 19: pp. 722727. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [10226440]
5
Dovio A, Data V, Angeli A P athophysiological significance and clinical utility of circulating osteoprotegerin | [Significato fisiopatologico e utilizzo clinico dell'osteoprotegerina circolante] Annali Italiani di Medicina Interna 19: pp. 819. ( 2004) Folyóiratcikk /Összefoglaló cikk /Tudományos [11283929]
6
Moe OW , Bonny O Genetic hypercalciuria JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (ISSN: 10466673) 17: pp. 729745. ( 2005) Folyóiratcikk /Összefoglaló cikk /Tudományos [10226442]
7
Gaudio A, Lasco A, Morabito N, Atteritano M, Vergara C, Catalano A, Fries W , Trifiletti A, Frisina N Hepatic osteodystrophy: Does the osteoprotegerin/receptor activator of nuclear factorkB ligand system play a role JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (ISSN: 03914097) 28: pp. 677682. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226448]
8
Sarkozi A, Then A, Szentmihalyi K Mineral element content of greater celandine (Chelidonium majus L.) ACTA ALIMENTARIA (ISSN: 01393006) 34: pp. 113120. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226444]
9
Fabrega E, Orive A, GarciaSuarez C, GarciaUnzueta M, Antonio Amado J, PonsRomero F Osteoprotegerin and RANKL in alcoholic liver cirrhosis LIVER INTERNATIONAL (ISSN: 14783223) 25: pp. 305310. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226443]
10
Han KO, Choi JT, Choi HA, Moon IG, Yim CH, Park W K, Yoon HK, Han IK The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone CLINICAL ENDOCRINOLOGY (ISSN: 03000664) 62: pp. 349353. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226441]
11
MezquitaRaya P, de la Higuera M, Garcia DF, Alonso G, RuizRequena ME, de Dios Luna J, EscobarJimenez F, Munoz Torres M The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 16: pp. 13681374. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226450]
12
Moschen AR, Kaser A, Stadlmann S, Millonig G, Kaser S, Muhllechner P, Habior A, Graziadei I, Vogel W , Tilg H The RANKL/OP G system and bone mineral density in patients with chronic liver disease JOURNAL OF HEPATOLOGY (ISSN: 01688278) 42: pp. 973983. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226446]
13
Perifanis V, Vyzantiadis T, Tziomalos K, Vakalopoulou S, Garipidou V, AthanassiouMetaxa M, Harsoulis F Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with betathalassaemia ANNALS OF HEMATOLOGY (ISSN: 09395555) 86: pp. 2330. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [10226451]
14
Messalli EM, Mainini G, Scaffa C, Cafiero A, Salzillo PL, Ragucci A, Cobellis L Raloxifene therapy interacts with serum osteoprotegerin in postmenopausal women MATURITAS (ISSN: 03785122) 56: pp. 3844. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [10226453]
15
Selimoglu MA, Ertekin V, Doneray H, Yildirim M Bone mineral density of children with Wilson disease: Efficacy of penicillamine and zinc therapy J CLIN GASTROENTEROL 42: pp. 194198. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [10300748]
16
FernándezGarcía D, MuñozTorres M, MezquitaRaya P, de la Higuera M, Alonso G, ReyesGarcía R, Ochoa AS, Ruiz Requena ME, Luna JD, EscobarJiménez F Effects of raloxifene therapy on circulating osteoprotegerin and RANK ligand levels in postmenopausal osteoporosis J ENDOCRINOL INVEST 31: pp. 416421. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [10391115]
17
Shapiro JR Osteogenesis Imperfecta and Other Defects of Bone Development as Occasional Causes of Adult Osteoporosis In: Osteoporosis, TwoVolume Set. Elsevier Inc., 2008. (ISBN 9780123705440) pp. 12471281. (Osteoporosis, TwoVolume Set)
Könyvrészlet /Könyvfejezet /Tudományos [13698713] 18
Yang GE, W ang X, Yang RM The study of bone metabolism and current treatment of hepatolenticular degeneration Chinese Journal of Contemporary Neurology and Neurosurgery 8: pp. 112114. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [10346639]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
261/342
3/30/2015
nyomtatobarat forma 19
Nakchbandi IA, van der Merwe SW Current understanding of osteoporosis associated with liver disease NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (ISSN: 17595045) 6: pp. 660670. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [10825954]
20
Guañabens N, Enjuanes A, Alvarez L, Peris P, Caballería L, Jesús Martínez de Osaba M, Cerdá D, Monegal A, Pons F, Parés A High osteoprotegerin serum levels in primary biliary cirrhosis are associated with disease severity but not with the mRNA gene expression in liver tissue J BONE MINER RES 27: pp. 347354. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [10626420]
21
Honsawek S, Chaiwatanarat T, Vejchapipat P, Chongsrisawat V, Thawornsuk N, Poovorawan Y Relationships between OP G; RANKL; bone metabolism; and bone mineral density in biliary atresia PEDIATR SURG INT 25: pp. 261267. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [10581518]
22
Boldo A, Taxel P Wilson's disease followed by liver transplant in a 20yearold female: Considerations for bone health Case report and review of the literature CONNECTICUT MEDICINE 73: pp. 7378. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [10588422]
23
Shapiro JR Inherited and Related Disorders of Bone Matrix Synthesis in Men In: Osteoporosis in Men. Elsevier Inc., 2010. (ISBN 9780123746023) pp. 505522. (Osteoporosis in Men)
Könyvrészlet /Könyvfejezet /Tudományos [13698712] 24
W agner D, FahrleitnerPammer A Levels of osteoprotegerin (OP G) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: Are they of any help? WIEN MED WOCHENSCHR 160: pp. 452457. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11112809]
25
Scott JPR, Sale C, Greeves JP, Casey A, Dutton J, Fraser W D The Effect of Training Status on the Metabolic Response of Bone to an Acute Bout of Exhaustive Treadmill Running J CLIN ENDOCRIN METAB 95: pp. 39183925. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11042780]
26
Quemeneur AS, Trocello JM, Ea HK, W oimant F, Lioté F Musculoskeletal conditions associated with Wilson's disease BEST PRACT RES CL RH 25: pp. 627636. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11773204]
27
Quemeneur AS, Trocello JM, de Vernejoul MC, W oimant F, Lioté F Rheumatic manifestations associated with Wilson's disease Revue du Rhumatisme Monographies 78: pp. 224230. ( 2011) Folyóiratcikk /Rövid közlemény /Tudományos [11726825]
28
Motoi O Risk factors for osteoporosis in chronic liver diseases Annals of Fundeni Hospital 16: pp. 4247. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [11726826]
29
Scott JPR, Sale C, Greeves JP, Casey A, Dutton J, Fraser W D The role of exercise intensity in the bone metabolic response to an acute bout of weightbearing exercise J APPL PHYSIOL 110: pp. 423432. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11283894]
30
Pfeiffer RF Wilson's disease. In: Handbook of Clinical Neurology . Elsevier, 2011. pp. 681709.
Könyvrészlet /Könyvfejezet /Tudományos [11385167] 31
Scott JPR, Sale C, Greeves JP, Casey A, Dutton J, Fraser W D Effect of fasting versus feeding on the bone metabolic response to running BONE (ISSN: 87563282) 51: (6) pp. 990999. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12528452]
32
Scott JP, Sale C, Greeves JP, Casey A, Dutton J, Fraser W D Effect of Recovery Duration between Two Bouts of Running on Bone Metabolism. MED SCI SPORT EXER 45: (3) pp. 429438. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12645719]
33
Purnak T, Beyazit Y, Ozaslan E, Efe C, Hayretci M The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease. WIEN KLIN WOCHENSCHR 124: (1516) pp. 526531. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12481117]
34
Kılıç N, M Akif Sümbüllü, Vildan Ertekin, Gülhan Çatal, Binali Çakur, Hüsamettin Oktay, Mukadder Ayşe Selimoğlu Do children with Wilson's disease have distinct craniofacial morphology? A cephalometric study INT J PEDIATR OTORHI 77: (8) pp. 12761279. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13148454]
35
ValdésFlores M, L CasasAvila, VP de LeónSuárez Genetic Diseases Related with Osteoporosis: Chapter 2 In: Yannis Diony ssiotis (szerk.) : Osteoporosis. InTech, 2013. (ISBN 9789535100263) pp. 2965. Paper http://dx.doi.org/10.5772/55546.
Könyvrészlet /Könyvfejezet /Tudományos [13127752] 36
Çetinkaya A, Hasan Özen H, Yüce A, SaltıkTemizel IN, Demir H, Gürakan F Bone mineralization in children with Wilson’ s disease Indian Journal of Gastroenterology 33: pp. 427431. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13850263]
37
Quemeneur AS, Trocello JM, Ea HK, Ostertag A, Leyendecker A, DuclosVallée JC, de Vernejoul MC, W oimant F, Lioté F Bone status and fractures in 85 adults with Wilson's disease. OSTEOPOROSIS INT (ISSN: 0937941X) 25: pp. 25732580. ( 2014)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
262/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [14114162] 38
Culafić D, Djonic D, CulaficVojinovic V, Ignjatovic S, Soldatovic I, Vasic J, Beck TJ, Djuric M Evidence of degraded BMD and geometry at the proximal femora in male patients with alcoholic liver cirrhosis. OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 26: pp. 253259. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [14164028]
39
Gatta A, Verardo A, Di Pascoli M, Giannini S, Bolognesi M Hepatic osteodystrophy Clinical Cases in Mineral and Bone Metabolism 11: pp. 185191. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14376344]
40
Nakchbandi IA Osteoporosis and fractures in liver disease: Relevance; pathogenesis and therapeutic implications WORLD J GASTROENTERO (ISSN: 10079327) 20: pp. 94279438. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14098524]
41
Varley I, Hughes DC, Greeves JP, Stellingwerff T, Ranson C, Fraser W D, Sale C RANK/RANKL/OP G pathway: Genetic associations with stress fracture period prevalence in elite athletes BONE (ISSN: 87563282) 71: pp. 131136. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14272389]
42
W eiss KH, Van de Moortele M, Gotthardt DN, Pfeiffenberger J, Seeßle J, Ullrich E, Gielen E, Borghs H, Adriaens E, Stremmel W , Meersseman W , Boonen S, Cassiman D Bone demineralisation in a large cohort of Wilson disease patients. JOURNAL OF INHERITED METABOLIC DISEASE (JIMD) (ISSN: 01418955) 38: p. 2015 Feb 7. [Epub ahead of print]. ( 2015) Folyóiratcikk /Szakcikk /Tudományos [14539662]
43
Shin JJ, Lee JP, Rah JH Fracture in a Young Male P atient Leading to the Diagnosis of Wilson's Disease: A Case Report J Bone Metab 22: pp. 3337. ( 2015) Folyóiratcikk /Szakcikk /Tudományos [14603283]
338. Hegedus D , Lakatos P , Lakatos P , Bajnok É , Szalay F Decreased bone mineral densitomety in Wilson disease; no correlation with the elevated osteoprotegerin level ZEITSCHRIFT FÜR GASTROENTEROLOGIE 40: p. 336. (2002) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391646] [ Admin láttamozott ] 339. Hollo G , Kothy P , Lakatos P , Vargha P EndothelinA receptor antagonist BQ485 protects against intraocular pressure spike induced by laser trabeculoplasty in the rabbit OPHTHALMOLOGICA 216:(6) pp. 459462. (2002) IF: 0.647 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1532656] [ Érvényesített ] Független idéző: 5 Függő idéző: 2 Összesen: 7 1 * Holló G, Visontai Z, Lakatos P, Vargha P Unoprostone isopropyl pretreatment decreases endothelin1 release and the intraocular pressure spike induced by laser trabeculoplasty in the rabbit Ophthalmologica (ISSN: 00303755) 217: (3) pp. 231236. ( 2003) Chemicals/CAS: unoprostone isopropyl ester, 120373242; Antihypertensive Agents; Dinoprost, 551111; Endothelin1; isopropyl unoprostone, 69553759 Tradenames: rescula, Ciba Vision, SwitzerlandTonoPen XL, Mentor, United States Manufacturers: Ciba Vision, SwitzerlandMentor, United States Folyóiratcikk [11380927] 2 * Koliakos G G, Konstas A G P, SchlötzerSchrehardt U, Hollo G, Mitova D, Kovatchev D, Maloutas S, Georgiadis N Endothelin1 concentration is increased in the aqueous humour of patients with exfoliation syndrome British Journal of Ophthalmology (ISSN: 00071161) 88: (4) pp. 523527. ( 2004) Chemicals/CAS: Endothelin1; Eye Proteins Folyóiratcikk [11380926] 3
Prasanna G, Hulet C, Desai D, Krishnamoorthy R R, Narayan S, Brun A M, Suburo A M, Yorio T Effect of elevated intraocular pressure on endothelin1 in a rat model of glaucoma Pharmacological Research (ISSN: 10436618) 51: (1) pp. 4150. ( 2005) Chemicals/CAS: Endothelin1; Saline Solution, Hypertonic Folyóiratcikk [11380925]
4
Schwinn D A, Afshari N A α1Adrenergic Receptor Antagonists and the Iris: New Mechanistic Insights into Floppy Iris Syndrome Survey of Ophthalmology (ISSN: 00396257) 51: (5) pp. 501512. ( 2006) Chemicals/CAS: adrenalin, 51434, 55312, 6912681; alfuzosin, 81403807; apraclonidine, 66711215; brimonidine, 59803984; chloroquine, 132730, 3545673, 50635, 54057; dipivefrine, 52365636, 56298249; doxazosin, 7419185 8; levofloxacin, 100986854, 138199710; phenoxybenzamine, 59961, 63923; phenylephrine, 532387, 59427, 61767; tamsulosin, 106133204, 106138889, 106463176, 80223990, 94666076; terazosin, 63074088, 63590647; Adrenergic Antagonists; Receptors, Adrenergic, alpha1 Tradenames: alphagan, Allergan, United States; cardura, Pfizer; flomax, Boehringer; hytrin, Abbott; iopidine, Alcon, United States; uroxatral, Labaz Manufacturers: Alcon, United States; Allergan, United States; Abbott; Boehringer; Labaz; Pfizer Folyóiratcikk [11380924]
5
Scherer W J Effect of topical prostaglandin analog use on outcome following selective laser trabeculoplasty Journal of Ocular Pharmacology and Therapeutics (ISSN: 10807683) 23: (5) pp. 503512. ( 2007) Chemicals/CAS: bimatoprost, 155206001; brimonidine, 59803984; latanoprost, 130209824; travoprost, 157283686; Amides; Antihypertensive Agents; bimatoprost; Cloprostenol, 40665927; latanoprost, 130209824; Lipids;
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
263/342
3/30/2015
nyomtatobarat forma Prostaglandins F, Synthetic; travoprost, 157283686 Folyóiratcikk [11380923] 6
W ang R F, Podos S M, Serle J B, Baltatu O C Effect of SP P 301, an endothelin antagonist, on intraocular pressure in glaucomatous monkey eyes Current Eye Research (ISSN: 02713683) 36: (1) pp. 4146. ( 2011) Chemicals/CAS: avosentan, 290815268; Antihypertensive Agents; Pyridines; Pyrimidines; Receptors, Endothelin; SPP301 Tradenames: spp 301, Speedel, Switzerland Manufacturers: Speedel, Switzerland Folyóiratcikk [11380922]
7
Rosenthal R, Fromm M Endothelin antagonism as an active principle for glaucoma therapy British Journal of Pharmacology (ISSN: 00071188) 162: (4) pp. 806816. ( 2011) Chemicals/CAS: ambrisentan, 177036941; bimatoprost, 155206001; bosentan, 147536978, 157212550; cyclo( dextro tryptophyl dextro aspartylprolyl dextro valylleucyl), 136553816; latanoprost, 130209824; n ( 2,6 dimethylpiperidinocarbonyl) 4 methylleucyl dextro ( 1 methoxycarbonyltryptophanyl) dextro norleucine, 156161896; perhydro 1 azepinylcarbonylleucyl dextro tryptophyl dextro tryptophan, 141594265; prostaglandin F2 alpha isopropyl ester, 53764902; tafluprost, 209860877; travoprost, 157283686; unoprostone isopropyl ester, 120373242 Tradenames: bq 123; bq 485; bq 788; rescula Folyóiratcikk [11380921]
340. Horváth C , Lakatos P , Balogh A Ajánlás a férfiak osteoporosisának diagnosztikájára és kezelésére 2003ban CA ÉS CSONT 5:(3) pp. 8284. (2002) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1807327] [ Admin láttamozott ] 341. Horváth C , Lakatos P , M arton I , Bors K , Poór G , Holló I Ajánlás az osteoporosis és más metabolikus csontbetegségek diagnosztikájára 2003ban CA ÉS CSONT 5:(3) pp. 5866. (2002) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1807369] [ Admin láttamozott ] 342. Horváth C , Lakatos P , Szűcs J , Takács I A metabolikus csontbetegség In: Horváth Cs (szerk.) Tabularium Endocrinologiae . 142 p. Budapest: M elania Kiadó, 2002. pp. 7687. (ISBN:9639106631) Nyelv: Magyar
Könyvrészlet /Szaktanulmány /Tudományos [1818708] [ Admin láttamozott ] 343. Horváth C , Lakatos P , Szűcs J A mellékpajzsmirigy In: Horváth Cs (szerk.) Tabularium Endocrinologiae . 142 p. Budapest: M elania Kiadó, 2002. pp. 7075. (ISBN:9639106631) Nyelv: Magyar
Könyvrészlet /Szaktanulmány /Tudományos [1889492] [ Admin láttamozott ] 344. Horváth Cs , Lakatos P , M arton I , Bors K , Poór Gy , Holló I , M OOT vezetősége Ajánlás az osteoporosis és más metabolikus csontbetegségek diagnosztikájára 2003ban In: Hatfaludy Zs , Rékassy B (szerk.) Útmutató klinikai irányelvek összefoglalója: 2002/3 . 368 p. Budapest: M edition Kiadó, 2002. pp. 308319. ( Útmutató; 2002/8. ) Nyelv: Magyar
Könyvrészlet /Könyvfejezet /Tudományos [1889625] [ Admin láttamozott ] 345. Kóthy P , Lakatos P , Holló G EndothelinA receptor antagonist BQ458 protects against intraocular pressure (IOP) spike in duced by laser trabeculoplasty in the rabbit 4th International Congress of Pathophysiology, Budapest, 13th July 2002 (2002) https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
264/342
3/30/2015
nyomtatobarat forma
Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [1779546] [Előadás] [ Admin láttamozott ] 346. Lakatos P , Speer G A Dvitamin biológiai és klinikai hatásai LEGE ARTIS MEDICINAE 12:(1) pp. 817. (2002) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [1335671] [ Érvényesített ] 347. Lakatos P , Horváth C , M arton I , Poór Gy , Holló I Ajánlás az életkorral járó osteoporosis gyógyszeres kezelésére CA ÉS CSONT 5:(3) pp. 6772. (2002) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1807344] [ Admin láttamozott ] 348. Lakatos P A férfiak korral járó osteoporosisa MAGYAR ANDROLÓGIA 7:(2) pp. 4952. (2002) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1807386] [ Érvényesített ] 349. Lakatos P Kommentár a "Javasoljunke hormonpótló kezelést a méhtest és petefészekrák túlélőinek?" című közleményhez NŐGYÓGYÁSZATI ÉS SZÜLÉSZETI TOVÁBBKÉPZŐ SZEMLE 4: pp. 109110. (2002) Nyelv: Magyar
Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [1807393] [ Admin láttamozott ] 350. Lakatos P , Speer G , Tabák Á , Bajnok É , Takács I , Horváth cs , Nagy Zs Szérum RANK ligand koncentráció összefüggése a csontminőséggel MAGYAR BELORVOSI ARCHIVUM 55:(Suppl. 3) p. 89. (2002) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1819771] [ Admin láttamozott ] 351. Lakatos P A korral járó osteoporosis gyógyszeres kezelése In: Gömör B (szerk.) Pharmindex zsebkönyv, 2002: Reumatológia . Budapest: M ediM edia Információs Kft., 2002. pp. 4754. Nyelv: Magyar
Könyvrészlet /Könyvfejezet /Tudományos [1889551] [ Admin láttamozott ] 352. Lakatos P , Horváth Cs , M arton I , Poór Gy , Holló I , M OOT vezetősége Ajánlás a korral járó osteoporosisok gyógyszeres kezelésére In: Hatfaludy Zs , Rékassy B (szerk.) Útmutató klinikai irányelvek összefoglalója: 2002/3 . 368 p. Budapest: M edition Kiadó, 2002. pp. 321329. ( Útmutató; 2002/8. ) Nyelv: Magyar
Könyvrészlet /Könyvfejezet /Tudományos [1889642] [ Admin láttamozott ] 353. Lakatos P Az osteoporosis és terápiája HÁZIORVOS TOVÁBBKÉPZŐ SZEMLE 7:(7) pp. 501504. (2002) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1974395] [ Érvényesített ] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
265/342
3/30/2015
nyomtatobarat forma
354. Lakatos P Az osteoporosis genetikája MOTESZ MAGAZIN 10:(4) pp. 2124. (2002) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1974396] [ Admin láttamozott ] 355. Lakatos PL , Bajnok É , Hegedűs D , Tóth T , Lakatos P , Szalay F Vitamin D receptor, oestrogen receptoralpha gene and interleukin1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 14:(7) pp. 733740. (2002) IF: 1.337 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1074568] [ Hitelesített ] Független idéző: 37 Függő idéző: 4 Összesen: 41 1
Trauner M, Boyer JL Cholestatic syndromes CURR OPIN GASTROENT 19: pp. 216231. ( 2003) Folyóiratcikk /Összefoglaló cikk /Tudományos [10226456]
2
Jones DEJ, Donaldson PT Genetic factors in the pathogenesis of primary biliary cirrhosis Clinics in Liver Disease (ISSN: 10893261) 7: pp. 841864. ( 2003) Folyóiratcikk /Összefoglaló cikk /Tudományos [10226469]
3
4
* Szalay F, Hegedus D, Lakatos PL, Tornai I, Bajnok E, Dunkel K, Lakatos P High serum osteoprotegerin and low RANKL in primary biliary cirrhosis J HEPATOL 38: pp. 395400. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [10226454] Floreani A P reventative therapy in primary biliary cirrhosis . Clinics in Liver Disease (ISSN: 10893261) 7: pp. 911921. ( 2003) Folyóiratcikk /Összefoglaló cikk /Tudományos [10226467]
5
* Lakatos PL, Bajnok E, Tornai I, Folhoffer A, Horváth A, Lakatos P, Szalay F Csokkent csontásványianyagtartalom és génpolimorfizmus primer biliaris cirrhosisban ORV HETIL 145: pp. 331336. ( 2004) Folyóiratcikk /Összefoglaló cikk /Tudományos [10226844]
6
* Lakatos PL, Bajnok E, Tornai I, Folhoffer A, Horvath A, Lakatos P, Habior A, Szalay F Insulinlike growth factor I gene microsatellite repeat, collagen type Iα1 gene Sp1 polymorphism, and bone disease in primary biliary cirrhosis European Journal of Gastroenterology and Hepatology (ISSN: 0954691X) 16: (8) pp. 753759. ( 2004) N1 : Chemicals/CASsomatomedin C, 67763966; Collagen Type I; collagen type I, alpha 1 chain; InsulinLike Growth Factor I, 67763966 Folyóiratcikk /Szakcikk /Tudományos [13121505]
7
Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DE, Lindor KM, Bassendine MF, W orman HJ P rimary biliary cirrhosis: Report of a focus study group HEPATOLOGY (ISSN: 02709139) 40: pp. 10131020. ( 2004) Folyóiratcikk /Összefoglaló cikk /Tudományos [10226459]
8
Hagymasi K, Tulassay Z A primer biliaris cirrhosis genetikája. ORV HETIL 146: pp. 21512156. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226470]
9
Invernizzi P, Selmi C, Mackay IR, Podda M, Gershwin ME From bases to basis: Linking genetics to causation in primary biliary cirrhosis CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (ISSN: 15423565) 3: pp. 401410. ( 2005) Folyóiratcikk /Összefoglaló cikk /Tudományos [10226466]
10
Pares A, Guanabens N, Rodes J Gene polymorphisms as predictors of decreased bone mineral density and osteoporosis in primary biliary cirrhosis EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 17: pp. 311315. ( 2005) EDITORIAL A FENTI KÖZLEMÉNYHEZ Folyóiratcikk /Összefoglaló cikk /Tudományos [10226461]
11
Selmi C, Invernizzi P, Zuin M, Podda M, Seldin MF, Gershwin ME Genes and (auto) immunity in primary biliary cirrhosis GENES AND IMMUNITY (ISSN: 14664879) 6: pp. 543556. ( 2005) Folyóiratcikk /Összefoglaló cikk /Tudományos [10226464]
12
Selmi C, Invernizzi P, Zuin M, Podda M, Gershwin ME Genetics and geoepidemiology of primary biliary cirrhosis: Following the footprints to disease etiology SEMINARS IN LIVER DISEASE (ISSN: 02728087) 25: pp. 265280. ( 2005) Folyóiratcikk /Összefoglaló cikk /Tudományos [10226463]
13 * Szalay F, Folhoffer A, Horvath A, Csak T, Speer G, Nagy Z, Lakatos P, Horvath C, Habior A, Tornai I, Lakatos PL Serum leptin; soluble leptin receptor; free leptin index and bone mineral density in patients with primary biliary cirrhosis EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 17: pp. 923928. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226462] 14
Tanaka A Genetic background of primary biliary cirrhosis HEPATOL RES 37: (Suppl. 3) pp. S377S383. ( 2007) Folyóiratcikk /Konferenciaközlemény /Tudományos [10260319]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
266/342
3/30/2015
nyomtatobarat forma 15
Jones DEJ P athogenesis of primary biliary cirrhosis GUT (ISSN: 00175749) 56: (11) pp. 16151624. ( 2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [10260318]
16
Parés A, Guañabens N Osteoporosis in P rimary Biliary Cirrhosis: P athogenesis and Treatment Clinics in Liver Disease (ISSN: 10893261) 12: (2) pp. 407424. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [10346640]
17
Jones DE P athogenesis of primary biliary cirrhosis POSTGRAD MED J 84: (987) pp. 2333. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [10300747]
18
Nakchbandi IA, van der Merwe SW Current understanding of osteoporosis associated with liver disease NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (ISSN: 17595045) 6: (11) pp. 660670. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [10825955]
19
Xu LZ, Guo LS, Shen ZW , Loss G, Gish R, W asilenko S, Mason AL Duplication of MER115 on chromosome 4 in patients with primary biliary cirrhosis LIVER INT 29: (3) pp. 375383. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [10544354]
20
Hohenester S, OudeElferink RPJ, Beuers U P rimary biliary cirrhosis SEMIN IMMUNOPATHOL 31: (3) pp. 283307. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [10809652]
21
Tanaka A, Nezu S, Uegaki S, Kikuchi K, Shibuya A, Miyakawa H, Takahashi S, Bianchi I, Zermiani P, Podda M, Ohira H, Invernizzi P, Takikawa H Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations. J HEPATOL 50: (6) pp. 12021209. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [10649833]
22
Adorini L Vitamin D receptor polymorphisms in primary biliary cirrhosis: A functional connection? J HEPATOL 50: (6) pp. 10711073. ( 2009) Folyóiratcikk /Rövid közlemény /Tudományos [10649832]
23
Selmi C, Torok NJ, Affronti A, Gershwin ME Genomic variants associated with primary biliary cirrhosis GENOME MEDICINE 2: (1) P aper 5. (2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11267844]
24
Guañabens N, Parés A Liver and bone ARCH BIOCHEM BIOPHYS 503: (1) pp. 8494. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11074847]
25
Falleti E, Bitetto D, Fabris C, Cussigh A, Fontanini E, Fornasiere E, Fumolo E, Bignulin S, Cmet S, Minisini R, Pirisi M, Toniutto P Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis WORLD J GASTROENTERO 16: (24) pp. 30163024. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11024830]
26
Gaugg M, Erlacher L Liver diseases and osteoporosis Austrian Journal of Clinical Endocrinology and Metabolism 4: (1) pp. 1419. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [11330728]
27
Hirschfield GM, Invernizzi P P rogress in the Genetics of P rimary Biliary Cirrhosis SEMIN LIVER DIS 31: (2) pp. 147156. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [11391072]
28
Zunigaa S, Firrincieli D, Housset C, Chignard N Vitamin D and the vitamin D receptor in liver pathophysiology CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (ISSN: 22107401) 35: (4) pp. 295302. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [11383169]
29
Falleti E, Bitetto D, Fabris C, Cmet S, Fornasiere E, Cussigh A, Fontanini E, Avellini C, Barbina G, Ceriani E, Pirisi M, Toniutto P Association between vitamin D receptor genetic polymorphisms and acute cellular rejection in livertransplanted patients TRANSPL INT 25: (3) pp. 314322. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12031801]
30
Sookoian S, Pirola CJ Genetic determinants of acquired cholestasis: A systems biology approach FRONT BIOSCI 17: (1) pp. 206220. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12031802]
31
Guañabens N, Parés A Osteoporosis in liver cirrhosis Gastroenterologia y Hepatologia (ISSN: 02105705) 35: (6) pp. 411420. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12433026]
32
Danzer C, Mattner J Impact of Microbes on Autoimmune Diseases ARCH IMMUNOL THER EX 61: (3) pp. 175186. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13062302]
33
Smyk DS, DP Bogdanos, EI Rigopoulou Risk Factors for Autoimmune Hepatitis: From Genes and P regnancy to Vaccinations and P ollutants
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
267/342
3/30/2015
nyomtatobarat forma Immunogastroenterology 2: (1) pp. 2937. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13236789] 34
Luong Kvq, Nguyen LTH The Role of Vitamin D in P rimary Biliary Cirrhosis: P ossible Genetic and Cell Signaling Mechanisms GASTROENT RES PRACT 2013: (2013) P aper 602321. (2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13062303]
35
Smyk DS, Orfanidou T, Invernizzi P, Bogdanos DP, Lenz M Vitamin D in autoimmune liver disease CLIN RES HEPATOL GAS 37: (5) pp. 535545. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13201249]
36
Firrincieli D, T Braescu, C Housset, N Chignard Illuminating liver fibrosis with vitamin D CLIN RES HEPATOL GAS 38: pp. 58. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [13483219]
37
Mo C, Lu Y, Deng Y, W ang J, Xie L, Li T, He Y, Qin X, Li S Lack of association between vitamin D receptor gene ApaI; BsmI; and TaqI polymorphisms and primary biliary cirrhosis risk: a metaanalysis. TUMOUR BIOL 35: pp. 49134920. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13698302]
38
Nakchbandi IA Osteoporosis and fractures in liver disease: Relevance; pathogenesis and therapeutic implications WORLD J GASTROENTERO (ISSN: 10079327) 20: pp. 94279438. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [14098523]
39
Li Y, Y Tang, Y Shi, S Han, J W ang, X Zhou, Y Chen, Z W u, Z Han, Y Han, K W u, D Fan P olymorphisms in the Vitamin D Receptor Gene and Risk of P rimary Biliary Cirrhosis: a meta‐analysis J GASTROEN HEPATOL 29: pp. 706715. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13483220]
40
Liu X, Liu Y, Cheng M, Zhang X, Xiao H A metabolomics study of the inhibitory effect of 17betaestradiol on osteoclast proliferation and differentiation Mol. BioSyst 11: pp. 635646. ( 2015) Folyóiratcikk /Szakcikk /Tudományos [14325338]
41
Fang F, W ang J, Pan J, Su GH, Xu LX, Li G Relationship between vitamin D (1;25dihydroxyvitamin D3) receptor gene polymorphisms and primary biliary cirrhosis risk: A metaanalysis GENETICS AND MOLECULAR RESEARCH (ISSN: 16765680) 14: pp. 981988. ( 2015) Folyóiratcikk /Szakcikk /Tudományos [14565804]
356. Lakatos PL , Bajnok E , Folhoffer A , Horvath A , Tornai I , Lakatos P , Szalay F Kollagén IA1 (COLIA1) gén és insulinlike growth factorI (IGFI) gén mikroszatellita repeat polimorfizmusa és a csont ásványianyagtartalma primer biliaris cirrhosisban. MAGYAR BELORVOSI ARCHIVUM 55:(SUPPL 3) p. 89. (2002) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1391618] [ Admin láttamozott ] 357. Lakatos PL , Bajnok E , Hegedűs D , Dunkel K , Toth T , Lakatos P , Szalay F Insulinlike growth factor I (IGFI) gene microsatellite repeat polymorphism and bone mineral density in Hungarian patients with primary biliary cirrhosis. GUT 51:(SUPPL III) p. A253. (2002) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391630] [ Admin láttamozott ] 358. Lakatos PL , Bajnok E , Hegedűs D , Toth T , Lakatos P , Szalay F Insulinlike growth factor I (IGFI) gene microsatellite repeat polymorphism; vitamin D receptor gene Bsm I and estrogen receptor alpha gene Pvu II and Xba I polymorphism and bone mineral density in Hungarian patients with primary biliary cirrhosis. ZEITSCHRIFT FÜR GASTROENTEROLOGIE 40: p. 343. (2002) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391639] [ Admin láttamozott ] 359. Lakatos PL , Bajnok E , Hegedűs D , Toth T , Lakatos P , Szalay F Insulinlike growth factor I (IGFI) gene M icrosatellite repeat polymorphism, vitamin D receptor gene Bsm I and estrogen receptor alpha gene Pvu II and Xba I polymorphism and bone mineral density in Hungarian patients with PBC GASTROENTEROLOGY 123:(1. Suppl) p. 66. (2002) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391649] [ Érvényesített ] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
268/342
3/30/2015
nyomtatobarat forma
360. Lakatos PL , Bajnok E , Hegedűs D , Toth T , Lakatos P , Szalay F IL1 receptor antagonist gene VNTR polymorphism in Hungarian patients with primary biliary cirrhosis. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 17:(SUPPL I) p. A513. (2002) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391652] [ Admin láttamozott ] 361. M adarasz E , Tamas G , Tabak A G , Speer G , Lakatos P , Kerenyi Z The determinants of fasting leptin levels and the characteristics of the leptin curves following a 75g oGTT in women with previous Gestational Diabetes M ellitus (GDM ) DIABETOLOGIA: CLINICAL AND EXPERIMENTAL DIABETES AND METABOLISM 45:(Suppl 2) p. A80. (2002) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1820965] [ Érvényesített ] Függő idéző: 1 Összesen: 1 1 * Madarasz Eszter, Tabak Adam Gy, Speer Gabor, Lakatos Peter, Kerenyi Zsuzsa, Tamas Gyula Abnormal glucose tolerance is associated with diminished postload change in leptin levels in women DIABETESMETABOLISM RESEARCH AND REVIEWS 25: (7) pp. 632638. ( 2009) Folyóiratcikk /Szakcikk [13237570]
362. M észáros Sz , Győri G , Kisfalvi K , Földes G , Lakatos P , M agdics M , Horváth Cs Ritka kórkép a mozgásszervi panaszok hátterében CA ÉS CSONT 5:(S1) pp. 3536. (2002) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2081226] [ Admin láttamozott ] 363. Nagy Z , Tabak A , Bajnok E , Takacs I , Speer G , Lakatos P Serum OPG levels and bone mineral content in healthy, postmenopausal osteoporotic and hyperthyroid subject JOURNAL OF BONE AND MINERAL RESEARCH 17:(Suppl. 1) p. S364. (2002) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1820967] [ Érvényesített ] 364. Nagy Z , Tabák Á , Bajnok É , Takács I , Speer G , Lakatos P Serum OPG Levels and Bone M ineral Content in Healthy, Postmenopausal Osteoporotic and Hyperthyroid Subject ASBM R Kongresszus, San Antonio (2002) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434090] poszter [ Admin láttamozott ] 365. Pákozdi A , Rass P , Lakatos P , Szabó Z , Végvári A , Szántó S , Szegedi Gy , Bakó Gy , Szekanecz Z A Dvitamin receptorgén BsmIpolimorfizmusa rheumatoid arthritisben és társuló orsteoporosisban CA ÉS CSONT 5:(12) pp. 1322. (2002) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [1974373] [ Érvényesített ] 366. Rass P , Pákozdi A , Lakatos P , Szabó Z , Végvári A , Szántó S , Szegedi Gy , Bakó Gy , Szekanecz Z A Dvitamin receptorgén BsmIpolimorfizmusának vizsgálata rheumatoid arthritisben és társuló orsteoporosisban CA ÉS CSONT 5:(12) pp. 2330. (2002) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1807376] [ Érvényesített ] 367. Speer G , Cseh K , M ucsi I , Takacs I , Dworak O , Winkler G , Szody R , Tisler A , Lakatos P Calciumsensing receptor A986S polymorphism in human rectal cancer INTERNATIONAL JOURNAL OF COLORECTAL DISEASE 17:(1) pp. 2024. (2002) IF: 1.902 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1109569] [ Érvényesített ] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
269/342
3/30/2015
nyomtatobarat forma
Független idéző: 10 Függő idéző: 2 Összesen: 12 1
* Takács I, Speer G, Bajnok E, Tabák A, Nagy Z, Horváth C, Kovács K, Lakatos P Lack of association between calciumsensing receptor gene "A986S" polymorphism and bone mineral density in Hungarian postmenopausal women. BONE (ISSN: 87563282) 30: (6) pp. 849852. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [12285917]
2
Famulski KS, AlHijailan RS, Dobler K, Pienkowska M, AlMohanna F, Paterson MC Aberrant sensing of extracellular Ca2+ by cultured ataxia telangiectasia fibroblasts ONCOGENE (ISSN: 09509232) 22: (3) pp. 471475. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [10292915]
3
Peters U, Chatterjee N, Yeager M, Chanock SJ, Schoen RE, McGlynn KA, Church TR, W eissfeld JL, Schatzkin A, Hayes RB Association of genetic variants in the calciumsensing receptor with risk of colorectal adenoma CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 13: (12) pp. 21812186. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [10292917]
4
* Donath J, Speer G, Poor G, Gergely P, Tabak A, Lakatos P Vitamin D receptor, oestrogen receptoralpha and calciumsensing receptor genotypes, bone mineral density and biochemical markers in P aget's disease of bone RHEUMATOLOGY (ISSN: 14620324) 43: (6) pp. 692695. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [10292916]
5
Jacobs E T, Haussler M R, Martínez M E Vitamin D activity and colorectal neoplasia: A pathway approach to epidemiologic studies Cancer Epidemiology Biomarkers and Prevention 14: (9) pp. 20612063. ( 2005) Chemicals/CAS: alitretinoin, 5300038; calcifediol, 19356173; calcitriol, 32222063, 3251163 0, 66772143; calcium carbonate, 13397267, 13701581, 14791732, 471341; retinoid X receptor alpha, 465567515; Vitamin D, 1406162 Folyóiratcikk /Ismertetés /Tudományos [11917862]
6
Dong LM, Ulrich CM, Hsu L, Duggan DJ, Benitez DS, W hite E, Slattery ML, Caan BJ, Potter JD, Peters U Genetic variation in calciumsensing receptor and risk for colon cancer CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 17: (10) pp. 27552765. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [10498073]
7
TfeltHansen J The role of calciumsensing receptor and signalling pathways in the pathophysiology in two in vitro models of malignant hypercalcemia: The rat rice H500 leydig testis cancer and prostate cancer (P C3) cells. Expression and regulation of pituitary tumor transforming gene in Leydig testis cancer and astrocyte and astrocytoma cells DANISH MEDICAL BULLETIN (ISSN: 09078916) 55: (1) pp. 1746. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [10393487]
8
Hendy G N, Guarnieri V, Canaff L Chapter 3 CalciumSensing Receptor and Associated Diseases In: Progress in Molecular Biology and Translational Science. (89) Elsevier, 2009. (ISBN 9780123747563) pp. 3195.
Chemicals/CAS: calcium, 14092945, 7440702; protein kinase C, 141436784; Calcium, 7440702; Protein Kinase C, 2.7.11.13; Receptors, CalciumSensing Könyvrészlet /Könyvfejezet /Tudományos [11917861] 9
Jenab M, Mckay J, BuenoDeMesquita HB, van Duijnhoven FJB, Ferrari P, Slimani N, Jansen EHJM, Pischon T, Rinaldi S, Tjonneland A, Olsen A, Overvad K, BoutronRuault MC, ClavelChapelon F, Engel P, Kaaks R, Linseisen J, Boeing H, Fisher E, Trichopoulou A, Dilis V, Oustoglou E, Berrino F, Vineis P, Mattiello A, Masala G, Tumino R, Vrieling A, van Gils CH, Peeters PH, Brustad M, Lund E, Chirlaque MD, Barricarte A, Suarez LR, Molina E, Dorronsoro M, Sala N, Hallmans G, Palmqvist R, Roddam A, Key TJ, Khaw KT, Bingham S, Boffetta P, Autier P, Byrnes G, Norat T, Riboli E Vitamin D Receptor and Calcium Sensing Receptor P olymorphisms and the Risk of Colorectal Cancer in European P opulations CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 18: (9) pp. 24852491. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11014920]
10
Jacobs ET, Martinez ME, Campbell PT, Conti DV, Duggan D, Figueiredo JC, Haile RW , Leroy EC, Poynter JN, Thompson PA, Baron JA Genetic variation in the retinoid X receptor and calciumsensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry CARCINOGENESIS (ISSN: 01433334) 31: (8) pp. 14121416. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11122683]
11
Kim KyeeZu, Shin Aesun, Kim Jeongseon, Park Ji W on, Park Sung Chan, Choi Hyo Seong, Chang Hee Jin, Kim Dae Yong, Oh Jae Hwan Association between CASR P olymorphisms, Calcium Intake, and Colorectal Cancer Risk PLOS ONE (ISSN: 19326203) 8: (3) P aper e59628. (2013) Folyóiratcikk /Szakcikk /Tudományos [13338797]
12
Leach K, Sexton PM, Christopoulos A, Conigrave AD Engendering biased signalling from the calciumsensing receptor for the pharmacotherapy of diverse disorders British Journal of Pharmacology (ISSN: 14765381) 171: (5) pp. 11421155. ( 2014) N1 Funding Details: 519461, NHMRC, National Health and Medical Research Council N1 Funding Details: APP1026962, NHMRC, National Health and Medical Research Council Folyóiratcikk /Tudományos [13816563]
368. Speer G , Tamás G , Kerényi Z , Cseh K , Winkler G , Lakatos P Kalciumanyagcsere és diabetes mellitus: a Dvitamin és a kalcium szerepe a diabetes patomechanizmusában, valamint a diabetes és az osteoporosis kapcsolata DIABETOLOGIA HUNGARICA 10:(3) pp. 181187. (2002) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [1335673] [ Érvényesített ] 369. Speer G , Nagy Zs , Takács I , Cseh K , Winkler G , Bajnok É , Lakatos P Szérum tumor necrosis factor alfa (TNFalfa)szint és bioaktívitás, valamint Dvitamin (VDR) és ösztrogénreceptor https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
270/342
3/30/2015
nyomtatobarat forma
(ER) genotípusok android típusú obesitasban. ORVOSI HETILAP 143: p. 993. (2002) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1819679] [ Admin láttamozott ] 370. Speer G , Tabák Á , Bajnok É , Takács I , Horváth Cs , Nagy Zs , Lakatos P A szérumRANK ligandszintjének kapcsolata a csontminőséggel CA ÉS CSONT 5:(Suppl. 1) p. 13. (2002) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1819707] [ Érvényesített ] 371. Speer G , Tabak A , Bajnok E , Takacs I , Nagy Z , Lakatos P Serum RANK ligand levels and bone mineral content in hyperthyroidism JOURNAL OF BONE AND MINERAL RESEARCH 17:(Suppl. 1) p. S364. (2002) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1820969] [ Érvényesített ] 372. Szalay F , Hegedus D , Bajnok E , Dunkel K , Lakatos PL , Lakatos P High serum osteoprotegerin and low RANKL levels in patients with primary biliary cirrhosis. GUT 51:(SUPPL III) p. A39. (2002) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391631] [ Admin láttamozott ] 373. Szalay F , Hegedus D , Bajnok E , Lakatos P , Lakatos P Elevated serum osteoprotegerin level inversely correlates with bone mineral density in patients with primary biliary cirrhosis (PBC). ZEITSCHRIFT FÜR GASTROENTEROLOGIE 40: p. 357. (2002) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391643] [ Admin láttamozott ] 374. Szombati I , Poór Gy , Tabak A , Temesvári P , Lakatos P Evaluation of estrogen receptor gene and calcium sensor gene polymorphisms in patients with primary osteoarthritis JOURNAL OF BONE AND MINERAL RESEARCH 17:(Suppl 1) p. S324. (2002) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1221465] XXIV Annual M eeting of the American Society for Bone and M ineral Researc. San Antonio, Sept 2024, 2002 [ Érvényesített ] 375. Szombati I , Poór G , Tabák Á , Temesvári I P , Lakatos P Az ösztrogénreceptorgén és a kalciumszenzorgén polimorfizmusának vizsgálata primer arthrosisos betegek körében CA ÉS CSONT 5:(Suppl 1) p. 14. (2002) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1820976] [ Érvényesített ] 376. Szűcs J , Bálint G , Genti G , Lakatos P , M OOT vezetősége A szekunder osteoporosisok kezelése CA ÉS CSONT 5:(3) pp. 7378. (2002) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1974382] [ Szerzői rekord ] 377. Takacs I , Speer G , Bajnok E , Tabak A , Nagy Z , Horvath C , Kovacs K , Lakatos P Lack of association between calciumsensing receptor gene "A986S" polymorphism and bone mineral density in Hungarian postmenopausal women. BONE 30:(6) pp. 849852. (2002) IF: 3.755 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1335565] [ Érvényesített ] Független idéző: 36 Függő idéző: 1 Összesen: 37 https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
271/342
3/30/2015
nyomtatobarat forma 1
Young R, W u F, Van de W ater N, Ames R, Gamble G, Reid I R Calcium sensing receptor gene A986S polymorphism and responsiveness to calcium supplementation in postmenopausal women Journal of Clinical Endocrinology & Metabolism 88: (2) pp. 697700. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [11842844]
2
Cetani F, Pardi E, Borsari S, Vignali E, Dipollina G, Braga V, Adami S, Pinchera A, Marcocci C Calciumsensing receptor gene polymorphism is not associated with bone mineral density in Italian postmenopausal women European Journal of Endocrinology (ISSN: 08044643) 148: (6) pp. 603607. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [11842843]
3
Spurr N K Genetics of calciumsensing regulation of calcium levels in the body Current Opinion in Pharmacology (ISSN: 14714892) 3: (3) pp. 291294. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [11842842]
4
Cusack S, Cashman K D Impact of genetic variation on metabolic response of bone to diet Proceedings of the Nutrition Society (ISSN: 00296651) 62: (4) pp. 901912. ( 2003) Folyóiratcikk /Konferenciaközlemény /Tudományos [11842841]
5
Zajickova K, Zofkova I Osteoporosis: Genetic analysis of multifactorial disease Endocrine Regulations (ISSN: 12100668) 37: (1) pp. 3144. ( 2003) Folyóiratcikk /Összefoglaló cikk /Tudományos [11851246]
6
Huang Q Y, Recker R R, Deng H W Searching for osteoporosis genes in the postgenome era: progress and challenges Osteoporosis International (ISSN: 0937941X) 14: (9) pp. 701715. ( 2003) Folyóiratcikk /Összefoglaló cikk /Tudományos [11842840]
7
Kos C H, Karaplis A C, Peng J B, Hediger M A, Goltzman D, Mohammad K S, Guise T A, Pollak M R The calciumsensing receptor is required for normal calcium homeostasis independent of parathyroid hormone Journal of Clinical Investigation (ISSN: 00219738) 111: (7) pp. 10211028. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [11842839]
8
Mo Xiaoyang, Zhang Yuanyuan, Lei Shufeng, Deng Hongwen A986S polymorphism of calciumsensing receptor gene is not related to bone mineral density or bone size in premenopausal Chinese women Journal of First Military Medical University 24: (10) pp. 10971101,1122. ( 2004) Folyóiratcikk [12787014]
9
Scillitani A, Guarnieri V, De Geronimo S, Muscarella L A, Battista C, D Agruma L, Bertoldo F, Florio C, Minisola S, Hendy G N, Cole D E C Blood ionized calcium is associated with clustered polymorphisms in the carboxylterminal tail of the calciumsensing receptor Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 89: (11) pp. 56345638. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [11851245]
10
O Connell M B, Stamm P L Calcium prevention and treatment of osteoporosis Clinical Reviews in Bone and Mineral Metabolism 2: (4) pp. 357371. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [11851244]
11
Bollerslev J, W ilson S G, Dick I M, Devine A, Dhaliwal S S, Prince R L Calciumsensing receptor gene polymorphism A986S does not predict serum calcium level, bone mineral density, calcaneal ultrasound indices, or fracture rate in a large cohort of elderly women Calcified Tissue International (ISSN: 0171967X) 74: (1) pp. 1217. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [11842838]
12 * Donath J, Speer G, Poor G, Gergely P, Tabak A, Lakatos P Vitamin D receptor, oestrogen receptoralpha and calciumsensing receptor genotypes, bone mineral density and biochemical markers in P aget's disease of bone Rheumatology (ISSN: 14620324) 43: (6) pp. 692695. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [11842837] 13
Dvornyk V, Liu P Y, Long J R, Zhang Y Y, Lei S F, Recker R R, Deng H W Contribution of genotype and ethnicity to bone mineral density variation in Caucasians and Chinese: a test for five candidate genes for bone mass Chinese Medical Journal (ISSN: 03666999) 118: (15) pp. 12351244. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [11842836]
14
Krivosikova Z, Spustova V, Dzurik R Genetic polymorphisms significantly associated with osteoporosis: The overview: P rehl'ad genetickĆńch polymorfizmov vĆńznamne asociovanĆńch s osteoporĆ zou Lekarsky Obzor (ISSN: 04574214) 54: (11) pp. 472477. ( 2005) Folyóiratcikk /Összefoglaló cikk /Tudományos [11851243]
15
Heaney Robert P GENETICS OF OSTEOP OROSIS In: Deng HW, LIu YZ (szerk.) : CURRENT TOPICS IN OSTEOPOROSIS. World Scientific Pub Co Inc, 2005. (ISBN 9789812561534) pp. 415 444.
D2 10.1142/9789812701220 Könyvrészlet /Könyvfejezet /Tudományos [12541270] 16
Zofkova I, Zajickova K, Hill M, Vankova M Role of intron 5 C/T polymorphism of the calcium sensing receptor gene in the regulation of the serum FSH and LH in post menopausal women Journal of Endocrinological Investigation (ISSN: 03914097) 28: (7) pp. 638642. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [11842835]
17
FaivreDefrance F, MarcelliTourvieille S, Odou M F, Porchet N, W emeau J L, Vantyghem M C Calcium sensing receptor: physiology and pathology Annales D Endocrinologie (ISSN: 00034266) 67: (1) pp. 4553. ( 2006) Folyóiratcikk /Összefoglaló cikk /Tudományos [11842834]
18
PerezCastrillon J L, Sanz A, Silva J, Justo I, Velasco E, Duenas A
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
272/342
3/30/2015
nyomtatobarat forma Calciumsensing receptor gene A986S polymorphism and bone mass in hypertensive women Archives of Medical Research (ISSN: 01884409) 37: (5) pp. 607611. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [11842833] 19
Rothe Hansjoerg, Mayer Gert Clinical importance of calciumsensing receptor gene polymorphism Arg(990)Gly in the age of calcimimetic therapy Current Pharmacogenomics 4: (2) pp. 153156. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [11842832]
20
Harding Brian, Curley Alan J, Hannan Fadil M, Christie Paul T, Bowl Michael R, Turner Jeremy J, Barber Mathew, Gillham Nasenya Irina, Hampson Geeta, Spector Tim D, Thakker Rajesh V Functional characterization of calcium sensing receptor polymorphisms and absence of association with indices of calcium homeostasis and bone mineral density Clinical Endocrinology (ISSN: 03000664) 65: (5) pp. 598605. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [11842831]
21
Liu Yong Jun, Shen Hui, Xiao Peng, Xiong Dong Hai, Li Li Hua, Recker Robert R, Deng Hong W en Molecular genetic studies of gene identification for osteoporosis: A 2004 update Journal of Bone and Mineral Research (ISSN: 08840431) 21: (10) pp. 1511+. ( 2006) Folyóiratcikk /Összefoglaló cikk /Tudományos [11842830]
22
Raue F, Haag C, Schulze E, FrankRaue K The role of the extracellullar calciumsensing receptor in health and disease Experimental and Clinical Endocrinology & Diabetes (ISSN: 09477349) 114: (8) pp. 397405. ( 2006) Folyóiratcikk /Összefoglaló cikk /Tudományos [11842829]
23
Maerz W infried, Seelhorst Ursula, W ellnitz Britta, Tiran Beate, ObermayerPietsch Barbara, Renner W ilfried, Boehm Bernhard O, Ritz Eberhard, Hoffmann Michael M Alanine to serine polymorphism at position 986 of the calciumsensing receptor associated with coronary heart disease, myocardial infarction, allcause, and cardiovascular mortality Journal of Clinical Endocrinology & Metabolism 92: (6) pp. 23632369. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [11842828]
24
Schlingmann Karl Peter Calciumsensing receptor and magnesium New Perspectives in Magnesium Research: Nutrition and Health &: pp. 272285. ( 2007) Folyóiratcikk /Ismertetés /Tudományos [11851242]
25
Yun Francisco H, W ong Betty Y, Chase Maretta, Shuen Andrew Y, Canaff Lucie, Thongthai Kansuda, Siminovitch Katherine, Hendy Geoffrey N, Cole David E Genetic variation at the calciumsensing receptor (CASR) locus: Implications for clinical molecular diagnostics Clinical Biochemistry (ISSN: 00099120) 40: (8) pp. 551561. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [11842826]
26
Lips Mirjam A, Syddall Holly E, Gaunt Tom R, Rodriguez Santiago, Day Ian N, Cooper Cyrus, Dennison Elaine M Interaction between birthweight and polymorphism in the calciumsensing receptor gene in determination of adult bone mass: The Hertfordshire Cohort Study Journal of Rheumatology (ISSN: 0315162X) 34: (4) pp. 769775. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [11842825]
27
Scillitani Alfredo, Guarnieri Vito, Battista Claudia, De Geronimo Simona, Muscarella Lucia Anna, Chiodini Iacopo, Cignarelli Mauro, Minisola Salvatore, Bertoldo Francesco, Francucci Cristiano M, Malavolta Nazzarena, Piovesan Alessandro, Mascia Maria Lucia, Muscarella Silvana, Hendy Geoffrey N, D Agruma Leonardo, Cole David E P rimary hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calciumsensing receptor Journal of Clinical Endocrinology & Metabolism 92: (1) pp. 277283. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [11842824]
28
Laaksonen M, Outila T, Karkkainen M, Kemi V, Rita H, Perola M, Valsta L, LambergAllardt C Associations of Vitamin D Receptor, CalciumSensing Receptor and P arathyroid Hormone Gene P olymorphisms with Calcium Homeostasis and P eripheral Bone Density in Adult Finns Journal of Nutrigenetics and Nutrigenomics (ISSN: 16616499) 2: (2) pp. 5563. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11842823]
29
Hendy Geoffrey N, Guarnieri Vito, Canaff Lucie CalciumSensing Receptor and Associated Diseases G PROTEINCOUPLED RECEPTORS IN HEALTH AND DISEASE, PT B 89: pp. 3195. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [12541269]
30
Greene R, Mousa S S, Ardawi M, Qari M, Mousa S A P harmacogenomics in osteoporosis: Steps toward personalized medicine Pharmacogenomics and Personalized Medicine (ISSN: 11787066) 2: (1) pp. 6978. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [11851240]
31
den Uyl D, Nurmohamed MT, van Tuyl LHD, Raterman HG, Lems W F (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; A systematic review of the association between cardiovascular disease and osteoporosis Arthritis Research and Therapy 13: (1) P aper R5. (2010) Folyóiratcikk /Szakcikk /Tudományos [12541288]
32
Shakhssalim Nasser, Kazemi Bahram, Basiri Abbas, Houshmand Massoud, Pakmanesh Hamid, Golestan Banafsheh, Eilanjegh Abolfazl Faraji, Kashi Amir Hossein, Kilani Mahboobeh, Azadvari Mohaddeseh Association between calciumsensing receptor gene polymorphisms and recurrent calcium kidney stone disease: A comprehensive gene analysis Scandinavian Journal of Urology and Nephrology (ISSN: 00365599) 44: (6) pp. 406412. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11842822]
33
O Seaghdha Conall M, Yang Qiong, Glazer Nicole L, Leak Tennille S, Dehghan Abbas, Smith Albert V, Kao W , Lohman Kurt, Hwang Shih Jen, Johnson Andrew D, Hofman Albert, Uitterlinden Andre G, Chen Yii Der Ida, Brown Edward M, Siscovick David S, Harris Tamara B, Psaty Bruce M, Coresh Josef, Gudnason Vilmundur, W itteman Jacqueline C, Liu Yong Mei, Kestenbaum Bryan R, Fox Caroline S, Koettgen Anna Common variants in the calciumsensing receptor gene are associated with total serum calcium levels Human Molecular Genetics (ISSN: 09646906) 19: (21) pp. 42964303. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11842821]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
273/342
3/30/2015
nyomtatobarat forma 34
W ade C, McBride C, Kardia S, Brody L Considerations for Designing a P rototype Genetic Test for Use in Translational Research Public Health Genomics (ISSN: 16624246) 13: (3) pp. 155165. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11842820]
35
Marini F, Brandi ML Genetic determinants of osteoporosis: Common bases to cardiovascular diseases? International Journal of Hypertension 2010: P aper 394579. (2010) Folyóiratcikk /Szakcikk /Tudományos [12787025]
36
Ferreira Larissa Gorayb, Pereira Alexandre Costa, Heilberg Ita Pfeferman Vitamin D Receptor and CalciumSensing Receptor Gene P olymorphisms in Hypercalciuric StoneForming P atients Nephron Clinical Practice (ISSN: 16602110) 114: (2) pp. C135C144. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11842819]
37
Raue Friedhelm, Haag Christine The CalciumSensing Receptor: P hysiology and P athophysiology In: Licata AA, Lerma EV (szerk.) : DISEASES OF THE PARATHYROID GLANDS. New York, USA: Springer New York, 2012. (ISBN 9781 441955494) pp. 6990.
D2 10.1007/9781441955500 Könyvrészlet /Könyvfejezet /Tudományos [12541268]
378. Takács I , Horváth Cs , Bajnok É , Speer G , Nagy Z , Tabák Á , Lakatos P Genetikai polimorfizmusok hatása a csontminőségre hyperthyreotikus postmenopausas nőknél ORVOSI HETILAP 143:(Suppl. 1) p. 995. (2002) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1819656] [ Admin láttamozott ] 379. Takács I , Horváth Cs , Bajnok É , Speer G , Nagy Zs , Lakatos P A genetikai polimorfizmusok hatása a csontminőségre hyperthyreosisos, posztmenopauzában lévő nőknél CA ÉS CSONT 5:(S1) p. 12. (2002) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1819698] [ Admin láttamozott ] 380. Takács I , Horváth Cs , Bajnok É , Speer G , Nagy Zs , Lakatos P Genetic Polymorphisms and Bone Quality in Postmenopausal Women JOURNAL OF BONE AND MINERAL RESEARCH 17:(Suppl. 1) p. S238. (2002) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1822613] [ Érvényesített ] 381. Takács I , Horváth Cs , Bajnok É , Speer G , Nagy Z , Lakatos P Genetic Polymorphisms and Bone Quality in Postmenopausal Women ASBM R Kongresszus, San Antonio (2002) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434086] poszter [ Admin láttamozott ] 382. Tamás G , Tabák ÁG , M adarász E , Speer G , Bekő G , Lakatos P , Kerényi Z A metabolikus szindróma jellegzetességei korábban gestatiós diabeteszes asszonyokban: a vér leptinszintje oGTT során DIABETOLOGIA HUNGARICA 10:(Suppl 1) p. 76. (2002) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1820981] [ Admin láttamozott ] 383. Tamás G , Tabák ÁG , Szalay J , Speer G , Lakatos P , Kerényi Z Leptin és hypertonia: a metabolikus szindróma jellemzői korábban gesztációs diabéteszes asszonyokban HYPERTONIA ÉS NEPHROLOGIA 6: p. 28. (2002) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1820982] ID: 22 [ Admin láttamozott ] 384. Tóth M , Speer G , Patócs A , Lakatos P , M iheller P , Takács I , Rácz K , Tulassay Zs Familiáris hypocalciuriás hypercalcaemia új calciumsensor gén mutáció ORVOSI HETILAP 143:(18. Suppl. 1.) p. 997. (2002) https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
274/342
3/30/2015
nyomtatobarat forma
Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1285814] [ Admin láttamozott ] 385. Visontai Z , Lakatos P , Holló G Uniprostone isopropyl (UI) pretreatment decreases both the endothelin1 (ET1) release and intraocular pressure (IOP) spike induced by laser trabeculoplasty (ALT) in the rabbit 4th International Congress of Pathophysilology, Budapest, 14th July, 2002 (2002) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [1779548] [Előadás] [ Admin láttamozott ]
2001 386. Bajnok É , Takács I , Tabák Á , Speer G , Lakatos P A hyperthyreosis, a csontásványianyagtartalom, a Dvitaminreceptorgén és az interleukin1receptorantagonista proteingén polimorfizmusának összefüggése a magyar női populációban. CA ÉS CSONT 4:(S1) p. 16. (2001) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1818588] [ Admin láttamozott ] 387. Bajnok E , Takacs L , Tabak A , Speer G , Nagy Z , Horvath C , Lakatos P Hyperthroidism, lossof bone mass, and their relation to vitamin D receptor (VDR) gene Bsm1 and interleukin1 receptor antagonist (IL1RN) gene VNTR polymorphisms in postmenopausal women JOURNAL OF BONE AND MINERAL RESEARCH 16:(Suppl 1) p. S250. (2001) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1820947] [ Érvényesített ] 388. Bajnok É , Takács I , Tabák Á , Speer G , Nagy Z , Horváth Cs , Lakatos P Hyperthyroidism, loss of bone mass, and their relation to vitamin D receptor (VDR) gene BsmI and interleukin1 receptor antagonist (IL1RN) gene VNTR polymorphisms in postmenopausal women ASBM R Kongresszus, Phoenix (2001) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434070] poszter [ Admin láttamozott ] 389. Bálint G , Bors K , Szekeres L , Balogh Á , Bossányi A , de Chatel R , Forgács S , Genti G , Holló I , Horváth C , Lakatos P , M arton I , Pap K , Poór Gy , Szathmári M , Szűcs J , Tamási L Ajánlás az osteoporosis mozgásprevenciójára, fizióterápiájára és az osteoporosisos beteg rehabilitációjára CA ÉS CSONT 3:(4) pp. 186188. (2001) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1807506] [ Admin láttamozott ] 390. I Barna , K Földes , P Lakatos Elevated serum parathyroid hormone levels, low dehydroepiandrosterone sulphate and decreased diurnal blood pressure variability in patients with renal hypertension NEPHROLOGY DIALYSIS TRANSPLANTATION 16:(6) p. 3. (2001) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1610101] [ Admin láttamozott ] 391. I Barna , P Lakatos , P Kempler , R de Châtel Are the diurnal indices, parathyroid hormone and dehydroepiandrosterone sulfate paralel changing cardiovascular risk factors? JOURNAL OF HYPERTENSION 19:(Suppl. 2) p. 44. (2001) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1610103] [ Admin láttamozott ] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
275/342
3/30/2015
nyomtatobarat forma
392. Barna I , Lakatos P , Kempler P , de Chatel R Cardiovascularis rizikótényezők; diurnális index, parathormon és dehydroepiandrosteron sulphat essentialis hypertoniában CARDIOLOGIA HUNGARICA 31:(2. Suppl) p. 94. (2001) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1761991] [ Admin láttamozott ] 393. Földes K , Lakatos P , Horváth C , Remport Á , Jansen J , Alföldi F , Gerő L A csontdenzitás és a csontmetabolizmust tükröző markerek vizsgálata vesetranszplantáció után: M ilyen tényezők játszanak szerepet az osteoporosis létrejöttében? CA ÉS CSONT 4:(2) pp. 7076. (2001) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1807442] [ Érvényesített ] 394. Győri G , Balogh É , Lakatos P , Szűcs J , Takács I Karboanhidráz II. deficientia következtében kialakult osteoporosis: esetbemutatás. CA ÉS CSONT 4:(S1) p. 32. (2001) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1819647] [ Admin láttamozott ] 395. Holló G , Kóthy P , Lakatos P Can intraocular pressure spikes induced by laser trabeculoplasty be prevented by endothelin antagonists? European Glaucoma Society, Closed M eeting, Paris , 31st August to 2nd September, 2001 , Abstract book p.67. (2001) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [1759338] [Előadás] [ Admin láttamozott ] 396. Holló G , Kóthy P , Lakatos P , Vargha P Prevention of ALT induced IOP elevation by BQ485, an endothelin A receptor antagonist EVER, Alicante , 12th October 2001 , Abstract book: p.90. (2001) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [1759339] [Előadás] [ Admin láttamozott ] 397. Holló G , Kóthy P , Lakatos P , Vargha P Prevention of ALT induced IOP elevation by BQ485, an endothelin A receptor antagonist OPHTHALMIC RESEARCH 33:(S1) Paper S90. (2001) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1881415] (EVER abstract, no:1204) [ Admin láttamozott ] 398. Horányi J , Duffek L , Szlávik R , Kemenes M , Darvas K , Lakatos P , Tóth M Intraoperatív diagnosztika a mellékpajzsmirigysebészetben MAGYAR SEBÉSZET 54:(Suppl.) p. 18. (2001) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2027907] 18. M agyar Kísérletes Sebészeti Kongresszus, Pécs, 2001.aug.3009.01. [ Admin láttamozott ] 399. Horváth C , Balogh Á , Bors K , Forgács S , Holló I , Lakatos P A M OOT 2002es irányelvei a calcipeniás osteopathiák diagnosztikájára CA ÉS CSONT 4:(4) pp. 165167. (2001) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1807419] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
276/342
3/30/2015
nyomtatobarat forma
[ Admin láttamozott ] 400. Horváth C , Lakatos P A csontanyagcsere újdonságai 2000ben MAGYAR ORVOS 9:(6) pp. 4245. (2001) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1807460] [ Admin láttamozott ] 401. Horváth C , Lakatos P , Lukács G A mellékpajzsmirigy betegségei In: Leövey A (szerk.) A klinikai endokrinológia és anyagcserebetegségek kézikönyve . 1054 p. Budapest: M edicina Könyvkiadó, 2001. p. 952. (ISBN:9632427165) Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1888584] [ Admin láttamozott ] 402. Hubina E , Lakatos P , Kovács L , Horváth Cs , Czirják S , Szabolcs I , Góth M A csont és ásványianyagtartalmának és anyagcseréjének vizsgálata acromegáliás betegeknél CA ÉS CSONT 4: pp. 160164. (2001) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1316899] [ Admin láttamozott ] 403. Hubina E , Lakatos P , Kovacs L , Szabolcs I , Racz K , Toth M , Szucs N , Goth M Egyéves növekedésihormonkezelés hatása a csontsűrűségre, az oszteokalcin és alulkarboxilált oszteokalcinszintekre növekedésihormonhiányos felnőttekben CA ÉS CSONT 4:(Suppl 1) pp. 2324. (2001) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1318349] A II. M agyar Oszteológiai Kongresszus / A M agyar Osteoporosis és Osteoarthrológiai Társaság (M OOT) X. Kongresszusa. Balatonfüred, 2001, május 2326. Ca és Csont 2001; 4 (Suppl 1). Abstr 36, 2324 old [ Admin láttamozott ] 404. Kadlecsek S , Lakatos P A csontanyagcsere sejtszintű szabályozása CA ÉS CSONT 4:(2) pp. 5460. (2001) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [1807447] [ Admin láttamozott ] 405. Kerenyi Z , Tabak A G , Speer G , M adarasz E , Lakatos P , Tamas G A986S polymorphism of the calciumsensing receptor, insulin secretion and metabolic syndrome in women with prior gestational diabetes DIABETOLOGIA: CLINICAL AND EXPERIMENTAL DIABETES AND METABOLISM 44:(Suppl 1) p. A87. (2001) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1820949] [ Érvényesített ] 406. Lakatos P , Horváth Cs , M arton I , Poór Gy , Holló I A M OOT 2002es terápiás irányelvei az osteoporosis kezelésére CA ÉS CSONT 4:(4) pp. 169171. (2001) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1015425] [ Admin láttamozott ] 407. Lakatos P A kalcium és csontanyagcsere élettana. In: Leövey A (szerk.) A klinikai endokrinológia és anyagcserebetegségek kézikönyve . 1054 p. https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
277/342
3/30/2015
nyomtatobarat forma
Budapest: M edicina Könyvkiadó, 2001. pp. 949951. (ISBN:9632427165) Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1799200] [ Admin láttamozott ] 408. Lakatos P A postmenopausális osteoporosis és kezelése PRAXIS: A MINŐSÉGI GYÓGYÍTÁS ELMÉLETE ÉS GYAKORLATA 10:(10) pp. 4954. (2001) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1807426] [ Érvényesített ] 409. Lakatos P "Az osteoporosis megelőzése, diagnózisa és kezelése" című közleményhez JAMA MAGYAR KIADÁS 3:(6) pp. 446447. (2001) Nyelv: Magyar
Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [1807452] [ Admin láttamozott ] 410. Lakatos P , Takács I , Kollin É , Horváth C Osteoporosis In: Leövey A (szerk.) A klinikai endokrinológia és anyagcserebetegségek kézikönyve . 1054 p. Budapest: M edicina Könyvkiadó, 2001. pp. 9851005. (ISBN:9632427165) Nyelv: Magyar
Könyvrészlet /Felsőoktatási tankönyv része /Oktatási [1818679] [ Admin láttamozott ] 411. Lakatos PL , Firneisz G , Lakatos P , Horváth Cs , Szalay F A csontásványianyag tartalom utánkövetéses vizsgálata postmenopausas primer biliaris cirrhosisos nőbetegekben ORVOSI HETILAP 142:(10) pp. 503508. (2001) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1074578] [ Érvényesített ] Független idéző: 3 Függő idéző: 3 Összesen: 6 1 * Szalay F, Hegedus D, Lakatos PL, Tornai I, Bajnok E, Dunkel K, Lakatos P High serum osteoprotegerin and low RANKL in primary biliary cirrhosis J HEPATOL 38: (4) pp. 395400. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [10226383] 2
Dobnig H, Fahrleitner A Bone Disease in Chronic Cholestatic Liver Disease: Chapter 22 In: eds Michael Trauner, Peter L M Jansen (szerk.) : Molecular Pathogenesis of Cholestasis. Springer, 2004. (ISBN 9780306482403) pp. 301313. (Medical Intelligence Unit)
Könyvrészlet [12519134] 3
Dobnig H, Fahrleitner A, Trauner M Chronische cholestatische Lebererkrankungen und metabolische Knochenstoffwechselstörungen Journal für Gastroenterologische und Hepatologische Erkrankungen 2: pp. 2329. ( 2004) Folyóiratcikk [12519132]
4 * Lakatos PL, Bajnok E, Tornai I, Folhoffer A, Horvath A, Lakatos P, Habior A, Szalay F Insulinlike growth factor I gene microsatellite repeat; collagen type I alpha 1 gene Sp1 polymorphism; and bone disease in primary biliary cirrhosis EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 16: (8) pp. 753759. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [10226384] 5 * Szalay F, Folhoffer A, Horvath A, Csak T, Speer G, Nagy Z, Lakatos P, Horvath C, Habior A, Tornai I, Lakatos PL Serum leptin; soluble leptin receptor; free leptin index and bone mineral density in patients with primary biliary cirrhosis EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 17: (9) pp. 923928. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [10226385] 6
Fang Y, Hu C, Tao X, W an Y, Tao F Effect of vitamin K on bone mineral density: a metaanalysis of randomized controlled trials. J BONE MINER RES 30: (1) pp. 6068. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [11996669]
412. Lakatos PL , Bajnok E , Lakatos P , Szalay F Vitamin D receptor BsmI; IL1 receptor antagonist gene VNTR and estrogen gene ERPuvII and XbaI polymorphism in Hungarian patients with primary biliary cirrhosis. GUT 49:(SUPPL III) p. 1990. (2001) Nyelv: Angol https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
278/342
3/30/2015
nyomtatobarat forma
Folyóiratcikk /Absztrakt /Tudományos [1391656] [ Admin láttamozott ] 413. Lakatos PL , Bajnok E , Lakatos P , Szalay F Vitamin D receptor BsmI; IL1 receptor antagonist gene VNTR and estrogen gene ERPuvII and XbaI polymorphism in Hungarian patients with primary biliary cirrhosis. ZEITSCHRIFT FÜR GASTROENTEROLOGIE 39: p. 403. (2001) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391663] [ Admin láttamozott ] 414. M olnár E , Tóth M , Speer G , Lakatos P , M iheller P , Takács I , Patócs A , Rácz K , Tulassay Zs Familiáris hypocalciuriás hypercalcaemiát eredményező új kalciumszenzorgénmutáció. CA ÉS CSONT 4:(S1) p. 18. (2001) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1818631] [ Admin láttamozott ] 415. Nagy Z , Speer G , Takács I , Bajnok É , Lakatos P Serum lipid levels and bone mineral density in postmenopausal women ASBM R Kongresszus, Phoenix (2001) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434080] poszter [ Admin láttamozott ] 416. Nagy Zs , Speer G , Takács I , Bajnok É , Lakatos P Serum leptin levels and bone mineral density in postmenopausal women. JOURNAL OF BONE AND MINERAL RESEARCH 16:(S1) p. 284. (2001) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1822570] [ Admin láttamozott ] 417. Speer G , Cseh K , Winkler G , Takacs I , Barna I , Nagy Z , Lakatos P Oestrogen and vitamin D receptor (VDR) genotypes and the expression of ErbB2 and EGF receptor in human rectal cancers. EUROPEAN JOURNAL OF CANCER 37:(12) pp. 14631468. (2001) IF: 3.460 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1335568] EIN: Eur J Cancer 2001 Oct;37(15):1963 [ Érvényesített ] Független idéző: 29 Függő idéző: 4 Összesen: 33 1
* Lakatos P Oestrogen and vitamin D receptor (VDR) genotypes and the expression of ErbB2 and EGF receptor in human rectal cancers (vol 37, pg 1463, 2001) EUROPEAN JOURNAL OF CANCER (ISSN: 09598049) 37: (15) pp. 19631963. ( 2001) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [11584880]
2
de Jong MM, Nolte IM, Meerman GJT, van der Graaf W TA, de Vries EGE, Sijmons RH, Hofstra RMW , Kleibeuker JH Lowpenetrance genes and their involvement in colorectal cancer susceptibility CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 11: (11) pp. 13321352. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11584879]
3
Tanaka Y, Sasaki M, Kaneuchi M, Fujimoto S, Dahiya R Single nucleotide polymorphisms of estrogen receptor alpha in human renal cell carcinoma BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (ISSN: 0006291X) 296: (5) pp. 12001206. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11584878]
4
McCullough M L, Robertson A S, Rodriguez C, Jacobs E J, Chao A, Jonas C, Calle E E, W illett W C, Thun M J Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer P revention Study II Nutrition Cohort (United States) Cancer Causes and Control 14: (1) pp. 112. ( 2003) Chemicals/CAS: calcium, 7440702; Calcium, 7440702; Vitamin D, 1406162 Folyóiratcikk /Szakcikk /Tudományos [11599769]
5
* Melczer Z, Banhidy F, Csomor S, Siklos P, Dworak O, Cseh K ErbB2/HER2 protein expression, serum tumour necrosis factoralpha (TFMalpha) and soluble tumour necrosis factor receptor 2 (TNFR2) concentrations in human carcinoma of the uterine cervix EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY (ISSN: 03922936) 24: (2) pp. 138142. ( 2003) Folyóiratcikk /Konferenciaközlemény /Tudományos [11584876]
6
Tanaka Y, Sasaki M, Kaneuchi M, Fujimoto S, Dahiya R
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
279/342
3/30/2015
nyomtatobarat forma Estrogen receptor alpha polymorphisms and renal cell carcinoma a possible risk MOLECULAR AND CELLULAR ENDOCRINOLOGY (ISSN: 03037207) 202: (SAP P ORO, JAP AN) pp. 109116. ( 2003) Folyóiratcikk /Konferenciaközlemény /Tudományos [11584875] 7
Tanaka Y, Sasaki M, Kaneuchi M, Shiina H, Igawa M, Dahiya R P olymorphisms of estrogen receptor alpha in prostate cancer MOLECULAR CARCINOGENESIS (ISSN: 08991987) 37: (4) pp. 202208. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [11584874]
8
Grant W B, Garland CR A critical review of studies on vitamin D in relation to colorectal cancer NUTRITION AND CANCERAN INTERNATIONAL JOURNAL (ISSN: 01635581) 48: (2) pp. 115123. ( 2004) Folyóiratcikk /Összefoglaló cikk /Tudományos [11584873]
9
Koizumi F, Kanzawa F, Ueda Y, Koh Y, Tsukiyama S, Taguchi F, Tamura T, Saijo N, Nishio K Synergistic interaction between the EGFR tyrosine kinase inhibitor gefitinib ("Iressa") and the DNA topoisomerase I inhibitor CP T11 (irinotecan) in human colorectal cancer cells INTERNATIONAL JOURNAL OF CANCER (ISSN: 00207136) 108: (3) pp. 464472. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [11584872]
10
Slattery ML, Sweeney C, Murtaugh M, Ma KN, W olff RK, Potter JD, Caan BJ, Samowitz W Associations between ER alpha, ER beta, and AR genotypes and colon and rectal cancer CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 14: (12) pp. 29362942. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [11584871]
11
Sauer T, Guren MG, Noren T, Dueland S Demonstration of EGFR gene copy loss in colorectal carcinomas by fluorescence in situ hybridization (FISH): a surrogate marker for sensitivity to specific antiEGFR therapy? HISTOPATHOLOGY (ISSN: 03090167) 47: (6) pp. 560564. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [11584870]
12 * Lakatos P L, Lakatos L A hereditaer és sporadikus colorectalis daganatok genetikája és a genetikai ismeretek jelentősége a mindennapi gyakorlatban: Sporadikus és IBDasszociált colorectalis tumorok, illetve a genetikai vizsgálatok jelentősége a diagnózisban, prognózisban és a kemoterápiára adott válasz megítélésében ORVOSI HETILAP (ISSN: 00306002) 147: (10) pp. 449455. ( 2006) Folyóiratcikk [11613635] 13
SmithJones PM, Solit D, Afroze F, Rosen N, Larson SM Early tumor response to Hsp90 therapy using HER2 P ET: Comparison with F18FDG P ET JOURNAL OF NUCLEAR MEDICINE (ISSN: 01615505) 47: (5) pp. 793796. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [11584869]
14
Zhai Y, Zhu GQ, Deng GH, Xie W M, Dong XJ, Zhang XM, Yu L, Yang H, Yuan XY, Zhang HX, Zhi LT, Yao ZJ, Shen Y, Qiang BQ, He FC Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers GASTROENTEROLOGY (ISSN: 00165085) 130: (7) pp. 20012009. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [11584868]
15 * Bajnok É, Takács I, Tabák Á, Speer G, Nagy Zs, Horváth Cs, Mészáros Sz, Kósa J, Nyiri P, Lakatos P Génpolimorfizmusok lehetséges szerepe a toxikus adenoma és az ezt kisérő Osteopathia kialakulásában MAGYAR BELORVOSI ARCHIVUM (ISSN: 01335464) 60: pp. 97102. ( 2006) Folyóiratcikk [11613632] 16
Park SY, Murphy SP, W ilkens LR, Nomura AMY, Henderson BE, Kolonel LN Calcium and vitamin D intake and risk of colorectal cancer: The multiethnic cohort study AMERICAN JOURNAL OF EPIDEMIOLOGY (ISSN: 00029262) 165: (7) pp. 784793. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [11584867]
17
Kadiyska T, Yakulov T, Kaneva R, Nedin D, Alexandrova A, Gegova A, Savov A, Mitev V, Kremensky I Vitamin D and estrogen receptor gene polymorphisms and the risk of colorectal cancer in Bulgaria International Journal of Colorectal Disease (ISSN: 01791958) 22: (4) pp. 395400. ( 2007) Chemicals/CAS: Deoxyribonucleases, Type II SiteSpecific, EC 3.1.21.4; endodeoxyribonuclease PvuII, EC 3.1.21.; endodeoxyribonuclease XBAI, EC 3.1.21.; Estrogen Receptor alpha; Vitamin D, 1406162 Folyóiratcikk /Szakcikk /Tudományos [11599767]
18
Janakiram NB, Rao CV Molecular markers and targets for colorectal cancer prevention ACTA PHARMACOLOGICA SINICA (ISSN: 16714083) 29: (1) pp. 120. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [11584866]
19
Kolonel Laurence N Nutritional Risk Factors for Gastrointestinal Cancers: The Multiethnic Cohort Study NUTRITION AND FITNESS: CULTURAL, GENETIC AND METABOLIC ASPECTS 98: (Shanghai, P EOP LES R CHINA) pp. 131149. ( 2008) BE Simopoulos, AP Folyóiratcikk /Konferenciaközlemény /Tudományos [12426372]
20
Barginear MF, Van Poznak C, Rosen N, Modi S, Hudis CA, Budman DR The Heat Shock P rotein 90 Chaperone Complex: An Evolving Therapeutic Target CURRENT CANCER DRUG TARGETS (ISSN: 15680096) 8: (6) pp. 522535. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [11584864]
21
Kallel I, Rebai M, Khabir A, Farid NR, Rebai A Genetic P olymorphisms in the EGFR (R521K) and Estrogen Receptor (T594T) Genes, EGFR and ErbB2 P rotein Expression, and Breast Cancer Risk in Tunisia JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (ISSN: 11107243) &: P aper 753683. (2009) Folyóiratcikk /Szakcikk /Tudományos [11584863]
22
Dilmeç F, Akkafa F, Özgönül A, Uzunköy A VDR gene BsmIG> a polymorphism and risk of colorectal cancer in Şanliurfa P rovince, Turkey Turkiye Klinikleri Journal of Medical Sciences 29: (6) pp. 13861391. ( 2009) Folyóiratcikk [13354602]
23
Anghel A, Narita D, Seclaman E, Popovici E, Anghel M, Tamas L Estrogen Receptor Alpha P olymorphisms and the Risk of Malignancies
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
280/342
3/30/2015
nyomtatobarat forma PATHOLOGY & ONCOLOGY RESEARCH 16: (4) pp. 485496. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11584861] 24
Lin J, Zee RYL, Liu KY, Zhang SMM, Lee IM, Manson JE, Giovannucci E, Buring JE, Cook NR Genetic variation in sexsteroid receptors and synthesizing enzymes and colorectal cancer risk in women CANCER CAUSES & CONTROL (ISSN: 09575243) 21: (6) pp. 897908. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11584860]
25
Takiishi T, Gysemans C, Bouillon R, Mathieu C Vitamin D and Diabetes ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (ISSN: 08898529) 39: (2) pp. 419+. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11584859]
26
Lin JH, Manson JE, Kraft P, Cochrane BB, Gunter MJ, Chlebowski RT, Zhang SMM Estrogen and progesteronerelated gene variants and colorectal cancer risk in women BMC MEDICAL GENETICS (ISSN: 14712350) 12: P aper 78. (2011) Folyóiratcikk /Szakcikk /Tudományos [11584858]
27
Touvier M, Chan DSM, Lau R, Aune D, Vieira R, Greenwood DC, Kampman E, Riboli E, Hercberg S, Norat T MetaAnalyses of Vitamin D Intake, 25Hydroxyvitamin D Status, Vitamin D Receptor P olymorphisms, and Colorectal Cancer Risk CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 20: (5) pp. 10031016. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11584857]
28
Gunduz M, Cacina C, Toptas B, YaylimEraltan I, Tekand Y, Isbir T Association of Vitamin D Receptor Gene P olymorphisms with Colon Cancer GENETIC TESTING AND MOLECULAR BIOMARKERS (ISSN: 19450265) 16: (9) pp. 10581061. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12661784]
29
Takiishi Tatiana, Gysemans Conny, Bouillon Roger, Mathieu Chantal Vitamin D and Diabetes RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (ISSN: 0889857X) 38: (1) pp. 179+. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12426371]
30
Bai YongHeng, Lu Hong, Hong Dan, Lin ChengCheng, Yu Zhen, Chen BiCheng Vitamin D receptor gene polymorphisms and colorectal cancer risk: A systematic metaanalysis WORLD JOURNAL OF GASTROENTEROLOGY (ISSN: 10079327) 18: (14) pp. 16721679. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12426370]
31
AlDaghri Nasser M, AlAttas Omar, Alokail Majed S, Alkharfy Khalid M, Draz Hossam M, Agliardi Cristina, Mohammed Abdul Khader, Guerini Franca R, Clerici Mario Vitamin D Receptor Gene P olymorphisms and HLA DRB1*04 Cosegregation in Saudi Type 2 Diabetes P atients JOURNAL OF IMMUNOLOGY (ISSN: 00221767) 188: (3) pp. 13251332. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12426369]
32
Piao Ying, Liu Zhaozhe, Ding Zhenyu, Xu Long, Guo Fang, Sun Qingqing, Xie Xiaodong EGF +61A > G polymorphism and gastrointestinal cancer risk: A HuGE review and metaanalysis GENE (ISSN: 03781119) 519: (1) pp. 2633. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13354591]
33
AlDaghri NM, AlAttas OS, Alkharfy KM, Khan N, Mohammed AK, Vinodson B, Ansari MGA, Alenad A, Alokail MS Association of VDRgene variants with factors related to the metabolic syndrome, type 2 diabetes and vitamin D deficiency Gene (ISSN: 18790038) 542: (2) pp. 129133. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13865583]
418. Speer G , Cseh K , Winkler G , Vargha P , Braun E , Takacs I , Lakatos P Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. EUROPEAN JOURNAL OF ENDOCRINOLOGY 144:(4) pp. 385389. (2001) IF: 2.133 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1335570] [ Érvényesített ] Független idéző: 61 Függő idéző: 3 Összesen: 64 1
* Speer G, Cseh K, Fuszek P, Dworak O, Vargha P, Takács I, Nagy Zs, Lakatos P Ösztrogén, Dvitamin és kálciumérzékelő receptorok genotípusainak szerepe a colorectális daganatok patogenezisében ORVOSI HETILAP (ISSN: 00306002) 142: (18) pp. 947951. ( 2001) Folyóiratcikk [11613660]
2
Galbiati F, Polastri L, Gregori S, Freschi M, Casorati M, Cavallaro U, Fiorina P, Bertuzzi F, Zerbi A, Pozza G, Adorini L, Folli F, Christofori G, Davalli AM Antitumorigenic and antiinsulinogenic effects of calcitriol on insulinoma cells and solid betacell tumors ENDOCRINOLOGY (ISSN: 00137227) 143: (10) pp. 40184030. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11584855]
3
Gyorffy B, Vasarhelyi B, Krikovszky D, Madacsy L, Tordai A, Tulassay T, Szabo A Genderspecific association of vitamin D receptor polymorphism combinations with type 1 diabetes mellitus EUROPEAN JOURNAL OF ENDOCRINOLOGY (ISSN: 08044643) 147: (6) pp. 803808. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11584854]
4
Taverna MJ, Sola A, GuyotArgenton C, Pacher N, Bruzzo F, Slama G, Reach G, Selam JL Taq I polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy DIABETOLOGIA 45: (3) pp. 436442. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11584853]
5
Rankinen T, Perusse L, W eisnagel SJ, Synder EE, Chagnon YC, Bouchard C The human obesity gene map: The 2001 update OBESITY RESEARCH (ISSN: 10717323) 10: (3) pp. 196243. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11584852]
6
Ogunkolade BW , Boucher BJ, Prahl JM, Bustin SA, Burrin JM, Noonan K, North BV, Mannan N, McDermott MF, DeLuca HF, Hitman GA Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
281/342
3/30/2015
nyomtatobarat forma genotype in Bangladeshi Asians DIABETES (ISSN: 00121797) 51: (7) pp. 22942300. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11584851] 7
* Lakatos P, Speer G Vitamin D: Biological and clinical effects: A Dvitamin biológiai és klinikai hatásai Lege Artis Medicinae (ISSN: 08664811) 12: (1) pp. 817. ( 2002) Folyóiratcikk /Összefoglaló cikk /Tudományos [11605418]
8
Mossetti G, Vuotto P, Rendina D, Numis FG, Viceconti R, Giordano F, Cioffi M, Scopacasa F, Nunziata V Association between vitamin D receptor gene polymorphisms and tubular citrate handling in calcium nephrolithiasis JOURNAL OF INTERNAL MEDICINE (ISSN: 09546820) 253: (2) pp. 194200. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [11584850]
9
Okura T, Koda M, Ando F, Niino N, Ohta S, Shimokata H Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution INTERNATIONAL JOURNAL OF OBESITY (ISSN: 03070565) 27: (9) pp. 10201027. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [11584849]
10
Rosmond R Association studies of genetic polymorphisms in central obesity: a critical review INTERNATIONAL JOURNAL OF OBESITY (ISSN: 03070565) 27: (10) pp. 11411151. ( 2003) Folyóiratcikk /Összefoglaló cikk /Tudományos [11584848]
11
Cai Q, Shu XO, Jin F, Dai Q, W en W , Cheng JR, Gao YT, Zheng W Genetic polymorphisms in the estrogen receptor α gene and risk of breast cancer: Results from the Shanghai breast cancer study Cancer Epidemiology Biomarkers and Prevention 12: (9) pp. 853859. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [13339012]
12
Chagnon YC, Rankinen T, Snyder EE, W eisnagel SJ, Perusse LK, Bouchard C The human obesity gene map: The 2002 update OBESITY RESEARCH (ISSN: 10717323) 11: (3) pp. 313367. ( 2003) Folyóiratcikk /Összefoglaló cikk /Tudományos [11584846]
13
Snyder EE, W alts B, Perusse L, Chagnon YC, W eisnagel SJ, Rankinen T, Bouchard C The human obesity gene map: The 2003 update OBESITY RESEARCH (ISSN: 10717323) 12: (3) pp. 369439. ( 2004) Folyóiratcikk /Összefoglaló cikk /Tudományos [11584845]
14
Jasinghe VJ, Perera CO, Barlow PJ Bioavailability of vitamin D2 from irradiated mushrooms: an in vivo study BRITISH JOURNAL OF NUTRITION (ISSN: 00071145) 93: (6) pp. 951955. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [11584844]
15
W uW ong J R, Nakane M, Traylor L, Ruan X, Kroeger P E, Tian J Cardiovascular disease in chronic kidney failure: Is there a role for vitamin D analogs? Current Opinion in Investigational Drugs (ISSN: 14724472) 6: (3) pp. 245254. ( 2005) Chemicals/CAS: 22 oxacalcitriol, 103909757; 7 dehydrocholesterol, 434162; alfacalcidol, 41294568; amlodipine, 88150429; angiotensin, 1407472; atrial natriuretic factor, 85637736; brain natriuretic peptide, 114471180; C reactive protein, 9007414; calcidiol 1 monooxygenase, 9081361; calcifediol, 19356173; calcitriol, 32222063, 32511 630, 66772143; calcium, 7440702; chlortalidone, 77361; doxercalciferol, 54573750; lisinopril, 76547983, 83915 837; metoprolol, 37350586; parathyroid hormone, 12584962, 68893823, 9002646; paricalcitol, 131918611; ramipril, 87333195; Calcitriol, 32222063; Cardiovascular Agents; Ergocalciferols; Immunosuppressive Agents; paricalcitol, 131918611; Vitamin D, 1406162 Manufacturers: Abbott; Bone Care; Chugai Folyóiratcikk /Összefoglaló cikk /Tudományos [11605416]
16
Santos RD, Vianna LM Effect of cholecalciferol supplementation on blood glucose in an experimental model of type 2 diabetes mellitus in spontaneously hypertensive rats and Wistar rats CLINICA CHIMICA ACTA (ISSN: 00098981) 358: (12) pp. 146150. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [11584843]
17
Uitterlinden AG, Fang Y, van Meurs JBJ, Pols HAP Genetic Vitamin D Receptor P olymorphisms and Risk of Disease In: Vitamin D. (2) Elsevier Inc., 2005. (ISBN 9780122526879) pp. 11211157.
Könyvrészlet /Könyvfejezet /Tudományos [13816577] 18.
Harne A J Influence of Vitamin D Receptor Gene P olymorphisms on Changes in Insulin Sensitivity with Aerobic Exercise Training 97 p. 2005.
University of Maryland Disszertáció /Külföldi fokozat (nem P hD) /Tudományos [11613658] 19
Fox CS, Yang Q, Cupples LA, Guo CY, Atwood LD, Murabito JM, Levy D, Mendelsohn ME, Housman DE, Shearman AM Sexspecific association between estrogen receptoralpha gene variation and measures of adiposity: The Framingham Heart Study JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 90: (11) pp. 62576262. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [11584842]
20
Perusse L, Rankinen T, Zuberi A, Chagnon YC, W eisnagel SJ, Argyropoulos G, W alts B, Snyder EE, Bouchard C The human obesity gene map: The 2004 update OBESITY RESEARCH (ISSN: 10717323) 13: (3) pp. 381490. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [11584841]
21
Huang Q, W ang TH, Lu W S, Mu PW , Yang YF, Liang W W , Li CX, Lin GP Estrogen receptor alpha gene polymorphism associated with type 2 diabetes mellitus and the serum lipid concentration in Chinese women in Guangzhou CHINESE MEDICAL JOURNAL (ISSN: 03666999) 119: (21) pp. 17941801. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [11584840]
22
Yamada Y, Kato K, Kameyama T, Yokoi K, Matsuo H, Segawa T, W atanabe S, Ichihara S, Yoshida H, Satoh K, Nozawa Y Genetic factors for obesity INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (ISSN: 11073756) 18: (5) pp. 843851. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [11584839]
23 * Bajnok É, Takács I, Tabák Á, Speer G, Nagy Zs, Horváth Cs, Mészáros Sz, Kósa J, Nyiri P, Lakatos P
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
282/342
3/30/2015
nyomtatobarat forma Génpolimorfizmusok lehetséges szerepe a toxikus adenoma és az ezt kisérő Osteopathia kialakulásában MAGYAR BELORVOSI ARCHIVUM (ISSN: 01335464) 60: pp. 97102. ( 2006) Folyóiratcikk [11613654] 24
Asarian L, Geary N Modulation of appetite by gonadal steroid hormones PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY BBIOLOGICAL SCIENCES 361: (1471) pp. 12511263. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [11584838]
25
Guo YF, Xiong DH, Shen H, Zhao LJ, Xiao P, Guo Y, W ang W , Yang TL, Recker RR, Deng HW P olymorphisms of the lowdensity lipoproteinreceptorrelatedprotein5 (LRP 5) gene are associated with obesity phenotypes in a large familybased association study JOURNAL OF MEDICAL GENETICS (ISSN: 00222593) 43: (10) pp. 798803. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [11584837]
26
Rankinen T, Zuberi A, Chagnon YC, W eisnagel SJ, Argyropoulos G, W alts B, Perusse L, Bouchard C The human obesity gene map: The 2005 update OBESITY (ISSN: 19307381) 14: (4) pp. 529644. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [11584836]
27
Jasinghe VJ, Perera CO Ultraviolet irradiation: The generator of Vitamin D2 in edible mushrooms FOOD CHEMISTRY (ISSN: 03088146) 95: (4) pp. 638643. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [11584835]
28
Valdivielso JM, Fernandez E Vitamin D receptor polymorphisms and diseases CLINICA CHIMICA ACTA (ISSN: 00098981) 371: (12) pp. 112. ( 2006) Folyóiratcikk /Összefoglaló cikk /Tudományos [11584834]
29
Gallagher CJ, Langefeld CD, Gordon CJ, Campbell JK, Mychalecky JC, BryerAsh M, Rich SS, Bowden DW , Sale MM Association of the estrogen receptoralpha gene with the metabolic syndrome and its component traits in AfricanAmerican families The Insulin Resistance Atherosclerosis Family Study DIABETES (ISSN: 00121797) 56: (8) pp. 21352141. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [11584833]
30
Gallagher CJ, Keene KL, Mychaleckyj JC, Langefeld CD, Hirschhorn JN, Henderson BE, Gordon CJ, Freedman BI, Rich SS, Bowden DW , Sale MM Investigation of the estrogen receptora gene with type 2 diabetes and/or nephropathy in AfricanAmerican and European American populations DIABETES (ISSN: 00121797) 56: (3) pp. 675684. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [11584832]
31
Keene KL, Mychaleckyj JC, Smith SG, Leak TS, Perlegas PS, Langefeld CD, Herrington DM, Freedman BI, Rich SS, Bowden DW , Sale MM Comprehensive evaluation of the estrogen receptor alpha gene reveals further evidence for association with type 2 diabetes enriched for nephropathy in an African American population HUMAN GENETICS (ISSN: 03406717) 123: (4) pp. 333341. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [11584831]
32
Dahlman I, Vaxillaire M, Nilsson M, Lecoeur C, Gu HF, CavalcantiProenca C, Efendic S, Ostenson CG, Brismar K, Charpentler G, Gustafsson JA, Froguel P, DahlmanW right K, Steffensen KR Estrogen receptor alpha gene variants associate with type 2 diabetes and fasting plasma glucose PHARMACOGENETICS AND GENOMICS (ISSN: 17446872) 18: (11) pp. 967975. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [11584830]
33
Palomer X, GonzalezClemente JM, BlancoVaca F, Mauricio D Role of vitamin D in the pathogenesis of type 2 diabetes mellitus DIABETES OBESITY & METABOLISM (ISSN: 14628902) 10: (3) pp. 185197. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [11584829]
34
TworowskaBardzinska U, Lwow F, Kubicka E, Laczman L, Jedzrzejuk D, Dunajska K, Milewicz A The vitamin D receptor gene BsmI polymorphism is not associated with anthropometric and biochemical parameters describing metabolic syndrome in postmenopausal women GYNECOLOGICAL ENDOCRINOLOGY (ISSN: 09513590) 24: (9) pp. 514518. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [11584828]
35
Goulart AC, Zee RYL, Rexrode KM Estrogen receptor 1 gene polymorphisms and decreased risk of obesity in women METABOLISMCLINICAL AND EXPERIMENTAL (ISSN: 00260495) 58: (6) pp. 759764. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11584827]
36
Makowski M, Polac I, Pertynski T Oestrogen receptor alpha polymorphisms in women with breast cancer and their clinical significance PRZEGLAD MENOPAUZALNY (ISSN: 16438876) 8: (1) pp. 4044. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [11584826]
37
Shi HF, Seeley RJ, Clegg DJ Sexual differences in the control of energy homeostasis FRONTIERS IN NEUROENDOCRINOLOGY (ISSN: 00913022) 30: (3) pp. 396404. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [11584825]
38
Bid H, Konwar R, Aggarwal C, Gautam S, Saxena M, Nayak V, Banerjee M Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus : AA North Indian study Indian Journal of Medical Sciences 63: (5) pp. 187194. ( 2009) Chemicals/CAS: Receptors, Calcitriol Folyóiratcikk /Szakcikk /Tudományos [11605414]
39
Beydoun MA, Boueiz A, Shroff MR, Beydoun HA, W ang Y, Zonderman AB Associations among 25Hydroxyvitamin D, Diet Quality, and Metabolic Disturbance Differ by Adiposity in Adults in the United States JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 95: (8) pp. 38143827. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11584824]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
283/342
3/30/2015
nyomtatobarat forma 40
Dilmec F, Uzer E, Akkafa F, Kose E, van Kuilenburg ABP Detection of VDR gene ApaI and TaqI polymorphisms in patients with type 2 diabetes mellitus using P CRRFLP method in a Turkish population JOURNAL OF DIABETES AND ITS COMPLICATIONS (ISSN: 10568727) 24: (3) pp. 186191. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11584823]
41
Nosratabadi R, Arababadi MK, Salehabad VA, Shamsizadeh A, Mahmoodi M, Sayadi AR, Kennedy D P olymorphisms within exon 9 but not intron 8 of the vitamin D receptor are associated with the nephropathic complication of type2 diabetes INTERNATIONAL JOURNAL OF IMMUNOGENETICS (ISSN: 17443121) 37: (6) pp. 493497. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11584822]
42
Alvarez JA, Ashraf A Role of Vitamin D in Insulin Secretion and Insulin Sensitivity for Glucose Homeostasis INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (ISSN: 16878337) 2010: P aper 351385. (2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11584821]
43
Casazza K, Page GP, Fernandez JR The Association Between the rs2234693 and rs9340799 Estrogen Receptor alpha Gene P olymorphisms and Risk Factors for Cardiovascular Disease: A Review BIOLOGICAL RESEARCH FOR NURSING (ISSN: 10998004) 12: (1) pp. 8497. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11584820]
44
PérezTorres I, De MacCarthy GB Sex hormone receptors in metabolic syndrome In: Sex Hormones: Development, Regulation and Disorders. Nova Science Publishers, Inc., 2011. (ISBN 9781613247150) pp. 5373.
Könyvrészlet /Könyvfejezet /Tudományos [13816576] 45
Ryba Monika, Malinowska Ewa, RybarczykKapturska Karolina, Brandt Agnieszka, Mysliwiec Malgorzata, Mysliwska Jolanta The association of the IVS1397T > C estrogen receptor a polymorphism with the regulatory conditions in longstanding type 1 diabetic girls MOLECULAR IMMUNOLOGY (ISSN: 01615890) 49: (12) pp. 324328. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12426354]
46
Nosratabadi R, Arababadi MK, Salehabad VA Vitamin D Receptor P olymorphisms in Type 2 Diabetes in Southeastern Iranian P atients LABMEDICINE 42: (1) pp. 3234. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11584819]
47
Ganasyam SR, Rao TB, Murthy YSR, Jyothy A, Sujatha M Association of estrogen receptorα gene & metallothionein1 gene polymorphisms in type 2 diabetic women of Andhra P radesh Indian Journal of Clinical Biochemistry (ISSN: 09701915) 27: (1) pp. 6973. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12661902]
48
Meshkani Reza, Saberi Hamzeh, MohammadTaghvaei Narges, Tabatabaiefar Mohammad Amin Estrogen receptor alpha gene polymorphisms are associated with type 2 diabetes and fasting glucose in male subjects MOLECULAR AND CELLULAR BIOCHEMISTRY (ISSN: 03008177) 359: (12) pp. 225233. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12426353]
49
Yang Huiqi, Sukocheva Olga A, Hussey Damian J, W atson David I Estrogen, male dominance and esophageal adenocarcinoma: Is there a link? WORLD JOURNAL OF GASTROENTEROLOGY (ISSN: 10079327) 18: (5) pp. 393400. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12426352]
50
Kallel I, Rebai M, Rebai A Mutations and polymorphisms of estrogens receptors genes and diseases susceptibility Journal of Receptors and Signal Transduction 32: (6) pp. 304313. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13339011]
51
W ang QJ, Xi B, Reilly KH, Liu M, Fu MS Quantitative assessment of the associations between four polymorphisms (FokI, ApaI, BsmI, TaqI) of vitamin D receptor gene and risk of diabetes mellitus MOLECULAR BIOLOGY REPORTS (ISSN: 03014851) 39: (10) pp. 94059414. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12661780]
52
Stivelman E, Retnakaran R Role of vitamin D in the pathophysiology and treatment of type 2 diabetes Current Diabetes Reviews (ISSN: 15733998) 8: (1) pp. 4247. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12661901]
53
Schmedes A, Hey H, Larsson I, Christensen MJ, Brandslund I Unsuccessful vitamin D treatment: Manglende respons på behandling med Dvitamin Ugeskrift for Laeger (ISSN: 00415782) 174: (9) pp. 566569. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12661900]
54
Skouroliakou M, Giannopoulou I, Maria SG, Kostara C, Koutri K, Kakavelaki C Vitamin D insufficiency in obese patients with severe mental illness taking olanzapine Mediterranean Journal of Nutrition and Metabolism (ISSN: 1973798X) 5: (3) pp. 219225. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13339010]
55
Ghattas MH, Mehanna ET, Mesbah NM, AboElmatty DM Association of estrogen receptor alpha gene polymorphisms with metabolic syndrome in Egyptian women METABOLISMCLINICAL AND EXPERIMENTAL (ISSN: 00260495) 62: (10) pp. 14371442. ( 2013) Folyóiratcikk /Tudományos [13816575]
56
Mohammadi F, Pourahmadi M, Mosalanejad M, Jamali H, Ghobadifar MA, Erfanian S Association of estrogen receptor α genes P vuII and XbaI polymorphisms with type 2 diabetes mellitus in the inpatient population of a hospital in southern iran Diabetes and Metabolism Journal 37: (4) pp. 270277. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13339009]
57
Gao W , Chen DW , Liu GJ, Ran XW Efficacy and safety of Vitamin D for type 2 diabetes mellitus: a systematic review National Medical Journal of China 93: (18) pp. 14011406. ( 2013)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
284/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Összefoglaló cikk /Tudományos [13339008] 58
Souza MA, da Fonseca AM, Bagnoli VR, de Barros N, Hortense VHS, Franzolin SOB, Soares Jr JM, Baracat EC P olymorphisms in the estrogen receptor alpha gene and mammographic density result study in Brazilian women Journal of Cancer Science and Therapy (ISSN: 19485956) 5: (12) pp. 446451. ( 2013) Folyóiratcikk /Tudományos [13816574]
59
Richer SP, Pizzimenti JJ The importance of vitamin D in systemic and ocular wellness Journal of Optometry 6: (3) pp. 124133. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13339007]
60
Girgis CM, CliftonBligh RJ, Hamrick MW , Holick MF, Gunton JE The roles of vitamin D in skeletal muscle: Form, function, and metabolism Endocrine Reviews (ISSN: 0163769X) 34: (1) pp. 3383. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13339006]
61
Li L, W u B, Liu JY, Yang LB Vitamin D receptor gene polymorphisms and type 2 diabetes: A Metaanalysis Archives of Medical Research (ISSN: 01884409) 44: (3) pp. 235241. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13339005]
62
AlDaghri NM, AlAttas OS, Alkharfy KM, Khan N, Mohammed AK, Vinodson B, Ansari MGA, Alenad A, Alokail MS Association of VDRgene variants with factors related to the metabolic syndrome, type 2 diabetes and vitamin D deficiency GENE (ISSN: 03781119) 542: (2) pp. 129133. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13857695]
63
Hoteit M, Arabi A, Habib R, Mahfouz R, Baddoura R, Halaby G, ElHajj Fuleihan G Estrogen receptor α is not a candidate gene for metabolic syndrome in Caucasian elderly subjects METABOLISMCLINICAL AND EXPERIMENTAL (ISSN: 00260495) 63: (1) pp. 5060. ( 2014) Folyóiratcikk /Tudományos [13816573]
64
Cherniack EP, Seldeen K, Troen BR Vitamin D: A regulator of metabolism and inflammation Current Nutrition and Food Science (ISSN: 22123881) 10: (1) pp. 311. ( 2014) Folyóiratcikk /Összefoglaló cikk /Tudományos [13857774]
419. Speer G , Cseh K , Fuszek P , Dworak O , Vargha P , Takács I , Nagy Z , Lakatos P Ösztrogén Dvitamin és kalciumérzékelő receptorok genotípusainak szerepe a colorectalis daganatok patogenezisében. ORVOSI HETILAP 142:(18) pp. 947951. (2001) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1335667] [ Érvényesített ] Független idéző: 5 Összesen: 5 1
Peters U, Chatterjee N, Yeager M, Chanock S J, Schoen R E, McGlynn K A, Church T R, W eissfeld J L, Schatzkin A, Hayes R B Association of genetic variants in the calciumsensing receptor with risk of colorectal adenoma Cancer Epidemiology Biomarkers and Prevention 13: (12) pp. 21812186. ( 2004) Chemicals/CAS: Receptors, CalciumSensing Folyóiratcikk /Szakcikk /Tudományos [11605508]
2
Msaouel P, Nixon A M, Bramos A P, Baiba E, Kentarchos N E Extracellular calcium sensing receptor: An overview of physiology, pathophysiology and clinical perspectives In Vivo (ISSN: 0258851X) 18: (6) pp. 739754. ( 2004) Folyóiratcikk /Összefoglaló cikk /Tudományos [11605507]
3
Gong Y L, Xie D W , Deng Z L, Bostick R M, Miao X J, Zhang J H, Gong Z H Vitamin D receptor gene Tru9I polymorphism and risk for incidental sporadic colorectal adenomas World Journal of Gastroenterology (ISSN: 10079327) 11: (31) pp. 47944799. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [11605506]
4
Shi H, Clegg D J Sex differences in the regulation of body weight Physiology and Behavior (ISSN: 00319384) 97: (2) pp. 199204. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11605505]
5
Brown L M, Gent L, Davis K, Clegg D J Metabolic impact of sex hormones on obesity Brain Research (ISSN: 00068993) 1350: pp. 7785. ( 2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11605504]
420. Speer G , Nagy Zs , Takács I , Bajnok É , Lakatos p A szérumleptinszint és a csont ásványianyagsűrűsége posztmenopauzális nőkben. CA ÉS CSONT 4:(S1) pp. 1819. (2001) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1819642] [ Admin láttamozott ] 421. Takács I , Speer G , Nagy Zs , Bajnok É , Lakatos P A kalciumszenzorreceptorgén polimorfizmusának (A986S) kapcsolata a csontdenzitással posztmenopauzás nőknél. CA ÉS CSONT 4:(S1) pp. 1718. (2001) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1818614] [ Admin láttamozott ] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
285/342
3/30/2015
nyomtatobarat forma
422. Takacs I , Speer G , Bajnok E , Nagy Z , Tabak A , Horvath C , Kiss L , Lakatos P Lack of association between CaSR gene A986S polymorphism and bone density in Hungarian postmenopausal women JOURNAL OF BONE AND MINERAL RESEARCH 16:(Suppl 1) p. S250. (2001) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1820955] [ Érvényesített ] 423. Takács I , Speer G , Bajnok É , Nagy Z , Tabák Á , Horváth Cs , Kiss L , Lakatos P Lack of association between CaSR gene A986S polymorphism and bone density in Hungarian postmenopausal women ASBM R Kongresszus, Phoenix (2001) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434077] poszter [ Admin láttamozott ] 424. Tamas G , Tabak A G , M adarasz E , Speer G , Beko G , NagySzabo J , Lakatos P , Kerenyi Z Characteristic features of the metabolic syndrome in women with prior GDM : Circulating leptin concentrations during oGTT DIABETOLOGIA: CLINICAL AND EXPERIMENTAL DIABETES AND METABOLISM 44:(Suppl 1) p. A246. (2001) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1820956] [ Érvényesített ] 425. Tóth E , M észáros Sz , Szathmári M , Lakatos P , Csupor E , Horváth Cs Férfiak Dvitaminhormonszintjének alakulása az életkor függvényében CA ÉS CSONT 4:(S1) p. 17. (2001) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2079947] [ Admin láttamozott ]
2000 426. Almasi Cs , Deak G , Tisler A , Speer G , Berta K , Ambrus Cs , Lakatos P , de Chatel R , M ucsi I Serum 25(OH)vitamin D levels correlate with serum markers of bone metabolism in patients on maintenance hemodialysis NEPHROLOGY DIALYSIS TRANSPLANTATION 15:(9) p. A47. (2000) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1120076] [ Admin láttamozott ] 427. Bajnok E , Takacs I , Vargha P , Speer G , Nagy Z , Lakatos P Lack of association between interleukin1 receptor antagonist protein gene polymorphism and bone mineral density in Hungarian postmenopausal women BONE 27:(4) pp. 559562. (2000) IF: 3.998 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1335571] [ Érvényesített ] Független idéző: 22 Függő idéző: 1 Összesen: 23 1
Huang W , O Keefe R J, Schwarz E M Gene polymorphisms and musculoskeletal disease Current Opinion in Orthopaedics (ISSN: 10419918) 12: (5) pp. 416423. ( 2001) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915217]
2
Gortz B, Fassbender W J Genetics of osteoporosis ORTHOPADE (ISSN: 00854530) 30: (7) pp. 412417. ( 2001) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915109]
3
W itkin SS, Gerber S, Ledger W J Influence of interleukin1 receptor antagonist gene polymorphism on disease CLINICAL INFECTIOUS DISEASES (ISSN: 10584838) 34: (2) pp. 204209. ( 2001) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915108]
4
Hsieh YY, Chang CC, Tsai FJ, W u JY, Shi YR, Tsai HD, Tsai CH P olymorphisms for interleukin1 beta (IL1 beta)511 promoter, IL1 beta exon 5, and IL1 receptor antagonist: Nonassociation with endometriosis JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (ISSN: 10580468) 18: (9) pp. 506511. ( 2001)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
286/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [11915107] 5
Lee SK, Kalinowski J, Jastrzebski S, Lorenzo JA 1,25 (OH)(2) vitamin D3stimulated osteoclast formation in spleenosteoblast cocultures is mediated in part by enhanced IL1 alpha and receptor activator of NFkappa B ligand production in osteoblasts JOURNAL OF IMMUNOLOGY (ISSN: 00221767) 169: (5) pp. 23742380. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11915106]
6
Sahin G, Ozturk C, Bagis S, Cimen O B, Erdogan C Correlation of serum cytokine levels with axial bone mineral density Singapore Medical Journal (ISSN: 00375675) 43: (11) pp. 576578. ( 2002) Chemicals/CAS: interleukin 8, 114308917; Cytokines Folyóiratcikk /Szakcikk /Tudományos [11915216]
7
Haukim N, Bidwell JL, Smith AJP, Keen LJ, Gallagher G, Kimberly R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C, D Alfonso S Cytokine gene polymorphism in human disease: online databases, Supplement 2 GENES AND IMMUNITY (ISSN: 14664879) 3: (6) pp. 313330. ( 2002) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915105]
8
Peacock M, Turner CH, Econs MJ, Foroud T Genetics of osteoporosis ENDOCRINE REVIEWS (ISSN: 0163769X) 23: (3) pp. 303326. ( 2002) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915104]
9
Han K, Choi JT, Moon G, Jeong MS, Yim CH, Chung HY, Jang HC, Yoon HK, Han IK Nonassociation of interleukin1 receptor antagonist genotypes with bone mineral density, bone turnover status, and estrogen responsiveness in Korean postmenopausal women BONE (ISSN: 87563282) 31: (5) pp. 612615. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11915103]
10
Tsai F J, Hsieh Y Y, Chang C C, Lin C C, Tsai C H P olymorphisms for interleukin 1β exon 5 and interleukin 1 receptor antagonist in Taiwanese children with febrile convulsions Archives of Pediatrics and Adolescent Medicine 156: (6) pp. 545548. ( 2002) Chemicals/CAS: Genetic Markers; Interleukin1; Receptors, Interleukin1 Folyóiratcikk /Szakcikk /Tudományos [11915215]
11 * Lakatos LP, Bajnok E, Hegedus D, Toth T, Lakatos P, Szalay F Vitamin D receptor, oestrogen receptoralpha gene and interleukin1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 14: (7) pp. 733740. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11915101] 12
Gu W K, Li X M, Roe B A, Lau K H W , Mohan S, Baylink D J Application of genomic resources and gene expression profiles to identify genes that regulate bone destiny Current Genomics (ISSN: 13892029) 4: (1) pp. 75102. ( 2003) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915214]
13
Gong G, Haynatzki G Association between bone mineral density and candidate genes in different ethnic populations and its implications CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 72: (2) pp. 113123. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [11915100]
14
Audí Parera L, Martí Aromir G Genetic factors determining bone mass: Factores genéticos determinantes de la masa ósea Revista Espanola de Pediatria 59: (1) pp. 4760. ( 2003) Chemicals/CAS: aromatase, 9039489; osteocalcin, 136461808; osteoprotegerin, 205944509; tumor necrosis factor receptor, 129203936, 184595015 Folyóiratcikk /Szakcikk /Tudományos [11915213]
15
Shimpuku H, Nosaka Y, Kawamura T, Tachi Y, Shinohara M, Ohura K Genetic polymorphisms of the interleukinI gene and early marginal bone loss around endosseous dental implants CLINICAL ORAL IMPLANTS RESEARCH (ISSN: 09057161) 14: (4) pp. 423429. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [11915099]
16
Liu YZ, Liu YJ, Recker RR, Deng HW Molecular studies of identification of genes for osteoporosis: the 2002 update JOURNAL OF ENDOCRINOLOGY (ISSN: 00220795) 177: (2) pp. 147196. ( 2003) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915098]
17
Kim JG, Lim KS, Ku SY, Kim SH, Choi YM, Moon SY Relations between interleukin1, its receptor antagonist gene polymorphism, and bone mineral density in postmenopausal Korean women JOURNAL OF BONE AND MINERAL METABOLISM (ISSN: 09148779) 24: (1) pp. 5357. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [11915097]
18
Sezgin M, Erdal ME, Altintas ZM, Ankarali HC, Barlas IO, Turkmen E Lack of association polymorphisms of the IL1RN, IL1A, and IL1B genes with knee osteoarthritis in Turkish patients CLINICAL AND INVESTIGATIVE MEDICINE (ISSN: 0147958X) 30: (2) pp. E86E92. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [11915096]
19
Chao TH, Yu HN, Huang CC, Liu W S, Tsai YW , W u W T Association of interleukin1 beta (511C/T) polymorphisms with osteoporosis in postmenopausal women ANNALS OF SAUDI MEDICINE (ISSN: 02564947) 30: (6) pp. 437441. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11915095]
20
Yilmaz IA, Ozge A, Erdal ME, Edgunlu TG, Cakmak SE, Yalin OO Cytokine P olymorphism in P atients with Migraine: Some Suggestive Clues of Migraine and Inflammation PAIN MEDICINE (ISSN: 15262375) 11: (4) pp. 492497. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11915094]
21
Lee YM, Fujikado N, Manaka H, Yasuda H, Iwakura Y IL1 plays an important role in the bone metabolism under physiological conditions INTERNATIONAL IMMUNOLOGY (ISSN: 09538178) 22: (10) pp. 805816. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11915093] Jung MY, Kang SW , Kim SK, Kim HJ, Yun DH, Yim SV, Hong SJ, Chung JH
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
287/342
3/30/2015
nyomtatobarat forma 22
The interleukin1 family gene polymorphisms in Korean patients with rheumatoid arthritis SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (ISSN: 03009742) 39: (3) pp. 190196. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11915092]
23
Confavreux CB, Chapurlat RD Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 22: (4) pp. 10231036. ( 2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915091]
428. Gy Deák , A Tislér , K Berta , I Kiss , Cs Almási , Cs Horváth , I Takács , P Lakatos , G Speer , R deChatel , I M ucsi Bone mineral density on maintenance hemodialysis is not determined by polymorphism of the estrogen receptor. AMERICAN JOURNAL OF NEPHROLOGY 11: p. 561. (2000) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1822436] [ Admin láttamozott ] 429. Deák Gy , Tislér A , Berta K , Kiss I , Almási Cs , Horváth Cs , Takács I , Lakatos P , Speer G , deChatel R , M ucsi I Bone mineral density on maintenance hemodialysis is not determined by polymorphism of the estrogen receptor Congress of American Society of Nephrology, Toronto (2000) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434066] poszter [ Admin láttamozott ] 430. F Szalay , PL Lakatos , G Firneisz , P Lakatos , Cs Horváth Urinary pyrolidine/creatinine; deoxypirolidine /creatinine ratio and bone mineral density follow up in postmenopausal primary biliary cirrhosis. ZEITSCHRIFT FÜR GASTROENTEROLOGIE 38: p. 425. (2000) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391684] [ Admin láttamozott ] 431. Fischer M , Lakatos P A Dvitaminellátottság vizsgálata 65 év felettiek körében CA ÉS CSONT 3:(1) pp. 2224. (2000) Nyelv: Magyar
Folyóiratcikk /Rövid közlemény /Tudományos [1974364] [ Érvényesített ] 432. Győri G , Csupor E , Lakatos P , M ajor A , Firneisz G , Horváth C Radiological findings and clinical evaluation of Albright's hereditary osteodystrophy (AHO): Two patients with pseudopseudohypoparathyroidism (pseudoPHP) EUROPEAN RADIOLOGY 10: p. 401. (2000) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1748210] [ Admin láttamozott ] 433. Halmos B , Szalay F , Cserniczky T , Nemesanszky E , Lakatos P , Barlage S , Schmitz G , Romics L , Csaszar A Association of primary biliary cirrhosis with vitamin D receptor BsmI genotype polymorphism in a Hungarian population DIGESTIVE DISEASES AND SCIENCES 45:(6) pp. 10911095. (2000) IF: 1.498 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1298714] [ Érvényesített ] Független idéző: 35 Függő idéző: 3 Összesen: 38 1
2
3
Trauner M, Boyer JL Cholestatic syndromes CURRENT OPINION IN GASTROENTEROLOGY (ISSN: 02671379) 17: (3) pp. 242256. ( 2001) Folyóiratcikk [10887511] * Csaszar A, Abel T Receptor polymorphisms and diseases EUROPEAN JOURNAL OF PHARMACOLOGY (ISSN: 00142999) 414: (1) pp. 922. ( 2001) Folyóiratcikk [10887510] Zofkova I, Hill M, Zajickova K Dehydroepiandrosterone status in postmenopausal women is determined by the gene for the vitamin D receptor HORMONE AND METABOLIC RESEARCH (ISSN: 00185043) 34: (3) pp. 127131. ( 2002) Folyóiratcikk [10887509]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
288/342
3/30/2015
nyomtatobarat forma 4
Gyorffy B, Vasarhelyi B, Krikovszky D, Madacsy L, Tordai A, Tulassay T, Szabo A Genderspecific association of vitamin D receptor polymorphism combinations with type 1 diabetes mellitus EUROPEAN JOURNAL OF ENDOCRINOLOGY (ISSN: 08044643) 147: (6) pp. 803808. ( 2002) Folyóiratcikk [10887508]
5
Peacock M, Turner CH, Econs MJ, Foroud T Genetics of osteoporosis ENDOCRINE REVIEWS (ISSN: 0163769X) 23: (3) pp. 303326. ( 2002) Folyóiratcikk [10887507]
6
* Lakatos LP, Bajnok E, Hegedus D, Toth T, Lakatos P, Szalay F Vitamin D receptor, oestrogen receptoralpha gene and interleukin1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (ISSN: 0954691X) 14: (7) pp. 733740. ( 2002) Folyóiratcikk [10887506]
7
Leslie W D, Bernstein CN, Leboff MS AGA Technical Review on osteoporosis in hepatic disorders GASTROENTEROLOGY (ISSN: 00165085) 125: (3) pp. 941966. ( 2003) Folyóiratcikk [10887505]
8
Jones D E J, Donaldson P T Genetic factors in the pathogenesis of primary biliary cirrhosis Clinics in Liver Disease (ISSN: 10893261) 7: (4) pp. 841864. ( 2003) PubMed ID: 14594133 UR: http://www.scopus.com/inward/record.url?eid=2s2.0 0141817494& partnerID=40& md5=585dbdb9c7f7447f1ebef370591ca084 Folyóiratcikk [10913051]
9
Pusl T, Beuers U Extrahepatic manifestations of cholestatic liver diseases CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (ISSN: 10800549) 28: (2) pp. 147157. ( 2005) Folyóiratcikk [10887504]
10
Invernizzi P, Selmi C, Mackay IR, Podda M, Gershwin ME From bases to basis: Linking genetics to causation in primary biliary cirrhosis Clinical Gastroenterology and Hepatology (ISSN: 15423565) 3: (5) pp. 401410. ( 2005) Folyóiratcikk /Összefoglaló cikk /Tudományos [13699387]
11
Selmi C, Invernizzi P, Zuin M, Podda M, Seldin MF, Gershwin ME Genes and (auto) immunity in primary biliary cirrhosis GENES AND IMMUNITY (ISSN: 14664879) 6: (7) pp. 543556. ( 2005) Folyóiratcikk [10887502]
12
Selmi C, Invernizzi P, Zuin M, Podda M, Gershwin ME Genetics and geoepidemiology of primary biliary cirrhosis: Following the footprints to disease etiology SEMINARS IN LIVER DISEASE (ISSN: 02728087) 25: (3) pp. 265280. ( 2005) Folyóiratcikk [10887501]
13
Hagymási K, Tulassay Z Genetics of primary biliary cirrhosis: A primer biliaris cirrhosis genetikája Orvosi Hetilap (ISSN: 00306002) 146: (42) pp. 21512155. ( 2005) PubMed ID: 16315996 Chemicals/CAS: Antigens, CD; Antigens, Differentiation; Apolipoproteins E; ATPBinding Cassette Transporters; Chemokines; Cytokines; cytotoxic Tlymphocyte antigen 4; Interleukin1; Interleukin10, 130068278 UR: http://www.scopus.com/inward/record.url?eid=2s2.0 33644831865& partnerID=40& md5=1ba7a877e1d929ad0427c4fc37d2a7da Folyóiratcikk [10913050]
14 * Szalay F, Folhoffer A, Horvath A, Csak T, Speer G, Nagy Z, Lakatos P, Horvath C, Habior A, Tornai I, Lakatos PL Serum leptin, soluble leptin receptor, free leptin index and bone mineral density in patients with primary biliary cirrhosis EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (ISSN: 0954691X) 17: (9) pp. 923928. ( 2005) Folyóiratcikk [10887500] 15
Honjo Y, Sasaki S, Kobayashi Y, Misawa H, Nakamura H 1,25dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic aciddependent transactivation by farnesoid X receptor JOURNAL OF ENDOCRINOLOGY (ISSN: 00220795) 188: (3) pp. 635643. ( 2006) Folyóiratcikk [10887499]
16
Sanchez A J, Jaime A M Liver disease and osteoporosis Nutrition in Clinical Practice (ISSN: 08845336) 21: (3) pp. 273278. ( 2006) PubMed ID: 16772544 Chemicals/CAS: ascorbic acid, 134032, 15421155, 50817; calcium, 7440702; vitamin K group, 12001795; Ascorbic Acid, 50817; Calcium, 7440702; Vitamin D, 1406162; Vitamin K, 12001795 UR: http://www.scopus.com/inward/record.url?eid=2s2.0 33750589530& partnerID=40& md5=326e73a01e17ccfc045906bae5aae49e Folyóiratcikk [10913049]
17
Tanaka A Genetic background of primary biliary cirrhosis HEPATOLOGY RESEARCH (ISSN: 13866346) 37: pp. S377S383. ( 2007) SU: Suppl. 3 Folyóiratcikk [10887498]
18
Huang H, Cheung R, Donaldson PT, Lammert F Genetics and Liver Diseases In: Textbook of Hepatology : From Basic Science to Clinical Practice, Third Edition. Blackwell Publishing Ltd, 2008. (ISBN 9781405127417) pp. 356383. (Textbook of Hepatology : From Basic Science to Clinical Practice, Third Edition)
Könyvrészlet /Könyvfejezet /Tudományos [13699386] 19
Xu LZ, Guo LS, Shen ZW , Loss G, Gish R, W asilenko S, Mason AL Duplication of MER115 on chromosome 4 in patients with primary biliary cirrhosis LIVER INTERNATIONAL (ISSN: 14783223) 29: (3) pp. 375383. ( 2009) Folyóiratcikk [10887497]
20
Tanaka A, Nezu S, Uegaki S, Kikuchi K, Shibuya A, Miyakawa H, Takahashi S, Bianchi I, Zermiani P, Podda M, Ohira H, Invernizzi P, Takikawa H
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
289/342
3/30/2015
nyomtatobarat forma Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations JOURNAL OF HEPATOLOGY (ISSN: 01688278) 50: (6) pp. 12021209. ( 2009) Folyóiratcikk [10887496] 21
Adorini L Vitamin D receptor polymorphisms in primary biliary cirrhosis: A functional connection? JOURNAL OF HEPATOLOGY (ISSN: 01688278) 50: (6) pp. 10711073. ( 2009) Folyóiratcikk [10887495]
22
Selmi C, Torok NJ, Affronti A, Gershwin ME Genomic variants associated with primary biliary cirrhosis Genome Medicine 2: (1) P aper 5. (2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [13699385]
23
W ariaghli G, Allali F, El Maghraoui A, HajjajHassouni N Osteoporosis in patients with primary biliary cirrhosis EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (ISSN: 0954691X) 22: (12) pp. 13971401. ( 2010) Folyóiratcikk [12428945]
24
Falleti E, Bitetto D, Fabris C, Cussigh A, Fontanini E, Fornasiere E, Fumolo E, Bignulin S, Cmet S, Minisini R, Pirisi M, Toniutto P Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis WORLD JOURNAL OF GASTROENTEROLOGY (ISSN: 10079327) 16: (24) pp. 30163024. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12428944]
25
Kakizaki S, Takizawa D, Tojima H, Horiguchi N, Yamazaki Y, Mori M Nuclear Receptors CAR and P XR; therapeutic targets for cholestatic liver disease FRONTIERS IN BIOSCIENCELANDMARK 16: pp. 2988+. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12428943]
26
Hirschfield GM, Invernizzi P P rogress in the Genetics of P rimary Biliary Cirrhosis SEMINARS IN LIVER DISEASE (ISSN: 02728087) 31: (2) pp. 147156. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12428942]
27
Zunigaa S, Firrincieli D, Housset C, Chignard N Vitamin D and the vitamin D receptor in liver pathophysiology CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (ISSN: 22107401) 35: (4) pp. 295302. ( 2011) Folyóiratcikk [12428941]
28
Falleti E, Bitetto D, Fabris C, Cmet S, Fornasiere E, Cussigh A, Fontanini E, Avellini C, Barbina G, Ceriani E, Pirisi M, Toniutto P Association between vitamin D receptor genetic polymorphisms and acute cellular rejection in livertransplanted patients TRANSPLANT INTERNATIONAL (ISSN: 09340874) 25: (3) pp. 314322. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12428940]
29
Kitson MT, Roberts SK Dlivering the message: The importance of vitamin D status in chronic liver disease Journal of Hepatology (ISSN: 01688278) 57: (4) pp. 897909. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13699384]
30
KempinskaPodhorecka A, W unsch E, Jarowicz T, RaszejaW yszomirska J, Loniewska B, Kaczmarczyk M, Milkiewicz M, Milkiewicz P Vitamin D Receptor P olymorphisms P redispose to P rimary Biliary Cirrhosis and Severity of the Disease in P olish P opulation GASTROENTEROLOGY RESEARCH & PRACTICE (ISSN: 16876121) 2012: P aper 408723. (2012) Folyóiratcikk /Szakcikk /Tudományos [12428939]
31
Halilbasic E, Baghdasaryan A, Trauner M Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases Clinics in Liver Disease (ISSN: 10893261) 17: (2) pp. 161189. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13699383]
32
Godoy P, Hewitt NJ, Albrecht U, Andersen ME, Ansari N, Bhattacharya S, Bode JG, Bolleyn J, Borner C, Böttger J, Braeuning A, Budinsky RA, Burkhardt B, Cameron NR, Camussi G, Cho CS, Choi YJ, Craig Rowlands J, Dahmen U, Damm G, Dirsch O, Donato MT, Dong J, Dooley S, Drasdo D, Eakins R, Ferreira KS, Fonsato V, Fraczek J, Gebhardt R, Gibson A, Glanemann M, Goldring CEP, GómezLechón MJ, Groothuis GMM, Gustavsson L, Guyot C, Hallifax D, Hammad S, Hayward A, Häussinger D, Hellerbrand C, Hewitt P, Hoehme S, Holzhütter HG, Houston JB, Hrach J, Ito K, Jaeschke H, Keitel V, Kelm JM, Kevin Park B, Kordes C, KullakUblick GA, Lecluyse EL, Lu P, LuebkeW heeler J, Lutz A, Maltman DJ, MatzSoja M, McMullen P, Merfort I, Messner S, Meyer C, Mwinyi J, Naisbitt DJ, Nussler AK, Olinga P, Pampaloni F, Pi J, Pluta L, Przyborski SA, Ramachandran A, Rogiers V, Rowe C, Schelcher C, Schmich K, Schwarz M, Singh B, Stelzer EHK, Stieger B, Stöber R, Sugiyama Y, Tetta C, Thasler W E, Vanhaecke T, Vinken M, W eiss TS, W idera A, W oods CG, Xu JJ, Yarborough KM, Hengstler JG Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and nonparenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME Archives of Toxicology 87: (8) pp. 13151530. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13699382]
33
Lng KVQ, Nguyn LTH The role of vitamin d in primary biliary cirrhosis: P ossible genetic and cell signaling mechanisms Gastroenterology Research and Practice 2013: P aper 602321. (2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13699381]
34
Smyk DS, Orfanidou T, Invernizzi P, Bogdanos DP, Lenzi M Vitamin D in autoimmune liver disease Clinics and Research in Hepatology and Gastroenterology (ISSN: 22107401) 37: (5) pp. 535545. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13699380]
35
Baghdasaryan Anna, Chiba Peter, Trauner Michael Clinical application of transcriptional activators of bile salt transporters MOLECULAR ASPECTS OF MEDICINE (ISSN: 00982997) 37: pp. 5776. ( 2014) Folyóiratcikk [14192917]
36
Firrincieli D, Braescu T, Housset C, Chignard N Illuminating liver fibrosis with vitamin D
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
290/342
3/30/2015
nyomtatobarat forma CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (ISSN: 22107401) 38: (1) pp. 58. ( 2014) Folyóiratcikk [14192916] 37
Mo Cuiju, Lu Yu, Deng Yan, W ang Jian, Xie Li, Li Taijie, He Yu, Qin Xue, Li Shan Lack of association between vitamin D receptor gene ApaI, BsmI, and TaqI polymorphisms and primary biliary cirrhosis risk: a metaanalysis TUMOR BIOLOGY (ISSN: 10104283) 35: (5) pp. 49134920. ( 2014) Folyóiratcikk [14192915]
38
Li Yuanjun, Tang Yawei, Shi Yongquan, Han Shuang, W ang Jingbo, Zhou Xinmin, Chen Yu, W u Zhidan, Han Zheyi, Han Ying, W u Kaichun, Fan Daiming P olymorphisms in the vitamin D receptor gene and risk of primary biliary cirrhosis: A metaanalysis JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (ISSN: 08159319) 29: (4) pp. 706715. ( 2014) Folyóiratcikk [14192914]
434. Hollo G , Lakatos P , Vargha P Immediate increase in aqueous humour endothelin 1 concentration and intraocular pressure after argon laser trabeculoplasty in the rabbit. OPHTHALMOLOGICA 214:(4) pp. 292295. (2000) IF: 0.494 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1723946] CI: Copyright 2000 S. Karger AG, Basel. : ophthalmology. Zeitschrift fur Augenheilkunde [ Érvényesített ] Független idéző: 11 Függő idéző: 3 Összesen: 14 1
* Hollo G, Kothy P, Lakatos P, Vargha P EndothelinA receptor antagonist BQ485 protects against intraocular pressure spike induced by laser trabeculoplasty in the rabbit OPHTHALMOLOGICA (ISSN: 00303755) 216: (6) pp. 459462. ( 2002) Folyóiratcikk [12432275]
2
* Hollo G, Visontai Z, Lakatos P, Vargha P Unoprostone isopropyl pretreatment decreases endothelin1 release and the intraocular pressure spike induced by laser trabeculoplasty in the rabbit OPHTHALMOLOGICA (ISSN: 00303755) 217: (3) pp. 231236. ( 2003) Folyóiratcikk [12432274]
3
* Koliakos GG, Konstas AGP, SchlotzerSchrehardt U, Hollo G, Mitova D, Kovatchev D, Maloutas S, Georgiadis N Endothelin1 concentration is increased in the aqueous humour of patients with exfoliation syndrome BRITISH JOURNAL OF OPHTHALMOLOGY (ISSN: 00071161) 88: (4) pp. 523527. ( 2004) Folyóiratcikk [12432273]
4
Prasanna G, Hulet C, Desai D, Krishnamoorthy RR, Narayan S, Brun AM, Suburo AM, Yorio T Effect of elevated intraocular pressure on endothelin1 in a rat model of glaucoma PHARMACOLOGICAL RESEARCH (ISSN: 10436618) 51: (1) pp. 4150. ( 2005) Folyóiratcikk [12432272]
5
W u H, Bao Y Morphologic study on trabecular meshwork after excimer laser trabecular ablation ab interno in miniature pigs Chinese Ophthalmic Research 24: (5) pp. 492495. ( 2006) Folyóiratcikk [13486507]
6
Scherer W J Effect of topical prostaglandin analog use on outcome following selective laser trabeculoplasty JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (ISSN: 10807683) 23: (5) pp. 503512. ( 2007) Folyóiratcikk [12432271]
7
Hirose A, Azuma H, Tokoro T, Hirai K EndothelinB receptors on suprachoroidal melanocytes mediate an endothelin1induced increase in the intracellular calcium concentration of rabbit ocular suprachoroidal tissue CURRENT EYE RESEARCH (ISSN: 02713683) 32: (6) pp. 585591. ( 2007) Folyóiratcikk [12432270]
8
Xiang Y, Chen ZQ, W ang RL, Xu LJ, Shi H, Chen L, Li GG, Zhang H Effects of endothelin on expression of fibronectin and collagen I in human trabecular meshwork Chinese Ophthalmic Research 28: (5) pp. 421425. ( 2010) Folyóiratcikk [13486506]
9
Xiang Y, Li B, Li GG, W ang RL, Chen ZQ, Xu LJ, Chen L, Shi H, Zhang H Effects of endothelin1 on the cytoskeleton protein Factin of human trabecular meshwork cells in vitro INTERNATIONAL JOURNAL OF OPHTHALMOLOGY (ISSN: 22223959) 3: (1) pp. 6163. ( 2010) Folyóiratcikk [12432269]
10
Rigosi E, Ensini M, Bottari D, Leone P, GalliResta L Loss of retinal capillary vasoconstrictor response to Endothelin1 following pressure increments in living isolated rat retinas EXPERIMENTAL EYE RESEARCH (ISSN: 00144835) 90: (1) pp. 3340. ( 2010) Folyóiratcikk [12432268]
11
Xiang Y, Li G, Xu L, Chen Z, W ang R, Zhang H The effect of endothelin1 on the phagocytic function of human trabecular meshwork cells in vitro Chinese Ophthalmic Research 28: (3) pp. 225230. ( 2010) Folyóiratcikk [13486505]
12
Rosenthal R, Fromm M Endothelin antagonism as an active principle for glaucoma therapy BRITISH JOURNAL OF PHARMACOLOGY (ISSN: 00071188) 162: (4) pp. 806816. ( 2011) Folyóiratcikk [12432267]
13
Choritz L, Machert M, Thieme H Correlation of endothelin1 concentration in aqueous humor with intraocular pressure in primary open angle and
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
291/342
3/30/2015
nyomtatobarat forma pseudoexfoliation glaucoma Investigative Ophthalmology and Visual Science 53: (11) pp. 73367342. ( 2012) Folyóiratcikk [13486504] 14
Shoshani YZ, Harris A, Shoja MM, Rusia D, Siesky B, Arieli Y, W irostko B Endothelin and Its Suspected Role in the P athogenesis and P ossible Treatment of Glaucoma CURRENT EYE RESEARCH (ISSN: 02713683) 37: (1) pp. 111. ( 2012) Folyóiratcikk [12432266]
435. Holló G , Lakatos P , Kóthy P Can immediate intraocular pressure elevation after argon laser trabeculoplasty be explained by acute increase of aqueous humour endothelin1 concentration? discussed poster , European Glaucoma Society 6th Congress, London , abstract book p.133 (2000) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [1759268] [Poszter] [ Admin láttamozott ] 436. Horányi J , Duffek L , Szlávik R , Pinkola K , Kemenes M , Dabasi G , Lakatos P , Tóth M , Darvas K Új intraoperatív diagnosztikus módszerek a mellékpajzsmirigysebészetben ORVOSI HETILAP 141:(Suppl 1) pp. 12491250. (2000) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2027985] M agyar Endokrinológiai és Anyagcsere Társaság, 18. Kongresszusa, M iskolcLillafüred, 2000. jún. 810. [ Admin láttamozott ] 437. Horváth C , Lakatos P , Balogh Á Ajánlás a férfiak osteoporosisának diagnosztikájára és kezelésére CA ÉS CSONT 3:(4) pp. 184185. (2000) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1807510] [ Admin láttamozott ] 438. Horváth C , Balogh Á , Bors K , Forgács S , Holló I , Lakatos P Ajánlás az osteoporosis és más anyagcserebetegségek diagnosztikájára 2001ben CA ÉS CSONT 3:(4) pp. 158166. (2000) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1807934] [ Admin láttamozott ] 439. Lakatos P , Horváth Cs , M arton I , Papp K , Poór Gy Ajánlás az involúciós osteoporosisok gyógyszeres kezelésére LEGE ARTIS MEDICINAE 10:(2) pp. 146151. (2000) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1015400] [ Admin láttamozott ] 440. Lakatos P , Horváth Cs , M arton I , Poór Gy , Holló I Ajánlás az involúciós osteoporosisok gyógyszeres kezelésére CA ÉS CSONT 3:(4) pp. 169173. (2000) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1015401] [ Admin láttamozott ] 441. Lakatos P , Foldes J , Nagy Z , Takacs I , Speer G , Horvath C , M ohan S , Baylink DJ , Stern PH Serum insulinlike growth factorI, insulinlike growth factor binding proteins, and bone mineral content in hyperthyroidism. THYROID 10:(5) pp. 417423. (2000) IF: 2.047 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1335572] GR: ETK 126/PHS HHS/United States GR: ETT 571/96/PHS HHS/United States GR: TW0016702/TW/FIC NIH HHS/United States [ Érvényesített ] Független idéző: 24 Függő idéző: 5 Összesen: 29 1
Kindblom J M, Göthe S, Forrest D, Törnell J, Vennström B, Ohlsson C GH substitution reverses the growth phenotype but not the defective ossification in thyroid hormone receptor α1/β/ mice
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
292/342
3/30/2015
nyomtatobarat forma Journal of Endocrinology (ISSN: 00220795) 171: (1) pp. 1522. ( 2001) Chemicals/CAS: Growth Hormone, 9002726; InsulinLike Growth Factor I, 67763966; Receptors, Thyroid Hormone Folyóiratcikk /Szakcikk /Tudományos [11915318] 2
Iglesias P, Bayón C, Méndez J, González Gancedo P, Grande C, Díez J J Serum insulinlike growth factor type 1, insulinlike growth factorbinding protein1, and insulinlike growth factorbinding protein3 concentrations in patients with thyroid dysfunction Thyroid (ISSN: 10507256) 11: (11) pp. 10431048. ( 2001) Folyóiratcikk /Szakcikk /Tudományos [11915317]
3
Mikosch P, ObermayerPietsch B, Jost R, Jauk B, Gallowitsch H J, Kresnik E, Leb G, Lind P Bone metabolism in patients with differentiated thyroid carcinoma receiving suppressive levothyroxine treatment Thyroid (ISSN: 10507256) 13: (4) pp. 347356. ( 2003) Chemicals/CAS: levothyroxine, 51489; osteocalcin, 136461808; thyrotropin, 9002715; Biological Markers; Estrogens; Thyroxine, 7488702 Folyóiratcikk /Szakcikk /Tudományos [11915316]
4
Krassas G E, Pontikides N, Kaltsas T, Dumas A, Frystyk J, Chen J W , Flyvbjerg A Free and total insulinlike growth factor (IGF)I, II, and IGF binding protein1, 2, and 3 serum levels in patients with active thyroid eye disease Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 88: (1) pp. 132135. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [11915315]
5
Laron Z, Özön A, Neyzi O Interactions between the thyroid hormones and the hormones of the growth hormone axis Pediatric Endocrinology Reviews 1: (SUP LL. 2) pp. 244250. ( 2003) Folyóiratcikk /Konferenciaközlemény /Tudományos [11915314]
6
Žofková I P athophysiological and Clinical Importance of InsulinLike Growth FactorI with Respect to Bone Metabolism Physiological Research (ISSN: 08628408) 52: (6) pp. 657679. ( 2003) Folyóiratcikk /Rövid közlemény /Tudományos [11915313]
7
Yoshihara HAI, Scanlan TS Selective thyroid hormone receptor modulators CURRENT TOPICS IN MEDICINAL CHEMISTRY (ISSN: 15680266) 3: (14) pp. 16011616. ( 2003) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915332]
8
Freitas FRS, Moriscot AS, Jorgetti V, Soares AG, Passarelli M, Scanlan TS, Brent GA, Bianco AC, Gouveia CHA Spared bone mass in rats treated with thyroid hormone receptor TR betaselective compound GC1 AMERICAN JOURNAL OF PHYSIOLOGYENDOCRINOLOGY AND METABOLISM (ISSN: 01931849) 285: (5) pp. E1135 E1141. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [11915331]
9
* Lakatos P Thyroid hormones: Beneficial or deleterious for bone? : P ajzsmirigyhormonok és a csont: Hasznos vagy káros? Orvoskepzes (ISSN: 00306037) 78: (1) pp. 1116. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [11915310]
10 * Lakatos P Thyroid hormones: Beneficial or deleterious for bone? Calcified Tissue International (ISSN: 0171967X) 73: (3) pp. 205209. ( 2003) Chemicals/CAS: thyrotropin, 9002715; Thyroid Hormones Folyóiratcikk /Összefoglaló cikk /Tudományos [11915311] 11
W u T J, Huang S M, Taylor R L, Kao P C Thyroxine Effects on Serum Insulinlike Growth Factor I Levels, Anthropometric Measures, and Body Composition in P atients After Thyroidectomy Annals of Clinical and Laboratory Science (ISSN: 00917370) 33: (4) pp. 423428. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [11915309]
12
Demori I, Cerdoni E, Fugassa E, Voci A 3,5Diiodothyronine mimics the effect of triiodothyronine on insulinlike growth factor binding protein4 expression in cultured rat hepatocytes Hormone and Metabolic Research (ISSN: 00185043) 36: (10) pp. 679685. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [11915308]
13
Xie Kejian, Pan Furong, Xia Yuxiang, Guan Yu Study on changes and correlation of insulinlike growth factor1 and bone mineral density in Graves disease Chinese Journal of Immunology (ISSN: 1000484X) 20: (6) pp. 433434,438. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [13159412]
14
ZimmermannBelsing T, Juul A, Juul Holst J, FeldtRasmussen U The insulinlike growth axis in patients with autoimmune thyrotoxicosis: Effect of antithyroid drug treatment Growth Hormone and IGF Research 14: (3) pp. 235244. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [11915307]
15
Peeters R P, Van Den Beld A W , Van Toor H, Uitterlinden A G, Janssen J A M J L, Lamberts S W J, Visser T J A polymorphism in type I deiodinase is associated with circulating free insulinlike growth factor I levels and body composition in humans Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 90: (1) pp. 256263. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [11915306]
16
Kindblom J M, Gevers E F, Skrtic S M, Lindberg M K, Göthe S, Törnell J, Vennström B, Ohlsson C Increased adipogenesis in bone marrow but decreased bone mineral density in mice devoid of thyroid hormone receptors Bone (ISSN: 87563282) 36: (4) pp. 607616. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [11915305]
17
Mutapcic L, W ren S M E, Leske D A, Fautsch M P, Holmes J M The effect of Lthyroxine supplementation on retinal vascular development in neonatal rats Current Eye Research (ISSN: 02713683) 30: (12) pp. 10351040. ( 2005) Chemicals/CAS: apyrase, 9000957; levothyroxine, 51489; sodium chloride, 7647145; somatomedin C, 67763966; thyrotropin, 9002715; thyroxine, 7488702; InsulinLike Growth Factor I, 67763966; Thyrotropin, 9002715; Thyroxine, 7488702 Manufacturers: Sigma, United States Folyóiratcikk /Szakcikk /Tudományos [11915304] Schenck P A
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
293/342
3/30/2015
nyomtatobarat forma 18
Calcium Homeostasis in Thyroid Disease in Dogs and Cats Veterinary Clinics of North America Small Animal Practice 37: (4) pp. 693708. ( 2007) Chemicals/CAS: calcitonin, 12321447, 21215623, 9007129; calcium, 7440702; carnitine, 461063, 541151, 5699 5; parathyroid hormone, 12584962, 68893823, 9002646; thiamazole, 60560; thyroxine, 7488702; Calcium, 7440 702 Folyóiratcikk /Összefoglaló cikk /Tudományos [11915303]
19
Ren M, Guan Q, Zhong X, Gong B, Sun Y, Xin W , Guo J, W ang H, Gao L, Zhao J P hosphatidylinositol 3kinase/nuclear factorκB signaling pathway is involved in the regulation of IGF1 on Fasassociated death domainlike interleukin1converting enzymeinhibitory protein expression in cultured FRTL thyroid cells Journal of Molecular Endocrinology (ISSN: 09525041) 38: (56) pp. 619625. ( 2007) Chemicals/CAS: 2 morpholino 8 phenylchromone, 154447366; DNA, 9007492; phosphatidylinositol 3 kinase, 115926 528; somatomedin C, 67763966; 1Phosphatidylinositol 3Kinase, EC 2.7.1.137; CASP8 and FADDLike Apoptosis Regulating Protein; Caspase 1, EC 3.4.22.36; FasAssociated Death Domain Protein; InsulinLike Growth Factor I, 67763 966; NFkappa B Folyóiratcikk /Szakcikk /Tudományos [11915302]
20
W exler J A, Sharretts J Thyroid and Bone Endocrinology and Metabolism Clinics of North America (ISSN: 08898529) 36: (3) pp. 673705. ( 2007) Chemicals/CAS: alcohol, 64175; alkaline phosphatase, 9001789; interleukin 8, 114308917; iodine 131, 10043660, 15124397; levothyroxine, 51489; liothyronine, 6138472, 6893023; osteoclast differentiation factor, 200145933; osteoprotegerin, 205944509; somatomedin C, 67763966; thiamazole, 60560; thyrotropin, 9002715; thyroxine deiodinase, 70712468; Diphosphonates; Iodine Radioisotopes; Receptors, Thyroid Hormone; Thyroxine, 7488702 Folyóiratcikk /Összefoglaló cikk /Tudományos [11915301]
21
Karasik D, Ferrari S L Contribution of genderspecific genetic factors to osteoporosis risk Annals of Human Genetics (ISSN: 00034800) 72: (5) pp. 696714. ( 2008) Chemicals/CAS: Gonadal Steroid Hormones; IL6 protein, human; Interleukin6; LDLReceptor Related Proteins; lipoprotein receptor related protein 5; Receptors, Estrogen Folyóiratcikk /Összefoglaló cikk /Tudományos [11915300]
22 * Stern PH Thyroid Hormone and Bone In: Principles of Bone Biology , TwoVolume Set. Elsevier Inc., 2008. (ISBN 9780123738844) pp. 935954.
Könyvrészlet /Könyvfejezet /Tudományos [13339355] 23
Karasik D, Kiel DP Genetics of Osteoporosis in Older Age In: Duque G, Kiel DP (szerk.) : Osteoporosis in Older Persons. London: Springer Verlag, 2009. (ISBN 9781846285158) pp. 8296.
Könyvrészlet /Könyvfejezet /Tudományos [11915330] 24
Akin F, Yaylali G F, Turgut S, Kaptanoglu B Growth hormone/insulinlike growth factor axis in patients with subclinical thyroid dysfunction Growth Hormone and IGF Research 19: (3) pp. 252255. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11915299]
25
Pepene C E, Seck T, Diel I, Minne H W , Ziegler R, Pfeilschifter J Effect of glucocorticoid, parathyroid and thyroid hormones excess on human iliac crest bone matrix insulinlike growth factor (IGF)I in patients with osteoporosis Experimental and Clinical Endocrinology and Diabetes 118: (5) pp. 310314. ( 2010) Chemicals/CAS: parathyroid hormone, 12584962, 68893823, 9002646; prednisone, 53032; somatomedin C, 67763 966; thyrotropin, 9002715; thyroxine, 7488702; Glucocorticoids; InsulinLike Growth Factor I, 67763966; Parathyroid Hormone; Prednisone, 53032; Thyroid Hormones Folyóiratcikk /Szakcikk /Tudományos [11915298]
26 * Linares G R, Xing W , Burghardt H, Baumgartner B, Chen S T, Ricart W , FernándezReal J M, Zorzano A, Mohan S Role of diabetes and obesityrelated protein in the regulation of osteoblast differentiation American Journal of Physiology Endocrinology and Metabolism 301: (1) pp. E40E48. ( 2011) Chemicals/CAS: alkaline phosphatase, 9001789; beta tubulin, 87090366; osteocalcin, 136461808; Nuclear Proteins; Osteocalcin, 104982038; RNA, Small Interfering; TP53INP2 protein, human Folyóiratcikk /Szakcikk /Tudományos [11915297] 27
Behan L A, Monson J P, Agha A The interaction between growth hormone and the thyroid axis in hypopituitary patients Clinical Endocrinology (ISSN: 03000664) 74: (3) pp. 281288. ( 2011) Chemicals/CAS: growth hormone, 36992731, 37267053, 66419509, 9002726; liothyronine, 6138472, 6893023; thyrotropin, 9002715; thyroxine, 7488702; Human Growth Hormone, 12629015; Thyroxine, 7488702; Triiodothyronine, 6893023 Folyóiratcikk /Összefoglaló cikk /Tudományos [11915296]
28
Song Delu, W ang Renyan, Zhong Yong, Li W eiye, Li Hui, Dong Fangtian Locally produced insulinlike growth factor1 by orbital fibroblasts as implicative pathogenic factor rather than systemically circulated IGF1 for patients with thyroidassociated ophthalmopathy GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (ISSN: 0721832X) 250: (3) pp. 433440. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12426379]
29 * Mohan S, Kesavan C Role of insulinlike growth factor1 in the regulation of skeletal growth Current Osteoporosis Reports 10: (2) pp. 178186. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13339354]
442. Lakatos P , Nagy Z , Kiss L , Horvath C , Takacs I , Foldes J , Speer G , Bossanyi A Prevention of corticosteroidinduced osteoporosis by alfacalcidol ZEITSCHRIFT FÜR RHEUMATOLOGIE 59:(Suppl. 1) pp. I/48I/52. (2000) IF: 0.730 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1335573] [ Érvényesített ] Független idéző: 41 Összesen: 41 https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
294/342
3/30/2015
nyomtatobarat forma 1
Clowes JA, Peel N, Eastell R Glucocorticoidinduced osteoporosis CURRENT OPINION IN RHEUMATOLOGY (ISSN: 10408711) 13: (4) pp. 326332. ( 2001) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915553]
2
Kumar R Glucocorticoidinduced osteoporosis CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (ISSN: 10624821) 10: (5) pp. 589595. ( 2001) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915554]
3
Kochetkova EA, Geltser BL Alphacalcidol in the treatment of osteopenic syndrome in patients with bronchial asthma TERAPEVTICHESKII ARKHIV (ISSN: 00403660) 74: (3) pp. 3235. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11915552]
4
Sasaki N, Kusano E, Ando Y, Nemoto J, Iimura O, Ito C, Takeda S, Yano K, Tsuda E, Asano Y Changes in osteoprotegerin and markers of bone metabolism during glucocorticoid treatment in patients with chronic glomerulonephritis BONE (ISSN: 87563282) 30: (6) pp. 853858. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11915551]
5
Sato S, Ohosone Y, Suwa A, Yasuoka H, Nojima T, Fujii T, Kuwana M, Nakamura K, Mimori T, Hirakata M Effect of intermittent cyclical etidronate therapy on corticosteroid induced osteoporosis in Japanese patients with connective tissue disease: 3 year Followup JOURNAL OF RHEUMATOLOGY (ISSN: 0315162X) 30: (12) pp. 26732679. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [11915550]
6
LafageProust MH, Boudignon B, Thomas T Glucocorticoidinduced osteoporosis: pathophysiological data and recent treatments JOINT BONE SPINE (ISSN: 1297319X) 70: (2) pp. 109118. ( 2003) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915549]
7
LafageProust MH, Boudignon B, Thomas T Glucocorticoidinduced osteoporosis: P athophysiological data and recent treatments Revue du Rhumatisme (Edition Francaise) 70: (3) pp. 217227. ( 2003) Folyóiratcikk /Összefoglaló cikk /Tudományos [13342053]
8
Richy F, Ethgen O, Bruyere O, Reginster JY Efficacy of alphacalcidol and calcitriol in primary and corticosteroidinduced osteoporosis: a metaanalysis of their effects on bone mineral density and fracture rate OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 15: (4) pp. 301310. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [11915548]
9
Ringe JD, Schacht E P revention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol RHEUMATOLOGY INTERNATIONAL (ISSN: 01728172) 24: (4) pp. 189197. ( 2004) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915547]
10
de Nijs RNJ, Jacobs JW G, Algra A, Lems W F, Bijlsma JW J P revention and treatment of glucocorticoidinduced osteoporosis with active vitamin D3 analogues: a review with meta analysis of randomized controlled trials including organ transplantation studies OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 15: (8) pp. 589602. ( 2004) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915546]
11
Ringe JD, Dorst A, Faber H, Schacht E, Rahlfs VW Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoidinduced osteoporosis RHEUMATOLOGY INTERNATIONAL (ISSN: 01728172) 24: (2) pp. 6370. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [11915545]
12
Ringe JD, Faber H, Fahramand P, Schacht E Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammationinduced osteoporosis Journal of Rheumatology (ISSN: 0315162X) 32: (SUP P L. 76) pp. 3340. ( 2005) Folyóiratcikk /Konferenciaközlemény /Tudományos [13342052]
13
Richy F, Deroisy R, Lecart MP, Hanssens L, Mawet A, Reginster JY DHormone analog alfacalcidol: an update on its role in postmenopausal osteoporosis and rheumatoid arthritis management AGING CLINICAL AND EXPERIMENTAL RESEARCH (ISSN: 15940667) 17: (2) pp. 133142. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [11915544]
14
Reginster JY, Lecart MP, Richy F Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss JOURNAL OF RHEUMATOLOGY (ISSN: 0315162X) 32: pp. 2125. ( 2005) SU: 76 Folyóiratcikk /Konferenciaközlemény /Tudományos [11915543]
15
Orimo H, Schacht E The Dhormone analog alfacalcidol: The pioneer beyond the horizon of osteoporosis treatment Journal of Rheumatology (ISSN: 0315162X) 32: (SUP P L. 76) pp. 410. ( 2005) Folyóiratcikk /Konferenciaközlemény /Tudományos [13342051]
16
Schacht E, Richy F, Reginster JY The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures Journal of Musculoskeletal Neuronal Interactions 5: (3) pp. 273284. ( 2005) Folyóiratcikk /Összefoglaló cikk /Tudományos [13342050]
17
Richy F, Schacht E, Bruyere O, Ethgen O, Gourlay M, Reginster JY Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosisrelated fractures: A comparative meta analysis CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 76: (3) pp. 176186. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [11915542]
18
Schacht E, Dukas L, Richy F Combined therapies in osteoporosis: Bisphosphonates and Vitamin Dhormone analogs Journal of Musculoskeletal Neuronal Interactions 7: (2) pp. 174184. ( 2007)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
295/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Összefoglaló cikk /Tudományos [13342049] 19
Farinotti M, Simi S, Di Pietrantonj C, McDowell N, Brait L, Lupo D, Filippini G Dietary interventions for multiple sclerosis COCHRANE DATABASE OF SYSTEMATIC REVIEWS (ISSN: 1469493X) 1: (1) P aper CD004192. (2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915541]
20
Iwamoto J, Seki A, Takeda T, Yamada H, Sato Y, Yeh JK Effects of alfacalcidol on cancellous and cortical bone mass in rats treated with glucocorticoid: A bone histomorphometry study JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY (ISSN: 03014800) 53: (3) pp. 191197. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [11915540]
21
Compston JE Emerging consensus on prevention and treatment of glucocorticoidinduced osteoporosis Current Rheumatology Reports (ISSN: 15233774) 9: (1) pp. 7884. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [13342048]
22
Kanis JA, Stevenson M, McCloskey EV, Davis S, LloydJones M Glucocorticoidinduced osteoporosis: a systematic review and costutility analysis HEALTH TECHNOLOGY ASSESSMENT (ISSN: 13665278) 11: (7) pp. 1+. ( 2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915539]
23
Ringe JD, Schacht E Improving the outcome of established therapies for osteoporosis by adding the active Dhormone analog alfacalcidol RHEUMATOLOGY INTERNATIONAL (ISSN: 01728172) 28: (2) pp. 103111. ( 2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915538]
24
Jacobs JW G, de Nijs RNJ, Lems W F, Geusens PPMM, Laan RFJ, Huisman AM, Algra A, Buskens E, Hofbauer LC, Oostveen ACM, Bruyn GAW , Dijkmans BAC, Bijlsma JW J P revention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: Relations of change in bone mineral density, bone markers, and calcium homeostasis JOURNAL OF RHEUMATOLOGY (ISSN: 0315162X) 34: (5) pp. 10511057. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [11915537]
25
Sewerynek E, Bajon K, Stuss M Secondary osteoporosis during longterm steroid treatment Przeglad Menopauzalny (ISSN: 16438876) 6: (6) pp. 336343. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [13342047]
26
Nicholas RS, Friede T, Hollis S, Young CA Anticholinergics for urinary symptoms in multiple sclerosis COCHRANE DATABASE OF SYSTEMATIC REVIEWS (ISSN: 1469493X) 1: (1) P aper CD004193. (2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915536]
27
Panopalis P, Yazdany J Bone health in systemic lupus erythematosus Current Rheumatology Reports (ISSN: 15233774) 11: (3) pp. 177184. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [13342046]
28
Polosa R, Benfatto GT Managing patients with chronic severe asthma: Rise to the challenge EUROPEAN JOURNAL OF INTERNAL MEDICINE (ISSN: 09536205) 20: (2) pp. 114124. ( 2009) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915535]
29
Ringe JD, Schacht E P otential of alfacalcidol for reducing increased risk of falls and fractures RHEUMATOLOGY INTERNATIONAL (ISSN: 01728172) 29: (10) pp. 11771185. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11915534]
30
Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W L, Curtis JR, Furst DE, McMahon M, Patkar NM, Volkmann E, Saag KG American College of Rheumatology 2010 Recommendations for the P revention and Treatment of GlucocorticoidInduced Osteoporosis ARTHRITIS CARE & RESEARCH (ISSN: 2151464X) 62: (11) pp. 15151526. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [11915533]
31
Jagannath VA, Fedorowicz Z, Asokan GV, Robak EW , W hamond L Vitamin D for the management of multiple sclerosis COCHRANE DATABASE OF SYSTEMATIC REVIEWS (ISSN: 1469493X) &: (12) P aper CD008422. (2010) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915532]
32
Sewerynek E Current indications for prevention and therapy of steroidinduced osteoporosis in men and women ENDOKRYNOLOGIA POLSKA (ISSN: 0423104X) 62: (1) pp. 3844. ( 2011) : F N Thomson Reuters W eb of Knowledge Folyóiratcikk /Összefoglaló cikk /Tudományos [11915531]
33
Ringe JD, Schacht E, Dukas L, Mazor Z P otency of a combined alfacalcidolalendronate therapy to reduce the risk of falls and fractures in elderly patients with glucocorticoidinduced osteoporosis ARZNEIMITTELFORSCHUNGDRUG RESEARCH 61: (2) pp. 104111. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [11915530]
34
Bjelakovic G, Gluud LL, Nikolova D, W hitfield K, W etterslev J, Simonetti RG, Bjelakovic M, Gluud C Vitamin D supplementation for prevention of mortality in adults COCHRANE DATABASE OF SYSTEMATIC REVIEWS (ISSN: 1469493X) &: (7) P aper CD007470. (2011) Folyóiratcikk /Összefoglaló cikk /Tudományos [11915529]
35
Lekamwasam S, Adachi J D, Agnusdei D, Bilezikian J, Boonen S, Borgstrom F, Cooper C, Diez Perez A, Eastell R, Hofbauer L C, Kanis J A, Langdahl B L, Lesnyak O, Lorenc R, McCloskey E, Messina O D, Napoli N, ObermayerPietsch B, Ralston S H, Sambrook P N, Silverman S, Sosa M, Stepan J, Suppan G, W ahl D A, Compston J E A framework for the development of guidelines for the management of glucocorticoidinduced osteoporosis OSTEOPOROSIS INTERNATIONAL (ISSN: 0937941X) 23: (9) pp. 22572276. ( 2012) CA Joint IOFECTS GIO Guidelines W ork Folyóiratcikk /Szakcikk /Tudományos [13159562]
36
Clarke Bart L
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
296/342
3/30/2015
nyomtatobarat forma CorticosteroidInduced Osteoporosis An Update for Dermatologists AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (ISSN: 11750561) 13: (3) pp. 167190. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13159561] 37
Farinotti Mariangela, Vacchi Laura, Simi Silvana, Di Pietrantonj Carlo, Brait Lorenzo, Filippini Graziella Dietary interventions for multiple sclerosis COCHRANE DATABASE OF SYSTEMATIC REVIEWS (ISSN: 1469493X) §: (12) P aper CD004192. (2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13159560]
38
Gröber U, Kisters K Influence of drugs on vitamin D and calcium metabolism DermatoEndocrinology 4: (2) pp. 158166. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13342045]
39
Rianthavorn Pornpimol, Pisutikul Kantima, Deekajorndech Tawatchai, Tepmongkol Supatporn, Suphapeetiporn Kanya P revention of bone loss in children receiving longterm glucocorticoids with calcium and alfacalcidol or menatetrenone JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM 25: (34) pp. 307312. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13159559]
40
Dionyssiotis Y Body composition in multiple sclerosis HIPPOKRATIA (ISSN: 11084189) 17: (1) pp. 711. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13342039]
41
W irth R, Dziewas R, Jäger M, W arnecke T, Smoliner C, Stingel K, Leischker AH Guideline of the German society for nutritional medicine (DGEM) in cooperation with the GESKES, the AKE, the DGN and the DGG: Clinical nutrition in neurology P art of the ongoing S3guideline project clinical nutrition Aktuelle Ernahrungsmedizin (ISSN: 03410501) 38: (4) pp. e49e89. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13342044]
443. Lakatos P A növekedési faktorok és a D vitamin hatása az ovárium endokrin funkciójára In: Paulin F , Szendei Gy (szerk.) Hyperandrogen állapotok korszerű szemlélete: A M agyar Szülészeti és Nőgyógyászati Endokrinológiai Társaság kiadványa . Budapest: M agyar Szülészeti és Nőgyógyászati Endokrinológiai Társaság, 2000. pp. 107115. Nyelv: Magyar
Könyvrészlet /Könyvfejezet /Tudományos [1799340] [ Admin láttamozott ] 444. Lakatos P Az oszteoporózis diagnosztikája és kezelése MAGYAR EGÉSZSÉGPIAC 3:(3) pp. 7984. (2000) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1974360] [ Admin láttamozott ] 445. Lakatos P Az orvoslás molekuláris genetikai forradalma ORVOSTOVÁBBKÉPZŐ SZEMLE 7:(5) pp. 1215. (2000) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1974369] [ Admin láttamozott ] 446. Lakatos PL , Firneisz G , Lakatos P , Horváth Cs , Szalay F A csont ásványianyagtartalmának utánkövetéses vizsgálata posztmenopauzális primer biliaris cirrhosisos nőbetegekben. CA ÉS CSONT 3:(SUPPL 1) p. S9. (2000) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1391673] [ Admin láttamozott ] 447. M ucsi I , Deak G , Tisler A , Berta K , Kiss I , Almasi Cs , Ambrus Cs , Szabo A , de Chatel R , Lakatos P Vitamin D receptor polymorphism and serum markers of bone metabolism in patients on maintenance hemodialysis NEPHROLOGY DIALYSIS TRANSPLANTATION 15:(9) p. A47. (2000) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1120077] [ Érvényesített ] 448. M ucsi I , Almási C , Deák Gy , Tislér A , Speer G , de Chatel R , Lakatos P , Horváth Cs Serum 25(OH) Vitamin D levels correlate with bone mineral density (BM D) and broad band ultrasound attenuation (BUA) in patients on maintenance hemodialysis JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 11: p. 580. (2000) Nyelv: Angol https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
297/342
3/30/2015
nyomtatobarat forma
Folyóiratcikk /Absztrakt /Tudományos [2079881] [ Admin láttamozott ] 449. Nagy Z , Speer G , Cseh K , M ohari K , Jánoki G , Takács I , Horváth C , Földes J , Lakatos P Tumornekrózisfaktoralfatermelés és a csont ásványianyagtartalma hyperthyreosisban CA ÉS CSONT 3:(1) pp. 1115. (2000) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1335662] [ Érvényesített ] 450. Speer G , Deak G , Tisler A , Berta K , Kiss I , Almasi Cs , Rosivall L , de Chatel R , Lakatos P , M ucsi I Polymorphism of the estrogen receptor in patients on maintenance hemodialysis NEPHROLOGY DIALYSIS TRANSPLANTATION 15:(9) p. A48. (2000) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1120074] [ Érvényesített ] 451. Speer G , Dworak O , Cseh K , Bori Z , Salamon D , Torok I , Winkler G , Vargha P , Nagy Z , Takacs I , Kucsera M , Lakatos P Vitamin D receptor gene BsmI polymorphism correlates with erbB2/HER2 expression in human rectal cancer ONCOLOGY 58:(3) pp. 242247. (2000) IF: 2.584 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1335574] CI: Copyright 2000 S. Karger AG, Basel [ Érvényesített ] Független idéző: 21 Függő idéző: 3 Összesen: 24 1
2
Parodi PW An assessment of the evidence linking calcium and vitamin D to colon cancer prevention AUSTRALIAN JOURNAL OF DAIRY TECHNOLOGY (ISSN: 00049433) 56: (1) pp. 3858. ( 2001) Folyóiratcikk /Szakcikk /Tudományos [11617153] * Speer G, Cseh K, Fuszek P, Dworak O, Vargha P, Takács I, Nagy Zs, Lakatos P Ösztrogén, Dvitamin és kálciumérzékelő receptorok genotípusainak szerepe a colorectális daganatok patogenezisében ORVOSI HETILAP (ISSN: 00306002) 142: (18) pp. 947951. ( 2001) Folyóiratcikk /Szakcikk /Tudományos [11617157]
3
Gomez C, Naves M, Fernandez JL, Diaz C, Cannata JB P athophisiology and general population data NEFROLOGIA (ISSN: 02116995) 21: (suppl. 1) pp. 4550. ( 2001) SU: 1 Folyóiratcikk /Szakcikk /Tudományos [11915745]
4
Grant W B An estimate of premature cancer mortality in the US due to inadequate doses of solar ultravioletB radiation CANCER (ISSN: 0008543X) 94: (6) pp. 18671875. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11617151]
5
Ylikomi T, Laaksi I, Lou YR, Martikainen P, Miettinen S, Pennanen P, Purmonen S, Syvala H, Vienonen A, Tuohimaa P Antiproliferative action of vitamin D VITAMINS AND HORMONES ADVANCES IN RESEARCH AND APPLICATIONS, VOL 64 64: pp. 357406. ( 2002) Folyóiratcikk /Összefoglaló cikk /Tudományos [11617150]
6
Gyorffy B, Vasarhelyi B, Krikovszky D, Madacsy L, Tordai A, Tulassay T, Szabo A Genderspecific association of vitamin D receptor polymorphism combinations with type 1 diabetes mellitus EUROPEAN JOURNAL OF ENDOCRINOLOGY (ISSN: 08044643) 147: (6) pp. 803808. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11617149]
7
* Melczer Z, Banhidy F, Csomor S, Siklos P, Dworak O, Cseh K ErbB2/HER2 protein expression, serum tumour necrosis factoralpha (TFMalpha) and soluble tumour necrosis factor receptor 2 (TNFR2) concentrations in human carcinoma of the uterine cervix EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY (ISSN: 03922936) 24: (2) pp. 138142. ( 2003) Folyóiratcikk /Konferenciaközlemény /Tudományos [11617148]
8
* Fuszek P, Lakatos P, Tabak A, Papp J, Nagy Z, Takacs I, Horvath H C, Lakatos P L, Speer G Relationship between serum calcium and CA 199 levels in colorectal cancer World Journal of Gastroenterology (ISSN: 10079327) 10: (13) pp. 18901892. ( 2004) Chemicals/CAS: 25 hydroxyvitamin D, 64719499; calcium ion, 14127618; calcium, 7440702; phosphate, 14066194, 14265442; CA199 Antigen; Calcium, 7440702; Receptors, CalciumSensing; Tumor Markers, Biological Folyóiratcikk /Szakcikk /Tudományos [11617156]
9
Uitterlinden AG, Fang Y, van Meurs JBJ, Pols HAP Genetic Vitamin D Receptor P olymorphisms and Risk of Disease In: Vitamin D. (2) Elsevier Inc., 2005. (ISBN 9780122526879) pp. 11211157.
Könyvrészlet /Könyvfejezet /Tudományos [13816595] 10
van Leeuwen JPTM, Pols HAP Vitamin D: Cancer and Differentiation In: Vitamin D. (2) Elsevier Inc., 2005. (ISBN 9780122526879) pp. 15711597.
Könyvrészlet /Könyvfejezet /Tudományos [13816594] 11
Plant A S, Tisman G Frequency of combined deficiencies of vitamin D and holotranscobalamin in cancer patients Nutrition and Cancer 56: (2) pp. 143148. ( 2006)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
298/342
3/30/2015
nyomtatobarat forma Chemicals/CAS: 25 hydroxyvitamin D, 64719499; cyanocobalamin, 53570766, 68199, 8064093; Biological Markers; Transcobalamins; Vitamin B 12, 68199; Vitamin D, 1406162; Vitamins Folyóiratcikk /Szakcikk /Tudományos [11617155] 12
Zhou W , Heist R S, Liu G, Neuberg D S, Asomaning K, Su L, W ain J C, Lynch T J, Giovannucci E, Christiani D C P olymorphisms of vitamin D receptor and survival in earlystage nonsmall cell lung cancer patients Cancer Epidemiology Biomarkers and Prevention 15: (11) pp. 22392245. ( 2006) Chemicals/CAS: Receptors, Calcitriol; Vitamin D, 1406162 Folyóiratcikk /Szakcikk /Tudományos [11617154]
13
Valdivielso JM, Fernandez E Vitamin D receptor polymorphisms and diseases CLINICA CHIMICA ACTA (ISSN: 00098981) 371: (12) pp. 112. ( 2006) Folyóiratcikk /Összefoglaló cikk /Tudományos [11617147]
14
RodriguezBores L, BarahonaGarrido J, YamamotoFurusho JK Basic and clinical aspects of asteoporosis in inflammatory bowed disease WORLD JOURNAL OF GASTROENTEROLOGY (ISSN: 10079327) 13: (46) pp. 61566165. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [11617146]
15
Zhou W , Heist RS, Christiani DC Lung cancer survival: Vitamin D could be just a marker of physical fitness Reply JOURNAL OF CLINICAL ONCOLOGY (ISSN: 0732183X) 25: (34) pp. 55385539. ( 2007) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [11617145]
16
Mullin GE, Dobs A Vitamin D and its role in cancer and immunity: A prescription for sunlight NUTRITION IN CLINICAL PRACTICE (ISSN: 08845336) 22: (3) pp. 305322. ( 2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [11617144]
17
Parisi E, Rene JM, Cardus A, Valcheva P, PinolFelis C, Valdivielso JM, Fernandez E Vitamin D receptor levels in colorectal cancer P ossible role of BsmI polymorphism JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (ISSN: 09600760) 111: (12) pp. 8790. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [11617143]
18
Dogan I, Onen HI, Yurdakul AS, Konac E, Ozturk C, Varol A, Ekmekci A P olymorphisms in the vitamin D receptor gene and risk of lung cancer MEDICAL SCIENCE MONITOR 15: (8) pp. BR232BR242. ( 2009) Folyóiratcikk /Szakcikk /Tudományos [11617142]
19
Van Leeuwen JPTM, Van Driel M, Feldman D, Muñoz A Vitamin D: Cancer and differentiation In: Vitamin D. Elsevier Inc., 2011. (ISBN 9780123819789) pp. 15911624.
Könyvrészlet /Könyvfejezet /Tudományos [13816593] 20
Khanh VQL, Lan THN Role of the Vitamin D in Leprosy AMERICAN JOURNAL OF THE MEDICAL SCIENCES (ISSN: 00029629) 343: (6) pp. 471482. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12431882]
21
Zöld E, Bodolay E, Zeher M, Barta Z The role of vitamin D in . Gastrointestinal diseases: A Dvitamin szerepe gastrointestinal is kórképekben Lege Artis Medicinae (ISSN: 08664811) 22: (5) pp. 337344. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12661894]
22
Pešta M Vitamin D receptor gene polymorphism: P olymorfizmus genu pro receptor vitaminu D Vnitrni Lekarstvi (ISSN: 0042773X) 58: (5) pp. 381385. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12661893]
23
Luong KVQ, Nguyen LTH The roles of vitamin D in seborrhoeic keratosis: P ossible genetic and cellular signalling mechanisms International Journal of Cosmetic Science (ISSN: 01425463) 35: (6) pp. 525531. ( 2013) Folyóiratcikk /Tudományos [13816592]
24
Perna L, Hoffmeister M, Schöttker B, Arndt V, Haug U, Holleczek B, Burwinkel B, OrdóñezMena JM, Brenner H Vitamin D receptor polymorphism and colorectal cancerspecific and allcause mortality Cancer Epidemiology (ISSN: 18777821) 37: (6) pp. 905907. ( 2013) Folyóiratcikk /Tudományos [13816591]
452. Speer G , Lakatos P A Dvitamin és a kalcium szerepe a tumorgenezis gátlásában CA ÉS CSONT 3:(2) pp. 5356. (2000) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [1335663] [ Érvényesített ] 453. Speer G , Lakatos P , Winkler G , Takács I , Braun E , Cseh K Dvitamin és ösztrogénreceptor genotipusok 2es típusú diabetes mellitusban és obesitásban, összefüggés az inzulinszekrécióval DIABETOLOGIA HUNGARICA 8:(Suppl. 1) p. 85. (2000) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1724576] [ Admin láttamozott ] 454. Speer G , Cseh K , Vargha P , Takács I , Winkler G , Lakatos P Ösztrogénreceptor, Dvitamin receptor és kalcium sensing receptor genotipusok szerepe a colorectalisdaganatok https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
299/342
3/30/2015
nyomtatobarat forma
patogenezisében. MAGYAR BELORVOSI ARCHIVUM LIII:(S3) p. 141. (2000) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1818575] [ Admin láttamozott ] 455. Szűcs J , Bálint G , Genti G , Szathmári M , Balogh Á , Bors K , Bossányi K , de Chatel R , Forgács S , Holló I , Horváth C , Lakatos P , M arton I , Pap K , Poór Gy , Szekeres L , Tamási L Ajánlás a szekunder osteoporosisok és más calcipeniás osteopathiák diagnosztikájára és kezelésére CA ÉS CSONT 3:(4) pp. 175181. (2000) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1808015] [ Admin láttamozott ] 456. I Takács , É Bajnok , Zs Nagy , G Speer , M Kucsera , L Kiss , Z Bori , Cs Horváth , P Lakatos Lack of association between IL1RA gene polymorphism and bone density in Hungarian postmenopausal women OSTEOPOROSIS INTERNATIONAL 11:(Suppl. 2) p. S149. (2000) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1822298] [ Érvényesített ] 457. Takács I , Bajnok Z , Nagy Z , Speer G , Kucsera M , Kiss L , Bori Z , Horváth Cs , Lakatos P Lack of association between IL1RA gene polymorphism and bone density in Hungarian postmenopausal women IOF, Chichago (2000) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434063] poszter [ Admin láttamozott ] 458. Tislér A , Deák Gy , Szabó A , Lakatos P , Horváth Cs , Ambrus C , Almási C , Kocsis I , Karim RM ; Berta K , de Chatel R , M ucsi I Serum markers of bone metabolism and bone mineral density (BM D) in patients on maintenance hemodialysis JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 11: p. 556. (2000) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [2079733] [ Admin láttamozott ]
1999 459. Bálint G , Bors K , Szekeres L , Balogh Á , Bossányi K , de Chatel R , Forgács S , Genti G , Holló I , Horváth C , Lakatos P , M arton I , Pap K , Poór Gy , Szathmári M , Szűcs J , Tamási L Ajánlás az osteoporosis mozgásprevenciójára, fizioterápiájára és az osteoporosisos betegek rehabilitációjára CA ÉS CSONT 2: pp. 161163. (1999) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1808062] [ Admin láttamozott ] 460. I Barna , P Lakatos , M Szathmári , A Keszei , P Kempler , R de Chatel Diurnal blood pressure variability and serum PTH level EUROPEAN JOURNAL OF MEDICAL RESEARCH 16:(Suppl 1) p. S85. (1999) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1761215] [ Admin láttamozott ] 461. Barna I , Varadi A , Lakatos P M etabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment. JOURNAL OF INTERNAL MEDICINE 245:(3) pp. 311313. (1999) Nyelv: Angol
Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [1593241] COM M ENT: J Intern M ed. 1998 Sep;244(3):2419. PM ID: 9747747 [ Érvényesített ] 462. Z Bori , G Speer , I Takács , Zs Nagy , Cs Horváth , P Lakatos https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
300/342
3/30/2015
nyomtatobarat forma
Interactive effect of vitamin D and estradiol receptor genotypes as a determinant of bone mineral density JOURNAL OF BONE AND MINERAL RESEARCH 14:(Suppl. 1) p. S333. (1999) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1822283] [ Érvényesített ] 463. Bori Z , Speer G , Takács I , Nagy Z , Horváth Cs , Lakatos P Interactive effect of vitamin D and estradiol receptor genotypes as a determinent of bone mineral density ASBM R Kongresszus, St. Louis (1999) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434055] poszter [ Admin láttamozott ] 464. de Chatel R , Szűcs J , Tamási L , Bálint G , Balogh Á , Bors K , Bossányi K , Forgács S , Genti G , Holló I , Horváth C , Lakatos P , M arton I , Pap K , Poór Gy , Szathmári M , Szekeres L Ajánlás a renalis osteodystrophia diagnosztikájára és kezelésére CA ÉS CSONT 2:(4) pp. 157158. (1999) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1808092] [ Admin láttamozott ] 465. Csupor E , Győri G , Lakatos P , M ajor A , Horváth C Családfakutatás és csontanyagcserevizsgálatok pseudopseudohypoparathyreosisban CA ÉS CSONT 2:(3) pp. 9399. (1999) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1808216] [ Admin láttamozott ] 466. Fischer M , Lakatos P A Dvitamin hiányról MEDICUS ANONYMUS 7:(6) p. 29. (1999) Nyelv: Magyar
Folyóiratcikk /Ismertetés /Tudományos [1808256] [ Admin láttamozott ] 467. Holló G , Lakatos P , Vargha P Immediate increase of aqueous humour endothelin1 concentration and intraocular pressure after argon laser trabeculoplasty in the rabbit XII Congress, European Society of Ophthalmology, Stockholm, Sweden , Abstract book p. 168 (SP296). (1999) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [1759260] [Előadás] [ Admin láttamozott ] 468. Holló G , Lakatos P , Vargha P Immediate increase of aqueous humour endothelin1 concentration after argon laser trabeculoplsaty is associated with biphasic intraocular pressure response in the rabbit Deutschen Ophthalmologischen Gesellschaft, Berlin , 2226 Sept., 1999 (1999) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [1759263] [Előadás] [ Admin láttamozott ] 469. Holló G , Lakatos P , Vargha P Immediate increase of aqueous humour endothelin1 concentration after argon laser trabeculoplsaty is associated with biphasic intraocular pressure response in the rabbit OPHTHALMOLOGE 96(S1): Paper S55. (1999) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1881406] (abstract) https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
301/342
3/30/2015
nyomtatobarat forma
[ Admin láttamozott ] 470. Horányi J , Horváth Cs , Lakatos P , Szathmári M , Forgács A , Szlávik R , Szűcs J , Flautner L Az osteoporosisszűrés jelentősége a primer hyperparathyreosisban szenvedők felismerésében. CA ÉS CSONT 2:(3) pp. 109112. (1999) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1323621] [ Érvényesített ] Független idéző: 1 Függő idéző: 1 Összesen: 2 1
Kovács L, Vörös A, Kovács G L, Papp P, Kiss J, Hubina E, Szabolcs I, Góth M A primer hyperparathyreosis diagnosztikája és kezelése. Tíz év tapasztalata a Semmelweis Egyetem Egészségtudományi Karán CA ÉS CSONT (ISSN: 14186721) 4: (4) pp. 152159. ( 2001) Folyóiratcikk /Szakcikk /Tudományos [12498713]
2 * Szabó P, Tóth M, Horányi J, Rácz K, Gláz E, Tulassay Zs Kettős energiájú röntgenabsorptiometriás és kvantitatív ultrahangosteodensitometriás vizsgálatok primer hyperparathyreosisban ORVOSI HETILAP (ISSN: 00306002) 142: pp. 22512254. ( 2001) Folyóiratcikk [12498710]
471. Horváth C , Balogh Á , Lakatos P Ajánlás a férfiak osteoporosisának diagnosztikájára és kezelésére CA ÉS CSONT 2:(4) pp. 159160. (1999) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1808065] [ Admin láttamozott ] 472. Horváth C , Balogh Á , Bors K , Forgács S , Lakatos P Ajánlás az osteoporosis és más anyagcserebetegségek diagnosztikájára CA ÉS CSONT 2:(4) pp. 135143. (1999) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1808196] [ Admin láttamozott ] 473. Horváth C , Krasznai I , Lakatos P , Szűcs J , M észáros S , Bors K , Hosszú É Az alkaron végzett csontsűrűségmérés módszereinek összehasonlító vizsgálata MAGYAR BELORVOSI ARCHIVUM 52:(2) pp. 163168. (1999) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1808220] [ Admin láttamozott ] 474. Horváth Cs , Bors K , Boros E , Lakatos P , Szűcs J , M észáros Sz Bone mineral density in patients 2 years after stroke JOURNAL OF BONE AND MINERAL RESEARCH 14:(Suppl. 1) p. S514. (1999) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [2074744] [ Érvényesített ] 475. I Barna , P Lakatos , M Szathmári , A Keszei , P Kempler , R de Châtel DIURNAL BLOOD PRESSURE VARIABILITY AND SERUM PTH LEVEL EUROPEAN JOURNAL OF INTERNAL MEDICINE 10:(Suppl.1) p. 85. (1999) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1608460] [ Admin láttamozott ] 476. Kucsera M , Takács I , Nagy Z , Speer G , Bori Z , Demeter J , Horváth C , Kiss L , Lakatos P A Dvitaminreceptor génjének polimorfizmusa és a szérum alulkarboxilált oszteokalcinszintjének összefüggése CA ÉS CSONT 2:(2) pp. 5458. (1999) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1335660] [ Érvényesített ] 477. Lakatos P (szerk.) A kalciumháztartás és a csontszövet anyagcserebetegségei Budapest: M edicina Könyvkiadó, 1999. 515 p. (ISBN:963242115 9) https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
302/342
3/30/2015
nyomtatobarat forma
Nyelv: Magyar
Könyv /Szakkönyv /Tudományos [1799187] [ Admin láttamozott ] 478. Lakatos P , Horváth C , M arton I , Pap K , Poór Gy Ajánlás az involúciós osteoporosisának kezelésére CA ÉS CSONT 2: pp. 144149. (1999) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1808193] [ Admin láttamozott ] 479. Lakatos P Az osteoporosis fluoridterápiája GYÓGYSZEREINK 49:(12) pp. 79. (1999) Nyelv: Magyar
Folyóiratcikk /Rövid közlemény /Tudományos [1808239] [ Admin láttamozott ] 480. Lakatos P A biszfoszfonátok hatása a csontátépülésre ORVOSTOVÁBBKÉPZŐ SZEMLE 6:(márc. ksz.) pp. 14. (1999) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1808262] [ Admin láttamozott ] 481. Lakatos P , Zsadányi J , Tóth M , Földes J , Takács I , Nagy Zs , Speer G Endothelin RIA fejlesztése és a felhasználás során szerzett tapasztalatok. MAGYAR RADIOLÓGIA 1:(S1) p. 12. (1999) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1818567] [ Admin láttamozott ] 482. Speer G , Cseh K , Bori Z , Dworak O , Vargha P , Salamon D , Winkler G , Nagy Z , Takács I , Kucsera M , Lakatos P A Dvitaminreceptorgén BsmI polimorfizmusa korrelál az erbB2/HER2 onkogén expressziójával humán rectalis daganatban MAGYAR BELORVOSI ARCHIVUM 52:(2) pp. 173178. (1999) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1335659] [ Érvényesített ] 483. Stern PH , Lakatos P Other pharmacologic agents influencing bone loss In: Rosen C , Glowacki J , Bilezikian JP (szerk.) The aging skeleton . San Diego; New York: Academic Press, 1999. pp. 221228. (ISBN:9780120986552) Nyelv: Angol
Könyvrészlet /Szaktanulmány /Tudományos [1888438] [ Admin láttamozott ] 484. Szűcs J , Bálint G , Genti G , Szathmári M , Balogh Á , Bors K , Bossányi K , de Chatel R , Forgács S , Holló I , Horváth C , Lakatos P , M arton I , Pap K , Poór Gy , Szekeres L , Tamási L Ajánlás a szekunder osteoporosisok és más calcipeniás osteopathiák diagnosztikájára és kezelésére CA ÉS CSONT 2:(4) pp. 150156. (1999) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1808190] [ Admin láttamozott ] 485. Takács I , Bajnok É , Nagy Z , Speer G , Bori Z , Kucsera M , Horváth C , Kiss L , Lakatos P Az interleukin1 receptor antagonista protein génjének polimorfizmusa és a csontásványianyagtartalom összefüggése postmenopausás nőknél. MAGYAR BELORVOSI ARCHIVUM 52:(2) pp. 169172. (1999) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1335658] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
303/342
3/30/2015
nyomtatobarat forma
[ Érvényesített ] 486. Winkler G , Lakatos P , Salamon F , Nagy Z , Speer G , Kovacs M , Harmos G , Dworak O , Cseh K Elevated serum TNFalpha level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients. DIABETIC MEDICINE 16:(3) pp. 207211. (1999) IF: 2.170 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1335575] [ Érvényesített ] Független idéző: 81 Függő idéző: 10 Összesen: 91 1
* W inkler G, Salamon F, Szekeres O, Braun E, Bernáth I, Speer G, Kovács M, Simon K, Cseh K A szérum tumor necrosis factoralpha tartalom android típusú elhízottakon és változása testsúly csökkentést követően (Előzetes megfigyelések) DIABETOLOGIA HUNGARICA (ISSN: 1217372X) 8: (1) pp. 2934. ( 2000) Folyóiratcikk /Szakcikk /Tudományos [11613741]
2
Tooke J E, Hannemann M M Adverse endothelial function and the insulin resistance syndrome Journal of Internal Medicine (ISSN: 09546820) 247: (4) pp. 425431. ( 2000) Folyóiratcikk /Összefoglaló cikk /Tudományos [11605841]
3
Garaulet M, PerezLlamas F, Fuente T, Zamora S, Tebar F J Anthropometric, computed tomography and fat cell data in an obese population: Relationship with insulin, leptin, tumor necrosis factoralpha, sex hormonebinding globulin and sex hormones European Journal of Endocrinology (ISSN: 08044643) 143: (5) pp. 657666. ( 2000) Folyóiratcikk /Szakcikk /Tudományos [11605840]
4
Banks W A, Morley J E Endocrine and metabolic changes in human aging Journal of the American Aging Association 23: (2) pp. 103115. ( 2000) Folyóiratcikk /Szakcikk /Tudományos [11605839]
5
Schiekofer S, Balletshofer B, Andrassy M, Bierhaus A, Nawroth P P Endothelial dysfunction in diabetes mellitus Seminars in Thrombosis and Hemostasis (ISSN: 00946176) 26: (5) pp. 503511. ( 2000) Chemicals/CAS: Endothelin1 Folyóiratcikk /Összefoglaló cikk /Tudományos [11605838]
6
Alessi M C, Bastelica D, Morange P, Berthet B, Leduc I, Verdier M, Geel O, JuhanVague I P lasminogen activator inhibitor 1, transforming growth factorβ1, and BMI are closely associated in human adipose tissue during morbid obesity Diabetes (ISSN: 00121797) 49: (8) pp. 13741380. ( 2000) Chemicals/CAS: Plasminogen Activator Inhibitor 1; RNA, Messenger; Transforming Growth Factor beta; Tumor Necrosis Factoralpha Folyóiratcikk /Szakcikk /Tudományos [11605837]
7
Pausova Z, Deslauriers B, Gaudet D, Tremblay J, Kotchen T A, Larochelle P, Cowley A W , Hamet P Role of tumor necrosis factorα gene locus in obesity and obesity associated hypertension in French Canadians Hypertension (ISSN: 0194911X) 36: (1) pp. 1419. ( 2000) Chemicals/CAS: Lipoprotein Lipase, EC 3.1.1.34; Tumor Necrosis Factoralpha Folyóiratcikk /Szakcikk /Tudományos [11605836]
8
9
* Cseh K, W inkler G, Melczer Z, Baranyi E The role of tumour necrosis factor (TNF)alpha resistance in obesity and insulin resistance DIABETOLOGIA 43: (4) pp. 525525. ( 2000) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [11613737] Kern P A, Ranganathan S, Li C, W ood L, Ranganathan G Adipose tissue tumor necrosis factor and interleukin6 expression in human obesity and insulin resistance American Journal of Physiology Endocrinology and Metabolism 280: (5 435) pp. E745E751. ( 2001) Chemicals/CAS: Interleukin6; RNA, Messenger; Tumor Necrosis Factoralpha Folyóiratcikk /Szakcikk /Tudományos [11605835]
10 * Halász A, Cserháti E, Magyar P, Kovács M, Cseh K Correlation between bronchial hyperreactivity and serum sTNFR1 (60kDa) level in symptomfree childhood asthmatic adults and their offspring Pediatric Asthma, Allergy and Immunology 15: (2) pp. 8188. ( 2001) Chemicals/CAS: methacholine, 55925; tumor necrosis factor receptor, 129203936, 184595015 Folyóiratcikk /Szakcikk /Tudományos [11605834] 11
Abdu T A M, Elhadd T, Pfeifer M, Clayton R N Endothelial dysfunction in endocrine disease Trends in Endocrinology and Metabolism (ISSN: 10432760) 12: (6) pp. 257265. ( 2001) Folyóiratcikk /Összefoglaló cikk /Tudományos [11605833]
12
Lagaud G J L, MasihKhan E, Kai S, Van Breemen C, Dubé G P Influence of type II diabetes on arterial tone and endothelial function in murine mesenteric resistance arteries Journal of Vascular Research (ISSN: 10181172) 38: (6) pp. 578589. ( 2001) Folyóiratcikk /Szakcikk /Tudományos [11605832]
13
Hulthe J, W ikstrand J, Fagerberg B Relationship between Creactive protein and intimamedia thickness in the carotid and femoral arteries and to antibodies against oxidized lowdensity lipoprotein in healthy men: The Atherosclerosis and Insulin Resistance (AIR) study Clinical Science (ISSN: 01435221) 100: (4) pp. 371378. ( 2001) Folyóiratcikk /Szakcikk /Tudományos [11605831]
14
Barroso Sergio Girão, Abreu Virgínia Genelhu de, Francischetti Emílio Antonio A P articipação do Tecido Adiposo Visceral na Gênese da Hipertensão e Doença Cardiovascular Aterogênica: Um Conceito Emergente
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
304/342
3/30/2015
nyomtatobarat forma Arquivos Brasileiros de Cardiologia (ISSN: 0066782X) 78: (6) pp. 618630. ( 2002) Folyóiratcikk [13816647] 15
Reynolds TH, Brown MD, Supiano MA, Dengel DR Aerobic exercise training improves insulin sensitivity independent of plasma tumor necrosis factoralpha levels in older female hypertensives METABOLISMCLINICAL AND EXPERIMENTAL (ISSN: 00260495) 51: (11) pp. 14021406. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11917168]
16
Mery C M, Rubio V, DuarteRojo A, SuazoBarahona J, PeláezLuna M, Milke P, RoblesDíaz G Android fat distribution as predictor of severity in acute pancreatitis Pancreatology (ISSN: 14243903) 2: (6) pp. 543549. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11605830]
17
W illiams I L, W heatcroft S, Shah A M, Kearney M T Obesity, atherosclerosis and the vascular endothelium: Mechanisms of reduced nitric oxide bioavailability in obese humans International Journal of Obesity (ISSN: 03070565) 26: (6) pp. 754764. ( 2002) Chemicals/CAS: Nitric Oxide Synthase Type III, EC 1.14.13.39; Nitric Oxide Synthase, EC 1.14.13.39; Nitric Oxide, 1010243 9; NOS3 protein, human, EC 1.14.13.39 Folyóiratcikk /Összefoglaló cikk /Tudományos [11605829]
18 * Halász A, Cserháti E, Magyar P, Kovács M, Cseh K Role of TNFα and its 55 and 75 kDa receptors in bronchial hyperreactivity Respiratory Medicine (ISSN: 09546111) 96: (4) pp. 262267. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11605828] 19 * Melczer Zs, Bánhidy F, Csömör Jr S, Kovács M, Siklós P, W inkler G, Cseh K Role of tumour necrosis factorα in insulin resistance during normal pregnancy European Journal of Obstetrics Gynecology and Reproductive Biology (ISSN: 03012115) 105: (1) pp. 710. ( 2002) Chemicals/CAS: CPeptide; Tumor Necrosis Factoralpha Folyóiratcikk /Szakcikk /Tudományos [11605827] 20
FernandezReal J M, Lainez B, Vendrell J, Rigla M, Castro A, Peñarroja G, Broch M, Pérez A, Richart C, Engel P, Ricart W Shedding of TNFα receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus American Journal of Physiology Endocrinology and Metabolism 282: (4 454) pp. E952E959. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11605826]
21 * Cseh K, Baranyi É, Melczer Z, Csákány G M, Speer G, Kovács M, Gerö G, Karádi I, W inkler G The pathophysiological influence of leptin and the tumor necrosis factor system on maternal insulin resistance: Negative correlation with anthropometric parameters of neonates in gestational diabetes Gynecological Endocrinology (ISSN: 09513590) 16: (6) pp. 453460. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11605825] 22
Bogdański P, PupekMusialik D, Łuczak M, Cymerys M, Bryl W Tumor necrosis factor alfa (TNFα) and its role in pathogenesis of obesityassociated hypertension: Znaczenie czynnika martwicy nowotworu (TNFα) w patogenezie nadciśnienia tȩtniczego zwia̧ zanego z otyłościa̧ Nadcisnienie Tetnicze 6: (2) pp. 133141. ( 2002) Folyóiratcikk /Összefoglaló cikk /Tudományos [11605824]
23 * W inkler G, Cseh K, Baranyi E, Melczer Z, Speer G, Hajós P, Salamon F, Turi Z, Kovács M, Vargha P, Karádi I Tumor necrosis factor system in insulin resistance in gestational diabetes Diabetes Research and Clinical Practice (ISSN: 01688227) 56: (2) pp. 9399. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [11605823] 24
Vendrell J, FernandezReal J M, Gutierrez C, Zamora A, Simon I, Bardaji A, Ricart W , Richart C A polymorphism in the promoter of the tumor necrosis factorα gene (308) is associated with coronary heart disease in type 2 diabetic patients Atherosclerosis (ISSN: 00219150) 167: (2) pp. 257264. ( 2003) Chemicals/CAS: Genetic Markers; Tumor Necrosis Factoralpha Folyóiratcikk /Szakcikk /Tudományos [11605822]
25
Engeli S, Feldpausch M, Gorzelniak K, Hartwig F, Heintze U, Janke J, Möhlig M, Pfeiffer A F H, Luft F C, Sharma A M Association between adiponectin and mediators of inflammation in obese women Diabetes (ISSN: 00121797) 52: (4) pp. 942947. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [11605821]
26
W ilkes J J, Hevener A, Olefsky J Chronic endothelin1 treatment leads to insulin resistance in vivo Diabetes (ISSN: 00121797) 52: (8) pp. 19041909. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [11605820]
27
DePalma R G, Hayes V W , Cafferata H T, Mohammadpour H A, Chow B K, Zacharski L R, Hall M R Cytokine signatures in atherosclerotic claudicants Journal of Surgical Research (ISSN: 00224804) 111: (2) pp. 215221. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [11605819]
28
Caballero A E Endothelial dysfunction in obesity and insulin resistance: A road to diabetes and heart disease Obesity Research (ISSN: 10717323) 11: (11) pp. 12781289. ( 2003) Folyóiratcikk /Összefoglaló cikk /Tudományos [11605818]
29
Bogdański P, KujawskaŁuczak M, Ła̧ cki J, PupekMusialik D, Januszewicz W, Manitius J, PupekMusialik D, Łuczak M, Czekalski S, Nartowicz E, Hruby Z Evaluation of selected interleukins, tumor necrosis factor, insulin and leptin in obese patients with hypertension: Ocena stȩżenia wybranych interleukin, czynnika martwicy nowotworów, insulinemii i leptynemii u otyłych z nadciśnieniem tȩtniczym Polski Merkuriusz Lekarski (ISSN: 14269686) 15: (88) pp. 347351. ( 2003) Folyóiratcikk /Konferenciaközlemény /Tudományos [11605817]
30 * W inkler G, Kiss S, Keszthelyi L, Sápi Z, Öry I, Salamon F, Kovács M, Vargha P, Szekeres O, Speer G, Karádi I, Sikter M, Kaszás E, Dworak O, Gerö G, Cseh K Expression of tumor necrosis factor (TNF)α protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNFα, soluble serum TNFreceptor2 concentrations and Cpeptide level European Journal of Endocrinology (ISSN: 08044643) 149: (2) pp. 129135. ( 2003) Chemicals/CAS: C peptide, 59112800; glucose, 50997, 84778643; CPeptide; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factoralpha
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
305/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [11605816] 31
FernándezReal J M, Ricart W Insulin resistance and chronic cardiovascular inflammatory syndrome Endocrine Reviews (ISSN: 0163769X) 24: (3) pp. 278301. ( 2003) Folyóiratcikk /Összefoglaló cikk /Tudományos [11605815]
32
W heatcroft S B, W illiams I L, Shah A M, Kearney M T P athophysiological implications of insulin resistance on vascular endothelial function Diabetic Medicine (ISSN: 07423071) 20: (4) pp. 255268. ( 2003) Chemicals/CAS: nitric oxide, 10102439; superoxide, 11062774; Endothelins; Nitric Oxide, 10102439 Folyóiratcikk /Összefoglaló cikk /Tudományos [11605814]
33
Izawa H, Yamada Y, Okada T, Tanaka M, Hirayama H, Yokota M P rediction of genetic risk for hypertension Hypertension (ISSN: 0194911X) 41: (5) pp. 10351040. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [11605813]
34 * Halász A, Cserháti E, Kósa L, Cseh K Relationship between the tumor necrosis factor system and the serum interleukin4, interleukin5, interleukin8, eosinophil cationic protein, and immunoglobulin E levels in the bronchial hyperreactivity of adults and their children Allergy and Asthma Proceedings (ISSN: 10885412) 24: (2) pp. 111118. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [11605812] 35
FernándezReal J M The adipocyte as a biocommunicator: El adipocito como biocomunicador Endocrinologia y Nutricion (ISSN: 15750922) 50: (6) pp. 187197. ( 2003) Folyóiratcikk /Összefoglaló cikk /Tudományos [11605811]
36
Dandona P, Aljada A Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents Journal of Diabetes and its Complications (ISSN: 10568727) 18: (2) pp. 91102. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [11605810]
37
Caballero A E Endothelial dysfunction, inflammation, and insulin resistance: A focus on subjects at risk for type 2 diabetes Current Diabetes Reports (ISSN: 15344827) 4: (4) pp. 237246. ( 2004) Folyóiratcikk /Összefoglaló cikk /Tudományos [11605809]
38
Głowińska B, Urban M, Hryniewicz A, Peczyńska J, Florys B, AlHwish M Endothelin1 plasma concentration in children and adolescents with atherogenic risk factors: Stȩżenie endoteliny1 u dzieci i młodzieży z czynnikami ryzyka miażdżycy Kardiologia Polska (ISSN: 00229032) 61: (10) pp. 329338. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [11605808]
39
Li Hua, Gong Yanchun, Guo Jizhen Essential hypertension is associated with subclinical inflammation Shanghai medical journal 27: (6) pp. 386388. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [12661747]
40
Dixon D, Goldberg R, Schneiderman N, Delamater A Gender differences in TNFα levels among obese vs nonobese Latino children European Journal of Clinical Nutrition (ISSN: 09543007) 58: (4) pp. 696699. ( 2004) Chemicals/CAS: glucose, 50997, 84778643; insulin, 9004108; Tumor Necrosis Factoralpha Folyóiratcikk /Szakcikk /Tudományos [11605807]
41
Yamada Y, Ichihara S, Izawa H, Tanaka M, Yokota M Genetic risk for coronary artery disease in individuals with or without type 2 diabetes Molecular Genetics and Metabolism (ISSN: 10967192) 81: (4) pp. 282290. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [11605806]
42
Gayet C, Bailhache E, Dumon H, Martin L, Siliart B, Nguyen P Insulin resistance and changes in plasma concentration of TNFα, IGF1, and NEFA in dogs during weight gain and obesity Journal of Animal Physiology and Animal Nutrition (ISSN: 14390396) 88: (34) pp. 157165. ( 2004) Chemicals/CAS: insulin, 9004108; somatomedin C, 67763966; Blood Glucose; Fatty Acids, Nonesterified; Insulin, 11061680; InsulinLike Growth Factor I, 67763966; Tumor Necrosis Factoralpha Folyóiratcikk /Konferenciaközlemény /Tudományos [11605805]
43
Carey A L, Bruce C R, Sacchetti M, Anderson M J, Olsen D B, Saltin B, Hawley J A, Febbraio M A Interleukin6 and tumor necrosis factorα are not increased in patients with Type 2 diabetes: Evidence that plasma interleukin6 is related to fat mass and not insulin responsiveness Diabetologia 47: (6) pp. 10291037. ( 2004) Chemicals/CAS: Glucose, 50997; Insulin, 11061680; Interleukin6; RNA, Messenger; Tumor Necrosis Factoralpha Folyóiratcikk /Szakcikk /Tudományos [11605804]
44
Lane JT Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective AMERICAN JOURNAL OF PHYSIOLOGYRENAL PHYSIOLOGY (ISSN: 1931857X) 286: (3) pp. F442F450. ( 2004) Folyóiratcikk /Összefoglaló cikk /Tudományos [11917166]
45
Blanchard G, Nguyen P, Gayet C, Leriche I, Siliart B, Paragon B M Rapid weight loss with a highprotein lowenergy diet allows the recovery of ideal body composition and insulin sensitivity in obese dogs Journal of Nutrition (ISSN: 00223166) 134: (8 SUP P L.) pp. 2148S2150S. ( 2004) Chemicals/CAS: somatomedin C, 67763966; Dietary Proteins; InsulinLike Growth Factor I, 67763966; Tumor Necrosis Factoralpha Folyóiratcikk /Konferenciaközlemény /Tudományos [11605802]
46
Reynolds IV T H, Supiano M A, Dengel D R Resistance training enhances insulinmediated glucose disposal with minimal effect on the tumor necrosis factoralpha system in older hypertensives Metabolism: Clinical and Experimental 53: (3) pp. 397402. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [11605801]
47
Li Xiaoping, Yang Chengti, Zhang Ling, Zhang Bin, Chnang Peng, Zhao Yang
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
306/342
3/30/2015
nyomtatobarat forma Serum Leptin and TNFalpha Levels in P atients with Essential Hypertension Chinese Journal of Hypertension 12: (3) pp. 211213. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [12661746] 48
Moon Y S, Kim D H, Song D K Serum tumor necrosis factorα levels and components of the metabolic syndrome in obese adolescents Metabolism: Clinical and Experimental 53: (7) pp. 863867. ( 2004) Chemicals/CAS: Blood Glucose; Cholesterol, 57885; Lipids; Receptors, Tumor Necrosis Factor; Triglycerides; Tumor Necrosis Factoralpha Folyóiratcikk /Szakcikk /Tudományos [11605800]
49
Caballero A E, Delgado A, AguilarSalinas C A, Herrera A N, Castillo J L, Cabrera T, GomezPerez F J, Rull J A The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: A placebocontrolled, randomized clinical trial Journal of Clinical Endocrinology and Metabolism (ISSN: 0021972X) 89: (8) pp. 39433948. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [11605799]
50
Anderson H D I, Rahmutula D, Gardner D G Tumor Necrosis Factorα Inhibits Endothelial Nitricoxide Synthase Gene P romoter Activity in Bovine Aortic Endothelial Cells Journal of Biological Chemistry (ISSN: 00219258) 279: (2) pp. 963969. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [11605798]
51
Shai I, Schulze M B, Manson J E, Rexrode K M, Stampfer M J, Mantzoros C, Hu F B A prospective study of soluble tumor necrosis factorα receptor II (sTNFRII) and risk of coronary heart disease among women with type 2 diabetes Diabetes Care (ISSN: 01495992) 28: (6) pp. 13761382. ( 2005) Chemicals/CAS: hemoglobin A1c, 62572116; Biological Markers; CReactive Protein, 9007414; Receptors, Tumor Necrosis Factor, Type II Folyóiratcikk /Összefoglaló cikk /Tudományos [11605797]
52
O Rourke R W , Kay T, Scholz M H, Diggs B, Jobe B A, Lewinsohn D M, Bakke A C Alterations in Tcell subset frequency in peripheral blood in obesity Obesity Surgery (ISSN: 09608923) 15: (10) pp. 14631468. ( 2005) Chemicals/CAS: Antigens, CD Folyóiratcikk /Szakcikk /Tudományos [11605796]
53
Diakakis G F, Parthenakis F I, Mavrakis H E, Patrianakos A P, Zacharis E A, Nyktari E G, Ganotakis E S, Vardas P E Association of impaired glucose tolerance with increased heart rate and subclinical inflammation Hellenic Journal of Cardiology (ISSN: 11099666) 46: (6) pp. 394401. ( 2005) Chemicals/CAS: Interleukin6; Tumor Necrosis Factoralpha Folyóiratcikk /Szakcikk /Tudományos [11605795]
54
Ho R C, Davy K P, Hickey M S, Melby C L Circulating tumor necrosis factor alpha is higher in nonobese, nondiabetic Mexican Americans compared to nonHispanic white adults Cytokine (ISSN: 10434666) 30: (1) pp. 1421. ( 2005) Chemicals/CAS: Glucose, 50997; Insulin, 11061680; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Tumor Necrosis Factoralpha Folyóiratcikk /Szakcikk /Tudományos [11605794]
55 * Kalmár T, Seres I, Balogh Z, Káplár M, W inkler G, Paragh G Correlation between the activities of lipoprotein lipase and paraoxonase in type 2 diabetes mellitus Diabetes and Metabolism 31: (6) pp. 574580. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [11605793] 56
Mousa S A Elevation of plasma von Willebrand factor and tumor necrosis factorα in obese subjects and their reduction by the low molecular weight heparin tinzaparin International Angiology (ISSN: 03929590) 24: (3) pp. 278281. ( 2005) Chemicals/CAS: von W illebrand factor, 109319166; Fibrinolytic Agents; Heparin, LowMolecularW eight; tinzaparin; Tumor Necrosis Factoralpha; von W illebrand Factor Folyóiratcikk /Szakcikk /Tudományos [11605792]
57
Shaw S G, Boden P J Insulin resistance, obesity and the metabolic syndrome. Is there a therapeutic role for endothelin1 antagonists? Current Vascular Pharmacology (ISSN: 15701611) 3: (4) pp. 359363. ( 2005) Chemicals/CAS: adiponectin, 283182398; glucose, 50997, 84778643; insulin receptor substrate 1, 175335327; insulin, 9004108; protein Shc, 192142395; tyrosine, 16870432, 55520406, 60184; Endothelin1 Folyóiratcikk /Összefoglaló cikk /Tudományos [11605791]
58
Caballero A E Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: The early start of a dangerous situation Archives of Medical Research (ISSN: 01884409) 36: (3) pp. 241249. ( 2005) Chemicals/CAS: metformin, 1115704, 657249; Cytokines; Glucose, 50997 Folyóiratcikk /Összefoglaló cikk /Tudományos [11605790]
59
Xu M E, Xiao S Z, Sun Y H, Zheng X X, OuYang Y, Guan C The study of antimetabolic syndrome effect of puerarin in vitro Life Sciences (ISSN: 00243205) 77: (25) pp. 31833196. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [11605789]
60
Gong Yanchun, Li Hua, Shen Yun, Guo Jizhen, Zhu Dingliang Tumor Necrosis Factoralpha gene polymorphism in hypertensive obesities Chinese Journal of Hypertension 13: (1) pp. 1923. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [12661744]
61
O Rourke R W , Kay T, Lyle E A, Traxler S A, Deveney C W , Jobe B A, Roberts Jr C T, Marks D, Rosenbaum J T Alterations in peripheral blood lymphocyte cytokine expression in obesity Clinical and Experimental Immunology (ISSN: 00099104) 146: (1) pp. 3946. ( 2006) Chemicals/CAS: 3 hydroxy 3 methylglutaryl coenzyme A, 1553555; insulin, 9004108; Cytokines; Leptin; RNA, Messenger Folyóiratcikk /Szakcikk /Tudományos [11605788]
62
W itteles R M, Fowler M B Cardiomyopathy of insulin resistance
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
307/342
3/30/2015
nyomtatobarat forma Heart Failure Clinics (ISSN: 15517136) 2: (1) pp. 1323. ( 2006) Chemicals/CAS: bisoprolol, 66722449; bucindolol, 71119114; carvedilol, 72956093; metformin, 1115704, 657249; metoprolol, 37350586; rosiglitazone, 122320734, 155141290; Adrenergic betaAntagonists Folyóiratcikk /Összefoglaló cikk /Tudományos [11605787] 63
Miller M A, Cappuccio F P Cellular adhesion molecules and their relationship with measures of obesity and metabolic syndrome in a multiethnic population International Journal of Obesity (ISSN: 03070565) 30: (8) pp. 11761182. ( 2006) Chemicals/CAS: endothelial leukocyte adhesion molecule 1, 128875252; insulin, 9004108; intercellular adhesion molecule 1, 126547895; Cell Adhesion Molecules; ESelectin; PSelectin; Vascular Cell Adhesion Molecule1 Folyóiratcikk /Szakcikk /Tudományos [11605786]
64
Mingen Xu, Shangzhi Xiao, Yonghong Sun, Yangou Yang, Xiaoxiang Zheng Effects of astragaloside Ⅳ on pathogenesis of metabolic syndrome in vitro Acta Pharmacologica Sinica (ISSN: 16714083) 27: (2) pp. 229236. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [13380772]
65
Browning L M, Jebb S A Nutritional influences on inflammation and type 2 diabetes risk Diabetes Technology and Therapeutics (ISSN: 15209156) 8: (1) pp. 4554. ( 2006) Folyóiratcikk /Konferenciaközlemény /Tudományos [11605784]
66
Fujita K, Nishizawa H, Funahashi T, Shimomura I, Shimabukuro M Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome Circulation Journal (ISSN: 13469843) 70: (11) pp. 14371442. ( 2006) Chemicals/CAS: 8 isoprostaglandin F2 alpha, 27415265; adiponectin, 283182398; C reactive protein, 9007414; 8epi prostaglandin F2alpha, 27415265; Adiponectin; CReactive Protein, 9007414; Dinoprost, 551111; Reactive Oxygen Species Folyóiratcikk /Szakcikk /Tudományos [11605783]
67
Bulcão C, Ferreira S R G, Giuffrida F M A, RibeiroFilho F F The new adipose tissue and adipocytokines Current Diabetes Reviews (ISSN: 15733998) 2: (1) pp. 1928. ( 2006) Folyóiratcikk /Összefoglaló cikk /Tudományos [11605782]
68
St Pierre D H, Bastard J P, Coderre L, Brochu M, Karelis A D, Lavoie M È, Malita F, Fontaine J, Mignault D, Cianflone K, Imbeault P, Doucet É, RabasaLhoret R Association of acylated ghrelin profiles with chronic inflammatory markers in overweight and obese postmenopausal women: A MONET study European Journal of Endocrinology (ISSN: 08044643) 157: (4) pp. 419426. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [11605781]
69
DePalma RG, Hayes VW Atherosclerosis: Risk Factors and Medical Management In: Vascular Surgery : Basic Science and Clinical Correlations: Second Edition. Blackwell Publishing, 2007. (ISBN 1405122021) pp. 439453.
Könyvrészlet /Könyvfejezet /Tudományos [13816632] 70
Brignardello E, Runzo C, Aragno M, Catalano M G, Cassader M, Perin P C, Boccuzzi G Dehydroepiandrosterone administration counteracts oxidative imbalance and advanced glycation end product formation in type 2 diabetic patients Diabetes Care (ISSN: 01495992) 30: (11) pp. 29222927. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [11605780]
71
Goodwin B L, Pendleton L C, Levy M M, Solomonson L P, Eichler D C Tumor necrosis factorα reduces argininosuccinate synthase expression and nitric oxide production in aortic endothelial cells American Journal of Physiology Heart and Circulatory Physiology 293: (2) pp. H1115H1121. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [11605779]
72
W itteles R M, Fowler M B InsulinResistant Cardiomyopathy. Clinical Evidence, Mechanisms, and Treatment Options Journal of the American College of Cardiology (ISSN: 07351097) 51: (2) pp. 93102. ( 2008) Chemicals/CAS: adenosine triphosphate, 15237442, 56655, 987655; carnitine, 461063, 541151, 56995; carvedilol, 72956093; dipeptidyl peptidase, 9032671; etomoxir, 82258364; exendin 4, 141732765, 141758749; glucagon like peptide 1, 89750141; growth hormone, 36992731, 37267053, 66419509, 9002726; insulin, 9004108; metformin, 1115704, 657249; metoprolol, 37350586; perhexiline, 6621472; ranolazine, 95635555; rosiglitazone, 122320734, 155141290; trimetazidine, 13171250, 5011347; Hypoglycemic Agents; Thiazolidinediones Folyóiratcikk /Összefoglaló cikk /Tudományos [11605778]
73
Pacholczyk M, Ferenc T, Kowalski J The metabolic syndrome. P art II: Its mechanisms of development and its complications POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ (ISSN: 00325449) 62: pp. 543558. ( 2008) Folyóiratcikk /Összefoglaló cikk /Tudományos [11917164]
74
Inadera H The usefulness of circulating adipokine levels for the assessment of obesityrelated health problems International Journal of Medical Sciences (ISSN: 14491907) 5: (5) pp. 248262. ( 2008) Chemicals/CAS: adiponectin, 283182398; C reactive protein, 9007414; cathepsin S, 71965463; interleukin 8, 114308 917; plasminogen activator inhibitor 1, 140208237; scatter factor, 67256217, 72980713; vasculotropin, 127464602; Adipokines; Biological Markers; Cytokines Folyóiratcikk /Összefoglaló cikk /Tudományos [11605777]
75
Vrtovec B, Fister M, Poglajen G, Starc V, Haddad F Diabetes Does Not Affect Ventricular Repolarization and Sudden Cardiac Death Risk in P atients with Dilated Cardiomyopathy PACEPACING AND CLINICAL ELECTROPHYSIOLOGY (ISSN: 01478389) 32: pp. S146S150. ( 2009) Folyóiratcikk /Konferenciaközlemény /Tudományos [11917163]
76
邵红, 谢立凯, 关红, 马彦, 赵巧丹, 杨乐, 韩艳 Chinese Journal of Gerontology 30: (24) pp. 38173818. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [13337578]
77
Ghazouani L, Hadj Khalifa S B, Abboud N, Hamda K B, Khalfallah A B, Brahim N, Almawi W Y, Mahjoub T TNFα 308G>A and IL6 174G>C polymorphisms in Tunisian patients with coronary artery disease Clinical Biochemistry (ISSN: 00099120) 43: (1314) pp. 10851089. ( 2010) Chemicals/CAS: Interleukin6; Tumor Necrosis Factoralpha
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
308/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [11605775] 78
W ang N, W an JB, Chan SW , Deng YH, Yu N, Zhang QW , W ang YT, Lee SMY Comparative study on saponin fractions from P anax notoginseng inhibiting inflammationinduced endothelial adhesion molecule expression and monocyte adhesion Chinese Medicine (ISSN: 17498546) 6: P aper 37. (2011) N1 Molecular Sequence Numbers: GENBANK: NM_012889, NM_012967, NM_017008; Folyóiratcikk /Szakcikk /Tudományos [12661889]
79
Shore SA Environmental perturbations: Obesity Comprehensive Physiology (ISSN: 20404603) 1: (1) pp. 263282. ( 2011) Folyóiratcikk /Szakcikk /Tudományos [12661888]
80
Galvao Roberto, Plavnik Frida Liane, Ribeiro Fernando Flexa, Ajzen Sergio Aron, Christofalo Dejaldo M de J, Kohlmann Osvaldo Jr Effects of Different Degrees of Insulin Sensitivity on Endothelial Function in Obese P atients ARQUIVOS BRASILEIROS DE CARDIOLOGIA (ISSN: 0066782X) 98: (1) pp. 4550. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12426321]
81
Dosi RV, Acharya DS, Patell RD Endothelial dysfunction in a cohort of indian patients with type2 diabetes mellitus Journal, Indian Academy of Clinical Medicine 13: (3) pp. 206209. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13337592]
82
Chen Su Mei, Xiong Guang Su, W u Shu Ming Is obesity an indicator of complications and mortality in acute pancreatitis? An updated metaanalysis JOURNAL OF DIGESTIVE DISEASES (ISSN: 17512972) 13: (5) pp. 244251. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12426320]
83
W alsh Jessica A, Duffin Kristina Callis, Crim Julia, Clegg Daniel O Lower Frequency of Obstructive Sleep Apnea in Spondyloarthritis patients Taking TNFInhibitors JOURNAL OF CLINICAL SLEEP MEDICINE (ISSN: 15509389) 8: (6) pp. 643648. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13337577]
84
Bhimaraj Arvind, Tang W H W ilson Role of Oxidative Stress in Disease P rogression in Stage B, a P recursor of Heart Failure HEART FAILURE CLINICS (ISSN: 15517136) 8: (1) pp. 101+. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [12661741]
85
Gan Lixia, Guo Kaiying, Cremona Maria Laura, McGraw Timothy E, Leibel Rudolph L, Zhang Yiying TNFalpha UpRegulates P rotein Level and Cell Surface Expression of the Leptin Receptor by Stimulating Its Export via a P KCDependent Mechanism ENDOCRINOLOGY (ISSN: 00137227) 153: (12) pp. 58215833. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [13337576]
86
Calder P C, Ahluwalia N, Albers R, Bosco N, BourdetSicard R, Haller D, Holgate S T, Jonsson L S, Latulippe M E, Marcos A, Moreines J, M'Rini C, Muller M, Pawelec G, van Neerven R J J, W atzl B, Zhao J A Consideration of Biomarkers to be used for Evaluation of Inflammation in Human Nutritional Studies BRITISH JOURNAL OF NUTRITION (ISSN: 00071145) 109: pp. S1S34. ( 2013) SU 1 Folyóiratcikk /Szakcikk /Tudományos [13337575]
87
BadowskaKozakiewicz Anna M Biological role of tumor necrosis factor type a in physiology and pathophysiology PRZEGLAD MENOPAUZALNY (ISSN: 16438876) 12: (2) pp. 136141. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13337574]
88
Chang Yanqin, Lin Meiling, Yue Jia Effects of P ructus P soraleae on weight and level of tumor necrosis factoralpha in ovarietomized rats Chinese Journal of Gerontology (ISSN: 10059202) 33: (23) pp. 58865888. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13816644]
89
Lu H, Gauvreau D, Tom F Q, Lapointe M, Luo X P, Cianflone K Inflammatory Markers and Adipokines Alter Adipocytederived ASP P roduction Through Direct and Indirect Immune Interaction EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (ISSN: 09477349) 121: (4) pp. 194200. ( 2013) Folyóiratcikk /Szakcikk /Tudományos [13337573]
90
Mohammadzadeh G, Ghaffari MA Additional effect of diabetes mellitus type 2 on the risk of coronary artery disease: Role of serum adiponectin Iranian Red Crescent Medical Journal (ISSN: 20741804) 16: (1) P aper e8742. (2014) Folyóiratcikk /Tudományos [13816631]
91
MenziesGow NJ, W ray H, Bailey SR, Harris PA, Elliott J The effect of tumour necrosis factorα and insulin on equine digital blood vessel function in vitro INFLAMMATION RESEARCH (ISSN: 10233830) 63: (8) pp. 637647. ( 2014) Folyóiratcikk /Tudományos [14221371]
1998 487. Abonyi M , Lakatos P , Schaff Zs , Prajda N , Weber G Hepatitis C vírus genotypes in hepatocellular carcinoma in Hungary Innovation Approaches to the Prevention, Diagnosis and Therapy of Cancer , The Fourth Joint Conference of the American Association for Cancer Research and the Japanese cancer Association , M aui, Hawaii , A56 (1998) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [1733289] [Előadás] [ Admin láttamozott ] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
309/342
3/30/2015
nyomtatobarat forma
488. Barna I , Lakatos P , Szathmári M , de Châtel R DIURNÁLIS VÉRNYOM ÁSINGADOZÁS ÉS PARATHORM ON HYPERTONIA ÉS NEPHROLOGIA 3:(Suppl.2) p. 62. (1998) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1608413] [ Admin láttamozott ] 489. Bori Z , Nagy Zs , Takács I , Speer G , Horváth Cs , Kiss L , Lakatos P A Dvitamin és ösztrogén receptor gén kölcsönhatása a csont ásványianyagtartalom meghatározásban CA ÉS CSONT 1:(S2) p. E11. (1998) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1818534] [ Admin láttamozott ] 490. Genti G , Lakatos P Az osteoporosis gyógyszeres kezelésének újabb lehetőségei: a biszfoszfonátok és a fluoridok ORVOSKÉPZÉS 73:(5) pp. 237243. (1998) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1808206] [ Érvényesített ] 491. Hollo G , Lakatos P Increase of endothelin1 concentration in aqueous humour induced by argon laser trabeculoplasty in the rabbit. A preliminary study. ACTA OPHTHALMOLOGICA SCANDINAVICA 76:(3) pp. 289293. (1998) IF: 0.532 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1723952] [ Érvényesített ] Független idéző: 5 Függő idéző: 5 Összesen: 10 1
* Hollo G, Lakatos P, Vargha P Immediate increase in aqueous humour endothelin 1 concentration and intraocular pressure after argon laser trabeculoplasty in the rabbit OPHTHALMOLOGICA (ISSN: 00303755) 214: (4) pp. 292295. ( 2000) Folyóiratcikk [12432316]
2
* Hollo G Membrane formation in the chamber angle after failure of argon laser trabeculoplasty BRITISH JOURNAL OF OPHTHALMOLOGY (ISSN: 00071161) 84: (6) pp. 673674. ( 2000) Folyóiratcikk [12432315]
3
Yew DT, Lai HW L, Ma SA, Zhou L, Lam KW Chromatographic identification of a biochemical alteration in the aqueous humour of megalophthalmic Black Moor goldfish Journal of Chromatography B: Biomedical Sciences and Applications 751: (2) pp. 349355. ( 2001) Folyóiratcikk [13486837]
4
W u KY, Hong SJ, W ang HZ, Lin CP, Lai YH Induction of cellular toxicity in cultured porcine corneal keratocytes by endothelin1 JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (ISSN: 10807683) 17: (5) pp. 449460. ( 2001) Folyóiratcikk [12432314]
5
Okafor MC, Delamere NA The inhibitory influence of endothelin on active sodiumpotassium transport in porcine lens INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (ISSN: 01460404) 42: (5) pp. 10181023. ( 2001) Folyóiratcikk [12432313]
6
* Hollo G, Kothy P, Lakatos P, Vargha P EndothelinA receptor antagonist BQ485 protects against intraocular pressure spike induced by laser trabeculoplasty in the rabbit OPHTHALMOLOGICA (ISSN: 00303755) 216: (6) pp. 459462. ( 2002) Folyóiratcikk [12432312]
7
* Hollo G, Visontai Z, Lakatos P, Vargha P Unoprostone isopropyl pretreatment decreases endothelin1 release and the intraocular pressure spike induced by laser trabeculoplasty in the rabbit OPHTHALMOLOGICA (ISSN: 00303755) 217: (3) pp. 231236. ( 2003) Folyóiratcikk [12432311]
8
9
10
Crouch ER, Lattanzio FA, W illiams PB, Mitrev PV, Theobald T, Allen RC Cyclosporinaugmented laser peripheral iridoplasty OPHTHALMIC SURGERY AND LASERS (ISSN: 10823069) 35: (6) pp. 475481. ( 2004) Folyóiratcikk [12432310] * Koliakos GG, Konstas AGP, SchlotzerSchrehardt U, Hollo G, Mitova D, Kovatchev D, Maloutas S, Georgiadis N Endothelin1 concentration is increased in the aqueous humour of patients with exfoliation syndrome BRITISH JOURNAL OF OPHTHALMOLOGY (ISSN: 00071161) 88: (4) pp. 523527. ( 2004) Folyóiratcikk [12432309] Scherer W J Effect of topical prostaglandin analog use on outcome following selective laser trabeculoplasty JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (ISSN: 10807683) 23: (5) pp. 503512. ( 2007)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
310/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [12432308]
492. Hollo G , Lakatos P , Farkas K Cold pressor test and plasma endothelin1 concentration in primary openangle and capsular glaucoma. JOURNAL OF GLAUCOMA 7:(2) pp. 105110. (1998) IF: 1.371 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1723954] [ Érvényesített ] Független idéző: 36 Függő idéző: 9 Összesen: 45 1
2
Vulpis V Endothelin, microcirculation and hemorheology Clinical Hemorheology and Microcirculation (ISSN: 13860291) 21: (34) pp. 273276. ( 1999) Folyóiratcikk [13056311] * Hollo G P lasma endothelin1 concentrations in patients with retinal vein occlusions BRITISH JOURNAL OF OPHTHALMOLOGY (ISSN: 00071161) 83: (1) pp. 127127. ( 1999) Folyóiratcikk [14143760]
3
Yüksel N, Karabaş VL, Demirci A, Arslan A, Altintaş O, Çaǧlar Y Comparison of blood flow velocities of the extraocular vessels in patients with pseudoexfoliation or primary openangle glaucoma Ophthalmologica (ISSN: 00303755) 215: (6) pp. 424429. ( 2001) Folyóiratcikk [13056310]
4
Ritch R Exfoliation syndrome Current Opinion in Ophthalmology (ISSN: 10408738) 12: (2) pp. 124130. ( 2001) Folyóiratcikk [13056308]
5
Ritch R, SchlötzerSchrehardt U Exfoliation syndrome Survey of Ophthalmology (ISSN: 00396257) 45: (4) pp. 265315. ( 2001) Folyóiratcikk [13056309]
6
Yüksel N, Karabaş VLevent, Arslan A, Demirci A, Çalar Y Ocular hemodynamics in pseudoexfoliation syndrome and pseudoexfoliation glaucoma Ophthalmology (ISSN: 01616420) 108: (6) pp. 10431049. ( 2001) Folyóiratcikk [13056307]
7
Harris A, JonescuCuypers C, Martin B, Kagemann L, Zalish M, Garzozi HJ Simultaneous management of blood flow and IOP in glaucoma Acta Ophthalmologica Scandinavica (ISSN: 13953907) 79: (4) pp. 336341. ( 2001) Folyóiratcikk [13056306]
8
Flammer J, Pache M, Resink T Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye Progress in Retinal and Eye Research (ISSN: 13509462) 20: (3) pp. 319349. ( 2001) Folyóiratcikk [13056305]
9
Poinoosawmy D, Indar A, Bunce C, GarwayHeath DF, Hitchings RA Effect of treatment by medicine or surgery on intraocular pressure and pulsatile ocular blood flow in normalpressure glaucoma Graefe's Archive for Clinical and Experimental Ophthalmology 240: (9) pp. 721726. ( 2002) Folyóiratcikk [13056304]
10
Ritch R Exfoliation syndrome: More than meets the eye Acta Ophthalmologica Scandinavica (ISSN: 13953907) 80: (5) pp. 465467. ( 2002) Folyóiratcikk [13056303]
11
Nicolela MT, Ferrier SN, Morrison CA, Archibald ML, LeVatte TL, W allace K, Chauhan BC, LeBlanc RP Effects of coldinduced vasospasm in glaucoma: The role of endothelin1 Investigative Ophthalmology and Visual Science 44: (6) pp. 25652572. ( 2003) Folyóiratcikk [13056302]
12
Vessani RM, Ritch R, Liebmann JM, Jofe M P lasma homocysteine is elevated in patients with exfoliation syndrome American Journal of Ophthalmology (ISSN: 00029394) 136: (1) pp. 4146. ( 2003) Folyóiratcikk [13056301]
13
Ritch R, SchlötzerSchrehardt U, Konstas AGP Why is glaucoma associated with exfoliation syndrome? Progress in Retinal and Eye Research (ISSN: 13509462) 22: (3) pp. 253275. ( 2003) Folyóiratcikk [13056300]
14 * Koliakos GG, Konstas AGP, SchlötzerSchrehardt U, Hollo G, Mitova D, Kovatchev D, Maloutas S, Georgiadis N Endothelin1 concentration is increased in the aqueous humour of patients with exfoliation syndrome British Journal of Ophthalmology (ISSN: 00071161) 88: (4) pp. 523527. ( 2004) Folyóiratcikk [13056299] 15 * Visontai Z, Mersich B, Holló G Carotid artery elasticity and baroreflex sensitivity in patients with glaucoma Journal of Glaucoma (ISSN: 10570829) 14: (1) pp. 3035. ( 2005) Folyóiratcikk [13056298] 16
Emre M, Orgül S, Haufschild T, Shaw SG, Flammer J Increased plasma endothelin1 levels in patients with progressive open angle glaucoma British Journal of Ophthalmology (ISSN: 00071161) 89: (1) pp. 6063. ( 2005) Folyóiratcikk [13056297]
17
Taniguchi T, Shimazawa M, Sasaoka M, Shimazaki A, Hara H Endothelin1 impairs retrograde axonal transport and leads to axonal injury in rat optic nerve
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
311/342
3/30/2015
nyomtatobarat forma Current Neurovascular Research (ISSN: 15672026) 3: (2) pp. 8188. ( 2006) Folyóiratcikk [13056296] 18
Irkec M Exfoliation and carotid stiffness British Journal of Ophthalmology (ISSN: 00071161) 90: (5) pp. 529530. ( 2006) Folyóiratcikk [13056295]
19 * Visontai Z, Merisch B, Kollai M, Holló G Increase of carotid artery stiffness and decrease of baroreflex sensitivity in exfoliation syndrome and glaucoma British Journal of Ophthalmology (ISSN: 00071161) 90: (5) pp. 563567. ( 2006) Folyóiratcikk [13056294]
20
Sasaoka M, Taniguchi T, Shimazawa M, Ishida N, Shimazaki A, Hara H Intravitreal injection of endothelin1 caused optic nerve damage following to ocular hypoperfusion in rabbits Experimental Eye Research (ISSN: 00144835) 83: (3) pp. 629637. ( 2006) Folyóiratcikk [13056293]
21
SchlötzerSchrehardt U, Naumann GOH Ocular and Systemic P seudoexfoliation Syndrome American Journal of Ophthalmology (ISSN: 00029394) 141: (5) pp. 921937.e2. ( 2006) Folyóiratcikk [13056292]
22 * Visontai Z, Horváth T, Kollai M, Holló G Decreased cardiovagal regulation in exfoliation syndrome Journal of Glaucoma (ISSN: 10570829) 17: (2) pp. 133138. ( 2008) Folyóiratcikk [13056291] 23
Ritch R Exfoliation syndrome: Beyond glaucoma Archives of Ophthalmology (ISSN: 00039950) 126: (6) pp. 859861. ( 2008) Folyóiratcikk [13056290]
24
Martinez A, Sanchez M Ocular haemodynamics in pseudoexfoliative and primary openangle glaucoma Eye (ISSN: 0950222X) 22: (4) pp. 515520. ( 2008) Folyóiratcikk [13056289]
25
Ritch R The management of exfoliative glaucoma Progress in Brain Research (ISSN: 00796123) 173: pp. 211224. ( 2008) Folyóiratcikk [13056288]
26
Agarwal R, Gupta SK, Agarwal P, Saxena R, Agrawal S Current concepts in the pathophysiology of glaucoma Indian Journal of Ophthalmology (ISSN: 03014738) 57: (4) pp. 257266. ( 2009) Folyóiratcikk [13056287]
27
Karadag R, Yagci R, Aydin B, Kanbay M, Erdurmus M, Keskin UC, Akcay A, Durmus M Effects of erytropoietin treatment and hemodialysis on the serum endothelin level and intraocular pressure of hemodialysis patients International Ophthalmology (ISSN: 01655701) 29: (5) pp. 385388. ( 2009) Folyóiratcikk [13056286]
28
Dayanir V, Topaloǧlu A, Ozsunar Y, Keceli M, Okyay P, Harris A Orbital blood flow parameters in unilateral pseudoexfoliation syndrome International Ophthalmology (ISSN: 01655701) 29: (1) pp. 2732. ( 2009) Folyóiratcikk [13056285]
29
Kurashima H, W atabe H, Sato N, Abe S, Ishida N, Yoshitomi T Effects of prostaglandin F2α analogues on endothelin1induced impairment of rabbit ocular blood flow: Comparison among tafluprost, travoprost, and latanoprost Experimental Eye Research (ISSN: 00144835) 91: (6) pp. 853859. ( 2010) Folyóiratcikk [13056284]
30
Gümüş M, Coşkun M, Çakmak HB, Ipek A, Kurt A, Aşik E, Şimşek S P reoperative and postoperative ocular blood flow in cases with cataract and pseudoexfoliation syndrome Turkiye Klinikleri Journal of Medical Sciences 30: (3) pp. 10091014. ( 2010) Folyóiratcikk [13056283]
31
Blagoeva H, Balabanov Ch, Petrov D P seudoexfoliation syndrome and glaucoma Acta Medica Bulgarica 37: (1) pp. 1221. ( 2010) Folyóiratcikk [13056282]
32
Venkataraman ST, Flanagan JG, Hudson C Vascular reactivity of optic nerve head and retinal blood vessels in glaucomaA review Microcirculation (ISSN: 10739688) 17: (7) pp. 568581. ( 2010) Folyóiratcikk [13056281]
33
Rosenthal R, Fromm M Endothelin antagonism as an active principle for glaucoma therapy British Journal of Pharmacology (ISSN: 00071188) 162: (4) pp. 806816. ( 2011) Folyóiratcikk [13056280]
34
Barbara TB, Krystyna CJ Investigation into the vasospastic mechanisms in the pathogenesis of glaucomatous neuropathy Klinika Oczna 113: (79) pp. 201208. ( 2011) Folyóiratcikk [13056279]
35 * Holló G, Gál A, Kóthy P, Molnár JM LOXL1 gene sequence variants and vascular disease in exfoliation syndrome and exfoliative glaucoma Journal of Glaucoma (ISSN: 10570829) 20: (3) pp. 143147. ( 2011) Folyóiratcikk [13056278]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
312/342
3/30/2015
nyomtatobarat forma 36
Shoshani YZ, Harris A, Shoja MM, Rusia D, Siesky B, Arieli Y, W irostko B Endothelin and its suspected role in the pathogenesis and possible treatment of glaucoma Current Eye Research (ISSN: 02713683) 37: (1) pp. 111. ( 2012) Folyóiratcikk [13056277]
37
Cellini M, Strobbe E, Gizzi C, Balducci N, Toschi PG, Campos EC Endothelin1 plasma levels and vascular endothelial dysfunction in primary open angle glaucoma Life Sciences (ISSN: 00243205) 91: (1314) pp. 699702. ( 2012) Folyóiratcikk [13056276]
38
Scharfenberg E, SchlötzerSchrehardt U P EX syndrome: Clinical diagnosis and systemic manifestations Ophthalmologe (ISSN: 0941293X) 109: (10) pp. 952961. ( 2012) Hiányzó nyelv: 'German; English' Folyóiratcikk [13056275]
39 * Holló G, Quaranta L, Cvenkel B, Astakhov YS, Teus MA, Kóthy P, Miglior S, Riva I, Akopov EL, Gros J, Stewart JA, Kristoffersen MS, Nelson LA, Stewart W C Risk factors associated with progression in exfoliative glaucoma patients Ophthalmic Research (ISSN: 00303747) 47: (4) pp. 208213. ( 2012) Folyóiratcikk [13056274] 40 * Holló G Systemic diseases in pseudoexfoliation syndrome Lege Artis Medicinae (ISSN: 08664811) 22: (89) pp. 493498. ( 2012) Folyóiratcikk [13056273] 41
Chen HY, Chang YC, Chen W C, Lane HY Association between plasma endothelin1 and severity of different types of glaucoma Journal of Glaucoma (ISSN: 10570829) 22: (2) pp. 117122. ( 2013) Folyóiratcikk [13486943]
42
Katsi V, Pavlidis AN, Kallistratos MS, Fitsios A, Bratsas A, Tousoulis D, Stefanadis C, Manolis AJ, Kallikazaros I Cardiovascular repercussions of the pseudoexfoliation syndrome North American Journal of Medical Sciences 5: (8) pp. 454459. ( 2013) Folyóiratcikk [13486942]
43 * Dimopoulos AT, Katsanos A, Mikropoulos DG, Giannopoulos T, Empeslidis T, Teus MA, Holló G, Konstas AGP Scanning laser polarimetry in eyes with exfoliation syndrome European Journal of Ophthalmology (ISSN: 11206721) 23: (5) pp. 743750. ( 2013) Folyóiratcikk [13486941] 44
Nagata A, Omachi K, Higashide T, Shirae S, Shimazaki A, Nakamura M, Ishida N, Sugiyama K OCT Evaluation of Neuroprotective Effects of Tafluprost on Retinal Injury After Intravitreal Injection of Endothelin1 in the Rat Eye INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (ISSN: 01460404) 55: (2) pp. 10401047. ( 2014) Folyóiratcikk [14143759]
45
Atas M, Arifoglu HB, Hashas ASK, Sarli B, Demircan S, Ozkose A, Goktas A Systemic Endothelial Function in P rimary OpenAngle Glaucoma JOURNAL OF OPHTHALMOLOGY (ISSN: 2090004X) P aper 529082. (2014) Folyóiratcikk [14143758]
493. Holló G , Farkas K , Lakatos P Cutaneous cold pressor test and venous endothelin1 level in capsular and primary open angle glaucoma INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 39(4): Paper S931. (1998) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1881404] (ARVO abstract No: 4284) [ Admin láttamozott ] 494. Horányi J , Dabasi G , Lakatos P , Szlávik R , Szűcs J M ellékpajzsmirigy adenomák lokalizációs diagnosztikájának fejlődése 150 operált esetünk alapján. MAGYAR SEBÉSZET 51: p. 132. (1998) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2027989] M agyar Sebész Társaság 54. Nagygyűlése, Budapest, 1998.jún.1517. [ Admin láttamozott ] 495. Horányi J , Horváth Cs , Lakatos P , Tóth M , Forgács A , Szűcs J , Flautner L A hyperparathyreosis miatt operált esetek számának és diagnosztikájának változásai In: M EAT (szerk.) A M agyar Endokrinológiai és Anyagcsere Társaság 17. Kongresszusa . Konferencia helye, ideje: Pécs , M agyarország , 1998.08.25 1998.08.27. p. 25. Nyelv: Magyar
Egyéb konferenciaközlemény /Absztrakt /Tudományos [2033965] [ Admin láttamozott ] 496. Horváth C , Novothny G , M észáros S , Lakatos P , Szűcs J A D vitamin hiány szerepe a gondozóintézetben ápolt betegek osteopeniájában https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
313/342
3/30/2015
nyomtatobarat forma
CA ÉS CSONT 1: pp. S10S16. (1998) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1808360] [ Admin láttamozott ] 497. Horváth C , Lakatos P , Vargha P , Bereczky J , Kudlák K , Seregély K , Szalóczy P , Halász F , Varga L , M észáros S Alkardenzitometriás vizsgálatok 60123 betegen CA ÉS CSONT 1:(1) pp. 2026. (1998) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1808420] [ Érvényesített ] 498. Kucsera M , Bori Z , Takács I , Nagy Zs , Speer G , Horváth Cs , Kiss L , Szekeres L , Balogh A , Lakatos P Vitamin receptor D gene polymorphism and serum undercsrboxylated osteocalcin levels. BONE 23:(5S) p. 272. (1998) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1822253] [ Admin láttamozott ] 499. Kucsera M , Bori T , Takács I , Nagy Z , Speer G , Horváth Cs , Kiss L , Szekeres L , Balogh A , Lakatos P Vitamin receptor D gene polymorphism and serum undercarboxylated osteocalcin levels. IOF, Berlin (1998) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434008] poszter [ Admin láttamozott ] 500. Lakatos P , Nagy Z , Takács I , Speer G , Horváth C , Vargha P Az alfacalcidol kalcium és csontanyagcserére kifejtett hatásainak felmérése CA ÉS CSONT 1:(1) pp. 1519. (1998) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1335645] [ Érvényesített ] 501. Lakatos P Dhormon: a legújabb adatok CA ÉS CSONT 1:(S1) pp. S5S9. (1998) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [1808367] [ Admin láttamozott ] 502. Lakatos P Az osteoporosis diagnosztikája és kezelése PRAXIS: A MINŐSÉGI GYÓGYÍTÁS ELMÉLETE ÉS GYAKORLATA 6:(12) pp. 2527. (1998) Nyelv: Magyar
Folyóiratcikk /Rövid közlemény /Tudományos [1808423] [ Admin láttamozott ] 503. Lakatos P , Kiss L , Nagy Z , Horváth Cs Alfacalcidol in glucocorticoid induced osteoporosis:three year follow up ZEITSCHRIFT FÜR RHEUMATOLOGIE 6: p. 57. 1 p. (1998) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1818515] [ Admin láttamozott ] 504. M arton A , Keresztes K , Hermányi Zs , Búzási K , Tőzsér B , Lakatos P , Horváth Cs , Kempler P Az alsó végtagi vérellátás, csont ásványianyag tartalom, autonom és sensoros neuropathia, valamint a serum endothelin szint összefüggéseinek vizsgálata cukorbetegekben DIABETOLOGIA HUNGARICA 6:(1) p. 49. (1998) M agyar Diabetes Társaság XIV. Kongresszusa. Eger, M agyarország: 1998.04.17 1998.04.19. Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1825315] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
314/342
3/30/2015
nyomtatobarat forma
[ Admin láttamozott ] 505. M észáros Sz , Novothny Gy , Hosszú É , Lakatos P , Szűcs J , Horváth Cs Plasma 25OHD3 level is responsible for low forearm density and low phalanx sos in women but not in men living in old people's homme OSTEOPOROSIS INTERNATIONAL 8:(S3) p. 39. (1998) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [2073593] [ Admin láttamozott ] 506. Nagy Z , Speer G , Kiss L , Horváth C , Takács I , Földes J , Bossányi A , Lakatos P Az alfacalcidol szerepe a glükokortikoid kezelés okozta osteoporosis megelőzésében. Hároméves követéses vizsgálat CA ÉS CSONT 1:(S1) pp. 2024. (1998) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1335654] [ Admin láttamozott ] 507. Speer G , Nagy Zs , Takács I , Horváth Cs , Földes J , Bori Z , Kiss L , Lakatos P Endothelin és csontbiokémiai markerek hyperthyreosisban. CA ÉS CSONT 1:(S2) p. E9. (1998) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1818560] [ Admin láttamozott ]
508. Speer G , Nagy Zs , Takács I , Horváth Cs , Földes J , Bori Z , Kiss L , Lakatos P Endothelin and bone biochemical markers in hyperthyroidism. BONE 23:(5S) p. 622. (1998) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1822263] [ Admin láttamozott ] 509. Speer G , Nagy Z , Takács I , Horváth Cs , Földes J , Bori Z , Kiss L , Lakatos P Endothelin and bone biochemical markers in hyperthyroidism IOF, Berlin (1998) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434043] Poszter [ Admin láttamozott ] 510. Winkler G , Lakatos P , Nagy Z , Speer G , Salamon F , Szekeres O , Kovacs M , Cseh K Elevated serum tumor necrosis factoralpha and endothelin 1 levels correlate with increased Cpeptide concentration in android type obesity DIABETES CARE 21:(10) pp. 17781779. (1998) Nyelv: Angol
Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [1335578] CON: Diabetes Care. 1998 Feb;21(2):2717. PM ID: 9539995 CIN: Diabetes Care. 1999 M ay;22(5):86870. PM ID: 10332710 [ Érvényesített ] Független idéző: 12 Függő idéző: 1 Összesen: 13 1
FernandezReal JM, Gutierrez C, Broch M, Casamitjana R, Vendrell J, Ricart W Insulin response to intravenous glucose correlates with plasma levels of the tumor necrosis factor receptor1 DIABETES CARE (ISSN: 01495992) 22: (5) pp. 868870. ( 1999) Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [11585021]
2
Tsukui S, Kanda T, Nara M, Nishino M, Kondo T, Kobayashi I Moderateintensity regular exercise decreases serum tumor necrosis factoralpha and HbA(1c) levels in healthy women INTERNATIONAL JOURNAL OF OBESITY (ISSN: 03070565) 24: (9) pp. 12071211. ( 2000) Folyóiratcikk /Szakcikk /Tudományos [11585020]
3
Beltowski J, W ojcicka G, Gorny D, Marciniak A The effect of dietaryinduced obesity on lipid peroxidation, antioxidant enzymes and total plasma antioxidant capacity JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (ISSN: 08675910) 51: (LAHTI, FINLAND) pp. 883896. ( 2000) PN: Part 2 Folyóiratcikk /Ismertetés /Tudományos [11585019]
4
Huntington MO, Krell KE, Armour W E, Liljenquist JE Temporary reversal by topotecan of marked insulin resistance in a patient with myelodysplastic syndrome Case report and possible mechanism for tumor necrosis factor alpha (TNFalpha)induced insulin resistance AM J CLIN ONCOLCANC 24: (3) pp. 279282. ( 2001)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
315/342
3/30/2015
nyomtatobarat forma Folyóiratcikk /Szakcikk /Tudományos [11613837] 5
* Speer G, Cseh K, W inkler G, Vargha P, Braun E, Takacs I, Lakatos P Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity EUROPEAN JOURNAL OF ENDOCRINOLOGY (ISSN: 08044643) 144: (4) pp. 385389. ( 2001) Folyóiratcikk /Szakcikk /Tudományos [11585018]
6
Moon YS, Kim DH, Song DK Serum tumor necrosis factoralpha levels and components of the metabolic syndrome in obese adolescents METABOLISMCLINICAL AND EXPERIMENTAL (ISSN: 00260495) 53: (7) pp. 863867. ( 2004) Folyóiratcikk /Szakcikk /Tudományos [11585017]
7
Kita A, Yamasaki H, Kuwahara H, Moriuchi A, Fukushima K, Kobayashi M, Fukushima T, Takahashi R, Abiru N, Uotani S, Kawasaki E, Eguchi K Identification of the promoter region required for human adiponectin gene transcription: Association with CCAAT/enhancer binding proteinb and tumor necrosis factora BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (ISSN: 0006291X) 331: (2) pp. 484490. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [11585016]
8
Plomgaard P, Bouzakri K, KroghMadsen R, Mittendorfer B, Zierath JR, Pedersen BK Tumor necrosis factoralpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation DIABETES (ISSN: 00121797) 54: (10) pp. 29392945. ( 2005) Folyóiratcikk /Szakcikk /Tudományos [11585015]
9
Bouzakri K, Zierath JR MAP 4K4 gene silencing in human skeletal muscle prevents tumor necrosis factoralphainduced insulin resistance JOURNAL OF BIOLOGICAL CHEMISTRY (ISSN: 00219258) 282: (11) pp. 77837789. ( 2007) Folyóiratcikk /Szakcikk /Tudományos [11585014]
10
Austin RL, Rune A, Bouzakri K, Zierath JR, Krook A SiRNAmediated reduction of inhibitor of nuclear factorkappa B kinase prevents tumor necrosis factoralphainduced insulin resistance in human skeletal muscle DIABETES (ISSN: 00121797) 57: (8) pp. 20662073. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [11585013]
11
Rodriguez S, Gaunt TR, Abdollahi MR, Sonnenberg S, Day INM Genetic Endocrinology of the Metabolic Syndrome Hauppauge: Nova Science Publishers Inc., 2009. ( Metabolic DiseasesLaboratory and Clinical Research ) 163 p. (ISBN 9781606921685)
Könyv /Szakkönyv /Tudományos [12661586] 12
Rodriguez S, Gaunt TR, Abdollahi MR, Sonnenberg S, Day INM The Metabolic Syndrome: Genetic Effects in Endocrine P athways In: Huber MN (szerk.) : DIABETES MELLITUS RESEARCH ADVANCES. Hauppauge: Nova Science Publishers Inc., 2009. (ISBN 978160021 7111) pp. 162.
Könyvrészlet /Könyvfejezet /Tudományos [12661585] 13
Hen K, Bogdański P, Szulińska M, Jablecka A, PupekMusialik D Influence of regular physical activity on oxidative stress in women with simple obesity: Ocena wpływu regularnej aktywności fizycznej na stres oksydacyjny u kobiet z otyłościa̧ prosta̧ Polski Merkuriusz Lekarski (ISSN: 14269686) 28: (166) pp. 284288. ( 2010) Folyóiratcikk /Szakcikk /Tudományos [12661883]
1997 511. F Szalay , P Lakatos , P Lakatos Jr Plasma endothelin1 and bone mineral density in primary biliary cirrhosis. ZEITSCHRIFT FÜR GASTROENTEROLOGIE 35: p. 402. (1997) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391707] [ Admin láttamozott ] 512. Földes J , Lakatos P , Zsadányi J , Horváth C Decreased serum IGFI and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism EUROPEAN JOURNAL OF ENDOCRINOLOGY 136:(3) pp. 277281. (1997) IF: 1.968 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802563] [ Érvényesített ] 513. Holló G , Lakatos P Laser trabeculoplasty and endothelin1. An experimental study. European Society of Ophthalmology, XIth Congress, 1997, Budapest, Abstract Book p. 241. , Semmelweis Tudományos Fórum, Budapest, 1997 (előadáskivonatok 6566.o.) (1997) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [1759229] [Előadás] [ Admin láttamozott ]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
316/342
3/30/2015
nyomtatobarat forma
514. Holló G , Lakatos P , Farkas K Endothelin1 and cold pressor test in glaucoma European Society of Ophthalmology, XIth Congress, 1997, Budapest, Abstract Book p. 241 , Semmelweis Tudományos Fórum, Budapest, 1997 (előadáskivonatok 67.o.) (1997) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [1759234] [Poszter] [ Admin láttamozott ] 515. Holló G , Lakatos P , Farkas K Az endothelinek és a glaukóma: II. A vér endothelin1 szintje és a perifáriás vasospasmus SZEMÉSZET 134:(4) pp. 203207. (1997) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1808431] [ Érvényesített ] 516. Holló G , Lakatos P Az endothelinek és a glaukóma: I. A szemnyomás szabályozása, az endothelin1 szerepe az argon lézer trabeculoplastica hatásmechanizmusában SZEMÉSZET 134:(2) pp. 5559. (1997) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1808474] [ Érvényesített ] 517. P Lakatos , J Demeter , M Kucsera , Z Bori , Z M arcsek , Zs Nagy , I Takács , L Szekeres , A Balogh , L Kiss , Cs Horváth , G M essner , K Rajczy Vitamin D receptor gene polymorpism and bone mineral density in osteoporotic Hungaian patients JOURNAL OF BONE AND MINERAL RESEARCH 12:(Suppl. 1) p. F588. (1997) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1820303] [ Érvényesített ] 518. P Lakatos , L Kiss , Zs Nagy , Cs Horváth , I Takács , G Speer , J Földes , A Bossányi , E Buzás , T M ajor Alphacalcidol in glucocorticoidinduced osteoporosis: three year followup ZEITSCHRIFT FÜR RHEUMATOLOGIE 57:(Suppl. 1) p. 6. (1997) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1820336] [ Admin láttamozott ] 519. Lakatos P , Lakatos P Jr , Szalay F Decreased plasma endothelin1 in patients with compensated primary biliary cirrhosis. JOURNAL OF HEPATOLOGY 26: p. S303. (1997) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391709] [ Admin láttamozott ] 520. Lakatos P , Foldes J , Horvath C , Kiss L , Tatrai A , Takacs I , Tarjan G , Stern P H Serum interleukin6 and bone metabolism in patients with thyroid function disorders JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 82:(1) pp. 7881. (1997) IF: 4.575 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802122] [ Érvényesített ] Független idéző: 58 Függő idéző: 4 Összesen: 62 1
Aust G, W olkersdorfer G, Fritzen R, Lohmann T Clinical immunology Endocrinopathies ALLERGOLOGIE (ISSN: 03445062) 20: (12) pp. 646651. ( 1997) W C: Allergy Folyóiratcikk /Szakcikk /Tudományos [12350507]
2
Lin SC, Yamate T, Taguchi Y, Borba VZC, Girasole G, OBrien CA, Bellido T, Abe E, Manolagas SC Regulation of the gp80 and gp130 subunits of the IL6 receptor by sex steroids in the murine bone marrow JOURNAL OF CLINICAL INVESTIGATION (ISSN: 00219738) 100: (8) pp. 19801990. ( 1997) Z9: 85 W C: Medicine, Research & Experimental Folyóiratcikk /Szakcikk /Tudományos [12350506]
3
Hidaka Y, Okumura M, Shimaoka Y, Takeoka K, Tada H, Amino N Increased serum concentration of interleukin5 in patients with Graves' disease and Hashimoto's thyroiditis
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
317/342
3/30/2015
nyomtatobarat forma THYROID (ISSN: 10507256) 8: (3) pp. 235239. ( 1998) Z9: 29 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350505] 4
Motomura K, Brent GA Mechanisms of thyroid hormone action Implications for the clinical manifestation of thyrotoxicosis ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (ISSN: 08898529) 27: (1) pp. 1+. ( 1998) Z9: 17 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350504]
5
Manolagas SC The role of IL6 type cytokines and their receptors in bone In: McCann SM, Lipton JM, Sternberg EM, Chrousos GP, Gold PW, Smith CC (szerk.) : NEUROIMMUNOMODULATION: MOLECULAR ASPECTS, INTEGRATIVE SYSTEMS, AND CLINICAL ADVANCES. New York: NEW YORK ACAD SCIENCES, 2 EAST 63RD ST, NEW YORK, NY 10021 USA, 1998. pp. 194204. (ANNALS OF THE NEW YORK ACADEMY OF SCIENCES)
BE: McCann, SM : Lipton, JM : Sternberg, EM : Chrousos, GP : Gold, PW : Smith, CC Z9: 108 W C: Multidisciplinary Sciences Könyvrészlet /Konferenciaközlemény /Tudományos [12350503] 6
Siddiqi A, Burrin JM, W ood DF, Monson JP Triiodothyronine regulates the production of interleukin6 and interleukin8 in human bone marrow stromal and osteoblast like cells JOURNAL OF ENDOCRINOLOGY (ISSN: 00220795) 157: (3) pp. 453461. ( 1998) Z9: 45 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350502]
7
Siddiqi A, Monson JP, W ood DF, Besser GM, Burrin JM Serum cytokines in thyrotoxicosis JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 84: (2) pp. 435439. ( 1999) Z9: 61 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350501]
8
Kim CH, Kim HK, Shong YK, Lee KU, Kim GS Thyroid hormone stimulates basal and interleukin (IL)1induced IL6 production in human bone marrow stromal cells: a possible mediator of thyroid hormoneinduced bone loss JOURNAL OF ENDOCRINOLOGY (ISSN: 00220795) 160: (1) pp. 97102. ( 1999) Z9: 20 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350500]
9
Manolagas SC Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis ENDOCRINE REVIEWS (ISSN: 0163769X) 21: (2) pp. 115137. ( 2000) Z9: 797 W C: Endocrinology & Metabolism Folyóiratcikk /Összefoglaló cikk /Tudományos [12350499]
10
de Martino M, Galli L, Chiarelli F, Verrotti A, Rossi ME, Bindi G, Galluzzi F, Salti R, Vierucci A Interleukin6 release by cultured peripheral blood mononuclear cells inversely correlates with height velocity, bone age, insulinlike growth factorI, and insulinlike growth factor binding protein3 serum levels in children with perinatal HIV1 infection CLINICAL IMMUNOLOGY (ISSN: 15216616) 94: (3) pp. 212218. ( 2000) Z9: 24 W C: Immunology Folyóiratcikk /Szakcikk /Tudományos [12350498]
11
Banks RE Measurement of cytokines in clinical samples using immunoassays: P roblems and pitfalls CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (ISSN: 10408363) 37: (2) pp. 131182. ( 2000) Z9: 29 W C: Medical Laboratory Technology Folyóiratcikk /Összefoglaló cikk /Tudományos [12350497]
12
Lucidarme N, Ruiz JC, Czernichow P, Leger J Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves' disease JOURNAL OF PEDIATRICS (ISSN: 00223476) 137: (1) pp. 5662. ( 2000) Z9: 17 W C: Pediatrics Folyóiratcikk /Szakcikk /Tudományos [12350496]
13
Salvi M, Pedrazzoni M, Girasole G, Giuliani N, Minelli R, W all JR, Roti E Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking EUROPEAN JOURNAL OF ENDOCRINOLOGY (ISSN: 08044643) 143: (MUNICH, GERMANY) pp. 197202. ( 2000) Z9: 57 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350495]
14 * Lakatos P, Foldes J, Nagy Z, Takacs I, Speer G, Horvath C, Mohan S, Baylink DJ, Stern PH Serum insulinlike growth factorI, insulinlike growth factor binding proteins, and bone mineral content in hyperthyroidism THYROID (ISSN: 10507256) 10: (5) pp. 417423. ( 2000) Z9: 27 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350494] 15 * Takacs I, Koller DL, Peacock M, Christian JC, Evans W E, Hui SL, Conneally PM, Johnston CC, Foroud T, Econs MJ Sib pair linkage and association studies between bone mineral density and the interleukim6 gene locus BONE (ISSN: 87563282) 27: (1) pp. 169173. ( 2000) Z9: 30 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350493] 16
ObermayerPietsch B, Dobnig H, W arnkross H, Dimai HP, W eber K, Berghold A, Leb G Variable bone mass recovery in hyperthyroid bone disease after radioiodine therapy in postmenopausal patients MATURITAS (ISSN: 03785122) 35: (2) pp. 159166. ( 2000) Z9: 4 W C: Geriatrics & Gerontology; Obstetrics & Gynecology Folyóiratcikk /Szakcikk /Tudományos [12350492]
17
Vieira Soares D, Buescu A, Vaisman M Absence of specific serum cytokines profile in patients with compensated autoimmune hypothyroidism Thyroidology Clinical and Experimental 13: (13) pp. 914. ( 2001) Folyóiratcikk /Szakcikk /Tudományos [13353674]
18
Serraclara A, Jodar E, Sarabia F, Hawkins F
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
318/342
3/30/2015
nyomtatobarat forma Bone mass after longterm euthyroidism in former hyperthyroid women treated with I131 Influence of menopausal status JOURNAL OF CLINICAL DENSITOMETRY (ISSN: 10946950) 4: (3) pp. 249255. ( 2001) Z9: 5 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350491] 19
Yen PM P hysiological and molecular basis of thyroid hormone action PHYSIOLOGICAL REVIEWS (ISSN: 00319333) 81: (3) pp. 10971142. ( 2001) Z9: 694 W C: Physiology Folyóiratcikk /Összefoglaló cikk /Tudományos [12350490]
20
Giuliani N, Sansoni P, Girasole G, Vescovini R, Passeri G, Passeri M, Pedrazzoni M Serum interleukin6, soluble interleukin6 receptor and soluble gp130 exhibit different patterns of age and menopauserelated changes EXPERIMENTAL GERONTOLOGY (ISSN: 05315565) 36: (3) pp. 547557. ( 2001) Z9: 60 W C: Geriatrics & Gerontology Folyóiratcikk /Szakcikk /Tudományos [12350489]
21
Vesper HW , Demers LM, Eastell R, Garnero P, Kleerekoper M, Robins SP, Srivastava AK, W arnick GR, W atts NB, Myers GL Assessment and recommendations on factors contributing to preanalytical variability of urinary pyridinoline and deoxypyridinoline CLINICAL CHEMISTRY (ISSN: 00099147) 48: (2) pp. 220235. ( 2002) Z9: 25 W C: Medical Laboratory Technology Folyóiratcikk /Összefoglaló cikk /Tudományos [12350488]
22
Akalin A, Colak O, Alatas O, Efe B Bone remodelling markers and serum cytokines in patients with hyperthyroidism CLINICAL ENDOCRINOLOGY (ISSN: 03000664) 57: (1) pp. 125129. ( 2002) Z9: 25 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350487]
23
Seck T, Diel I, Bismar H, Ziegler R, Pfeilschifter J Expression of interleukin6 (IL6) and IL6 receptor mRNA in human bone samples from pre and postmenopausal women BONE (ISSN: 87563282) 30: (1) pp. 217222. ( 2002) Z9: 8 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350486]
24
W ahrenberg H, W ennlund A, Hoffstedt J Increased adipose tissue secretion of interleukin6, but not of leptin, plasminogen activator inhibitor1 or tumour necrosis factor alpha, in Graves' hyperthyroidism EUROPEAN JOURNAL OF ENDOCRINOLOGY (ISSN: 08044643) 146: (5) pp. 607611. ( 2002) Z9: 17 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350485]
25
Simsek G, Uzun H, Karter Y, Aydin S, Yigit G Effects of osteoporotic cytokines in ovaryintact and ovariectomised rats with induced hyperthyroidism; Is skeletal responsiveness to thyroid hormone altered in estrogen deficiency ? TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (ISSN: 00408727) 201: (2) pp. 8189. ( 2003) Z9: 4 W C: Medicine, General & Internal; Medicine, Research & Experimental Folyóiratcikk /Szakcikk /Tudományos [12350484]
26
Iqbal AA, Burgess EH, Gallina DL, Nanes MS, Cook CB Hypercalcemia in hyperthyroidism: P atterns of serum calcium, parathyroid hormone, and 1,25dihydroxyvitamin D3 levels during management of thyrotoxicosis Endocrine Practice (ISSN: 1530891X) 9: (6) pp. 517521. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [13353672]
27
Simsek G, Karter Y, Aydin S, Uzun H Osteoporotic cytokines and bone metabolism on rats with induced hyperthyroidism; changes as a result of reversal to euthyroidism CHINESE JOURNAL OF PHYSIOLOGY (ISSN: 03044920) 46: (4) pp. 181186. ( 2003) Z9: 21 W C: Physiology Folyóiratcikk /Szakcikk /Tudományos [12350483]
28
Senturk T, Kozaci LD, Kok F, Kadikoylu G, Bolaman Z P roinflammatory cytokine levels in hyperthyroidism CLINICAL AND INVESTIGATIVE MEDICINEMEDECINE CLINIQUE ET EXPERIMENTALE 26: (2) pp. 5863. ( 2003) Z9: 20 W C: Medicine, Research & Experimental Folyóiratcikk /Szakcikk /Tudományos [12350482]
29
UgurAltun B, Altun A, Arikan E, Guldiken S, Tugrul A Relationships existing between the serum cytokine levels and bone mineral density in women in the premenopausal period affected by Graves' disease with subclinical hyperthyroidism ENDOCRINE RESEARCH (ISSN: 07435800) 29: (4) pp. 389398. ( 2003) Z9: 8 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350481]
30 * Lakatos P Thyroid hormones: Beneficial or deleterious for bone? CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 73: (3) pp. 205209. ( 2003) Z9: 28 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350480] 31
Kanatani M, Sugimoto T, Sowa H, Kobayashi T, Kanzawa M, Chihara K Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKLRANK interaction JOURNAL OF CELLULAR PHYSIOLOGY (ISSN: 00219541) 201: (1) pp. 1725. ( 2004) Z9: 22 W C: Cell Biology; Physiology Folyóiratcikk /Szakcikk /Tudományos [12350479]
32
MarquesDeak A, Cizza G, Sternberg E Brainimmune interactions and disease susceptibility MOLECULAR PSYCHIATRY (ISSN: 13594184) 10: (3) pp. 239250. ( 2005) Z9: 34 W C: Biochemistry & Molecular Biology; Neurosciences; Psychiatry Folyóiratcikk /Összefoglaló cikk /Tudományos [12350478]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
319/342
3/30/2015
nyomtatobarat forma 33
Rusinska A, ChlebnaSokol D Evaluation of interleukin1 and6 in the etiopathogenesis of idiopathic osteoporosis and osteopenia in children ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (ISSN: 0004069X) 53: (3) pp. 257265. ( 2005) Z9: 7 W C: Immunology Folyóiratcikk /Szakcikk /Tudományos [12350477]
34
Sozer V, Uzun H, Guner I, Aydin S, Yucel R, Karter Y, Simsek C, Kaya S, Yigit G, Simsek G Bone metabolism in ovariectomized rats with induced hyperthyroidism: The effect of estrogen replacement CHINESE JOURNAL OF PHYSIOLOGY (ISSN: 03044920) 49: (6) pp. 335341. ( 2006) Z9: 3 W C: Physiology Folyóiratcikk /Szakcikk /Tudományos [12350476]
35
Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Barani L, Ferrannini E, Serio M Increase of interferongammainducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy CLINICAL ENDOCRINOLOGY (ISSN: 03000664) 64: (2) pp. 189195. ( 2006) Z9: 26 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350475]
36
Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Romagnani P, Grosso M, Ferrannini E, Serio M Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process EUROPEAN JOURNAL OF ENDOCRINOLOGY (ISSN: 08044643) 154: (5) pp. 651658. ( 2006) Z9: 41 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350474]
37
Zonenberg A, Telejko B, Szelachowska M, Modzelewska A, Nikołajuk A, Górska M Markers of endothelial dysfunction in patients with iodine induced hyperthyroidism Endokrynologia Polska (ISSN: 0423104X) 57: (3) pp. 210217. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [13353671]
38
Diaz Chico B Nicolks, Navarro Bosch Domingo, Diaz Chico Juan C, Escrich Escriche Eduardo Molecular mechanisms of estrogen action in target tissues In: Sanchez AC, Alsina JC, DuenasDiez JL (szerk.) : Selective Estrogen Receptor Modulators: New Brand of Multitarget Drugs. Heidelberg; New York: SpringerVerlag GmbH, 2006. (ISBN 9783540242277) p. 3
BE Sanchez, AC; Alsina, JC; DuenasDiez, JL Könyvrészlet /Könyvfejezet /Tudományos [12426334] 39
GarcíaPérez MA P hysiological regulation of bone metabolism and estrogen agonism In: Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs. Springer Berlin Heidelberg, 2006. (ISBN 3540242279) pp. 161186.
Könyvrészlet /Könyvfejezet /Tudományos [13857553] 40
Mulder JE, Moreira Kulak CA, Shane E Secondary Osteoporosis In: Dy namics of Bone and Cartilage Metabolism. Elsevier Inc., 2006. (ISBN 9780120885626) pp. 717737.
Könyvrészlet /Könyvfejezet /Tudományos [13353670] 41
Sekeroglu MR, Altun ZB, Algun E, Dulger H, Noyan T, Balaharoglu R, Ozturk M Serum cytokines and bone metabolism in patients with thyroid dysfunction ADVANCES IN THERAPY (ISSN: 0741238X) 23: (3) pp. 475480. ( 2006) Z9: 7 W C: Medicine, Research & Experimental; Pharmacology & Pharmacy Folyóiratcikk /Szakcikk /Tudományos [12350473]
42
Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Serio M, Miccoli P Serum levels of the interferongammainducible a chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy BRITISH JOURNAL OF SURGERY (ISSN: 00071323) 93: (10) pp. 12261231. ( 2006) Z9: 31 W C: Surgery Folyóiratcikk /Szakcikk /Tudományos [12350472]
43
Shinkov A Thyroid and bone metabolism. Influence of the clinical and subclinical disorders of thyroid function Endokrinologya 11: (3) pp. 132140. ( 2006) Folyóiratcikk /Összefoglaló cikk /Tudományos [13353669]
44
Dai JC, He P, Chen X, Greenfield EM TNF alpha and P TH utilize distinct mechanisms to induce IL6 and RANKL expression with markedly different kinetics BONE (ISSN: 87563282) 38: (4) pp. 509520. ( 2006) Z9: 22 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350471]
45
Mysliwiec J, Zbucki R, W innicka MM, Sawicki B, Nikolajuk A, Kaminski K, Mysliwiec P, Musial W , Bondyra Z, W alecki J, Gorska M A crucial role of interleukin6 in the pathogenesis of thyrotoxicosisrelated disturbances of bone turnover in mice HORMONE AND METABOLIC RESEARCH (ISSN: 00185043) 39: (12) pp. 884888. ( 2007) Z9: 5 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350470]
46
Simmons J, Zeitler P, Steelman J Advances in the Diagnosis and Treatment of Osteoporosis Advances in Pediatrics 54: (1) pp. 85114. ( 2007) Folyóiratcikk /Összefoglaló cikk /Tudományos [13353668]
47
Demartini ADAC, Kulak CAM, Borba VC, Cat MNL, Dondoni RS, Sandrini R, NesiFranca S, De Lacerda Filho L Bone mineral density of children and adolescents with congenital hypothyroidism ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (ISSN: 00042730) 51: (7) pp. 10841092. ( 2007) Z9: 2 W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350469]
48
Schenck PA Calcium homeostasis in thyroid disease in dogs and cats VETERINARY CLINICS OF NORTH AMERICASMALL ANIMAL PRACTICE (ISSN: 01955616) 37: (4) pp. 693+. ( 2007) Z9: 1 W C: Veterinary Sciences Folyóiratcikk /Összefoglaló cikk /Tudományos [12350468]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
320/342
3/30/2015
nyomtatobarat forma 49
W exler JA, Sharretts J Thyroid and bone ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (ISSN: 08898529) 36: (3) pp. 673+. ( 2007) Z9: 19 W C: Endocrinology & Metabolism Folyóiratcikk /Összefoglaló cikk /Tudományos [12350467]
50
Trifanescu R, Fica S, Dimuleselt D, Barbit C, Sirbu A, Rotaru M, Florea S, Purice M, Coculescu M Thyroid hormones and proinflammatory cytokines' profile in amiodaroneinduced thyrotoxicosis ACTA ENDOCRINOLOGICABUCHAREST 3: (4) pp. 417435. ( 2007) W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350466]
51
van de Ven AC, Erdtsieck RJ Changes of bone mineral density, quantitative ultrasound parameters and markers of bone turnover during treatment of hyperthyroidism NETHERLANDS JOURNAL OF MEDICINE (ISSN: 03002977) 66: (10) pp. 428432. ( 2008) Z9: 7 W C: Medicine, General & Internal Folyóiratcikk /Szakcikk /Tudományos [12350465]
52
Antonelli A, Ferri C, Fallahi P, Ferrari SM, Giuggioli D, Colaci M, Manfredi A, Frascerra S, Franzoni F, Galetta F, Ferrannini E CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis a longitudinal study RHEUMATOLOGY (ISSN: 14620324) 47: (1) pp. 4549. ( 2008) Z9: 23 W C: Rheumatology Folyóiratcikk /Szakcikk /Tudományos [12350464]
53 * Stern PH Thyroid Hormone and Bone In: Principles of Bone Biology , TwoVolume Set. Chicago: Elsevier Inc., 2008. (ISBN 9780123738844) pp. 935954.
Könyvrészlet /Könyvfejezet /Tudományos [13353667] 54
Antonelli A, Fallahi P, Delle Sedie A, Feffari SM, Maccheroni M, Bombardieri S, Riente L, Ferrannini E High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthtritis CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (ISSN: 0392856X) 27: (1) pp. 2227. ( 2009) Z9: 6 W C: Rheumatology Folyóiratcikk /Szakcikk /Tudományos [12350463]
55
Mysliwiec J, Adamczyk M, Nikolajuk A, Gorska M Interleukin6 and its considerable role in the pathogenesis of thyrotoxicosisrelated disturbances of bone turnover in postmenopausal women ENDOKRYNOLOGIA POLSKA (ISSN: 0423104X) 62: (4) pp. 299302. ( 2011) W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350462]
56
Amaresh Reddy P, Harinarayan CV, Sachan A, Suresh V, Rajagopal G Bone disease in thyrotoxicosis Indian Journal of Medical Research (ISSN: 09715916) 135: (3) pp. 277286. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13353666]
57
Kota SK, Jammula S, Kota SK, Krishna SVS, Modi KD Effect of thyroid disorders on skeletal health Turkish Journal of Endocrinology and Metabolism (ISSN: 13012193) 16: (1) pp. 1925. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13353665]
58
Gu X, Zheng L, Chen X, Ruan L, Zhang H, Ge S, Zhu H, Lin X, Shen F Elevated Serum IL16 and RANTES Levels in P atients with Autoimmune Thyroid Diseases and Modulation by Methimazole Therapy HORMONE AND METABOLIC RESEARCH (ISSN: 00185043) 44: (6) pp. 482487. ( 2012) Folyóiratcikk /Szakcikk /Tudományos [12426333]
59
Haras M, Onose G, Capisizu A, Vulpoi C EVOLUTIVE P ARTICULARITIES IN THYROTOXIC OSTEOP OROSIS ACTA ENDOCRINOLOGICABUCHAREST 8: (1) pp. 4758. ( 2012) W C: Endocrinology & Metabolism Folyóiratcikk /Szakcikk /Tudományos [12350461]
60
Rozing MP, W estendorp RGJ, Maier AB, W ijsman CA, Frolich M, de Craen AJM, van Heemst D Serum triiodothyronine levels and inflammatory cytokine production capacity AGE 34: (1) pp. 195201. ( 2012) W C: Geriatrics & Gerontology Folyóiratcikk /Szakcikk /Tudományos [12350460]
61
Chen CY, Tsai MM, Chi HC, Lin KH Biological significance of a thyroid hormoneregulated secretome BIOCHIMICA ET BIOPHYSICA ACTAPROTEINS AND PROTEOMICS (ISSN: 15709639) 1834: (11) pp. 22712284. ( 2013) Folyóiratcikk /Összefoglaló cikk /Tudományos [13857552]
62
Christy AL, D'Souza V, Babu RP, Takodara S, Manjrekar P, Hegde A, Rukmini MS Utility of Cterminal telopeptide in evaluating levothyroxine replacement therapyinduced bone loss Biomarker Insights (ISSN: 11772719) 9: pp. 16. ( 2014) Folyóiratcikk /Szakcikk /Tudományos [13857551]
521. Lakatos P , Takács I , Büki B , Németh J , Horváth C A kalciumürítés vizsgálata. (A vizelet kalcium/kreatinin hányadosának magyarországi normálértékei). M ulticentrikus tanulmány ORVOSI HETILAP 138:(22) pp. 14051409. (1997) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1802562] [ Érvényesített ] Független idéző: 2 Függő idéző: 2 Összesen: 4 https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
321/342
3/30/2015
nyomtatobarat forma 1
Vieth R, Chan PCR, MacFarlane GD Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level American Journal of Clinical Nutrition (ISSN: 00029165) 73: (2) pp. 288294. ( 2001) Folyóiratcikk /Szakcikk /Tudományos [13338691]
2 * Csupor E, Szucs J, Mészáros S, Lakatos P, Tóth E, Horváth C Bone mineral density in the renal form of primary hyperparathyroidism Lege Artis Medicinae (ISSN: 08664811) 13: (2) pp. 134138. ( 2003) Folyóiratcikk /Szakcikk /Tudományos [13338690] 3 * Rass P, Pákozdi A, Lakatos P, Zilahi E, Sipka S, Szegedi G, Szekanecz Z Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis Rheumatology International (ISSN: 01728172) 26: (11) pp. 964971. ( 2006) Folyóiratcikk /Szakcikk /Tudományos [13338689] 4
Topal C, Algun E, Sayarlioglu H, Erkoc R, Soyoral Y, Dogan E, Sekeroglu R, Cekici S Diurnal rhythm of urinary calcium excretion in adults Renal Failure (ISSN: 0886022X) 30: (5) pp. 499501. ( 2008) Folyóiratcikk /Szakcikk /Tudományos [13338688]
522. Lakatos P Oszteoporózis In: Kopper L , M arcsek Z , Kovalszky I M olekuláris medicina . 374 p. Budapest: M edicina Könyvkiadó, 1997. pp. 283285. (ISBN:9632423453) Nyelv: Magyar
Könyvrészlet /Szaktanulmány /Tudományos [1886678] [ Admin láttamozott ] 523. Lakatos P , Demeter J , Kucsera M , Bori Z , M arcsek Z , Nagy Z , Takács I , Szekeres L , Balogh A , iss L , Horváth Cs , M essner G , Rajczy K Vitamin D receptor gene polymorphism and bone mineral density in osteoporotic Hungarian patients ASBM R Kongresszus, Cincinatti (1997) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2434001] poszter [ Admin láttamozott ] 524. M arton A , Lakatos P , Horváth Cs , Vargha P , Keresztes K , Hermányi Zs , Tamási L , Fazakas Á , Tőzsér B , Búzási K , Kempler P Az alsó végtagi vérellátás, a sensoros és autonom neuropathia, a csont ásványianyagtartalom és a szérum endothelin szint vizsgálata diabeteses betegekben: első megfigyelések MAGYAR BELORVOSI ARCHIVUM 50:(4) pp. 420423. (1997) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1779903] [ Érvényesített ] 525. M arton A , Keresztes K , Hermányi Zs , Búzási K , Tőzsér B , Lakatos P , Horváth Cs , Kempler P Alsó végtagi vérellátás, csont ásványianyagtartalom, autonom és sensoros neuropathia, valamint serum endothelin összefüggéseinek vizsgálata cukorbetegekben DIABETOLOGIA HUNGARICA 6:(S1) p. 49. (1997) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2065090] [ Admin láttamozott ] 526. Nagy Z , M ohari K , Janoki G , Cseh K , Takacs I , Kiss L , Horvath C , Foldes J , Lakatos P Tumor necrosis factor alpha production and bone mineral content in hyperthyroidism JOURNAL OF BONE AND MINERAL RESEARCH 12:(Suppl. 1) p. S358. (1997) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1247258] [ Érvényesített ] 527. Nagy Z , M ohari J , Janoki G , Cseh K , Takács I , Kiss L , Horváth Cs , Földes J , Lakatos P Tunor necrosis factor alpha and bone mineral content in hyperthyroidism ASBM R Kongresszus, Cincinatti (1997) Nyelv: Angol https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
322/342
3/30/2015
nyomtatobarat forma
Egyéb /Nem besorolt /Tudományos [2433990] poszter [ Admin láttamozott ] 528. Szalay F , Lakatos P , Lakatos P Jr Plasma endothelin1 in primary biliary cirrhosis and chronic hepatitis C GASTROENTEROLOGY 112:(4. Suppl.) p. A1392. (1997) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1391708] [ Érvényesített ] 529. Takács István , Lakatos Péter Ajánlás az Alpha D3 vitamin kezelés monitorozására osteoporosisos betegeknél HÁZIORVOS TOVÁBBKÉPZŐ SZEMLE 2:(3) pp. 276278. (1997) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1802441] [ Érvényesített ]
1996 530. Földes J , Lakatos P Pajzsmirigy és osteoporosis ORVOSI HETILAP 137:(25) pp. 13471354. (1996) Nyelv: Magyar
Folyóiratcikk /Összefoglaló cikk /Tudományos [1802564] [ Érvényesített ] 531. Hosszú É , Lakatos P , Horváth Cs , Földes J Effects of growth hormone therapy on IGFBP3 and levels in children with growth hormone deficiency and Turner's syndrome MEDICAL SCIENCE MONITORINTERNATIONAL MEDICAL JOURNAL FOR EXPERIMENTAL AND CLINICAL RESEARCH 2:(S3) p. 32. (1996) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [2008670] [ Admin láttamozott ] 532. Hosszú É , Lakatos P , Horváth Cs , Földes J Effect of growth hormone therapy on IGFBP3 and CICP levels in children with growth hormone deficiency OSTEOPOROSIS INTERNATIONAL 6:(S) p. 179. 1 p. (1996) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [2061258] [ Admin láttamozott ] 533. P Lakatos , L Kiss , Cs Horváth , I Takács , J Földes , A Bossányi , E Buzás , T M ajor Effect of alphacalcidol on bone in patients treated with glucocorticoids JOURNAL OF BONE AND MINERAL RESEARCH 11:(Suppl. 1) p. S545. (1996) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1820286] [ Érvényesített ] 534. Lakatos P , Kiss L , Horvath C , Takacs I , Foldes J , Bossanyi A , Buzas E , M ajor T Glükokortikoidok okozta csontvesztés mérséklése alfacalcidollal LEGE ARTIS MEDICINAE 6:(11) pp. 624629. (1996) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1802349] [ Érvényesített ] Független idéző: 4 Összesen: 4 1
Amin S, LaValley MP, Simms RW , Felson DT The role of vitamin D in corticosteroidinduced osteoporosis: A meta analytic approach Arthritis and Rheumatism (ISSN: 00043591) 42: (8) pp. 17401751. ( 1999) Folyóiratcikk /Szakcikk /Tudományos [13366353]
2
Ringe JD, Faber H Calcium and vitamin D in the prevention and treatment of glucocorticoidinduced osteoporosis Clinical and Experimental Rheumatology (ISSN: 0392856X) 18: (5 SUP P L. 21) pp. S44S48. ( 2000) Folyóiratcikk /Összefoglaló cikk /Tudományos [13366352]
3
Amin S, Lavalley MP, Simms RW , Felson DT The comparative efficacy of drug therapies used for the management of corticosteroidinduced osteoporosis: A metaregression
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
323/342
3/30/2015
nyomtatobarat forma Journal of Bone and Mineral Research (ISSN: 08840431) 17: (8) pp. 15121526. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [13366351] 4
Ringe JD Treatment of glucocorticoidlnduced osteoporosis with calcium, vitamin D and Dmetabolites Frontiers of Hormone Research (ISSN: 03013073) 30: pp. 127135. ( 2002) Folyóiratcikk /Szakcikk /Tudományos [13366350]
535. Lakatos P , Tátrai A , Földes J , Horváth C , M akó J , Stern P H Endothelin concentrations are elevated in plasma of patients with primary and secondary hyperparathyroidism CALCIFIED TISSUE INTERNATIONAL 58:(1) pp. 7071. (1996) IF: 2.344 Nyelv: Angol
Folyóiratcikk /Rövid közlemény /Tudományos [1802565] [ Érvényesített ] Független idéző: 8 Összesen: 8 1
Achmad TH, W interscheidt A, Lindemann C, Rao GS Oxidized low density lipoprotein acts on endothelial cells in culture to enhance endothelin secretion and monocyte migration METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (ISSN: 03790355) 19: (3) pp. 153159. ( 1997) Folyóiratcikk [12432325]
2
Silverberg SJ Editorial: Cardiovascular disease in primary hyperparathyroidism JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 85: (10) pp. 35133514. ( 2000) Folyóiratcikk [12432324]
3
Silverberg SJ Nonclassical target organs in primary hyperparathyroidism JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 17: (BETHESDA, MARYLAND) pp. N117N125. ( 2002) SU 2 Folyóiratcikk [12432323]
4
Silverberg SJ, Bilezikian JP Asymptomatic primary hyperparathyroidism: a medical perspective SURGICAL CLINICS OF NORTH AMERICA (ISSN: 00396109) 84: (3) pp. 787+. ( 2004) Folyóiratcikk [12432322]
5
Letizia C, Ferrari P, Cotesta D, Caliumi C, Cianci R, Cerci S, Petramala L, Celi M, Minisola S, D'Erasmo E, Mazzuoli GF Ambulatory monitoring of blood pressure (AMBP ) in patients with primary hyperparathyroidism JOURNAL OF HUMAN HYPERTENSION (ISSN: 09509240) 19: (11) pp. 901906. ( 2005) Folyóiratcikk [12432321]
6
Bollerslev J, Rosen T, Mollerup CL, Nordenstrom J, Baranowski M, Franco C, Pernow Y, Isaksen GA, Godang K, Ueland T, Jansson S Effect of Surgery on Cardiovascular Risk Factors in Mild P rimary Hyperparathyroidism JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 94: (7) pp. 22552261. ( 2009) CA SIPH Study Grp Folyóiratcikk [12432320]
7
Vaidya A, Forman JP Vitamin D and Hypertension Current Evidence and Future Directions HYPERTENSION (ISSN: 0194911X) 56: (5) pp. 774779. ( 2010) Folyóiratcikk [12432319]
8
Persson A, Bollerslev J, Rosen T, Mollerup CL, Franco C, Isaksen GA, Ueland T, Jansson S, Caidahl K Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism CLINICAL ENDOCRINOLOGY (ISSN: 03000664) 74: (2) pp. 174180. ( 2011) CA Grp, SS Folyóiratcikk [12432318]
536. Lakatos P Az ipriflavon hatása a kalcium és csontanyagcserére, valamint a porcra In: Horváth Cs (szerk.) Osteochin (Ipriflavon) az osteoporosis kezelésében: Preklinikai és klinikai monográfia . 184 p. Budapest: M edintel Kiadó, 1996. pp. 5460. (ISBN:9638433116) Nyelv: Magyar
Könyvrészlet /Szaktanulmány /Tudományos [1886654] [ Admin láttamozott ] 537. Lakatos P Kontrollált vizsgálatok senilis osteoporosisban In: Horváth Cs (szerk.) Osteochin (Ipriflavon) az osteoporosis kezelésében: Preklinikai és klinikai monográfia . 184 p. Budapest: M edintel Kiadó, 1996. pp. 118122. (ISBN:9638433116) Nyelv: Magyar
Könyvrészlet /Szaktanulmány /Tudományos [1886672] [ Admin láttamozott ]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
324/342
3/30/2015
nyomtatobarat forma
538. Lakatos P , Kiss L , Horváth Cs , Földes J , Bossányi A , Búzás E , M ajor T Effect of 1alphaOHvitamin D3 on bone metabolism in patients treated with glucocorticoid OSTEOPOROSIS INTERNATIONAL 6:(S1) p. 279. (1996) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [2061265] [ Admin láttamozott ] 539. Lakatos P , Kiss L , Horváth Cs , Földes J , Bossányi A , Búzás E , M ajor T Glükokortikoidok okozta csontvesztés csökkentése alfacalcidol kezeléssel MAGYAR BELORVOSI ARCHIVUM 49:(S2) p. 172. (1996) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [2061317] [ Admin láttamozott ] 540. Lakatos P , Kiss L , Horváth Cs , Takács I , Földes J , Bossanyi A , Buzas E , M ajor T Effect of alphacalcidol on bone in patients treated with glucocorticoids ASBM R Kongresszus, Seattle (1996) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2433988] poszter [ Admin láttamozott ] 541. M arton A , Keresztes K , Hermányi Zs , Lakatos P , Horváth Cs , Tamási L , Zempléni M , Fazekas Á , Kempler P Alsó végtagi obliterativ arteriopathia, sensoros és autonom neuropathia, serum endothelin aktivitás és a csont ásványi anyagtartalom összefüggéseinek vizsgálata diabeteses betegeken DIABETOLOGIA HUNGARICA 4:(1) p. 35. (1996) M agyar Diabetes Társaság XIII. Kongresszusa. Keszthely, M agyarország: 1996.03.30 1996.04.02. Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1822333] [ Admin láttamozott ] 542. M arton A , Keresztes K , Hermányi Zs , Lakatos P , Horváth Cs , Tamási L , Fazakas Á , Zempléni M , Kempler P Is there connection between lower limb blood flow, autonomic and sensory neuropathy, serum endothelin activity and osteoporosis in diabetic patients? DIABETOLOGIA: CLINICAL AND EXPERIMENTAL DIABETES AND METABOLISM 39:(Suppl. 1) p. A259. (1996) 32nd Annual M eeting of the European Association for the Study of Diabetes. Vienna, Ausztria: 1996.09.01 1996.09.05. Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1822423] [ Érvényesített ] 543. M arton A , Lakatos P , Horváth Cs , Hermányi Zs , Vargha P , Fazekas A , Kempler P , Zemplényi M , Tamási L Is there correlation between lower limb blood flow, autonomic and sensory neuropathy, serum endothelin activity and osteoporosis in diabetic patients? MEDICAL SCIENCE MONITORINTERNATIONAL MEDICAL JOURNAL FOR EXPERIMENTAL AND CLINICAL RESEARCH 2:(3) p. 15. (1996) V. Semmelweis Science Fair. Budapest, M agyarország: 1996.09.26 1996.09.27. Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1822741] [ Admin láttamozott ] 544. M arton A , Lakatos P , Horváth Cs , Keresztes K , Hermányi Zs , Vargha P , Fazekas Á , Tamási L , Zempléni M , Kempler P Alsó végtagi obliterativ arteriopathia, szenzoros és autonom neuropathia, szérum endothelin szint és a csont ásványianyagtartalom összefüggéseinek vizsgálata diabeteses betegeken MAGYAR BELORVOSI ARCHIVUM 49:(2) p. 178. (1996) M agyar Belgyógyász Társaság XXXVI. Nagygyűlése. Budapest, M agyarország: 1996.11.21 1996.11.23. Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1822778] [ Admin láttamozott ] 545. Szalay F , Lakatos P , Lakatos P Jr https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
325/342
3/30/2015
nyomtatobarat forma
Plazma endothelin1 szint primer biliáris cirrhosisban; krónikus C hepatitisben és egyéb májbetegségekben. MAGYAR BELORVOSI ARCHIVUM 49:(SUPPL 2) p. 201. (1996) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1391712] [ Admin láttamozott ] 546. I Takács , L Kiss , Cs Horváth , J Földes , P Lakatos Serum levels of type I collagen carboxyterminal propeptide and bone metabolism in hyperthyroidism. JOURNAL OF BONE AND MINERAL RESEARCH 11:(Suppl. 1) p. T565. (1996) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1820279] [ Érvényesített ] 547. Takács I , Kiss L , Horváth Cs , Földes J , Lakatos P Serum levels of type I. collagen carboxyterminal propeptide and bone metabolism in hyperthyroidism ASBM R Kongresszus, Seattle (1996) Nyelv: Angol
Egyéb /Nem besorolt /Tudományos [2433984] poszter [ Admin láttamozott ]
1995 548. Bálint É , Lakatos P Diurnális ritmusok a kalciumanyagcserében LEGE ARTIS MEDICINAE 5:(4) pp. 330335. (1995) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1974349] [ Érvényesített ] 549. Lakatos P , Blumsohn A , Eastell R , Tarjan G , Shinoda H , Stern P H Circadian rhythm of in vitro boneresorbing activity in human serum JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 80:(11) pp. 31853190. (1995) IF: 4.002 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802370] [ Érvényesített ] Független idéző: 20 Függő idéző: 4 Összesen: 24 1
Greenspan SL, Holland S, MaitlandRamsey L, Poku M, Freeman A, Yuan W Y, Kher U, Gertz B Alendronate stimulation of nocturnal parathyroid hormone secretion: A mechanism to explain the continued improvement in bone mineral density accompanying alendronate therapy PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS (ISSN: 1081650X) 108: (3) pp. 230238. ( 1996) Folyóiratcikk [12428889]
2
Vesely DL, Sothern RB, Scheving LE, Bremner FW , Third JLHC, McCormick JB, Dawson S, Kahn S, Augustine G, Ryan M, Greco J, Nemchausky BA, Shirazi P, Kanabrocki EL Circadian relationships between circulating atrial natriuretic peptides and serum calcium and phosphate in healthy humans METABOLISMCLINICAL AND EXPERIMENTAL (ISSN: 00260495) 45: (8) pp. 10211028. ( 1996) Folyóiratcikk [12428888]
3
McKane W R, Khosla S, Egan KS, Robins SP, Burritt MF, Riggs BL Role of calcium intake in modulating agerelated increases in parathyroid function and bone resorption JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 81: (5) pp. 16991703. ( 1996) Folyóiratcikk [12428887]
4
Samuels MH, Veldhuis JD, Kramer P, Urban RJ, Bauer R, Mundy GR Episodic secretion of parathyroid hormone in postmenopausal women: Assessment by deconvolution analysis and approximate entropy JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 12: (4) pp. 616623. ( 1997) Folyóiratcikk [12428886]
5
Fujita T, Ohgitani S, Fujii Y Overnight suppression of parathyroid hormone and bone resorption markers by active absorbable algae calcium. A doubleblind crossover study CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 60: (6) pp. 506512. ( 1997) Folyóiratcikk [12428885]
6
Gertz BJ, Clemens JD, Holland SD, Yuan W , Greenspan S Application of a new serum assay for type I collagen crosslinked Ntelopeptides: Assessment of diurnal changes in bone turnover with and without alendronate treatment CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 63: (SEATTLE, WASHINGTON) pp. 102106. ( 1998) Folyóiratcikk [12428884]
7
Scopacasa F, Horowitz M, W ishart JM, Need AG, Morris HA, W ittert G, Nordin BEC Calcium supplementation suppresses bone resorption in early postmenopausal women CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 62: (1) pp. 812. ( 1998)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
326/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [12428883] 8
* Igarashi K, Miyoshi K, Shinoda H, Saeki S, Mitani H Diurnal variation in tooth movement in response to orthodontic force in rats AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS (ISSN: 08895406) 114: (1) pp. 814. ( 1998) Folyóiratcikk [12428882]
9
Heshmati HM, Riggs BL, Burritt MF, McAlister CA, W ollan P, Khosla S Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 83: (3) pp. 751756. ( 1998) Folyóiratcikk [12428881]
10
Black A, Schoknecht PA, Ralston SL, Shapses SA Diurnal variation and of age differences in the biochemical markers of bone turnover in horses JOURNAL OF ANIMAL SCIENCE (JAS) (ISSN: 00218812) 77: (1) pp. 7583. ( 1999) Folyóiratcikk [12428880]
11
Zikan V, Haas T, Stepan JJ Acute effects in healthy women of oral calcium on the calciumparathyroid axis and bone resorption as assessed by serum beta CrossLaps CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 68: (6) pp. 352357. ( 2001) Folyóiratcikk [12428879]
12 * Miyoshi K, Igarashi K, Saeki S, Shinoda H, Mitani H Tooth movement and changes in periodontal tissue in response to orthodontic force in rats vary depending on the time of day the force is applied EUROPEAN JOURNAL OF ORTHODONTICS (ISSN: 01415387) 23: (4) pp. 329338. ( 2001) Folyóiratcikk [12428878] 13
Ostrowska Z, KosKudla B, Marek B, Kajdaniuk D, CiesielskaKopacz N The relationship between the daily profile of chosen biochemical markers of bone metabolism and melatonin and other hormone secretion in rats under physiological conditions NEUROENDOCRINOLOGY LETTERS (ISSN: 0172780X) 23: (56) pp. 417425. ( 2002) Folyóiratcikk [12428877]
14 * Shao P, OhtsukaIsoya M, Shinoda H Circadian rhythms in serum bone markers and their relation to the effect of etidronate in rats CHRONOBIOLOGY INTERNATIONAL (ISSN: 07420528) 20: (2) pp. 325336. ( 2003) Folyóiratcikk [12428876] 15
Henriksen DB, Alexandersen P, Bjarnason NH, Vilsboll T, Hartmann B, Henriksen EEG, Byrjalsen I, Krarup T, Holst JJ, Christiansen C Role of gastrointestinal hormones in postprandial reduction of bone resorption JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 18: (12) pp. 21802189. ( 2003) Folyóiratcikk [12428875]
16
Henriksen DB, Alexandersen P, Byrjalsen I, Hartmann B, Bone HG, Christiansen C, Holst JJ Reduction of nocturnal rise in bone resorption by subcutaneous GLP 2 BONE (ISSN: 87563282) 34: (1) pp. 140147. ( 2004) Folyóiratcikk [12428874]
17 * Clowes JA, Khosla S, Eastell R P otential role of pancreatic and enteric hormones in regulating bone turnover JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 20: (9) pp. 14971506. ( 2005) Folyóiratcikk [12428873] 18
Schmitt CP, Homme M, Schaefer F Structural organization and biological relevance of oscillatory parathyroid hormone secretion PEDIATRIC NEPHROLOGY (ISSN: 0931041X) 20: (Heidelberg, GERMANY) pp. 346351. ( 2005) Folyóiratcikk [12428872]
19
Zvonic S, Ptitsyn AA, Kilroy G, W u XY, Conrad SA, Scott LK, Guilak F, Pelled G, Gazit D, Gimble JM Circadian oscillation of gene expression in murine calvarial bone JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 22: (3) pp. 357365. ( 2007) Folyóiratcikk [12428871]
20
Straub RH, Cutolo M Circadian rhythms in rheumatoid arthritis Implications for pathophysiology and therapeutic management ARTHRITIS AND RHEUMATISM (ISSN: 00043591) 56: (2) pp. 399408. ( 2007) Folyóiratcikk [12428870]
21
Cutolo M, Straub RH Circadian rhythms in arthritis: Hormonal effects on the immune/inflammatory reaction AUTOIMMUNITY REVIEWS (ISSN: 15689972) 7: (Tel Aviv, ISRAEL) pp. 223228. ( 2008) Folyóiratcikk [12428869]
22
Tsuruoka S, Hasegawa G, Kaneda T, Maeda A, Fujimura A Dosing timedependent effect of raloxifene on plasma fibrinogen concentration in ovariectomized rats CHRONOBIOLOGY INTERNATIONAL (ISSN: 07420528) 25: (5) pp. 808818. ( 2008) Folyóiratcikk [12428868]
23
W alsh JS, Henriksen DB Feeding and bone ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (ISSN: 00039861) 503: (1) pp. 1119. ( 2010) Folyóiratcikk [12428867]
24
Spies CM, Cutolo M, Straub RH, Burmester GR, Buttgereit F More Night Than Day Circadian Rhythms in P olymyalgia Rheumatica and Ankylosing Spondylitis JOURNAL OF RHEUMATOLOGY (ISSN: 0315162X) 37: (5) pp. 894899. ( 2010) Folyóiratcikk [12428866]
550. Lakatos P , Tátrai Á , Földes J , Kiss L , Horváth Cs , M akó J , Stern P H https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
327/342
3/30/2015
nyomtatobarat forma
Plasma endothelin levels in primary and secondary hyperparathyroidism JOURNAL OF BONE AND MINERAL RESEARCH 10:(Suppl. 1) p. S402. (1995) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1880751] [ Érvényesített ] 551. Lakatos Péter (szerk.) Osteoporosis, osteomalacia, hyperparathyreosis a gyakorlatban Budapest: SOTE, 1995. (ISBN:963 7731 61 X) Nyelv: Magyar
Könyv /Szakkönyv /Tudományos [1547142] [ Szerzői rekord ] 552. Poór Gy , Holló I , Balogh Á , Bálint G , Bély M , Berkő P , Bossányi A , Forgács S , Halász K , Horváth Cs , Kollin É , Lakatos P , M arton I , Pap K , Szathmári M , Szekeres L , Szűcs J A Nemzeti Osteoporosis Program irányelvei ORVOSI HETILAP 136:(53) pp. 29132918. (1995) Nyelv: Magyar
Folyóiratcikk /Jelentés /Tudományos [1811019] [ Szerzői rekord ] 553. Stern P H , Tatrai A , Semler D E , Suk Kyeong Lee , Lakatos P , Strieleman P J , Tarjan G , Sanders J L Endothelin receptors, second messengers, and actions in bone JOURNAL OF NUTRITION 125:(7 Suppl) pp. 2028S2032S. (1995) Nyelv: Angol
Folyóiratcikk /Konferenciaközlemény /Tudományos [1802369] [ Érvényesített ]
1993 554. Haga C S , Lakatos P , Osetek E , Stern P H The effect of elevated calcium on bone cells and neuronal cells. NORTHWESTERN DENTAL RESEARCH 4:(1) pp. 46. (1993) Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802373] [ Érvényesített ] 555. Lakatos P , Caplice M D , Khanna V , Stern P H Thyroid hormones increase insulinlike growth factor I content in the medium of rat bone tissue JOURNAL OF BONE AND MINERAL RESEARCH 8:(12) pp. 14751481. (1993) IF: 5.243 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802374] [ Érvényesített ] Független idéző: 19 Függő idéző: 6 Összesen: 25 1
KAW AGUCHI H, PILBEAM CC, RAISZ LG ANABOLIC EFFECTS OF 3,3',5TRIIODOTHYRONINE AND TRIIODOTHYROACETIC ACID IN CULTURED NEONATAL MOUSE P ARIETAL BONES ENDOCRINOLOGY (ISSN: 00137227) 135: (3) pp. 971976. ( 1994) Folyóiratcikk [12432011]
2
VARGA F, RUMPLER M, KLAUSHOFER K THYROIDHORMONES INCREASE INSULINLIKE GROWTHFACTOR MESSENGERRNA LEVELS IN THE CLONAL OSTEOBLASTIC CELLLINE MC3T3E1 FEBS LETTERS (ISSN: 00145793) 345: (1) pp. 6770. ( 1994) Folyóiratcikk [12432010]
3
KLAUSHOFER K, VARGA F, GLANTSCHNIG H, FRATZLZELMAN N, CZERW ENKA E, LEIS HJ, KOLLER K, PETERLIK M THE REGULATORY ROLE OF THYROIDHORMONES IN BONE CELLGROWTH AND DIFFERENTIATION JOURNAL OF NUTRITION (ISSN: 00223166) 125: (VIENNA, AUSTRIA) pp. S1996S2003. ( 1995) SU S Folyóiratcikk [12432009]
4
Akita S, Hirano A, Fujii T Identification of IGFI in the calvarial suture of young rats: Histochemical analysis of the cranial sagittal sutures in a hyperthyroid rat model PLASTIC AND RECONSTRUCTIVE SURGERY (ISSN: 00321052) 97: (1) pp. 112. ( 1996) Folyóiratcikk [12432008]
5
Glantschnig H, Varga F, Klaushofer K Thyroid hormone and retinoic acid induce the synthesis of insulinlike growth factorbinding protein4 in mouse osteoblastic cells ENDOCRINOLOGY (ISSN: 00137227) 137: (1) pp. 281286. ( 1996) Folyóiratcikk [12432007]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
328/342
3/30/2015
nyomtatobarat forma 6
* Foldes J, Lakatos P, Zsadanyi J, Horvath C Decreased serum IGFI and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism EUROPEAN JOURNAL OF ENDOCRINOLOGY (ISSN: 08044643) 136: (3) pp. 277281. ( 1997) Folyóiratcikk [12432006]
7
* Lakatos P, Foldes J, Horvath C, Kiss L, Tatrai A, Takacs I, Tarjan G, Stern PH Serum interleukin6 and bone metabolism in patients with thyroid function disorders JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (ISSN: 0021972X) 82: (1) pp. 7881. ( 1997) Folyóiratcikk [12432005]
8
VasilatosYounken R, Dunnington EA, Siegel PB, McMurtry JP Tissuespecific alterations in insulinlike growth factorI concentrations in response to 3,3',5triiodoLthyronine supplementation in the growth hormone receptordeficient sexlinked dwarf chicken GENERAL AND COMPARATIVE ENDOCRINOLOGY (ISSN: 00166480) 105: (1) pp. 3139. ( 1997) Folyóiratcikk [12432004]
9
Seck T, ScheidtNave C, Ziegler R, Pfeilschifter J P ositive association between circulating free thyroxine and insulinlike growth factor I concentrations in euthyroid elderly individuals CLINICAL ENDOCRINOLOGY (ISSN: 03000664) 48: (3) pp. 361366. ( 1998) Folyóiratcikk [12432003]
10
Morales O, Lindgren U, Haldosen LA Growth hormoneregulated intracellular signaling in UMR 106 osteosarcoma cells JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 15: (11) pp. 22842290. ( 2000) Folyóiratcikk [12432002]
11 * Huang BK, Golden LA, Tarjan G, Madison LD, Stern PH Insulinlike growth factor I production is essential for anabolic effects of thyroid hormone in osteoblasts JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 15: (SAN FRANCISCO, CALIFORNIA) pp. 188197. ( 2000) Folyóiratcikk [12432001] 12 * Lakatos P, Foldes J, Nagy Z, Takacs I, Speer G, Horvath C, Mohan S, Baylink DJ, Stern PH Serum insulinlike growth factorI, insulinlike growth factor binding proteins, and bone mineral content in hyperthyroidism THYROID (ISSN: 10507256) 10: (5) pp. 417423. ( 2000) Folyóiratcikk [12432000] 13
Bland R Steroid hormone receptor expression and action in bone CLINICAL SCIENCE (ISSN: 01435221) 98: (2) pp. 217240. ( 2000) Folyóiratcikk [12431999]
14
Hulbert AJ Thyroid hormones and their effects: a new perspective BIOLOGICAL REVIEWS (ISSN: 14647931) 75: (4) pp. 519631. ( 2000) Folyóiratcikk [12431998]
15
McCarthy AD, Etcheverry SB, Cortizo AM Effect of advanced glycation endproducts on the secretion of insulinlike growth factorI and its binding proteins: role in osteoblast development ACTA DIABETOLOGICA (ISSN: 09405429) 38: (3) pp. 113122. ( 2001) Folyóiratcikk [12431997]
16
Pepene CE, Kasperk CH, Pfeilschifter J, Borcsok I, Gozariu L, Ziegler R, Seck T Effects of triiodothyronine on the insulinlike growth factor system in primary human osteoblastic cells in vitro BONE (ISSN: 87563282) 29: (6) pp. 540546. ( 2001) Folyóiratcikk [12431996]
17
Robson H, Siebler T, Shalet SM, W illiams GR Interactions between GH, IGFI, glucocorticoids, and thyroid hormones during skeletal growth PEDIATRIC RESEARCH (ISSN: 00313998) 52: (2) P aper UNSP 00313998/02/52020137. (2002) Folyóiratcikk /Összefoglaló cikk /Tudományos [12431995]
18
Harvey CB, O'Shea PJ, Scott AJ, Robson H, Siebler T, Shalet SM, Smarut J, Chassande O, W illiams GR Molecular mechanisms of thyroid hormone effects on bone growth and function MOLECULAR GENETICS AND METABOLISM (ISSN: 10967192) 75: (1) pp. 1730. ( 2002) Folyóiratcikk [12431994]
19 * Bhattacharyya RS, Stern PH IGFI and MAP kinase involvement in the stimulatory effects of LNCaP prostate cancer cell conditioned media on cell proliferation and protein synthesis in MC3T3E1 osteoblastic cells JOURNAL OF CELLULAR BIOCHEMISTRY (ISSN: 07302312) 90: (5) pp. 925937. ( 2003) Folyóiratcikk [12431993] 20
Pepene CE, Seck T, Pfeilschifter J, Gozariu L, Ziegler R, Kasperk CH The effects of triiodothyronine on human osteoblastlike cells metabolism and interactions with growth hormone EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (ISSN: 09477349) 111: (2) pp. 6672. ( 2003) Folyóiratcikk [12431992]
21 * Lakatos P Thyroid hormones: Beneficial or deleterious for bone? CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 73: (3) pp. 205209. ( 2003) Folyóiratcikk [12431991] 22
O'Shea PJ, Bassett JHD, Sriskantharajah S, Ying H, Cheng SY, W illiams GR Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alpha 1 or beta MOLECULAR ENDOCRINOLOGY (ISSN: 08888809) 19: (12) pp. 30453059. ( 2005) Folyóiratcikk [12431990]
23
Davis PJ Cytokines and growth factors and thyroid hormone CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (ISSN: 1752296X) 15: (5) pp. 428428. ( 2008) Folyóiratcikk [12431989]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
329/342
3/30/2015
nyomtatobarat forma 24
Giustina A, Mazziotti G, Canalis E Growth hormone, insulinlike growth factors, and the skeleton ENDOCRINE REVIEWS (ISSN: 0163769X) 29: (5) pp. 535559. ( 2008) Folyóiratcikk [12431988]
25
Linares GR, Xing W R, Burghardt H, Baumgartner B, Chen ST, Ricart W , FernandezReal JM, Zorzano A, Mohan S Role of diabetes and obesityrelated protein in the regulation of osteoblast differentiation AMERICAN JOURNAL OF PHYSIOLOGYENDOCRINOLOGY AND METABOLISM (ISSN: 01931849) 301: (1) pp. E40E48. ( 2011) Folyóiratcikk [12431987]
556. Nii M M , Lakatos P , Osetek E M , Stern P H Effects of high calcium on bone metabolism. NORTHWESTERN DENTAL RESEARCH 4:(1) pp. 78. (1993) Nyelv: Angol
Folyóiratcikk /Rövid közlemény /Tudományos [1802371] [ Érvényesített ] 557. Stern PH , Lakatos P , Blumsohn A , Tarjan G , Shinoda H , Eastell R Relation of diurnal rythm of cortisol to boneresorbing activity in human serum In: Christiansen C , Riis B (szerk.) Fourth International Symposium on Osteoporosis . Denmark: Proceedings of Science, 1993. pp. 263264. Nyelv: Angol
Könyvrészlet /Konferenciaközlemény /Tudományos [1886544] [ Admin láttamozott ] 558. Tanguay D , Schwarz R D , Greene C S , Forbes D P , Perry H T , Lakatos P , Stern P H Temporomandibular joint synovial fluid effect on resorption of mouse calvarial bone in vitro. NORTHWESTERN DENTAL RESEARCH 4:(1) pp. 1116. (1993) Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802372] [ Érvényesített ]
1992 559. Lakatos P , Tatrai A , Stern P H Effects of gallium nitrate on calcium transients in UM R106 rat osteoblastic osteosarcoma cells BONE 13:(5) pp. 379386. (1992) IF: 2.405 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802375] M anufacturers: fujisawa pharmaceutical, United States [ Érvényesített ] Független idéző: 4 Összesen: 4 1
COLOMINA MT, LLOBET JM, SIRVENT JJ, DOMINGO JL, CORBELLA J EVALUATION OF THE REP RODUCTIVE TOXICITY OF GALLIUM NITRATE IN MICE FOOD AND CHEMICAL TOXICOLOGY (ISSN: 02786915) 31: (11) pp. 847851. ( 1993) Folyóiratcikk [12432564]
2
STERN LS, MATKOVIC V, W EISBRODE SE, APSELOFF G, SHEPARD DR, MAYS DC, GERBER N THE EFFECTS OF GALLIUM NITRATE ON OSTEOP ENIA INDUCED BY OVARIECTOMY AND A LOWCALCIUM DIET IN RATS BONE AND MINERAL (ISSN: 01696009) 25: (1) pp. 5969. ( 1994) Folyóiratcikk [12432563]
3
Bernstein LR Mechanisms of therapeutic activity for gallium PHARMACOLOGICAL REVIEWS (ISSN: 00316997) 50: (4) pp. 665682. ( 1998) Folyóiratcikk [12432562]
4
Cortizo MC, Oberti TG, Cortizo MS, Cortizo AM, de Mele MAFL Chlorhexidine delivery system from titanium/polybenzyl acrylate coating: Evaluation of cytotoxicity and early bacterial adhesion JOURNAL OF DENTISTRY (ISSN: 03005712) 40: (4) pp. 329337. ( 2012) Folyóiratcikk [12432561]
560. Lakatos P , Stern P H Effects of cyclosporins and transforming growth factor β1 on thyroid hormone action in cultured fetal rat limb bones CALCIFIED TISSUE INTERNATIONAL 50:(2) pp. 123128. (1992) IF: 1.931 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802377] M anufacturers: sandoz, United States; sigma, United States; smith kline beecham, United States [ Érvényesített ] Független idéző: 7 Függő idéző: 3 Összesen: 10 1
* SHANKAR G, STERN PH INTERACTIONS OF TUMORNECROSISFACTOR WITH LOCAL AND SYSTEMIC FACTORS IN FETALRAT LIMB BONES
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
330/342
3/30/2015
nyomtatobarat forma CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 51: (5) pp. 387392. ( 1992) Folyóiratcikk [12432230] 2
* LAKATOS P, CAPLICE MD, KHANNA V, STERN PH THYROIDHORMONES INCREASE INSULINLIKE GROWTH FACTORI CONTENT IN THE MEDIUM OF RAT BONE TISSUE JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 8: (12) pp. 14751481. ( 1993) Folyóiratcikk [12432229]
3
RUCINSKI B, LIU CC, EPSTEIN S UTILIZATION OF CYCLOSP ORINEH TO ELUCIDATE THE P OSSIBLE MECHANISMS OF CYCLOSP ORINEA INDUCED OSTEOP ENIA IN THE RAT METABOLISMCLINICAL AND EXPERIMENTAL (ISSN: 00260495) 43: (9) pp. 11141118. ( 1994) Folyóiratcikk [12432228]
4
KLAUSHOFER K, VARGA F, GLANTSCHNIG H, FRATZLZELMAN N, CZERW ENKA E, LEIS HJ, KOLLER K, PETERLIK M THE REGULATORY ROLE OF THYROIDHORMONES IN BONE CELLGROWTH AND DIFFERENTIATION JOURNAL OF NUTRITION (ISSN: 00223166) 125: (VIENNA, AUSTRIA) pp. S1996S2003. ( 1995) SU S Folyóiratcikk [12432227]
5
Gouveia CHA, Jorgetti V, Bianco AC Effects of thyroid hormone administration and estrogen deficiency on bone mass of female rats JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 12: (12) pp. 20982107. ( 1997) Folyóiratcikk [12432226]
6
Akiyama N, Matsuo Y, Sai H, Noda M, KizakaKondoh S Identification of a series of transforming growth factor betaresponsive genes by retrovirusmediated gene trap screening MOLECULAR AND CELLULAR BIOLOGY (ISSN: 02707306) 20: (9) pp. 32663273. ( 2000) Folyóiratcikk [12432225]
7
Yen PM P hysiological and molecular basis of thyroid hormone action PHYSIOLOGICAL REVIEWS (ISSN: 00319333) 81: (3) pp. 10971142. ( 2001) Folyóiratcikk [12432224]
8
Harvey CB, O'Shea PJ, Scott AJ, Robson H, Siebler T, Shalet SM, Smarut J, Chassande O, W illiams GR Molecular mechanisms of thyroid hormone effects on bone growth and function MOLECULAR GENETICS AND METABOLISM (ISSN: 10967192) 75: (1) pp. 1730. ( 2002) Folyóiratcikk [12432223]
9
10
* Lakatos P Thyroid hormones: Beneficial or deleterious for bone? CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 73: (3) pp. 205209. ( 2003) Folyóiratcikk [12432222] Fujikawa M, Kamihira K, Sato K, Okamura K, Kidota S, Lida M Elevated bone resorption markers in a patient with hypercalcemia associated with postpartum thyrotoxicosis and hypoadrenocorticism due to pituitary failure JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (ISSN: 03914097) 27: (8) pp. 782787. ( 2004) Folyóiratcikk [12432221]
561. Stern PH , Lakatos P Effect of pharmacological agents on osteoclasts In: Rifkin BR , Gay CV (szerk.) Biology and physiology of the osteoclast . Boca Raton FL: CRC Press, 1992. pp. 357395. (ISBN:9780849354373) Nyelv: Angol
Könyvrészlet /Szaktanulmány /Tudományos [1886558] [ Admin láttamozott ] 562. Tatrai A , Foster S , Lakatos P , Shankar G , Stern P H Endothelin1 actions on resorption, collagen and noncollagen protein synthesis, and phosphatidylinositol turnover in bone organ cultures ENDOCRINOLOGY 131:(2) pp. 603607. (1992) IF: 4.771 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802376] [ Érvényesített ] 563. Tatrai A , Lakatos P , Thompson S , Stern P H Effects of endothelin1 on signal transduction in UM R106 osteoblastic cells JOURNAL OF BONE AND MINERAL RESEARCH 7:(10) pp. 12011209. (1992) IF: 4.758 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802378] M anufacturers: calbiochem, United States; sigma, United States [ Érvényesített ] Független idéző: 19 Függő idéző: 7 Összesen: 26 1
* TATRAI A, STERN PH ENDOTHELIN1 MODULATES CALCIUM SIGNALING BY EP IDERMAL GROWTHFACTOR, ALP HATHROMBIN, AND P ROSTAGLANDINE(1) IN UMR106 OSTEOBLASTIC CELLS JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 8: (8) pp. 943952. ( 1993) Z9: 16 W C: Endocrinology & Metabolism
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
331/342
3/30/2015
nyomtatobarat forma Folyóiratcikk [12350587] 2
* HAGA CS, STERN PH RESP ONSES OF OSTEOBLASTIC CELLS (UMR106) EXP OSED TO ELEVATED EXTRACELLULAR CALCIUM JOURNAL OF ENDODONTICS (ISSN: 00992399) 19: (9) pp. 462465. ( 1993) Z9: 3 W C: Dentistry, Oral Surgery & Medicine Folyóiratcikk [12350586]
3
GREEN J, FOELLMER O, KLEEMAN CR, BASIC MM ENDOTHELIN RECEP TOR IN OSTEOBLASTIC CELLS IS COUP LED TO MULTIP LE MESSENGER SIGNALS AMERICAN JOURNAL OF PHYSIOLOGYCELL PHYSIOLOGY (ISSN: 03636143) 267: (5) pp. C1329C1337. ( 1994) Z9: 6 W C: Cell Biology; Physiology Folyóiratcikk [12350585]
4
RUBANYI GM, POLOKOFF MA ENDOTHELINS MOLECULARBIOLOGY, BIOCHEMISTRY, P HARMACOLOGY, P HYSIOLOGY, AND P ATHOP HYSIOLOGY PHARMACOLOGICAL REVIEWS (ISSN: 00316997) 46: (3) pp. 325415. ( 1994) Z9: 1382 W C: Pharmacology & Pharmacy Folyóiratcikk [12350584]
5
6
* TATRAI A, LEE SK, STERN PH U73122, A P HOSP HOLIP ASEC ANTAGONIST, INHIBITS EFFECTS OF ENDOTHELIN1 AND P ARATHYROID HORMONE ON SIGNALTRANSDUCTION IN UMR106 OSTEOBLASTIC CELLS BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR CELL RESEARCH (ISSN: 01674889) 1224: (3) pp. 575582. ( 1994) Z9: 40 W C: Biochemistry & Molecular Biology; Cell Biology Folyóiratcikk [12350583] GREEN J, SCHOTLAND S, STAUBER DJ, KLEEMAN CR, CLEMENS TL CELLMATRIX INTERACTION IN BONE TYP EI COLLAGEN MODULATES SIGNALTRANSDUCTION IN OSTEOBLASTLIKE CELLS AMERICAN JOURNAL OF PHYSIOLOGYCELL PHYSIOLOGY (ISSN: 03636143) 268: (5) pp. C1090C1103. ( 1995) Z9: 31 W C: Cell Biology; Physiology Folyóiratcikk [12350582]
7
* STERN PH, TATRAI A, SEMLER DE, LEE SH, LAKATOS P, STRIELEMAN PJ, TARJAN G, SANDERS JL ENDOTHELIN RECEP TORS, 2ND MESSENGERS, AND ACTIONS IN BONE JOURNAL OF NUTRITION (ISSN: 00223166) 125: (VIENNA, AUSTRIA) pp. S2028S2032. ( 1995) Z9: 47 SU: S W C: Nutrition & Dietetics Folyóiratcikk [12350581]
8
* SEMLER DE, OHLSTEIN EH, NAMBI P, SLATER C, STERN PH ENDOTHELIN1EVOKED CALCIUM TRANSIENTS IN UMR106 OSTEOBLASTIC OSTEOSARCOMA CELLS ARE MEDIATED THROUGH ENDOTHELINA AND ENDOTHELINB RECEP TORS JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (ISSN: 00223565) 272: (3) pp. 10521058. ( 1995) Z9: 27 W C: Pharmacology & Pharmacy Folyóiratcikk [12350580]
9
* LEE SK, STERN PH ENDOTHELIN(B) RECEP TOR ACTIVATION ENHANCES P ARATHYROID HORMONEINDUCED CALCIUM SIGNALS IN UMR106 CELLS JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 10: (9) pp. 13431351. ( 1995) Z9: 9 W C: Endocrinology & Metabolism Folyóiratcikk [12350579]
10
Perkins SL, Sarraj E, Kling SJ, Kohan DE Endothelin stimulates osteoblastic production of IL6 but not macrophage colonystimulating factor AMERICAN JOURNAL OF PHYSIOLOGYENDOCRINOLOGY AND METABOLISM (ISSN: 01931849) 272: (3) pp. E461 E468. ( 1997) Z9: 11 W C: Endocrinology & Metabolism; Physiology Folyóiratcikk [12350578]
11
Suzuki A, Shinoda J, W atanabeTomita Y, Ozaki N, Oiso Y, Kozawa O ETA receptor mediates the signaling of endothelin1 in osteoblastlike cells BONE (ISSN: 87563282) 21: (2) pp. 143146. ( 1997) Z9: 21 W C: Endocrinology & Metabolism Folyóiratcikk [12350577]
12
Matsuno M, Kozawa O, Suzuki A, Tokuda H, Kaida T, Matsuno H, Niwa M, Uematsu T Involvement of protein kinase C activation in endothelin1induced secretion of interleukin6 in osteoblastlike cells CELLULAR SIGNALLING (ISSN: 08986568) 10: (2) pp. 107111. ( 1998) Z9: 12 W C: Cell Biology Folyóiratcikk [12350576]
13
Mathias RS, Mikoshiba K, Michikawa T, Miyawaki A, Ives HE IP 3 receptor blockade fails to prevent intracellular Ca2+ release by ET1 and alphathrombin AMERICAN JOURNAL OF PHYSIOLOGYCELL PHYSIOLOGY (ISSN: 03636143) 274: (6) pp. C1456C1465. ( 1998) Z9: 13 W C: Cell Biology; Physiology Folyóiratcikk [12350575]
14
Leis HJ, Zach D, Huber E, W indischhofer W P rostaglandin endoperoxide synthase2 contributes to the endothelin/sarafotoxininduced prostaglandin E2 synthesis in mouse osteoblastic cells (MC3T3E1): Evidence for a protein tyrosine kinasesignaling pathway and involvement of protein kinase C ENDOCRINOLOGY (ISSN: 00137227) 139: (3) pp. 12681277. ( 1998) Z9: 11 W C: Endocrinology & Metabolism Folyóiratcikk [12350574]
15
Hierl T, Borcsok I, Sommer U, Ziegler R, Kasperk C Regulation of interleukin6 expression in human osteoblastic cells in vitro EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (ISSN: 09477349) 106: (4) pp. 324333. ( 1998) Z9: 28 W C: Endocrinology & Metabolism Folyóiratcikk [12350573]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
332/342
3/30/2015
nyomtatobarat forma 16
Tokuda H, Kozawa O, Harada A, Uematsu T Extracellular sphingomyelinase induces interleukin6 synthesis in osteoblasts JOURNAL OF CELLULAR BIOCHEMISTRY (ISSN: 07302312) 72: (2) pp. 262268. ( 1999) Z9: 2 W C: Biochemistry & Molecular Biology; Cell Biology Folyóiratcikk [12350572]
17
Kawamura H, Otsuka T, Tokuda H, Matsuno H, Niwa M, Matsui N, Uematsu T, Kozawa O Involvement of p42/p44 MAP kinase in endothelin1induced interleukin6 synthesis in osteoblastlike cells BONE (ISSN: 87563282) 24: (4) pp. 315320. ( 1999) Z9: 16 W C: Endocrinology & Metabolism Folyóiratcikk [12350571]
18
Lam HC, Lee JK, Lai KH Detection and characterization of endothelin in transformed human osteoblast cell culture medium ENDOCRINE (ISSN: 1355008X) 12: (1) pp. 7780. ( 2000) Z9: 5 W C: Endocrinology & Metabolism Folyóiratcikk [12350570]
19 * Semler DE, Morris DL, Stern PH Endothelin stimulated Ca2+ signaling and endothelin receptor expression ave decreased by parathyroid hormone treatment in UMR106 Osteoblastic osteosarcoma cells CELL CALCIUM (ISSN: 01434160) 28: (1) pp. 5564. ( 2000) Z9: 5 W C: Cell Biology Folyóiratcikk [12350569] 20
Kozawa O, Kawamura H, Hatakeyama D, Matsuno H, Uematsu T Endothelin1 induces vascular endothelial growth factor synthesis in osteoblasts Involvement of p38 mitogenactivated protein kinase CELLULAR SIGNALLING (ISSN: 08986568) 12: (6) pp. 375380. ( 2000) Z9: 24 W C: Cell Biology Folyóiratcikk [12350568]
21
Zach D, W indischhofer W , Leis HJ Endothelin and sarafotoxininduced receptormediated calcium mobilization in a clonal murine osteoblastlike cell line, MC3T3E1/B BONE (ISSN: 87563282) 28: (6) pp. 595602. ( 2001) Z9: 5 W C: Endocrinology & Metabolism Folyóiratcikk [12350567]
22
Sodam BR, Awumey EMK, Sampson W H, Epstein S The endothelin receptor antagonist, L754,142 does not prevent cyclosporine Ainduced osteopenia in rats CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 68: (2) pp. 117121. ( 2001) Z9: 2 W C: Endocrinology & Metabolism Folyóiratcikk [12350566]
23
Okafor MC, Delamere NA The inhibitory influence of endothelin on active sodiumpotassium transport in porcine lens INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (ISSN: 01460404) 42: (5) pp. 10181023. ( 2001) Z9: 17 W C: Ophthalmology Folyóiratcikk [12350565]
24
W ang XD, Tokuda H, Hirade K, Kozawa O Stressactivated protein kinase/cjun Nterminal kinase (JNK) plays a part in endothelin1induced vascular endothelial growth factor synthesis in osteoblasts JOURNAL OF CELLULAR BIOCHEMISTRY (ISSN: 07302312) 87: (4) pp. 417423. ( 2002) Z9: 11 W C: Biochemistry & Molecular Biology; Cell Biology Folyóiratcikk [12350564]
25
Okafor MC, Mukhopadhyay P, Delamere NA Studies on endothelin release and Na,K transport in porcine lens INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (ISSN: 01460404) 43: (3) pp. 790796. ( 2002) Z9: 11 W C: Ophthalmology Folyóiratcikk [12350563]
26
W inet H, CaulkinsPennell C, Bao JY A potential role for muscle pumpgenerated intravascular solitons in maintenance of tissueengineered bioreactors implanted in bone In: Chwang AT, Teng MH, Valentine DT (szerk.) : ADVANCES IN ENGINEERING MECHANICS REFLECTIONS AND OUTLOOKS: IN HONOR OF THEODORE YT WU. Singapore, World Scientific Publ.Inc., 2005. (ISBN 9812561447) pp. 493512.
Könyvrészlet /Konferenciaközlemény /Tudományos [12350562]
564. Zséli J , Bősze P , Kollin É , Horváth Cs , Lakatos P , Szűcs J , Szathmári M , László J , Holló I Axialis és appendicularis osteoporosis csíkgonád szindrómában. Foton abszorpciometriás és röntgenmorfometriás vizsgálatok ORVOSI HETILAP 133:(10) pp. 593597. (1992) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1323331] [ Érvényesített ]
1991 565. Lakatos P , Stern P H Evidence for direct nongenomic effects of triiodothyronine on bone rudiments in rats: Stimulation of the inositol phosphate second messenger system ACTA ENDOCRINOLOGICA 125:(5) pp. 603608. (1991) IF: 1.375 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802379] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
333/342
3/30/2015
nyomtatobarat forma
[ Érvényesített ] Független idéző: 14 Függő idéző: 2 Összesen: 16 1
TAKAHASHI N, BREITMAN TR COVALENT MODIFICATION OF P ROTEINS BY LIGANDS OF STEROIDHORMONE RECEP TORS PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (ISSN: 00278424) 89: (22) pp. 1080710811. ( 1992) Folyóiratcikk [12431788]
2
W ARNICK PR, DAVIS PJ, DAVIS FB, CODY V, GALINDO J, BLAS SD RABBIT SKELETALMUSCLE SARCOP LASMICRETICULUM CA2+ATP ASE ACTIVITY STIMULATION INVITRO BY THYROIDHORMONE ANALOGS AND BIP YRIDINES BIOCHIMICA ET BIOPHYSICA ACTA (ISSN: 00063002) 1153: (2) pp. 184190. ( 1993) Folyóiratcikk [12431787]
3
4
5
* LAKATOS P, CAPLICE MD, KHANNA V, STERN PH THYROIDHORMONES INCREASE INSULINLIKE GROWTH FACTORI CONTENT IN THE MEDIUM OF RAT BONE TISSUE JOURNAL OF BONE AND MINERAL RESEARCH (ISSN: 08840431) 8: (12) pp. 14751481. ( 1993) Folyóiratcikk [12431786] VARGA F, RUMPLER M, KLAUSHOFER K THYROIDHORMONES INCREASE INSULINLIKE GROWTHFACTOR MESSENGERRNA LEVELS IN THE CLONAL OSTEOBLASTIC CELLLINE MC3T3E1 FEBS LETTERS (ISSN: 00145793) 345: (1) pp. 6770. ( 1994) Folyóiratcikk [12431785] * TATRAI A, LEE SK, STERN PH U73122, A P HOSP HOLIP ASEC ANTAGONIST, INHIBITS EFFECTS OF ENDOTHELIN1 AND P ARATHYROID HORMONE ON SIGNALTRANSDUCTION IN UMR106 OSTEOBLASTIC CELLS BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR CELL RESEARCH (ISSN: 01674889) 1224: (3) pp. 575582. ( 1994) Folyóiratcikk [12431784]
6
KLAUSHOFER K, VARGA F, GLANTSCHNIG H, FRATZLZELMAN N, CZERW ENKA E, LEIS HJ, KOLLER K, PETERLIK M THE REGULATORY ROLE OF THYROIDHORMONES IN BONE CELLGROWTH AND DIFFERENTIATION JOURNAL OF NUTRITION (ISSN: 00223166) 125: (VIENNA, AUSTRIA) pp. S1996S2003. ( 1995) SU S Folyóiratcikk [12431783]
7
Luegmayr E, Varga F, Frank T, Roschger P, Klaushofer K Effects of triiodothyronine on morphology, growth behavior, and the actin cytoskeleton in mouse osteoblastic cells (MC3T3 E1) BONE (ISSN: 87563282) 18: (6) pp. 591599. ( 1996) Folyóiratcikk [12431782]
8
Rouayrenc JF, Vignon F, Bringer J, Pujol P Nongenomic steroid effects: estrogen action revisited ANNALES D ENDOCRINOLOGIE (ISSN: 00034266) 61: (6) pp. 517523. ( 2000) Folyóiratcikk [12431781]
9
Hulbert AJ Thyroid hormones and their effects: a new perspective BIOLOGICAL REVIEWS (ISSN: 14647931) 75: (4) pp. 519631. ( 2000) Folyóiratcikk [12431780]
10
Pietras RJ, Nemere I, Szego CM Steroid hormone receptors in target cell membranes ENDOCRINE (ISSN: 1355008X) 14: (3) pp. 417427. ( 2001) Folyóiratcikk [12431779]
11
Harvey CB, O'Shea PJ, Scott AJ, Robson H, Siebler T, Shalet SM, Smarut J, Chassande O, W illiams GR Molecular mechanisms of thyroid hormone effects on bone growth and function MOLECULAR GENETICS AND METABOLISM (ISSN: 10967192) 75: (1) pp. 1730. ( 2002) Folyóiratcikk [12431778]
12
Bassett JHD, Harvey CB, W illiams GR Mechanisms of thyroid hormone receptorspecific nuclear and extra nuclear actions MOLECULAR AND CELLULAR ENDOCRINOLOGY (ISSN: 03037207) 213: (BLAUBEUREN ULM, GERMANY) pp. 111. ( 2003) Folyóiratcikk [12431777]
13
Fujikawa M, Kamihira K, Sato K, Okamura K, Kidota S, Lida M Elevated bone resorption markers in a patient with hypercalcemia associated with postpartum thyrotoxicosis and hypoadrenocorticism due to pituitary failure JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (ISSN: 03914097) 27: (8) pp. 782787. ( 2004) Folyóiratcikk [12431776]
14
Kong W M, Martin NM, Smith KL, Gardiner JV, Connoley IP, Stephens DA, Dhillo W S, Ghatei MA, Small CJ, Bloom SR Triiodothyronine stimulates food intake via the hypothalamic ventromedial nucleus independent of changes in energy expenditure ENDOCRINOLOGY (ISSN: 00137227) 145: (11) pp. 52525258. ( 2004) Folyóiratcikk [12431775]
15
Scarlett A, Parsons MP, Hanson PL, Sidhu KK, Milligan TP, Burrin JM Thyroid hormone stimulation of extracellular signalregulated kinase and cell proliferation in human osteoblastlike cells is initiated at integrin alpha(V)beta(3) JOURNAL OF ENDOCRINOLOGY (ISSN: 00220795) 196: (3) pp. 509517. ( 2008) Folyóiratcikk [12431774]
16
Zhang LQ, CooperKuhn CM, Nannmark U, Blomgren K, Kuhn HG Stimulatory effects of thyroid hormone on brain angiogenesis in vivo and in vitro JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (ISSN: 0271678X) 30: (2) pp. 323335. ( 2010) Folyóiratcikk [12431773]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
334/342
3/30/2015
nyomtatobarat forma
566. Lakatos P , Krasznai I Experience with the Novo DPA scanner CALCIFIED TISSUE INTERNATIONAL 49:(4) pp. 298299. (1991) Nyelv: Angol
Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [1802380] [ Érvényesített ] 567. Lakatos P , M ong S , Stern P H Gallium nitrate inhibits bone resorption and collagen synthesis in neonatal mouse calvariae JOURNAL OF BONE AND MINERAL RESEARCH 6:(10) pp. 11211126. (1991) IF: 5.365 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802381] M anufacturers: fujisawa pharmaceutical, Japan; bachem, United States; collaborative research, United States; hoffmann la roche; sigma [ Érvényesített ] Független idéző: 8 Függő idéző: 2 Összesen: 10 1
* LAKATOS P, TATRAI A, STERN PH EFFECTS OF GALLIUM NITRATE ON CALCIUM TRANSIENTS IN UMR106 RAT OSTEOBLASTIC OSTEOSARCOMA CELLS BONE (ISSN: 87563282) 13: (5) pp. 379386. ( 1992) Folyóiratcikk [12432219]
2
BLAIR HC, TEITELBAUM SL, TAN HL, SCHLESINGER PH REVERSIBLE INHIBITION OF OSTEOCLASTIC ACTIVITY BY BONEBOUND GALLIUM(III) JOURNAL OF CELLULAR BIOCHEMISTRY (ISSN: 07302312) 48: (4) pp. 401410. ( 1992) Folyóiratcikk [12432218]
3
SOHN MH, JONES BJ, W HITING JH, DATZ FL, LYNCH RE, MORTON KA DISTRIBUTION OF GA67 IN NORMAL AND HYP OTRANSFERRINEMIC TUMORBEARING MICE JOURNAL OF NUCLEAR MEDICINE (ISSN: 01615505) 34: (12) pp. 21352143. ( 1993) Folyóiratcikk [12432217]
4
JENIS LG, W AUD CE, STEIN GS, LIAN JB, BARAN DT EFFECT OF GALLIUM NITRATE INVITRO AND IN NORMAL RATS JOURNAL OF CELLULAR BIOCHEMISTRY (ISSN: 07302312) 52: (3) pp. 330336. ( 1993) Folyóiratcikk [12432216]
5
BOCKMAN RS, GUIDON PT, PAN LC, SALVATORI R, KAW AGUCHI A GALLIUM NITRATE INCREASES TYP EI COLLAGEN AND FIBRONECTIN MESSENGERRNA AND COLLAGEN P ROTEINLEVELS IN BONE AND FIBROBLAST CELLS JOURNAL OF CELLULAR BIOCHEMISTRY (ISSN: 07302312) 52: (4) pp. 396403. ( 1993) Folyóiratcikk [12432215]
6
MONTUORI E, LLORET AP OSTEOP OROSIS DETECTION, P REVENTION, TREATMENT MEDICINABUENOS AIRES (ISSN: 00257680) 53: (1) pp. 6576. ( 1993) Folyóiratcikk [12432214]
7
DONNELLY R, BOCKMAN R, DICARLO E, BETTS F, BOSKEY A THE EFFECT OF GALLIUM NITRATE ON HEALING OF VITAMINDDEFICIENT AND P HOSP HATEDEFICIENT RICKETS IN THE IMMATURE RAT CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 53: (6) pp. 400410. ( 1993) Folyóiratcikk [12432213]
8
STERN LS, MATKOVIC V, W EISBRODE SE, APSELOFF G, SHEPARD DR, MAYS DC, GERBER N THE EFFECTS OF GALLIUM NITRATE ON OSTEOP ENIA INDUCED BY OVARIECTOMY AND A LOWCALCIUM DIET IN RATS BONE AND MINERAL (ISSN: 01696009) 25: (1) pp. 5969. ( 1994) Folyóiratcikk [12432212]
9
10
* LIN JR, BEKERSKY I, BROW N NS, MONG S, LEE F, NEW MAN RA, HO DH NORMOCALCEMIC EFFECT OF GALLIUM NITRATE IN A HYP ERCALCEMIC RAT MODEL CANCER RESEARCH (ISSN: 00085472) 55: (2) pp. 307311. ( 1995) Folyóiratcikk [12432211] Gruber HE, Norton HJ, Singer FR In vivo morphologic changes in the rat osteoclast induced by gallium nitrate: The result of toxicity or other effects? MINERAL AND ELECTROLYTE METABOLISM (ISSN: 03780392) 25: (3) pp. 127134. ( 1999) Folyóiratcikk [12432210]
568. Szalay F , Lakatos P , Nemeth J , Abonyi M , Buki B , Tarjan G , Hollo I Osteocalcin szérum szint csökkenése nemalkoholos és alkoholos idült májbetegekben ORVOSI HETILAP 132:(24) pp. 13011305. (1991) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1690357] [ Érvényesített ] Független idéző: 4 Összesen: 4 1
Aller R, Castrillon J L P, de Luis D A, Conde R, Izaola O, Sagrado M G, Velasco M C, Alvarez T, Pacheco D Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease ANNALS OF HEPATOLOGY OFFICIAL JOURNAL OF THE MEXICAN ASSOCIATION OF HEPATOLOGY (ISSN: 16652681) 10: (1) pp. 5055. ( 2011)
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
335/342
3/30/2015
nyomtatobarat forma Chemicals/CAS: cholesterol, 57885; glucose, 50997, 84778643; insulin, 9004108; osteocalcin, 136461808; Biological Markers; Osteocalcin, 104982038 Folyóiratcikk /Szakcikk /Tudományos [11969108] 2
Yilmaz Y, Kurt R, Eren F, Imeryuz N Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: Association with ballooning degeneration SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (ISSN: 00365513) 71: (8) pp. 631636. ( 2011) Chemicals/CAS: aprotinin, 11004210, 12407793, 50936635, 52229706, 58591290, 9050742, 9075109, 9087701; osteocalcin, 136461808 Folyóiratcikk /Szakcikk /Tudományos [11969107]
3
Yilmaz Y Review article: Nonalcoholic fatty liver disease and osteoporosis Clinical and molecular crosstalk ALIMENTARY PHARMACOLOGY & THERAPEUTICS (ISSN: 02692813) 36: (4) pp. 345352. ( 2012) Folyóiratcikk /Összefoglaló cikk /Tudományos [13701130]
4
Sharma R Biochemical Mechanisms of Fatty Liver and Bioactive Foods: Fatty Liver, Diagnosis, Nutrition Therapy In: Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease. Elsevier Inc., 2013. (ISBN 9780123971548) pp. 623655. (Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease)
Könyvrészlet /Könyvfejezet /Tudományos [13701129]
569. Tarjan G , Lakatos P Calcitonin and bone mass status in congenital hypothyroidism [1] CALCIFIED TISSUE INTERNATIONAL 49:(3) p. 226. (1991) Nyelv: Angol
Folyóiratcikk /Hozzászólás, helyreigazítás /Tudományos [1802382] [ Érvényesített ] 570. Zseli J , Bosze P , Lakatos P , Vargha P , Tarjan G , Kollin E , Horvath C , Laszlo J , Hollo I Serum bone GLA protein in streak gonad syndrome CALCIFIED TISSUE INTERNATIONAL 48:(6) pp. 387391. (1991) IF: 2.602 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802383] [ Érvényesített ] Független idéző: 3 Összesen: 3 1
TAKEUCHI H, NAKAGAW A Y, IGARASHI Y STUDIES ON GENEEXP RESSION IN CALVARIA AND SERUM LEVELS OF INSULINLIKE GROWTH FACTORI AND BONE GLA P ROTEIN IN THE METHIMAZOLEINDUCED CONGENITAL HYP OTHYROID RAT ENDOCRINE JOURNAL (ISSN: 09188959) 40: (3) pp. 351362. ( 1993) Folyóiratcikk [12433052]
2
Moura MD, Navarro PAAS, de Sa MFS, Ferriani RA, Unzer SM, Reis RM Hypogonadotropic hypogonadism: retrospective analysis of 19 cases INTERNATIONAL JOURNAL OF GYNECOLOGY AND OBSTETRICS (ISSN: 00207292) 71: (2) pp. 141145. ( 2000) Folyóiratcikk [12433051]
3
Gallicchio CT, FigueiredoAlves ST, Tortora RP, Mendonca LM, Farias MLF, Guimaraes MM Effect of puberty on the relationship between bone markers of turnover and bone mineral density in Turner's syndrome HORMONE RESEARCH (ISSN: 03010163) 61: (4) pp. 193199. ( 2004) Folyóiratcikk [12433050]
1990 571. Földes J , Vana S , Bános C , Lakatos P , Tarján G The measurement of the serum sexhormone binding globulin in various thyroid diseases. ACTA MEDICA HUNGARICA 47:(12) pp. 8190. (1990) IF: 0.090 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802295] [ Érvényesített ] 572. Földes J , Bános C , Lakatos P , Tarján G Szérum "sexhormone binding globulin" tartalom vizsgálata pajzsmirigybetegségekben ORVOSI HETILAP 131:(29) pp. 15791582. (1990) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1802296] [ Érvényesített ] 573. Lakatos P , Tarján G , Vargha P Egészséges nők és férfiak szérum osteocalcin értékei az életkor függvényében ORVOSI HETILAP 131:(16) pp. 853857. (1990) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1802297] [ Érvényesített ] 574. Szalay F , Lakatos P , Németh J , Abonyi M , Büki B , Tarján G , Holló I https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
336/342
3/30/2015
nyomtatobarat forma
Decreased osteocalcin level in nonalcoholic and alcohol liver diseases JOURNAL OF HEPATOLOGY SUPPLEMENT 11:(2) p. 234. (1990) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1697757] [ Admin láttamozott ]
1989 575. Földes J , Váradi G , Lakatos P , Bános C , Tarján G Pajzsmirigyműködés súlyos nempajzsmirigy eredetű betegségekben ORVOSI HETILAP 130:(45) pp. 24152418. (1989) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1802299] [ Érvényesített ] 576. Földes J , Váradi G , Lakatos P , Bános C , Tarján G Thyroid function in severe "nonthyroidal illness". Longitudinal studies in haematological patients. ACTA MEDICA HUNGARICA 46:(23) pp. 133142. (1989) IF: 0.016 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802300] [ Érvényesített ] 577. Földes J , Lakatos P , Tarján G , Krasznai I , Holló I Effect of thyroid hormone treatment on bone mineral content in patients with hypothyroidism and euthyroid benign adenoma In: Pickardt CR , Pfannenstiel P , Weinheimer B (szerk.) Schilddrüse 1987 . Stuttgart; New York: Georg Thieme Verlag, 1989. pp. 294297. Nyelv: Angol
Könyvrészlet /Könyvfejezet /Tudományos [1831045] [ Admin láttamozott ] 578. Gyertyánfy G , Lakatos P Hazai gyártmányú 125 Itheophyllin készlet klinikai vizsgálata IZOTÓPTECHNIKA 32:(3) pp. 160167. (1989) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1974344] [ Érvényesített ] 579. Lakatos P , Tarján G , M érei J , Földes J , Holló I Androgens and bone mineral content in patients with subtotal thyroidectomy for benign nodular disease. ACTA MEDICA HUNGARICA 46:(4) pp. 297305. (1989) IF: 0.016 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802298] [ Érvényesített ] 580. Lakatos P , Krasznai I , Vargha P , Gergely I , Holló I Changes with aging in the bone mineral content of the lumbar spine and femoral neck in healthy women in Hungary. ACTA MEDICA HUNGARICA 46:(1) pp. 7383. (1989) IF: 0.016 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802301] [ Érvényesített ] 581. Lakatos P , Tarján G , Korányi L Radioimmunoassay a szérum osteocalcin szintjének mérésére IZOTÓPTECHNIKA 32:(1) pp. 3137. (1989) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1808491] [ Érvényesített ] 582. Szalay F , Lakatos P , Németh J , Abonyi M , Büki B , Tarján G , Holló I Decreased serum osteocalcin level in patients with alcoholic and nonalcoholic chronic liver disease JOURNAL OF HEPATOLOGY SUPPLEMENT 9:(1) p. 233. (1989) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1697740] [ Admin láttamozott ] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
337/342
3/30/2015
nyomtatobarat forma
1988 583. Földes J , Váradi G , Lakatos P , Bános C , Tarján G Thyroid function in "nonthyroidalillness". Longitudinal study in patients with hematological diseases. ACTA MEDICA AUSTRIACA 15:(Suppl 1) pp. 4547. (1988) Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802302] [ Admin láttamozott ] 584. Krasznai I , Lakatos P , Horváth C , Holló I A csont ásványianyagtartalmának nyomonkövetése monokromatikus és kettős sugárzás elnyelésén (SPAn, illetve DPAn) alapuló módszerrel IZOTÓPTECHNIKA 31:(4) pp. 259269. (1988) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1808486] [ Érvényesített ] 585. Lakatos P , Tarján G Osteocalcin. M i a szérum osteocalcin mérésének módszere és jelentősége? MAGYAR BELORVOSI ARCHIVUM 41: pp. 305306. (1988) Nyelv: Magyar
Folyóiratcikk /Rövid közlemény /Tudományos [1808501] [ Admin láttamozott ]
1987 586. Foldes J , Tarjan G , Csillag J , Lakatos P Diagnostic value of a sensitive TSH method in thyroid diseases RADIOLOGIA DIAGNOSTICA 28:(6) pp. 813816. (1987) Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802303] [ Érvényesített ] 587. Földes J , Bános C , Csillag J , Lakatos P , Tarján G Examination of serum thyrotropic hormone level by 'supersensitive' immunoradiometric assay in functioning thyroid adenoma. ACTA MEDICA HUNGARICA 44:(4) pp. 329336. (1987) IF: 0.033 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802304] [ Érvényesített ] 588. Földes J , Bános C , Csillag J , Lakatos P , Tarján G Szérum thyreotrophormon tartalom vizsgálata "supersensitiv" immunradiometria assay segítségével funkcionáló pajzsmirigy adenomában ORVOSI HETILAP 128:(10) pp. 503506. (1987) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1802306] [ Érvényesített ] 589. Földes J , Csillag J , Lakatos P , Tarján G Serum TSH determination by IRM AmatTSH assay in patients with functioning thyroid nodules In: Leb G , Passath A , Eber O , Höfer H (szerk.) Thyrothropin . Berlin; New York: Walter de Gruyter, 1987. pp. 285287. Nyelv: Angol
Könyvrészlet /Könyvfejezet /Tudományos [1830999] [ Admin láttamozott ] 590. Földes János , De Chatel R , Bános Csaba , Lakatos Péter , Tarján Gábor Vizelet 6ketoprostaglandin F1 (6ketoPGF) tartalma és annak összefüggése a plazma renin aktivitással hyperthyreosisban ORVOSI HETILAP 128:(31) pp. 16151619. (1987) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1684441] [ Érvényesített ]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
338/342
3/30/2015
nyomtatobarat forma
591. Krasznai I , Lakatos P , Horváth Cs , Holló I Precision of estimation of bone mineral content (BM C) by single and dual photon absorptiometry in longitudinal studies NUCLEAR MEDICINE ANNUAL 26: pp. 212213. (1987) Nyelv: Angol
Folyóiratcikk /Rövid közlemény /Tudományos [1778888] [ Admin láttamozott ] 592. Lakatos P , Krasznai I , Vargha P , Gergely I , Holló I A lumbális csigolyák és a combnyak ásványianyagtartalma egészséges magyar női populációban az életkor függvényében ORVOSI HETILAP 128:(39) pp. 20492056. (1987) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1802305] [ Érvényesített ] 593. Lakatos P , Tarján G , Földes J , Krasznai I , Holló I The effect of thyroid hormone treatment on bone mineral content in patients with hypothyroidism and euthyroid benign adenoma In: Christiansen C , Johansen JS , Riis BJ (szerk.) Osteoporosis 1987 . Copenhagen: Osteopress Aps, 1987. pp. 452453. Nyelv: Angol
Könyvrészlet /Könyvfejezet /Tudományos [1831017] [ Admin láttamozott ]
1986 594. Barsony J , Lakatos P , Foldes J , Feher T Effect of vitamin D3 loading and thyroid hormone replacement therapy on the decreased serum 25hydroxyvitamin D level in patients with hypothyroidism ACTA ENDOCRINOLOGICA 113:(3) pp. 329334. (1986) IF: 1.591 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802308] Tradenames: thyranon M anufacturers: chinoin, Hungary; amersham; organon [ Érvényesített ] 595. Bársony J , Lakatos P , Földes J , Fehér T D3vitamin terhelés és thyroxin kezelés hatása hypothyreosisos betegek alacsony szérum 25hidroxiD3vitamin szintjére ORVOSI HETILAP 127:(5) pp. 255259. (1986) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1802311] [ Admin láttamozott ] 596. Földes J , Bános C , Lakatos P , Váradi A , Gara A , Istvánffy M Serum"free"thyroxine and triiodothyronine levels: their significance in preclinical hyperthyroidism and subclinical hypothyroidism. ACTA MEDICA HUNGARICA 43:(4) pp. 373380. (1986) IF: 0.089 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802307] [ Érvényesített ] Független idéző: 5 Összesen: 5 1
SCHLOTE B, SCHAAF L, SCHMIDT R, POHL T, VARDARLI I, SCHIEBELER H, ZOBER MA, USADEL KH MENTAL AND P HYSICAL STATE IN SUBCLINICAL HYP ERTHYROIDISM INVESTIGATIONS IN A NORMAL WORKING P OP ULATION BIOLOGICAL PSYCHIATRY (ISSN: 00063223) 32: (1) pp. 4856. ( 1992) Folyóiratcikk [12432545]
2
SCHLOTE B, NOW OTNY B, SCHAAF L, KLEINBOHL D, SCHMIDT R, TEUBER J, PASCHKE R, VARDARLI I, KAUMEIER S, USADEL KH SUBCLINICAL HYP ERTHYROIDISM P HYSICAL AND MENTAL STATE OF P ATIENTS EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (ISSN: 09401334) 241: (6) pp. 357364. ( 1992) Folyóiratcikk [12432544]
3
Arem R, Escalante D Subclinical hypothyroidism: Epidemiology, diagnosis, and significance ADVANCES IN INTERNAL MEDICINE (ISSN: 00652822) 41: pp. 213250. ( 1996) Folyóiratcikk [12432543]
4
Sher L, Rosenthal NE, W ehr TA
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
339/342
3/30/2015
nyomtatobarat forma Free thyroxine and thyroidstimulating hormone levels in patients with seasonal affective disorder and matched controls JOURNAL OF AFFECTIVE DISORDERS (ISSN: 01650327) 56: (23) pp. 195199. ( 1999) Folyóiratcikk [12432542] 5
Sher L Role of thyroid hormones in the effects of selenium on mood, behavior, and cognitive function MEDICAL HYPOTHESES (ISSN: 03069877) 57: (4) pp. 480483. ( 2001) Folyóiratcikk [12432541]
597. Földes J , Bános C , Lakatos P , Váradi A , Gara A , Istvánffy M A szérum "szabad"thyroxin és trijódthyronin tartalom meghatározásának jelentősége praeklinikus hyperthyreosisban és subklinikus hypothyreosisban ORVOSI HETILAP 127:(22) pp. 13151319. (1986) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1802309] [ Admin láttamozott ] 598. Földes J , Istvánffy M , Halmágyi M , Váradi A , Lakatos P , Pártos O Hyperthyroidism and the heart: study of left ventricular function in preclinical hyperthyroidism. ACTA MEDICA HUNGARICA 43:(1) pp. 2329. (1986) IF: 0.089 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802312] [ Érvényesített ] 599. Földes J , Bános Cs , Istvánffy M , Lakatos P Diagnostic value of freethyroid hormone determinations in preclinical hyperthyroidism and subclinical hypothyroidism In: Pfannenstiel P , Emrich D , Weinheimer B (szerk.) Schilddrüse 1985 . Stuttgart; New York: Georg Thieme Verlag, 1986. p. 339. Nyelv: Angol
Könyvrészlet /Könyvfejezet /Tudományos [1830973] [ Admin láttamozott ] 600. Lakatos P , Holló I , Horváth Cs Severe postmenopausal osteoporosis and thyroid hormones ARCHIVES OF INTERNAL MEDICINE 146:(9) p. 1859. (1986) IF: 2.034 Nyelv: Angol
Folyóiratcikk /Rövid közlemény /Tudományos [1778870] [ Érvényesített ] Független idéző: 4 Függő idéző: 2 Összesen: 6 1 * LAKATOS P, STERN PH EFFECTS OF CYCLOSP ORINS AND TRANSFORMING GROWTHFACTOR BETA1 ON THYROIDHORMONE ACTION IN CULTURED FETALRAT LIMB BONES CALCIFIED TISSUE INTERNATIONAL (ISSN: 0171967X) 50: (2) pp. 123128. ( 1992) Folyóiratcikk /Szakcikk /Tudományos [12356563] 2 * FOLDES J, TARJAN G, SZATHMARI M, VARGA F, KRASZNAI I, HORVATH C BONEMINERAL DENSITY IN P ATIENTS WITH ENDOGENOUS SUBCLINICAL HYP ERTHYROIDISM IS THIS THYROID STATUS A RISK FACTOR FOR OSTEOP OROSIS CLINICAL ENDOCRINOLOGY (ISSN: 03000664) 39: (5) pp. 521527. ( 1993) Folyóiratcikk /Szakcikk /Tudományos [12356562] 3
Gurlek A, Gedik O Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women THYROID (ISSN: 10507256) 9: (6) pp. 539543. ( 1999) Folyóiratcikk /Szakcikk /Tudományos [12356561]
4
Stathatos N, W artofsky L Effects of thyroid hormone on bone CLIN REV BONE MINER METABOL (ISSN: 15348644) 2: (2) pp. 135150. ( 2004) Folyóiratcikk /Összefoglaló cikk /Tudományos [14617173]
5
Stern PH Thyroid Hormone and Bone In: Principles of Bone Biology , TwoVolume Set. Elsevier Inc., 2008. (ISBN 9780123738844) pp. 935954.
Könyvrészlet /Könyvfejezet /Tudományos [14617172] 6
Stern Paula H Thyroid and Thyroid Hormone: Normal Function, Diseases, Disorders, Emerging Therapeutics In: Bronner Felix, FarachCarson Mary C, Roach Helmtrud I (szerk.) : BoneMetabolic Functions and Modulators. Springer London, 2012. (ISBN 978 1447127444) pp. 6986. (Topics in Bone Biology )
Könyvrészlet /Könyvfejezet /Tudományos [14617177]
601. Lakatos P , Földes J , Bános C Pajzsmirigyhormonokkal szembeni generalizált szöveti rezisztencia esete ORVOSI HETILAP 127:(10) pp. 583586. (1986) https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
340/342
3/30/2015
nyomtatobarat forma
Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1802310] [ Érvényesített ] 602. SZALAY F , KOLLIN E , BUKI B , ABONYI M , FEHER T , HORVATH C , LAKATOS P , HOLLO I M ETABOLIC BONEDISEASE IN PRIM ARY BILIARYCIRRHOSIS DIGESTIVE DISEASES AND SCIENCES 31:(10 Suppl) p. S369. (1986) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1856750] [ Érvényesített ] 603. Szalay F , Kollin É , Büki B , Abonyi M , Horváth Cs , Lakatos P Hepatic osteodystrophy in chronic alcoholic liver disease JOURNAL OF HEPATOLOGY 3:(Suppl. 1) p. S81. (1986) Nyelv: Angol
Folyóiratcikk /Absztrakt /Tudományos [1880374] [ Érvényesített ]
1985 604. Foldes J , Banos C , Lakatos P , Tako J Effect of domperidone on serum TSH and growth hormone in thyroid patients ACTA MEDICA HUNGARICA 42:(34) pp. 133143. (1985) IF: 0.094 Nyelv: Angol
Folyóiratcikk /Szakcikk /Tudományos [1802313] Tradenames: motilium M anufacturers: chimimport, Hungary; egyt, Hungary; gedeon richter, Hungary [ Érvényesített ] Független idéző: 4 Összesen: 4 1
Arem R, Escalante D Subclinical hypothyroidism: Epidemiology, diagnosis, and significance ADVANCES IN INTERNAL MEDICINE (ISSN: 00652822) 41: pp. 213250. ( 1996) Folyóiratcikk [12432556]
2
Selim MH Neurologic aspects of thyroid disease NEUROLOGIST (ISSN: 10747931) 7: (3) pp. 135146. ( 2001) Folyóiratcikk [12432555]
3
Okun MS, W atts RL Depression associated with P arkinson's disease Clinical features and treatment NEUROLOGY (ISSN: 00283878) 58: (4) pp. S63S70. ( 2002) SU 1 Folyóiratcikk [12432554]
4
Reddymasu SC, Soykan I, McCallum RW Domperidone: Review of pharmacology and clinical applications in gastroenterology AMERICAN JOURNAL OF GASTROENTEROLOGY (ISSN: 00029270) 102: (9) pp. 20362045. ( 2007) Folyóiratcikk [12432553]
1984 605. Földes J , Bános Cs , de Chatel R , Lakatos P , Gyertyánfy G Vizelet 6ketoprosztaglandin F1alfa ürítés vizsgálata endokrin és nemendokrin belgyógyászati betegségekben MAGYAR BELORVOSI ARCHIVUM 37:(suppl 5) p. 117. (1984) Nyelv: Magyar
Folyóiratcikk /Absztrakt /Tudományos [1696566] [ Admin láttamozott ] 606. Földes J , Bános C , Lakatos P , Tako J Dopamin receptor blokkoló (domperidon) hatása a szérum TSH és növekedésihormon tartalmára pajzsmirigy betegeken ORVOSI HETILAP 125:(51) pp. 30953101. (1984) Nyelv: Magyar
Folyóiratcikk /Szakcikk /Tudományos [1778939] [ Admin láttamozott ]
1982 607. Adorján J , Kiss L , Lakatos P Szexualitásról sorkatonáknak. (Sexual life of soldiers) Budapest: Zrínyi Katonai Kiadó, 1982. Nyelv: Magyar
Könyv /Szakkönyv /Ismeretterjesztő [1830939] https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
341/342
3/30/2015
nyomtatobarat forma
[ Admin láttamozott ]
https://vm.mtmt.hu/search/download.php?type=3&lang=0&flag=533211&orderby=3D1a&dtitle=+Lakatos+P%C3%A9ter+%28Osteol%C3%B3gia%2C+…
342/342